Citrus Sinensis ID: 008759
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 554 | 2.2.26 [Sep-21-2011] | |||||||
| Q39008 | 608 | Mitogen-activated protein | yes | no | 0.936 | 0.853 | 0.527 | 1e-133 | |
| Q9SZ67 | 1895 | Probable WRKY transcripti | no | no | 0.537 | 0.157 | 0.553 | 1e-85 | |
| O22040 | 666 | Mitogen-activated protein | no | no | 0.380 | 0.316 | 0.446 | 4e-48 | |
| Q9FZ36 | 651 | Mitogen-activated protein | no | no | 0.373 | 0.317 | 0.447 | 6e-48 | |
| Q61083 | 619 | Mitogen-activated protein | yes | no | 0.425 | 0.381 | 0.430 | 1e-47 | |
| E9Q3S4 | 1311 | Mitogen-activated protein | no | no | 0.375 | 0.158 | 0.45 | 5e-47 | |
| Q9Y2U5 | 619 | Mitogen-activated protein | yes | no | 0.429 | 0.384 | 0.437 | 1e-46 | |
| Q54R82 | 942 | Mitogen-activated protein | no | no | 0.371 | 0.218 | 0.443 | 3e-46 | |
| Q61084 | 626 | Mitogen-activated protein | no | no | 0.373 | 0.330 | 0.463 | 4e-46 | |
| Q99759 | 626 | Mitogen-activated protein | no | no | 0.373 | 0.330 | 0.463 | 5e-46 |
| >sp|Q39008|M3K1_ARATH Mitogen-activated protein kinase kinase kinase 1 OS=Arabidopsis thaliana GN=MEKK1 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 477 bits (1228), Expect = e-133, Method: Compositional matrix adjust.
Identities = 293/555 (52%), Positives = 366/555 (65%), Gaps = 36/555 (6%)
Query: 6 RFLSPREKSAGKAAMDPRKMRQKPRLERRNAAKHIEYDVASTSSSL--DDSSSSSSLITR 63
R L+ +KS G+ D + + RLERR+AA++I YD AS SSS D S S+SSL+TR
Sbjct: 3 RILARMKKSTGRRGGD-KNITPVRRLERRDAARNINYDAASCSSSSAEDLSVSTSSLMTR 61
Query: 64 SLDLSDRTSFRIEGVEGEFERICRSLGLSGPEDFAIPAAAWEARKNRSASDLLPRSRLKQ 123
SL+ + TSFRI G GE +RI RSLG+SGP+D AI AWEA K RS+SD++ R +
Sbjct: 62 SLEFPEPTSFRIGGGVGEMDRIYRSLGVSGPDDLAISFDAWEACKKRSSSDVVNRFKSFD 121
Query: 124 LDTLKETVERQSDAAGAVVGELCDRVSDIVRIRNETEL-----TRTKLTQVAELSC---R 175
LD +++ + +G VVG D ++ V+ ++ +E T+L+++ L R
Sbjct: 122 LDKVRDQDLSEEGPSGVVVGS--DSMNHKVQGQDLSEAGPSGGIVTELSEIGNLITPVDR 179
Query: 176 ASGAGNNDALAVMETTELPPSGLAESSACCVSSNYVKG-------IKGVRPPLLKPPPGM 228
G + VME T + +S V +N V IKG+RPP+LKPPP M
Sbjct: 180 LVADGVVENRRVMERTPT----IVKSKGYLVPNNVVAVGVGVGGGIKGLRPPVLKPPPAM 235
Query: 229 RQPVIDNACSTWDILRDFAPKDGI---TPSSVMNDRALSSSSDDEDNEKEGEEADRAIVK 285
++P ID+ S+WD L FAP + + + SS ++ E+ + E R I
Sbjct: 236 KRPPIDHRGSSWDFLTHFAPSETVKRPSSSSSSSEDGCDEEEGKEEEAEAEEMGARFIQL 295
Query: 286 EEEDDMVLSESCSFTTEHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSV 345
+ D E+CSFTT +E DSSST + S I P+G IIT WQKG LLGRGSFGSV
Sbjct: 296 GDTAD----ETCSFTT-NEGDSSSTVSN-TSPIYPDG--GAIITSWQKGQLLGRGSFGSV 347
Query: 346 YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL 405
YEGIS DG FFAVKEVSLLDQGSQA++ I QLE EI LLS+ +H+NIV+Y GT KD S L
Sbjct: 348 YEGISGDGDFFAVKEVSLLDQGSQAQECIQQLEGEIKLLSQLQHQNIVRYRGTAKDGSNL 407
Query: 406 YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN 465
YIFLELVT+GSLL LYQRY LRDS VS YTRQIL GLKYLHD+ +HRDIKCANILVDAN
Sbjct: 408 YIFLELVTQGSLLKLYQRYQLRDSVVSLYTRQILDGLKYLHDKGFIHRDIKCANILVDAN 467
Query: 466 GSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNK-GYGLPADIWSLGCTVLEMLT 524
G+VKLADFGLAK +K ND+KSC+GT FWMAPEVIN K+ GYG PADIWSLGCTVLEM T
Sbjct: 468 GAVKLADFGLAKVSKFNDIKSCKGTPFWMAPEVINRKDSDGYGSPADIWSLGCTVLEMCT 527
Query: 525 SQIPYAPMECVSAIF 539
QIPY+ +E V A+F
Sbjct: 528 GQIPYSDLEPVQALF 542
|
Involved in the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6) downstream of bacterial flagellin receptor FLS2. May be involved in the cold and salinity stress-mediated MAP kinase signaling cascade (MEKK1, MEK1/MKK2 and MPK4/MPK6). Activates downstream MKK2, MKK4 and MKK5. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 5 |
| >sp|Q9SZ67|WRK19_ARATH Probable WRKY transcription factor 19 OS=Arabidopsis thaliana GN=WRKY19 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 317 bits (812), Expect = 1e-85, Method: Compositional matrix adjust.
Identities = 185/334 (55%), Positives = 218/334 (65%), Gaps = 36/334 (10%)
Query: 214 IKGVRPPLLKPPPGMRQPVIDNACSTWDILRDFAPKDGITPSSVMNDRALSSSSDDEDNE 273
IKG+RPP+L+ P M+ I STWD + FAP + + P S ++ +E
Sbjct: 1527 IKGLRPPVLQLQPAMKLSHIPRG-STWDFVTHFAPPETVAPPSSSSEAREEEVETEETGA 1585
Query: 274 KEGEEADRAIVKEEEDDMVLSESCSFTTEHEDDSSSTTTEPMSNISP----NGRFKRIIT 329
D+ E+CSFT ++ DSS T +SN SP G F IT
Sbjct: 1586 MFIPLGDK-------------ETCSFTV-NKGDSSRT----ISNTSPIYASEGSF---IT 1624
Query: 330 YWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
WQKG LLGRGS GSVYEGIS DG FFA KEVSLLDQGSQA + I Q+E IALLS+ +H
Sbjct: 1625 CWQKGQLLGRGSLGSVYEGISADGDFFAFKEVSLLDQGSQAHEWIQQVEGGIALLSQLQH 1684
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQD 449
+NIV+Y GT KDES LYIFLELVT+GSL LYQR L DS VS YTRQIL GLKYLHD+
Sbjct: 1685 QNIVRYRGTTKDESNLYIFLELVTQGSLRKLYQRNQLGDSVVSLYTRQILDGLKYLHDKG 1744
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF--WMAPEVINNKN--KG 505
+HR+IKCAN+LVDANG+VKLADFGLAK V S T + WMAPEVI N G
Sbjct: 1745 FIHRNIKCANVLVDANGTVKLADFGLAK------VMSLWRTPYWNWMAPEVILNPKDYDG 1798
Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIF 539
YG PADIWSLGCTVLEMLT QIPY+ +E +A++
Sbjct: 1799 YGTPADIWSLGCTVLEMLTGQIPYSDLEIGTALY 1832
|
Transcription factor. Interacts specifically with the W box (5'-(T)TGAC[CT]-3'), a frequently occurring elicitor-responsive cis-acting element. May act also as a disease resistance protein with a serine/threonine-protein kinase activity. Arabidopsis thaliana (taxid: 3702) |
| >sp|O22040|ANP1_ARATH Mitogen-activated protein kinase kinase kinase ANP1 OS=Arabidopsis thaliana GN=ANP1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 193 bits (490), Expect = 4e-48, Method: Compositional matrix adjust.
Identities = 100/224 (44%), Positives = 142/224 (63%), Gaps = 13/224 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL---LDQGSQAKQSISQLEQEIALLSR 386
W+KG L+GRG+FG+VY G++ D G AVK+V + + + I +LE+E+ LL
Sbjct: 69 WRKGQLIGRGAFGTVYMGMNLDSGELLAVKQVLIAANFASKEKTQAHIQELEEEVKLLKN 128
Query: 387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYL 445
H NIV+Y GT +++ L I LE V GS+ +L +++ +S V YTRQ+LLGL+YL
Sbjct: 129 LSHPNIVRYLGTVREDDTLNILLEFVPGGSISSLLEKFGPFPESVVRTYTRQLLLGLEYL 188
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFG----LAKATKLNDVKSCRGTAFWMAPEVINN 501
H+ ++HRDIK ANILVD G +KLADFG +A+ + KS +GT +WMAPEVI
Sbjct: 189 HNHAIMHRDIKGANILVDNKGCIKLADFGASKQVAELATMTGAKSMKGTPYWMAPEVI-- 246
Query: 502 KNKGYGLPADIWSLGCTVLEMLTSQIPYAPM--ECVSAIFIKTV 543
G+ ADIWS+GCTV+EM+T + P++ E + FI T
Sbjct: 247 LQTGHSFSADIWSVGCTVIEMVTGKAPWSQQYKEVAAIFFIGTT 290
|
May be involved in an oxidative stress-mediated signaling cascade that phosphorylates downstream MAP kinases MPK3 and MPK6. May suppress auxin signaling that promotes cell cycle. Functionally redundant to ANP2 and ANP3 in the positive regulation of cytokinesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q9FZ36|M3K2_ARATH Mitogen-activated protein kinase kinase kinase 2 OS=Arabidopsis thaliana GN=ANP2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 192 bits (488), Expect = 6e-48, Method: Compositional matrix adjust.
Identities = 98/219 (44%), Positives = 145/219 (66%), Gaps = 12/219 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQS---ISQLEQEIALLSR 386
W+KG L+GRG+FG+VY G++ D G AVK+V + + +++ I +LE+E+ LL
Sbjct: 68 WRKGQLIGRGAFGTVYMGMNLDSGELLAVKQVLITSNCASKEKTQAHIQELEEEVKLLKN 127
Query: 387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYL 445
H NIV+Y GT +++ L I LE V GS+ +L +++ +S V YT Q+LLGL+YL
Sbjct: 128 LSHPNIVRYLGTVREDETLNILLEFVPGGSISSLLEKFGAFPESVVRTYTNQLLLGLEYL 187
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFG----LAKATKLNDVKSCRGTAFWMAPEVINN 501
H+ ++HRDIK ANILVD G +KLADFG +A+ ++ KS +GT +WMAPEVI
Sbjct: 188 HNHAIMHRDIKGANILVDNQGCIKLADFGASKQVAELATISGAKSMKGTPYWMAPEVI-- 245
Query: 502 KNKGYGLPADIWSLGCTVLEMLTSQIPYAPM-ECVSAIF 539
G+ ADIWS+GCTV+EM+T + P++ + ++AIF
Sbjct: 246 LQTGHSFSADIWSVGCTVIEMVTGKAPWSQQYKEIAAIF 284
|
Involved in cortical microtubules organization and stabilization by regulating the phosphorylation state of microtubule-associated proteins such as MAP65-1. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q61083|M3K2_MOUSE Mitogen-activated protein kinase kinase kinase 2 OS=Mus musculus GN=Map3k2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 191 bits (484), Expect = 1e-47, Method: Compositional matrix adjust.
Identities = 112/260 (43%), Positives = 152/260 (58%), Gaps = 24/260 (9%)
Query: 299 FTTEHED----------DSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEG 348
FT E++D D+ + T +++ISP R R T W+ G LLG+G+FG VY
Sbjct: 317 FTPEYDDSRIRRRGSDIDNPTLT---VTDISPPSRSPRAPTNWRLGKLLGQGAFGRVYLC 373
Query: 349 IS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGT--DKDESKL 405
D G AVK+V + + + ++ LE EI LL HE IVQYYG D E L
Sbjct: 374 YDVDTGRELAVKQVQFNPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPQEKTL 433
Query: 406 YIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA 464
IF+EL GS+ + + Y L ++ YTRQIL G+ YLH +VHRDIK ANIL D+
Sbjct: 434 SIFMELSPGGSIKDQLKAYGALTENVTRKYTRQILEGVHYLHSNMIVHRDIKGANILRDS 493
Query: 465 NGSVKLADFGLAKATKL-----NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTV 519
G++KL DFG +K + +KS GT +WM+PEVI+ +GYG ADIWS+ CTV
Sbjct: 494 TGNIKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVIS--GEGYGRKADIWSVACTV 551
Query: 520 LEMLTSQIPYAPMECVSAIF 539
+EMLT + P+A E ++AIF
Sbjct: 552 VEMLTEKPPWAEFEAMAAIF 571
|
Component of a protein kinase signal transduction cascade. Regulates the JNK and ERK5 pathways by phosphorylating and activating MAP2K5 and MAP2K7. Plays a role in caveolae kiss-and-run dynamics. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|E9Q3S4|M3K19_MOUSE Mitogen-activated protein kinase kinase kinase 19 OS=Mus musculus GN=Map3k19 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 189 bits (480), Expect = 5e-47, Method: Compositional matrix adjust.
Identities = 99/220 (45%), Positives = 139/220 (63%), Gaps = 12/220 (5%)
Query: 330 YWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQA-KQSISQLEQEIALLSRFE 388
+W KG++LGRG++G+VY G++ G AVK+V+L A ++ +L++E+ LL +
Sbjct: 1043 FWTKGEILGRGAYGTVYCGLTSLGQLIAVKQVALDTSDKLATEKEYRKLQEEVDLLKALK 1102
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHD 447
H NIV Y GT +E+ L IF+E V GS+ ++ R+ L + YTRQIL G+ YLHD
Sbjct: 1103 HVNIVAYLGTCLEENTLSIFMEFVPGGSISSIINRFGPLPEMVFCKYTRQILQGVAYLHD 1162
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAK--------ATKLNDVKSCRGTAFWMAPEVI 499
VVHRDIK N+++ G +KL DFG AK T + +KS RGT +WMAPEVI
Sbjct: 1163 NCVVHRDIKGNNVMLMPTGIIKLIDFGCAKRLAWAGLNGTHSDMLKSMRGTPYWMAPEVI 1222
Query: 500 NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIF 539
N GYG +DIWS+GCTV EM T + P A M+ ++A+F
Sbjct: 1223 N--ESGYGRKSDIWSIGCTVFEMATGKPPLASMDRMAAMF 1260
|
Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9Y2U5|M3K2_HUMAN Mitogen-activated protein kinase kinase kinase 2 OS=Homo sapiens GN=MAP3K2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 188 bits (477), Expect = 1e-46, Method: Compositional matrix adjust.
Identities = 113/258 (43%), Positives = 149/258 (57%), Gaps = 20/258 (7%)
Query: 299 FTTEHED--------DSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS 350
FT E++D D + T M +ISP R R T W+ G LLG+G+FG VY
Sbjct: 317 FTPEYDDSRIRRRGSDIDNPTLTVM-DISPPSRSPRAPTNWRLGKLLGQGAFGRVYLCYD 375
Query: 351 -DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGT--DKDESKLYI 407
D G AVK+V + + ++ LE EI LL HE IVQYYG D E L I
Sbjct: 376 VDTGRELAVKQVQFDPDSPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPQEKTLSI 435
Query: 408 FLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG 466
F+E + GS+ + + Y L ++ YTRQIL G+ YLH +VHRDIK ANIL D+ G
Sbjct: 436 FMEYMPGGSIKDQLKAYGALTENVTRKYTRQILEGVHYLHSNMIVHRDIKGANILRDSTG 495
Query: 467 SVKLADFGLAKATKL-----NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLE 521
+VKL DFG +K + +KS GT +WM+PEVI+ +GYG ADIWS+ CTV+E
Sbjct: 496 NVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVIS--GEGYGRKADIWSVACTVVE 553
Query: 522 MLTSQIPYAPMECVSAIF 539
MLT + P+A E ++AIF
Sbjct: 554 MLTEKPPWAEFEAMAAIF 571
|
Component of a protein kinase signal transduction cascade. Regulates the JNK and ERK5 pathways by phosphorylating and activating MAP2K5 and MAP2K7 (By similarity). Plays a role in caveolae kiss-and-run dynamics. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q54R82|MKKA_DICDI Mitogen-activated protein kinase kinase kinase A OS=Dictyostelium discoideum GN=mkkA PE=1 SV=2 | Back alignment and function description |
|---|
Score = 186 bits (473), Expect = 3e-46, Method: Compositional matrix adjust.
Identities = 95/214 (44%), Positives = 142/214 (66%), Gaps = 8/214 (3%)
Query: 331 WQKGDLLGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGS--QAKQSISQLEQEIALLSRF 387
WQKG +LGRG +GSVY G++ D G FAVK++ ++D S + K I +EI ++
Sbjct: 170 WQKGQILGRGGYGSVYLGLNKDTGELFAVKQLEIVDINSDPKLKNMILSFSKEIEVMRSL 229
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLH 446
H+NIV+Y GT D+S L +FLE + GS+ +L ++ ++ + YT+QIL GL +LH
Sbjct: 230 RHDNIVRYLGTSLDQSFLSVFLEYIPGGSISSLLGKFGAFSENVIKVYTKQILQGLSFLH 289
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATK--LNDVKSCRGTAFWMAPEVINNKNK 504
++HRDIK ANIL+D G VKL+DFG +K+ ++ KS +GT +WMAPEVI K
Sbjct: 290 ANSIIHRDIKGANILIDTKGIVKLSDFGCSKSFSGIVSQFKSMQGTPYWMAPEVI--KQT 347
Query: 505 GYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAI 538
G+G +DIWSLGC ++EM T+Q P++ + ++A+
Sbjct: 348 GHGRSSDIWSLGCVIVEMATAQPPWSNITELAAV 381
|
Regulates cell-type differentiation and spatial patterning, required for the proper induction and maintenance of prespore cell differentiation. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q61084|M3K3_MOUSE Mitogen-activated protein kinase kinase kinase 3 OS=Mus musculus GN=Map3k3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 186 bits (472), Expect = 4e-46, Method: Compositional matrix adjust.
Identities = 101/218 (46%), Positives = 135/218 (61%), Gaps = 11/218 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
W++G LLG+G+FG VY D G A K+V + + +S LE EI LL +H
Sbjct: 362 WRRGKLLGQGAFGRVYLCYDVDTGRELASKQVQFDPDSPETSKEVSALECEIQLLKNLQH 421
Query: 390 ENIVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLH 446
E IVQYYG D+ E L IF+E + GS+ + + Y L +S YTRQIL G+ YLH
Sbjct: 422 ERIVQYYGCLRDRAEKILTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLH 481
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKL-----NDVKSCRGTAFWMAPEVINN 501
+VHRDIK ANIL D+ G+VKL DFG +K + ++S GT +WM+PEVI+
Sbjct: 482 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVIS- 540
Query: 502 KNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIF 539
+GYG AD+WSLGCTV+EMLT + P+A E ++AIF
Sbjct: 541 -GEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIF 577
|
Component of a protein kinase signal transduction cascade. Mediates activation of the NF-kappa-B, AP1 and DDIT3 transcriptional regulators. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q99759|M3K3_HUMAN Mitogen-activated protein kinase kinase kinase 3 OS=Homo sapiens GN=MAP3K3 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 186 bits (472), Expect = 5e-46, Method: Compositional matrix adjust.
Identities = 101/218 (46%), Positives = 135/218 (61%), Gaps = 11/218 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
W++G LLG+G+FG VY D G A K+V + + +S LE EI LL +H
Sbjct: 362 WRRGKLLGQGAFGRVYLCYDVDTGRELASKQVQFDPDSPETSKEVSALECEIQLLKNLQH 421
Query: 390 ENIVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLH 446
E IVQYYG D+ E L IF+E + GS+ + + Y L +S YTRQIL G+ YLH
Sbjct: 422 ERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLH 481
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKL-----NDVKSCRGTAFWMAPEVINN 501
+VHRDIK ANIL D+ G+VKL DFG +K + ++S GT +WM+PEVI+
Sbjct: 482 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGMRSVTGTPYWMSPEVIS- 540
Query: 502 KNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIF 539
+GYG AD+WSLGCTV+EMLT + P+A E ++AIF
Sbjct: 541 -GEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIF 577
|
Component of a protein kinase signal transduction cascade. Mediates activation of the NF-kappa-B, AP1 and DDIT3 transcriptional regulators. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 554 | ||||||
| 255545546 | 555 | Mitogen-activated protein kinase kinase | 0.859 | 0.857 | 0.656 | 0.0 | |
| 356509460 | 566 | PREDICTED: mitogen-activated protein kin | 0.871 | 0.853 | 0.594 | 1e-171 | |
| 224082218 | 548 | predicted protein [Populus trichocarpa] | 0.861 | 0.870 | 0.652 | 1e-165 | |
| 357489127 | 593 | Mitogen-activated protein kinase kinase | 0.942 | 0.880 | 0.604 | 1e-163 | |
| 356552843 | 590 | PREDICTED: mitogen-activated protein kin | 0.884 | 0.830 | 0.573 | 1e-163 | |
| 32400274 | 592 | putative mitogen-activated protein kinas | 0.940 | 0.880 | 0.595 | 1e-159 | |
| 356518515 | 555 | PREDICTED: mitogen-activated protein kin | 0.864 | 0.863 | 0.610 | 1e-157 | |
| 224066881 | 558 | predicted protein [Populus trichocarpa] | 0.864 | 0.858 | 0.646 | 1e-156 | |
| 357461677 | 540 | Mitogen-activated protein kinase kinase | 0.844 | 0.866 | 0.607 | 1e-154 | |
| 449445122 | 565 | PREDICTED: mitogen-activated protein kin | 0.880 | 0.863 | 0.576 | 1e-153 |
| >gi|255545546|ref|XP_002513833.1| Mitogen-activated protein kinase kinase kinase, putative [Ricinus communis] gi|223546919|gb|EEF48416.1| Mitogen-activated protein kinase kinase kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 649 bits (1674), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 351/535 (65%), Positives = 397/535 (74%), Gaps = 59/535 (11%)
Query: 20 MDPRKMRQKPRLERRNAAKHIEYDVASTSSSLDDSSSSSSLITRSLDLSDRTSFRIEGVE 79
MDP+ R +PRLERRNAAKHIEYD S+ SSLD SS SSSL+TRSLDL + TSFRIEG +
Sbjct: 1 MDPKNGRSRPRLERRNAAKHIEYDATSSFSSLDASSCSSSLVTRSLDLPEGTSFRIEGTD 60
Query: 80 GEFERICRSLGLSGPEDFAIPAAAWEARKNRSASDLLPRSRLKQLDTLKETVERQSDAAG 139
GEF+RICRS+GL+GPEDF IP AAWEA K RSASDLLPRSRL D+ + E +
Sbjct: 61 GEFDRICRSIGLTGPEDFEIPTAAWEAMKVRSASDLLPRSRLYVSDSPR-IAEAKHKEQE 119
Query: 140 AVVGELCDRVSDIVRIRNETELTRTKLTQVAELSCRASGAGNNDALAVMETTELPPSGLA 199
ELC RV D VR + TELT+ K QV + SG G
Sbjct: 120 QEKSELCARVLDTVRTDDSTELTQEK--QVQPVKLNVSGGG------------------- 158
Query: 200 ESSACCVSSNYVKGIKGVRPPLLKPPPGMRQPVIDNACSTWDILRDFAPKDGITPSSVMN 259
IKGVRPPLLKPPP M PVID CSTWDILRDFAP++ S ++
Sbjct: 159 --------------IKGVRPPLLKPPPSMTLPVIDKCCSTWDILRDFAPENDRRSSMLIA 204
Query: 260 DRALSSSSDDEDNEKEGEEADRAIVKEEEDDM---------------VLSESCSFTTEHE 304
+ LSS DDE EE AI K EE++ VLSESCSFTT ++
Sbjct: 205 EGGLSS--DDE------EEVAAAINKGEEEEEEEDDDDNLSRIREIGVLSESCSFTTSND 256
Query: 305 DDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLL 364
DDSSSTTTE MSNISP+ RF+R+I+ W+KGDLLGRGSFGSVYEGI+ DGFFFA+KEVSLL
Sbjct: 257 DDSSSTTTELMSNISPHERFRRMISDWEKGDLLGRGSFGSVYEGIAHDGFFFAIKEVSLL 316
Query: 365 DQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY 424
DQGSQ KQSI QLEQEIALLS+FEHENIV+YYGTDKD+S LYIFLELVT+GSL+NLYQRY
Sbjct: 317 DQGSQGKQSIYQLEQEIALLSQFEHENIVRYYGTDKDDSNLYIFLELVTQGSLMNLYQRY 376
Query: 425 HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV 484
HLRDSQVSAYTRQIL GLKYLHD++VVHRDIKCANILVDA+GSVKLADFGLAKATKLNDV
Sbjct: 377 HLRDSQVSAYTRQILHGLKYLHDRNVVHRDIKCANILVDASGSVKLADFGLAKATKLNDV 436
Query: 485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIF 539
KSC+GTAFWMAPEV+N K GYGLPADIWSLGCTVLEMLT Q+PY+ +EC+ A+F
Sbjct: 437 KSCKGTAFWMAPEVVNRKTHGYGLPADIWSLGCTVLEMLTRQVPYSHLECMQALF 491
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356509460|ref|XP_003523467.1| PREDICTED: mitogen-activated protein kinase kinase kinase 1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 608 bits (1568), Expect = e-171, Method: Compositional matrix adjust.
Identities = 331/557 (59%), Positives = 394/557 (70%), Gaps = 74/557 (13%)
Query: 1 MHHLPRFLSPREKSAGKAAMDPRKMRQKPRLERRNAAKHI--EYDVASTSSSLDDSSSSS 58
MH+L R PR+++ MD + R+KP+LERRNA K+ EYDV S S S
Sbjct: 1 MHYLSRIFEPRKQTK---TMDRKNPRRKPKLERRNALKYSSSEYDVVS-------SPSDD 50
Query: 59 SLITRSLDLSDRTSFRIEGVEGEFERICRSLGLSGPEDFAIPAAAWEARKNRSASDLLPR 118
+L TRS++ DRTSFRIEGVEGEF+RICRSLGLSGPEDFAIPAAAWEA K RS+SD+LPR
Sbjct: 51 TLYTRSMEFYDRTSFRIEGVEGEFDRICRSLGLSGPEDFAIPAAAWEAMKFRSSSDILPR 110
Query: 119 SRLKQLDTLKETVERQSDAAGAVVGELCDRVSDIVRIRNETELTRTKLTQVAELSCRASG 178
+L LD +E VE E+++ ++ + AE +
Sbjct: 111 LKLDNLDIPEEDVE------------------------EESKVNEVRMFKSAEEGELSEN 146
Query: 179 AGNNDALAVMETTELPPSGLAESSACCVSSNYVKGIKGVRPPLLKPPPGMRQPVIDN-AC 237
G +D++ V E E SSN GIKG+RPP+LKPPPG R V+D+ AC
Sbjct: 147 HGVSDSVRVREIDE--------------SSN---GIKGIRPPMLKPPPGTRVQVVDDSAC 189
Query: 238 STWDILRDFAPKDGITPSSVMNDRALSSSSDDEDNEKEGEEADRAIVKEEEDDMV----- 292
S+WD+LRD AP+ G +N S+ + ++EGE + K EE+ V
Sbjct: 190 SSWDLLRDLAPQGG--EGLPLNH---SNEEREVAEKEEGEVGTKESPKREEEQNVDNAAR 244
Query: 293 -------LSESCSFTTEHEDDSSSTTTEPMSN-ISPNGRFKRIITY--WQKGDLLGRGSF 342
LSESCSF+T +EDDSSS+TT+P SN ISP GR KRIIT WQKG+ LG GSF
Sbjct: 245 IAEIVAGLSESCSFSTSNEDDSSSSTTDPRSNNISPQGRIKRIITAGSWQKGEFLGGGSF 304
Query: 343 GSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE 402
GSVYEGISDDGFFFAVKEVSLLDQG+Q KQS+ QLEQEIALLS+FEH+NIVQYYGT+ D+
Sbjct: 305 GSVYEGISDDGFFFAVKEVSLLDQGTQGKQSVYQLEQEIALLSQFEHDNIVQYYGTEMDQ 364
Query: 403 SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV 462
SKLYIFLELVTKGSL +LYQ+Y LRDSQVSAYTRQIL GLKYLHD++VVHRDIKCANILV
Sbjct: 365 SKLYIFLELVTKGSLRSLYQKYTLRDSQVSAYTRQILHGLKYLHDRNVVHRDIKCANILV 424
Query: 463 DANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEM 522
DA+GSVKLADFGLAKATKLNDVKS +GTAFWMAPEV+ KNKGYGLPAD+WSLGCTVLEM
Sbjct: 425 DASGSVKLADFGLAKATKLNDVKSMKGTAFWMAPEVVKGKNKGYGLPADMWSLGCTVLEM 484
Query: 523 LTSQIPYAPMECVSAIF 539
LT Q+PY +EC+ A+F
Sbjct: 485 LTGQLPYRDLECMQALF 501
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224082218|ref|XP_002306607.1| predicted protein [Populus trichocarpa] gi|222856056|gb|EEE93603.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 588 bits (1516), Expect = e-165, Method: Compositional matrix adjust.
Identities = 356/546 (65%), Positives = 403/546 (73%), Gaps = 69/546 (12%)
Query: 1 MHHLPRFLSPREKSAGKAAMDPRKMRQKPRLERRNAAKHIEYDVASTSSSLDDSSSSSSL 60
MHHLP+FL+ ++K++ +MDP+ R+ RLERRNA KHI+YD A+ S S D SSSSSL
Sbjct: 1 MHHLPQFLTRKKKTS---SMDPKNRRRP-RLERRNALKHIDYD-ATPSFSSLDDSSSSSL 55
Query: 61 ITRSLDLSDRTSFRIEGVEGEFERICRSLGLSGPEDFAIPAAAWEARKNRSASDLLPRSR 120
TRSLDL DRTSFRIEG EGE +RICRSLGLSGPEDFAIPAAAWEA K RSASDLL RSR
Sbjct: 56 FTRSLDLPDRTSFRIEGTEGELDRICRSLGLSGPEDFAIPAAAWEAMKARSASDLLRRSR 115
Query: 121 L------KQLDTLKETVERQSDAAGAVVGELCDRVSDIVRIRNETELTRTKLTQVAELSC 174
L K + K VE + ELC V VR+R+ + T+L ++
Sbjct: 116 LLGPDSPKAAEEFKAIVEMTNQQEER---ELCAGVLKSVRVRDSS----TELNTCHDI-- 166
Query: 175 RASGAGNNDALAVMETTELPPSGLAESSACCVSSNYVKGIKGVRPPLLKPPPGMRQPVID 234
+N ++V GIKG RPPLLKPPP M PVID
Sbjct: 167 ------DNRGVSV-------------------------GIKGPRPPLLKPPPSMTLPVID 195
Query: 235 NACSTWDILRDFAPK-DGITPSSVMNDRALSSSSDDEDNEKEGEEADRAIVKEEEDDMVL 293
CSTWD+ RDFAP+ DG+ V N++ SS DD+ E+ + D A
Sbjct: 196 KECSTWDLFRDFAPENDGV----VNNNKEFSSGDDDDGRERRPQVIDAA----------- 240
Query: 294 SESCSFTTEHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDG 353
SCSFTT ++DDSSS+TTEPMSNISPN RF+R IT W+KG+LLGRGSFGSVYEGISDDG
Sbjct: 241 --SCSFTTSNDDDSSSSTTEPMSNISPNLRFRRSITDWEKGELLGRGSFGSVYEGISDDG 298
Query: 354 FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVT 413
FFFAVKEVSLLDQGSQ KQSI QLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVT
Sbjct: 299 FFFAVKEVSLLDQGSQGKQSIYQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVT 358
Query: 414 KGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADF 473
KGSLL LYQRY+LRDSQVSAYTRQIL GLKYLHDQ+VVHRDIKCAN+LVDANGSVKLADF
Sbjct: 359 KGSLLKLYQRYNLRDSQVSAYTRQILHGLKYLHDQNVVHRDIKCANLLVDANGSVKLADF 418
Query: 474 GLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME 533
GLAKATK NDVKSC+GTAFWMAPEV+NNKN+GYGLPADIWSLGCTVLEMLT QIPY+ +E
Sbjct: 419 GLAKATKFNDVKSCKGTAFWMAPEVVNNKNQGYGLPADIWSLGCTVLEMLTRQIPYSELE 478
Query: 534 CVSAIF 539
+ A+F
Sbjct: 479 SMQALF 484
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357489127|ref|XP_003614851.1| Mitogen-activated protein kinase kinase kinase [Medicago truncatula] gi|355516186|gb|AES97809.1| Mitogen-activated protein kinase kinase kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 581 bits (1497), Expect = e-163, Method: Compositional matrix adjust.
Identities = 330/546 (60%), Positives = 395/546 (72%), Gaps = 24/546 (4%)
Query: 1 MHHLPRFLSPREKSAGKAAMDPRKMRQKPRLERRNAAKHIEYDVASTSSSLDDSSSSSS- 59
M+HLPR R KS M+ +K +Q P+L+RRNA K+ YD +SSS + S S SS
Sbjct: 1 MNHLPRIFGYRNKST--TEMNSKKKKQ-PKLQRRNAVKNFNYDAQPSSSSPESSESVSSS 57
Query: 60 -LITRSLDLSDRTSFRIEGVEGEFERICRSLGLSGPEDFAIPAAAWEARKNRSASDLLPR 118
L TRS+D DR SFR+EGV+GEF+ ICRSLGL+GPEDF+IPAAAWEA K RS+SD+LPR
Sbjct: 58 ILCTRSMDFYDRKSFRVEGVDGEFDIICRSLGLNGPEDFSIPAAAWEAMKVRSSSDVLPR 117
Query: 119 SRLKQLDTLKETVERQSDAAGAVVGELCDRVSDIVRIRNETELTRTKLTQVAELSCRASG 178
+ + D K V + D G V E DRV +VR + E + +S R S
Sbjct: 118 LNVTEFDETK--VSDEIDEVGVV--ECDDRV--LVR-DSPAESSVGDSGGEVNVSIRDSP 170
Query: 179 AGNNDALAVMETTELPPSGLAESSACCVSSNYVKGIKGVRPPLLKPPPGMRQPVIDNACS 238
A ++ E + G E+S+C S GIKG+RPP+LKPPPG+R V+D+ CS
Sbjct: 171 AESSGCCTGGEI-RVSVRGFDETSSCSTGSG---GIKGIRPPMLKPPPGVRVSVVDDTCS 226
Query: 239 TWDILRDFAPKDGITPSSVMNDRALSSSSDDEDNEKEGEEADRAIVKEEEDDMV--LSES 296
TWDILRDFAP+ + D+ + + E +E I +EE D++ S S
Sbjct: 227 TWDILRDFAPE---GEGKEREEEEEEEKVDEVEEKGEADEVGLKIEEEENGDIIGEFSRS 283
Query: 297 CSFTTEHEDDSSSTTTEPMSN-ISPNGRFKRIIT--YWQKGDLLGRGSFGSVYEGISDDG 353
CSFTT EDDSSSTTT+ SN ISPN R K +IT WQKG+LLGRGSFG+VYEGIS+DG
Sbjct: 284 CSFTTSQEDDSSSTTTDTRSNSISPNVRLKPVITPGSWQKGELLGRGSFGTVYEGISEDG 343
Query: 354 FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVT 413
FFFAVK+VSLLDQGSQ KQS+ QLE EIALLS+FEHENIV+Y GT+ DES LYIF+E VT
Sbjct: 344 FFFAVKQVSLLDQGSQGKQSVVQLEHEIALLSQFEHENIVRYIGTEMDESNLYIFIEFVT 403
Query: 414 KGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADF 473
KGSLL+LY+RY LRDSQVSAYTRQIL GLKYLHD+++VHRDIKCANILVDANGSVK+ADF
Sbjct: 404 KGSLLSLYRRYKLRDSQVSAYTRQILHGLKYLHDRNIVHRDIKCANILVDANGSVKVADF 463
Query: 474 GLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME 533
GLAKA KLNDVKSC+GTAFWMAPEV+ K KGYGLPADIWSLGCTVLEMLT Q+PYAPME
Sbjct: 464 GLAKAIKLNDVKSCQGTAFWMAPEVVRGKVKGYGLPADIWSLGCTVLEMLTGQVPYAPME 523
Query: 534 CVSAIF 539
C+SA+F
Sbjct: 524 CISAVF 529
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356552843|ref|XP_003544772.1| PREDICTED: mitogen-activated protein kinase kinase kinase 1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 581 bits (1497), Expect = e-163, Method: Compositional matrix adjust.
Identities = 330/575 (57%), Positives = 393/575 (68%), Gaps = 85/575 (14%)
Query: 1 MHHLPRFLSPREKSAGKAAMDP--------RKMRQKPRLERRNAAKHIEYDVASTSSSLD 52
M+HLPR R+K A + MDP K Q+P+LERRNAAKH EYD S SS D
Sbjct: 1 MNHLPRIFGNRKKQA--SDMDPTKKKKKSKGKKHQQPKLERRNAAKHFEYDAGSLCSSRD 58
Query: 53 DSSSSSSL-----ITRSLDLSDRTSFRIEGVEGEFERICRSLGLSGPEDFAIPAAAWEAR 107
+ +S+S TRS++L DR SFRIEGVEGEF++ICRSLGLSGPEDF+IPAAAWEA
Sbjct: 59 EYDASTSSSSSLHCTRSMELFDRKSFRIEGVEGEFDQICRSLGLSGPEDFSIPAAAWEAM 118
Query: 108 KNRSASDLLPRSRLKQLDTLKETVERQSDAAGAVVGELCDRVSDIVRIRNETELTRTKLT 167
K R +SDLLP R+ G E + +
Sbjct: 119 KLRCSSDLLP---------------RRPKHGGEEE-----------EFDEEPKEKEKEEV 152
Query: 168 QVAELSCRASGAGNNDALAVMETTELPPSGLAESSACCVSSNYVKGIKGVRPPLLKPPPG 227
++A L + D V++ +P AESS CC GIKG RPP+LKPPPG
Sbjct: 153 EIAVLE-------SEDRARVLDECVVP----AESSGCC------GGIKGFRPPMLKPPPG 195
Query: 228 MRQPVIDNA-CSTWDILRDFAPK-DGITPSSVMNDRALSSSSDDEDNEKEGEEADRAIVK 285
+R V+D+A CSTWD++RDFAPK +G S + +SSDDED+ + E+ + +
Sbjct: 196 VRVSVVDDATCSTWDLMRDFAPKGEGGGKDSYVE----LNSSDDEDDHEREEKEEEEEEE 251
Query: 286 EEEDDMV------------------LSESCSFTTEHEDDSSSTTTEPMSN-ISPNGRFKR 326
EEE ++ + + F+T +EDDSSST+T P SN ISPNGR KR
Sbjct: 252 EEEGEVGGVRVESVEEENAAAIAEIVGDFSGFSTSNEDDSSSTSTGPRSNNISPNGRIKR 311
Query: 327 IITY--WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 384
+IT WQKG+LLGRGSFGSVYEGIS+DGFFFAVKEVSLLDQG+Q +QS+ QLEQEIALL
Sbjct: 312 VITAGNWQKGELLGRGSFGSVYEGISEDGFFFAVKEVSLLDQGNQGRQSVYQLEQEIALL 371
Query: 385 SRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
S+FEHENIVQY GT+ D S LYIF+ELVTKGSL NLYQRY+LRDSQVSAYTRQIL GLKY
Sbjct: 372 SQFEHENIVQYIGTEMDASNLYIFIELVTKGSLRNLYQRYNLRDSQVSAYTRQILHGLKY 431
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNK 504
LHD+++VHRDIKCANILVDANGSVKLADFGLAKATK NDVKSC+GTAFWMAPEV+ KN
Sbjct: 432 LHDRNIVHRDIKCANILVDANGSVKLADFGLAKATKFNDVKSCKGTAFWMAPEVVKGKNT 491
Query: 505 GYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIF 539
GYGLPADIWSLGCTVLEMLT QIPY+ +EC+ A+F
Sbjct: 492 GYGLPADIWSLGCTVLEMLTGQIPYSHLECMQALF 526
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|32400274|emb|CAE00640.1| putative mitogen-activated protein kinase 1 [Medicago sativa] | Back alignment and taxonomy information |
|---|
Score = 568 bits (1464), Expect = e-159, Method: Compositional matrix adjust.
Identities = 325/546 (59%), Positives = 386/546 (70%), Gaps = 25/546 (4%)
Query: 1 MHHLPRFLSPREKSAGKAAMDPRKMRQKPRLERRNAAKHIEYDVASTSSSLDDSSSSSS- 59
M+HLPR R KS M+ +K +Q P+L+RRNA K+ YD +SSS + S S+SS
Sbjct: 1 MNHLPRIFGYRNKST--TEMNSKKKKQ-PKLQRRNAVKNFNYDAQPSSSSPESSESASSS 57
Query: 60 ---LITRSLDLSDRTSFRIEGVEGEFERICRSLGLSGPEDFAIPAAAWEARKNRSASDLL 116
L TRS+D DR SFR+EGV+GEF+ ICRSLGL+GPEDF+IPAAAWEA K RS+SD+L
Sbjct: 58 ASILCTRSMDFHDRKSFRVEGVDGEFDIICRSLGLNGPEDFSIPAAAWEAMKFRSSSDVL 117
Query: 117 PRSRLKQLDTLKETVERQSDAAGAVVGELCDRVSDIVRIRNETELTRTKLTQVAELSCRA 176
PR + + D K + E D G V CD D V +R+ + V S R
Sbjct: 118 PRLNVSEFDETKTSGE--IDQVGVVD---CD---DRVLVRDSPAESSGGEVNV---SIRD 166
Query: 177 SGAGNNDALAVMETTELPPSGLAESSACCVSSNYVKGIKGVRPPLLKPPPGMRQPVIDNA 236
S A ++ E +P G E+S C S GIKG+RPP+LKPPPG+R V+D+
Sbjct: 167 SPAKSSGCCTGGEI-RVPVRGFDETSNCSTGSG---GIKGIRPPMLKPPPGVRVSVVDDT 222
Query: 237 CSTWDILRDFAPKDGITPSSVMNDRALSSSSDDEDNEKEGEEADRAIVKEEEDDMVLSES 296
CSTWDILRDFAP+ + +E E E + + S S
Sbjct: 223 CSTWDILRDFAPEGEGKEREEQEEEEEKVDEVEEKEEVGELELKVEEEENGDIIGEFSRS 282
Query: 297 CSFTTEHEDDSSSTTTEPMSN-ISPNGRFKRIIT--YWQKGDLLGRGSFGSVYEGISDDG 353
CSFTT EDDSSSTTT+ SN ISPN R K +IT WQKG+LLGRGSFG+VYEGIS+DG
Sbjct: 283 CSFTTSQEDDSSSTTTDTRSNSISPNVRLKPVITPGSWQKGELLGRGSFGTVYEGISEDG 342
Query: 354 FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVT 413
FFFAVK+VSLLDQGSQ KQS+ QLE EIALLS+FEHENIV+Y GT+ DES LYIF+E VT
Sbjct: 343 FFFAVKQVSLLDQGSQGKQSVVQLEHEIALLSQFEHENIVRYIGTEMDESNLYIFIEFVT 402
Query: 414 KGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADF 473
KGSLL+LY+RY LRDSQVSAYTRQIL GLKYLHD+++VHRDIKCANILVDANGSVK+ADF
Sbjct: 403 KGSLLSLYRRYKLRDSQVSAYTRQILHGLKYLHDRNIVHRDIKCANILVDANGSVKVADF 462
Query: 474 GLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME 533
GLAKA KLNDVKSC+GTAFWMAPEV+ K KGYGLPADIWSLGCTVLEMLT +IPY+PME
Sbjct: 463 GLAKAIKLNDVKSCQGTAFWMAPEVVRGKVKGYGLPADIWSLGCTVLEMLTGKIPYSPME 522
Query: 534 CVSAIF 539
C+SA+F
Sbjct: 523 CISAMF 528
|
Source: Medicago sativa Species: Medicago sativa Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356518515|ref|XP_003527924.1| PREDICTED: mitogen-activated protein kinase kinase kinase 1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 560 bits (1442), Expect = e-157, Method: Compositional matrix adjust.
Identities = 324/531 (61%), Positives = 384/531 (72%), Gaps = 52/531 (9%)
Query: 20 MDPRKMRQKPRLERRNAAKHI--EYDVASTSSSLDDSSSSSSLITRSLDLSDRTSFRIEG 77
MD + R+KP+LERRNA K+ EYD S S S +L TRS++ DRTSFRIEG
Sbjct: 1 MDRKNPRRKPKLERRNALKYSSSEYDAGS-------SPSDDTLYTRSMEFYDRTSFRIEG 53
Query: 78 VEGEFERICRSLGLSGPEDFAIPAAAWEARKNRSASDLLPRSRLKQLDTLKETVERQSDA 137
VEGEF+RICRSLGLSGPEDFAIPAAAWEA K R +SD+LPR + LD L D
Sbjct: 54 VEGEFDRICRSLGLSGPEDFAIPAAAWEAIKFRYSSDILPRLK---LDNL--------DI 102
Query: 138 AGAVVGELCDRVSDIVRIRNETELTRTKLTQVAELSCRASGAGNNDALAVMETTELPPSG 197
GE +V++ + I N E KL++ + D+ +V +
Sbjct: 103 PEEEEGEEELKVNEDI-IVNSVE--EGKLSE-----------KHGDSSSVRVRVRVRVRE 148
Query: 198 LAESSACCVSSNYVKGIKGVRPPLLKPPPGMRQPVIDNA-CSTWDILRDFAPK--DGITP 254
+ ESS GIKG RPP+LKPPPG R V+D++ CSTWD+LRD AP+ +G+
Sbjct: 149 IDESST---------GIKGTRPPMLKPPPGARVQVVDDSTCSTWDLLRDLAPQGEEGLPL 199
Query: 255 SSVMNDRALSSSSDDEDNEKE-GEEADRAIVKEEEDDMV--LSESCSFTTEHEDDSSSTT 311
+ N+ ++ + EKE GE R K EE++ V LSESCSF+T +EDDSSS+T
Sbjct: 200 NRSENESEVAREVERGAVEKEEGEVGTRESPKREEEENVAGLSESCSFSTSNEDDSSSST 259
Query: 312 TEPM-SNISPNGRFKRIITY--WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGS 368
T+P +NISP GR KRIIT WQKG+ LG GSFGSVYEGISDDGFFFAVKEVSLLDQG+
Sbjct: 260 TDPTSNNISPQGRIKRIITAESWQKGEFLGGGSFGSVYEGISDDGFFFAVKEVSLLDQGT 319
Query: 369 QAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD 428
Q KQS+ QLEQEIALLS+FEHENIVQYYGT+ D+SKLYIFLELVTKGSL +LYQ+Y LRD
Sbjct: 320 QGKQSVYQLEQEIALLSQFEHENIVQYYGTEMDQSKLYIFLELVTKGSLRSLYQKYTLRD 379
Query: 429 SQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR 488
SQVS+YTRQIL GLKYLHD++VVHRDIKCANILVDA+GSVKLADFGLAKATKLNDVKS +
Sbjct: 380 SQVSSYTRQILHGLKYLHDRNVVHRDIKCANILVDASGSVKLADFGLAKATKLNDVKSMK 439
Query: 489 GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIF 539
GTAFWMAPEV+ KNKGYGLPADIWSLGCTVLEMLT Q+PY +E V A++
Sbjct: 440 GTAFWMAPEVVKGKNKGYGLPADIWSLGCTVLEMLTGQLPYCDLESVRALY 490
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224066881|ref|XP_002302260.1| predicted protein [Populus trichocarpa] gi|222843986|gb|EEE81533.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 558 bits (1437), Expect = e-156, Method: Compositional matrix adjust.
Identities = 346/535 (64%), Positives = 398/535 (74%), Gaps = 56/535 (10%)
Query: 20 MDPRKMRQKPRLERRNAAKHIEYDVASTSSSLDDSSSSSSLITRSLDLSDRTSFRIEGVE 79
MDP+ R+ RLERRNA +H+ YD +TSSS SSSSL+++SLDL DRTSFRIEG E
Sbjct: 1 MDPKNRRRP-RLERRNALRHVAYD--ATSSSSSLDDSSSSLLSQSLDLPDRTSFRIEGTE 57
Query: 80 GEFERICRSLGLSGPEDFAIPAAAWEARKNRSASDLLPRSRLKQLDTLKETVERQSDAAG 139
GEF+RI RSLGLSGPEDF+IP AAWEA K RSASD+LPRSRL D+ K E + G
Sbjct: 58 GEFDRIFRSLGLSGPEDFSIPEAAWEAMKVRSASDILPRSRLFGSDSPKAAEEAKVVVEG 117
Query: 140 AVVGELCDRVSDIVRIRNETELTRTKLTQVAELSCRASGAGNNDALAVMETTELPPSGLA 199
EL RV + VR+R+ + T++ + AEL+ +N L V
Sbjct: 118 -TKSELHARVLNSVRVRDSS--TQSTQNEPAELNKFRDA--DNRCLPV------------ 160
Query: 200 ESSACCVSSNYVKGIKGVRPPLLKPPPGMRQPVIDNACSTWDILRDFAPKDGITPSSVMN 259
GIKG+RPPLLKPPP M PVID CSTWD+ RDFAP++ V+N
Sbjct: 161 -------------GIKGLRPPLLKPPPSMTLPVIDKECSTWDLFRDFAPEN----DRVVN 203
Query: 260 DRALSSSSD---------------DEDNEKEGEEADRAIVKEEEDDMVLSESCSFTTEHE 304
+ S+ D D DN++E EE I + +VLSESCSF+T ++
Sbjct: 204 NNIESTYDDGEEEKEERREQVINADADNKREEEENLLRI----GETVVLSESCSFSTSND 259
Query: 305 DDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLL 364
DDSSS+TTEPMSNISPN RF+R ITYW+KG+LLGRGSFGSVYEGISDDGFFFAVKEVSLL
Sbjct: 260 DDSSSSTTEPMSNISPNVRFRRAITYWEKGELLGRGSFGSVYEGISDDGFFFAVKEVSLL 319
Query: 365 DQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY 424
DQGS+ KQSI QLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSL LYQRY
Sbjct: 320 DQGSKGKQSIYQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLQKLYQRY 379
Query: 425 HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV 484
+LRDSQVS+YTRQIL GLKYLHDQ+VVHRDIKCAN+LVDANGSVKLADFGLAKATKLNDV
Sbjct: 380 NLRDSQVSSYTRQILHGLKYLHDQNVVHRDIKCANLLVDANGSVKLADFGLAKATKLNDV 439
Query: 485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIF 539
KSC+GTAFWMAPEV+NNKN+GYGLPADIWSLGCTVLEMLT QIPY+ +E + A+F
Sbjct: 440 KSCKGTAFWMAPEVVNNKNQGYGLPADIWSLGCTVLEMLTRQIPYSELESMQALF 494
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357461677|ref|XP_003601120.1| Mitogen-activated protein kinase kinase kinase [Medicago truncatula] gi|355490168|gb|AES71371.1| Mitogen-activated protein kinase kinase kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 551 bits (1421), Expect = e-154, Method: Compositional matrix adjust.
Identities = 322/530 (60%), Positives = 371/530 (70%), Gaps = 62/530 (11%)
Query: 20 MDPRKMRQKPRLERRNAAKHIEYDVASTSSSLDDSSSSSSLITRSLDLSDRTSFRIEGVE 79
MD +K+R+KP+LERRNA K+ +YD S+SSS SS SL TRS++L DRTSFRIEGVE
Sbjct: 1 MDSKKLRRKPKLERRNAQKYTDYDAGSSSSSF--DDSSGSLYTRSMELYDRTSFRIEGVE 58
Query: 80 GEFERICRSLGLSGPEDFAIPAAAWEARKNRSASDLLPRSRLKQLDTLKETVERQSDAAG 139
GEF+RICRSLGLSGPEDFAIPAAAWEA K RS SD LP +L +LD LKE
Sbjct: 59 GEFDRICRSLGLSGPEDFAIPAAAWEAMKIRSNSDGLPSLKLDELD-LKEK--------- 108
Query: 140 AVVGELCDRVSDIVRIRNETELTRTKLTQVAELSCRASGAGNNDALAVMETTELPPSGLA 199
+V+D+ + N+ EL + C + D + V E
Sbjct: 109 --------KVNDMRELENKGELNK---------KCE-----DRDMIRVRVRDE------- 139
Query: 200 ESSACCVSSNYVKGIKGVRPPLLKPPPGMRQPVI-DNACSTWDILRDFAP-----KDGI- 252
V + GI G+RPP++KPPPGMR PV+ DN CSTWD+L+D AP ++G
Sbjct: 140 -VDDSVVVVSSSGGINGIRPPMIKPPPGMRVPVVVDNTCSTWDLLKDLAPVGEGEEEGFD 198
Query: 253 TPSSVMNDRALSSSSDDEDNEKEGEEADRAIVKEEEDDMVLSESCSFTTEHEDDSSSTTT 312
+ DNE + AIV L ES F+T +EDDSSST T
Sbjct: 199 REVEENEGEEVGREEGVVDNEARID----AIVAG------LMESSLFSTSNEDDSSSTAT 248
Query: 313 EPMSN-ISPNGRFKRIIT--YWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQ 369
EP SN +SPNGR R IT WQKG LG GSFGSVYEGISDDGFFFAVKEVSLLDQG Q
Sbjct: 249 EPRSNNVSPNGRINRFITPGSWQKGGFLGGGSFGSVYEGISDDGFFFAVKEVSLLDQGEQ 308
Query: 370 AKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS 429
KQS+ QLEQEIALLSRFEH+NIVQYYGT+ DESKL+IF+ELVTKGSL +LYQRY LRDS
Sbjct: 309 GKQSVYQLEQEIALLSRFEHDNIVQYYGTEMDESKLHIFIELVTKGSLRSLYQRYTLRDS 368
Query: 430 QVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRG 489
QV+AYTRQIL GLKYLHDQ+VVHRDIKCANILV A+GSVKLADFGLAKATKLNDVKSC+G
Sbjct: 369 QVAAYTRQILHGLKYLHDQNVVHRDIKCANILVHASGSVKLADFGLAKATKLNDVKSCKG 428
Query: 490 TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIF 539
TAFWMAPEV+ KNKGYGLPADIWSLGCTVLEMLT QIPY+ +E + A+F
Sbjct: 429 TAFWMAPEVVRGKNKGYGLPADIWSLGCTVLEMLTGQIPYSNLEPMQALF 478
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449445122|ref|XP_004140322.1| PREDICTED: mitogen-activated protein kinase kinase kinase 1-like [Cucumis sativus] gi|449519384|ref|XP_004166715.1| PREDICTED: mitogen-activated protein kinase kinase kinase 1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 548 bits (1413), Expect = e-153, Method: Compositional matrix adjust.
Identities = 317/550 (57%), Positives = 381/550 (69%), Gaps = 62/550 (11%)
Query: 1 MHHLPRFLSPREKSAGKAAMDPRKMRQKPRLERRNAAKHIEYDVASTSSSLDDSSSSSSL 60
M+ LP+F SPR K + MDPRK+ KP+L R NAAK+I+YD S+SSS SS SL
Sbjct: 1 MNRLPQFFSPRNK---RKPMDPRKIPGKPKLGRLNAAKNIDYDAPSSSSS--LEDSSGSL 55
Query: 61 ITRSLDLSDRTSFRIEGVEGEFERICRSLGLSGPEDFAIPAAAWEARKNRSASDLLPRSR 120
TRS++ D +SFRI+G++GE + ICR+LGL+GP+DFAIP AWEARK RS+S+LLPRSR
Sbjct: 56 YTRSMENPDPSSFRIKGLDGEVDLICRTLGLAGPDDFAIPMEAWEARKVRSSSELLPRSR 115
Query: 121 LKQLDTLKETVERQSDAAGA-VVGELCDRVSDIVRIRNETELTRTKLTQVAELSCRASGA 179
L +DT +T E D + ELC RV D VRI +L++TK T+ AEL+ R
Sbjct: 116 LYPMDTSPKTEEISEDKEDKEIQDELCRRVKDSVRI--SVDLSKTK-TEFAELNERR--- 169
Query: 180 GNNDALAVMETTELPPSGLAESSACCVSSNYVKGIKGVRPPLLKPPPGMRQPVIDNACST 239
+A ++ C S GI G RPPLLKPPP MR P DNA ST
Sbjct: 170 ------------------MATATGCSSRS----GINGARPPLLKPPPSMRLPNFDNAYST 207
Query: 240 WDILRDFAPKDGITPSSVMNDRALSSSSDDEDNEKEGE----------EADRAIVKEEED 289
WDIL+ FAP +DE E+ GE E + V+ E+
Sbjct: 208 WDILKGFAPL-----------------VEDEHQEEVGERVEPLVEVEGEGEGNTVRPVEN 250
Query: 290 DMVLSESCSFTTEHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI 349
++ SFTT ++DDSSS+TTEP +NISPN R IIT W G LLGRGSFGSVYE I
Sbjct: 251 ASLIGSWGSFTTSNDDDSSSSTTEP-ANISPNMRVNPIITSWVLGRLLGRGSFGSVYEAI 309
Query: 350 SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFL 409
S+DG FFA+KEVSLLD+ SQ +QSI QL+QEIALLS FEHENIVQYYGT D SKLYIFL
Sbjct: 310 SEDGTFFALKEVSLLDEDSQGRQSIYQLQQEIALLSEFEHENIVQYYGTHSDGSKLYIFL 369
Query: 410 ELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVK 469
ELV++GSL++LYQR L DS VSAYTRQIL GLKYLH+++V+HRDIKCANILVD NGSVK
Sbjct: 370 ELVSQGSLMSLYQRTSLMDSIVSAYTRQILSGLKYLHERNVIHRDIKCANILVDVNGSVK 429
Query: 470 LADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY 529
LADFGLAKATKLNDVKSC+GTA+WMAPEV+N K +GYGLPADIWSLGCTVLEMLT ++PY
Sbjct: 430 LADFGLAKATKLNDVKSCKGTAYWMAPEVVNGKGQGYGLPADIWSLGCTVLEMLTRKLPY 489
Query: 530 APMECVSAIF 539
+ E V A+F
Sbjct: 490 SEFESVRALF 499
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 554 | ||||||
| TAIR|locus:2133559 | 608 | MEKK1 "MAPK/ERK kinase kinase | 0.947 | 0.863 | 0.486 | 6.2e-117 | |
| TAIR|locus:2133539 | 773 | MAPKKK9 "mitogen-activated pro | 0.566 | 0.406 | 0.576 | 4.5e-105 | |
| TAIR|locus:2133529 | 560 | MEKK3 "MAPK/ERK kinase kinase | 0.395 | 0.391 | 0.686 | 1.2e-89 | |
| TAIR|locus:2118116 | 1895 | WRKY19 [Arabidopsis thaliana ( | 0.416 | 0.121 | 0.632 | 1e-75 | |
| TAIR|locus:2026674 | 883 | YDA "YODA" [Arabidopsis thalia | 0.375 | 0.235 | 0.528 | 5.5e-51 | |
| TAIR|locus:2024832 | 609 | MAP3KA "mitogen-activated prot | 0.375 | 0.341 | 0.5 | 7.4e-50 | |
| TAIR|locus:2174969 | 716 | MAPKKK5 "mitogen-activated pro | 0.375 | 0.290 | 0.474 | 2.1e-47 | |
| ZFIN|ZDB-GENE-070910-1 | 620 | map3k3 "mitogen-activated prot | 0.373 | 0.333 | 0.463 | 2.6e-45 | |
| UNIPROTKB|F1NAY6 | 620 | LOC420419 "Uncharacterized pro | 0.373 | 0.333 | 0.454 | 4.1e-45 | |
| DICTYBASE|DDB_G0283265 | 1267 | mkkA "octicosapeptide/Phox/Bem | 0.371 | 0.162 | 0.443 | 4.2e-45 |
| TAIR|locus:2133559 MEKK1 "MAPK/ERK kinase kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1152 (410.6 bits), Expect = 6.2e-117, P = 6.2e-117
Identities = 269/553 (48%), Positives = 335/553 (60%)
Query: 4 LPRFLSPREKSAGKAAMDPRKMRQKPRLERRNAAKHIEYDVAXXXXXXXXXXXXXXXXXX 63
+ R L+ +KS G+ D + + RLERR+AA++I YD A
Sbjct: 1 MDRILARMKKSTGRRGGD-KNITPVRRLERRDAARNINYDAASCSSSSAEDLSVSTSSLM 59
Query: 64 XXXXXXX--TSFRIEGVEGEFERICRSLGLSGPEDFAIPAAAWEARKNRSASDLLPRSRL 121
TSFRI G GE +RI RSLG+SGP+D AI AWEA K RS+SD++ R +
Sbjct: 60 TRSLEFPEPTSFRIGGGVGEMDRIYRSLGVSGPDDLAISFDAWEACKKRSSSDVVNRFKS 119
Query: 122 KQLDTLKETVERQSDAAGAVVGELCDRVSDIVRIRNETELTR-----TKLTQVAELSC-- 174
LD +++ + +G VVG D ++ V+ ++ +E T+L+++ L
Sbjct: 120 FDLDKVRDQDLSEEGPSGVVVGS--DSMNHKVQGQDLSEAGPSGGIVTELSEIGNLITPV 177
Query: 175 -RASGAGNNDALAVMETTE--LPPSG-LAESSACCVSSNYVKGIKGVRPPLLKPPPGMRQ 230
R G + VME T + G L ++ V GIKG+RPP+LKPPP M++
Sbjct: 178 DRLVADGVVENRRVMERTPTIVKSKGYLVPNNVVAVGVGVGGGIKGLRPPVLKPPPAMKR 237
Query: 231 PVIDNACSTWDILRDFAPKDGI---TPSSVMNDRALXXXXXXXXXXXXXXXXXRAIVKEE 287
P ID+ S+WD L FAP + + + SS ++ R I +
Sbjct: 238 PPIDHRGSSWDFLTHFAPSETVKRPSSSSSSSEDGCDEEEGKEEEAEAEEMGARFIQLGD 297
Query: 288 EDDMVLSESCSFXXXXXXXXXXXXXXPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYE 347
D E+CSF S I P+G IIT WQKG LLGRGSFGSVYE
Sbjct: 298 TAD----ETCSFTTNEGDSSSTVSNT--SPIYPDGG--AIITSWQKGQLLGRGSFGSVYE 349
Query: 348 GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407
GIS DG FFAVKEVSLLDQGSQA++ I QLE EI LLS+ +H+NIV+Y GT KD S LYI
Sbjct: 350 GISGDGDFFAVKEVSLLDQGSQAQECIQQLEGEIKLLSQLQHQNIVRYRGTAKDGSNLYI 409
Query: 408 FLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS 467
FLELVT+GSLL LYQRY LRDS VS YTRQIL GLKYLHD+ +HRDIKCANILVDANG+
Sbjct: 410 FLELVTQGSLLKLYQRYQLRDSVVSLYTRQILDGLKYLHDKGFIHRDIKCANILVDANGA 469
Query: 468 VKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNK-GYGLPADIWSLGCTVLEMLTSQ 526
VKLADFGLAK +K ND+KSC+GT FWMAPEVIN K+ GYG PADIWSLGCTVLEM T Q
Sbjct: 470 VKLADFGLAKVSKFNDIKSCKGTPFWMAPEVINRKDSDGYGSPADIWSLGCTVLEMCTGQ 529
Query: 527 IPYAPMECVSAIF 539
IPY+ +E V A+F
Sbjct: 530 IPYSDLEPVQALF 542
|
|
| TAIR|locus:2133539 MAPKKK9 "mitogen-activated protein kinase kinase kinase 9" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 894 (319.8 bits), Expect = 4.5e-105, Sum P(2) = 4.5e-105
Identities = 195/338 (57%), Positives = 227/338 (67%)
Query: 212 KGIKGVRPPLLKPPPGMRQPVIDNACSTWDILRDFAPKDGITPSSVMNDRALXXXXXXXX 271
+GIKGVRP +LKPPP M+ P +D S+WDIL FAP I R
Sbjct: 387 RGIKGVRPSVLKPPPVMKLPPVDLPGSSWDILTHFAPDSEIV-------RRPSSSSSSEN 439
Query: 272 XXXXXXXXXRAIVKEEEDDMVLS------ESCSFXXXXXXXXXXXXXXPMSNISP---NG 322
+ KEE DM + E+CSF +SN SP +G
Sbjct: 440 GCDEEEAEDDKVEKEETGDMFIQLEDTTDEACSFTTNEGDSSST-----VSNTSPICVSG 494
Query: 323 RFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIA 382
I T WQKG LL +GSFGSVYE IS+DG FFAVKEVSLLDQGSQA++ I QLE EIA
Sbjct: 495 G--SINTSWQKGQLLRQGSFGSVYEAISEDGDFFAVKEVSLLDQGSQAQECIQQLEGEIA 552
Query: 383 LLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGL 442
LLS+ EH+NI++Y GTDKD S LYIFLELVT+GSLL LY+RY +RDS +S YT+QIL GL
Sbjct: 553 LLSQLEHQNILRYRGTDKDGSNLYIFLELVTQGSLLELYRRYQIRDSLISLYTKQILDGL 612
Query: 443 KYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNK 502
KYLH + +HRDIKCA ILVDANG+VKLADFGLAK +KLND+KS + T FWMAPEVIN K
Sbjct: 613 KYLHHKGFIHRDIKCATILVDANGTVKLADFGLAKVSKLNDIKSRKETLFWMAPEVINRK 672
Query: 503 -NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIF 539
N GY PADIWSLGCTVLEM T QIPY+ +E V A+F
Sbjct: 673 DNDGYRSPADIWSLGCTVLEMCTGQIPYSDLEPVEALF 710
|
|
| TAIR|locus:2133529 MEKK3 "MAPK/ERK kinase kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 765 (274.4 bits), Expect = 1.2e-89, Sum P(2) = 1.2e-89
Identities = 151/220 (68%), Positives = 176/220 (80%)
Query: 321 NGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQE 380
N R IT W KG LLGRGS+ SVYE IS+DG FFAVKEVSLLD+G QA++ I QLE E
Sbjct: 293 NFRKPEDITSWLKGQLLGRGSYASVYEAISEDGDFFAVKEVSLLDKGIQAQECIQQLEGE 352
Query: 381 IALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILL 440
IALLS+ +H+NIV+Y GT KD SKLYIFLELVT+GS+ LY+RY L + VS YTRQIL
Sbjct: 353 IALLSQLQHQNIVRYRGTAKDVSKLYIFLELVTQGSVQKLYERYQLSYTVVSLYTRQILA 412
Query: 441 GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVIN 500
GL YLHD+ VHRDIKCAN+LVDANG+VKLADFGLA+A+K ND+ SC+GT FWMAPEVIN
Sbjct: 413 GLNYLHDKGFVHRDIKCANMLVDANGTVKLADFGLAEASKFNDIMSCKGTLFWMAPEVIN 472
Query: 501 NKNK-GYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIF 539
K+ G G PADIWSLGCTVLEM T QIPY+ ++ + A F
Sbjct: 473 RKDSDGNGSPADIWSLGCTVLEMCTGQIPYSDLKPIQAAF 512
|
|
| TAIR|locus:2118116 WRKY19 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 713 (256.0 bits), Expect = 1.0e-75, Sum P(2) = 1.0e-75
Identities = 160/253 (63%), Positives = 181/253 (71%)
Query: 295 ESCSFXXXXXXXXXXXXXXPMSNISP----NGRFKRIITYWQKGDLLGRGSFGSVYEGIS 350
E+CSF +SN SP G F IT WQKG LLGRGS GSVYEGIS
Sbjct: 1594 ETCSFTVNKGDSSRT-----ISNTSPIYASEGSF---ITCWQKGQLLGRGSLGSVYEGIS 1645
Query: 351 DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLE 410
DG FFA KEVSLLDQGSQA + I Q+E IALLS+ +H+NIV+Y GT KDES LYIFLE
Sbjct: 1646 ADGDFFAFKEVSLLDQGSQAHEWIQQVEGGIALLSQLQHQNIVRYRGTTKDESNLYIFLE 1705
Query: 411 LVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKL 470
LVT+GSL LYQR L DS VS YTRQIL GLKYLHD+ +HR+IKCAN+LVDANG+VKL
Sbjct: 1706 LVTQGSLRKLYQRNQLGDSVVSLYTRQILDGLKYLHDKGFIHRNIKCANVLVDANGTVKL 1765
Query: 471 ADFGLAKATKLNDVKSCRGTAFW--MAPEVI-NNKN-KGYGLPADIWSLGCTVLEMLTSQ 526
ADFGLAK V S T +W MAPEVI N K+ GYG PADIWSLGCTVLEMLT Q
Sbjct: 1766 ADFGLAK------VMSLWRTPYWNWMAPEVILNPKDYDGYGTPADIWSLGCTVLEMLTGQ 1819
Query: 527 IPYAPMECVSAIF 539
IPY+ +E +A++
Sbjct: 1820 IPYSDLEIGTALY 1832
|
|
| TAIR|locus:2026674 YDA "YODA" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 536 (193.7 bits), Expect = 5.5e-51, P = 5.5e-51
Identities = 112/212 (52%), Positives = 147/212 (69%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
W+KG LLG GSFG VY G S+ G A+KEV+L ++++S QL QEI++LSR H
Sbjct: 400 WKKGRLLGMGSFGHVYLGFNSESGEMCAMKEVTLCSDDPKSRESAQQLGQEISVLSRLRH 459
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQ 448
+NIVQYYG++ + KLYI+LE V+ GS+ L Q Y ++ + YT+QIL GL YLH +
Sbjct: 460 QNIVQYYGSETVDDKLYIYLEYVSGGSIYKLLQEYGQFGENAIRNYTQQILSGLAYLHAK 519
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAK-ATKLNDVKSCRGTAFWMAPEVINNKNKGYG 507
+ VHRDIK ANILVD +G VK+ADFG+AK T + S +G+ +WMAPEVI N N G
Sbjct: 520 NTVHRDIKGANILVDPHGRVKVADFGMAKHITAQSGPLSFKGSPYWMAPEVIKNSN-GSN 578
Query: 508 LPADIWSLGCTVLEMLTSQIPYAPMECVSAIF 539
L DIWSLGCTVLEM T++ P++ E V A+F
Sbjct: 579 LAVDIWSLGCTVLEMATTKPPWSQYEGVPAMF 610
|
|
| TAIR|locus:2024832 MAP3KA "mitogen-activated protein kinase kinase kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 519 (187.8 bits), Expect = 7.4e-50, P = 7.4e-50
Identities = 106/212 (50%), Positives = 143/212 (67%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
W+KG LG G+FG VY G S+ G A+KEV ++ +K+ + QL QEI LL++ H
Sbjct: 214 WKKGKFLGSGTFGQVYLGFNSEKGKMCAIKEVKVISDDQTSKECLKQLNQEINLLNQLCH 273
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQ 448
NIVQYYG++ E L ++LE V+ GS+ L + Y + + YTRQIL GL YLH +
Sbjct: 274 PNIVQYYGSELSEETLSVYLEYVSGGSIHKLLKDYGSFTEPVIQNYTRQILAGLAYLHGR 333
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAK-ATKLNDVKSCRGTAFWMAPEVINNKNKGYG 507
+ VHRDIK ANILVD NG +KLADFG+AK T + + S +G+ +WMAPEV+ ++N GY
Sbjct: 334 NTVHRDIKGANILVDPNGEIKLADFGMAKHVTAFSTMLSFKGSPYWMAPEVVMSQN-GYT 392
Query: 508 LPADIWSLGCTVLEMLTSQIPYAPMECVSAIF 539
DIWSLGCT+LEM TS+ P++ E V+AIF
Sbjct: 393 HAVDIWSLGCTILEMATSKPPWSQFEGVAAIF 424
|
|
| TAIR|locus:2174969 MAPKKK5 "mitogen-activated protein kinase kinase kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 481 (174.4 bits), Expect = 2.1e-47, Sum P(2) = 2.1e-47
Identities = 104/219 (47%), Positives = 141/219 (64%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
W+KG L+GRG+FGSVY S+ G A+KEV L ++ + I QLEQEI LLS +H
Sbjct: 346 WKKGKLIGRGTFGSVYVASNSETGALCAMKEVELFPDDPKSAECIKQLEQEIKLLSNLQH 405
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLH 446
NIVQY+G++ E + +I+LE V GS+ N Y R H + +S V +TR IL GL YLH
Sbjct: 406 PNIVQYFGSETVEDRFFIYLEYVHPGSI-NKYIRDHCGTMTESVVRNFTRHILSGLAYLH 464
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAK-ATKLNDVKSCRGTAFWMAPEVIN----- 500
++ VHRDIK AN+LVDA+G VKLADFG+AK T S +G+ +WMAPE++
Sbjct: 465 NKKTVHRDIKGANLLVDASGVVKLADFGMAKHLTGQRADLSLKGSPYWMAPELMQAVMQK 524
Query: 501 NKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIF 539
+ N DIWSLGCT++EM T + P++ E +A+F
Sbjct: 525 DSNPDLAFAVDIWSLGCTIIEMFTGKPPWSEFEGAAAMF 563
|
|
| ZFIN|ZDB-GENE-070910-1 map3k3 "mitogen-activated protein kinase kinase kinase 3" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 453 (164.5 bits), Expect = 2.6e-45, Sum P(2) = 2.6e-45
Identities = 101/218 (46%), Positives = 134/218 (61%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
W++G LLG+G+FG VY D G A K+V + + +S LE EI LL H
Sbjct: 356 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVHFDPASPETSKEVSALECEIQLLKNLHH 415
Query: 390 ENIVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLH 446
E IVQYYG D +E L IF+E + GS+ + + Y L ++ YTRQIL G+ YLH
Sbjct: 416 ERIVQYYGCLRDHNEKTLTIFMEYMPGGSVKDQLKAYGALTENVTRKYTRQILEGMSYLH 475
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKL-----NDVKSCRGTAFWMAPEVINN 501
+VHRDIK ANIL D+ G+VKL DFG +K + V+S GT +WM+PEVI+
Sbjct: 476 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSSTGVRSVTGTPYWMSPEVISG 535
Query: 502 KNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIF 539
+ GYG AD+WSLGCTV+EMLT + P+A E ++AIF
Sbjct: 536 E--GYGRKADVWSLGCTVVEMLTEKPPWAEFEAMAAIF 571
|
|
| UNIPROTKB|F1NAY6 LOC420419 "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 447 (162.4 bits), Expect = 4.1e-45, Sum P(2) = 4.1e-45
Identities = 99/218 (45%), Positives = 135/218 (61%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
W+ G LLGRG+FG VY +D G +VK+V + + ++ LE EI LL H
Sbjct: 357 WRLGKLLGRGAFGEVYLCYDADTGRELSVKQVPFDPDSQETSKEVNALECEIQLLKTLRH 416
Query: 390 ENIVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLH 446
+ IVQYYG D +E KL IF+E + GS+ + + Y L ++ YTRQIL G+ YLH
Sbjct: 417 DRIVQYYGCLRDPEERKLSIFVEYMPGGSIKDQLKAYGALTENVTRKYTRQILQGVFYLH 476
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKL-----NDVKSCRGTAFWMAPEVINN 501
+VHRDIK ANIL D+ G+VKL DFG +K + +KS GT +WM+PEVI+
Sbjct: 477 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISG 536
Query: 502 KNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIF 539
+ GYG AD+WS+ CTV+EMLT + P+A E ++AIF
Sbjct: 537 E--GYGRKADVWSVACTVVEMLTEKPPWAEFEAMAAIF 572
|
|
| DICTYBASE|DDB_G0283265 mkkA "octicosapeptide/Phox/Bem1p domain-containing protein" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 474 (171.9 bits), Expect = 4.2e-45, Sum P(2) = 4.2e-45
Identities = 95/214 (44%), Positives = 142/214 (66%)
Query: 331 WQKGDLLGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGS--QAKQSISQLEQEIALLSRF 387
WQKG +LGRG +GSVY G++ D G FAVK++ ++D S + K I +EI ++
Sbjct: 495 WQKGQILGRGGYGSVYLGLNKDTGELFAVKQLEIVDINSDPKLKNMILSFSKEIEVMRSL 554
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLH 446
H+NIV+Y GT D+S L +FLE + GS+ +L ++ ++ + YT+QIL GL +LH
Sbjct: 555 RHDNIVRYLGTSLDQSFLSVFLEYIPGGSISSLLGKFGAFSENVIKVYTKQILQGLSFLH 614
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATK--LNDVKSCRGTAFWMAPEVINNKNK 504
++HRDIK ANIL+D G VKL+DFG +K+ ++ KS +GT +WMAPEVI K
Sbjct: 615 ANSIIHRDIKGANILIDTKGIVKLSDFGCSKSFSGIVSQFKSMQGTPYWMAPEVI--KQT 672
Query: 505 GYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAI 538
G+G +DIWSLGC ++EM T+Q P++ + ++A+
Sbjct: 673 GHGRSSDIWSLGCVIVEMATAQPPWSNITELAAV 706
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q39008 | M3K1_ARATH | 2, ., 7, ., 1, 1, ., 2, 5 | 0.5279 | 0.9368 | 0.8536 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 554 | |||
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-115 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-91 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-79 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-73 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-69 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-65 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 9e-65 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 9e-63 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 9e-62 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-61 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-61 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-58 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-57 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 9e-55 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-54 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-53 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 7e-53 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-51 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-51 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-49 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-48 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-48 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 8e-46 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 5e-45 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-44 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-43 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-43 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-42 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-42 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-41 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 8e-41 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-40 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 7e-40 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 8e-40 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-39 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-39 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 6e-39 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-38 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-38 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 5e-38 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-37 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 7e-37 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-36 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-35 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-35 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 9e-35 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 9e-35 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-34 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-34 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-34 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-34 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-34 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-33 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-33 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-33 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-32 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-32 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 8e-32 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-31 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 6e-31 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-30 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-30 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-30 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 5e-30 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 7e-30 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-29 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-29 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-29 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 5e-29 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 7e-29 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 7e-29 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 9e-29 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-28 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-28 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-28 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-28 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-28 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-28 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-28 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-28 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-28 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-28 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-28 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-28 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 6e-28 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 7e-28 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 8e-28 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 9e-28 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-27 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-27 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-27 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-27 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-27 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-27 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-27 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 7e-27 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 8e-27 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-26 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-26 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-26 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-26 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-26 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 5e-26 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 6e-26 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 9e-26 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-25 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-25 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-25 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-25 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-25 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 5e-25 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-25 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 6e-25 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 7e-25 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 7e-25 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-24 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-24 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-24 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 5e-24 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 6e-24 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 8e-24 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-23 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-23 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-23 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-23 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-23 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 8e-23 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 8e-23 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 9e-23 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-22 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-22 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-22 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-22 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-22 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-22 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-22 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-22 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-22 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-22 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-22 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-22 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-22 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-22 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-22 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 7e-22 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 9e-22 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 9e-22 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-21 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-21 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-21 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-21 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-21 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-21 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-21 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-21 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-21 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-21 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-21 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-21 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-21 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-21 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 6e-21 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 7e-21 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 7e-21 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 9e-21 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-20 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-20 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-20 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-20 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-20 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-20 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-20 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-20 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-20 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-20 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-20 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 5e-20 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-20 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 7e-20 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-19 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-19 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-19 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-19 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-19 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-19 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-19 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-19 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-19 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 5e-19 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-19 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-19 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 6e-19 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 6e-19 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 6e-19 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 6e-19 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 7e-19 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 9e-19 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-18 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-18 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-18 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-18 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-18 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-18 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-18 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 4e-18 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-18 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-18 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 6e-18 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-17 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-17 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-17 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-17 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-17 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-17 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-17 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-17 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 5e-17 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 5e-17 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 7e-17 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 8e-17 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-16 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-16 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-16 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-16 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-16 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-16 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-16 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-16 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-16 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-16 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-16 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 5e-16 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 6e-16 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 7e-16 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 8e-16 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 8e-16 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 9e-16 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-15 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-15 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-15 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-15 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-15 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-15 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-15 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-15 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-15 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-15 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-15 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-15 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-15 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-15 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-15 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 5e-15 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 6e-15 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 7e-15 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 7e-15 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 8e-15 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 8e-15 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 9e-15 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-14 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-14 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-14 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-14 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 6e-14 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 6e-14 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-13 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-13 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-13 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-13 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-13 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-13 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-13 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-13 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 8e-13 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-12 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-12 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-12 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-12 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-12 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 1e-11 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-11 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-11 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-11 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-11 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 8e-10 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 9e-10 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-09 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-09 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-09 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-09 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-09 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-09 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 7e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 8e-09 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-08 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 3e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 4e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 8e-08 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-07 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-07 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 4e-07 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 6e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-06 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-06 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 9e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 8e-05 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 6e-04 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 340 bits (875), Expect = e-115
Identities = 130/212 (61%), Positives = 163/212 (76%), Gaps = 4/212 (1%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
W+KG+LLG GSFGSVYEG++ DDG FFAVKEVSL D G ++++ QLEQEIALLS+ +H
Sbjct: 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQH 61
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQ 448
NIVQY GT+++E LYIFLELV GSL L ++Y + + YTRQILLGL+YLHD+
Sbjct: 62 PNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDR 121
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAK-ATKLNDVKSCRGTAFWMAPEVINNKNKGYG 507
+ VHRDIK ANILVD NG VKLADFG+AK + + KS +G+ +WMAPEVI + GYG
Sbjct: 122 NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQG-GYG 180
Query: 508 LPADIWSLGCTVLEMLTSQIPYAPMECVSAIF 539
L ADIWSLGCTVLEM T + P++ +E V+A+F
Sbjct: 181 LAADIWSLGCTVLEMATGKPPWSQLEGVAAVF 212
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 280 bits (719), Expect = 2e-91
Identities = 108/218 (49%), Positives = 144/218 (66%), Gaps = 14/218 (6%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
W +G+LLGRGSFGSVY + D G AVK V L +++ + LE+EI +LS +H
Sbjct: 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVEL---SGDSEEELEALEREIRILSSLQH 58
Query: 390 ENIVQYYGTDKDESK--LYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLH 446
NIV+YYG+++DE K L IFLE V+ GSL +L +++ L + + YTRQIL GL YLH
Sbjct: 59 PNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLH 118
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV----KSCRGTAFWMAPEVINNK 502
+VHRDIK ANILVD++G VKLADFG AK + S RGT +WMAPEVI
Sbjct: 119 SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR-- 176
Query: 503 NKGYGLPADIWSLGCTVLEMLTSQIPYAPME-CVSAIF 539
+ YG ADIWSLGCTV+EM T + P++ + ++A++
Sbjct: 177 GEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALY 214
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 249 bits (639), Expect = 2e-79
Identities = 103/210 (49%), Positives = 133/210 (63%), Gaps = 16/210 (7%)
Query: 332 QKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
Q GDL+GRG+FG VY+G++ + G F A+K++SL +A +SI Q EI LL +H
Sbjct: 3 QLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQ---EIDLLKNLKHP 59
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQD 449
NIV+Y G+ + LYI LE GSL + +++ +S V+ Y Q+L GL YLH+Q
Sbjct: 60 NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG 119
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDV----KSCRGTAFWMAPEVINNKNKG 505
V+HRDIK ANIL +G VKLADFG+ ATKLNDV S GT +WMAPEVI G
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGV--ATKLNDVSKDDASVVGTPYWMAPEVIE--MSG 175
Query: 506 YGLPADIWSLGCTVLEMLTSQIPY---APM 532
+DIWSLGCTV+E+LT PY PM
Sbjct: 176 ASTASDIWSLGCTVIELLTGNPPYYDLNPM 205
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 234 bits (600), Expect = 1e-73
Identities = 80/212 (37%), Positives = 120/212 (56%), Gaps = 9/212 (4%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
++ + LG GSFG VY G A+K + + K+ ++ +EI +L + +H
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKK----KKIKKDRERILREIKILKKLKH 56
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQ 448
NIV+ Y +DE KLY+ +E G L +L ++ L + + Y RQIL L+YLH +
Sbjct: 57 PNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSK 116
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPEVINNKNKGYG 507
+VHRD+K NIL+D +G VKLADFGLA+ + + GT +MAPEV+ KGYG
Sbjct: 117 GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVL--LGKGYG 174
Query: 508 LPADIWSLGCTVLEMLTSQIPYAPMECVSAIF 539
DIWSLG + E+LT + P+ + + +F
Sbjct: 175 KAVDIWSLGVILYELLTGKPPFPGDDQLLELF 206
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 223 bits (570), Expect = 3e-69
Identities = 101/218 (46%), Positives = 139/218 (63%), Gaps = 9/218 (4%)
Query: 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
T W++G LLG+G+FG VY D G AVK+V + K+ ++ LE EI LL
Sbjct: 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLH 446
+HE IVQYYG +D+ L IF+E + GS+ + + Y L ++ YTRQIL G++YLH
Sbjct: 62 QHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLH 121
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAK-----ATKLNDVKSCRGTAFWMAPEVINN 501
+VHRDIK ANIL D+ G+VKL DFG +K + +KS GT +WM+PEVI+
Sbjct: 122 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVIS- 180
Query: 502 KNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIF 539
+GYG AD+WS+GCTV+EMLT + P+A E ++AIF
Sbjct: 181 -GEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIF 217
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 213 bits (545), Expect = 1e-65
Identities = 78/214 (36%), Positives = 127/214 (59%), Gaps = 11/214 (5%)
Query: 330 YWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE 388
++ + +G+G FG VY+ G A+K + L ++K+ ++ EI +L + +
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKL-----ESKEKKEKIINEIQILKKCK 55
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLR--DSQVSAYTRQILLGLKYLH 446
H NIV+YYG+ + +L+I +E + GSL +L + + +SQ++ +++L GL+YLH
Sbjct: 56 HPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH 115
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAK-ATKLNDVKSCRGTAFWMAPEVINNKNKG 505
++HRDIK ANIL+ ++G VKL DFGL+ + + GT +WMAPEVIN K
Sbjct: 116 SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVIN--GKP 173
Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIF 539
Y ADIWSLG T +E+ + PY+ + + A+F
Sbjct: 174 YDYKADIWSLGITAIELAEGKPPYSELPPMKALF 207
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 211 bits (540), Expect = 9e-65
Identities = 76/203 (37%), Positives = 108/203 (53%), Gaps = 8/203 (3%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
++ LG GSFG+VY+ G AVK + + S+ Q +EI +L R H
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQ---TARREIRILRRLSH 57
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQ 448
NIV+ +D+ LY+ +E G L + R L + + QIL GL+YLH
Sbjct: 58 PNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSN 117
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSC--RGTAFWMAPEVINNKNKGY 506
++HRD+K NIL+D NG VK+ADFGLAK + GT ++MAPEV+ GY
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVL-LGGNGY 176
Query: 507 GLPADIWSLGCTVLEMLTSQIPY 529
G D+WSLG + E+LT + P+
Sbjct: 177 GPKVDVWSLGVILYELLTGKPPF 199
|
Length = 260 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 206 bits (526), Expect = 9e-63
Identities = 94/217 (43%), Positives = 131/217 (60%), Gaps = 12/217 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
WQ+G+ +G G+FG VY ++ D G AVKE+ + Q + K +I ++ E+ +L +H
Sbjct: 2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRI--QDNDPK-TIKEIADEMKVLELLKH 58
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV-SAYTRQILLGLKYLHDQ 448
N+V+YYG + K+YIF+E + G+L L + + D V YT Q+L GL YLH
Sbjct: 59 PNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSH 118
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLN------DVKSCRGTAFWMAPEVI-NN 501
+VHRDIK ANI +D NG +KL DFG A K N +V+S GT +MAPEVI
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178
Query: 502 KNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAI 538
K KG+G ADIWSLGC VLEM T + P++ ++ I
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQI 215
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 203 bits (519), Expect = 9e-62
Identities = 97/220 (44%), Positives = 141/220 (64%), Gaps = 14/220 (6%)
Query: 331 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQ--AKQSISQLEQEIALLSRFE 388
W KG++LG+G++G+VY G+++ G AVK+V L D + A++ +L++E+ LL +
Sbjct: 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVEL-DTSNVLAAEKEYEKLQEEVDLLKSLK 60
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHD 447
H NIVQY GT D++ + IF+E V GS+ ++ R+ L + YT+QIL G+ YLH+
Sbjct: 61 HVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHN 120
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAK--------ATKLNDVKSCRGTAFWMAPEVI 499
VVHRDIK N+++ NG +KL DFG A+ T N +KS GT +WMAPEVI
Sbjct: 121 NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVI 180
Query: 500 NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIF 539
N GYG +DIWS+GCTV EM T + P A M+ ++A+F
Sbjct: 181 N--ESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMF 218
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 203 bits (519), Expect = 1e-61
Identities = 101/223 (45%), Positives = 133/223 (59%), Gaps = 16/223 (7%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQS----ISQLEQEIALLS 385
W KG L+G GSFGSVY G+ + G AVK+V L + +K + L +EIALL
Sbjct: 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLK 61
Query: 386 RFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKY 444
+HENIVQY G+ D L IFLE V GS+ L Y ++ V + RQIL GL Y
Sbjct: 62 ELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNY 121
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK--------SCRGTAFWMAP 496
LH++ ++HRDIK ANILVD G +K++DFG++K + N + S +G+ FWMAP
Sbjct: 122 LHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181
Query: 497 EVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIF 539
EV+ K Y ADIWSLGC V+EMLT + P+ + AIF
Sbjct: 182 EVV--KQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIF 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 203 bits (518), Expect = 2e-61
Identities = 90/220 (40%), Positives = 133/220 (60%), Gaps = 11/220 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL----LDQGSQAKQSI-SQLEQEIALL 384
W KG+L+G+G++G VY ++ G AVK+V L + ++ + L EI L
Sbjct: 3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETL 62
Query: 385 SRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQ-VSAYTRQILLGLK 443
+H NIVQY G + E L IFLE V GS+ + + Y + Q V +T Q+L GL
Sbjct: 63 KDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLA 122
Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK---LNDVK-SCRGTAFWMAPEVI 499
YLH + ++HRD+K N+LVDA+G K++DFG++K + ND S +G+ FWMAPEVI
Sbjct: 123 YLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVI 182
Query: 500 NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIF 539
++ ++GY DIWSLGC VLEM + P++ E ++A+F
Sbjct: 183 HSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMF 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 196 bits (500), Expect = 1e-58
Identities = 85/209 (40%), Positives = 120/209 (57%), Gaps = 16/209 (7%)
Query: 332 QKGDLLGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
+ +G+GSFG VY+ I A+K + L +A+ I ++QEI LS+
Sbjct: 4 TLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDL----EEAEDEIEDIQQEIQFLSQCRSP 59
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
I +YYG+ SKL+I +E GS L+L + L ++ ++ R++LLGL+YLH++
Sbjct: 60 YITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGK 119
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR----GTAFWMAPEVINNKNKGY 506
+HRDIK ANIL+ G VKLADFG+ + +L S R GT FWMAPEVI K GY
Sbjct: 120 IHRDIKAANILLSEEGDVKLADFGV--SGQLTSTMSKRNTFVGTPFWMAPEVI--KQSGY 175
Query: 507 GLPADIWSLGCTVLEMLTSQIPYA---PM 532
ADIWSLG T +E+ + P + PM
Sbjct: 176 DEKADIWSLGITAIELAKGEPPLSDLHPM 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 190 bits (486), Expect = 2e-57
Identities = 74/192 (38%), Positives = 109/192 (56%), Gaps = 11/192 (5%)
Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
LG G FG+VY G A+K + + + +L +EI +L + H NIV+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKK----EDSSSLLEELLREIEILKKLNHPNIVKL 56
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVVHR 453
YG +DE+ LY+ +E GSL +L + L + ++ QIL GL+YLH ++HR
Sbjct: 57 YGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHR 116
Query: 454 DIKCANILVDA-NGSVKLADFGLAK--ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 510
D+K NIL+D+ NG VKLADFGL+K + + +K+ GT +MAPEV+ K Y +
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGY-YSEKS 175
Query: 511 DIWSLGCTVLEM 522
DIWSLG + E+
Sbjct: 176 DIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 185 bits (471), Expect = 9e-55
Identities = 100/218 (45%), Positives = 135/218 (61%), Gaps = 11/218 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
W+ G LLGRG+FG VY +D G AVK+V + + ++ LE EI LL H
Sbjct: 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRH 63
Query: 390 ENIVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLH 446
+ IVQYYG D +E KL IF+E + GS+ + + Y L ++ YTRQIL G+ YLH
Sbjct: 64 DRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLH 123
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKL-----NDVKSCRGTAFWMAPEVINN 501
+VHRDIK ANIL D+ G+VKL DFG +K + +KS GT +WM+PEVI+
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVIS- 182
Query: 502 KNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIF 539
+GYG AD+WS+ CTV+EMLT + P+A E ++AIF
Sbjct: 183 -GEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIF 219
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 184 bits (467), Expect = 3e-54
Identities = 102/220 (46%), Positives = 137/220 (62%), Gaps = 11/220 (5%)
Query: 329 TYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
T W+ G LLG+G+FG VY +D G AVK+V + + + ++ LE EI LL
Sbjct: 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL 61
Query: 388 EHENIVQYYGTDKD--ESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKY 444
HE IVQYYG +D E L IF+E + GS+ + + Y L ++ YTRQIL G+ Y
Sbjct: 62 LHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSY 121
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL-----NDVKSCRGTAFWMAPEVI 499
LH +VHRDIK ANIL D+ G+VKL DFG +K + +KS GT +WM+PEVI
Sbjct: 122 LHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVI 181
Query: 500 NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIF 539
+ +GYG ADIWS+GCTV+EMLT + P+A E ++AIF
Sbjct: 182 S--GEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIF 219
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 182 bits (463), Expect = 1e-53
Identities = 101/218 (46%), Positives = 136/218 (62%), Gaps = 11/218 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
W++G LLG+G+FG VY D G A K+V + + + +S LE EI LL +H
Sbjct: 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQH 63
Query: 390 ENIVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLH 446
E IVQYYG D+ E L IF+E + GS+ + + Y L +S YTRQIL G+ YLH
Sbjct: 64 ERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLH 123
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKL-----NDVKSCRGTAFWMAPEVINN 501
+VHRDIK ANIL D+ G+VKL DFG +K + ++S GT +WM+PEVI+
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVIS- 182
Query: 502 KNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIF 539
+GYG AD+WSLGCTV+EMLT + P+A E ++AIF
Sbjct: 183 -GEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIF 219
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 180 bits (458), Expect = 7e-53
Identities = 80/216 (37%), Positives = 122/216 (56%), Gaps = 19/216 (8%)
Query: 335 DLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
+ LG GS+GSVY+ I + G A+K V + ++ + ++ +EI++L + + IV
Sbjct: 9 EKLGEGSYGSVYKAIHKETGQVVAIKVVPV-------EEDLQEIIKEISILKQCDSPYIV 61
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
+YYG+ + L+I +E GS+ ++ + L + +++A Q L GL+YLH +
Sbjct: 62 KYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKI 121
Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLNDV----KSCRGTAFWMAPEVINNKNKGYG 507
HRDIK NIL++ G KLADFG+ + +L D + GT FWMAPEVI GY
Sbjct: 122 HRDIKAGNILLNEEGQAKLADFGV--SGQLTDTMAKRNTVIGTPFWMAPEVIQ--EIGYN 177
Query: 508 LPADIWSLGCTVLEMLTSQIPYAPMECVSAIF-IKT 542
ADIWSLG T +EM + PY+ + + AIF I
Sbjct: 178 NKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN 213
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 176 bits (450), Expect = 1e-51
Identities = 67/200 (33%), Positives = 110/200 (55%), Gaps = 17/200 (8%)
Query: 335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
+G+GSFG VY DG + +KE+ L + + ++ E+ +L + H NI+
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKERE---DALNEVKILKKLNHPNII 62
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRY-----HLRDSQVSAYTRQILLGLKYLHDQ 448
+YY + +++ KL I +E G L ++ + Q+ + Q+ L LKYLH +
Sbjct: 63 KYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR 122
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV----KSCRGTAFWMAPEVINNKNK 504
++HRDIK NI + +NG VKL DFG++K L+ K+ GT ++++PE+ +NK
Sbjct: 123 KILHRDIKPQNIFLTSNGLVKLGDFGISKV--LSSTVDLAKTVVGTPYYLSPELC--QNK 178
Query: 505 GYGLPADIWSLGCTVLEMLT 524
Y +DIWSLGC + E+ T
Sbjct: 179 PYNYKSDIWSLGCVLYELCT 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 175 bits (447), Expect = 3e-51
Identities = 80/211 (37%), Positives = 116/211 (54%), Gaps = 13/211 (6%)
Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
+G G++G VY+ G A+K + L ++QEI++L H NIV Y
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPG-----DDFEIIQQEISMLKECRHPNIVAY 65
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
+G+ KL+I +E GSL ++YQ R L + Q++ R+ L GL YLH+ +HR
Sbjct: 66 FGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHR 125
Query: 454 DIKCANILVDANGSVKLADFGLA---KATKLNDVKSCRGTAFWMAPEVI-NNKNKGYGLP 509
DIK ANIL+ +G VKLADFG++ AT + KS GT +WMAPEV + GY
Sbjct: 126 DIKGANILLTEDGDVKLADFGVSAQLTAT-IAKRKSFIGTPYWMAPEVAAVERKGGYDGK 184
Query: 510 ADIWSLGCTVLEMLTSQIPYAPMECVSAIFI 540
DIW+LG T +E+ Q P + + A+F+
Sbjct: 185 CDIWALGITAIELAELQPPMFDLHPMRALFL 215
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 170 bits (432), Expect = 6e-49
Identities = 70/207 (33%), Positives = 113/207 (54%), Gaps = 15/207 (7%)
Query: 332 QKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
++ +LG+GS G VY+ G +A+K++ + QL +E+ L E
Sbjct: 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEF----RKQLLRELKTLRSCESP 59
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLH-DQ 448
+V+ YG E ++ I LE + GSL +L ++ + + ++ RQIL GL YLH +
Sbjct: 60 YVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKR 119
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR----GTAFWMAPEVINNKNK 504
++HRDIK +N+L+++ G VK+ADFG++K L + GT +M+PE I ++
Sbjct: 120 HIIHRDIKPSNLLINSKGEVKIADFGISK--VLENTLDQCNTFVGTVTYMSPERIQGES- 176
Query: 505 GYGLPADIWSLGCTVLEMLTSQIPYAP 531
Y ADIWSLG T+LE + P+ P
Sbjct: 177 -YSYAADIWSLGLTLLECALGKFPFLP 202
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 169 bits (431), Expect = 1e-48
Identities = 83/216 (38%), Positives = 121/216 (56%), Gaps = 20/216 (9%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
+K +G G+ G VY+ G A+K++ L KQ+ + EI ++ +H
Sbjct: 24 LEK---IGEGASGEVYKATDRATGKEVAIKKMRL------RKQNKELIINEILIMKDCKH 74
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLR--DSQVSAYTRQILLGLKYLHD 447
NIV YY + +L++ +E + GSL ++ + +R + Q++ R++L GL+YLH
Sbjct: 75 PNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHS 134
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR----GTAFWMAPEVINNKN 503
Q+V+HRDIK NIL+ +GSVKLADFG A +L KS R GT +WMAPEVI K
Sbjct: 135 QNVIHRDIKSDNILLSKDGSVKLADFGF--AAQLTKEKSKRNSVVGTPYWMAPEVI--KR 190
Query: 504 KGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIF 539
K YG DIWSLG +EM + PY + A+F
Sbjct: 191 KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALF 226
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 168 bits (428), Expect = 2e-48
Identities = 90/215 (41%), Positives = 126/215 (58%), Gaps = 18/215 (8%)
Query: 336 LLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
+LG+G++G VY A+KE+ D + + L +EIAL S +H NIVQ
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDS-----RYVQPLHEEIALHSYLKHRNIVQ 69
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQR----YHLRDSQVSAYTRQILLGLKYLHDQDV 450
Y G+D + IF+E V GSL L + + + YT+QIL GLKYLHD +
Sbjct: 70 YLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQI 129
Query: 451 VHRDIKCANILVDA-NGSVKLADFGLAKATKLNDVKSC----RGTAFWMAPEVINNKNKG 505
VHRDIK N+LV+ +G VK++DFG +K +L + C GT +MAPEVI+ +G
Sbjct: 130 VHRDIKGDNVLVNTYSGVVKISDFGTSK--RLAGINPCTETFTGTLQYMAPEVIDKGPRG 187
Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAPM-ECVSAIF 539
YG PADIWSLGCT++EM T + P+ + E +A+F
Sbjct: 188 YGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMF 222
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 8e-46
Identities = 74/210 (35%), Positives = 123/210 (58%), Gaps = 14/210 (6%)
Query: 331 WQKGDLLGRGSFGSVYEGISD--DGFFFAVKEVSLLDQGSQAKQSISQ-LEQEIALLSRF 387
W KG LG G+F S Y D G AVK+V+ + S ++ + + L +EI L++R
Sbjct: 2 WLKGQQLGTGAFSSCY-QARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLH 446
H +I++ G ++S +F+E + GS+ +L +Y +++ + YT Q+L GL YLH
Sbjct: 61 NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLH 120
Query: 447 DQDVVHRDIKCANILVDANGS-VKLADFGLA-----KATKLNDVK-SCRGTAFWMAPEVI 499
+ ++HRD+K AN+L+D+ G +++ADFG A K T + + GT +MAPEV+
Sbjct: 121 ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVL 180
Query: 500 NNKNKGYGLPADIWSLGCTVLEMLTSQIPY 529
+ YG D+WS+GC ++EM T++ P+
Sbjct: 181 RGEQ--YGRSCDVWSVGCVIIEMATAKPPW 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 5e-45
Identities = 65/214 (30%), Positives = 102/214 (47%), Gaps = 18/214 (8%)
Query: 332 QKGDLLGRGSFGSVYEGISDDGFFF-----AVKEVSLLDQGSQAKQSISQLEQEIALLSR 386
+ G LG G+FG VY+G AVK L +G+ ++ +E +++ +
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVK---TLKEGASEEEREE-FLEEASIMKK 57
Query: 387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKY 444
H NIV+ G LYI E + G LL+ +++ L + QI G++Y
Sbjct: 58 LSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEY 117
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA----FWMAPEVIN 500
L ++ VHRD+ N LV N VK++DFGL++ +D RG WMAPE +
Sbjct: 118 LESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESL- 176
Query: 501 NKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPME 533
K+ + +D+WS G + E+ T + PY M
Sbjct: 177 -KDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMS 209
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 1e-44
Identities = 64/212 (30%), Positives = 103/212 (48%), Gaps = 17/212 (8%)
Query: 332 QKGDLLGRGSFGSVYEGISDDGFFF-----AVKEVSLLDQGSQAKQSISQLEQEIALLSR 386
G LG G+FG VY+G AVK L + + +Q I + +E ++ +
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKT---LKEDASEQQ-IEEFLREARIMRK 57
Query: 387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLN--LYQRYHLRDSQVSAYTRQILLGLKY 444
+H N+V+ G +E LYI +E + G LL+ R L S + ++ QI G++Y
Sbjct: 58 LDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEY 117
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKA---TKLNDVKSCRGTAFWMAPEVINN 501
L ++ +HRD+ N LV N VK++DFGL++ + + WMAPE +
Sbjct: 118 LESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESL-- 175
Query: 502 KNKGYGLPADIWSLGCTVLEMLTS-QIPYAPM 532
K + +D+WS G + E+ T + PY M
Sbjct: 176 KEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGM 207
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 2e-43
Identities = 85/218 (38%), Positives = 126/218 (57%), Gaps = 15/218 (6%)
Query: 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
+ +Q+ +L+GRG++G+VY G G A+K ++L +S +++E+ALLS+
Sbjct: 1 SLYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINL----DTPDDDVSDIQREVALLSQL 56
Query: 388 EH---ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
NI +YYG+ +L+I +E GS+ L + + + +S R++L+ LKY
Sbjct: 57 RQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKY 116
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR----GTAFWMAPEVIN 500
+H V+HRDIK ANILV G+VKL DFG+ A LN S R GT +WMAPEVI
Sbjct: 117 IHKVGVIHRDIKAANILVTNTGNVKLCDFGV--AALLNQNSSKRSTFVGTPYWMAPEVI- 173
Query: 501 NKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAI 538
+ K Y ADIWSLG T+ EM T PY+ ++ A+
Sbjct: 174 TEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM 211
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 154 bits (392), Expect = 2e-43
Identities = 66/213 (30%), Positives = 105/213 (49%), Gaps = 20/213 (9%)
Query: 333 KGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
G LG G+FG VY+G AVK + + ++Q I + +E ++ +
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTL----KEDASEQQIEEFLREARIMRKL 58
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH----LRDSQVSAYTRQILLGLK 443
+H NIV+ G +E L I +E + G LL+ Y R + L S + ++ QI G++
Sbjct: 59 DHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLD-YLRKNRPKELSLSDLLSFALQIARGME 117
Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA---TKLNDVKSCRGTAFWMAPEVIN 500
YL ++ +HRD+ N LV N VK++DFGL++ VK + WMAPE +
Sbjct: 118 YLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESL- 176
Query: 501 NKNKGYGLPADIWSLGCTVLEMLTS-QIPYAPM 532
K + +D+WS G + E+ T + PY M
Sbjct: 177 -KEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGM 208
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 1e-42
Identities = 74/210 (35%), Positives = 110/210 (52%), Gaps = 20/210 (9%)
Query: 335 DLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
+ +G+GSFG+V + DG KE +D G+ ++ QL E+ +L +H NIV
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKE---IDYGNMTEKEKQQLVSEVNILRELKHPNIV 62
Query: 394 QYYGTDKDESK--LYIFLELVTKGSLLNLYQRY-----HLRDSQVSAYTRQILLGLKYLH 446
+YY D S LYI +E G L L Q+ ++ + + Q+LL L H
Sbjct: 63 RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECH 122
Query: 447 -----DQDVVHRDIKCANILVDANGSVKLADFGLAK--ATKLNDVKSCRGTAFWMAPEVI 499
V+HRD+K ANI +DAN +VKL DFGLAK + K+ GT ++M+PE +
Sbjct: 123 NRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQL 182
Query: 500 NNKNKGYGLPADIWSLGCTVLEMLTSQIPY 529
N+ + Y +DIWSLGC + E+ P+
Sbjct: 183 NHMS--YDEKSDIWSLGCLIYELCALSPPF 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 150 bits (382), Expect = 5e-42
Identities = 73/204 (35%), Positives = 108/204 (52%), Gaps = 22/204 (10%)
Query: 337 LGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ------EIALLSRFEH 389
LG+GSFG V D G +A+K + K+ I + ++ E +LSR H
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLK--------KKKIIKRKEVEHTLTERNILSRINH 52
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
IV+ + + E KLY+ LE G L + L + + + Y +I+L L+YLH
Sbjct: 53 PFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSL 112
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR---GTAFWMAPEVINNKNKG 505
+++RD+K NIL+DA+G +KL DFGLAK ++ GT ++APEV+ KG
Sbjct: 113 GIIYRDLKPENILLDADGHIKLTDFGLAK-ELSSEGSRTNTFCGTPEYLAPEVL--LGKG 169
Query: 506 YGLPADIWSLGCTVLEMLTSQIPY 529
YG D WSLG + EMLT + P+
Sbjct: 170 YGKAVDWWSLGVLLYEMLTGKPPF 193
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 2e-41
Identities = 68/223 (30%), Positives = 113/223 (50%), Gaps = 33/223 (14%)
Query: 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVS--LLDQGSQAKQSISQLEQEI-ALLSRFEH 389
G ++G GSF +V + +A+K + L + + K ++E+E+ L+ H
Sbjct: 6 GKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIK--EKKVKYVKIEKEVLTRLNG--H 61
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQ 448
I++ Y T +DE LY LE G LL ++Y D + + Y +ILL L+YLH +
Sbjct: 62 PGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSK 121
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAK---------ATKLNDVKSCR----------- 488
++HRD+K NIL+D + +K+ DFG AK + K +
Sbjct: 122 GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFAS 181
Query: 489 --GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY 529
GTA +++PE++N K G +D+W+LGC + +MLT + P+
Sbjct: 182 FVGTAEYVSPELLNEKPAGKS--SDLWALGCIIYQMLTGKPPF 222
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 8e-41
Identities = 84/215 (39%), Positives = 127/215 (59%), Gaps = 13/215 (6%)
Query: 331 WQKGDLLGRGSFGSVYEGISDDGF-FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
+ K + +G+GSFG VY+GI + A+K + L +A+ I ++QEI +LS+ +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDL----EEAEDEIEDIQQEITVLSQCDS 61
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQD 449
I +YYG+ +KL+I +E + GS L+L + L ++ ++ R+IL GL YLH +
Sbjct: 62 PYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSER 121
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR----GTAFWMAPEVINNKNKG 505
+HRDIK AN+L+ G VKLADFG+A +L D + R GT FWMAPEVI K
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPEVI--KQSA 177
Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFI 540
Y ADIWSLG T +E+ + P + + + +F+
Sbjct: 178 YDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFL 212
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 2e-40
Identities = 73/210 (34%), Positives = 111/210 (52%), Gaps = 22/210 (10%)
Query: 335 DLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ------EIALLSRF 387
LG GSFG V G ++A+K +S K I +L+Q E +L
Sbjct: 7 KTLGTGSFGRVMLVRHKGSGKYYALKILS--------KAKIVKLKQVEHVLNEKRILQSI 58
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLH 446
H +V YG+ +D+S LY+ +E V G L + ++ V+ Y Q++L L+YLH
Sbjct: 59 RHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLH 118
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGY 506
D+V+RD+K N+L+D++G +K+ DFG AK K C GT ++APE+I +KGY
Sbjct: 119 SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLC-GTPEYLAPEII--LSKGY 175
Query: 507 GLPADIWSLGCTVLEMLTSQIPYA---PME 533
G D W+LG + EML P+ P++
Sbjct: 176 GKAVDWWALGILIYEMLAGYPPFFDDNPIQ 205
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 146 bits (369), Expect = 7e-40
Identities = 74/220 (33%), Positives = 115/220 (52%), Gaps = 13/220 (5%)
Query: 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR 386
W+ LG G+FG VY+ + G F A K + + ++++ + EI +LS
Sbjct: 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQI-----ESEEELEDFMVEIDILSE 58
Query: 387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKY 444
+H NIV Y E+KL+I +E G+L ++ L + Q+ RQ+L L +
Sbjct: 59 CKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNF 118
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK--SCRGTAFWMAPEVI--- 499
LH V+HRD+K NIL+ +G VKLADFG++ K K + GT +WMAPEV+
Sbjct: 119 LHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACE 178
Query: 500 NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIF 539
K+ Y ADIWSLG T++E+ + P+ + + +
Sbjct: 179 TFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLL 218
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 8e-40
Identities = 83/214 (38%), Positives = 131/214 (61%), Gaps = 11/214 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
+ K + +G+GSFG V++GI D V + ++D +A+ I ++QEI +LS+ +
Sbjct: 6 FTKLEKIGKGSFGEVFKGI--DNRTQKVVAIKIIDL-EEAEDEIEDIQQEITVLSQCDSP 62
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
+ +YYG+ ++KL+I +E + GS L+L + L ++Q++ R+IL GL YLH +
Sbjct: 63 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKK 122
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR----GTAFWMAPEVINNKNKGY 506
+HRDIK AN+L+ +G VKLADFG+A +L D + R GT FWMAPEVI K Y
Sbjct: 123 IHRDIKAANVLLSEHGEVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPEVI--KQSAY 178
Query: 507 GLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFI 540
ADIWSLG T +E+ + P++ + + +F+
Sbjct: 179 DSKADIWSLGITAIELAKGEPPHSELHPMKVLFL 212
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 1e-39
Identities = 75/219 (34%), Positives = 106/219 (48%), Gaps = 30/219 (13%)
Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQ------EIALLSRFEH 389
LG G FG V FA+K V K+ I + Q E +L H
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVK--------KRHIVETGQQEHIFSEKEILEECNH 52
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
IV+ Y T KD+ +Y+ +E G L L R + Y ++L +YLH++
Sbjct: 53 PFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNR 112
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS----CRGTAFWMAPEVINNKNK 504
+++RD+K N+L+D+NG VKL DFG AK KL + C GT ++APE+I NK
Sbjct: 113 GIIYRDLKPENLLLDSNGYVKLVDFGFAK--KLKSGQKTWTFC-GTPEYVAPEII--LNK 167
Query: 505 GYGLPADIWSLGCTVLEMLTSQIPYA-----PMECVSAI 538
GY D WSLG + E+LT + P+ PME + I
Sbjct: 168 GYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDI 206
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 5e-39
Identities = 58/217 (26%), Positives = 98/217 (45%), Gaps = 25/217 (11%)
Query: 335 DLLGRGSFGSVYEGISDDGFFF----AVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
LG G+FG VY+G AVK + + +++ +E ++ + H
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTL----KEDASEEERKDFLKEARVMKKLGHP 56
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLL----------NLYQRYHLRDSQVSAYTRQILL 440
N+V+ G +E LY+ LE + G LL ++ L + ++ QI
Sbjct: 57 NVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAK 116
Query: 441 GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-KSCRGTAF---WMAP 496
G++YL + VHRD+ N LV + VK++DFGL++ +D + G WMAP
Sbjct: 117 GMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAP 176
Query: 497 EVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPM 532
E + + + +D+WS G + E+ T PY +
Sbjct: 177 ESLKDGI--FTSKSDVWSFGVLLWEIFTLGATPYPGL 211
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 6e-39
Identities = 79/207 (38%), Positives = 113/207 (54%), Gaps = 23/207 (11%)
Query: 335 DLLGRGSFGSVY--EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ-----EIALLSRF 387
LG+GS+GSVY + +SD F+A+KEV L S+SQ E+ EI +L+
Sbjct: 6 KKLGKGSYGSVYKVKRLSD-NQFYALKEVDL--------GSMSQKEREDAVNEIRILASV 56
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-----LRDSQVSAYTRQILLGL 442
H NI+ Y D +KL I +E G L + + + ++ Q+L GL
Sbjct: 57 NHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGL 116
Query: 443 KYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNK 502
+ LH+Q ++HRD+K ANIL+ AN VK+ D G++K K N K+ GT +MAPEV K
Sbjct: 117 QALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPHYMAPEVW--K 174
Query: 503 NKGYGLPADIWSLGCTVLEMLTSQIPY 529
+ Y +DIWSLGC + EM T P+
Sbjct: 175 GRPYSYKSDIWSLGCLLYEMATFAPPF 201
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 1e-38
Identities = 71/221 (32%), Positives = 122/221 (55%), Gaps = 23/221 (10%)
Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
+G G+ VY I + A+K + L + + S+ +L +E+ +S+ H N+V+Y
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDL----EKCQTSVDELRKEVQAMSQCNHPNVVKY 64
Query: 396 YGTDKDESKLYIFLELVTKGSLLNL----YQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
Y + +L++ + ++ GSLL++ Y R L ++ ++ +++L GL+YLH +
Sbjct: 65 YTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQI 124
Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR------GTAFWMAPEVINNKNKG 505
HRDIK NIL+ +GSVK+ADFG++ + ++ + GT WMAPEV+ + G
Sbjct: 125 HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVH-G 183
Query: 506 YGLPADIWSLGCTVLEMLTSQIPYA---PMECVSAIFIKTV 543
Y ADIWS G T +E+ T PY+ PM+ + + T+
Sbjct: 184 YDFKADIWSFGITAIELATGAAPYSKYPPMK----VLMLTL 220
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 142 bits (358), Expect = 2e-38
Identities = 81/214 (37%), Positives = 125/214 (58%), Gaps = 13/214 (6%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
+ K + +G+GSFG V++GI + A+K + L +A+ I ++QEI +LS+ +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDL----EEAEDEIEDIQQEITVLSQCDS 61
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQD 449
+ +YYG+ +KL+I +E + GS L+L + + Q++ ++IL GL YLH +
Sbjct: 62 PYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEK 121
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR----GTAFWMAPEVINNKNKG 505
+HRDIK AN+L+ G VKLADFG+A +L D + R GT FWMAPEVI +
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPEVI--QQSA 177
Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIF 539
Y ADIWSLG T +E+ + P + M + +F
Sbjct: 178 YDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF 211
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 140 bits (356), Expect = 5e-38
Identities = 68/227 (29%), Positives = 118/227 (51%), Gaps = 24/227 (10%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
++ +++G G++G VY+ G A+K + ++ + ++++E +L ++
Sbjct: 8 FELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII------EDEEEEIKEEYNILRKYSN 61
Query: 389 HENIVQYYGT------DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS----AYT-RQ 437
H NI +YG ++ +L++ +EL GS+ +L + + ++ AY R+
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121
Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK--ATKLNDVKSCRGTAFWMA 495
L GL YLH+ V+HRDIK NIL+ N VKL DFG++ + L + GT +WMA
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMA 181
Query: 496 PEVI---NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIF 539
PEVI + Y +D+WSLG T +E+ + P M + A+F
Sbjct: 182 PEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALF 228
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 141 bits (356), Expect = 3e-37
Identities = 75/214 (35%), Positives = 110/214 (51%), Gaps = 19/214 (8%)
Query: 331 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EH 389
++ LG GSFG VY D A+K ++ + + + + +EI +L+
Sbjct: 2 YRILRKLGEGSFGEVYLAR--DRKLVALKVLAK--KLESKSKEVERFLREIQILASLNHP 57
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH----LRDSQVSAYTRQILLGLKYL 445
NIV+ Y +DE LY+ +E V GSL +L ++ L +S+ QIL L+YL
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 446 HDQDVVHRDIKCANILVDANGS-VKLADFGLAKATKLNDV--------KSCRGTAFWMAP 496
H + ++HRDIK NIL+D +G VKL DFGLAK + GT +MAP
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177
Query: 497 EVINNKNKGYGLPA-DIWSLGCTVLEMLTSQIPY 529
EV+ + Y + DIWSLG T+ E+LT P+
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPF 211
|
Length = 384 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 7e-37
Identities = 65/201 (32%), Positives = 107/201 (53%), Gaps = 14/201 (6%)
Query: 337 LGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
LG G+ G V + G AVK + L + Q+ +E+ +L + IV +
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRL----EINEAIQKQILRELDILHKCNSPYIVGF 64
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLR--DSQVSAYTRQILLGLKYLHDQ-DVVH 452
YG + + I +E + GSL + + R + + +L GL YLH++ ++H
Sbjct: 65 YGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIH 124
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKL-NDV-KSCRGTAFWMAPEVINNKNKGYGLPA 510
RD+K +NILV++ G +KL DFG+ + +L N + K+ GT+ +MAPE I Y + +
Sbjct: 125 RDVKPSNILVNSRGQIKLCDFGV--SGQLVNSLAKTFVGTSSYMAPERIQ--GNDYSVKS 180
Query: 511 DIWSLGCTVLEMLTSQIPYAP 531
DIWSLG +++E+ T + PY P
Sbjct: 181 DIWSLGLSLIELATGRFPYPP 201
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 1e-36
Identities = 70/203 (34%), Positives = 118/203 (58%), Gaps = 18/203 (8%)
Query: 337 LGRGSFGSVY--EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
+G GSFG +Y + SD +KE+ L + K++ ++E+ LL++ +H NIV
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHC-VIKEIDLTKMPVKEKEAS---KKEVILLAKMKHPNIVT 63
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVV 451
++ + ++ +L+I +E G L+ R + Q+ ++ QI LGLK++HD+ ++
Sbjct: 64 FFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKIL 123
Query: 452 HRDIKCANILVDANGSV-KLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGY 506
HRDIK NI + NG V KL DFG+A+ +LND +C GT ++++PE+ +N+ Y
Sbjct: 124 HRDIKSQNIFLSKNGMVAKLGDFGIAR--QLNDSMELAYTCVGTPYYLSPEIC--QNRPY 179
Query: 507 GLPADIWSLGCTVLEMLTSQIPY 529
DIWSLGC + E+ T + P+
Sbjct: 180 NNKTDIWSLGCVLYELCTLKHPF 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 1e-35
Identities = 67/206 (32%), Positives = 106/206 (51%), Gaps = 22/206 (10%)
Query: 332 QKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQ--LEQEIALLSRFE 388
+K + LG G++G VY+ G A+K++ L ++ I L +EI+LL +
Sbjct: 2 EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRL----DNEEEGIPSTAL-REISLLKELK 56
Query: 389 HENIVQYYGTDKDESKLYIFLELVTK--GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLH 446
H NIV+ E KLY+ E L+ L + + + Q+L GL Y H
Sbjct: 57 HPNIVKLLDVIHTERKLYLVFEYCDMDLKKYLDKRPG-PLSPNLIKSIMYQLLRGLAYCH 115
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKL------NDVKSCRGTAFWMAPEVIN 500
++HRD+K NIL++ +G +KLADFGLA+A + ++V T ++ APE++
Sbjct: 116 SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV----TLWYRAPEILL 171
Query: 501 NKNKGYGLPADIWSLGCTVLEMLTSQ 526
+K Y DIWS+GC EM+T +
Sbjct: 172 G-SKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 2e-35
Identities = 69/201 (34%), Positives = 109/201 (54%), Gaps = 12/201 (5%)
Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
+G+G F VY+ I DG A+K+V + + AK L +EI LL + +H N+++Y
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEM-MDAKARQDCL-KEIDLLKQLDHPNVIKY 67
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLY-----QRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
+ + ++L I LEL G L + Q+ + + + Y Q+ L+++H + +
Sbjct: 68 LASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRI 127
Query: 451 VHRDIKCANILVDANGSVKLADFGLAK--ATKLNDVKSCRGTAFWMAPEVINNKNKGYGL 508
+HRDIK AN+ + A G VKL D GL + ++K S GT ++M+PE I GY
Sbjct: 128 MHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI--HENGYNF 185
Query: 509 PADIWSLGCTVLEMLTSQIPY 529
+DIWSLGC + EM Q P+
Sbjct: 186 KSDIWSLGCLLYEMAALQSPF 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 9e-35
Identities = 63/206 (30%), Positives = 108/206 (52%), Gaps = 18/206 (8%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL-LDQGSQAKQSISQLEQEIALLSRFE 388
+QK +G G++G VY+ G A+K++ L + K ++ +EI LL
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTAL----REIKLLKELN 56
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ-----RYHLRDSQVSAYTRQILLGLK 443
H NI++ + + LY+ E + +LY+ + L +S + +Y Q+L GL
Sbjct: 57 HPNIIKLLDVFRHKGDLYLVFEFM----DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLA 112
Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAK--ATKLNDVKSCRGTAFWMAPEVINN 501
+ H ++HRD+K N+L++ G +KLADFGLA+ + + T ++ APE++
Sbjct: 113 FCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLG 172
Query: 502 KNKGYGLPADIWSLGCTVLEMLTSQI 527
+KGY P DIWS+GC E+L+ +
Sbjct: 173 -DKGYSTPVDIWSVGCIFAELLSRRP 197
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 9e-35
Identities = 68/220 (30%), Positives = 111/220 (50%), Gaps = 17/220 (7%)
Query: 337 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
+ +G++G V+ G +A+K + D K + Q+ E +LS+ + +V+
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADM--IRKNQVDQVLTERDILSQAQSPYVVKL 58
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVHRD 454
Y + + + LY+ +E + G L +L + D V+ Y +I+L L+YLH ++HRD
Sbjct: 59 YYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRD 118
Query: 455 IKCANILVDANGSVKLADFGLAKA-------TKLNDVKSCR---GTAFWMAPEVINNKNK 504
+K NIL+D+NG +KL DFGL+K +D K + GT ++APEVI +
Sbjct: 119 LKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVIL--GQ 176
Query: 505 GYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTVA 544
G+ D WSLGC + E L P+ E IF +
Sbjct: 177 GHSKTVDWWSLGCILYEFLVGIPPFH-GETPEEIFQNILN 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 1e-34
Identities = 81/209 (38%), Positives = 117/209 (55%), Gaps = 10/209 (4%)
Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
+G G++G VY+ + G AVK + L + G S ++QEI ++ +H NIV Y
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKL-EPGD----DFSLIQQEIFMVKECKHCNIVAY 71
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
+G+ KL+I +E GSL ++Y L + Q++ R+ L GL YLH + +HRD
Sbjct: 72 FGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRD 131
Query: 455 IKCANILVDANGSVKLADFGLAK--ATKLNDVKSCRGTAFWMAPEVIN-NKNKGYGLPAD 511
IK ANIL+ NG VKLADFG+A + KS GT +WMAPEV KN GY D
Sbjct: 132 IKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCD 191
Query: 512 IWSLGCTVLEMLTSQIPYAPMECVSAIFI 540
IW++G T +E+ Q P + + A+F+
Sbjct: 192 IWAVGITAIELAELQPPMFDLHPMRALFL 220
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 2e-34
Identities = 68/203 (33%), Positives = 110/203 (54%), Gaps = 14/203 (6%)
Query: 337 LGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
LG G+ GSV + + + G FA+K ++ KQ + +E+ + + IV+Y
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQ----ILRELEINKSCKSPYIVKY 64
Query: 396 YGT--DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAY-----TRQILLGLKYLHDQ 448
YG D+ S + I +E GSL ++Y++ R ++ +L GL YLH +
Sbjct: 65 YGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR 124
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGL 508
++HRDIK +NIL+ G VKL DFG++ + + GT+F+MAPE I K Y +
Sbjct: 125 KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGTSFYMAPERIQGKP--YSI 182
Query: 509 PADIWSLGCTVLEMLTSQIPYAP 531
+D+WSLG T+LE+ ++ P+ P
Sbjct: 183 TSDVWSLGLTLLEVAQNRFPFPP 205
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 2e-34
Identities = 64/204 (31%), Positives = 112/204 (54%), Gaps = 21/204 (10%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL-----LSRFEHE 390
+G+GSFG V++ + D +A+K++ L +++ E+E A+ L++ +
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDL--------SKMNRREREEAIDEARVLAKLDSS 59
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHD 447
I++YY + D+ KL I +E G L L + L + QV + QILLGL +LH
Sbjct: 60 YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS 119
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--KSCRGTAFWMAPEVINNKNKG 505
+ ++HRDIK N+ +DA +VK+ D G+AK N + GT ++++PE+ ++K
Sbjct: 120 KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELC--EDKP 177
Query: 506 YGLPADIWSLGCTVLEMLTSQIPY 529
Y +D+W+LG + E T + P+
Sbjct: 178 YNEKSDVWALGVVLYECCTGKHPF 201
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 130 bits (327), Expect = 4e-34
Identities = 78/211 (36%), Positives = 121/211 (57%), Gaps = 10/211 (4%)
Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
+G G++G VY+ + + G A+K + L + + + ++QEI ++ +H NIV Y
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKL-----EPGEDFAVVQQEIIMMKDCKHSNIVAY 71
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
+G+ KL+I +E GSL ++Y L +SQ++ +R+ L GL YLH + +HRD
Sbjct: 72 FGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRD 131
Query: 455 IKCANILVDANGSVKLADFGLAK--ATKLNDVKSCRGTAFWMAPEVINNKNK-GYGLPAD 511
IK ANIL+ NG VKLADFG++ + KS GT +WMAPEV + K GY D
Sbjct: 132 IKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCD 191
Query: 512 IWSLGCTVLEMLTSQIPYAPMECVSAIFIKT 542
IW++G T +E+ Q P + + A+F+ T
Sbjct: 192 IWAVGITAIELAELQPPMFDLHPMRALFLMT 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 5e-34
Identities = 69/202 (34%), Positives = 102/202 (50%), Gaps = 21/202 (10%)
Query: 338 GRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
G+G+FG V D FA+K ++ Q K S+ + E +L H +V +
Sbjct: 9 GKGAFGKVCIVQKRDTKKMFAMKYMN--KQKCVEKGSVRNVLNERRILQELNHPFLVNLW 66
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQRYHL------RDSQVSAYTRQILLGLKYLHDQDV 450
+ +DE +Y+ ++L+ G L RYHL + QV + +I+L L+YLH + +
Sbjct: 67 YSFQDEENMYLVVDLLLGGDL-----RYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121
Query: 451 VHRDIKCANILVDANGSVKLADFGLA---KATKLNDVKSCRGTAFWMAPEVINNKNKGYG 507
+HRDIK NIL+D G V + DF +A L S GT +MAPEV+ +GY
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS--GTPGYMAPEVL--CRQGYS 177
Query: 508 LPADIWSLGCTVLEMLTSQIPY 529
+ D WSLG T E L + PY
Sbjct: 178 VAVDWWSLGVTAYECLRGKRPY 199
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 1e-33
Identities = 62/195 (31%), Positives = 102/195 (52%), Gaps = 13/195 (6%)
Query: 337 LGRGSFGS--VYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
LG+G+FG +Y DD KEV+L + ++ EI +LS +H NI+
Sbjct: 8 LGKGAFGEATLYRRTEDDSLV-VWKEVNLTRLSEKERRDA---LNEIVILSLLQHPNIIA 63
Query: 395 YYGTDKDESKLYIFLELVTKGSL---LNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
YY D++ L I +E G+L + + + V Y QI+ + Y+H ++
Sbjct: 64 YYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGIL 123
Query: 452 HRDIKCANILVDANGSVKLADFGLAK--ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLP 509
HRDIK NI + G +KL DFG++K ++ + ++ GT ++M+PE+ + Y
Sbjct: 124 HRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELC--QGVKYNFK 181
Query: 510 ADIWSLGCTVLEMLT 524
+DIW+LGC + E+LT
Sbjct: 182 SDIWALGCVLYELLT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 1e-33
Identities = 64/201 (31%), Positives = 103/201 (51%), Gaps = 23/201 (11%)
Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQ--SISQLEQEIALLSRFEHENIV 393
+G G++G VY+ + G A+K++ + K+ I+ + EI LL + H NIV
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRM----ENEKEGFPITAIR-EIKLLQKLRHPNIV 61
Query: 394 QYYG--TDKDESKLYIFLELVT---KGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
+ T K + +Y+ E + G L + +SQ+ Y +Q+L GL+YLH
Sbjct: 62 RLKEIVTSKGKGSIYMVFEYMDHDLTGLLDS--PEVKFTESQIKCYMKQLLEGLQYLHSN 119
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT----AFWM-APEVINNKN 503
++HRDIK +NIL++ +G +KLADFGLA+ S T W PE++
Sbjct: 120 GILHRDIKGSNILINNDGVLKLADFGLAR--PYTKRNSADYTNRVITLWYRPPELLLGAT 177
Query: 504 KGYGLPADIWSLGCTVLEMLT 524
+ YG D+WS+GC + E+
Sbjct: 178 R-YGPEVDMWSVGCILAELFL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 4e-33
Identities = 65/177 (36%), Positives = 102/177 (57%), Gaps = 13/177 (7%)
Query: 357 AVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGS 416
AVK++ L Q Q L E+ ++ ++H NIV+ Y + +L++ +E + G+
Sbjct: 48 AVKKMDLRKQ-----QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGA 102
Query: 417 LLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL- 475
L ++ + + Q++ +L L +LH Q V+HRDIK +IL+ ++G VKL+DFG
Sbjct: 103 LTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFC 162
Query: 476 AKATKLNDV---KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY 529
A+ +K +V KS GT +WMAPEVI+ YG DIWSLG V+EM+ + PY
Sbjct: 163 AQVSK--EVPRRKSLVGTPYWMAPEVISRLP--YGTEVDIWSLGIMVIEMVDGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 70/207 (33%), Positives = 114/207 (55%), Gaps = 9/207 (4%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
+G GSFG+VY A+K++S G Q+ + + +E+ L + H N ++Y
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSY--SGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80
Query: 396 YGTDKDESKLYIFLE--LVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
G E ++ +E L + +L ++++ L++ +++A L GL YLH + +HR
Sbjct: 81 KGCYLREHTAWLVMEYCLGSASDILEVHKK-PLQEVEIAAICHGALQGLAYLHSHERIHR 139
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKG-YGLPADI 512
DIK NIL+ G+VKLADFG A+ ++ S GT +WMAPEVI ++G Y D+
Sbjct: 140 DIKAGNILLTEPGTVKLADFG--SASLVSPANSFVGTPYWMAPEVILAMDEGQYDGKVDV 197
Query: 513 WSLGCTVLEMLTSQIPYAPMECVSAIF 539
WSLG T +E+ + P M +SA++
Sbjct: 198 WSLGITCIELAERKPPLFNMNAMSALY 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 4e-32
Identities = 65/199 (32%), Positives = 118/199 (59%), Gaps = 21/199 (10%)
Query: 337 LGRGSFG-SVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
+G GSFG ++ +DG + +KE+++ + ++ + +E+A+LS +H NIVQY
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKERE---ESRKEVAVLSNMKHPNIVQY 64
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLR------DSQVSAYTRQILLGLKYLHDQD 449
+ ++ LYI ++ G +LY++ + + + Q+ + QI L LK++HD+
Sbjct: 65 QESFEENGNLYIVMDYCEGG---DLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK 121
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDV----KSCRGTAFWMAPEVINNKNKG 505
++HRDIK NI + +G++KL DFG+A+ LN ++C GT ++++PE+ +N+
Sbjct: 122 ILHRDIKSQNIFLTKDGTIKLGDFGIARV--LNSTVELARTCIGTPYYLSPEIC--ENRP 177
Query: 506 YGLPADIWSLGCTVLEMLT 524
Y +DIW+LGC + EM T
Sbjct: 178 YNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 8e-32
Identities = 68/212 (32%), Positives = 103/212 (48%), Gaps = 19/212 (8%)
Query: 325 KRIITYWQKGDLLGRGSFGSVYEG---ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEI 381
KR + + ++ LG G FG V D V SL S +Q S E+EI
Sbjct: 3 KRHLKFIKQ---LGEGHFGKVELCRYDPLGDNTGEQVAVKSL--NHSGEEQHRSDFEREI 57
Query: 382 ALLSRFEHENIVQYYG--TDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQ 437
+L +HENIV+Y G L + +E + GSL + QR+ + ++ ++ Q
Sbjct: 58 EILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQ 117
Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGT-AF 492
I G+ YL Q +HRD+ NILV++ VK++DFGLAK + VK + F
Sbjct: 118 ICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIF 177
Query: 493 WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT 524
W APE + + + +D+WS G T+ E+ T
Sbjct: 178 WYAPECL--RTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 3e-31
Identities = 68/206 (33%), Positives = 105/206 (50%), Gaps = 21/206 (10%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
LG G FG V+ G + AVK L G+ + ++ QE ++ + H+ +VQ Y
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKT---LKPGTMSPEA---FLQEAQIMKKLRHDKLVQLY 67
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
+E +YI E ++KGSLL+ + LR Q+ QI G+ YL ++ +HR
Sbjct: 68 AVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHR 127
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYG--- 507
D+ NILV N K+ADFGLA+ + ++ + G F W APE N YG
Sbjct: 128 DLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAAN-----YGRFT 182
Query: 508 LPADIWSLGCTVLEMLT-SQIPYAPM 532
+ +D+WS G + E++T ++PY M
Sbjct: 183 IKSDVWSFGILLTEIVTYGRVPYPGM 208
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 6e-31
Identities = 74/213 (34%), Positives = 118/213 (55%), Gaps = 10/213 (4%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
+ + + +G+G+ G+VY I G A+K+++L Q K+ I EI ++ +H
Sbjct: 21 YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ--PKKELIIN---EILVMRENKH 75
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQD 449
NIV Y + +L++ +E + GSL ++ + + Q++A R+ L L++LH
Sbjct: 76 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ 135
Query: 450 VVHRDIKCANILVDANGSVKLADFGL-AKATKLNDVKSCR-GTAFWMAPEVINNKNKGYG 507
V+HRDIK NIL+ +GSVKL DFG A+ T +S GT +WMAPEV+ K YG
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA--YG 193
Query: 508 LPADIWSLGCTVLEMLTSQIPYAPMECVSAIFI 540
DIWSLG +EM+ + PY + A+++
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL 226
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 1e-30
Identities = 71/202 (35%), Positives = 110/202 (54%), Gaps = 14/202 (6%)
Query: 337 LGRGSFGSVYEGISD-DGFFFAVKEVSLLD-QGSQAKQSISQLEQEIALLSRFEHENIVQ 394
+GRG F VY DG A+K+V + D ++A+ + EI LL + H N+++
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIK---EIDLLKQLNHPNVIK 66
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLY-----QRYHLRDSQVSAYTRQILLGLKYLHDQD 449
YY + ++++L I LEL G L + Q+ + + V Y Q+ L+++H +
Sbjct: 67 YYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR 126
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAK--ATKLNDVKSCRGTAFWMAPEVINNKNKGYG 507
V+HRDIK AN+ + A G VKL D GL + ++K S GT ++M+PE I+ GY
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH--ENGYN 184
Query: 508 LPADIWSLGCTVLEMLTSQIPY 529
+DIWSLGC + EM Q P+
Sbjct: 185 FKSDIWSLGCLLYEMAALQSPF 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 3e-30
Identities = 65/203 (32%), Positives = 105/203 (51%), Gaps = 21/203 (10%)
Query: 336 LLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQ-AKQSISQLEQEIALLSRFEHENIV 393
+G G++G V + G A+K++S + AK+ + +EI LL HENI+
Sbjct: 7 PIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRIL----REIKLLRHLRHENII 62
Query: 394 Q----YYGTDKDE-SKLYIFLELVTKGSLLN--LYQRYHLRDSQVSAYTRQILLGLKYLH 446
++ + +YI EL + L+ + L D + + QIL GLKYLH
Sbjct: 63 GLLDILRPPSPEDFNDVYIVTEL--METDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLH 120
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----WM-APEVINN 501
+V+HRD+K +NILV++N +K+ DFGLA+ ++ + T + W APE++ +
Sbjct: 121 SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLS 180
Query: 502 KNKGYGLPADIWSLGCTVLEMLT 524
+ Y DIWS+GC E+LT
Sbjct: 181 -SSRYTKAIDIWSVGCIFAELLT 202
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 120 bits (301), Expect = 3e-30
Identities = 75/207 (36%), Positives = 116/207 (56%), Gaps = 9/207 (4%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
+G GSFG+VY S AVK++S G Q + + +E+ L + +H N ++Y
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSY--SGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86
Query: 396 YGTDKDESKLYIFLE--LVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
G E ++ +E L + LL ++++ L++ +++A T L GL YLH +++HR
Sbjct: 87 KGCYLKEHTAWLVMEYCLGSASDLLEVHKK-PLQEVEIAAITHGALQGLAYLHSHNMIHR 145
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKG-YGLPADI 512
DIK NIL+ G VKLADFG A+K + S GT +WMAPEVI ++G Y D+
Sbjct: 146 DIKAGNILLTEPGQVKLADFG--SASKSSPANSFVGTPYWMAPEVILAMDEGQYDGKVDV 203
Query: 513 WSLGCTVLEMLTSQIPYAPMECVSAIF 539
WSLG T +E+ + P M +SA++
Sbjct: 204 WSLGITCIELAERKPPLFNMNAMSALY 230
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 5e-30
Identities = 65/204 (31%), Positives = 100/204 (49%), Gaps = 17/204 (8%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
LG G FG V+EG+ ++ AVK L G+ E ++ + H ++Q Y
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKT---LKPGTM---DPKDFLAEAQIMKKLRHPKLIQLY 67
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
E +YI EL+ GSLL Q L+ Q+ Q+ G+ YL Q+ +HR
Sbjct: 68 AVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHR 127
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVIN-NKNKGYGLP 509
D+ N+LV N K+ADFGLA+ K + ++ G F W APE N+ + +
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNR---FSIK 184
Query: 510 ADIWSLGCTVLEMLT-SQIPYAPM 532
+D+WS G + E++T ++PY M
Sbjct: 185 SDVWSFGILLTEIVTYGRMPYPGM 208
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 7e-30
Identities = 70/207 (33%), Positives = 116/207 (56%), Gaps = 11/207 (5%)
Query: 330 YWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
+W+ LG G+FG VY+ + + A +V +D +++++ + EI +L+ +H
Sbjct: 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKV--ID--TKSEEELEDYMVEIDILASCDH 61
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSL--LNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
NIV+ E+ L+I +E G++ + L L + Q+ +Q L L YLH+
Sbjct: 62 PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE 121
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGL-AKATK-LNDVKSCRGTAFWMAPEVI---NNK 502
++HRD+K NIL +G +KLADFG+ AK T+ + S GT +WMAPEV+ +K
Sbjct: 122 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSK 181
Query: 503 NKGYGLPADIWSLGCTVLEMLTSQIPY 529
++ Y AD+WSLG T++EM + P+
Sbjct: 182 DRPYDYKADVWSLGITLIEMAQIEPPH 208
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 1e-29
Identities = 65/207 (31%), Positives = 99/207 (47%), Gaps = 38/207 (18%)
Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQ-----EI-ALLSRFEH 389
LG G+FGSVY + + G A+K + K+ E+ E+ +L EH
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIK---------KMKKKFYSWEECMNLREVKSLRKLNEH 57
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD------SQVSAYTRQILLGLK 443
NIV+ ++ +LY E + NLYQ R S + + QIL GL
Sbjct: 58 PNIVKLKEVFRENDELYFVFEYMEG----NLYQLMKDRKGKPFSESVIRSIIYQILQGLA 113
Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR------GTAFWMAPE 497
++H HRD+K N+LV VK+ADFGLA+ +++S T ++ APE
Sbjct: 114 HIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAR-----EIRSRPPYTDYVSTRWYRAPE 168
Query: 498 VINNKNKGYGLPADIWSLGCTVLEMLT 524
++ ++ Y P DIW+LGC + E+ T
Sbjct: 169 IL-LRSTSYSSPVDIWALGCIMAELYT 194
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 2e-29
Identities = 60/210 (28%), Positives = 110/210 (52%), Gaps = 17/210 (8%)
Query: 335 DLLGRGSFGSVY--EGISDDGFFFAVKEVSL--LDQGSQAKQSISQLEQEIALLS----R 386
+ LG G+FG VY ++ A+KE+++ G ++ + ++ ++ +
Sbjct: 6 EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ 65
Query: 387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLY-----QRYHLRDSQVSAYTRQILLG 441
H NIV+YY T + +LYI ++L+ L + ++ + ++ Q++L
Sbjct: 66 LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA 125
Query: 442 LKYLH-DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VKSCRGTAFWMAPEVI 499
L+YLH ++ +VHRD+ NI++ + V + DFGLAK + + S GT + PE++
Sbjct: 126 LRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIV 185
Query: 500 NNKNKGYGLPADIWSLGCTVLEMLTSQIPY 529
KN+ YG AD+W+ GC + +M T Q P+
Sbjct: 186 --KNEPYGEKADVWAFGCILYQMCTLQPPF 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 2e-29
Identities = 62/208 (29%), Positives = 108/208 (51%), Gaps = 8/208 (3%)
Query: 339 RGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYG 397
+G+FGSVY G +FA+K + D ++ + + + E+ I ++ + E + + Y
Sbjct: 6 KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAI-MMIQGESPYVAKLYY 64
Query: 398 TDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIK 456
+ + + LY+ +E + G +L + L + Y +++LG++ LH + ++HRDIK
Sbjct: 65 SFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIK 124
Query: 457 CANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLG 516
N+L+D G +KL DFGL++ N K GT ++APE I G +D WSLG
Sbjct: 125 PENLLIDQTGHLKLTDFGLSRNGLEN--KKFVGTPDYLAPETIL--GVGDDKMSDWWSLG 180
Query: 517 CTVLEMLTSQIPYAPMECVSAIFIKTVA 544
C + E L P+ E A+F ++
Sbjct: 181 CVIFEFLFGYPPFHA-ETPDAVFDNILS 207
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 5e-29
Identities = 75/222 (33%), Positives = 122/222 (54%), Gaps = 17/222 (7%)
Query: 335 DLLGRGSFGSVYEGI-SDDGFFFAVKEVSL-LDQGSQAKQSISQLEQEIALLSRFEHENI 392
D LG+G++GSVY+ + G A+KE+ L LD+ +Q+ E+ +L + I
Sbjct: 7 DELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESK-----FNQIIMELDILHKAVSPYI 61
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLY----QRYHLRDSQVSAYTRQILLGLKYLHDQ 448
V +YG E +Y+ +E + GSL LY + + + T ++ GLK+L ++
Sbjct: 62 VDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE 121
Query: 449 -DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVIN----NKN 503
+++HRD+K N+LV+ NG VKL DFG++ + K+ G +MAPE I N+N
Sbjct: 122 HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGGPNQN 181
Query: 504 KGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTVAV 545
Y + +D+WSLG ++LEM + PY P E + IF + A+
Sbjct: 182 PTYTVQSDVWSLGLSILEMALGRYPYPP-ETYANIFAQLSAI 222
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 7e-29
Identities = 74/209 (35%), Positives = 117/209 (55%), Gaps = 13/209 (6%)
Query: 337 LGRGSFGSVYEGISDD---GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
+G GSFG+VY + D A+K++S G Q+ + + +E+ L R +H N +
Sbjct: 33 IGHGSFGAVY--FARDVRTNEVVAIKKMSY--SGKQSNEKWQDIIKEVKFLQRIKHPNSI 88
Query: 394 QYYGTDKDESKLYIFLE--LVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
+Y G E ++ +E L + LL ++++ L++ +++A T L GL YLH +++
Sbjct: 89 EYKGCYLREHTAWLVMEYCLGSASDLLEVHKK-PLQEVEIAAITHGALQGLAYLHSHNMI 147
Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKG-YGLPA 510
HRDIK NIL+ G VKLADFG A+ + S GT +WMAPEVI ++G Y
Sbjct: 148 HRDIKAGNILLTEPGQVKLADFG--SASIASPANSFVGTPYWMAPEVILAMDEGQYDGKV 205
Query: 511 DIWSLGCTVLEMLTSQIPYAPMECVSAIF 539
D+WSLG T +E+ + P M +SA++
Sbjct: 206 DVWSLGITCIELAERKPPLFNMNAMSALY 234
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 7e-29
Identities = 76/224 (33%), Positives = 120/224 (53%), Gaps = 26/224 (11%)
Query: 335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENI 392
+L+G G++G VY+G G A+K ++D ++ I +QEI +L ++ H NI
Sbjct: 12 ELVGNGTYGQVYKGRHVKTGQLAAIK---VMDVTGDEEEEI---KQEINMLKKYSHHRNI 65
Query: 393 VQYYGT--DKD----ESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLK 443
YYG K+ + +L++ +E GS+ +L + L++ ++ R+IL GL
Sbjct: 66 ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLS 125
Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR----GTAFWMAPEVI 499
+LH V+HRDIK N+L+ N VKL DFG+ + +L+ R GT +WMAPEVI
Sbjct: 126 HLHQHKVIHRDIKGQNVLLTENAEVKLVDFGV--SAQLDRTVGRRNTFIGTPYWMAPEVI 183
Query: 500 ---NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFI 540
N + Y +D+WSLG T +EM P M + A+F+
Sbjct: 184 ACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL 227
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 9e-29
Identities = 72/212 (33%), Positives = 115/212 (54%), Gaps = 22/212 (10%)
Query: 324 FKRIITYWQKGDLLGRGSFGSVY---EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQE 380
+RI T +G G+FG V+ + IS ++A+K +++ + + KQ + E
Sbjct: 3 LERIKT-------VGTGTFGRVHLVRDRIS--EHYYALKVMAIPEV-IRLKQ-EQHVHNE 51
Query: 381 IALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA--YTRQI 438
+L H I++ + T+ D+ LY+ +E V G L + Y R R S + Y +I
Sbjct: 52 KRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFS-YLRNSGRFSNSTGLFYASEI 110
Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VKSCRGTAFWMAPE 497
+ L+YLH +++V+RD+K NIL+D G +KL DFG AK KL D + GT ++APE
Sbjct: 111 VCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAK--KLRDRTWTLCGTPEYLAPE 168
Query: 498 VINNKNKGYGLPADIWSLGCTVLEMLTSQIPY 529
VI ++KG+ D W+LG + EML P+
Sbjct: 169 VI--QSKGHNKAVDWWALGILIYEMLVGYPPF 198
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 66/182 (36%), Positives = 106/182 (58%), Gaps = 10/182 (5%)
Query: 361 VSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNL 420
V ++D Q ++ + L E+ ++ ++H+N+V+ Y + +L++ +E + G+L ++
Sbjct: 51 VKMMDLRKQQRREL--LFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDI 108
Query: 421 YQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL-AKAT 479
+ L + Q++ +L L YLH Q V+HRDIK +IL+ +G VKL+DFG A+ +
Sbjct: 109 VSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQIS 168
Query: 480 KLNDV---KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVS 536
K DV KS GT +WMAPEVI+ YG DIWSLG V+EM+ + PY V
Sbjct: 169 K--DVPKRKSLVGTPYWMAPEVISRTP--YGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ 224
Query: 537 AI 538
A+
Sbjct: 225 AM 226
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 67/202 (33%), Positives = 111/202 (54%), Gaps = 15/202 (7%)
Query: 336 LLGRGSFGSVYEG-ISDDGFFFAVK----EVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
+LG+GSFG V+ + FFA+K +V L+D + + +E+ + L+ +EH
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVEC----TMVEKRVLSLA-WEHP 56
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD-SQVSAYTRQILLGLKYLHDQD 449
+ Y T + + L+ +E + G L+ Q H D + + Y +I+ GL++LH +
Sbjct: 57 FLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG 116
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR--GTAFWMAPEVINNKNKGYG 507
+V+RD+K NIL+D +G +K+ADFG+ K L D K+C GT ++APE++ + Y
Sbjct: 117 IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQK--YN 174
Query: 508 LPADIWSLGCTVLEMLTSQIPY 529
D WS G + EML Q P+
Sbjct: 175 TSVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 70/196 (35%), Positives = 109/196 (55%), Gaps = 10/196 (5%)
Query: 337 LGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
+G GS G V + G AVK++ L Q Q L E+ ++ ++HEN+V+
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQ-----QRRELLFNEVVIMRDYQHENVVEM 82
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI 455
Y + +L++ +E + G+L ++ + + Q++A +L L LH Q V+HRDI
Sbjct: 83 YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDI 142
Query: 456 KCANILVDANGSVKLADFGL-AKATK-LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIW 513
K +IL+ +G VKL+DFG A+ +K + KS GT +WMAPE+I+ YG DIW
Sbjct: 143 KSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLP--YGPEVDIW 200
Query: 514 SLGCTVLEMLTSQIPY 529
SLG V+EM+ + PY
Sbjct: 201 SLGIMVIEMVDGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 70/207 (33%), Positives = 113/207 (54%), Gaps = 9/207 (4%)
Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
+G GSFG+VY + A+K++S G Q+ + + +E+ L + H N +QY
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSY--SGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 396 YGTDKDESKLYIFLE--LVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
G E ++ +E L + LL ++++ L++ +++A T L GL YLH +++HR
Sbjct: 81 RGCYLREHTAWLVMEYCLGSASDLLEVHKK-PLQEVEIAAVTHGALQGLAYLHSHNMIHR 139
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKG-YGLPADI 512
D+K NIL+ G VKL DFG A+ + GT +WMAPEVI ++G Y D+
Sbjct: 140 DVKAGNILLSEPGLVKLGDFG--SASIMAPANXFVGTPYWMAPEVILAMDEGQYDGKVDV 197
Query: 513 WSLGCTVLEMLTSQIPYAPMECVSAIF 539
WSLG T +E+ + P M +SA++
Sbjct: 198 WSLGITCIELAERKPPLFNMNAMSALY 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 2e-28
Identities = 72/207 (34%), Positives = 112/207 (54%), Gaps = 13/207 (6%)
Query: 331 WQKGDLLGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
W+ LG G+FG VY+ + + G A K + +++++ + EI +L+ H
Sbjct: 14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVIE-----TKSEEELEDYMVEIEILATCNH 68
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSL--LNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
IV+ G + KL+I +E G++ + L L + Q+ RQ+L L+YLH
Sbjct: 69 PYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHS 128
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGL-AKATK-LNDVKSCRGTAFWMAPEVI---NNK 502
++HRD+K N+L+ +G +KLADFG+ AK K L S GT +WMAPEV+ K
Sbjct: 129 MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMK 188
Query: 503 NKGYGLPADIWSLGCTVLEMLTSQIPY 529
+ Y ADIWSLG T++EM + P+
Sbjct: 189 DTPYDYKADIWSLGITLIEMAQIEPPH 215
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 2e-28
Identities = 74/233 (31%), Positives = 115/233 (49%), Gaps = 20/233 (8%)
Query: 330 YWQKGDLLGRGSFGSV----YEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 384
Y +K +LG G FG V Y+ +D G AVK + + +Q+ S ++EI +L
Sbjct: 5 YLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTL----KRECGQQNTSGWKKEINIL 60
Query: 385 SRFEHENIVQYYG--TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGL 442
HENIV+Y G +++ L + +E V GSL + ++ L +Q+ + +QI G+
Sbjct: 61 KTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGM 120
Query: 443 KYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-----KSCRGTAFWMAPE 497
YLH Q +HRD+ N+L+D + VK+ DFGLAKA + FW A E
Sbjct: 121 AYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVE 180
Query: 498 VINNKNKGYGLPADIWSLGCTVLEMLTSQIPY--APMECVSAIFIKTVAVTVI 548
+ K + +D+WS G T+ E+LT P + I K +TV+
Sbjct: 181 CL--KENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVV 231
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 2e-28
Identities = 69/205 (33%), Positives = 111/205 (54%), Gaps = 14/205 (6%)
Query: 337 LGRGSFGSVY----EGISDDGFFFAVK---EVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
LG G++G V+ G D G +A+K + +++ + A+ + ++ Q + + R
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTE-RQVLEAVRRCPF 66
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
+V + + ++KL++ L+ V G L +LYQR H +S+V Y +I+L L +LH
Sbjct: 67 --LVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQL 124
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAK---ATKLNDVKSCRGTAFWMAPEVINNKNKG 505
+++RDIK NIL+D+ G V L DFGL+K A + S GT +MAPEVI + G
Sbjct: 125 GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGG 184
Query: 506 YGLPADIWSLGCTVLEMLTSQIPYA 530
+ D WSLG E+LT P+
Sbjct: 185 HDKAVDWWSLGVLTFELLTGASPFT 209
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 2e-28
Identities = 82/229 (35%), Positives = 118/229 (51%), Gaps = 29/229 (12%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
W+ + +G+G++G VY+ + DG AVK +LD S + I E E +L
Sbjct: 24 WEIIETIGKGTYGKVYKVTNKKDGSLAAVK---ILDPISDVDEEI---EAEYNILQSLPN 77
Query: 389 HENIVQYYG----TDK-DESKLYIFLELVTKGS-------LLNLYQRYHLRDSQVSAYTR 436
H N+V++YG DK +L++ LEL GS LL QR L ++ +S
Sbjct: 78 HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQR--LDEAMISYILY 135
Query: 437 QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA---KATKLNDVKSCRGTAFW 493
LLGL++LH+ ++HRD+K NIL+ G VKL DFG++ +T+L S GT FW
Sbjct: 136 GALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFW 194
Query: 494 MAPEVI---NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIF 539
MAPEVI + Y D+WSLG T +E+ P M V +F
Sbjct: 195 MAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLF 243
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 73/224 (32%), Positives = 118/224 (52%), Gaps = 26/224 (11%)
Query: 335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENI 392
+++G G++G VY+G G A+K + + + + +++ EI +L ++ H NI
Sbjct: 22 EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEE------EIKLEINMLKKYSHHRNI 75
Query: 393 VQYYGTDKDES------KLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLK 443
YYG +S +L++ +E GS+ +L + L++ ++ R+IL GL
Sbjct: 76 ATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLA 135
Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR----GTAFWMAPEVI 499
+LH V+HRDIK N+L+ N VKL DFG+ + +L+ R GT +WMAPEVI
Sbjct: 136 HLHAHKVIHRDIKGQNVLLTENAEVKLVDFGV--SAQLDRTVGRRNTFIGTPYWMAPEVI 193
Query: 500 ---NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFI 540
N + Y +DIWSLG T +EM P M + A+F+
Sbjct: 194 ACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL 237
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 61/173 (35%), Positives = 101/173 (58%), Gaps = 4/173 (2%)
Query: 359 KEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLL 418
K+V++ + +Q L E+ ++ + HEN+V Y + +L++ +E + G+L
Sbjct: 48 KQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT 107
Query: 419 NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL-AK 477
++ + + Q++ +L L YLH+Q V+HRDIK +IL+ ++G +KL+DFG A+
Sbjct: 108 DIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQ 167
Query: 478 ATK-LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY 529
+K + KS GT +WMAPEVI+ YG DIWSLG V+EM+ + PY
Sbjct: 168 VSKEVPKRKSLVGTPYWMAPEVISRLP--YGTEVDIWSLGIMVIEMIDGEPPY 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 4e-28
Identities = 68/230 (29%), Positives = 120/230 (52%), Gaps = 13/230 (5%)
Query: 307 SSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLD 365
SSS+++ S + ++ ++ + +G G+ G+VY+ I G +A+K +
Sbjct: 52 SSSSSSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVI---- 107
Query: 366 QGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH 425
G+ Q+ +EI +L H N+V+ + ++ + LE + GSL +
Sbjct: 108 YGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEG---THI 164
Query: 426 LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK--ATKLND 483
+ ++ RQIL G+ YLH + +VHRDIK +N+L+++ +VK+ADFG+++ A ++
Sbjct: 165 ADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP 224
Query: 484 VKSCRGTAFWMAPEVIN---NKNKGYGLPADIWSLGCTVLEMLTSQIPYA 530
S GT +M+PE IN N G DIWSLG ++LE + P+
Sbjct: 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFG 274
|
Length = 353 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 4e-28
Identities = 73/236 (30%), Positives = 119/236 (50%), Gaps = 11/236 (4%)
Query: 307 SSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQ 366
S E + +I G K+ T ++K +G+G+ G+VY + +EV++
Sbjct: 1 SDEEILEKLRSIVSVGDPKKKYTRFEK---IGQGASGTVYTAMD----VATGQEVAIRQM 53
Query: 367 GSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHL 426
Q + + EI ++ ++ NIV Y + +L++ +E + GSL ++ +
Sbjct: 54 NLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM 113
Query: 427 RDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS 486
+ Q++A R+ L L++LH V+HRDIK NIL+ +GSVKL DFG K
Sbjct: 114 DEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 173
Query: 487 CR--GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFI 540
GT +WMAPEV+ K YG DIWSLG +EM+ + PY + A+++
Sbjct: 174 STMVGTPYWMAPEVVT--RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL 227
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 6e-28
Identities = 77/231 (33%), Positives = 124/231 (53%), Gaps = 13/231 (5%)
Query: 313 EPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAK 371
E + +I G K+ T ++K +G+G+ G+VY I G A+K+++L Q +
Sbjct: 6 EKLRSIVSVGDPKKKYTRFEK---IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKK-- 60
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV 431
+ EI ++ ++ NIV Y + +L++ +E + GSL ++ + + Q+
Sbjct: 61 ---ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI 117
Query: 432 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL-AKATKLNDVKSCR-G 489
+A R+ L L +LH V+HRDIK NIL+ +GSVKL DFG A+ T +S G
Sbjct: 118 AAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVG 177
Query: 490 TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFI 540
T +WMAPEV+ K YG DIWSLG +EM+ + PY + A+++
Sbjct: 178 TPYWMAPEVVT--RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL 226
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 7e-28
Identities = 66/215 (30%), Positives = 100/215 (46%), Gaps = 35/215 (16%)
Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ- 394
LG G+FG VY+ G A+K++ + ++ I+ L +EI +L + +H N+V
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGF--PITAL-REIKILKKLKHPNVVPL 72
Query: 395 ----YYGTDKDESKLYIFLELVT-------KGSLLNLYQRYHLRDSQVSAYTRQILLGLK 443
DK + K +VT G L N L +SQ+ Y Q+L G+
Sbjct: 73 IDMAVERPDKSKRKRGSVY-MVTPYMDHDLSGLLEN--PSVKLTESQIKCYMLQLLEGIN 129
Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAK-------------ATKLNDVKSCRGT 490
YLH+ ++HRDIK ANIL+D G +K+ADFGLA+ + T
Sbjct: 130 YLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVT 189
Query: 491 AFWMAPE-VINNKNKGYGLPADIWSLGCTVLEMLT 524
++ PE ++ + Y DIW +GC EM T
Sbjct: 190 RWYRPPELLLGERR--YTTAVDIWGIGCVFAEMFT 222
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 8e-28
Identities = 57/198 (28%), Positives = 100/198 (50%), Gaps = 21/198 (10%)
Query: 337 LGRGSFGSVYE-GISDDGFFFAVKEVSL--LDQGSQAKQSISQLEQEIALLSRFEHENIV 393
+G G+ G V++ + G A+K+V+L L+ G +Q +EI L +H +V
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIP-----NQALREIKALQACQHPYVV 62
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-----LRDSQVSAYTRQILLGLKYLHDQ 448
+ S + +E + L + L ++QV +Y R +L G+ Y+H
Sbjct: 63 KLLDVFPHGSGFVLVMEYMPSD----LSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN 118
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR---GTAFWMAPEVINNKNKG 505
++HRD+K AN+L+ A+G +K+ADFGLA+ + + T ++ APE++ K
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARK- 177
Query: 506 YGLPADIWSLGCTVLEML 523
Y D+W++GC E+L
Sbjct: 178 YDPGVDLWAVGCIFAELL 195
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 112 bits (280), Expect = 9e-28
Identities = 68/202 (33%), Positives = 109/202 (53%), Gaps = 14/202 (6%)
Query: 337 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQ-GSQAKQSISQLEQEIALLSRFEHENIVQ 394
+GRG F VY D A+K+V + + ++A+Q + EI LL + H N+++
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVK---EIDLLKQLNHPNVIK 66
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLY-----QRYHLRDSQVSAYTRQILLGLKYLHDQD 449
Y + ++++L I LEL G L + Q+ + + V Y Q+ ++++H +
Sbjct: 67 YLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR 126
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAK--ATKLNDVKSCRGTAFWMAPEVINNKNKGYG 507
V+HRDIK AN+ + A G VKL D GL + ++K S GT ++M+PE I+ GY
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH--ENGYN 184
Query: 508 LPADIWSLGCTVLEMLTSQIPY 529
+DIWSLGC + EM Q P+
Sbjct: 185 FKSDIWSLGCLLYEMAALQSPF 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 1e-27
Identities = 67/203 (33%), Positives = 109/203 (53%), Gaps = 17/203 (8%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
+QK + +G G++G VY+ + G A+K++ L D ++ S + +EI+LL H
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAI--REISLLKELNH 58
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
NIV+ E+KLY+ E + + ++ + + +Y Q+L GL + H
Sbjct: 59 PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS 118
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA------TKLNDVKSCRGTAFWMAPEVINN 501
V+HRD+K N+L++ G++KLADFGLA+A T ++V T ++ APE++
Sbjct: 119 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYRAPEILLG 174
Query: 502 KNKGYGLPADIWSLGCTVLEMLT 524
K Y DIWSLGC EM+T
Sbjct: 175 -CKYYSTAVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 1e-27
Identities = 70/206 (33%), Positives = 106/206 (51%), Gaps = 21/206 (10%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL---SR 386
+++ +G G++G+VY+ + G F A+K+V + S+ +S L +EIALL
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRV--PLSEEGIPLSTL-REIALLKQLES 57
Query: 387 FEHENIVQYYG-----TDKDESKLYIFLELVTKGSLLNLYQRYH----LRDSQVSAYTRQ 437
FEH NIV+ E KL + E V + L Y L + RQ
Sbjct: 58 FEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQD--LATYLSKCPKPGLPPETIKDLMRQ 115
Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-DVKSCRGTAFWMAP 496
+L G+ +LH +VHRD+K NILV ++G VK+ADFGLA+ + S T ++ AP
Sbjct: 116 LLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAP 175
Query: 497 EVINNKNKGYGLPADIWSLGCTVLEM 522
EV+ + Y P D+WS+GC E+
Sbjct: 176 EVLLQSS--YATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 64/206 (31%), Positives = 112/206 (54%), Gaps = 23/206 (11%)
Query: 336 LLGRGSFGSV----YEGISDDGFFFAVK----EVSLLDQGSQAKQSISQLEQEIALLSRF 387
+LG+GSFG V +G + +AVK +V L D + + E+ + L+
Sbjct: 2 VLGKGSFGKVLLAELKGTDE---LYAVKVLKKDVILQDDDVEC----TMTEKRVLALAG- 53
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLH 446
+H + Q + + + +L+ +E V G L+ QR + + Y +I+LGL++LH
Sbjct: 54 KHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLH 113
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEVINNKN 503
++ +++RD+K N+L+D+ G +K+ADFG+ K L V + C GT ++APE+++ +
Sbjct: 114 ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFC-GTPDYIAPEILSYQP 172
Query: 504 KGYGLPADIWSLGCTVLEMLTSQIPY 529
YG D W+LG + EML Q P+
Sbjct: 173 --YGPAVDWWALGVLLYEMLAGQSPF 196
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 62/211 (29%), Positives = 105/211 (49%), Gaps = 24/211 (11%)
Query: 336 LLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
++G G++G V + + G A+K+ + K++ + E+ +L + HENIV
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALR---EVKVLRQLRHENIVN 64
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVVH 452
+ + +LY+ E V + +LL L + L V +Y Q+L + Y H +++H
Sbjct: 65 LKEAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIH 123
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRG---------TAFWMAPEVINNKN 503
RDIK NILV +G +KL DFG A+A R T ++ APE++ +
Sbjct: 124 RDIKPENILVSESGVLKLCDFGFARAL------RARPASPLTDYVATRWYRAPELL-VGD 176
Query: 504 KGYGLPADIWSLGCTVLEMLTSQIPYAPMEC 534
YG P D+W++GC + E+L + P P +
Sbjct: 177 TNYGKPVDVWAIGCIMAELLDGE-PLFPGDS 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 64/203 (31%), Positives = 99/203 (48%), Gaps = 15/203 (7%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
LG G FG V+EG+ + A+K +L KQ ++E+ L R H++++ +
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIK---ILKSDDLLKQQ--DFQKEVQALKRLRHKHLISLF 68
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA---YTRQILLGLKYLHDQDVVHR 453
+YI EL+ KGSLL + + V++ Q+ G+ YL +Q+ +HR
Sbjct: 69 AVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHR 128
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 510
D+ NILV + K+ADFGLA+ K DV W APE ++ + +
Sbjct: 129 DLAARNILVGEDLVCKVADFGLARLIK-EDVYLSSDKKIPYKWTAPEAASHGT--FSTKS 185
Query: 511 DIWSLGCTVLEMLT-SQIPYAPM 532
D+WS G + EM T Q+PY M
Sbjct: 186 DVWSFGILLYEMFTYGQVPYPGM 208
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 71/236 (30%), Positives = 112/236 (47%), Gaps = 45/236 (19%)
Query: 332 QKGDLLGRGSFGSVY---EGISDDGFFFAVKEV--SLLDQGSQAKQSISQLEQEIALLSR 386
+ ++GRG+FG V+ + D G +A+K + S + + +Q I+ + E +L+
Sbjct: 4 EVIKVIGRGAFGEVWLVRD--KDTGQVYAMKVLRKSDMIKRNQ----IAHVRAERDILAD 57
Query: 387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYL 445
+ IV+ Y + +DE LY+ +E + G L+NL R + Y +++L L +
Sbjct: 58 ADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSV 117
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAK-----------------ATKLNDVKSCR 488
H +HRDIK NIL+DA+G +KLADFGL K ++V R
Sbjct: 118 HKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRR 177
Query: 489 --------------GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYA 530
GT ++APEV+ + YGL D WSLG + EML P+
Sbjct: 178 RDHKQRRVRANSTVGTPDYIAPEVL--RGTPYGLECDWWSLGVILYEMLYGFPPFY 231
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 3e-27
Identities = 74/231 (32%), Positives = 125/231 (54%), Gaps = 13/231 (5%)
Query: 313 EPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGSQAK 371
E + I G K+ T ++K +G+G+ G+V+ I G A+K+++L Q +
Sbjct: 6 EKLRTIVSIGDPKKKYTRYEK---IGQGASGTVFTAIDVATGQEVAIKQINL-----QKQ 57
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV 431
+ EI ++ ++ NIV + + +L++ +E + GSL ++ + ++Q+
Sbjct: 58 PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQI 117
Query: 432 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL-AKATKLNDVKSCR-G 489
+A R+ L L++LH V+HRDIK N+L+ +GSVKL DFG A+ T +S G
Sbjct: 118 AAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVG 177
Query: 490 TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFI 540
T +WMAPEV+ K YG DIWSLG +EM+ + PY + A+++
Sbjct: 178 TPYWMAPEVVT--RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL 226
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 7e-27
Identities = 69/198 (34%), Positives = 108/198 (54%), Gaps = 18/198 (9%)
Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
+G G++G VY+G + G A+K++ L S+ + S +EI+LL +H NIV
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRL---ESEEEGVPSTAIREISLLKELQHPNIVCL 64
Query: 396 YGTDKDESKLYIFLELVT---KGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVH 452
ES+LY+ E ++ K L +L + ++ V +Y QIL G+ + H + V+H
Sbjct: 65 QDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLH 124
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKL------NDVKSCRGTAFWMAPEVINNKNKGY 506
RD+K N+L+D G +KLADFGLA+A + ++V T ++ APEV+ + Y
Sbjct: 125 RDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV----TLWYRAPEVLLGSPR-Y 179
Query: 507 GLPADIWSLGCTVLEMLT 524
P DIWS+G EM T
Sbjct: 180 STPVDIWSIGTIFAEMAT 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 109 bits (276), Expect = 8e-27
Identities = 67/213 (31%), Positives = 115/213 (53%), Gaps = 22/213 (10%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQ-LEQEIALLSRFE 388
++KG LG G++ VY+ + G A+K++ L + +AK I+ +EI LL +
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKL-GERKEAKDGINFTALREIKLLQELK 60
Query: 389 HENI---VQYYGTDKDESKLYIF----LELVTK-GSLLNLYQRYHLRDSQVSAYTRQILL 440
H NI + +G + + ++ F LE V K S++ L + + +Y L
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIV-------LTPADIKSYMLMTLR 113
Query: 441 GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK-SCRGTAFWM-APEV 498
GL+YLH ++HRD+K N+L+ ++G +KLADFGLA++ + K + + W APE+
Sbjct: 114 GLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPEL 173
Query: 499 INNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP 531
+ YG+ D+WS+GC E+L ++P+ P
Sbjct: 174 LFGARH-YGVGVDMWSVGCIFAELLL-RVPFLP 204
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 1e-26
Identities = 70/207 (33%), Positives = 117/207 (56%), Gaps = 25/207 (12%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL-LDQGSQAKQSISQLEQEIALLSRFE 388
+++ + LG G++ +VY+G + G A+KE+ L ++G+ S +EI+L+ +
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTP-----STAIREISLMKELK 56
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-----LRDSQVSAYTRQILLGLK 443
HENIV+ + E+KL + E + K L Y H L + V ++T Q+L G+
Sbjct: 57 HENIVRLHDVIHTENKLMLVFEYMDKD--LKKYMDTHGVRGALDPNTVKSFTYQLLKGIA 114
Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA------TKLNDVKSCRGTAFWMAPE 497
+ H+ V+HRD+K N+L++ G +KLADFGLA+A T N+V T ++ AP+
Sbjct: 115 FCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV----TLWYRAPD 170
Query: 498 VINNKNKGYGLPADIWSLGCTVLEMLT 524
V+ ++ Y DIWS+GC + EM+T
Sbjct: 171 VLLG-SRTYSTSIDIWSVGCIMAEMIT 196
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 1e-26
Identities = 68/202 (33%), Positives = 107/202 (52%), Gaps = 16/202 (7%)
Query: 336 LLGRGSFGS---VYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
++G GSFG V SD +A+KE+ L S + S +E LL++ +H NI
Sbjct: 7 VVGEGSFGRALLVQHVNSDQ--KYAMKEIRLPKSSSAVEDS----RKEAVLLAKMKHPNI 60
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQ-VSAYTRQILLGLKYLHDQD 449
V + + + + LYI +E G L+ QR L + + Q+ LG++++H++
Sbjct: 61 VAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR 120
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR--GTAFWMAPEVINNKNKGYG 507
V+HRDIK NI + NG VKL DFG A+ +C GT +++ PE+ +N Y
Sbjct: 121 VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIW--ENMPYN 178
Query: 508 LPADIWSLGCTVLEMLTSQIPY 529
+DIWSLGC + E+ T + P+
Sbjct: 179 NKSDIWSLGCILYELCTLKHPF 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-26
Identities = 70/201 (34%), Positives = 110/201 (54%), Gaps = 11/201 (5%)
Query: 336 LLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
L+G GS+G V + + G A+K+ L + + + I+ +EI +L + HEN+V
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKF-LESEDDKMVKKIAM--REIRMLKQLRHENLVN 64
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVVH 452
+ + +LY+ E V ++L+ ++Y L +S+V Y QIL G+++ H +++H
Sbjct: 65 LIEVFRRKKRLYLVFEFVDH-TVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIH 123
Query: 453 RDIKCANILVDANGSVKLADFGLAK--ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 510
RDIK NILV +G VKL DFG A+ A T ++ APE++ K YG
Sbjct: 124 RDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTK-YGRAV 182
Query: 511 DIWSLGCTVLEMLTSQIPYAP 531
DIW++GC V EMLT + P P
Sbjct: 183 DIWAVGCLVTEMLTGE-PLFP 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 69/204 (33%), Positives = 110/204 (53%), Gaps = 19/204 (9%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
+QK + +G G++G VY+ G A+K++ L + + S + +EI+LL H
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRL-ETEDEGVPSTAI--REISLLKELNH 57
Query: 390 ENIVQYYGTDKDESKLYI---FLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLH 446
NIV+ E+KLY+ FL+L K + + L + +Y Q+L G+ Y H
Sbjct: 58 PNIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTG-LDPPLIKSYLYQLLQGIAYCH 116
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKA------TKLNDVKSCRGTAFWMAPEVIN 500
V+HRD+K N+L+D G++KLADFGLA+A T ++V T ++ APE++
Sbjct: 117 SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV----TLWYRAPEILL 172
Query: 501 NKNKGYGLPADIWSLGCTVLEMLT 524
++ Y P DIWS+GC EM+
Sbjct: 173 G-SRQYSTPVDIWSIGCIFAEMVN 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 66/203 (32%), Positives = 105/203 (51%), Gaps = 17/203 (8%)
Query: 334 GDLLGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
G+ LG GSFG V G ++A+K L + + + + QE ++L H I
Sbjct: 23 GETLGTGSFGRVRIAKHKGTGEYYAIK--CLKKREILKMKQVQHVAQEKSILMELSHPFI 80
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS-----QVSA-YTRQILLGLKYLH 446
V + +DE+++Y LE V G L HLR + V+ Y +++L +YLH
Sbjct: 81 VNMMCSFQDENRVYFLLEFVVGGELFT-----HLRKAGRFPNDVAKFYHAELVLAFEYLH 135
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGY 506
+D+++RD+K N+L+D G VK+ DFG AK C GT ++APEVI ++KG+
Sbjct: 136 SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLC-GTPEYLAPEVI--QSKGH 192
Query: 507 GLPADIWSLGCTVLEMLTSQIPY 529
G D W++G + E + P+
Sbjct: 193 GKAVDWWTMGVLLYEFIAGYPPF 215
|
Length = 329 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 5e-26
Identities = 62/208 (29%), Positives = 103/208 (49%), Gaps = 22/208 (10%)
Query: 336 LLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
+GRG+FG+V + + G AVK + + K+ + L+ ++ + IV+
Sbjct: 11 EIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLD---VVMRSSDCPYIVK 67
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQ------VSAYTRQILLGLKYL-HD 447
+YG E +I +EL+ SL Y+ + + + L YL +
Sbjct: 68 FYGALFREGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE 126
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLA-----KATKLNDVKSCRGTAFWMAPEVIN-N 501
++HRD+K +NIL+D NG++KL DFG++ K D CR +MAPE I+ +
Sbjct: 127 LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDA-GCRP---YMAPERIDPS 182
Query: 502 KNKGYGLPADIWSLGCTVLEMLTSQIPY 529
GY + +D+WSLG T+ E+ T + PY
Sbjct: 183 ARDGYDVRSDVWSLGITLYEVATGKFPY 210
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 6e-26
Identities = 66/221 (29%), Positives = 109/221 (49%), Gaps = 24/221 (10%)
Query: 324 FKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIA 382
F ++ ++K +G+G+FG V++ A+K+V L++ + I+ L +EI
Sbjct: 7 FCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKV-LMENEKEGF-PITAL-REIK 63
Query: 383 LLSRFEHENIVQYY--------GTDKDESKLYIFLELVT---KGSLLNLYQRYHLRDSQV 431
+L +HEN+V ++ + Y+ E G L N ++ L S++
Sbjct: 64 ILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTL--SEI 121
Query: 432 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL--NDVKSC-- 487
+ +L GL Y+H ++HRD+K ANIL+ +G +KLADFGLA+A L N +
Sbjct: 122 KKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYT 181
Query: 488 -RGTAFWM-APEVINNKNKGYGLPADIWSLGCTVLEMLTSQ 526
R W PE++ + YG P D+W GC + EM T
Sbjct: 182 NRVVTLWYRPPELLLG-ERDYGPPIDMWGAGCIMAEMWTRS 221
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 9e-26
Identities = 75/227 (33%), Positives = 121/227 (53%), Gaps = 25/227 (11%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
W+ + +G+G++G V++ ++ +G AVK +LD + I E E +L +
Sbjct: 20 WEIIETIGKGTYGKVFKVLNKKNGSKAAVK---ILDPIHDIDEEI---EAEYNILKALSD 73
Query: 389 HENIVQYYGT-----DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS----AYT-RQI 438
H N+V++YG K+ +L++ LEL GS+ +L + + R ++ AY +
Sbjct: 74 HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEA 133
Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA---KATKLNDVKSCRGTAFWMA 495
L+GL++LH +HRD+K NIL+ G VKL DFG++ +T+L S GT FWMA
Sbjct: 134 LMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMA 192
Query: 496 PEVI---NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIF 539
PEVI + Y D+WSLG T +E+ P A + + A+F
Sbjct: 193 PEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALF 239
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 68/202 (33%), Positives = 109/202 (53%), Gaps = 14/202 (6%)
Query: 336 LLGRGSFGSVY-----EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
+LG+GSFG V+ G D G +A+K +L + + + + + E +L+ H
Sbjct: 3 VLGQGSFGKVFLVRKITG-PDAGQLYAMK---VLKKATLKVRDRVRTKMERDILAEVNHP 58
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQD 449
IV+ + + E KLY+ L+ + G L L + + V Y ++ L L +LH
Sbjct: 59 FIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG 118
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK--SCRGTAFWMAPEVINNKNKGYG 507
+++RD+K NIL+D G +KL DFGL+K + ++ K S GT +MAPEV+N +G+
Sbjct: 119 IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN--RRGHT 176
Query: 508 LPADIWSLGCTVLEMLTSQIPY 529
AD WS G + EMLT +P+
Sbjct: 177 QSADWWSFGVLMFEMLTGSLPF 198
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-25
Identities = 75/226 (33%), Positives = 113/226 (50%), Gaps = 27/226 (11%)
Query: 337 LGRGSFGSV----YEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
LG G FG V Y+ D+ G AVK + G+ I+ L++EI +L HEN
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH----IADLKKEIEILRNLYHEN 67
Query: 392 IVQYYG--TDKDESKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHD 447
IV+Y G T+ + + + +E + GSL R + Q Y QI G+ YL
Sbjct: 68 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS 127
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGT-AFWMAPE-VINN 501
+ VHRD+ N+LV++ VK+ DFGL KA + + VK + FW APE +I +
Sbjct: 128 RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQS 187
Query: 502 KNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIFIKTVAVT 546
K + + +D+WS G T+ E+LT +PM +F+K + T
Sbjct: 188 K---FYIASDVWSFGVTLYELLTYCDSESSPM----TLFLKMIGPT 226
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 66/201 (32%), Positives = 109/201 (54%), Gaps = 17/201 (8%)
Query: 335 DLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
+G G++G V G A+K++S + + ++++ +EI +L RF+HENI+
Sbjct: 11 SYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTL----REIKILRRFKHENII 66
Query: 394 QYYGTDKDES-----KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
+ S +YI EL+ + L L + HL + + + QIL GLKY+H
Sbjct: 67 GILDIIRPPSFESFNDVYIVQELM-ETDLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSA 125
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----WM-APEVINNKN 503
+V+HRD+K +N+L++ N +K+ DFGLA+ + T + W APE++ N +
Sbjct: 126 NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLN-S 184
Query: 504 KGYGLPADIWSLGCTVLEMLT 524
KGY DIWS+GC + EML+
Sbjct: 185 KGYTKAIDIWSVGCILAEMLS 205
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 2e-25
Identities = 63/198 (31%), Positives = 111/198 (56%), Gaps = 18/198 (9%)
Query: 337 LGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
+G+GS+G V DG + +K+++L + + +++ EQE LLS+ +H NIV Y
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAA---EQEAQLLSQLKHPNIVAY 64
Query: 396 YGT-DKDESKLYIFLELVTKGSLLNLYQRYH------LRDSQVSAYTRQILLGLKYLHDQ 448
+ + ++ LYI + G +LY + L ++QV + QI + L+YLH++
Sbjct: 65 RESWEGEDGLLYIVMGFCEGG---DLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK 121
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATK-LNDVKSCR-GTAFWMAPEVINNKNKGY 506
++HRD+K N+ + +K+ D G+A+ + D+ S GT ++M+PE+ +NK Y
Sbjct: 122 HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKP--Y 179
Query: 507 GLPADIWSLGCTVLEMLT 524
+D+W+LGC V EM T
Sbjct: 180 NYKSDVWALGCCVYEMAT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 60/205 (29%), Positives = 103/205 (50%), Gaps = 14/205 (6%)
Query: 332 QKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
+ G +G+G FG V G G AVK L D + A+ ++ E ++++ H N
Sbjct: 9 KLGATIGKGEFGDVMLGDYR-GQKVAVK--CLKDDSTAAQAFLA----EASVMTTLRHPN 61
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHDQ 448
+VQ G + LYI E + KGSL++ + R + +Q + + G++YL ++
Sbjct: 62 LVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK 121
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGL 508
+ VHRD+ N+LV + K++DFGLAK S + W APE + + K +
Sbjct: 122 NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG-QDSGKLPVKWTAPEAL--REKKFST 178
Query: 509 PADIWSLGCTVLEMLT-SQIPYAPM 532
+D+WS G + E+ + ++PY +
Sbjct: 179 KSDVWSFGILLWEIYSFGRVPYPRI 203
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 5e-25
Identities = 62/203 (30%), Positives = 108/203 (53%), Gaps = 17/203 (8%)
Query: 336 LLGRGSFGSVYEG-ISDDGFFFAVK----EVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
+LG+GSFG V + FFA+K +V L D + + +E+ + L+ +EH
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVEC----TMVERRVLALA-WEHP 56
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD-SQVSAYTRQILLGLKYLHDQD 449
+ + T + + L+ +E + G L+ Q D ++ Y +I+ GL++LH +
Sbjct: 57 FLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG 116
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEVINNKNKGY 506
+++RD+K N+L+D +G +K+ADFG+ K + K+ C GT ++APE++ K + Y
Sbjct: 117 IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC-GTPDYIAPEIL--KGQKY 173
Query: 507 GLPADIWSLGCTVLEMLTSQIPY 529
D WS G + EML Q P+
Sbjct: 174 NESVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 6e-25
Identities = 60/198 (30%), Positives = 96/198 (48%), Gaps = 11/198 (5%)
Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
+G+G +G V+ D G A+K + + + E +L+ + E +V+
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMK--KSLLFKLNEVRHVLTERDILTTTKSEWLVKL 66
Query: 396 YGTDKDESKLYIFLELVTKG---SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVH 452
+D+ LY+ +E V G +LLN L + Y ++ + LH+ +H
Sbjct: 67 LYAFQDDEYLYLAMEYVPGGDFRTLLN--NLGVLSEDHARFYMAEMFEAVDALHELGYIH 124
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADI 512
RD+K N L+DA+G +KL DFGL+K + S G+ +MAPEV+ KGY D
Sbjct: 125 RDLKPENFLIDASGHIKLTDFGLSKGI-VTYANSVVGSPDYMAPEVLR--GKGYDFTVDY 181
Query: 513 WSLGCTVLEMLTSQIPYA 530
WSLGC + E L P++
Sbjct: 182 WSLGCMLYEFLCGFPPFS 199
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 6e-25
Identities = 68/203 (33%), Positives = 112/203 (55%), Gaps = 11/203 (5%)
Query: 336 LLGRGSFGSVY----EGISDDGFFFAVKEVSLLDQGSQAK-QSISQLEQEIALLSRFEHE 390
+LG G++G V+ D G +A+K + +AK ++ E+ + R +
Sbjct: 7 VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVR-QSP 65
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQD 449
+V + + E+KL++ L+ V+ G + +LYQR + + +V Y+ +I+L L++LH
Sbjct: 66 FLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLG 125
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAK---ATKLNDVKSCRGTAFWMAPEVINNKNKGY 506
+V+RDIK NIL+D+ G V L DFGL+K + + S GT +MAPE+I K G+
Sbjct: 126 IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKG-GH 184
Query: 507 GLPADIWSLGCTVLEMLTSQIPY 529
G D WSLG + E+LT P+
Sbjct: 185 GKAVDWWSLGILIFELLTGASPF 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 7e-25
Identities = 71/223 (31%), Positives = 101/223 (45%), Gaps = 37/223 (16%)
Query: 336 LLGRGSFGSVYEGISDDGFFFAVKE----VSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
LG G+FG VYEG + D V L +G+ Q + +E L+S F H N
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPN 60
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILL----------- 440
IV+ G YI +EL+ G LL+ +LRD++V + +L
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLS-----YLRDARVERFGPPLLTLKELLDICLDV 115
Query: 441 --GLKYLHDQDVVHRDIKCANILV-----DANGSVKLADFGLAKATKLNDVKSCRGTAF- 492
G YL +HRD+ N LV DA+ VK+ DFGLA+ +D G
Sbjct: 116 AKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLL 175
Query: 493 ---WMAPE-VINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYA 530
WMAPE +++ K + +D+WS G + E+LT Q PY
Sbjct: 176 PVRWMAPESLLDGK---FTTQSDVWSFGVLMWEILTLGQQPYP 215
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 7e-25
Identities = 57/209 (27%), Positives = 88/209 (42%), Gaps = 33/209 (15%)
Query: 335 DLLGRGSFGSVYEGISDDGFF----FAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
LG GSFG V G AVK + + + +E A++ +HE
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLK----SDKLSDIMDDFLKEAAIMHSLDHE 56
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA--------YTRQILLGL 442
N+++ YG + + EL GSLL+ LR + Y QI G+
Sbjct: 57 NLIRLYGVVLTHPLMMVT-ELAPLGSLLD-----RLRKDALGHFLISTLCDYAVQIANGM 110
Query: 443 KYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF-------WMA 495
+YL + +HRD+ NIL+ ++ VK+ DFGL +A N+ W A
Sbjct: 111 RYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNE--DHYVMEEHLKVPFAWCA 168
Query: 496 PEVINNKNKGYGLPADIWSLGCTVLEMLT 524
PE + + + +D+W G T+ EM T
Sbjct: 169 PESLRTRT--FSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 67/199 (33%), Positives = 99/199 (49%), Gaps = 6/199 (3%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQ-SISQLEQEIALLSRFEHENIVQY 395
LG GSFG V + F V + ++ KQ + + E +L+ H V
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVA-IKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNL 96
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVHRD 454
YG+ KDES LY+ LE V G +R + V Y QI+L +YL ++V+RD
Sbjct: 97 YGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRD 156
Query: 455 IKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWS 514
+K N+L+D +G +K+ DFG AK C GT ++APE++ N G+G AD W+
Sbjct: 157 LKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLC-GTPEYIAPEIL--LNVGHGKAADWWT 213
Query: 515 LGCTVLEMLTSQIPYAPME 533
LG + E+L P+ E
Sbjct: 214 LGIFIYEILVGCPPFYANE 232
|
Length = 340 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 2e-24
Identities = 72/208 (34%), Positives = 104/208 (50%), Gaps = 18/208 (8%)
Query: 336 LLGRGSFGSVY---EGISDDGFFFAV-KEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
L+GRG FG V E + D + V K+ LL A++++S E+E +LS
Sbjct: 8 LVGRGHFGEVQVVREKATGDIYAMKVMKKSVLL-----AQETVSFFEEERDILSISNSPW 62
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQD 449
I Q +D+ LY+ +E G LL+L RY + Y +++L + +H
Sbjct: 63 IPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG 122
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDV---KSCRGTAFWMAPEV---INNKN 503
VHRDIK N+L+D G +KLADFG A N + K GT ++APEV +N
Sbjct: 123 YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDG 182
Query: 504 KG-YGLPADIWSLGCTVLEMLTSQIPYA 530
KG YG+ D WSLG EM+ + P+
Sbjct: 183 KGTYGVECDWWSLGVIAYEMIYGRSPFH 210
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-24
Identities = 66/206 (32%), Positives = 102/206 (49%), Gaps = 22/206 (10%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
LG G FG V+ G + A+K L QGS S E L+ + +H +V+ Y
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKS---LKQGSM---SPEAFLAEANLMKQLQHPRLVRLY 67
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
E +YI E + GSL++ + L +++ QI G+ ++ ++ +HR
Sbjct: 68 AVVTQEP-IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHR 126
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYG--- 507
D++ ANILV K+ADFGLA+ + N+ + G F W APE IN YG
Sbjct: 127 DLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN-----YGTFT 181
Query: 508 LPADIWSLGCTVLEMLT-SQIPYAPM 532
+ +D+WS G + E++T +IPY M
Sbjct: 182 IKSDVWSFGILLTEIVTYGRIPYPGM 207
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 5e-24
Identities = 64/203 (31%), Positives = 107/203 (52%), Gaps = 15/203 (7%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
LG G FG V+ G ++ AVK L G+ S+ +E L+ +H+ +V+ Y
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKT---LKPGTM---SVQAFLEEANLMKTLQHDKLVRLY 67
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
E +YI E + KGSLL+ + + ++ ++ QI G+ Y+ ++ +HR
Sbjct: 68 AVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHR 127
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 510
D++ AN+LV + K+ADFGLA+ + N+ + G F W APE IN + + + +
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS--FTIKS 185
Query: 511 DIWSLGCTVLEMLT-SQIPYAPM 532
D+WS G + E++T +IPY M
Sbjct: 186 DVWSFGILLYEIVTYGKIPYPGM 208
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 6e-24
Identities = 68/204 (33%), Positives = 106/204 (51%), Gaps = 18/204 (8%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
LG+G FG V+ G + A+K L G+ + ++ QE ++ + HE +VQ Y
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKT---LKPGTMSPEA---FLQEAQVMKKLRHEKLVQLY 67
Query: 397 GTDKDESKLYIFLELVTKGSLLNL----YQRYHLRDSQVSAYTRQILLGLKYLHDQDVVH 452
+E +YI E ++KGSLL+ +Y LR Q+ QI G+ Y+ + VH
Sbjct: 68 AVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVERMNYVH 125
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLP 509
RD++ ANILV N K+ADFGLA+ + N+ + +G F W APE + +
Sbjct: 126 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--FTIK 183
Query: 510 ADIWSLGCTVLEMLTS-QIPYAPM 532
+D+WS G + E+ T ++PY M
Sbjct: 184 SDVWSFGILLTELTTKGRVPYPGM 207
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 8e-24
Identities = 62/208 (29%), Positives = 98/208 (47%), Gaps = 20/208 (9%)
Query: 337 LGRGSFGSVYEGI--SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
LG G+FGSV +G+ G V V L Q A + +E +++++ +H IV+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVA-VKTLKQEHIAAGK-KEFLREASVMAQLDHPCIVR 60
Query: 395 YYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
G K E L + +EL G LL L +R + S + Q+ +G+ YL + VHR
Sbjct: 61 LIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHR 119
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLND--VKSCRGTAF---WMAPEVINNKNKGYGL 508
D+ N+L+ K++DFG+++A ++ + W APE IN YG
Sbjct: 120 DLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECIN-----YGK 174
Query: 509 ---PADIWSLGCTVLEMLT-SQIPYAPM 532
+D+WS G T+ E + PY M
Sbjct: 175 FSSKSDVWSYGVTLWEAFSYGAKPYGEM 202
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 62/213 (29%), Positives = 114/213 (53%), Gaps = 28/213 (13%)
Query: 330 YWQKGDLLGRGSFG---SVYEGISDDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLS 385
++ LG+G++G S + + A+K+++ + + AK+++ +E+ LL
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRAL----RELKLLR 56
Query: 386 RF-EHENIVQYYGTD----KDESKLYIFLELVTKGSLLNLYQRYH----LRDSQVSAYTR 436
F H+NI Y D + ++LY++ EL+ +L+Q L D+ ++
Sbjct: 57 HFRGHKNITCLYDMDIVFPGNFNELYLYEELME----ADLHQIIRSGQPLTDAHFQSFIY 112
Query: 437 QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR------GT 490
QIL GLKY+H +V+HRD+K N+LV+A+ +K+ DFGLA+ N ++ T
Sbjct: 113 QILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVAT 172
Query: 491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEML 523
++ APE++ + + Y D+WS+GC + E+L
Sbjct: 173 RWYRAPEIMLS-FQSYTKAIDVWSVGCILAELL 204
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 2e-23
Identities = 62/211 (29%), Positives = 106/211 (50%), Gaps = 20/211 (9%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
++K + +G G++G+V++ + + A+K V L D + S +EI LL +H
Sbjct: 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD---DEGVPSSALREICLLKELKH 58
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY------HLRDSQVSAYTRQILLGLK 443
+NIV+ Y + KL + E + ++Y + V ++ Q+L GL
Sbjct: 59 KNIVRLYDVLHSDKKLTLVFEYCDQD-----LKKYFDSCNGDIDPEIVKSFMFQLLKGLA 113
Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRG---TAFWMAPEVIN 500
+ H +V+HRD+K N+L++ NG +KLADFGLA+A + V+ T ++ P+V+
Sbjct: 114 FCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGI-PVRCYSAEVVTLWYRPPDVLF 172
Query: 501 NKNKGYGLPADIWSLGCTVLEMLTSQIPYAP 531
K Y D+WS GC E+ + P P
Sbjct: 173 GA-KLYSTSIDMWSAGCIFAELANAGRPLFP 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 2e-23
Identities = 63/214 (29%), Positives = 94/214 (43%), Gaps = 33/214 (15%)
Query: 337 LGRGSFGSVYEG------ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
LG G+FG V+ G +D AVK + + + + + E+E LL+ F+HE
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTL----KETASNDARKDFEREAELLTNFQHE 68
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD----------------SQVSAY 434
NIV++YG + + E + G L N + R H D SQ+
Sbjct: 69 NIVKFYGVCTEGDPPIMVFEYMEHGDL-NKFLRSHGPDAAFLKSPDSPMGELTLSQLLQI 127
Query: 435 TRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF-- 492
QI G+ YL Q VHRD+ N LV + VK+ DFG+++ D G
Sbjct: 128 AVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLP 187
Query: 493 --WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT 524
WM PE I + + +D+WS G + E+ T
Sbjct: 188 IRWMPPESI--MYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 2e-23
Identities = 67/203 (33%), Positives = 107/203 (52%), Gaps = 21/203 (10%)
Query: 336 LLGRGSFGSV----YEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
LG+G+FGSV Y+ + D+ G AVK++ Q S A+ + E+EI +L +H+
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKL----QHSTAEH-LRDFEREIEILKSLQHD 65
Query: 391 NIVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYHLR--DSQVSAYTRQILLGLKYLH 446
NIV+Y G L + +E + GSL + Q++ R ++ Y QI G++YL
Sbjct: 66 NIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG 125
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKS-CRGTAFWMAPEVINN 501
+ VHRD+ NILV++ VK+ DFGL K + V+ FW APE +
Sbjct: 126 SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESL-T 184
Query: 502 KNKGYGLPADIWSLGCTVLEMLT 524
++K + + +D+WS G + E+ T
Sbjct: 185 ESK-FSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 4e-23
Identities = 60/205 (29%), Positives = 106/205 (51%), Gaps = 23/205 (11%)
Query: 337 LGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL--SRFEHENIV 393
LG+G FG V + G +A K++ + + ++ E++I SRF IV
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRF----IV 56
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHL--------RDSQVSAYTRQILLGLKYL 445
+ + L + + L+ G L +YH+ +++ Y QI+ GL++L
Sbjct: 57 SLAYAFETKDDLCLVMTLMNGGDL-----KYHIYNVGEPGFPEARAIFYAAQIICGLEHL 111
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VKSCRGTAFWMAPEVINNKNK 504
H + +V+RD+K N+L+D +G+V+++D GLA K +K GT +MAPEV+ + +
Sbjct: 112 HQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVL--QGE 169
Query: 505 GYGLPADIWSLGCTVLEMLTSQIPY 529
Y D ++LGCT+ EM+ + P+
Sbjct: 170 VYDFSVDWFALGCTLYEMIAGRSPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 8e-23
Identities = 61/199 (30%), Positives = 99/199 (49%), Gaps = 16/199 (8%)
Query: 334 GDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
G +G G FG VY+G+ ++ AVK S ++ + QE ++ +F+H
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFL----QEAYIMRQFDH 66
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHD 447
+IV+ G + ++I +EL G L + Q +Y L + + Y+ Q+ L YL
Sbjct: 67 PHIVKLIGVITENP-VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES 125
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-KSCRGT--AFWMAPEVINNKNK 504
+ VHRDI N+LV + VKL DFGL++ + K+ +G WMAPE IN +
Sbjct: 126 KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRR- 184
Query: 505 GYGLPADIWSLGCTVLEML 523
+ +D+W G + E+L
Sbjct: 185 -FTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 8e-23
Identities = 68/235 (28%), Positives = 114/235 (48%), Gaps = 25/235 (10%)
Query: 325 KRIITYWQKGDLLGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
KR + + +G G++G VY+ D G A+K+V L + I+ + +EI +
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRL--DNEKEGFPITAI-REIKI 59
Query: 384 LSRFEHENIVQYYG--TD--------KDESKLYIFLELVTKGSLLNLYQR--YHLRDSQV 431
L + H NIV TD KD+ Y+ E + L+ L + H + +
Sbjct: 60 LRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHI 118
Query: 432 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK--SCRG 489
++ +Q+L GL Y H ++ +HRDIKC+NIL++ G +KLADFGLA+ + + + +
Sbjct: 119 KSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKV 178
Query: 490 TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT------SQIPYAPMECVSAI 538
W P + + YG D+WS GC + E+ T + A +E +S +
Sbjct: 179 ITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRL 233
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 9e-23
Identities = 66/211 (31%), Positives = 104/211 (49%), Gaps = 28/211 (13%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
LGRG++G V + G AVK + + K+ + L+ I++ S + V +
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLD--ISMRSV-DCPYTVTF 65
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV-----SAYTRQILLGLKYLHDQ-D 449
YG E ++I +E V SL Y++ + + + I+ L+YLH +
Sbjct: 66 YGALFREGDVWICME-VMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS 124
Query: 450 VVHRDIKCANILVDANGSVKLADFG--------LAKATKLNDVKSCRGTAFWMAPEVIN- 500
V+HRD+K +N+L++ NG VKL DFG +AK G +MAPE IN
Sbjct: 125 VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDA-------GCKPYMAPERINP 177
Query: 501 -NKNKGYGLPADIWSLGCTVLEMLTSQIPYA 530
KGY + +D+WSLG T++E+ T + PY
Sbjct: 178 ELNQKGYDVKSDVWSLGITMIELATGRFPYD 208
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 1e-22
Identities = 62/202 (30%), Positives = 111/202 (54%), Gaps = 8/202 (3%)
Query: 336 LLGRGSFGSVY--EGIS--DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
+LG G++G V+ +S D G +A+K + +AK + + L +
Sbjct: 7 VLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 66
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
+V + + ++KL++ L+ + G L +L QR ++ +V Y+ +I+L L++LH +
Sbjct: 67 LVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGI 126
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVK---SCRGTAFWMAPEVINNKNKGYG 507
++RDIK NIL+D+NG V L DFGL+K ++V+ S GT +MAP+++ + G+
Sbjct: 127 IYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHD 186
Query: 508 LPADIWSLGCTVLEMLTSQIPY 529
D WS+G + E+LT P+
Sbjct: 187 KAVDWWSMGVLMYELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 1e-22
Identities = 61/210 (29%), Positives = 102/210 (48%), Gaps = 17/210 (8%)
Query: 332 QKGDLLGRGSFGSVYEGI---SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE 388
+K +LG G+FG+VY+G+ + V L ++ S ++ ++ E +++ +
Sbjct: 10 EKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSP--KANKEILDEAYVMASVD 67
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYL 445
H ++V+ G I +L+ G LL+ Y R H + + + QI G+ YL
Sbjct: 68 HPHVVRLLGICLSSQVQLI-TQLMPLGCLLD-YVRNHKDNIGSQYLLNWCVQIAKGMSYL 125
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAK--ATKLNDVKSCRGTA--FWMAPEVINN 501
++ +VHRD+ N+LV VK+ DFGLAK + + G WMA E I +
Sbjct: 126 EEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILH 185
Query: 502 KNKGYGLPADIWSLGCTVLEMLT-SQIPYA 530
+ Y +D+WS G TV E++T PY
Sbjct: 186 RI--YTHKSDVWSYGVTVWELMTFGAKPYE 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 1e-22
Identities = 63/199 (31%), Positives = 109/199 (54%), Gaps = 10/199 (5%)
Query: 332 QKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
Q ++LG G+ G+VY+ AVK + L KQ +S+LE +L + +
Sbjct: 4 QYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELE----ILYKCDSP 59
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
I+ +YG E+++ I E + GSL ++Y++ + + + ++ GL YL +
Sbjct: 60 YIIGFYGAFFVENRISICTEFMDGGSL-DVYRK--IPEHVLGRIAVAVVKGLTYLWSLKI 116
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 510
+HRD+K +N+LV+ G VKL DFG++ + K+ GT +MAPE I+ + YG+ +
Sbjct: 117 LHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGEQ--YGIHS 174
Query: 511 DIWSLGCTVLEMLTSQIPY 529
D+WSLG + +E+ + PY
Sbjct: 175 DVWSLGISFMELALGRFPY 193
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 1e-22
Identities = 67/209 (32%), Positives = 107/209 (51%), Gaps = 18/209 (8%)
Query: 326 RIITYWQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 384
R +T ++K + +G G++G VY + G A+K+V + D + IS L +EI LL
Sbjct: 4 RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRM-DN-ERDGIPISSL-REITLL 60
Query: 385 SRFEHENIVQYYGTDKDESKLYIFL-------ELVTKGSLLNLYQRYHLRDSQVSAYTRQ 437
H NIV+ + IFL +L SLL+ +SQV Q
Sbjct: 61 LNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDL---ASLLDNMPT-PFSESQVKCLMLQ 116
Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL--NDVKSCRGTAFWMA 495
+L GL+YLH+ ++HRD+K +N+L+ G +K+ADFGLA+ L + T ++ A
Sbjct: 117 LLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRA 176
Query: 496 PEVINNKNKGYGLPADIWSLGCTVLEMLT 524
PE++ Y D+W++GC + E+L
Sbjct: 177 PELLLG-CTTYTTAIDMWAVGCILAELLA 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 1e-22
Identities = 59/210 (28%), Positives = 98/210 (46%), Gaps = 23/210 (10%)
Query: 335 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
+ +G+G+FG VY+G+ AVK ++ + QE +L +++H NIV+
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFL----QEAEILKQYDHPNIVK 56
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQIL-------LGLKYLHD 447
G + +YI +ELV GSLL LR + +++L G++YL
Sbjct: 57 LIGVCVQKQPIYIVMELVPGGSLLT-----FLRKKKNRLTVKKLLQMSLDAAAGMEYLES 111
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA----FWMAPEVINNKN 503
++ +HRD+ N LV N +K++DFG+++ + G W APE +N
Sbjct: 112 KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGR 171
Query: 504 KGYGLPADIWSLGCTVLEMLT-SQIPYAPM 532
Y +D+WS G + E + PY M
Sbjct: 172 --YTSESDVWSYGILLWETFSLGDTPYPGM 199
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 1e-22
Identities = 69/213 (32%), Positives = 104/213 (48%), Gaps = 22/213 (10%)
Query: 324 FKRIITYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIA 382
F ++ TY +K D LG GS+ +VY+G S G A+KE+ L + +I +E +
Sbjct: 1 FGKLETY-KKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAI----REAS 55
Query: 383 LLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQIL 439
LL +H NIV + + L + E + L Y L V + Q+L
Sbjct: 56 LLKDLKHANIVTLHDIIHTKKTLTLVFEYLDTD--LKQYMDDCGGGLSMHNVRLFLFQLL 113
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA------TKLNDVKSCRGTAFW 493
GL Y H + V+HRD+K N+L+ G +KLADFGLA+A T N+V T ++
Sbjct: 114 RGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV----TLWY 169
Query: 494 MAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQ 526
P+V+ + Y D+W +GC EM T +
Sbjct: 170 RPPDVLLGSTE-YSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 2e-22
Identities = 73/239 (30%), Positives = 120/239 (50%), Gaps = 42/239 (17%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
LG GS G V+ + SD AVK++ L D QS+ +EI ++ R +H+NIV+
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTD-----PQSVKHALREIKIIRRLDHDNIVKV 67
Query: 396 Y------GTDKDES--------KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLG 441
Y G+D E +YI E + + L N+ ++ L + + Q+L G
Sbjct: 68 YEVLGPSGSDLTEDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLSEEHARLFMYQLLRG 126
Query: 442 LKYLHDQDVVHRDIKCANILVDANGSV-KLADFGLAKATKLNDVKSCRG-------TAFW 493
LKY+H +V+HRD+K AN+ ++ V K+ DFGLA+ ++ S +G T ++
Sbjct: 127 LKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARI--VDPHYSHKGYLSEGLVTKWY 184
Query: 494 MAPEVI---NNKNKGYGLPADIWSLGCTVLEMLTSQIPYA---PMECVSAIFIKTVAVT 546
+P ++ NN K D+W+ GC EMLT + +A +E + I +++V V
Sbjct: 185 RSPRLLLSPNNYTKA----IDMWAAGCIFAEMLTGKPLFAGAHELEQMQLI-LESVPVV 238
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 2e-22
Identities = 56/199 (28%), Positives = 95/199 (47%), Gaps = 14/199 (7%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
LG G FG V+ G A+K ++ +G+ ++ +E ++ + H N+VQ Y
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIK---MIREGAMSED---DFIEEAKVMMKLSHPNLVQLY 65
Query: 397 GTDKDESKLYIFLELVTKGSLLN-LYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
G + ++I E + G LLN L +R L + + ++YL +HRD
Sbjct: 66 GVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRD 125
Query: 455 IKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPAD 511
+ N LV + VK++DFGLA+ + S +GT F W PEV + + +D
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSR--FSSKSD 183
Query: 512 IWSLGCTVLEMLT-SQIPY 529
+WS G + E+ + ++PY
Sbjct: 184 VWSFGVLMWEVFSEGKMPY 202
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 2e-22
Identities = 60/207 (28%), Positives = 110/207 (53%), Gaps = 25/207 (12%)
Query: 336 LLGRGSFGSVYEG-ISDDGFFFAVK----EVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
+LG+GSFG V + G +FAVK +V L+D + + +E+ + L+ +E+
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVEC----TMVEKRVLALA-WENP 56
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS------QVSAYTRQILLGLKY 444
+ Y T + + L+ +E + G L+ +H++D + + Y +I+ GL++
Sbjct: 57 FLTHLYCTFQTKEHLFFVMEFLNGGDLM-----FHIQDKGRFDLYRATFYAAEIVCGLQF 111
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR--GTAFWMAPEVINNK 502
LH + +++RD+K N+++D +G +K+ADFG+ K D ++ GT ++APE++
Sbjct: 112 LHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGL 171
Query: 503 NKGYGLPADIWSLGCTVLEMLTSQIPY 529
Y D WS G + EML Q P+
Sbjct: 172 K--YTFSVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 3e-22
Identities = 67/205 (32%), Positives = 108/205 (52%), Gaps = 18/205 (8%)
Query: 336 LLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGS--QAKQSISQLEQEIALLSRFEH 389
+LG+G +G V++ +D G FA+K +L + + + ++ + + E +L +H
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMK---VLKKATIVRNQKDTAHTKAERNILEAVKH 59
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHD 447
IV + KLY+ LE ++ G L +R + D+ Y +I L L++LH
Sbjct: 60 PFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDT-ACFYLSEISLALEHLHQ 118
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEVINNKNK 504
Q +++RD+K NIL+DA G VKL DFGL K + + C GT +MAPE++
Sbjct: 119 QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFC-GTIEYMAPEIL--MRS 175
Query: 505 GYGLPADIWSLGCTVLEMLTSQIPY 529
G+G D WSLG + +MLT P+
Sbjct: 176 GHGKAVDWWSLGALMYDMLTGAPPF 200
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 3e-22
Identities = 65/207 (31%), Positives = 105/207 (50%), Gaps = 24/207 (11%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
LG G FG V+ G + AVK L G+ + +S +E ++ + H+ +VQ Y
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKT---LKPGTMSPES---FLEEAQIMKKLRHDKLVQLY 67
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQ----RYHLRDSQVSAYTRQILLGLKYLHDQDVVH 452
+E +YI E ++KGSLL+ + R L+ + Q+ G+ Y+ + +H
Sbjct: 68 AVVSEEP-IYIVTEYMSKGSLLDFLKDGEGRA-LKLPNLVDMAAQVAAGMAYIERMNYIH 125
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYG-- 507
RD++ ANILV K+ADFGLA+ + N+ + +G F W APE YG
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEA-----ALYGRF 180
Query: 508 -LPADIWSLGCTVLEMLTS-QIPYAPM 532
+ +D+WS G + E++T ++PY M
Sbjct: 181 TIKSDVWSFGILLTELVTKGRVPYPGM 207
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 3e-22
Identities = 64/203 (31%), Positives = 111/203 (54%), Gaps = 16/203 (7%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
G+++G G FG+V +G G AVK + D +QA +E A++++ H+N+V
Sbjct: 11 GEIIGEGEFGAVLQG-EYTGQKVAVKNIKC-DVTAQA------FLEETAVMTKLHHKNLV 62
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHDQDV 450
+ G LYI +EL++KG+L+N + R + Q+ ++ + G++YL + +
Sbjct: 63 RLLGVILHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKL 121
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 510
VHRD+ NILV +G K++DFGLA+ + V + + W APE + K+K + +
Sbjct: 122 VHRDLAARNILVSEDGVAKVSDFGLARVGSMG-VDNSKLPVKWTAPEAL--KHKKFSSKS 178
Query: 511 DIWSLGCTVLEMLT-SQIPYAPM 532
D+WS G + E+ + + PY M
Sbjct: 179 DVWSYGVLLWEVFSYGRAPYPKM 201
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 3e-22
Identities = 68/203 (33%), Positives = 108/203 (53%), Gaps = 11/203 (5%)
Query: 337 LGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR---FEHENI 392
+G+G+FG VY+ D +A+K +S + AK+ ++ E +L R E I
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLS--KKEIVAKKEVAHTIGERNILVRTLLDESPFI 58
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
V + + +S LY+ + ++ G L +L + + + Y +++L L++LH D+V
Sbjct: 59 VGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIV 118
Query: 452 HRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKGYGLP 509
+RD+K NIL+DA G + L DFGL+KA T + GT ++APEV+ ++ KGY
Sbjct: 119 YRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDE-KGYTKH 177
Query: 510 ADIWSLGCTVLEMLTSQIP-YAP 531
D WSLG V EM P YA
Sbjct: 178 VDFWSLGVLVFEMCCGWSPFYAE 200
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 4e-22
Identities = 63/203 (31%), Positives = 104/203 (51%), Gaps = 16/203 (7%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
LG+G FG V+ G + A+K L G+ ++ QE ++ + H+ +V Y
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKT---LKPGTMMPEA---FLQEAQIMKKLRHDKLVPLY 67
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
+E +YI E + KGSLL+ + +L+ Q+ QI G+ Y+ + +HR
Sbjct: 68 AVVSEEP-IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHR 126
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 510
D++ ANILV N K+ADFGLA+ + N+ + +G F W APE + + +
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--FTIKS 184
Query: 511 DIWSLGCTVLEMLTS-QIPYAPM 532
D+WS G + E++T ++PY M
Sbjct: 185 DVWSFGILLTELVTKGRVPYPGM 207
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 5e-22
Identities = 72/206 (34%), Positives = 107/206 (51%), Gaps = 31/206 (15%)
Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR---FEHENI 392
+G G++G+VY+ G F A+K V + Q ++ +S + +E+ALL R F+H NI
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRV--QTNEDGLPLSTV-REVALLKRLEAFDHPNI 64
Query: 393 VQYYG------TDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
V+ TD+ E+K+ + E V + + L+ L + RQ L GL +
Sbjct: 65 VRLMDVCATSRTDR-ETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDF 123
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRG-------TAFWMAPE 497
LH +VHRD+K NILV + G VKLADFGLA+ + SC+ T ++ APE
Sbjct: 124 LHANCIVHRDLKPENILVTSGGQVKLADFGLAR------IYSCQMALTPVVVTLWYRAPE 177
Query: 498 VINNKNKGYGLPADIWSLGCTVLEML 523
V+ Y P D+WS+GC EM
Sbjct: 178 VLLQST--YATPVDMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 7e-22
Identities = 57/201 (28%), Positives = 105/201 (52%), Gaps = 13/201 (6%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
++K ++GRG+FG V+ D +K++ + + + + E +L H
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAA---QNECQVLKLLSH 58
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLH 446
NI++YY ++ L I +E G+L Q L + + + QILL L ++H
Sbjct: 59 PNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH 118
Query: 447 DQDVVHRDIKCANILVDANGSV-KLADFGLAK--ATKLNDVKSCRGTAFWMAPEVINNKN 503
+ ++HRD+K NIL+D + V K+ DFG++K ++K + + GT +++PE+ +
Sbjct: 119 TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK-SKAYTVVGTPCYISPELC--EG 175
Query: 504 KGYGLPADIWSLGCTVLEMLT 524
K Y +DIW+LGC + E+ +
Sbjct: 176 KPYNQKSDIWALGCVLYELAS 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 9e-22
Identities = 67/203 (33%), Positives = 103/203 (50%), Gaps = 17/203 (8%)
Query: 336 LLGRGSFGSVYEGI---SDDGFFFAV--KEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
+LG+GSFG V +D+ + V K+V L D + E+ I L+ +H
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDC----TMTEKRILALAA-KHP 56
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQD 449
+ + + + +L+ +E V G L+ QR D S Y ++ L L +LH
Sbjct: 57 FLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG 116
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEVINNKNKGY 506
V++RD+K NIL+DA G KLADFG+ K LN V + C GT ++APE++ + Y
Sbjct: 117 VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFC-GTPDYIAPEIL--QELEY 173
Query: 507 GLPADIWSLGCTVLEMLTSQIPY 529
G D W+LG + EM+ Q P+
Sbjct: 174 GPSVDWWALGVLMYEMMAGQPPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 9e-22
Identities = 63/201 (31%), Positives = 102/201 (50%), Gaps = 25/201 (12%)
Query: 337 LGRGSFGSVY---EGISDDGFFFAV-KEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
LG+GSFG+VY + + V KE+ + G Q QE LLS+ +H I
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPV---GELNPNETVQANQEAQLLSKLDHPAI 64
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-----LRDSQVSAYTRQILLGLKYLHD 447
V+++ + + I E L + L ++QV + Q+LLG+ Y+H
Sbjct: 65 VKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ 124
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSC------RGTAFWMAPEVINN 501
+ ++HRD+K NI + N +K+ DFG+++ + SC GT ++M+PE +
Sbjct: 125 RRILHRDLKAKNIFLKNN-LLKIGDFGVSRLL----MGSCDLATTFTGTPYYMSPEAL-- 177
Query: 502 KNKGYGLPADIWSLGCTVLEM 522
K++GY +DIWSLGC + EM
Sbjct: 178 KHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 67/213 (31%), Positives = 103/213 (48%), Gaps = 32/213 (15%)
Query: 338 GRGSFGSVYEGISDDGF---FFAVKEVSLLDQGSQAKQSISQLE-QEIALLSRFEHENIV 393
GRG++G VY+ +G +A+K+ + ISQ +EIALL +HEN+V
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKK---FKGDKEQYTGISQSACREIALLRELKHENVV 65
Query: 394 QYYGT--DKDESKLYIFLELVTKGSLLNLYQ--RYH-------LRDSQVSAYTRQILLGL 442
+ + +Y+ + +L+Q ++H + S V + QIL G+
Sbjct: 66 SLVEVFLEHADKSVYLLFDYAEH----DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGV 121
Query: 443 KYLHDQDVVHRDIKCANILV----DANGSVKLADFGLA----KATK-LNDVKSCRGTAFW 493
YLH V+HRD+K ANILV G VK+ D GLA K L D+ T ++
Sbjct: 122 HYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWY 181
Query: 494 MAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQ 526
APE++ + Y DIW++GC E+LT +
Sbjct: 182 RAPELLLGA-RHYTKAIDIWAIGCIFAELLTLE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 1e-21
Identities = 54/194 (27%), Positives = 96/194 (49%), Gaps = 8/194 (4%)
Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
+G GS+G V++ + + G A+K+ + K+ I+ +EI +L + +H N+V
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKK-IAL--REIRMLKQLKHPNLVNL 65
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
+ + KL++ E L L + + + + Q L + + H + +HRD
Sbjct: 66 IEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRD 125
Query: 455 IKCANILVDANGSVKLADFGLAK--ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADI 512
+K NIL+ G +KL DFG A+ +D T ++ APE++ + YG P D+
Sbjct: 126 VKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQ-YGPPVDV 184
Query: 513 WSLGCTVLEMLTSQ 526
W++GC E+LT Q
Sbjct: 185 WAIGCVFAELLTGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 1e-21
Identities = 66/201 (32%), Positives = 103/201 (51%), Gaps = 20/201 (9%)
Query: 337 LGRGSFGSVYEG--ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR---FEHEN 391
+G G++G V++ + + G F A+K V + Q + +S + +E+A+L FEH N
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRV--QTGEEGMPLSTI-REVAVLRHLETFEHPN 65
Query: 392 IVQYYG------TDKDESKLYIFLELVTKG--SLLNLYQRYHLRDSQVSAYTRQILLGLK 443
+V+ + TD+ E+KL + E V + + L+ + + Q+L GL
Sbjct: 66 VVRLFDVCTVSRTDR-ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLD 124
Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWM-APEVINNK 502
+LH VVHRD+K NILV ++G +KLADFGLA+ + W APEV+
Sbjct: 125 FLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVL--L 182
Query: 503 NKGYGLPADIWSLGCTVLEML 523
Y P D+WS+GC EM
Sbjct: 183 QSSYATPVDLWSVGCIFAEMF 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 2e-21
Identities = 69/225 (30%), Positives = 108/225 (48%), Gaps = 29/225 (12%)
Query: 324 FKRIITYWQKGDLLGRGSFGSVYEG---ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQE 380
F ++ TY K D LG G++ +VY+G ++D+ A+KE+ L + +I +E
Sbjct: 2 FGKLETY-IKLDKLGEGTYATVYKGRSKLTDN--LVALKEIRLEHEEGAPCTAI----RE 54
Query: 381 IALLSRFEHENIVQYYGTDKDESKLYIFLELVTK---------GSLLNLYQRYHLRDSQV 431
++LL +H NIV + E L + E + K G+ +N++ V
Sbjct: 55 VSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHN--------V 106
Query: 432 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL-NDVKSCRGT 490
+ Q+L GL Y H + V+HRD+K N+L++ G +KLADFGLA+A + S
Sbjct: 107 KLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV 166
Query: 491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECV 535
W P I + Y D+W +GC EM T + P P V
Sbjct: 167 TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR-PLFPGSTV 210
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 2e-21
Identities = 57/199 (28%), Positives = 100/199 (50%), Gaps = 14/199 (7%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
LG G FG V G + A+K ++ +GS ++ + +E ++ + HE +VQ Y
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIK---MIKEGSMSE---DEFIEEAKVMMKLSHEKLVQLY 65
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
G + +YI E ++ G LLN + + SQ+ + + G+ YL + +HRD
Sbjct: 66 GVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRD 125
Query: 455 IKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPAD 511
+ N LVD G VK++DFGL++ ++ S G+ F W PEV+ + +D
Sbjct: 126 LAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSK--FSSKSD 183
Query: 512 IWSLGCTVLEMLT-SQIPY 529
+W+ G + E+ + ++PY
Sbjct: 184 VWAFGVLMWEVYSLGKMPY 202
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 2e-21
Identities = 70/219 (31%), Positives = 116/219 (52%), Gaps = 35/219 (15%)
Query: 331 WQKGDLLGRGSFGSVYEG---ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
++K + +G G++G VY+ ++++ A+K++ L +Q + S + +EI+LL
Sbjct: 4 YEKVEKIGEGTYGVVYKARDRVTNE--TIALKKIRL-EQEDEGVPSTAI--REISLLKEM 58
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQ--------VSAYTRQIL 439
+H NIV+ E +LY+ E L+L + H+ S + Y QIL
Sbjct: 59 QHGNIVRLQDVVHSEKRLYLVFEY------LDLDLKKHMDSSPDFAKNPRLIKTYLYQIL 112
Query: 440 LGLKYLHDQDVVHRDIKCANILVD-ANGSVKLADFGLAKA------TKLNDVKSCRGTAF 492
G+ Y H V+HRD+K N+L+D ++KLADFGLA+A T ++V T +
Sbjct: 113 RGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV----TLW 168
Query: 493 WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP 531
+ APE++ ++ Y P DIWS+GC EM+ +Q P P
Sbjct: 169 YRAPEILLG-SRHYSTPVDIWSVGCIFAEMV-NQKPLFP 205
|
Length = 294 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 3e-21
Identities = 64/195 (32%), Positives = 93/195 (47%), Gaps = 11/195 (5%)
Query: 337 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
LG GS+ +VY+GIS +G A+K +S+ + +I +E +LL +H NIV
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAI----REASLLKGLKHANIVLL 68
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVVH 452
+ + L E + L Y H L V + Q+L GL Y+H Q ++H
Sbjct: 69 HDIIHTKETLTFVFEYMHTD--LAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILH 126
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKL-NDVKSCRGTAFWMAPEVINNKNKGYGLPAD 511
RD+K N+L+ G +KLADFGLA+A + + S W P + Y D
Sbjct: 127 RDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALD 186
Query: 512 IWSLGCTVLEMLTSQ 526
IW GC +EML Q
Sbjct: 187 IWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 3e-21
Identities = 49/191 (25%), Positives = 97/191 (50%), Gaps = 19/191 (9%)
Query: 357 AVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGS 416
AVK+++L S +K+ + L+QEI + +H NI+ Y + +S+LY+ L+ GS
Sbjct: 29 AVKKINL---DSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85
Query: 417 LLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADF 473
+L + + L + ++ + +L L Y+H + +HR +K ++IL+ +G V L+
Sbjct: 86 CEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGL 145
Query: 474 GLA--------KATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPADIWSLGCTVLEM 522
+ + ++D + + W++PEV+ +GY +DI+S+G T E+
Sbjct: 146 RYSVSMIKHGKRQRVVHD--FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACEL 203
Query: 523 LTSQIPYAPME 533
+P+ M
Sbjct: 204 ANGHVPFKDMP 214
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 3e-21
Identities = 55/203 (27%), Positives = 105/203 (51%), Gaps = 25/203 (12%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
+G G++G V I + G A+K++ D + AK+++ +E+ +L F+H+NI+
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTL----RELKILRHFKHDNIIA 68
Query: 395 ----YYGTDKDESKLYIFLELVTKGSLLNLYQRYH----LRDSQVSAYTRQILLGLKYLH 446
D +Y+ ++L+ +L+ H L + + + Q+L GLKY+H
Sbjct: 69 IRDILRPPGADFKDVYVVMDLMES----DLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIH 124
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR------GTAFWMAPEVIN 500
+V+HRD+K +N+LV+ + +++ DFG+A+ + + T ++ APE++
Sbjct: 125 SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLL 184
Query: 501 NKNKGYGLPADIWSLGCTVLEML 523
+ Y D+WS+GC EML
Sbjct: 185 SLP-EYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 3e-21
Identities = 61/209 (29%), Positives = 103/209 (49%), Gaps = 16/209 (7%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
LG G FG V+ + AVK + S+ E ++ +H+ +V+ +
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMK------PGSMSVEAFLAEANVMKTLQHDKLVKLH 67
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA---YTRQILLGLKYLHDQDVVHR 453
E +YI E + KGSLL+ + + ++ QI G+ ++ ++ +HR
Sbjct: 68 AVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHR 126
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPA 510
D++ ANILV A+ K+ADFGLA+ + N+ + G F W APE IN + + + +
Sbjct: 127 DLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS--FTIKS 184
Query: 511 DIWSLGCTVLEMLT-SQIPYAPMECVSAI 538
D+WS G ++E++T +IPY M I
Sbjct: 185 DVWSFGILLMEIVTYGRIPYPGMSNPEVI 213
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 3e-21
Identities = 71/223 (31%), Positives = 117/223 (52%), Gaps = 12/223 (5%)
Query: 336 LLGRGSFGSVYEGI--SDDGFFFAVKEVSLLDQGS-QAKQSISQLEQE---IALLSRFEH 389
++GRG FG VY G +D G +A+K LD+ + KQ + E ++L+S +
Sbjct: 1 IIGRGGFGEVY-GCRKADTGKMYAMK---CLDKKRIKMKQGETLALNERIMLSLVSTGDC 56
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSL-LNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
IV KL L+L+ G L +L Q ++++ Y +I+LGL+++H++
Sbjct: 57 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNR 116
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGL 508
VV+RD+K ANIL+D +G V+++D GLA + GT +MAPEV+ K Y
Sbjct: 117 FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVL-QKGVAYDS 175
Query: 509 PADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTVAVTVIIIL 551
AD +SLGC + ++L P+ + I + +T+ + L
Sbjct: 176 SADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVEL 218
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 3e-21
Identities = 63/202 (31%), Positives = 102/202 (50%), Gaps = 15/202 (7%)
Query: 336 LLGRGSFGSVYEG-ISDDGFFFAVK----EVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
+LG+GSFG V + + G +AVK +V L D + + E+ I L+R H
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMT----EKRILSLAR-NHP 56
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD-SQVSAYTRQILLGLKYLHDQD 449
+ Q Y + +L+ +E V G L+ Q+ D ++ Y +I L +LHD+
Sbjct: 57 FLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG 116
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR--GTAFWMAPEVINNKNKGYG 507
+++RD+K N+L+D G KLADFG+ K N + GT ++APE++ + YG
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEIL--QEMLYG 174
Query: 508 LPADIWSLGCTVLEMLTSQIPY 529
D W++G + EML P+
Sbjct: 175 PSVDWWAMGVLLYEMLCGHAPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 3e-21
Identities = 59/207 (28%), Positives = 105/207 (50%), Gaps = 25/207 (12%)
Query: 336 LLGRGSFGSVY---EGISDDGFFFAVK----EVSLLDQGSQAKQSISQLEQEI-ALLSR- 386
+LG+GSFG V +D+ +A+K +V + D + + +E+ + AL +
Sbjct: 7 VLGKGSFGKVMLAERKGTDE--LYAIKILKKDVIIQDDDVEC----TMVEKRVLALPGKP 60
Query: 387 -FEHENIVQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKY 444
F + Q + + +LY +E V G L+ ++ Q ++ Y +I +GL +
Sbjct: 61 PF----LTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFF 116
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR--GTAFWMAPEVINNK 502
LH + +++RD+K N+++DA G +K+ADFG+ K + GT ++APE+I
Sbjct: 117 LHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEII--A 174
Query: 503 NKGYGLPADIWSLGCTVLEMLTSQIPY 529
+ YG D W+ G + EML Q P+
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 93.1 bits (232), Expect = 4e-21
Identities = 64/214 (29%), Positives = 98/214 (45%), Gaps = 52/214 (24%)
Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQ-----EIALLSRFE-H 389
+G G+F V + S G ++A+K K+ LEQ EI L R H
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIK---------CMKKHFKSLEQVNNLREIQALRRLSPH 57
Query: 390 ENIVQYYGT--DKDESKLYIFLELVTKGSLLNLY-----QRYHLRDSQVSAYTRQILLGL 442
NI++ D+ +L + EL+ +NLY ++ L + +V +Y Q+L L
Sbjct: 58 PNILRLIEVLFDRKTGRLALVFELMD----MNLYELIKGRKRPLPEKRVKSYMYQLLKSL 113
Query: 443 KYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRG------------T 490
++H + HRDIK NIL+ + +KLADFG SCRG T
Sbjct: 114 DHMHRNGIFHRDIKPENILIKDD-ILKLADFG-----------SCRGIYSKPPYTEYIST 161
Query: 491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT 524
++ APE + + YG DIW++GC E+L+
Sbjct: 162 RWYRAPECLLT-DGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 6e-21
Identities = 64/214 (29%), Positives = 112/214 (52%), Gaps = 26/214 (12%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
+GRG++G V S+ A+K+++ D AK+++ +EI LL +HEN++
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTL----REIKLLRHLDHENVIA 68
Query: 395 YYGTDKDESK-----LYIFLELVTKGSLLNLYQRYHLRDSQVSA------YTRQILLGLK 443
+ +YI EL+ +L+Q +R SQ + + Q+L GLK
Sbjct: 69 IKDIMPPPHREAFNDVYIVYELMDT----DLHQI--IRSSQTLSDDHCQYFLYQLLRGLK 122
Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VKSCRGTAFWMAPEVINN 501
Y+H +V+HRD+K +N+L++AN +K+ DFGLA+ T + T ++ APE++ N
Sbjct: 123 YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLN 182
Query: 502 KNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECV 535
++ Y D+WS+GC E+L + + + V
Sbjct: 183 CSE-YTTAIDVWSVGCIFAELLGRKPLFPGKDYV 215
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 7e-21
Identities = 61/200 (30%), Positives = 106/200 (53%), Gaps = 13/200 (6%)
Query: 337 LGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
LG+G FG V + + G +A K++ ++ + ++ LE+EI L + IV
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEI--LEKVNSPFIVNL 58
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYH-----LRDSQVSAYTRQILLGLKYLHDQDV 450
+ ++ L + + L+ G L Y Y+ L +V Y+ QI G+ +LH D+
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLK--YHIYNVGERGLEMERVIHYSAQITCGILHLHSMDI 116
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR-GTAFWMAPEVINNKNKGYGLP 509
V+RD+K N+L+D G+ +L+D GLA K + R GT +MAPE++ K + Y P
Sbjct: 117 VYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEIL--KEEPYSYP 174
Query: 510 ADIWSLGCTVLEMLTSQIPY 529
D +++GC++ EM+ + P+
Sbjct: 175 VDWFAMGCSIYEMVAGRTPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 7e-21
Identities = 64/218 (29%), Positives = 95/218 (43%), Gaps = 34/218 (15%)
Query: 337 LGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
LG G+FG VYEG D V +L + S+ +S E ++S+F H+NI
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDES--DFLMEALIMSKFNHQNI 71
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILL--------GLKY 444
V+ G + +I LEL+ G L + + R + S+ T + LL G KY
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 445 LHDQDVVHRDIKCANILVDANGS---VKLADFGLAKATKLNDVKSCRGTAF----WMAPE 497
L + +HRDI N L+ G K+ADFG+A+ G A WM PE
Sbjct: 132 LEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPE 191
Query: 498 -----VINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY 529
+ +K D+WS G + E+ + +PY
Sbjct: 192 AFLDGIFTSK-------TDVWSFGVLLWEIFSLGYMPY 222
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 9e-21
Identities = 58/198 (29%), Positives = 108/198 (54%), Gaps = 11/198 (5%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSI-SQLEQEIALLSRFEHENIVQY 395
LG G+ GSV + K+V + AK S+ Q+ +E+ ++ IV +
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIG----AKSSVRKQILRELQIMHECRSPYIVSF 68
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHD-QDVVHR 453
YG +E+ + + +E + GSL +Y++ + + ++ GL YL++ ++HR
Sbjct: 69 YGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHR 128
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPEVINNKNKGYGLPADI 512
DIK +NILV++ G +KL DFG++ +N + + GT+ +M+PE I + Y + +D+
Sbjct: 129 DIKPSNILVNSRGQIKLCDFGVS-GELINSIADTFVGTSTYMSPERI--QGGKYTVKSDV 185
Query: 513 WSLGCTVLEMLTSQIPYA 530
WSLG +++E+ + P+A
Sbjct: 186 WSLGISIIELALGKFPFA 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 1e-20
Identities = 59/200 (29%), Positives = 97/200 (48%), Gaps = 14/200 (7%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
LG G FG V+ G A+K + ++G+ +++ + E ++ + H +VQ Y
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAI---NEGAMSEEDFIE---EAKVMMKLSHPKLVQLY 65
Query: 397 GTDKDESKLYIFLELVTKGSLLN-LYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
G + LYI E + G LLN L QR L + + + + G++YL +HRD
Sbjct: 66 GVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRD 125
Query: 455 IKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGLPAD 511
+ N LV + G VK++DFG+ + ++ S G F W PEV N Y +D
Sbjct: 126 LAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSK--YSSKSD 183
Query: 512 IWSLGCTVLEMLTS-QIPYA 530
+WS G + E+ T ++P+
Sbjct: 184 VWSFGVLMWEVFTEGKMPFE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 1e-20
Identities = 65/213 (30%), Positives = 108/213 (50%), Gaps = 13/213 (6%)
Query: 324 FKRIITYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIA 382
F ++ TY K D LG G++ +V++G S A+KE+ L + +I +E++
Sbjct: 1 FGKLETY-VKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI----REVS 55
Query: 383 LLSRFEHENIVQYYG---TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQIL 439
LL +H NIV + T++ + ++ +L+ K L N + + V + Q+L
Sbjct: 56 LLKNLKHANIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHN--VKIFMFQLL 113
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL-NDVKSCRGTAFWMAPEV 498
GL Y H + ++HRD+K N+L++ G +KLADFGLA+A + S W P
Sbjct: 114 RGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPD 173
Query: 499 INNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP 531
+ + Y P D+W +GC + EM T + P P
Sbjct: 174 VLLGSTEYSTPIDMWGVGCILYEMATGR-PMFP 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 2e-20
Identities = 60/199 (30%), Positives = 104/199 (52%), Gaps = 9/199 (4%)
Query: 336 LLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
+LG+G FG V + G +A K + + +S++ E++I L + + +V
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQI--LEKVNSQFVVN 64
Query: 395 YYGTDKDESKLYIFLELVTKGSL-LNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVV 451
+ + L + L ++ G L ++Y + + + Y +IL GL+ LH ++ V
Sbjct: 65 LAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTV 124
Query: 452 HRDIKCANILVDANGSVKLADFGLA-KATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 510
+RD+K NIL+D G ++++D GLA K + ++ GT +MAPEV+NN+ Y L
Sbjct: 125 YRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQR--YTLSP 182
Query: 511 DIWSLGCTVLEMLTSQIPY 529
D W LGC + EM+ Q P+
Sbjct: 183 DYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 2e-20
Identities = 64/217 (29%), Positives = 100/217 (46%), Gaps = 53/217 (24%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ-------------EIAL 383
+G G++G V S D + K +I +L + E+ L
Sbjct: 23 VGSGAYGQV---------------CSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRL 67
Query: 384 LSRFEHENIVQYYGTDKDESKLYIF-----LE------LVTK--GSLLNLYQRYH-LRDS 429
L +HEN++ L +F LE LVT G+ LN + L D
Sbjct: 68 LKHMDHENVI---------GLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDD 118
Query: 430 QVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRG 489
+ QIL GLKY+H ++HRD+K +NI V+ + +K+ DFGLA+ T +++
Sbjct: 119 HIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD-DEMTGYVA 177
Query: 490 TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQ 526
T ++ APE++ N Y DIWS+GC + E+LT +
Sbjct: 178 TRWYRAPEIMLNWMH-YNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 3e-20
Identities = 60/203 (29%), Positives = 96/203 (47%), Gaps = 18/203 (8%)
Query: 337 LGRGSFGSV----YEGISDDGFFFAVKEVSLLDQGSQAKQSISQL--EQEIALL-SRFEH 389
LGRG FG V Y+ + +A+K +L A+ + L E+ I + H
Sbjct: 7 LGRGHFGKVLLAEYKKTGE---LYAIK--ALKKGDIIARDEVESLMCEKRIFETANSERH 61
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQD 449
+V + + E + +E G L+ + + Y ++LGL+YLH+
Sbjct: 62 PFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENK 121
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEVINNKNKGY 506
+V+RD+K N+L+D G VK+ADFGL K ++ C GT ++APEV+ + Y
Sbjct: 122 IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFC-GTPEFLAPEVLTETS--Y 178
Query: 507 GLPADIWSLGCTVLEMLTSQIPY 529
D W LG + EML + P+
Sbjct: 179 TRAVDWWGLGVLIYEMLVGESPF 201
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 3e-20
Identities = 65/198 (32%), Positives = 98/198 (49%), Gaps = 9/198 (4%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
+G+GSFG V DG F+AVK + + +Q E+ + LL +H +V
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNV-LLKNVKHPFLVGL 61
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
+ + + KLY L+ V G L QR + + Y +I L YLH ++++RD
Sbjct: 62 HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRD 121
Query: 455 IKCANILVDANGSVKLADFGLAK-ATKLNDVKS--CRGTAFWMAPEVINNKNKGYGLPAD 511
+K NIL+D+ G V L DFGL K + + S C GT ++APEV+ + + Y D
Sbjct: 122 LKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFC-GTPEYLAPEVL--RKQPYDRTVD 178
Query: 512 IWSLGCTVLEMLTSQIPY 529
W LG + EML P+
Sbjct: 179 WWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 3e-20
Identities = 60/200 (30%), Positives = 100/200 (50%), Gaps = 8/200 (4%)
Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN-IVQ 394
++GRG+FG V + V + LL + K+S S E + F + +VQ
Sbjct: 50 VIGRGAFGEVQ--LVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 107
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
+ +D+ LY+ +E + G L+NL Y + + YT +++L L +H ++HRD
Sbjct: 108 LFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRD 167
Query: 455 IKCANILVDANGSVKLADFGLAKATKLNDVKSCR---GTAFWMAPEVINNKNKG--YGLP 509
+K N+L+D +G +KLADFG + C GT +++PEV+ ++ YG
Sbjct: 168 VKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRE 227
Query: 510 ADIWSLGCTVLEMLTSQIPY 529
D WS+G + EML P+
Sbjct: 228 CDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 3e-20
Identities = 60/200 (30%), Positives = 99/200 (49%), Gaps = 8/200 (4%)
Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN-IVQ 394
++GRG+FG V + V + LL + K+S S E + F + +VQ
Sbjct: 50 VIGRGAFGEVQ--LVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 107
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 454
+ +D+ LY+ +E + G L+NL Y + + YT +++L L +H +HRD
Sbjct: 108 LFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRD 167
Query: 455 IKCANILVDANGSVKLADFGLAKATKLNDVKSCR---GTAFWMAPEVINNKNKG--YGLP 509
+K N+L+D +G +KLADFG + C GT +++PEV+ ++ YG
Sbjct: 168 VKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRE 227
Query: 510 ADIWSLGCTVLEMLTSQIPY 529
D WS+G + EML P+
Sbjct: 228 CDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 4e-20
Identities = 66/199 (33%), Positives = 104/199 (52%), Gaps = 17/199 (8%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSI---SQLEQEIALLSRFEHENI 392
+G G++GSV + G AVK++S + QSI + +E+ LL +HEN+
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLS------RPFQSIIHAKRTYRELRLLKHMKHENV 78
Query: 393 VQYYGTDKDESKLYIF--LELVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
+ L F + LVT L N+ + L D V QIL GLKY+H
Sbjct: 79 IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 138
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYG 507
D++HRD+K +N+ V+ + +K+ DFGLA+ T +++ T ++ APE++ N Y
Sbjct: 139 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLNWMH-YN 196
Query: 508 LPADIWSLGCTVLEMLTSQ 526
DIWS+GC + E+LT +
Sbjct: 197 QTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 4e-20
Identities = 51/159 (32%), Positives = 83/159 (52%), Gaps = 24/159 (15%)
Query: 380 EIALLSRFEHENIVQY----YGTDKDESKLYIFLELVT---KGSLLNLYQRYHLRDSQVS 432
EI +L + +H NIV G++ D K+Y+ +E V K + + Q + S+V
Sbjct: 54 EINILLKLQHPNIVTVKEVVVGSNLD--KIYMVMEYVEHDLKSLMETMKQPFLQ--SEVK 109
Query: 433 AYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA-------KATKLNDVK 485
Q+L G+ +LHD ++HRD+K +N+L++ G +K+ DFGLA K V
Sbjct: 110 CLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV- 168
Query: 486 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT 524
T ++ APE++ + Y D+WS+GC E+LT
Sbjct: 169 ----TLWYRAPELLLGAKE-YSTAIDMWSVGCIFAELLT 202
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 4e-20
Identities = 58/216 (26%), Positives = 100/216 (46%), Gaps = 30/216 (13%)
Query: 337 LGRGSFGSVYEGI-----SDDGFF-FAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
LG+GSFG VYEG+ + A+K V+ + + + + E +++ F
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVN----ENASMRERIEFLNEASVMKEFNCH 69
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQ----VSAYTRQILL------ 440
++V+ G + +EL+ KG L + Y R +++ + T Q +
Sbjct: 70 HVVRLLGVVSTGQPTLVVMELMAKGDLKS-YLRSRRPEAENNPGLGPPTLQKFIQMAAEI 128
Query: 441 --GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--KSCRGT--AFWM 494
G+ YL + VHRD+ N +V + +VK+ DFG+ + D K +G WM
Sbjct: 129 ADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188
Query: 495 APEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY 529
APE + K+ + +D+WS G + EM T ++ PY
Sbjct: 189 APESL--KDGVFTTKSDVWSFGVVLWEMATLAEQPY 222
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 5e-20
Identities = 66/205 (32%), Positives = 109/205 (53%), Gaps = 23/205 (11%)
Query: 337 LGRGSFGSVYEGISD--DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN--- 391
+G G+FG V+ ++D DG A+K+ + Q S ++ +E+ +L F+H+N
Sbjct: 8 IGYGAFGVVW-SVTDPRDGKRVALKK---MPNVFQNLVSCKRVFRELKMLCFFKHDNVLS 63
Query: 392 ---IVQYYGTDKDESKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHD 447
I+Q D E ++Y+ EL+ + L + L V + QIL GLKYLH
Sbjct: 64 ALDILQPPHIDPFE-EIYVVTELM-QSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHS 121
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA-----FWMAPEVINNK 502
++HRDIK N+LV++N +K+ DFGLA+ + ++ S T ++ APE++
Sbjct: 122 AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE--SKHMTQEVVTQYYRAPEILMG- 178
Query: 503 NKGYGLPADIWSLGCTVLEMLTSQI 527
++ Y DIWS+GC E+L +I
Sbjct: 179 SRHYTSAVDIWSVGCIFAELLGRRI 203
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 91.1 bits (227), Expect = 5e-20
Identities = 53/168 (31%), Positives = 87/168 (51%), Gaps = 38/168 (22%)
Query: 380 EIALLSRF-EHENIVQYYGT-----DKDESKLYIFLEL--------VTKGSLLNLYQRYH 425
EI L +H NIV+ DKD +Y+ E + L ++++RY
Sbjct: 56 EIMFLQELGDHPNIVKLLNVIKAENDKD---IYLVFEYMETDLHAVIRANILEDVHKRYI 112
Query: 426 LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK 485
+ Y Q+L LKY+H +V+HRD+K +NIL++++ VKLADFGLA++ L++++
Sbjct: 113 M-------Y--QLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARS--LSELE 161
Query: 486 SCRG---------TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT 524
T ++ APE++ + Y D+WS+GC + EML
Sbjct: 162 ENPENPVLTDYVATRWYRAPEILLGSTR-YTKGVDMWSVGCILGEMLL 208
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 7e-20
Identities = 61/202 (30%), Positives = 105/202 (51%), Gaps = 12/202 (5%)
Query: 336 LLGRGSFGSVY---EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
++GRG+FG V S +A+K +S + ++ + E++I ++ E I
Sbjct: 50 VIGRGAFGEVQLVRHKSSKQ--VYAMKLLSKFEMIKRSDSAFFWEERDI--MAHANSEWI 105
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVH 452
VQ + +D+ LY+ +E + G L+NL Y + + YT +++L L +H +H
Sbjct: 106 VQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIH 165
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR---GTAFWMAPEVINNK--NKGYG 507
RD+K N+L+D +G +KLADFG N + C GT +++PEV+ ++ + YG
Sbjct: 166 RDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYG 225
Query: 508 LPADIWSLGCTVLEMLTSQIPY 529
D WS+G + EML P+
Sbjct: 226 RECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 1e-19
Identities = 55/201 (27%), Positives = 100/201 (49%), Gaps = 13/201 (6%)
Query: 336 LLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
+LG+G FG V + G +A K++ + ++++ E++I L + +V
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQI--LEKVNSRFVVS 64
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHL-----RDSQVSAYTRQILLGLKYLHDQD 449
+ + L + L L+ G L + Y++ + + Y +I GL+ LH +
Sbjct: 65 LAYAYETKDALCLVLTLMNGGDLK--FHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER 122
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLND-VKSCRGTAFWMAPEVINNKNKGYGL 508
+V+RD+K NIL+D G ++++D GLA + ++ GT +MAPEV+ N+ Y
Sbjct: 123 IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNER--YTF 180
Query: 509 PADIWSLGCTVLEMLTSQIPY 529
D W LGC + EM+ + P+
Sbjct: 181 SPDWWGLGCLIYEMIEGKSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 1e-19
Identities = 63/199 (31%), Positives = 100/199 (50%), Gaps = 9/199 (4%)
Query: 336 LLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
++G+GSFG V DG F+AVK + + +Q+ E+ + LL +H +V
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNV-LLKNLKHPFLVG 60
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHR 453
+ + + KLY L+ V G L QR + + Y ++ + YLH ++++R
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120
Query: 454 DIKCANILVDANGSVKLADFGLAK-ATKLNDVKS--CRGTAFWMAPEVINNKNKGYGLPA 510
D+K NIL+D+ G V L DFGL K + + S C GT ++APEV+ + + Y
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC-GTPEYLAPEVL--RKEPYDRTV 177
Query: 511 DIWSLGCTVLEMLTSQIPY 529
D W LG + EML P+
Sbjct: 178 DWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 1e-19
Identities = 67/200 (33%), Positives = 107/200 (53%), Gaps = 10/200 (5%)
Query: 336 LLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGS-QAKQSISQLEQE---IALLSRFEHE 390
++GRG FG VY +D G +A+K LD+ + KQ + E ++L+S +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMK---CLDKKRIKMKQGETLALNERIMLSLVSTGDCP 57
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSL-LNLYQRYHLRDSQVSAYTRQILLGLKYLHDQD 449
IV KL L+L+ G L +L Q + ++ Y +I+LGL+++H++
Sbjct: 58 FIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF 117
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLP 509
VV+RD+K ANIL+D +G V+++D GLA + GT +MAPEV+ K Y
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVL-QKGTAYDSS 176
Query: 510 ADIWSLGCTVLEMLTSQIPY 529
AD +SLGC + ++L P+
Sbjct: 177 ADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 1e-19
Identities = 55/148 (37%), Positives = 76/148 (51%), Gaps = 8/148 (5%)
Query: 379 QEIALLSRFEHENIVQYYGTDKDESKL---YIFLELVTKGSLLNLYQRYHLRDSQVSAYT 435
+E+ LL HENI+ +D S L Y EL+ L L L + +
Sbjct: 58 RELKLLKHLRHENIISL--SDIFISPLEDIYFVTELLGT-DLHRLLTSRPLEKQFIQYFL 114
Query: 436 RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMA 495
QIL GLKY+H VVHRD+K +NIL++ N +K+ DFGLA+ + T ++ A
Sbjct: 115 YQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQD-PQMTGYVSTRYYRA 173
Query: 496 PEVINNKNKGYGLPADIWSLGCTVLEML 523
PE++ K Y + DIWS GC EML
Sbjct: 174 PEIMLTWQK-YDVEVDIWSAGCIFAEML 200
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 1e-19
Identities = 63/198 (31%), Positives = 101/198 (51%), Gaps = 10/198 (5%)
Query: 337 LGRGSFGSVYEGISDDGF-FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
+G+GSFG V + D +A+K ++ ++ ++ E +L++ IV
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALK--TIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPL 58
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD-SQVSAYTRQILLGLKYLHDQDVVHRD 454
+ + KLY+ L + G L + QR D S+ YT ++L L+ LH +V++RD
Sbjct: 59 KFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRD 118
Query: 455 IKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEVINNKNKGYGLPAD 511
+K NIL+D G + L DFGL K +D K+ C GT ++APE++ GY D
Sbjct: 119 LKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC-GTPEYLAPELLL--GHGYTKAVD 175
Query: 512 IWSLGCTVLEMLTSQIPY 529
W+LG + EMLT P+
Sbjct: 176 WWTLGVLLYEMLTGLPPF 193
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 1e-19
Identities = 65/234 (27%), Positives = 107/234 (45%), Gaps = 38/234 (16%)
Query: 337 LGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
+G G FG V G A+K L GS KQ + L E +++ +F+H NI
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKT---LKAGSSDKQRLDFL-TEASIMGQFDHPNI 67
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQD 449
++ G + I E + GSL + + R + Q+ R I G+KYL + +
Sbjct: 68 IRLEGVVTKSRPVMIITEYMENGSL-DKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN 126
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKG 505
VHRD+ NILV++N K++DFGL++ + ++ K + W APE I +
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRK-- 184
Query: 506 YGLPADIWSLGCTVLEMLT-SQIPY-------------------APMECVSAIF 539
+ +D+WS G + E+++ + PY PM+C SA++
Sbjct: 185 FTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALY 238
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 2e-19
Identities = 60/205 (29%), Positives = 99/205 (48%), Gaps = 14/205 (6%)
Query: 335 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
+LLG+G+FG V++G D AVK D + K + E +L +++H NIV+
Sbjct: 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKE-DLPQELK---IKFLSEARILKQYDHPNIVK 56
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVH 452
G +YI +ELV G L+ ++ L+ Q+ + G+ YL ++ +H
Sbjct: 57 LIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIH 116
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA----FWMAPEVINNKNKGYGL 508
RD+ N LV N +K++DFG+++ + + S G W APE +N Y
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSRQED-DGIYSSSGLKQIPIKWTAPEALNYGR--YSS 173
Query: 509 PADIWSLGCTVLEMLTSQI-PYAPM 532
+D+WS G + E + + PY M
Sbjct: 174 ESDVWSYGILLWETFSLGVCPYPGM 198
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 2e-19
Identities = 62/208 (29%), Positives = 101/208 (48%), Gaps = 11/208 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
++K + LG GS+ +VY+G S +G A+K + L ++ +I +E +LL +H
Sbjct: 7 YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAI----REASLLKGLKH 62
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLH 446
NIV + + L + E V L Y H L V + Q+L GL Y+H
Sbjct: 63 ANIVLLHDIIHTKETLTLVFEYVHTD--LCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH 120
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKL-NDVKSCRGTAFWMAPEVINNKNKG 505
+ ++HRD+K N+L+ G +KLADFGLA+A + + S W P + +
Sbjct: 121 QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTE 180
Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAPME 533
Y D+W +GC +EM+ + M+
Sbjct: 181 YSTCLDMWGVGCIFVEMIQGVAAFPGMK 208
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 3e-19
Identities = 69/211 (32%), Positives = 108/211 (51%), Gaps = 29/211 (13%)
Query: 336 LLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
+G G+ G VY+ G AVK++ + K+ + L+ + L S + IV+
Sbjct: 22 EIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLD--VVLKS-HDCPYIVK 78
Query: 395 YYGTDKDESKLYIFLELVTK--GSLLNLYQRY-------HLRDSQVSAYTRQILLGLKYL 445
YG +S ++I +EL++ LL Q + + V A L YL
Sbjct: 79 CYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKA--------LHYL 130
Query: 446 HD-QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEVI-- 499
+ V+HRD+K +NIL+DA+G+VKL DFG++ +L D K+ G A +MAPE I
Sbjct: 131 KEKHGVIHRDVKPSNILLDASGNVKLCDFGISG--RLVDSKAKTRSAGCAAYMAPERIDP 188
Query: 500 NNKNKGYGLPADIWSLGCTVLEMLTSQIPYA 530
+ N Y + AD+WSLG +++E+ T Q PY
Sbjct: 189 PDPNPKYDIRADVWSLGISLVELATGQFPYK 219
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 5e-19
Identities = 59/205 (28%), Positives = 106/205 (51%), Gaps = 21/205 (10%)
Query: 336 LLGRGSFGSVY----EGISDDGFFFAVK----EVSLLDQGSQAKQSISQLEQEIALLSRF 387
+LG+GSFG V +G + +A+K +V + D + + +E+ + LS
Sbjct: 7 VLGKGSFGKVMLAERKGTDE---LYAIKILKKDVVIQDDDVEC----TMVEKRVLALSG- 58
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLH 446
+ + Q + + +LY +E V G L+ + Q ++ Y +I +GL +LH
Sbjct: 59 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLH 118
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--KSCRGTAFWMAPEVINNKNK 504
+ +++RD+K N+++D+ G +K+ADFG+ K + V K+ GT ++APE+I +
Sbjct: 119 SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEII--AYQ 176
Query: 505 GYGLPADIWSLGCTVLEMLTSQIPY 529
YG D W+ G + EML Q P+
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQAPF 201
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 5e-19
Identities = 60/199 (30%), Positives = 106/199 (53%), Gaps = 11/199 (5%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSI-SQLEQEIALLSRFEHENIVQ 394
LG G+ G V + + G A K + L + K +I +Q+ +E+ +L IV
Sbjct: 9 LGAGNGGVVTKVLHRPSGLIMARKLIHL-----EIKPAIRNQIIRELKVLHECNSPYIVG 63
Query: 395 YYGTDKDESKLYIFLELVTKGSL-LNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ-DVVH 452
+YG + ++ I +E + GSL L + + ++ + + +L GL YL ++ ++H
Sbjct: 64 FYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMH 123
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADI 512
RD+K +NILV++ G +KL DFG++ + S GT +M+PE + + Y + +DI
Sbjct: 124 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTH--YTVQSDI 181
Query: 513 WSLGCTVLEMLTSQIPYAP 531
WSLG +++EM + P P
Sbjct: 182 WSLGLSLVEMAIGRYPIPP 200
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 5e-19
Identities = 61/222 (27%), Positives = 103/222 (46%), Gaps = 29/222 (13%)
Query: 330 YWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQ--------- 379
Y QKG LG G++G V + + G A+K+V +++ + + +
Sbjct: 10 YIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLR 69
Query: 380 EIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQI 438
E+ +++ +HENI+ + + + ++++ L + + L +SQV QI
Sbjct: 70 ELKIMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIRLTESQVKCILLQI 128
Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA--------TKLNDVKSCRG- 489
L GL LH +HRD+ ANI +++ G K+ADFGLA+ T D R
Sbjct: 129 LNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRRE 188
Query: 490 -------TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT 524
T ++ APE++ K Y D+WS+GC E+LT
Sbjct: 189 EMTSKVVTLWYRAPELLMGAEK-YHFAVDMWSVGCIFAELLT 229
|
Length = 335 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 6e-19
Identities = 60/201 (29%), Positives = 104/201 (51%), Gaps = 13/201 (6%)
Query: 336 LLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
+LG+G FG V + G +A K++ + +S++ E++I L + +V
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQI--LEKVNSRFVVS 64
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS-----QVSAYTRQILLGLKYLHDQD 449
+ + L + L L+ G L + YH+ ++ + Y +I GL+ LH +
Sbjct: 65 LAYAYETKDALCLVLTLMNGGDLK--FHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER 122
Query: 450 VVHRDIKCANILVDANGSVKLADFGLA-KATKLNDVKSCRGTAFWMAPEVINNKNKGYGL 508
+V+RD+K NIL+D +G ++++D GLA + +K GT +MAPEV+ KN+ Y
Sbjct: 123 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV--KNERYTF 180
Query: 509 PADIWSLGCTVLEMLTSQIPY 529
D W+LGC + EM+ Q P+
Sbjct: 181 SPDWWALGCLLYEMIAGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 6e-19
Identities = 66/236 (27%), Positives = 103/236 (43%), Gaps = 46/236 (19%)
Query: 323 RFKRIITYWQKGDLLGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEI 381
FK+I LLG+G G V+ + G FA+K + + + K EQEI
Sbjct: 2 HFKKI-------KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEI 54
Query: 382 ALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQI 438
L+ +H + Y + + E+ L + ++ G L L QR L + Y ++
Sbjct: 55 --LATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEV 112
Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK------------------ 480
LL L+YLH +V+RD+K NIL+ +G + L+DF L+K +
Sbjct: 113 LLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSS 172
Query: 481 ----LNDVK---------SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEML 523
++ S GT ++APEVI G+G D W+LG + EML
Sbjct: 173 VNSIPSETFSEEPSFRSNSFVGTEEYIAPEVI--SGDGHGSAVDWWTLGILLYEML 226
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 6e-19
Identities = 75/241 (31%), Positives = 117/241 (48%), Gaps = 44/241 (18%)
Query: 304 EDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVS 362
ED+ + N SPN +K G+++G GSFG VYE I D A+K+V
Sbjct: 48 EDEDEEKMIDNDINRSPNKSYKL-------GNIIGNGSFGVVYEAICIDTSEKVAIKKVL 100
Query: 363 LLDQGSQAKQSISQLEQEIALLSRFEHENIV---QYYGTD---KDESKLYIFLELVTK-- 414
Q Q K +E+ ++ H NI+ YY T+ K+E IFL +V +
Sbjct: 101 ---QDPQYKN------RELLIMKNLNHINIIFLKDYYYTECFKKNEKN--IFLNVVMEFI 149
Query: 415 GSLLNLYQRYHLRDSQ------VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG-S 467
++ Y +++ R++ V Y+ Q+ L Y+H + + HRD+K N+L+D N +
Sbjct: 150 PQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHT 209
Query: 468 VKLADFGLAKATKLNDVKSCRGTA-----FWMAPEVINNKNKGYGLPADIWSLGCTVLEM 522
+KL DFG AK N + R + F+ APE++ Y D+WSLGC + EM
Sbjct: 210 LKLCDFGSAK----NLLAGQRSVSYICSRFYRAPELMLGATN-YTTHIDLWSLGCIIAEM 264
Query: 523 L 523
+
Sbjct: 265 I 265
|
Length = 440 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 6e-19
Identities = 66/223 (29%), Positives = 110/223 (49%), Gaps = 25/223 (11%)
Query: 324 FKRIITYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIA 382
F ++ TY K + LG G++ +V++G S A+KE+ L + +I +E++
Sbjct: 2 FGKMETY-IKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI----REVS 56
Query: 383 LLSRFEHENIVQYYG---TDKDESKLYIFLELVTK------GSLLNLYQRYHLRDSQVSA 433
LL +H NIV + TDK + ++ +L+ K G++++++ V
Sbjct: 57 LLKDLKHANIVTLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHN--------VKI 108
Query: 434 YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL-NDVKSCRGTAF 492
+ QIL GL Y H + V+HRD+K N+L++ G +KLADFGLA+A + S
Sbjct: 109 FLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTL 168
Query: 493 WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECV 535
W P + + Y D+W +GC EM + + P P V
Sbjct: 169 WYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGR-PLFPGSTV 210
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 7e-19
Identities = 62/209 (29%), Positives = 103/209 (49%), Gaps = 30/209 (14%)
Query: 336 LLGRGSFGSVY---EGISDDGFFFAVK----EVSLLDQGSQAKQSISQLEQEIALLSRFE 388
LLG+G+FG V E + G ++A+K EV + AK ++ E +L
Sbjct: 2 LLGKGTFGKVILVREKAT--GKYYAMKILKKEVII------AKDEVAHTLTESRVLQNTR 53
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA------YTRQILLGL 442
H + + + +L +E G L +HL +V + Y +I+ L
Sbjct: 54 HPFLTALKYSFQTHDRLCFVMEYANGGELF-----FHLSRERVFSEDRARFYGAEIVSAL 108
Query: 443 KYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVIN 500
YLH DVV+RD+K N+++D +G +K+ DFGL K + +K+ GT ++APEV+
Sbjct: 109 GYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 168
Query: 501 NKNKGYGLPADIWSLGCTVLEMLTSQIPY 529
+ + YG D W LG + EM+ ++P+
Sbjct: 169 DND--YGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 86.7 bits (214), Expect = 9e-19
Identities = 65/213 (30%), Positives = 94/213 (44%), Gaps = 33/213 (15%)
Query: 337 LGRGSFGSVYEG------ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
LG G+FG V+ D AVK +L D A++ +E LL+ +HE
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVK--TLKDASDNARKD---FHREAELLTNLQHE 67
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH---------------LRDSQVSAYT 435
+IV++YG + L + E + G L N + R H L SQ+
Sbjct: 68 HIVKFYGVCVEGDPLIMVFEYMKHGDL-NKFLRAHGPDAVLMAEGNRPAELTQSQMLHIA 126
Query: 436 RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF--- 492
+QI G+ YL Q VHRD+ N LV N VK+ DFG+++ D G
Sbjct: 127 QQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 186
Query: 493 -WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT 524
WM PE I + + +D+WSLG + E+ T
Sbjct: 187 RWMPPESIMYRK--FTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 1e-18
Identities = 60/200 (30%), Positives = 102/200 (51%), Gaps = 12/200 (6%)
Query: 336 LLGRGSFGSVY---EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
LLG+G+FG V E + G ++A+K L + AK ++ E +L H +
Sbjct: 2 LLGKGTFGKVILVREKAT--GRYYAMK--ILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 57
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
+ +L +E G L +L + + + Y +I+ L+YLH +DVV
Sbjct: 58 TALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVV 117
Query: 452 HRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKGYGLP 509
+RDIK N+++D +G +K+ DFGL K + +K+ GT ++APEV+ + + YG
Sbjct: 118 YRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND--YGRA 175
Query: 510 ADIWSLGCTVLEMLTSQIPY 529
D W LG + EM+ ++P+
Sbjct: 176 VDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 1e-18
Identities = 48/145 (33%), Positives = 82/145 (56%), Gaps = 7/145 (4%)
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHD 447
H +V + + ES+L+ +E V G L+ QR L + Y+ +I L L YLH+
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE 114
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAK-ATKLNDVKS--CRGTAFWMAPEVINNKNK 504
+ +++RD+K N+L+D+ G +KL D+G+ K + D S C GT ++APE++ ++
Sbjct: 115 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-GTPNYIAPEILRGED- 172
Query: 505 GYGLPADIWSLGCTVLEMLTSQIPY 529
YG D W+LG + EM+ + P+
Sbjct: 173 -YGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 2e-18
Identities = 71/239 (29%), Positives = 111/239 (46%), Gaps = 39/239 (16%)
Query: 333 KGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
K ++G G FG V+ GI G + L G KQ L E +++ +F H N
Sbjct: 9 KQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFL-SEASIMGQFSHHN 67
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYT-----RQILLGLKYLH 446
I++ G I E + G+L + Y R H D + S+Y R I G+KYL
Sbjct: 68 IIRLEGVVTKFKPAMIITEYMENGAL-DKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLS 124
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA------FWMAPEVIN 500
D + VHRD+ NILV++N K++DFGL++ + +D + T+ W APE I
Sbjct: 125 DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLE-DDPEGTYTTSGGKIPIRWTAPEAIA 183
Query: 501 NKNKGYGLPADIWSLGCTVLEMLT-SQIPY-------------------APMECVSAIF 539
+ + +D+WS G + E+++ + PY APM+C SA++
Sbjct: 184 YRK--FTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVY 240
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 2e-18
Identities = 63/207 (30%), Positives = 101/207 (48%), Gaps = 28/207 (13%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
LG G +G VYEG+ AVK + + + + +E A++ +H N+VQ
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVEEFLKEAAVMKEIKHPNLVQL 67
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD---SQVSAYT-----RQILLGLKYLHD 447
G E YI E +T G+LL+ +LR+ +V+A QI ++YL
Sbjct: 68 LGVCTREPPFYIITEFMTYGNLLD-----YLRECNRQEVNAVVLLYMATQISSAMEYLEK 122
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVIN-NKN 503
++ +HRD+ N LV N VK+ADFGL++ + + G F W APE + NK
Sbjct: 123 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK- 181
Query: 504 KGYGLPADIWSLGCTVLEMLTSQI-PY 529
+ + +D+W+ G + E+ T + PY
Sbjct: 182 --FSIKSDVWAFGVLLWEIATYGMSPY 206
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 2e-18
Identities = 56/205 (27%), Positives = 95/205 (46%), Gaps = 26/205 (12%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
+G G FG V+ G + A+K + + S +E ++ + H +VQ Y
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIR------EGAMSEEDFIEEAQVMMKLSHPKLVQLY 65
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILL--------GLKYLHDQ 448
G + S + + E + G L + +LR +Q ++++ LL G+ YL
Sbjct: 66 GVCTERSPICLVFEFMEHGCLSD-----YLR-AQRGKFSQETLLGMCLDVCEGMAYLESS 119
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKG 505
+V+HRD+ N LV N VK++DFG+ + + S GT F W +PEV +
Sbjct: 120 NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSK-- 177
Query: 506 YGLPADIWSLGCTVLEMLTS-QIPY 529
Y +D+WS G + E+ + + PY
Sbjct: 178 YSSKSDVWSFGVLMWEVFSEGKTPY 202
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 3e-18
Identities = 65/204 (31%), Positives = 100/204 (49%), Gaps = 19/204 (9%)
Query: 336 LLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQE------IALLSRFE 388
++G+GSFG V DG +AVK + Q K +++ EQ+ LL +
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVL-------QKKIVLNRKEQKHIMAERNVLLKNVK 54
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
H +V + + + KLY L+ V G L +L + + + Y +I L YLH
Sbjct: 55 HPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHS 114
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKG 505
++V+RD+K NIL+D+ G V L DFGL K + + + GT ++APEVI + +
Sbjct: 115 INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVI--RKQP 172
Query: 506 YGLPADIWSLGCTVLEMLTSQIPY 529
Y D W LG + EML P+
Sbjct: 173 YDNTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 4e-18
Identities = 57/202 (28%), Positives = 105/202 (51%), Gaps = 15/202 (7%)
Query: 336 LLGRGSFGSVY-EGISDDGFFFAVK----EVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
+LG+GSFG V +A+K +V + D + + +E+ + L + +
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVEC----TMVEKRV-LALQDKPP 61
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQD 449
+ Q + + +LY +E V G L+ Q+ ++ Q Y +I +GL +LH +
Sbjct: 62 FLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG 121
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--KSCRGTAFWMAPEVINNKNKGYG 507
+++RD+K N+++D+ G +K+ADFG+ K ++ V ++ GT ++APE+I + YG
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEII--AYQPYG 179
Query: 508 LPADIWSLGCTVLEMLTSQIPY 529
D W+ G + EML Q P+
Sbjct: 180 KSVDWWAYGVLLYEMLAGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 4e-18
Identities = 60/200 (30%), Positives = 102/200 (51%), Gaps = 12/200 (6%)
Query: 336 LLGRGSFGSVY---EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
LLG+G+FG V E S G ++A+K L + AK ++ E +L H +
Sbjct: 2 LLGKGTFGKVILVREKAS--GKYYAMK--ILKKEVIIAKDEVAHTLTESRVLKNTRHPFL 57
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
+ + + +L +E V G L +L + + + Y +I+ L YLH +V
Sbjct: 58 TSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIV 117
Query: 452 HRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKGYGLP 509
+RD+K N+++D +G +K+ DFGL K T +K+ GT ++APEV+ + + YG
Sbjct: 118 YRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDND--YGRA 175
Query: 510 ADIWSLGCTVLEMLTSQIPY 529
D W LG + EM+ ++P+
Sbjct: 176 VDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 4e-18
Identities = 58/205 (28%), Positives = 104/205 (50%), Gaps = 15/205 (7%)
Query: 336 LLGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
++GRG+FG V + +A+K ++ + +A+ + + E+ + L + + I
Sbjct: 8 VIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNV--LVNGDCQWITT 65
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVVH 452
+ +DE+ LY+ ++ G LL L ++ L + Y +++L + +H VH
Sbjct: 66 LHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVH 125
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR-----GTAFWMAPEVINNKNKG-- 505
RDIK N+L+D NG ++LADFG K+N + + GT +++PE++ G
Sbjct: 126 RDIKPDNVLLDMNGHIRLADFG--SCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMG 183
Query: 506 -YGLPADIWSLGCTVLEMLTSQIPY 529
YG D WSLG + EML + P+
Sbjct: 184 KYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 6e-18
Identities = 66/216 (30%), Positives = 95/216 (43%), Gaps = 36/216 (16%)
Query: 337 LGRGSFGSVYEG------ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
LG G+FG V+ + D AVK +L D A++ ++E LL+ +HE
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVK--ALKDPTLAARKD---FQREAELLTNLQHE 67
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD------------------SQVS 432
+IV++YG D L + E + G L N + R H D SQ+
Sbjct: 68 HIVKFYGVCGDGDPLIMVFEYMKHGDL-NKFLRAHGPDAMILVDGQPRQAKGELGLSQML 126
Query: 433 AYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF 492
QI G+ YL Q VHRD+ N LV AN VK+ DFG+++ D G
Sbjct: 127 HIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 186
Query: 493 ----WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT 524
WM PE I + + +D+WS G + E+ T
Sbjct: 187 LPIRWMPPESIMYRK--FTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 6e-18
Identities = 46/132 (34%), Positives = 78/132 (59%), Gaps = 7/132 (5%)
Query: 402 ESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANI 460
ES+L+ +E V+ G L+ QR L + Y+ +I L L +LH++ +++RD+K N+
Sbjct: 68 ESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNV 127
Query: 461 LVDANGSVKLADFGLAK-ATKLNDVKS--CRGTAFWMAPEVINNKNKGYGLPADIWSLGC 517
L+DA G +KL D+G+ K + D S C GT ++APE++ + + YG D W+LG
Sbjct: 128 LLDAEGHIKLTDYGMCKEGIRPGDTTSTFC-GTPNYIAPEIL--RGEDYGFSVDWWALGV 184
Query: 518 TVLEMLTSQIPY 529
+ EM+ + P+
Sbjct: 185 LMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-17
Identities = 63/201 (31%), Positives = 100/201 (49%), Gaps = 13/201 (6%)
Query: 336 LLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGS--QAKQSISQLEQEIALLSRFEHENI 392
++G+GSFG V + F+AVK +L + + + K+ + + LL +H +
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVK---VLQKKAILKKKEEKHIMSERNVLLKNVKHPFL 58
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVV 451
V + + + KLY L+ + G L QR + + Y +I L YLH ++V
Sbjct: 59 VGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIV 118
Query: 452 HRDIKCANILVDANGSVKLADFGLAKAT-KLNDVKS--CRGTAFWMAPEVINNKNKGYGL 508
+RD+K NIL+D+ G + L DFGL K + N S C GT ++APEV++ + Y
Sbjct: 119 YRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC-GTPEYLAPEVLHKQP--YDR 175
Query: 509 PADIWSLGCTVLEMLTSQIPY 529
D W LG + EML P+
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-17
Identities = 44/134 (32%), Positives = 77/134 (57%), Gaps = 7/134 (5%)
Query: 400 KDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCA 458
+ S+L++ +E V G L+ QR L + Y +I + L +LH++ +++RD+K
Sbjct: 66 QTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLD 125
Query: 459 NILVDANGSVKLADFGLAK-ATKLNDVKS--CRGTAFWMAPEVINNKNKGYGLPADIWSL 515
N+L+DA+G +KL D+G+ K D S C GT ++APE++ + + YG D W+L
Sbjct: 126 NVLLDADGHIKLTDYGMCKEGLGPGDTTSTFC-GTPNYIAPEIL--RGEEYGFSVDWWAL 182
Query: 516 GCTVLEMLTSQIPY 529
G + EM+ + P+
Sbjct: 183 GVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 1e-17
Identities = 58/205 (28%), Positives = 105/205 (51%), Gaps = 15/205 (7%)
Query: 336 LLGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
++GRG+FG V + + G +A+K ++ + +A+ + + E+++ L + I
Sbjct: 8 VIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDV--LVNGDRRWITN 65
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVH 452
+ +DE+ LY+ ++ G LL L ++ L + Y +++L + +H VH
Sbjct: 66 LHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVH 125
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR-----GTAFWMAPEVINNKNKG-- 505
RDIK N+L+D NG ++LADFG +L + + GT +++PE++ G
Sbjct: 126 RDIKPDNVLLDKNGHIRLADFG--SCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKG 183
Query: 506 -YGLPADIWSLGCTVLEMLTSQIPY 529
YG D WSLG + EML + P+
Sbjct: 184 RYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 2e-17
Identities = 51/159 (32%), Positives = 84/159 (52%), Gaps = 11/159 (6%)
Query: 380 EIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSL-----LNLYQRYHLRDSQVSAY 434
E+ L+ +H IV+++ K + KL + +E + G L L + ++ +V
Sbjct: 115 ELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLL 174
Query: 435 TRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK----ATKLNDVKSCRGT 490
QI+L L +H + ++HRD+K ANI + G +KL DFG +K + L+ S GT
Sbjct: 175 FYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGT 234
Query: 491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY 529
+++APE+ K Y AD+WSLG + E+LT P+
Sbjct: 235 PYYLAPELWERKR--YSKKADMWSLGVILYELLTLHRPF 271
|
Length = 478 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 2e-17
Identities = 60/203 (29%), Positives = 107/203 (52%), Gaps = 11/203 (5%)
Query: 336 LLGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
++GRG+FG V + + FA+K ++ + +A+ + + E+++ L +++ I
Sbjct: 8 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDV--LVNGDNQWITT 65
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLR--DSQVSAYTRQILLGLKYLHDQDVVH 452
+ +DE+ LY+ ++ G LL L ++ R + Y ++++ + +H VH
Sbjct: 66 LHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVH 125
Query: 453 RDIKCANILVDANGSVKLADFG-LAKATKLNDVKS--CRGTAFWMAPEVINNKNKG---Y 506
RDIK NIL+D NG ++LADFG K + V+S GT +++PE++ G Y
Sbjct: 126 RDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKY 185
Query: 507 GLPADIWSLGCTVLEMLTSQIPY 529
G D WSLG + EML + P+
Sbjct: 186 GPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 68/228 (29%), Positives = 106/228 (46%), Gaps = 24/228 (10%)
Query: 332 QKGDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQ-LEQEIALLSR 386
G LG G+FG V E G+S AV +V++ A S + L E+ ++S
Sbjct: 38 SFGKTLGAGAFGKVVEATAYGLSKSD---AVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 387 F-EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS-----AYTRQILL 440
HENIV G + + E G LLN +R R+S ++ +++ Q+
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRK--RESFLTLEDLLSFSYQVAK 152
Query: 441 GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----WMAP 496
G+ +L ++ +HRD+ N+L+ VK+ DFGLA+ + +G A WMAP
Sbjct: 153 GMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAP 212
Query: 497 EVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIFIKTV 543
E I N Y +D+WS G + E+ + PY P V + F K +
Sbjct: 213 ESIFNCV--YTFESDVWSYGILLWEIFSLGSNPY-PGMPVDSKFYKLI 257
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 3e-17
Identities = 66/212 (31%), Positives = 102/212 (48%), Gaps = 36/212 (16%)
Query: 335 DLLGRGSFGSVYEGI-SDDGFFFAVKEV-SLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
+++G+GS+G V I + G A+K++ + + S A +++ +EI LL H +I
Sbjct: 6 EVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDA----TRILREIKLLRLLRHPDI 61
Query: 393 VQ----YYGTDKDESK-LYIFLELVTKGSLLNLYQRYHLRDS------QVSAYTRQILLG 441
V+ + E K +Y+ EL+ +L+Q D Q Y Q+L
Sbjct: 62 VEIKHIMLPPSRREFKDIYVVFELMES----DLHQVIKANDDLTPEHHQFFLY--QLLRA 115
Query: 442 LKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWM------- 494
LKY+H +V HRD+K NIL +A+ +K+ DFGLA+ ND FW
Sbjct: 116 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA-FNDTP---TAIFWTDYVATRW 171
Query: 495 --APEVINNKNKGYGLPADIWSLGCTVLEMLT 524
APE+ + Y DIWS+GC E+LT
Sbjct: 172 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 203
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 3e-17
Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 18/206 (8%)
Query: 337 LGRGSFGSVYEG-ISDDGFFFAVKEV-SLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
+GRG+FG V+ G + D AVK L +AK QE +L ++ H NIV+
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAK-----FLQEARILKQYSHPNIVR 57
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVH 452
G + +YI +ELV G L + L+ ++ G++YL + +H
Sbjct: 58 LIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIH 117
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRG-----TAFWMAPEVINNKNKGYG 507
RD+ N LV +K++DFG+++ + + V + G W APE +N Y
Sbjct: 118 RDLAARNCLVTEKNVLKISDFGMSREEE-DGVYASTGGMKQIPVKWTAPEALNYGR--YS 174
Query: 508 LPADIWSLGCTVLEMLT-SQIPYAPM 532
+D+WS G + E + +PYA +
Sbjct: 175 SESDVWSFGILLWEAFSLGAVPYANL 200
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 5e-17
Identities = 65/235 (27%), Positives = 102/235 (43%), Gaps = 52/235 (22%)
Query: 331 WQKGDLLGRGSFGSVY----------------------EGISDDGFFFAVKEVSLLDQGS 368
++K + +G G++G VY EGI A++E+SLL
Sbjct: 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPT----ALREISLL---- 54
Query: 369 QAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKG--SLLNLYQRYH- 425
Q +S+ + LL V++ + LY+ E + ++ R
Sbjct: 55 ---QMLSESIYIVRLLD-------VEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPG 104
Query: 426 --LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD-ANGSVKLADFGLAKATKLN 482
L + ++ Q+L G+ + H V+HRD+K N+LVD G +K+AD GL +A +
Sbjct: 105 RPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI- 163
Query: 483 DVKSCRG---TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC 534
VKS T ++ APEV+ Y P DIWS+GC EM Q P P +
Sbjct: 164 PVKSYTHEIVTLWYRAPEVLLGSTH-YSTPVDIWSVGCIFAEMSRKQ-PLFPGDS 216
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 5e-17
Identities = 51/167 (30%), Positives = 84/167 (50%), Gaps = 33/167 (19%)
Query: 379 QEIALLSRFEHENIVQYYG------TDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQ 430
+E+ L+ H+NI+ + ++ +Y+ +EL+ NL Q L +
Sbjct: 64 RELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDA----NLCQVIQMDLDHER 119
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
+S Q+L G+K+LH ++HRD+K +NI+V ++ ++K+ DFGLA+ GT
Sbjct: 120 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GT 170
Query: 491 AFWM----------APEVINNKNKGYGLPADIWSLGCTVLEMLTSQI 527
+F M APEVI GY DIWS+GC + EM+ +
Sbjct: 171 SFMMTPYVVTRYYRAPEVI--LGMGYKENVDIWSVGCIMGEMIRGTV 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 84.0 bits (207), Expect = 7e-17
Identities = 65/226 (28%), Positives = 111/226 (49%), Gaps = 36/226 (15%)
Query: 337 LGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
+G G FG V+ FF K +S +G + ++ SQL E+ ++ +H+NIV+Y
Sbjct: 21 IGNGRFGEVFLVKHKRTQEFFCWKAISY--RGLKEREK-SQLVIEVNVMRELKHKNIVRY 77
Query: 396 YGT--DKDESKLYIFLELVTKGSLLNLYQRYH-----LRDSQVSAYTRQILLGLKYLHD- 447
+K KLYI +E G L Q+ + + + + TRQ+L L Y H+
Sbjct: 78 IDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNL 137
Query: 448 ------QDVVHRDIKCANILV---------------DANGS--VKLADFGLAKATKLNDV 484
+ V+HRD+K NI + + NG K+ DFGL+K + +
Sbjct: 138 KDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESM 197
Query: 485 -KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY 529
SC GT ++ +PE++ ++ K Y +D+W+LGC + E+ + + P+
Sbjct: 198 AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243
|
Length = 1021 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 8e-17
Identities = 55/206 (26%), Positives = 104/206 (50%), Gaps = 22/206 (10%)
Query: 337 LGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
LG+G FG V + G +A K+++ + + +E+ I L++ IV
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRI--LAKVHSRFIVSL 58
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYH----------LRDSQVSAYTRQILLGLKYL 445
+ ++ L + + ++ G L RYH + + YT QI+ GL++L
Sbjct: 59 AYAFQTKTDLCLVMTIMNGGDL-----RYHIYNVDEENPGFPEPRACFYTAQIISGLEHL 113
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAK--ATKLNDVKSCRGTAFWMAPEVINNKN 503
H + +++RD+K N+L+D +G+V+++D GLA + K GT +MAPE++ +
Sbjct: 114 HQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELL--QG 171
Query: 504 KGYGLPADIWSLGCTVLEMLTSQIPY 529
+ Y D ++LG T+ EM+ ++ P+
Sbjct: 172 EEYDFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 61/214 (28%), Positives = 105/214 (49%), Gaps = 25/214 (11%)
Query: 336 LLGRGSFGSVYEGISDDGF-FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
L+ G++G+VY + FA+K+++ Q + I Q+ E +L+ E+ +V
Sbjct: 8 LISNGAYGAVYLVRHKETRQRFAMKKIN--KQNLILRNQIQQVFVERDILTFAENPFVVS 65
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHR 453
+ + + + L + +E V G L + L Y + +L L+YLH+ +VHR
Sbjct: 66 MFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHR 125
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLN------------------DVKSCRGTAFWMA 495
D+K N+L+ + G +KL DFGL+K ++ D + C GT ++A
Sbjct: 126 DLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVC-GTPEYIA 184
Query: 496 PEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY 529
PEVI +GYG P D W++G + E L +P+
Sbjct: 185 PEVI--LRQGYGKPVDWWAMGIILYEFLVGCVPF 216
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 1e-16
Identities = 64/247 (25%), Positives = 110/247 (44%), Gaps = 56/247 (22%)
Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
LG G+FG V D +A+K +L + + ++ ++ E +L+ ++E +V+
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMK--TLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVHRD 454
Y + +D+ LY ++ + G +++L R + ++ Y ++ L ++ +H +HRD
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRD 126
Query: 455 IKCANILVDANGSVKLADFGLAKATK------------------------LNDVKSCR-- 488
IK NIL+D +G +KL DFGL + +DV +CR
Sbjct: 127 IKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCG 186
Query: 489 -----------------------GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTS 525
GT ++APEV+ KGY D WS+G + EML
Sbjct: 187 DRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVL--LRKGYTQLCDWWSVGVILFEMLVG 244
Query: 526 QIPY-AP 531
Q P+ AP
Sbjct: 245 QPPFLAP 251
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 1e-16
Identities = 60/196 (30%), Positives = 99/196 (50%), Gaps = 10/196 (5%)
Query: 336 LLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
+G G++GSV I G A+K++S + Q++ + +E+ LL +HEN++
Sbjct: 22 QVGSGAYGSVCSAIDKRTGEKVAIKKLS---RPFQSEIFAKRAYRELTLLKHMQHENVIG 78
Query: 395 YYGTDKDESKLYIFLE--LVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDV 450
F + LV +L + + L + +V Q+L GLKY+H +
Sbjct: 79 LLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAGI 138
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPA 510
+HRD+K N+ V+ + +K+ DFGLA+ ++ T ++ APEVI N Y
Sbjct: 139 IHRDLKPGNLAVNEDCELKILDFGLARHADA-EMTGYVVTRWYRAPEVILNWMH-YNQTV 196
Query: 511 DIWSLGCTVLEMLTSQ 526
DIWS+GC + EMLT +
Sbjct: 197 DIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 2e-16
Identities = 58/221 (26%), Positives = 96/221 (43%), Gaps = 25/221 (11%)
Query: 335 DLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENI 392
D++G G+FG V + I DG + + S+ E+ +L + H NI
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR--DFAGELEVLCKLGHHPNI 70
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-----------------LRDSQVSAYT 435
+ G + LY+ +E G+LL+ ++ L Q+ +
Sbjct: 71 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 130
Query: 436 RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSC-RGTAFWM 494
+ G+ YL + +HRD+ NILV N K+ADFGL++ ++ K+ R WM
Sbjct: 131 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWM 190
Query: 495 APEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMEC 534
A E +N Y +D+WS G + E+++ PY M C
Sbjct: 191 AIESLNYSV--YTTNSDVWSYGVLLWEIVSLGGTPYCGMTC 229
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 61/222 (27%), Positives = 98/222 (44%), Gaps = 27/222 (12%)
Query: 335 DLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
D++G G+FG V + I DG + + S+ E E+ L H NI+
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEV-LCKLGHHPNII 59
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNL------------YQRYHLRDSQVSAYTRQILL- 440
G + LY+ +E G+LL+ + + S +S ++Q+L
Sbjct: 60 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS--SQQLLHF 117
Query: 441 ------GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSC-RGTAFW 493
G+ YL + +HRD+ NILV N K+ADFGL++ ++ K+ R W
Sbjct: 118 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRW 177
Query: 494 MAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMEC 534
MA E +N Y +D+WS G + E+++ PY M C
Sbjct: 178 MAIESLNYSV--YTTNSDVWSYGVLLWEIVSLGGTPYCGMTC 217
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 2e-16
Identities = 62/238 (26%), Positives = 103/238 (43%), Gaps = 49/238 (20%)
Query: 336 LLGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
++GRG+FG V D G +A+K+ L K+ ++ + E +L+ ++ +V+
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHIYAMKK--LRKSEMLEKEQVAHVRAERDILAEADNPWVVK 65
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHR 453
Y + +DE+ LY+ +E + G ++ L + + + Y + +L + +H +HR
Sbjct: 66 LYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHR 125
Query: 454 DIKCANILVDANGSVKLADFGLAKATKLNDVK---------------------------- 485
DIK N+L+DA G +KL+DFGL K +
Sbjct: 126 DIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKA 185
Query: 486 ------------SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP 531
S GT ++APEV GY D WSLG + EML + Y P
Sbjct: 186 ETWKRNRRALAYSTVGTPDYIAPEVF--LQTGYNKECDWWSLGVIMYEML---VGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 63/220 (28%), Positives = 101/220 (45%), Gaps = 23/220 (10%)
Query: 335 DLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
D++G G+FG V I DG L + S+ E E+ L H NI+
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEV-LCKLGHHPNII 66
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQ---------VSAYTRQILL---- 440
G ++ LYI +E G+LL+ ++ + ++ S T Q LL
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 441 ----GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSC-RGTAFWMA 495
G++YL ++ +HRD+ N+LV N + K+ADFGL++ ++ K+ R WMA
Sbjct: 127 DVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVRWMA 186
Query: 496 PEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMEC 534
E +N Y +D+WS G + E+++ PY M C
Sbjct: 187 IESLNYSV--YTTKSDVWSFGVLLWEIVSLGGTPYCGMTC 224
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-16
Identities = 66/231 (28%), Positives = 107/231 (46%), Gaps = 35/231 (15%)
Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
G LG G FG V GI D AV + + ++ +S L E+ ++ +
Sbjct: 20 GKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 79
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNL------------YQRYHLRDSQVS---- 432
H+NI+ G + LY+ +E +KG+L Y + D Q++
Sbjct: 80 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDL 139
Query: 433 -AYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA 491
+ T Q+ G++YL Q +HRD+ N+LV N +K+ADFGLA+ +N++ + T
Sbjct: 140 VSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DVNNIDYYKKTT 197
Query: 492 F------WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT---SQIPYAPME 533
WMAPE + ++ Y +D+WS G + E+ T S P P+E
Sbjct: 198 NGRLPVKWMAPEALFDRV--YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 246
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 3e-16
Identities = 66/211 (31%), Positives = 104/211 (49%), Gaps = 15/211 (7%)
Query: 332 QKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
+K LLG G FG+V++GI +G + Q +Q+ ++ + + +H
Sbjct: 10 RKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHA 69
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS----QVSAYTRQILLGLKYLH 446
IV+ G S L + +L GSLL+ + R H RDS ++ + QI G+ YL
Sbjct: 70 YIVRLLGICPGAS-LQLVTQLSPLGSLLD-HVRQH-RDSLDPQRLLNWCVQIAKGMYYLE 126
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK----SCRGTAFWMAPEVINNK 502
+ +VHR++ NIL+ ++ V++ADFG+A +D K + WMA E I
Sbjct: 127 EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFG 186
Query: 503 NKGYGLPADIWSLGCTVLEMLT-SQIPYAPM 532
Y +D+WS G TV EM++ PYA M
Sbjct: 187 R--YTHQSDVWSYGVTVWEMMSYGAEPYAGM 215
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 4e-16
Identities = 58/206 (28%), Positives = 103/206 (50%), Gaps = 23/206 (11%)
Query: 336 LLGRGSFGSVYE-GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
+LG+G FG V + G +A K++ + ++++ E+ I L + +V
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRI--LEKVNSRFVVS 64
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLR-------DSQVSA-YTRQILLGLKYLH 446
+ + L + L ++ G L ++H+ D Q + Y ++ GL+ L
Sbjct: 65 LAYAYETKDALCLVLTIMNGGDL-----KFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ 119
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR---GTAFWMAPEVINNKN 503
+ +V+RD+K NIL+D G ++++D GL A ++ + ++ R GT +MAPEVINN+
Sbjct: 120 RERIVYRDLKPENILLDDRGHIRISDLGL--AVQIPEGETVRGRVGTVGYMAPEVINNEK 177
Query: 504 KGYGLPADIWSLGCTVLEMLTSQIPY 529
Y D W LGC + EM+ Q P+
Sbjct: 178 --YTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 5e-16
Identities = 57/211 (27%), Positives = 99/211 (46%), Gaps = 23/211 (10%)
Query: 336 LLGRGSFGSVYEG--ISDDG--FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
++G+G FG VY G I DG AVK ++ + + + Q +E ++ F H N
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITD----LEEVEQFLKEGIIMKDFSHPN 57
Query: 392 IVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS---AYTRQILLGLKYLH 446
++ G + S L + L + G L N + R + V + Q+ G++YL
Sbjct: 58 VLSLLGICLPSEGSPL-VVLPYMKHGDLRN-FIRSETHNPTVKDLIGFGLQVAKGMEYLA 115
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKAT------KLNDVKSCRGTAFWMAPEVIN 500
+ VHRD+ N ++D + +VK+ADFGLA+ +++ + WMA E +
Sbjct: 116 SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQ 175
Query: 501 NKNKGYGLPADIWSLGCTVLEMLTSQIPYAP 531
+ + +D+WS G + E++T P P
Sbjct: 176 TQK--FTTKSDVWSFGVLLWELMTRGAPPYP 204
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 5e-16
Identities = 59/229 (25%), Positives = 97/229 (42%), Gaps = 38/229 (16%)
Query: 337 LGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
+G+G+FG V++ G+ F V V +L + + A + ++E AL++ F+H NI
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVA-VKMLKEEASA-DMQADFQREAALMAEFDHPNI 70
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQR------------------YHLRDSQVS-- 432
V+ G + + E + G L + L +S
Sbjct: 71 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCT 130
Query: 433 ---AYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRG 489
+Q+ G+ YL ++ VHRD+ N LV N VK+ADFGL++ D
Sbjct: 131 EQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASE 190
Query: 490 TAF----WMAPEVI-NNKNKGYGLPADIWSLGCTVLEMLTSQI-PYAPM 532
WM PE I N+ Y +D+W+ G + E+ + + PY M
Sbjct: 191 NDAIPIRWMPPESIFYNR---YTTESDVWAYGVVLWEIFSYGMQPYYGM 236
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 6e-16
Identities = 63/214 (29%), Positives = 111/214 (51%), Gaps = 21/214 (9%)
Query: 327 IITYWQKGDLLGRGSFGSVYEGISDD-GFFFAVKEVSLLDQG-SQAKQSISQLEQEIALL 384
++ +Q+ +G G+ G V G AVK++S Q + AK++ +E+ LL
Sbjct: 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAY----RELVLL 74
Query: 385 SRFEHENIVQYYG------TDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTR 436
H+NI+ + ++ +Y+ +EL+ NL Q H L ++S
Sbjct: 75 KCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA----NLCQVIHMELDHERMSYLLY 130
Query: 437 QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR-GTAFWMA 495
Q+L G+K+LH ++HRD+K +NI+V ++ ++K+ DFGLA+ N + + T ++ A
Sbjct: 131 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRA 190
Query: 496 PEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY 529
PEVI GY DIWS+GC + E++ + +
Sbjct: 191 PEVI--LGMGYKENVDIWSVGCIMGELVKGSVIF 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 7e-16
Identities = 58/200 (29%), Positives = 102/200 (51%), Gaps = 11/200 (5%)
Query: 336 LLGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
LLG+G+FG V G ++A+K L + AK ++ E +L H +
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMK--ILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 59
Query: 395 YYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLH-DQDVVH 452
+ + +L +E G L +L + + + Y +I+ L YLH +++VV+
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 119
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLND---VKSCRGTAFWMAPEVINNKNKGYGLP 509
RD+K N+++D +G +K+ DFGL K + D +K+ GT ++APEV+ + + YG
Sbjct: 120 RDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYLAPEVLEDND--YGRA 176
Query: 510 ADIWSLGCTVLEMLTSQIPY 529
D W LG + EM+ ++P+
Sbjct: 177 VDWWGLGVVMYEMMCGRLPF 196
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 8e-16
Identities = 63/218 (28%), Positives = 110/218 (50%), Gaps = 24/218 (11%)
Query: 330 YWQKGDLLGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE 388
YW +LG G+ G+V DG FAVK ++D ++ ++ + E+ L +
Sbjct: 34 YWIS-RVLGSGATGTVLCAKRVSDGEPFAVK---VVDMEGMSEADKNRAQAEVCCLLNCD 89
Query: 389 HENIVQ-----YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTR------- 436
+IV+ ++ + + ++ + +L Q R +
Sbjct: 90 FFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLF 149
Query: 437 -QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK---ATKLNDV-KSCRGTA 491
Q+LL + ++H + ++HRDIK ANIL+ +NG VKL DFG +K AT +DV ++ GT
Sbjct: 150 IQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTP 209
Query: 492 FWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY 529
+++APE+ + K Y AD++SLG + E+LT + P+
Sbjct: 210 YYVAPEIW--RRKPYSKKADMFSLGVLLYELLTLKRPF 245
|
Length = 496 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 8e-16
Identities = 63/219 (28%), Positives = 93/219 (42%), Gaps = 30/219 (13%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEV---SLLDQGSQAKQSISQLEQEIALLSRFEHE 390
DLL G+FG ++ GI D +EV ++ D S+ + ++ L QE LL H+
Sbjct: 11 SDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQ--VTLLLQESCLLYGLSHQ 68
Query: 391 NI-----VQYYGTDKDE--------SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQ 437
NI V + L +FL + L L Q+ Q
Sbjct: 69 NILPILHVCIEDGEPPFVLYPYMNWGNLKLFL---QQCRLGEANNPQALSTQQLVHMAIQ 125
Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT-----AF 492
I G+ YLH + V+H+DI N ++D VK+ D L++ D C G
Sbjct: 126 IACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDY-HCLGDNENRPVK 184
Query: 493 WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYA 530
WMA E + NK Y +D+WS G + E++T Q PY
Sbjct: 185 WMALESLVNKE--YSSASDVWSFGVLLWELMTLGQTPYV 221
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 9e-16
Identities = 57/240 (23%), Positives = 104/240 (43%), Gaps = 51/240 (21%)
Query: 337 LGRGSFGSVY-EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
+G G+FG V D +A+K + D + + ++ E +L+ ++E +V+
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKAD--VLMRNQAAHVKAERDILAEADNEWVVKL 66
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVHRD 454
Y + +D+ LY ++ + G +++L R + + ++ Y ++ ++ +H +HRD
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRD 126
Query: 455 IKCANILVDANGSVKLADFGLAKATK------------------------LNDVKSCR-- 488
IK NIL+D +G +KL DFGL + +++ CR
Sbjct: 127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLK 186
Query: 489 -------------------GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY 529
GT ++APEV+ GY D WS+G + EML Q P+
Sbjct: 187 PLERRRKRQHQRCLAHSLVGTPNYIAPEVL--LRTGYTQLCDWWSVGVILYEMLVGQPPF 244
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 1e-15
Identities = 64/225 (28%), Positives = 95/225 (42%), Gaps = 39/225 (17%)
Query: 327 IITYWQKGDLLGRGSFGSVYEG------ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQE 380
I+ W+ LG G+FG V+ D AVK +L + A+Q ++E
Sbjct: 7 IVLKWE----LGEGAFGKVFLAECHNLLPEQDKMLVAVK--ALKEASESARQD---FQRE 57
Query: 381 IALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD------------ 428
LL+ +H++IV++YG + L + E + G L N + R H D
Sbjct: 58 AELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKILAGGEDVAP 116
Query: 429 -----SQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND 483
Q+ A QI G+ YL VHRD+ N LV VK+ DFG+++ D
Sbjct: 117 GQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD 176
Query: 484 VKSCRGTAF----WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT 524
G WM PE I + + +DIWS G + E+ T
Sbjct: 177 YYRVGGRTMLPIRWMPPESILYRK--FTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 1e-15
Identities = 59/205 (28%), Positives = 108/205 (52%), Gaps = 11/205 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSI-SQLEQEIALLSRFE 388
++K LG G+ G V++ G A K + L + K +I +Q+ +E+ +L
Sbjct: 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHL-----EIKPAIRNQIIRELQVLHECN 61
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV-SAYTRQILLGLKYLHD 447
IV +YG + ++ I +E + GSL + ++ Q+ + ++ GL YL +
Sbjct: 62 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 121
Query: 448 Q-DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGY 506
+ ++HRD+K +NILV++ G +KL DFG++ + S GT +M+PE + + Y
Sbjct: 122 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTH--Y 179
Query: 507 GLPADIWSLGCTVLEMLTSQIPYAP 531
+ +DIWS+G +++EM + P P
Sbjct: 180 SVQSDIWSMGLSLVEMAIGRYPIPP 204
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 1e-15
Identities = 61/245 (24%), Positives = 103/245 (42%), Gaps = 55/245 (22%)
Query: 336 LLGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
++G+G+FG V D G +A+K +LL K ++ ++ E +L+ + +V
Sbjct: 8 VIGKGAFGEVRLVQKKDTGKIYAMK--TLLKSEMFKKDQLAHVKAERDVLAESDSPWVVS 65
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVHR 453
Y + +D LY+ +E + G L+ + +Y V+ Y + +L ++ +H +HR
Sbjct: 66 LYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHR 125
Query: 454 DIKCANILVDANGSVKLADFGLAKA----------------------------------- 478
DIK NIL+D G +KL+DFGL+
Sbjct: 126 DIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSIN 185
Query: 479 ------TKLNDVKSCR--------GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT 524
++ K R GT ++APE+ +GYG D WSLG + E L
Sbjct: 186 LTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFL--QQGYGQECDWWSLGAIMFECLI 243
Query: 525 SQIPY 529
P+
Sbjct: 244 GWPPF 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-15
Identities = 59/195 (30%), Positives = 102/195 (52%), Gaps = 9/195 (4%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI---V 393
+G G++G+V + D A + L + Q++ + +E+ LL +HEN+ +
Sbjct: 23 VGSGAYGTVCSAL--DRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLL 80
Query: 394 QYYGTDKDESKLYIF-LELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
+ D + + F L + G+ L L + L + ++ Q+L GLKY+H ++
Sbjct: 81 DVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGII 140
Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPAD 511
HRD+K N+ V+ + +K+ DFGLA+ T +++ T ++ APEVI N Y D
Sbjct: 141 HRDLKPGNLAVNEDCELKILDFGLARQTD-SEMTGYVVTRWYRAPEVILNWMH-YTQTVD 198
Query: 512 IWSLGCTVLEMLTSQ 526
IWS+GC + EMLT +
Sbjct: 199 IWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 1e-15
Identities = 51/173 (29%), Positives = 95/173 (54%), Gaps = 6/173 (3%)
Query: 375 SQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSA 433
+Q+ +E+ +L IV +YG + ++ I +E + GSL L + + + +
Sbjct: 48 NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGK 107
Query: 434 YTRQILLGLKYLHDQ-DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF 492
+ +L GL YL ++ ++HRD+K +NILV++ G +KL DFG++ + S GT
Sbjct: 108 VSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS 167
Query: 493 WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC--VSAIFIKTV 543
+M+PE + + Y + +DIWS+G +++E+ + P P + + AIF + V
Sbjct: 168 YMSPERLQGTH--YSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPV 218
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 67/218 (30%), Positives = 105/218 (48%), Gaps = 33/218 (15%)
Query: 333 KGDLLGRGSFGSVYEGISDDGF---FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
+G +GRG++G VY+ DG +A+K++ +G+ S + EIALL +H
Sbjct: 5 EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQI----EGTGISMSACR---EIALLRELKH 57
Query: 390 ENIV--QYYGTDKDESKLYIFLELVT----------KGSLLNLYQRYHLRDSQVSAYTRQ 437
N++ Q + K+++ + + S N + L S V + Q
Sbjct: 58 PNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKAN-KKPMQLPRSMVKSLLYQ 116
Query: 438 ILLGLKYLHDQDVVHRDIKCANILV----DANGSVKLADFGLAK-----ATKLNDVKSCR 488
IL G+ YLH V+HRD+K ANILV G VK+AD G A+ L D+
Sbjct: 117 ILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176
Query: 489 GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQ 526
T ++ APE++ + Y DIW++GC E+LTS+
Sbjct: 177 VTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-15
Identities = 57/192 (29%), Positives = 95/192 (49%), Gaps = 9/192 (4%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
+G G++GSV D V L + Q+ + +E+ LL +HEN++
Sbjct: 23 VGSGAYGSVCSAY--DTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80
Query: 397 GTDKDESKLYIFLE--LVTK---GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
+ + F E LVT L N+ + L D V Q+L GLKY+H ++
Sbjct: 81 DVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGII 140
Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPAD 511
HRD+K +N+ V+ + +++ DFGLA+ +++ T ++ APE++ N Y D
Sbjct: 141 HRDLKPSNVAVNEDCELRILDFGLARQAD-DEMTGYVATRWYRAPEIMLNWMH-YNQTVD 198
Query: 512 IWSLGCTVLEML 523
IWS+GC + E+L
Sbjct: 199 IWSVGCIMAELL 210
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-15
Identities = 60/222 (27%), Positives = 110/222 (49%), Gaps = 37/222 (16%)
Query: 327 IITYWQKGDLLGRGSFGSV---YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
++ +Q +G G+ G V Y+ + D A+K++S + Q + + +E+ L
Sbjct: 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNV--AIKKLS---RPFQNQTHAKRAYRELVL 69
Query: 384 LSRFEHENIVQYYG------TDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYT 435
+ H+NI+ + ++ +Y+ +EL+ NL Q + L ++S
Sbjct: 70 MKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA----NLCQVIQMELDHERMSYLL 125
Query: 436 RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMA 495
Q+L G+K+LH ++HRD+K +NI+V ++ ++K+ DFGLA+ GT+F M
Sbjct: 126 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GTSFMMT 176
Query: 496 PEVINNKNK--------GYGLPADIWSLGCTVLEMLTSQIPY 529
P V+ + GY DIWS+GC + EM+ +I +
Sbjct: 177 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 2e-15
Identities = 63/222 (28%), Positives = 106/222 (47%), Gaps = 27/222 (12%)
Query: 334 GDLLGRGSFGSVYEGI--SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
G +LG+G FGSV E S+DG F V V +L + I + +E A + F+H N
Sbjct: 4 GRMLGKGEFGSVREAQLKSEDGSFQKVA-VKMLKADIFSSSDIEEFLREAACMKEFDHPN 62
Query: 392 IVQYYGTD---KDESKLYI---FLELVTKGSLLNLYQRYHLRDSQVSAYTRQILL----- 440
+++ G + + +L I L + G L + + + Q L+
Sbjct: 63 VIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTL-PLQTLVRFMID 121
Query: 441 ---GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----- 492
G++YL ++ +HRD+ N +++ N +V +ADFGL+K D +G A
Sbjct: 122 IASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYR-QGCASKLPVK 180
Query: 493 WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPME 533
W+A E + + Y +D+W+ G T+ E++T Q PYA +E
Sbjct: 181 WLALESL--ADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE 220
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-15
Identities = 62/233 (26%), Positives = 101/233 (43%), Gaps = 43/233 (18%)
Query: 336 LLGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
++GRG+FG V D G +A+K + D K+ ++ + E +L + +V+
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHIYAMKILRKADM--LEKEQVAHIRAERDILVEADGAWVVK 65
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHR 453
+ + +D+ LY+ +E + G ++ L + L + Y + +L + +H +HR
Sbjct: 66 MFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHR 125
Query: 454 DIKCANILVDANGSVKLADFGLAKATK--------------------LNDVKSCR----- 488
DIK N+L+DA G VKL+DFGL K ++ S R
Sbjct: 126 DIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETW 185
Query: 489 ------------GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY 529
GT ++APEV GY D WSLG + EML P+
Sbjct: 186 KKNRRQLAYSTVGTPDYIAPEVF--MQTGYNKLCDWWSLGVIMYEMLIGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 2e-15
Identities = 51/217 (23%), Positives = 88/217 (40%), Gaps = 26/217 (11%)
Query: 336 LLGRGSFGSVYEG------ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
LGRG FG V+ VK + + S+ +E+ + + H
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD----ENLQSEFRRELDMFRKLSH 67
Query: 390 ENIVQYYGTDKDESKLYIFLE----------LVTKGSLLNLYQRYHLRDSQVSAYTRQIL 439
+N+V+ G ++ Y+ LE L S + L Q A QI
Sbjct: 68 KNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIA 127
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAP 496
LG+ +L + VHRD+ N LV + VK++ L+K ++ R W+AP
Sbjct: 128 LGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAP 187
Query: 497 EVINNKNKGYGLPADIWSLGCTVLEMLTS-QIPYAPM 532
E + + + +D+WS G + E+ T ++P+ +
Sbjct: 188 EAVQEDD--FSTKSDVWSFGVLMWEVFTQGELPFYGL 222
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 56/204 (27%), Positives = 104/204 (50%), Gaps = 13/204 (6%)
Query: 336 LLGRGSFGSVYEGISDDGF-FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
++G G++G V + + A+K+ ++ + K++ + E+ +L + ENIV+
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLR---ELKMLRTLKQENIVE 64
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVH 452
+ KLY+ E V K ++L L + + +V +Y Q++ + + H D+VH
Sbjct: 65 LKEAFRRRGKLYLVFEYVEK-NMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVH 123
Query: 453 RDIKCANILVDANGSVKLADFGLAK-ATKLNDVKSCR--GTAFWMAPEVINNKNKGYGLP 509
RDIK N+L+ N +KL DFG A+ ++ ++ T ++ +PE++ YG
Sbjct: 124 RDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELL--LGAPYGKA 181
Query: 510 ADIWSLGCTVLEMLTSQIPYAPME 533
D+WS+GC + E+ Q P P E
Sbjct: 182 VDMWSVGCILGELSDGQ-PLFPGE 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 2e-15
Identities = 61/251 (24%), Positives = 107/251 (42%), Gaps = 58/251 (23%)
Query: 337 LGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
LG G+FG V D +A+K +L + + ++ ++ E +L+ ++E +V+
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMK--TLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66
Query: 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYHL-RDSQVSAYTRQILLGLKYLHDQDVVHRD 454
Y + +D+ LY ++ + G +++L R + + Y ++ ++ +H +HRD
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRD 126
Query: 455 IKCANILVDANGSVKLADFGLAK------------------------ATKLNDVKSCR-- 488
IK NIL+D +G +KL DFGL + + D +CR
Sbjct: 127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCG 186
Query: 489 -----------------------GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTS 525
GT ++APEV+ GY D WS+G + EML
Sbjct: 187 DRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVL--LRTGYTQLCDWWSVGVILYEMLVG 244
Query: 526 QIPY---APME 533
Q P+ P+E
Sbjct: 245 QPPFLAQTPLE 255
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 3e-15
Identities = 50/165 (30%), Positives = 82/165 (49%), Gaps = 29/165 (17%)
Query: 379 QEIALLSRFEHENIVQYYGTDKDESKL------YIFLELVTKGSLLNLYQ--RYHLRDSQ 430
+E+ L+ H+NI+ + L YI +EL+ NL Q + L +
Sbjct: 72 RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA----NLCQVIQMELDHER 127
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
+S Q+L G+K+LH ++HRD+K +NI+V ++ ++K+ DFGLA+ GT
Sbjct: 128 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---------GT 178
Query: 491 AFWMAPEVINNKNK--------GYGLPADIWSLGCTVLEMLTSQI 527
+F M P V+ + GY DIWS+GC + EM+ +
Sbjct: 179 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV 223
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 3e-15
Identities = 58/202 (28%), Positives = 99/202 (49%), Gaps = 24/202 (11%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
+G+G FG V G G AVK + D +QA E +++++ H N+VQ
Sbjct: 14 IGKGEFGDVMLG-DYRGNKVAVKCIKN-DATAQA------FLAEASVMTQLRHSNLVQLL 65
Query: 397 GTD-KDESKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHDQDVVH 452
G +++ LYI E + KGSL++ + R L + ++ + ++YL + VH
Sbjct: 66 GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVH 125
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA----FWMAPEVINNKNKGYGL 508
RD+ N+LV + K++DFGL K + S + T W APE + + K +
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEAL--REKKFST 178
Query: 509 PADIWSLGCTVLEMLT-SQIPY 529
+D+WS G + E+ + ++PY
Sbjct: 179 KSDVWSFGILLWEIYSFGRVPY 200
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 5e-15
Identities = 57/209 (27%), Positives = 104/209 (49%), Gaps = 20/209 (9%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEV----SLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
LG G+FG V +G+ + K++ +L ++ K ++ +E ++ + ++ I
Sbjct: 3 LGSGNFGCVKKGV----YKMRKKQIDVAIKVLKNENE-KSVRDEMMREAEIMHQLDNPYI 57
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
V+ G + E+ L + +E+ + G L ++ + S V Q+ +G+KYL ++
Sbjct: 58 VRMIGVCEAEA-LMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNF 116
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA-----FWMAPEVINNKNKG 505
VHRD+ N+L+ K++DFGL+KA +D +A W APE IN +
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRK-- 174
Query: 506 YGLPADIWSLGCTVLEMLT-SQIPYAPME 533
+ +D+WS G T+ E + Q PY M+
Sbjct: 175 FSSRSDVWSYGITMWEAFSYGQKPYKKMK 203
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 6e-15
Identities = 66/218 (30%), Positives = 104/218 (47%), Gaps = 33/218 (15%)
Query: 333 KGDLLGRGSFGSVYEGISDDGFF---FAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
+G +GRG++G VY+ DG +A+K++ +G+ S + EIALL +H
Sbjct: 5 EGCKVGRGTYGHVYKAKRKDGKDDRDYALKQI----EGTGISMSACR---EIALLRELKH 57
Query: 390 ENIV--QYYGTDKDESKLYIFLELVT----------KGSLLNLYQRYHLRDSQVSAYTRQ 437
N++ Q + K+++ + + S N + L V + Q
Sbjct: 58 PNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKAN-KKPVQLPRGMVKSLLYQ 116
Query: 438 ILLGLKYLHDQDVVHRDIKCANILV----DANGSVKLADFGLAK-----ATKLNDVKSCR 488
IL G+ YLH V+HRD+K ANILV G VK+AD G A+ L D+
Sbjct: 117 ILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176
Query: 489 GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQ 526
T ++ APE++ + Y DIW++GC E+LTS+
Sbjct: 177 VTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 7e-15
Identities = 58/221 (26%), Positives = 98/221 (44%), Gaps = 39/221 (17%)
Query: 337 LGRGSFGSVY----EGISD----DGFFFAVKEVSLL--------DQGSQAKQSISQLEQE 380
LG G FG V+ +G+ D + +L D A++ +E
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARED---FLKE 69
Query: 381 IALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTR---- 436
+ +LSR NI + G + L + +E + G L Q++ S ++ ++
Sbjct: 70 VKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSF 129
Query: 437 --------QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR 488
QI G++YL + VHRD+ N LV N ++K+ADFG+++ +D +
Sbjct: 130 STLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQ 189
Query: 489 GTAF----WMAPE-VINNKNKGYGLPADIWSLGCTVLEMLT 524
G A WMA E V+ K + +D+W+ G T+ E+LT
Sbjct: 190 GRAPLPIRWMAWESVLLGK---FTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 7e-15
Identities = 64/241 (26%), Positives = 106/241 (43%), Gaps = 44/241 (18%)
Query: 325 KRIITYWQKGDLLGRGSFGSVY----EGISDDGFFFAVKEVSLLDQGSQA---------- 370
++ +T+ +K LG G FG V+ EG+ F K+ SL G+Q
Sbjct: 4 RKRLTFKEK---LGEGQFGEVHLCEAEGMEK----FMDKDFSLDVSGNQPVLVAVKMLRE 56
Query: 371 ---KQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLR 427
K + + +EI ++SR + NI++ L + E + G L R+ +
Sbjct: 57 DANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQ 116
Query: 428 DSQVSAYTR------------QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL 475
++ A QI G+KYL + VHRD+ N LV N ++K+ADFG+
Sbjct: 117 EAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGM 176
Query: 476 AKATKLNDVKSCRGTAF----WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT--SQIPY 529
++ D +G A WM+ E I + +D+W+ G T+ E+LT + PY
Sbjct: 177 SRNLYSGDYYRIQGRAVLPIRWMSWESILLGK--FTTASDVWAFGVTLWEILTLCKEQPY 234
Query: 530 A 530
+
Sbjct: 235 S 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 8e-15
Identities = 62/231 (26%), Positives = 103/231 (44%), Gaps = 35/231 (15%)
Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
G LG G FG V G+ + K + + ++ +S L E+ ++ +
Sbjct: 23 GKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 82
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNL------------YQRYHLRDSQVS---- 432
H+NI+ G + LY+ +E +KG+L Y + + Q+S
Sbjct: 83 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142
Query: 433 ---AYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VK 485
AY Q+ G++YL + +HRD+ N+LV + +K+ADFGLA+ D
Sbjct: 143 VSCAY--QVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 200
Query: 486 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT---SQIPYAPME 533
+ R WMAPE + ++ Y +D+WS G + E+ T S P P+E
Sbjct: 201 NGRLPVKWMAPEALFDRI--YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 249
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 8e-15
Identities = 63/211 (29%), Positives = 96/211 (45%), Gaps = 22/211 (10%)
Query: 336 LLGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
++G G FG V G A+K L G KQ L E +++ +F+H N
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKT---LKAGYTEKQRRDFL-SEASIMGQFDHPN 66
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQD 449
I+ G + I E + GSL +++ Q+ R I G+KYL D
Sbjct: 67 IIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG 126
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAF---WMAPEVINNK 502
VHRD+ NILV++N K++DFGL++ L D + RG W APE I +
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPIRWTAPEAIAYR 184
Query: 503 NKGYGLPADIWSLGCTVLEMLT-SQIPYAPM 532
+ +D+WS G + E+++ + PY M
Sbjct: 185 K--FTSASDVWSYGIVMWEVMSYGERPYWEM 213
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 9e-15
Identities = 62/231 (26%), Positives = 102/231 (44%), Gaps = 37/231 (16%)
Query: 334 GDLLGRGSFGSV----YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
G LG G+FG V G+ + V V +L + ++ +S L E+ ++ +
Sbjct: 17 GKPLGEGAFGQVVKAEAVGLDNPNETSTVA-VKML-KDDATEKDLSDLVSEMEMMKMIGK 74
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSL-------------------LNLYQRYHLRDS 429
H+NI+ G E LY+ +E G+L + +D
Sbjct: 75 HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134
Query: 430 QVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--KSC 487
AY Q+ G+++L + +HRD+ N+LV + +K+ADFGLA+ D K+
Sbjct: 135 VSFAY--QVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTT 192
Query: 488 RG--TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT---SQIPYAPME 533
G WMAPE + ++ Y +D+WS G + E+ T S P P+E
Sbjct: 193 NGRLPVKWMAPEALFDRV--YTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 241
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 1e-14
Identities = 61/233 (26%), Positives = 101/233 (43%), Gaps = 43/233 (18%)
Query: 336 LLGRGSFGSV-YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
++GRG+FG V D G +A+K + D K+ + + E +L + +V+
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHVYAMKILRKADM--LEKEQVGHIRAERDILVEADSLWVVK 65
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHR 453
+ + +D+ LY+ +E + G ++ L + L + + Y + +L + +H +HR
Sbjct: 66 MFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHR 125
Query: 454 DIKCANILVDANGSVKLADFGLAKATK--------------------LNDVKSCR----- 488
DIK N+L+D+ G VKL+DFGL K ++ S R
Sbjct: 126 DIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETW 185
Query: 489 ------------GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY 529
GT ++APEV GY D WSLG + EML P+
Sbjct: 186 KRNRRQLAFSTVGTPDYIAPEVF--MQTGYNKLCDWWSLGVIMYEMLIGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 1e-14
Identities = 54/204 (26%), Positives = 97/204 (47%), Gaps = 10/204 (4%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
LG G+FG+V +G+ V +L + +L +E ++ + ++ IV+
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 397 GTDKDESKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI 455
G + ES + +EL G L Q+ H+ + ++ Q+ +G+KYL + + VHRD+
Sbjct: 63 GICEAES-WMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDL 121
Query: 456 KCANILVDANGSVKLADFGLAKATKLND-VKSCRGTA----FWMAPEVINNKNKGYGLPA 510
N+L+ K++DFGL+KA ++ + W APE +N + +
Sbjct: 122 AARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYK--FSSKS 179
Query: 511 DIWSLGCTVLEMLT-SQIPYAPME 533
D+WS G + E + Q PY M+
Sbjct: 180 DVWSFGVLMWEAFSYGQKPYKGMK 203
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 1e-14
Identities = 61/215 (28%), Positives = 98/215 (45%), Gaps = 26/215 (12%)
Query: 335 DLLGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
+++G G FG V G F A+K L G KQ L E +++ +F+H
Sbjct: 10 EVIGAGEFGEVCRGRLKLPGKREIFVAIKT---LKSGYTEKQRRDFL-SEASIMGQFDHP 65
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVS-----AYTRQILLGLKYL 445
NI+ G + I E + G+L + + D Q + R I G+KYL
Sbjct: 66 NIIHLEGVVTKSRPVMIITEFMENGALDSFLR---QNDGQFTVIQLVGMLRGIAAGMKYL 122
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAF---WMAPEV 498
+ + VHRD+ NILV++N K++DFGL++ + + S G W APE
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEA 182
Query: 499 INNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPM 532
I + + +D+WS G + E+++ + PY M
Sbjct: 183 IAYRK--FTSASDVWSYGIVMWEVMSYGERPYWDM 215
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 4e-14
Identities = 71/240 (29%), Positives = 105/240 (43%), Gaps = 53/240 (22%)
Query: 334 GDLLGRGSFGSVYE----GIS----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLS 385
G LG G FG V GI D AVK L D + + ++ L E+ L+
Sbjct: 17 GKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVK--MLKDNATD--KDLADLISEMELMK 72
Query: 386 RF-EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLR----------------- 427
+H+NI+ G E LY+ +E KG+L R LR
Sbjct: 73 LIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNL-----REFLRARRPPGPDYTFDITKVP 127
Query: 428 DSQVS-------AYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK 480
+ Q+S AY Q+ G++YL + +HRD+ N+LV + +K+ADFGLA+
Sbjct: 128 EEQLSFKDLVSCAY--QVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVH 185
Query: 481 LND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT---SQIPYAPME 533
D + R WMAPE + ++ Y +D+WS G + E+ T S P P+E
Sbjct: 186 DIDYYKKTSNGRLPVKWMAPEALFDRV--YTHQSDVWSFGILMWEIFTLGGSPYPGIPVE 243
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 6e-14
Identities = 63/227 (27%), Positives = 100/227 (44%), Gaps = 37/227 (16%)
Query: 334 GDLLGRGSFGSVYEGI--SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
G +LG G FGSV EG DDG V V + I + E A + F+H N
Sbjct: 4 GKILGEGEFGSVMEGQLSQDDGSQLKVA-VKTMKLDIHTYSEIEEFLSEAACMKDFDHPN 62
Query: 392 IVQYYG---TDKDESKL---YIFLELVTKGSLLN--LYQR-----YHLRDSQVSAYTRQI 438
+++ G K+ + L + G L + LY R L + + I
Sbjct: 63 VMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDI 122
Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-----------VKSC 487
LG++YL +++ +HRD+ N ++ + +V +ADFGL+K D VK
Sbjct: 123 ALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK-- 180
Query: 488 RGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPME 533
W+A E + ++ Y +D+W+ G T+ E+ T Q PY +E
Sbjct: 181 -----WIAIESL--ADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE 220
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 6e-14
Identities = 59/235 (25%), Positives = 99/235 (42%), Gaps = 55/235 (23%)
Query: 332 QKGDLLGRGSFGSVYEGISDDGFFFAVK--------EVSLLDQGSQAKQSISQLEQEIAL 383
G LG G FG V + F +K V +L + + + + + L E L
Sbjct: 3 VLGKTLGEGEFGKVVKA-----TAFRLKGRAGYTTVAVKMLKENASSSE-LRDLLSEFNL 56
Query: 384 LSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQ------------- 430
L + H ++++ YG + L + +E GSL R LR+S+
Sbjct: 57 LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSL-----RSFLRESRKVGPSYLGSDGNR 111
Query: 431 -----------------VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADF 473
+ ++ QI G++YL + +VHRD+ N+LV +K++DF
Sbjct: 112 NSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDF 171
Query: 474 GLAKATKLND--VKSCRG--TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT 524
GL++ D VK +G WMA E + + Y +D+WS G + E++T
Sbjct: 172 GLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHI--YTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 57/224 (25%), Positives = 101/224 (45%), Gaps = 40/224 (17%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKE-------VSLLDQGSQAKQSISQLEQEIALLSRFEH 389
LG+GSFG VYEGI+ VK+ + +++ + ++ I L E +++ F
Sbjct: 14 LGQGSFGMVYEGIAKG----VVKDEPETRVAIKTVNEAASMRERIEFL-NEASVMKEFNC 68
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD----------------SQVSA 433
++V+ G + +EL+T+G L + +LR ++
Sbjct: 69 HHVVRLLGVVSQGQPTLVIMELMTRGDL-----KSYLRSLRPEMENNPVQAPPSLKKMIQ 123
Query: 434 YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF- 492
+I G+ YL+ VHRD+ N +V + +VK+ DFG+ + D G
Sbjct: 124 MAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 183
Query: 493 ---WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPM 532
WM+PE + K+ + +D+WS G + E+ T ++ PY M
Sbjct: 184 PVRWMSPESL--KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGM 225
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 52/204 (25%), Positives = 108/204 (52%), Gaps = 12/204 (5%)
Query: 329 TYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVK-EVSLLDQGSQAKQSISQLEQEIALLSR 386
T ++ +LG G+FG+VY+GI +G + + +L++ + K ++ +++ + +++
Sbjct: 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEAL-IMAS 65
Query: 387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKY 444
+H ++V+ G + + + +L+ G LL+ + ++ + + QI G+ Y
Sbjct: 66 MDHPHLVRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMY 124
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKSCRGTAFWMAPEVIN 500
L ++ +VHRD+ N+LV + VK+ DFGLA+ K + + WMA E I+
Sbjct: 125 LEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184
Query: 501 NKNKGYGLPADIWSLGCTVLEMLT 524
+ + +D+WS G T+ E++T
Sbjct: 185 YRK--FTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 49/185 (26%), Positives = 85/185 (45%), Gaps = 14/185 (7%)
Query: 361 VSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNL 420
V + D + ++ + L+ E+ L F H NI+ + S L++ + GS +L
Sbjct: 30 VRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSL 89
Query: 421 YQRYHLRDSQVSAYTRQILLG----LKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA 476
+ Y + A IL G L YLH +HR+IK ++IL+ +G V L+
Sbjct: 90 LKTYF-PEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHL 148
Query: 477 KATKLNDVKSCRGTAF---------WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQI 527
+ N K+ F W++PE++ GY + +DI+S+G T E+ T ++
Sbjct: 149 YSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRV 208
Query: 528 PYAPM 532
P+ M
Sbjct: 209 PFQDM 213
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 63/231 (27%), Positives = 100/231 (43%), Gaps = 35/231 (15%)
Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
G LG G FG V GI D V + + + +S L E+ ++ +
Sbjct: 17 GKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGK 76
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLY-------------------QRYHLRDS 429
H+NI+ G + LY+ +E +KG+L ++ +D
Sbjct: 77 HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDL 136
Query: 430 QVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VK 485
AY Q+ G++YL Q +HRD+ N+LV + +K+ADFGLA+ D
Sbjct: 137 VSCAY--QVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTT 194
Query: 486 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT---SQIPYAPME 533
+ R WMAPE + ++ Y +D+WS G + E+ T S P P+E
Sbjct: 195 NGRLPVKWMAPEALFDRV--YTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 243
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 22/219 (10%)
Query: 334 GDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
G LG G FGSV EG ++ D V V + + + E + F+H N+
Sbjct: 4 GKTLGEGEFGSVMEGQLNQDDSILKVA-VKTMKIAICTRSEMEDFLSEAVCMKEFDHPNV 62
Query: 393 VQYYGT--DKDESKLY----IFLELVTKGSLLN--LYQRY-----HLRDSQVSAYTRQIL 439
++ G ES+ Y + L + G L + LY R +L + + I
Sbjct: 63 MRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIA 122
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV----KSCRGTAFWMA 495
G++YL + +HRD+ N +++ N +V +ADFGL+K D + + W+A
Sbjct: 123 SGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIA 182
Query: 496 PEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPME 533
E + ++ Y +D+WS G T+ E+ T Q PY +E
Sbjct: 183 IESL--ADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE 219
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 65/209 (31%), Positives = 108/209 (51%), Gaps = 22/209 (10%)
Query: 329 TYWQKGDLLGRGSFGSVYEGI-SDDG----FFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
T ++K +LG G+FG+VY+G+ +G A+KE L + + K + L+ E +
Sbjct: 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE---LREATSPKANKEILD-EAYV 62
Query: 384 LSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTR----QIL 439
++ ++ ++ + G S + + +L+ G LL+ Y R H +D+ S Y QI
Sbjct: 63 MASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLD-YVREH-KDNIGSQYLLNWCVQIA 119
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKSCRGTAFWMA 495
G+ YL ++ +VHRD+ N+LV VK+ DFGLAK K + + WMA
Sbjct: 120 KGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMA 179
Query: 496 PEVINNKNKGYGLPADIWSLGCTVLEMLT 524
E I ++ Y +D+WS G TV E++T
Sbjct: 180 LESILHRI--YTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 3e-13
Identities = 59/228 (25%), Positives = 96/228 (42%), Gaps = 40/228 (17%)
Query: 337 LGRGSFGSVY----EGI-----------SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEI 381
LG G FG V+ EG+ AVK + + K + + +EI
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKML----RADVTKTARNDFLKEI 68
Query: 382 ALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-------- 433
++SR ++ NI++ G + L + E + G L + + + A
Sbjct: 69 KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128
Query: 434 -----YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR 488
QI G+KYL + VHRD+ N LV + ++K+ADFG+++ D +
Sbjct: 129 ANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQ 188
Query: 489 GTAF----WMAPEVINNKNKGYGLPADIWSLGCTVLEM--LTSQIPYA 530
G A WMA E I + +D+W+ G T+ EM L + PY+
Sbjct: 189 GRAVLPIRWMAWESILLGK--FTTASDVWAFGVTLWEMFTLCKEQPYS 234
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 4e-13
Identities = 51/167 (30%), Positives = 81/167 (48%), Gaps = 22/167 (13%)
Query: 375 SQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLY-----QRYHLRDS 429
QLE EI L R HENI++ + E+ Y ++T+ +LY + + +D
Sbjct: 208 IQLENEILALGRLNHENILKIEEILRSEANTY----MITQKYDFDLYSFMYDEAFDWKDR 263
Query: 430 ----QVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK 485
Q A +Q+L ++Y+HD+ ++HRDIK NI ++ +G + L DFG A +
Sbjct: 264 PLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFG--TAMPFEKER 321
Query: 486 SCR-----GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQI 527
GT +PE++ GY DIWS G +L+ML+
Sbjct: 322 EAFDYGWVGTVATNSPEIL--AGDGYCEITDIWSCGLILLDMLSHDF 366
|
Length = 501 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 8e-13
Identities = 46/143 (32%), Positives = 77/143 (53%), Gaps = 4/143 (2%)
Query: 339 RGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYG 397
RG+FG VY G ++ +AVK V D + K + Q++ E L+ + IV Y
Sbjct: 14 RGAFGKVYLGRKKNNSKLYAVKVVKKADMIN--KNMVHQVQAERDALALSKSPFIVHLYY 71
Query: 398 TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVHRDIK 456
+ + + +Y+ +E + G + +L Y D +++ Y ++ L L YLH ++HRD+K
Sbjct: 72 SLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLK 131
Query: 457 CANILVDANGSVKLADFGLAKAT 479
N+L+ G +KL DFGL+K T
Sbjct: 132 PDNMLISNEGHIKLTDFGLSKVT 154
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 1e-12
Identities = 63/215 (29%), Positives = 92/215 (42%), Gaps = 25/215 (11%)
Query: 335 DLLGRGSFGSVYEGISDDGFFFA---VKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
D +G G FG V G + G A VKE+ + S QE+ H N
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKEL----RASATPDEQLLFLQEVQPYRELNHPN 56
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLR-DSQVSAYTR---QILLGLKYL 445
++Q G + + LE G L N + R + +Q R ++ GL +L
Sbjct: 57 VLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWL 116
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND---VKSCRGTAF-WMAPEVINN 501
H D +H D+ N + A+ SVK+ D+GLA D K C W+APE++
Sbjct: 117 HQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEI 176
Query: 502 KNKGYGLPAD------IWSLGCTVLEMLTSQI-PY 529
+ + LP D IWSLG T+ E+ T+ PY
Sbjct: 177 RGQDL-LPKDQTKKSNIWSLGVTMWELFTAADQPY 210
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 1e-12
Identities = 51/207 (24%), Positives = 91/207 (43%), Gaps = 16/207 (7%)
Query: 336 LLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
+LG G FG + G S A+ L G KQ L E L +F+H N
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIH---TLRAGCSDKQRRGFL-AEALTLGQFDHSN 67
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQD 449
IV+ G + + I E ++ G+L + +++ L Q+ + G+KYL +
Sbjct: 68 IVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG 127
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSC---RGTAFWMAPEVINNKNKGY 506
VH+ + +LV+++ K++ F + K + + + W APE I + +
Sbjct: 128 YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHH--F 185
Query: 507 GLPADIWSLGCTVLEMLT-SQIPYAPM 532
+D+WS G + E+++ + PY M
Sbjct: 186 SSASDVWSFGIVMWEVMSYGERPYWDM 212
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 2e-12
Identities = 62/225 (27%), Positives = 99/225 (44%), Gaps = 41/225 (18%)
Query: 337 LGRGSFGSVY-------EGISDDGFFFAVKE-------VSLLDQGSQAKQSISQLEQEIA 382
LG G FG V+ + + F F V++ V +L + K + + +E+
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKIL-RPDANKNARNDFLKEVK 71
Query: 383 LLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQ------------ 430
+LSR + NI++ G DE L + E + G L +HL D +
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131
Query: 431 --VSAYTR------QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN 482
+Y+ QI G+KYL + VHRD+ N LV N ++K+ADFG+++
Sbjct: 132 LPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAG 191
Query: 483 DVKSCRGTAF----WMAPEVINNKNKGYGLPADIWSLGCTVLEML 523
D +G A WMA E I + +D+W+ G T+ E+L
Sbjct: 192 DYYRIQGRAVLPIRWMAWECILMGK--FTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 59/219 (26%), Positives = 101/219 (46%), Gaps = 36/219 (16%)
Query: 337 LGRGSFGSVYEGISDD------GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
LG+GSFG VYEG + D AVK V ++ + ++ I L E +++ F
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTV---NESASLRERIEFL-NEASVMKGFTCH 69
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS---------------QVSAYT 435
++V+ G + +EL+ G L + Y R ++ Q++A
Sbjct: 70 HVVRLLGVVSKGQPTLVVMELMAHGDLKS-YLRSLRPEAENNPGRPPPTLQEMIQMAA-- 126
Query: 436 RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF--- 492
+I G+ YL+ + VHRD+ N +V + +VK+ DFG+ + D G
Sbjct: 127 -EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185
Query: 493 -WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY 529
WMAPE + K+ + +D+WS G + E+ + ++ PY
Sbjct: 186 RWMAPESL--KDGVFTTSSDMWSFGVVLWEITSLAEQPY 222
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 4e-12
Identities = 47/156 (30%), Positives = 68/156 (43%), Gaps = 24/156 (15%)
Query: 380 EIALLSRFEHENIVQYYGT-----------DKDESKLYIFLELVTKGSLLNLYQRYHLRD 428
E LL H ++++ T S LY +L TK S + +
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYL---TKRS-----RPLPIDQ 158
Query: 429 SQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-DVKSC 487
+ + +QIL GL+YLH Q ++HRD+K NI ++ V + D G A+ +
Sbjct: 159 ALI--IEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGL 216
Query: 488 RGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEML 523
GT APEV+ Y ADIWS G + EML
Sbjct: 217 AGTVETNAPEVL--ARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 4e-12
Identities = 65/255 (25%), Positives = 98/255 (38%), Gaps = 63/255 (24%)
Query: 337 LGRGSFGSVYEG----ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
LG G+FG VY+G ++ +V +L + Q + QE L+S +H NI
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQ--EFRQEAELMSDLQHPNI 70
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTR---------------- 436
V G E + E + G L + +R+S S
Sbjct: 71 VCLLGVCTKEQPTCMLFEYLAHGDL----HEFLVRNSPHSDVGAESGDETVKSSLDCSDF 126
Query: 437 -----QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA 491
QI G++YL VHRD+ N LV +VK++DFGL++ D + +
Sbjct: 127 LHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKS 186
Query: 492 F----WMAPEVINNKNKGYG---LPADIWSLGCT-------------------VLEMLTS 525
WM PE I YG +DIWS G V+EM+ S
Sbjct: 187 LLPVRWMPPEAIL-----YGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRS 241
Query: 526 -QIPYAPMECVSAIF 539
Q+ P +C + ++
Sbjct: 242 RQLLPCPEDCPARVY 256
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 1e-11
Identities = 48/171 (28%), Positives = 78/171 (45%), Gaps = 18/171 (10%)
Query: 377 LEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTR 436
L+ E+ + F H NIV Y T +++L++ + GS +L H D
Sbjct: 46 LQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICT-HFMDGMSELAIA 104
Query: 437 QILLG----LKYLHDQDVVHRDIKCANILVDANGSVKLADFGL----------AKATKLN 482
IL G L Y+H VHR +K ++IL+ +G V L+ GL + ++
Sbjct: 105 YILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLS--GLRSNLSMINHGQRLRVVH 162
Query: 483 DV-KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM 532
D K W++PEV+ +GY +DI+S+G T E+ +P+ M
Sbjct: 163 DFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 213
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 57/205 (27%), Positives = 103/205 (50%), Gaps = 14/205 (6%)
Query: 329 TYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVK-EVSLLDQGSQAKQSISQLEQEIALLSR 386
T +K +LG G+FG+VY+GI DG + + +L + + K + L+ E +++
Sbjct: 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILD-EAYVMAG 65
Query: 387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLK 443
+ + G S + + +L+ G LL+ Y R + + + + QI G+
Sbjct: 66 VGSPYVCRLLGICL-TSTVQLVTQLMPYGCLLD-YVRENKDRIGSQDLLNWCVQIAKGMS 123
Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK----SCRGTAFWMAPEVI 499
YL + +VHRD+ N+LV + VK+ DFGLA+ +++ + + WMA E I
Sbjct: 124 YLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESI 183
Query: 500 NNKNKGYGLPADIWSLGCTVLEMLT 524
++ + +D+WS G TV E++T
Sbjct: 184 LHRR--FTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 3e-11
Identities = 59/204 (28%), Positives = 99/204 (48%), Gaps = 25/204 (12%)
Query: 337 LGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIA-LLSRFEHEN 391
LG+G+F ++Y+G+ SD +EVS++ + + S E A L+S+ H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 392 IVQYYG-TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAY-----TRQILLGLKYL 445
+V+ YG +DE+ + E V G L +++ H + VS + +Q+ L YL
Sbjct: 63 LVKLYGVCVRDENI--MVEEYVKFGPL-DVF--LHREKNNVSLHWKLDVAKQLASALHYL 117
Query: 446 HDQDVVHRDIKCANILV---DANGS----VKLADFGLAKATKLNDVKSCRGTAFWMAPEV 498
D+ +VH ++ NILV N +KL+D G+ + + W+APE
Sbjct: 118 EDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP--ITVLSREERVERIPWIAPEC 175
Query: 499 INNKNKGYGLPADIWSLGCTVLEM 522
I N + AD WS G T+LE+
Sbjct: 176 IRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 4e-11
Identities = 45/150 (30%), Positives = 64/150 (42%), Gaps = 5/150 (3%)
Query: 380 EIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQIL 439
E +L H +I+Q GT + L L + ++ + A R +L
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYLAAKRNIAICDILAIERSVL 192
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA---KATKLNDVKSCRGTAFWMAP 496
++YLH+ ++HRDIK NI ++ G V L DFG A N GT AP
Sbjct: 193 RAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAP 252
Query: 497 EVINNKNKGYGLPADIWSLGCTVLEMLTSQ 526
E++ YG DIWS G + EM T
Sbjct: 253 ELL--ARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 4e-11
Identities = 58/221 (26%), Positives = 91/221 (41%), Gaps = 34/221 (15%)
Query: 337 LGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
LG +FG +Y+G D A+K +L D + Q + +QE +L++ H N
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIK--TLKDINN--PQQWGEFQQEASLMAELHHPN 68
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSA----------------- 433
IV G E + + E + +G L L R D S+
Sbjct: 69 IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128
Query: 434 YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF- 492
QI G++YL VH+D+ NIL+ VK++D GL++ D + +
Sbjct: 129 IAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188
Query: 493 ---WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQI-PY 529
WM PE I + +DIWS G + E+ + + PY
Sbjct: 189 PIRWMPPEAIMYGK--FSSDSDIWSFGVVLWEIFSFGLQPY 227
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 8e-10
Identities = 36/114 (31%), Positives = 59/114 (51%), Gaps = 7/114 (6%)
Query: 433 AYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF 492
++T Q+ G+++L ++ VHRD+ N+L+ VK+ DFGLA+ + +G+ F
Sbjct: 241 SFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTF 300
Query: 493 ----WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIFIK 541
WMAPE I + Y +D+WS G + E+ + PY M S + K
Sbjct: 301 LPVKWMAPESIFDNL--YTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNK 352
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (144), Expect = 9e-10
Identities = 39/118 (33%), Positives = 61/118 (51%), Gaps = 8/118 (6%)
Query: 415 GSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD-ANGSVKLAD 472
G L +L ++ L +++V RQ++ L LH +++H DIK N+L D A + L D
Sbjct: 94 GDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCD 153
Query: 473 FGLAKATKLNDVKSC-RGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY 529
+GL K SC GT + +PE I N Y + D W++G E+LT + P+
Sbjct: 154 YGLCKII---GTPSCYDGTLDYFSPEKIKGHN--YDVSFDWWAVGVLTYELLTGKHPF 206
|
Length = 267 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 57/226 (25%), Positives = 95/226 (42%), Gaps = 44/226 (19%)
Query: 337 LGRGSFGSVYEGISDDGFFFA------VKEVSLLDQGSQAKQSI-SQLEQEIALLSRFEH 389
LG FG VY+G F + V++ +A+ + + + E + SR +H
Sbjct: 13 LGEDRFGKVYKG-----HLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQH 67
Query: 390 ENIVQYYGT-DKDESKLYIFLELVTKGSLLNLYQRYHLR-----------DSQVSA---- 433
NIV G K++ IF + S +L++ +R D V +
Sbjct: 68 PNIVCLLGVVTKEQPLSMIF----SYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEP 123
Query: 434 -----YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR 488
QI G+++L VVH+D+ N+LV +VK++D GL + D
Sbjct: 124 ADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLM 183
Query: 489 GTAF----WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQI-PY 529
G + WM+PE I + + +DIWS G + E+ + + PY
Sbjct: 184 GNSLLPIRWMSPEAIMYGK--FSIDSDIWSYGVVLWEVFSYGLQPY 227
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 58/216 (26%), Positives = 95/216 (43%), Gaps = 31/216 (14%)
Query: 337 LGRGSFGSVYEGISDDGFFFA---VKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
+G G FG V G + G+ A VKE+ + S + Q + +E +H N++
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKEL----RVSASVQEQMKFLEEAQPYRSLQHSNLL 58
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS--------QVSAYTRQILLGLKYL 445
Q G + + + +E G L + + Q A +I LGL +L
Sbjct: 59 QCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMAC--EIALGLLHL 116
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----WMAPEVINN 501
H + +H D+ N L+ A+ +VK+ D+GL+ D + W+APE+++
Sbjct: 117 HKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDE 176
Query: 502 KNKGYGLPAD------IWSLGCTVLEM--LTSQIPY 529
+ G L D +WSLG T+ E+ L SQ PY
Sbjct: 177 VH-GNLLVVDQTKESNVWSLGVTIWELFELGSQ-PY 210
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 35/106 (33%), Positives = 56/106 (52%), Gaps = 9/106 (8%)
Query: 434 YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF- 492
++ Q+ G+++L ++ VHRD+ N+L+ VK+ DFGLA+ + +G+ F
Sbjct: 244 FSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFL 303
Query: 493 ---WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT---SQIPYAPM 532
WMAPE I N Y +D+WS G + E+ T + P PM
Sbjct: 304 PLKWMAPESIFNNL--YTTLSDVWSFGILLWEIFTLGGTPYPELPM 347
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-09
Identities = 35/105 (33%), Positives = 49/105 (46%), Gaps = 16/105 (15%)
Query: 426 LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK 485
L +QV+A RQ+L + Y+H + ++HRDIK N+LV+ + L DFG A +
Sbjct: 257 LGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACF-----AR 311
Query: 486 SCRGTAFWM---------APEVINNKNKGYGLPADIWSLGCTVLE 521
T F APEV+ Y DIWS G + E
Sbjct: 312 GSWSTPFHYGIAGTVDTNAPEVL--AGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 32/95 (33%), Positives = 53/95 (55%), Gaps = 6/95 (6%)
Query: 434 YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF- 492
Y+ Q+ G+++L + +HRD+ NIL+ N VK+ DFGLA+ + +G A
Sbjct: 184 YSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243
Query: 493 ---WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT 524
WMAPE I ++ Y + +D+WS G + E+ +
Sbjct: 244 PLKWMAPETIFDRV--YTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 33/95 (34%), Positives = 53/95 (55%), Gaps = 6/95 (6%)
Query: 434 YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF- 492
Y+ Q+ G+++L + +HRD+ NIL+ N VK+ DFGLA+ + +G+A
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238
Query: 493 ---WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT 524
WMAPE I +K Y +D+WS G + E+ +
Sbjct: 239 PLKWMAPESIFDKV--YTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 3e-09
Identities = 33/96 (34%), Positives = 53/96 (55%), Gaps = 6/96 (6%)
Query: 433 AYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF 492
+Y+ Q+ G+++L + +HRD+ NIL+ N VK+ DFGLA+ + +G A
Sbjct: 177 SYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 236
Query: 493 ----WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT 524
WMAPE I +K Y +D+WS G + E+ +
Sbjct: 237 LPLKWMAPESIFDKV--YTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 7e-09
Identities = 36/114 (31%), Positives = 53/114 (46%), Gaps = 13/114 (11%)
Query: 426 LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK 485
L + ++ A Q L L+ LH Q + + L+ +GSV A T
Sbjct: 14 LNEEEIWAVCLQCLGALRELHRQAKSGNILLTWDGLLKLDGSV-------AFKTPEQS-- 64
Query: 486 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIF 539
R ++MAPEVI + + Y ADI+SLG T+ E L ++PY +SAI
Sbjct: 65 --RPDPYFMAPEVI--QGQSYTEKADIYSLGITLYEALDYELPYNEERELSAIL 114
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 8e-09
Identities = 32/98 (32%), Positives = 43/98 (43%), Gaps = 8/98 (8%)
Query: 436 RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA-KATKLNDVKSCRGTAFWM 494
R++L L YLH + ++HRD+K NI +D + L DFG A K D C G W
Sbjct: 192 RRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYG---WS 248
Query: 495 APEVINNKN----KGYGLPADIWSLGCTVLEMLTSQIP 528
N+ Y DIWS G + EM +
Sbjct: 249 GTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 52/204 (25%), Positives = 92/204 (45%), Gaps = 26/204 (12%)
Query: 337 LGRGSFGSVYEGISD---DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
LG+G+F +++GI D EV L + + +++S+ H+++V
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 394 QYYGTD--KDESKLYIFLELVTKGSL-LNLYQRYHLRDS----QVSAYTRQILLGLKYLH 446
YG DES + E V GSL L + +L + +V+ +Q+ L +L
Sbjct: 63 LNYGVCVCGDESIM--VQEYVKFGSLDTYLKKNKNLINISWKLEVA---KQLAWALHFLE 117
Query: 447 DQDVVHRDIKCANILV-----DANGS---VKLADFGLAKATKLNDVKSCRGTAFWMAPEV 498
D+ + H ++ N+L+ G+ +KL+D G++ ++ R W+ PE
Sbjct: 118 DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIP--WVPPEC 175
Query: 499 INNKNKGYGLPADIWSLGCTVLEM 522
I N + L AD WS G T+ E+
Sbjct: 176 IENP-QNLSLAADKWSFGTTLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 3e-08
Identities = 36/130 (27%), Positives = 67/130 (51%), Gaps = 16/130 (12%)
Query: 402 ESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANI 460
E +++ L+ G L + ++ ++ + V + ++++ L LH + +V RD+ NI
Sbjct: 57 EDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNI 116
Query: 461 LVDANGSVKLADFGLAKATKLNDVK-SCRGTA---FWMAPEV--INNKNKGYGLPADIWS 514
L+D G ++L F + ++V+ SC G A + APEV I+ + + D WS
Sbjct: 117 LLDDRGHIQLTYFS-----RWSEVEDSCDGEAVENMYCAPEVGGISEETEA----CDWWS 167
Query: 515 LGCTVLEMLT 524
LG + E+LT
Sbjct: 168 LGAILFELLT 177
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 4e-08
Identities = 36/116 (31%), Positives = 59/116 (50%), Gaps = 8/116 (6%)
Query: 433 AYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF 492
+++ Q+ G+ +L ++ +HRD+ NIL+ K+ DFGLA+ + + +G A
Sbjct: 218 SFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNAR 277
Query: 493 ----WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIFIKTV 543
WMAPE I N Y +D+WS G + E+ + PY M V + F K +
Sbjct: 278 LPVKWMAPESIFNCV--YTFESDVWSYGILLWEIFSLGSSPYPGMP-VDSKFYKMI 330
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 8e-08
Identities = 38/116 (32%), Positives = 63/116 (54%), Gaps = 10/116 (8%)
Query: 434 YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VK-SCR 488
++ Q+ G+ +L ++ +HRD+ N+L+ K+ DFGLA+ +ND VK + R
Sbjct: 217 FSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDI-MNDSNYVVKGNAR 275
Query: 489 GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIFIKTV 543
WMAPE I + Y + +D+WS G + E+ + + PY P V++ F K V
Sbjct: 276 LPVKWMAPESIFDCV--YTVQSDVWSYGILLWEIFSLGKSPY-PGILVNSKFYKMV 328
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 1e-07
Identities = 45/166 (27%), Positives = 70/166 (42%), Gaps = 16/166 (9%)
Query: 375 SQLEQEIALLSRFEHENIVQYYGTDKDE-SKLYIFLELVTKGSLLNLYQRYH-LRDSQVS 432
++ +E AL +R H NIV + + L+ E V +L + L +
Sbjct: 23 ARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAADGALPAGETG 82
Query: 433 AYTRQILLGLKYLHDQDVVHRDIKCANILVDANG---SVKLADFGL---------AKATK 480
Q+L L H+Q +VHRD+K NI+V G K+ DFG+ A
Sbjct: 83 RLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVAT 142
Query: 481 LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQ 526
L GT + APE + + + +D+++ G LE LT Q
Sbjct: 143 LTRTTEVLGTPTYCAPEQL--RGEPVTPNSDLYAWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 3e-07
Identities = 42/172 (24%), Positives = 76/172 (44%), Gaps = 15/172 (8%)
Query: 371 KQSISQLEQEIALLSRFEHENIVQYYGTDKDES----KLYIFLELVTKGSLLNLYQRYHL 426
K I E EI L R + NI++ YG D +L + LE T+G L
Sbjct: 59 KVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLRE----VLD 114
Query: 427 RDSQVSAYTR-QILL----GLKYLHDQD-VVHRDIKCANILVDANGSVKLADFGLAKATK 480
++ +S T+ + + GL L+ ++++ + LV N +K+ GL K
Sbjct: 115 KEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILS 174
Query: 481 LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM 532
K+ + + +++N+ Y + DI+SLG + E+ T +IP+ +
Sbjct: 175 SPPFKNVNFMVY-FSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL 225
|
Length = 283 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 4e-07
Identities = 27/62 (43%), Positives = 34/62 (54%), Gaps = 7/62 (11%)
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
+ RQ+L GL+ LH +VHRDIK N+LV +G VK+ DFG A V C G
Sbjct: 311 IKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA-------VDMCTGI 363
Query: 491 AF 492
F
Sbjct: 364 NF 365
|
Length = 507 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 6e-07
Identities = 37/117 (31%), Positives = 56/117 (47%), Gaps = 30/117 (25%)
Query: 437 QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL----------NDVKS 486
+I ++Y+H + V+HRD+K NIL+ G V + D+G A KL ++
Sbjct: 121 KICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180
Query: 487 CR----------GTAFWMAPEVINNKNKGYGLPA----DIWSLGCTVLEMLTSQIPY 529
C GT +MAPE + G+PA DI++LG + +MLT PY
Sbjct: 181 CYSSMTIPGKIVGTPDYMAPE------RLLGVPASESTDIYALGVILYQMLTLSFPY 231
|
Length = 932 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 51/218 (23%), Positives = 90/218 (41%), Gaps = 36/218 (16%)
Query: 337 LGRGSFGSV-----YEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR----- 386
+G G FG V Y VKE+ K + S EQ L
Sbjct: 3 IGNGWFGKVLLSEIYTDTG--VARVVVKEL---------KANASSKEQNEFLQQGDPYRI 51
Query: 387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTR---QILLG 441
+H NI+Q G + + E G L + +++H R+SQ+ R +I G
Sbjct: 52 LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAG 111
Query: 442 LKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----WMAPE 497
+ ++H + +H D+ N + ++ +VK+ D+G+ + D W+APE
Sbjct: 112 VTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPE 171
Query: 498 VINNKNKGY-----GLPADIWSLGCTVLEML-TSQIPY 529
++ + G P+++W+LG T+ E+ + PY
Sbjct: 172 LVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPY 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 60/208 (28%), Positives = 95/208 (45%), Gaps = 30/208 (14%)
Query: 337 LGRGSFGSVYEGI-------SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR-FE 388
LGRG+ +Y GI DDG+ + + +L + + IS E A + R
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 389 HENIVQYYGT-DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA------YTRQILLG 441
H++IV YG +D I +E + L+L+ R S V +Q+
Sbjct: 63 HKHIVLLYGVCVRDVEN--IMVEEFVEFGPLDLFMH---RKSDVLTTPWKFKVAKQLASA 117
Query: 442 LKYLHDQDVVHRDIKCANILVDANG-------SVKLADFGLAKATKLNDVKSCRGTAFWM 494
L YL D+D+VH ++ NIL+ G +KL+D G+ T L+ + C W+
Sbjct: 118 LSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP-ITVLSR-QECVERIPWI 175
Query: 495 APEVINNKNKGYGLPADIWSLGCTVLEM 522
APE + + +K + AD WS G T+ E+
Sbjct: 176 APECVED-SKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 9e-06
Identities = 41/161 (25%), Positives = 77/161 (47%), Gaps = 16/161 (9%)
Query: 331 WQKGDLLGRGSFGSVYEGISDDGFFF---AVKEVSLLDQGSQAKQSI---SQLEQE-IAL 383
W+ L+G G FG VYE AV ++ L+ + +++ + + + IAL
Sbjct: 14 WKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIAL 73
Query: 384 LSRF---EHENIVQYYGTDK-DESKLY---IFLELVTKGSLLNLYQRYHLRDSQ-VSAYT 435
+H I +YYG ++Y I LE + + + +++R ++ + +
Sbjct: 74 WKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIM 132
Query: 436 RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA 476
+ +L L+Y+H+ + H DIK NI+VD N + D+G+A
Sbjct: 133 KDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIA 173
|
Length = 294 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 8e-05
Identities = 45/160 (28%), Positives = 69/160 (43%), Gaps = 32/160 (20%)
Query: 382 ALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYT--RQIL 439
+L+S+ H ++ +G S+ + E V G L ++ R T +Q+
Sbjct: 68 SLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLA 127
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT----KLNDVKSCRGTAF--- 492
L YL D+++VH ++ NIL LA GLA+ T KL+D G +F
Sbjct: 128 SALSYLEDKNLVHGNVCAKNIL--------LARLGLAEGTSPFIKLSD----PGVSFTAL 175
Query: 493 ----------WMAPEVINNKNKGYGLPADIWSLGCTVLEM 522
W+APE + N AD WS G T+LE+
Sbjct: 176 SREERVERIPWIAPECVPGGN-SLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 4e-04
Identities = 56/226 (24%), Positives = 102/226 (45%), Gaps = 38/226 (16%)
Query: 316 SNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSI 374
S +S + I++ ++ +++ RG G+ Y+G S +G F VKE++ ++ SI
Sbjct: 677 SKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVN-------SI 729
Query: 375 SQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGS----LLNL-YQRYHLRDS 429
EIA + + +H NIV+ G + E Y+ E + + L NL ++R
Sbjct: 730 P--SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRNLSWER------ 781
Query: 430 QVSAYTRQILLG----LKYLH---DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN 482
R+I +G L++LH VV ++ I++D L L+ L
Sbjct: 782 -----RRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR---LSLPGLLC 833
Query: 483 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIP 528
C ++ ++APE + K +DI+ G ++E+LT + P
Sbjct: 834 TDTKCFISSAYVAPE--TRETKDITEKSDIYGFGLILIELLTGKSP 877
|
Length = 968 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 6e-04
Identities = 20/42 (47%), Positives = 25/42 (59%), Gaps = 1/42 (2%)
Query: 436 RQILLGLKYLHDQDVVHRDIKCANILVD-ANGSVKLADFGLA 476
RQIL L LH +VHRD+K NI+ +GS K+ D G A
Sbjct: 262 RQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAA 303
|
Length = 566 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 554 | |||
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.98 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.98 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.98 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.98 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.98 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.98 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.98 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.98 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.98 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.98 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.98 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.98 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.98 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.98 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.98 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.98 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.98 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.97 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.97 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.97 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.97 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.97 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.96 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.96 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.96 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.96 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.96 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.96 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.95 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.95 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.94 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.92 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.92 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.91 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.87 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.87 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.86 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.86 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.85 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.85 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.84 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.84 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.81 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.8 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.8 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.77 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.77 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.77 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.76 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.75 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.75 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.73 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.72 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.71 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.69 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.66 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.65 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.64 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.56 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.53 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.45 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.41 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.38 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.36 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.35 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.23 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.21 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.17 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.13 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.13 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.12 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.09 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.09 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.97 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.95 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.84 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.82 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.74 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.65 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.56 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.53 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.49 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.47 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.33 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.21 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.18 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.14 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.11 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 97.99 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.95 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.93 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.93 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.91 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.89 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.89 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.82 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.81 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.64 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.52 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.47 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.35 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.33 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.3 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.24 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.22 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.17 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.02 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.01 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.67 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.62 | |
| PLN02236 | 344 | choline kinase | 96.55 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.44 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.38 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.06 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.93 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.9 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.32 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.31 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.24 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.15 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 95.1 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 94.96 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 93.64 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 93.4 | |
| PTZ00296 | 442 | choline kinase; Provisional | 93.36 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 92.37 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 91.4 |
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-45 Score=372.67 Aligned_cols=214 Identities=31% Similarity=0.503 Sum_probs=191.0
Q ss_pred cccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcE
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL 405 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~ 405 (554)
..++|+++++||+|+||+||.++. ++++.||+|++++..... +...++...|..||..++||+||+++..|++..++
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~--~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL 100 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVE--KKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL 100 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhh--hhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence 357899999999999999999998 789999999987644333 34567889999999999999999999999999999
Q ss_pred EEEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccc-c-C
Q 008759 406 YIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK-L-N 482 (554)
Q Consensus 406 ~LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~-~-~ 482 (554)
|||+||+.||.|...|++ ..+.+..++.|+.+|+.||.|||++|||||||||+|||++.+|+++|+||||++..- . .
T Consensus 101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~ 180 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGD 180 (357)
T ss_pred EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCC
Confidence 999999999999999985 569999999999999999999999999999999999999999999999999998533 2 2
Q ss_pred CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHHH
Q 008759 483 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTVA 544 (554)
Q Consensus 483 ~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~~ 544 (554)
...+.+||+.|||||++.+. +|+..+||||||+++|+||+|.+||...+.....-+|...
T Consensus 181 ~t~tfcGT~eYmAPEil~~~--gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~ 240 (357)
T KOG0598|consen 181 ATRTFCGTPEYMAPEILLGK--GYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKG 240 (357)
T ss_pred ccccccCCccccChHHHhcC--CCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcC
Confidence 44567899999999999766 5999999999999999999999999998876666665543
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=373.36 Aligned_cols=215 Identities=28% Similarity=0.518 Sum_probs=190.7
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCc
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~ 404 (554)
....+|.+.+.||.|+|++||+|++ .++..||||++..... .+...+.+..|+.+|+.++|||||.+++++...+.
T Consensus 7 ~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l---~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~ 83 (429)
T KOG0595|consen 7 RVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL---NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDF 83 (429)
T ss_pred cccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc---CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCe
Confidence 4567899999999999999999999 7789999999975332 34556778899999999999999999999999999
Q ss_pred EEEEEeecccCchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCC------CcEEEEecCccc
Q 008759 405 LYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN------GSVKLADFGLAK 477 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~~-~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~------g~vKL~DFGlA~ 477 (554)
+|||||||.||+|..|+++. .+++..++.++.||+.||++||+++||||||||.|||++.. -.+||+|||+|+
T Consensus 84 i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 84 IYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 99999999999999999876 79999999999999999999999999999999999999765 358999999999
Q ss_pred ccccCC-ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHHHH
Q 008759 478 ATKLND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTVAV 545 (554)
Q Consensus 478 ~~~~~~-~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~~~ 545 (554)
...... ..+.+|++.|||||+++.. .|+.|+|+||+|+|+|+|++|+.||......+-+..+..+.
T Consensus 164 ~L~~~~~a~tlcGSplYMAPEV~~~~--~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~ 230 (429)
T KOG0595|consen 164 FLQPGSMAETLCGSPLYMAPEVIMSQ--QYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGN 230 (429)
T ss_pred hCCchhHHHHhhCCccccCHHHHHhc--cccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccc
Confidence 876554 4677899999999999654 49999999999999999999999999877777766555443
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-44 Score=355.85 Aligned_cols=214 Identities=30% Similarity=0.501 Sum_probs=194.1
Q ss_pred ccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEE
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~ 406 (554)
+++|+..+.||.|+||+|.+++. .+|.+||+|++...... .-..+++..+|..+|+.+.||++++++++|.+.+++|
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vV--klKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVV--KLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHH--HHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 56899999999999999999998 67999999998753322 2334678889999999999999999999999999999
Q ss_pred EEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCCcc
Q 008759 407 IFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK 485 (554)
Q Consensus 407 LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~~~ 485 (554)
|||||+.||.|..++++ ..|++..++.|+.||+.||+|||+++|++|||||+|||+|.+|.+||+|||+|+..... ..
T Consensus 121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-T~ 199 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-TW 199 (355)
T ss_pred EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc-EE
Confidence 99999999999999987 56999999999999999999999999999999999999999999999999999988766 45
Q ss_pred CccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHHHHH
Q 008759 486 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTVAVT 546 (554)
Q Consensus 486 s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~~~~ 546 (554)
+.||||.|+|||++..++ |+.++|+|+||+++|||+.|.+||.....++..-+|+.+.+
T Consensus 200 TlCGTPeYLAPEii~sk~--ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v 258 (355)
T KOG0616|consen 200 TLCGTPEYLAPEIIQSKG--YNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKV 258 (355)
T ss_pred EecCCccccChHHhhcCC--CCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcc
Confidence 677999999999997654 99999999999999999999999999999888888877643
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=376.17 Aligned_cols=216 Identities=34% Similarity=0.588 Sum_probs=194.8
Q ss_pred cceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEE
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~L 407 (554)
.+|..+++||+|+|+.||++++ .+|..||+|++....... ....+.+.+||+|.+.|+|||||++|++|++.+++||
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k--~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYi 95 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKK--PKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYI 95 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcC--cchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEE
Confidence 5799999999999999999999 899999999997533322 2335678899999999999999999999999999999
Q ss_pred EEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccccc--CCc
Q 008759 408 FLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL--NDV 484 (554)
Q Consensus 408 VmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~--~~~ 484 (554)
|+|+|..++|..++++ ..+++.+++.|++||+.||.|||+++|||||||..|||++.+.+|||+|||||..... ...
T Consensus 96 vLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk 175 (592)
T KOG0575|consen 96 VLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERK 175 (592)
T ss_pred EEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCccccc
Confidence 9999999999999986 5699999999999999999999999999999999999999999999999999987653 345
Q ss_pred cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHHHHHHH
Q 008759 485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTVAVTVI 548 (554)
Q Consensus 485 ~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~~~~~~ 548 (554)
.+.||||.|+|||+++.. +++..+||||+||+||.||+|++||......+..-+|..+..++
T Consensus 176 ~TlCGTPNYIAPEVl~k~--gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~ 237 (592)
T KOG0575|consen 176 KTLCGTPNYIAPEVLNKS--GHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSM 237 (592)
T ss_pred ceecCCCcccChhHhccC--CCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccc
Confidence 678999999999999754 58999999999999999999999999988888888887776655
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=365.34 Aligned_cols=207 Identities=31% Similarity=0.483 Sum_probs=180.6
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchh--HHHHHHHHHHHHHHHhCCCCceeeeeeeccCC
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQA--KQSISQLEQEIALLSRFEHENIVQYYGTDKDE 402 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~--~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~ 402 (554)
.+.++|.+.+.||+|+||.|-+|.. .+|+.||||++......... ......+.+|+++|++++|||||+++++|...
T Consensus 169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ 248 (475)
T KOG0615|consen 169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP 248 (475)
T ss_pred hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC
Confidence 4678999999999999999999998 88999999999864433322 12233467999999999999999999999999
Q ss_pred CcEEEEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCC---CcEEEEecCcccc
Q 008759 403 SKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN---GSVKLADFGLAKA 478 (554)
Q Consensus 403 ~~~~LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~---g~vKL~DFGlA~~ 478 (554)
+..||||||++||.|.+.+-. ..+.+..-+.|++||+.||.|||++||+||||||+|||+..+ -.+||+|||+|+.
T Consensus 249 ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~ 328 (475)
T KOG0615|consen 249 DSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV 328 (475)
T ss_pred CceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence 999999999999999997765 457888889999999999999999999999999999999876 5799999999998
Q ss_pred ccc-CCccCccCCCcccChhhhcccCCCCC-chhhHHHHHHHHHHHHcCCCCCCCC
Q 008759 479 TKL-NDVKSCRGTAFWMAPEVINNKNKGYG-LPADIWSLGCTVLEMLTSQIPYAPM 532 (554)
Q Consensus 479 ~~~-~~~~s~~GT~~Y~APEvl~~~~~~~s-~ksDIwSLGvllyeLLTG~~PF~~~ 532 (554)
... ....+.||||.|.|||++..++..+. .++|||||||+||-+|+|.+||...
T Consensus 329 ~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~ 384 (475)
T KOG0615|consen 329 SGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEE 384 (475)
T ss_pred cccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccc
Confidence 754 44678899999999999987765444 4899999999999999999999864
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=363.11 Aligned_cols=216 Identities=29% Similarity=0.487 Sum_probs=189.8
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCc
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~ 404 (554)
.-.++|++++.||+|+||.||+|+. .+|..||+|++++... .....++++..|-.+|....+++||+||..|++..+
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M--~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~ 215 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEM--LKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEY 215 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHH--HhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCe
Confidence 3567999999999999999999998 7899999999975433 334557889999999999999999999999999999
Q ss_pred EEEEEeecccCchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccccc--
Q 008759 405 LYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL-- 481 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~~-~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~-- 481 (554)
+||||||++||++..+|.+. .|++..++.|+.+++.||..||+.|+|||||||+|+|||..|++||+||||+.....
T Consensus 216 LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~ 295 (550)
T KOG0605|consen 216 LYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKH 295 (550)
T ss_pred eEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhh
Confidence 99999999999999999874 599999999999999999999999999999999999999999999999999842110
Q ss_pred --------------------CC---------------------------ccCccCCCcccChhhhcccCCCCCchhhHHH
Q 008759 482 --------------------ND---------------------------VKSCRGTAFWMAPEVINNKNKGYGLPADIWS 514 (554)
Q Consensus 482 --------------------~~---------------------------~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwS 514 (554)
.. ..+.+|||.|||||++.+++ |+..+|+||
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg--Y~~~cDwWS 373 (550)
T KOG0605|consen 296 RIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG--YGKECDWWS 373 (550)
T ss_pred hhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC--CCccccHHH
Confidence 00 01235999999999998765 999999999
Q ss_pred HHHHHHHHHcCCCCCCCCChhHHHHHHHHHH
Q 008759 515 LGCTVLEMLTSQIPYAPMECVSAIFIKTVAV 545 (554)
Q Consensus 515 LGvllyeLLTG~~PF~~~e~~~~i~~i~~~~ 545 (554)
||||+||||.|.+||..-++.+..-+|.+..
T Consensus 374 LG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr 404 (550)
T KOG0605|consen 374 LGCIMYEMLVGYPPFCSETPQETYRKIVNWR 404 (550)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 9999999999999999998888877776543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=348.46 Aligned_cols=212 Identities=29% Similarity=0.523 Sum_probs=187.7
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCc
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~ 404 (554)
....+.+.++.||+|..|+||++++ .+++.+|+|++... ......+++.+|+++++.++|||||.+|++|..+..
T Consensus 76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~----~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~ 151 (364)
T KOG0581|consen 76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN----IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE 151 (364)
T ss_pred cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc----CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc
Confidence 3445777889999999999999999 78999999999542 234556789999999999999999999999999984
Q ss_pred -EEEEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHH-CCccccCCccccEEEcCCCcEEEEecCccccccc
Q 008759 405 -LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGSVKLADFGLAKATKL 481 (554)
Q Consensus 405 -~~LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs-~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~ 481 (554)
++|+||||++|+|..++.. ..+++..+..++.+|++||.|||+ .+||||||||+||||+..|+|||||||.+...-+
T Consensus 152 ~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn 231 (364)
T KOG0581|consen 152 EISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN 231 (364)
T ss_pred eEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhh
Confidence 9999999999999999986 569999999999999999999996 9999999999999999999999999999988776
Q ss_pred CCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC-----ChhHHHHHHHH
Q 008759 482 NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM-----ECVSAIFIKTV 543 (554)
Q Consensus 482 ~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~-----e~~~~i~~i~~ 543 (554)
....+..||..|||||.+.+.. |+.++||||||++++||.+|+.||... .+.+.+-.|..
T Consensus 232 S~a~tfvGT~~YMsPERi~g~~--Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~ 296 (364)
T KOG0581|consen 232 SIANTFVGTSAYMSPERISGES--YSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD 296 (364)
T ss_pred hhcccccccccccChhhhcCCc--CCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc
Confidence 7778899999999999997654 899999999999999999999999884 44444444443
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=362.50 Aligned_cols=217 Identities=29% Similarity=0.500 Sum_probs=192.5
Q ss_pred ccccccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeecc
Q 008759 322 GRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK 400 (554)
Q Consensus 322 ~~~~~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~ 400 (554)
+...+..+.|+.+++||+|+||.||+|++ .+|+.||+|++...... ........+||.||++|.||||++|.+...
T Consensus 110 ~w~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~---~~~~~t~~REI~ILr~l~HpNIikL~eivt 186 (560)
T KOG0600|consen 110 GWGPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEK---EGFPITAIREIKILRRLDHPNIIKLEEIVT 186 (560)
T ss_pred cccccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCC---CcchHHHHHHHHHHHhcCCCcccceeeEEE
Confidence 44566678899999999999999999999 89999999999864422 234556789999999999999999999876
Q ss_pred CC--CcEEEEEeecccCchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcc
Q 008759 401 DE--SKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA 476 (554)
Q Consensus 401 ~~--~~~~LVmE~~~ggsL~~ll~~~--~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA 476 (554)
+. ..+|||+|||+. +|.-++... +|++.+++.|++||+.||+|||.+||+|||||.+|||||.+|.+||+|||||
T Consensus 187 ~~~~~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLA 265 (560)
T KOG0600|consen 187 SKLSGSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLA 265 (560)
T ss_pred ecCCceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccce
Confidence 65 689999999988 787777764 6999999999999999999999999999999999999999999999999999
Q ss_pred cccccC---CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHH
Q 008759 477 KATKLN---DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTV 543 (554)
Q Consensus 477 ~~~~~~---~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~ 543 (554)
+++... .+++.+.|+||+|||++.+.. .|+.++|+||.||||.||++|++.|.+...++++.+|..
T Consensus 266 r~y~~~~~~~~T~rVvTLWYRpPELLLG~t-~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfk 334 (560)
T KOG0600|consen 266 RFYTPSGSAPYTSRVVTLWYRPPELLLGAT-SYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFK 334 (560)
T ss_pred eeccCCCCcccccceEEeeccChHHhcCCc-ccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHH
Confidence 976544 367778999999999998865 699999999999999999999999999999888888764
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=343.08 Aligned_cols=213 Identities=28% Similarity=0.483 Sum_probs=187.6
Q ss_pred cceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEE
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~L 407 (554)
+.|+.+.++|+|+||+||+|++ .+|+.||||++.-.. ......+-.++||++|++++|+|+|.++.+|.....++|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese---dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhL 78 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE---DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHL 78 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC---ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEE
Confidence 4688889999999999999999 789999999987432 223444567899999999999999999999999999999
Q ss_pred EEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccc--cCCc
Q 008759 408 FLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK--LNDV 484 (554)
Q Consensus 408 VmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~--~~~~ 484 (554)
|+|||+..-|..+-.. .+++...++.|+.|++.|+.|+|++++|||||||+||||+.+|.+||||||+|+... ...+
T Consensus 79 VFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~Y 158 (396)
T KOG0593|consen 79 VFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNY 158 (396)
T ss_pred EeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchh
Confidence 9999998555544332 579999999999999999999999999999999999999999999999999998754 3446
Q ss_pred cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHHHH
Q 008759 485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTVAV 545 (554)
Q Consensus 485 ~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~~~ 545 (554)
+.++.|.||+|||++.+.. .|+..+|||++||++.||++|.+.|++....+++|.|..-.
T Consensus 159 TDYVATRWYRaPELLvGDt-qYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktL 218 (396)
T KOG0593|consen 159 TDYVATRWYRAPELLVGDT-QYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTL 218 (396)
T ss_pred hhhhhhhhccChhhhcccC-cCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHH
Confidence 6678999999999998754 48999999999999999999999999999999999987543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=341.56 Aligned_cols=215 Identities=35% Similarity=0.551 Sum_probs=186.6
Q ss_pred cccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeee-eccCC
Q 008759 325 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYG-TDKDE 402 (554)
Q Consensus 325 ~~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~-~~~~~ 402 (554)
+....+|++.++||+|+||.||+++. .+|..+|.|.+..... .....+.+..|+.+|++++|||||++|+ .|..+
T Consensus 15 ~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~m---d~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~ 91 (375)
T KOG0591|consen 15 QKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMM---DAKARQDCVKEISLLKQLNHPNIVQYYAHSFIED 91 (375)
T ss_pred cccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhc---cHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhcc
Confidence 34567899999999999999999998 8999999999874332 2334567889999999999999999999 56666
Q ss_pred Cc-EEEEEeecccCchHHHHhhh-----cCChHHHHHHHHHHHHHHHHHHH--CC--ccccCCccccEEEcCCCcEEEEe
Q 008759 403 SK-LYIFLELVTKGSLLNLYQRY-----HLRDSQVSAYTRQILLGLKYLHD--QD--VVHRDIKCANILVDANGSVKLAD 472 (554)
Q Consensus 403 ~~-~~LVmE~~~ggsL~~ll~~~-----~l~e~~i~~i~~QIl~gL~yLHs--~g--IIHrDIKPeNILld~~g~vKL~D 472 (554)
+. ++||||+|.+|+|..+++.+ .+++..++.++.|++.||.++|. .. |+||||||.||+++.+|.|||+|
T Consensus 92 ~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGD 171 (375)
T KOG0591|consen 92 NEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGD 171 (375)
T ss_pred chhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeecc
Confidence 65 89999999999999998754 48999999999999999999999 44 99999999999999999999999
Q ss_pred cCcccccccCC--ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHHH
Q 008759 473 FGLAKATKLND--VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTVA 544 (554)
Q Consensus 473 FGlA~~~~~~~--~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~~ 544 (554)
|||++...... ..+.+|||+||+||++.+. +|++++|||||||++|||..-+.||.+....+.--+|..+
T Consensus 172 fGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~--~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qg 243 (375)
T KOG0591|consen 172 FGLGRFLSSKTTFAHSLVGTPYYMSPERIHES--GYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQG 243 (375)
T ss_pred chhHhHhcchhHHHHhhcCCCcccCHHHHhcC--CCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcC
Confidence 99999876543 4577899999999999665 4999999999999999999999999988666665555544
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=354.65 Aligned_cols=214 Identities=31% Similarity=0.539 Sum_probs=185.7
Q ss_pred cccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhC-CCCceeeeeeeccCC
Q 008759 325 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDE 402 (554)
Q Consensus 325 ~~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIVkl~~~~~~~ 402 (554)
++...+|..++.||+|+|++||+|++ .+++.||+|++.+... ......+.+..|-.+|.+| .||.|++||.+|+++
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~I--ike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~ 146 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYI--IKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDE 146 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHH--HhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecc
Confidence 35567899999999999999999999 7899999998864322 2233346677888899999 799999999999999
Q ss_pred CcEEEEEeecccCchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccccc
Q 008759 403 SKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL 481 (554)
Q Consensus 403 ~~~~LVmE~~~ggsL~~ll~~~-~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~ 481 (554)
..+|+|+||+.+|+|.+++++. .|.+..++.|+.||+.||+|||++|||||||||+|||++.||++||+|||.|+....
T Consensus 147 ~sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~ 226 (604)
T KOG0592|consen 147 ESLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSP 226 (604)
T ss_pred cceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence 9999999999999999999986 489999999999999999999999999999999999999999999999999986432
Q ss_pred C---------------CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHH
Q 008759 482 N---------------DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKT 542 (554)
Q Consensus 482 ~---------------~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~ 542 (554)
. ...+++||..|.+||+|.... .++.+|||+||||+|+||.|.+||.+....-.+-+|+
T Consensus 227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~--~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~ 300 (604)
T KOG0592|consen 227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSP--AGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQ 300 (604)
T ss_pred hhccccCccCcccccCcccceeeeecccCHHHhcCCC--CCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHH
Confidence 1 124578999999999997765 6778999999999999999999999987765555544
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=346.90 Aligned_cols=219 Identities=30% Similarity=0.490 Sum_probs=189.4
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCC-CCceeeeeeeccCCC
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDES 403 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIVkl~~~~~~~~ 403 (554)
...+.|.+++.||+|+||+|++|.+ .++..||+|++.............+.+.+|+.+++.++ ||||++++.++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 4467899999999999999999988 78899999966543111111133456778999999999 999999999999999
Q ss_pred cEEEEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCC-CcEEEEecCccccc--
Q 008759 404 KLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAKAT-- 479 (554)
Q Consensus 404 ~~~LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~-g~vKL~DFGlA~~~-- 479 (554)
.+|+||||+.||.|.+++.. ..+.+..++.+++||+.||.|||++||+||||||+|||++.+ +++||+|||++...
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~ 173 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPG 173 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccCC
Confidence 99999999999999999887 679999999999999999999999999999999999999999 99999999999877
Q ss_pred ccCCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHHH
Q 008759 480 KLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTVA 544 (554)
Q Consensus 480 ~~~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~~ 544 (554)
......+.+||+.|+|||++.+....-+.++||||+|++||.|++|+.||...+......+|..+
T Consensus 174 ~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~ 238 (370)
T KOG0583|consen 174 EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKG 238 (370)
T ss_pred CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcC
Confidence 34567888999999999999876532358999999999999999999999997776666665443
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=356.39 Aligned_cols=216 Identities=26% Similarity=0.446 Sum_probs=188.2
Q ss_pred ccccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCC-CCceeeeeeeccC
Q 008759 324 FKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKD 401 (554)
Q Consensus 324 ~~~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIVkl~~~~~~ 401 (554)
.+..+++|.+.++||+|+||+|+++.. .+++.||||++++.... ....++.+..|.+|+.... ||++++++.+|++
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il--~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT 440 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDIL--QRDEVESLMCEKRIFELANRHPFLVNLFSCFQT 440 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeecccee--ccccHHHHHHHHHHHHHhccCCeEeeccccccc
Confidence 345578999999999999999999998 67899999999864433 3445677888888888775 9999999999999
Q ss_pred CCcEEEEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccc-
Q 008759 402 ESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK- 480 (554)
Q Consensus 402 ~~~~~LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~- 480 (554)
.+++|+||||+.||++..+.+...|++..++.|+.+|+.||.|||++||||||||.+|||+|.+|++||+||||++...
T Consensus 441 ~~~l~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~ 520 (694)
T KOG0694|consen 441 KEHLFFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG 520 (694)
T ss_pred CCeEEEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCC
Confidence 9999999999999996666666789999999999999999999999999999999999999999999999999998743
Q ss_pred -cCCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHH
Q 008759 481 -LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTV 543 (554)
Q Consensus 481 -~~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~ 543 (554)
.+...+.+|||.|||||++.+. .|+.++|||+|||+|||||+|+.||.+-+-.+..-.|.+
T Consensus 521 ~g~~TsTfCGTpey~aPEil~e~--~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~ 582 (694)
T KOG0694|consen 521 QGDRTSTFCGTPEFLAPEVLTEQ--SYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVN 582 (694)
T ss_pred CCCccccccCChhhcChhhhccC--cccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc
Confidence 4456678999999999999654 499999999999999999999999997665555544443
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=332.40 Aligned_cols=218 Identities=27% Similarity=0.390 Sum_probs=189.5
Q ss_pred ccccccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeec-
Q 008759 322 GRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTD- 399 (554)
Q Consensus 322 ~~~~~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~- 399 (554)
....+-.+.|+.++.|++|+||.||+|++ +++..||+|+++......- .--.-.+||.+|.+++|||||.+-.+.
T Consensus 69 l~gCrsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~G---FPItsLREIniLl~~~H~NIV~vkEVVv 145 (419)
T KOG0663|consen 69 LGGCRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEG---FPITSLREINILLKARHPNIVEVKEVVV 145 (419)
T ss_pred ccCcccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCC---CcchhHHHHHHHHhcCCCCeeeeEEEEe
Confidence 44556778999999999999999999999 8899999999987543221 112356999999999999999997754
Q ss_pred -cCCCcEEEEEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcc
Q 008759 400 -KDESKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA 476 (554)
Q Consensus 400 -~~~~~~~LVmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA 476 (554)
.+-+.+|||||||+. +|..++.. ..|...+++.++.|++.||+|||.++|+|||||++|+|++..|.+||+|||+|
T Consensus 146 G~~~d~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLA 224 (419)
T KOG0663|consen 146 GSNMDKIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLA 224 (419)
T ss_pred ccccceeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchh
Confidence 455679999999988 88888876 36899999999999999999999999999999999999999999999999999
Q ss_pred cccccC--CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHHH
Q 008759 477 KATKLN--DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTVA 544 (554)
Q Consensus 477 ~~~~~~--~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~~ 544 (554)
+.+... ..+..+.|.||+|||++.+.. .|+.++||||+|||+.|||++++.|.+..-.+++.+|...
T Consensus 225 R~ygsp~k~~T~lVVTLWYRaPELLLG~~-tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~l 293 (419)
T KOG0663|consen 225 REYGSPLKPYTPLVVTLWYRAPELLLGAK-TYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKL 293 (419)
T ss_pred hhhcCCcccCcceEEEeeecCHHHhcCCc-ccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHH
Confidence 987654 456677999999999998765 6999999999999999999999999998888888877653
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=338.38 Aligned_cols=212 Identities=50% Similarity=0.787 Sum_probs=183.1
Q ss_pred ccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCC--c
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES--K 404 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~--~ 404 (554)
..+|..++.||+|+||.||++.+ ++|..+|+|.+..... ...+.+.+|+.+|.+++|||||+++|...... .
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~-----~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~ 90 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS-----PTSESLEREIRILSRLNHPNIVQYYGSSSSRENDE 90 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccc-----hhHHHHHHHHHHHHhCCCCCEEeeCCccccccCee
Confidence 45688999999999999999999 5699999999876411 11677899999999999999999999744443 6
Q ss_pred EEEEEeecccCchHHHHhhhc--CChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcC-CCcEEEEecCccccccc
Q 008759 405 LYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA-NGSVKLADFGLAKATKL 481 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~~~--l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~-~g~vKL~DFGlA~~~~~ 481 (554)
++++|||+.+|+|.+++.+.+ +++..++.|.+||+.||.|||++|||||||||+|||++. ++.+||+|||+++....
T Consensus 91 ~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 91 YNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred eEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 999999999999999999864 899999999999999999999999999999999999999 79999999999986552
Q ss_pred -----CCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCC-CChhHHHHHHHHHH
Q 008759 482 -----NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP-MECVSAIFIKTVAV 545 (554)
Q Consensus 482 -----~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~-~e~~~~i~~i~~~~ 545 (554)
.......||+.|||||++.. .....+++|||||||++.||+||+.||.. .+..+.+++++...
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~-g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~ 239 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRN-GEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED 239 (313)
T ss_pred ccccccccccccCCccccCchhhcC-CCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC
Confidence 23445779999999999975 21233589999999999999999999999 78888888887543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=339.55 Aligned_cols=211 Identities=35% Similarity=0.561 Sum_probs=183.9
Q ss_pred cceeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCC-cEEE
Q 008759 329 TYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES-KLYI 407 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~-~~~L 407 (554)
....+.+.||.|+||+||+|.+.....+|+|++......... .+.|.+|+.+|.+++|||||+++|++.... .++|
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~---~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~i 117 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDES---RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCI 117 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHH---HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEE
Confidence 445666779999999999999986666999998754333222 678999999999999999999999998887 7999
Q ss_pred EEeecccCchHHHHhh---hcCChHHHHHHHHHHHHHHHHHHHCC-ccccCCccccEEEcCCC-cEEEEecCccccccc-
Q 008759 408 FLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQD-VVHRDIKCANILVDANG-SVKLADFGLAKATKL- 481 (554)
Q Consensus 408 VmE~~~ggsL~~ll~~---~~l~e~~i~~i~~QIl~gL~yLHs~g-IIHrDIKPeNILld~~g-~vKL~DFGlA~~~~~- 481 (554)
||||+.+|+|..++.. ..++...+..++.||+.||.|||+++ ||||||||+|||++.++ ++||+|||+++....
T Consensus 118 VtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 118 VTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred EEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 9999999999999976 57999999999999999999999999 99999999999999998 999999999987654
Q ss_pred -CCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHH
Q 008759 482 -NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKT 542 (554)
Q Consensus 482 -~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~ 542 (554)
.......||+.|||||++.+....|+.++||||||+++|||+||+.||..+.+.+.++...
T Consensus 198 ~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~ 259 (362)
T KOG0192|consen 198 KTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVV 259 (362)
T ss_pred cccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 3444468999999999997433359999999999999999999999999999877666554
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=318.98 Aligned_cols=211 Identities=27% Similarity=0.436 Sum_probs=186.0
Q ss_pred cceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEE
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~L 407 (554)
.+|...++||+|.||.||+|++ .+|+.||+|+++...... .......+||.+|+.++|+||+.++++|.+.+.+.|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kd---Gi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~l 78 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKD---GINRTALREIKLLQELKHPNIIELIDVFPHKSNLSL 78 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccccc---CccHHHHHHHHHHHHccCcchhhhhhhccCCCceEE
Confidence 4678889999999999999999 899999999998753321 112456799999999999999999999999999999
Q ss_pred EEeecccCchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC--
Q 008759 408 FLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-- 483 (554)
Q Consensus 408 VmE~~~ggsL~~ll~~~--~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~-- 483 (554)
|+|||+. +|+..++.. .+...+++.|+.++++||+|||.++|+||||||.|+||+.+|.+||+|||+|+......
T Consensus 79 VfEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 79 VFEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred EEEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence 9999987 899888764 48899999999999999999999999999999999999999999999999999865433
Q ss_pred ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHHH
Q 008759 484 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTVA 544 (554)
Q Consensus 484 ~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~~ 544 (554)
....+-|.||+|||++.+.. .|+..+||||.|||+.||+-|.+-|.+....+++-+|...
T Consensus 158 ~~~~V~TRWYRAPELLfGsr-~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~ 217 (318)
T KOG0659|consen 158 QTHQVVTRWYRAPELLFGSR-QYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRA 217 (318)
T ss_pred cccceeeeeccChHHhccch-hcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHH
Confidence 23336899999999998764 5899999999999999999999999999999988877654
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=345.62 Aligned_cols=208 Identities=30% Similarity=0.562 Sum_probs=186.6
Q ss_pred cceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEE
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~L 407 (554)
++|.+.+.||+|+||+||+|+. .+.+.||+|.+.+.. .....++.+.+|++|++.++|||||.++++|....++|+
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~g---r~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~v 78 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSG---RNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWV 78 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcC---CchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEE
Confidence 5788999999999999999998 788999999987533 234557889999999999999999999999999999999
Q ss_pred EEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC--c
Q 008759 408 FLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--V 484 (554)
Q Consensus 408 VmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~--~ 484 (554)
|+||+.| +|..++.. ..++++.+..++.+++.||.|||+++|+|||+||.|||+..+|.+|+||||+|+....+. .
T Consensus 79 Vte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vl 157 (808)
T KOG0597|consen 79 VTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVL 157 (808)
T ss_pred Eehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceee
Confidence 9999998 99998876 579999999999999999999999999999999999999999999999999999865543 4
Q ss_pred cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHH
Q 008759 485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKT 542 (554)
Q Consensus 485 ~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~ 542 (554)
.+..|||.|||||++.+ +.|+..+|+||||||+|||++|++||......+.+-+|.
T Consensus 158 tsikGtPlYmAPElv~e--~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~ 213 (808)
T KOG0597|consen 158 TSIKGTPLYMAPELVEE--QPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSIL 213 (808)
T ss_pred eeccCcccccCHHHHcC--CCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHh
Confidence 56789999999999964 459999999999999999999999999877766655554
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=343.15 Aligned_cols=213 Identities=27% Similarity=0.455 Sum_probs=188.4
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCC-CCceeeeeeeccCCC
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDES 403 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIVkl~~~~~~~~ 403 (554)
.+.++|.+.++||.|+||.||+|+. .+|..||||.++..-.. .+.. --.+|+.-|++++ |||||++.+++.+.+
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s---~ee~-~nLREvksL~kln~hpniikL~Evi~d~~ 82 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS---WEEC-MNLREVKSLRKLNPHPNIIKLKEVIRDND 82 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc---HHHH-HHHHHHHHHHhcCCCCcchhhHHHhhccC
Confidence 3567899999999999999999998 78999999988743222 2211 2348999999998 999999999999888
Q ss_pred -cEEEEEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccc
Q 008759 404 -KLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK 480 (554)
Q Consensus 404 -~~~LVmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~ 480 (554)
.+|+|||||+. +|+++++. ..|++..++.|+.||++||+|+|++|++||||||+||||..+..|||+|||+|+...
T Consensus 83 ~~L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 83 RILYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred ceEeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccc
Confidence 99999999987 89998875 459999999999999999999999999999999999999989999999999999865
Q ss_pred c-CCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHHH
Q 008759 481 L-NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTVA 544 (554)
Q Consensus 481 ~-~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~~ 544 (554)
. ..++.++.|.||+|||++.... .|+.++|||++|||++|+++-++.|.+....++||+|..-
T Consensus 162 SkpPYTeYVSTRWYRAPEvLLrs~-~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~V 225 (538)
T KOG0661|consen 162 SKPPYTEYVSTRWYRAPEVLLRSG-YYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEV 225 (538)
T ss_pred cCCCcchhhhcccccchHHhhhcc-ccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHH
Confidence 4 4567788999999999997654 5899999999999999999999999999999999999754
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=329.87 Aligned_cols=210 Identities=29% Similarity=0.482 Sum_probs=179.3
Q ss_pred cceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEE
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~L 407 (554)
++|++.+.||+|+||+||+|.+ .+++.||+|++..... ........+.+|+.++..++|+||+++++.+.+...+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~l 78 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADM--LEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYL 78 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHH--HHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEE
Confidence 3689999999999999999988 6789999999874221 123344678889999999999999999999999999999
Q ss_pred EEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC---
Q 008759 408 FLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--- 483 (554)
Q Consensus 408 VmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~--- 483 (554)
||||+.+|+|.+++.+ ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 79 v~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 158 (363)
T cd05628 79 IMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE 158 (363)
T ss_pred EEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccc
Confidence 9999999999998865 568999999999999999999999999999999999999999999999999986432110
Q ss_pred ----------------------------------ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 008759 484 ----------------------------------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY 529 (554)
Q Consensus 484 ----------------------------------~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF 529 (554)
....+||+.|+|||++.+. .++.++|||||||++|+|++|+.||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~--~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT--GYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCC--CCCCchhhhhhHHHHHHHHhCCCCC
Confidence 1234699999999999654 4889999999999999999999999
Q ss_pred CCCChhHHHHHHH
Q 008759 530 APMECVSAIFIKT 542 (554)
Q Consensus 530 ~~~e~~~~i~~i~ 542 (554)
......+...++.
T Consensus 237 ~~~~~~~~~~~i~ 249 (363)
T cd05628 237 CSETPQETYKKVM 249 (363)
T ss_pred CCCCHHHHHHHHH
Confidence 8876655544443
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=342.58 Aligned_cols=212 Identities=33% Similarity=0.569 Sum_probs=192.9
Q ss_pred cccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcE
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL 405 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~ 405 (554)
...+|...++||+|..|.||.+.. .+++.||+|.+.+..+.. .+-+.+|+.+|+..+|+|||++++.|...+.+
T Consensus 271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~-----keLilnEi~Vm~~~~H~NiVnfl~Sylv~deL 345 (550)
T KOG0578|consen 271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK-----KELLLNEILVMRDLHHPNIVNFLDSYLVGDEL 345 (550)
T ss_pred hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc-----hhhhHHHHHHHHhccchHHHHHHHHhccccee
Confidence 345788889999999999999988 788999999998654433 24578999999999999999999999999999
Q ss_pred EEEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC--C
Q 008759 406 YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--D 483 (554)
Q Consensus 406 ~LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~--~ 483 (554)
|.|||||+||+|.+++....+.+.++..+|++++.||+|||.+||+|||||.+|||++.+|.+||+|||++..+... .
T Consensus 346 WVVMEym~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K 425 (550)
T KOG0578|consen 346 WVVMEYMEGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK 425 (550)
T ss_pred EEEEeecCCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999876544 3
Q ss_pred ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHHHH
Q 008759 484 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTVAV 545 (554)
Q Consensus 484 ~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~~~ 545 (554)
..+.+|||+|||||++..+. |++++||||||++++||+.|++||....+..++|+|.++-
T Consensus 426 R~TmVGTPYWMAPEVvtrk~--YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng 485 (550)
T KOG0578|consen 426 RSTMVGTPYWMAPEVVTRKP--YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG 485 (550)
T ss_pred cccccCCCCccchhhhhhcc--cCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcC
Confidence 55678999999999996654 9999999999999999999999999999999999987653
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=345.48 Aligned_cols=218 Identities=28% Similarity=0.517 Sum_probs=193.5
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCc
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~ 404 (554)
...+-|++++.||.|+-|.|-+|++ .+|+..|||++....... ......+++||.||+.+.||||+++|+++.+..+
T Consensus 9 ~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s--~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~ 86 (786)
T KOG0588|consen 9 NTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELS--SSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQH 86 (786)
T ss_pred ccccceeccccccCCCCceehhhhcccccceeEEEeeccccccc--cccccchhhhhHHHHHhcCCCeeeeeeeeccCce
Confidence 3456799999999999999999999 899999999998643222 2334678899999999999999999999999999
Q ss_pred EEEEEeecccCchHHHHh-hhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccc-cC
Q 008759 405 LYIFLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK-LN 482 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~-~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~-~~ 482 (554)
+|+|+||+.+|.|++++- ++++++.++..+++||+.|+.|+|..+|+||||||+|+|++..++|||+|||+|.... ..
T Consensus 87 lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk 166 (786)
T KOG0588|consen 87 LYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK 166 (786)
T ss_pred EEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCc
Confidence 999999999999999775 4679999999999999999999999999999999999999999999999999997644 44
Q ss_pred CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHHHHH
Q 008759 483 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTVAVT 546 (554)
Q Consensus 483 ~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~~~~ 546 (554)
...+.||+|.|+|||++.+.. ..+.++||||.|||||.||||++||.+......+.|...++.
T Consensus 167 lLeTSCGSPHYA~PEIV~G~p-YdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f 229 (786)
T KOG0588|consen 167 LLETSCGSPHYAAPEIVSGRP-YDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVF 229 (786)
T ss_pred cccccCCCcccCCchhhcCCC-CCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcc
Confidence 567889999999999999876 357899999999999999999999998888877777766654
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=328.80 Aligned_cols=209 Identities=29% Similarity=0.496 Sum_probs=178.5
Q ss_pred ceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEE
Q 008759 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (554)
Q Consensus 330 ~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LV 408 (554)
.|++++.||+|+||+||+|.+ .+++.||+|++..... ........+.+|+.++..++|+||+++++.+.+.+.+|+|
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~--~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv 79 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDV--LNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFV 79 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHh--hhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEE
Confidence 688999999999999999988 7789999999874221 1233456788999999999999999999999999999999
Q ss_pred EeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC-----
Q 008759 409 LELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN----- 482 (554)
Q Consensus 409 mE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~----- 482 (554)
|||+.+|+|.+++.+ ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~ 159 (381)
T cd05626 80 MDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKY 159 (381)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccc
Confidence 999999999998876 45888999999999999999999999999999999999999999999999997532100
Q ss_pred --------------------------------------------CccCccCCCcccChhhhcccCCCCCchhhHHHHHHH
Q 008759 483 --------------------------------------------DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCT 518 (554)
Q Consensus 483 --------------------------------------------~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvl 518 (554)
......||+.|+|||++.+. .++.++|||||||+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~~~DiwSlG~i 237 (381)
T cd05626 160 YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK--GYTQLCDWWSVGVI 237 (381)
T ss_pred ccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCC--CCCCccceeehhhH
Confidence 01234699999999999654 48899999999999
Q ss_pred HHHHHcCCCCCCCCChhHHHHHHH
Q 008759 519 VLEMLTSQIPYAPMECVSAIFIKT 542 (554)
Q Consensus 519 lyeLLTG~~PF~~~e~~~~i~~i~ 542 (554)
+|||++|..||......+....+.
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~ 261 (381)
T cd05626 238 LFEMLVGQPPFLAPTPTETQLKVI 261 (381)
T ss_pred HHHHHhCCCCCcCCCHHHHHHHHH
Confidence 999999999998877665555443
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=326.36 Aligned_cols=209 Identities=29% Similarity=0.505 Sum_probs=178.9
Q ss_pred cceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEE
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~L 407 (554)
++|++.+.||+|+||+||+|.+ .+++.||+|++..... ........+.+|+.++..++|+||+++++.+.+.+.+|+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 78 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEM--LEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYL 78 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEE
Confidence 3689999999999999999998 6789999999974221 122345667889999999999999999999999999999
Q ss_pred EEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC---
Q 008759 408 FLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--- 483 (554)
Q Consensus 408 VmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~--- 483 (554)
||||+.+|+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 79 v~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (364)
T cd05599 79 IMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE 158 (364)
T ss_pred EECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccc
Confidence 9999999999998875 458999999999999999999999999999999999999999999999999986532110
Q ss_pred -------------------------------------ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCC
Q 008759 484 -------------------------------------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQ 526 (554)
Q Consensus 484 -------------------------------------~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~ 526 (554)
....+||+.|+|||++... .++.++|||||||++|+|++|.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT--GYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCC--CCCCeeeeecchhHHHHhhcCC
Confidence 1124599999999998654 4889999999999999999999
Q ss_pred CCCCCCChhHHHHHH
Q 008759 527 IPYAPMECVSAIFIK 541 (554)
Q Consensus 527 ~PF~~~e~~~~i~~i 541 (554)
.||......+....+
T Consensus 237 ~Pf~~~~~~~~~~~i 251 (364)
T cd05599 237 PPFCSDNPQETYRKI 251 (364)
T ss_pred CCCCCCCHHHHHHHH
Confidence 999887766554443
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=329.25 Aligned_cols=209 Identities=28% Similarity=0.487 Sum_probs=178.6
Q ss_pred ceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEE
Q 008759 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (554)
Q Consensus 330 ~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LV 408 (554)
+|+++++||+|+||.||+|.+ .+++.||+|++.... .........+.+|+.+++.++|+||+++++.+.+.+.+|+|
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~--~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv 79 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKD--VLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 79 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHH--hhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEE
Confidence 588999999999999999998 678999999986422 11234456788999999999999999999999999999999
Q ss_pred EeecccCchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC-----
Q 008759 409 LELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN----- 482 (554)
Q Consensus 409 mE~~~ggsL~~ll~~~-~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~----- 482 (554)
|||+.+|+|.+++.+. .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~ 159 (382)
T cd05625 80 MDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159 (382)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccc
Confidence 9999999999988764 5888999999999999999999999999999999999999999999999997432100
Q ss_pred --------------------------------------------CccCccCCCcccChhhhcccCCCCCchhhHHHHHHH
Q 008759 483 --------------------------------------------DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCT 518 (554)
Q Consensus 483 --------------------------------------------~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvl 518 (554)
......||+.|+|||++.+. .++.++|||||||+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~~~DiwSlGvi 237 (382)
T cd05625 160 YQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT--GYTQLCDWWSVGVI 237 (382)
T ss_pred cccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCC--CCCCeeeEEechHH
Confidence 01234689999999999654 48899999999999
Q ss_pred HHHHHcCCCCCCCCChhHHHHHHH
Q 008759 519 VLEMLTSQIPYAPMECVSAIFIKT 542 (554)
Q Consensus 519 lyeLLTG~~PF~~~e~~~~i~~i~ 542 (554)
+|||++|+.||......+....+.
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~ 261 (382)
T cd05625 238 LYEMLVGQPPFLAQTPLETQMKVI 261 (382)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHH
Confidence 999999999999887766655554
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=328.81 Aligned_cols=209 Identities=27% Similarity=0.472 Sum_probs=177.2
Q ss_pred cceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEE
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~L 407 (554)
++|++++.||+|+||.||++.+ .+++.||+|++..... ........+.+|+.++..++||||+++++++.+.+.+|+
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~l 78 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEM--FKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYL 78 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHH--HHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEE
Confidence 3689999999999999999988 6899999999864221 123345678899999999999999999999999999999
Q ss_pred EEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC----
Q 008759 408 FLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN---- 482 (554)
Q Consensus 408 VmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~---- 482 (554)
||||+.+|+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 79 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 158 (377)
T cd05629 79 IMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA 158 (377)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence 9999999999998865 45888999999999999999999999999999999999999999999999998532110
Q ss_pred ---------------------------------------------CccCccCCCcccChhhhcccCCCCCchhhHHHHHH
Q 008759 483 ---------------------------------------------DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGC 517 (554)
Q Consensus 483 ---------------------------------------------~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGv 517 (554)
.....+||+.|+|||++.+. .++.++|||||||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGv 236 (377)
T cd05629 159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ--GYGQECDWWSLGA 236 (377)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccC--CCCCceeeEecch
Confidence 00124699999999999654 4889999999999
Q ss_pred HHHHHHcCCCCCCCCChhHHHHHH
Q 008759 518 TVLEMLTSQIPYAPMECVSAIFIK 541 (554)
Q Consensus 518 llyeLLTG~~PF~~~e~~~~i~~i 541 (554)
++|+|++|..||......+....+
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i 260 (377)
T cd05629 237 IMFECLIGWPPFCSENSHETYRKI 260 (377)
T ss_pred hhhhhhcCCCCCCCCCHHHHHHHH
Confidence 999999999999877665444333
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=322.56 Aligned_cols=220 Identities=29% Similarity=0.536 Sum_probs=195.8
Q ss_pred cccccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccC
Q 008759 323 RFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD 401 (554)
Q Consensus 323 ~~~~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~ 401 (554)
.|....+.|++...||.|..++||+|+. ..+..||||++... ........+.+|+..++.++||||++++..|..
T Consensus 20 ~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLE----kc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv 95 (516)
T KOG0582|consen 20 EFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLE----KCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVV 95 (516)
T ss_pred cCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehh----hhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEe
Confidence 3445567999999999999999999998 77899999999862 233447889999999999999999999999999
Q ss_pred CCcEEEEEeecccCchHHHHhh---hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccc
Q 008759 402 ESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA 478 (554)
Q Consensus 402 ~~~~~LVmE~~~ggsL~~ll~~---~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~ 478 (554)
+..+|+||.||.+|++.++++. .++.+..+..|+++++.||.|||.+|.||||||+.||||+.+|.|||+|||..-.
T Consensus 96 ~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~ 175 (516)
T KOG0582|consen 96 DSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSAS 175 (516)
T ss_pred cceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeee
Confidence 9999999999999999999986 4699999999999999999999999999999999999999999999999997643
Q ss_pred cccCC------ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHHHHH
Q 008759 479 TKLND------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTVAVT 546 (554)
Q Consensus 479 ~~~~~------~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~~~~ 546 (554)
..... .....||++|||||+++....+|+.|+||||||++..||.+|..||..+.+++.++.-+.+.+
T Consensus 176 l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~p 249 (516)
T KOG0582|consen 176 LFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDP 249 (516)
T ss_pred ecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCC
Confidence 22111 145679999999999888888899999999999999999999999999999999888777654
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=319.53 Aligned_cols=212 Identities=33% Similarity=0.545 Sum_probs=185.2
Q ss_pred ccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCc-eeeeeeeccCCC--
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN-IVQYYGTDKDES-- 403 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hpn-IVkl~~~~~~~~-- 403 (554)
...|..+++||+|+||+||+|+. .+|+.||+|++....... ..-....+|+.+|+.++|+| ||++++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~E---G~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~ 86 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEE---GVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNH 86 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEecccccc---CCCchhhHHHHHHHHhCCCcceEEEEeeeeecccc
Confidence 44677788899999999999999 789999999998754321 12234679999999999999 999999988776
Q ss_pred ----cEEEEEeecccCchHHHHhhh-----cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecC
Q 008759 404 ----KLYIFLELVTKGSLLNLYQRY-----HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFG 474 (554)
Q Consensus 404 ----~~~LVmE~~~ggsL~~ll~~~-----~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFG 474 (554)
.+++||||++. +|..++... +++...++.+++||+.||.|||+++|+||||||.||||+.+|.+||+|||
T Consensus 87 ~~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 87 RGIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred cccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccc
Confidence 89999999987 888888753 47778899999999999999999999999999999999999999999999
Q ss_pred cccccc--cCCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHHH
Q 008759 475 LAKATK--LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTVA 544 (554)
Q Consensus 475 lA~~~~--~~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~~ 544 (554)
+|+... ........+|.||+|||++.+.. .|+..+||||+|||++||++++..|.+....+++++|..-
T Consensus 166 lAra~~ip~~~yt~evvTlWYRaPEvLlGs~-~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~ 236 (323)
T KOG0594|consen 166 LARAFSIPMRTYTPEVVTLWYRAPEVLLGST-SYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRL 236 (323)
T ss_pred hHHHhcCCcccccccEEEeeccCHHHhcCCC-cCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHH
Confidence 998754 33466778999999999998765 4999999999999999999999999999989998888653
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=327.95 Aligned_cols=213 Identities=26% Similarity=0.451 Sum_probs=182.0
Q ss_pred cccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcE
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL 405 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~ 405 (554)
..++|++.+.||+|+||.||++.+ .+++.||+|++..... ........+.+|+.+++.++||||+++++++.++..+
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEM--IKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHh--hhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 456899999999999999999998 6789999999864221 1122345577899999999999999999999999999
Q ss_pred EEEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC--
Q 008759 406 YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-- 483 (554)
Q Consensus 406 ~LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~-- 483 (554)
|+||||+.+|+|.+++....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~ 198 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV 198 (370)
T ss_pred EEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCce
Confidence 999999999999999988889999999999999999999999999999999999999999999999999997654322
Q ss_pred -ccCccCCCcccChhhhcccC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHH
Q 008759 484 -VKSCRGTAFWMAPEVINNKN--KGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIK 541 (554)
Q Consensus 484 -~~s~~GT~~Y~APEvl~~~~--~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i 541 (554)
.....||+.|+|||++.+.. ..++.++|||||||++|+|++|+.||...........+
T Consensus 199 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i 259 (370)
T cd05621 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKI 259 (370)
T ss_pred ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 23556999999999996543 23778999999999999999999999877655444433
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=309.63 Aligned_cols=214 Identities=30% Similarity=0.502 Sum_probs=191.1
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCc
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~ 404 (554)
..+++|++++.||+|.||.||+|+. .++..+|+|++.+.. ....+...++.+|++|.+.|+||||+++|++|.+...
T Consensus 19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsq--i~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~r 96 (281)
T KOG0580|consen 19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQ--ILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKR 96 (281)
T ss_pred cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHH--HHHhcchhhhhheeEeecccCCccHHhhhhheeccce
Confidence 4578999999999999999999998 788999999987432 2334445678899999999999999999999999999
Q ss_pred EEEEEeecccCchHHHHh--h-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccccc
Q 008759 405 LYIFLELVTKGSLLNLYQ--R-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL 481 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~--~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~ 481 (554)
+||++||...|+|...|+ . ..+.+.....|++|++.||.|+|.++||||||||+|+|++.+|.+||+|||.+.....
T Consensus 97 iyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~ 176 (281)
T KOG0580|consen 97 IYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 176 (281)
T ss_pred eEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecCC
Confidence 999999999999999998 3 3589999999999999999999999999999999999999999999999999988877
Q ss_pred CCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHHH
Q 008759 482 NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTVA 544 (554)
Q Consensus 482 ~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~~ 544 (554)
+...+.|||..|++||++.+.. ++..+|+|++|++.||+|.|.+||.... ....|+.+..
T Consensus 177 ~kR~tlcgt~dyl~pEmv~~~~--hd~~Vd~w~lgvl~yeflvg~ppFes~~-~~etYkrI~k 236 (281)
T KOG0580|consen 177 NKRKTLCGTLDYLPPEMVEGRG--HDKFVDLWSLGVLCYEFLVGLPPFESQS-HSETYKRIRK 236 (281)
T ss_pred CCceeeecccccCCHhhcCCCC--ccchhhHHHHHHHHHHHHhcCCchhhhh-hHHHHHHHHH
Confidence 8888899999999999996654 8899999999999999999999999887 5555555543
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=312.96 Aligned_cols=205 Identities=29% Similarity=0.476 Sum_probs=177.3
Q ss_pred cceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEE
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~L 407 (554)
++|++.+.||+|+||.||+|.+ .+++.||+|++..... ........+.+|+.+++.++||||+++++.+.+.+.+|+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 78 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEV--IRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYM 78 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHH--hhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEE
Confidence 3688999999999999999998 5789999999864211 112234568899999999999999999999999999999
Q ss_pred EEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCCccC
Q 008759 408 FLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS 486 (554)
Q Consensus 408 VmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~~~s 486 (554)
||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++..... ...
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-~~~ 157 (291)
T cd05612 79 LMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-TWT 157 (291)
T ss_pred EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC-ccc
Confidence 9999999999998875 45889999999999999999999999999999999999999999999999998765433 234
Q ss_pred ccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHH
Q 008759 487 CRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAI 538 (554)
Q Consensus 487 ~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i 538 (554)
..||+.|+|||++.+. .++.++|||||||++|+|++|+.||......+..
T Consensus 158 ~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~ 207 (291)
T cd05612 158 LCGTPEYLAPEVIQSK--GHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIY 207 (291)
T ss_pred ccCChhhcCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 5699999999998654 4788999999999999999999999887654433
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=320.35 Aligned_cols=210 Identities=29% Similarity=0.503 Sum_probs=180.9
Q ss_pred cccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcE
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL 405 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~ 405 (554)
..++|++.+.||+|+||.||+|.+ .+++.||+|++..... ........+.+|+.++..++||||+++++.+...+.+
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 93 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREI--LKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRV 93 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHH--hhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEE
Confidence 357899999999999999999998 6789999999874221 1123346788999999999999999999999999999
Q ss_pred EEEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCCc
Q 008759 406 YIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV 484 (554)
Q Consensus 406 ~LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~~ 484 (554)
|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 94 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~- 172 (329)
T PTZ00263 94 YFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT- 172 (329)
T ss_pred EEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc-
Confidence 999999999999998876 458889999999999999999999999999999999999999999999999987654332
Q ss_pred cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHH
Q 008759 485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIK 541 (554)
Q Consensus 485 ~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i 541 (554)
....||+.|+|||++.+. .++.++|||||||++|+|++|+.||......+....+
T Consensus 173 ~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i 227 (329)
T PTZ00263 173 FTLCGTPEYLAPEVIQSK--GHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKI 227 (329)
T ss_pred ceecCChhhcCHHHHcCC--CCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 345699999999999654 3788999999999999999999999887665544333
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=327.04 Aligned_cols=209 Identities=27% Similarity=0.478 Sum_probs=177.2
Q ss_pred cceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEE
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~L 407 (554)
++|++++.||+|+||.||+|.+ .+++.||+|++..... ........+.+|+.+|..++|+||+++++.+.+.+.+|+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 78 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADV--LMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYF 78 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHH--HhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEE
Confidence 3689999999999999999998 6789999999864221 112334667899999999999999999999999999999
Q ss_pred EEeecccCchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC----
Q 008759 408 FLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN---- 482 (554)
Q Consensus 408 VmE~~~ggsL~~ll~~~-~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~---- 482 (554)
||||+.+|+|.+++.+. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 79 v~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~ 158 (376)
T cd05598 79 VMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (376)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccc
Confidence 99999999999998764 5788889999999999999999999999999999999999999999999997422100
Q ss_pred -----------------------------------------CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHH
Q 008759 483 -----------------------------------------DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLE 521 (554)
Q Consensus 483 -----------------------------------------~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllye 521 (554)
......||+.|||||++.+. .++.++|||||||++|+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvilye 236 (376)
T cd05598 159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT--GYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCC--CCCcceeeeeccceeee
Confidence 01134699999999999654 47899999999999999
Q ss_pred HHcCCCCCCCCChhHHHHHH
Q 008759 522 MLTSQIPYAPMECVSAIFIK 541 (554)
Q Consensus 522 LLTG~~PF~~~e~~~~i~~i 541 (554)
|++|+.||......+....+
T Consensus 237 ll~G~~Pf~~~~~~~~~~~i 256 (376)
T cd05598 237 MLVGQPPFLADTPAETQLKV 256 (376)
T ss_pred hhhCCCCCCCCCHHHHHHHH
Confidence 99999999987766554443
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=336.87 Aligned_cols=205 Identities=28% Similarity=0.427 Sum_probs=184.9
Q ss_pred ceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCC-C-----CceeeeeeeccCC
Q 008759 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-H-----ENIVQYYGTDKDE 402 (554)
Q Consensus 330 ~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~-H-----pnIVkl~~~~~~~ 402 (554)
+|.+.++||+|+||.|.+|++ .+++.||||+++. .+....+...|+.+|..++ | -|+|+++++|...
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN------~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr 260 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKN------KKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR 260 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeecc------ChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc
Confidence 799999999999999999999 7899999999974 3455677789999999997 4 3899999999999
Q ss_pred CcEEEEEeecccCchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCC--cEEEEecCccc
Q 008759 403 SKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG--SVKLADFGLAK 477 (554)
Q Consensus 403 ~~~~LVmE~~~ggsL~~ll~~~---~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g--~vKL~DFGlA~ 477 (554)
+++|||+|++.. +|+++++.. +++...++.+++||+.||.+||+.||||+||||+|||+...+ .|||+|||.++
T Consensus 261 ~HlciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc 339 (586)
T KOG0667|consen 261 NHLCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSC 339 (586)
T ss_pred cceeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccc
Confidence 999999999977 899999864 588999999999999999999999999999999999997554 79999999998
Q ss_pred ccccCCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHHH
Q 008759 478 ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTVA 544 (554)
Q Consensus 478 ~~~~~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~~ 544 (554)
....... +...+..|+|||++.+.. |+.+.||||||||++||++|.+.|.+....+++.+|..-
T Consensus 340 ~~~q~vy-tYiQSRfYRAPEVILGlp--Y~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~ 403 (586)
T KOG0667|consen 340 FESQRVY-TYIQSRFYRAPEVILGLP--YDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEV 403 (586)
T ss_pred ccCCcce-eeeeccccccchhhccCC--CCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHH
Confidence 8766555 777999999999998765 999999999999999999999999999999999888754
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=317.35 Aligned_cols=216 Identities=25% Similarity=0.439 Sum_probs=190.7
Q ss_pred cccccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccC
Q 008759 323 RFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD 401 (554)
Q Consensus 323 ~~~~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~ 401 (554)
+-+...++|..+++||+|+||+|-+|+. .+++.||+|++++. ....+..+.+...|-++|+..+||++..+...|+.
T Consensus 162 ~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKe--viiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt 239 (516)
T KOG0690|consen 162 KNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKE--VIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQT 239 (516)
T ss_pred cceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhh--heeehHHhhhhhhHHHHHHhccCcHHHHhhhhhcc
Confidence 3445678999999999999999999998 78999999998743 23445667788899999999999999999999999
Q ss_pred CCcEEEEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccc--
Q 008759 402 ESKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA-- 478 (554)
Q Consensus 402 ~~~~~LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~-- 478 (554)
.+++|+||||..||.|.-.+.+ ..+++...+.|..+|+.||.|||+++||+||||.+|+|++.+|++||+||||++.
T Consensus 240 ~drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I 319 (516)
T KOG0690|consen 240 QDRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI 319 (516)
T ss_pred CceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcc
Confidence 9999999999999999988876 4689999999999999999999999999999999999999999999999999986
Q ss_pred cccCCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHH
Q 008759 479 TKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKT 542 (554)
Q Consensus 479 ~~~~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~ 542 (554)
......++.||||.|+|||++... .|++++|||.+||++|||++|++||.+.+....+-.|.
T Consensus 320 ~~g~t~kTFCGTPEYLAPEVleDn--DYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl 381 (516)
T KOG0690|consen 320 KYGDTTKTFCGTPEYLAPEVLEDN--DYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELIL 381 (516)
T ss_pred cccceeccccCChhhcCchhhccc--cccceeehhhhhHHHHHHHhccCcccccchhHHHHHHH
Confidence 234456788999999999999654 49999999999999999999999999987655544443
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=317.71 Aligned_cols=205 Identities=29% Similarity=0.471 Sum_probs=178.6
Q ss_pred cceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEE
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~L 407 (554)
++|++.+.||+|+||.||+|.+ .+++.||+|++..... ........+.+|+.++..++||||+++++.+...+.+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~l 78 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLL--FKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYL 78 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHH--hhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEE
Confidence 3689999999999999999998 5689999999874221 112334678899999999999999999999999999999
Q ss_pred EEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCCccC
Q 008759 408 FLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS 486 (554)
Q Consensus 408 VmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~~~s 486 (554)
||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ....
T Consensus 79 v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-~~~~ 157 (333)
T cd05600 79 AMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-YANS 157 (333)
T ss_pred EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-ccCC
Confidence 9999999999999875 4588999999999999999999999999999999999999999999999999876543 3345
Q ss_pred ccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHH
Q 008759 487 CRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAI 538 (554)
Q Consensus 487 ~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i 538 (554)
..||+.|+|||++.+. .++.++|||||||++|+|++|..||......+..
T Consensus 158 ~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~ 207 (333)
T cd05600 158 VVGSPDYMAPEVLRGK--GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETW 207 (333)
T ss_pred cccCccccChhHhcCC--CCCCccceecchHHHhhhhhCCCCCCCCCHHHHH
Confidence 5699999999999655 4889999999999999999999999877655443
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=322.42 Aligned_cols=215 Identities=26% Similarity=0.473 Sum_probs=192.5
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCc
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~ 404 (554)
...-+|++.+.||+|+||+|-+|.. ..|+.||||.++... ...++.+-++.+||+|++.|+||||+++|.+|...+.
T Consensus 50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdk--IkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdK 127 (668)
T KOG0611|consen 50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDK--IKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDK 127 (668)
T ss_pred chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhh--cccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCce
Confidence 3445899999999999999999998 789999999987544 3456778899999999999999999999999999999
Q ss_pred EEEEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccccc-C
Q 008759 405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL-N 482 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~-~ 482 (554)
+.|||||..+|.|++|+.. ..+++.+++.+++||++|+.|+|+++++|||||.+|||+|.|+++||+||||+..+.. .
T Consensus 128 IvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k 207 (668)
T KOG0611|consen 128 IVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK 207 (668)
T ss_pred EEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcccc
Confidence 9999999999999999976 4699999999999999999999999999999999999999999999999999987654 3
Q ss_pred CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHH
Q 008759 483 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTV 543 (554)
Q Consensus 483 ~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~ 543 (554)
...++||++.|.+||++++.. .-++.+|-||||++||.|+.|.+||.+.+..-.+-.|..
T Consensus 208 fLqTFCGSPLYASPEIvNG~P-Y~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~ 267 (668)
T KOG0611|consen 208 FLQTFCGSPLYASPEIVNGTP-YKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISR 267 (668)
T ss_pred HHHHhcCCcccCCccccCCCC-CCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhc
Confidence 467889999999999998876 347899999999999999999999999877655544443
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=322.71 Aligned_cols=209 Identities=29% Similarity=0.494 Sum_probs=178.6
Q ss_pred cceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEE
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~L 407 (554)
++|++.+.||+|+||.||++.+ .+++.||+|++..... ........+.+|+.++..++|+||+++++.+.+.+.+|+
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l 78 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADM--LEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYL 78 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHH--hhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 3688999999999999999998 6789999999874221 123345678889999999999999999999999999999
Q ss_pred EEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC---
Q 008759 408 FLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--- 483 (554)
Q Consensus 408 VmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~--- 483 (554)
||||+.+|+|.+++.+ ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus 79 v~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~ 158 (360)
T cd05627 79 IMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE 158 (360)
T ss_pred EEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence 9999999999998865 468999999999999999999999999999999999999999999999999986432110
Q ss_pred ----------------------------------ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 008759 484 ----------------------------------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY 529 (554)
Q Consensus 484 ----------------------------------~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF 529 (554)
....+||+.|+|||++.+. .++.++|||||||++|+|++|+.||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~--~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT--GYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCC--CCCCcceeccccceeeecccCCCCC
Confidence 1134699999999999654 4889999999999999999999999
Q ss_pred CCCChhHHHHHH
Q 008759 530 APMECVSAIFIK 541 (554)
Q Consensus 530 ~~~e~~~~i~~i 541 (554)
........+.++
T Consensus 237 ~~~~~~~~~~~i 248 (360)
T cd05627 237 CSETPQETYRKV 248 (360)
T ss_pred CCCCHHHHHHHH
Confidence 887765554443
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=322.89 Aligned_cols=213 Identities=26% Similarity=0.443 Sum_probs=181.7
Q ss_pred cccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcE
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL 405 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~ 405 (554)
..++|++.+.||+|+||.||+|.+ .+++.||+|++..... ........+.+|+.++..++||||+++++.+...+.+
T Consensus 41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~--~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (371)
T cd05622 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEM--IKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 118 (371)
T ss_pred chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHh--hhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 347899999999999999999998 6789999999864221 1122345577899999999999999999999999999
Q ss_pred EEEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC--
Q 008759 406 YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-- 483 (554)
Q Consensus 406 ~LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~-- 483 (554)
|+||||+.+|+|..++....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 119 ~lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~ 198 (371)
T cd05622 119 YMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 198 (371)
T ss_pred EEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcc
Confidence 999999999999999988889999999999999999999999999999999999999999999999999987654322
Q ss_pred -ccCccCCCcccChhhhcccC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHH
Q 008759 484 -VKSCRGTAFWMAPEVINNKN--KGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIK 541 (554)
Q Consensus 484 -~~s~~GT~~Y~APEvl~~~~--~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i 541 (554)
.....||+.|+|||++.... ..++.++|||||||++|+|++|+.||...........+
T Consensus 199 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i 259 (371)
T cd05622 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI 259 (371)
T ss_pred cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 23456999999999986542 23788999999999999999999999887665444433
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=318.26 Aligned_cols=210 Identities=30% Similarity=0.443 Sum_probs=179.3
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CC-CcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCC
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES 403 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~-g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~ 403 (554)
...++|++.+.||+|+||.||+|.+ .+ +..||+|++..... ........+.+|+.++..++||||+++++++.+.+
T Consensus 27 ~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~ 104 (340)
T PTZ00426 27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKI--IKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES 104 (340)
T ss_pred CChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHh--hhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence 4567899999999999999999986 33 46899998864221 12233456789999999999999999999999999
Q ss_pred cEEEEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC
Q 008759 404 KLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN 482 (554)
Q Consensus 404 ~~~LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~ 482 (554)
.+|+||||+.+|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 105 ~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~ 184 (340)
T PTZ00426 105 YLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR 184 (340)
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence 99999999999999999875 46889999999999999999999999999999999999999999999999998765432
Q ss_pred CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHH
Q 008759 483 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFI 540 (554)
Q Consensus 483 ~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~ 540 (554)
.....||+.|+|||++.+. .++.++|||||||++|+|++|..||...+.......
T Consensus 185 -~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~ 239 (340)
T PTZ00426 185 -TYTLCGTPEYIAPEILLNV--GHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQK 239 (340)
T ss_pred -cceecCChhhcCHHHHhCC--CCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHH
Confidence 3345699999999999654 478899999999999999999999998766544333
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=315.78 Aligned_cols=199 Identities=29% Similarity=0.490 Sum_probs=171.5
Q ss_pred eeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEEEeecc
Q 008759 335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVT 413 (554)
Q Consensus 335 ~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LVmE~~~ 413 (554)
+.||+|+||.||+|.+ .+|+.||+|++..... ........+.+|+.++..++||||+++++.+...+.+|+||||+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~ 78 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVI--IAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh--hhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCC
Confidence 4699999999999998 6799999999874221 123344567889999999999999999999999999999999999
Q ss_pred cCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccccc--CCccCccCC
Q 008759 414 KGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL--NDVKSCRGT 490 (554)
Q Consensus 414 ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~--~~~~s~~GT 490 (554)
+++|..++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... .......||
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt 158 (323)
T cd05571 79 GGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGT 158 (323)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecC
Confidence 9999988865 4689999999999999999999999999999999999999999999999999875322 223445699
Q ss_pred CcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHH
Q 008759 491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSA 537 (554)
Q Consensus 491 ~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~ 537 (554)
+.|+|||++.+. .++.++|||||||++|+|++|+.||...+....
T Consensus 159 ~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~ 203 (323)
T cd05571 159 PEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL 203 (323)
T ss_pred ccccChhhhcCC--CCCccccCcccchhhhhhhcCCCCCCCCCHHHH
Confidence 999999999654 488999999999999999999999987665443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=318.34 Aligned_cols=210 Identities=33% Similarity=0.527 Sum_probs=181.4
Q ss_pred cceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEE
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~L 407 (554)
++|++++.||+|+||+||+|.+ .+++.||+|++..... ........+.+|+.++..++|+||+++++.+.+.+.+|+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 78 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDM--IKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYL 78 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHH--hhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEE
Confidence 3689999999999999999998 5799999999874221 112344678889999999999999999999999999999
Q ss_pred EEeecccCchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC---
Q 008759 408 FLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--- 483 (554)
Q Consensus 408 VmE~~~ggsL~~ll~~~-~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~--- 483 (554)
||||+.+++|.+++.+. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 79 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (350)
T cd05573 79 VMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE 158 (350)
T ss_pred EEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence 99999999999998764 68999999999999999999999999999999999999999999999999987644322
Q ss_pred ----------------------------ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChh
Q 008759 484 ----------------------------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECV 535 (554)
Q Consensus 484 ----------------------------~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~ 535 (554)
.....||+.|+|||++.+. .++.++|||||||++|+|++|+.||......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 236 (350)
T cd05573 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT--PYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236 (350)
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcCC--CCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence 2344699999999999665 4889999999999999999999999988766
Q ss_pred HHHHHHH
Q 008759 536 SAIFIKT 542 (554)
Q Consensus 536 ~~i~~i~ 542 (554)
....++.
T Consensus 237 ~~~~~i~ 243 (350)
T cd05573 237 ETYNKII 243 (350)
T ss_pred HHHHHHh
Confidence 5554443
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=322.13 Aligned_cols=212 Identities=28% Similarity=0.456 Sum_probs=181.1
Q ss_pred ccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEE
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~ 406 (554)
.++|++.+.||+|+||.||++.+ .++..||+|++..... ........+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEM--IKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHh--hhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 56899999999999999999998 6789999999864221 11223345778999999999999999999999999999
Q ss_pred EEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC---
Q 008759 407 IFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--- 483 (554)
Q Consensus 407 LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~--- 483 (554)
+||||+.+|+|..++....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 120 lv~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~ 199 (370)
T cd05596 120 MVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVR 199 (370)
T ss_pred EEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCccc
Confidence 99999999999999988889999999999999999999999999999999999999999999999999987654321
Q ss_pred ccCccCCCcccChhhhcccC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHH
Q 008759 484 VKSCRGTAFWMAPEVINNKN--KGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIK 541 (554)
Q Consensus 484 ~~s~~GT~~Y~APEvl~~~~--~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i 541 (554)
.....||+.|+|||++.... ..++.++|||||||++|+|++|+.||...........+
T Consensus 200 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i 259 (370)
T cd05596 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI 259 (370)
T ss_pred CCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHH
Confidence 23456999999999986532 23788999999999999999999999987665444433
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=318.83 Aligned_cols=212 Identities=27% Similarity=0.421 Sum_probs=184.4
Q ss_pred ccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEE
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~ 406 (554)
.+.|++++.||.|.-|+||++.. .++..+|+|++.+... .....+.+.+.|.+||+.+.||+++.||..|..+...|
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l--~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~c 153 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESL--ASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSC 153 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHH--hhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeE
Confidence 56899999999999999999998 5579999999875332 22455677888999999999999999999999999999
Q ss_pred EEEeecccCchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccc---
Q 008759 407 IFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK--- 480 (554)
Q Consensus 407 LVmE~~~ggsL~~ll~~~---~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~--- 480 (554)
++||||.||+|..++++. .|++..++.|+.+++.||+|||..|||+|||||+||||.++|+|.|+||.|+....
T Consensus 154 l~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 154 LVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP 233 (459)
T ss_pred EEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence 999999999999999864 49999999999999999999999999999999999999999999999999873210
Q ss_pred -------------------------------c-C-----------------------CccCccCCCcccChhhhcccCCC
Q 008759 481 -------------------------------L-N-----------------------DVKSCRGTAFWMAPEVINNKNKG 505 (554)
Q Consensus 481 -------------------------------~-~-----------------------~~~s~~GT~~Y~APEvl~~~~~~ 505 (554)
. . ...+++||-.|+|||++.+. +
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~--G 311 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE--G 311 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC--C
Confidence 0 0 01134699999999999765 4
Q ss_pred CCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHH
Q 008759 506 YGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTV 543 (554)
Q Consensus 506 ~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~ 543 (554)
++.++|||+||+++||||.|..||.+....+.++.+..
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~ 349 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVG 349 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhc
Confidence 88999999999999999999999999998888777654
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=316.61 Aligned_cols=214 Identities=29% Similarity=0.491 Sum_probs=187.7
Q ss_pred cccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccC----
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD---- 401 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~---- 401 (554)
+..+|...+.||+|+||.|+.+.+ .+|..||+|++... -...-..++..+|+.+|+.++|+||+.+++.+..
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~---F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~ 96 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNP---FENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRD 96 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhh---hhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccc
Confidence 445677789999999999999999 88999999988621 1234456788899999999999999999998765
Q ss_pred -CCcEEEEEeecccCchHHHHhhhc-CChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccc
Q 008759 402 -ESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT 479 (554)
Q Consensus 402 -~~~~~LVmE~~~ggsL~~ll~~~~-l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~ 479 (554)
-+.+|+|+|+|+. +|..+++... +.+..+..++.||+.||+|+|+.||+||||||.|+|++.+..+||+|||+|+..
T Consensus 97 ~f~DvYiV~elMet-DL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~ 175 (359)
T KOG0660|consen 97 KFNDVYLVFELMET-DLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYL 175 (359)
T ss_pred ccceeEEehhHHhh-HHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeec
Confidence 2469999999955 8999998877 999999999999999999999999999999999999999999999999999987
Q ss_pred c----cCCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHHHH
Q 008759 480 K----LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTVAV 545 (554)
Q Consensus 480 ~----~~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~~~ 545 (554)
. ....+..+.|.||.|||++... ..|+.+.||||+|||+.|||+|++.|.+.+..+++-.|....
T Consensus 176 ~~~~~~~~mTeYVaTRWYRAPElll~~-~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~l 244 (359)
T KOG0660|consen 176 DKFFEDGFMTEYVATRWYRAPELLLNS-SEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELL 244 (359)
T ss_pred cccCcccchhcceeeeeecCHHHHhcc-ccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhc
Confidence 4 4445677899999999998544 469999999999999999999999999999999988876543
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=324.03 Aligned_cols=218 Identities=29% Similarity=0.488 Sum_probs=180.8
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccc---------hhHHHHHHHHHHHHHHHhCCCCceeee
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGS---------QAKQSISQLEQEIALLSRFEHENIVQY 395 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~---------~~~~~~~~~~~Ei~iL~~l~HpnIVkl 395 (554)
..++.|++++.||+|.||.|-+|.+ .+++.||||++....... .....+++..+||.+|+++.|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 4678999999999999999999999 789999999996532111 111224578899999999999999999
Q ss_pred eeeccC--CCcEEEEEeecccCchHHHHhhhc-CChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEe
Q 008759 396 YGTDKD--ESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLAD 472 (554)
Q Consensus 396 ~~~~~~--~~~~~LVmE~~~ggsL~~ll~~~~-l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~D 472 (554)
+.+..+ .+.+|||+|||..|.+...=.... +.+.+++.|++.++.||+|||.+|||||||||+|+||+.+|+|||+|
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsD 253 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISD 253 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeec
Confidence 998655 568999999999998865443344 88999999999999999999999999999999999999999999999
Q ss_pred cCcccccccC-------CccCccCCCcccChhhhcccCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHH
Q 008759 473 FGLAKATKLN-------DVKSCRGTAFWMAPEVINNKNK--GYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTV 543 (554)
Q Consensus 473 FGlA~~~~~~-------~~~s~~GT~~Y~APEvl~~~~~--~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~ 543 (554)
||.+...... ......|||.|+|||.+.+... ..+.+.|||||||+||.|+.|++||.+-...+..-+|++
T Consensus 254 FGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn 333 (576)
T KOG0585|consen 254 FGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVN 333 (576)
T ss_pred cceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhc
Confidence 9988754211 2334679999999999876331 246789999999999999999999988776666666654
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=305.69 Aligned_cols=208 Identities=28% Similarity=0.490 Sum_probs=175.9
Q ss_pred ccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEE
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~ 406 (554)
+++|++.+.||.|+||.||+|.+ .++..||+|++....... ....+.+|+.+++.++||||+++++++...+.+|
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 79 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG----APCTAIREVSLLKNLKHANIVTLHDIIHTERCLT 79 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCC----cchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence 45799999999999999999998 678999999986432211 1235678999999999999999999999999999
Q ss_pred EEEeecccCchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC--
Q 008759 407 IFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-- 482 (554)
Q Consensus 407 LVmE~~~ggsL~~ll~~~--~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~-- 482 (554)
+||||+.+ +|.+++... .++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 80 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 80 LVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred EEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 99999986 888877653 4788899999999999999999999999999999999999999999999998764322
Q ss_pred CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHH
Q 008759 483 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIK 541 (554)
Q Consensus 483 ~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i 541 (554)
......+|+.|+|||++.+. ..++.++|||||||++|+|++|+.||......+.+..+
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~ 216 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGS-TEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLI 216 (288)
T ss_pred cccCceecccccChHHhcCC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 22345689999999998643 34788999999999999999999999887766655444
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=318.34 Aligned_cols=206 Identities=29% Similarity=0.462 Sum_probs=178.3
Q ss_pred cceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCC-----
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE----- 402 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~----- 402 (554)
-.|.-.+++|.|+||.||.|.. .++..||||++....... .+|+.+|+.+.|||||+++.+|...
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k---------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~ 94 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK---------NRELQIMRKLDHPNIVRLLYFFSSSTESDE 94 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC---------cHHHHHHHhcCCcCeeeEEEEEEecCCCch
Confidence 3688889999999999999998 668999999987544322 3789999999999999998877532
Q ss_pred CcEEEEEeecccCchHHHHhh-----hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCC-CcEEEEecCcc
Q 008759 403 SKLYIFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLA 476 (554)
Q Consensus 403 ~~~~LVmE~~~ggsL~~ll~~-----~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~-g~vKL~DFGlA 476 (554)
-++.+|||||+. +|..+++. ..++.-.++-|+.||++||.|||+.||+||||||.|+|+|.+ |.+||||||.|
T Consensus 95 ~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSA 173 (364)
T KOG0658|consen 95 VYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSA 173 (364)
T ss_pred hHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcc
Confidence 256689999987 88888874 468888999999999999999999999999999999999976 89999999999
Q ss_pred ccccc-CCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHHHH
Q 008759 477 KATKL-NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTVAV 545 (554)
Q Consensus 477 ~~~~~-~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~~~ 545 (554)
+.... ....+..+|..|+|||++.+.. .|+.+.||||.||++.||+-|++-|.+....+++..|+.-.
T Consensus 174 K~L~~~epniSYicSRyYRaPELifga~-~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~l 242 (364)
T KOG0658|consen 174 KVLVKGEPNISYICSRYYRAPELIFGAT-EYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVL 242 (364)
T ss_pred eeeccCCCceeEEEeccccCHHHHcCcc-ccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHh
Confidence 87544 3456778999999999998765 69999999999999999999999999999999888776543
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=312.31 Aligned_cols=207 Identities=28% Similarity=0.470 Sum_probs=174.6
Q ss_pred eeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHH---HhCCCCceeeeeeeccCCCcEE
Q 008759 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL---SRFEHENIVQYYGTDKDESKLY 406 (554)
Q Consensus 331 y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL---~~l~HpnIVkl~~~~~~~~~~~ 406 (554)
|++.+.||+|+||.||+|.+ .+++.||+|++..... ......+.+.+|+.++ ..++||||+++++++...+.+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~ 78 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDI--IARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVC 78 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEE
Confidence 67899999999999999988 6789999999874321 1122344566666554 5667999999999999999999
Q ss_pred EEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccccc--CCc
Q 008759 407 IFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL--NDV 484 (554)
Q Consensus 407 LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~--~~~ 484 (554)
+||||+.+++|..++....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ...
T Consensus 79 lv~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (324)
T cd05589 79 FVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT 158 (324)
T ss_pred EEEcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCcc
Confidence 999999999999998888899999999999999999999999999999999999999999999999999865322 223
Q ss_pred cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHH
Q 008759 485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIK 541 (554)
Q Consensus 485 ~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i 541 (554)
....||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+.+..+
T Consensus 159 ~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i 213 (324)
T cd05589 159 STFCGTPEFLAPEVLTET--SYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSI 213 (324)
T ss_pred cccccCccccCHhHhcCC--CCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 345699999999998654 4788999999999999999999999887665544443
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=303.41 Aligned_cols=200 Identities=27% Similarity=0.456 Sum_probs=172.2
Q ss_pred ceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEE
Q 008759 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (554)
Q Consensus 330 ~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LV 408 (554)
.|++.+.||+|+||.||+|.+ .+++.||+|.+...... .......+.+|+.++..++|+||+++++.+.+.+.+|+|
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv 78 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK--KRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLV 78 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhh--hhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEE
Confidence 378889999999999999998 78999999988643221 122234577899999999999999999999999999999
Q ss_pred EeecccCchHHHHhh---hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC-Cc
Q 008759 409 LELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-DV 484 (554)
Q Consensus 409 mE~~~ggsL~~ll~~---~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~-~~ 484 (554)
|||+.+|+|..++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 79 ~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 158 (285)
T cd05631 79 LTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETV 158 (285)
T ss_pred EEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCee
Confidence 999999999887753 25888999999999999999999999999999999999999999999999998765432 23
Q ss_pred cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008759 485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME 533 (554)
Q Consensus 485 ~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e 533 (554)
....||+.|+|||++.+. .++.++|||||||++|+|++|+.||....
T Consensus 159 ~~~~g~~~y~aPE~~~~~--~~~~~~DvwslGvil~el~~g~~pf~~~~ 205 (285)
T cd05631 159 RGRVGTVGYMAPEVINNE--KYTFSPDWWGLGCLIYEMIQGQSPFRKRK 205 (285)
T ss_pred cCCCCCCCccCHhhhcCC--CCCcccCchhHHHHHHHHHhCCCCCCCCC
Confidence 445699999999999654 48899999999999999999999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=311.62 Aligned_cols=200 Identities=29% Similarity=0.500 Sum_probs=171.6
Q ss_pred eeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEEEeecc
Q 008759 335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVT 413 (554)
Q Consensus 335 ~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LVmE~~~ 413 (554)
+.||+|+||.||++.+ .+|..||+|++..... ........+.+|+.+++.++||||+++++.+...+.+|+||||+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~ 78 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVI--IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh--hhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCC
Confidence 4699999999999998 6799999999874221 123345667789999999999999999999999999999999999
Q ss_pred cCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccccc--CCccCccCC
Q 008759 414 KGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL--NDVKSCRGT 490 (554)
Q Consensus 414 ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~--~~~~s~~GT 490 (554)
+++|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .......||
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt 158 (323)
T cd05595 79 GGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGT 158 (323)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCC
Confidence 9999988865 4589999999999999999999999999999999999999999999999999875322 223345699
Q ss_pred CcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHH
Q 008759 491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAI 538 (554)
Q Consensus 491 ~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i 538 (554)
+.|+|||++.+. .++.++|||||||++|+|++|+.||...+.....
T Consensus 159 ~~y~aPE~~~~~--~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~ 204 (323)
T cd05595 159 PEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF 204 (323)
T ss_pred cCcCCcccccCC--CCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHH
Confidence 999999998654 4789999999999999999999999877655443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=305.57 Aligned_cols=204 Identities=29% Similarity=0.507 Sum_probs=172.0
Q ss_pred ccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEE
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~ 406 (554)
.++|++.+.||+|+||.||+|.+ .+++.||+|++....... ....+.+|+.+++.++||||+++++++.+...+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 79 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG----TPFTAIREASLLKGLKHANIVLLHDIIHTKETLT 79 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccc----cchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEE
Confidence 36799999999999999999998 578999999987432211 1234668999999999999999999999999999
Q ss_pred EEEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccccc--C
Q 008759 407 IFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL--N 482 (554)
Q Consensus 407 LVmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~--~ 482 (554)
+||||+.+ +|.+++.. ..+.+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .
T Consensus 80 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 158 (303)
T cd07869 80 LVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH 158 (303)
T ss_pred EEEECCCc-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc
Confidence 99999975 66666654 3588999999999999999999999999999999999999999999999999875432 2
Q ss_pred CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHH
Q 008759 483 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSA 537 (554)
Q Consensus 483 ~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~ 537 (554)
......+|+.|+|||++.+.. .++.++|||||||++|+|++|..||........
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 212 (303)
T cd07869 159 TYSNEVVTLWYRPPDVLLGST-EYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD 212 (303)
T ss_pred cCCCCcccCCCCChHHHcCCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH
Confidence 233456899999999986433 478899999999999999999999998755433
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=311.30 Aligned_cols=211 Identities=27% Similarity=0.433 Sum_probs=177.8
Q ss_pred cceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEE
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~L 407 (554)
++|++++.||+|+||.||++.+ .+++.||+|++..... ........+.+|+.++..++|+||+++++++.+.+++|+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 78 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEM--LKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYL 78 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHH--hhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEE
Confidence 4689999999999999999998 6789999999864211 122334567889999999999999999999999999999
Q ss_pred EEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC--
Q 008759 408 FLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-- 483 (554)
Q Consensus 408 VmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~-- 483 (554)
||||+.+++|.+++.+ ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 158 (331)
T cd05597 79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV 158 (331)
T ss_pred EEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc
Confidence 9999999999999875 358999999999999999999999999999999999999999999999999986543322
Q ss_pred -ccCccCCCcccChhhhccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHH
Q 008759 484 -VKSCRGTAFWMAPEVINNK---NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIK 541 (554)
Q Consensus 484 -~~s~~GT~~Y~APEvl~~~---~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i 541 (554)
.....||+.|+|||++... ...++.++|||||||++|+|++|+.||......+...++
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i 220 (331)
T cd05597 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 220 (331)
T ss_pred cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHH
Confidence 1224599999999998642 224678999999999999999999999876655544333
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=308.44 Aligned_cols=208 Identities=26% Similarity=0.423 Sum_probs=175.0
Q ss_pred ceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhC-CCCceeeeeeeccCCCcEEE
Q 008759 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESKLYI 407 (554)
Q Consensus 330 ~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIVkl~~~~~~~~~~~L 407 (554)
+|++.+.||+|+||.||+|.+ .++..||+|++..... ........+..|..++..+ +|++|+++++++...+.+|+
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l 78 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVV--IQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYF 78 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEE
Confidence 478899999999999999998 5788999999874221 1122334566777888777 58999999999999999999
Q ss_pred EEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccccc--CCc
Q 008759 408 FLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL--NDV 484 (554)
Q Consensus 408 VmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~--~~~ 484 (554)
||||+.+|+|..++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ...
T Consensus 79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~ 158 (323)
T cd05616 79 VMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTT 158 (323)
T ss_pred EEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCcc
Confidence 9999999999988865 4689999999999999999999999999999999999999999999999999875432 223
Q ss_pred cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHH
Q 008759 485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIK 541 (554)
Q Consensus 485 ~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i 541 (554)
....||+.|+|||++.+. .++.++|||||||++|+|++|+.||......+.+..+
T Consensus 159 ~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i 213 (323)
T cd05616 159 KTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI 213 (323)
T ss_pred ccCCCChhhcCHHHhcCC--CCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 345699999999999654 4889999999999999999999999987765554443
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=300.22 Aligned_cols=208 Identities=25% Similarity=0.452 Sum_probs=177.3
Q ss_pred cceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEE
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~L 407 (554)
++|++.+.||+|+||.||+|++ .+++.||+|++...... ......+.+|+.+++.++|+||+++++++...+.+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 77 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN---EEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYL 77 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccc---ccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEE
Confidence 3689999999999999999999 57889999998753221 2234567789999999999999999999999999999
Q ss_pred EEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC---C
Q 008759 408 FLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN---D 483 (554)
Q Consensus 408 VmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~---~ 483 (554)
||||+.++.+..+... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++...... .
T Consensus 78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (287)
T cd07848 78 VFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN 157 (287)
T ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccc
Confidence 9999999877765543 46899999999999999999999999999999999999999999999999998765332 2
Q ss_pred ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHH
Q 008759 484 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIK 541 (554)
Q Consensus 484 ~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i 541 (554)
.....||+.|+|||++.+. .++.++|||||||++|+|++|+.||......+..+.+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~ 213 (287)
T cd07848 158 YTEYVATRWYRSPELLLGA--PYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTI 213 (287)
T ss_pred ccccccccccCCcHHHcCC--CCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 2345689999999999654 3788999999999999999999999987766655544
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=308.10 Aligned_cols=208 Identities=26% Similarity=0.416 Sum_probs=174.9
Q ss_pred ceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCC-CceeeeeeeccCCCcEEE
Q 008759 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH-ENIVQYYGTDKDESKLYI 407 (554)
Q Consensus 330 ~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~H-pnIVkl~~~~~~~~~~~L 407 (554)
+|++.+.||+|+||.||+|.+ .+++.||+|++..... ........+..|+.++..+.| ++|+++++++...+.+|+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l 78 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVI--IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 78 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEE
Confidence 488999999999999999998 5688999999874221 112334567789999999876 468899999999999999
Q ss_pred EEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccc--cCCc
Q 008759 408 FLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK--LNDV 484 (554)
Q Consensus 408 VmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~--~~~~ 484 (554)
||||+.+|+|..++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.... ....
T Consensus 79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (324)
T cd05587 79 VMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTT 158 (324)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCce
Confidence 9999999999988865 458899999999999999999999999999999999999999999999999986532 2223
Q ss_pred cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHH
Q 008759 485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIK 541 (554)
Q Consensus 485 ~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i 541 (554)
....||+.|+|||++.+. .++.++|||||||++|+|+||+.||......+.+..+
T Consensus 159 ~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i 213 (324)
T cd05587 159 RTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSI 213 (324)
T ss_pred eeecCCccccChhhhcCC--CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 345699999999999654 3788999999999999999999999887665544433
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=311.41 Aligned_cols=200 Identities=28% Similarity=0.496 Sum_probs=171.8
Q ss_pred eeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEEEeecc
Q 008759 335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVT 413 (554)
Q Consensus 335 ~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LVmE~~~ 413 (554)
+.||+|+||.||++.+ .+++.||+|++..... ........+.+|+.+++.++||||+++++.+...+.+|+||||+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~ 78 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVI--IAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVN 78 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCC
Confidence 4699999999999998 6799999999874221 123345677889999999999999999999999999999999999
Q ss_pred cCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccccc--CCccCccCC
Q 008759 414 KGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL--NDVKSCRGT 490 (554)
Q Consensus 414 ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~--~~~~s~~GT 490 (554)
+++|..++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... .......||
T Consensus 79 ~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt 158 (328)
T cd05593 79 GGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGT 158 (328)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCC
Confidence 9999988865 4589999999999999999999999999999999999999999999999999875322 223345699
Q ss_pred CcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHH
Q 008759 491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAI 538 (554)
Q Consensus 491 ~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i 538 (554)
+.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+..
T Consensus 159 ~~y~aPE~~~~~--~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~ 204 (328)
T cd05593 159 PEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF 204 (328)
T ss_pred cCccChhhhcCC--CCCccCCccccchHHHHHhhCCCCCCCCCHHHHH
Confidence 999999998654 4788999999999999999999999877654443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=307.47 Aligned_cols=199 Identities=30% Similarity=0.472 Sum_probs=170.7
Q ss_pred eccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEEEeecccC
Q 008759 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKG 415 (554)
Q Consensus 337 LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LVmE~~~gg 415 (554)
||+|+||.||+|.+ .+++.||+|++..... ........+.+|+.++..++||||+++++.+...+.+|+||||+.+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 78 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHI--VSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGG 78 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCC
Confidence 79999999999998 5788999999864221 12334567788999999999999999999999999999999999999
Q ss_pred chHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccccc--CCccCccCCCc
Q 008759 416 SLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL--NDVKSCRGTAF 492 (554)
Q Consensus 416 sL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~--~~~~s~~GT~~ 492 (554)
+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... .......||+.
T Consensus 79 ~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~ 158 (312)
T cd05585 79 ELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPE 158 (312)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCcc
Confidence 99998865 4689999999999999999999999999999999999999999999999999875322 22334569999
Q ss_pred ccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHH
Q 008759 493 WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIF 539 (554)
Q Consensus 493 Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~ 539 (554)
|+|||++.+. .++.++|||||||++|+|++|+.||......+...
T Consensus 159 y~aPE~~~~~--~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~ 203 (312)
T cd05585 159 YLAPELLLGH--GYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYR 203 (312)
T ss_pred cCCHHHHcCC--CCCCccceechhHHHHHHHhCCCCcCCCCHHHHHH
Confidence 9999999654 48899999999999999999999998766554433
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=311.17 Aligned_cols=211 Identities=26% Similarity=0.421 Sum_probs=178.1
Q ss_pred cceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEE
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~L 407 (554)
++|++.+.||+|+||.||++.+ .+++.||+|++..... ........+.+|+.++..++|+||+++++++...+.+|+
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~l 78 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEM--LKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYL 78 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHH--HhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 4789999999999999999998 6788999999864211 122334557789999999999999999999999999999
Q ss_pred EEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCCc-
Q 008759 408 FLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV- 484 (554)
Q Consensus 408 VmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~~- 484 (554)
||||+.+|+|..++.+ ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 79 v~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 158 (331)
T cd05624 79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV 158 (331)
T ss_pred EEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence 9999999999999976 4688999999999999999999999999999999999999999999999999876543221
Q ss_pred --cCccCCCcccChhhhcccC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHH
Q 008759 485 --KSCRGTAFWMAPEVINNKN---KGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIK 541 (554)
Q Consensus 485 --~s~~GT~~Y~APEvl~~~~---~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i 541 (554)
....||+.|+|||++.+.. ..++.++|||||||++|+|++|+.||......+.+.++
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i 220 (331)
T cd05624 159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 220 (331)
T ss_pred eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHH
Confidence 2346999999999986521 23678999999999999999999999877665544433
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=324.31 Aligned_cols=213 Identities=29% Similarity=0.493 Sum_probs=186.0
Q ss_pred ccccccceeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCC
Q 008759 324 FKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES 403 (554)
Q Consensus 324 ~~~~~~~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~ 403 (554)
+....+.+++++.||+|.||.||+|.++....||+|.++.... ....|.+|+.+|++|+|+|||++|+++..+.
T Consensus 201 wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m------~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~ 274 (468)
T KOG0197|consen 201 WEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM------SPEAFLREAQIMKKLRHEKLVKLYGVCTKQE 274 (468)
T ss_pred eeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecccc------ChhHHHHHHHHHHhCcccCeEEEEEEEecCC
Confidence 3344456788899999999999999999888999999985322 2356789999999999999999999999988
Q ss_pred cEEEEEeecccCchHHHHhh---hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccc
Q 008759 404 KLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK 480 (554)
Q Consensus 404 ~~~LVmE~~~ggsL~~ll~~---~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~ 480 (554)
.+|||||||..|+|.++|+. ..+...+...++.||++|++||+++++|||||...||||+++..+||+|||||+...
T Consensus 275 piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~ 354 (468)
T KOG0197|consen 275 PIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIG 354 (468)
T ss_pred ceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccC
Confidence 99999999999999999986 458889999999999999999999999999999999999999999999999999666
Q ss_pred cCCccCccC---CCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHHH
Q 008759 481 LNDVKSCRG---TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIFIKTVA 544 (554)
Q Consensus 481 ~~~~~s~~G---T~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i~~i~~~ 544 (554)
.+.+....| ...|.|||.+.... ++.++||||||++||||+| |+.||..+...+.+-.+..+
T Consensus 355 d~~Y~~~~~~kfPIkWtAPEa~~~~~--FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~G 420 (468)
T KOG0197|consen 355 DDEYTASEGGKFPIKWTAPEALNYGK--FSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERG 420 (468)
T ss_pred CCceeecCCCCCCceecCHHHHhhCC--cccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhcc
Confidence 555544333 45599999997654 8999999999999999999 99999999998887666543
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=305.01 Aligned_cols=203 Identities=28% Similarity=0.473 Sum_probs=169.5
Q ss_pred ceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCC-----C
Q 008759 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE-----S 403 (554)
Q Consensus 330 ~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~-----~ 403 (554)
+|++.++||+|+||.||+|.+ .++..||+|++..... .......+.+|+.+++.++||||+++++++... .
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 77 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE---HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 77 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc---cchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCc
Confidence 589999999999999999998 6789999998863211 112235678999999999999999999886432 3
Q ss_pred cEEEEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC
Q 008759 404 KLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN 482 (554)
Q Consensus 404 ~~~LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~ 482 (554)
.+|+||||+. ++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 78 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 156 (338)
T cd07859 78 DIYVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 156 (338)
T ss_pred eEEEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence 5899999996 578887765 46899999999999999999999999999999999999999999999999998754321
Q ss_pred C-----ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhH
Q 008759 483 D-----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVS 536 (554)
Q Consensus 483 ~-----~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~ 536 (554)
. .....||+.|+|||++.+....++.++|||||||++|+|++|+.||.......
T Consensus 157 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~ 215 (338)
T cd07859 157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH 215 (338)
T ss_pred cCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHH
Confidence 1 23456999999999986543458899999999999999999999998765443
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=308.58 Aligned_cols=204 Identities=32% Similarity=0.499 Sum_probs=171.5
Q ss_pred eeeccCCceeEEEEec----CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEEEe
Q 008759 335 DLLGRGSFGSVYEGIS----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLE 410 (554)
Q Consensus 335 ~~LG~GsfG~VY~a~~----~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LVmE 410 (554)
++||+|+||.||++++ .+++.||+|++...... ........+.+|+.+++.++||||+++++.+..++.+|+|||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIV-RNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHH-hhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 6799999999999986 36889999998742211 112234567789999999999999999999999999999999
Q ss_pred ecccCchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC--CccCc
Q 008759 411 LVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--DVKSC 487 (554)
Q Consensus 411 ~~~ggsL~~ll~~~-~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~--~~~s~ 487 (554)
|+.+++|.+++.+. .+.+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... .....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 160 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTF 160 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCccccc
Confidence 99999999988764 4788889999999999999999999999999999999999999999999998753222 23345
Q ss_pred cCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHH
Q 008759 488 RGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIK 541 (554)
Q Consensus 488 ~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i 541 (554)
.||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+.+..+
T Consensus 161 ~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~ 212 (323)
T cd05584 161 CGTIEYMAPEILMRS--GHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKI 212 (323)
T ss_pred CCCccccChhhccCC--CCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 699999999998654 3788999999999999999999999887765544433
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=322.54 Aligned_cols=213 Identities=31% Similarity=0.555 Sum_probs=191.5
Q ss_pred ccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCc-E
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK-L 405 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~-~ 405 (554)
.+.|..+++||+|+||.++++++ .++..|++|++.......... ...++|+.++++++|||||.+++.|..+++ +
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r---~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l 79 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPER---RSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLL 79 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhh---HHHHHHHHHHHhccCCCeeeeccchhcCCceE
Confidence 46789999999999999999998 678899999998765543332 367899999999999999999999999988 9
Q ss_pred EEEEeecccCchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC
Q 008759 406 YIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN 482 (554)
Q Consensus 406 ~LVmE~~~ggsL~~ll~~~---~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~ 482 (554)
+|||+|++||+|.+.+.+. .++++.+..|+.|++.||.|||+++|+|||||+.|||++.++.|||+|||+|+.....
T Consensus 80 ~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 80 CIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred EEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 9999999999999988653 4899999999999999999999999999999999999999999999999999987655
Q ss_pred --CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHHHH
Q 008759 483 --DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTVAV 545 (554)
Q Consensus 483 --~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~~~ 545 (554)
...+..||+.||+||++.+.. |+.++|||||||++|||++-+.+|...+....+.+|..+.
T Consensus 160 ~~~a~tvvGTp~YmcPEil~d~p--Yn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~ 222 (426)
T KOG0589|consen 160 DSLASTVVGTPYYMCPEILSDIP--YNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL 222 (426)
T ss_pred hhhhheecCCCcccCHHHhCCCC--CCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhcc
Confidence 456778999999999996654 9999999999999999999999999999988888887654
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=308.61 Aligned_cols=211 Identities=27% Similarity=0.422 Sum_probs=177.8
Q ss_pred cceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEE
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~L 407 (554)
++|++.++||+|+||.||++.+ .+++.||+|++..... ........+.+|+.++..++|+||+++++.+.+.+.+|+
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 78 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEM--LKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYL 78 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHH--HHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEE
Confidence 3689999999999999999998 5688999999863211 112233457789999999999999999999999999999
Q ss_pred EEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC--
Q 008759 408 FLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-- 483 (554)
Q Consensus 408 VmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~-- 483 (554)
||||+.+|+|.+++.+ ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 79 v~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~ 158 (332)
T cd05623 79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 158 (332)
T ss_pred EEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcc
Confidence 9999999999999976 458889999999999999999999999999999999999999999999999987543221
Q ss_pred -ccCccCCCcccChhhhccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHH
Q 008759 484 -VKSCRGTAFWMAPEVINNK---NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIK 541 (554)
Q Consensus 484 -~~s~~GT~~Y~APEvl~~~---~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i 541 (554)
.....||+.|+|||++... ...++.++|||||||++|+|++|+.||...+..+...++
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i 220 (332)
T cd05623 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 220 (332)
T ss_pred eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 2234699999999998632 234788999999999999999999999987766655444
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=308.07 Aligned_cols=204 Identities=29% Similarity=0.475 Sum_probs=167.6
Q ss_pred ccceeeeeeeccCCceeEEEEec------CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhC-CCCceeeeeeecc
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDK 400 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~------~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIVkl~~~~~ 400 (554)
.++|+++++||+|+||.||+|.+ .++..||+|++.... .......+.+|+.++..+ +||||+++++++.
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA----TASEHKALMSELKILIHIGNHLNVVNLLGACT 81 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc----chHHHHHHHHHHHHHHHhccCcceeeEEeEec
Confidence 46899999999999999999974 345789999886321 122345788999999999 8999999999876
Q ss_pred CC-CcEEEEEeecccCchHHHHhhh-------------------------------------------------------
Q 008759 401 DE-SKLYIFLELVTKGSLLNLYQRY------------------------------------------------------- 424 (554)
Q Consensus 401 ~~-~~~~LVmE~~~ggsL~~ll~~~------------------------------------------------------- 424 (554)
.. ..+|+||||+.+|+|.+++...
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 54 4689999999999999988642
Q ss_pred --------cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC----ccCccCCCc
Q 008759 425 --------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAF 492 (554)
Q Consensus 425 --------~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~----~~s~~GT~~ 492 (554)
.+.+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... .....+++.
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 25667888899999999999999999999999999999999999999999997643221 122345678
Q ss_pred ccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHH
Q 008759 493 WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSA 537 (554)
Q Consensus 493 Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~ 537 (554)
|+|||++.+. .++.++|||||||++|||++ |..||......+.
T Consensus 242 y~aPE~~~~~--~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~ 285 (338)
T cd05102 242 WMAPESIFDK--VYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE 285 (338)
T ss_pred ccCcHHhhcC--CCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH
Confidence 9999998654 47899999999999999997 9999987654433
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=315.58 Aligned_cols=215 Identities=32% Similarity=0.514 Sum_probs=188.0
Q ss_pred cccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCC-CCceeeeeeeccCC
Q 008759 325 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDE 402 (554)
Q Consensus 325 ~~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIVkl~~~~~~~ 402 (554)
..+...|++++.||+|.||.||+|+. .+|+.+|+|.+........ .....+.+|+.+|+++. |||||.++++|.+.
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~--~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~ 108 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGK--EDREDVRREVAILQQLSGHPNIVQLKDAFEDP 108 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhcccc--ccHHHHHHHHHHHHhccCCCCEEEEEEEEEcC
Confidence 45567899999999999999999999 5699999999976443322 24567889999999998 99999999999999
Q ss_pred CcEEEEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCC----CcEEEEecCcccc
Q 008759 403 SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN----GSVKLADFGLAKA 478 (554)
Q Consensus 403 ~~~~LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~----g~vKL~DFGlA~~ 478 (554)
+.+|+|||++.||.|.+.+....+++..+..+++|++.++.|||+.||+||||||+|||+... +.+|++|||++..
T Consensus 109 ~~~~lvmEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~ 188 (382)
T KOG0032|consen 109 DSVYLVMELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF 188 (382)
T ss_pred CeEEEEEEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence 999999999999999998866569999999999999999999999999999999999999543 4799999999988
Q ss_pred ccc-CCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHH
Q 008759 479 TKL-NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTV 543 (554)
Q Consensus 479 ~~~-~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~ 543 (554)
... ......+||+.|+|||++... .|+..+||||+|+++|.||+|..||...........+..
T Consensus 189 ~~~~~~~~~~~Gtp~y~APEvl~~~--~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~ 252 (382)
T KOG0032|consen 189 IKPGERLHTIVGTPEYVAPEVLGGR--PYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILR 252 (382)
T ss_pred ccCCceEeeecCCccccCchhhcCC--CCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHc
Confidence 765 345678899999999999654 499999999999999999999999999887666664443
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=305.67 Aligned_cols=197 Identities=31% Similarity=0.524 Sum_probs=167.2
Q ss_pred ccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEE
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~ 406 (554)
..+|+.++.||+|+||.||+|.+ .+++.||+|++.... .......+.+|+.+++.++|+||+++++++...+.+|
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 148 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH----EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQ 148 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC----cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEE
Confidence 46788889999999999999998 578999999986422 2334467889999999999999999999999999999
Q ss_pred EEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC--Cc
Q 008759 407 IFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--DV 484 (554)
Q Consensus 407 LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~--~~ 484 (554)
+||||+.+++|... ....+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... ..
T Consensus 149 lv~e~~~~~~L~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~ 225 (353)
T PLN00034 149 VLLEFMDGGSLEGT---HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPC 225 (353)
T ss_pred EEEecCCCCccccc---ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccccc
Confidence 99999999998653 23566778889999999999999999999999999999999999999999998765432 22
Q ss_pred cCccCCCcccChhhhccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008759 485 KSCRGTAFWMAPEVINNK---NKGYGLPADIWSLGCTVLEMLTSQIPYAP 531 (554)
Q Consensus 485 ~s~~GT~~Y~APEvl~~~---~~~~s~ksDIwSLGvllyeLLTG~~PF~~ 531 (554)
....||..|+|||++... ...++.++|||||||++|+|++|+.||..
T Consensus 226 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~ 275 (353)
T PLN00034 226 NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGV 275 (353)
T ss_pred cccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 345699999999988432 12245689999999999999999999974
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=309.99 Aligned_cols=210 Identities=31% Similarity=0.476 Sum_probs=179.3
Q ss_pred cceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEE
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~L 407 (554)
++|++.+.||+|+||+||++.+ .+++.||+|++..... ........+.+|+.++..++|+||+++++.+.+.+.+|+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~l 78 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVL--LAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYL 78 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEE
Confidence 3689999999999999999998 6799999999874321 123345678899999999999999999999999999999
Q ss_pred EEeecccCchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC--
Q 008759 408 FLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-- 483 (554)
Q Consensus 408 VmE~~~ggsL~~ll~~~--~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~-- 483 (554)
||||+.+++|.+++.+. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 79 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 79 VMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV 158 (330)
T ss_pred EECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence 99999999999999764 68999999999999999999999999999999999999999999999999997654332
Q ss_pred -ccCccCCCcccChhhhccc----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHH
Q 008759 484 -VKSCRGTAFWMAPEVINNK----NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFI 540 (554)
Q Consensus 484 -~~s~~GT~~Y~APEvl~~~----~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~ 540 (554)
.....||+.|+|||++... ...++.++|||||||++|+|++|+.||........+..
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~ 220 (330)
T cd05601 159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNN 220 (330)
T ss_pred eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHH
Confidence 2234689999999998642 23478899999999999999999999987766554443
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=305.26 Aligned_cols=202 Identities=27% Similarity=0.462 Sum_probs=177.7
Q ss_pred ccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEE
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~ 406 (554)
.++|++.+.||+|+||.||++.+ .++..+|+|.+.... .......+.+|+.++..++||||+++++++...+.++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI----KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc----CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 46899999999999999999998 678899999887421 1234467889999999999999999999999999999
Q ss_pred EEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHC-CccccCCccccEEEcCCCcEEEEecCcccccccCCc
Q 008759 407 IFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQ-DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV 484 (554)
Q Consensus 407 LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~-gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~~ 484 (554)
+||||+.+++|.+++.. ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++........
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 159 (331)
T cd06649 80 ICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA 159 (331)
T ss_pred EEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccccc
Confidence 99999999999999876 4588999999999999999999986 599999999999999999999999999876655445
Q ss_pred cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChh
Q 008759 485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECV 535 (554)
Q Consensus 485 ~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~ 535 (554)
....||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+..
T Consensus 160 ~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~tg~~p~~~~~~~ 208 (331)
T cd06649 160 NSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVELAIGRYPIPPPDAK 208 (331)
T ss_pred ccCCCCcCcCCHhHhcCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 556799999999999654 4889999999999999999999999876553
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=324.82 Aligned_cols=207 Identities=40% Similarity=0.708 Sum_probs=186.0
Q ss_pred ceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEE
Q 008759 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (554)
Q Consensus 330 ~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LV 408 (554)
.|...++||+|+||.||+|.+ .+++.||+|++.+. ..+..+..+++|+.+|.+++++||.++|+.+..+..++++
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le----~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwii 89 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLE----EAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWII 89 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechh----hcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHH
Confidence 566779999999999999999 88999999999863 3455677899999999999999999999999999999999
Q ss_pred EeecccCchHHHHhhhcC-ChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC--cc
Q 008759 409 LELVTKGSLLNLYQRYHL-RDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VK 485 (554)
Q Consensus 409 mE~~~ggsL~~ll~~~~l-~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~--~~ 485 (554)
||||.||++.++++...+ .+..+..++++++.||.|||.++.+|||||+.|||+..+|.+||+|||.+....... ..
T Consensus 90 Mey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~ 169 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRK 169 (467)
T ss_pred HHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhccc
Confidence 999999999999998776 888999999999999999999999999999999999999999999999987654332 36
Q ss_pred CccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHH
Q 008759 486 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKT 542 (554)
Q Consensus 486 s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~ 542 (554)
+++||++|||||++.+ .+|+.++||||||++.|||++|.+||....++-.+|.|-
T Consensus 170 tfvGTPfwMAPEVI~~--~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIp 224 (467)
T KOG0201|consen 170 TFVGTPFWMAPEVIKQ--SGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIP 224 (467)
T ss_pred cccccccccchhhhcc--ccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEecc
Confidence 7789999999999973 459999999999999999999999999998877666553
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=307.84 Aligned_cols=200 Identities=32% Similarity=0.500 Sum_probs=170.3
Q ss_pred ceeeeeeeccCCceeEEEEec----CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCC-CCceeeeeeeccCCCc
Q 008759 330 YWQKGDLLGRGSFGSVYEGIS----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDESK 404 (554)
Q Consensus 330 ~y~i~~~LG~GsfG~VY~a~~----~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIVkl~~~~~~~~~ 404 (554)
+|++++.||+|+||+||++.+ .+++.||+|++...... ......+.+..|+.++..++ |+||+++++++...+.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~ 79 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALV-QKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAK 79 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHh-hhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCE
Confidence 488999999999999999876 36899999998642211 12233456788999999994 8999999999999999
Q ss_pred EEEEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC-
Q 008759 405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN- 482 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~- 482 (554)
+|+||||+.+|+|.+++.+ ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 80 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~ 159 (332)
T cd05614 80 LHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE 159 (332)
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccC
Confidence 9999999999999998865 46899999999999999999999999999999999999999999999999998754322
Q ss_pred --CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008759 483 --DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP 531 (554)
Q Consensus 483 --~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~ 531 (554)
......||+.|+|||++.+.. .++.++|||||||++|+|++|+.||..
T Consensus 160 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~elltg~~pf~~ 209 (332)
T cd05614 160 KERTYSFCGTIEYMAPEIIRGKG-GHGKAVDWWSLGILIFELLTGASPFTL 209 (332)
T ss_pred CCccccccCCccccCHHHhcCCC-CCCCccccccchhhhhhhhcCCCCCCC
Confidence 122456999999999986432 467899999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=306.68 Aligned_cols=200 Identities=30% Similarity=0.478 Sum_probs=166.3
Q ss_pred eeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHH-HHHHhCCCCceeeeeeeccCCCcEEEEEeec
Q 008759 335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEI-ALLSRFEHENIVQYYGTDKDESKLYIFLELV 412 (554)
Q Consensus 335 ~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei-~iL~~l~HpnIVkl~~~~~~~~~~~LVmE~~ 412 (554)
+.||+|+||+||+|.+ .+++.||+|++...... .......+..|. .+++.++|+||+++++.+...+.+|+||||+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~ 78 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAIL--KKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYI 78 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHH--hhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCC
Confidence 4699999999999998 57889999998742211 112223344444 4567889999999999999999999999999
Q ss_pred ccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccccc--CCccCccC
Q 008759 413 TKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL--NDVKSCRG 489 (554)
Q Consensus 413 ~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~--~~~~s~~G 489 (554)
.+++|..++.. ..+.+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... .......|
T Consensus 79 ~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~g 158 (325)
T cd05602 79 NGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCG 158 (325)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccC
Confidence 99999998876 4588889999999999999999999999999999999999999999999999875322 22344569
Q ss_pred CCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHH
Q 008759 490 TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAI 538 (554)
Q Consensus 490 T~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i 538 (554)
|+.|+|||++.+. .++.++|||||||++|+|++|+.||......+.+
T Consensus 159 t~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 205 (325)
T cd05602 159 TPEYLAPEVLHKQ--PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY 205 (325)
T ss_pred CccccCHHHHcCC--CCCCccccccccHHHHHHhcCCCCCCCCCHHHHH
Confidence 9999999999654 4888999999999999999999999877665443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=308.92 Aligned_cols=200 Identities=28% Similarity=0.493 Sum_probs=170.9
Q ss_pred eeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEEEeecc
Q 008759 335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVT 413 (554)
Q Consensus 335 ~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LVmE~~~ 413 (554)
+.||+|+||.||++.+ .++..||+|++..... ........+.+|+.++..++||||+++++.+...+.+|+||||+.
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~--~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~ 78 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVI--VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYAN 78 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCC
Confidence 4699999999999998 6799999999874221 122344567789999999999999999999999999999999999
Q ss_pred cCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHH-CCccccCCccccEEEcCCCcEEEEecCccccccc--CCccCccC
Q 008759 414 KGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGSVKLADFGLAKATKL--NDVKSCRG 489 (554)
Q Consensus 414 ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs-~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~--~~~~s~~G 489 (554)
+++|..++.+ ..+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+++.... .......|
T Consensus 79 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 158 (325)
T cd05594 79 GGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCG 158 (325)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccC
Confidence 9999988865 468999999999999999999997 7999999999999999999999999999875322 22334569
Q ss_pred CCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHH
Q 008759 490 TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAI 538 (554)
Q Consensus 490 T~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i 538 (554)
|+.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+..
T Consensus 159 t~~y~aPE~~~~~--~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~ 205 (325)
T cd05594 159 TPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF 205 (325)
T ss_pred CcccCCHHHHccC--CCCCccccccccceeeeeccCCCCCCCCCHHHHH
Confidence 9999999999654 4789999999999999999999999876654433
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=317.57 Aligned_cols=190 Identities=27% Similarity=0.317 Sum_probs=163.5
Q ss_pred ccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEE
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~ 406 (554)
...|.+.+.||+|+||.||+|.+ .+++.||+|.... ..+.+|+.+|++++|+|||++++++...+..|
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-----------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~ 236 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-----------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTC 236 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-----------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEE
Confidence 34799999999999999999998 5688999995431 23468999999999999999999999999999
Q ss_pred EEEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC-
Q 008759 407 IFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND- 483 (554)
Q Consensus 407 LVmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~- 483 (554)
+|||++. ++|..++.. ..+++.++..|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++......
T Consensus 237 lv~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 237 LVLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred EEEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 9999996 577777754 358999999999999999999999999999999999999999999999999987654322
Q ss_pred ---ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008759 484 ---VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP 531 (554)
Q Consensus 484 ---~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~ 531 (554)
.....||+.|+|||++.+. .++.++|||||||++|||++|..|+..
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~--~~~~~sDvwSlGviL~El~~g~~~lf~ 364 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGD--PYTPSVDIWSAGLVIFEAAVHTASLFS 364 (461)
T ss_pred cccccccCCCcCCcCHHHHcCC--CCCchHHHHHHHHHHHHHHHcCCCccc
Confidence 1234699999999999654 488999999999999999998876543
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=304.04 Aligned_cols=200 Identities=28% Similarity=0.494 Sum_probs=167.1
Q ss_pred eeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHh-CCCCceeeeeeeccCCCcEEEEEeec
Q 008759 335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR-FEHENIVQYYGTDKDESKLYIFLELV 412 (554)
Q Consensus 335 ~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~-l~HpnIVkl~~~~~~~~~~~LVmE~~ 412 (554)
+.||+|+||.||+|.+ .+++.||+|++...... .......+..|..++.. .+||||+++++.+...+.+|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~ 78 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVL--EDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh--hhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCC
Confidence 4699999999999998 67889999998742211 12223445566666664 47999999999999999999999999
Q ss_pred ccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccccc--CCccCccC
Q 008759 413 TKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL--NDVKSCRG 489 (554)
Q Consensus 413 ~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~--~~~~s~~G 489 (554)
.+|+|..++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... .......|
T Consensus 79 ~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~g 158 (316)
T cd05592 79 NGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCG 158 (316)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccC
Confidence 99999988865 4689999999999999999999999999999999999999999999999999875432 22334569
Q ss_pred CCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHH
Q 008759 490 TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAI 538 (554)
Q Consensus 490 T~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i 538 (554)
|+.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+.+
T Consensus 159 t~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~ 205 (316)
T cd05592 159 TPDYIAPEILKGQ--KYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELF 205 (316)
T ss_pred CccccCHHHHcCC--CCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9999999999654 3788999999999999999999999887664443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=295.08 Aligned_cols=209 Identities=30% Similarity=0.495 Sum_probs=169.7
Q ss_pred cceeeeeeeccCCceeEEEEec--CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhC---CCCceeeeeeecc---
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS--DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF---EHENIVQYYGTDK--- 400 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~--~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l---~HpnIVkl~~~~~--- 400 (554)
++|++.+.||+|+||.||+|.+ .+++.||+|.+........ ....+.+|+.+++.+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~ 77 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG---MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 77 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCC---chHHHHHHHHHHHhhcccCCCCcceEEEEEeccc
Confidence 3688999999999999999987 3478899998875332211 112344566666555 6999999999874
Q ss_pred --CCCcEEEEEeecccCchHHHHhh---hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCc
Q 008759 401 --DESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL 475 (554)
Q Consensus 401 --~~~~~~LVmE~~~ggsL~~ll~~---~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGl 475 (554)
....+++||||+.+ +|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 78 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 78 TDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCCCCcEEEEEccCCC-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 34579999999975 88888764 3488899999999999999999999999999999999999999999999999
Q ss_pred ccccccCC-ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHH
Q 008759 476 AKATKLND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTV 543 (554)
Q Consensus 476 A~~~~~~~-~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~ 543 (554)
++...... .....||+.|+|||++.+. .++.++|||||||++|+|++|++||......+.+..+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~ 223 (290)
T cd07862 157 ARIYSFQMALTSVVVTLWYRAPEVLLQS--SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILD 223 (290)
T ss_pred eEeccCCcccccccccccccChHHHhCC--CCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHH
Confidence 87654332 3345689999999998654 478899999999999999999999998877766655543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=305.61 Aligned_cols=200 Identities=32% Similarity=0.502 Sum_probs=167.1
Q ss_pred eeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHH-HHHhCCCCceeeeeeeccCCCcEEEEEeec
Q 008759 335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIA-LLSRFEHENIVQYYGTDKDESKLYIFLELV 412 (554)
Q Consensus 335 ~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~-iL~~l~HpnIVkl~~~~~~~~~~~LVmE~~ 412 (554)
+.||+|+||+||+|.+ .+++.||+|++..... ........+..|.. +++.++||||+++++.+...+.+|+||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 78 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAI--LKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYV 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHH--hhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCC
Confidence 4699999999999998 6799999999874221 11222344455554 567899999999999999999999999999
Q ss_pred ccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccccc--CCccCccC
Q 008759 413 TKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL--NDVKSCRG 489 (554)
Q Consensus 413 ~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~--~~~~s~~G 489 (554)
.+++|..++++ ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... .......|
T Consensus 79 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (323)
T cd05575 79 NGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCG 158 (323)
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccC
Confidence 99999988875 4588999999999999999999999999999999999999999999999999875322 22334569
Q ss_pred CCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHH
Q 008759 490 TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAI 538 (554)
Q Consensus 490 T~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i 538 (554)
|+.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+..
T Consensus 159 t~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~ 205 (323)
T cd05575 159 TPEYLAPEVLRKQ--PYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMY 205 (323)
T ss_pred ChhhcChhhhcCC--CCCccccccccchhhhhhhcCCCCCCCCCHHHHH
Confidence 9999999998654 4888999999999999999999999887654443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=304.66 Aligned_cols=200 Identities=31% Similarity=0.496 Sum_probs=166.6
Q ss_pred eeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHH-HHHhCCCCceeeeeeeccCCCcEEEEEeec
Q 008759 335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIA-LLSRFEHENIVQYYGTDKDESKLYIFLELV 412 (554)
Q Consensus 335 ~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~-iL~~l~HpnIVkl~~~~~~~~~~~LVmE~~ 412 (554)
++||+|+||.||+|++ .++..||+|++...... .......+..|.. +++.++||||+++++.+.+.+.+|+||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTIL--KKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYV 78 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHH--HhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCC
Confidence 4699999999999998 67899999998742211 1222344555554 678899999999999999999999999999
Q ss_pred ccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccccc--CCccCccC
Q 008759 413 TKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL--NDVKSCRG 489 (554)
Q Consensus 413 ~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~--~~~~s~~G 489 (554)
.+++|..++.+ ..+.+..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.... .......|
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (321)
T cd05603 79 NGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCG 158 (321)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccC
Confidence 99999887765 4588999999999999999999999999999999999999999999999999875322 22334568
Q ss_pred CCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHH
Q 008759 490 TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAI 538 (554)
Q Consensus 490 T~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i 538 (554)
|+.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+..
T Consensus 159 t~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 205 (321)
T cd05603 159 TPEYLAPEVLRKE--PYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMY 205 (321)
T ss_pred CcccCCHHHhcCC--CCCCcCcccccchhhhhhhcCCCCCCCCCHHHHH
Confidence 9999999998654 4788999999999999999999999887654433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=304.21 Aligned_cols=203 Identities=28% Similarity=0.475 Sum_probs=170.2
Q ss_pred eeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhC-CCCceeeeeeeccCCCcEEEEEeec
Q 008759 335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESKLYIFLELV 412 (554)
Q Consensus 335 ~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIVkl~~~~~~~~~~~LVmE~~ 412 (554)
+.||+|+||+||+|.+ .+++.||+|++..... ........+..|+.++..+ +||||+++++++...+.+|+||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~ 78 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVI--LQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFV 78 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHH--hhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCC
Confidence 4699999999999998 5789999999874211 1122345567788888776 6999999999999999999999999
Q ss_pred ccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccccc--CCccCccC
Q 008759 413 TKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL--NDVKSCRG 489 (554)
Q Consensus 413 ~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~--~~~~s~~G 489 (554)
.+|+|..++.+ ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... .......|
T Consensus 79 ~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~g 158 (320)
T cd05590 79 NGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCG 158 (320)
T ss_pred CCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCccccccc
Confidence 99999988865 4689999999999999999999999999999999999999999999999999875322 22334569
Q ss_pred CCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHH
Q 008759 490 TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIK 541 (554)
Q Consensus 490 T~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i 541 (554)
|+.|+|||++.+. .++.++|||||||++|+|++|+.||......+.+..+
T Consensus 159 t~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i 208 (320)
T cd05590 159 TPDYIAPEILQEM--LYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI 208 (320)
T ss_pred CccccCHHHHcCC--CCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHH
Confidence 9999999998654 4788999999999999999999999887665544333
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=304.09 Aligned_cols=203 Identities=28% Similarity=0.442 Sum_probs=170.5
Q ss_pred eeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhC-CCCceeeeeeeccCCCcEEEEEeec
Q 008759 335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESKLYIFLELV 412 (554)
Q Consensus 335 ~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIVkl~~~~~~~~~~~LVmE~~ 412 (554)
++||+|+||.||+|.+ .+++.||+|++..... ........+..|..++..+ +||||+++++++...+.+|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~ 78 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVI--LQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYV 78 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHh--hhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCC
Confidence 4699999999999998 5688999999874211 1123345567788888765 7999999999999999999999999
Q ss_pred ccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccccc--CCccCccC
Q 008759 413 TKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL--NDVKSCRG 489 (554)
Q Consensus 413 ~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~--~~~~s~~G 489 (554)
.+++|..++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .......|
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 158 (321)
T cd05591 79 NGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCG 158 (321)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCcccccccc
Confidence 99999988765 4688999999999999999999999999999999999999999999999999875322 22334569
Q ss_pred CCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHH
Q 008759 490 TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIK 541 (554)
Q Consensus 490 T~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i 541 (554)
|+.|+|||++.+. .++.++|||||||++|+|++|+.||......+.+..+
T Consensus 159 t~~y~aPE~~~~~--~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i 208 (321)
T cd05591 159 TPDYIAPEILQEL--EYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESI 208 (321)
T ss_pred CccccCHHHHcCC--CCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 9999999998654 4888999999999999999999999887765554443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=305.61 Aligned_cols=202 Identities=31% Similarity=0.458 Sum_probs=168.2
Q ss_pred eeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHH-HHHhCCCCceeeeeeeccCCCcEEEEEeec
Q 008759 335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIA-LLSRFEHENIVQYYGTDKDESKLYIFLELV 412 (554)
Q Consensus 335 ~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~-iL~~l~HpnIVkl~~~~~~~~~~~LVmE~~ 412 (554)
+.||+|+||+||+|.+ .+|+.||+|++...... .......+..|.. +++.++||||+++++.+...+.+|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~ 78 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVL--NRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFV 78 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh--hhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCC
Confidence 4699999999999998 67999999998742211 1222344555554 567799999999999999999999999999
Q ss_pred ccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccc--cCCccCccC
Q 008759 413 TKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK--LNDVKSCRG 489 (554)
Q Consensus 413 ~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~--~~~~~s~~G 489 (554)
.+++|..++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++... ........|
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~g 158 (325)
T cd05604 79 NGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCG 158 (325)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccC
Confidence 99999888765 468999999999999999999999999999999999999999999999999987532 222344569
Q ss_pred CCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHH
Q 008759 490 TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFI 540 (554)
Q Consensus 490 T~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~ 540 (554)
|+.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+....
T Consensus 159 t~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~ 207 (325)
T cd05604 159 TPEYLAPEVIRKQ--PYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDN 207 (325)
T ss_pred ChhhCCHHHHcCC--CCCCcCccccccceehhhhcCCCCCCCCCHHHHHHH
Confidence 9999999999654 478899999999999999999999988765554333
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=302.38 Aligned_cols=207 Identities=26% Similarity=0.431 Sum_probs=174.0
Q ss_pred ceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCC-CCceeeeeeeccCCCcEEE
Q 008759 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDESKLYI 407 (554)
Q Consensus 330 ~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIVkl~~~~~~~~~~~L 407 (554)
.|+..+.||+|+||.||+|.+ .+++.||+|++..... ........+..|+.++..+. |++|+++++++.+.+.+|+
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l 78 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVV--IQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYF 78 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEE
Confidence 367889999999999999998 6789999999874221 11233456777888888876 5778899999999999999
Q ss_pred EEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC--Cc
Q 008759 408 FLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--DV 484 (554)
Q Consensus 408 VmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~--~~ 484 (554)
||||+.+|+|..++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... ..
T Consensus 79 v~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~ 158 (323)
T cd05615 79 VMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTT 158 (323)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCccc
Confidence 9999999999998876 46899999999999999999999999999999999999999999999999998754322 23
Q ss_pred cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHH
Q 008759 485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFI 540 (554)
Q Consensus 485 ~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~ 540 (554)
....||+.|+|||++.+. .++.++|||||||++|+|++|+.||......+....
T Consensus 159 ~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~ 212 (323)
T cd05615 159 RTFCGTPDYIAPEIIAYQ--PYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQS 212 (323)
T ss_pred cCccCCccccCHHHHcCC--CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 345699999999999654 478899999999999999999999988766544333
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=318.49 Aligned_cols=213 Identities=28% Similarity=0.487 Sum_probs=181.9
Q ss_pred ccccceeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcE
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL 405 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~ 405 (554)
...+++.++..||+|.||+||+|.+.. .||||++.+.... .+.++.|++|+.+|++.+|.||+-+.|++.....
T Consensus 389 Ip~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt---~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~- 462 (678)
T KOG0193|consen 389 IPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPT---PEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL- 462 (678)
T ss_pred cCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCC---HHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-
Confidence 344567789999999999999999853 5999999875543 3367899999999999999999999999988777
Q ss_pred EEEEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccc----
Q 008759 406 YIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT---- 479 (554)
Q Consensus 406 ~LVmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~---- 479 (554)
.||+.+|+|.+|+.+++- ..|...+.+.|++||++|+.|||.++|||||||..|||+.+++.|||+||||+...
T Consensus 463 AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~ 542 (678)
T KOG0193|consen 463 AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWS 542 (678)
T ss_pred eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeec
Confidence 999999999999998864 46888899999999999999999999999999999999999999999999999643
Q ss_pred ccCCccCccCCCcccChhhhccc-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHHH
Q 008759 480 KLNDVKSCRGTAFWMAPEVINNK-NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTVA 544 (554)
Q Consensus 480 ~~~~~~s~~GT~~Y~APEvl~~~-~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~~ 544 (554)
.........|...|||||+++.. ...|++.+|||||||++|||+||.+||......+.||..+.+
T Consensus 543 g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG 608 (678)
T KOG0193|consen 543 GEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRG 608 (678)
T ss_pred cccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEeccc
Confidence 23345556688889999999643 334899999999999999999999999955556666665554
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=285.98 Aligned_cols=211 Identities=47% Similarity=0.795 Sum_probs=180.9
Q ss_pred cceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEE
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~L 407 (554)
+.|+++++||+|+||.||+|.+ .+++.|++|.+...............+.+|+.+++.++||||+++++++.....+|+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4689999999999999999998 678999999987543333334446678899999999999999999999999999999
Q ss_pred EEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC---
Q 008759 408 FLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--- 483 (554)
Q Consensus 408 VmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~--- 483 (554)
||||+.+++|.+++.. ..+++..+..++.|++.||.|||+.||+|+||+|+|||++.++.++|+|||+++......
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~ 161 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG 161 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence 9999999999998865 457888999999999999999999999999999999999999999999999987543221
Q ss_pred --ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHH
Q 008759 484 --VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIK 541 (554)
Q Consensus 484 --~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i 541 (554)
.....++..|+|||++.+.. ++.++|||||||++|+|++|+.||...+.....+.+
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~ 219 (263)
T cd06625 162 TGMKSVTGTPYWMSPEVISGEG--YGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKI 219 (263)
T ss_pred ccccCCCcCccccCcceeccCC--CCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHH
Confidence 12345788999999997644 788999999999999999999999887776655543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=305.09 Aligned_cols=193 Identities=28% Similarity=0.525 Sum_probs=166.7
Q ss_pred eeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhC-CCCceeeeeeeccCCCcEEEEEeec
Q 008759 335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESKLYIFLELV 412 (554)
Q Consensus 335 ~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIVkl~~~~~~~~~~~LVmE~~ 412 (554)
+.||+|+||.||+|.+ .+++.||+|++..... ........+..|+.++..+ +||||+++++++.+.+.+|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~--~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~ 78 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELV--NDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFV 78 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCC
Confidence 4699999999999998 6789999999874221 1233456678899999888 6999999999999999999999999
Q ss_pred ccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccc--cCCccCccC
Q 008759 413 TKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK--LNDVKSCRG 489 (554)
Q Consensus 413 ~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~--~~~~~s~~G 489 (554)
.+|+|..++.+ ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++... ........|
T Consensus 79 ~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 158 (329)
T cd05588 79 SGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCG 158 (329)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccC
Confidence 99999988765 569999999999999999999999999999999999999999999999999987532 222334579
Q ss_pred CCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008759 490 TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP 531 (554)
Q Consensus 490 T~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~ 531 (554)
|+.|+|||++.+. .++.++|+|||||++|+|++|+.||..
T Consensus 159 t~~y~aPE~~~~~--~~~~~~DiwslG~~l~el~~g~~Pf~~ 198 (329)
T cd05588 159 TPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred CccccCHHHHcCC--CCCCccceechHHHHHHHHHCCCCccc
Confidence 9999999999654 478899999999999999999999963
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=317.02 Aligned_cols=206 Identities=27% Similarity=0.417 Sum_probs=175.2
Q ss_pred cceeeeeeeccCCceeEEEEec-CC-CcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEE
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS-DD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~-~~-g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~ 406 (554)
..|.+.+.||+|+||.||+|.. .+ +..+|+|.+... .......+.+|+.+|..++|||||++++.+...+.+|
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~-----~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~ 141 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN-----DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLL 141 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC-----CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEE
Confidence 3599999999999999999987 44 678888876432 1233356778999999999999999999999999999
Q ss_pred EEEeecccCchHHHHhh-----hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccccc
Q 008759 407 IFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL 481 (554)
Q Consensus 407 LVmE~~~ggsL~~ll~~-----~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~ 481 (554)
|||||+.+|+|.+++.+ ..+.+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 142 lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 221 (478)
T PTZ00267 142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD 221 (478)
T ss_pred EEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence 99999999999987753 2488889999999999999999999999999999999999999999999999986543
Q ss_pred CC----ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHH
Q 008759 482 ND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIK 541 (554)
Q Consensus 482 ~~----~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i 541 (554)
.. ....+||+.|+|||++.+. .++.++|||||||++|+|++|+.||......+.+..+
T Consensus 222 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~ 283 (478)
T PTZ00267 222 SVSLDVASSFCGTPYYLAPELWERK--RYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQV 283 (478)
T ss_pred ccccccccccCCCccccCHhHhCCC--CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 22 2345699999999998654 4889999999999999999999999877665544443
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=302.53 Aligned_cols=206 Identities=28% Similarity=0.471 Sum_probs=171.8
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCC-
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES- 403 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~- 403 (554)
.+.++|++.+.||+|+||.||++.+ .+|..||+|++..... .......+.+|+.+++.++||||+++++++....
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 94 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ---NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKS 94 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc---chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCC
Confidence 4568899999999999999999998 6789999999864321 1233456778999999999999999999876443
Q ss_pred -----cEEEEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccc
Q 008759 404 -----KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA 478 (554)
Q Consensus 404 -----~~~LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~ 478 (554)
.+|+||||+.++ |...+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 95 ~~~~~~~~lv~e~~~~~-l~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~ 172 (359)
T cd07876 95 LEEFQDVYLVMELMDAN-LCQVIH-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 172 (359)
T ss_pred ccccceeEEEEeCCCcC-HHHHHh-ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccc
Confidence 579999999874 555543 3578889999999999999999999999999999999999999999999999876
Q ss_pred cccC-CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHH
Q 008759 479 TKLN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAI 538 (554)
Q Consensus 479 ~~~~-~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i 538 (554)
.... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+.+
T Consensus 173 ~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~ 231 (359)
T cd07876 173 ACTNFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQW 231 (359)
T ss_pred cccCccCCCCcccCCCCCchhccCC--CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 4332 23345689999999999654 4888999999999999999999999987665443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=314.50 Aligned_cols=205 Identities=28% Similarity=0.438 Sum_probs=169.0
Q ss_pred ccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccC-----
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD----- 401 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~----- 401 (554)
...|+++++||+|+||.||+|.+ .+++.||+|++.... ....+|+.+++.++|+||+++++++..
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~ 135 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---------QYKNRELLIMKNLNHINIIFLKDYYYTECFKK 135 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---------chHHHHHHHHHhcCCCCCcceeeeEeeccccc
Confidence 45799999999999999999998 678999999885311 123479999999999999999886532
Q ss_pred ---CCcEEEEEeecccCchHHHHhh-----hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCC-cEEEEe
Q 008759 402 ---ESKLYIFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG-SVKLAD 472 (554)
Q Consensus 402 ---~~~~~LVmE~~~ggsL~~ll~~-----~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g-~vKL~D 472 (554)
...+++||||+.+ +|..++.. ..+++..++.|+.||+.||.|||++||+||||||+|||++.++ .+||+|
T Consensus 136 ~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~D 214 (440)
T PTZ00036 136 NEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCD 214 (440)
T ss_pred CCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeec
Confidence 2247799999986 56665532 3588999999999999999999999999999999999998665 799999
Q ss_pred cCcccccccC-CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHH
Q 008759 473 FGLAKATKLN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTV 543 (554)
Q Consensus 473 FGlA~~~~~~-~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~ 543 (554)
||+++..... ......||+.|+|||++.+.. .|+.++|||||||++|+|++|.+||.+....+.+.++..
T Consensus 215 FGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~ 285 (440)
T PTZ00036 215 FGSAKNLLAGQRSVSYICSRFYRAPELMLGAT-NYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQ 285 (440)
T ss_pred cccchhccCCCCcccCCCCcCccCHHHhcCCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 9999865432 334557899999999986532 488999999999999999999999998877777666543
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=301.73 Aligned_cols=193 Identities=27% Similarity=0.517 Sum_probs=166.7
Q ss_pred eeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhC-CCCceeeeeeeccCCCcEEEEEeec
Q 008759 335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESKLYIFLELV 412 (554)
Q Consensus 335 ~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIVkl~~~~~~~~~~~LVmE~~ 412 (554)
++||+|+||.||+|.+ .+++.||+|++..... ........+.+|+.++.++ +|+||+++++++...+.+|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELV--HDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYV 78 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCC
Confidence 4699999999999998 6789999999874221 2233456688899998888 6999999999999999999999999
Q ss_pred ccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccc--cCCccCccC
Q 008759 413 TKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK--LNDVKSCRG 489 (554)
Q Consensus 413 ~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~--~~~~~s~~G 489 (554)
.+++|..++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++... ........|
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (327)
T cd05617 79 NGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCG 158 (327)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccC
Confidence 99999988765 469999999999999999999999999999999999999999999999999987532 222334569
Q ss_pred CCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008759 490 TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP 531 (554)
Q Consensus 490 T~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~ 531 (554)
|+.|+|||++.+. .++.++|||||||++|+|++|+.||..
T Consensus 159 t~~y~aPE~~~~~--~~~~~~DiwslGvil~ell~g~~pf~~ 198 (327)
T cd05617 159 TPNYIAPEILRGE--EYGFSVDWWALGVLMFEMMAGRSPFDI 198 (327)
T ss_pred CcccCCHHHHCCC--CCCchheeehhHHHHHHHHhCCCCCCc
Confidence 9999999999654 478899999999999999999999963
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=292.56 Aligned_cols=201 Identities=26% Similarity=0.456 Sum_probs=172.3
Q ss_pred ceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEE
Q 008759 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (554)
Q Consensus 330 ~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LV 408 (554)
.|++.++||+|+||.||++.+ .+++.||+|++...... .......+.+|+.+++.++|+||+++++.+...+.+|+|
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK--KRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 78 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhh--hhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEE
Confidence 378899999999999999998 67899999998642211 122234567899999999999999999999999999999
Q ss_pred EeecccCchHHHHhh---hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC-c
Q 008759 409 LELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-V 484 (554)
Q Consensus 409 mE~~~ggsL~~ll~~---~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~-~ 484 (554)
|||+.+++|..++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++....... .
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 158 (285)
T cd05605 79 LTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETI 158 (285)
T ss_pred EeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCcc
Confidence 999999999987754 358899999999999999999999999999999999999999999999999987654322 2
Q ss_pred cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh
Q 008759 485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC 534 (554)
Q Consensus 485 ~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~ 534 (554)
....|++.|+|||++.+. .++.++|||||||++|+|++|+.||.....
T Consensus 159 ~~~~~~~~y~aPE~~~~~--~~~~~~Diws~G~~l~el~~g~~pf~~~~~ 206 (285)
T cd05605 159 RGRVGTVGYMAPEVVKNE--RYTFSPDWWGLGCLIYEMIEGKSPFRQRKE 206 (285)
T ss_pred ccccCCCCccCcHHhcCC--CCCccccchhHHHHHHHHHHCCCCCCCCch
Confidence 345689999999999654 478899999999999999999999987543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=303.69 Aligned_cols=202 Identities=32% Similarity=0.524 Sum_probs=172.0
Q ss_pred eeeccCCceeEEEEec----CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEEEe
Q 008759 335 DLLGRGSFGSVYEGIS----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLE 410 (554)
Q Consensus 335 ~~LG~GsfG~VY~a~~----~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LVmE 410 (554)
+.||+|+||.||++.+ .+|+.||+|++..... .......+.+|+.++.+++||||+++++.+...+.+|+|||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 78 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL---KVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILD 78 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh---hhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEc
Confidence 5799999999999875 4689999999874221 11223456789999999999999999999999999999999
Q ss_pred ecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC--CccCc
Q 008759 411 LVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--DVKSC 487 (554)
Q Consensus 411 ~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~--~~~s~ 487 (554)
|+.+++|.+++.+ ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .....
T Consensus 79 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 158 (318)
T cd05582 79 FLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF 158 (318)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecc
Confidence 9999999998865 45899999999999999999999999999999999999999999999999998764332 23345
Q ss_pred cCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHH
Q 008759 488 RGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIK 541 (554)
Q Consensus 488 ~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i 541 (554)
.||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+.+..+
T Consensus 159 ~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i 210 (318)
T cd05582 159 CGTVEYMAPEVVNRR--GHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI 210 (318)
T ss_pred cCChhhcCHHHHcCC--CCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHH
Confidence 699999999999654 4788999999999999999999999887765554443
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=300.57 Aligned_cols=198 Identities=28% Similarity=0.489 Sum_probs=166.9
Q ss_pred eeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHh-CCCCceeeeeeeccCCCcEEEEEeec
Q 008759 335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR-FEHENIVQYYGTDKDESKLYIFLELV 412 (554)
Q Consensus 335 ~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~-l~HpnIVkl~~~~~~~~~~~LVmE~~ 412 (554)
+.||+|+||.||+|.+ .++..||+|++...... .......+..|..++.. ++|+||+++++++.+.+++|+||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~ 78 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVL--IDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh--hcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCC
Confidence 4699999999999998 67899999998742111 11223455677777765 48999999999999999999999999
Q ss_pred ccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccc--cCCccCccC
Q 008759 413 TKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK--LNDVKSCRG 489 (554)
Q Consensus 413 ~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~--~~~~~s~~G 489 (554)
.+++|..++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++... ........|
T Consensus 79 ~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (316)
T cd05620 79 NGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCG 158 (316)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCC
Confidence 99999988865 468899999999999999999999999999999999999999999999999987432 223345669
Q ss_pred CCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhH
Q 008759 490 TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVS 536 (554)
Q Consensus 490 T~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~ 536 (554)
|+.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+
T Consensus 159 t~~y~aPE~~~~~--~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~ 203 (316)
T cd05620 159 TPDYIAPEILQGL--KYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE 203 (316)
T ss_pred CcCccCHHHHcCC--CCCcccchhhhHHHHHHHHhCCCCCCCCCHHH
Confidence 9999999999654 48889999999999999999999998766543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=304.03 Aligned_cols=192 Identities=29% Similarity=0.538 Sum_probs=165.4
Q ss_pred eeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhC-CCCceeeeeeeccCCCcEEEEEeec
Q 008759 335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESKLYIFLELV 412 (554)
Q Consensus 335 ~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIVkl~~~~~~~~~~~LVmE~~ 412 (554)
+.||+|+||.||+|.+ .+++.||+|++...... .......+.+|+.++..+ +||||+++++++...+.+|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~ 78 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVN--DDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYV 78 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhc--chhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCC
Confidence 4699999999999998 67899999998753211 223445677888888776 7999999999999999999999999
Q ss_pred ccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccccc--CCccCccC
Q 008759 413 TKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL--NDVKSCRG 489 (554)
Q Consensus 413 ~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~--~~~~s~~G 489 (554)
.+++|..++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... .......|
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~g 158 (329)
T cd05618 79 NGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCG 158 (329)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccC
Confidence 99999888765 4689999999999999999999999999999999999999999999999999875322 22334569
Q ss_pred CCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 008759 490 TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYA 530 (554)
Q Consensus 490 T~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~ 530 (554)
|+.|+|||++.+. .++.++|||||||++|+|++|+.||.
T Consensus 159 t~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~Pf~ 197 (329)
T cd05618 159 TPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFD 197 (329)
T ss_pred CccccCHHHHcCC--CCCCccceecccHHHHHHhhCCCCCc
Confidence 9999999999654 47889999999999999999999995
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=291.97 Aligned_cols=192 Identities=27% Similarity=0.466 Sum_probs=165.2
Q ss_pred eccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEEEeecccC
Q 008759 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKG 415 (554)
Q Consensus 337 LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LVmE~~~gg 415 (554)
||+|+||+||++.+ .+++.||+|++..... ........+..|+.+++.++|+||+++++++.....+|+||||+.+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g 78 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRL--KKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGG 78 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHH--hhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCC
Confidence 79999999999998 6789999999864221 11223456778999999999999999999999999999999999999
Q ss_pred chHHHHhh-----hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC--ccCcc
Q 008759 416 SLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VKSCR 488 (554)
Q Consensus 416 sL~~ll~~-----~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~--~~s~~ 488 (554)
+|..++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++....... .....
T Consensus 79 ~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 158 (280)
T cd05608 79 DLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA 158 (280)
T ss_pred CHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccC
Confidence 99887632 358899999999999999999999999999999999999999999999999987654322 23456
Q ss_pred CCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008759 489 GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM 532 (554)
Q Consensus 489 GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~ 532 (554)
||+.|+|||++.+. .++.++|+|||||++|+|++|+.||...
T Consensus 159 g~~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~g~~pf~~~ 200 (280)
T cd05608 159 GTPGFMAPELLQGE--EYDFSVDYFALGVTLYEMIAARGPFRAR 200 (280)
T ss_pred CCcCccCHHHhcCC--CCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 89999999999754 4788999999999999999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=299.73 Aligned_cols=199 Identities=30% Similarity=0.519 Sum_probs=167.3
Q ss_pred eeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHh-CCCCceeeeeeeccCCCcEEEEEeec
Q 008759 335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR-FEHENIVQYYGTDKDESKLYIFLELV 412 (554)
Q Consensus 335 ~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~-l~HpnIVkl~~~~~~~~~~~LVmE~~ 412 (554)
+.||+|+||.||+|.+ .+++.||+|++..... ........+..|..++.. ++||||+++++++.+.+.+|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~ 78 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVV--LMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYL 78 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh--hhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCC
Confidence 4699999999999998 5688999999874211 011223445667777775 48999999999999999999999999
Q ss_pred ccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccccc--CCccCccC
Q 008759 413 TKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL--NDVKSCRG 489 (554)
Q Consensus 413 ~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~--~~~~s~~G 489 (554)
.+|+|..++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... .......|
T Consensus 79 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (316)
T cd05619 79 NGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCG 158 (316)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecC
Confidence 99999998876 4688999999999999999999999999999999999999999999999999875322 22334569
Q ss_pred CCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHH
Q 008759 490 TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSA 537 (554)
Q Consensus 490 T~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~ 537 (554)
|+.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+.
T Consensus 159 t~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~ 204 (316)
T cd05619 159 TPDYIAPEILLGQ--KYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEEL 204 (316)
T ss_pred CccccCHHHHcCC--CCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHH
Confidence 9999999998654 488999999999999999999999987765443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=299.24 Aligned_cols=201 Identities=29% Similarity=0.496 Sum_probs=169.9
Q ss_pred eeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhC-CCCceeeeeeeccCCCcEEEEEeec
Q 008759 335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESKLYIFLELV 412 (554)
Q Consensus 335 ~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIVkl~~~~~~~~~~~LVmE~~ 412 (554)
+.||+|+||+||+|.+ .+++.||+|++..... ........+..|+.++..+ +||||+++++++...+.+|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 78 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVI--LQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYV 78 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHH--hhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCC
Confidence 4699999999999988 5688999999874221 1123345667888888877 6999999999999999999999999
Q ss_pred ccCchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccccc--CCccCccC
Q 008759 413 TKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL--NDVKSCRG 489 (554)
Q Consensus 413 ~ggsL~~ll~~~-~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~--~~~~s~~G 489 (554)
.+++|..++.+. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... .......|
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (318)
T cd05570 79 NGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCG 158 (318)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceec
Confidence 999999888765 699999999999999999999999999999999999999999999999999865322 22334568
Q ss_pred CCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHH
Q 008759 490 TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIF 539 (554)
Q Consensus 490 T~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~ 539 (554)
|+.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+...
T Consensus 159 ~~~y~aPE~~~~~--~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~ 206 (318)
T cd05570 159 TPDYIAPEILSYQ--PYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQ 206 (318)
T ss_pred CccccCHHHhcCC--CCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHH
Confidence 9999999999654 47889999999999999999999998776554433
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=310.61 Aligned_cols=191 Identities=26% Similarity=0.342 Sum_probs=166.0
Q ss_pred ccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEE
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~ 406 (554)
...|++++.||+|+||.||+|.+ .+++.||+|... ...+.+|+.+++.++||||++++++|......|
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-----------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 159 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTC 159 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-----------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeE
Confidence 35799999999999999999998 788999999643 134578999999999999999999999999999
Q ss_pred EEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccccc---C
Q 008759 407 IFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL---N 482 (554)
Q Consensus 407 LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~---~ 482 (554)
+|||++. ++|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... .
T Consensus 160 lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~ 238 (391)
T PHA03212 160 LILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN 238 (391)
T ss_pred EEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence 9999996 477777654 5689999999999999999999999999999999999999999999999999865322 2
Q ss_pred CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008759 483 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM 532 (554)
Q Consensus 483 ~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~ 532 (554)
......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...
T Consensus 239 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~elltg~~p~~~~ 286 (391)
T PHA03212 239 KYYGWAGTIATNAPELLARD--PYGPAVDIWSAGIVLFEMATCHDSLFEK 286 (391)
T ss_pred ccccccCccCCCChhhhcCC--CCCcHHHHHHHHHHHHHHHHCCCCcCCc
Confidence 23345799999999999654 4889999999999999999999887643
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=294.09 Aligned_cols=204 Identities=28% Similarity=0.399 Sum_probs=169.2
Q ss_pred ccceeeeeeeccCCceeEEEEecC-----------------CCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCC
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGISD-----------------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~~-----------------~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hp 390 (554)
.++|.+.+.||+|+||.||+|.+. ++..||+|.+.... .......+.+|+.++..++||
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~ 79 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA----NKNARNDFLKEVKILSRLKDP 79 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC----CHHHHHHHHHHHHHHhhcCCC
Confidence 357899999999999999999753 23479999886422 233456788999999999999
Q ss_pred ceeeeeeeccCCCcEEEEEeecccCchHHHHhhh--------------------cCChHHHHHHHHHHHHHHHHHHHCCc
Q 008759 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY--------------------HLRDSQVSAYTRQILLGLKYLHDQDV 450 (554)
Q Consensus 391 nIVkl~~~~~~~~~~~LVmE~~~ggsL~~ll~~~--------------------~l~e~~i~~i~~QIl~gL~yLHs~gI 450 (554)
||+++++++...+.+|+||||+.+++|.+++... .+++..+..++.||+.||.|||++||
T Consensus 80 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i 159 (304)
T cd05096 80 NIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNF 159 (304)
T ss_pred CeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCc
Confidence 9999999999999999999999999999988643 24567788999999999999999999
Q ss_pred cccCCccccEEEcCCCcEEEEecCcccccccCCc----cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc--
Q 008759 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDV----KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-- 524 (554)
Q Consensus 451 IHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~~----~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-- 524 (554)
+||||||+|||++.++.+||+|||+++....... ....++..|+|||++... .++.++|||||||++|+|++
T Consensus 160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~~~~ 237 (304)
T cd05096 160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG--KFTTASDVWAFGVTLWEILMLC 237 (304)
T ss_pred cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcC--CCCchhhhHHHHHHHHHHHHcc
Confidence 9999999999999999999999999876433221 223457889999998654 38899999999999999986
Q ss_pred CCCCCCCCChhHH
Q 008759 525 SQIPYAPMECVSA 537 (554)
Q Consensus 525 G~~PF~~~e~~~~ 537 (554)
+..||......+.
T Consensus 238 ~~~p~~~~~~~~~ 250 (304)
T cd05096 238 KEQPYGELTDEQV 250 (304)
T ss_pred CCCCCCcCCHHHH
Confidence 6788887665443
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=300.64 Aligned_cols=201 Identities=28% Similarity=0.485 Sum_probs=175.4
Q ss_pred ccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEE
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~ 406 (554)
.++|++.++||+|+||.||++.+ .++..+|+|.+.... .......+.+|+++++.++|+||++++++|...+.+|
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI----KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc----CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEE
Confidence 36899999999999999999998 578899999876421 1233457889999999999999999999999999999
Q ss_pred EEEeecccCchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHHC-CccccCCccccEEEcCCCcEEEEecCcccccccCCc
Q 008759 407 IFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQ-DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV 484 (554)
Q Consensus 407 LVmE~~~ggsL~~ll~~~-~l~e~~i~~i~~QIl~gL~yLHs~-gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~~ 484 (554)
+||||+.+++|.+++... .+++..+..++.|++.||.|||++ +|+|+||||+|||++.++.+||+|||++........
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~ 159 (333)
T cd06650 80 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA 159 (333)
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhcc
Confidence 999999999999998764 578888999999999999999985 799999999999999999999999999876544444
Q ss_pred cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh
Q 008759 485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC 534 (554)
Q Consensus 485 ~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~ 534 (554)
....||..|+|||++.+. .++.++|+|||||++|+|++|+.||.....
T Consensus 160 ~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~~l~~g~~p~~~~~~ 207 (333)
T cd06650 160 NSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAIGRYPIPPPDA 207 (333)
T ss_pred ccCCCCccccCHHHhcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcch
Confidence 456799999999998653 478899999999999999999999986554
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=295.13 Aligned_cols=207 Identities=28% Similarity=0.487 Sum_probs=173.5
Q ss_pred ccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEE
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~ 406 (554)
.+.|.+.+.||+|+||.||+|.+ .++..||+|++....... ....+.+|+.+++.++|+||+++++++..++.+|
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 80 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG----APCTAIREVSLLKDLKHANIVTLHDIVHTDKSLT 80 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCC----cchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEE
Confidence 35799999999999999999998 578899999987533221 1234668999999999999999999999999999
Q ss_pred EEEeecccCchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC--
Q 008759 407 IFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-- 482 (554)
Q Consensus 407 LVmE~~~ggsL~~ll~~~--~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~-- 482 (554)
+||||+.+ +|..++... .++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 81 LVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred EEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 99999986 777766543 3788899999999999999999999999999999999999999999999998754322
Q ss_pred CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHH
Q 008759 483 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFI 540 (554)
Q Consensus 483 ~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~ 540 (554)
......+|+.|+|||++.+.. .++.++|||||||++|+|+||+.||...+..+.+..
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~ 216 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSS-EYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHL 216 (309)
T ss_pred ccccccccccccCCHHHhCCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 223345889999999986432 478899999999999999999999988766554433
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=311.79 Aligned_cols=202 Identities=30% Similarity=0.467 Sum_probs=174.2
Q ss_pred ccccccceeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCC
Q 008759 324 FKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES 403 (554)
Q Consensus 324 ~~~~~~~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~ 403 (554)
+...++.|...++||+|+||.||+|...+|..||||++....... ...|.+|+.+|.+++|||+|+|+|+|.+.+
T Consensus 70 l~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~-----~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~ 144 (361)
T KOG1187|consen 70 LRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG-----EREFLNEVEILSRLRHPNLVKLLGYCLEGG 144 (361)
T ss_pred HHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc-----hhHHHHHHHHHhcCCCcCcccEEEEEecCC
Confidence 344567888889999999999999999988999999766422211 345999999999999999999999999988
Q ss_pred -cEEEEEeecccCchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHHCC---ccccCCccccEEEcCCCcEEEEecCcc
Q 008759 404 -KLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQD---VVHRDIKCANILVDANGSVKLADFGLA 476 (554)
Q Consensus 404 -~~~LVmE~~~ggsL~~ll~~~---~l~e~~i~~i~~QIl~gL~yLHs~g---IIHrDIKPeNILld~~g~vKL~DFGlA 476 (554)
+.+||+|||.+|+|.+++... .++|....+|+.++++||+|||... |||||||++|||+|.+.+.||+|||+|
T Consensus 145 ~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa 224 (361)
T KOG1187|consen 145 EHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLA 224 (361)
T ss_pred ceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCc
Confidence 599999999999999998753 6799999999999999999999854 999999999999999999999999999
Q ss_pred ccccc-CCcc-Cc-cCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008759 477 KATKL-NDVK-SC-RGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM 532 (554)
Q Consensus 477 ~~~~~-~~~~-s~-~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~ 532 (554)
+.... .... .. .||.+|++||.+... ..+.++||||||++++||+||+.|....
T Consensus 225 ~~~~~~~~~~~~~~~gt~gY~~PEy~~~g--~lt~KsDVySFGVvllElitgr~~~d~~ 281 (361)
T KOG1187|consen 225 KLGPEGDTSVSTTVMGTFGYLAPEYASTG--KLTEKSDVYSFGVVLLELITGRKAVDQS 281 (361)
T ss_pred ccCCccccceeeecCCCCccCChhhhccC--CcCcccccccchHHHHHHHhCCcccCCC
Confidence 76654 3222 22 799999999999653 3788999999999999999999888753
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=301.14 Aligned_cols=210 Identities=27% Similarity=0.445 Sum_probs=176.6
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCC--
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE-- 402 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~-- 402 (554)
.+.++|++.+.||.|+||+||+|.+ .+++.||+|++.... ........+.+|+.+++.++|+||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPF---QSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATS 88 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchh---hhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccc
Confidence 3457899999999999999999998 678899999886422 1122345677899999999999999999887533
Q ss_pred ----CcEEEEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccc
Q 008759 403 ----SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA 478 (554)
Q Consensus 403 ----~~~~LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~ 478 (554)
..+|++|+++ +++|..++....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 89 ~~~~~~~~~~~~~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~ 167 (343)
T cd07878 89 IENFNEVYLVTNLM-GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQ 167 (343)
T ss_pred ccccCcEEEEeecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCcccee
Confidence 4578999988 66898888877899999999999999999999999999999999999999999999999999876
Q ss_pred cccCCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHH
Q 008759 479 TKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIK 541 (554)
Q Consensus 479 ~~~~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i 541 (554)
.... .....||+.|+|||++.+.. .++.++|||||||++|+|++|+.||...+..+.+..+
T Consensus 168 ~~~~-~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~ 228 (343)
T cd07878 168 ADDE-MTGYVATRWYRAPEIMLNWM-HYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRI 228 (343)
T ss_pred cCCC-cCCccccccccCchHhcCCc-cCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 5432 34456899999999986532 4788999999999999999999999887766555443
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=304.07 Aligned_cols=207 Identities=29% Similarity=0.495 Sum_probs=173.2
Q ss_pred ceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCC-----
Q 008759 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES----- 403 (554)
Q Consensus 330 ~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~----- 403 (554)
+|++++.||+|+||.||++.+ .+++.||+|++..... .....+.+.+|+.+++.++|+||+++++++...+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 77 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQ---NLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFE 77 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEecccccc---chHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccc
Confidence 478899999999999999998 6899999998853211 1233467889999999999999999999988776
Q ss_pred cEEEEEeecccCchHHHHh-hhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC
Q 008759 404 KLYIFLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN 482 (554)
Q Consensus 404 ~~~LVmE~~~ggsL~~ll~-~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~ 482 (554)
.+|+||||+.+ +|..++. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 78 ~~~lv~e~~~~-~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~ 156 (372)
T cd07853 78 EIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD 156 (372)
T ss_pred eEEEEeecccc-CHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence 78999999975 6666654 456899999999999999999999999999999999999999999999999998764322
Q ss_pred C---ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHH
Q 008759 483 D---VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIK 541 (554)
Q Consensus 483 ~---~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i 541 (554)
. .....+|+.|+|||++.+.. .++.++|||||||++|+|++|+.||......+.+-.+
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i 217 (372)
T cd07853 157 ESKHMTQEVVTQYYRAPEILMGSR-HYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLI 217 (372)
T ss_pred ccccCCCCCcCCCcCCHHHHcCCC-CCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 2 23345789999999986533 4788999999999999999999999887766555443
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=339.09 Aligned_cols=215 Identities=29% Similarity=0.427 Sum_probs=187.7
Q ss_pred ccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEE
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~ 406 (554)
.++|.++++||+|+||.|.+++. .+++.||+|++.+..... .....-|..|-.+|..-+.+=|++++.+|+++.++|
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlK--r~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LY 151 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLK--RAETACFREERDIMVFGNSEWIVQLHYAFQDERYLY 151 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhh--chhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceE
Confidence 46899999999999999999998 789999999987522211 122345778889999989999999999999999999
Q ss_pred EEEeecccCchHHHHhhhc-CChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC-C-
Q 008759 407 IFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-D- 483 (554)
Q Consensus 407 LVmE~~~ggsL~~ll~~~~-l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~-~- 483 (554)
|||||+.||+|..++.++. +++..++.|+.+|+.||.-||+.|+|||||||+|||||..|+|||+|||.+-....+ .
T Consensus 152 lVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V 231 (1317)
T KOG0612|consen 152 LVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTV 231 (1317)
T ss_pred EEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCcE
Confidence 9999999999999999887 999999999999999999999999999999999999999999999999998765533 2
Q ss_pred -ccCccCCCcccChhhhcccC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHHH
Q 008759 484 -VKSCRGTAFWMAPEVINNKN---KGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTVA 544 (554)
Q Consensus 484 -~~s~~GT~~Y~APEvl~~~~---~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~~ 544 (554)
....+|||.|++||++...+ ..|+..+|||||||++||||+|..||+.-..++..-+|..+
T Consensus 232 ~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~h 296 (1317)
T KOG0612|consen 232 RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNH 296 (1317)
T ss_pred EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhch
Confidence 33457999999999985432 34899999999999999999999999998888877777765
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=302.30 Aligned_cols=199 Identities=33% Similarity=0.518 Sum_probs=165.8
Q ss_pred eccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhC---CCCceeeeeeeccCCCcEEEEEeec
Q 008759 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF---EHENIVQYYGTDKDESKLYIFLELV 412 (554)
Q Consensus 337 LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l---~HpnIVkl~~~~~~~~~~~LVmE~~ 412 (554)
||+|+||+||+|.+ .+++.||+|++..... ........+..|..++..+ .||||+++++.+...+.+|+||||+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~ 78 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEI--VAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYM 78 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHH--hhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCC
Confidence 79999999999998 6789999999864221 1122334455666666655 6999999999999999999999999
Q ss_pred ccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccccc--CCccCccC
Q 008759 413 TKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL--NDVKSCRG 489 (554)
Q Consensus 413 ~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~--~~~~s~~G 489 (554)
.+|+|..++.+ ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .......|
T Consensus 79 ~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~g 158 (330)
T cd05586 79 SGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCG 158 (330)
T ss_pred CCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccC
Confidence 99999988865 4589999999999999999999999999999999999999999999999999875322 22345569
Q ss_pred CCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHH
Q 008759 490 TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAI 538 (554)
Q Consensus 490 T~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i 538 (554)
|+.|+|||++.+. ..++.++|||||||++|+|++|+.||...+..+.+
T Consensus 159 t~~y~aPE~~~~~-~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~ 206 (330)
T cd05586 159 TTEYLAPEVLLDE-KGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMY 206 (330)
T ss_pred CccccCHHHHcCC-CCCCCccceeccccEEEEeccCCCCCCCCCHHHHH
Confidence 9999999998643 24788999999999999999999999887655443
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=281.48 Aligned_cols=199 Identities=37% Similarity=0.591 Sum_probs=172.8
Q ss_pred eeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEEE
Q 008759 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFL 409 (554)
Q Consensus 331 y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LVm 409 (554)
|+++++||+|+||+||++.+ .+++.||+|.+...... ........+|+.++..++|+||+++++++......++||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~---~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~ 77 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIE---EEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVM 77 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHH---HHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccccc---ccccchhhhhhhccccccccccccccccccccccccccc
Confidence 78999999999999999999 66779999999854322 222233456999999999999999999999999999999
Q ss_pred eecccCchHHHHh-hhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccc--ccCCccC
Q 008759 410 ELVTKGSLLNLYQ-RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT--KLNDVKS 486 (554)
Q Consensus 410 E~~~ggsL~~ll~-~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~--~~~~~~s 486 (554)
|++.+++|.+++. ...++...+..++.||+.||.+||++||+|+||||+|||++.++.++|+|||++... .......
T Consensus 78 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 157 (260)
T PF00069_consen 78 EYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNP 157 (260)
T ss_dssp EEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999997 567999999999999999999999999999999999999999999999999998753 2233445
Q ss_pred ccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008759 487 CRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME 533 (554)
Q Consensus 487 ~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e 533 (554)
..++..|+|||++.. ...++.++|+||||+++|+|++|..||....
T Consensus 158 ~~~~~~y~aPE~~~~-~~~~~~~~Di~slG~il~~l~~~~~p~~~~~ 203 (260)
T PF00069_consen 158 FVGTPEYMAPEVLQQ-GKKYTRKSDIWSLGIILYELLTGKLPFEESN 203 (260)
T ss_dssp SSSSGGGSCHHHHTT-TSSBSTHHHHHHHHHHHHHHHHSSSSSTTSS
T ss_pred ccccccccccccccc-ccccccccccccccccccccccccccccccc
Confidence 668999999999861 2247889999999999999999999999884
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=299.37 Aligned_cols=210 Identities=27% Similarity=0.426 Sum_probs=174.9
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCC--
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE-- 402 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~-- 402 (554)
.+.++|++.+.||+|+||.||++.+ .+++.||+|++..... .......+.+|+.+++.++|+||+++++.+...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~ 97 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ---NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKS 97 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc---CchhHHHHHHHHHHHHhcCCCCccccceeeccccc
Confidence 3567899999999999999999998 6789999998864221 123345677899999999999999999877543
Q ss_pred ----CcEEEEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccc
Q 008759 403 ----SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA 478 (554)
Q Consensus 403 ----~~~~LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~ 478 (554)
..+|+||||+.+ .|..++. ..++...+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 98 ~~~~~~~~lv~e~~~~-~l~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 175 (364)
T cd07875 98 LEEFQDVYIVMELMDA-NLCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 175 (364)
T ss_pred ccccCeEEEEEeCCCC-CHHHHHH-hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccc
Confidence 357999999986 5666554 3578889999999999999999999999999999999999999999999999976
Q ss_pred cccCC-ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHH
Q 008759 479 TKLND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKT 542 (554)
Q Consensus 479 ~~~~~-~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~ 542 (554)
..... .....+|+.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+.+..+.
T Consensus 176 ~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~ 238 (364)
T cd07875 176 AGTSFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVI 238 (364)
T ss_pred cCCCCcccCCcccCCcCCHHHHhCC--CCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 54332 2345689999999999654 48889999999999999999999999887766555443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=307.26 Aligned_cols=205 Identities=21% Similarity=0.382 Sum_probs=164.1
Q ss_pred cccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCC------CCceeeeeeec
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE------HENIVQYYGTD 399 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~------HpnIVkl~~~~ 399 (554)
..++|++.++||+|+||+||+|.+ .+++.||+|++..... ....+..|+.++..++ |.+|++++++|
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~------~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK------YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh------hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 346899999999999999999998 6788999999863211 1223445666666554 45688898887
Q ss_pred cCC-CcEEEEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHH-CCccccCCccccEEEcCCC----------
Q 008759 400 KDE-SKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANG---------- 466 (554)
Q Consensus 400 ~~~-~~~~LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs-~gIIHrDIKPeNILld~~g---------- 466 (554)
... .++|+|||++ +++|.+++.+ ..+++..+..|+.||+.||.|||+ .|||||||||+|||++.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~ 279 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRA 279 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccc
Confidence 654 5789999988 5567776654 568999999999999999999998 5999999999999998765
Q ss_pred ------cEEEEecCcccccccCCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHH
Q 008759 467 ------SVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFI 540 (554)
Q Consensus 467 ------~vKL~DFGlA~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~ 540 (554)
.+||+|||++.... .......||+.|+|||++.+. .|+.++|||||||++|||++|++||...+..+.+..
T Consensus 280 ~~~~~~~vkl~DfG~~~~~~-~~~~~~~gt~~Y~APE~~~~~--~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~ 356 (467)
T PTZ00284 280 LPPDPCRVRICDLGGCCDER-HSRTAIVSTRHYRSPEVVLGL--GWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHL 356 (467)
T ss_pred cCCCCceEEECCCCccccCc-cccccccCCccccCcHHhhcC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 49999999875433 223456799999999999654 488999999999999999999999988776655544
Q ss_pred H
Q 008759 541 K 541 (554)
Q Consensus 541 i 541 (554)
+
T Consensus 357 i 357 (467)
T PTZ00284 357 M 357 (467)
T ss_pred H
Confidence 3
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=299.07 Aligned_cols=209 Identities=27% Similarity=0.434 Sum_probs=174.2
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCC--
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE-- 402 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~-- 402 (554)
...++|++.+.||+|+||.||++.+ .+++.||+|++..... .......+.+|+.+++.++|+||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 90 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ---NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKS 90 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc---ChHHHHHHHHHHHHHHHhCCCchhceeeeeecccc
Confidence 3567899999999999999999998 6789999998864221 223345677899999999999999999987543
Q ss_pred ----CcEEEEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccc
Q 008759 403 ----SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA 478 (554)
Q Consensus 403 ----~~~~LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~ 478 (554)
..+|+||||+.+ .|..++. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 91 ~~~~~~~~lv~e~~~~-~l~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~ 168 (355)
T cd07874 91 LEEFQDVYLVMELMDA-NLCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_pred ccccceeEEEhhhhcc-cHHHHHh-hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCccccc
Confidence 357999999987 4555554 3588889999999999999999999999999999999999999999999999976
Q ss_pred cccCC-ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHH
Q 008759 479 TKLND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIK 541 (554)
Q Consensus 479 ~~~~~-~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i 541 (554)
..... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+.+...
T Consensus 169 ~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~ 230 (355)
T cd07874 169 AGTSFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV 230 (355)
T ss_pred CCCccccCCccccCCccCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 54332 3345689999999999654 4888999999999999999999999988766655444
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=282.43 Aligned_cols=210 Identities=48% Similarity=0.793 Sum_probs=176.7
Q ss_pred cceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCC--CcE
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE--SKL 405 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~--~~~ 405 (554)
++|+++++||+|+||.||++.+ .++..|++|++...............+.+|+.+++.+.|+||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4789999999999999999998 6789999998864333223334567888999999999999999999988663 568
Q ss_pred EEEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccccc---
Q 008759 406 YIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL--- 481 (554)
Q Consensus 406 ~LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~--- 481 (554)
|++|||+.+++|.+++.+ ..+++..+..++.|++.+|.|||+++|+|+||||+|||++.++.++|+|||++.....
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 899999999999998876 3578888999999999999999999999999999999999999999999999875432
Q ss_pred --CCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHH
Q 008759 482 --NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFI 540 (554)
Q Consensus 482 --~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~ 540 (554)
.......++..|+|||++.+. .++.++|+|||||++|+|++|+.||...+....+..
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~ 220 (265)
T cd06652 162 SGTGMKSVTGTPYWMSPEVISGE--GYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFK 220 (265)
T ss_pred cccccccCCCCccccChhhhcCC--CCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHH
Confidence 122334588999999998653 478899999999999999999999987655554443
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=286.37 Aligned_cols=206 Identities=32% Similarity=0.517 Sum_probs=166.3
Q ss_pred ceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHh---CCCCceeeeeeeccC----
Q 008759 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR---FEHENIVQYYGTDKD---- 401 (554)
Q Consensus 330 ~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~---l~HpnIVkl~~~~~~---- 401 (554)
+|++.+.||+|+||+||+|.+ .+++.||+|.+......... ...+.+|+.+++. ++||||+++++++..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~---~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~ 77 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGL---PLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTD 77 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCC---chHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCC
Confidence 488999999999999999998 67999999988753221111 1233456665554 479999999998754
Q ss_pred -CCcEEEEEeecccCchHHHHhh---hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccc
Q 008759 402 -ESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477 (554)
Q Consensus 402 -~~~~~LVmE~~~ggsL~~ll~~---~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~ 477 (554)
...++++|||+.+ +|..++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 78 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 78 RETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred CCceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccc
Confidence 3468999999986 78877765 248899999999999999999999999999999999999999999999999987
Q ss_pred ccccCC-ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHH
Q 008759 478 ATKLND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIK 541 (554)
Q Consensus 478 ~~~~~~-~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i 541 (554)
...... .....+|..|+|||++.+. .++.++|||||||++|+|++|+.||......+.+.++
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~ 219 (288)
T cd07863 157 IYSCQMALTPVVVTLWYRAPEVLLQS--TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKI 219 (288)
T ss_pred cccCcccCCCccccccccCchHhhCC--CCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHH
Confidence 654332 2345689999999998654 4889999999999999999999999877665554443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=291.47 Aligned_cols=218 Identities=26% Similarity=0.463 Sum_probs=187.9
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccc---cchhHHHHHHHHHHHHHHHhC-CCCceeeeeeecc
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQ---GSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDK 400 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~---~~~~~~~~~~~~~Ei~iL~~l-~HpnIVkl~~~~~ 400 (554)
.+...|.-.+.||.|..++|-++.+ .+|+.+|+|++..... .....+..+...+|+.||+++ .||+|+++.+++.
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 3455677788999999999999988 7899999999875432 223455566777899999998 5999999999999
Q ss_pred CCCcEEEEEeecccCchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccc
Q 008759 401 DESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT 479 (554)
Q Consensus 401 ~~~~~~LVmE~~~ggsL~~ll~~~-~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~ 479 (554)
.+..+++|+|+|..|.|.+++... .+++...+.|++|++.|++|||.++||||||||+|||++++.++||+|||+++..
T Consensus 94 s~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l 173 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQL 173 (411)
T ss_pred CcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeecc
Confidence 999999999999999999999864 6999999999999999999999999999999999999999999999999999876
Q ss_pred ccC-CccCccCCCcccChhhhccc----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHH
Q 008759 480 KLN-DVKSCRGTAFWMAPEVINNK----NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTV 543 (554)
Q Consensus 480 ~~~-~~~s~~GT~~Y~APEvl~~~----~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~ 543 (554)
..+ .....||||+|+|||.+... ..+|+..+|+|++|+|||.||.|++||....-+-++-.|..
T Consensus 174 ~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~Ime 242 (411)
T KOG0599|consen 174 EPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIME 242 (411)
T ss_pred CCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHh
Confidence 544 45678899999999998542 34589999999999999999999999998776555544443
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=284.67 Aligned_cols=205 Identities=23% Similarity=0.411 Sum_probs=171.9
Q ss_pred cceeeeeeeccCCceeEEEEec----CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCc
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~----~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~ 404 (554)
..|++.+.||+|+||.||+|++ ..+..||+|.+.... .......+.+|+.++.+++||||+++++.+...+.
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 80 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC----SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT 80 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC----CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence 5789999999999999999975 346789999886421 12334568899999999999999999999999999
Q ss_pred EEEEEeecccCchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC
Q 008759 405 LYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN 482 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~~--~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~ 482 (554)
.|+||||+.+|+|.+++... .+++..+..++.||+.||.|||++|++||||||+|||++.++.++++|||.+......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 99999999999999998763 5889999999999999999999999999999999999999999999999987553222
Q ss_pred Cc---cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHHH
Q 008759 483 DV---KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIF 539 (554)
Q Consensus 483 ~~---~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i~ 539 (554)
.. ....++..|+|||++.+. .++.++|||||||++|+|++ |..||......+.+.
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~ 219 (266)
T cd05064 161 AIYTTMSGKSPVLWAAPEAIQYH--HFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIK 219 (266)
T ss_pred chhcccCCCCceeecCHHHHhhC--CccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHH
Confidence 11 122356789999998654 47889999999999999775 999998876654433
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=311.83 Aligned_cols=210 Identities=28% Similarity=0.415 Sum_probs=176.1
Q ss_pred cccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCC--
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES-- 403 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~-- 403 (554)
..++|.+.+.||+|+||+||+|.+ .+++.||+|++..... .......+.+|+.++..++|+||++++..+....
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~---~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM---SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC---CHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence 346899999999999999999988 6799999999875332 2334566789999999999999999987764322
Q ss_pred ------cEEEEEeecccCchHHHHhh-----hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEe
Q 008759 404 ------KLYIFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLAD 472 (554)
Q Consensus 404 ------~~~LVmE~~~ggsL~~ll~~-----~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~D 472 (554)
.+++||||+.+|+|.+++.. ..+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|
T Consensus 107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~D 186 (496)
T PTZ00283 107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGD 186 (496)
T ss_pred CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEe
Confidence 37899999999999998864 2488899999999999999999999999999999999999999999999
Q ss_pred cCcccccccC----CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHH
Q 008759 473 FGLAKATKLN----DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIK 541 (554)
Q Consensus 473 FGlA~~~~~~----~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i 541 (554)
||+++..... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||......+.+.++
T Consensus 187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~--~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~ 257 (496)
T PTZ00283 187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRK--PYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKT 257 (496)
T ss_pred cccCeeccccccccccccccCCcceeCHHHhCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 9998764322 22345699999999999654 4889999999999999999999999877665544433
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=285.60 Aligned_cols=201 Identities=28% Similarity=0.477 Sum_probs=172.2
Q ss_pred eeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEEE
Q 008759 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFL 409 (554)
Q Consensus 331 y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LVm 409 (554)
|+..+.||+|+||+||++.+ .+++.||+|.+..... ........+.+|+.+++.++|+||+.+++.+..++.+|++|
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~ 79 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRI--KKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVL 79 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhh--hhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEE
Confidence 67788999999999999998 6789999999864221 11223345678999999999999999999999999999999
Q ss_pred eecccCchHHHHhh---hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC-Ccc
Q 008759 410 ELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-DVK 485 (554)
Q Consensus 410 E~~~ggsL~~ll~~---~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~-~~~ 485 (554)
||+.+++|..++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++...... ...
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 159 (285)
T cd05632 80 TIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIR 159 (285)
T ss_pred EeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCccc
Confidence 99999999887754 25899999999999999999999999999999999999999999999999998654322 233
Q ss_pred CccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChh
Q 008759 486 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECV 535 (554)
Q Consensus 486 s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~ 535 (554)
...|+..|+|||++.+. .++.++|+|||||++|+|++|..||......
T Consensus 160 ~~~g~~~~~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~ 207 (285)
T cd05632 160 GRVGTVGYMAPEVLNNQ--RYTLSPDYWGLGCLIYEMIEGQSPFRGRKEK 207 (285)
T ss_pred CCCCCcCccChHHhcCC--CCCcccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence 45689999999999654 4788999999999999999999999876543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=319.45 Aligned_cols=199 Identities=41% Similarity=0.713 Sum_probs=176.2
Q ss_pred eeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEEEeeccc
Q 008759 336 LLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTK 414 (554)
Q Consensus 336 ~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LVmE~~~g 414 (554)
+||+|+||+||-|++ .+...+|||.+.. ......+-+++||.+-+.++|.|||+++|.+..++++-|+||.++|
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpe-----kdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPG 656 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPE-----KDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPG 656 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccc-----ccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCC
Confidence 699999999999999 6788999999874 2234557789999999999999999999999999999999999999
Q ss_pred CchHHHHhh--hcC--ChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcC-CCcEEEEecCccccccc--CCccCc
Q 008759 415 GSLLNLYQR--YHL--RDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA-NGSVKLADFGLAKATKL--NDVKSC 487 (554)
Q Consensus 415 gsL~~ll~~--~~l--~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~-~g~vKL~DFGlA~~~~~--~~~~s~ 487 (554)
|+|.++++. +++ .+..+..|.+||++||.|||++.|||||||-+|+||+. .|.+||.|||.++.... ....++
T Consensus 657 GSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETF 736 (1226)
T KOG4279|consen 657 GSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETF 736 (1226)
T ss_pred CcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCcccccc
Confidence 999999986 345 77889999999999999999999999999999999974 68999999999886432 234567
Q ss_pred cCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHH
Q 008759 488 RGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIF 539 (554)
Q Consensus 488 ~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~ 539 (554)
.||..|||||++..+..+|+.++|||||||++.||.||++||..+...++.+
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAM 788 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAM 788 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhh
Confidence 8999999999999999999999999999999999999999999876554443
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=302.36 Aligned_cols=211 Identities=27% Similarity=0.478 Sum_probs=173.2
Q ss_pred ccccccceeeeeeeccCCceeEEEEec------CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhC-CCCceeeee
Q 008759 324 FKRIITYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYY 396 (554)
Q Consensus 324 ~~~~~~~y~i~~~LG~GsfG~VY~a~~------~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIVkl~ 396 (554)
+....++|++++.||+|+||.||+|.+ .++..||+|.+..... ......+.+|+.+++.+ +|+||++++
T Consensus 33 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~E~~il~~l~~h~nIv~~~ 108 (374)
T cd05106 33 WEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH----TDEREALMSELKILSHLGQHKNIVNLL 108 (374)
T ss_pred ccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC----HHHHHHHHHHHHHHHhhccCCceeeEe
Confidence 334456899999999999999999874 2345799998864221 22346788999999999 899999999
Q ss_pred eeccCCCcEEEEEeecccCchHHHHhhh----------------------------------------------------
Q 008759 397 GTDKDESKLYIFLELVTKGSLLNLYQRY---------------------------------------------------- 424 (554)
Q Consensus 397 ~~~~~~~~~~LVmE~~~ggsL~~ll~~~---------------------------------------------------- 424 (554)
+++.....+|+||||+.+|+|.+++...
T Consensus 109 ~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (374)
T cd05106 109 GACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVS 188 (374)
T ss_pred eEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcc
Confidence 9999999999999999999999987532
Q ss_pred -------------------cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCCc-
Q 008759 425 -------------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV- 484 (554)
Q Consensus 425 -------------------~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~~- 484 (554)
.+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~ 268 (374)
T cd05106 189 SSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY 268 (374)
T ss_pred ccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce
Confidence 256778899999999999999999999999999999999999999999999876433221
Q ss_pred ---cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHHHH
Q 008759 485 ---KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIFI 540 (554)
Q Consensus 485 ---~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i~~ 540 (554)
....++..|||||++... .++.++|||||||++|+|++ |+.||........++.
T Consensus 269 ~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~ 326 (374)
T cd05106 269 VVKGNARLPVKWMAPESIFDC--VYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYK 326 (374)
T ss_pred eeccCCCCccceeCHHHhcCC--CCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHH
Confidence 122356679999998644 48899999999999999997 9999987655444433
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=316.51 Aligned_cols=209 Identities=35% Similarity=0.638 Sum_probs=183.2
Q ss_pred eeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCc--EEEE
Q 008759 332 QKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK--LYIF 408 (554)
Q Consensus 332 ~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~--~~LV 408 (554)
+....||+|+|-+||+|.| .+|..||.-.++..+ ..+....+++|..|+.+|+.|+|+||+++|+.|.+... +.+|
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d-~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~i 121 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRD-VTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFI 121 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHH-hhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeee
Confidence 3457899999999999999 678888877665433 23445667899999999999999999999999987655 8899
Q ss_pred EeecccCchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHHCC--ccccCCccccEEEcCC-CcEEEEecCcccccccCCc
Q 008759 409 LELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQD--VVHRDIKCANILVDAN-GSVKLADFGLAKATKLNDV 484 (554)
Q Consensus 409 mE~~~ggsL~~ll~~~-~l~e~~i~~i~~QIl~gL~yLHs~g--IIHrDIKPeNILld~~-g~vKL~DFGlA~~~~~~~~ 484 (554)
+|++..|+|..|+++. .+....++.|++||+.||.|||++. |||||||++||||+.+ |.|||+|+|||........
T Consensus 122 TEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~a 201 (632)
T KOG0584|consen 122 TELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHA 201 (632)
T ss_pred eecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcccc
Confidence 9999999999999875 5888899999999999999999986 9999999999999754 8999999999998888888
Q ss_pred cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHHH
Q 008759 485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTVA 544 (554)
Q Consensus 485 ~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~~ 544 (554)
+++.|||.|||||++. ..|+..+||||||.+|+||.|+.+||..=..-.+|||..++
T Consensus 202 ksvIGTPEFMAPEmYE---E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~S 258 (632)
T KOG0584|consen 202 KSVIGTPEFMAPEMYE---ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTS 258 (632)
T ss_pred ceeccCccccChHHHh---hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHc
Confidence 8899999999999985 24999999999999999999999999987777788876543
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=305.32 Aligned_cols=213 Identities=28% Similarity=0.424 Sum_probs=186.9
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCc
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~ 404 (554)
.+.+-|.+.+.||+|.|..|-+|++ -+|..||||++.+.+... ....++.+|+++++.++|||||+||.+...+..
T Consensus 15 kIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~---~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTK 91 (864)
T KOG4717|consen 15 KIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDT---LSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTK 91 (864)
T ss_pred ceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccch---hhhhHHHHHHHHHHHhcCcCeeeeeehhcccce
Confidence 4567899999999999999999999 899999999997644433 234578899999999999999999999999999
Q ss_pred EEEEEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEc-CCCcEEEEecCcccccc-
Q 008759 405 LYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD-ANGSVKLADFGLAKATK- 480 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld-~~g~vKL~DFGlA~~~~- 480 (554)
+|||+|+-++|+|++|+.+ .++.+..+++|++||+.|+.|+|+..+|||||||+|+.+. .-|-|||+|||++..+.
T Consensus 92 lyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 92 LYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred EEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 9999999999999999865 5799999999999999999999999999999999998775 55899999999997654
Q ss_pred cCCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHH
Q 008759 481 LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKT 542 (554)
Q Consensus 481 ~~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~ 542 (554)
.....+.||+..|.|||++.+... -.+++||||||||||-|++|++||.....-+.+-+|.
T Consensus 172 G~kL~TsCGSLAYSAPEILLGDsY-DAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmIm 232 (864)
T KOG4717|consen 172 GKKLTTSCGSLAYSAPEILLGDSY-DAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIM 232 (864)
T ss_pred cchhhcccchhhccCchhhhcCcc-CCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhh
Confidence 445778899999999999987652 2468999999999999999999999887776665553
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=300.61 Aligned_cols=210 Identities=29% Similarity=0.459 Sum_probs=172.6
Q ss_pred ccccceeeeeeeccCCceeEEEEec------CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhC-CCCceeeeeee
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGT 398 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~------~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIVkl~~~ 398 (554)
...++|+++++||+|+||.||+|.+ .++..||+|++..... ....+.+.+|+.++..+ +||||++++++
T Consensus 32 ~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~----~~~~~~~~~Ei~il~~l~~HpnIv~l~~~ 107 (375)
T cd05104 32 FPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH----LTEREALMSELKVLSYLGNHINIVNLLGA 107 (375)
T ss_pred cchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC----cHHHHHHHHHHHHHHHhcCCcceeeeeee
Confidence 3456899999999999999999963 3567899998863221 22345688999999999 89999999999
Q ss_pred ccCCCcEEEEEeecccCchHHHHhhh------------------------------------------------------
Q 008759 399 DKDESKLYIFLELVTKGSLLNLYQRY------------------------------------------------------ 424 (554)
Q Consensus 399 ~~~~~~~~LVmE~~~ggsL~~ll~~~------------------------------------------------------ 424 (554)
+...+..|+||||+.+|+|.+++...
T Consensus 108 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 187 (375)
T cd05104 108 CTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRR 187 (375)
T ss_pred eccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccc
Confidence 99999999999999999999888542
Q ss_pred ----------------------cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC
Q 008759 425 ----------------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN 482 (554)
Q Consensus 425 ----------------------~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~ 482 (554)
.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 267 (375)
T cd05104 188 SVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRND 267 (375)
T ss_pred ccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence 2567778899999999999999999999999999999999999999999998765432
Q ss_pred Cc----cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHHHHH
Q 008759 483 DV----KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIFIK 541 (554)
Q Consensus 483 ~~----~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i~~i 541 (554)
.. ....++..|+|||++.+. .++.++|||||||++|+|++ |..||........+++.
T Consensus 268 ~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~ 329 (375)
T cd05104 268 SNYVVKGNARLPVKWMAPESIFNC--VYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKM 329 (375)
T ss_pred ccccccCCCCCCcceeChhHhcCC--CCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHH
Confidence 21 122356679999999654 48899999999999999998 99999877554444443
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=301.16 Aligned_cols=194 Identities=25% Similarity=0.324 Sum_probs=166.1
Q ss_pred cccceeeeeeeccCCceeEEEEec---CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCC
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGIS---DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES 403 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~---~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~ 403 (554)
...+|.+++.||+|+||.||+|.. ..+..|++|.+... ....+|+.+|+.++|+||+++++.+....
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----------~~~~~E~~il~~l~h~~iv~~~~~~~~~~ 159 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----------KTPGREIDILKTISHRAIINLIHAYRWKS 159 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----------ccHHHHHHHHHhcCCCCccceeeeEeeCC
Confidence 345899999999999999999975 34678899977531 12457999999999999999999999999
Q ss_pred cEEEEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC
Q 008759 404 KLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN 482 (554)
Q Consensus 404 ~~~LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~ 482 (554)
.+|++||++.+ +|..++.. ..+++..+..|+.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 160 ~~~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 160 TVCMVMPKYKC-DLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred EEEEEehhcCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 99999999975 67777754 46899999999999999999999999999999999999999999999999998764432
Q ss_pred C----ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008759 483 D----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME 533 (554)
Q Consensus 483 ~----~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e 533 (554)
. .....||+.|+|||++.+. .|+.++|||||||++|+|++|+.||.+..
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvil~el~~g~~pf~~~~ 291 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALD--PYCAKTDIWSAGLVLFEMSVKNVTLFGKQ 291 (392)
T ss_pred cccccccccccccCccCHhHhcCC--CCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 2 2245699999999999654 48889999999999999999999997653
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=284.63 Aligned_cols=192 Identities=29% Similarity=0.475 Sum_probs=163.6
Q ss_pred eccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEEEeecccC
Q 008759 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKG 415 (554)
Q Consensus 337 LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LVmE~~~gg 415 (554)
||+|+||.||++.+ .+|+.||+|++....... ......+..|+.++++++||||+++++.+.....+|+||||+.++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~--~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~ 78 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKK--KSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGG 78 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhc--chhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCC
Confidence 79999999999998 679999999986422111 112234557999999999999999999999999999999999999
Q ss_pred chHHHHhh---hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC-ccCccCCC
Q 008759 416 SLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VKSCRGTA 491 (554)
Q Consensus 416 sL~~ll~~---~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~-~~s~~GT~ 491 (554)
+|..++.. ..+.+..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++....... .....||.
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~ 158 (277)
T cd05607 79 DLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTN 158 (277)
T ss_pred CHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCC
Confidence 99887754 247888889999999999999999999999999999999999999999999987654332 23456899
Q ss_pred cccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008759 492 FWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM 532 (554)
Q Consensus 492 ~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~ 532 (554)
.|+|||++.+.. ++.++|+|||||++|+|++|+.||...
T Consensus 159 ~y~aPE~~~~~~--~~~~~DvwslGv~l~el~~g~~p~~~~ 197 (277)
T cd05607 159 GYMAPEILKEEP--YSYPVDWFAMGCSIYEMVAGRTPFKDH 197 (277)
T ss_pred CccCHHHHccCC--CCCchhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999986544 889999999999999999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=286.07 Aligned_cols=194 Identities=30% Similarity=0.514 Sum_probs=170.3
Q ss_pred ceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEE
Q 008759 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (554)
Q Consensus 330 ~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LV 408 (554)
+|++.++||+|+||.||+|.+ .+++.||+|.+.... .......+.+|+.++.+++||||+++++.+...+..++|
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 77 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI----TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISIC 77 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC----ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEE
Confidence 578889999999999999998 788999999886421 122345688999999999999999999999999999999
Q ss_pred EeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCCccCcc
Q 008759 409 LELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR 488 (554)
Q Consensus 409 mE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~~~s~~ 488 (554)
|||+.+++|..+ ..+++..+..++.|++.||.|||+.||+|+||||+|||++.++.++|+|||++............
T Consensus 78 ~e~~~~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~ 154 (279)
T cd06619 78 TEFMDGGSLDVY---RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV 154 (279)
T ss_pred EecCCCCChHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccccccCCC
Confidence 999999998654 35788889999999999999999999999999999999999999999999999776555455567
Q ss_pred CCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008759 489 GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM 532 (554)
Q Consensus 489 GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~ 532 (554)
+|..|+|||++.+. .++.++|+|||||++|+|++|+.||...
T Consensus 155 ~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~~l~~g~~pf~~~ 196 (279)
T cd06619 155 GTNAYMAPERISGE--QYGIHSDVWSLGISFMELALGRFPYPQI 196 (279)
T ss_pred CChhhcCceeecCC--CCCCcchHHHHHHHHHHHHhCCCCchhh
Confidence 99999999998654 4788999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=280.02 Aligned_cols=211 Identities=45% Similarity=0.796 Sum_probs=180.0
Q ss_pred ceeeeeeeccCCceeEEEEecCCCcEEEEEEEeccccc-chhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEE
Q 008759 330 YWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQG-SQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (554)
Q Consensus 330 ~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~-~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LV 408 (554)
+|++++.||+|+||.||+|...+++.+|+|.+...... .........+.+|+.+++.++|+||+++++++.+.+.+|++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 48889999999999999999888999999988753221 12234456788999999999999999999999999999999
Q ss_pred EeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccccc------
Q 008759 409 LELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL------ 481 (554)
Q Consensus 409 mE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~------ 481 (554)
|||+.+++|.+++.+ ..+++..+..++.|++.||.|||+.+|+|+||+|+|||++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (265)
T cd06631 81 MEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGT 160 (265)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccccc
Confidence 999999999999876 4688999999999999999999999999999999999999999999999999875321
Q ss_pred --CCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHH
Q 008759 482 --NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKT 542 (554)
Q Consensus 482 --~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~ 542 (554)
.......++..|+|||++.+. .++.++|+|||||++|+|++|..||...+.....+.+.
T Consensus 161 ~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~ 221 (265)
T cd06631 161 HSNMLKSMHGTPYWMAPEVINES--GYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIG 221 (265)
T ss_pred ccccccccCCCccccChhhhcCC--CCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhh
Confidence 112234588999999998654 37889999999999999999999999877666555443
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=286.15 Aligned_cols=199 Identities=28% Similarity=0.481 Sum_probs=171.0
Q ss_pred eeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEEE
Q 008759 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFL 409 (554)
Q Consensus 331 y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LVm 409 (554)
|++.+.||+|+||.||++.+ .+++.||+|.+...... .......+.+|+.+++.++|+||+++++.+.+.+.+|+||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~ 79 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK--KRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhcc--chHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEE
Confidence 67889999999999999998 67899999988643221 1223355678999999999999999999999999999999
Q ss_pred eecccCchHHHHhh---hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC-Ccc
Q 008759 410 ELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-DVK 485 (554)
Q Consensus 410 E~~~ggsL~~ll~~---~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~-~~~ 485 (554)
||+.+++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++...... ...
T Consensus 80 e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 159 (285)
T cd05630 80 TLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK 159 (285)
T ss_pred EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcccc
Confidence 99999999988754 25888999999999999999999999999999999999999999999999998754332 223
Q ss_pred CccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008759 486 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME 533 (554)
Q Consensus 486 s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e 533 (554)
...||..|+|||++.+. .++.++|+|||||++|+|++|+.||....
T Consensus 160 ~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~~l~~l~~g~~Pf~~~~ 205 (285)
T cd05630 160 GRVGTVGYMAPEVVKNE--RYTFSPDWWALGCLLYEMIAGQSPFQQRK 205 (285)
T ss_pred CCCCCccccChHHHcCC--CCCCccccHHHHHHHHHHHhCCCCCCCCC
Confidence 45689999999999654 47889999999999999999999998643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=276.73 Aligned_cols=212 Identities=61% Similarity=1.016 Sum_probs=183.0
Q ss_pred ceeeeeeeccCCceeEEEEecC-CCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEE
Q 008759 330 YWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (554)
Q Consensus 330 ~y~i~~~LG~GsfG~VY~a~~~-~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LV 408 (554)
+|+..+.||+|+||.||+|.+. ++..|++|.+.........++..+.+.+|+.+++.++|+||+++++.+.....+|++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4778899999999999999984 899999999876544444455667889999999999999999999999999999999
Q ss_pred EeecccCchHHHHhhhc-CChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC-ccC
Q 008759 409 LELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VKS 486 (554)
Q Consensus 409 mE~~~ggsL~~ll~~~~-l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~-~~s 486 (554)
|||+.+++|.+++.+.. +++..+..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++....... ...
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~ 160 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS 160 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccccccc
Confidence 99999999999987654 8899999999999999999999999999999999999999999999999987654332 345
Q ss_pred ccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHH
Q 008759 487 CRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKT 542 (554)
Q Consensus 487 ~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~ 542 (554)
..++..|++||.+.... .++.++|+|||||++|+|++|+.||......+....+.
T Consensus 161 ~~~~~~y~~pe~~~~~~-~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 215 (258)
T cd06632 161 FKGSPYWMAPEVIAQQG-GYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIG 215 (258)
T ss_pred cCCCcceeCHHHhcCCC-CCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHH
Confidence 56899999999985433 37889999999999999999999998877655555443
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=290.37 Aligned_cols=204 Identities=30% Similarity=0.518 Sum_probs=177.9
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCc
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~ 404 (554)
.+.+.|++.+.||+|.|+.||++.+ .+|+.||+|.+...+-... ..+.+.+|++|-+.++|||||++.+.......
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~---~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~ 84 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR---DFQKLEREARICRKLQHPNIVRLHDSIQEESF 84 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc---cHHHHHHHHHHHHhcCCCcEeehhhhhcccce
Confidence 4557899999999999999999998 7899999999875443322 45778999999999999999999999999999
Q ss_pred EEEEEeecccCchH-HHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCC---CcEEEEecCcccccc
Q 008759 405 LYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN---GSVKLADFGLAKATK 480 (554)
Q Consensus 405 ~~LVmE~~~ggsL~-~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~---g~vKL~DFGlA~~~~ 480 (554)
.|||+|+|+|+.|. ++.++.-+++..+..+++||+.+|.|+|.+||||||+||.|+|+-.. .-+||+|||+|....
T Consensus 85 ~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 85 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred eEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 99999999999886 46677788999999999999999999999999999999999999543 359999999998765
Q ss_pred cC-CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh
Q 008759 481 LN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC 534 (554)
Q Consensus 481 ~~-~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~ 534 (554)
.+ ......|||.|||||++... .|+..+|||+.|++||-||.|++||.+.+.
T Consensus 165 ~g~~~~G~~GtP~fmaPEvvrkd--py~kpvDiW~cGViLfiLL~G~~PF~~~~~ 217 (355)
T KOG0033|consen 165 DGEAWHGFAGTPGYLSPEVLKKD--PYSKPVDIWACGVILYILLVGYPPFWDEDQ 217 (355)
T ss_pred CccccccccCCCcccCHHHhhcC--CCCCcchhhhhhHHHHHHHhCCCCCCCccH
Confidence 33 34567799999999999544 599999999999999999999999998544
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=275.14 Aligned_cols=206 Identities=31% Similarity=0.545 Sum_probs=177.0
Q ss_pred ceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEE
Q 008759 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (554)
Q Consensus 330 ~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LV 408 (554)
+|.+.+.||+|+||.||+|.+ .++..|++|.+...... ......+.+|+.+++.++||||+++++.+...+.+|+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 77 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN---RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIV 77 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC---HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEE
Confidence 478889999999999999998 67899999988643222 33456788999999999999999999999999999999
Q ss_pred EeecccCchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC--
Q 008759 409 LELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-- 483 (554)
Q Consensus 409 mE~~~ggsL~~ll~~~---~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~-- 483 (554)
|||+.+++|.+++... .+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||+++......
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~ 157 (256)
T cd08529 78 MEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF 157 (256)
T ss_pred EEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence 9999999999998763 57888999999999999999999999999999999999999999999999987654332
Q ss_pred ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHH
Q 008759 484 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFI 540 (554)
Q Consensus 484 ~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~ 540 (554)
.....+++.|+|||++.+.. ++.++|+|||||++|+|++|+.||......+...+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~ 212 (256)
T cd08529 158 ANTIVGTPYYLSPELCEDKP--YNEKSDVWALGVVLYECCTGKHPFDANNQGALILK 212 (256)
T ss_pred hhccccCccccCHHHhcCCC--CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 22345889999999986543 78899999999999999999999987775544443
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=283.46 Aligned_cols=203 Identities=33% Similarity=0.553 Sum_probs=176.5
Q ss_pred cceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEE
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~L 407 (554)
++|++.+.||+|+||.||++.+ .+++.+|+|++..... ........+.+|+.+++.+.||||+++++.+.....+|+
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKI--VKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYL 78 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEE
Confidence 3689999999999999999998 5789999998864221 112335678899999999999999999999999999999
Q ss_pred EEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCCccC
Q 008759 408 FLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS 486 (554)
Q Consensus 408 VmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~~~s 486 (554)
||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+|+||+|.|||++.++.+||+|||++...... ...
T Consensus 79 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-~~~ 157 (290)
T cd05580 79 VMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-TYT 157 (290)
T ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-CCC
Confidence 9999999999999876 45899999999999999999999999999999999999999999999999998776544 334
Q ss_pred ccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhH
Q 008759 487 CRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVS 536 (554)
Q Consensus 487 ~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~ 536 (554)
..+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||...+..+
T Consensus 158 ~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 205 (290)
T cd05580 158 LCGTPEYLAPEIILSK--GYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ 205 (290)
T ss_pred CCCCccccChhhhcCC--CCCccccHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 5689999999998654 46789999999999999999999998776443
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=286.13 Aligned_cols=201 Identities=22% Similarity=0.302 Sum_probs=170.4
Q ss_pred eeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccC----CCcEEEEEe
Q 008759 335 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD----ESKLYIFLE 410 (554)
Q Consensus 335 ~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~----~~~~~LVmE 410 (554)
..||+|++|.||+|.+ +|+.||+|.+..... ......+.+.+|+.+|.+++||||+++++++.+ ...+++|||
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~E 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHK--GHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILE 102 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEecccccc--ccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEE
Confidence 5699999999999988 688999999875322 223345778899999999999999999998866 457899999
Q ss_pred ecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHH-CCccccCCccccEEEcCCCcEEEEecCcccccccCCccCcc
Q 008759 411 LVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR 488 (554)
Q Consensus 411 ~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs-~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~~~s~~ 488 (554)
|+.+|+|.+++.. ..+++.....++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++...... ....
T Consensus 103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-~~~~ 181 (283)
T PHA02988 103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-FKNV 181 (283)
T ss_pred eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-cccc
Confidence 9999999999875 458888899999999999999998 499999999999999999999999999987644322 3345
Q ss_pred CCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHH
Q 008759 489 GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIF 539 (554)
Q Consensus 489 GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~ 539 (554)
+|..|+|||++.+....++.++|||||||++|||++|+.||......+...
T Consensus 182 ~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~ 232 (283)
T PHA02988 182 NFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYD 232 (283)
T ss_pred CcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 889999999997644468999999999999999999999999876654433
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=286.10 Aligned_cols=208 Identities=32% Similarity=0.590 Sum_probs=179.2
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCc
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~ 404 (554)
....+|++.+.||+|+||.||+|.+ .+++.|++|.+..... .....+.+|+.+++.+.|+||+++++.+.....
T Consensus 17 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~-----~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~ 91 (296)
T cd06654 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-----PKKELIINEILVMRENKNPNIVNYLDSYLVGDE 91 (296)
T ss_pred CcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc-----chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCE
Confidence 4456899999999999999999997 6789999998874322 123567889999999999999999999999999
Q ss_pred EEEEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC-
Q 008759 405 LYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND- 483 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~- 483 (554)
+|+||||+.+++|.+++....+.+.++..++.|++.||.|||++||+|+||||+|||++.++.++|+|||++.......
T Consensus 92 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 92 LWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred EEEeecccCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 9999999999999999987778999999999999999999999999999999999999999999999999987543322
Q ss_pred -ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHH
Q 008759 484 -VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFI 540 (554)
Q Consensus 484 -~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~ 540 (554)
.....+++.|+|||.+.+. .++.++|+|||||++|+|++|+.||........++.
T Consensus 172 ~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~ 227 (296)
T cd06654 172 KRSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL 227 (296)
T ss_pred ccCcccCCccccCHHHHcCC--CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHH
Confidence 2334688999999998653 367899999999999999999999987766544443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=278.21 Aligned_cols=212 Identities=46% Similarity=0.782 Sum_probs=178.6
Q ss_pred cceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCC--CcE
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE--SKL 405 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~--~~~ 405 (554)
..|++++.||+|+||.||+|.+ .++..|++|.+...............+.+|+.+++.++|+||+++++.+.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4689999999999999999998 6799999998864332223344567888999999999999999999988653 568
Q ss_pred EEEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC--
Q 008759 406 YIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-- 482 (554)
Q Consensus 406 ~LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~-- 482 (554)
+++|||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||+++.....
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence 999999999999998875 45888999999999999999999999999999999999999999999999998764321
Q ss_pred ---CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHH
Q 008759 483 ---DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKT 542 (554)
Q Consensus 483 ---~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~ 542 (554)
......++..|+|||++.+. .++.++|+|||||++|+|++|+.||........+..+.
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 222 (264)
T cd06653 162 SGTGIKSVTGTPYWMSPEVISGE--GYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIA 222 (264)
T ss_pred cCccccccCCcccccCHhhhcCC--CCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHH
Confidence 12234588999999998653 37889999999999999999999998877666655443
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=298.48 Aligned_cols=210 Identities=37% Similarity=0.646 Sum_probs=187.2
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCc
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~ 404 (554)
...+-|.++.+||+|+||.||++++ ..|+.+|+|.+.+ ...++.+..|+.+++++..+++|++||.+.....
T Consensus 30 ~PEEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV-------~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sD 102 (502)
T KOG0574|consen 30 PPEEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV-------DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSD 102 (502)
T ss_pred ChHHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc-------cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCc
Confidence 3445688899999999999999999 7899999999976 3346778899999999999999999999988999
Q ss_pred EEEEEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC
Q 008759 405 LYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN 482 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~ 482 (554)
+|||||||..|++.++++. ..+.+.++..+++..+.||+|||...-||||||..|||++.+|..||+|||.|-.....
T Consensus 103 LWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT 182 (502)
T KOG0574|consen 103 LWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT 182 (502)
T ss_pred eEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhh
Confidence 9999999999999998864 57999999999999999999999999999999999999999999999999988654332
Q ss_pred --CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHHH
Q 008759 483 --DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTVA 544 (554)
Q Consensus 483 --~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~~ 544 (554)
...+..|||.|||||++...+ |+.++||||||++..||..|++||....++-+||.|-+.
T Consensus 183 MAKRNTVIGTPFWMAPEVI~EIG--Y~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~ 244 (502)
T KOG0574|consen 183 MAKRNTVIGTPFWMAPEVIEEIG--YDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTK 244 (502)
T ss_pred HHhhCccccCcccccHHHHHHhc--cchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCC
Confidence 245667999999999997654 999999999999999999999999999999888876443
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=324.77 Aligned_cols=214 Identities=29% Similarity=0.542 Sum_probs=179.0
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccC--C
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD--E 402 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~--~ 402 (554)
...++|++++.||+|+||+||+|.+ .++..||+|++..... .......+..|+.+|..++|||||+++++|.. .
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l---~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~ 86 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL---KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN 86 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc---CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence 4567899999999999999999998 6788999998875322 12334678899999999999999999998754 4
Q ss_pred CcEEEEEeecccCchHHHHhh-----hcCChHHHHHHHHHHHHHHHHHHHC-------CccccCCccccEEEcC------
Q 008759 403 SKLYIFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQ-------DVVHRDIKCANILVDA------ 464 (554)
Q Consensus 403 ~~~~LVmE~~~ggsL~~ll~~-----~~l~e~~i~~i~~QIl~gL~yLHs~-------gIIHrDIKPeNILld~------ 464 (554)
..+||||||+.+++|..++.. ..+++..++.|+.||+.||.|||+. +||||||||+||||+.
T Consensus 87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence 579999999999999998865 3589999999999999999999984 4999999999999964
Q ss_pred -----------CCcEEEEecCcccccccCC-ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008759 465 -----------NGSVKLADFGLAKATKLND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM 532 (554)
Q Consensus 465 -----------~g~vKL~DFGlA~~~~~~~-~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~ 532 (554)
.+.+||+|||++....... ...+.||+.|+|||++.+....++.++||||||||+|+|+||..||...
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred cccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 2358999999997654332 3456799999999999765556889999999999999999999999887
Q ss_pred ChhHHHHHHH
Q 008759 533 ECVSAIFIKT 542 (554)
Q Consensus 533 e~~~~i~~i~ 542 (554)
.....++.++
T Consensus 247 ~~~~qli~~l 256 (1021)
T PTZ00266 247 NNFSQLISEL 256 (1021)
T ss_pred CcHHHHHHHH
Confidence 7666655543
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=278.42 Aligned_cols=206 Identities=26% Similarity=0.459 Sum_probs=174.5
Q ss_pred cceeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEE
Q 008759 329 TYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LV 408 (554)
++|++.+.||+|+||.||++.+.++..+|+|.+..... ....+.+|+.+++.++||||+++++++.....+|+|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 77 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM------SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIV 77 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc------cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEE
Confidence 46889999999999999999988888899998753211 124578899999999999999999999999999999
Q ss_pred EeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCCcc-
Q 008759 409 LELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK- 485 (554)
Q Consensus 409 mE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~~~- 485 (554)
|||+.+|+|.+++.. ..+++..+..++.|++.||.|||++||+|+||||+||+++.++.+||+|||+++........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 999999999998864 34788999999999999999999999999999999999999999999999998764332221
Q ss_pred --CccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHH
Q 008759 486 --SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIFIKT 542 (554)
Q Consensus 486 --s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i~~i~ 542 (554)
...++..|+|||++.+. .++.++|+||||+++|+|++ |+.||......+.+..+.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~--~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~ 215 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFS--KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMIS 215 (256)
T ss_pred cCCCCCchhhCChhhcccC--ccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 22355679999998654 47889999999999999999 999998877665554443
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=285.47 Aligned_cols=205 Identities=29% Similarity=0.495 Sum_probs=172.9
Q ss_pred ccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEE
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~ 406 (554)
.+.|++.+.||.|+||.||+|.+ .++..||+|.+....... ....+.+|+.+++.++|+||+++++++...+.+|
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~ 80 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEG----APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLT 80 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccC----chhHHHHHHHHHHhcCCCCcceEEEEEecCCeEE
Confidence 46799999999999999999988 578999999987533221 1234668999999999999999999999999999
Q ss_pred EEEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC--
Q 008759 407 IFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-- 482 (554)
Q Consensus 407 LVmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~-- 482 (554)
+||||+.+ +|..++.. ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++......
T Consensus 81 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 81 LVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred EEEecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 99999985 78887764 35888999999999999999999999999999999999999999999999998754322
Q ss_pred CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHH
Q 008759 483 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAI 538 (554)
Q Consensus 483 ~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i 538 (554)
......+++.|+|||++.+.. .++.++|||||||++|+|++|++||...+..+.+
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~-~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~ 214 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLGST-DYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQL 214 (301)
T ss_pred cccccceeecccCcHHHhCCC-CCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 222345789999999986533 4788999999999999999999999887665443
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=278.33 Aligned_cols=205 Identities=29% Similarity=0.520 Sum_probs=174.3
Q ss_pred ccceeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEE
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~L 407 (554)
.++|+++++||+|+||.||+|.+.++..||+|.+.... ...+.+.+|+.+++.++|+||+++++.+...+..|+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 78 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT------MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYI 78 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc------hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEE
Confidence 46899999999999999999998888889999875321 124578899999999999999999999999999999
Q ss_pred EEeecccCchHHHHhh---hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCCc
Q 008759 408 FLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV 484 (554)
Q Consensus 408 VmE~~~ggsL~~ll~~---~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~~ 484 (554)
+|||+.+++|.+++.. ..++...+..++.|++.||.|||+++++|+||||+|||++.++.++|+|||++........
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 79 ITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred EEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 9999999999998865 3478888899999999999999999999999999999999999999999999976543221
Q ss_pred ---cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHHHH
Q 008759 485 ---KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIFI 540 (554)
Q Consensus 485 ---~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i~~ 540 (554)
....++..|+|||++... .++.++|||||||++|+|++ |..||......+....
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~ 216 (261)
T cd05072 159 TAREGAKFPIKWTAPEAINFG--SFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSA 216 (261)
T ss_pred eccCCCccceecCCHHHhccC--CCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHH
Confidence 223356789999998654 37889999999999999998 9999987655444333
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=277.43 Aligned_cols=210 Identities=47% Similarity=0.808 Sum_probs=178.0
Q ss_pred ceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccch----hHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCc
Q 008759 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQ----AKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (554)
Q Consensus 330 ~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~----~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~ 404 (554)
.|.++..||.|+||.||+|.+ .+++.||+|.+........ .....+.+.+|+.+++.++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 478889999999999999998 5789999998865433221 23345678899999999999999999999999999
Q ss_pred EEEEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC
Q 008759 405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND 483 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~ 483 (554)
+++||||+.+++|..++.. ..+++..+..++.|++.||.|||++|++||||+|+|||++.++.++|+|||+++......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS 160 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence 9999999999999999976 457888999999999999999999999999999999999999999999999987654211
Q ss_pred --------ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHH
Q 008759 484 --------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIK 541 (554)
Q Consensus 484 --------~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i 541 (554)
.....|+..|+|||.+.+. .++.++|+|||||++|+|++|+.||........++.+
T Consensus 161 ~~~~~~~~~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~ 224 (267)
T cd06628 161 LSTKTNGARPSLQGSVFWMAPEVVKQT--SYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKI 224 (267)
T ss_pred ccCCccccccccCCCcCccChhHhccC--CCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHH
Confidence 1123578899999998654 3778999999999999999999999887666555543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=281.27 Aligned_cols=205 Identities=38% Similarity=0.596 Sum_probs=174.5
Q ss_pred ccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEE
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~ 406 (554)
.++|++++.||+|+||.||+|.+ .++..||+|++.... ......+.+|+.++..++|+||+++++.+.....+|
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-----~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~ 82 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP-----GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLW 82 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc-----cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEE
Confidence 45799999999999999999998 678999999886422 122345778999999999999999999999999999
Q ss_pred EEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC--
Q 008759 407 IFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-- 483 (554)
Q Consensus 407 LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~-- 483 (554)
+||||+.+++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 83 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd06646 83 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAK 162 (267)
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccccc
Confidence 99999999999998864 468999999999999999999999999999999999999999999999999987653221
Q ss_pred ccCccCCCcccChhhhccc-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHH
Q 008759 484 VKSCRGTAFWMAPEVINNK-NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSA 537 (554)
Q Consensus 484 ~~s~~GT~~Y~APEvl~~~-~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~ 537 (554)
.....+++.|+|||.+... ...++.++|+|||||++|+|++|+.||....+...
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~ 217 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA 217 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh
Confidence 2344688999999998532 23367899999999999999999999976654433
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=278.18 Aligned_cols=210 Identities=48% Similarity=0.807 Sum_probs=177.6
Q ss_pred ceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccC--CCcEE
Q 008759 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD--ESKLY 406 (554)
Q Consensus 330 ~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~--~~~~~ 406 (554)
.|+.++.||+|+||.||+|.+ .++..|++|++...............+.+|+.+++.++|+||+++++.+.. ...++
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 688999999999999999998 678999999887544333334455678899999999999999999998765 46789
Q ss_pred EEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC---
Q 008759 407 IFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--- 482 (554)
Q Consensus 407 LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~--- 482 (554)
++|||+.+++|.+++.. ..+++..+..++.|++.||.|||+++|+|+||||+||+++.++.+||+|||++......
T Consensus 83 l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 162 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMS 162 (266)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccccc
Confidence 99999999999998875 45888899999999999999999999999999999999999999999999998754321
Q ss_pred --CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHH
Q 008759 483 --DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIK 541 (554)
Q Consensus 483 --~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i 541 (554)
......++..|+|||.+.+. .++.++|+|||||++|+|++|+.||...+....+..+
T Consensus 163 ~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~ 221 (266)
T cd06651 163 GTGIRSVTGTPYWMSPEVISGE--GYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKI 221 (266)
T ss_pred CCccccCCccccccCHHHhCCC--CCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHH
Confidence 12234588899999998653 4788999999999999999999999887766655544
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=286.60 Aligned_cols=200 Identities=29% Similarity=0.488 Sum_probs=173.9
Q ss_pred cceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEE
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~L 407 (554)
++|++.+.||+|+||.||++.+ .++..+|+|.+.... ......++.+|+.++..++||||+++++.+..++.+|+
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 76 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI----KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISI 76 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc----CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEE
Confidence 3689999999999999999998 678889999876421 12334568899999999999999999999999999999
Q ss_pred EEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHH-CCccccCCccccEEEcCCCcEEEEecCcccccccCCcc
Q 008759 408 FLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK 485 (554)
Q Consensus 408 VmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs-~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~~~ 485 (554)
||||+.+++|.+++.+ ..+++..+..++.||+.||.|||+ .+|+|+||||+|||++.++.+||+|||++.........
T Consensus 77 v~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 156 (308)
T cd06615 77 CMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN 156 (308)
T ss_pred EeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccccc
Confidence 9999999999999876 458889999999999999999997 58999999999999999999999999998765444445
Q ss_pred CccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh
Q 008759 486 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC 534 (554)
Q Consensus 486 s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~ 534 (554)
...++..|+|||++.+. .++.++|+|||||++|+|++|+.||...+.
T Consensus 157 ~~~~~~~~~aPE~~~~~--~~~~~~DiwslG~~l~~l~~g~~p~~~~~~ 203 (308)
T cd06615 157 SFVGTRSYMSPERLQGT--HYTVQSDIWSLGLSLVEMAIGRYPIPPPDA 203 (308)
T ss_pred cCCCCcCccChhHhcCC--CCCccchHHHHHHHHHHHHhCCCCCCCcch
Confidence 56789999999998543 378899999999999999999999976553
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=310.23 Aligned_cols=213 Identities=27% Similarity=0.479 Sum_probs=182.5
Q ss_pred ccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEE
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~ 406 (554)
...|..++.||-|+||.|.++.. .+...||+|.+.+.+. ..++.+.+++.|..||..-..+-||+||..|++.+++|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDV--l~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLY 705 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADV--LMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLY 705 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHH--HhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceE
Confidence 34689999999999999999987 6788999998875432 23455677889999999999999999999999999999
Q ss_pred EEEeecccCchHHHHhhhc-CChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccccc----
Q 008759 407 IFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL---- 481 (554)
Q Consensus 407 LVmE~~~ggsL~~ll~~~~-l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~---- 481 (554)
+||+|+.||++..+|.+.+ |.+..++.|+.++.+|++++|+.|+|||||||+|||||.+|+|||+||||+.-...
T Consensus 706 FVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHds 785 (1034)
T KOG0608|consen 706 FVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 785 (1034)
T ss_pred EEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecccc
Confidence 9999999999999888765 66777888999999999999999999999999999999999999999999953210
Q ss_pred -----CC-----------------------------------ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHH
Q 008759 482 -----ND-----------------------------------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLE 521 (554)
Q Consensus 482 -----~~-----------------------------------~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllye 521 (554)
+. ....+||+.|+|||++... +|+.-+||||.||||||
T Consensus 786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~--g~~q~cdwws~gvil~e 863 (1034)
T KOG0608|consen 786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLART--GYTQLCDWWSVGVILYE 863 (1034)
T ss_pred ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhccc--CccccchhhHhhHHHHH
Confidence 00 0122599999999999654 48999999999999999
Q ss_pred HHcCCCCCCCCChhHHHHHHHHH
Q 008759 522 MLTSQIPYAPMECVSAIFIKTVA 544 (554)
Q Consensus 522 LLTG~~PF~~~e~~~~i~~i~~~ 544 (554)
|+.|+.||..-.+.+..+++++-
T Consensus 864 m~~g~~pf~~~tp~~tq~kv~nw 886 (1034)
T KOG0608|consen 864 MLVGQPPFLADTPGETQYKVINW 886 (1034)
T ss_pred HhhCCCCccCCCCCcceeeeeeh
Confidence 99999999988887777776653
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=283.28 Aligned_cols=202 Identities=33% Similarity=0.566 Sum_probs=174.3
Q ss_pred cceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEE
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~L 407 (554)
++|++++.||+|+||.||++.+ .++..||+|.+.... .......+.+|+.++..++|+||+++++.+...+.+|+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~----~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 76 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL----DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYM 76 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc----CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEE
Confidence 3688999999999999999998 589999999886421 12234678899999999999999999999999999999
Q ss_pred EEeecccCchHHHHhhh----cCChHHHHHHHHHHHHHHHHHHH-CCccccCCccccEEEcCCCcEEEEecCcccccccC
Q 008759 408 FLELVTKGSLLNLYQRY----HLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGSVKLADFGLAKATKLN 482 (554)
Q Consensus 408 VmE~~~ggsL~~ll~~~----~l~e~~i~~i~~QIl~gL~yLHs-~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~ 482 (554)
||||+.+++|..++... .+++..+..++.||+.||.|||+ .+|+|+||||+|||++.++.+||+|||++......
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 77 CMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS 156 (286)
T ss_pred EEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence 99999999999988764 68999999999999999999997 59999999999999999999999999998765544
Q ss_pred CccCccCCCcccChhhhcccC----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCh
Q 008759 483 DVKSCRGTAFWMAPEVINNKN----KGYGLPADIWSLGCTVLEMLTSQIPYAPMEC 534 (554)
Q Consensus 483 ~~~s~~GT~~Y~APEvl~~~~----~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~ 534 (554)
......+++.|+|||++.+.. ..++.++|+|||||++|+|++|+.||.....
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 212 (286)
T cd06622 157 LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY 212 (286)
T ss_pred ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch
Confidence 444556888999999985432 1357899999999999999999999976543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=279.60 Aligned_cols=207 Identities=32% Similarity=0.514 Sum_probs=172.8
Q ss_pred ceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEE
Q 008759 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (554)
Q Consensus 330 ~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LV 408 (554)
+|++.+.||+|+||.||+|.+ .++..||+|++...... ......+.+|+.+++.++||||+++++.+..++.+|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE---EGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLI 77 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEecccccc---CCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEE
Confidence 488899999999999999998 57999999988643221 12234577899999999999999999999999999999
Q ss_pred EeecccCchHHHHhh----hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC--
Q 008759 409 LELVTKGSLLNLYQR----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-- 482 (554)
Q Consensus 409 mE~~~ggsL~~ll~~----~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~-- 482 (554)
|||+. ++|.+++.. ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++......
T Consensus 78 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 78 FEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred EecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 99998 478777754 35889999999999999999999999999999999999999999999999998754322
Q ss_pred CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHH
Q 008759 483 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIK 541 (554)
Q Consensus 483 ~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i 541 (554)
......+++.|+|||++.+.. .++.++|||||||++|+|+||+.||......+.++.+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~-~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~ 214 (285)
T cd07861 157 VYTHEVVTLWYRAPEVLLGSP-RYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRI 214 (285)
T ss_pred cccCCcccccccChHHhcCCC-CcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 122335788999999986543 4688999999999999999999999877655554443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=278.80 Aligned_cols=206 Identities=31% Similarity=0.485 Sum_probs=174.9
Q ss_pred ccceeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEE
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~L 407 (554)
.+.|++.+.||+|+||.||+|.+.+++.||+|.+..... ..+.+.+|+.+++.++|+||+++++++...+.+|+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 78 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM------DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYI 78 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc------cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeee
Confidence 357999999999999999999987788999998864221 13457789999999999999999999999999999
Q ss_pred EEeecccCchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCCc
Q 008759 408 FLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV 484 (554)
Q Consensus 408 VmE~~~ggsL~~ll~~~---~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~~ 484 (554)
+|||+.+++|.+++... .+++..+..++.|++.||.|||++||+|+||||+|||++.++.+||+|||++........
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 79 VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred eeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 99999999999998753 488999999999999999999999999999999999999999999999999887653332
Q ss_pred cCccC---CCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHHHHH
Q 008759 485 KSCRG---TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIFIK 541 (554)
Q Consensus 485 ~s~~G---T~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i~~i 541 (554)
....+ +..|+|||++.+. .++.++|+|||||++|+|++ |+.||......+.+..+
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~ 217 (261)
T cd05068 159 EAREGAKFPIKWTAPEAALYN--RFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQV 217 (261)
T ss_pred cccCCCcCceeccCccccccC--CCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 22223 4579999988543 47889999999999999999 99999887665544433
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=281.55 Aligned_cols=207 Identities=29% Similarity=0.439 Sum_probs=172.5
Q ss_pred ccceeeeeeeccCCceeEEEEecCC-C-----cEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccC
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGISDD-G-----FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD 401 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~~~-g-----~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~ 401 (554)
.++|++.+.||+|+||.||+|.+.. + ..|++|.+.... .......+.+|+.++..++||||+++++++..
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~----~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~ 79 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA----EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK 79 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC----CHHHHHHHHHHHHHHHhcCCcccceEEEEEcC
Confidence 4578999999999999999998732 2 578999876321 22334568899999999999999999999999
Q ss_pred CCcEEEEEeecccCchHHHHhh-----------------hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcC
Q 008759 402 ESKLYIFLELVTKGSLLNLYQR-----------------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA 464 (554)
Q Consensus 402 ~~~~~LVmE~~~ggsL~~ll~~-----------------~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~ 464 (554)
....|++|||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+|+||||+|||++.
T Consensus 80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~ 159 (283)
T cd05048 80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGE 159 (283)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcC
Confidence 8999999999999999998865 23677888999999999999999999999999999999999
Q ss_pred CCcEEEEecCcccccccCC----ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHHH
Q 008759 465 NGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIF 539 (554)
Q Consensus 465 ~g~vKL~DFGlA~~~~~~~----~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i~ 539 (554)
++.++|+|||++....... .....+++.|+|||.+... .++.++|||||||++|||++ |..||......+...
T Consensus 160 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~ 237 (283)
T cd05048 160 GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYG--KFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIE 237 (283)
T ss_pred CCcEEECCCcceeeccccccccccCCCcccccccCHHHhccC--cCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 9999999999987543221 2233467889999998654 37889999999999999998 999998876655443
Q ss_pred H
Q 008759 540 I 540 (554)
Q Consensus 540 ~ 540 (554)
.
T Consensus 238 ~ 238 (283)
T cd05048 238 M 238 (283)
T ss_pred H
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=289.27 Aligned_cols=190 Identities=32% Similarity=0.508 Sum_probs=156.6
Q ss_pred eeeeccCCceeEEEEecC---CCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccC--CCcEEEE
Q 008759 334 GDLLGRGSFGSVYEGISD---DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD--ESKLYIF 408 (554)
Q Consensus 334 ~~~LG~GsfG~VY~a~~~---~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~--~~~~~LV 408 (554)
+++||+|+||+||+|.+. +++.||+|.+..... ...+.+|+.+++.++||||+++++.+.. ...+|++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 78 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-------SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 78 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-------cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEE
Confidence 568999999999999863 568999998863211 1346689999999999999999998754 4578999
Q ss_pred EeecccCchHHHHhh----------hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEE----cCCCcEEEEecC
Q 008759 409 LELVTKGSLLNLYQR----------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV----DANGSVKLADFG 474 (554)
Q Consensus 409 mE~~~ggsL~~ll~~----------~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILl----d~~g~vKL~DFG 474 (554)
|||+.+ +|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07868 79 FDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred EeccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence 999876 67776642 147888899999999999999999999999999999999 456789999999
Q ss_pred cccccccC-----CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008759 475 LAKATKLN-----DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM 532 (554)
Q Consensus 475 lA~~~~~~-----~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~ 532 (554)
+++..... ......||+.|+|||++.+.. .++.++|||||||++|+|++|++||...
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGAR-HYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ceeccCCCCccccccCCccccccccCCHHHcCCC-CcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 99765322 223456899999999986533 4788999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=303.19 Aligned_cols=214 Identities=29% Similarity=0.503 Sum_probs=180.8
Q ss_pred CccccccccceeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCC-CCceeeeeeec
Q 008759 321 NGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTD 399 (554)
Q Consensus 321 ~~~~~~~~~~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIVkl~~~~ 399 (554)
+..++.-...|+++++||.||-+.||++...+.+.||+|.+.... ...+.+.-+.+|+.+|.+++ |.+||+||++-
T Consensus 353 ~~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~---~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYE 429 (677)
T KOG0596|consen 353 NEIIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLE---ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYE 429 (677)
T ss_pred CeeEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhh---cCHHHHHHHHHHHHHHHHhcCCceEEEEeeee
Confidence 345666677899999999999999999999888899999876533 23456778999999999996 99999999999
Q ss_pred cCCCcEEEEEeecccCchHHHHhhhc--CChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccc
Q 008759 400 KDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477 (554)
Q Consensus 400 ~~~~~~~LVmE~~~ggsL~~ll~~~~--l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~ 477 (554)
..++.+|||||+-+. +|..+|+++. ++...++.|..||+.++.++|..||||.||||.|||+ -.|.+||+|||+|.
T Consensus 430 v~d~~lYmvmE~Gd~-DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~ 507 (677)
T KOG0596|consen 430 VTDGYLYMVMECGDI-DLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIAN 507 (677)
T ss_pred ccCceEEEEeecccc-cHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhc
Confidence 999999999997654 8999998764 4445889999999999999999999999999999999 78999999999998
Q ss_pred ccccCC----ccCccCCCcccChhhhcccCCC---------CCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHH
Q 008759 478 ATKLND----VKSCRGTAFWMAPEVINNKNKG---------YGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIF 539 (554)
Q Consensus 478 ~~~~~~----~~s~~GT~~Y~APEvl~~~~~~---------~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~ 539 (554)
.+.... ..+-+||+.||+||.+...... .++++||||||||||+|+.|+.||.......+-+
T Consensus 508 aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl 582 (677)
T KOG0596|consen 508 AIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKL 582 (677)
T ss_pred ccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHH
Confidence 876543 2355799999999999653322 5688999999999999999999998776544433
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=278.23 Aligned_cols=210 Identities=25% Similarity=0.460 Sum_probs=178.2
Q ss_pred cceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEE
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~L 407 (554)
++|++.+.||+|+||.||+|.+ .+++.||+|++...... ....+.+.+|+.+++.++|+||+++++.+.....+++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~ 77 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDD---PVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHL 77 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccC---ccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEE
Confidence 4689999999999999999998 56899999988643211 1122456789999999999999999999999999999
Q ss_pred EEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC--c
Q 008759 408 FLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--V 484 (554)
Q Consensus 408 VmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~--~ 484 (554)
||||+.+++|..++.. ..+++..+..++.||+.+|.|||++||+|+||||+|||++.++.++|+|||++....... .
T Consensus 78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 157 (286)
T cd07847 78 VFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY 157 (286)
T ss_pred EEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccc
Confidence 9999999988887754 468999999999999999999999999999999999999999999999999987654332 2
Q ss_pred cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHH
Q 008759 485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKT 542 (554)
Q Consensus 485 ~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~ 542 (554)
....++..|+|||++.+.. .++.++|||||||++|+|++|+.||......+.++.+.
T Consensus 158 ~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~ 214 (286)
T cd07847 158 TDYVATRWYRAPELLVGDT-QYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIR 214 (286)
T ss_pred cCcccccccCCHHHHhCCC-CcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 2345788999999986532 46889999999999999999999999887776666554
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=274.75 Aligned_cols=209 Identities=37% Similarity=0.624 Sum_probs=179.7
Q ss_pred cceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEE
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~L 407 (554)
++|++.+.||.|+||.||+|.+ .+++.+++|++.... ....+.+.+|+.+++.++||||+++++.+.....+|+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~-----~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l 77 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP-----GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWI 77 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc-----hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEE
Confidence 5799999999999999999998 568899999987432 2245678899999999999999999999999999999
Q ss_pred EEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC--C
Q 008759 408 FLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--D 483 (554)
Q Consensus 408 VmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~--~ 483 (554)
+|||+.+++|.+++.. ..+++..+..++.|++.||.|||++||+|+||||+||+++.++.+||+|||++...... .
T Consensus 78 ~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 157 (262)
T cd06613 78 VMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAK 157 (262)
T ss_pred EEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhc
Confidence 9999999999998865 46899999999999999999999999999999999999999999999999998764432 2
Q ss_pred ccCccCCCcccChhhhccc-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHH
Q 008759 484 VKSCRGTAFWMAPEVINNK-NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKT 542 (554)
Q Consensus 484 ~~s~~GT~~Y~APEvl~~~-~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~ 542 (554)
.....++..|++||++... ...++.++|+|||||++|+|++|+.||........++...
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~ 217 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLIS 217 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 2345688899999998654 1147789999999999999999999998877666555443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=279.78 Aligned_cols=206 Identities=36% Similarity=0.618 Sum_probs=175.1
Q ss_pred ccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEE
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~ 406 (554)
.++|++.+.||+|+||.||+|.+ .+++.||+|.+.... ......+.+|+.+++.++||||+++++.+...+.+|
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-----~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~ 82 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP-----GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLW 82 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc-----hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Confidence 35789999999999999999998 678999999886432 222345778999999999999999999999999999
Q ss_pred EEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC--C
Q 008759 407 IFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--D 483 (554)
Q Consensus 407 LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~--~ 483 (554)
+||||+.+++|.+++.. ..+++.++..++.|++.||.|||++||+|+||||+|||++.++.++|+|||++...... .
T Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd06645 83 ICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAK 162 (267)
T ss_pred EEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcccc
Confidence 99999999999998865 46899999999999999999999999999999999999999999999999998654322 2
Q ss_pred ccCccCCCcccChhhhccc-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHH
Q 008759 484 VKSCRGTAFWMAPEVINNK-NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAI 538 (554)
Q Consensus 484 ~~s~~GT~~Y~APEvl~~~-~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i 538 (554)
.....|+..|+|||++... ...++.++|+|||||++|+|++|..||........+
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~ 218 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL 218 (267)
T ss_pred cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH
Confidence 2344689999999997422 234788999999999999999999999776554443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=283.45 Aligned_cols=209 Identities=31% Similarity=0.588 Sum_probs=181.2
Q ss_pred cccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcE
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL 405 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~ 405 (554)
....|++.+.||.|+||.||+|.+ .+++.|++|.+..... .....+.+|+.+++.++|+||+++++.+...+.+
T Consensus 17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 91 (296)
T cd06655 17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ-----PKKELIINEILVMKELKNPNIVNFLDSFLVGDEL 91 (296)
T ss_pred CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC-----chHHHHHHHHHHHHhcCCCceeeeeeeEecCceE
Confidence 345799999999999999999998 7799999999864322 2235678899999999999999999999999999
Q ss_pred EEEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC--
Q 008759 406 YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-- 483 (554)
Q Consensus 406 ~LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~-- 483 (554)
|+||||+.+++|..++....+++.++..++.|++.||.|||++||+|+||||+|||++.++.+||+|||++.......
T Consensus 92 ~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 171 (296)
T cd06655 92 FVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK 171 (296)
T ss_pred EEEEEecCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccccccc
Confidence 999999999999999988889999999999999999999999999999999999999999999999999987543322
Q ss_pred ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHH
Q 008759 484 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKT 542 (554)
Q Consensus 484 ~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~ 542 (554)
.....++..|+|||.+.+. .++.++|+|||||++|+|++|+.||...+....++.+.
T Consensus 172 ~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~ 228 (296)
T cd06655 172 RSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA 228 (296)
T ss_pred CCCcCCCccccCcchhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 2234688999999998654 37889999999999999999999999887766655543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=282.26 Aligned_cols=207 Identities=29% Similarity=0.473 Sum_probs=173.6
Q ss_pred cceeeeeeeccCCceeEEEEec------CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCC
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE 402 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~------~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~ 402 (554)
..|.+.+.||+|+||.||++.. .++..+|+|.+... .......+.+|+.++.+++|+||+++++++...
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-----SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG 79 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc-----CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 4789999999999999999974 34567888887632 233456788999999999999999999999999
Q ss_pred CcEEEEEeecccCchHHHHhhh--------------cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcE
Q 008759 403 SKLYIFLELVTKGSLLNLYQRY--------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSV 468 (554)
Q Consensus 403 ~~~~LVmE~~~ggsL~~ll~~~--------------~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~v 468 (554)
+.+|+||||+.+++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcE
Confidence 9999999999999999988643 37889999999999999999999999999999999999999999
Q ss_pred EEEecCcccccccCC----ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHH
Q 008759 469 KLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIFIKT 542 (554)
Q Consensus 469 KL~DFGlA~~~~~~~----~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i~~i~ 542 (554)
||+|||+++...... .....++..|+|||++.+. .++.++|+|||||++|+|++ |..||......+.+..+.
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~ 236 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT 236 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 999999987543222 1223357789999998654 47889999999999999998 999998776655444433
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=285.68 Aligned_cols=205 Identities=33% Similarity=0.582 Sum_probs=177.9
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCc
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~ 404 (554)
....+|.+.+.||+|+||.||++.+ .+++.||+|.+..... .....+.+|+.+++.++|+||+++++.+...+.
T Consensus 16 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~ 90 (297)
T cd06656 16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ-----PKKELIINEILVMRENKNPNIVNYLDSYLVGDE 90 (297)
T ss_pred ChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc-----chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCE
Confidence 4457899999999999999999998 6899999999864222 123557889999999999999999999999999
Q ss_pred EEEEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC-
Q 008759 405 LYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND- 483 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~- 483 (554)
+|+||||+.+++|.+++.+..+++.++..++.|++.+|.|||+.||+|+||||+|||++.++.++|+|||++.......
T Consensus 91 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 91 LWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred EEEeecccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 9999999999999999988788999999999999999999999999999999999999999999999999987654332
Q ss_pred -ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHH
Q 008759 484 -VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSA 537 (554)
Q Consensus 484 -~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~ 537 (554)
.....+++.|++||.+.+. .++.++|+|||||++|+|++|..||...+....
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~ 223 (297)
T cd06656 171 KRSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA 223 (297)
T ss_pred CcCcccCCccccCHHHHcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh
Confidence 2234688999999998653 478899999999999999999999977554433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=298.47 Aligned_cols=213 Identities=29% Similarity=0.460 Sum_probs=174.3
Q ss_pred ccccccccceeeeeeeccCCceeEEEEecC------CCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCC-CCceee
Q 008759 322 GRFKRIITYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQ 394 (554)
Q Consensus 322 ~~~~~~~~~y~i~~~LG~GsfG~VY~a~~~------~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIVk 394 (554)
+++....+.|+++++||+|+||.||+|.+. .+..||+|++..... ....+.+.+|+.++..+. ||||++
T Consensus 30 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~----~~~~~~~~~Ei~~l~~l~~HpnIv~ 105 (400)
T cd05105 30 SRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTAR----SSEKQALMSELKIMTHLGPHLNIVN 105 (400)
T ss_pred CceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCC----hHHHHHHHHHHHHHHhcCCCCCeee
Confidence 445555678999999999999999999852 235799998864221 223457889999999996 999999
Q ss_pred eeeeccCCCcEEEEEeecccCchHHHHhhh--------------------------------------------------
Q 008759 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRY-------------------------------------------------- 424 (554)
Q Consensus 395 l~~~~~~~~~~~LVmE~~~ggsL~~ll~~~-------------------------------------------------- 424 (554)
+++++.....+||||||+.+|+|.+++.+.
T Consensus 106 l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 185 (400)
T cd05105 106 LLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADT 185 (400)
T ss_pred EEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccc
Confidence 999999999999999999999999887542
Q ss_pred -----------------------------------------------cCChHHHHHHHHHHHHHHHHHHHCCccccCCcc
Q 008759 425 -----------------------------------------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKC 457 (554)
Q Consensus 425 -----------------------------------------------~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKP 457 (554)
.+++..+..++.||+.||.|||+++|+|+||||
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp 265 (400)
T cd05105 186 TQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAA 265 (400)
T ss_pred cccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCh
Confidence 256677888999999999999999999999999
Q ss_pred ccEEEcCCCcEEEEecCcccccccCC----ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008759 458 ANILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPM 532 (554)
Q Consensus 458 eNILld~~g~vKL~DFGlA~~~~~~~----~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~ 532 (554)
+|||++.++.+||+|||+++...... .....++..|+|||++.+. .++.++|||||||++|+|++ |..||...
T Consensus 266 ~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwSlGvil~ellt~g~~P~~~~ 343 (400)
T cd05105 266 RNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDN--LYTTLSDVWSYGILLWEIFSLGGTPYPGM 343 (400)
T ss_pred HhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCC--CCCchhhHHHHHHHHHHHHHCCCCCCccc
Confidence 99999999999999999987643222 1223467789999998654 47889999999999999997 99999887
Q ss_pred ChhHHHHH
Q 008759 533 ECVSAIFI 540 (554)
Q Consensus 533 e~~~~i~~ 540 (554)
...+.++.
T Consensus 344 ~~~~~~~~ 351 (400)
T cd05105 344 IVDSTFYN 351 (400)
T ss_pred chhHHHHH
Confidence 55444443
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=280.99 Aligned_cols=206 Identities=30% Similarity=0.461 Sum_probs=173.1
Q ss_pred cceeeeeeeccCCceeEEEEecC------CCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCC
Q 008759 329 TYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE 402 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~~------~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~ 402 (554)
+.|.+.+.||+|+||.||+|.+. ++..||+|.+.... ..+....+.+|+++++.++|+||+++++.+...
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 80 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA----SNDARKDFEREAELLTNFQHENIVKFYGVCTEG 80 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC----CHHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence 56888999999999999999863 34789999886422 122346788999999999999999999999999
Q ss_pred CcEEEEEeecccCchHHHHhhh---------------cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCc
Q 008759 403 SKLYIFLELVTKGSLLNLYQRY---------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS 467 (554)
Q Consensus 403 ~~~~LVmE~~~ggsL~~ll~~~---------------~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~ 467 (554)
...|+||||+.+++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe
Confidence 9999999999999999998643 3677888999999999999999999999999999999999999
Q ss_pred EEEEecCcccccccCC----ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHHHH
Q 008759 468 VKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIFI 540 (554)
Q Consensus 468 vKL~DFGlA~~~~~~~----~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i~~ 540 (554)
+||+|||+++...... .....+++.|+|||++.+. .++.++|||||||++|+|++ |..||......+.+..
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~ 236 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIEC 236 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccC--CcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 9999999987543222 1233457889999998654 38889999999999999998 9999987765554433
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=275.36 Aligned_cols=205 Identities=29% Similarity=0.524 Sum_probs=175.5
Q ss_pred ceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEE
Q 008759 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (554)
Q Consensus 330 ~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LV 408 (554)
+|++.+.||+|+||.||++.+ .++..||+|.+..... ....+.+.+|+.+++.++|+||+++++.+...+.+|++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 76 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS----SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIV 76 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc----hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEE
Confidence 478999999999999999998 6789999999864321 22345677899999999999999999999999999999
Q ss_pred EeecccCchHHHHhh---hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC--
Q 008759 409 LELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-- 483 (554)
Q Consensus 409 mE~~~ggsL~~ll~~---~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~-- 483 (554)
|||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++.......
T Consensus 77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 156 (255)
T cd08219 77 MEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY 156 (255)
T ss_pred EeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccccc
Confidence 999999999988754 247888999999999999999999999999999999999999999999999987653322
Q ss_pred ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHH
Q 008759 484 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFI 540 (554)
Q Consensus 484 ~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~ 540 (554)
.....+++.|+|||++.+. .++.++|+||||+++|+|++|..||...+.......
T Consensus 157 ~~~~~~~~~~~aPE~~~~~--~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~ 211 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENM--PYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILK 211 (255)
T ss_pred cccccCCccccCHHHHccC--CcCchhhhhhhchhheehhhccCCCCCCCHHHHHHH
Confidence 2345688999999998654 378899999999999999999999987765544443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=279.67 Aligned_cols=201 Identities=26% Similarity=0.455 Sum_probs=169.7
Q ss_pred ccceeeeeeeccCCceeEEEEec-----CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCC
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS-----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE 402 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~-----~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~ 402 (554)
...|++.+.||+|+||+||+|.+ .++..+++|.+.... .......+.+|+.+++.++|+||+++++++...
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 79 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN----NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE 79 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC----CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC
Confidence 35789999999999999999984 356789999886321 233446788999999999999999999999999
Q ss_pred CcEEEEEeecccCchHHHHhh------------------hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcC
Q 008759 403 SKLYIFLELVTKGSLLNLYQR------------------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA 464 (554)
Q Consensus 403 ~~~~LVmE~~~ggsL~~ll~~------------------~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~ 464 (554)
...|+||||+.+++|.+++.. ..+++.++..++.||+.||.|||++||+|+||||+|||++.
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~ 159 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGE 159 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcC
Confidence 999999999999999998852 23677888899999999999999999999999999999999
Q ss_pred CCcEEEEecCcccccccCC----ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCh
Q 008759 465 NGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMEC 534 (554)
Q Consensus 465 ~g~vKL~DFGlA~~~~~~~----~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~ 534 (554)
++.+||+|||+++...... .....++..|+|||++.+. .++.++|+|||||++|+|++ |..||.....
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~~g~~p~~~~~~ 232 (283)
T cd05090 160 QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYG--KFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN 232 (283)
T ss_pred CCcEEeccccccccccCCcceecccCCCccceecChHHhccC--CCCchhhhHHHHHHHHHHHcCCCCCCCCCCH
Confidence 9999999999987643221 2233456789999998654 37889999999999999998 9999987654
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=288.74 Aligned_cols=206 Identities=24% Similarity=0.409 Sum_probs=171.2
Q ss_pred eeeeeccC--CceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEEE
Q 008759 333 KGDLLGRG--SFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFL 409 (554)
Q Consensus 333 i~~~LG~G--sfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LVm 409 (554)
++++||+| +|++||++.+ .+|+.||+|.+..... .......+.+|+.+++.++||||+++++++..++..|+||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 78 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC---TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVT 78 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhc---cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEE
Confidence 56789999 7899999988 7899999999864321 1233456778999999999999999999999999999999
Q ss_pred eecccCchHHHHhh---hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC----
Q 008759 410 ELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN---- 482 (554)
Q Consensus 410 E~~~ggsL~~ll~~---~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~---- 482 (554)
||+.+++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++++||+........
T Consensus 79 e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 79 SFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred eccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 99999999999864 34889999999999999999999999999999999999999999999999865332111
Q ss_pred -----CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHH
Q 008759 483 -----DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIK 541 (554)
Q Consensus 483 -----~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i 541 (554)
......++..|+|||++.+....++.++|||||||++|+|++|+.||......+.+...
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~ 222 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK 222 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHH
Confidence 11223467789999999765445889999999999999999999999877655544443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=279.02 Aligned_cols=205 Identities=39% Similarity=0.679 Sum_probs=178.5
Q ss_pred cceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEE
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~L 407 (554)
++|++.+.||.|+||.||+|.+ .++..|++|.+.... .......+.+|+.+++.++|+||+++++.+.....+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 76 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE----AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWI 76 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc----cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEE
Confidence 3688899999999999999998 578999999987432 12234567899999999999999999999999999999
Q ss_pred EEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC--Ccc
Q 008759 408 FLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--DVK 485 (554)
Q Consensus 408 VmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~--~~~ 485 (554)
|+||+.+++|.+++....+++..+..++.|++.||.|||+++|+|+||+|+||+++.++.++|+|||+++..... ...
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 156 (274)
T cd06609 77 IMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRN 156 (274)
T ss_pred EEEeeCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccccccc
Confidence 999999999999998878999999999999999999999999999999999999999999999999998765433 233
Q ss_pred CccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHH
Q 008759 486 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIF 539 (554)
Q Consensus 486 s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~ 539 (554)
...+++.|++||++.+.. ++.++|||||||++|+|+||+.||........+.
T Consensus 157 ~~~~~~~y~~PE~~~~~~--~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~ 208 (274)
T cd06609 157 TFVGTPFWMAPEVIKQSG--YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLF 208 (274)
T ss_pred cccCCccccChhhhccCC--CCchhhHHHHHHHHHHHHhCCCCcccCchHHHHH
Confidence 456888999999996544 7899999999999999999999998766554443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=310.36 Aligned_cols=212 Identities=33% Similarity=0.545 Sum_probs=186.6
Q ss_pred cceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEE
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~L 407 (554)
+.|.-++-||.|+||.||.|++ .+...||||++.+.. .+..+....+..|+..|.+++|||++.+.|||..+...||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySG--KQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWL 103 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSG--KQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWL 103 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccc--cccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHH
Confidence 3466677899999999999999 889999999987643 3445567789999999999999999999999999999999
Q ss_pred EEeecccCchHHHHh--hhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCCcc
Q 008759 408 FLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK 485 (554)
Q Consensus 408 VmE~~~ggsL~~ll~--~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~~~ 485 (554)
|||||-| +-.+++. +.++.+..+..|+.+.+.||.|||+.+.||||||..|||++..|.|||+|||.|.... ...
T Consensus 104 VMEYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~--PAn 180 (948)
T KOG0577|consen 104 VMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA--PAN 180 (948)
T ss_pred HHHHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcC--chh
Confidence 9999977 6666664 5689999999999999999999999999999999999999999999999999876543 345
Q ss_pred CccCCCcccChhhhcccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHHHH
Q 008759 486 SCRGTAFWMAPEVINNKNK-GYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTVAV 545 (554)
Q Consensus 486 s~~GT~~Y~APEvl~~~~~-~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~~~ 545 (554)
+++|||+|||||++..-.. .|+-++||||||++..||...++|+.+|..+.++|.|..+.
T Consensus 181 sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNe 241 (948)
T KOG0577|consen 181 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE 241 (948)
T ss_pred cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcC
Confidence 7889999999999864322 38899999999999999999999999999999999997654
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=277.34 Aligned_cols=205 Identities=25% Similarity=0.418 Sum_probs=172.1
Q ss_pred cceeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEE
Q 008759 329 TYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LV 408 (554)
.+|++.+.||+|+||.||++.+.++..+|+|.+..... ....+.+|+.+++.++|+||+++++.+...+..|+|
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM------SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIV 77 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC------CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEE
Confidence 46888999999999999999987788899998753211 123567899999999999999999999999999999
Q ss_pred EeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCCccC
Q 008759 409 LELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS 486 (554)
Q Consensus 409 mE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~~~s 486 (554)
|||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 78 TEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred EecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 999999999998865 357888999999999999999999999999999999999999999999999987654332222
Q ss_pred c---cCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHHHHH
Q 008759 487 C---RGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIFIK 541 (554)
Q Consensus 487 ~---~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i~~i 541 (554)
. .++..|+|||.+.+. .++.++|||||||++|+|++ |+.||......+....+
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~ 214 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYS--RFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESV 214 (256)
T ss_pred cCCCCCCccccCHHHhccC--CCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Confidence 2 234579999998654 47889999999999999999 89999876655544433
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=338.52 Aligned_cols=210 Identities=43% Similarity=0.759 Sum_probs=184.0
Q ss_pred cccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCC
Q 008759 325 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES 403 (554)
Q Consensus 325 ~~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~ 403 (554)
..+.-+|+.+.+||.|.||.||-|.+ .+|...|+|.++..... ......+.+|..+|..++|||+|++||+-.+.+
T Consensus 1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~---~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRe 1307 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD---HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHRE 1307 (1509)
T ss_pred ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc---cccCcchHHHHHHHHhccCccccccCceeecHH
Confidence 34455899999999999999999999 88999999999764433 444567889999999999999999999999999
Q ss_pred cEEEEEeecccCchHHHHhhhc-CChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC
Q 008759 404 KLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN 482 (554)
Q Consensus 404 ~~~LVmE~~~ggsL~~ll~~~~-l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~ 482 (554)
..+|+||||++|+|.++++..+ .++.-...|..|++.||.|||+.|||||||||+|||++.+|.+|++|||.|+.+..+
T Consensus 1308 kv~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1308 KVYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred HHHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCc
Confidence 9999999999999999998865 455556778999999999999999999999999999999999999999999876654
Q ss_pred C------ccCccCCCcccChhhhcccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHH
Q 008759 483 D------VKSCRGTAFWMAPEVINNKN-KGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSA 537 (554)
Q Consensus 483 ~------~~s~~GT~~Y~APEvl~~~~-~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~ 537 (554)
. .....||+.|||||++.+.. ++...+.|||||||++.||.||+.||..++..=+
T Consensus 1388 ~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~a 1449 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWA 1449 (1509)
T ss_pred hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhH
Confidence 3 34567999999999998754 5678899999999999999999999999876433
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=282.71 Aligned_cols=209 Identities=29% Similarity=0.485 Sum_probs=177.6
Q ss_pred cceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEE
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~L 407 (554)
++|++.+.||+|+||.||+|.+ .+++.||+|.+..... ........+..|+.++..++|+||+++++.+......|+
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 78 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEM--IKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCL 78 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEecccc--chHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEE
Confidence 3689999999999999999998 5699999999875322 112345678899999999999999999999999999999
Q ss_pred EEeecccCchHHHHhh---hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC-
Q 008759 408 FLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND- 483 (554)
Q Consensus 408 VmE~~~ggsL~~ll~~---~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~- 483 (554)
||||+.+++|.+++.+ ..+++..+..++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++.......
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 79 VMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred EEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 9999999999999875 358899999999999999999999999999999999999999999999999986542211
Q ss_pred ------------------------------ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008759 484 ------------------------------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME 533 (554)
Q Consensus 484 ------------------------------~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e 533 (554)
.....||..|+|||++.+. .++.++|||||||++|+|++|+.||...+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD--GHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCC--CCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 1123578899999999654 37889999999999999999999998877
Q ss_pred hhHHHHHH
Q 008759 534 CVSAIFIK 541 (554)
Q Consensus 534 ~~~~i~~i 541 (554)
....+..+
T Consensus 237 ~~~~~~~~ 244 (316)
T cd05574 237 RDETFSNI 244 (316)
T ss_pred hHHHHHHH
Confidence 65555443
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=308.00 Aligned_cols=215 Identities=26% Similarity=0.394 Sum_probs=188.7
Q ss_pred cccceeeeeeeccCCceeEEEEecCCC-cEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcE
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGISDDG-FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL 405 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~~~g-~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~ 405 (554)
.+.+++++..||-|+||.|=++..+.. ..+|+|++++....... ..+++..|-+||..++.|+||++|.+|.++.++
T Consensus 418 ~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtk--QqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyv 495 (732)
T KOG0614|consen 418 KLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTK--QQEHVFSERNIMMECRSDFIVRLYRTFRDSKYV 495 (732)
T ss_pred chhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchh--HHHHHHhHHHHHHhcCchHHHHHHHHhccchhh
Confidence 356778888999999999999887443 35999998765544332 346788999999999999999999999999999
Q ss_pred EEEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC-
Q 008759 406 YIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND- 483 (554)
Q Consensus 406 ~LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~- 483 (554)
||+||-|-||.|+.++.. ..|.+...+.|+..++.|++|||.+|||+|||||+|+|++.+|-+||.|||+|+....+.
T Consensus 496 YmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K 575 (732)
T KOG0614|consen 496 YMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK 575 (732)
T ss_pred hhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCCc
Confidence 999999999999999976 468999999999999999999999999999999999999999999999999999876654
Q ss_pred ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHHHH
Q 008759 484 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTVAV 545 (554)
Q Consensus 484 ~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~~~ 545 (554)
.-+++|||.|.|||++..++ ++.++|.|+||+++||||+|.+||.+.+++...-.|+.+.
T Consensus 576 TwTFcGTpEYVAPEIILnKG--HD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGi 635 (732)
T KOG0614|consen 576 TWTFCGTPEYVAPEIILNKG--HDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGI 635 (732)
T ss_pred eeeecCCcccccchhhhccC--cchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhh
Confidence 45688999999999997654 8899999999999999999999999999888776666554
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=273.94 Aligned_cols=196 Identities=28% Similarity=0.526 Sum_probs=165.3
Q ss_pred eeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEEEeecc
Q 008759 335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVT 413 (554)
Q Consensus 335 ~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LVmE~~~ 413 (554)
+.||+|+||.||+|.+ .+++.+|+|.+... ........+.+|+++++.++|+||+++++++.....+|+||||+.
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 76 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET----LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQ 76 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc----CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeecc
Confidence 3699999999999998 57899999987532 123344678899999999999999999999999999999999999
Q ss_pred cCchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCCccCc----
Q 008759 414 KGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSC---- 487 (554)
Q Consensus 414 ggsL~~ll~~~--~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~~~s~---- 487 (554)
+++|.+++... .+++..+..++.|++.||.|||++||+|+||||+|||++.++.+||+|||++...........
T Consensus 77 ~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 156 (252)
T cd05084 77 GGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK 156 (252)
T ss_pred CCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence 99999998653 478899999999999999999999999999999999999999999999999875443221111
Q ss_pred cCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhH
Q 008759 488 RGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVS 536 (554)
Q Consensus 488 ~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~ 536 (554)
..+..|+|||.+.+.. ++.++|||||||++|+|++ |..||......+
T Consensus 157 ~~~~~y~aPE~~~~~~--~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~ 204 (252)
T cd05084 157 QIPVKWTAPEALNYGR--YSSESDVWSFGILLWEAFSLGAVPYANLSNQQ 204 (252)
T ss_pred CCceeecCchhhcCCC--CChHHHHHHHHHHHHHHHhCCCCCccccCHHH
Confidence 2345699999986543 7889999999999999998 999998766544
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=280.13 Aligned_cols=210 Identities=34% Similarity=0.605 Sum_probs=178.7
Q ss_pred ccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEE
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~ 406 (554)
.++|++.+.||.|+||.||++.+ .++..+|+|.+... .......+.+|+.+++.++|+||+++++.+.....+|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE-----SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLW 78 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC-----CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEE
Confidence 35789999999999999999998 57899999998642 2334467889999999999999999999999999999
Q ss_pred EEEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC--
Q 008759 407 IFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-- 482 (554)
Q Consensus 407 LVmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~-- 482 (554)
+||||+.+++|..++.. ..+++..+..++.|++.||.|||++||+|+||||+|||++.++.++|+|||++......
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (280)
T cd06611 79 ILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ 158 (280)
T ss_pred EEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence 99999999999999875 35899999999999999999999999999999999999999999999999987654322
Q ss_pred CccCccCCCcccChhhhccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHH
Q 008759 483 DVKSCRGTAFWMAPEVINNK---NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKT 542 (554)
Q Consensus 483 ~~~s~~GT~~Y~APEvl~~~---~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~ 542 (554)
......+++.|++||++... ...++.++|+|||||++|+|++|+.||...+....+..+.
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 221 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKIL 221 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHh
Confidence 22334589999999998532 2346789999999999999999999998877655544443
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=293.15 Aligned_cols=189 Identities=26% Similarity=0.333 Sum_probs=160.6
Q ss_pred cceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEE
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~L 407 (554)
..|++++.||+|+||.||+|.+ .++..||+|+... .....|+.+++.++|+||+++++++......|+
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~-----------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 134 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK-----------GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCM 134 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc-----------cccHHHHHHHHhCCCCCCcChhheEEeCCeeEE
Confidence 4699999999999999999998 5678899996432 123468999999999999999999999999999
Q ss_pred EEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC-Cc
Q 008759 408 FLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-DV 484 (554)
Q Consensus 408 VmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~-~~ 484 (554)
|||++.+ +|..++.. ..+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... ..
T Consensus 135 v~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 213 (357)
T PHA03209 135 VLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAF 213 (357)
T ss_pred EEEccCC-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCccc
Confidence 9999965 77777654 45889999999999999999999999999999999999999999999999998753322 23
Q ss_pred cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCC-CCCC
Q 008759 485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQI-PYAP 531 (554)
Q Consensus 485 ~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~-PF~~ 531 (554)
....||+.|+|||++.+. .++.++|||||||++|+|+++.. +|..
T Consensus 214 ~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvvl~ell~~~~~~f~~ 259 (357)
T PHA03209 214 LGLAGTVETNAPEVLARD--KYNSKADIWSAGIVLFEMLAYPSTIFED 259 (357)
T ss_pred ccccccccccCCeecCCC--CCCchhhHHHHHHHHHHHHHcCCccccC
Confidence 345699999999998654 48899999999999999998544 4443
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=313.61 Aligned_cols=216 Identities=31% Similarity=0.547 Sum_probs=189.6
Q ss_pred ccceeeeeeeccCCceeEEEEecC-CCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEE
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~~-~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~ 406 (554)
.+.|.|+.-||.|+||.||+|.++ ++-..|.|++. ....+.++.+.-||.||..+.||+||+|++.|..++.+|
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIe-----tkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLw 105 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIE-----TKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLW 105 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhc-----ccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceE
Confidence 457999999999999999999984 55566677665 345667788999999999999999999999999999999
Q ss_pred EEEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccc--cC
Q 008759 407 IFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK--LN 482 (554)
Q Consensus 407 LVmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~--~~ 482 (554)
|++|||.||-+..++-. ..+.+.++..+|+|++.||.|||+++|||||||..|||++-+|.|+|+|||.+.... ..
T Consensus 106 iliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~q 185 (1187)
T KOG0579|consen 106 ILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQ 185 (1187)
T ss_pred EEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHh
Confidence 99999999999887754 569999999999999999999999999999999999999999999999999865432 22
Q ss_pred CccCccCCCcccChhhhcc---cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHHHHHHH
Q 008759 483 DVKSCRGTAFWMAPEVINN---KNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTVAVTVI 548 (554)
Q Consensus 483 ~~~s~~GT~~Y~APEvl~~---~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~~~~~~ 548 (554)
...++.|||+|||||+++. +.++|++++||||||++|.||..+.+|-....++-.+++|....+..
T Consensus 186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPT 254 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT 254 (1187)
T ss_pred hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCc
Confidence 3567889999999999875 34569999999999999999999999999999999999988766544
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=281.36 Aligned_cols=209 Identities=27% Similarity=0.469 Sum_probs=175.3
Q ss_pred ceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEE
Q 008759 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (554)
Q Consensus 330 ~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LV 408 (554)
+|++.+.||+|+||.||+|.+ .+++.|++|++...............+..|+.+++.++|+||+++++++.+.+.+|+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 478889999999999999998 5789999999975433211223345677899999999999999999999999999999
Q ss_pred EeecccCchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC--Cc
Q 008759 409 LELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--DV 484 (554)
Q Consensus 409 mE~~~ggsL~~ll~~~--~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~--~~ 484 (554)
|||+ +++|..++... .+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++...... ..
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM 159 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCccc
Confidence 9999 88999999765 4899999999999999999999999999999999999999999999999998765432 22
Q ss_pred cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHH
Q 008759 485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFI 540 (554)
Q Consensus 485 ~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~ 540 (554)
....+++.|+|||.+.+. ..++.++|+|||||++|+|++|.+||......+.+.+
T Consensus 160 ~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~ 214 (298)
T cd07841 160 THQVVTRWYRAPELLFGA-RHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGK 214 (298)
T ss_pred cccccceeeeCHHHHhCC-CCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHH
Confidence 233568889999988543 2478899999999999999999888877665544433
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=274.82 Aligned_cols=200 Identities=33% Similarity=0.554 Sum_probs=172.1
Q ss_pred cceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEE
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~L 407 (554)
++|++.+.||+|+||.||+|++ .+++.||+|.+...... .......+.+|+.+++.++||||+++++.+...+.+|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMM--DAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNI 79 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccC--CHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEE
Confidence 5799999999999999999998 67899999988643222 23344668889999999999999999999999999999
Q ss_pred EEeecccCchHHHHhh-----hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC
Q 008759 408 FLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN 482 (554)
Q Consensus 408 VmE~~~ggsL~~ll~~-----~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~ 482 (554)
+|||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++......
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~ 159 (267)
T cd08228 80 VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence 9999999999988753 23788899999999999999999999999999999999999999999999998765432
Q ss_pred C--ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008759 483 D--VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM 532 (554)
Q Consensus 483 ~--~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~ 532 (554)
. .....+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~aPE~~~~~--~~~~~~Di~slG~~l~el~~g~~p~~~~ 209 (267)
T cd08228 160 TTAAHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred hHHHhcCCCCccccChhhhccC--CCCchhhHHHHHHHHHHHhcCCCCCccc
Confidence 2 2234588899999998654 3788999999999999999999999654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=276.61 Aligned_cols=202 Identities=26% Similarity=0.487 Sum_probs=172.1
Q ss_pred cceeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEE
Q 008759 329 TYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LV 408 (554)
++|++.+.||+|+||.||++.+.++..+|+|.+..... ....+.+|+.++..++||||+++++++.....+|++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM------SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIV 77 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc------cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEE
Confidence 47899999999999999999887777799998763211 124578899999999999999999999998999999
Q ss_pred EeecccCchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCCcc-
Q 008759 409 LELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK- 485 (554)
Q Consensus 409 mE~~~ggsL~~ll~~~--~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~~~- 485 (554)
|||+.+++|.+++... .+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||+++........
T Consensus 78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 9999999999998753 5889999999999999999999999999999999999999999999999998765433222
Q ss_pred --CccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHH
Q 008759 486 --SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAI 538 (554)
Q Consensus 486 --s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i 538 (554)
...++..|++||++.+. .++.++|||||||++|+|++ |..||......+..
T Consensus 158 ~~~~~~~~~y~~pe~~~~~--~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~ 211 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYS--KFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETV 211 (256)
T ss_pred cCCCccChhhCCHHHHhcC--cccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHH
Confidence 22356779999998654 37889999999999999999 99999877654433
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=319.27 Aligned_cols=203 Identities=25% Similarity=0.325 Sum_probs=171.8
Q ss_pred cceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEE
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~L 407 (554)
++|+++++||+|+||.||+|.+ .+++.||+|++..... ......+++.+|+.++..++||||+++++++.+.+..|+
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~--~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyL 79 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLS--ENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYY 79 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccc--cCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEE
Confidence 5799999999999999999998 6789999999864221 122334678899999999999999999999999999999
Q ss_pred EEeecccCchHHHHhhh------------cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCc
Q 008759 408 FLELVTKGSLLNLYQRY------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL 475 (554)
Q Consensus 408 VmE~~~ggsL~~ll~~~------------~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGl 475 (554)
||||+.|++|.+++... .++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 80 VMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGL 159 (932)
T PRK13184 80 TMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGA 159 (932)
T ss_pred EEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCc
Confidence 99999999999988641 234556788999999999999999999999999999999999999999999
Q ss_pred ccccccC--------------------CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChh
Q 008759 476 AKATKLN--------------------DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECV 535 (554)
Q Consensus 476 A~~~~~~--------------------~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~ 535 (554)
++..... ......||+.|||||++.+. .++.++|||||||++|+|+||..||......
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~--~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ 237 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGV--PASESTDIYALGVILYQMLTLSFPYRRKKGR 237 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCC--CCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 9765210 01124599999999998654 3789999999999999999999999765443
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=284.80 Aligned_cols=200 Identities=28% Similarity=0.499 Sum_probs=166.3
Q ss_pred cceeeeeeeccCCceeEEEEec-CCCc----EEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCC
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS-DDGF----FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES 403 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~-~~g~----~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~ 403 (554)
.+|++.+.||+|+||.||+|.+ .++. .||+|.+... ........+.+|+.+++.++|+||+++++++...
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~- 81 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA----TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS- 81 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc----CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-
Confidence 5799999999999999999986 3343 3888887532 1223345688999999999999999999998764
Q ss_pred cEEEEEeecccCchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccccc
Q 008759 404 KLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL 481 (554)
Q Consensus 404 ~~~LVmE~~~ggsL~~ll~~~--~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~ 481 (554)
..++++||+.+|+|.+++... .++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 82 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccC
Confidence 578999999999999988764 478888999999999999999999999999999999999999999999999986543
Q ss_pred CCc----cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChh
Q 008759 482 NDV----KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECV 535 (554)
Q Consensus 482 ~~~----~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~ 535 (554)
... ....++..|+|||++... .++.++|||||||++|+|++ |..||......
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~ 218 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 218 (316)
T ss_pred CCcceeccCCccceeecChHHhccC--CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 221 122346789999998654 47899999999999999998 99999876543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=278.12 Aligned_cols=205 Identities=30% Similarity=0.513 Sum_probs=170.2
Q ss_pred ceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEE
Q 008759 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (554)
Q Consensus 330 ~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LV 408 (554)
+|++.+.||+|+||.||+|.+ .+|..+|+|.+...... ......+.+|+.+++.++|+||+++++.+.+...+|+|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~---~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv 77 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD---EGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLV 77 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccccc---ccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEE
Confidence 488899999999999999998 67899999998743211 11224567899999999999999999999999999999
Q ss_pred EeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC--Cc
Q 008759 409 LELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--DV 484 (554)
Q Consensus 409 mE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~--~~ 484 (554)
+||+.+ +|..++.. ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||+++..... ..
T Consensus 78 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (284)
T cd07839 78 FEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCY 156 (284)
T ss_pred EecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCc
Confidence 999986 67776653 45899999999999999999999999999999999999999999999999998754332 22
Q ss_pred cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHH
Q 008759 485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIF 539 (554)
Q Consensus 485 ~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~ 539 (554)
....+++.|+|||++.+.. .++.++|||||||++|+|++|..||......+..+
T Consensus 157 ~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~ 210 (284)
T cd07839 157 SAEVVTLWYRPPDVLFGAK-LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL 210 (284)
T ss_pred CCCccccCCcChHHHhCCc-ccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHH
Confidence 3345789999999986532 46889999999999999999999876655444433
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=277.05 Aligned_cols=204 Identities=25% Similarity=0.430 Sum_probs=168.8
Q ss_pred cccceeeeeeeccCCceeEEEEecC------CCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeecc
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK 400 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~~------~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~ 400 (554)
..++|++.+.||+|+||.||+|.+. ++..||+|.+.... .......+.+|+.+++.++|+||+++++.+.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~----~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~ 79 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA----SMRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC----CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 4568999999999999999998752 35679999875321 1123356789999999999999999999999
Q ss_pred CCCcEEEEEeecccCchHHHHhhh-----------cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEE
Q 008759 401 DESKLYIFLELVTKGSLLNLYQRY-----------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVK 469 (554)
Q Consensus 401 ~~~~~~LVmE~~~ggsL~~ll~~~-----------~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vK 469 (554)
.....++||||+.+++|.+++... .+....+..++.|++.||.|||++|++|+||||+|||++.++.++
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEE
Confidence 999999999999999999988652 245677888999999999999999999999999999999999999
Q ss_pred EEecCcccccccCCc----cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhH
Q 008759 470 LADFGLAKATKLNDV----KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVS 536 (554)
Q Consensus 470 L~DFGlA~~~~~~~~----~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~ 536 (554)
|+|||+++....... ....+++.|+|||++.+. .++.++|||||||++|+|++ |..||......+
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~ 229 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ 229 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcC--CcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 999999875432211 123457789999998654 47889999999999999999 799998765543
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=280.47 Aligned_cols=208 Identities=32% Similarity=0.569 Sum_probs=176.0
Q ss_pred ccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEE
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~ 406 (554)
.+.|++++.||.|+||.||+|.+ .++..+++|.+... .......+.+|+.+++.++|+||+++++.+..++.+|
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK-----SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLW 85 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC-----CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEE
Confidence 46789999999999999999998 56899999998642 2334567888999999999999999999999999999
Q ss_pred EEEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC--
Q 008759 407 IFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-- 482 (554)
Q Consensus 407 LVmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~-- 482 (554)
+||||+.+++|..++.+ ..+++..+..++.||+.+|.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 86 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~ 165 (292)
T cd06644 86 IMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ 165 (292)
T ss_pred EEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccccc
Confidence 99999999999887754 45899999999999999999999999999999999999999999999999988653322
Q ss_pred CccCccCCCcccChhhhccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHH
Q 008759 483 DVKSCRGTAFWMAPEVINNK---NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFI 540 (554)
Q Consensus 483 ~~~s~~GT~~Y~APEvl~~~---~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~ 540 (554)
......+++.|+|||++.+. ...++.++|+|||||++|+|++|..||...........
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~ 226 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLK 226 (292)
T ss_pred ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHH
Confidence 22344688999999998532 22367899999999999999999999987665444333
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=274.51 Aligned_cols=202 Identities=28% Similarity=0.485 Sum_probs=172.0
Q ss_pred ccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEE
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~ 406 (554)
...|.+.+.||+|+||.||+|.+ .++..+|+|++... ......+.+|+.+++.++|+||+++++.+...+.++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED------TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 78 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC------chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcE
Confidence 35688999999999999999998 56889999987631 122456788999999999999999999999999999
Q ss_pred EEEeecccCchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC
Q 008759 407 IFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND 483 (554)
Q Consensus 407 LVmE~~~ggsL~~ll~~~---~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~ 483 (554)
++|||+.+++|.+++... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 79 IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 158 (263)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence 999999999999988653 47888899999999999999999999999999999999999999999999987654432
Q ss_pred cc---CccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHH
Q 008759 484 VK---SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSA 537 (554)
Q Consensus 484 ~~---s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~ 537 (554)
.. ...++..|+|||.+.+. .++.++|||||||++|+|++ |..||...+..+.
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~ 214 (263)
T cd05052 159 YTAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV 214 (263)
T ss_pred eeccCCCCCccccCCHHHhccC--CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 21 12345679999988554 47889999999999999998 9999987665443
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=273.18 Aligned_cols=206 Identities=31% Similarity=0.495 Sum_probs=175.2
Q ss_pred cccceeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEE
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~ 406 (554)
..++|++.+.||+|+||.||+|.+.++..+|+|.+..... ....+.+|+.+++.++|+||+++++.+......+
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM------SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIY 77 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc------CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceE
Confidence 3568999999999999999999988788999998864221 2346788999999999999999999999889999
Q ss_pred EEEeecccCchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC
Q 008759 407 IFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND 483 (554)
Q Consensus 407 LVmE~~~ggsL~~ll~~~---~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~ 483 (554)
+||||+.+++|.+++... .++...+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++.......
T Consensus 78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 999999999999998653 58899999999999999999999999999999999999999999999999987654322
Q ss_pred c---cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHHHH
Q 008759 484 V---KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIFI 540 (554)
Q Consensus 484 ~---~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i~~ 540 (554)
. ....++..|+|||.+.+. .++.++|+|||||++|+|++ |+.||........+..
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~ 216 (261)
T cd05034 158 YTAREGAKFPIKWTAPEAANYG--RFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQ 216 (261)
T ss_pred hhhhhccCCCccccCHHHhccC--CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 1 122345679999998654 37889999999999999998 9999987765544433
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=278.29 Aligned_cols=209 Identities=32% Similarity=0.588 Sum_probs=176.2
Q ss_pred cceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEE
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~L 407 (554)
+.|++.+.||+|+||.||++.+ .++..+++|.+... .......+.+|+.+++.++|+||+++++.+...+..|+
T Consensus 5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~-----~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~ 79 (282)
T cd06643 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK-----SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWI 79 (282)
T ss_pred HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC-----CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEE
Confidence 3578889999999999999998 56788899987532 12345678889999999999999999999999999999
Q ss_pred EEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC--C
Q 008759 408 FLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--D 483 (554)
Q Consensus 408 VmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~--~ 483 (554)
||||+.+++|..++.+ ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++...... .
T Consensus 80 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~ 159 (282)
T cd06643 80 LIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR 159 (282)
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccccc
Confidence 9999999999887754 46899999999999999999999999999999999999999999999999998654322 2
Q ss_pred ccCccCCCcccChhhhcc---cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHH
Q 008759 484 VKSCRGTAFWMAPEVINN---KNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKT 542 (554)
Q Consensus 484 ~~s~~GT~~Y~APEvl~~---~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~ 542 (554)
.....++..|+|||++.. ....++.++|||||||++|+|++|+.||......+....+.
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~ 221 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIA 221 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHh
Confidence 233468999999999842 22346789999999999999999999998877665555543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=277.47 Aligned_cols=205 Identities=38% Similarity=0.680 Sum_probs=177.6
Q ss_pred cceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEE
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~L 407 (554)
..|+..+.||.|+||.||+|.+ .++..+|+|.+.... .......+.+|+.+++.+.|+||+++++.+.+...+|+
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE----AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWI 79 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc----cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence 4677889999999999999998 568999999887422 12345678899999999999999999999999999999
Q ss_pred EEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC--cc
Q 008759 408 FLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VK 485 (554)
Q Consensus 408 VmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~--~~ 485 (554)
||||+.+++|.+++....+++.++..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 80 v~e~~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06640 80 IMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred EEecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCccccc
Confidence 9999999999999988889999999999999999999999999999999999999999999999999987654322 22
Q ss_pred CccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHH
Q 008759 486 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIF 539 (554)
Q Consensus 486 s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~ 539 (554)
...++..|+|||++.+. .++.++|+|||||++|+|++|..||.........+
T Consensus 160 ~~~~~~~y~apE~~~~~--~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~ 211 (277)
T cd06640 160 TFVGTPFWMAPEVIQQS--AYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF 211 (277)
T ss_pred cccCcccccCHhHhccC--CCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh
Confidence 34578899999998654 37889999999999999999999998776554443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=269.52 Aligned_cols=207 Identities=29% Similarity=0.544 Sum_probs=174.1
Q ss_pred ceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccC-CCcEEE
Q 008759 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD-ESKLYI 407 (554)
Q Consensus 330 ~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~-~~~~~L 407 (554)
.|++.+.||+|+||.||++.+ .+++.||+|++...... ....+.+.+|+.+++.++|+||+++++.+.. ...+|+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~l 77 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNAS---RRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYI 77 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcC---HHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEE
Confidence 488999999999999999998 56889999998643221 2334567889999999999999999988764 446899
Q ss_pred EEeecccCchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC--
Q 008759 408 FLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-- 482 (554)
Q Consensus 408 VmE~~~ggsL~~ll~~~---~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~-- 482 (554)
+|||+.+++|.+++... .+++.++..++.|++.||.+||++||+|+||||+|||++.++.++|+|||++......
T Consensus 78 v~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 78 VMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred EecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence 99999999999988652 4889999999999999999999999999999999999999999999999998765322
Q ss_pred CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHH
Q 008759 483 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIK 541 (554)
Q Consensus 483 ~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i 541 (554)
......+++.|+|||++.+. .++.++|+|||||++|+|++|+.||...+.....+.+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~ 214 (257)
T cd08223 158 MASTLIGTPYYMSPELFSNK--PYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRI 214 (257)
T ss_pred ccccccCCcCccChhHhcCC--CCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 22344688999999998654 4788999999999999999999999877765554443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=278.05 Aligned_cols=200 Identities=31% Similarity=0.493 Sum_probs=169.5
Q ss_pred ccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEE
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~ 406 (554)
.++|++.+.||+|+||.||+|.+ .+++.||+|.+....... ....+.+|+.+++.++|+||+++++++...+..|
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG----APFTAIREASLLKDLKHANIVTLHDIIHTKKTLT 79 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC----CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEE
Confidence 46899999999999999999998 578999999987532211 1123568999999999999999999999999999
Q ss_pred EEEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC--
Q 008759 407 IFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-- 482 (554)
Q Consensus 407 LVmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~-- 482 (554)
+||||+.+ +|.+++.. ..+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||+++.....
T Consensus 80 lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 80 LVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred EEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 99999986 88888765 35788999999999999999999999999999999999999999999999998654322
Q ss_pred CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008759 483 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME 533 (554)
Q Consensus 483 ~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e 533 (554)
......++..|+|||++.+.. .++.++|||||||++|+|++|+.||....
T Consensus 159 ~~~~~~~~~~~~aPE~~~~~~-~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 208 (291)
T cd07844 159 TYSNEVVTLWYRPPDVLLGST-EYSTSLDMWGVGCIFYEMATGRPLFPGST 208 (291)
T ss_pred cccccccccccCCcHHhhcCc-ccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 122234688899999986432 47889999999999999999999998765
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=275.46 Aligned_cols=207 Identities=27% Similarity=0.464 Sum_probs=176.3
Q ss_pred ceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEE
Q 008759 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (554)
Q Consensus 330 ~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LV 408 (554)
+|++++.||+|+||.||+|.+ .++..|++|++...... ......+.+|+.+++.++|+||+++++.+.....+|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~---~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v 77 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE---GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLV 77 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc---chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEE
Confidence 488999999999999999998 57899999998753321 22345688999999999999999999999999999999
Q ss_pred EeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC---
Q 008759 409 LELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--- 483 (554)
Q Consensus 409 mE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~--- 483 (554)
|||+ +++|.+++.. ..+++..+..++.||+.+|.|||++||+|+||||+||+++.++.++|+|||++.......
T Consensus 78 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (286)
T cd07832 78 MEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL 156 (286)
T ss_pred eccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCc
Confidence 9999 9999998865 358999999999999999999999999999999999999999999999999987654332
Q ss_pred ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHH
Q 008759 484 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIK 541 (554)
Q Consensus 484 ~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i 541 (554)
.....++..|+|||++.+. ..++.++|||||||++|+|++|.+||........+.++
T Consensus 157 ~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~ 213 (286)
T cd07832 157 YSHQVATRWYRAPELLYGA-RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIV 213 (286)
T ss_pred cccccCcccccCceeeecc-ccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHH
Confidence 3345689999999998543 24688999999999999999999888776655544443
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=275.14 Aligned_cols=207 Identities=29% Similarity=0.466 Sum_probs=176.1
Q ss_pred ccceeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEE
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~L 407 (554)
..+|++++.||.|+||.||+|.+.++..+++|.+.... ......+..|+.+++.++|+||+++++++.....+|+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD-----LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYI 79 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc-----hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEE
Confidence 45789999999999999999999779999999986422 2234567889999999999999999999999999999
Q ss_pred EEeecccCchHHHHhh---hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC-
Q 008759 408 FLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND- 483 (554)
Q Consensus 408 VmE~~~ggsL~~ll~~---~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~- 483 (554)
||||+.+++|.+++.. ..+.+..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.......
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 80 ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred EEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 9999999999999875 347889999999999999999999999999999999999999999999999987654322
Q ss_pred -ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHHHHH
Q 008759 484 -VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIFIK 541 (554)
Q Consensus 484 -~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i~~i 541 (554)
.....++..|++||++... .++.++|||||||++|+|++ |+.||......+.+..+
T Consensus 160 ~~~~~~~~~~~~~PE~~~~~--~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~ 217 (261)
T cd05148 160 LSSDKKIPYKWTAPEAASHG--TFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI 217 (261)
T ss_pred cccCCCCceEecCHHHHccC--CCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH
Confidence 1223456789999998543 47889999999999999998 89999877655544433
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=275.52 Aligned_cols=207 Identities=34% Similarity=0.649 Sum_probs=172.5
Q ss_pred ccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhC-CCCceeeeeeeccC----
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKD---- 401 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIVkl~~~~~~---- 401 (554)
.+.|++.+.||+|+||.||+|.+ .+++.||+|++..... ....+.+|+.++..+ +|+||+++++.+..
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~------~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 78 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD------EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 78 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCC
Confidence 35678889999999999999988 6789999999864321 124567889999988 69999999998764
Q ss_pred --CCcEEEEEeecccCchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcc
Q 008759 402 --ESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA 476 (554)
Q Consensus 402 --~~~~~LVmE~~~ggsL~~ll~~~---~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA 476 (554)
...+|++|||+.+++|.+++... .+++..+..++.|++.||.|||+++|+|+||||+|||++.++.++|+|||++
T Consensus 79 ~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 79 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred CCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCc
Confidence 24689999999999999988752 4788999999999999999999999999999999999999999999999998
Q ss_pred cccccC--CccCccCCCcccChhhhccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHH
Q 008759 477 KATKLN--DVKSCRGTAFWMAPEVINNK---NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFI 540 (554)
Q Consensus 477 ~~~~~~--~~~s~~GT~~Y~APEvl~~~---~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~ 540 (554)
...... ......|++.|+|||++... ...++.++|||||||++|+|++|..||.........+.
T Consensus 159 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~ 227 (272)
T cd06637 159 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL 227 (272)
T ss_pred eecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHH
Confidence 754322 23345689999999998632 22478899999999999999999999987766555543
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=269.27 Aligned_cols=201 Identities=28% Similarity=0.496 Sum_probs=172.4
Q ss_pred eeeccCCceeEEEEecC-C---CcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEEEe
Q 008759 335 DLLGRGSFGSVYEGISD-D---GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLE 410 (554)
Q Consensus 335 ~~LG~GsfG~VY~a~~~-~---g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LVmE 410 (554)
+.||+|+||.||+|.+. . +..|++|.+...... .....+.+|+.++..++|+||+++++++.....+++|||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 76 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASE----EERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLE 76 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccch----hHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEE
Confidence 46999999999999984 3 889999988753221 145678899999999999999999999999999999999
Q ss_pred ecccCchHHHHhh----------hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccc
Q 008759 411 LVTKGSLLNLYQR----------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK 480 (554)
Q Consensus 411 ~~~ggsL~~ll~~----------~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~ 480 (554)
|+.+++|.++++. ..+++..+..++.|++.||.|||++||+|+||||+|||++.++.+||+|||++....
T Consensus 77 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 77 YMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVY 156 (262)
T ss_pred eccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccc
Confidence 9999999999876 458999999999999999999999999999999999999999999999999997665
Q ss_pred cCC----ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHHHHH
Q 008759 481 LND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIFIK 541 (554)
Q Consensus 481 ~~~----~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i~~i 541 (554)
... .....++..|+|||.+... .++.++|||||||++|+|++ |..||......+....+
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~ 220 (262)
T cd00192 157 DDDYYRKKTGGKLPIRWMAPESLKDG--IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYL 220 (262)
T ss_pred cccccccccCCCcCccccCHHHhccC--CcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 432 3344578899999998654 47889999999999999999 69999988655444333
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=274.37 Aligned_cols=200 Identities=26% Similarity=0.406 Sum_probs=161.1
Q ss_pred eeccCCceeEEEEecC---CCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEEEeec
Q 008759 336 LLGRGSFGSVYEGISD---DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELV 412 (554)
Q Consensus 336 ~LG~GsfG~VY~a~~~---~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LVmE~~ 412 (554)
.||+|+||.||+|... ....+++|.+... ........+.+|+.+++.++|+||+++++.+.....+|+||||+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~ 77 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRAS----ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFC 77 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCcc----CChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeC
Confidence 5899999999999753 3346777765431 12333456788999999999999999999999999999999999
Q ss_pred ccCchHHHHhhhc------CChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC---
Q 008759 413 TKGSLLNLYQRYH------LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--- 483 (554)
Q Consensus 413 ~ggsL~~ll~~~~------l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~--- 483 (554)
.+|+|.+++.... +.+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 78 PLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred CCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 9999999986532 3566788999999999999999999999999999999999999999999986532221
Q ss_pred -ccCccCCCcccChhhhccc-----CCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHHH
Q 008759 484 -VKSCRGTAFWMAPEVINNK-----NKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIF 539 (554)
Q Consensus 484 -~~s~~GT~~Y~APEvl~~~-----~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i~ 539 (554)
.....+++.|+|||++... ...++.++|||||||++|+|++ |..||......+.+.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~ 220 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLK 220 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHH
Confidence 1223356779999998542 2246789999999999999999 889998876655433
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=273.51 Aligned_cols=211 Identities=42% Similarity=0.748 Sum_probs=178.0
Q ss_pred ceeeeeeeccCCceeEEEEec-CCCcEEEEEEEeccccc-----chhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCC
Q 008759 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQG-----SQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES 403 (554)
Q Consensus 330 ~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~-----~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~ 403 (554)
+|.+.+.||.|+||.||+|.+ .+++.+|+|.+...... .......+.+.+|+.+++.++|+||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 488899999999999999987 57899999988642111 112233467888999999999999999999999999
Q ss_pred cEEEEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC
Q 008759 404 KLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN 482 (554)
Q Consensus 404 ~~~LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~ 482 (554)
.+++||||+.+++|.+++.+ ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 161 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI 161 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence 99999999999999998876 46888899999999999999999999999999999999999999999999998754321
Q ss_pred ----CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHH
Q 008759 483 ----DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFI 540 (554)
Q Consensus 483 ----~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~ 540 (554)
......++..|+|||++......++.++|+||||+++|+|++|..||...+....++.
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~ 223 (272)
T cd06629 162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFK 223 (272)
T ss_pred ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHH
Confidence 1223458889999999876544578899999999999999999999987766555544
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=297.91 Aligned_cols=202 Identities=27% Similarity=0.431 Sum_probs=175.9
Q ss_pred cccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcE
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL 405 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~ 405 (554)
..+.|..-++||+|+||.||-++- .+|+.||+|++.+.... .+....-.++|..+|.+++.++||.+-.+|.+.+.+
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiK--kr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~L 260 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIK--KRKGETMALNEKQILEKVSSPFIVSLAYAFETKDAL 260 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHH--HhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCce
Confidence 345788889999999999999987 78999999987643322 222334466899999999999999999999999999
Q ss_pred EEEEeecccCchHHHHhh-h--cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC
Q 008759 406 YIFLELVTKGSLLNLYQR-Y--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN 482 (554)
Q Consensus 406 ~LVmE~~~ggsL~~ll~~-~--~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~ 482 (554)
|+||..|.||+|.-.+-+ + +|++..+..|+.+|+.||++||+.+||+|||||+|||+|+.|+|.|+|+|||..+..+
T Consensus 261 ClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g 340 (591)
T KOG0986|consen 261 CLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG 340 (591)
T ss_pred EEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence 999999999999865543 3 6999999999999999999999999999999999999999999999999999987766
Q ss_pred Cc-cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008759 483 DV-KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM 532 (554)
Q Consensus 483 ~~-~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~ 532 (554)
.. ...+||.+|||||+++... |+...|||+|||++|||+.|+-||...
T Consensus 341 ~~~~~rvGT~GYMAPEvl~ne~--Y~~s~Dwf~lGCllYemi~G~sPFr~~ 389 (591)
T KOG0986|consen 341 KPIRGRVGTVGYMAPEVLQNEV--YDFSPDWFSLGCLLYEMIAGHSPFRQR 389 (591)
T ss_pred CccccccCcccccCHHHHcCCc--ccCCccHHHHHhHHHHHHcccCchhhh
Confidence 54 4458999999999997654 899999999999999999999999753
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=274.97 Aligned_cols=203 Identities=32% Similarity=0.486 Sum_probs=170.1
Q ss_pred ccceeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEE
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~L 407 (554)
.++|++.++||+|+||.||+|.+.+...+|+|++..... ....+.+|+.+++.++|+||+++++.+. ....|+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~------~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~l 77 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM------SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYI 77 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc------CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEE
Confidence 457999999999999999999987667799998864221 1245788999999999999999999874 456899
Q ss_pred EEeecccCchHHHHhh---hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCCc
Q 008759 408 FLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV 484 (554)
Q Consensus 408 VmE~~~ggsL~~ll~~---~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~~ 484 (554)
||||+.+++|.+++.. ..+++..+..++.|++.||.|||+++|+|+||||+|||++.++.++|+|||++........
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 78 VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 157 (262)
T ss_pred EEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence 9999999999999875 3478889999999999999999999999999999999999999999999999876543322
Q ss_pred ---cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHHH
Q 008759 485 ---KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIF 539 (554)
Q Consensus 485 ---~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i~ 539 (554)
....++..|++||++.+. .++.++|+|||||++|+|++ |..||......+.+.
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~--~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~ 214 (262)
T cd05071 158 TARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD 214 (262)
T ss_pred ccccCCcccceecCHhHhccC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHH
Confidence 123466789999988544 37889999999999999999 899998776554433
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=269.62 Aligned_cols=207 Identities=29% Similarity=0.513 Sum_probs=177.3
Q ss_pred ceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEE
Q 008759 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (554)
Q Consensus 330 ~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LV 408 (554)
+|+..+.||.|+||.||.+.. .++..+++|.+...... ......+.+|+.++++++|+||+++++++.+.+.++++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~ 77 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS---EKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIE 77 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccc---hhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEE
Confidence 488999999999999999988 77899999998653322 23345678999999999999999999999999999999
Q ss_pred EeecccCchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC--
Q 008759 409 LELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-- 483 (554)
Q Consensus 409 mE~~~ggsL~~ll~~~---~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~-- 483 (554)
|||+.+++|.+++.+. .+++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.+||+|||++.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~ 157 (256)
T cd08221 78 MEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSM 157 (256)
T ss_pred EEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccccc
Confidence 9999999999998764 48889999999999999999999999999999999999999999999999987654332
Q ss_pred ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHH
Q 008759 484 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIK 541 (554)
Q Consensus 484 ~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i 541 (554)
.....+++.|+|||++.+.. ++.++|+|||||++|+|++|..||......+....+
T Consensus 158 ~~~~~~~~~y~ape~~~~~~--~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~ 213 (256)
T cd08221 158 AETVVGTPYYMSPELCQGVK--YNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKI 213 (256)
T ss_pred ccccCCCccccCHhhcCCCC--CCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 23456899999999986543 678899999999999999999999876655544443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=279.70 Aligned_cols=206 Identities=28% Similarity=0.536 Sum_probs=168.2
Q ss_pred cceeeeeeeccCCceeEEEEec-CCCc--EEEEEEEecccccchhHHHHHHHHHHHHHHHhC-CCCceeeeeeeccCCCc
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS-DDGF--FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESK 404 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~-~~g~--~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIVkl~~~~~~~~~ 404 (554)
++|++.+.||+|+||.||+|++ .++. .+++|.++... .....+.+.+|+.++.++ +||||+++++.+...+.
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 77 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA----SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGY 77 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC----CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCc
Confidence 5789999999999999999987 3443 46777765311 122345688899999999 79999999999999999
Q ss_pred EEEEEeecccCchHHHHhhh-----------------cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCc
Q 008759 405 LYIFLELVTKGSLLNLYQRY-----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS 467 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~~-----------------~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~ 467 (554)
+|++|||+.+++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~ 157 (297)
T cd05089 78 LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLA 157 (297)
T ss_pred ceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCe
Confidence 99999999999999998653 3778889999999999999999999999999999999999999
Q ss_pred EEEEecCcccccccCCcc-CccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHHHH
Q 008759 468 VKLADFGLAKATKLNDVK-SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIFI 540 (554)
Q Consensus 468 vKL~DFGlA~~~~~~~~~-s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i~~ 540 (554)
+||+|||++......... ....+..|+|||++... .++.++|||||||++|+|++ |..||......+...+
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~ 230 (297)
T cd05089 158 SKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYS--VYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEK 230 (297)
T ss_pred EEECCcCCCccccceeccCCCCcCccccCchhhccC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 999999998643222111 12235579999998544 47889999999999999997 9999988766554333
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=281.74 Aligned_cols=203 Identities=29% Similarity=0.534 Sum_probs=166.8
Q ss_pred ccceeeeeeeccCCceeEEEEec-CCCcE--EEEEEEecccccchhHHHHHHHHHHHHHHHhC-CCCceeeeeeeccCCC
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFF--FAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDES 403 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~-~~g~~--vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIVkl~~~~~~~~ 403 (554)
.++|++.+.||+|+||.||+|.+ .++.. +++|.+.. .........+.+|+.++.++ +|+||+++++++...+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~----~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~ 81 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE----YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 81 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecc----cCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC
Confidence 45789999999999999999997 45544 46665542 11233446788899999999 8999999999999999
Q ss_pred cEEEEEeecccCchHHHHhhh-----------------cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCC
Q 008759 404 KLYIFLELVTKGSLLNLYQRY-----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG 466 (554)
Q Consensus 404 ~~~LVmE~~~ggsL~~ll~~~-----------------~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g 466 (554)
.+|+||||+.+++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~ 161 (303)
T cd05088 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 161 (303)
T ss_pred CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC
Confidence 999999999999999998643 367888999999999999999999999999999999999999
Q ss_pred cEEEEecCcccccccCCc-cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhH
Q 008759 467 SVKLADFGLAKATKLNDV-KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVS 536 (554)
Q Consensus 467 ~vKL~DFGlA~~~~~~~~-~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~ 536 (554)
.+||+|||++........ ....++..|+|||++... .++.++|||||||++|+|+| |..||......+
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 231 (303)
T cd05088 162 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE 231 (303)
T ss_pred cEEeCccccCcccchhhhcccCCCcccccCHHHHhcc--CCcccccchhhhhHHHHHHhcCCCCcccCChHH
Confidence 999999999864322111 112246679999988554 37889999999999999998 999998765543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=304.30 Aligned_cols=216 Identities=28% Similarity=0.492 Sum_probs=183.9
Q ss_pred ccccccceeeeeeeccCCceeEEEEecC--CC--cE-EEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeee
Q 008759 324 FKRIITYWQKGDLLGRGSFGSVYEGISD--DG--FF-FAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGT 398 (554)
Q Consensus 324 ~~~~~~~y~i~~~LG~GsfG~VY~a~~~--~g--~~-vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~ 398 (554)
+....++..+.++||+|.||.||+|... ++ .. ||+|..+... ...+..+..+.+|.+++++++|||||++||+
T Consensus 152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~--~~~~~~~~e~m~EArvMr~l~H~NVVr~yGV 229 (474)
T KOG0194|consen 152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSS--ELTKEQIKEFMKEARVMRQLNHPNVVRFYGV 229 (474)
T ss_pred cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccc--cccHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 3334456677899999999999999872 22 23 7888876411 2335667889999999999999999999999
Q ss_pred ccCCCcEEEEEeecccCchHHHHhhhc--CChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcc
Q 008759 399 DKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA 476 (554)
Q Consensus 399 ~~~~~~~~LVmE~~~ggsL~~ll~~~~--l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA 476 (554)
+.....+|+|||+|.||+|.++|++.+ ++..+...++.+.+.||+|||++++|||||-.+|+|++.++.+||+||||+
T Consensus 230 a~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs 309 (474)
T KOG0194|consen 230 AVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLS 309 (474)
T ss_pred EcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccc
Confidence 999999999999999999999999865 999999999999999999999999999999999999999999999999998
Q ss_pred cccccCC-cc-CccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHH
Q 008759 477 KATKLND-VK-SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIFIKTV 543 (554)
Q Consensus 477 ~~~~~~~-~~-s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i~~i~~ 543 (554)
+...... .. .+.....|+|||.+... .|+.++|||||||++||+++ |..||.++...+..-++..
T Consensus 310 ~~~~~~~~~~~~~klPirWLAPEtl~~~--~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~ 377 (474)
T KOG0194|consen 310 RAGSQYVMKKFLKKLPIRWLAPETLNTG--IFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVK 377 (474)
T ss_pred cCCcceeeccccccCcceecChhhhccC--ccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHh
Confidence 7654211 12 23467889999999765 48999999999999999999 8999999999887777744
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=277.05 Aligned_cols=197 Identities=34% Similarity=0.522 Sum_probs=165.6
Q ss_pred ceeeeeeeccCCceeEEEEec-----CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccC--C
Q 008759 330 YWQKGDLLGRGSFGSVYEGIS-----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD--E 402 (554)
Q Consensus 330 ~y~i~~~LG~GsfG~VY~a~~-----~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~--~ 402 (554)
+|++.+.||+|+||+||++.. .++..+|+|.+..... ......+.+|+.+|+.++||||+++++++.. .
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (283)
T cd05080 5 YLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG----QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG 80 (283)
T ss_pred hceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC----hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 458999999999999988642 4678999998864211 2234567789999999999999999998754 3
Q ss_pred CcEEEEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC
Q 008759 403 SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN 482 (554)
Q Consensus 403 ~~~~LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~ 482 (554)
..+|++|||+.+++|.+++....+++.++..++.|++.||.|||++||+||||||+|||++.++.++|+|||+++.....
T Consensus 81 ~~~~lv~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 81 KGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160 (283)
T ss_pred ceEEEEecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence 46899999999999999998888999999999999999999999999999999999999999999999999998765432
Q ss_pred C-----ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008759 483 D-----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM 532 (554)
Q Consensus 483 ~-----~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~ 532 (554)
. .....++..|++||.+... .++.++|||||||++|+|++|+.||...
T Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~ 213 (283)
T cd05080 161 HEYYRVREDGDSPVFWYAVECLKEN--KFSYASDVWSFGVTLYELLTHCDSKQSP 213 (283)
T ss_pred chhhccCCCCCCCceeeCHhHhccc--CCCcccccHHHHHHHHHHHhCCCCCCCC
Confidence 1 1122356679999998543 3788999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=272.88 Aligned_cols=201 Identities=31% Similarity=0.515 Sum_probs=176.2
Q ss_pred ceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEE
Q 008759 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (554)
Q Consensus 330 ~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LV 408 (554)
.|++.+.||.|+||.||+|.+ .++..||+|++..... ......+.+.+|+.++++++||||+++++.+.....+|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 78 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKC--VEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLV 78 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhh--cchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEE
Confidence 488999999999999999998 5799999999874322 1123456788999999999999999999999999999999
Q ss_pred EeecccCchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC-CccC
Q 008759 409 LELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-DVKS 486 (554)
Q Consensus 409 mE~~~ggsL~~ll~~~-~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~-~~~s 486 (554)
|||+.+++|..++... .+.+..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++...... ....
T Consensus 79 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 158 (258)
T cd05578 79 VDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTS 158 (258)
T ss_pred EeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCccccc
Confidence 9999999999998765 7899999999999999999999999999999999999999999999999998765433 2334
Q ss_pred ccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh
Q 008759 487 CRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC 534 (554)
Q Consensus 487 ~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~ 534 (554)
..++..|++||++.... ++.++|+||||+++|+|++|..||.....
T Consensus 159 ~~~~~~y~~PE~~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 204 (258)
T cd05578 159 TSGTPGYMAPEVLCRQG--YSVAVDWWSLGVTAYECLRGKRPYRGHSR 204 (258)
T ss_pred cCCChhhcCHHHHcccC--CCCcccchhhHHHHHHHHhCCCCCCCCCc
Confidence 56888999999986543 78899999999999999999999987653
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-33 Score=281.68 Aligned_cols=191 Identities=32% Similarity=0.511 Sum_probs=156.0
Q ss_pred eeeeeccCCceeEEEEecC---CCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeecc--CCCcEEE
Q 008759 333 KGDLLGRGSFGSVYEGISD---DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK--DESKLYI 407 (554)
Q Consensus 333 i~~~LG~GsfG~VY~a~~~---~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~--~~~~~~L 407 (554)
.+.+||+|+||.||+|.+. ++..||+|.+..... ...+.+|+.+++.++||||+++++++. ....+|+
T Consensus 5 ~g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~l 77 (317)
T cd07867 5 EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-------SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWL 77 (317)
T ss_pred eceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-------cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEE
Confidence 3468999999999999863 567899998763211 234678999999999999999999874 4567899
Q ss_pred EEeecccCchHHHHhh----------hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEE----cCCCcEEEEec
Q 008759 408 FLELVTKGSLLNLYQR----------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV----DANGSVKLADF 473 (554)
Q Consensus 408 VmE~~~ggsL~~ll~~----------~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILl----d~~g~vKL~DF 473 (554)
||||+.+ +|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 78 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07867 78 LFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred EEeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence 9999886 66666532 137788899999999999999999999999999999999 56679999999
Q ss_pred CcccccccC-----CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008759 474 GLAKATKLN-----DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM 532 (554)
Q Consensus 474 GlA~~~~~~-----~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~ 532 (554)
|+++..... ......+|+.|+|||++.+.. .++.++|||||||++|+|+||++||...
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGAR-HYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred cceeccCCCcccccccCcceecccccCcHHhcCCC-ccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 999765432 123456899999999986532 4788999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=276.07 Aligned_cols=200 Identities=31% Similarity=0.494 Sum_probs=165.5
Q ss_pred cceeeeeeeccCCceeEEEEec-CCCcE----EEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCC
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFF----FAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES 403 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~-~~g~~----vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~ 403 (554)
++|++.+.||+|+||+||+|.+ .++.. +++|.+.. .........+..|+.++..+.||||+++++++. ..
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~----~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~ 81 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQD----RSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GA 81 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccc----ccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CC
Confidence 5788999999999999999987 45553 56666532 222334466778888999999999999999875 45
Q ss_pred cEEEEEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccccc
Q 008759 404 KLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL 481 (554)
Q Consensus 404 ~~~LVmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~ 481 (554)
..++++||+.+|+|.+++.. ..+++..+..++.||+.||.|||+++++|+||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 67899999999999999865 3578999999999999999999999999999999999999999999999999876432
Q ss_pred CC----ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChh
Q 008759 482 ND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECV 535 (554)
Q Consensus 482 ~~----~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~ 535 (554)
.. .....++..|++||++.+. .++.++|||||||++|||++ |..||......
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~ 218 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFG--RYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH 218 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccC--CcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 21 2233467789999998654 37899999999999999998 99999876553
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=273.44 Aligned_cols=206 Identities=28% Similarity=0.468 Sum_probs=172.6
Q ss_pred cccceeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEE
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~ 406 (554)
..++|++.+.||+|+||.||+|.+.++..+|+|.+...... ...+.+|+.++++++|+||+++++.+. ....|
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~------~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~ 76 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS------PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIY 76 (260)
T ss_pred chHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC------HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcE
Confidence 34688999999999999999999888888999988742221 245789999999999999999999875 45689
Q ss_pred EEEeecccCchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC
Q 008759 407 IFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND 483 (554)
Q Consensus 407 LVmE~~~ggsL~~ll~~~---~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~ 483 (554)
++|||+.+++|.+++... .+++..+..++.|++.||.|||++||+|+||||+|||++.++.++|+|||++.......
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 999999999999998652 47889999999999999999999999999999999999999999999999987654322
Q ss_pred c---cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHHHHH
Q 008759 484 V---KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIFIK 541 (554)
Q Consensus 484 ~---~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i~~i 541 (554)
. ....++..|+|||++... .++.++|+||||+++|+|++ |.+||...+..+....+
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~ 216 (260)
T cd05070 157 YTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQV 216 (260)
T ss_pred cccccCCCCCccccChHHHhcC--CCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 1 122356679999998543 37889999999999999999 99999887665544443
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=309.52 Aligned_cols=210 Identities=29% Similarity=0.533 Sum_probs=176.1
Q ss_pred cceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCC-----
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE----- 402 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~----- 402 (554)
.-|...+.||+|+||.||++++ .+|+.||+|.+.... .....+...+|+++|++++|+|||++++.-.+.
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~----~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~ 88 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES----SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLV 88 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhc----ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcc
Confidence 3577788999999999999997 889999999987533 122346678999999999999999999975443
Q ss_pred -CcEEEEEeecccCchHHHHhh----hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEc--CCC--cEEEEec
Q 008759 403 -SKLYIFLELVTKGSLLNLYQR----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD--ANG--SVKLADF 473 (554)
Q Consensus 403 -~~~~LVmE~~~ggsL~~ll~~----~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld--~~g--~vKL~DF 473 (554)
....+|||||.||+|...+++ +++++.+++.++..+..||.|||++||+||||||.||++. .+| ..||+||
T Consensus 89 ~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDf 168 (732)
T KOG4250|consen 89 TRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDF 168 (732)
T ss_pred cccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecc
Confidence 357899999999999999975 5899999999999999999999999999999999999984 334 3699999
Q ss_pred CcccccccC-CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh----hHHHHHHHH
Q 008759 474 GLAKATKLN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC----VSAIFIKTV 543 (554)
Q Consensus 474 GlA~~~~~~-~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~----~~~i~~i~~ 543 (554)
|.|+....+ ...+..||+.|++||++.. .+.|+..+|.|||||++|++.||.+||.+... .+.++.+++
T Consensus 169 G~Arel~d~s~~~S~vGT~~YLhPel~E~-q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~t 242 (732)
T KOG4250|consen 169 GAARELDDNSLFTSLVGTEEYLHPELYER-QKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIIT 242 (732)
T ss_pred cccccCCCCCeeeeecCchhhcChHHHhh-ccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhc
Confidence 999987654 4677889999999999963 23588899999999999999999999976432 335555544
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=272.76 Aligned_cols=202 Identities=28% Similarity=0.490 Sum_probs=171.2
Q ss_pred cccceeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEE
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~ 406 (554)
..+.|+++++||+|+||.||+|...+++.||+|.+..... ....+.+|+.+++.++|+||+++++.+. .+.+|
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~------~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM------SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIY 76 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC------cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcE
Confidence 3468999999999999999999998899999998864222 1246788999999999999999999864 56789
Q ss_pred EEEeecccCchHHHHhh---hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC
Q 008759 407 IFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND 483 (554)
Q Consensus 407 LVmE~~~ggsL~~ll~~---~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~ 483 (554)
++|||+.+++|.+++.. ..+++.++..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 99999999999998864 357888999999999999999999999999999999999999999999999987654222
Q ss_pred c---cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHH
Q 008759 484 V---KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSA 537 (554)
Q Consensus 484 ~---~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~ 537 (554)
. ....++..|+|||++... .++.++||||||+++|+|++ |++||......+.
T Consensus 157 ~~~~~~~~~~~~y~~pe~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~ 212 (260)
T cd05067 157 YTAREGAKFPIKWTAPEAINYG--TFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV 212 (260)
T ss_pred cccccCCcccccccCHHHhccC--CcCcccchHHHHHHHHHHHhCCCCCCCCCChHHH
Confidence 1 123456789999998654 37889999999999999999 9999987765443
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=305.98 Aligned_cols=202 Identities=24% Similarity=0.439 Sum_probs=170.0
Q ss_pred ccccceeeeeeeccCCceeEEEEecCCC-cEEEEEEEecccccchhHHHHHHHHHHHHHHHhCC-CCceeeeeee-ccC-
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGISDDG-FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGT-DKD- 401 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~~~g-~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIVkl~~~-~~~- 401 (554)
.-.-++++.+.|.+|||+.||+|.+..+ ..||+|++.. ..++.++.+.+||.++++|. |+|||.|++. ...
T Consensus 34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~-----~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~ 108 (738)
T KOG1989|consen 34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYV-----NDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINR 108 (738)
T ss_pred ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeec-----CCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccc
Confidence 3344788999999999999999999555 9999998875 34667788999999999997 9999999993 211
Q ss_pred --C---CcEEEEEeecccCchHHHHhh---hcCChHHHHHHHHHHHHHHHHHHHCC--ccccCCccccEEEcCCCcEEEE
Q 008759 402 --E---SKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQD--VVHRDIKCANILVDANGSVKLA 471 (554)
Q Consensus 402 --~---~~~~LVmE~~~ggsL~~ll~~---~~l~e~~i~~i~~QIl~gL~yLHs~g--IIHrDIKPeNILld~~g~vKL~ 471 (554)
. -.++|.||||.||.|-++++. .+|.+.+|++|+.++++|+.+||.+. |||||||-+||||+.+|+.|||
T Consensus 109 ~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLC 188 (738)
T KOG1989|consen 109 SSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLC 188 (738)
T ss_pred cCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeC
Confidence 1 257899999999999998874 46999999999999999999999998 9999999999999999999999
Q ss_pred ecCcccccccCCcc-----------CccCCCcccChhhhcc-cCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008759 472 DFGLAKATKLNDVK-----------SCRGTAFWMAPEVINN-KNKGYGLPADIWSLGCTVLEMLTSQIPYAPM 532 (554)
Q Consensus 472 DFGlA~~~~~~~~~-----------s~~GT~~Y~APEvl~~-~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~ 532 (554)
|||.|...-..... ..--|+.|+|||+++- .+...+.|+|||+|||+||.|+....||...
T Consensus 189 DFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s 261 (738)
T KOG1989|consen 189 DFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES 261 (738)
T ss_pred cccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC
Confidence 99998653222200 1126899999999853 2345889999999999999999999999876
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=305.46 Aligned_cols=194 Identities=33% Similarity=0.560 Sum_probs=169.8
Q ss_pred eeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEEEe
Q 008759 331 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLE 410 (554)
Q Consensus 331 y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LVmE 410 (554)
..-++-||.|+.|.||+|+.. ++.||||+++- .-+.+|.-|++|+|+||+.+.|+|...-.+|||||
T Consensus 126 IsELeWlGSGaQGAVF~Grl~-netVAVKKV~e------------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiME 192 (904)
T KOG4721|consen 126 ISELEWLGSGAQGAVFLGRLH-NETVAVKKVRE------------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIME 192 (904)
T ss_pred hhhhhhhccCcccceeeeecc-CceehhHHHhh------------hhhhhHHHHHhccCcceeeEeeeecCCceeEEeee
Confidence 334567999999999999886 56899998752 12356788999999999999999999999999999
Q ss_pred ecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccccc-CCccCcc
Q 008759 411 LVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL-NDVKSCR 488 (554)
Q Consensus 411 ~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~-~~~~s~~ 488 (554)
||..|-|..+|+. ..+.......|..+|+.|+.|||.+.|||||||.-||||..+..|||+|||.++.... ...-+++
T Consensus 193 fCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSFa 272 (904)
T KOG4721|consen 193 FCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSFA 272 (904)
T ss_pred ccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhhh
Confidence 9999999999986 4688888999999999999999999999999999999999999999999999876543 3345678
Q ss_pred CCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHH
Q 008759 489 GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIF 539 (554)
Q Consensus 489 GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~ 539 (554)
||..|||||++... ..+.|+|||||||+|||||||..||.+.+....|+
T Consensus 273 GTVaWMAPEvIrne--PcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIw 321 (904)
T KOG4721|consen 273 GTVAWMAPEVIRNE--PCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIW 321 (904)
T ss_pred hhHhhhCHHHhhcC--CcccccceehhHHHHHHHHhcCCCccccchheeEE
Confidence 99999999999544 58899999999999999999999999887765554
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=278.93 Aligned_cols=205 Identities=28% Similarity=0.479 Sum_probs=169.1
Q ss_pred ccccccceeeeeeeccCCceeEEEEecC--------CCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhC-CCCceee
Q 008759 324 FKRIITYWQKGDLLGRGSFGSVYEGISD--------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQ 394 (554)
Q Consensus 324 ~~~~~~~y~i~~~LG~GsfG~VY~a~~~--------~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIVk 394 (554)
+....++|.+++.||+|+||.||++.+. +...+|+|.+.... .......+.+|+.++..+ +|+||++
T Consensus 13 ~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~~e~~~l~~l~~h~~i~~ 88 (307)
T cd05098 13 WEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA----TEKDLSDLISEMEMMKMIGKHKNIIN 88 (307)
T ss_pred ceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC----ChHHHHHHHHHHHHHHHhcCCCCEee
Confidence 3344578999999999999999999752 23579999886421 122345678899999999 7999999
Q ss_pred eeeeccCCCcEEEEEeecccCchHHHHhhh-----------------cCChHHHHHHHHHHHHHHHHHHHCCccccCCcc
Q 008759 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRY-----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKC 457 (554)
Q Consensus 395 l~~~~~~~~~~~LVmE~~~ggsL~~ll~~~-----------------~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKP 457 (554)
+++++...+.+|+||||+.+++|.+++... .++..++..++.||+.||.|||++||+||||||
T Consensus 89 ~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp 168 (307)
T cd05098 89 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAA 168 (307)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccH
Confidence 999999999999999999999999998652 367788999999999999999999999999999
Q ss_pred ccEEEcCCCcEEEEecCcccccccCC----ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008759 458 ANILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPM 532 (554)
Q Consensus 458 eNILld~~g~vKL~DFGlA~~~~~~~----~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~ 532 (554)
+|||++.++.+||+|||++....... .....+++.|+|||++.+. .++.++|+|||||++|+|++ |..||...
T Consensus 169 ~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~el~~~g~~p~~~~ 246 (307)
T cd05098 169 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR--IYTHQSDVWSFGVLLWEIFTLGGSPYPGV 246 (307)
T ss_pred HheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccC--CCCcHHHHHHHHHHHHHHHcCCCCCCCcC
Confidence 99999999999999999987543221 1112245689999998654 37889999999999999998 89999765
Q ss_pred Ch
Q 008759 533 EC 534 (554)
Q Consensus 533 e~ 534 (554)
..
T Consensus 247 ~~ 248 (307)
T cd05098 247 PV 248 (307)
T ss_pred CH
Confidence 44
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=275.02 Aligned_cols=211 Identities=31% Similarity=0.593 Sum_probs=174.5
Q ss_pred ccccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhC-CCCceeeeeeecc-
Q 008759 324 FKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDK- 400 (554)
Q Consensus 324 ~~~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIVkl~~~~~- 400 (554)
+....++|++.+.||+|+||.||++.+ .+++.+|+|++.... .....+.+|+.+++.+ +|+||+++++.+.
T Consensus 13 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~------~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 13 FPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH------DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred CCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc------chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 445678999999999999999999988 678899999875321 1124567899999998 6999999999873
Q ss_pred ----CCCcEEEEEeecccCchHHHHhh-----hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEE
Q 008759 401 ----DESKLYIFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLA 471 (554)
Q Consensus 401 ----~~~~~~LVmE~~~ggsL~~ll~~-----~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~ 471 (554)
..+.+|+||||+.+++|.+++.. ..+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~ 166 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLV 166 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEc
Confidence 45679999999999999987652 347888899999999999999999999999999999999999999999
Q ss_pred ecCcccccccC--CccCccCCCcccChhhhccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHH
Q 008759 472 DFGLAKATKLN--DVKSCRGTAFWMAPEVINNK---NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFI 540 (554)
Q Consensus 472 DFGlA~~~~~~--~~~s~~GT~~Y~APEvl~~~---~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~ 540 (554)
|||++...... ......|++.|+|||++... ...++.++|||||||++|+|++|+.||........+..
T Consensus 167 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~ 240 (286)
T cd06638 167 DFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFK 240 (286)
T ss_pred cCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhh
Confidence 99998765432 22344689999999998532 23478899999999999999999999988766555443
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=274.43 Aligned_cols=200 Identities=34% Similarity=0.598 Sum_probs=172.8
Q ss_pred cceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEE
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~L 407 (554)
.+|++.+.||+|+||.||++.+ .++..+++|.+..... ........+.+|+.+++.++|+||+++++.+...+.+++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~--~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~ 79 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDL--MDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 79 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhh--hhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEE
Confidence 5688899999999999999997 6899999998864322 223334678899999999999999999999999999999
Q ss_pred EEeecccCchHHHHhh-----hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC
Q 008759 408 FLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN 482 (554)
Q Consensus 408 VmE~~~ggsL~~ll~~-----~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~ 482 (554)
+|||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++......
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 80 VLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 9999999999998863 34788999999999999999999999999999999999999999999999998765432
Q ss_pred C--ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008759 483 D--VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM 532 (554)
Q Consensus 483 ~--~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~ 532 (554)
. .....++..|+|||.+.+. .++.++|+||||+++|+|++|..||...
T Consensus 160 ~~~~~~~~~~~~~~ape~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~ 209 (267)
T cd08229 160 TTAAHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred CcccccccCCcCccCHHHhcCC--CccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 2 2344688999999998654 3788999999999999999999999754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=293.14 Aligned_cols=213 Identities=26% Similarity=0.403 Sum_probs=180.1
Q ss_pred ccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCC-CCceeeeeeeccCCCcE
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDESKL 405 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIVkl~~~~~~~~~~ 405 (554)
..+|..+.+||+|+||+|.++.. .+...||||+++..-... ....+--..|-++|.... -|++++++.+|++-+.+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQ--dDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL 425 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQ--DDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL 425 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeee--cCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence 46899999999999999999987 567899999987532211 112233456777777664 68999999999999999
Q ss_pred EEEEeecccCchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccc--ccC
Q 008759 406 YIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT--KLN 482 (554)
Q Consensus 406 ~LVmE~~~ggsL~~ll~~~-~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~--~~~ 482 (554)
|+||||+.||+|.-.+++. .+.+..+..|+.+|+.||-|||++|||+||||.+|||++.+|+|||+|||+++.. ...
T Consensus 426 yFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~ 505 (683)
T KOG0696|consen 426 YFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGV 505 (683)
T ss_pred eeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccCCc
Confidence 9999999999999888874 6899999999999999999999999999999999999999999999999999863 334
Q ss_pred CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHHH
Q 008759 483 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTVA 544 (554)
Q Consensus 483 ~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~~ 544 (554)
...+.+|||.|+|||++.. ++|+..+||||+||+|||||.|++||.+.+..+.+-.|..+
T Consensus 506 TTkTFCGTPdYiAPEIi~Y--qPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~eh 565 (683)
T KOG0696|consen 506 TTKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEH 565 (683)
T ss_pred ceeeecCCCcccccceEEe--cccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc
Confidence 4567889999999999955 45999999999999999999999999987766655555433
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=275.72 Aligned_cols=201 Identities=31% Similarity=0.490 Sum_probs=167.4
Q ss_pred ccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEE
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~ 406 (554)
.+.|++.+.||+|+||.||+|.+ .++..|++|.+....... ....+.+|+.+++.++|+||+++++++......|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~----~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 79 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG----VPFTAIREASLLKGLKHANIVLLHDIIHTKETLT 79 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC----CcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEE
Confidence 46899999999999999999988 678999999986432211 1234568999999999999999999999999999
Q ss_pred EEEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC--
Q 008759 407 IFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-- 482 (554)
Q Consensus 407 LVmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~-- 482 (554)
+||||+. ++|..++.. ..+.+..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||+++.....
T Consensus 80 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 158 (291)
T cd07870 80 FVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ 158 (291)
T ss_pred EEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence 9999997 466655543 35788889999999999999999999999999999999999999999999998754322
Q ss_pred CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh
Q 008759 483 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC 534 (554)
Q Consensus 483 ~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~ 534 (554)
......+++.|+|||++.+.. .++.++|||||||++|+|++|..||.....
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~-~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~ 209 (291)
T cd07870 159 TYSSEVVTLWYRPPDVLLGAT-DYSSALDIWGAGCIFIEMLQGQPAFPGVSD 209 (291)
T ss_pred CCCCccccccccCCceeecCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCchh
Confidence 123345789999999986432 467899999999999999999999987654
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=281.14 Aligned_cols=204 Identities=34% Similarity=0.579 Sum_probs=175.5
Q ss_pred ccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEE
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~ 406 (554)
.+.|.....||+|+||.||++.+ .++..||+|++... .....+.+.+|+.++..++|+||+++++.+...+..|
T Consensus 21 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~ 95 (292)
T cd06658 21 REYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR-----KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELW 95 (292)
T ss_pred HHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc-----hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEE
Confidence 34566678899999999999988 67899999988642 2233456889999999999999999999999999999
Q ss_pred EEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC--c
Q 008759 407 IFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--V 484 (554)
Q Consensus 407 LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~--~ 484 (554)
+||||+.+++|.+++....+.+..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++....... .
T Consensus 96 lv~e~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~ 175 (292)
T cd06658 96 VVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR 175 (292)
T ss_pred EEEeCCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccC
Confidence 99999999999999877788999999999999999999999999999999999999999999999999986543222 2
Q ss_pred cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHH
Q 008759 485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAI 538 (554)
Q Consensus 485 ~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i 538 (554)
....++..|+|||++.+. .++.++|+||||+++|+|++|+.||......+.+
T Consensus 176 ~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~ 227 (292)
T cd06658 176 KSLVGTPYWMAPEVISRL--PYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAM 227 (292)
T ss_pred ceeecCccccCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 334589999999998554 3788999999999999999999999877665443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=276.63 Aligned_cols=201 Identities=30% Similarity=0.477 Sum_probs=169.7
Q ss_pred cceeeeeeeccCCceeEEEEec------CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCC
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE 402 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~------~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~ 402 (554)
.+|.+.+.||+|+||.||+|.+ .++..+++|.+.. ......+.+.+|+.+++.++|+||+++++++...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD-----PTLAARKDFQREAELLTNLQHEHIVKFYGVCGDG 79 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCC-----ccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence 5789999999999999999974 2456688887753 1223345688999999999999999999999999
Q ss_pred CcEEEEEeecccCchHHHHhhh-----------------cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCC
Q 008759 403 SKLYIFLELVTKGSLLNLYQRY-----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN 465 (554)
Q Consensus 403 ~~~~LVmE~~~ggsL~~ll~~~-----------------~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~ 465 (554)
..+++||||+.+++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN 159 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence 9999999999999999998653 26788899999999999999999999999999999999999
Q ss_pred CcEEEEecCcccccccCC----ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhH
Q 008759 466 GSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVS 536 (554)
Q Consensus 466 g~vKL~DFGlA~~~~~~~----~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~ 536 (554)
+.++|+|||++....... .....++..|+|||++.+. .++.++|||||||++|+|+| |..||......+
T Consensus 160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 233 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE 233 (291)
T ss_pred CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999987543322 2234467889999998654 47889999999999999999 999997765544
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=271.23 Aligned_cols=202 Identities=35% Similarity=0.698 Sum_probs=172.0
Q ss_pred ceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccch-hHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEE
Q 008759 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQ-AKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (554)
Q Consensus 330 ~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~-~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~L 407 (554)
.|+.++.||+|+||.||++.+ .++..||+|++........ .......+.+|+.+++.++|+||+++++.+.+.+.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 478889999999999999998 7789999999875332221 12345788899999999999999999999999999999
Q ss_pred EEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCC-cEEEEecCcccccccCC--
Q 008759 408 FLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG-SVKLADFGLAKATKLND-- 483 (554)
Q Consensus 408 VmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g-~vKL~DFGlA~~~~~~~-- 483 (554)
||||+.+++|.+++.+ ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++ .+||+|||++.......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG 160 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence 9999999999998876 4588899999999999999999999999999999999998776 59999999987654321
Q ss_pred ----ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008759 484 ----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME 533 (554)
Q Consensus 484 ----~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e 533 (554)
.....++..|+|||++.+. .++.++|+|||||++|+|++|..||....
T Consensus 161 ~~~~~~~~~~~~~~~~PE~~~~~--~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 212 (268)
T cd06630 161 AGEFQGQLLGTIAFMAPEVLRGE--QYGRSCDVWSVGCVIIEMATAKPPWNAEK 212 (268)
T ss_pred CCccccccccccceeCHhHhccC--CCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 1123578899999998653 47889999999999999999999997544
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=276.80 Aligned_cols=207 Identities=29% Similarity=0.455 Sum_probs=173.8
Q ss_pred cceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEE
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~L 407 (554)
++|++.+.||+|+||.||++.+ .+++.|++|.+..... ........+.+|+.++..++|+||+++++.+...+.+|+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 78 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNL--ILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCM 78 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhh--hhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEE
Confidence 3688999999999999999998 6688999998864221 122334577899999999999999999999999999999
Q ss_pred EEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC---
Q 008759 408 FLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--- 483 (554)
Q Consensus 408 VmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~--- 483 (554)
||||+.+++|..++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~ 158 (305)
T cd05609 79 VMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN 158 (305)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc
Confidence 9999999999999876 457888999999999999999999999999999999999999999999999886421110
Q ss_pred --------------ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHH
Q 008759 484 --------------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIF 539 (554)
Q Consensus 484 --------------~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~ 539 (554)
.....++..|+|||.+... .++.++|+|||||++|+|++|..||.+....+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~ 226 (305)
T cd05609 159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQ--GYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG 226 (305)
T ss_pred ccccccccchhhccccCCccCccccCchhccCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 0123478889999998653 47899999999999999999999998766544333
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=274.80 Aligned_cols=210 Identities=31% Similarity=0.520 Sum_probs=176.6
Q ss_pred cceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEE
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~L 407 (554)
+.|++.+.||+|+||.||+|.+ .+++.||+|.+...... ....+.+.+|+.+++.++|+||+++++++.....+|+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 77 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD---KMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYL 77 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCc---chhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEE
Confidence 3688999999999999999998 56899999987642221 1234567789999999999999999999999999999
Q ss_pred EEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC--Cc
Q 008759 408 FLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--DV 484 (554)
Q Consensus 408 VmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~--~~ 484 (554)
||||+.+++|..+... ..+.+..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++...... ..
T Consensus 78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 157 (286)
T cd07846 78 VFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY 157 (286)
T ss_pred EEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcccc
Confidence 9999999999887654 35899999999999999999999999999999999999999999999999998764332 22
Q ss_pred cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHH
Q 008759 485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKT 542 (554)
Q Consensus 485 ~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~ 542 (554)
....++..|+|||++.+.. .++.++|||||||++|+|++|+.||......+.+.++.
T Consensus 158 ~~~~~~~~y~aPE~~~~~~-~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~ 214 (286)
T cd07846 158 TDYVATRWYRAPELLVGDT-KYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHII 214 (286)
T ss_pred CcccceeeccCcHHhcccc-ccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHH
Confidence 3345889999999986432 46789999999999999999999998766555544443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=272.18 Aligned_cols=203 Identities=26% Similarity=0.412 Sum_probs=169.7
Q ss_pred ccceeeeeeeccCCceeEEEEecC------CCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccC
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD 401 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~~------~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~ 401 (554)
.++|++.+.||+|+||.||+|.+. ++..||+|.+.... .......+.+|+.++..++|+||+++++.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~----~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 80 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA----SMRERIEFLNEASVMKEFNCHHVVRLLGVVST 80 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc----CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence 468999999999999999999873 34789999875321 12233567889999999999999999999999
Q ss_pred CCcEEEEEeecccCchHHHHhhh-----------cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEE
Q 008759 402 ESKLYIFLELVTKGSLLNLYQRY-----------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKL 470 (554)
Q Consensus 402 ~~~~~LVmE~~~ggsL~~ll~~~-----------~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL 470 (554)
....|+||||+.+++|.+++... .+.+..+..++.||+.||.|||+++|+|+||||+|||++.++.+||
T Consensus 81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEE
Confidence 99999999999999999988642 2566788899999999999999999999999999999999999999
Q ss_pred EecCcccccccCC----ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhH
Q 008759 471 ADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVS 536 (554)
Q Consensus 471 ~DFGlA~~~~~~~----~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~ 536 (554)
+|||+++...... .....++..|+|||.+... .++.++|||||||++|+|++ |..||......+
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 229 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG--VFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE 229 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcC--CCCcccchHHHHHHHHHhhccCCCCCccCCHHH
Confidence 9999987644322 1223467889999998544 37889999999999999998 999998765443
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=271.22 Aligned_cols=211 Identities=31% Similarity=0.614 Sum_probs=176.3
Q ss_pred cccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhC-CCCceeeeeeeccCCC-
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDES- 403 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIVkl~~~~~~~~- 403 (554)
..++|++.+.||+|+||.||+|.+ .+++.+++|++..... ....+.+|+.+++++ .|+||+++++.+....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~------~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 77 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED------EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNP 77 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch------hHHHHHHHHHHHHHhcCCCChheEEEEEEecCC
Confidence 457899999999999999999998 5788999998864221 235688999999998 6999999999986543
Q ss_pred -----cEEEEEeecccCchHHHHhh-----hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEec
Q 008759 404 -----KLYIFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADF 473 (554)
Q Consensus 404 -----~~~LVmE~~~ggsL~~ll~~-----~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DF 473 (554)
.+|+||||+.+++|.++++. ..+++..+..++.|++.||.|||++||+|+||+|+||+++.++.++|+||
T Consensus 78 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~ 157 (275)
T cd06608 78 PGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDF 157 (275)
T ss_pred CCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCC
Confidence 58999999999999998764 35889999999999999999999999999999999999999999999999
Q ss_pred CcccccccC--CccCccCCCcccChhhhccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHH
Q 008759 474 GLAKATKLN--DVKSCRGTAFWMAPEVINNK---NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTV 543 (554)
Q Consensus 474 GlA~~~~~~--~~~s~~GT~~Y~APEvl~~~---~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~ 543 (554)
|++...... ......++..|+|||++... ...++.++|||||||++|+|++|+.||........++.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 232 (275)
T cd06608 158 GVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPR 232 (275)
T ss_pred ccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhc
Confidence 998754322 22345689999999998543 22467889999999999999999999987766666555443
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=268.39 Aligned_cols=201 Identities=44% Similarity=0.797 Sum_probs=174.7
Q ss_pred ceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEE
Q 008759 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (554)
Q Consensus 330 ~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LV 408 (554)
+|++.+.||+|+||.||+|.+ .+++.|++|.+...... ......+.+|+.+++.++|+||+++++.+...+.+++|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv 77 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND---PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIF 77 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc---hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEE
Confidence 588999999999999999987 57899999998754322 34567889999999999999999999999999999999
Q ss_pred EeecccCchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCCc---
Q 008759 409 LELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--- 484 (554)
Q Consensus 409 mE~~~ggsL~~ll~~~-~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~~--- 484 (554)
+||+.+++|.+++... .+.+..+..++.|++.||.|||++||+|+||+|+||+++.++.+||+|||++........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~ 157 (264)
T cd06626 78 MEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG 157 (264)
T ss_pred EecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc
Confidence 9999999999998764 478888999999999999999999999999999999999999999999999876543221
Q ss_pred ---cCccCCCcccChhhhcccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008759 485 ---KSCRGTAFWMAPEVINNKN-KGYGLPADIWSLGCTVLEMLTSQIPYAPME 533 (554)
Q Consensus 485 ---~s~~GT~~Y~APEvl~~~~-~~~s~ksDIwSLGvllyeLLTG~~PF~~~e 533 (554)
....++..|++||++.+.. ..++.++||||||+++|+|++|+.||...+
T Consensus 158 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~ 210 (264)
T cd06626 158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELD 210 (264)
T ss_pred ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCc
Confidence 1245788999999986543 337789999999999999999999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=269.18 Aligned_cols=207 Identities=32% Similarity=0.611 Sum_probs=176.6
Q ss_pred cceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEE
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~L 407 (554)
++|++++.||.|+||+||+|.. .++..+++|++..... ......+.+|+.+++.++|+||+++++.+...+.+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i 76 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC----QTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWL 76 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCc----chHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEE
Confidence 4689999999999999999997 5788999998864221 1245678899999999999999999999999999999
Q ss_pred EEeecccCchHHHHhh----hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC
Q 008759 408 FLELVTKGSLLNLYQR----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND 483 (554)
Q Consensus 408 VmE~~~ggsL~~ll~~----~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~ 483 (554)
|||++.+++|.+++.. ..+++..+..++.|++.||.|||++||+|+||+|+||+++.++.++|+|||++.......
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 77 VMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred EEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 9999999999999865 247889999999999999999999999999999999999999999999999987644322
Q ss_pred ------ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHH
Q 008759 484 ------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFI 540 (554)
Q Consensus 484 ------~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~ 540 (554)
.....++..|++||++... ..++.++|+|||||++|+|++|+.||........+..
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~ 218 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQV-HGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLML 218 (267)
T ss_pred cccccccccccCChhhcChHHHccc-cCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHH
Confidence 1234588999999998655 2478899999999999999999999987765544333
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=277.04 Aligned_cols=207 Identities=25% Similarity=0.382 Sum_probs=171.4
Q ss_pred cceeeeeeeccCCceeEEEEecC------CCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCC
Q 008759 329 TYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE 402 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~~------~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~ 402 (554)
..|++.+.||+|+||.||+|.+. ++..||+|++.... .......+.+|+.++..++||||+++++.+...
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~ 80 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA----EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE 80 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC----CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence 46788999999999999999863 35789999887422 122345688999999999999999999999999
Q ss_pred CcEEEEEeecccCchHHHHhh-----------------hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCC
Q 008759 403 SKLYIFLELVTKGSLLNLYQR-----------------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN 465 (554)
Q Consensus 403 ~~~~LVmE~~~ggsL~~ll~~-----------------~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~ 465 (554)
...++++||+.+++|.+++.. ..++...+..++.|++.||.|||++||+||||||+|||++.+
T Consensus 81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK 160 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence 999999999999999998742 236777889999999999999999999999999999999999
Q ss_pred CcEEEEecCcccccccCCc----cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHHHH
Q 008759 466 GSVKLADFGLAKATKLNDV----KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIFI 540 (554)
Q Consensus 466 g~vKL~DFGlA~~~~~~~~----~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i~~ 540 (554)
+.+||+|||+++....... ....+++.|+|||++.... ++.++|||||||++|||++ |..||......+.+..
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGK--FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEM 238 (283)
T ss_pred CceEecccccccccccchheeeccCccCCccccCHHHHhcCC--CCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 9999999999876432221 2234577899999986543 7889999999999999998 8999987766554444
Q ss_pred H
Q 008759 541 K 541 (554)
Q Consensus 541 i 541 (554)
+
T Consensus 239 i 239 (283)
T cd05091 239 I 239 (283)
T ss_pred H
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=271.28 Aligned_cols=205 Identities=27% Similarity=0.461 Sum_probs=171.9
Q ss_pred cceeeeeeeccCCceeEEEEecC----CCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCc
Q 008759 329 TYWQKGDLLGRGSFGSVYEGISD----DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~~----~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~ 404 (554)
++|++.+.||+|+||.||+|.+. +...||+|.+.... .......+.+|+.++..++|+||+++++.+...+.
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 79 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS----SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRP 79 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC----ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCc
Confidence 57899999999999999999873 24588999876422 22334567889999999999999999999999999
Q ss_pred EEEEEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccccc-
Q 008759 405 LYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL- 481 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~- 481 (554)
+|++|||+.+++|.+++.. ..+++..+..++.|++.||.|||++||+|+||||+|||++.++.++|+|||+++....
T Consensus 80 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 80 VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred eEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 9999999999999999865 3588999999999999999999999999999999999999999999999999987642
Q ss_pred -CCcc--CccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHHH
Q 008759 482 -NDVK--SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIF 539 (554)
Q Consensus 482 -~~~~--s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i~ 539 (554)
.... ...++..|+|||.+.+. .++.++|||||||++|+|++ |..||......+...
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~--~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~ 219 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYR--KFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIK 219 (266)
T ss_pred ccceeccCCCCCccccChhhhccC--CCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHH
Confidence 1111 22346789999998654 47889999999999999998 999998776554433
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=274.04 Aligned_cols=204 Identities=28% Similarity=0.467 Sum_probs=168.9
Q ss_pred ccceeeeeeeccCCceeEEEEecC------CCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccC
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD 401 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~~------~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~ 401 (554)
.+.|++.+.||+|+||.||+|.+. .+..|++|.+.... .......+.+|+.+++.++|+||+++++++.+
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC----SEQDESDFLMEALIMSKFNHQNIVRLIGVSFE 80 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC----CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 357899999999999999999883 46788999775322 12233567889999999999999999999998
Q ss_pred CCcEEEEEeecccCchHHHHhhh--------cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCC---cEEE
Q 008759 402 ESKLYIFLELVTKGSLLNLYQRY--------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG---SVKL 470 (554)
Q Consensus 402 ~~~~~LVmE~~~ggsL~~ll~~~--------~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g---~vKL 470 (554)
....|+||||+.+++|.+++... .+++..+..++.||+.||.|||+++++|+||||+|||++.++ .+||
T Consensus 81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 81 RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEe
Confidence 89999999999999999998653 378889999999999999999999999999999999998765 5999
Q ss_pred EecCcccccccCCcc----CccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHH
Q 008759 471 ADFGLAKATKLNDVK----SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSA 537 (554)
Q Consensus 471 ~DFGlA~~~~~~~~~----s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~ 537 (554)
+|||+++........ ....+..|+|||++.+.. ++.++|||||||++|+|++ |+.||........
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~ 230 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGI--FTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV 230 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCC--cCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 999998765322211 122356799999986543 8899999999999999997 9999987665443
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=277.53 Aligned_cols=203 Identities=39% Similarity=0.684 Sum_probs=175.2
Q ss_pred cceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEE
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~L 407 (554)
+.|+..+.||+|+||.||+|.+ .++..||+|.+.... .......+.+|+.+++.++|+||+++++.+...+.+|+
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE----AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWI 79 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc----chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEE
Confidence 4577788999999999999987 668899999876322 12334678899999999999999999999999999999
Q ss_pred EEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC--cc
Q 008759 408 FLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VK 485 (554)
Q Consensus 408 VmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~--~~ 485 (554)
||||+.+++|.+++....+.+..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++....... ..
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06642 80 IMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred EEEccCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhh
Confidence 9999999999999988789999999999999999999999999999999999999999999999999987644322 22
Q ss_pred CccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHH
Q 008759 486 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSA 537 (554)
Q Consensus 486 s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~ 537 (554)
...++..|+|||++.+. .++.++|+|||||++|+|++|+.||........
T Consensus 160 ~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~ 209 (277)
T cd06642 160 TFVGTPFWMAPEVIKQS--AYDFKADIWSLGITAIELAKGEPPNSDLHPMRV 209 (277)
T ss_pred cccCcccccCHHHhCcC--CCchhhhHHHHHHHHHHHHhCCCCCcccchhhH
Confidence 34588899999998654 478899999999999999999999986654443
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=270.80 Aligned_cols=202 Identities=28% Similarity=0.488 Sum_probs=166.0
Q ss_pred eeeeeeeccCCceeEEEEecC----CCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCc--
Q 008759 331 WQKGDLLGRGSFGSVYEGISD----DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK-- 404 (554)
Q Consensus 331 y~i~~~LG~GsfG~VY~a~~~----~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~-- 404 (554)
|++++.||+|+||.||+|... .+..||+|.+..... .......+.+|+.+++.++|+||+++++.+.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 77 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH---TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQ 77 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC---CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccc
Confidence 578899999999999999862 247899998864221 23345678899999999999999999998765443
Q ss_pred ----EEEEEeecccCchHHHHhh-------hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEec
Q 008759 405 ----LYIFLELVTKGSLLNLYQR-------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADF 473 (554)
Q Consensus 405 ----~~LVmE~~~ggsL~~ll~~-------~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DF 473 (554)
.+++|||+.+++|..++.. ..+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+||
T Consensus 78 ~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 78 KIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred cCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCc
Confidence 7999999999999988743 24788889999999999999999999999999999999999999999999
Q ss_pred CcccccccCCc----cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHH
Q 008759 474 GLAKATKLNDV----KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSA 537 (554)
Q Consensus 474 GlA~~~~~~~~----~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~ 537 (554)
|+++....... ....++..|+|||++... .++.++|||||||++|||++ |..||......+.
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~ 224 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADR--VYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEI 224 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccC--CCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 99876543221 112356789999998543 47889999999999999999 9999987665443
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=269.21 Aligned_cols=200 Identities=32% Similarity=0.577 Sum_probs=172.5
Q ss_pred cceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEE
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~L 407 (554)
+.|++.+.||+|+||.||+|.+ .+++.||+|.+...... .......+.+|+.++++++|+||+++++.+...+..++
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~l 79 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMM--DAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNI 79 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeeccccc--chhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 5799999999999999999999 48999999988643221 12234678899999999999999999999999999999
Q ss_pred EEeecccCchHHHHhh-----hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC
Q 008759 408 FLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN 482 (554)
Q Consensus 408 VmE~~~ggsL~~ll~~-----~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~ 482 (554)
||||+.+++|..++.. ..+++.++..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++......
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~ 159 (267)
T cd08224 80 VLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence 9999999999998853 24788999999999999999999999999999999999999999999999998754332
Q ss_pred C--ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008759 483 D--VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM 532 (554)
Q Consensus 483 ~--~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~ 532 (554)
. .....++..|+|||.+.+. .++.++|+|||||++|+|++|+.||...
T Consensus 160 ~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~ 209 (267)
T cd08224 160 TTAAHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred CcccceecCCccccCHHHhccC--CCCchhcHHHHHHHHHHHHHCCCCcccC
Confidence 2 2334588999999998654 4788999999999999999999999654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=274.17 Aligned_cols=204 Identities=40% Similarity=0.710 Sum_probs=175.6
Q ss_pred ceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCC---CCceeeeeeeccCCCcE
Q 008759 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE---HENIVQYYGTDKDESKL 405 (554)
Q Consensus 330 ~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~---HpnIVkl~~~~~~~~~~ 405 (554)
.|++.+.||+|+||.||+|.+ .+++.|++|.+..... ......+.+|+.+++.++ |+||+++++.+.....+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~ 77 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP----DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRL 77 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCC----chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEE
Confidence 578889999999999999998 7789999998864221 223456778999999886 99999999999999999
Q ss_pred EEEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC--
Q 008759 406 YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-- 483 (554)
Q Consensus 406 ~LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~-- 483 (554)
|+||||+.+++|.++++...+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++.......
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06917 78 WIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK 157 (277)
T ss_pred EEEEecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccc
Confidence 999999999999999988888999999999999999999999999999999999999999999999999987654332
Q ss_pred ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHH
Q 008759 484 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAI 538 (554)
Q Consensus 484 ~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i 538 (554)
.....|+..|+|||.+... ..++.++|+|||||++|+|++|..||...+....+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~ 211 (277)
T cd06917 158 RSTFVGTPYWMAPEVITEG-KYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM 211 (277)
T ss_pred cccccCCcceeCHHHhccC-CccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh
Confidence 2334688999999998543 34688999999999999999999999877655443
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=278.62 Aligned_cols=208 Identities=28% Similarity=0.494 Sum_probs=170.9
Q ss_pred ccccccceeeeeeeccCCceeEEEEec--------CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhC-CCCceee
Q 008759 324 FKRIITYWQKGDLLGRGSFGSVYEGIS--------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQ 394 (554)
Q Consensus 324 ~~~~~~~y~i~~~LG~GsfG~VY~a~~--------~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIVk 394 (554)
+.....+|.+++.||+|+||.||++.+ .....+|+|.+.... .......+.+|+.++..+ +|+||++
T Consensus 7 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~~E~~~l~~l~~h~~iv~ 82 (314)
T cd05099 7 WEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA----TDKDLADLISEMELMKLIGKHKNIIN 82 (314)
T ss_pred ccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC----ChHHHHHHHHHHHHHHhccCCCCeee
Confidence 334456899999999999999999974 234578999876321 123356688899999999 6999999
Q ss_pred eeeeccCCCcEEEEEeecccCchHHHHhhh-----------------cCChHHHHHHHHHHHHHHHHHHHCCccccCCcc
Q 008759 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRY-----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKC 457 (554)
Q Consensus 395 l~~~~~~~~~~~LVmE~~~ggsL~~ll~~~-----------------~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKP 457 (554)
+++++...+.+|++|||+.+++|.+++... .+++..+..++.||+.||.|||++||+||||||
T Consensus 83 ~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp 162 (314)
T cd05099 83 LLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAA 162 (314)
T ss_pred EEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccc
Confidence 999999999999999999999999998642 367788899999999999999999999999999
Q ss_pred ccEEEcCCCcEEEEecCcccccccCC----ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008759 458 ANILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPM 532 (554)
Q Consensus 458 eNILld~~g~vKL~DFGlA~~~~~~~----~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~ 532 (554)
+|||++.++.+||+|||+++...... .....++..|+|||++.+. .++.++|||||||++|+|++ |..||...
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~~l~el~~~g~~p~~~~ 240 (314)
T cd05099 163 RNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDR--VYTHQSDVWSFGILMWEIFTLGGSPYPGI 240 (314)
T ss_pred eeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccC--CcCccchhhHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999997654321 1112245679999998654 47889999999999999999 89999876
Q ss_pred ChhHH
Q 008759 533 ECVSA 537 (554)
Q Consensus 533 e~~~~ 537 (554)
...+.
T Consensus 241 ~~~~~ 245 (314)
T cd05099 241 PVEEL 245 (314)
T ss_pred CHHHH
Confidence 65443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=268.10 Aligned_cols=201 Identities=38% Similarity=0.661 Sum_probs=175.5
Q ss_pred cceeeeeeeccCCceeEEEEecC-CCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEE
Q 008759 329 TYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~~-~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~L 407 (554)
+.|++.+.||+|+||.||+|.+. ++..|++|.+.... ....+.+|+.+++.++|+||+++++.+.....+|+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l 75 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-------DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWI 75 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH-------HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEE
Confidence 57889999999999999999984 58999999886421 15678899999999999999999999999999999
Q ss_pred EEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC--
Q 008759 408 FLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-- 483 (554)
Q Consensus 408 VmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~-- 483 (554)
++||+.+++|.+++.. ..+++..+..++.|++.||.|||+.+|+|+||+|+||+++.++.++|+|||++.......
T Consensus 76 ~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (256)
T cd06612 76 VMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK 155 (256)
T ss_pred EEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCccc
Confidence 9999999999999864 458899999999999999999999999999999999999999999999999987654332
Q ss_pred ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHH
Q 008759 484 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAI 538 (554)
Q Consensus 484 ~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i 538 (554)
.....++..|++||++.+. .++.++||||||+++|+|++|+.||.........
T Consensus 156 ~~~~~~~~~y~~PE~~~~~--~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~ 208 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQEI--GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI 208 (256)
T ss_pred cccccCCccccCHHHHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh
Confidence 2334588899999998654 4788999999999999999999999876554443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=269.95 Aligned_cols=204 Identities=28% Similarity=0.491 Sum_probs=171.9
Q ss_pred cccceeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEE
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~ 406 (554)
..+.|++.+.||+|+||.||++.+..+..+++|.+... ......+.+|+.+++.++|+||+++++.+.. ...|
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG------SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIY 76 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCC------hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeE
Confidence 45789999999999999999998877788999987631 2234568889999999999999999999877 7889
Q ss_pred EEEeecccCchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC
Q 008759 407 IFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND 483 (554)
Q Consensus 407 LVmE~~~ggsL~~ll~~~---~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~ 483 (554)
++|||+.+++|.+++... .++...+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||++.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 999999999999998752 36778889999999999999999999999999999999999999999999987543322
Q ss_pred c---cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHHH
Q 008759 484 V---KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIF 539 (554)
Q Consensus 484 ~---~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i~ 539 (554)
. ....++..|+|||++... .++.++|+|||||++|+|++ |+.||...+..+...
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~ 214 (260)
T cd05073 157 YTAREGAKFPIKWTAPEAINFG--SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIR 214 (260)
T ss_pred cccccCCcccccccCHhHhccC--CcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 1 122356779999998654 37889999999999999999 999998876554443
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=286.13 Aligned_cols=204 Identities=28% Similarity=0.459 Sum_probs=167.5
Q ss_pred ccceeeeeeeccCCceeEEEEec------CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhC-CCCceeeeeeecc
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDK 400 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~------~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIVkl~~~~~ 400 (554)
.++|++++.||+|+||.||+|.+ .+++.||+|++.... .......+.+|+.++.++ +|+||+++++++.
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~ 81 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA----TASEYKALMTELKILIHIGHHLNVVNLLGACT 81 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC----CHHHHHHHHHHHHHHHhhccCcchhheeeeEe
Confidence 35799999999999999999964 235789999886321 122345678899999999 7999999999875
Q ss_pred C-CCcEEEEEeecccCchHHHHhh--------------------------------------------------------
Q 008759 401 D-ESKLYIFLELVTKGSLLNLYQR-------------------------------------------------------- 423 (554)
Q Consensus 401 ~-~~~~~LVmE~~~ggsL~~ll~~-------------------------------------------------------- 423 (554)
. ...++++|||+.+++|.+++..
T Consensus 82 ~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (337)
T cd05054 82 KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE 161 (337)
T ss_pred cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence 4 4678999999999999988753
Q ss_pred ------hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC----ccCccCCCcc
Q 008759 424 ------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAFW 493 (554)
Q Consensus 424 ------~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~----~~s~~GT~~Y 493 (554)
..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++....... .....++..|
T Consensus 162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y 241 (337)
T cd05054 162 GDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 241 (337)
T ss_pred hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence 146788899999999999999999999999999999999999999999999997653222 1223456789
Q ss_pred cChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHH
Q 008759 494 MAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSA 537 (554)
Q Consensus 494 ~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~ 537 (554)
+|||++.+. .++.++|||||||++|+|++ |..||......+.
T Consensus 242 ~aPE~~~~~--~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~ 284 (337)
T cd05054 242 MAPESIFDK--VYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE 284 (337)
T ss_pred cCcHHhcCC--CCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH
Confidence 999998654 48899999999999999998 9999987554333
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=277.71 Aligned_cols=211 Identities=29% Similarity=0.476 Sum_probs=175.3
Q ss_pred ccccccceeeeeeeccCCceeEEEEec------CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhC-CCCceeeee
Q 008759 324 FKRIITYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYY 396 (554)
Q Consensus 324 ~~~~~~~y~i~~~LG~GsfG~VY~a~~------~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIVkl~ 396 (554)
+....++|.+.+.||+|+||.||++.+ .++..+|+|.+..... ....+.+.+|+.+++++ +|+||++++
T Consensus 30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~~h~~iv~~~ 105 (302)
T cd05055 30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH----SSEREALMSELKIMSHLGNHENIVNLL 105 (302)
T ss_pred ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC----hHHHHHHHHHHHHHHhccCCCCcceEE
Confidence 444567899999999999999999974 2355789998764221 22346788999999999 799999999
Q ss_pred eeccCCCcEEEEEeecccCchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEec
Q 008759 397 GTDKDESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADF 473 (554)
Q Consensus 397 ~~~~~~~~~~LVmE~~~ggsL~~ll~~~---~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DF 473 (554)
+.+...+.+|++|||+.+++|..+++.. .+++.++..++.||+.||.|||+++|+|+||||+|||++.++.++|+||
T Consensus 106 ~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~df 185 (302)
T cd05055 106 GACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDF 185 (302)
T ss_pred EEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCC
Confidence 9999999999999999999999998753 2789999999999999999999999999999999999999999999999
Q ss_pred CcccccccCC----ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHHHH
Q 008759 474 GLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIFI 540 (554)
Q Consensus 474 GlA~~~~~~~----~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i~~ 540 (554)
|+++...... .....++..|+|||++.+.. ++.++|||||||++|+|++ |..||......+.+..
T Consensus 186 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~ 255 (302)
T cd05055 186 GLARDIMNDSNYVVKGNARLPVKWMAPESIFNCV--YTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYK 255 (302)
T ss_pred cccccccCCCceeecCCCCcccccCCHhhhccCC--CCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHH
Confidence 9987543322 11234577899999986543 7889999999999999998 9999987665544433
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=271.93 Aligned_cols=206 Identities=31% Similarity=0.535 Sum_probs=172.8
Q ss_pred ceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEE
Q 008759 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (554)
Q Consensus 330 ~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LV 408 (554)
+|++.+.||.|++|.||+|.+ .++..||+|++...... .....+.+|+.+++.++|+||+++++.+...+.+|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 76 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE----GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLV 76 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc----cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEE
Confidence 488999999999999999998 57899999998753221 1224566899999999999999999999999999999
Q ss_pred EeecccCchHHHHhhh----cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC--
Q 008759 409 LELVTKGSLLNLYQRY----HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-- 482 (554)
Q Consensus 409 mE~~~ggsL~~ll~~~----~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~-- 482 (554)
|||+.+ +|.+++... .+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus 77 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 77 FEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred EecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 999986 787777642 4889999999999999999999999999999999999999999999999998754322
Q ss_pred CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHH
Q 008759 483 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIK 541 (554)
Q Consensus 483 ~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i 541 (554)
......++..|++||++.+.. .++.++|+|||||++|+|++|+.||...+..+...++
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~-~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~ 213 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSR-TYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKI 213 (284)
T ss_pred ccccccccccccChHHhcCCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH
Confidence 122345788999999986532 4688999999999999999999999887665544433
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=274.78 Aligned_cols=201 Identities=27% Similarity=0.459 Sum_probs=166.8
Q ss_pred ceeeeeeeccCCceeEEEEecC------CCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCC
Q 008759 330 YWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES 403 (554)
Q Consensus 330 ~y~i~~~LG~GsfG~VY~a~~~------~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~ 403 (554)
+|++.+.||+|+||.||+|.+. ....+++|.+.... .......+.+|+.++..++||||+++++.+...+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 76 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA----SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDG 76 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC----CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC
Confidence 4788899999999999999862 23568888775321 1233467889999999999999999999999999
Q ss_pred cEEEEEeecccCchHHHHhhh-------------------------cCChHHHHHHHHHHHHHHHHHHHCCccccCCccc
Q 008759 404 KLYIFLELVTKGSLLNLYQRY-------------------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCA 458 (554)
Q Consensus 404 ~~~LVmE~~~ggsL~~ll~~~-------------------------~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPe 458 (554)
..|++|||+.+++|.+++... .+++..+..++.|++.||.|||+++|+||||||+
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ 156 (290)
T cd05045 77 PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAAR 156 (290)
T ss_pred CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhh
Confidence 999999999999999987642 3677888999999999999999999999999999
Q ss_pred cEEEcCCCcEEEEecCcccccccCC----ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 008759 459 NILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPME 533 (554)
Q Consensus 459 NILld~~g~vKL~DFGlA~~~~~~~----~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e 533 (554)
|||++.++.+||+|||+++...... .....++..|+|||.+.+. .++.++|||||||++|+|++ |..||....
T Consensus 157 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 234 (290)
T cd05045 157 NVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDH--IYTTQSDVWSFGVLLWEIVTLGGNPYPGIA 234 (290)
T ss_pred eEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccC--CcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence 9999999999999999987543221 1223456789999998544 47889999999999999998 999998765
Q ss_pred hhH
Q 008759 534 CVS 536 (554)
Q Consensus 534 ~~~ 536 (554)
...
T Consensus 235 ~~~ 237 (290)
T cd05045 235 PER 237 (290)
T ss_pred HHH
Confidence 443
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=271.29 Aligned_cols=203 Identities=27% Similarity=0.457 Sum_probs=169.9
Q ss_pred cceeeeeeeccCCceeEEEEecC-C---CcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCc
Q 008759 329 TYWQKGDLLGRGSFGSVYEGISD-D---GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~~-~---g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~ 404 (554)
.+|++++.||+|+||.||+|.+. + +..+|+|.+.... .......+.+|+.++..++||||+++++++...+.
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 79 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY----TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKP 79 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC----CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence 57899999999999999999872 2 3478888875321 12335678899999999999999999999999999
Q ss_pred EEEEEeecccCchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC
Q 008759 405 LYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN 482 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~~--~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~ 482 (554)
+|+||||+.+++|.+++... .++..++..++.|++.||.|||++||+|+||||+|||++.++.++|+|||++......
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 80 VMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 99999999999999998763 4788899999999999999999999999999999999999999999999998765432
Q ss_pred Cc-----cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHH
Q 008759 483 DV-----KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSA 537 (554)
Q Consensus 483 ~~-----~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~ 537 (554)
.. ....++..|++||.+.+. .++.++|+|||||++|+|++ |..||......+.
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~ 218 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYR--KFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV 218 (267)
T ss_pred cceeeecCCCccceeecCHhHhccC--ccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHH
Confidence 21 111235679999998654 37889999999999999886 9999987765443
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=282.52 Aligned_cols=203 Identities=32% Similarity=0.593 Sum_probs=170.4
Q ss_pred cccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCC---
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE--- 402 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~--- 402 (554)
+.++|++.+.||+|+||.||+|.+ .+|+.||+|++.... .......+.+|+.+++.++|+||+++++++...
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 78 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE----HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFE 78 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc----cchhHHHHHHHHHHHHhCCCCCcCchhheeeccccc
Confidence 356899999999999999999988 678999999886321 122345677899999999999999999875443
Q ss_pred --CcEEEEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccc
Q 008759 403 --SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK 480 (554)
Q Consensus 403 --~~~~LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~ 480 (554)
...|++|||+.+ +|..++....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 79 ~~~~~~lv~e~~~~-~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 79 SFNDVYIVQELMET-DLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD 157 (336)
T ss_pred ccceEEEEehhccc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence 458999999976 78888887789999999999999999999999999999999999999999999999999987543
Q ss_pred cCC-----ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChh
Q 008759 481 LND-----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECV 535 (554)
Q Consensus 481 ~~~-----~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~ 535 (554)
... .....||+.|+|||++.+. ..++.++|||||||++|+|++|+.||...+..
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslGvil~el~~G~~~f~~~~~~ 216 (336)
T cd07849 158 PEHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL 216 (336)
T ss_pred ccccccCCcCCcCcCCCccChHHhhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 221 1234689999999987543 34788999999999999999999999776543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=266.94 Aligned_cols=198 Identities=29% Similarity=0.515 Sum_probs=166.5
Q ss_pred eeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEEEeeccc
Q 008759 335 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTK 414 (554)
Q Consensus 335 ~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LVmE~~~g 414 (554)
++||+|+||.||+|...++..+|+|.+.... .......+.+|+.+++.++|+||+++++.+...+..++||||+.+
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDL----PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPG 76 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcC----CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCC
Confidence 3699999999999998888999999876322 122334688999999999999999999999999999999999999
Q ss_pred CchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCCc---cCccC
Q 008759 415 GSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV---KSCRG 489 (554)
Q Consensus 415 gsL~~ll~~~--~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~~---~s~~G 489 (554)
++|.+++... .+.+..+..++.|++.+|.|||++|++|+||||+||+++.++.+||+|||++........ ....+
T Consensus 77 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05085 77 GDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI 156 (250)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence 9999988653 478889999999999999999999999999999999999999999999999865433221 11234
Q ss_pred CCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHH
Q 008759 490 TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAI 538 (554)
Q Consensus 490 T~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i 538 (554)
+..|+|||++... .++.++||||||+++|+|++ |..||.........
T Consensus 157 ~~~y~aPE~~~~~--~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~ 204 (250)
T cd05085 157 PIKWTAPEALNYG--RYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAR 204 (250)
T ss_pred cccccCHHHhccC--CCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHH
Confidence 5679999998654 37889999999999999998 99999877654443
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-32 Score=271.82 Aligned_cols=201 Identities=28% Similarity=0.481 Sum_probs=166.8
Q ss_pred ccceeeeeeeccCCceeEEEEec-CCCc----EEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCC
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGF----FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE 402 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~-~~g~----~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~ 402 (554)
.++|++.++||+|+||+||+|.+ .++. .||+|.+.... .......+.+|+.++..+.|+||+++++.+..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~- 80 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT----SPKANKEILDEAYVMAGVGSPYVCRLLGICLT- 80 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC----CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-
Confidence 45799999999999999999986 4444 47888876322 22334568899999999999999999998865
Q ss_pred CcEEEEEeecccCchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccc
Q 008759 403 SKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK 480 (554)
Q Consensus 403 ~~~~LVmE~~~ggsL~~ll~~~--~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~ 480 (554)
...+++|||+.+|+|.+++... .+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 81 STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence 4578999999999999998753 58999999999999999999999999999999999999999999999999987654
Q ss_pred cCCc----cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChh
Q 008759 481 LNDV----KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECV 535 (554)
Q Consensus 481 ~~~~----~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~ 535 (554)
.... ....+++.|++||.+.+. .++.++|||||||++|||++ |..||......
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 218 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILHR--RFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR 218 (279)
T ss_pred cccceeecCCCccchhhCCHHHhccC--CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 3221 112346789999998543 47889999999999999998 99999876543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=272.54 Aligned_cols=209 Identities=27% Similarity=0.516 Sum_probs=177.3
Q ss_pred cceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEE
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~L 407 (554)
++|++.+.||+|+||.||+|.+ .+++.|++|++..... .......+.+|+++++.++|+||+++++.+...+.+|+
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i 77 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED---DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYL 77 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc---cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEE
Confidence 3689999999999999999998 5688999998864222 12234678899999999999999999999999999999
Q ss_pred EEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC---
Q 008759 408 FLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--- 483 (554)
Q Consensus 408 VmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~--- 483 (554)
+|||+.++.+..+..+ ..+++..+..++.||+.||.|||+++|+|+||+|+||+++.++.+||+|||++.......
T Consensus 78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~ 157 (288)
T cd07833 78 VFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASP 157 (288)
T ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccc
Confidence 9999999877776654 458999999999999999999999999999999999999999999999999987654332
Q ss_pred ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHH
Q 008759 484 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIK 541 (554)
Q Consensus 484 ~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i 541 (554)
.....++..|+|||++.... .++.++|+||||+++|+|++|+.||......+.+..+
T Consensus 158 ~~~~~~~~~~~~PE~~~~~~-~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~ 214 (288)
T cd07833 158 LTDYVATRWYRAPELLVGDT-NYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLI 214 (288)
T ss_pred ccCcccccCCcCCchhcCCC-CcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 23456789999999986542 4788999999999999999999999877665555443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=280.24 Aligned_cols=204 Identities=35% Similarity=0.579 Sum_probs=174.5
Q ss_pred cceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEE
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~L 407 (554)
..|.....||+|+||.||++.+ .+++.||+|++..... .....+.+|+.++..++||||+++++.+...+.+|+
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-----~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~i 95 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ-----QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWV 95 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc-----chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEE
Confidence 3445556799999999999998 5789999999864221 223557789999999999999999999999999999
Q ss_pred EEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC--Ccc
Q 008759 408 FLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--DVK 485 (554)
Q Consensus 408 VmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~--~~~ 485 (554)
||||+.+++|..++....+++..+..++.|++.||.|||++||+|+||||+|||++.++.+||+|||++...... ...
T Consensus 96 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~ 175 (297)
T cd06659 96 LMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK 175 (297)
T ss_pred EEecCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccccccc
Confidence 999999999999888778999999999999999999999999999999999999999999999999998654332 223
Q ss_pred CccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHH
Q 008759 486 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIF 539 (554)
Q Consensus 486 s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~ 539 (554)
...++..|+|||++.+. .++.++|||||||++|+|++|+.||......+.+.
T Consensus 176 ~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~ 227 (297)
T cd06659 176 SLVGTPYWMAPEVISRT--PYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK 227 (297)
T ss_pred ceecCccccCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 45689999999998654 37889999999999999999999998766554443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-32 Score=268.52 Aligned_cols=199 Identities=26% Similarity=0.492 Sum_probs=167.3
Q ss_pred ccceeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeec-cCCCcEE
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTD-KDESKLY 406 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~-~~~~~~~ 406 (554)
..+|++.+.||+|+||.||++... +..+++|.+... ...+.+.+|+.+++.++|+||+++++++ ...+..|
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~-------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND-------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 76 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC-------chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceE
Confidence 357899999999999999999765 678899987531 1235678999999999999999999875 4556799
Q ss_pred EEEeecccCchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC
Q 008759 407 IFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND 483 (554)
Q Consensus 407 LVmE~~~ggsL~~ll~~~---~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~ 483 (554)
++|||+.+++|.++++.. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 156 (256)
T cd05082 77 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 156 (256)
T ss_pred EEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC
Confidence 999999999999998753 37788899999999999999999999999999999999999999999999987543322
Q ss_pred ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHH
Q 008759 484 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSA 537 (554)
Q Consensus 484 ~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~ 537 (554)
....++..|+|||++... .++.++|||||||++|+|++ |+.||......+.
T Consensus 157 -~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~ 208 (256)
T cd05082 157 -DTGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV 208 (256)
T ss_pred -CCCccceeecCHHHHccC--CCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 233456789999998543 47889999999999999997 9999987655443
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-32 Score=271.93 Aligned_cols=205 Identities=39% Similarity=0.695 Sum_probs=175.8
Q ss_pred cceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEE
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~L 407 (554)
+-|++.+.||.|+||.||+|.+ .++..||+|.+.... .......+.+|+.++..++|+||+++++.+.....+|+
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 79 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE----AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWI 79 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc----chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEE
Confidence 3477888999999999999987 678999999875322 12334678899999999999999999999999999999
Q ss_pred EEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC--cc
Q 008759 408 FLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VK 485 (554)
Q Consensus 408 VmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~--~~ 485 (554)
||||+.+++|..++....+++..+..++.|++.+|.|||++|++|+||+|.||+++.++.++|+|||++....... ..
T Consensus 80 v~e~~~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06641 80 IMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred EEEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhc
Confidence 9999999999999988889999999999999999999999999999999999999999999999999986544322 22
Q ss_pred CccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHH
Q 008759 486 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIF 539 (554)
Q Consensus 486 s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~ 539 (554)
...++..|++||.+.+. .++.++|+|||||++|+|++|..||..........
T Consensus 160 ~~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~ 211 (277)
T cd06641 160 TFVGTPFWMAPEVIKQS--AYDSKADIWSLGITAIELAKGEPPHSELHPMKVLF 211 (277)
T ss_pred cccCCccccChhhhccC--CCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHH
Confidence 34588899999998653 36789999999999999999999998766544433
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=273.94 Aligned_cols=204 Identities=27% Similarity=0.410 Sum_probs=171.0
Q ss_pred ccceeeeeeeccCCceeEEEEecCC-----------------CcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCC
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGISDD-----------------GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~~~-----------------g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hp 390 (554)
.++|++++.||+|+||.||+|.+.. +..||+|.+.... .......+.+|+.++..++|+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~~~~e~~~l~~l~~~ 79 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA----SDNAREDFLKEVKILSRLSDP 79 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc----CHHHHHHHHHHHHHHHhcCCC
Confidence 3578999999999999999988632 2457889876422 123456788999999999999
Q ss_pred ceeeeeeeccCCCcEEEEEeecccCchHHHHhhh------------cCChHHHHHHHHHHHHHHHHHHHCCccccCCccc
Q 008759 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCA 458 (554)
Q Consensus 391 nIVkl~~~~~~~~~~~LVmE~~~ggsL~~ll~~~------------~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPe 458 (554)
||+++++++..+..++++|||+.+++|..++.+. .+++..+..++.|++.||.|||++||+|+||||+
T Consensus 80 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~ 159 (296)
T cd05051 80 NIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATR 159 (296)
T ss_pred CEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchh
Confidence 9999999999999999999999999999998764 3788899999999999999999999999999999
Q ss_pred cEEEcCCCcEEEEecCcccccccCC----ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc--CCCCCCCC
Q 008759 459 NILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT--SQIPYAPM 532 (554)
Q Consensus 459 NILld~~g~vKL~DFGlA~~~~~~~----~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT--G~~PF~~~ 532 (554)
|||++.++.++|+|||+++...... .....+++.|+|||++... .++.++|||||||++|+|++ |..||...
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05051 160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLG--KFTTKSDVWAFGVTLWEILTLCREQPYEHL 237 (296)
T ss_pred ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcC--CCCccchhhhhHHHHHHHHhcCCCCCCCCc
Confidence 9999999999999999987543322 1233467789999998654 37889999999999999998 78899876
Q ss_pred ChhHH
Q 008759 533 ECVSA 537 (554)
Q Consensus 533 e~~~~ 537 (554)
...+.
T Consensus 238 ~~~~~ 242 (296)
T cd05051 238 TDQQV 242 (296)
T ss_pred ChHHH
Confidence 55443
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-32 Score=273.44 Aligned_cols=204 Identities=25% Similarity=0.403 Sum_probs=167.6
Q ss_pred ccceeeeeeeccCCceeEEEEecC------CCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccC
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD 401 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~~------~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~ 401 (554)
.++|++.+.||+|+||.||+|... .+..||+|.+.... .......+.+|+.+++.++|+||+++++.+..
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA----SLRERIEFLNEASVMKGFTCHHVVRLLGVVSK 80 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC----CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 468999999999999999998642 35589999875321 12223457789999999999999999999999
Q ss_pred CCcEEEEEeecccCchHHHHhhhc-----------CChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEE
Q 008759 402 ESKLYIFLELVTKGSLLNLYQRYH-----------LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKL 470 (554)
Q Consensus 402 ~~~~~LVmE~~~ggsL~~ll~~~~-----------l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL 470 (554)
.+..|+||||+.+|+|.+++.+.. +....+..++.||+.||.|||+++|+||||||+|||++.++.++|
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEE
Confidence 999999999999999999986521 345678889999999999999999999999999999999999999
Q ss_pred EecCcccccccCCc----cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHH
Q 008759 471 ADFGLAKATKLNDV----KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSA 537 (554)
Q Consensus 471 ~DFGlA~~~~~~~~----~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~ 537 (554)
+|||+++....... ....++..|+|||.+.+. .++.++|+|||||++|+|++ |..||......+.
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~--~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~ 230 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG--VFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV 230 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccC--CCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 99999875432211 122356789999998654 37889999999999999998 8999987665443
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-32 Score=270.56 Aligned_cols=200 Identities=24% Similarity=0.404 Sum_probs=162.4
Q ss_pred eeeccCCceeEEEEecC---CCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEEEee
Q 008759 335 DLLGRGSFGSVYEGISD---DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLEL 411 (554)
Q Consensus 335 ~~LG~GsfG~VY~a~~~---~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LVmE~ 411 (554)
+.||+|+||.||+|... ++..+++|.+..... ......+.+|+.+++.++||||+++++.+.+...+|+||||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 76 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS----VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEF 76 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC----hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEEC
Confidence 35899999999999753 446788997764221 22335688899999999999999999999999999999999
Q ss_pred cccCchHHHHhhh------cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC--
Q 008759 412 VTKGSLLNLYQRY------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-- 483 (554)
Q Consensus 412 ~~ggsL~~ll~~~------~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~-- 483 (554)
+.+|+|.+++... .+....+..++.|++.||.|||+++|+|+||||+|||++.++.+||+|||+++......
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~ 156 (269)
T cd05087 77 CPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY 156 (269)
T ss_pred CCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence 9999999988642 24556777899999999999999999999999999999999999999999986543221
Q ss_pred --ccCccCCCcccChhhhcccC-----CCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHH
Q 008759 484 --VKSCRGTAFWMAPEVINNKN-----KGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAI 538 (554)
Q Consensus 484 --~~s~~GT~~Y~APEvl~~~~-----~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i 538 (554)
.....++..|+|||++.... ..++.++|||||||++|+|++ |..||......+.+
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~ 219 (269)
T cd05087 157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVL 219 (269)
T ss_pred ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHH
Confidence 12234678899999986432 125779999999999999996 99999877655543
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-32 Score=269.23 Aligned_cols=202 Identities=29% Similarity=0.483 Sum_probs=169.2
Q ss_pred cceeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEE
Q 008759 329 TYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LV 408 (554)
+.|.+...||+|+||.||+|.+..+..+|+|.+..... ....+.+|+.+++.++|+||+++++++. .+..|++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~------~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v 78 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM------MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIV 78 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc------cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEE
Confidence 57899999999999999999987777899998753221 1245778999999999999999999875 4568999
Q ss_pred EeecccCchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCCc-
Q 008759 409 LELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV- 484 (554)
Q Consensus 409 mE~~~ggsL~~ll~~~---~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~~- 484 (554)
|||+.+++|.+++... .+++..+..++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 79 TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred EEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 9999999999998753 378888999999999999999999999999999999999999999999999876533221
Q ss_pred --cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHHH
Q 008759 485 --KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIF 539 (554)
Q Consensus 485 --~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i~ 539 (554)
....++..|+|||.+.+. .++.++|||||||++|+|++ |..||......+...
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~ 214 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLE 214 (260)
T ss_pred ccCCCccchhhCCHHHhccC--CcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 123456789999988644 37889999999999999999 999998876554433
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=276.34 Aligned_cols=199 Identities=28% Similarity=0.466 Sum_probs=173.1
Q ss_pred cceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEE
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~L 407 (554)
++|++.+.||+|+||+||++.+ .++..||+|++.... .......+.+|+.+++.++|+||+++++.+...+.+|+
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA----KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM 80 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC----cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence 5788999999999999999998 578999999876422 12234678899999999999999999999999999999
Q ss_pred EEeecccCchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHH-CCccccCCccccEEEcCCCcEEEEecCcccccccCCcc
Q 008759 408 FLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK 485 (554)
Q Consensus 408 VmE~~~ggsL~~ll~~~-~l~e~~i~~i~~QIl~gL~yLHs-~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~~~ 485 (554)
||||+.+++|..++... .+++..+..++.|++.+|.|||+ .+|+|+||||+||+++.++.++|+|||++.........
T Consensus 81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~~ 160 (284)
T cd06620 81 CMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIAD 160 (284)
T ss_pred EEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhccC
Confidence 99999999999988763 58899999999999999999997 58999999999999999999999999998654433334
Q ss_pred CccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008759 486 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME 533 (554)
Q Consensus 486 s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e 533 (554)
...|+..|+|||++.+. .++.++|+|||||++|+|++|+.||....
T Consensus 161 ~~~~~~~~~aPE~~~~~--~~~~~~Di~slG~~l~~l~tg~~p~~~~~ 206 (284)
T cd06620 161 TFVGTSTYMSPERIQGG--KYTVKSDVWSLGISIIELALGKFPFAFSN 206 (284)
T ss_pred ccccCcccCCHHHHccC--CCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence 45689999999998654 47889999999999999999999998644
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-32 Score=266.32 Aligned_cols=199 Identities=28% Similarity=0.490 Sum_probs=172.0
Q ss_pred ccceeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEE
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~L 407 (554)
.++|++.+.||.|+||.||+|... ++.+|+|.+..... ..+++.+|+.++..++|+||+++++.+...+..|+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 77 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST------AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYI 77 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh------HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEE
Confidence 457899999999999999999875 78899998864211 35678899999999999999999999998999999
Q ss_pred EEeecccCchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCCc
Q 008759 408 FLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV 484 (554)
Q Consensus 408 VmE~~~ggsL~~ll~~~---~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~~ 484 (554)
||||+.+++|.+++... .+++..+..++.|++.||.|||++||+|+||||+|||++.++.+||+|||++........
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~ 157 (256)
T cd05039 78 VTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD 157 (256)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccccc
Confidence 99999999999998764 489999999999999999999999999999999999999999999999999876633222
Q ss_pred cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhH
Q 008759 485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVS 536 (554)
Q Consensus 485 ~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~ 536 (554)
....+..|+|||.+... .++.++|+|||||++|+|++ |..||......+
T Consensus 158 -~~~~~~~~~ape~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~ 207 (256)
T cd05039 158 -SGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD 207 (256)
T ss_pred -cCCCcccccCchhhcCC--cCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 33356679999998644 37789999999999999997 999998775543
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-32 Score=271.89 Aligned_cols=206 Identities=33% Similarity=0.634 Sum_probs=171.9
Q ss_pred ccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhC-CCCceeeeeeeccC----
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKD---- 401 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIVkl~~~~~~---- 401 (554)
.+.|++.+.||.|+||.||+|.+ .+++.+|+|++... ......+..|+.++..+ +|+||+++++++..
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~------~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 88 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT------EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPP 88 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC------hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhccccc
Confidence 35788889999999999999998 67899999988642 12235677889999888 69999999998853
Q ss_pred --CCcEEEEEeecccCchHHHHhh---hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcc
Q 008759 402 --ESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA 476 (554)
Q Consensus 402 --~~~~~LVmE~~~ggsL~~ll~~---~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA 476 (554)
...+|++|||+.+++|.+++.. ..+++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++
T Consensus 89 ~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~ 168 (282)
T cd06636 89 GHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVS 168 (282)
T ss_pred CCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcch
Confidence 4678999999999999998865 24788889999999999999999999999999999999999999999999998
Q ss_pred ccccc--CCccCccCCCcccChhhhccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHH
Q 008759 477 KATKL--NDVKSCRGTAFWMAPEVINNK---NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIF 539 (554)
Q Consensus 477 ~~~~~--~~~~s~~GT~~Y~APEvl~~~---~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~ 539 (554)
..... .......|++.|+|||++... ...++.++|+|||||++|+|++|..||........++
T Consensus 169 ~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~ 236 (282)
T cd06636 169 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF 236 (282)
T ss_pred hhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh
Confidence 75432 223445689999999998532 2347889999999999999999999998776555444
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-32 Score=275.80 Aligned_cols=209 Identities=28% Similarity=0.498 Sum_probs=172.0
Q ss_pred ccccccceeeeeeeccCCceeEEEEec--------CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhC-CCCceee
Q 008759 324 FKRIITYWQKGDLLGRGSFGSVYEGIS--------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQ 394 (554)
Q Consensus 324 ~~~~~~~y~i~~~LG~GsfG~VY~a~~--------~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIVk 394 (554)
+.....+|.+++.||+|+||.||+|.. .++..+|+|.+... ........+.+|+.++..+ +|+||++
T Consensus 10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~~E~~~l~~l~~h~~i~~ 85 (304)
T cd05101 10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD----ATEKDLSDLVSEMEMMKMIGKHKNIIN 85 (304)
T ss_pred ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc----cchHHHHHHHHHHHHHHhhccCCCchh
Confidence 344567899999999999999999963 23457899987531 1223356788999999999 7999999
Q ss_pred eeeeccCCCcEEEEEeecccCchHHHHhhh-----------------cCChHHHHHHHHHHHHHHHHHHHCCccccCCcc
Q 008759 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRY-----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKC 457 (554)
Q Consensus 395 l~~~~~~~~~~~LVmE~~~ggsL~~ll~~~-----------------~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKP 457 (554)
+++.+.....+|+||||+.+++|.+++.+. .++...+..++.||+.||.|||++||+||||||
T Consensus 86 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp 165 (304)
T cd05101 86 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAA 165 (304)
T ss_pred eeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeeccccc
Confidence 999999999999999999999999998652 356677889999999999999999999999999
Q ss_pred ccEEEcCCCcEEEEecCcccccccCC----ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008759 458 ANILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPM 532 (554)
Q Consensus 458 eNILld~~g~vKL~DFGlA~~~~~~~----~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~ 532 (554)
+|||++.++.+||+|||+++...... .....+++.|+|||++.+. .++.++|||||||++|+|++ |..||...
T Consensus 166 ~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~ 243 (304)
T cd05101 166 RNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLMWEIFTLGGSPYPGI 243 (304)
T ss_pred ceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccC--CCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence 99999999999999999987654321 1122356789999998654 47889999999999999998 88999877
Q ss_pred ChhHHH
Q 008759 533 ECVSAI 538 (554)
Q Consensus 533 e~~~~i 538 (554)
...+..
T Consensus 244 ~~~~~~ 249 (304)
T cd05101 244 PVEELF 249 (304)
T ss_pred CHHHHH
Confidence 655443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=273.73 Aligned_cols=205 Identities=28% Similarity=0.455 Sum_probs=170.9
Q ss_pred cceeeeeeeccCCceeEEEEec------CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCC
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE 402 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~------~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~ 402 (554)
.+|.+.+.||+|+||.||++.. .++..+++|.+... .......+.+|++++..++|+||+++++++...
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-----SESARQDFQREAELLTVLQHQHIVRFYGVCTEG 79 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC-----CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence 4688899999999999999963 34668888876532 223456788999999999999999999999999
Q ss_pred CcEEEEEeecccCchHHHHhhh----------------cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCC
Q 008759 403 SKLYIFLELVTKGSLLNLYQRY----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG 466 (554)
Q Consensus 403 ~~~~LVmE~~~ggsL~~ll~~~----------------~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g 466 (554)
...|++|||+.+++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL 159 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC
Confidence 9999999999999999988653 377888999999999999999999999999999999999999
Q ss_pred cEEEEecCcccccccCCc----cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHHHH
Q 008759 467 SVKLADFGLAKATKLNDV----KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIFI 540 (554)
Q Consensus 467 ~vKL~DFGlA~~~~~~~~----~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i~~ 540 (554)
.+||+|||++........ ....+++.|+|||++.+. .++.++|||||||++|+|++ |..||......+.+..
T Consensus 160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 236 (280)
T cd05092 160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR--KFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIEC 236 (280)
T ss_pred CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccC--CcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHH
Confidence 999999999875432221 122356789999998654 37889999999999999998 9999987665544433
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-32 Score=261.18 Aligned_cols=205 Identities=38% Similarity=0.690 Sum_probs=179.1
Q ss_pred ceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEE
Q 008759 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (554)
Q Consensus 330 ~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LV 408 (554)
+|.+.+.||+|++|.||++.+ .++..+++|++..... .....+.+|+.+++.++|+||+++++++......+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~ 75 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-----EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIV 75 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-----hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence 478889999999999999998 5789999999874222 3456788999999999999999999999999999999
Q ss_pred EeecccCchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC-cc
Q 008759 409 LELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VK 485 (554)
Q Consensus 409 mE~~~ggsL~~ll~~~--~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~-~~ 485 (554)
+||+.+++|.+++... .+++..+..++.|++.+|.+||.+|++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 76 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 155 (253)
T cd05122 76 MEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN 155 (253)
T ss_pred EecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccccc
Confidence 9999999999998765 68999999999999999999999999999999999999999999999999987765443 34
Q ss_pred CccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHH
Q 008759 486 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIK 541 (554)
Q Consensus 486 s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i 541 (554)
...++..|++||.+.... ++.++|+||||+++|+|++|+.||...+..+.+...
T Consensus 156 ~~~~~~~~~~PE~~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~ 209 (253)
T cd05122 156 TMVGTPYWMAPEVINGKP--YDYKADIWSLGITAIELAEGKPPYSELPPMKALFKI 209 (253)
T ss_pred ceecCCcccCHHHHcCCC--CCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHH
Confidence 556889999999986543 788999999999999999999999987665555444
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=274.63 Aligned_cols=210 Identities=26% Similarity=0.440 Sum_probs=175.8
Q ss_pred ccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCC--Cc
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE--SK 404 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~--~~ 404 (554)
.+.|++.+.||.|+||.||+|.+ .+++.+++|.+...... ......+.+|+.++..++||||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 80 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK---EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDK 80 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc---ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCc
Confidence 45789999999999999999998 57899999998753322 12234567899999999999999999988776 89
Q ss_pred EEEEEeecccCchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC
Q 008759 405 LYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN 482 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~~--~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~ 482 (554)
+|+||||+.+ +|.+++... .+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++......
T Consensus 81 ~~lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 81 IYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159 (293)
T ss_pred EEEEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence 9999999985 888887653 4899999999999999999999999999999999999999999999999998765443
Q ss_pred --CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHH
Q 008759 483 --DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKT 542 (554)
Q Consensus 483 --~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~ 542 (554)
......+++.|+|||.+.+.. .++.++|+|||||++|+|++|..||......+.+.++.
T Consensus 160 ~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~ 220 (293)
T cd07843 160 LKPYTQLVVTLWYRAPELLLGAK-EYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIF 220 (293)
T ss_pred ccccccccccccccCchhhcCCc-cccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 223345788999999986433 36789999999999999999999999877766555443
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-32 Score=276.07 Aligned_cols=212 Identities=27% Similarity=0.474 Sum_probs=175.1
Q ss_pred cccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCC--C
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE--S 403 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~--~ 403 (554)
..++|++.+.||+|+||.||+|.+ .+|..||+|++....... .....+.+|+.++++++|+||+++++++... +
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD---GIPISSLREITLLLNLRHPNIVELKEVVVGKHLD 81 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC---CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCC
Confidence 457899999999999999999998 679999999987532211 1122456799999999999999999988654 5
Q ss_pred cEEEEEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccccc
Q 008759 404 KLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL 481 (554)
Q Consensus 404 ~~~LVmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~ 481 (554)
.+|+||||+.+ +|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 82 ~~~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 82 SIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160 (309)
T ss_pred eEEEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence 68999999976 78777764 4588999999999999999999999999999999999999999999999999876543
Q ss_pred C--CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHH
Q 008759 482 N--DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTV 543 (554)
Q Consensus 482 ~--~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~ 543 (554)
. ......+++.|+|||++.+. ..++.++|||||||++|+|++|+.||...+..+.+..+..
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~ 223 (309)
T cd07845 161 PAKPMTPKVVTLWYRAPELLLGC-TTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQ 223 (309)
T ss_pred ccCCCCcccccccccChhhhcCC-CCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 2 22333468889999998643 2478899999999999999999999998877666554443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-32 Score=282.29 Aligned_cols=207 Identities=28% Similarity=0.447 Sum_probs=172.5
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCC--
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE-- 402 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~-- 402 (554)
.+.++|++.+.||+|+||.||+|.+ .+++.||+|++..... .......+.+|+.+++.++|+||+++++++...
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ---NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKS 89 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc---ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCC
Confidence 3567899999999999999999998 6899999998753211 122345677899999999999999999987543
Q ss_pred ----CcEEEEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccc
Q 008759 403 ----SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA 478 (554)
Q Consensus 403 ----~~~~LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~ 478 (554)
..+|+||||+.+ +|..++... ++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 90 ~~~~~~~~lv~e~~~~-~l~~~~~~~-l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 167 (353)
T cd07850 90 LEEFQDVYLVMELMDA-NLCQVIQMD-LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 167 (353)
T ss_pred ccccCcEEEEEeccCC-CHHHHHhhc-CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCcccee
Confidence 357999999976 777776644 88999999999999999999999999999999999999999999999999976
Q ss_pred cccCC-ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHH
Q 008759 479 TKLND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIF 539 (554)
Q Consensus 479 ~~~~~-~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~ 539 (554)
..... .....++..|+|||++.+. .++.++|||||||++|+|++|+.||...+....+.
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~ 227 (353)
T cd07850 168 AGTSFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWN 227 (353)
T ss_pred CCCCCCCCCCcccccccCHHHHhCC--CCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 54332 2334588999999999654 48899999999999999999999998776554433
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-32 Score=272.69 Aligned_cols=194 Identities=31% Similarity=0.469 Sum_probs=159.9
Q ss_pred eeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHH---HHHhCCCCceeeeeeeccCCCcEEEEEee
Q 008759 336 LLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIA---LLSRFEHENIVQYYGTDKDESKLYIFLEL 411 (554)
Q Consensus 336 ~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~---iL~~l~HpnIVkl~~~~~~~~~~~LVmE~ 411 (554)
+||+|+||.||++.+ .++..+|+|++.......... ...+.+|.. ++....|+||+.+++.+...+.+|+||||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG--ETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDL 78 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchH--HHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEec
Confidence 489999999999998 678999999886433221111 122233433 34445799999999999999999999999
Q ss_pred cccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCCccCccCC
Q 008759 412 VTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490 (554)
Q Consensus 412 ~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~~~s~~GT 490 (554)
+.+++|..++.. ..+++..+..++.|++.||.|||+++|+|+||||+|||++.++.++|+|||++............||
T Consensus 79 ~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 158 (279)
T cd05633 79 MNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGT 158 (279)
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCccCcCCC
Confidence 999999988865 4589999999999999999999999999999999999999999999999999875544444445699
Q ss_pred CcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008759 491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM 532 (554)
Q Consensus 491 ~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~ 532 (554)
..|+|||++... ..++.++|+|||||++|+|++|..||...
T Consensus 159 ~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 199 (279)
T cd05633 159 HGYMAPEVLQKG-TAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (279)
T ss_pred cCccCHHHhcCC-CCCCchhhhHHHHHHHHHHHhCCCCcCCC
Confidence 999999998532 34788999999999999999999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-32 Score=266.04 Aligned_cols=207 Identities=31% Similarity=0.580 Sum_probs=176.4
Q ss_pred ceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEE
Q 008759 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (554)
Q Consensus 330 ~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LV 408 (554)
+|++.+.||+|+||.||++.+ .+++.|++|++...... ......+.+|+.+++.++|+||+++++++...+..|+|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 77 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS---PKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIV 77 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC---hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEE
Confidence 488999999999999999998 67899999998753221 22345778999999999999999999999999999999
Q ss_pred EeecccCchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC--
Q 008759 409 LELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-- 483 (554)
Q Consensus 409 mE~~~ggsL~~ll~~~---~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~-- 483 (554)
|||+.+++|.+++... .+++.++..++.|++.||.|||+++++|+||+|+|||++.++.++|+|||++.......
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 157 (256)
T cd08218 78 MDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL 157 (256)
T ss_pred EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh
Confidence 9999999999988653 47888999999999999999999999999999999999999999999999987654332
Q ss_pred ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHH
Q 008759 484 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIK 541 (554)
Q Consensus 484 ~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i 541 (554)
.....|++.|+|||++.+. .++.++|+|||||++|+|++|+.||...+..+....+
T Consensus 158 ~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~ 213 (256)
T cd08218 158 ARTCIGTPYYLSPEICENR--PYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKI 213 (256)
T ss_pred hhhccCCccccCHHHhCCC--CCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHH
Confidence 2234588899999998654 3778999999999999999999999877665554443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-32 Score=265.60 Aligned_cols=199 Identities=35% Similarity=0.581 Sum_probs=175.2
Q ss_pred cceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEE
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~L 407 (554)
++|++.+.||+|+||.||+|.+ .+++.|++|++...... .....+.+|+.++..++|+||+++++.+.....+|+
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 76 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE----EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISI 76 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch----HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEE
Confidence 3688999999999999999998 56999999988753221 345678899999999999999999999999999999
Q ss_pred EEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHH-CCccccCCccccEEEcCCCcEEEEecCcccccccCCcc
Q 008759 408 FLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK 485 (554)
Q Consensus 408 VmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs-~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~~~ 485 (554)
||||+.+++|.+++.. ..+++..+..++.||+.+|.|||+ ++++|+||+|+||+++.++.++|+|||++.........
T Consensus 77 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 77 VLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ 156 (264)
T ss_pred EEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence 9999999999999876 568999999999999999999999 99999999999999999999999999998765433322
Q ss_pred --CccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008759 486 --SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME 533 (554)
Q Consensus 486 --s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e 533 (554)
...++..|+|||.+... .++.++|+||||+++|+|++|..||....
T Consensus 157 ~~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 204 (264)
T cd06623 157 CNTFVGTVTYMSPERIQGE--SYSYAADIWSLGLTLLECALGKFPFLPPG 204 (264)
T ss_pred ccceeecccccCHhhhCCC--CCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 45688999999998654 47889999999999999999999998774
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-32 Score=273.15 Aligned_cols=196 Identities=30% Similarity=0.460 Sum_probs=160.8
Q ss_pred eeccCCceeEEEEec-CCCcEEEEEEEecccccchhHH-HHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEEEeecc
Q 008759 336 LLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQ-SISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVT 413 (554)
Q Consensus 336 ~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LVmE~~~ 413 (554)
+||+|+||.||++.+ .+++.||+|++........... ........+.++....|+||+++++.+...+.+|+||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999998 6789999999875322111111 11111222344555679999999999999999999999999
Q ss_pred cCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCCccCccCCCc
Q 008759 414 KGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF 492 (554)
Q Consensus 414 ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~~~s~~GT~~ 492 (554)
+++|..++.. ..+++..++.++.|++.||.|||+.+|+||||||+|||++.++.++|+|||++............|+..
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 160 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHG 160 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCCcCcCCCcC
Confidence 9999988865 458999999999999999999999999999999999999999999999999987654444445679999
Q ss_pred ccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008759 493 WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM 532 (554)
Q Consensus 493 Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~ 532 (554)
|+|||++.... .++.++|||||||++|+|++|+.||...
T Consensus 161 y~aPE~~~~~~-~~~~~~Di~s~G~~l~~l~~g~~p~~~~ 199 (278)
T cd05606 161 YMAPEVLQKGV-AYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (278)
T ss_pred CcCcHHhcCCC-CCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence 99999986432 4788999999999999999999999865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-32 Score=269.51 Aligned_cols=201 Identities=27% Similarity=0.468 Sum_probs=163.1
Q ss_pred eeeeeeeccCCceeEEEEecCC-Cc--EEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccC------
Q 008759 331 WQKGDLLGRGSFGSVYEGISDD-GF--FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD------ 401 (554)
Q Consensus 331 y~i~~~LG~GsfG~VY~a~~~~-g~--~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~------ 401 (554)
|.+++.||+|+||.||+|.+.. +. .+|+|.+.... ........+.+|+.+++.++|+||+++++.+..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 77 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI---CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEG 77 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCc---CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccC
Confidence 3567899999999999998843 33 58899876422 123445678899999999999999999987532
Q ss_pred CCcEEEEEeecccCchHHHHhh-------hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecC
Q 008759 402 ESKLYIFLELVTKGSLLNLYQR-------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFG 474 (554)
Q Consensus 402 ~~~~~LVmE~~~ggsL~~ll~~-------~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFG 474 (554)
....+++|||+.+|+|..++.. ..+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||
T Consensus 78 ~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 78 YPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred CCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCC
Confidence 2357899999999999987732 237888899999999999999999999999999999999999999999999
Q ss_pred cccccccCCc----cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhH
Q 008759 475 LAKATKLNDV----KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVS 536 (554)
Q Consensus 475 lA~~~~~~~~----~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~ 536 (554)
+++....... ....+++.|++||.+... .++.++|||||||++|+|++ |+.||...+..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 222 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADR--VYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE 222 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCC--CcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 9886543221 222356789999998644 47889999999999999999 899998765543
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=275.83 Aligned_cols=203 Identities=27% Similarity=0.410 Sum_probs=168.2
Q ss_pred cceeeeeeeccCCceeEEEEecCC---------------CcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCcee
Q 008759 329 TYWQKGDLLGRGSFGSVYEGISDD---------------GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~~~---------------g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIV 393 (554)
++|++.+.||+|+||.||+|++.. ...||+|.+.... .......+.+|++++.+++|+||+
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~ei~~l~~l~h~~i~ 80 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV----TKTARNDFLKEIKIMSRLKNPNII 80 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC----CHHHHHHHHHHHHHHHhCCCCCcC
Confidence 578999999999999999998632 2358999876321 123345688999999999999999
Q ss_pred eeeeeccCCCcEEEEEeecccCchHHHHhhh-------------cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccE
Q 008759 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRY-------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANI 460 (554)
Q Consensus 394 kl~~~~~~~~~~~LVmE~~~ggsL~~ll~~~-------------~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNI 460 (554)
++++++...+..|+||||+.+++|.+++... .+.+..+..++.|++.||.|||++|++|+||||+||
T Consensus 81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni 160 (295)
T cd05097 81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC 160 (295)
T ss_pred eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence 9999999999999999999999999988643 257778899999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCcccccccCCc----cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc--CCCCCCCCCh
Q 008759 461 LVDANGSVKLADFGLAKATKLNDV----KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT--SQIPYAPMEC 534 (554)
Q Consensus 461 Lld~~g~vKL~DFGlA~~~~~~~~----~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT--G~~PF~~~e~ 534 (554)
|++.++.+||+|||++........ ....++..|+|||++... .++.++|+|||||++|+|++ |..||.....
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~ 238 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG--KFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD 238 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccC--CcCchhhHHHHHHHHHHHHHcCCCCCCcccCh
Confidence 999999999999999875433221 122356789999998654 37899999999999999988 7789987665
Q ss_pred hHH
Q 008759 535 VSA 537 (554)
Q Consensus 535 ~~~ 537 (554)
.+.
T Consensus 239 ~~~ 241 (295)
T cd05097 239 EQV 241 (295)
T ss_pred HHH
Confidence 443
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-32 Score=270.93 Aligned_cols=199 Identities=30% Similarity=0.526 Sum_probs=163.8
Q ss_pred cceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHH-HHhCCCCceeeeeeeccCCCcEE
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL-LSRFEHENIVQYYGTDKDESKLY 406 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~i-L~~l~HpnIVkl~~~~~~~~~~~ 406 (554)
++|++.+.||+|+||.||++.+ .+|..||+|++....... ....+..|+.+ ++.++|+||+++++.+...+.+|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~ 76 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ----EQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVW 76 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH----HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEE
Confidence 3689999999999999999998 579999999987532211 12334455554 66678999999999999999999
Q ss_pred EEEeecccCchHHHHhh-----hcCChHHHHHHHHHHHHHHHHHHHC-CccccCCccccEEEcCCCcEEEEecCcccccc
Q 008759 407 IFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQ-DVVHRDIKCANILVDANGSVKLADFGLAKATK 480 (554)
Q Consensus 407 LVmE~~~ggsL~~ll~~-----~~l~e~~i~~i~~QIl~gL~yLHs~-gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~ 480 (554)
++|||+. ++|..++.. ..+++..+..++.||+.||.|||++ +++||||||+|||++.++.+||+|||++....
T Consensus 77 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~ 155 (283)
T cd06617 77 ICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155 (283)
T ss_pred EEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 9999997 477777654 2488999999999999999999997 99999999999999999999999999987654
Q ss_pred cCCc-cCccCCCcccChhhhcccC--CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008759 481 LNDV-KSCRGTAFWMAPEVINNKN--KGYGLPADIWSLGCTVLEMLTSQIPYAPM 532 (554)
Q Consensus 481 ~~~~-~s~~GT~~Y~APEvl~~~~--~~~s~ksDIwSLGvllyeLLTG~~PF~~~ 532 (554)
.... ....++..|+|||++.+.. ..++.++|+|||||++|+|++|+.||...
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 210 (283)
T cd06617 156 DSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSW 210 (283)
T ss_pred cccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcc
Confidence 3322 2245888999999885422 34678999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-32 Score=273.42 Aligned_cols=207 Identities=27% Similarity=0.497 Sum_probs=171.8
Q ss_pred ccccccceeeeeeeccCCceeEEEEecC------CCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhC-CCCceeeee
Q 008759 324 FKRIITYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYY 396 (554)
Q Consensus 324 ~~~~~~~y~i~~~LG~GsfG~VY~a~~~------~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIVkl~ 396 (554)
+....++|++.+.||+|+||.||++.+. ....+|+|.+.... .......+.+|+.++..+ +|+||++++
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~----~~~~~~~~~~E~~~l~~l~~h~~i~~~~ 82 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA----TEKDLSDLVSEMEMMKMIGKHKNIINLL 82 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC----CHHHHHHHHHHHHHHHhhcCCCCeeeEE
Confidence 3344568999999999999999999863 23688999876421 123345688999999999 799999999
Q ss_pred eeccCCCcEEEEEeecccCchHHHHhh-----------------hcCChHHHHHHHHHHHHHHHHHHHCCccccCCcccc
Q 008759 397 GTDKDESKLYIFLELVTKGSLLNLYQR-----------------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCAN 459 (554)
Q Consensus 397 ~~~~~~~~~~LVmE~~~ggsL~~ll~~-----------------~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeN 459 (554)
+.+...+.+|++|||+.+++|..+++. ..+++..+..++.||+.||.|||++||+||||||+|
T Consensus 83 ~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~N 162 (293)
T cd05053 83 GVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARN 162 (293)
T ss_pred EEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceee
Confidence 999999999999999999999999864 247788899999999999999999999999999999
Q ss_pred EEEcCCCcEEEEecCcccccccCCc----cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCh
Q 008759 460 ILVDANGSVKLADFGLAKATKLNDV----KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMEC 534 (554)
Q Consensus 460 ILld~~g~vKL~DFGlA~~~~~~~~----~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~ 534 (554)
||++.++.+||+|||+++....... ....++..|+|||++.+. .++.++|||||||++|+|++ |..||.....
T Consensus 163 il~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 240 (293)
T cd05053 163 VLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 240 (293)
T ss_pred EEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccC--CcCcccceeehhhHHHHHhcCCCCCCCCCCH
Confidence 9999999999999999876543221 122345679999998554 47889999999999999998 9999987765
Q ss_pred hH
Q 008759 535 VS 536 (554)
Q Consensus 535 ~~ 536 (554)
.+
T Consensus 241 ~~ 242 (293)
T cd05053 241 EE 242 (293)
T ss_pred HH
Confidence 44
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-32 Score=271.59 Aligned_cols=210 Identities=33% Similarity=0.592 Sum_probs=175.0
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhC-CCCceeeeeeeccCC-
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDE- 402 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIVkl~~~~~~~- 402 (554)
...++|.+.+.||+|+||.||++.+ .+++.+|+|++.... .....+.+|+.++.++ +|+||+++++.+...
T Consensus 19 ~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~------~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~ 92 (291)
T cd06639 19 DPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS------DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKAD 92 (291)
T ss_pred CCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc------cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecc
Confidence 4567899999999999999999998 678999999886321 1234567888999988 799999999987643
Q ss_pred ----CcEEEEEeecccCchHHHHhh-----hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEec
Q 008759 403 ----SKLYIFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADF 473 (554)
Q Consensus 403 ----~~~~LVmE~~~ggsL~~ll~~-----~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DF 473 (554)
..+|+||||+.+++|.++++. ..+++..+..++.|++.||.|||+++|+|+||||+|||++.++.+||+||
T Consensus 93 ~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~df 172 (291)
T cd06639 93 KLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDF 172 (291)
T ss_pred ccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeec
Confidence 468999999999999988753 35888999999999999999999999999999999999999999999999
Q ss_pred CcccccccCC--ccCccCCCcccChhhhcccC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHH
Q 008759 474 GLAKATKLND--VKSCRGTAFWMAPEVINNKN---KGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIK 541 (554)
Q Consensus 474 GlA~~~~~~~--~~s~~GT~~Y~APEvl~~~~---~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i 541 (554)
|++....... .....++..|+|||++.... ..++.++|||||||++|+|++|+.||...+..+.++.+
T Consensus 173 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~ 245 (291)
T cd06639 173 GVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKI 245 (291)
T ss_pred ccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHH
Confidence 9987644322 22346889999999985432 12678999999999999999999999988776666554
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-32 Score=271.32 Aligned_cols=208 Identities=31% Similarity=0.512 Sum_probs=173.6
Q ss_pred ceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEE
Q 008759 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (554)
Q Consensus 330 ~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LV 408 (554)
+|++.+.||.|+||.||+|.+ .++..||+|.+...... ......+.+|++++++++||||+++++++.+.+.+|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET---EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 77 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccc---cccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEE
Confidence 478899999999999999998 57899999988643211 12234678899999999999999999999999999999
Q ss_pred EeecccCchHHHHhh---hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC--C
Q 008759 409 LELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--D 483 (554)
Q Consensus 409 mE~~~ggsL~~ll~~---~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~--~ 483 (554)
|||+. ++|..++.. ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.+||+|||++...... .
T Consensus 78 ~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 156 (284)
T cd07860 78 FEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 156 (284)
T ss_pred eeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc
Confidence 99996 478887754 35788999999999999999999999999999999999999999999999998754332 1
Q ss_pred ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHH
Q 008759 484 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKT 542 (554)
Q Consensus 484 ~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~ 542 (554)
.....+++.|+|||++.+.. .++.++|||||||++|+|+||+.||...+..+.++++.
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~ 214 (284)
T cd07860 157 YTHEVVTLWYRAPEILLGCK-YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 214 (284)
T ss_pred cccccccccccCCeEEecCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 22334788999999885432 36788999999999999999999998776666555543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-32 Score=267.31 Aligned_cols=199 Identities=31% Similarity=0.530 Sum_probs=166.9
Q ss_pred eeeccCCceeEEEEecC--CC--cEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEEEe
Q 008759 335 DLLGRGSFGSVYEGISD--DG--FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLE 410 (554)
Q Consensus 335 ~~LG~GsfG~VY~a~~~--~g--~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LVmE 410 (554)
+.||+|+||.||+|.+. ++ ..+|+|.+...... ...+.+.+|+.++++++|+||+++++.+.. ..+++|||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e 75 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS----DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTE 75 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH----HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEE
Confidence 46899999999999873 23 36899988642221 456788899999999999999999999888 88999999
Q ss_pred ecccCchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC----
Q 008759 411 LVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND---- 483 (554)
Q Consensus 411 ~~~ggsL~~ll~~~---~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~---- 483 (554)
|+.+++|.+++.+. .+++..+..++.|++.||.|||++|++|+||||+|||++.++.+||+|||+++......
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 76 LAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred ecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 99999999998764 47889999999999999999999999999999999999999999999999987654321
Q ss_pred -ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHHHH
Q 008759 484 -VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIFI 540 (554)
Q Consensus 484 -~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i~~ 540 (554)
.....++..|++||.+.+. .++.++|||||||++|+|++ |+.||......+....
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~ 212 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTR--TFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKK 212 (257)
T ss_pred cccCCCCCceecCHHHhccc--CcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 1123467889999998654 37889999999999999998 9999987766554333
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=281.79 Aligned_cols=199 Identities=31% Similarity=0.539 Sum_probs=170.3
Q ss_pred ccceee-eeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCC-CCceeeeeeeccCCCc
Q 008759 328 ITYWQK-GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDESK 404 (554)
Q Consensus 328 ~~~y~i-~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIVkl~~~~~~~~~ 404 (554)
.+.|++ .+.||+|+|+.|--+.. .+|..||||++.+. ......++.+|++++.+++ |+||++|+++|.+++.
T Consensus 76 ~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq-----~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~ 150 (463)
T KOG0607|consen 76 EDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ-----PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTR 150 (463)
T ss_pred HHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcC-----CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccce
Confidence 345655 46899999999999998 89999999998742 3455678889999999986 9999999999999999
Q ss_pred EEEEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCc---EEEEecCcccccc
Q 008759 405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS---VKLADFGLAKATK 480 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~---vKL~DFGlA~~~~ 480 (554)
+|||||-|.||.|...+++ ..|++.++.++++.|+.||.|||.+||.||||||+|||...... |||+||.|....+
T Consensus 151 FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k 230 (463)
T KOG0607|consen 151 FYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIK 230 (463)
T ss_pred EEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccc
Confidence 9999999999998887765 67999999999999999999999999999999999999976654 7999999876543
Q ss_pred cC---------CccCccCCCcccChhhhc---ccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008759 481 LN---------DVKSCRGTAFWMAPEVIN---NKNKGYGLPADIWSLGCTVLEMLTSQIPYAP 531 (554)
Q Consensus 481 ~~---------~~~s~~GT~~Y~APEvl~---~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~ 531 (554)
.+ ...+.+|+..|||||++. +....|+.+.|.||||+|+|-||+|++||-+
T Consensus 231 ~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG 293 (463)
T KOG0607|consen 231 LNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVG 293 (463)
T ss_pred cCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccC
Confidence 22 234556888999999874 2333489999999999999999999999964
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-32 Score=274.56 Aligned_cols=203 Identities=27% Similarity=0.411 Sum_probs=167.9
Q ss_pred cceeeeeeeccCCceeEEEEecC-----------------CCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCc
Q 008759 329 TYWQKGDLLGRGSFGSVYEGISD-----------------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~~-----------------~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hpn 391 (554)
++|++.+.||+|+||.||++.+. +...+|+|.+.... .......+.+|+.+++.++|+|
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~~~E~~~l~~l~~~~ 80 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA----NKNARNDFLKEIKIMSRLKDPN 80 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC----CHHHHHHHHHHHHHHHhCCCCC
Confidence 56899999999999999998542 34578899876321 2333467889999999999999
Q ss_pred eeeeeeeccCCCcEEEEEeecccCchHHHHhhhc------------CChHHHHHHHHHHHHHHHHHHHCCccccCCcccc
Q 008759 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH------------LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCAN 459 (554)
Q Consensus 392 IVkl~~~~~~~~~~~LVmE~~~ggsL~~ll~~~~------------l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeN 459 (554)
|+++++++...+.+|+||||+.+++|.+++.... +++..+..++.||+.||.|||++||+|+||||+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~N 160 (296)
T cd05095 81 IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN 160 (296)
T ss_pred cceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChhe
Confidence 9999999999999999999999999999886532 5566799999999999999999999999999999
Q ss_pred EEEcCCCcEEEEecCcccccccCCc----cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc--CCCCCCCCC
Q 008759 460 ILVDANGSVKLADFGLAKATKLNDV----KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT--SQIPYAPME 533 (554)
Q Consensus 460 ILld~~g~vKL~DFGlA~~~~~~~~----~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT--G~~PF~~~e 533 (554)
||++.++.++|+|||+++....... ....++..|++||++... .++.++|+|||||++|||++ |..||....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLG--KFTTASDVWAFGVTLWEILTLCKEQPYSQLS 238 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcC--CccchhhhhHHHHHHHHHHHhCCCCCccccC
Confidence 9999999999999999876433221 122346789999987554 38899999999999999998 789998765
Q ss_pred hhHH
Q 008759 534 CVSA 537 (554)
Q Consensus 534 ~~~~ 537 (554)
..+.
T Consensus 239 ~~~~ 242 (296)
T cd05095 239 DEQV 242 (296)
T ss_pred hHHH
Confidence 5443
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-32 Score=267.90 Aligned_cols=200 Identities=27% Similarity=0.473 Sum_probs=165.0
Q ss_pred eeccCCceeEEEEec---CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEEEeec
Q 008759 336 LLGRGSFGSVYEGIS---DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELV 412 (554)
Q Consensus 336 ~LG~GsfG~VY~a~~---~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LVmE~~ 412 (554)
.||+|+||.||+|.+ .++..+|+|++.... ......+.+.+|+.++..+.|+||+++++.+. ....++||||+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~ 77 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN---NDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELA 77 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC---CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecC
Confidence 589999999999964 467899999876432 22334567889999999999999999999875 45678999999
Q ss_pred ccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCCc-----cC
Q 008759 413 TKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-----KS 486 (554)
Q Consensus 413 ~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~~-----~s 486 (554)
.+++|.+++.. ..+++..+..++.|++.||.|||++||+||||||.|||++.++.+||+|||++........ ..
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05116 78 ELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH 157 (257)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCC
Confidence 99999998865 4688999999999999999999999999999999999999999999999999876543221 12
Q ss_pred ccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHHHHH
Q 008759 487 CRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIFIK 541 (554)
Q Consensus 487 ~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i~~i 541 (554)
..++..|+|||.+... .++.++|+|||||++|||++ |..||......+....+
T Consensus 158 ~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i 211 (257)
T cd05116 158 GKWPVKWYAPECMNYY--KFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMI 211 (257)
T ss_pred CCCCccccCHhHhccC--CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 2345789999998543 47889999999999999998 99999877655444333
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-32 Score=272.38 Aligned_cols=201 Identities=28% Similarity=0.497 Sum_probs=170.5
Q ss_pred ceeeeeeeccCCceeEEEEec----CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhC-CCCceeeeeeeccCCCc
Q 008759 330 YWQKGDLLGRGSFGSVYEGIS----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESK 404 (554)
Q Consensus 330 ~y~i~~~LG~GsfG~VY~a~~----~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIVkl~~~~~~~~~ 404 (554)
.|++.+.||.|+||.||++.+ .+|..||+|++..... .......+++.+|+.++..+ +|+||+++++++..+..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~ 79 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATI-VQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTK 79 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhh-hhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCe
Confidence 478899999999999999987 3789999999864221 11122345678899999999 58999999999999999
Q ss_pred EEEEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC
Q 008759 405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND 483 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~ 483 (554)
+|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++|++||||+|+|||++.++.+||+|||++.......
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 159 (290)
T cd05613 80 LHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE 159 (290)
T ss_pred EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceeccccc
Confidence 9999999999999998865 458889999999999999999999999999999999999999999999999987654322
Q ss_pred ---ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008759 484 ---VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP 531 (554)
Q Consensus 484 ---~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~ 531 (554)
.....|+..|++||.+......++.++||||||+++|+|++|..||..
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~ 210 (290)
T cd05613 160 VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTV 210 (290)
T ss_pred ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCc
Confidence 223458899999999865444577899999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=271.94 Aligned_cols=203 Identities=30% Similarity=0.489 Sum_probs=168.3
Q ss_pred eeeeeeccCCceeEEEEecC-----CCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEE
Q 008759 332 QKGDLLGRGSFGSVYEGISD-----DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (554)
Q Consensus 332 ~i~~~LG~GsfG~VY~a~~~-----~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~ 406 (554)
++.+.||.|.||.||+|.+. .+..|++|.+.. .........+.+|+.++.+++||||+++++++...+.++
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~----~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~ 77 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP----SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLF 77 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST----TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc----ccccccceeeeeccccccccccccccccccccccccccc
Confidence 46789999999999999875 467889998853 122334678889999999999999999999999888899
Q ss_pred EEEeecccCchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC
Q 008759 407 IFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND 483 (554)
Q Consensus 407 LVmE~~~ggsL~~ll~~~---~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~ 483 (554)
+||||+.+|+|.+++... .+++..+..|+.||+.||.|||+++|+|++|+++|||++.++.+||+|||++.......
T Consensus 78 lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 78 LVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp EEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999999999999999875 68999999999999999999999999999999999999999999999999987652211
Q ss_pred ----ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHHHH
Q 008759 484 ----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIFI 540 (554)
Q Consensus 484 ----~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i~~ 540 (554)
.........|+|||.+.... ++.++||||||+++|||++ |+.||......+.+..
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~--~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~ 217 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGE--YTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEK 217 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSE--ESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHH
T ss_pred cccccccccccccccccccccccc--cccccccccccccccccccccccccccccccccccc
Confidence 12334677899999996654 7899999999999999999 7899998866554433
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-32 Score=268.97 Aligned_cols=206 Identities=27% Similarity=0.479 Sum_probs=170.6
Q ss_pred ccceeeeeeeccCCceeEEEEec-CCC---cEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCC
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS-DDG---FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES 403 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~-~~g---~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~ 403 (554)
...|++.+.||+|+||.||+|.+ .++ ..||+|.+.... .......+..|+.+++.++||||+++++++....
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 78 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY----TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSR 78 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC----CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCC
Confidence 35689999999999999999987 333 369999876421 2334567889999999999999999999999999
Q ss_pred cEEEEEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccccc
Q 008759 404 KLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL 481 (554)
Q Consensus 404 ~~~LVmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~ 481 (554)
.+++||||+.+++|.+++.. ..++..++..++.|++.||.|||++|++|+||||+|||++.++.+||+|||++.....
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 79 PVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred ceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCcccccccc
Confidence 99999999999999998875 3478899999999999999999999999999999999999999999999999875433
Q ss_pred CCc----cC-c--cCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHHH
Q 008759 482 NDV----KS-C--RGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIF 539 (554)
Q Consensus 482 ~~~----~s-~--~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i~ 539 (554)
... .. . ..+..|++||.+.+. .++.++|||||||++|||++ |..||......+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~ 222 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYR--KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIN 222 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccC--cccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHH
Confidence 211 11 1 124579999998654 47889999999999999987 999998776554433
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-31 Score=273.43 Aligned_cols=204 Identities=23% Similarity=0.352 Sum_probs=153.4
Q ss_pred ccceeeeeeeccCCceeEEEEecCC----CcEEEEEEEecccccchhHHH------HHHHHHHHHHHHhCCCCceeeeee
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGISDD----GFFFAVKEVSLLDQGSQAKQS------ISQLEQEIALLSRFEHENIVQYYG 397 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~~~----g~~vAvK~v~~~~~~~~~~~~------~~~~~~Ei~iL~~l~HpnIVkl~~ 397 (554)
.++|++.++||+|+||+||+|.+.+ +..+|+|+............. ......++..+..+.|+||+++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 3689999999999999999999743 456666654322211111100 011223344566778999999998
Q ss_pred eccCCC----cEEEEEeecccCchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEe
Q 008759 398 TDKDES----KLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLAD 472 (554)
Q Consensus 398 ~~~~~~----~~~LVmE~~~ggsL~~ll~~~-~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~D 472 (554)
++.... ..+++|+++.. ++.+++... ..++..+..++.|++.||.|||+++|+||||||+|||++.++.++|+|
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~D 169 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIID 169 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEE
Confidence 765433 34678887754 555665543 367888899999999999999999999999999999999999999999
Q ss_pred cCcccccccC---------CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh
Q 008759 473 FGLAKATKLN---------DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC 534 (554)
Q Consensus 473 FGlA~~~~~~---------~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~ 534 (554)
||+++..... ......||+.|+|||++.+. .++.++|||||||++|+|++|++||.....
T Consensus 170 FGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~--~~~~~~DiwSlG~~l~el~~g~~P~~~~~~ 238 (294)
T PHA02882 170 YGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGA--CVTRRGDLESLGYCMLKWAGIKLPWKGFGH 238 (294)
T ss_pred cCCceeeccCCcccccccccccccCCCccccCHHHhCCC--CCCcHHHHHHHHHHHHHHHhCCCCCCcccc
Confidence 9999764321 11234699999999998654 488999999999999999999999987743
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-32 Score=267.53 Aligned_cols=202 Identities=28% Similarity=0.477 Sum_probs=168.4
Q ss_pred cceeeeeeeccCCceeEEEEecC-CC---cEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCc
Q 008759 329 TYWQKGDLLGRGSFGSVYEGISD-DG---FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~~-~g---~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~ 404 (554)
++|+..+.||+|+||.||+|.+. ++ ..+++|.+.... .......+.+|+.++..++|+||+++++++...+.
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY----TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP 80 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC----CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence 47888999999999999999873 33 378888876421 12234568899999999999999999999999999
Q ss_pred EEEEEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC
Q 008759 405 LYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN 482 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~ 482 (554)
.|+||||+.+++|..++.. ..+++..+..++.|++.||.|||++||+|+||||+|||++.++.+||+|||++......
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 9999999999999999865 35888999999999999999999999999999999999999999999999998755332
Q ss_pred Ccc-----CccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhH
Q 008759 483 DVK-----SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVS 536 (554)
Q Consensus 483 ~~~-----s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~ 536 (554)
... ....+..|+|||++... .++.++|||||||++|+|++ |+.||......+
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~ 218 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYR--KFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE 218 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcC--CcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH
Confidence 211 11234579999998654 47889999999999999997 999998765544
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-32 Score=278.77 Aligned_cols=207 Identities=29% Similarity=0.484 Sum_probs=169.7
Q ss_pred ccccceeeeeeeccCCceeEEEEecC--------CCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhC-CCCceeeee
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGISD--------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYY 396 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~~--------~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIVkl~ 396 (554)
....+|++++.||+|+||.||+|.+. .+..||+|.+... ........+.+|+.++.++ +|+||++++
T Consensus 9 ~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 84 (334)
T cd05100 9 LSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD----ATDKDLSDLVSEMEMMKMIGKHKNIINLL 84 (334)
T ss_pred cCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc----cCHHHHHHHHHHHHHHHhhcCCCCeeeee
Confidence 33457999999999999999999752 2236899977632 1223456788999999999 799999999
Q ss_pred eeccCCCcEEEEEeecccCchHHHHhhh-----------------cCChHHHHHHHHHHHHHHHHHHHCCccccCCcccc
Q 008759 397 GTDKDESKLYIFLELVTKGSLLNLYQRY-----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCAN 459 (554)
Q Consensus 397 ~~~~~~~~~~LVmE~~~ggsL~~ll~~~-----------------~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeN 459 (554)
+.+...+.+|++|||+.+|+|.+++.+. .+....+..++.||+.||.|||++||+||||||+|
T Consensus 85 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N 164 (334)
T cd05100 85 GACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARN 164 (334)
T ss_pred EEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccce
Confidence 9999999999999999999999998642 25667888899999999999999999999999999
Q ss_pred EEEcCCCcEEEEecCcccccccCC----ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCh
Q 008759 460 ILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMEC 534 (554)
Q Consensus 460 ILld~~g~vKL~DFGlA~~~~~~~----~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~ 534 (554)
||++.++.+||+|||+++...... .....++..|+|||++.+. .++.++|||||||++|+|++ |..||.....
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 242 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 242 (334)
T ss_pred EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccC--CcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence 999999999999999987654321 1112245679999998654 37889999999999999998 8999987765
Q ss_pred hHHH
Q 008759 535 VSAI 538 (554)
Q Consensus 535 ~~~i 538 (554)
.+..
T Consensus 243 ~~~~ 246 (334)
T cd05100 243 EELF 246 (334)
T ss_pred HHHH
Confidence 4443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-31 Score=263.93 Aligned_cols=200 Identities=35% Similarity=0.585 Sum_probs=171.1
Q ss_pred ceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeecc--CCCcEE
Q 008759 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK--DESKLY 406 (554)
Q Consensus 330 ~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~--~~~~~~ 406 (554)
+|++.+.||.|+||.||++.+ .++..+|+|++..... .....+.+..|+.+++.++|+||+++++.+. ....+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 77 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM---TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLY 77 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC---CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEE
Confidence 478899999999999999998 6789999998864222 2333467889999999999999999999765 345689
Q ss_pred EEEeecccCchHHHHhh-----hcCChHHHHHHHHHHHHHHHHHH-----HCCccccCCccccEEEcCCCcEEEEecCcc
Q 008759 407 IFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLH-----DQDVVHRDIKCANILVDANGSVKLADFGLA 476 (554)
Q Consensus 407 LVmE~~~ggsL~~ll~~-----~~l~e~~i~~i~~QIl~gL~yLH-----s~gIIHrDIKPeNILld~~g~vKL~DFGlA 476 (554)
++|||+.+++|.+++.. ..+++..+..++.||+.||.||| +.+|+|+||||+|||++.++.+||+|||++
T Consensus 78 ~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred EEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccc
Confidence 99999999999998864 35888999999999999999999 899999999999999999999999999998
Q ss_pred cccccCC--ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh
Q 008759 477 KATKLND--VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC 534 (554)
Q Consensus 477 ~~~~~~~--~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~ 534 (554)
....... .....+++.|++||++.... ++.++|+||||+++|+|++|+.||...+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~pE~~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 215 (265)
T cd08217 158 KILGHDSSFAKTYVGTPYYMSPEQLNHMS--YDEKSDIWSLGCLIYELCALSPPFTARNQ 215 (265)
T ss_pred ccccCCcccccccccCCCccChhhhcCCC--CCchhHHHHHHHHHHHHHHCCCcccCcCH
Confidence 8765433 33456899999999986543 78899999999999999999999987753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=296.95 Aligned_cols=204 Identities=26% Similarity=0.495 Sum_probs=182.0
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCc
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~ 404 (554)
.....|.+.++||+|.|+.|.++.+ .++..||+|.+.... ........+.+|+.++..++|||||+++.+......
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~---ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ 129 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQ---LNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEAT 129 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcc---cChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecce
Confidence 4456899999999999999999999 789999999886432 223334558899999999999999999999999999
Q ss_pred EEEEEeecccCchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC-
Q 008759 405 LYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN- 482 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~~-~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~- 482 (554)
+|+||||+.+|.+++++.+. .+.+..++.++.|++++++|||+++|||||||.+|||++.+.++||+|||++.....+
T Consensus 130 lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~ 209 (596)
T KOG0586|consen 130 LYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGL 209 (596)
T ss_pred eEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecccc
Confidence 99999999999999999774 5778889999999999999999999999999999999999999999999999886544
Q ss_pred CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008759 483 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME 533 (554)
Q Consensus 483 ~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e 533 (554)
...+.+|++.|.|||++++.. ..++.+|+||||+++|.|++|.+||.+..
T Consensus 210 ~lqt~cgsppyAaPEl~~g~~-y~gpe~D~Wslgvvly~LV~GsLPFDG~~ 259 (596)
T KOG0586|consen 210 MLQTFCGSPPYAAPELFNGKK-YDGPEVDIWSLGVVLYALVEGSLPFDGQN 259 (596)
T ss_pred cccccCCCCCccChHhhcCcc-cCCcceehhhhhhhheeeeecccccCCcc
Confidence 467889999999999998876 45789999999999999999999998654
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-31 Score=267.56 Aligned_cols=197 Identities=28% Similarity=0.491 Sum_probs=162.6
Q ss_pred eeccCCceeEEEEec---CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEEEeec
Q 008759 336 LLGRGSFGSVYEGIS---DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELV 412 (554)
Q Consensus 336 ~LG~GsfG~VY~a~~---~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LVmE~~ 412 (554)
.||+|+||.||+|.+ .++..+|+|++.... .....+.+.+|+.+++.++|+||+++++.+. ...+++||||+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~----~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~ 76 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN----EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMA 76 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc----ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeC
Confidence 389999999999976 345679999876421 2334467889999999999999999999875 45789999999
Q ss_pred ccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCCc-----c
Q 008759 413 TKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-----K 485 (554)
Q Consensus 413 ~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~~-----~ 485 (554)
.+++|.+++.. ..+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++........ .
T Consensus 77 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05115 77 SGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS 156 (257)
T ss_pred CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence 99999998864 4689999999999999999999999999999999999999999999999999875432211 1
Q ss_pred CccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHHH
Q 008759 486 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIF 539 (554)
Q Consensus 486 s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i~ 539 (554)
...++..|+|||++... .++.++|||||||++|+|++ |..||......+...
T Consensus 157 ~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~ 209 (257)
T cd05115 157 AGKWPLKWYAPECINFR--KFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMS 209 (257)
T ss_pred CCCCCcccCCHHHHccC--CCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHH
Confidence 12235789999998643 37889999999999999996 999998877655443
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-32 Score=265.40 Aligned_cols=200 Identities=24% Similarity=0.429 Sum_probs=170.3
Q ss_pred cceeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEE
Q 008759 329 TYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LV 408 (554)
.+|++.+.||+|+||.||++.+.++..+|+|.+..... ....+.+|+++++.++|+||+++++.+......|+|
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 77 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM------SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLV 77 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC------CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEE
Confidence 47888999999999999999987788999998763221 123577899999999999999999999999999999
Q ss_pred EeecccCchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCCcc-
Q 008759 409 LELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK- 485 (554)
Q Consensus 409 mE~~~ggsL~~ll~~~--~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~~~- 485 (554)
|||+.+++|.+++... .+++..+..++.|++.+|.|||+++++|+||||+||+++.++.++|+|||++.........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 9999999999988653 4788999999999999999999999999999999999999999999999998765433222
Q ss_pred --CccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhH
Q 008759 486 --SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVS 536 (554)
Q Consensus 486 --s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~ 536 (554)
...++..|+|||++.+. .++.++|||||||++|+|++ |..||.......
T Consensus 158 ~~~~~~~~~~~aPe~~~~~--~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 209 (256)
T cd05112 158 STGTKFPVKWSSPEVFSFS--KYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE 209 (256)
T ss_pred cCCCccchhhcCHhHhccC--CcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH
Confidence 22345689999998653 47889999999999999998 999998765443
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-32 Score=275.30 Aligned_cols=203 Identities=33% Similarity=0.600 Sum_probs=175.5
Q ss_pred ccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEE
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~ 406 (554)
.++|.+.+.||+|+||.||++.+ .++..|++|.+.... ......+.+|+.+++.++||||+++++.+...+.+|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-----~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~ 92 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ-----QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELW 92 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc-----chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEE
Confidence 46889999999999999999987 578899999886322 122356788999999999999999999999999999
Q ss_pred EEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC--c
Q 008759 407 IFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--V 484 (554)
Q Consensus 407 LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~--~ 484 (554)
+|+||+.+++|.+++.+..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++....... .
T Consensus 93 lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~ 172 (293)
T cd06647 93 VVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 172 (293)
T ss_pred EEEecCCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccccc
Confidence 99999999999999988888999999999999999999999999999999999999999999999999886543322 2
Q ss_pred cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHH
Q 008759 485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSA 537 (554)
Q Consensus 485 ~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~ 537 (554)
....+++.|++||.+... .++.++|+|||||++|+|++|+.||........
T Consensus 173 ~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~ 223 (293)
T cd06647 173 STMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA 223 (293)
T ss_pred ccccCChhhcCchhhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh
Confidence 334588899999998653 478899999999999999999999987655443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=269.10 Aligned_cols=197 Identities=31% Similarity=0.539 Sum_probs=172.9
Q ss_pred ceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEE
Q 008759 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (554)
Q Consensus 330 ~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LV 408 (554)
+|+..+.||.|+||.||++.+ .+++.+++|.+..... ......+.+|+.+++.++|+||+++++.+...+.+|++
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~----~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 77 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN----EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISIC 77 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC----hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEE
Confidence 578889999999999999998 5789999998875321 23456788999999999999999999999999999999
Q ss_pred EeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHH-CCccccCCccccEEEcCCCcEEEEecCcccccccCCcc
Q 008759 409 LELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK 485 (554)
Q Consensus 409 mE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs-~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~~~ 485 (554)
|||+.+++|.+++.. ..+++..+..++.|++.+|.|||+ .|++|+||||+||+++.++.++|+|||++.........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 157 (265)
T cd06605 78 MEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK 157 (265)
T ss_pred EEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh
Confidence 999999999999875 468889999999999999999999 99999999999999999999999999998765433333
Q ss_pred CccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008759 486 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM 532 (554)
Q Consensus 486 s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~ 532 (554)
...++..|++||.+.+. .++.++|||||||++|+|++|..||...
T Consensus 158 ~~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 202 (265)
T cd06605 158 TFVGTSSYMAPERIQGN--DYSVKSDIWSLGLSLIELATGRFPYPPE 202 (265)
T ss_pred cccCChhccCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 36688999999998654 4788999999999999999999999765
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-32 Score=281.13 Aligned_cols=202 Identities=29% Similarity=0.470 Sum_probs=165.7
Q ss_pred ccceeeeeeeccCCceeEEEEec------CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhC-CCCceeeeeeecc
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDK 400 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~------~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIVkl~~~~~ 400 (554)
.++|++++.||+|+||.||+|.+ .+++.||+|.+.... .......+.+|+.++..+ +|+||+++++++.
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA----THSEHRALMSELKILIHIGHHLNVVNLLGACT 81 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC----ChHHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence 45899999999999999999974 457899999886422 123345688999999999 6899999999775
Q ss_pred C-CCcEEEEEeecccCchHHHHhhh-------------------------------------------------------
Q 008759 401 D-ESKLYIFLELVTKGSLLNLYQRY------------------------------------------------------- 424 (554)
Q Consensus 401 ~-~~~~~LVmE~~~ggsL~~ll~~~------------------------------------------------------- 424 (554)
. ...+++||||+.+|+|.+++...
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 4 45689999999999999988542
Q ss_pred -------------cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC----ccCc
Q 008759 425 -------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSC 487 (554)
Q Consensus 425 -------------~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~----~~s~ 487 (554)
.++..++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 25667778899999999999999999999999999999999999999999987643221 1123
Q ss_pred cCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChh
Q 008759 488 RGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECV 535 (554)
Q Consensus 488 ~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~ 535 (554)
.++..|+|||++.+. .++.++|||||||++|+|++ |..||......
T Consensus 242 ~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~ 288 (343)
T cd05103 242 RLPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 288 (343)
T ss_pred CCCcceECcHHhcCC--CCCchhhHHHHHHHHHHHHHCCCCCCCCcccc
Confidence 356779999998654 47889999999999999997 99999876543
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-31 Score=266.58 Aligned_cols=196 Identities=43% Similarity=0.734 Sum_probs=166.8
Q ss_pred eeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEEEee
Q 008759 333 KGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLEL 411 (554)
Q Consensus 333 i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LVmE~ 411 (554)
....||+|+||.||+|.+ .++..|++|.+... .....+.+.+|+.+++.++|+||+++++++...+.+++||||
T Consensus 12 ~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 86 (268)
T cd06624 12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER-----DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQ 86 (268)
T ss_pred ceEEEecCCceEEEEeEecCCCcEEEEEEecCC-----CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEec
Confidence 345799999999999997 67889999987642 223446788999999999999999999999999999999999
Q ss_pred cccCchHHHHhhh--cC--ChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcC-CCcEEEEecCcccccccCC--c
Q 008759 412 VTKGSLLNLYQRY--HL--RDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA-NGSVKLADFGLAKATKLND--V 484 (554)
Q Consensus 412 ~~ggsL~~ll~~~--~l--~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~-~g~vKL~DFGlA~~~~~~~--~ 484 (554)
+.+++|.+++... .+ .+..+..++.||+.||.|||++||+||||||+|||++. ++.++|+|||++....... .
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~ 166 (268)
T cd06624 87 VPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCT 166 (268)
T ss_pred CCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCcc
Confidence 9999999988753 34 77888899999999999999999999999999999976 6799999999987543222 2
Q ss_pred cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008759 485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME 533 (554)
Q Consensus 485 ~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e 533 (554)
....+++.|+|||++......++.++|+||||+++|+|++|..||....
T Consensus 167 ~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~ 215 (268)
T cd06624 167 ETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELG 215 (268)
T ss_pred ccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcccc
Confidence 2345889999999986655457889999999999999999999998654
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-31 Score=265.18 Aligned_cols=196 Identities=28% Similarity=0.497 Sum_probs=162.8
Q ss_pred eeeccCCceeEEEEec-CC---CcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEEEe
Q 008759 335 DLLGRGSFGSVYEGIS-DD---GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLE 410 (554)
Q Consensus 335 ~~LG~GsfG~VY~a~~-~~---g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LVmE 410 (554)
+.||+|+||.||+|.+ .. +..+|+|.+...... ...+.+.+|+.+++.+.|+||+++++++. .+.+++|||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e 75 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA----AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVME 75 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch----HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEE
Confidence 4699999999999976 22 378999988643221 34467889999999999999999999875 456899999
Q ss_pred ecccCchHHHHhhhc-CChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCCcc----
Q 008759 411 LVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK---- 485 (554)
Q Consensus 411 ~~~ggsL~~ll~~~~-l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~~~---- 485 (554)
|+.+++|.+++.... +++..+..++.|++.+|.|||.++|+|+||||+|||++.++.+||+|||+++........
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 76 LAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred eCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence 999999999997654 899999999999999999999999999999999999999999999999998765433211
Q ss_pred -CccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHH
Q 008759 486 -SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSA 537 (554)
Q Consensus 486 -s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~ 537 (554)
...++..|+|||.+.+. .++.++|||||||++|+|++ |..||......+.
T Consensus 156 ~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~ 207 (257)
T cd05060 156 TAGRWPLKWYAPECINYG--KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEV 207 (257)
T ss_pred cCccccccccCHHHhcCC--CCCccchHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence 11234679999998554 37889999999999999998 9999988766443
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-31 Score=269.95 Aligned_cols=208 Identities=30% Similarity=0.508 Sum_probs=171.6
Q ss_pred cceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEE
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~L 407 (554)
++|++.+.||+|+||.||+|.+ .+++.||+|.+...... ......+.+|+.+++.++|+||+++++++.....+|+
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 78 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED---EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYL 78 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccc---ccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEE
Confidence 5799999999999999999998 57899999988643211 1223567789999999999999999999999999999
Q ss_pred EEeecccCchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcC-CCcEEEEecCcccccccC-
Q 008759 408 FLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA-NGSVKLADFGLAKATKLN- 482 (554)
Q Consensus 408 VmE~~~ggsL~~ll~~~---~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~-~g~vKL~DFGlA~~~~~~- 482 (554)
||||+.+ +|..++... .+.+..+..++.||+.||.|||++||+|+||+|+|||++. ++.+||+|||++......
T Consensus 79 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 79 VFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred EEecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 9999975 677766542 2577888899999999999999999999999999999985 567999999998754322
Q ss_pred -CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHH
Q 008759 483 -DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIK 541 (554)
Q Consensus 483 -~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i 541 (554)
......+++.|+|||++.+. ..++.++|||||||++|+|+||+.||...+..+.++.+
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~ 216 (294)
T PLN00009 158 RTFTHEVVTLWYRAPEILLGS-RHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKI 216 (294)
T ss_pred cccccCceeecccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 22334578899999998643 24788999999999999999999999987776666554
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-31 Score=263.29 Aligned_cols=206 Identities=28% Similarity=0.500 Sum_probs=174.9
Q ss_pred ceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEE
Q 008759 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (554)
Q Consensus 330 ~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LV 408 (554)
+|++.+.||+|+||.||++.+ .+++.+|+|.+..... .......+.+|+.+++.++|+||+++++.+...+.+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 77 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM---TKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIV 77 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc---ccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEE
Confidence 488999999999999999988 6789999999874322 223356788999999999999999999999989999999
Q ss_pred EeecccCchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCC-cEEEEecCcccccccCC-
Q 008759 409 LELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG-SVKLADFGLAKATKLND- 483 (554)
Q Consensus 409 mE~~~ggsL~~ll~~~---~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g-~vKL~DFGlA~~~~~~~- 483 (554)
|||+.+++|.+++... .+++..+..++.|++.+|.|||++||+|+||||+||+++.++ .+||+|||++.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 78 MEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred EecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 9999999999998753 378899999999999999999999999999999999998654 68999999987654332
Q ss_pred ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHH
Q 008759 484 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFI 540 (554)
Q Consensus 484 ~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~ 540 (554)
.....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+.......
T Consensus 158 ~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~ 212 (256)
T cd08220 158 AYTVVGTPCYISPELCEGK--PYNQKSDIWALGCVLYELASLKRAFEAANLPALVLK 212 (256)
T ss_pred ccccccCCcccCchhccCC--CCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHH
Confidence 2335688999999998654 367899999999999999999999987765444433
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-32 Score=297.31 Aligned_cols=201 Identities=27% Similarity=0.395 Sum_probs=157.1
Q ss_pred ccccceeeeeeeccCCceeEEEEecC--CCcEEEEEEEec------------ccccchhHHHHHHHHHHHHHHHhCCCCc
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGISD--DGFFFAVKEVSL------------LDQGSQAKQSISQLEQEIALLSRFEHEN 391 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~~--~g~~vAvK~v~~------------~~~~~~~~~~~~~~~~Ei~iL~~l~Hpn 391 (554)
.+.++|++++.||+|+||+||+|..+ ++...+.|.+.. .............+.+|+.+|..++|+|
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 35678999999999999999998652 222222221110 0011112233456889999999999999
Q ss_pred eeeeeeeccCCCcEEEEEeecccCchHHHHhhhc------CChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCC
Q 008759 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH------LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN 465 (554)
Q Consensus 392 IVkl~~~~~~~~~~~LVmE~~~ggsL~~ll~~~~------l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~ 465 (554)
||++++++...+..|+||+++.+ +|..++.... .....++.|+.||+.||.|||++|||||||||+|||++.+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~ 303 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCD 303 (501)
T ss_pred cCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC
Confidence 99999999999999999999965 5666554322 2355678899999999999999999999999999999999
Q ss_pred CcEEEEecCcccccccCC---ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 008759 466 GSVKLADFGLAKATKLND---VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY 529 (554)
Q Consensus 466 g~vKL~DFGlA~~~~~~~---~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF 529 (554)
+.+||+|||+++...... .....||+.|+|||++.+. .++.++|||||||++|||++|..++
T Consensus 304 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 304 GKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGD--GYCEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred CCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCC--CCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 999999999997654322 2235699999999999654 4889999999999999999987643
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-31 Score=268.06 Aligned_cols=203 Identities=29% Similarity=0.558 Sum_probs=171.6
Q ss_pred eeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCC--CcEEE
Q 008759 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE--SKLYI 407 (554)
Q Consensus 331 y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~--~~~~L 407 (554)
|++.+.||.|+||.||+|.+ .+++.+|+|.+.... ........+.+|+.+++.++|+||+++++.+... ...|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l 77 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN---EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYM 77 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc---ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEE
Confidence 67889999999999999998 568999999998532 1122335677899999999999999999999887 89999
Q ss_pred EEeecccCchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC--
Q 008759 408 FLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-- 483 (554)
Q Consensus 408 VmE~~~ggsL~~ll~~~--~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~-- 483 (554)
||||+.+ +|..++... .+++..+..++.||+.||.|||++|++|+||+|+|||++.++.++|+|||++.......
T Consensus 78 v~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~ 156 (287)
T cd07840 78 VFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA 156 (287)
T ss_pred Eeccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc
Confidence 9999986 788877654 68999999999999999999999999999999999999999999999999987654432
Q ss_pred -ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHH
Q 008759 484 -VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAI 538 (554)
Q Consensus 484 -~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i 538 (554)
.....++..|+|||.+.+.. .++.++|||||||++|+|++|+.||......+.+
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~-~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~ 211 (287)
T cd07840 157 DYTNRVITLWYRPPELLLGAT-RYGPEVDMWSVGCILAELFLGKPIFQGSTELEQL 211 (287)
T ss_pred cccccccccccCCceeeEccc-cCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 23345688899999875433 4788999999999999999999999876654433
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-31 Score=269.59 Aligned_cols=196 Identities=31% Similarity=0.534 Sum_probs=163.6
Q ss_pred cceeeeeeeccCCceeEEEEec-----CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccC--
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS-----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD-- 401 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~-----~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~-- 401 (554)
.+|++.+.||+|+||.||++.. .++..||+|.+... .....+.+.+|+.+++.++|+||+++++++..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 78 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS-----TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 78 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC-----CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCC
Confidence 4788999999999999999873 46889999987642 23345678899999999999999999997643
Q ss_pred CCcEEEEEeecccCchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccc
Q 008759 402 ESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT 479 (554)
Q Consensus 402 ~~~~~LVmE~~~ggsL~~ll~~~--~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~ 479 (554)
...+|+||||+.+++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 79 RRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred CCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 45689999999999999998753 4888999999999999999999999999999999999999999999999998865
Q ss_pred ccCCc-----cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008759 480 KLNDV-----KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP 531 (554)
Q Consensus 480 ~~~~~-----~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~ 531 (554)
..... ....++..|+|||++.+. .++.++|||||||++|||++|..|+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~~~~~~~ 213 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYELFTYSDKSCS 213 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccC--CcChHHHHHHHHHHHHHHhhcCCcCCC
Confidence 43221 112234569999998654 378899999999999999998877643
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-31 Score=268.84 Aligned_cols=196 Identities=30% Similarity=0.568 Sum_probs=160.5
Q ss_pred eeeccCCceeEEEEec-CCCc--EEEEEEEecccccchhHHHHHHHHHHHHHHHhC-CCCceeeeeeeccCCCcEEEEEe
Q 008759 335 DLLGRGSFGSVYEGIS-DDGF--FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESKLYIFLE 410 (554)
Q Consensus 335 ~~LG~GsfG~VY~a~~-~~g~--~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIVkl~~~~~~~~~~~LVmE 410 (554)
+.||+|+||.||+|.+ .++. .+++|.+... ........+.+|+.++.++ +||||+++++++...+.+|++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 76 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY----ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE 76 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc----CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEE
Confidence 3689999999999998 4444 4677776521 1123345678899999999 79999999999999999999999
Q ss_pred ecccCchHHHHhhh-----------------cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEec
Q 008759 411 LVTKGSLLNLYQRY-----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADF 473 (554)
Q Consensus 411 ~~~ggsL~~ll~~~-----------------~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DF 473 (554)
|+.+++|.+++... .+++.++..++.|++.||.|||++||+|+||||+|||++.++.+||+||
T Consensus 77 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~df 156 (270)
T cd05047 77 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADF 156 (270)
T ss_pred eCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCC
Confidence 99999999998643 3678889999999999999999999999999999999999999999999
Q ss_pred CcccccccCC-ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhH
Q 008759 474 GLAKATKLND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVS 536 (554)
Q Consensus 474 GlA~~~~~~~-~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~ 536 (554)
|++....... ......+..|+|||++... .++.++|||||||++|+|++ |..||......+
T Consensus 157 gl~~~~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~ 219 (270)
T cd05047 157 GLSRGQEVYVKKTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE 219 (270)
T ss_pred CCccccchhhhccCCCCccccCChHHHccC--CCCchhhHHHHHHHHHHHHcCCCCCccccCHHH
Confidence 9985432211 1112245679999998543 47889999999999999997 999998765544
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-31 Score=269.76 Aligned_cols=208 Identities=28% Similarity=0.468 Sum_probs=170.5
Q ss_pred cceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCC-CCceeeeeeeccCCCc--
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDESK-- 404 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIVkl~~~~~~~~~-- 404 (554)
++|++.+.||+|+||.||+|.+ .+++.||+|++...... ......+.+|+.+++.+. |+||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~---~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 77 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDE---EGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNG 77 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccc---cCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCC
Confidence 3689999999999999999998 67899999987643211 112345778999999995 6999999998876655
Q ss_pred ---EEEEEeecccCchHHHHhh------hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcC-CCcEEEEecC
Q 008759 405 ---LYIFLELVTKGSLLNLYQR------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA-NGSVKLADFG 474 (554)
Q Consensus 405 ---~~LVmE~~~ggsL~~ll~~------~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~-~g~vKL~DFG 474 (554)
.|+||||+.+ +|..++.. ..+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 78 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 78 KPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred CceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999986 68777643 24788999999999999999999999999999999999998 8899999999
Q ss_pred cccccccC--CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHH
Q 008759 475 LAKATKLN--DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIK 541 (554)
Q Consensus 475 lA~~~~~~--~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i 541 (554)
++...... ......+++.|+|||++.+.. .++.++|+|||||++|+|++|..||...+..+...++
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~ 224 (295)
T cd07837 157 LGRAFSIPVKSYTHEIVTLWYRAPEVLLGST-HYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHI 224 (295)
T ss_pred cceecCCCccccCCcccccCCCChHHhhCCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 98754322 223335788999999885432 4788999999999999999999999987776665544
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-31 Score=270.50 Aligned_cols=207 Identities=29% Similarity=0.497 Sum_probs=169.3
Q ss_pred ccccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCC
Q 008759 324 FKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE 402 (554)
Q Consensus 324 ~~~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~ 402 (554)
+....+.|++.+.||+|+||.||+|.+ .+++.||+|++....... .....+.+|+.+++.++||||+++++++...
T Consensus 7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 83 (310)
T cd07865 7 FCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKE---GFPITALREIKILQLLKHENVVNLIEICRTK 83 (310)
T ss_pred ccchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcC---CchhHHHHHHHHHHhCCCCCccceEEEEecc
Confidence 345567899999999999999999998 579999999886432211 1123456799999999999999999987554
Q ss_pred --------CcEEEEEeecccCchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEe
Q 008759 403 --------SKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLAD 472 (554)
Q Consensus 403 --------~~~~LVmE~~~ggsL~~ll~~~--~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~D 472 (554)
...|+||||+.+ +|..++... .+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~d 162 (310)
T cd07865 84 ATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLAD 162 (310)
T ss_pred cccccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECc
Confidence 346999999976 677777654 589999999999999999999999999999999999999999999999
Q ss_pred cCcccccccCC------ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChh
Q 008759 473 FGLAKATKLND------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECV 535 (554)
Q Consensus 473 FGlA~~~~~~~------~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~ 535 (554)
||++....... .....++..|+|||++.+. ..++.++|+||||+++|+|++|+.||......
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~ 230 (310)
T cd07865 163 FGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQ 230 (310)
T ss_pred CCCcccccCCcccCCCCccCcccCccccCcHHhcCC-cccCchhhhHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99987543221 1233478889999988543 23678999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=281.56 Aligned_cols=201 Identities=29% Similarity=0.479 Sum_probs=168.7
Q ss_pred cccceeeeeeeccCCceeEEEEec---CC--CcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccC
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGIS---DD--GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD 401 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~---~~--g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~ 401 (554)
.+..|++.+.||+|+||.||+|.. ++ ...||+|.++..+.. ........+|+.+++.++||||+.+..+|..
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~---tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~ 98 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDG---TGISMSACREIALLRELKHPNVISLVKVFLS 98 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCC---CCcCHHHHHHHHHHHHhcCCcchhHHHHHhc
Confidence 356899999999999999999964 22 337899988754322 1222456799999999999999999998877
Q ss_pred -CCcEEEEEeecccCchHHHHhh------hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCC----CcEEE
Q 008759 402 -ESKLYIFLELVTKGSLLNLYQR------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN----GSVKL 470 (554)
Q Consensus 402 -~~~~~LVmE~~~ggsL~~ll~~------~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~----g~vKL 470 (554)
+..++|++||.+. +|..+++- ..++...++.|+.||+.|+.|||+++|+||||||.||||..+ |.|||
T Consensus 99 ~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 99 HDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred cCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEe
Confidence 7889999999988 67776642 248888999999999999999999999999999999999888 89999
Q ss_pred EecCcccccccC-----CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008759 471 ADFGLAKATKLN-----DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM 532 (554)
Q Consensus 471 ~DFGlA~~~~~~-----~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~ 532 (554)
+|||+++.+... .....+.|.||+|||++.+.. .|+.+.|||++|||+.||||-++.|.+.
T Consensus 178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~-hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGAR-HYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred ecccHHHHhhccccccccCCceEEEEEecChHHhcccc-cccchhhhHHHHHHHHHHHccCccccch
Confidence 999999876543 234456899999999998754 6999999999999999999999999764
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-31 Score=268.69 Aligned_cols=203 Identities=29% Similarity=0.422 Sum_probs=170.2
Q ss_pred ccceeeeeeeccCCceeEEEEecCC-----CcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccC-
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGISDD-----GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD- 401 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~~~-----g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~- 401 (554)
.++|++.+.||+|+||.||+|.+.. +..+++|.+... ........+.+|+.+++.++|+||+++++++..
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~----~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 80 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH----ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED 80 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC----CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 4579999999999999999999854 688889887532 123345678899999999999999999998655
Q ss_pred CCcEEEEEeecccCchHHHHhh---------hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEe
Q 008759 402 ESKLYIFLELVTKGSLLNLYQR---------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLAD 472 (554)
Q Consensus 402 ~~~~~LVmE~~~ggsL~~ll~~---------~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~D 472 (554)
....+++++|+.+++|..++.. ..+++..+..++.||+.||.|||+++++|+||||+|||++.++.+||+|
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECC
Confidence 5678999999999999999865 2478899999999999999999999999999999999999999999999
Q ss_pred cCcccccccCCc----cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhH
Q 008759 473 FGLAKATKLNDV----KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVS 536 (554)
Q Consensus 473 FGlA~~~~~~~~----~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~ 536 (554)
||+++....... ....++..|+|||++... .++.++|||||||++|+|++ |+.||......+
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~ 227 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNK--EYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE 227 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcC--CCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH
Confidence 999875432221 223467789999998544 47889999999999999999 999998765544
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-31 Score=269.61 Aligned_cols=198 Identities=33% Similarity=0.558 Sum_probs=169.7
Q ss_pred cceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccC--CCcE
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD--ESKL 405 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~--~~~~ 405 (554)
+.|+..+.||.|++|.||+|.+ .+++.+|+|.+..... ......+.+|+++++.++|+||+++++++.. .+.+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 76 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN----PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSI 76 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc----hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeE
Confidence 3688899999999999999998 6789999998874322 2334668899999999999999999998754 3478
Q ss_pred EEEEeecccCchHHHHhh-----hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccc
Q 008759 406 YIFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK 480 (554)
Q Consensus 406 ~LVmE~~~ggsL~~ll~~-----~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~ 480 (554)
|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 77 GIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 999999999999887653 347888999999999999999999999999999999999999999999999987654
Q ss_pred cCCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008759 481 LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM 532 (554)
Q Consensus 481 ~~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~ 532 (554)
........++..|++||.+.+. .++.++|||||||++|+|++|+.||...
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~ 206 (287)
T cd06621 157 NSLAGTFTGTSFYMAPERIQGK--PYSITSDVWSLGLTLLEVAQNRFPFPPE 206 (287)
T ss_pred ccccccccCCccccCHHHhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 4433445688899999998654 4788999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=259.83 Aligned_cols=210 Identities=28% Similarity=0.456 Sum_probs=182.4
Q ss_pred ceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEE
Q 008759 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (554)
Q Consensus 330 ~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LV 408 (554)
.|...++||+|+||+||+|++ .++..||+|.++..+.... .-....+|+-+|+.++|.|||++++....++.+-+|
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddeg---vpssalreicllkelkhknivrl~dvlhsdkkltlv 79 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEG---VPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCC---CcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEe
Confidence 466778999999999999998 7799999999987554322 234567999999999999999999999999999999
Q ss_pred EeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC--Cc
Q 008759 409 LELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--DV 484 (554)
Q Consensus 409 mE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~--~~ 484 (554)
+|||.. .|..++.. ..+....++.++.|++.||.|+|+.++.||||||.|+||+.+|++||+|||+++..... ..
T Consensus 80 fe~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcy 158 (292)
T KOG0662|consen 80 FEFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCY 158 (292)
T ss_pred HHHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEee
Confidence 999977 78877765 45888889999999999999999999999999999999999999999999999876543 34
Q ss_pred cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHHH
Q 008759 485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIFIKTVA 544 (554)
Q Consensus 485 ~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i~~i~~~ 544 (554)
.....|.||.+|.++.+.. -|+...|+||.|||+.|+.. |++.|.+.+..+++.+|...
T Consensus 159 saevvtlwyrppdvlfgak-ly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~ 218 (292)
T KOG0662|consen 159 SAEVVTLWYRPPDVLFGAK-LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRL 218 (292)
T ss_pred eceeeeeeccCcceeeeee-hhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHH
Confidence 4556899999999998754 58999999999999999987 89999999988888887653
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=270.68 Aligned_cols=205 Identities=27% Similarity=0.440 Sum_probs=170.5
Q ss_pred ccceeeeeeeccCCceeEEEEecC------CCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccC
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD 401 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~~------~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~ 401 (554)
.++|++.+.||+|+||.||+|.+. ++..||+|.+.... .......+.+|+.+++.++|+||+++++++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~ 79 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA----SADMQADFQREAALMAEFDHPNIVKLLGVCAV 79 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc----CHHHHHHHHHHHHHHHhcCCCchheEEEEEcC
Confidence 357899999999999999999863 57889999876321 12334568899999999999999999999999
Q ss_pred CCcEEEEEeecccCchHHHHhhh-----------------------cCChHHHHHHHHHHHHHHHHHHHCCccccCCccc
Q 008759 402 ESKLYIFLELVTKGSLLNLYQRY-----------------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCA 458 (554)
Q Consensus 402 ~~~~~LVmE~~~ggsL~~ll~~~-----------------------~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPe 458 (554)
...+|++|||+.+++|.+++... .+++..+..++.||+.||.|||+++++||||||+
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ 159 (288)
T cd05050 80 GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATR 159 (288)
T ss_pred CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHh
Confidence 99999999999999999988642 3567788999999999999999999999999999
Q ss_pred cEEEcCCCcEEEEecCcccccccCC----ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 008759 459 NILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPME 533 (554)
Q Consensus 459 NILld~~g~vKL~DFGlA~~~~~~~----~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e 533 (554)
|||++.++.++|+|||++....... ......+..|+|||++.+. .++.++|||||||++|+|++ |..||.+..
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~~~~~p~~~~~ 237 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN--RYTTESDVWAYGVVLWEIFSYGMQPYYGMA 237 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcC--CCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999987543221 1222356679999998654 47889999999999999998 889998776
Q ss_pred hhHHH
Q 008759 534 CVSAI 538 (554)
Q Consensus 534 ~~~~i 538 (554)
..+..
T Consensus 238 ~~~~~ 242 (288)
T cd05050 238 HEEVI 242 (288)
T ss_pred HHHHH
Confidence 54443
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=267.52 Aligned_cols=204 Identities=25% Similarity=0.466 Sum_probs=170.6
Q ss_pred cceeeeeeeccCCceeEEEEecC------CCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCC
Q 008759 329 TYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE 402 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~~------~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~ 402 (554)
++|++.+.||+|+||.||+|+.. +.+.+++|.+.... .......+.+|++++++++|+||+++++.+...
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 80 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK----DENLQSEFRRELDMFRKLSHKNVVRLLGLCREA 80 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc----chHHHHHHHHHHHHHHhcCCcceeeeEEEECCC
Confidence 57889999999999999999863 34678888775321 122456788999999999999999999999999
Q ss_pred CcEEEEEeecccCchHHHHhhh----------cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEe
Q 008759 403 SKLYIFLELVTKGSLLNLYQRY----------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLAD 472 (554)
Q Consensus 403 ~~~~LVmE~~~ggsL~~ll~~~----------~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~D 472 (554)
+..|+||||+.+++|.+++... .+++..+..++.||+.+|.|||++||+|+||||+|||++.++.++|+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcc
Confidence 9999999999999999998753 388999999999999999999999999999999999999999999999
Q ss_pred cCcccccccCC---ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHH
Q 008759 473 FGLAKATKLND---VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAI 538 (554)
Q Consensus 473 FGlA~~~~~~~---~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i 538 (554)
||++....... .....++..|++||.+.+.. ++.++||||||+++|+|++ |..||......+.+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~ 228 (275)
T cd05046 161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDD--FSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVL 228 (275)
T ss_pred cccccccCcccccccCCceeEEeecChhhhccCC--CCchhhHHHHHHHHHHHHhCCCCCccccchHHHH
Confidence 99986543221 22334677899999986543 6789999999999999998 89999776554433
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=267.93 Aligned_cols=206 Identities=32% Similarity=0.548 Sum_probs=173.0
Q ss_pred eeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEEE
Q 008759 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFL 409 (554)
Q Consensus 331 y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LVm 409 (554)
|++.+.||.|++|.||+|.+ .+|..||+|++...... ......+.+|+.+++.++|+||+++++++.+.+..|++|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~ 77 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED---EGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVF 77 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc---ccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEE
Confidence 57788999999999999998 67999999998753221 112245678999999999999999999999999999999
Q ss_pred eecccCchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC--Cc
Q 008759 410 ELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--DV 484 (554)
Q Consensus 410 E~~~ggsL~~ll~~~---~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~--~~ 484 (554)
||+. ++|.+++... .+++..+..++.|++.||.|||+++++|+||+|+|||++.++.++|+|||++...... ..
T Consensus 78 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~ 156 (283)
T cd07835 78 EFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY 156 (283)
T ss_pred eccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcccc
Confidence 9996 5888888664 4899999999999999999999999999999999999999999999999998654322 12
Q ss_pred cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHH
Q 008759 485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIK 541 (554)
Q Consensus 485 ~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i 541 (554)
....++..|+|||++.+.. .++.++|||||||++|+|++|+.||...+....++.+
T Consensus 157 ~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 212 (283)
T cd07835 157 THEVVTLWYRAPEILLGSR-QYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRI 212 (283)
T ss_pred CccccccCCCCCceeecCc-ccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 2334688999999885532 3688999999999999999999999887776665554
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=262.29 Aligned_cols=201 Identities=31% Similarity=0.539 Sum_probs=169.7
Q ss_pred eeeeeeeccCCceeEEEEecC-C----CcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcE
Q 008759 331 WQKGDLLGRGSFGSVYEGISD-D----GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL 405 (554)
Q Consensus 331 y~i~~~LG~GsfG~VY~a~~~-~----g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~ 405 (554)
+++.+.||.|+||.||++.+. . +..+|+|.+..... ......+.+|+.++..++|+||+++++.+.+.+..
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 76 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD----EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPL 76 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC----hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCee
Confidence 356789999999999999984 3 38899998864221 22456788999999999999999999999999999
Q ss_pred EEEEeecccCchHHHHhhhc---CChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC
Q 008759 406 YIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN 482 (554)
Q Consensus 406 ~LVmE~~~ggsL~~ll~~~~---l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~ 482 (554)
|++|||+.+++|.+++.... +++..+..++.||+.||.|||+++++|+||||+||+++.++.++|+|||++......
T Consensus 77 ~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 77 MIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred EEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccc
Confidence 99999999999999987533 899999999999999999999999999999999999999999999999998765433
Q ss_pred Ccc---CccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHH
Q 008759 483 DVK---SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSA 537 (554)
Q Consensus 483 ~~~---s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~ 537 (554)
... ...+++.|++||.+... .++.++|+|||||++|+|++ |+.||......+.
T Consensus 157 ~~~~~~~~~~~~~y~~Pe~~~~~--~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~ 213 (258)
T smart00219 157 DYYKKKGGKLPIRWMAPESLKDG--KFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEV 213 (258)
T ss_pred cccccccCCCcccccChHHhccC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 211 12367889999998443 47889999999999999998 8999987555443
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=263.53 Aligned_cols=198 Identities=31% Similarity=0.552 Sum_probs=169.7
Q ss_pred eccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEEEeecccC
Q 008759 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKG 415 (554)
Q Consensus 337 LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LVmE~~~gg 415 (554)
||.|+||.||++.+ .+++.+++|.+..... ........+.+|+.+++.++|+||+++++.+......|++|||+.++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADM--IRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGG 78 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhh--hhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCC
Confidence 68999999999999 4699999998864322 22345677889999999999999999999999999999999999999
Q ss_pred chHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC----------Cc
Q 008759 416 SLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN----------DV 484 (554)
Q Consensus 416 sL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~----------~~ 484 (554)
+|.+++.+ ..+++..+..++.||+.||.|||+++|+|+||+|+|||++.++.++|+|||++...... ..
T Consensus 79 ~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~ 158 (265)
T cd05579 79 DLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKED 158 (265)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccc
Confidence 99999876 46899999999999999999999999999999999999999999999999998754332 12
Q ss_pred cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHH
Q 008759 485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAI 538 (554)
Q Consensus 485 ~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i 538 (554)
....++..|++||.+.... ++.++|+||||+++|+|++|..||......+..
T Consensus 159 ~~~~~~~~~~~Pe~~~~~~--~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~ 210 (265)
T cd05579 159 KRIVGTPDYIAPEVILGQG--HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIF 210 (265)
T ss_pred cCcccCccccCHHHhcCCC--CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 2345788999999986544 778999999999999999999999876654433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-31 Score=261.62 Aligned_cols=203 Identities=36% Similarity=0.551 Sum_probs=175.9
Q ss_pred ceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEE
Q 008759 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (554)
Q Consensus 330 ~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LV 408 (554)
+|++.+.||+|+||.||++.+ .++..+++|.+...... ......+.+|+.+++.++|+||+++++.+.....+|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 77 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS---QKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIV 77 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc---HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEE
Confidence 478899999999999999987 67889999998743221 23345677899999999999999999999999999999
Q ss_pred EeecccCchHHHHhh-----hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC
Q 008759 409 LELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND 483 (554)
Q Consensus 409 mE~~~ggsL~~ll~~-----~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~ 483 (554)
|||+.+++|..++.+ ..+.+..+..++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 78 MEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred ehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 999999999998866 457888999999999999999999999999999999999999999999999998765544
Q ss_pred ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHH
Q 008759 484 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSA 537 (554)
Q Consensus 484 ~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~ 537 (554)
.....+++.|++||.+.+. .++.++|+||||+++|+|++|+.||...+....
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~--~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~ 209 (256)
T cd08530 158 AKTQIGTPHYMAPEVWKGR--PYSYKSDIWSLGCLLYEMATFAPPFEARSMQDL 209 (256)
T ss_pred cccccCCccccCHHHHCCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 4445688999999998654 377899999999999999999999988775443
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=264.93 Aligned_cols=200 Identities=30% Similarity=0.570 Sum_probs=168.1
Q ss_pred ccceeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEE
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~L 407 (554)
.+.|++.+.||+|+||.||++.. +++.||+|.+.... ....+.+|+.++..++|+||+++++.+..+ ..|+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~-------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~ 75 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV-------TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYI 75 (254)
T ss_pred HHHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc-------hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEE
Confidence 46799999999999999999875 57789999876311 234678899999999999999999998654 5799
Q ss_pred EEeecccCchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCCc
Q 008759 408 FLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV 484 (554)
Q Consensus 408 VmE~~~ggsL~~ll~~~---~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~~ 484 (554)
+|||+.+++|.+++... .++...+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++...... .
T Consensus 76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-~ 154 (254)
T cd05083 76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-V 154 (254)
T ss_pred EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc-C
Confidence 99999999999998753 4788889999999999999999999999999999999999999999999998754322 2
Q ss_pred cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHHH
Q 008759 485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIF 539 (554)
Q Consensus 485 ~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i~ 539 (554)
.....+..|+|||.+.+. .++.++|+|||||++|+|++ |+.||......+...
T Consensus 155 ~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~ 208 (254)
T cd05083 155 DNSKLPVKWTAPEALKHK--KFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKE 208 (254)
T ss_pred CCCCCCceecCHHHhccC--CcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHH
Confidence 223356779999998543 47889999999999999997 999998877654433
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=262.18 Aligned_cols=196 Identities=29% Similarity=0.512 Sum_probs=166.0
Q ss_pred eeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEEEeeccc
Q 008759 335 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTK 414 (554)
Q Consensus 335 ~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LVmE~~~g 414 (554)
++||+|+||.||++.+.+++.|++|++...... .....+.+|+.+++++.|+||+++++++......|+||||+.+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 76 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP----DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPG 76 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH----HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCC
Confidence 469999999999999866999999988643221 3346788999999999999999999999999999999999999
Q ss_pred CchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCCcc----Ccc
Q 008759 415 GSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK----SCR 488 (554)
Q Consensus 415 gsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~~~----s~~ 488 (554)
++|.+++.. ..++...+..++.|++.+|.|||+++|+||||||+|||++.++.++|+|||++......... ...
T Consensus 77 ~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (251)
T cd05041 77 GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ 156 (251)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence 999999865 34788889999999999999999999999999999999999999999999998754422111 122
Q ss_pred CCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhH
Q 008759 489 GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVS 536 (554)
Q Consensus 489 GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~ 536 (554)
.+..|+|||.+.+. .++.++|+|||||++|+|++ |..||.......
T Consensus 157 ~~~~y~~PE~~~~~--~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~ 203 (251)
T cd05041 157 IPIKWTAPEALNYG--RYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ 203 (251)
T ss_pred ceeccCChHhhccC--CCCcchhHHHHHHHHHHHHhccCCCCccCCHHH
Confidence 35679999998654 47889999999999999999 899998766443
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=267.82 Aligned_cols=201 Identities=19% Similarity=0.321 Sum_probs=159.5
Q ss_pred eeccCCceeEEEEecCCCc---EEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEEEeec
Q 008759 336 LLGRGSFGSVYEGISDDGF---FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELV 412 (554)
Q Consensus 336 ~LG~GsfG~VY~a~~~~g~---~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LVmE~~ 412 (554)
.||+|+||.||++...++. .+++|.+.... .......+.+|+.+++.++||||+++++.+.....+|+||||+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 77 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA----SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYC 77 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC----ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecC
Confidence 5999999999999764333 44555544311 1223467889999999999999999999999999999999999
Q ss_pred ccCchHHHHhhh-----cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC----C
Q 008759 413 TKGSLLNLYQRY-----HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN----D 483 (554)
Q Consensus 413 ~ggsL~~ll~~~-----~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~----~ 483 (554)
.+|+|.+++.+. .+....+..++.||+.||.|||+++|+||||||+|||++.++.++|+|||++...... .
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 78 ELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred CCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 999999988753 2455677889999999999999999999999999999999999999999997643221 1
Q ss_pred ccCccCCCcccChhhhcccC-----CCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHHHH
Q 008759 484 VKSCRGTAFWMAPEVINNKN-----KGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIFI 540 (554)
Q Consensus 484 ~~s~~GT~~Y~APEvl~~~~-----~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i~~ 540 (554)
.....++..|+|||++.... ..++.++|||||||++|+|++ |..||......+.+..
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~ 220 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNH 220 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 22345788999999985321 235778999999999999997 6789987665544443
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=266.30 Aligned_cols=206 Identities=29% Similarity=0.461 Sum_probs=169.6
Q ss_pred cceeeeeeeccCCceeEEEEecCC----CcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCc
Q 008759 329 TYWQKGDLLGRGSFGSVYEGISDD----GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~~~----g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~ 404 (554)
.+|.+.++||+|+||.||+|.+.+ ...+++|.+..... ....+.+.+|+.+++.++|+||+++++.+.+ ..
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~----~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~ 80 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS----PSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NP 80 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC----HHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CC
Confidence 468899999999999999998732 34688887764221 2334678899999999999999999998865 56
Q ss_pred EEEEEeecccCchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC
Q 008759 405 LYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN 482 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~~--~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~ 482 (554)
.|+||||+.+++|.+++... .+++..+..++.||+.||.|||++|++|+||||+|||++.++.++|+|||+++.....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 78999999999999999763 4789999999999999999999999999999999999999999999999998765433
Q ss_pred Cc---cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHHHHH
Q 008759 483 DV---KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIFIK 541 (554)
Q Consensus 483 ~~---~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i~~i 541 (554)
.. ....++..|+|||.+... .++.++|||||||++|+|++ |..||......+....+
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~ 221 (270)
T cd05056 161 SYYKASKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRI 221 (270)
T ss_pred cceecCCCCccccccChhhhccC--CCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 21 112245679999998544 47889999999999999996 99999887765554443
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-31 Score=263.84 Aligned_cols=193 Identities=33% Similarity=0.529 Sum_probs=168.0
Q ss_pred eccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEEEeecccC
Q 008759 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKG 415 (554)
Q Consensus 337 LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LVmE~~~gg 415 (554)
||.|+||.||+|.+ .+++.+++|++..... ......+.+.+|+.+++.++|+||+++++.+.+...+|++|||+.++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHI--VETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGG 78 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcc--hhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCC
Confidence 79999999999998 5689999999874322 12233467889999999999999999999999999999999999999
Q ss_pred chHHHHhhh-cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC-ccCccCCCcc
Q 008759 416 SLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VKSCRGTAFW 493 (554)
Q Consensus 416 sL~~ll~~~-~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~-~~s~~GT~~Y 493 (554)
+|.+++.+. .+++..+..++.||+.||.|||+++++|+||+|+||+++.++.++|+|||++....... .....+++.|
T Consensus 79 ~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~ 158 (262)
T cd05572 79 ELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEY 158 (262)
T ss_pred cHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcCc
Confidence 999998764 57899999999999999999999999999999999999999999999999987665432 2334588999
Q ss_pred cChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008759 494 MAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME 533 (554)
Q Consensus 494 ~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e 533 (554)
++||.+... .++.++|+||||+++|+|++|..||...+
T Consensus 159 ~~PE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~ 196 (262)
T cd05572 159 VAPEIILNK--GYDFSVDYWSLGILLYELLTGRPPFGEDD 196 (262)
T ss_pred cChhHhcCC--CCCChhhhhhhHHHHHHHHhCCCCcCCCC
Confidence 999998643 37889999999999999999999998776
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=264.75 Aligned_cols=190 Identities=26% Similarity=0.420 Sum_probs=159.1
Q ss_pred eeeccCCceeEEEEecCC-C----------cEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCC
Q 008759 335 DLLGRGSFGSVYEGISDD-G----------FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES 403 (554)
Q Consensus 335 ~~LG~GsfG~VY~a~~~~-g----------~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~ 403 (554)
+.||+|+||.||+|.+.+ + ..+++|.+.... . ....+.+|+.+++.++|+||+++++++.. .
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-----~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~ 73 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH-----R-DSLAFFETASLMSQLSHKHLVKLYGVCVR-D 73 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch-----h-hHHHHHHHHHHHHcCCCcchhheeeEEec-C
Confidence 469999999999999843 3 246667654211 1 14678899999999999999999999887 7
Q ss_pred cEEEEEeecccCchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCC-------cEEEEecC
Q 008759 404 KLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG-------SVKLADFG 474 (554)
Q Consensus 404 ~~~LVmE~~~ggsL~~ll~~~--~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g-------~vKL~DFG 474 (554)
..++||||+.+++|.+++... .++...+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus 74 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 74 ENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred CcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCC
Confidence 789999999999999998764 488899999999999999999999999999999999999887 79999999
Q ss_pred cccccccCCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 008759 475 LAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPME 533 (554)
Q Consensus 475 lA~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e 533 (554)
++..... .....++..|+|||++.+....++.++|||||||++|+|++ |..||....
T Consensus 154 ~a~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~ 211 (259)
T cd05037 154 IPITVLS--REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS 211 (259)
T ss_pred ccccccc--ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC
Confidence 9876543 22344677899999987653457889999999999999999 688887764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-31 Score=285.48 Aligned_cols=211 Identities=28% Similarity=0.456 Sum_probs=172.3
Q ss_pred ccccccceeeeeeeccCCceeEEEEec------CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCC-CCceeeee
Q 008759 324 FKRIITYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYY 396 (554)
Q Consensus 324 ~~~~~~~y~i~~~LG~GsfG~VY~a~~------~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIVkl~ 396 (554)
+....++|.++++||+|+||.||+|++ ..+..||+|++..... ......+.+|+.+|..+. |+||++++
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~----~~~~~~~~~E~~~l~~l~~H~niv~~~ 107 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR----SSEKQALMSELKIMSHLGPHLNIVNLL 107 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC----hhHHHHHHHHHHHHHhcCCCCCeEEEE
Confidence 334456789999999999999999985 2456899999864221 222346889999999997 99999999
Q ss_pred eeccCCCcEEEEEeecccCchHHHHhhh----------------------------------------------------
Q 008759 397 GTDKDESKLYIFLELVTKGSLLNLYQRY---------------------------------------------------- 424 (554)
Q Consensus 397 ~~~~~~~~~~LVmE~~~ggsL~~ll~~~---------------------------------------------------- 424 (554)
+++...+.+|+||||+.+|+|.+++.+.
T Consensus 108 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (401)
T cd05107 108 GACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESA 187 (401)
T ss_pred EEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCcccc
Confidence 9999999999999999999999988642
Q ss_pred -----------------------------------------------cCChHHHHHHHHHHHHHHHHHHHCCccccCCcc
Q 008759 425 -----------------------------------------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKC 457 (554)
Q Consensus 425 -----------------------------------------------~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKP 457 (554)
.+.+..+..|+.||+.||.|||+++|+||||||
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp 267 (401)
T cd05107 188 DYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAA 267 (401)
T ss_pred CccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCc
Confidence 145566788999999999999999999999999
Q ss_pred ccEEEcCCCcEEEEecCcccccccCC----ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008759 458 ANILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPM 532 (554)
Q Consensus 458 eNILld~~g~vKL~DFGlA~~~~~~~----~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~ 532 (554)
+|||++.++.+||+|||+++...... .....++..|+|||++... .++.++|||||||++|||++ |..||...
T Consensus 268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslGvil~e~l~~g~~P~~~~ 345 (401)
T cd05107 268 RNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNN--LYTTLSDVWSFGILLWEIFTLGGTPYPEL 345 (401)
T ss_pred ceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCC--CCCcHhHHHHHHHHHHHHHHcCCCCCCCC
Confidence 99999999999999999987543211 1223467889999998654 37889999999999999998 89999876
Q ss_pred ChhHHHHH
Q 008759 533 ECVSAIFI 540 (554)
Q Consensus 533 e~~~~i~~ 540 (554)
...+.++.
T Consensus 346 ~~~~~~~~ 353 (401)
T cd05107 346 PMNEQFYN 353 (401)
T ss_pred CchHHHHH
Confidence 65444433
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-31 Score=263.00 Aligned_cols=200 Identities=30% Similarity=0.489 Sum_probs=165.3
Q ss_pred eeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHH-HHhCCCCceeeeeeeccCCCcEEEEEeec
Q 008759 335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL-LSRFEHENIVQYYGTDKDESKLYIFLELV 412 (554)
Q Consensus 335 ~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~i-L~~l~HpnIVkl~~~~~~~~~~~LVmE~~ 412 (554)
+.||.|+||.||+|.+ .+++.||+|++...... .......+..|..+ ....+|+||+++++.+...+.+|+||||+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMI--AKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYL 79 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhh--HHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEecc
Confidence 5699999999999998 67899999988642211 11222334445444 44558999999999999999999999999
Q ss_pred ccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCCccCccCCC
Q 008759 413 TKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA 491 (554)
Q Consensus 413 ~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~~~s~~GT~ 491 (554)
.+++|..+++. ..+++..+..++.||+.||.|||+.||+|+||+|+|||++.++.++|+|||++..... .....+++
T Consensus 80 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~--~~~~~~~~ 157 (260)
T cd05611 80 NGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE--NKKFVGTP 157 (260)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc--cccCCCCc
Confidence 99999999876 4689999999999999999999999999999999999999999999999999876433 22345889
Q ss_pred cccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHH
Q 008759 492 FWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFI 540 (554)
Q Consensus 492 ~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~ 540 (554)
.|++||.+.+.. ++.++||||||+++|+|++|..||...+..+.+..
T Consensus 158 ~y~~pe~~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~ 204 (260)
T cd05611 158 DYLAPETILGVG--DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDN 204 (260)
T ss_pred CccChhhhcCCC--CcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 999999986543 78899999999999999999999988766554433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=273.22 Aligned_cols=200 Identities=31% Similarity=0.495 Sum_probs=165.9
Q ss_pred ceeeeeeeccCCceeEEEEec-C--CCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCC--Cc
Q 008759 330 YWQKGDLLGRGSFGSVYEGIS-D--DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE--SK 404 (554)
Q Consensus 330 ~y~i~~~LG~GsfG~VY~a~~-~--~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~--~~ 404 (554)
.|++.++||+|+||.||+|.+ . ++..||+|.+..... ........+.+|+.++..++||||+++++.+... ..
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKE--QYTGISQSACREIALLRELKHENVVSLVEVFLEHADKS 78 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccc--cccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCce
Confidence 478899999999999999998 4 589999999875321 1122235567899999999999999999999887 78
Q ss_pred EEEEEeecccCchHHHHhh------hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcC----CCcEEEEecC
Q 008759 405 LYIFLELVTKGSLLNLYQR------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA----NGSVKLADFG 474 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~------~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~----~g~vKL~DFG 474 (554)
+|+||||+.+ +|..++.. ..+++..++.++.||+.||.|||+++|+||||||+|||++. ++.+||+|||
T Consensus 79 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 79 VYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 9999999986 55555532 24788899999999999999999999999999999999999 8999999999
Q ss_pred cccccccCC-----ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008759 475 LAKATKLND-----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME 533 (554)
Q Consensus 475 lA~~~~~~~-----~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e 533 (554)
++....... .....+++.|+|||++.+. ..++.++|||||||++|+|++|+.||....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 220 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTLEPIFKGRE 220 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence 987643221 2334678999999988543 247889999999999999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-31 Score=276.46 Aligned_cols=208 Identities=27% Similarity=0.474 Sum_probs=175.2
Q ss_pred cccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCC--
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES-- 403 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~-- 403 (554)
+.++|++.+.||+|+||.||++.+ .++..||+|++.... ........+.+|+.+++.++|+||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF---QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 456899999999999999999987 679999999885321 12233456789999999999999999999886543
Q ss_pred ----cEEEEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccc
Q 008759 404 ----KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT 479 (554)
Q Consensus 404 ----~~~LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~ 479 (554)
.+|+||||+ +++|..++....+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++...
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~ 168 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQT 168 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccc
Confidence 468999999 668988888778999999999999999999999999999999999999999999999999998765
Q ss_pred ccCCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHH
Q 008759 480 KLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFI 540 (554)
Q Consensus 480 ~~~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~ 540 (554)
.. ......+++.|++||++.+.. .++.++|+|||||++|+|++|+.||...+.......
T Consensus 169 ~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~ 227 (343)
T cd07880 169 DS-EMTGYVVTRWYRAPEVILNWM-HYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLME 227 (343)
T ss_pred cc-CccccccCCcccCHHHHhCCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 43 223446789999999986432 378899999999999999999999988766544443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=268.52 Aligned_cols=194 Identities=28% Similarity=0.477 Sum_probs=165.3
Q ss_pred eccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEEEeecccC
Q 008759 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKG 415 (554)
Q Consensus 337 LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LVmE~~~gg 415 (554)
||+|+||+||+|.+ .+|+.||+|++..... ........+..|+.+++.++||||+++++.+...+.+|+||||+.++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRL--KKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGG 78 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhh--hhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCC
Confidence 69999999999987 6789999999864221 11223445678999999999999999999999999999999999999
Q ss_pred chHHHHhhh---cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC-CccCccCCC
Q 008759 416 SLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-DVKSCRGTA 491 (554)
Q Consensus 416 sL~~ll~~~---~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~-~~~s~~GT~ 491 (554)
+|.+++.+. .+++..+..++.|++.||.|||++||+|+||+|+|||++.++.++|+|||++...... ......++.
T Consensus 79 ~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 158 (277)
T cd05577 79 DLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTP 158 (277)
T ss_pred cHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCCC
Confidence 999988653 5889999999999999999999999999999999999999999999999998764322 223445788
Q ss_pred cccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh
Q 008759 492 FWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC 534 (554)
Q Consensus 492 ~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~ 534 (554)
.|++||++.+.. ++.++|+|||||++|+|++|+.||.....
T Consensus 159 ~y~~PE~~~~~~--~~~~~Di~slG~il~~l~~g~~p~~~~~~ 199 (277)
T cd05577 159 GYMAPEVLQGEV--YDFSVDWFALGCTLYEMIAGRSPFRQRKE 199 (277)
T ss_pred CcCCHHHhcCCC--CCchhhhHHHHHHHHHHhhCCCCCCCCcc
Confidence 999999986543 78899999999999999999999976543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.5e-31 Score=257.60 Aligned_cols=199 Identities=53% Similarity=0.922 Sum_probs=175.7
Q ss_pred ceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCC--CcEE
Q 008759 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE--SKLY 406 (554)
Q Consensus 330 ~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~--~~~~ 406 (554)
+|++.+.||+|++|.||+|.+ .++..+++|++...... ......+.+|+.++++++|+||+++++.+... ..++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 77 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS---EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLN 77 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc---hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEE
Confidence 478889999999999999998 47999999998753322 34457788999999999999999999999888 8999
Q ss_pred EEEeecccCchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC--
Q 008759 407 IFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-- 483 (554)
Q Consensus 407 LVmE~~~ggsL~~ll~~~-~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~-- 483 (554)
++|||+.+++|.+++... .+++..+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 78 IFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred EEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence 999999999999998765 78999999999999999999999999999999999999999999999999987765443
Q ss_pred --ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008759 484 --VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME 533 (554)
Q Consensus 484 --~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e 533 (554)
.....++..|++||.+.+.. ++.++|+||||+++|+|++|..||...+
T Consensus 158 ~~~~~~~~~~~y~~pE~~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~~ 207 (260)
T cd06606 158 EGTGSVRGTPYWMAPEVIRGEE--YGRAADIWSLGCTVIEMATGKPPWSELG 207 (260)
T ss_pred ccccCCCCCccccCHhhhcCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 34456889999999986543 7889999999999999999999998876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.6e-31 Score=258.57 Aligned_cols=207 Identities=45% Similarity=0.770 Sum_probs=179.2
Q ss_pred ceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEE
Q 008759 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (554)
Q Consensus 330 ~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LV 408 (554)
+|++.+.||+|++|.||++.+ .+++.|++|.+...... ......+.+|++++..++|+|++++++++.....+|++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 77 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK---EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYII 77 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC---HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEE
Confidence 478899999999999999988 57889999998754321 23456789999999999999999999999999999999
Q ss_pred EeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCCc--c
Q 008759 409 LELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--K 485 (554)
Q Consensus 409 mE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~~--~ 485 (554)
|||+.+++|.+++.. ..+++..+..++.|++.+|.|||++||+|+||||+||+++.++.++|+|||++........ .
T Consensus 78 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 157 (254)
T cd06627 78 LEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDA 157 (254)
T ss_pred EecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccccc
Confidence 999999999998876 4689999999999999999999999999999999999999999999999999876554332 3
Q ss_pred CccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHH
Q 008759 486 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIK 541 (554)
Q Consensus 486 s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i 541 (554)
...++..|++||.+.+.. ++.++|+|+||+++|+|++|+.||.........+..
T Consensus 158 ~~~~~~~y~~pe~~~~~~--~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~ 211 (254)
T cd06627 158 SVVGTPYWMAPEVIEMSG--ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRI 211 (254)
T ss_pred ccccchhhcCHhhhcCCC--CCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence 456889999999986543 788999999999999999999999877665555443
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-31 Score=271.27 Aligned_cols=209 Identities=32% Similarity=0.538 Sum_probs=174.9
Q ss_pred ccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEE
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~ 406 (554)
.+.|++.+.||+|+||.||+|.+ .+++.||+|++...... .......+.+|+.+++.++||||+++++++...+..|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~ 91 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQ--SNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAW 91 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccC--cHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEE
Confidence 35688899999999999999998 57899999988643222 2334467889999999999999999999999999999
Q ss_pred EEEeecccCchHHHHh--hhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCCc
Q 008759 407 IFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV 484 (554)
Q Consensus 407 LVmE~~~ggsL~~ll~--~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~~ 484 (554)
+||||+.+ +|.+++. ...+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++......
T Consensus 92 lv~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-- 168 (307)
T cd06607 92 LVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-- 168 (307)
T ss_pred EEHHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC--
Confidence 99999985 5666554 346899999999999999999999999999999999999999999999999998654322
Q ss_pred cCccCCCcccChhhhccc-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHH
Q 008759 485 KSCRGTAFWMAPEVINNK-NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIK 541 (554)
Q Consensus 485 ~s~~GT~~Y~APEvl~~~-~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i 541 (554)
....+++.|+|||++.+. ...++.++||||||+++|+|++|+.||...+....++.+
T Consensus 169 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~ 226 (307)
T cd06607 169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 226 (307)
T ss_pred CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHH
Confidence 334688899999988532 234788999999999999999999999887766655543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-31 Score=265.88 Aligned_cols=203 Identities=28% Similarity=0.439 Sum_probs=166.2
Q ss_pred eeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCC-CCceeeeeeeccCC--CcEE
Q 008759 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDE--SKLY 406 (554)
Q Consensus 331 y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIVkl~~~~~~~--~~~~ 406 (554)
|++.+.||+|+||.||+|.+ .+++.||+|++........ .....+|+.++.++. |+||+++++++.+. +.++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~----~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 76 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE----QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLA 76 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch----hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEE
Confidence 67889999999999999998 6789999998864322111 123346888888885 99999999999877 8899
Q ss_pred EEEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC-C
Q 008759 407 IFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-D 483 (554)
Q Consensus 407 LVmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~-~ 483 (554)
+||||+.+ +|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||+++. +.+||+|||++...... .
T Consensus 77 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~ 154 (282)
T cd07831 77 LVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP 154 (282)
T ss_pred EEEecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence 99999986 67666654 35899999999999999999999999999999999999999 99999999998765432 2
Q ss_pred ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHH
Q 008759 484 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFI 540 (554)
Q Consensus 484 ~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~ 540 (554)
.....++..|+|||++.... .++.++|||||||++|+|++|..||...+..+.+..
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~-~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~ 210 (282)
T cd07831 155 YTEYISTRWYRAPECLLTDG-YYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAK 210 (282)
T ss_pred cCCCCCCcccCChhHhhcCC-CCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHH
Confidence 23445889999999875432 367899999999999999999999988766554433
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-31 Score=268.68 Aligned_cols=201 Identities=34% Similarity=0.580 Sum_probs=172.5
Q ss_pred ceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEE
Q 008759 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (554)
Q Consensus 330 ~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LV 408 (554)
.|...+.||+|++|.||++.+ .++..+++|++.... ....+.+.+|+.+++.++|+||+++++.+...+..|++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-----~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v 94 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK-----QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVV 94 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc-----hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEE
Confidence 345567899999999999997 678999999876322 22345678999999999999999999999999999999
Q ss_pred EeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC--ccC
Q 008759 409 LELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VKS 486 (554)
Q Consensus 409 mE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~--~~s 486 (554)
+||+.+++|.+++....++...+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++....... ...
T Consensus 95 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~ 174 (285)
T cd06648 95 MEFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS 174 (285)
T ss_pred EeccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCccccc
Confidence 999999999999988788999999999999999999999999999999999999999999999999876543221 223
Q ss_pred ccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHH
Q 008759 487 CRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSA 537 (554)
Q Consensus 487 ~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~ 537 (554)
..|++.|+|||++.+. .++.++|+|||||++|+|++|+.||........
T Consensus 175 ~~~~~~y~aPE~~~~~--~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~ 223 (285)
T cd06648 175 LVGTPYWMAPEVISRL--PYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA 223 (285)
T ss_pred ccCCccccCHHHhcCC--CCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHH
Confidence 4589999999998654 378899999999999999999999987655443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=270.49 Aligned_cols=196 Identities=32% Similarity=0.530 Sum_probs=165.1
Q ss_pred cceeeeeeeccCCceeEEEEec-----CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCC-
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS-----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE- 402 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~-----~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~- 402 (554)
..|++.+.||+|+||.||++.. .++..||+|.+.... .......+.+|+.+++.++|+||+++++++...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 79 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES----GGNHIADLKKEIEILRNLYHENIVKYKGICTEDG 79 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc----cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCC
Confidence 3578899999999999999973 468899999876422 123346788999999999999999999988765
Q ss_pred -CcEEEEEeecccCchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccc
Q 008759 403 -SKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT 479 (554)
Q Consensus 403 -~~~~LVmE~~~ggsL~~ll~~~--~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~ 479 (554)
..+++||||+.+++|.+++.+. .+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++...
T Consensus 80 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 80 GNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred CCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccc
Confidence 5789999999999999998653 4788999999999999999999999999999999999999999999999998765
Q ss_pred ccCC-----ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 008759 480 KLND-----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYA 530 (554)
Q Consensus 480 ~~~~-----~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~ 530 (554)
.... .....++..|+|||++.+. .++.++|||||||++|+|++++.|+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~il~ellt~~~~~~ 213 (284)
T cd05079 160 ETDKEYYTVKDDLDSPVFWYAPECLIQS--KFYIASDVWSFGVTLYELLTYCDSES 213 (284)
T ss_pred ccCccceeecCCCCCCccccCHHHhccC--CCCccccchhhhhhhhhhhcCCCCCc
Confidence 4321 1234467789999998654 47889999999999999999877653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.8e-31 Score=275.91 Aligned_cols=208 Identities=30% Similarity=0.507 Sum_probs=173.2
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCC--
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE-- 402 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~-- 402 (554)
.+.++|++.+.||+|+||.||+|.+ .+++.||+|++..... .......+.+|+.++..++|+||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~ 90 (345)
T cd07877 14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ---SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 90 (345)
T ss_pred hccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch---hhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccc
Confidence 4567899999999999999999987 6799999998864221 122345677899999999999999999887532
Q ss_pred ----CcEEEEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccc
Q 008759 403 ----SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA 478 (554)
Q Consensus 403 ----~~~~LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~ 478 (554)
...|++++++ +++|..+++...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus 91 ~~~~~~~~lv~~~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~ 169 (345)
T cd07877 91 LEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH 169 (345)
T ss_pred ccccccEEEEehhc-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccc
Confidence 3578888887 66898888877899999999999999999999999999999999999999999999999999876
Q ss_pred cccCCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHH
Q 008759 479 TKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIF 539 (554)
Q Consensus 479 ~~~~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~ 539 (554)
... ......++..|+|||++.+. ..++.++|||||||++|+|++|+.||........+.
T Consensus 170 ~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~ 228 (345)
T cd07877 170 TDD-EMTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 228 (345)
T ss_pred ccc-cccccccCCCccCHHHHhCc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 432 23345689999999998542 247889999999999999999999998766554433
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.2e-33 Score=292.64 Aligned_cols=198 Identities=32% Similarity=0.529 Sum_probs=172.6
Q ss_pred eeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEEEeec
Q 008759 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELV 412 (554)
Q Consensus 334 ~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LVmE~~ 412 (554)
.++||.|.||+||-|++ ++|+.||+|++.+..-..+ ...++.+|+.||+++.||.||.+-..|.+.+.+|.|||-+
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~k---qesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl 645 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTK---QESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL 645 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCc---hHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh
Confidence 46899999999999998 8899999999976443322 2367889999999999999999999999999999999999
Q ss_pred ccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCC---CcEEEEecCcccccccCC-ccC
Q 008759 413 TKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN---GSVKLADFGLAKATKLND-VKS 486 (554)
Q Consensus 413 ~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~---g~vKL~DFGlA~~~~~~~-~~s 486 (554)
.|.-|.-+|.. ..+++...+.++.||+.||.|||.+||+|+||||+|||+... -++||||||+|+.+.... ..+
T Consensus 646 ~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrs 725 (888)
T KOG4236|consen 646 HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRS 725 (888)
T ss_pred cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhh
Confidence 88666666643 579999999999999999999999999999999999999654 379999999999887654 456
Q ss_pred ccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhH
Q 008759 487 CRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVS 536 (554)
Q Consensus 487 ~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~ 536 (554)
.+|||.|+|||++..+ +|+...||||+|+|+|--|.|..||...+...
T Consensus 726 VVGTPAYLaPEVLrnk--GyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIn 773 (888)
T KOG4236|consen 726 VVGTPAYLAPEVLRNK--GYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIN 773 (888)
T ss_pred hcCCccccCHHHHhhc--cccccccceeeeEEEEEEecccccCCCccchh
Confidence 7899999999999655 59999999999999999999999998765433
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-31 Score=264.07 Aligned_cols=204 Identities=33% Similarity=0.583 Sum_probs=174.9
Q ss_pred cceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCC-CCceeeeeeeccCCCcEE
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDESKLY 406 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIVkl~~~~~~~~~~~ 406 (554)
++|++.+.||+|+||.||++.+ .++..|++|++...... .......+.+|+.++.++. |+||+++++.+...+.+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~ 78 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLI--KEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLY 78 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhcc--chHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEE
Confidence 3689999999999999999998 57999999988642221 1223356788999999998 999999999999999999
Q ss_pred EEEeecccCchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC--
Q 008759 407 IFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-- 483 (554)
Q Consensus 407 LVmE~~~ggsL~~ll~~~-~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~-- 483 (554)
+||||+.+++|.+++.+. .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 79 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~ 158 (280)
T cd05581 79 FVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP 158 (280)
T ss_pred EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccc
Confidence 999999999999999775 68999999999999999999999999999999999999999999999999987643322
Q ss_pred --------------------ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhH
Q 008759 484 --------------------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVS 536 (554)
Q Consensus 484 --------------------~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~ 536 (554)
.....++..|++||++... .++.++|+|||||++++|++|+.||.......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~ 229 (280)
T cd05581 159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEK--PAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL 229 (280)
T ss_pred ccCCCCCccccccccccccccccccCCccccCHHHhCCC--CCChhhhHHHHHHHHHHHHhCCCCCCCccHHH
Confidence 1223478899999998654 37889999999999999999999999776433
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-31 Score=267.09 Aligned_cols=206 Identities=37% Similarity=0.647 Sum_probs=177.8
Q ss_pred cccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcE
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL 405 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~ 405 (554)
..+.|+..+.||+|+||.||++.+ .++..|++|++..... ....+.+|+.++..++|+||+++++.+......
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 90 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ------NKELIINEILIMKDCKHPNIVDYYDSYLVGDEL 90 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch------hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEE
Confidence 445688889999999999999998 4789999999874322 345678899999999999999999999999999
Q ss_pred EEEEeecccCchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC-
Q 008759 406 YIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN- 482 (554)
Q Consensus 406 ~LVmE~~~ggsL~~ll~~~--~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~- 482 (554)
|+++||+.+++|.+++... .+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++......
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 91 WVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred EEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 9999999999999999876 6899999999999999999999999999999999999999999999999987654322
Q ss_pred -CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHH
Q 008759 483 -DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFI 540 (554)
Q Consensus 483 -~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~ 540 (554)
......++..|++||++.+. .++.++|+|||||++|+|++|+.||...........
T Consensus 171 ~~~~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~ 227 (286)
T cd06614 171 SKRNSVVGTPYWMAPEVIKRK--DYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFL 227 (286)
T ss_pred hhhccccCCcccCCHhHhcCC--CCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 12334578899999998654 378899999999999999999999988766554443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.9e-31 Score=257.44 Aligned_cols=202 Identities=33% Similarity=0.623 Sum_probs=175.3
Q ss_pred ceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEE
Q 008759 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (554)
Q Consensus 330 ~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LV 408 (554)
+|++.+.||.|+||.||++.+ .++..|++|++...... ......+.+|+++++.++|+|++++++.+......++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv 77 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS---EKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIV 77 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC---hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEE
Confidence 488899999999999999998 57899999998753321 33456688999999999999999999999999999999
Q ss_pred EeecccCchHHHHhh-----hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC
Q 008759 409 LELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND 483 (554)
Q Consensus 409 mE~~~ggsL~~ll~~-----~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~ 483 (554)
|||+++++|.+++.. ..+++..+..++.|++.||.|||++|++|+||+|+|||++.++.++|+|||++.......
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 78 MEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred EEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 999999999998875 458899999999999999999999999999999999999999999999999987654332
Q ss_pred --ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhH
Q 008759 484 --VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVS 536 (554)
Q Consensus 484 --~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~ 536 (554)
.....+++.|+|||.+.... ++.++|+||||+++|+|++|+.||...+..+
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~--~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~ 210 (258)
T cd08215 158 DLAKTVVGTPYYLSPELCQNKP--YNYKSDIWSLGCVLYELCTLKHPFEGENLLE 210 (258)
T ss_pred ceecceeeeecccChhHhccCC--CCccccHHHHHHHHHHHHcCCCCCCCCcHHH
Confidence 23346889999999986543 7789999999999999999999998876443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=267.12 Aligned_cols=210 Identities=29% Similarity=0.569 Sum_probs=172.0
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCC-
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES- 403 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~- 403 (554)
...++|++.+.||+|+||.||+|.+ .+++.||+|++...... ......+.+|+.+++.++||||+++++.+.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~ 80 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK---EGFPITAIREIKILRQLNHRNIVNLKEIVTDKQD 80 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccc---cCchHHHHHHHHHHHhCCCCCeeeeeheecCcch
Confidence 4567899999999999999999998 56899999998753221 112245678999999999999999999876654
Q ss_pred ---------cEEEEEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEe
Q 008759 404 ---------KLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLAD 472 (554)
Q Consensus 404 ---------~~~LVmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~D 472 (554)
.+|+||||+.+ ++..++.. ..+++..+..++.||+.||.|||+.||+|+||||+||+++.++.+||+|
T Consensus 81 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~d 159 (302)
T cd07864 81 ALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLAD 159 (302)
T ss_pred hhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCc
Confidence 79999999987 56666654 3589999999999999999999999999999999999999999999999
Q ss_pred cCcccccccCC---ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHH
Q 008759 473 FGLAKATKLND---VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFI 540 (554)
Q Consensus 473 FGlA~~~~~~~---~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~ 540 (554)
||++....... .....++..|++||++.+.. .++.++|||||||++|+|++|+.||...+..+.+..
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~ 229 (302)
T cd07864 160 FGLARLYNSEESRPYTNKVITLWYRPPELLLGEE-RYGPAIDVWSCGCILGELFTKKPIFQANQELAQLEL 229 (302)
T ss_pred ccccccccCCcccccccceeccCccChHHhcCCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 99987654322 12234678899999885432 367899999999999999999999987766554433
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=265.17 Aligned_cols=202 Identities=29% Similarity=0.506 Sum_probs=168.4
Q ss_pred ccceeeeeeeccCCceeEEEEec-CCCc----EEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCC
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGF----FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE 402 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~-~~g~----~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~ 402 (554)
..+|++++.||+|+||.||+|.+ .++. .+|+|...... .......+.+|+.++..++|+||+++++++..
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 80 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET----SPKANKEILDEAYVMASVDHPHVVRLLGICLS- 80 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC----CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-
Confidence 35789999999999999999987 3333 58888765322 23445678899999999999999999998876
Q ss_pred CcEEEEEeecccCchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccc
Q 008759 403 SKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK 480 (554)
Q Consensus 403 ~~~~LVmE~~~ggsL~~ll~~~--~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~ 480 (554)
...++||||+.+|+|.+++... .+++..+..++.||+.||.|||+++|+|+||||+|||++.++.+||+|||+++...
T Consensus 81 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 81 SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccccccc
Confidence 7899999999999999998763 58899999999999999999999999999999999999999999999999987654
Q ss_pred cCCc----cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhH
Q 008759 481 LNDV----KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVS 536 (554)
Q Consensus 481 ~~~~----~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~ 536 (554)
.... ....++..|++||.+... .++.++|+|||||++|+|++ |+.||......+
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~ 219 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHR--IYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE 219 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcC--CcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH
Confidence 3221 112245679999988543 47889999999999999998 999998765543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=262.06 Aligned_cols=196 Identities=26% Similarity=0.493 Sum_probs=158.6
Q ss_pred eeeccCCceeEEEEecC----CCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeecc-CCCcEEEEE
Q 008759 335 DLLGRGSFGSVYEGISD----DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK-DESKLYIFL 409 (554)
Q Consensus 335 ~~LG~GsfG~VY~a~~~----~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~-~~~~~~LVm 409 (554)
+.||+|+||.||+|.+. ++..+|+|.+.... .......+.+|+.+++.++||||+++++.+. .++..|++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 76 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT----DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVL 76 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC----CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEE
Confidence 46899999999999862 34578999875321 2233567888999999999999999999764 456789999
Q ss_pred eecccCchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC----
Q 008759 410 ELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND---- 483 (554)
Q Consensus 410 E~~~ggsL~~ll~~~--~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~---- 483 (554)
||+.+++|.+++.+. .+....+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++......
T Consensus 77 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 156 (262)
T cd05058 77 PYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV 156 (262)
T ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence 999999999998753 35677788899999999999999999999999999999999999999999987543211
Q ss_pred --ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhH
Q 008759 484 --VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVS 536 (554)
Q Consensus 484 --~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~ 536 (554)
.....++..|+|||.+... .++.++|||||||++|+|++ |.+||...+..+
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~ 210 (262)
T cd05058 157 HNHTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD 210 (262)
T ss_pred cccccCcCCccccChhHhccC--ccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 1233467789999998653 47889999999999999999 567777655443
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=276.16 Aligned_cols=210 Identities=28% Similarity=0.470 Sum_probs=173.5
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhC-CCCceeeeeeeccCC-
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDE- 402 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIVkl~~~~~~~- 402 (554)
.+.++|++.+.||+|+||.||+|.+ .++..+|+|++...... ......+.+|+.++.++ +|+||+++++++...
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~---~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~ 80 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRN---ATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEN 80 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCc---chhhhhhhHHHHHHHHhcCCCCccceeeeeccCC
Confidence 4567899999999999999999998 57889999988532111 12234567899999999 999999999987653
Q ss_pred -CcEEEEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccccc
Q 008759 403 -SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL 481 (554)
Q Consensus 403 -~~~~LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~ 481 (554)
..+|+||||+.+ +|..++....+.+..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.....
T Consensus 81 ~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~ 159 (337)
T cd07852 81 DKDIYLVFEYMET-DLHAVIRANILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSE 159 (337)
T ss_pred CceEEEEeccccc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccc
Confidence 468999999985 898888777788889999999999999999999999999999999999999999999999875432
Q ss_pred CC-------ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHH
Q 008759 482 ND-------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFI 540 (554)
Q Consensus 482 ~~-------~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~ 540 (554)
.. .....+|..|+|||++.+. ..++.++|+|||||++|+|++|+.||......+...+
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~ 224 (337)
T cd07852 160 LEENPENPVLTDYVATRWYRAPEILLGS-TRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEK 224 (337)
T ss_pred ccccccCcchhcccccccccCceeeecc-ccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 21 2234588999999987543 2467899999999999999999999987665554443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=259.94 Aligned_cols=206 Identities=31% Similarity=0.604 Sum_probs=173.7
Q ss_pred ceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEE
Q 008759 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (554)
Q Consensus 330 ~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LV 408 (554)
+|.+.+.||.|+||.||++.+ .++..+|+|.+....... .....+.+|+.+++.++|+||+++++.+.....+|+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv 77 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV---KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIV 77 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc---hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEE
Confidence 488999999999999999998 568999999987532111 2235677899999999999999999999999999999
Q ss_pred EeecccCchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCc-EEEEecCcccccccCC-
Q 008759 409 LELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS-VKLADFGLAKATKLND- 483 (554)
Q Consensus 409 mE~~~ggsL~~ll~~~---~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~-vKL~DFGlA~~~~~~~- 483 (554)
+||+.+++|.+++... .+++..+..++.|++.||.|||+++|+|+||||+|||++.++. +||+|||++.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 78 MEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 9999999999988653 3788899999999999999999999999999999999998864 6999999987654332
Q ss_pred -ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHH
Q 008759 484 -VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFI 540 (554)
Q Consensus 484 -~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~ 540 (554)
.....|++.|+|||++... .++.++|+|||||++|+|++|..||......+.+..
T Consensus 158 ~~~~~~~~~~~~ape~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~ 213 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQNR--PYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLK 213 (257)
T ss_pred cccccCCCccccCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHH
Confidence 2234589999999998554 378899999999999999999999987665554443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=273.27 Aligned_cols=208 Identities=28% Similarity=0.475 Sum_probs=170.0
Q ss_pred eeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHH---------HHHHHHHHHHHHHhCCCCceeeeeeecc
Q 008759 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQ---------SISQLEQEIALLSRFEHENIVQYYGTDK 400 (554)
Q Consensus 331 y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~---------~~~~~~~Ei~iL~~l~HpnIVkl~~~~~ 400 (554)
+.+.+.||.|+||+||+|.+ .+++.||+|++........... ....+.+|+.+++.++|+||+++++++.
T Consensus 11 ~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 90 (335)
T PTZ00024 11 IQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYV 90 (335)
T ss_pred hhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEe
Confidence 34568899999999999998 5799999999864322110000 0124678999999999999999999999
Q ss_pred CCCcEEEEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccc
Q 008759 401 DESKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT 479 (554)
Q Consensus 401 ~~~~~~LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~ 479 (554)
..+..|+||||+.+ +|.+++.. ..+++..+..++.||+.||.|||++||+|+||+|+|||++.++.++|+|||++...
T Consensus 91 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~~~~ 169 (335)
T PTZ00024 91 EGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRY 169 (335)
T ss_pred cCCcEEEEEecccc-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccceeec
Confidence 99999999999975 78887765 46899999999999999999999999999999999999999999999999998754
Q ss_pred cc----------------CCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHH
Q 008759 480 KL----------------NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFI 540 (554)
Q Consensus 480 ~~----------------~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~ 540 (554)
.. .......+++.|+|||.+.+.. .++.++|+|||||++|+|++|+.||...+..+.+..
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~ 245 (335)
T PTZ00024 170 GYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAE-KYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGR 245 (335)
T ss_pred ccccccccccccccccccccccccccccCCCCChhcccCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 41 1112234688899999986543 368899999999999999999999988776554433
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-32 Score=302.48 Aligned_cols=212 Identities=28% Similarity=0.438 Sum_probs=183.8
Q ss_pred ccceeeeeeeccCCceeEEEEec------CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccC
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD 401 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~------~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~ 401 (554)
..+.+..+.||+|.||+||+|.- .+...||||.++.. ...+..+.|++|+.++..++|||||+|+|.|..
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~----a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~ 560 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK----AENQARQDFRREAELLAELQHPNIVRLLGVCRE 560 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc----ccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc
Confidence 34667788999999999999974 35678999987642 223355789999999999999999999999999
Q ss_pred CCcEEEEEeecccCchHHHHhhh-----------c----CChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCC
Q 008759 402 ESKLYIFLELVTKGSLLNLYQRY-----------H----LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG 466 (554)
Q Consensus 402 ~~~~~LVmE~~~ggsL~~ll~~~-----------~----l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g 466 (554)
++.+|||+|||..|+|..+|... . +...+.+.|+.||+.|+.||-++.+|||||-..|+||+++.
T Consensus 561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENL 640 (774)
T ss_pred CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccce
Confidence 99999999999999999999631 1 67788999999999999999999999999999999999999
Q ss_pred cEEEEecCcccccccCCccCc----cCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHHHHH
Q 008759 467 SVKLADFGLAKATKLNDVKSC----RGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIFIK 541 (554)
Q Consensus 467 ~vKL~DFGlA~~~~~~~~~s~----~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i~~i 541 (554)
.|||+||||++.....++... .-..+||+||.|+... |+.++|||||||+|||+++ |+.||.++.+.+.|..|
T Consensus 641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~k--FTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i 718 (774)
T KOG1026|consen 641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGK--FTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECI 718 (774)
T ss_pred EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCc--ccchhhhhhhhhhhhhhhccccCcccccchHHHHHHH
Confidence 999999999987655544333 3467799999997765 8999999999999999999 99999999999998887
Q ss_pred HHHH
Q 008759 542 TVAV 545 (554)
Q Consensus 542 ~~~~ 545 (554)
-.+.
T Consensus 719 ~~g~ 722 (774)
T KOG1026|consen 719 RAGQ 722 (774)
T ss_pred HcCC
Confidence 7654
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=274.80 Aligned_cols=207 Identities=29% Similarity=0.492 Sum_probs=171.4
Q ss_pred ccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCC----
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE---- 402 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~---- 402 (554)
..+|.+.+.||.|+||.||+|.+ .++..||+|++..... ...+.+.+|+.+++.++||||+++++.+...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~-----~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-----QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDL 78 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC-----chHHHHHHHHHHHHhcCCCcchhhHhhhccccccc
Confidence 46899999999999999999998 6789999999865332 2346678899999999999999999765543
Q ss_pred ----------CcEEEEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcC-CCcEEEE
Q 008759 403 ----------SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA-NGSVKLA 471 (554)
Q Consensus 403 ----------~~~~LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~-~g~vKL~ 471 (554)
..+|+||||+.+ +|..++....+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+
T Consensus 79 ~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 79 TEDVGSLTELNSVYIVQEYMET-DLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred ccccccccccceEEEEeecccc-cHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEEC
Confidence 357999999975 8888887778999999999999999999999999999999999999974 5678999
Q ss_pred ecCcccccccC-----CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHH
Q 008759 472 DFGLAKATKLN-----DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIK 541 (554)
Q Consensus 472 DFGlA~~~~~~-----~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i 541 (554)
|||++...... ......++..|+|||++... ..++.++|||||||++|+|++|+.||......+....+
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~ 231 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLI 231 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCc-cccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 99998754321 11223578899999987542 34788999999999999999999999877665554433
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=264.23 Aligned_cols=192 Identities=26% Similarity=0.431 Sum_probs=157.8
Q ss_pred eeeccCCceeEEEEecCC-------------CcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccC
Q 008759 335 DLLGRGSFGSVYEGISDD-------------GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD 401 (554)
Q Consensus 335 ~~LG~GsfG~VY~a~~~~-------------g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~ 401 (554)
+.||+|+||.||+|...+ ...+++|.+.. ........+.+|+.++..++||||+++++++..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~-----~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~ 75 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDP-----SHRDISLAFFETASMMRQVSHKHIVLLYGVCVR 75 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecCh-----hhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 368999999999998522 22477776543 122334567888999999999999999999999
Q ss_pred CCcEEEEEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCc-------EEEEe
Q 008759 402 ESKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS-------VKLAD 472 (554)
Q Consensus 402 ~~~~~LVmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~-------vKL~D 472 (554)
....++||||+.+++|..++.. ..+++..+..++.||+.||.|||+++|+||||||+|||++.++. ++++|
T Consensus 76 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 76 DVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred CCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 8999999999999999988864 35889999999999999999999999999999999999987664 89999
Q ss_pred cCcccccccCCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHH-cCCCCCCCCCh
Q 008759 473 FGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEML-TSQIPYAPMEC 534 (554)
Q Consensus 473 FGlA~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLL-TG~~PF~~~e~ 534 (554)
||++..... .....++..|+|||++... ..++.++|||||||++|+|+ +|..||.....
T Consensus 156 ~g~~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~ 215 (262)
T cd05077 156 PGIPITVLS--RQECVERIPWIAPECVEDS-KNLSIAADKWSFGTTLWEICYNGEIPLKDKTL 215 (262)
T ss_pred CCCCccccC--cccccccccccChhhhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCcch
Confidence 998765432 2234578899999988532 34788999999999999998 58999976543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=267.76 Aligned_cols=207 Identities=29% Similarity=0.522 Sum_probs=168.2
Q ss_pred ccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCC----
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE---- 402 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~---- 402 (554)
.++|++.++||+|+||.||+|.+ .+++.+|+|++........ ....+.+|+.+++.++|+||+++++.+...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG---FPITALREIKILKKLKHPNVVPLIDMAVERPDKS 83 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCC---cchhHHHHHHHHHhcCCCCccchhhheecccccc
Confidence 57899999999999999999998 5789999999865322111 123456899999999999999999876433
Q ss_pred ----CcEEEEEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcc
Q 008759 403 ----SKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA 476 (554)
Q Consensus 403 ----~~~~LVmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA 476 (554)
..+|+||||+.+ +|..++.. ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++
T Consensus 84 ~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 162 (311)
T cd07866 84 KRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLA 162 (311)
T ss_pred cccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccc
Confidence 357999999986 56665543 36899999999999999999999999999999999999999999999999998
Q ss_pred cccccCC-------------ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHH
Q 008759 477 KATKLND-------------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIF 539 (554)
Q Consensus 477 ~~~~~~~-------------~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~ 539 (554)
....... .....+++.|+|||++.+. ..++.++|||||||++|+|++|+.||......+...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~ 237 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGE-RRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLH 237 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHhhCC-CccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 7543221 1223468889999988543 247889999999999999999999998776654433
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-32 Score=274.94 Aligned_cols=200 Identities=27% Similarity=0.499 Sum_probs=175.7
Q ss_pred cccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhC-CCCceeeeeeeccCCCc
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESK 404 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIVkl~~~~~~~~~ 404 (554)
-+++|.++.+||+|+|.+|.++.. .+.+.||+|++++.. -+..+.+...+.|-.+..+- +||++|-++.+|+++..
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel--~nddedidwvqtek~vfe~asn~pflvglhscfqtesr 325 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKEL--VNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESR 325 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHh--cCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccce
Confidence 357899999999999999999998 789999999987532 22344566677777777665 69999999999999999
Q ss_pred EEEEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccc-c-c
Q 008759 405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT-K-L 481 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~-~-~ 481 (554)
+++|.||+.||+|.-.+++ .+++++.++.|..+|+.||.|||++|||+||||.+|+|++..|++||+|+|+++.. . .
T Consensus 326 lffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~g 405 (593)
T KOG0695|consen 326 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPG 405 (593)
T ss_pred EEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCCC
Confidence 9999999999999876664 67999999999999999999999999999999999999999999999999999863 2 3
Q ss_pred CCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 008759 482 NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYA 530 (554)
Q Consensus 482 ~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~ 530 (554)
....+.+|||.|.|||++.+.. |+..+|||+||++++||+.|+-||.
T Consensus 406 d~tstfcgtpnyiapeilrgee--ygfsvdwwalgvlmfemmagrspfd 452 (593)
T KOG0695|consen 406 DTTSTFCGTPNYIAPEILRGEE--YGFSVDWWALGVLMFEMMAGRSPFD 452 (593)
T ss_pred cccccccCCCcccchhhhcccc--cCceehHHHHHHHHHHHHcCCCCcc
Confidence 3456788999999999997654 8999999999999999999999995
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-31 Score=262.27 Aligned_cols=207 Identities=30% Similarity=0.545 Sum_probs=175.8
Q ss_pred eeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEEE
Q 008759 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFL 409 (554)
Q Consensus 331 y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LVm 409 (554)
|++.+.||.|++|.||+|.+ .+++.+++|.+...... ......+.+|+.+++.++|+||+++++.+...+.+|+||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 77 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES---EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVF 77 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc---chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEE
Confidence 56778999999999999998 57899999988643221 123456778999999999999999999999999999999
Q ss_pred eecccCchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC--cc
Q 008759 410 ELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VK 485 (554)
Q Consensus 410 E~~~ggsL~~ll~~~--~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~--~~ 485 (554)
||+.+ +|..++... .+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||.+....... ..
T Consensus 78 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~ 156 (283)
T cd05118 78 EFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYT 156 (283)
T ss_pred eccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccccc
Confidence 99986 777777653 68899999999999999999999999999999999999999999999999987654432 22
Q ss_pred CccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHH
Q 008759 486 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKT 542 (554)
Q Consensus 486 s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~ 542 (554)
...++..|++||.+.+. ..++.++|+||||+++|+|++|+.||...+..+.+.++.
T Consensus 157 ~~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~ 212 (283)
T cd05118 157 HYVVTRWYRAPELLLGD-KGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIF 212 (283)
T ss_pred CccCcccccCcHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 34578889999998654 247889999999999999999999998888777666654
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=262.23 Aligned_cols=207 Identities=30% Similarity=0.594 Sum_probs=172.5
Q ss_pred ceeeeeeeccCCceeEEEEecC--CCcEEEEEEEeccccc-----chhHHHHHHHHHHHHHHHh-CCCCceeeeeeeccC
Q 008759 330 YWQKGDLLGRGSFGSVYEGISD--DGFFFAVKEVSLLDQG-----SQAKQSISQLEQEIALLSR-FEHENIVQYYGTDKD 401 (554)
Q Consensus 330 ~y~i~~~LG~GsfG~VY~a~~~--~g~~vAvK~v~~~~~~-----~~~~~~~~~~~~Ei~iL~~-l~HpnIVkl~~~~~~ 401 (554)
.|++.+.||+|+||.||+|.+. .++.+|+|.+...... .........+.+|+.++.+ ++|+||+++++.+..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 4788899999999999999984 4789999988643211 1223445667788888865 799999999999999
Q ss_pred CCcEEEEEeecccCchHHHHhh-----hcCChHHHHHHHHHHHHHHHHHHH-CCccccCCccccEEEcCCCcEEEEecCc
Q 008759 402 ESKLYIFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGSVKLADFGL 475 (554)
Q Consensus 402 ~~~~~LVmE~~~ggsL~~ll~~-----~~l~e~~i~~i~~QIl~gL~yLHs-~gIIHrDIKPeNILld~~g~vKL~DFGl 475 (554)
.+.+|++|||+.+++|.+++.. ..+++..++.++.|++.+|.|||+ .+|+|+||+|+|||++.++.++|+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 9999999999999999988743 358889999999999999999996 7899999999999999999999999999
Q ss_pred ccccccC-CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHH
Q 008759 476 AKATKLN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAI 538 (554)
Q Consensus 476 A~~~~~~-~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i 538 (554)
+...... ......++..|++||.+.+. .++.++|+||||+++|+|++|+.||.........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~--~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~ 222 (269)
T cd08528 161 AKQKQPESKLTSVVGTILYSCPEIVKNE--PYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLA 222 (269)
T ss_pred eeecccccccccccCcccCcChhhhcCC--CCchHHHHHHHHHHHHHHHhCCCcccccCHHHHH
Confidence 8765443 23445689999999999654 3788999999999999999999999876554433
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=269.04 Aligned_cols=199 Identities=27% Similarity=0.513 Sum_probs=163.7
Q ss_pred cceeeeeeeccCCceeEEEEec-CCCc----EEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCC
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS-DDGF----FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES 403 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~-~~g~----~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~ 403 (554)
++|+..+.||+|+||.||+|.+ .++. .+|+|.+.... .......+.+|+.++..++|+||+++++.+...
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~- 81 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT----GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP- 81 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC----CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-
Confidence 5788999999999999999987 4454 46777765321 122234678899999999999999999988654
Q ss_pred cEEEEEeecccCchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccccc
Q 008759 404 KLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL 481 (554)
Q Consensus 404 ~~~LVmE~~~ggsL~~ll~~~--~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~ 481 (554)
..++++||+.+|+|.+++... .+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 82 TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccC
Confidence 567999999999999988753 478889999999999999999999999999999999999999999999999976432
Q ss_pred CC----ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCh
Q 008759 482 ND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMEC 534 (554)
Q Consensus 482 ~~----~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~ 534 (554)
.. .....++..|++||++.+. .++.++|||||||++|+|++ |..||.....
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~DiwslG~~l~el~t~g~~p~~~~~~ 217 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHYR--KFTHQSDVWSYGVTIWELMTFGGKPYDGIPT 217 (303)
T ss_pred cccccccCCCccccccCCHHHhccC--CCChHHHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 21 1123356789999998643 47889999999999999997 9999987543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=274.90 Aligned_cols=206 Identities=25% Similarity=0.490 Sum_probs=171.6
Q ss_pred ccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccC----C
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD----E 402 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~----~ 402 (554)
..+|++.+.||+|+||.||+|.+ .++..||+|++..... .......+.+|+.+++.++|+||+++++.+.. .
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 80 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD---VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADF 80 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc---cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCC
Confidence 36899999999999999999998 6799999998864221 12234567789999999999999999987753 3
Q ss_pred CcEEEEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccccc
Q 008759 403 SKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL 481 (554)
Q Consensus 403 ~~~~LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~ 481 (554)
..+|+||||+.+ +|..++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 159 (334)
T cd07855 81 KDVYVVMDLMES-DLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSS 159 (334)
T ss_pred ceEEEEEehhhh-hHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecc
Confidence 578999999964 78887754 4589999999999999999999999999999999999999999999999999876432
Q ss_pred CC------ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHH
Q 008759 482 ND------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAI 538 (554)
Q Consensus 482 ~~------~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i 538 (554)
.. .....++..|+|||++.... .++.++|||||||++|+|++|+.||...+....+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~ 221 (334)
T cd07855 160 SPTEHKYFMTEYVATRWYRAPELLLSLP-EYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQL 221 (334)
T ss_pred cCcCCCcccccccccccccChHHhcCCc-ccccccchHHHHHHHHHHHcCCCccCCCChHHHH
Confidence 21 12346889999999985433 4788999999999999999999999887665443
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=266.20 Aligned_cols=194 Identities=23% Similarity=0.397 Sum_probs=159.2
Q ss_pred eeeccCCceeEEEEecC-CC-------cEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEE
Q 008759 335 DLLGRGSFGSVYEGISD-DG-------FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (554)
Q Consensus 335 ~~LG~GsfG~VY~a~~~-~g-------~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~ 406 (554)
+.||+|+||.||+|.+. .+ ..+++|.+.. ......+.+.+|+.+++.+.||||+++++.+......+
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~-----~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~ 75 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDK-----SHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESI 75 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcc-----hhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcE
Confidence 36999999999999873 22 2366676542 22344567788999999999999999999999989999
Q ss_pred EEEeecccCchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCc--------EEEEecCcc
Q 008759 407 IFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS--------VKLADFGLA 476 (554)
Q Consensus 407 LVmE~~~ggsL~~ll~~~--~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~--------vKL~DFGlA 476 (554)
+||||+.+|+|..++... .+++..+..++.||+.||.|||++||+||||||+|||++.++. ++++|||++
T Consensus 76 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 76 MVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred EEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccc
Confidence 999999999999998753 4788899999999999999999999999999999999987765 699999987
Q ss_pred cccccCCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcC-CCCCCCCChhH
Q 008759 477 KATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTS-QIPYAPMECVS 536 (554)
Q Consensus 477 ~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG-~~PF~~~e~~~ 536 (554)
..... .....++..|+|||++.+. ..++.++|||||||++|+|++| ..||...+...
T Consensus 156 ~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~ 213 (258)
T cd05078 156 ITVLP--KEILLERIPWVPPECIENP-QNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK 213 (258)
T ss_pred cccCC--chhccccCCccCchhccCC-CCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH
Confidence 65432 2334588899999998643 3478899999999999999998 57776655543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=265.03 Aligned_cols=198 Identities=32% Similarity=0.518 Sum_probs=167.9
Q ss_pred cceeeeeeeccCCceeEEEEec-----CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccC--
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS-----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD-- 401 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~-----~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~-- 401 (554)
.+|++.+.||+|+||.||++.. .++..+|+|.+...... .....+.+|+.+++.+.|+||+++++++..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~----~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~ 79 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE----QHRSDFEREIEILRTLDHENIVKYKGVCEKPG 79 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch----HHHHHHHHHHHHHHhCCCCChheEEeeeecCC
Confidence 4678889999999999999985 24789999988743221 345678999999999999999999998876
Q ss_pred CCcEEEEEeecccCchHHHHhhhc--CChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccc
Q 008759 402 ESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT 479 (554)
Q Consensus 402 ~~~~~LVmE~~~ggsL~~ll~~~~--l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~ 479 (554)
....+++|||+.+++|.+++.... +++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++...
T Consensus 80 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 80 GRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred CCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 567999999999999999997654 899999999999999999999999999999999999999999999999998765
Q ss_pred ccCCc-----cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008759 480 KLNDV-----KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM 532 (554)
Q Consensus 480 ~~~~~-----~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~ 532 (554)
..... ....++..|++||.+... .++.++|||||||++|+|++|..||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~ 215 (284)
T cd05038 160 PEDKDYYYVKEPGESPIFWYAPECLRTS--KFSSASDVWSFGVTLYELFTYGDPSQSP 215 (284)
T ss_pred ccCCcceeccCCCCCcccccCcHHHccC--CCCcccchHHHhhhhheeeccCCCcccc
Confidence 42211 122345679999998654 4788999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=269.06 Aligned_cols=206 Identities=24% Similarity=0.402 Sum_probs=169.8
Q ss_pred eeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEEEe
Q 008759 331 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLE 410 (554)
Q Consensus 331 y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LVmE 410 (554)
|.+++.+|.|+++.||++.. +++.||+|++.... ........+.+|+.+++.++|+||+++++++...+..|++||
T Consensus 4 ~~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~---~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e 79 (314)
T cd08216 4 TLIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDS---CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSP 79 (314)
T ss_pred hhhhHhhcCCceEEEEEecC-CCCEEEEEEEeccc---cchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEe
Confidence 45566666666666666555 78999999987532 123345779999999999999999999999999999999999
Q ss_pred ecccCchHHHHhh---hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC----
Q 008759 411 LVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND---- 483 (554)
Q Consensus 411 ~~~ggsL~~ll~~---~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~---- 483 (554)
|+.+++|.+++.. ..+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||.+.......
T Consensus 80 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 80 LMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred ccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 9999999999875 358889999999999999999999999999999999999999999999999886432211
Q ss_pred -----ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHH
Q 008759 484 -----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFI 540 (554)
Q Consensus 484 -----~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~ 540 (554)
.....++..|+|||++......++.++|+|||||++|+|++|+.||........+..
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~ 221 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLE 221 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 123347788999999976544588899999999999999999999998766554443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=271.72 Aligned_cols=203 Identities=26% Similarity=0.447 Sum_probs=167.5
Q ss_pred eeeccC--CceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEEEee
Q 008759 335 DLLGRG--SFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLEL 411 (554)
Q Consensus 335 ~~LG~G--sfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LVmE~ 411 (554)
..||+| +||+||++.+ .+|+.||+|++...... ....+.+.+|+.+++.++||||++++++|...+.+|+||||
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~ 80 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCT---EEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPF 80 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCC---HHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEec
Confidence 456666 9999999998 68999999998643221 23457888999999999999999999999999999999999
Q ss_pred cccCchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC-C----
Q 008759 412 VTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-D---- 483 (554)
Q Consensus 412 ~~ggsL~~ll~~~---~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~-~---- 483 (554)
+.+++|.+++.+. .+++..+..++.||+.||.|||++||+||||||+|||++.++.++++||+.+...... .
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 81 MAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred ccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 9999999988763 4888999999999999999999999999999999999999999999999865322111 0
Q ss_pred ----ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHH
Q 008759 484 ----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFI 540 (554)
Q Consensus 484 ----~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~ 540 (554)
.....++..|++||++.+....++.++|||||||++|+|++|..||......+.+..
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~ 221 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQ 221 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHH
Confidence 111235667999999976544578899999999999999999999988765554433
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=262.86 Aligned_cols=198 Identities=32% Similarity=0.529 Sum_probs=163.0
Q ss_pred eeeccCCceeEEEEecCC-------CcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEE
Q 008759 335 DLLGRGSFGSVYEGISDD-------GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (554)
Q Consensus 335 ~~LG~GsfG~VY~a~~~~-------g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~L 407 (554)
+.||+|+||.||+|.+.+ +..+++|.+.... .......+.+|+.+++.++||||+++++++......|+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 76 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA----TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYI 76 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc----chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEE
Confidence 369999999999998732 2578999875321 12234567889999999999999999999999999999
Q ss_pred EEeecccCchHHHHhhh--------cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCC-----cEEEEecC
Q 008759 408 FLELVTKGSLLNLYQRY--------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG-----SVKLADFG 474 (554)
Q Consensus 408 VmE~~~ggsL~~ll~~~--------~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g-----~vKL~DFG 474 (554)
||||+.+++|.+++... .+++.++..++.||+.||.|||+++++|+||||+|||++.++ .++|+|||
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg 156 (269)
T cd05044 77 IMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFG 156 (269)
T ss_pred EEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcc
Confidence 99999999999988642 367788999999999999999999999999999999999887 89999999
Q ss_pred cccccccCCc----cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHH
Q 008759 475 LAKATKLNDV----KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAI 538 (554)
Q Consensus 475 lA~~~~~~~~----~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i 538 (554)
++........ ....++..|+|||++.+. .++.++|||||||++|+|++ |+.||......+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~ 223 (269)
T cd05044 157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLDG--KFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVL 223 (269)
T ss_pred cccccccccccccCcccCCCccccCHHHHccC--CcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHH
Confidence 9875433221 122356789999998654 37889999999999999998 99999876654443
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=263.69 Aligned_cols=203 Identities=29% Similarity=0.443 Sum_probs=173.0
Q ss_pred ccccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCC
Q 008759 324 FKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE 402 (554)
Q Consensus 324 ~~~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~ 402 (554)
...-.++|.+.+.||+|||+-||++.. .++..||+|++.- ...+.++..++|+...++++||||++++++...+
T Consensus 16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c-----~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~ 90 (302)
T KOG2345|consen 16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILC-----HSQEDIEEALREIDNHRKFNSPNVLRLVDHQLRE 90 (302)
T ss_pred EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeec-----cchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHh
Confidence 334457999999999999999999998 7899999999874 2345677889999999999999999999876443
Q ss_pred -----CcEEEEEeecccCchHHHHhhh-----cCChHHHHHHHHHHHHHHHHHHHCC--ccccCCccccEEEcCCCcEEE
Q 008759 403 -----SKLYIFLELVTKGSLLNLYQRY-----HLRDSQVSAYTRQILLGLKYLHDQD--VVHRDIKCANILVDANGSVKL 470 (554)
Q Consensus 403 -----~~~~LVmE~~~ggsL~~ll~~~-----~l~e~~i~~i~~QIl~gL~yLHs~g--IIHrDIKPeNILld~~g~vKL 470 (554)
...||++.|...|+|.+.++.. .+++.++..|+.+|++||++||... +.||||||.|||+...+.++|
T Consensus 91 ~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl 170 (302)
T KOG2345|consen 91 EKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVL 170 (302)
T ss_pred hccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEE
Confidence 3499999999999999988642 4899999999999999999999999 999999999999999999999
Q ss_pred EecCcccccccC-----------CccCccCCCcccChhhhccc-CCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008759 471 ADFGLAKATKLN-----------DVKSCRGTAFWMAPEVINNK-NKGYGLPADIWSLGCTVLEMLTSQIPYAP 531 (554)
Q Consensus 471 ~DFGlA~~~~~~-----------~~~s~~GT~~Y~APEvl~~~-~~~~s~ksDIwSLGvllyeLLTG~~PF~~ 531 (554)
.|||.++...-. ......+|..|+|||++.-+ ....+.++|||||||++|+|+.|.-||..
T Consensus 171 ~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~ 243 (302)
T KOG2345|consen 171 MDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFER 243 (302)
T ss_pred EeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchH
Confidence 999998653211 12233489999999998654 33478899999999999999999999964
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=273.76 Aligned_cols=210 Identities=29% Similarity=0.480 Sum_probs=176.9
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCc
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~ 404 (554)
.+.++|++.+.||+|+||.||+|.+ .++..||+|++.... ........+.+|+.+++.++|+||+++++.+...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF---QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASS 88 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEeccccc---chhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccc
Confidence 3567899999999999999999998 578899999876421 112234567789999999999999999988766554
Q ss_pred ------EEEEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccc
Q 008759 405 ------LYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA 478 (554)
Q Consensus 405 ------~~LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~ 478 (554)
+|+|+||+ +++|.+++....+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++..
T Consensus 89 ~~~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~ 167 (343)
T cd07851 89 LEDFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARH 167 (343)
T ss_pred ccccccEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccc
Confidence 89999999 55899998888899999999999999999999999999999999999999999999999999876
Q ss_pred cccCCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHH
Q 008759 479 TKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIK 541 (554)
Q Consensus 479 ~~~~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i 541 (554)
.... .....++..|+|||++.+.. .++.++|||||||++|+|++|+.||...+..+.+..+
T Consensus 168 ~~~~-~~~~~~~~~y~aPE~~~~~~-~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i 228 (343)
T cd07851 168 TDDE-MTGYVATRWYRAPEIMLNWM-HYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRI 228 (343)
T ss_pred cccc-ccCCcccccccCHHHHhCCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 5433 34456889999999986432 4788999999999999999999999887766554443
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=305.30 Aligned_cols=205 Identities=31% Similarity=0.516 Sum_probs=176.2
Q ss_pred cceeeeeeeccCCceeEEEEec--CCCc----EEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCC
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS--DDGF----FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE 402 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~--~~g~----~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~ 402 (554)
...++++.||+|.||.||.|.. .++. .||+|.+.. ....+....|.+|..+++.++|||||+++|.+.+.
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~----~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~ 767 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKR----LSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS 767 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccc----cCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC
Confidence 3567889999999999999986 3343 488887764 23355678899999999999999999999999999
Q ss_pred CcEEEEEeecccCchHHHHhhh--------cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecC
Q 008759 403 SKLYIFLELVTKGSLLNLYQRY--------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFG 474 (554)
Q Consensus 403 ~~~~LVmE~~~ggsL~~ll~~~--------~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFG 474 (554)
...+|++|||.+|+|..+++.. .+...+...++.+|++|+.||+++++|||||..+|+|++....|||+|||
T Consensus 768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccc
Confidence 9999999999999999999864 37888999999999999999999999999999999999999999999999
Q ss_pred cccccccCCccCc----cCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHHH
Q 008759 475 LAKATKLNDVKSC----RGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIF 539 (554)
Q Consensus 475 lA~~~~~~~~~s~----~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i~ 539 (554)
||+-+....+... .-...|||||.+... .++.++|||||||++||++| |..||....+.+.+.
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~--iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~ 915 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDG--IFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLL 915 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhc--ccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHH
Confidence 9995443333322 234679999999764 48999999999999999999 999999998877654
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=270.62 Aligned_cols=204 Identities=30% Similarity=0.463 Sum_probs=172.6
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccC-CC
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD-ES 403 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~-~~ 403 (554)
.+.++|++.+.||.|+||.||+|.+ .+++.||+|++..... .....+.+.+|+.++..++||||++++++|.. ..
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS---TPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc---ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 4567899999999999999999987 6899999998753221 11233567789999999999999999998865 56
Q ss_pred cEEEEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC
Q 008759 404 KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND 483 (554)
Q Consensus 404 ~~~LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~ 483 (554)
.+|++|||+. ++|..++....+++..+..++.||+.||.|||++||+|+||+|.|||++.++.++|+|||++..... .
T Consensus 84 ~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~-~ 161 (328)
T cd07856 84 DIYFVTELLG-TDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP-Q 161 (328)
T ss_pred cEEEEeehhc-cCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC-C
Confidence 7899999985 5899888877888889999999999999999999999999999999999999999999999875432 2
Q ss_pred ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChh
Q 008759 484 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECV 535 (554)
Q Consensus 484 ~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~ 535 (554)
.....++..|+|||++.+. ..++.++|+|||||++|+|++|+.||...+..
T Consensus 162 ~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~ 212 (328)
T cd07856 162 MTGYVSTRYYRAPEIMLTW-QKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHV 212 (328)
T ss_pred cCCCcccccccCceeeecc-CCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 2344578899999987542 24788999999999999999999999876653
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-31 Score=272.93 Aligned_cols=204 Identities=29% Similarity=0.489 Sum_probs=169.8
Q ss_pred cccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCC---
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE--- 402 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~--- 402 (554)
+.++|.+.+.||+|+||+||+|.+ .++..||+|.+..... .......+.+|+.+++.++|+||+++++++...
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~ 79 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD---NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHRE 79 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc---ccchhHHHHHHHHHHHhcCCCCccchHHheeccccc
Confidence 346799999999999999999998 6799999998864221 122235667899999999999999999987543
Q ss_pred --CcEEEEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccc
Q 008759 403 --SKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT 479 (554)
Q Consensus 403 --~~~~LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~ 479 (554)
..+|+||||+. ++|.+++.. ..+++..+..++.||+.||.|||+++++|+||||+|||++.++.+||+|||++...
T Consensus 80 ~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 158 (337)
T cd07858 80 AFNDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT 158 (337)
T ss_pred ccCcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence 35899999997 478777765 46899999999999999999999999999999999999999999999999998765
Q ss_pred ccC--CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChh
Q 008759 480 KLN--DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECV 535 (554)
Q Consensus 480 ~~~--~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~ 535 (554)
... ......++..|+|||++.... .++.++|||||||++|+|++|+.||...+..
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 215 (337)
T cd07858 159 SEKGDFMTEYVVTRWYRAPELLLNCS-EYTTAIDVWSVGCIFAELLGRKPLFPGKDYV 215 (337)
T ss_pred CCCcccccccccccCccChHHHhcCC-CCCCcccHHHHHHHHHHHHcCCCCCCCCChH
Confidence 432 223445889999999986432 3788999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=268.41 Aligned_cols=199 Identities=34% Similarity=0.568 Sum_probs=171.4
Q ss_pred eeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEEE
Q 008759 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFL 409 (554)
Q Consensus 331 y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LVm 409 (554)
|....+||+|+||.||++.. .++..+|+|++.... ......+.+|+.+++.++|+||+++++.+...+..|+||
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 96 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK-----QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 96 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc-----hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEE
Confidence 34457899999999999988 678999999875321 223456889999999999999999999999999999999
Q ss_pred eecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC--CccCc
Q 008759 410 ELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--DVKSC 487 (554)
Q Consensus 410 E~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~--~~~s~ 487 (554)
||+.+++|.+++....+++..+..++.|++.+|.|||++||+|+||+|+||+++.++.++|+|||++...... .....
T Consensus 97 e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~ 176 (292)
T cd06657 97 EFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL 176 (292)
T ss_pred ecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccccccccc
Confidence 9999999999987778899999999999999999999999999999999999999999999999988654332 22334
Q ss_pred cCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhH
Q 008759 488 RGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVS 536 (554)
Q Consensus 488 ~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~ 536 (554)
.+++.|++||.+... .++.++|+||||+++|+|++|..||......+
T Consensus 177 ~~~~~y~~pE~~~~~--~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~ 223 (292)
T cd06657 177 VGTPYWMAPELISRL--PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK 223 (292)
T ss_pred ccCccccCHHHhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 588999999998543 37889999999999999999999998765543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-31 Score=264.77 Aligned_cols=191 Identities=23% Similarity=0.338 Sum_probs=156.5
Q ss_pred eeccCCceeEEEEecC-------------------------CCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCC
Q 008759 336 LLGRGSFGSVYEGISD-------------------------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390 (554)
Q Consensus 336 ~LG~GsfG~VY~a~~~-------------------------~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hp 390 (554)
+||+|+||.||+|... ....+++|.+.. ........+.+|+.+++.++|+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~-----~~~~~~~~~~~~~~~~~~l~h~ 76 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDP-----SHRDIALAFFETASLMSQVSHI 76 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecCh-----HHHHHHHHHHHHHHHHhcCCCC
Confidence 6999999999998741 113577777642 1223345677889999999999
Q ss_pred ceeeeeeeccCCCcEEEEEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCC--
Q 008759 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG-- 466 (554)
Q Consensus 391 nIVkl~~~~~~~~~~~LVmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g-- 466 (554)
||+++++++......|+||||+.+++|..++.+ ..+++..+..++.||+.||.|||++||+||||||+|||++..+
T Consensus 77 niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 77 HLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLA 156 (274)
T ss_pred CeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcc
Confidence 999999999999999999999999999998864 4588999999999999999999999999999999999997654
Q ss_pred -----cEEEEecCcccccccCCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHH-cCCCCCCCCCh
Q 008759 467 -----SVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEML-TSQIPYAPMEC 534 (554)
Q Consensus 467 -----~vKL~DFGlA~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLL-TG~~PF~~~e~ 534 (554)
.+||+|||++...... ....++..|+|||.+... ..++.++|||||||++|+|+ +|+.||.....
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~--~~~~~~~~~~aPe~~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~ 227 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR--EERVERIPWIAPECVPGG-NSLSTAADKWSFGTTLLEICFDGEVPLKERTP 227 (274)
T ss_pred cCccceeeecCCccccccccc--cccccCCcccCchhhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCccccCh
Confidence 4899999987543221 223578889999988543 35789999999999999995 79999987644
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=267.25 Aligned_cols=210 Identities=33% Similarity=0.545 Sum_probs=175.6
Q ss_pred cceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEE
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~L 407 (554)
..|...+.||+|+||.||++.+ .++..+|+|++...... .......+.+|+.+++.++|+|++++++++...+..|+
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 102 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQ--SNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWL 102 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCC--chHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEE
Confidence 4588889999999999999998 67899999988643222 23345678899999999999999999999999999999
Q ss_pred EEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCCcc
Q 008759 408 FLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK 485 (554)
Q Consensus 408 VmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~~~ 485 (554)
||||+.+ +|.+++.. ..+++.++..++.||+.||.|||+++|+|+||+|+||+++.++.++|+|||++..... ..
T Consensus 103 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~--~~ 179 (317)
T cd06635 103 VMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP--AN 179 (317)
T ss_pred EEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC--cc
Confidence 9999976 66666643 4588899999999999999999999999999999999999999999999998765432 23
Q ss_pred CccCCCcccChhhhccc-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHH
Q 008759 486 SCRGTAFWMAPEVINNK-NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTV 543 (554)
Q Consensus 486 s~~GT~~Y~APEvl~~~-~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~ 543 (554)
...+++.|+|||++... ...++.++|||||||++|+|++|+.||........++.+..
T Consensus 180 ~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~ 238 (317)
T cd06635 180 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 238 (317)
T ss_pred cccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh
Confidence 34688999999997532 23478899999999999999999999988776666665543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-31 Score=263.23 Aligned_cols=192 Identities=24% Similarity=0.395 Sum_probs=159.8
Q ss_pred ccceeeeeee--ccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHh-CCCCceeeeeeeccCCC
Q 008759 328 ITYWQKGDLL--GRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR-FEHENIVQYYGTDKDES 403 (554)
Q Consensus 328 ~~~y~i~~~L--G~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~-l~HpnIVkl~~~~~~~~ 403 (554)
.+.|.+.+.+ |+|+||.||++.. .++..+|+|.+...... . .|+.+... .+|+||+++++.+...+
T Consensus 13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~--------~--~e~~~~~~~~~h~~iv~~~~~~~~~~ 82 (267)
T PHA03390 13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN--------A--IEPMVHQLMKDNPNFIKLYYSVTTLK 82 (267)
T ss_pred HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc--------h--hhHHHHHHhhcCCCEEEEEEEEecCC
Confidence 3456666665 9999999999998 67889999988642111 0 12222222 26999999999999999
Q ss_pred cEEEEEeecccCchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCC-cEEEEecCccccccc
Q 008759 404 KLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG-SVKLADFGLAKATKL 481 (554)
Q Consensus 404 ~~~LVmE~~~ggsL~~ll~~~-~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g-~vKL~DFGlA~~~~~ 481 (554)
.+|+||||+.+++|.+++... .+++..+..++.||+.||.|||+.||+||||||+|||++.++ .++|+|||++.....
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 162 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT 162 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCC
Confidence 999999999999999998765 789999999999999999999999999999999999999998 999999999876543
Q ss_pred CCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008759 482 NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME 533 (554)
Q Consensus 482 ~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e 533 (554)
. ....++..|+|||++.+. .++.++|||||||++|+|++|+.||....
T Consensus 163 ~--~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~~l~~g~~p~~~~~ 210 (267)
T PHA03390 163 P--SCYDGTLDYFSPEKIKGH--NYDVSFDWWAVGVLTYELLTGKHPFKEDE 210 (267)
T ss_pred C--ccCCCCCcccChhhhcCC--CCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 2 234589999999999654 37889999999999999999999998543
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-31 Score=264.38 Aligned_cols=200 Identities=30% Similarity=0.522 Sum_probs=165.3
Q ss_pred cceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCC-CCceeeeeeeccCCCcEE
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDESKLY 406 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIVkl~~~~~~~~~~~ 406 (554)
++|+..+.||+|+||.||++.+ .++..+|+|.+..... ......+.+|+.++.++. |+||+++++++......+
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~----~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~ 79 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD----EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCW 79 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC----hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEE
Confidence 3566778899999999999998 6789999998864222 133456788999999986 999999999999999999
Q ss_pred EEEeecccCchHHHHh------hhcCChHHHHHHHHHHHHHHHHHHHC-CccccCCccccEEEcCCCcEEEEecCccccc
Q 008759 407 IFLELVTKGSLLNLYQ------RYHLRDSQVSAYTRQILLGLKYLHDQ-DVVHRDIKCANILVDANGSVKLADFGLAKAT 479 (554)
Q Consensus 407 LVmE~~~ggsL~~ll~------~~~l~e~~i~~i~~QIl~gL~yLHs~-gIIHrDIKPeNILld~~g~vKL~DFGlA~~~ 479 (554)
++|||+.. ++.+++. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 80 ~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 158 (288)
T cd06616 80 ICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQL 158 (288)
T ss_pred EEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHh
Confidence 99999875 4444332 24588999999999999999999975 9999999999999999999999999998754
Q ss_pred ccC-CccCccCCCcccChhhhcccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008759 480 KLN-DVKSCRGTAFWMAPEVINNKN-KGYGLPADIWSLGCTVLEMLTSQIPYAPME 533 (554)
Q Consensus 480 ~~~-~~~s~~GT~~Y~APEvl~~~~-~~~s~ksDIwSLGvllyeLLTG~~PF~~~e 533 (554)
... ......|+..|+|||++.... ..++.++|||||||++|+|++|+.||....
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 214 (288)
T cd06616 159 VDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN 214 (288)
T ss_pred ccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc
Confidence 332 223346889999999986542 347889999999999999999999997654
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=261.71 Aligned_cols=205 Identities=29% Similarity=0.493 Sum_probs=171.7
Q ss_pred eeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCC-CCceeeeeeeccCCCcEEEE
Q 008759 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDESKLYIF 408 (554)
Q Consensus 331 y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIVkl~~~~~~~~~~~LV 408 (554)
|++.+.||+|+||.||+|.. .+++.|++|++...... .......+|+..+.+++ |+||+++++.+..++..|+|
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv 76 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS----WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFV 76 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc----hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEE
Confidence 67889999999999999998 56889999987642221 11223456889999999 99999999999999999999
Q ss_pred EeecccCchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC-Cc
Q 008759 409 LELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-DV 484 (554)
Q Consensus 409 mE~~~ggsL~~ll~~~---~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~-~~ 484 (554)
|||+ +++|.+++... .+++..+..++.|++.+|.|||++||+|+||+|+||+++.++.++|+|||++...... ..
T Consensus 77 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (283)
T cd07830 77 FEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY 155 (283)
T ss_pred EecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCc
Confidence 9999 77888877653 5799999999999999999999999999999999999999999999999998765432 23
Q ss_pred cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHH
Q 008759 485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIK 541 (554)
Q Consensus 485 ~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i 541 (554)
....++..|+|||++.... .++.++|+||||+++++|++|+.||......+.+.++
T Consensus 156 ~~~~~~~~~~aPE~~~~~~-~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~ 211 (283)
T cd07830 156 TDYVSTRWYRAPEILLRST-SYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKI 211 (283)
T ss_pred CCCCCcccccCceeeecCc-CcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHH
Confidence 3456889999999885433 4688999999999999999999999877666555544
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-32 Score=272.86 Aligned_cols=195 Identities=28% Similarity=0.439 Sum_probs=164.2
Q ss_pred cccceeee-eeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhC-CCCceeeeeeeccC--
Q 008759 327 IITYWQKG-DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKD-- 401 (554)
Q Consensus 327 ~~~~y~i~-~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIVkl~~~~~~-- 401 (554)
++++|.+- ++||-|-.|.|..|.+ .+++.+|+|++.- .....+|+++--.. .|+|||.++++|..
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D----------s~KARrEVeLHw~~s~h~~iV~IidVyeNs~ 128 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD----------SPKARREVELHWMASGHPHIVSIIDVYENSY 128 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc----------CHHHHhHhhhhhhhcCCCceEEeehhhhhhc
Confidence 34455543 5799999999999988 7899999997752 12345777765554 59999999998654
Q ss_pred --CCcEEEEEeecccCchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCC---CcEEEEec
Q 008759 402 --ESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN---GSVKLADF 473 (554)
Q Consensus 402 --~~~~~LVmE~~~ggsL~~ll~~~---~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~---g~vKL~DF 473 (554)
..++.+|||.|+||.|...++.. .|++.++..|++||..|+.|||+.+|.||||||+|+|+..+ ..+||+||
T Consensus 129 ~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDf 208 (400)
T KOG0604|consen 129 QGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDF 208 (400)
T ss_pred cCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccc
Confidence 45789999999999999988764 39999999999999999999999999999999999999654 47999999
Q ss_pred Ccccccc-cCCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008759 474 GLAKATK-LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME 533 (554)
Q Consensus 474 GlA~~~~-~~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e 533 (554)
|+|+... .....+.+.||+|.|||++... .|+...|+|||||++|-||+|.+||+...
T Consensus 209 GFAK~t~~~~~L~TPc~TPyYvaPevlg~e--KydkscdmwSlgVimYIlLCGyPPFYS~h 267 (400)
T KOG0604|consen 209 GFAKETQEPGDLMTPCFTPYYVAPEVLGPE--KYDKSCDMWSLGVIMYILLCGYPPFYSNH 267 (400)
T ss_pred ccccccCCCccccCCcccccccCHHHhCch--hcCCCCCccchhHHHHHhhcCCCcccccC
Confidence 9999865 4567788899999999999543 48999999999999999999999998654
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-31 Score=270.19 Aligned_cols=205 Identities=31% Similarity=0.531 Sum_probs=174.3
Q ss_pred ceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCC-----
Q 008759 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES----- 403 (554)
Q Consensus 330 ~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~----- 403 (554)
+|++.+.||.|+||.||+|.+ .++..|++|.+..... .....+.+.+|+.+++.++|+||+++++.+....
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 77 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD---DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFN 77 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc---cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCccccc
Confidence 588999999999999999998 5689999998874321 1233467889999999999999999999987765
Q ss_pred cEEEEEeecccCchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC
Q 008759 404 KLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN 482 (554)
Q Consensus 404 ~~~LVmE~~~ggsL~~ll~~~-~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~ 482 (554)
.+|++|||+.+ +|..++.+. .+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++......
T Consensus 78 ~~~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~ 156 (330)
T cd07834 78 DVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156 (330)
T ss_pred ceEEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence 78999999985 788877653 6899999999999999999999999999999999999999999999999999865443
Q ss_pred C-----ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHH
Q 008759 483 D-----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIF 539 (554)
Q Consensus 483 ~-----~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~ 539 (554)
. .....++..|+|||++.+.. .++.++|+|||||++|+|++|..||......+.+.
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~ 217 (330)
T cd07834 157 EDEKGFLTEYVVTRWYRAPELLLSSS-RYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLN 217 (330)
T ss_pred ccccccccccccccCcCCceeeeccc-CCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHH
Confidence 2 33456889999999987653 57889999999999999999999998877655443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=258.50 Aligned_cols=205 Identities=31% Similarity=0.510 Sum_probs=167.8
Q ss_pred eeeeeeeccCCceeEEEEecC-CCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhC---CCCceeeeeeeccCCCc--
Q 008759 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF---EHENIVQYYGTDKDESK-- 404 (554)
Q Consensus 331 y~i~~~LG~GsfG~VY~a~~~-~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l---~HpnIVkl~~~~~~~~~-- 404 (554)
|++.+.||+|+||.||+|.+. ++..||+|++...... ......+.+|+.++..+ .|+||+++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~ 77 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSE---EGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDR 77 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEecccccc---chhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCC
Confidence 678899999999999999984 5899999998753321 11223455677666555 59999999999887766
Q ss_pred ---EEEEEeecccCchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccc
Q 008759 405 ---LYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA 478 (554)
Q Consensus 405 ---~~LVmE~~~ggsL~~ll~~~---~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~ 478 (554)
++++|||+.+ +|.+++... .+++..+..++.||+.||.|||+.+|+|+||+|+|||++.++.+||+|||++..
T Consensus 78 ~~~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 78 ELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred CceeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCccee
Confidence 9999999986 788877652 489999999999999999999999999999999999999999999999999876
Q ss_pred cccCC-ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHH
Q 008759 479 TKLND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIK 541 (554)
Q Consensus 479 ~~~~~-~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i 541 (554)
..... .....++..|+|||++.+.. ++.++|+|||||++|+|++|+.||......+.+.++
T Consensus 157 ~~~~~~~~~~~~~~~~~~PE~~~~~~--~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~ 218 (287)
T cd07838 157 YSFEMALTSVVVTLWYRAPEVLLQSS--YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKI 218 (287)
T ss_pred ccCCcccccccccccccChHHhccCC--CCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHH
Confidence 54332 23345788999999986543 788999999999999999999999877665554443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=265.19 Aligned_cols=209 Identities=33% Similarity=0.551 Sum_probs=174.7
Q ss_pred cceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEE
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~L 407 (554)
+.|...+.||+|+||+||+|.+ .++..|++|++...... .......+.+|+.+++.++|+|++++++.+.+....|+
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 98 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQ--TNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWL 98 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccC--chHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 4467778899999999999998 67899999988653322 22344678889999999999999999999999999999
Q ss_pred EEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCCcc
Q 008759 408 FLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK 485 (554)
Q Consensus 408 VmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~~~ 485 (554)
||||+.+ +|.+++.. ..+++.++..++.||+.+|.|||++||+|+||+|+||+++.++.+||+|||++..... ..
T Consensus 99 v~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--~~ 175 (313)
T cd06633 99 VMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP--AN 175 (313)
T ss_pred EEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC--CC
Confidence 9999975 66666643 3588899999999999999999999999999999999999999999999998764322 23
Q ss_pred CccCCCcccChhhhccc-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHH
Q 008759 486 SCRGTAFWMAPEVINNK-NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKT 542 (554)
Q Consensus 486 s~~GT~~Y~APEvl~~~-~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~ 542 (554)
...|+..|+|||++... ...++.++|||||||++|+|++|..||...+....++.+.
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~ 233 (313)
T cd06633 176 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA 233 (313)
T ss_pred CccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 45688999999998532 2347889999999999999999999999887766666554
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=269.89 Aligned_cols=208 Identities=28% Similarity=0.476 Sum_probs=170.8
Q ss_pred cccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCC---
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE--- 402 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~--- 402 (554)
+..+|.+.+.||+|+||.||+|.+ .++..||+|++..... .......+.+|+.+++.++|+||+++++++...
T Consensus 13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 89 (342)
T cd07879 13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ---SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSG 89 (342)
T ss_pred cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc---cccchhHHHHHHHHHHhcCCCCccchhheecccccC
Confidence 456899999999999999999998 6789999998864221 122234577899999999999999999987654
Q ss_pred ---CcEEEEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccc
Q 008759 403 ---SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT 479 (554)
Q Consensus 403 ---~~~~LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~ 479 (554)
..+|+||||+.. +|..++ ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 90 ~~~~~~~lv~e~~~~-~l~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~ 167 (342)
T cd07879 90 DEFQDFYLVMPYMQT-DLQKIM-GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHA 167 (342)
T ss_pred CCCceEEEEeccccc-CHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCC
Confidence 346999999975 666654 346889999999999999999999999999999999999999999999999998764
Q ss_pred ccCCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHH
Q 008759 480 KLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIK 541 (554)
Q Consensus 480 ~~~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i 541 (554)
.. ......++..|+|||++.+.. .++.++|||||||++|+|++|+.||...+....+..+
T Consensus 168 ~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~ 227 (342)
T cd07879 168 DA-EMTGYVVTRWYRAPEVILNWM-HYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQI 227 (342)
T ss_pred CC-CCCCceeeecccChhhhcCcc-ccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 32 223446788999999986532 3788999999999999999999999987665554443
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=260.65 Aligned_cols=201 Identities=31% Similarity=0.484 Sum_probs=169.5
Q ss_pred ceeeeeeeccCCceeEEEEec----CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhC-CCCceeeeeeeccCCCc
Q 008759 330 YWQKGDLLGRGSFGSVYEGIS----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESK 404 (554)
Q Consensus 330 ~y~i~~~LG~GsfG~VY~a~~----~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIVkl~~~~~~~~~ 404 (554)
+|++.+.||+|+||.||++.+ .++..||+|++..... .........+.+|+.++..+ +|+||+++++.+.....
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~-~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~ 79 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATI-VQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTK 79 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHH-HhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCE
Confidence 478899999999999999875 3578899998874221 11223345678899999999 59999999999999999
Q ss_pred EEEEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC
Q 008759 405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND 483 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~ 483 (554)
+|+||||+.+++|..++.. ..+.+..+..++.|++.+|.|||+.+++|+||||.|||++.++.++|+|||++.......
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 159 (288)
T cd05583 80 LHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE 159 (288)
T ss_pred EEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccccc
Confidence 9999999999999998865 458899999999999999999999999999999999999999999999999987643322
Q ss_pred ---ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008759 484 ---VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP 531 (554)
Q Consensus 484 ---~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~ 531 (554)
.....|+..|++||.+.+....++.++|+||||+++|+|++|..||..
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 210 (288)
T cd05583 160 EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTV 210 (288)
T ss_pred ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCccc
Confidence 123458899999999866544467899999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=259.37 Aligned_cols=206 Identities=32% Similarity=0.532 Sum_probs=174.4
Q ss_pred eeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEEE
Q 008759 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFL 409 (554)
Q Consensus 331 y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LVm 409 (554)
|++.+.||+|+||.||+|.+ .+++.|++|++..... .......+..|+.+++.++|+||+++++.+.....+|+||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~ 77 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNE---EEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVF 77 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccc---cccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEe
Confidence 56778999999999999999 5699999999875331 1222355678999999999999999999999999999999
Q ss_pred eecccCchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC--cc
Q 008759 410 ELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VK 485 (554)
Q Consensus 410 E~~~ggsL~~ll~~~--~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~--~~ 485 (554)
||+.+ +|.+++.+. .+++..+..++.|++.||.|||++||+|+||+|+||+++.++.++|+|||++....... ..
T Consensus 78 e~~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~ 156 (282)
T cd07829 78 EYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYT 156 (282)
T ss_pred cCcCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccC
Confidence 99985 899988775 68999999999999999999999999999999999999999999999999987654322 22
Q ss_pred CccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHH
Q 008759 486 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIK 541 (554)
Q Consensus 486 s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i 541 (554)
...++..|+|||.+... ..++.++|+|||||++|+|++|+.||......+.+.++
T Consensus 157 ~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~ 211 (282)
T cd07829 157 HEVVTLWYRAPEILLGS-KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKI 211 (282)
T ss_pred ccccCcCcCChHHhcCC-cCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence 34467889999998654 24788999999999999999999999887766555444
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=267.29 Aligned_cols=203 Identities=30% Similarity=0.521 Sum_probs=165.3
Q ss_pred ceeeeeeeccCCceeEEEEec-CC--CcEEEEEEEecccccchhHHHHHHHHHHHHHHHhC-CCCceeeeeeeccC----
Q 008759 330 YWQKGDLLGRGSFGSVYEGIS-DD--GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKD---- 401 (554)
Q Consensus 330 ~y~i~~~LG~GsfG~VY~a~~-~~--g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIVkl~~~~~~---- 401 (554)
+|++.+.||+|+||.||++.+ .+ +..||+|++..... .....+.+.+|+.++..+ +|+||+++++.+..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 77 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFS---KKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGN 77 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccc---cchhHHHHHHHHHHHHHhcCCCChheeeeeeeecccc
Confidence 488899999999999999998 44 78999998863211 122345677899999998 59999999986432
Q ss_pred CCcEEEEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccc
Q 008759 402 ESKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK 480 (554)
Q Consensus 402 ~~~~~LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~ 480 (554)
...+|++|+|+.+ +|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 78 ~~~~~~~~e~~~~-~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 78 FNELYLYEELMEA-DLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFS 156 (332)
T ss_pred CCcEEEEEecccC-CHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence 3468899999874 78777754 568999999999999999999999999999999999999999999999999987543
Q ss_pred cCC------ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHH
Q 008759 481 LND------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSA 537 (554)
Q Consensus 481 ~~~------~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~ 537 (554)
... .....||+.|+|||++.+. ..++.++|||||||++|+|++|..||...+....
T Consensus 157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~ 218 (332)
T cd07857 157 ENPGENAGFMTEYVATRWYRAPEIMLSF-QSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQ 218 (332)
T ss_pred cccccccccccCcccCccccCcHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHH
Confidence 221 2234689999999987543 3478899999999999999999999987665443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=256.91 Aligned_cols=200 Identities=28% Similarity=0.456 Sum_probs=162.9
Q ss_pred eeeeeeeccCCceeEEEEec----CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCC---
Q 008759 331 WQKGDLLGRGSFGSVYEGIS----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES--- 403 (554)
Q Consensus 331 y~i~~~LG~GsfG~VY~a~~----~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~--- 403 (554)
|.+.+.||+|+||.||+|.+ .++..+|+|++..... .....+.+.+|+.+++.++||||+++++.+....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIF---SSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKG 77 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccC---ChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCC
Confidence 56788999999999999975 3478999998864222 1233567889999999999999999999875432
Q ss_pred ---cEEEEEeecccCchHHHHhhh-------cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEec
Q 008759 404 ---KLYIFLELVTKGSLLNLYQRY-------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADF 473 (554)
Q Consensus 404 ---~~~LVmE~~~ggsL~~ll~~~-------~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DF 473 (554)
..+++++|+.+++|..++... .++...+..++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 78 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 78 RLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred cccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcc
Confidence 347889999999998876421 3678889999999999999999999999999999999999999999999
Q ss_pred CcccccccCC----ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChh
Q 008759 474 GLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECV 535 (554)
Q Consensus 474 GlA~~~~~~~----~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~ 535 (554)
|+++...... .....+++.|++||.+... .++.++|||||||++|+|++ |+.||...+..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~sDi~slG~il~el~~~g~~p~~~~~~~ 222 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADN--VYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS 222 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcC--ccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH
Confidence 9987653222 1223356789999998654 37889999999999999999 89999876553
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=256.88 Aligned_cols=208 Identities=28% Similarity=0.482 Sum_probs=169.1
Q ss_pred ceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEE
Q 008759 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (554)
Q Consensus 330 ~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LV 408 (554)
+|.+.+.||+|+||.||++.+ ..+..+++|.++.............++..|+.+++.++||||+++++.+.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 488999999999999999988 4455566666554332222222334567889999999999999999999999999999
Q ss_pred EeecccCchHHHHhh-----hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC
Q 008759 409 LELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND 483 (554)
Q Consensus 409 mE~~~ggsL~~ll~~-----~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~ 483 (554)
|||+.+++|..++.. ..+++..+..++.|++.||.|||++|++|+||||+||+++. +.++|+|||++.......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~ 159 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC 159 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence 999999999988753 35888999999999999999999999999999999999964 679999999987654322
Q ss_pred --ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHH
Q 008759 484 --VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFI 540 (554)
Q Consensus 484 --~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~ 540 (554)
.....+++.|++||.+.+. .++.++|+||||+++|+|++|..||...........
T Consensus 160 ~~~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~ 216 (260)
T cd08222 160 DLATTFTGTPYYMSPEALKHQ--GYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLR 216 (260)
T ss_pred ccccCCCCCcCccCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHH
Confidence 2244588899999998543 477899999999999999999999987665554444
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-30 Score=291.72 Aligned_cols=148 Identities=30% Similarity=0.532 Sum_probs=132.6
Q ss_pred ccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEE
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~ 406 (554)
++.|+++++||+|+||+||+|.+ .+++.||+|++..... ........+..|+.++..++|+||+++++.+....++|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~--~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 80 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADM--INKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVY 80 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhc--cCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEE
Confidence 46899999999999999999998 5799999999874322 12334567889999999999999999999999999999
Q ss_pred EEEeecccCchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccc
Q 008759 407 IFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477 (554)
Q Consensus 407 LVmE~~~ggsL~~ll~~~-~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~ 477 (554)
|||||+.+++|..++... .+.+..++.|+.||+.||.|||.++||||||||+||||+.++.+||+|||+++
T Consensus 81 lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 81 LVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999998764 57888999999999999999999999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-30 Score=251.35 Aligned_cols=194 Identities=36% Similarity=0.578 Sum_probs=168.6
Q ss_pred eccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEEEeecccC
Q 008759 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKG 415 (554)
Q Consensus 337 LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LVmE~~~gg 415 (554)
||+|+||.||++.+ .+++.+++|.+..... ........+..|+.+++.++|+||+++++.+.....+|+||||+.++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 78 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKI--IKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGG 78 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhh--cchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCC
Confidence 69999999999998 5689999998875322 12234567889999999999999999999999999999999999999
Q ss_pred chHHHHhhh-cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC--CccCccCCCc
Q 008759 416 SLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--DVKSCRGTAF 492 (554)
Q Consensus 416 sL~~ll~~~-~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~--~~~s~~GT~~ 492 (554)
+|.+++... .+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++...... ......++..
T Consensus 79 ~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~ 158 (250)
T cd05123 79 ELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPE 158 (250)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCcc
Confidence 999998765 6899999999999999999999999999999999999999999999999998765443 2344568899
Q ss_pred ccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh
Q 008759 493 WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC 534 (554)
Q Consensus 493 Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~ 534 (554)
|++||.+.+.. ++.++|+||||+++|+|++|..||...+.
T Consensus 159 ~~~Pe~~~~~~--~~~~~D~~slG~~~~~l~~g~~p~~~~~~ 198 (250)
T cd05123 159 YLAPEVLLGKG--YGKAVDWWSLGVLLYEMLTGKPPFYAEDR 198 (250)
T ss_pred ccChHHhCCCC--CCchhhHHHHHHHHHHHHHCCCCCCCCCH
Confidence 99999986543 67899999999999999999999977664
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=258.84 Aligned_cols=217 Identities=28% Similarity=0.447 Sum_probs=178.3
Q ss_pred cccccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCC-CCceeeeeeecc
Q 008759 323 RFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDK 400 (554)
Q Consensus 323 ~~~~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIVkl~~~~~ 400 (554)
+++.-.++.+.+..||.|+.|+|++++. .+|..+|||.+.. ..+++..++++..+.++.+.+ .|+||+++|+|.
T Consensus 86 r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~r----t~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi 161 (391)
T KOG0983|consen 86 RYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRR----TGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFI 161 (391)
T ss_pred ccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecc----cCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEe
Confidence 3445566778888999999999999998 6799999999875 334566678888888877765 899999999999
Q ss_pred CCCcEEEEEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHC-CccccCCccccEEEcCCCcEEEEecCccc
Q 008759 401 DESKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQ-DVVHRDIKCANILVDANGSVKLADFGLAK 477 (554)
Q Consensus 401 ~~~~~~LVmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~-gIIHrDIKPeNILld~~g~vKL~DFGlA~ 477 (554)
.+..+++.||.|.. .+..++++ ..+++.-+-.+...++.||.||.++ +|||||+||+|||+|..|++||||||++-
T Consensus 162 ~n~dV~IcMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsG 240 (391)
T KOG0983|consen 162 TNTDVFICMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISG 240 (391)
T ss_pred eCchHHHHHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccc
Confidence 99999999999965 56666664 4688888888999999999999865 79999999999999999999999999986
Q ss_pred ccccC-CccCccCCCcccChhhhccc-CCCCCchhhHHHHHHHHHHHHcCCCCCCCC-ChhHHHHHHHHH
Q 008759 478 ATKLN-DVKSCRGTAFWMAPEVINNK-NKGYGLPADIWSLGCTVLEMLTSQIPYAPM-ECVSAIFIKTVA 544 (554)
Q Consensus 478 ~~~~~-~~~s~~GT~~Y~APEvl~~~-~~~~s~ksDIwSLGvllyeLLTG~~PF~~~-e~~~~i~~i~~~ 544 (554)
..-.. ......|-+.|||||.+.-. ...|+.++||||||++++||.||+.||..- ...+.+-++.+.
T Consensus 241 rlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ 310 (391)
T KOG0983|consen 241 RLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNE 310 (391)
T ss_pred eeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhc
Confidence 54333 34455688999999999765 334899999999999999999999999874 345555555543
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-30 Score=274.39 Aligned_cols=203 Identities=27% Similarity=0.415 Sum_probs=175.1
Q ss_pred cceeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEE
Q 008759 329 TYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LV 408 (554)
+...++++||+|-||.|.+|....+..||+|.++... .++....|.+|+++|.+++|||||.++++|..++.++||
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a----~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI 613 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDA----TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI 613 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCccc----chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence 4667889999999999999999888999999887533 234457899999999999999999999999999999999
Q ss_pred EeecccCchHHHHhhhcC---ChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCCcc
Q 008759 409 LELVTKGSLLNLYQRYHL---RDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK 485 (554)
Q Consensus 409 mE~~~ggsL~~ll~~~~l---~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~~~ 485 (554)
||||+.|+|.+++..... .......|+.||+.|++||.+.++|||||.+.|+|++.++++||+|||+++......+.
T Consensus 614 ~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy 693 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY 693 (807)
T ss_pred HHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCce
Confidence 999999999999987632 34456679999999999999999999999999999999999999999999876555444
Q ss_pred Cc----cCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc--CCCCCCCCChhHH
Q 008759 486 SC----RGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT--SQIPYAPMECVSA 537 (554)
Q Consensus 486 s~----~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT--G~~PF~~~e~~~~ 537 (554)
.. .....|||+|.+.-.. ++.++|+|+||+++||+++ ...||..+...+.
T Consensus 694 ~vqgr~vlpiRwmawEsillgk--FttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v 749 (807)
T KOG1094|consen 694 RVQGRAVLPIRWMAWESILLGK--FTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV 749 (807)
T ss_pred eeecceeeeeeehhHHHHHhcc--ccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH
Confidence 33 3468899999986544 8899999999999999865 7889998876554
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-30 Score=262.53 Aligned_cols=209 Identities=32% Similarity=0.541 Sum_probs=172.8
Q ss_pred cceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEE
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~L 407 (554)
..|...+.||+|+||.||+|.+ .++..+++|.+...... .......+.+|+.+++.++|+|++++++++......|+
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 92 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ--SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 92 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEeccccc--ChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEE
Confidence 4577788999999999999998 57889999988643221 12334567889999999999999999999999999999
Q ss_pred EEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCCcc
Q 008759 408 FLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK 485 (554)
Q Consensus 408 VmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~~~ 485 (554)
||||+.+ +|.+++.. ..+++..+..++.|++.||.|||+++++||||||+|||++.++.++|+|||++...... .
T Consensus 93 v~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--~ 169 (308)
T cd06634 93 VMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--N 169 (308)
T ss_pred EEEccCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc--c
Confidence 9999975 67666543 35888999999999999999999999999999999999999999999999998654432 2
Q ss_pred CccCCCcccChhhhccc-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHH
Q 008759 486 SCRGTAFWMAPEVINNK-NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKT 542 (554)
Q Consensus 486 s~~GT~~Y~APEvl~~~-~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~ 542 (554)
...+++.|+|||++.+. ...++.++|||||||++|+|++|..||...+..+.++.+.
T Consensus 170 ~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~ 227 (308)
T cd06634 170 XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA 227 (308)
T ss_pred cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHh
Confidence 34588999999998532 2236789999999999999999999998877665555443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-30 Score=258.97 Aligned_cols=204 Identities=30% Similarity=0.505 Sum_probs=166.3
Q ss_pred ccccceeeeeeeccCCceeEEEEecC-CCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCC-CCceeeeeeeccCCC
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDES 403 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~~-~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIVkl~~~~~~~~ 403 (554)
...+.|++.+.||+|+||.||+|.+. +++.||+|.+..... ......+..|+.++.+.. |+||+++++++....
T Consensus 12 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~----~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~ 87 (296)
T cd06618 12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN----KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDS 87 (296)
T ss_pred CCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC----hHHHHHHHHHHHHHHhccCCCchHhhheeeecCC
Confidence 34578999999999999999999984 599999999864221 122345556776666664 999999999999999
Q ss_pred cEEEEEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHH-CCccccCCccccEEEcCCCcEEEEecCcccccc
Q 008759 404 KLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGSVKLADFGLAKATK 480 (554)
Q Consensus 404 ~~~LVmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs-~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~ 480 (554)
.+|++|||+.+ +|..++.. ..+++..+..++.||+.||.|||+ .||+||||+|+|||++.++.+||+|||++....
T Consensus 88 ~~~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 88 DVFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred eEEEEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 99999999865 67776654 358888899999999999999997 599999999999999999999999999987543
Q ss_pred cC-CccCccCCCcccChhhhcccC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCh
Q 008759 481 LN-DVKSCRGTAFWMAPEVINNKN--KGYGLPADIWSLGCTVLEMLTSQIPYAPMEC 534 (554)
Q Consensus 481 ~~-~~~s~~GT~~Y~APEvl~~~~--~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~ 534 (554)
.. ......++..|+|||.+.... ..++.++||||||+++|+|++|+.||.....
T Consensus 167 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 223 (296)
T cd06618 167 DSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT 223 (296)
T ss_pred CCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh
Confidence 22 222335788999999986542 3478899999999999999999999976433
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=300.54 Aligned_cols=197 Identities=38% Similarity=0.637 Sum_probs=165.9
Q ss_pred ccccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeec---
Q 008759 324 FKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTD--- 399 (554)
Q Consensus 324 ~~~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~--- 399 (554)
+.+...+|+.+++||+|+||.||++++ -+|+.||||++.... .......+.+|+.+|.+++|||||++|..|
T Consensus 474 ~SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~----s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs 549 (1351)
T KOG1035|consen 474 FSRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA----SDKLYSKILREVKLLARLNHPNVVRYYSAWVES 549 (1351)
T ss_pred hhhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch----HHHHHHHHHHHHHHHhhcCCcceeeeehhhhcc
Confidence 356788999999999999999999999 799999999998643 344456788999999999999999997310
Q ss_pred ---------------------------------------------------------c------C---------------
Q 008759 400 ---------------------------------------------------------K------D--------------- 401 (554)
Q Consensus 400 ---------------------------------------------------------~------~--------------- 401 (554)
. .
T Consensus 550 ~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~ 629 (1351)
T KOG1035|consen 550 TAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRN 629 (1351)
T ss_pred CCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccc
Confidence 0 0
Q ss_pred ------------------------------C--------CcEEEEEeecccCchHHHHhhhcCC--hHHHHHHHHHHHHH
Q 008759 402 ------------------------------E--------SKLYIFLELVTKGSLLNLYQRYHLR--DSQVSAYTRQILLG 441 (554)
Q Consensus 402 ------------------------------~--------~~~~LVmE~~~ggsL~~ll~~~~l~--e~~i~~i~~QIl~g 441 (554)
+ ..+||-||||+..+|.+++.++.+. ....+++++||+.|
T Consensus 630 ~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEG 709 (1351)
T KOG1035|consen 630 LSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEG 709 (1351)
T ss_pred cccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHH
Confidence 0 1368999999999999998887764 77889999999999
Q ss_pred HHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccc--------------------cCCccCccCCCcccChhhhcc
Q 008759 442 LKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK--------------------LNDVKSCRGTAFWMAPEVINN 501 (554)
Q Consensus 442 L~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~--------------------~~~~~s~~GT~~Y~APEvl~~ 501 (554)
|.|+|++|||||||||.||+++.++.|||+|||+|+... ....++..||..|+|||++.+
T Consensus 710 LaYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~ 789 (1351)
T KOG1035|consen 710 LAYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD 789 (1351)
T ss_pred HHHHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence 999999999999999999999999999999999997611 012345579999999999976
Q ss_pred cCC-CCCchhhHHHHHHHHHHHHc
Q 008759 502 KNK-GYGLPADIWSLGCTVLEMLT 524 (554)
Q Consensus 502 ~~~-~~s~ksDIwSLGvllyeLLT 524 (554)
... .|+.|+||||||+|++||+.
T Consensus 790 ~~~~~Yn~KiDmYSLGIVlFEM~y 813 (1351)
T KOG1035|consen 790 TSSNKYNSKIDMYSLGIVLFEMLY 813 (1351)
T ss_pred cccccccchhhhHHHHHHHHHHhc
Confidence 542 59999999999999999973
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=275.38 Aligned_cols=216 Identities=24% Similarity=0.371 Sum_probs=180.4
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchh--HHHHHHHHHHHHHHHhCCCCceeeeeeeccC-
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQA--KQSISQLEQEIALLSRFEHENIVQYYGTDKD- 401 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~--~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~- 401 (554)
-+.++|-++.+||+|+|+.||+|.+ ...++||+|+-.+.+..... ..+.++..+|.+|-+.|.||-||++|++|.-
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 3567899999999999999999999 66889999987655443322 3456778899999999999999999999864
Q ss_pred CCcEEEEEeecccCchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHHCC--ccccCCccccEEEc---CCCcEEEEecCc
Q 008759 402 ESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQD--VVHRDIKCANILVD---ANGSVKLADFGL 475 (554)
Q Consensus 402 ~~~~~LVmE~~~ggsL~~ll~~~-~l~e~~i~~i~~QIl~gL~yLHs~g--IIHrDIKPeNILld---~~g~vKL~DFGl 475 (554)
.+.+|-|+|||+|.+|.-||++. -+++.+++.|+.||+.||.||.... |||-||||.|||+- .-|.+||+||||
T Consensus 540 tdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGL 619 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGL 619 (775)
T ss_pred cccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecch
Confidence 56789999999999999999875 4899999999999999999999874 99999999999994 447899999999
Q ss_pred ccccccCCc---------cCccCCCcccChhhhccc--CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHH
Q 008759 476 AKATKLNDV---------KSCRGTAFWMAPEVINNK--NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIK 541 (554)
Q Consensus 476 A~~~~~~~~---------~s~~GT~~Y~APEvl~~~--~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i 541 (554)
++....... ....||.||++||.+.-. +...+.++||||+|||+|+.|.|+.||..--.-+.|+..
T Consensus 620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqe 696 (775)
T KOG1151|consen 620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQE 696 (775)
T ss_pred hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhh
Confidence 987654322 234599999999987533 334788999999999999999999999987766666543
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-31 Score=279.66 Aligned_cols=203 Identities=30% Similarity=0.475 Sum_probs=175.0
Q ss_pred cceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhH---HHHHHHHHHHHHHHhCC---CCceeeeeeeccC
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAK---QSISQLEQEIALLSRFE---HENIVQYYGTDKD 401 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~---~~~~~~~~Ei~iL~~l~---HpnIVkl~~~~~~ 401 (554)
..|...+.||+|+||.|++|++ .+...|++|.+.+........ ..+-.+-.||.||..++ |+||++++++|.+
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 4689999999999999999999 567788888876422211111 11123457999999998 9999999999999
Q ss_pred CCcEEEEEeecc-cCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccc
Q 008759 402 ESKLYIFLELVT-KGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT 479 (554)
Q Consensus 402 ~~~~~LVmE~~~-ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~ 479 (554)
++++||+||-.. |-+|.+++.. ..+.+.+++.|++|++.|+++||++||||||||-+|+.++.+|.+||+|||.+..+
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~~ 720 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAYT 720 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhhh
Confidence 999999999764 4588898875 46999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008759 480 KLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM 532 (554)
Q Consensus 480 ~~~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~ 532 (554)
+.+......||..|.|||++.+.. ..+..-|||+||++||.++....||++.
T Consensus 721 ksgpfd~f~gtv~~aapevl~g~~-y~gk~qdiwalgillytivykenpyyni 772 (772)
T KOG1152|consen 721 KSGPFDVFVGTVDYAAPEVLGGEK-YLGKPQDIWALGILLYTIVYKENPYYNI 772 (772)
T ss_pred cCCCcceeeeeccccchhhhCCCc-cCCCcchhhhhhheeeEEEeccCCCcCC
Confidence 999999999999999999997654 4577899999999999999999999863
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=286.99 Aligned_cols=219 Identities=30% Similarity=0.569 Sum_probs=187.3
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhC-CCCceeeeeeecc---
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDK--- 400 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIVkl~~~~~--- 400 (554)
....-|++.+.||.|.+|.||+++. .+++..|+|+....... -+.++.|+++|+.. .|||++.+|++|.
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~------deEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE------EEEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc------cHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 3456789999999999999999998 78899999987653322 23566788899887 5999999999874
Q ss_pred --CCCcEEEEEeecccCchHHHHhh---hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCc
Q 008759 401 --DESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL 475 (554)
Q Consensus 401 --~~~~~~LVmE~~~ggsL~~ll~~---~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGl 475 (554)
..+++|||||||.+|+..++.+. ..+.+..+.+|++.++.||.+||.+.+||||||-.|||++.+|.|||+|||.
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGv 169 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGV 169 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeee
Confidence 35689999999999999999876 3588999999999999999999999999999999999999999999999998
Q ss_pred ccccc--cCCccCccCCCcccChhhhcccCC---CCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHHHHHHHHH
Q 008759 476 AKATK--LNDVKSCRGTAFWMAPEVINNKNK---GYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTVAVTVIII 550 (554)
Q Consensus 476 A~~~~--~~~~~s~~GT~~Y~APEvl~~~~~---~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~~~~~~~~ 550 (554)
+.... .....++.|||.|||||++....+ .|+..+|+||||++..||--|.+|+.+|.++-++|+|..+....++
T Consensus 170 SaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLk 249 (953)
T KOG0587|consen 170 SAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLK 249 (953)
T ss_pred eeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCcccc
Confidence 76543 234557789999999999965432 3788999999999999999999999999999999999877665443
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-29 Score=238.09 Aligned_cols=207 Identities=38% Similarity=0.627 Sum_probs=177.0
Q ss_pred eeeeeeeccCCceeEEEEecC-CCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEEE
Q 008759 331 WQKGDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFL 409 (554)
Q Consensus 331 y~i~~~LG~GsfG~VY~a~~~-~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LVm 409 (554)
|.+.+.||.|++|.||++... ++..+++|.+...... ...+.+.+|+..+..++|+|++++++.+......++++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~----~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 76 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE----KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVM 76 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch----HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEE
Confidence 567889999999999999984 5899999998753222 24567889999999999999999999999889999999
Q ss_pred eecccCchHHHHhhhc--CChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC---Cc
Q 008759 410 ELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN---DV 484 (554)
Q Consensus 410 E~~~ggsL~~ll~~~~--l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~---~~ 484 (554)
|++.+++|.+++.... +++..+..++.+++.+|.+||+++++|+||+|.||+++.++.++|+|||++...... ..
T Consensus 77 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~ 156 (225)
T smart00221 77 EYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALL 156 (225)
T ss_pred eccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccc
Confidence 9999999999987654 889999999999999999999999999999999999999999999999998765543 22
Q ss_pred cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCC-CChhHHHHHHH
Q 008759 485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP-MECVSAIFIKT 542 (554)
Q Consensus 485 ~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~-~e~~~~i~~i~ 542 (554)
....++..|++||.+. ....++.++|+|+||+++|+|++|+.||.. .+....++..+
T Consensus 157 ~~~~~~~~~~~pe~~~-~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~ 214 (225)
T smart00221 157 KTVKGTPFYLAPEVLL-GGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVW 214 (225)
T ss_pred cceeccCCcCCHhHhc-CCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHH
Confidence 3456788899999985 344577899999999999999999999987 56655554443
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-30 Score=245.84 Aligned_cols=206 Identities=30% Similarity=0.508 Sum_probs=169.8
Q ss_pred ccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhC-CCCceeeeeeeccCCCcE
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESKL 405 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIVkl~~~~~~~~~~ 405 (554)
.+....+..||+|+||.|-+.++ .+|...|+|.+...-. .+..+++.+|+.+..+. .+|++|.+||....+..+
T Consensus 45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn----~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN----SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC----hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 34555667899999999999888 8899999999976332 33446777888876554 699999999999999999
Q ss_pred EEEEeecccCchHHHHhh-----hcCChHHHHHHHHHHHHHHHHHHHC-CccccCCccccEEEcCCCcEEEEecCccccc
Q 008759 406 YIFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQ-DVVHRDIKCANILVDANGSVKLADFGLAKAT 479 (554)
Q Consensus 406 ~LVmE~~~ggsL~~ll~~-----~~l~e~~i~~i~~QIl~gL~yLHs~-gIIHrDIKPeNILld~~g~vKL~DFGlA~~~ 479 (554)
++.||.|.. +|..++.+ ..+++.-+-+|+..++.||.|||++ .|||||+||+||||+.+|+|||||||++-..
T Consensus 121 wIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L 199 (282)
T KOG0984|consen 121 WICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYL 199 (282)
T ss_pred EEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceee
Confidence 999999976 77776643 3588888999999999999999986 7999999999999999999999999998665
Q ss_pred ccCCccC-ccCCCcccChhhhccc--CCCCCchhhHHHHHHHHHHHHcCCCCCCCCC-hhHHH
Q 008759 480 KLNDVKS-CRGTAFWMAPEVINNK--NKGYGLPADIWSLGCTVLEMLTSQIPYAPME-CVSAI 538 (554)
Q Consensus 480 ~~~~~~s-~~GT~~Y~APEvl~~~--~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e-~~~~i 538 (554)
.+...++ -.|--.|||||.++.. ..+|+.++||||||++++||.+++.||.... +.+++
T Consensus 200 ~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qL 262 (282)
T KOG0984|consen 200 VDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQL 262 (282)
T ss_pred hhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHH
Confidence 5444333 3466779999998754 2359999999999999999999999999874 44443
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=247.54 Aligned_cols=179 Identities=21% Similarity=0.286 Sum_probs=151.4
Q ss_pred CCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEEEeecccCchH
Q 008759 340 GSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLL 418 (554)
Q Consensus 340 GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LVmE~~~ggsL~ 418 (554)
|.||.||++++ .+++.||+|.+.... ...+|...+....||||+++++++...+.+|+||||+.+++|.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~----------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 73 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS----------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLW 73 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh----------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHH
Confidence 89999999999 788999999986421 1223444455567999999999999999999999999999999
Q ss_pred HHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCCccCccCCCcccChh
Q 008759 419 NLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 497 (554)
Q Consensus 419 ~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~~~s~~GT~~Y~APE 497 (554)
+++.+ ..+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++...... .....++..|+|||
T Consensus 74 ~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~y~aPE 152 (237)
T cd05576 74 SHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-CDGEAVENMYCAPE 152 (237)
T ss_pred HHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc-cccCCcCccccCCc
Confidence 98765 46899999999999999999999999999999999999999999999999987654432 23344677899999
Q ss_pred hhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008759 498 VINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP 531 (554)
Q Consensus 498 vl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~ 531 (554)
.+... .++.++|+|||||++|+|++|..||..
T Consensus 153 ~~~~~--~~~~~~DvwslG~il~el~~g~~~~~~ 184 (237)
T cd05576 153 VGGIS--EETEACDWWSLGAILFELLTGKTLVEC 184 (237)
T ss_pred ccCCC--CCCchhhHHHHHHHHHHHHHCcchhhc
Confidence 88543 378899999999999999999988753
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.3e-30 Score=276.81 Aligned_cols=201 Identities=30% Similarity=0.408 Sum_probs=170.8
Q ss_pred cccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhC-CCCceeeeeeeccCCCc
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESK 404 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIVkl~~~~~~~~~ 404 (554)
+...|.+...||.|+|+.|-.+.+ .+++.+++|++.... ....+|+.++... +||||+++.+.+.+..+
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~---------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~ 390 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA---------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKE 390 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc---------cccccccchhhhhcCCCcceeecceecCCce
Confidence 567888889999999999999988 789999999987531 1234667666555 69999999999999999
Q ss_pred EEEEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEE-cCCCcEEEEecCcccccccCC
Q 008759 405 LYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV-DANGSVKLADFGLAKATKLND 483 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILl-d~~g~vKL~DFGlA~~~~~~~ 483 (554)
.|+|||++.|+.+.+-+...+....++..|++||+.++.|||.+|||||||||+|||+ +..|+++|+|||.++.....
T Consensus 391 ~~~v~e~l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~- 469 (612)
T KOG0603|consen 391 IYLVMELLDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS- 469 (612)
T ss_pred eeeeehhccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence 9999999999988777665554447888899999999999999999999999999999 68999999999998776554
Q ss_pred ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHH
Q 008759 484 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIF 539 (554)
Q Consensus 484 ~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~ 539 (554)
..+.+-|..|.|||++. .++|+.++||||||++||+||+|+.||........++
T Consensus 470 ~~tp~~t~~y~APEvl~--~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~ 523 (612)
T KOG0603|consen 470 CDTPALTLQYVAPEVLA--IQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIH 523 (612)
T ss_pred hcccchhhcccChhhhc--cCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHH
Confidence 44556899999999996 4569999999999999999999999998765553333
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.7e-29 Score=260.47 Aligned_cols=138 Identities=27% Similarity=0.366 Sum_probs=116.6
Q ss_pred CCCCccccccc-cceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCC-----C-
Q 008759 318 ISPNGRFKRII-TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-----H- 389 (554)
Q Consensus 318 ~~~~~~~~~~~-~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~-----H- 389 (554)
+.+......+. .+|.+.++||+|.|++||+|++ ++.++||+|+++ ..+.+.+....||.+|++++ |
T Consensus 66 YHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvK------SAqhYtEaAlDEIklL~~v~~~Dp~~~ 139 (590)
T KOG1290|consen 66 YHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVK------SAQHYTEAALDEIKLLQQVREGDPNDP 139 (590)
T ss_pred CceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEe------hhhHHHHHHHHHHHHHHHHHhcCCCCC
Confidence 44444444555 7999999999999999999999 889999999987 45566778889999999985 2
Q ss_pred --CceeeeeeeccC----CCcEEEEEeecccCchHHHHhh---hcCChHHHHHHHHHHHHHHHHHHH-CCccccCCcccc
Q 008759 390 --ENIVQYYGTDKD----ESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCAN 459 (554)
Q Consensus 390 --pnIVkl~~~~~~----~~~~~LVmE~~~ggsL~~ll~~---~~l~e~~i~~i~~QIl~gL~yLHs-~gIIHrDIKPeN 459 (554)
.+||+|++.|.. ..++|||+|++.. .|..+++. .+++...++.|++|||.||.|||. +||||.||||+|
T Consensus 140 ~~~~VV~LlD~FkhsGpNG~HVCMVfEvLGd-nLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPEN 218 (590)
T KOG1290|consen 140 GKKCVVQLLDHFKHSGPNGQHVCMVFEVLGD-NLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPEN 218 (590)
T ss_pred CCceeeeeeccceecCCCCcEEEEEehhhhh-HHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcce
Confidence 369999999865 4589999999965 66666654 369999999999999999999996 699999999999
Q ss_pred EEE
Q 008759 460 ILV 462 (554)
Q Consensus 460 ILl 462 (554)
||+
T Consensus 219 vLl 221 (590)
T KOG1290|consen 219 VLL 221 (590)
T ss_pred eee
Confidence 999
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-30 Score=275.67 Aligned_cols=202 Identities=27% Similarity=0.437 Sum_probs=179.1
Q ss_pred ccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCC------Cceeeeeeecc
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH------ENIVQYYGTDK 400 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~H------pnIVkl~~~~~ 400 (554)
-++|.+....|+|-|++|..|.+ ..|+.||||+|... ....+.-+.|++||.+|+. -|+++|+.+|.
T Consensus 431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN------E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~ 504 (752)
T KOG0670|consen 431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN------EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFK 504 (752)
T ss_pred cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc------hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhh
Confidence 45789999999999999999999 56889999999742 2333556789999999973 47999999999
Q ss_pred CCCcEEEEEeecccCchHHHHhhh----cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCC-cEEEEecCc
Q 008759 401 DESKLYIFLELVTKGSLLNLYQRY----HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG-SVKLADFGL 475 (554)
Q Consensus 401 ~~~~~~LVmE~~~ggsL~~ll~~~----~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g-~vKL~DFGl 475 (554)
+.+++|||||.+.- +|.++|+++ +|....++.|++|++.||..|..+||+|.||||+||||+... .+||||||.
T Consensus 505 hknHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGS 583 (752)
T KOG0670|consen 505 HKNHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGS 583 (752)
T ss_pred hcceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcc
Confidence 99999999998865 789999876 478889999999999999999999999999999999998764 689999999
Q ss_pred ccccccCCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHH
Q 008759 476 AKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAI 538 (554)
Q Consensus 476 A~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i 538 (554)
|.....+..+.+..+..|.|||++.+.. |++..|+||+||+||||+||++.|++..+.+++
T Consensus 584 A~~~~eneitPYLVSRFYRaPEIiLG~~--yd~~iD~WSvgctLYElYtGkIlFpG~TNN~ML 644 (752)
T KOG0670|consen 584 ASFASENEITPYLVSRFYRAPEIILGLP--YDYPIDTWSVGCTLYELYTGKILFPGRTNNQML 644 (752)
T ss_pred ccccccccccHHHHHHhccCcceeecCc--ccCCccceeeceeeEEeeccceecCCCCcHHHH
Confidence 9999888888888899999999998776 888999999999999999999999998876664
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-30 Score=265.63 Aligned_cols=202 Identities=26% Similarity=0.408 Sum_probs=171.3
Q ss_pred cccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCC-C-Cc----eeeeeeec
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-H-EN----IVQYYGTD 399 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~-H-pn----IVkl~~~~ 399 (554)
+..+|.+..+||+|+||.|-.+++ ..+..+|+|+++.. ....+...-|+++|+++. + |+ +|++.++|
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V------~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF 160 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV------DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF 160 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH------HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh
Confidence 367899999999999999999999 56899999998742 233455667899999994 2 33 78888999
Q ss_pred cCCCcEEEEEeecccCchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcC------------
Q 008759 400 KDESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA------------ 464 (554)
Q Consensus 400 ~~~~~~~LVmE~~~ggsL~~ll~~~---~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~------------ 464 (554)
...++.|||+|.+.. ++.+++..+ .++...++.+.+||+++++|||+.+++|.||||+|||+..
T Consensus 161 dyrghiCivfellG~-S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 161 DYRGHICIVFELLGL-STFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred hccCceEEEEeccCh-hHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCc
Confidence 999999999999854 889999874 4889999999999999999999999999999999999821
Q ss_pred --------CCcEEEEecCcccccccCCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhH
Q 008759 465 --------NGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVS 536 (554)
Q Consensus 465 --------~g~vKL~DFGlA~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~ 536 (554)
+-.|+|+|||.|+..... ..+.+.|..|+|||++.+.+ +++++||||+||||+|+.||...|..-++.+
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e~-hs~iVsTRHYRAPEViLgLG--wS~pCDvWSiGCIL~ElytG~~LFqtHen~E 316 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHEH-HSTIVSTRHYRAPEVILGLG--WSQPCDVWSIGCILVELYTGETLFQTHENLE 316 (415)
T ss_pred cceeccCCCcceEEEecCCcceeccC-cceeeeccccCCchheeccC--cCCccCceeeeeEEEEeeccceecccCCcHH
Confidence 235899999998765433 35667899999999998775 8999999999999999999999999887666
Q ss_pred HH
Q 008759 537 AI 538 (554)
Q Consensus 537 ~i 538 (554)
.+
T Consensus 317 HL 318 (415)
T KOG0671|consen 317 HL 318 (415)
T ss_pred HH
Confidence 44
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-31 Score=258.71 Aligned_cols=214 Identities=27% Similarity=0.483 Sum_probs=176.3
Q ss_pred ccccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccC-
Q 008759 324 FKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD- 401 (554)
Q Consensus 324 ~~~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~- 401 (554)
+....+.|+...+||+|.||.||+|+. ++|+.||+|++....... ..-....+|+.+|..++|+|++.++..|..
T Consensus 12 ~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKe---GfpitalreikiL~~lkHenv~nliEic~tk 88 (376)
T KOG0669|consen 12 FCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKE---GFPITALREIKILQLLKHENVVNLIEICRTK 88 (376)
T ss_pred ceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhcccc---CCcHHHHHHHHHHHHhcchhHHHHHHHHhhc
Confidence 334456788889999999999999998 778888998765422211 112345689999999999999999987643
Q ss_pred -------CCcEEEEEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEe
Q 008759 402 -------ESKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLAD 472 (554)
Q Consensus 402 -------~~~~~LVmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~D 472 (554)
...+||||.+|+. +|.-++.. -.++..++..++++++.||.|+|...|+|||+|++|+||+.+|.+||+|
T Consensus 89 ~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklAD 167 (376)
T KOG0669|consen 89 ATPTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLAD 167 (376)
T ss_pred cCCcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeec
Confidence 2348999999987 77777764 3689999999999999999999999999999999999999999999999
Q ss_pred cCcccccccC------CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHH
Q 008759 473 FGLAKATKLN------DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKT 542 (554)
Q Consensus 473 FGlA~~~~~~------~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~ 542 (554)
||+++..... .++..+.|.+|++||.+.+.. .|+++.|||..|||+.||+||.+-|.+-...+++..|-
T Consensus 168 FGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r-~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is 242 (376)
T KOG0669|consen 168 FGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDR-EYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLIS 242 (376)
T ss_pred cccccceecccccCCCCcccceeeeecCCHHHhhccc-ccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHH
Confidence 9999764322 244556799999999998754 58999999999999999999999999887777766553
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-30 Score=256.25 Aligned_cols=201 Identities=31% Similarity=0.517 Sum_probs=166.0
Q ss_pred cceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHh-CCCCceeeeeeeccCCCcEE
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR-FEHENIVQYYGTDKDESKLY 406 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~-l~HpnIVkl~~~~~~~~~~~ 406 (554)
++.+-+..||.|.||+|++-.+ ..|+..|+|.++.... ....+++..|.....+ -+.||||++||....++-.|
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~----~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcW 139 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI----EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCW 139 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc----hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCcee
Confidence 3455567899999999999988 7899999999986433 2334667777765544 46899999999999999999
Q ss_pred EEEeecccCchHHHHh------hhcCChHHHHHHHHHHHHHHHHHHH-CCccccCCccccEEEcCCCcEEEEecCccccc
Q 008759 407 IFLELVTKGSLLNLYQ------RYHLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGSVKLADFGLAKAT 479 (554)
Q Consensus 407 LVmE~~~ggsL~~ll~------~~~l~e~~i~~i~~QIl~gL~yLHs-~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~ 479 (554)
|.||+|.- +|..+++ +..+++.-+-.|.-..+.||.||.. ..|||||+||+|||++..|.|||||||++-..
T Consensus 140 iCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqL 218 (361)
T KOG1006|consen 140 ICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQL 218 (361)
T ss_pred eeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhH
Confidence 99999976 6766654 3468888888888899999999986 58999999999999999999999999998543
Q ss_pred ccCCc-cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh
Q 008759 480 KLNDV-KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC 534 (554)
Q Consensus 480 ~~~~~-~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~ 534 (554)
..... +.-.|-..|||||.+.....+|+.++|+||||++|||+.||+.||..++.
T Consensus 219 v~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s 274 (361)
T KOG1006|consen 219 VDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS 274 (361)
T ss_pred HHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH
Confidence 33222 22346778999999987777899999999999999999999999998765
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=272.66 Aligned_cols=209 Identities=29% Similarity=0.476 Sum_probs=176.7
Q ss_pred cceeeeeeeccCCceeEEEEecC---C--CcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCC
Q 008759 329 TYWQKGDLLGRGSFGSVYEGISD---D--GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES 403 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~~---~--g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~ 403 (554)
....+.++||+|-||.||+|... . .-.||+|+.+... .....+.|.+|..++++++||||++++|.+.+ .
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~----t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~ 463 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC----TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-Q 463 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC----ChhhHHHHHHHHHHHHhCCCcchhheeeeeec-c
Confidence 45567789999999999999862 2 3467888877422 22335789999999999999999999999865 5
Q ss_pred cEEEEEeecccCchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccccc
Q 008759 404 KLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL 481 (554)
Q Consensus 404 ~~~LVmE~~~ggsL~~ll~~~--~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~ 481 (554)
..|||||++..|.|..|++.. .++......|+.||+.+|.|||++++|||||...|||+.....|||+||||++....
T Consensus 464 P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed 543 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLED 543 (974)
T ss_pred ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccc
Confidence 789999999999999999874 588888899999999999999999999999999999999999999999999998765
Q ss_pred CCcc-C--ccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHHH
Q 008759 482 NDVK-S--CRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIFIKTVA 544 (554)
Q Consensus 482 ~~~~-s--~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i~~i~~~ 544 (554)
..+. . ......|||||.++... ++.++|||.|||++||+|. |..||.+.++.+.|.++.++
T Consensus 544 ~~yYkaS~~kLPIKWmaPESINfRr--FTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnG 608 (974)
T KOG4257|consen 544 DAYYKASRGKLPIKWMAPESINFRR--FTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENG 608 (974)
T ss_pred cchhhccccccceeecCccccchhc--ccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCC
Confidence 5432 2 22456699999997654 8899999999999999998 99999999888877766554
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-30 Score=259.29 Aligned_cols=209 Identities=31% Similarity=0.497 Sum_probs=174.5
Q ss_pred ceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCC-----
Q 008759 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES----- 403 (554)
Q Consensus 330 ~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~----- 403 (554)
+.+..+.||-|.||.||.+.+ ++|+.+++|++.... +.-..-+++.+|+.+|..++|.|++..++..+...
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvf---q~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFq 130 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVF---QNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQ 130 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHH---HHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHH
Confidence 344557899999999999999 899999999886432 22334467889999999999999999988765433
Q ss_pred cEEEEEeecccCchHHHHh-hhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC
Q 008759 404 KLYIFLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN 482 (554)
Q Consensus 404 ~~~LVmE~~~ggsL~~ll~-~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~ 482 (554)
.+|.++|+|.. +|..++- ...++...++-++.||++||+|||+.||.||||||.|+|++.|..+||||||+++.....
T Consensus 131 EiYV~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 131 ELYVLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQR 209 (449)
T ss_pred HHHHHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchh
Confidence 46788888876 5666554 356888999999999999999999999999999999999999999999999999876544
Q ss_pred C---ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHH
Q 008759 483 D---VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTV 543 (554)
Q Consensus 483 ~---~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~ 543 (554)
. .+....|.+|+|||++++.. .|+.++||||+|||+.|||..+..|....+.+++-.|..
T Consensus 210 ~~~hMTqEVVTQYYRAPEiLMGaR-hYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItd 272 (449)
T KOG0664|consen 210 DRLNMTHEVVTQYYRAPELLMGAR-RYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIID 272 (449)
T ss_pred hhhhhHHHHHHHHhccHHHhhcch-hhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHH
Confidence 3 23345789999999998764 689999999999999999999999999999888776653
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=271.84 Aligned_cols=210 Identities=27% Similarity=0.439 Sum_probs=178.3
Q ss_pred ccccceeeeeeeccCCceeEEEEec--CCC--cEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccC
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS--DDG--FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD 401 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~--~~g--~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~ 401 (554)
...+...+.++||+|.||.|++|.| ..| ..||||++..... ......|.+|+.+|.+|+|+|+++|||...+
T Consensus 107 Ipee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l----~~~mddflrEas~M~~L~H~hliRLyGvVl~ 182 (1039)
T KOG0199|consen 107 IPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSL----NAIMDDFLREASHMLKLQHPHLIRLYGVVLD 182 (1039)
T ss_pred ccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCcc----chhHHHHHHHHHHHHhccCcceeEEeeeecc
Confidence 3455677889999999999999988 234 4679999875333 2256789999999999999999999999876
Q ss_pred CCcEEEEEeecccCchHHHHhh---hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccc
Q 008759 402 ESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA 478 (554)
Q Consensus 402 ~~~~~LVmE~~~ggsL~~ll~~---~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~ 478 (554)
..+.||||++..|+|.+.|.+ ..|.......|+.||+.|+.||..+++|||||-..|+|+.....|||+||||.+.
T Consensus 183 -qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRa 261 (1039)
T KOG0199|consen 183 -QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRA 261 (1039)
T ss_pred -chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceec
Confidence 678899999999999998876 3477788899999999999999999999999999999999999999999999998
Q ss_pred cccCCccC-----ccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHH
Q 008759 479 TKLNDVKS-----CRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIFIKT 542 (554)
Q Consensus 479 ~~~~~~~s-----~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i~~i~ 542 (554)
...+.-.. ......|+|||.+.... ++.++|+|+|||++|||+| |+.||.+....+.+.+|.
T Consensus 262 Lg~ned~Yvm~p~rkvPfAWCaPEsLrh~k--FShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD 329 (1039)
T KOG0199|consen 262 LGENEDMYVMAPQRKVPFAWCAPESLRHRK--FSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID 329 (1039)
T ss_pred cCCCCcceEecCCCcCcccccCHhHhcccc--ccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc
Confidence 76554222 22456799999997665 8899999999999999999 999999988877776665
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=267.33 Aligned_cols=201 Identities=28% Similarity=0.501 Sum_probs=175.7
Q ss_pred ccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEE
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~ 406 (554)
..+.....+||-|.||.||.|.| +-.-.||||.++- ....+..|+.|..+++.++|||+|+|+|+|..+-.+|
T Consensus 266 RtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE------DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFY 339 (1157)
T KOG4278|consen 266 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE------DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFY 339 (1157)
T ss_pred chheeeeeccCCCcccceeeeeeeccceeeehhhhhh------cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeE
Confidence 34566778999999999999998 5567899998762 3345678999999999999999999999999999999
Q ss_pred EEEeecccCchHHHHhhhc---CChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC
Q 008759 407 IFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND 483 (554)
Q Consensus 407 LVmE~~~ggsL~~ll~~~~---l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~ 483 (554)
||+|||..|+|.+||+... ++.-.+.+++.||..|+.||..+++|||||...|.|+.++..|||+||||++......
T Consensus 340 IiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT 419 (1157)
T KOG4278|consen 340 IITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT 419 (1157)
T ss_pred EEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCc
Confidence 9999999999999998754 5556677889999999999999999999999999999999999999999999988777
Q ss_pred ccCccC---CCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhH
Q 008759 484 VKSCRG---TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVS 536 (554)
Q Consensus 484 ~~s~~G---T~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~ 536 (554)
++...| ...|.|||.+... .++.++|||+|||+|||+.| |--||.+.+.-+
T Consensus 420 YTAHAGAKFPIKWTAPEsLAyN--tFSiKSDVWAFGVLLWEIATYGMsPYPGidlSq 474 (1157)
T KOG4278|consen 420 YTAHAGAKFPIKWTAPESLAYN--TFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 474 (1157)
T ss_pred eecccCccCcccccCccccccc--ccccchhhHHHHHHHHHHHhcCCCCCCCccHHH
Confidence 666655 4559999998543 48899999999999999998 999999987544
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=257.70 Aligned_cols=202 Identities=30% Similarity=0.459 Sum_probs=164.1
Q ss_pred cccceeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHH--HHhCCCCceeeeeeeccCC--
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL--LSRFEHENIVQYYGTDKDE-- 402 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~i--L~~l~HpnIVkl~~~~~~~-- 402 (554)
+.+..++.+.||+|.||.||+|.++ |..||||++...+... ..+|.+| -..++|+||+.+++....+
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE~S--------WfrEtEIYqTvmLRHENILgFIaaD~~~~g 279 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDERS--------WFRETEIYQTVMLRHENILGFIAADNKDNG 279 (513)
T ss_pred hhheeEEEEEecCccccceeecccc-CCceEEEEecccchhh--------hhhHHHHHHHHHhccchhhhhhhccccCCC
Confidence 3457889999999999999999987 7799999998543322 3344444 4567999999999876543
Q ss_pred --CcEEEEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHH-----C---CccccCCccccEEEcCCCcEEEEe
Q 008759 403 --SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD-----Q---DVVHRDIKCANILVDANGSVKLAD 472 (554)
Q Consensus 403 --~~~~LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs-----~---gIIHrDIKPeNILld~~g~vKL~D 472 (554)
.++|||++|.+.|+|++||++..++.....+++..++.||+|||. + .|.|||||..||||..+|.+.|+|
T Consensus 280 s~TQLwLvTdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD 359 (513)
T KOG2052|consen 280 SWTQLWLVTDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 359 (513)
T ss_pred ceEEEEEeeecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence 379999999999999999999999999999999999999999995 2 399999999999999999999999
Q ss_pred cCcccccccC------CccCccCCCcccChhhhcccCCC--C-C-chhhHHHHHHHHHHHHcC----------CCCCCCC
Q 008759 473 FGLAKATKLN------DVKSCRGTAFWMAPEVINNKNKG--Y-G-LPADIWSLGCTVLEMLTS----------QIPYAPM 532 (554)
Q Consensus 473 FGlA~~~~~~------~~~s~~GT~~Y~APEvl~~~~~~--~-s-~ksDIwSLGvllyeLLTG----------~~PF~~~ 532 (554)
+|||...... .....+||-.|||||++....+. + + ..+||||||+++||+... ++||.++
T Consensus 360 LGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~ 439 (513)
T KOG2052|consen 360 LGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV 439 (513)
T ss_pred ceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC
Confidence 9999764332 23455799999999999765422 1 1 358999999999999742 6799876
Q ss_pred ChhHH
Q 008759 533 ECVSA 537 (554)
Q Consensus 533 e~~~~ 537 (554)
-+.+.
T Consensus 440 Vp~DP 444 (513)
T KOG2052|consen 440 VPSDP 444 (513)
T ss_pred CCCCC
Confidence 54443
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.2e-29 Score=260.12 Aligned_cols=192 Identities=29% Similarity=0.440 Sum_probs=161.0
Q ss_pred cceeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHh--CCCCceeeeeeeccCCC---
Q 008759 329 TYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR--FEHENIVQYYGTDKDES--- 403 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~--l~HpnIVkl~~~~~~~~--- 403 (554)
...++.++||+|.||.||+|...+ +.||||++.. +..+.++.|.+|.+. ++|+||+++++.-...+
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~~-~~VAVKifp~--------~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~ 280 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLDN-RLVAVKIFPE--------QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADR 280 (534)
T ss_pred CchhhHHHhhcCccceeehhhccC-ceeEEEecCH--------HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccc
Confidence 345677899999999999998864 8999999873 333556677666654 57999999999866555
Q ss_pred -cEEEEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHH---------CCccccCCccccEEEcCCCcEEEEec
Q 008759 404 -KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD---------QDVVHRDIKCANILVDANGSVKLADF 473 (554)
Q Consensus 404 -~~~LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs---------~gIIHrDIKPeNILld~~g~vKL~DF 473 (554)
.++||++|...|+|.+||+.+.+++....+++..|++||+|||+ ..|+|||||..||||..|++..|+||
T Consensus 281 ~eywLVt~fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 281 MEYWLVTEFHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred cceeEEeeeccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 89999999999999999999999999999999999999999996 24999999999999999999999999
Q ss_pred CcccccccC----CccCccCCCcccChhhhcccCCCCC----chhhHHHHHHHHHHHHcCCCCC
Q 008759 474 GLAKATKLN----DVKSCRGTAFWMAPEVINNKNKGYG----LPADIWSLGCTVLEMLTSQIPY 529 (554)
Q Consensus 474 GlA~~~~~~----~~~s~~GT~~Y~APEvl~~~~~~~s----~ksDIwSLGvllyeLLTG~~PF 529 (554)
|||...... .....+||..|||||++.+...-.+ .+.||||+|.+||||++...-+
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~ 424 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDA 424 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccc
Confidence 999875433 2334679999999999977542221 3589999999999999876655
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=273.62 Aligned_cols=210 Identities=26% Similarity=0.442 Sum_probs=180.9
Q ss_pred cceeeeeeeccCCceeEEEEec----CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCc
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~----~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~ 404 (554)
....|.++||.|.||.||+|+. +....||||.++.. ........|+.|..|+-++.||||++|.|+......
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G----ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~P 704 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG----YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKP 704 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccC----ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCce
Confidence 3568899999999999999987 33578999998752 223345679999999999999999999999999999
Q ss_pred EEEEEeecccCchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC
Q 008759 405 LYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN 482 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~~--~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~ 482 (554)
+.||+|||++|+|..+|++. .|...++..+++.|+.|++||-+.|+|||||...||||+.+-.+|++||||++.....
T Consensus 705 vMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd 784 (996)
T KOG0196|consen 705 VMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 784 (996)
T ss_pred eEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccC
Confidence 99999999999999999864 5888899999999999999999999999999999999999999999999999876544
Q ss_pred Cc---cCcc--CCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHHH
Q 008759 483 DV---KSCR--GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIFIKTVA 544 (554)
Q Consensus 483 ~~---~s~~--GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i~~i~~~ 544 (554)
.. ++.. -...|.|||.+.... ++.++||||+|++|||.++ |..||.+|.+.+.|..|..+
T Consensus 785 ~~~~ytt~GGKIPiRWTAPEAIa~RK--FTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~g 850 (996)
T KOG0196|consen 785 PEAAYTTLGGKIPIRWTAPEAIAYRK--FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQG 850 (996)
T ss_pred CCccccccCCccceeecChhHhhhcc--cCchhhccccceEEEEecccCCCcccccchHHHHHHHHhc
Confidence 32 1221 246799999997654 8889999999999999887 99999999998887776543
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-28 Score=286.64 Aligned_cols=188 Identities=24% Similarity=0.413 Sum_probs=158.4
Q ss_pred ccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEE
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~ 406 (554)
...|...+.||+|+||.||+|.+ .++..||+|.+..... ....|+.++++++|||||++++++.+....|
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~ 759 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS---------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAY 759 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc---------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCE
Confidence 34566778999999999999998 6899999998863221 1124578899999999999999999999999
Q ss_pred EEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHH---HCCccccCCccccEEEcCCCcEEEEecCcccccccCC
Q 008759 407 IFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLH---DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND 483 (554)
Q Consensus 407 LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLH---s~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~ 483 (554)
+||||+.+|+|.++++ .+++..+..++.||+.||.||| +.+|+||||||+|||++.++..++. ||.......
T Consensus 760 lv~Ey~~~g~L~~~l~--~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~-- 834 (968)
T PLN00113 760 LIHEYIEGKNLSEVLR--NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT-- 834 (968)
T ss_pred EEEeCCCCCcHHHHHh--cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc--
Confidence 9999999999999986 4788899999999999999999 6799999999999999998888775 665543321
Q ss_pred ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008759 484 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP 531 (554)
Q Consensus 484 ~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~ 531 (554)
.....+|+.|||||++.+. .++.++|||||||++|||+||+.||..
T Consensus 835 ~~~~~~t~~y~aPE~~~~~--~~~~~sDv~S~Gvvl~el~tg~~p~~~ 880 (968)
T PLN00113 835 DTKCFISSAYVAPETRETK--DITEKSDIYGFGLILIELLTGKSPADA 880 (968)
T ss_pred CCCccccccccCcccccCC--CCCcccchhhHHHHHHHHHhCCCCCCc
Confidence 1234688999999998654 488999999999999999999999853
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=228.37 Aligned_cols=193 Identities=38% Similarity=0.672 Sum_probs=165.3
Q ss_pred CceeEEEEecC-CCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEEEeecccCchHH
Q 008759 341 SFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN 419 (554)
Q Consensus 341 sfG~VY~a~~~-~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LVmE~~~ggsL~~ 419 (554)
+||.||+|.+. +++.+++|++........ ...+.+|+.+++.++|+||+++++.+......+++|||+.+++|..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~ 76 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK----RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFD 76 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH----HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHH
Confidence 58999999994 589999999875322111 4678899999999999999999999999899999999999999999
Q ss_pred HHhhhc-CChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC-CccCccCCCcccChh
Q 008759 420 LYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-DVKSCRGTAFWMAPE 497 (554)
Q Consensus 420 ll~~~~-l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~-~~~s~~GT~~Y~APE 497 (554)
++.... ++...+..++.+++.+|.+||+.+|+|+||+|.||+++.++.++|+|||++...... ......++..|++||
T Consensus 77 ~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE 156 (244)
T smart00220 77 LLKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPE 156 (244)
T ss_pred HHHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHH
Confidence 987654 889999999999999999999999999999999999999999999999998765543 344556889999999
Q ss_pred hhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHH
Q 008759 498 VINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIF 539 (554)
Q Consensus 498 vl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~ 539 (554)
.+... .++.++|+|+||+++|+|++|..||......+.++
T Consensus 157 ~~~~~--~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~ 196 (244)
T smart00220 157 VLLGK--GYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELF 196 (244)
T ss_pred HHccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence 98643 37789999999999999999999998744444333
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-28 Score=238.75 Aligned_cols=208 Identities=23% Similarity=0.442 Sum_probs=177.2
Q ss_pred ccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCC-CCceeeeeeeccCC--C
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDE--S 403 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIVkl~~~~~~~--~ 403 (554)
.++|++.+++|+|.|+.||.|.. .++..+++|+++.. ..+.+.+|+.||+.+. ||||+++++...+. .
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV--------kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sk 108 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV--------KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESK 108 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH--------HHHHHHHHHHHHHhccCCCCeeehhhhhcCcccc
Confidence 46899999999999999999998 77889999988742 2356889999999997 99999999987664 4
Q ss_pred cEEEEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCC-CcEEEEecCcccccccC
Q 008759 404 KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAKATKLN 482 (554)
Q Consensus 404 ~~~LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~-g~vKL~DFGlA~~~~~~ 482 (554)
..-||+||+.+.+...++. .++...++.++.|++.||.|+|+.||+|||+||.|++|+.. ..++|+|+|||.++..+
T Consensus 109 tpaLiFE~v~n~Dfk~ly~--tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~ 186 (338)
T KOG0668|consen 109 TPSLIFEYVNNTDFKQLYP--TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
T ss_pred CchhHhhhhccccHHHHhh--hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence 6789999999988877765 47788899999999999999999999999999999999865 57999999999987665
Q ss_pred Ccc-CccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCC-CChhHHHHHHHHHHH
Q 008759 483 DVK-SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP-MECVSAIFIKTVAVT 546 (554)
Q Consensus 483 ~~~-s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~-~e~~~~i~~i~~~~~ 546 (554)
... -...+..|--||++..-. .|+...|+|||||++..|+..+-||.. .++.+++.+|..-..
T Consensus 187 ~eYnVRVASRyfKGPELLVdy~-~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLG 251 (338)
T KOG0668|consen 187 KEYNVRVASRYFKGPELLVDYQ-MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLG 251 (338)
T ss_pred ceeeeeeehhhcCCchheeech-hccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhC
Confidence 433 345678899999987643 589999999999999999999888875 578888888876443
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=264.89 Aligned_cols=195 Identities=24% Similarity=0.316 Sum_probs=140.8
Q ss_pred cccceeeeeeeccCCceeEEEEec-CC----CcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeee---
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGIS-DD----GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGT--- 398 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~-~~----g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~--- 398 (554)
..++|++.+.||+|+||.||+|.+ .+ +..||+|++..... . +....+ .+....+.+++.++..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~----~---e~~~~e--~l~~~~~~~~~~~~~~~~~ 200 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA----V---EIWMNE--RVRRACPNSCADFVYGFLE 200 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch----h---HHHHHH--HHHhhchhhHHHHHHhhhc
Confidence 356899999999999999999998 55 78999998753111 0 011111 1111122222222221
Q ss_pred ---ccCCCcEEEEEeecccCchHHHHhhhcC---------------------ChHHHHHHHHHHHHHHHHHHHCCccccC
Q 008759 399 ---DKDESKLYIFLELVTKGSLLNLYQRYHL---------------------RDSQVSAYTRQILLGLKYLHDQDVVHRD 454 (554)
Q Consensus 399 ---~~~~~~~~LVmE~~~ggsL~~ll~~~~l---------------------~e~~i~~i~~QIl~gL~yLHs~gIIHrD 454 (554)
......+++||||+.+++|.++++...+ ....+..++.||+.||.|||+++|+|||
T Consensus 201 ~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRD 280 (566)
T PLN03225 201 PVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRD 280 (566)
T ss_pred ccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCc
Confidence 2456689999999999999998865321 1234567999999999999999999999
Q ss_pred CccccEEEcC-CCcEEEEecCcccccccC---CccCccCCCcccChhhhcccCC--------------------CCCchh
Q 008759 455 IKCANILVDA-NGSVKLADFGLAKATKLN---DVKSCRGTAFWMAPEVINNKNK--------------------GYGLPA 510 (554)
Q Consensus 455 IKPeNILld~-~g~vKL~DFGlA~~~~~~---~~~s~~GT~~Y~APEvl~~~~~--------------------~~s~ks 510 (554)
|||+|||++. ++.+||+|||+++..... ......+|+.|||||.+..... .++.++
T Consensus 281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~ 360 (566)
T PLN03225 281 VKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 360 (566)
T ss_pred CCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence 9999999985 589999999999754322 2345678999999997643221 134467
Q ss_pred hHHHHHHHHHHHHcCCCCCC
Q 008759 511 DIWSLGCTVLEMLTSQIPYA 530 (554)
Q Consensus 511 DIwSLGvllyeLLTG~~PF~ 530 (554)
|||||||++|||+++..|+.
T Consensus 361 DVwSlGviL~el~~~~~~~~ 380 (566)
T PLN03225 361 DIYSAGLIFLQMAFPNLRSD 380 (566)
T ss_pred ccHHHHHHHHHHHhCcCCCc
Confidence 99999999999999877654
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-28 Score=246.32 Aligned_cols=210 Identities=25% Similarity=0.395 Sum_probs=181.0
Q ss_pred ccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCC---
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES--- 403 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~--- 403 (554)
..+|.-+..+|.|.- .|..+.+ -.++.+|+|++.... ......++..+|+.++..++|+||++++.+|.-..
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf---~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~ 91 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPF---QNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLE 91 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCcc---ccCccchhhhhhhhhhhhhcccceeeeeeccCccccHH
Confidence 457888899999998 6777777 678999999886542 22444567789999999999999999999986543
Q ss_pred ---cEEEEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccc
Q 008759 404 ---KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK 480 (554)
Q Consensus 404 ---~~~LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~ 480 (554)
.+|+|||+|.. +|...+. ..+.-..++.++.|++.|++|||+.||+||||||+||++..++.+||.|||+|+...
T Consensus 92 ~~~e~y~v~e~m~~-nl~~vi~-~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~ 169 (369)
T KOG0665|consen 92 EFQEVYLVMELMDA-NLCQVIL-MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTED 169 (369)
T ss_pred HHHhHHHHHHhhhh-HHHHHHH-HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccC
Confidence 58999999987 7777666 567888999999999999999999999999999999999999999999999998766
Q ss_pred cC-CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHHHH
Q 008759 481 LN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTVAV 545 (554)
Q Consensus 481 ~~-~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~~~ 545 (554)
.. ..+....|..|.|||++.+.+ |...+||||+||++.||++|...|.+.+-.+++.++....
T Consensus 170 ~~~~mtpyVvtRyyrapevil~~~--~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~l 233 (369)
T KOG0665|consen 170 TDFMMTPYVVTRYYRAPEVILGMG--YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQL 233 (369)
T ss_pred cccccCchhheeeccCchheeccC--CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHh
Confidence 65 556678999999999997665 8889999999999999999999999999999998887654
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.6e-27 Score=256.39 Aligned_cols=207 Identities=25% Similarity=0.352 Sum_probs=151.4
Q ss_pred ccceeeeeeeccCCceeEEEEec-----------------CCCcEEEEEEEecccccchhH---------HHHHHHHHHH
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS-----------------DDGFFFAVKEVSLLDQGSQAK---------QSISQLEQEI 381 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~-----------------~~g~~vAvK~v~~~~~~~~~~---------~~~~~~~~Ei 381 (554)
.++|.+.++||+|+||+||+|.+ ..++.||+|.+.......... ........|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 56899999999999999999964 345689999986432211100 0112233466
Q ss_pred HHHHhCCCCce-----eeeeeeccC--------CCcEEEEEeecccCchHHHHhhh------------------------
Q 008759 382 ALLSRFEHENI-----VQYYGTDKD--------ESKLYIFLELVTKGSLLNLYQRY------------------------ 424 (554)
Q Consensus 382 ~iL~~l~HpnI-----Vkl~~~~~~--------~~~~~LVmE~~~ggsL~~ll~~~------------------------ 424 (554)
.++.+++|.++ ++++++|.. ....||||||+.+++|.++++..
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77777776554 566666542 35689999999999999887631
Q ss_pred -cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC-cc--CccCCCcccChhhhc
Q 008759 425 -HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VK--SCRGTAFWMAPEVIN 500 (554)
Q Consensus 425 -~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~-~~--s~~GT~~Y~APEvl~ 500 (554)
.+.+..++.++.|++.+|.|||+++|+||||||+|||++.++.+||+|||++....... .. ...+|+.|+|||++.
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~ 383 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELV 383 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhc
Confidence 12445678899999999999999999999999999999999999999999986543221 11 123588999999985
Q ss_pred ccCC------------------CCC--chhhHHHHHHHHHHHHcCCC-CCCCCCh
Q 008759 501 NKNK------------------GYG--LPADIWSLGCTVLEMLTSQI-PYAPMEC 534 (554)
Q Consensus 501 ~~~~------------------~~s--~ksDIwSLGvllyeLLTG~~-PF~~~e~ 534 (554)
.... .|+ .+.||||+||++|+|++|.+ ||.....
T Consensus 384 ~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~ 438 (507)
T PLN03224 384 MPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRL 438 (507)
T ss_pred CCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhh
Confidence 3211 011 24799999999999999986 8865433
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=261.23 Aligned_cols=210 Identities=28% Similarity=0.494 Sum_probs=174.1
Q ss_pred ccccccceeeeeeeccCCceeEEEEecC--------CCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCC-CCceee
Q 008759 324 FKRIITYWQKGDLLGRGSFGSVYEGISD--------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQ 394 (554)
Q Consensus 324 ~~~~~~~y~i~~~LG~GsfG~VY~a~~~--------~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIVk 394 (554)
+....++.++.+.||+|.||.|++|... ....||+|..+.... ....+.+..|+.+++.+. |+||+.
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~----~~~~~~~~~El~~m~~~g~H~niv~ 366 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENAS----SSEKKDLMSELNVLKELGKHPNIVN 366 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccC----cHHHHHHHHHHHHHHHhcCCcchhh
Confidence 3334445577789999999999999741 146788887764222 244577899999999984 999999
Q ss_pred eeeeccCCCcEEEEEeecccCchHHHHhhhc-----------------CChHHHHHHHHHHHHHHHHHHHCCccccCCcc
Q 008759 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYH-----------------LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKC 457 (554)
Q Consensus 395 l~~~~~~~~~~~LVmE~~~ggsL~~ll~~~~-----------------l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKP 457 (554)
++|++...+.+++|+||+..|+|..+++... +...+...++.||+.|++||+++.+|||||-.
T Consensus 367 llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAa 446 (609)
T KOG0200|consen 367 LLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAA 446 (609)
T ss_pred heeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhh
Confidence 9999999999999999999999999998777 88899999999999999999999999999999
Q ss_pred ccEEEcCCCcEEEEecCcccccccCCccC---ccC--CCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCC
Q 008759 458 ANILVDANGSVKLADFGLAKATKLNDVKS---CRG--TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAP 531 (554)
Q Consensus 458 eNILld~~g~vKL~DFGlA~~~~~~~~~s---~~G--T~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~ 531 (554)
.|||++.+..+||+|||+++......... ..+ ...|||||.+... .|+.++||||||+++|||+| |..||.+
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~--~ft~kSDVWSfGI~L~EifsLG~~PYp~ 524 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDR--VFTSKSDVWSFGILLWEIFTLGGTPYPG 524 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccC--cccccchhhHHHHHHHHHhhCCCCCCCC
Confidence 99999999999999999998654433222 222 3449999999763 48999999999999999999 9999998
Q ss_pred CChhHHHH
Q 008759 532 MECVSAIF 539 (554)
Q Consensus 532 ~e~~~~i~ 539 (554)
....+.++
T Consensus 525 ~~~~~~l~ 532 (609)
T KOG0200|consen 525 IPPTEELL 532 (609)
T ss_pred CCcHHHHH
Confidence 66444443
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.3e-27 Score=257.79 Aligned_cols=198 Identities=30% Similarity=0.522 Sum_probs=166.3
Q ss_pred ceeeeeeeccCCceeEEEEec-CCCc----EEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCc
Q 008759 330 YWQKGDLLGRGSFGSVYEGIS-DDGF----FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (554)
Q Consensus 330 ~y~i~~~LG~GsfG~VY~a~~-~~g~----~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~ 404 (554)
..+..++||+|+||+||+|.+ ..|+ .||+|++.. ....+....+..|+.+|..+.|||+++|++++....
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~----~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~- 771 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIE----FTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST- 771 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeec----cCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-
Confidence 456678999999999999998 4454 556666543 333444567889999999999999999999998766
Q ss_pred EEEEEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC
Q 008759 405 LYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN 482 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~ 482 (554)
+.||++|+..|+|.++++. ..+.....+.|+.||++||.|||.+.++||||-..|+||..-.++||.|||+++.....
T Consensus 772 ~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 772 LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 7899999999999999875 46888899999999999999999999999999999999999999999999999876543
Q ss_pred Cc--c--CccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCh
Q 008759 483 DV--K--SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMEC 534 (554)
Q Consensus 483 ~~--~--s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~ 534 (554)
.. . .....+.|||-|.+... .|+.++|||||||++||++| |.-||.++..
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~~--~~thqSDVWsfGVtiWElmTFGa~Py~gi~~ 906 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRIR--KYTHQSDVWSFGVTIWELMTFGAKPYDGIPA 906 (1177)
T ss_pred cccccccccccCcHHHHHHHhhcc--CCCchhhhhhhhhhHHHHHhcCCCccCCCCH
Confidence 22 1 22245669999998654 48999999999999999999 9999998754
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-25 Score=207.29 Aligned_cols=181 Identities=42% Similarity=0.689 Sum_probs=158.0
Q ss_pred eccCCceeEEEEecC-CCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEEEeecccC
Q 008759 337 LGRGSFGSVYEGISD-DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKG 415 (554)
Q Consensus 337 LG~GsfG~VY~a~~~-~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LVmE~~~gg 415 (554)
||+|.+|.||++... +++.+++|++....... ....+.+|+.+++.+.|++|+++++++......+++||++.++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~ 76 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS----LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGG 76 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh----HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCC
Confidence 689999999999984 58999999987533211 3467889999999999999999999999999999999999999
Q ss_pred chHHHHhhh--cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcC-CCcEEEEecCcccccccCC--ccCccCC
Q 008759 416 SLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA-NGSVKLADFGLAKATKLND--VKSCRGT 490 (554)
Q Consensus 416 sL~~ll~~~--~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~-~g~vKL~DFGlA~~~~~~~--~~s~~GT 490 (554)
+|..++... .++...+..++.+++.+|.+||++|++|+||+|.||+++. ++.++|+|||.+....... .....+.
T Consensus 77 ~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~ 156 (215)
T cd00180 77 SLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGT 156 (215)
T ss_pred cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCC
Confidence 999999875 6899999999999999999999999999999999999999 8999999999987665443 3445588
Q ss_pred CcccChhhhcccCCCCCchhhHHHHHHHHHHH
Q 008759 491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEM 522 (554)
Q Consensus 491 ~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeL 522 (554)
..|++||.+... ..++.+.|+|+||+++++|
T Consensus 157 ~~~~~pe~~~~~-~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 157 PAYMAPEVLLGK-GYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred CCccChhHhccc-CCCCchhhhHHHHHHHHHH
Confidence 889999998654 2467899999999999998
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-27 Score=235.60 Aligned_cols=200 Identities=22% Similarity=0.365 Sum_probs=165.9
Q ss_pred cccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhC-CCCceeeeee-eccCCC
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYG-TDKDES 403 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIVkl~~-~~~~~~ 403 (554)
+.+.|.+.+.||+|.||.+.+|.+ .++..+++|.+.. .....+.|.+|...--.| .|.||+.-|+ .|+..+
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~------p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d 95 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPR------PQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSD 95 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCc------chhhHHHHHHHhccceeeccchhhhHHHHHHhhcCc
Confidence 457899999999999999999999 6788999998863 233456788888766555 4899998876 578888
Q ss_pred cEEEEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcC--CCcEEEEecCccccccc
Q 008759 404 KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA--NGSVKLADFGLAKATKL 481 (554)
Q Consensus 404 ~~~LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~--~g~vKL~DFGlA~~~~~ 481 (554)
.+++++||++.|+|..-+...++.+...+.++.|+++||.|+|++++||||||.+||||.. ...|||||||+.+....
T Consensus 96 ~YvF~qE~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 96 AYVFVQEFAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred eEEEeeccCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 9999999999999999888889999999999999999999999999999999999999943 34899999998765432
Q ss_pred CCccCccCCCcccChhhhcccCCC---CCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008759 482 NDVKSCRGTAFWMAPEVINNKNKG---YGLPADIWSLGCTVLEMLTSQIPYAPME 533 (554)
Q Consensus 482 ~~~~s~~GT~~Y~APEvl~~~~~~---~s~ksDIwSLGvllyeLLTG~~PF~~~e 533 (554)
.......+..|.+||++...... .++.+|+|.||+++|.+|||++||....
T Consensus 176 -tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~ 229 (378)
T KOG1345|consen 176 -TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS 229 (378)
T ss_pred -eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhh
Confidence 23333456779999998654322 4667999999999999999999998543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-27 Score=258.56 Aligned_cols=212 Identities=39% Similarity=0.615 Sum_probs=186.6
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCc
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~ 404 (554)
....+|++...+|.|+||.||++++ .++...|+|++++.. ...+.-+++|+-+++..+|+|||.|++.+...+.
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep-----~dd~~~iqqei~~~~dc~h~nivay~gsylr~dk 86 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP-----GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDK 86 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccC-----CccccccccceeeeecCCCcChHHHHhhhhhhcC
Confidence 3456899999999999999999999 789999999998633 2334567899999999999999999999999999
Q ss_pred EEEEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccccc--
Q 008759 405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL-- 481 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~-- 481 (554)
+++.||||.+|+|.++++- ..+.+.++...+++.++||+|||++|-+|||||-.|||++..|.+|+.|||.+-.+..
T Consensus 87 lwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati 166 (829)
T KOG0576|consen 87 LWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI 166 (829)
T ss_pred cEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhh
Confidence 9999999999999998875 5699999999999999999999999999999999999999999999999998755432
Q ss_pred CCccCccCCCcccChhhhc-ccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHH
Q 008759 482 NDVKSCRGTAFWMAPEVIN-NKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKT 542 (554)
Q Consensus 482 ~~~~s~~GT~~Y~APEvl~-~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~ 542 (554)
...++..||++|||||+-. ....+|+..+|||++|++..|+-.-+.|-....++..+|.-.
T Consensus 167 ~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmT 228 (829)
T KOG0576|consen 167 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMT 228 (829)
T ss_pred hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhh
Confidence 3456788999999999852 334469999999999999999999999999988888877643
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-26 Score=241.57 Aligned_cols=213 Identities=27% Similarity=0.408 Sum_probs=175.6
Q ss_pred ccccccceeeeeeeccCCceeEEEEec-C---CCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCC-CCceeeeeee
Q 008759 324 FKRIITYWQKGDLLGRGSFGSVYEGIS-D---DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGT 398 (554)
Q Consensus 324 ~~~~~~~y~i~~~LG~GsfG~VY~a~~-~---~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIVkl~~~ 398 (554)
++.+.+.|.++++||+|+|++||++.+ . ..++||+|.+... ....++.+|+++|..+. +.||+++.++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t-------s~p~ri~~El~~L~~~gG~~ni~~~~~~ 103 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT-------SSPSRILNELEMLYRLGGSDNIIKLNGC 103 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc-------cCchHHHHHHHHHHHhccchhhhcchhh
Confidence 445677899999999999999999988 3 5789999988642 22356889999999885 9999999999
Q ss_pred ccCCCcEEEEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcC-CCcEEEEecCccc
Q 008759 399 DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA-NGSVKLADFGLAK 477 (554)
Q Consensus 399 ~~~~~~~~LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~-~g~vKL~DFGlA~ 477 (554)
+..+++..+||||++.....+++.. ++...++.|++.++.||.++|.+|||||||||.|||++. .+.-.|+|||+|.
T Consensus 104 ~rnnd~v~ivlp~~~H~~f~~l~~~--l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 104 FRNNDQVAIVLPYFEHDRFRDLYRS--LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred hccCCeeEEEecccCccCHHHHHhc--CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHH
Confidence 9999999999999999999988865 456789999999999999999999999999999999975 4678999999996
Q ss_pred ccccC---------------C-------------------------------ccCccCCCcccChhhhcccCCCCCchhh
Q 008759 478 ATKLN---------------D-------------------------------VKSCRGTAFWMAPEVINNKNKGYGLPAD 511 (554)
Q Consensus 478 ~~~~~---------------~-------------------------------~~s~~GT~~Y~APEvl~~~~~~~s~ksD 511 (554)
..... . .....||++|+|||++...+ ..+.++|
T Consensus 182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~-~QttaiD 260 (418)
T KOG1167|consen 182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCP-RQTTAID 260 (418)
T ss_pred HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhcc-CcCCccc
Confidence 21000 0 00124999999999997655 4688999
Q ss_pred HHHHHHHHHHHHcCCCCCCC-CChhHHHHHHHHHHH
Q 008759 512 IWSLGCTVLEMLTSQIPYAP-MECVSAIFIKTVAVT 546 (554)
Q Consensus 512 IwSLGvllyeLLTG~~PF~~-~e~~~~i~~i~~~~~ 546 (554)
|||.|+|++.+++++.||.. .+....+.-|...+.
T Consensus 261 iws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG 296 (418)
T KOG1167|consen 261 IWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFG 296 (418)
T ss_pred eeeccceeehhhccccccccCccccchHHHHHHHhC
Confidence 99999999999999999975 455666666555443
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.2e-26 Score=252.68 Aligned_cols=193 Identities=35% Similarity=0.560 Sum_probs=158.0
Q ss_pred ceeeeeeeccCCcee-EEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhC-CCCceeeeeeeccCCCcEEE
Q 008759 330 YWQKGDLLGRGSFGS-VYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESKLYI 407 (554)
Q Consensus 330 ~y~i~~~LG~GsfG~-VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIVkl~~~~~~~~~~~L 407 (554)
.|.-.+.+|.|+-|+ ||+|... |+.||||.+. .+......+|+.+|+.. +|||||++|+.-.+...+||
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll--------~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YI 580 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVYE-GREVAVKRLL--------EEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYI 580 (903)
T ss_pred eeccHHHcccCCCCcEEEEEeeC-CceehHHHHh--------hHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEE
Confidence 344556799999886 7899875 6799999765 33445677999999988 59999999999999999999
Q ss_pred EEeecccCchHHHHhhh--c---CChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcC---CC--cEEEEecCccc
Q 008759 408 FLELVTKGSLLNLYQRY--H---LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA---NG--SVKLADFGLAK 477 (554)
Q Consensus 408 VmE~~~ggsL~~ll~~~--~---l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~---~g--~vKL~DFGlA~ 477 (554)
..|+|.. +|.+++... . ........++.|++.||++||+.+||||||||.||||.. ++ .++|+|||+++
T Consensus 581 alELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsK 659 (903)
T KOG1027|consen 581 ALELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSK 659 (903)
T ss_pred EehHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccc
Confidence 9999976 899998763 1 111345678999999999999999999999999999976 34 68999999998
Q ss_pred ccccCC-----ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCh
Q 008759 478 ATKLND-----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMEC 534 (554)
Q Consensus 478 ~~~~~~-----~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~ 534 (554)
....+. .....||-+|+|||++.... -..++|||||||++|+.++ |..||...-.
T Consensus 660 kl~~~~sS~~r~s~~sGt~GW~APE~L~~~~--~~~avDiFslGCvfyYvltgG~HpFGd~~~ 720 (903)
T KOG1027|consen 660 KLAGGKSSFSRLSGGSGTSGWQAPEQLREDR--KTQAVDIFSLGCVFYYVLTGGSHPFGDSLE 720 (903)
T ss_pred ccCCCcchhhcccCCCCcccccCHHHHhccc--cCcccchhhcCceEEEEecCCccCCCchHH
Confidence 765443 34567999999999997655 3568999999999999999 5999986543
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-24 Score=219.94 Aligned_cols=198 Identities=25% Similarity=0.395 Sum_probs=169.5
Q ss_pred cccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCC-CCceeeeeeeccCCCc
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDESK 404 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIVkl~~~~~~~~~ 404 (554)
+.-.|.++++||+|+||.+++|.+ -+++.||||.-.. +...-++..|.+..+.|. .++|.++|.++....+
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr-------kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~ 98 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR-------KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKY 98 (449)
T ss_pred ecccceeccccccCcceeeecccccccCceEEEEeccc-------cCCcchHHHHHHHHHHHcCCCCCCceeeeccccch
Confidence 345799999999999999999998 8899999996553 223356778888888875 7999999999999999
Q ss_pred EEEEEeecccCchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCC-----cEEEEecCccc
Q 008759 405 LYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG-----SVKLADFGLAK 477 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~~--~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g-----~vKL~DFGlA~ 477 (554)
..||||++. -+|.+++.-+ .|+...+..++.|++.-++|+|++++|+|||||+|+||...+ .|.|+|||+|+
T Consensus 99 NiLVidLLG-PSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK 177 (449)
T KOG1165|consen 99 NILVIDLLG-PSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK 177 (449)
T ss_pred hhhhhhhhC-cCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchh
Confidence 999999985 4899888753 599999999999999999999999999999999999997544 58999999998
Q ss_pred ccccC---------CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh
Q 008759 478 ATKLN---------DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC 534 (554)
Q Consensus 478 ~~~~~---------~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~ 534 (554)
.+... ..++..||..||+-....+.. .+++.|+-|||-+++++|-|.+||.+++.
T Consensus 178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrE--QSRRDDLEaLGHvFmYFLRGsLPWQGLKA 241 (449)
T KOG1165|consen 178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLGRE--QSRRDDLEALGHVFMYFLRGSLPWQGLKA 241 (449)
T ss_pred hhcCccccccCccccccccccceeeeEeeccccch--hhhhhhHHHhhhhhhhhccCCCccccccC
Confidence 76433 345667999999988877665 67899999999999999999999988643
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.8e-23 Score=201.78 Aligned_cols=200 Identities=37% Similarity=0.544 Sum_probs=170.3
Q ss_pred eeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCC-ceeeeeeeccCCCcEEEEE
Q 008759 331 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE-NIVQYYGTDKDESKLYIFL 409 (554)
Q Consensus 331 y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hp-nIVkl~~~~~~~~~~~LVm 409 (554)
|.+.+.||.|+||.||++.+. ..+++|.+........ .....+.+|+.++..+.|+ +|+++++.+......++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 77 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKS--KEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVM 77 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccch--hHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEE
Confidence 778899999999999999887 7788898875333221 2456788999999999988 7999999997777789999
Q ss_pred eecccCchHHHHhhh----cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCC-cEEEEecCcccccccC--
Q 008759 410 ELVTKGSLLNLYQRY----HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG-SVKLADFGLAKATKLN-- 482 (554)
Q Consensus 410 E~~~ggsL~~ll~~~----~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g-~vKL~DFGlA~~~~~~-- 482 (554)
+++.++++..++... .+....+..++.|++.++.|+|..+++||||||+|||++..+ .++++|||++......
T Consensus 78 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~ 157 (384)
T COG0515 78 EYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS 157 (384)
T ss_pred ecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence 999999999777664 588999999999999999999999999999999999999998 7999999998754332
Q ss_pred ------CccCccCCCcccChhhhcccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCh
Q 008759 483 ------DVKSCRGTAFWMAPEVINNKN-KGYGLPADIWSLGCTVLEMLTSQIPYAPMEC 534 (554)
Q Consensus 483 ------~~~s~~GT~~Y~APEvl~~~~-~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~ 534 (554)
......||..|++||.+.+.. ..+....|+|++|++++++++|..||.....
T Consensus 158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~ 216 (384)
T COG0515 158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKN 216 (384)
T ss_pred cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 235567999999999997632 3478899999999999999999999877653
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.4e-24 Score=226.74 Aligned_cols=168 Identities=20% Similarity=0.174 Sum_probs=130.5
Q ss_pred ccccccceeeeeeeccCCceeEEEEecC--CCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceee-eeeecc
Q 008759 324 FKRIITYWQKGDLLGRGSFGSVYEGISD--DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ-YYGTDK 400 (554)
Q Consensus 324 ~~~~~~~y~i~~~LG~GsfG~VY~a~~~--~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVk-l~~~~~ 400 (554)
...+...|.+.+.||+|+||+||+|.+. +++.+|+|++...............+.+|+++|+.++|+||+. +++.
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~-- 90 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT-- 90 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc--
Confidence 4456678999999999999999999873 6788899986522110011233466899999999999999985 5543
Q ss_pred CCCcEEEEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCC-ccccEEEcCCCcEEEEecCccccc
Q 008759 401 DESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI-KCANILVDANGSVKLADFGLAKAT 479 (554)
Q Consensus 401 ~~~~~~LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDI-KPeNILld~~g~vKL~DFGlA~~~ 479 (554)
+..||||||+.|++|... .. .. ...++.|++.+|.|||++||+|||| ||+|||++.++.+||+|||+++..
T Consensus 91 --~~~~LVmE~~~G~~L~~~-~~--~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~ 162 (365)
T PRK09188 91 --GKDGLVRGWTEGVPLHLA-RP--HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVF 162 (365)
T ss_pred --CCcEEEEEccCCCCHHHh-Cc--cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceec
Confidence 457999999999999632 11 11 2467899999999999999999999 999999999999999999999854
Q ss_pred ccC----------CccCccCCCcccChhhhcc
Q 008759 480 KLN----------DVKSCRGTAFWMAPEVINN 501 (554)
Q Consensus 480 ~~~----------~~~s~~GT~~Y~APEvl~~ 501 (554)
... ......+++.|+|||.+..
T Consensus 163 ~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 163 RRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 322 1234568888999999854
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-23 Score=217.56 Aligned_cols=197 Identities=28% Similarity=0.350 Sum_probs=159.9
Q ss_pred ceeeeeeeccCCceeEEEEecCC--CcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCC----Cceeeeeeec-cCC
Q 008759 330 YWQKGDLLGRGSFGSVYEGISDD--GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH----ENIVQYYGTD-KDE 402 (554)
Q Consensus 330 ~y~i~~~LG~GsfG~VY~a~~~~--g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~H----pnIVkl~~~~-~~~ 402 (554)
.|.+.+.||+|+||.||+|.+.. ...+|+|+......... ..+..|+.++..+.. .++..+++.+ ...
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~-----~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~ 93 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP-----SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTE 93 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC-----ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCC
Confidence 89999999999999999999854 35888888764322111 145677777777762 6899999999 577
Q ss_pred CcEEEEEeecccCchHHHHhh---hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCC-----CcEEEEecC
Q 008759 403 SKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-----GSVKLADFG 474 (554)
Q Consensus 403 ~~~~LVmE~~~ggsL~~ll~~---~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~-----g~vKL~DFG 474 (554)
...||||+++. .+|.++... ..++..++..++.|++.+|++||+.|++||||||+|+++... ..+.|+|||
T Consensus 94 ~~~~iVM~l~G-~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 94 DFNFIVMSLLG-PSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred ceeEEEEeccC-ccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 88999999885 489888754 358999999999999999999999999999999999999865 369999999
Q ss_pred cccccc--cC---------C-ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh
Q 008759 475 LAKATK--LN---------D-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC 534 (554)
Q Consensus 475 lA~~~~--~~---------~-~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~ 534 (554)
+++... .. . .....||..|+++.+..+.. .+++.|+|||+.++.+|+.|.+||...+.
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e--~~r~DDles~~Y~l~el~~g~LPW~~~~~ 242 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIE--QGRRDDLESLFYMLLELLKGSLPWEALEM 242 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCc--cCCchhhhhHHHHHHHHhcCCCCCccccc
Confidence 998221 11 1 12345999999999986654 78899999999999999999999987664
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.8e-23 Score=202.83 Aligned_cols=198 Identities=24% Similarity=0.312 Sum_probs=165.2
Q ss_pred cccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCC-CceeeeeeeccCCCc
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH-ENIVQYYGTDKDESK 404 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~H-pnIVkl~~~~~~~~~ 404 (554)
..+.|.++++||.|+||.+|+|.. .+|..||+|+-..... -.++..|..+...+++ ..|..+..++.+..+
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~-------hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~y 85 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK-------HPQLLYESKVYRILQGGVGIPHIRHYGTEKDY 85 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC-------CcchhHHHHHHHHhccCCCCchhhhhcccccc
Confidence 457899999999999999999998 8899999997653222 1356678888888875 677788888888889
Q ss_pred EEEEEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCC---CcEEEEecCccccc
Q 008759 405 LYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN---GSVKLADFGLAKAT 479 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~---g~vKL~DFGlA~~~ 479 (554)
-.|||+++. -+|.++++- ..++..+++.++-|++.-|+|+|.+++|||||||+|+|+.-+ ..+.|+|||+++.+
T Consensus 86 nvlVMdLLG-PsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 86 NVLVMDLLG-PSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred ceeeeeccC-ccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhh
Confidence 999999985 489998864 468889999999999999999999999999999999999654 46899999999875
Q ss_pred ccC---------CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh
Q 008759 480 KLN---------DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC 534 (554)
Q Consensus 480 ~~~---------~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~ 534 (554)
... ......||..|.+-..+.+.. .+.+.|+-|+|.++.++.-|.+||.++..
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~e--qSRRDDmeSvgYvLmYfnrG~LPWQglka 226 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIE--QSRRDDMESVGYVLMYFNRGSLPWQGLKA 226 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhh--hhhhhhhhhhcceeeeeecCCCcccccch
Confidence 432 233456999999987775544 57889999999999999999999998754
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.9e-23 Score=236.96 Aligned_cols=143 Identities=15% Similarity=0.231 Sum_probs=109.9
Q ss_pred CCC-Cceeeeeeec-------cCCCcEEEEEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCc
Q 008759 387 FEH-ENIVQYYGTD-------KDESKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIK 456 (554)
Q Consensus 387 l~H-pnIVkl~~~~-------~~~~~~~LVmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIK 456 (554)
++| .||+++++.| .....++++||++ +++|.+++.. ..+++.+++.|++||+.||.|||++||+|||||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK 107 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR 107 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence 344 5777777766 2334678888987 4599999965 348999999999999999999999999999999
Q ss_pred cccEEEcCCC-------------------cEEEEecCcccccccC------------------CccCccCCCcccChhhh
Q 008759 457 CANILVDANG-------------------SVKLADFGLAKATKLN------------------DVKSCRGTAFWMAPEVI 499 (554)
Q Consensus 457 PeNILld~~g-------------------~vKL~DFGlA~~~~~~------------------~~~s~~GT~~Y~APEvl 499 (554)
|+||||+..| .+||+|||+++..... ......||++|||||++
T Consensus 108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~ 187 (793)
T PLN00181 108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED 187 (793)
T ss_pred chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence 9999996544 4556666665431100 00113478999999998
Q ss_pred cccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008759 500 NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM 532 (554)
Q Consensus 500 ~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~ 532 (554)
.+.. |+.++|||||||++|||++|..||...
T Consensus 188 ~~~~--~~~~sDVwSlGviL~ELl~~~~~~~~~ 218 (793)
T PLN00181 188 NGSS--SNCASDVYRLGVLLFELFCPVSSREEK 218 (793)
T ss_pred ccCC--CCchhhhhhHHHHHHHHhhCCCchhhH
Confidence 6543 889999999999999999999988653
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.7e-22 Score=205.58 Aligned_cols=208 Identities=25% Similarity=0.409 Sum_probs=166.0
Q ss_pred cceeeeeeeccCCceeEEEEecCC------CcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccC-
Q 008759 329 TYWQKGDLLGRGSFGSVYEGISDD------GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD- 401 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~~~------g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~- 401 (554)
.++++..++-+|+||.||.|++.+ .+.+-+|.++. ....-.+..+..|.-+|..+.|||+.++.+.+..
T Consensus 284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~----~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~ 359 (563)
T KOG1024|consen 284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQ----HASQIQVNLLLQESMLLYGASHPNLLSVLGVSIED 359 (563)
T ss_pred hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHh----cccHHHHHHHHHHHHHHhcCcCCCccceeEEEeec
Confidence 357777889999999999997643 23444554442 2223335567888888999999999999998654
Q ss_pred CCcEEEEEeecccCchHHHHhhh---------cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEe
Q 008759 402 ESKLYIFLELVTKGSLLNLYQRY---------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLAD 472 (554)
Q Consensus 402 ~~~~~LVmE~~~ggsL~~ll~~~---------~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~D 472 (554)
....+.++.++.-|+|..+++.. .+...++..++.|++.|+.|||+.||||.||...|.+|++.-+|||+|
T Consensus 360 ~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltD 439 (563)
T KOG1024|consen 360 YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTD 439 (563)
T ss_pred cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEecc
Confidence 45678889999999999999832 256667888999999999999999999999999999999999999999
Q ss_pred cCcccccccCCccC----ccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHH
Q 008759 473 FGLAKATKLNDVKS----CRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIFIKT 542 (554)
Q Consensus 473 FGlA~~~~~~~~~s----~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i~~i~ 542 (554)
=.+++-.....+.. .-....||+||.+.... |+.++|+||||+++|||+| |+.||...++.++..-+.
T Consensus 440 saLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~--yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylk 512 (563)
T KOG1024|consen 440 SALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSH--YSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLK 512 (563)
T ss_pred chhccccCcccccccCCCCCCcccccCHHHHhhhh--hcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHh
Confidence 99887654433321 12356699999996544 8999999999999999999 999999999988765544
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=2e-21 Score=188.04 Aligned_cols=143 Identities=17% Similarity=0.161 Sum_probs=110.5
Q ss_pred eeeeccCCceeEEEEecCCCcEEEEEEEecccccchh---------------------HHHHHHHHHHHHHHHhCCCCce
Q 008759 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQA---------------------KQSISQLEQEIALLSRFEHENI 392 (554)
Q Consensus 334 ~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~---------------------~~~~~~~~~Ei~iL~~l~HpnI 392 (554)
..+||+|+||.||+|.+.+|+.||+|+++........ ........+|+.++..+.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4679999999999999988999999999753211100 0011234569999999987776
Q ss_pred eeeeeeccCCCcEEEEEeecccCchHHH-HhhhcCChHHHHHHHHHHHHHHHHH-HHCCccccCCccccEEEcCCCcEEE
Q 008759 393 VQYYGTDKDESKLYIFLELVTKGSLLNL-YQRYHLRDSQVSAYTRQILLGLKYL-HDQDVVHRDIKCANILVDANGSVKL 470 (554)
Q Consensus 393 Vkl~~~~~~~~~~~LVmE~~~ggsL~~l-l~~~~l~e~~i~~i~~QIl~gL~yL-Hs~gIIHrDIKPeNILld~~g~vKL 470 (554)
...+.... ...+|||||+.++++... +....++...+..++.|++.+|.+| |+.||+||||||+|||++ ++.++|
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~L 158 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLYI 158 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEEE
Confidence 43332221 223899999999877654 4556788999999999999999999 799999999999999998 588999
Q ss_pred EecCccccc
Q 008759 471 ADFGLAKAT 479 (554)
Q Consensus 471 ~DFGlA~~~ 479 (554)
+|||++...
T Consensus 159 iDFG~a~~~ 167 (190)
T cd05147 159 IDVSQSVEH 167 (190)
T ss_pred EEccccccC
Confidence 999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.8e-21 Score=183.57 Aligned_cols=144 Identities=19% Similarity=0.180 Sum_probs=113.1
Q ss_pred eeeeccCCceeEEEEecCCCcEEEEEEEecccccc---------------------hhHHHHHHHHHHHHHHHhCCCCce
Q 008759 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGS---------------------QAKQSISQLEQEIALLSRFEHENI 392 (554)
Q Consensus 334 ~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~---------------------~~~~~~~~~~~Ei~iL~~l~HpnI 392 (554)
...||+|+||.||+|.+.+|+.||+|++....... ........+..|+..+.++.|++|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 56899999999999998889999999987542110 011112345688999999999887
Q ss_pred eeeeeeccCCCcEEEEEeecccCchH-HHHhhhcCChHHHHHHHHHHHHHHHHHHH-CCccccCCccccEEEcCCCcEEE
Q 008759 393 VQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGSVKL 470 (554)
Q Consensus 393 Vkl~~~~~~~~~~~LVmE~~~ggsL~-~ll~~~~l~e~~i~~i~~QIl~gL~yLHs-~gIIHrDIKPeNILld~~g~vKL 470 (554)
......... ..||||||+.|+++. ..+....++...+..++.|++.+|.+||. +||+||||||+|||++ ++.++|
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~l 158 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPYI 158 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEEE
Confidence 443333222 248999999988543 34555678888999999999999999999 9999999999999998 899999
Q ss_pred EecCcccccc
Q 008759 471 ADFGLAKATK 480 (554)
Q Consensus 471 ~DFGlA~~~~ 480 (554)
+|||++....
T Consensus 159 iDFG~a~~~~ 168 (190)
T cd05145 159 IDVSQAVELD 168 (190)
T ss_pred EEcccceecC
Confidence 9999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.4e-20 Score=184.70 Aligned_cols=188 Identities=17% Similarity=0.088 Sum_probs=139.6
Q ss_pred eeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCC-CCceeeeeeeccCCCcEEEEEe
Q 008759 332 QKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDESKLYIFLE 410 (554)
Q Consensus 332 ~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIVkl~~~~~~~~~~~LVmE 410 (554)
.+...|++|+||+||++.. .+..++.+.+....... ..-....+.+|+++|+++. |++|++++++ +..|++||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~-~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWL-RGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhh-hhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 3467899999999998766 67777777665322211 1111225789999999995 5889999886 45799999
Q ss_pred ecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCC-ccccEEEcCCCcEEEEecCcccccccCCc-----
Q 008759 411 LVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDI-KCANILVDANGSVKLADFGLAKATKLNDV----- 484 (554)
Q Consensus 411 ~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDI-KPeNILld~~g~vKL~DFGlA~~~~~~~~----- 484 (554)
|+.|.+|...+.. ....++.|++.+|.++|.+||+|||| ||+|||++.+|.++|+|||++........
T Consensus 79 yI~G~~L~~~~~~------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L 152 (218)
T PRK12274 79 YLAGAAMYQRPPR------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLL 152 (218)
T ss_pred eecCccHHhhhhh------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHH
Confidence 9999988754322 12357889999999999999999999 79999999999999999999975443221
Q ss_pred c----------CccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008759 485 K----------SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP 531 (554)
Q Consensus 485 ~----------s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~ 531 (554)
. -...++.|+.|+.-.-....--...++++.|+-+|.++|+.+|+..
T Consensus 153 ~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 153 AREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 0 0126888999986533221112567999999999999999988754
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.5e-21 Score=191.68 Aligned_cols=174 Identities=16% Similarity=0.162 Sum_probs=131.5
Q ss_pred cccceeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHH------HHHHHHHHHhCCCCceeeeeeecc
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQ------LEQEIALLSRFEHENIVQYYGTDK 400 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~------~~~Ei~iL~~l~HpnIVkl~~~~~ 400 (554)
+.++|++.++||.|+||.||++.. ++..+|+|++....... ...... +.+|+..+.++.|++|..+.+.+.
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~--~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRT--ERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCch--HHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 356899999999999999999755 57789999986433221 222222 679999999999999998887754
Q ss_pred CC--------CcEEEEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEe
Q 008759 401 DE--------SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLAD 472 (554)
Q Consensus 401 ~~--------~~~~LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~D 472 (554)
.. +..+|+|||++|.+|.++.. +++ ....+++.+|..||..|++||||||.|||++.+| ++|+|
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~---~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liD 177 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE---ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIID 177 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhh---ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEE
Confidence 32 45899999999999987632 222 3466999999999999999999999999999988 99999
Q ss_pred cCcccccccCCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHH
Q 008759 473 FGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEML 523 (554)
Q Consensus 473 FGlA~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLL 523 (554)
||........... ..++... .|+.++|+|+||+++..+.
T Consensus 178 fg~~~~~~e~~a~----------d~~vler--~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 178 LSGKRCTAQRKAK----------DRIDLER--HYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCCcccccchhhH----------HHHHHHh--HhcccccccceeEeehHHH
Confidence 9987554321111 0122222 3667899999999986653
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.2e-22 Score=218.81 Aligned_cols=187 Identities=30% Similarity=0.504 Sum_probs=159.9
Q ss_pred eeccCCceeEEEEec----CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCC-CCceeeeeeeccCCCcEEEEEe
Q 008759 336 LLGRGSFGSVYEGIS----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDESKLYIFLE 410 (554)
Q Consensus 336 ~LG~GsfG~VY~a~~----~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIVkl~~~~~~~~~~~LVmE 410 (554)
.+|+|.||.|+++.. ..+..||+|+.++.......+. +...|..++..++ ||++|++...++.+..++++++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~---~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld 77 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT---HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILD 77 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc---ccccHHHHHhhccCCCceeeeeeeeccccchhHhhh
Confidence 379999999998764 4578999998876444333222 4556778888887 9999999999999999999999
Q ss_pred ecccCchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCCccCccC
Q 008759 411 LVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRG 489 (554)
Q Consensus 411 ~~~ggsL~~ll~~~-~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~~~s~~G 489 (554)
+..+|.|...+... .+.+..++.+..+++.++.++|+.+|+|||+|++||+++.+|++++.|||+.+..-..... +|
T Consensus 78 ~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~--cg 155 (612)
T KOG0603|consen 78 FLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA--CG 155 (612)
T ss_pred hcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc--cc
Confidence 99999988877654 4677788899999999999999999999999999999999999999999998765433333 79
Q ss_pred CCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008759 490 TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP 531 (554)
Q Consensus 490 T~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~ 531 (554)
|..|||||+++ ++..++|+||||+++++|+||..||..
T Consensus 156 t~eymApEI~~----gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 156 TYEYRAPEIIN----GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred chhhhhhHhhh----ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 99999999997 356789999999999999999999998
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.1e-20 Score=175.32 Aligned_cols=112 Identities=36% Similarity=0.485 Sum_probs=95.5
Q ss_pred CchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCCccCccCCCc
Q 008759 415 GSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF 492 (554)
Q Consensus 415 gsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~~~s~~GT~~ 492 (554)
|+|.+++.. ..+++..++.|+.||+.||.|||+++ ||+|||++.++.+|+ ||++....... ..||+.
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---~~g~~~ 69 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ---SRVDPY 69 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc---CCCccc
Confidence 688898875 35999999999999999999999999 999999999999999 99987654322 258999
Q ss_pred ccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHH
Q 008759 493 WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIF 539 (554)
Q Consensus 493 Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~ 539 (554)
|||||++.+. .|+.++|||||||++|||+||+.||.........+
T Consensus 70 y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~ 114 (176)
T smart00750 70 FMAPEVIQGQ--SYTEKADIYSLGITLYEALDYELPYNEERELSAIL 114 (176)
T ss_pred ccChHHhcCC--CCcchhhHHHHHHHHHHHHhCCCCccccchhcHHH
Confidence 9999999654 48899999999999999999999998765444333
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.8e-19 Score=182.16 Aligned_cols=199 Identities=23% Similarity=0.337 Sum_probs=132.4
Q ss_pred ceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCC---C-------ceeeeeee
Q 008759 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH---E-------NIVQYYGT 398 (554)
Q Consensus 330 ~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~H---p-------nIVkl~~~ 398 (554)
.+..+..||.|+++.||.+++ .+++.+|+|++.... .......+++.+|.-....+.+ | .++-.++.
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~--~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~ 90 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPA--DASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDL 90 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESS--TTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEeccc--ccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEE
Confidence 457789999999999999999 779999999998655 3334456777777655554332 1 11111111
Q ss_pred ---------cc---CCC-----cEEEEEeecccCchHHHHh---hhc-----CChHHHHHHHHHHHHHHHHHHHCCcccc
Q 008759 399 ---------DK---DES-----KLYIFLELVTKGSLLNLYQ---RYH-----LRDSQVSAYTRQILLGLKYLHDQDVVHR 453 (554)
Q Consensus 399 ---------~~---~~~-----~~~LVmE~~~ggsL~~ll~---~~~-----l~e~~i~~i~~QIl~gL~yLHs~gIIHr 453 (554)
+. ..+ +.+++|+-+.+ +|.+++. ... +.......+..|+++.+++||..||+|+
T Consensus 91 ~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHg 169 (288)
T PF14531_consen 91 LRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHG 169 (288)
T ss_dssp EEETTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEES
T ss_pred EEEcCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEec
Confidence 11 111 34677887754 7777653 211 2222234566899999999999999999
Q ss_pred CCccccEEEcCCCcEEEEecCcccccccCCccCccCCCcccChhhhcccC------CCCCchhhHHHHHHHHHHHHcCCC
Q 008759 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKN------KGYGLPADIWSLGCTVLEMLTSQI 527 (554)
Q Consensus 454 DIKPeNILld~~g~vKL~DFGlA~~~~~~~~~s~~GT~~Y~APEvl~~~~------~~~s~ksDIwSLGvllyeLLTG~~ 527 (554)
||+|+|||++.+|.++|+||+.....+..... ...+..|.+||+..... ..++.+.|.|+||+++|.|+||.+
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l 248 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL 248 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCceeec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence 99999999999999999999977654433222 34567899999875431 136889999999999999999999
Q ss_pred CCCCC
Q 008759 528 PYAPM 532 (554)
Q Consensus 528 PF~~~ 532 (554)
||.-.
T Consensus 249 Pf~~~ 253 (288)
T PF14531_consen 249 PFGLS 253 (288)
T ss_dssp STCCC
T ss_pred CCCCC
Confidence 99854
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=4e-19 Score=174.95 Aligned_cols=133 Identities=23% Similarity=0.363 Sum_probs=104.2
Q ss_pred eeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhC-----CCCceeeeeeeccCCC---c
Q 008759 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-----EHENIVQYYGTDKDES---K 404 (554)
Q Consensus 334 ~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l-----~HpnIVkl~~~~~~~~---~ 404 (554)
.++||+|+||.||. + .++.. ++|++..... ...+.+.+|+.++..+ .||||+++|+++.++. .
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~-----~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~ 78 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD-----GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGY 78 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEecccc-----chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeE
Confidence 46899999999996 5 34444 6888764221 1235688999999999 5799999999998764 3
Q ss_pred EE-EEEee--cccCchHHHHhhhcCChHHHHHHHHHHHHHH-HHHHHCCccccCCccccEEEcCC----CcEEEEe-cCc
Q 008759 405 LY-IFLEL--VTKGSLLNLYQRYHLRDSQVSAYTRQILLGL-KYLHDQDVVHRDIKCANILVDAN----GSVKLAD-FGL 475 (554)
Q Consensus 405 ~~-LVmE~--~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL-~yLHs~gIIHrDIKPeNILld~~----g~vKL~D-FGl 475 (554)
++ +|||| +.+++|.+++++..+.+. ..++.|++.++ .|||+++|+||||||+|||++.. +.++|+| ||.
T Consensus 79 v~~~I~e~~G~~~~tL~~~l~~~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 79 VYDVIADFDGKPSITLTEFAEQCRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEEEEecCCCCcchhHHHHHHcccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 34 78999 457999999987666555 35678888887 99999999999999999999743 3799999 554
Q ss_pred c
Q 008759 476 A 476 (554)
Q Consensus 476 A 476 (554)
.
T Consensus 157 ~ 157 (210)
T PRK10345 157 S 157 (210)
T ss_pred c
Confidence 3
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.3e-20 Score=209.15 Aligned_cols=203 Identities=27% Similarity=0.436 Sum_probs=161.1
Q ss_pred eeeeeeccCCceeEEEEec-CCCcEEEEEEEeccc-ccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEEE
Q 008759 332 QKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLD-QGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFL 409 (554)
Q Consensus 332 ~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~-~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LVm 409 (554)
....++|.|.+|.|+.+.. .....++.|.+.+.. ...........+..|+-+-..+.|+|++..+....+....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 4567899999998887766 445556666554210 12222333333777888888999999988888777766666669
Q ss_pred eecccCchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC-----
Q 008759 410 ELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----- 483 (554)
Q Consensus 410 E~~~ggsL~~ll~~~-~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~----- 483 (554)
|||.+ +|..++... .+...++..+++|++.||.|||..||.|||||++|+|+..+|.+||+|||.+.......
T Consensus 401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~ 479 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIH 479 (601)
T ss_pred hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhhh
Confidence 99999 999998876 78899999999999999999999999999999999999999999999999987644322
Q ss_pred -ccCccCCCcccChhhhcccCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCChhHH
Q 008759 484 -VKSCRGTAFWMAPEVINNKNKGYG-LPADIWSLGCTVLEMLTSQIPYAPMECVSA 537 (554)
Q Consensus 484 -~~s~~GT~~Y~APEvl~~~~~~~s-~ksDIwSLGvllyeLLTG~~PF~~~e~~~~ 537 (554)
....+|+..|+|||++.+.. |+ +..||||.|++++.|++|+.||......+.
T Consensus 480 ~~~g~~gS~pY~apE~~~~~~--ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~ 533 (601)
T KOG0590|consen 480 ESSGIVGSDPYLAPEVLTGKE--YDPRAVDVWSCGIIYICMILGRFPWKVAKKSDN 533 (601)
T ss_pred hhcCcccCCcCcCcccccccc--cCcchhhhhhccceEEEEecCCCcccccccccc
Confidence 23456999999999997654 44 469999999999999999999986654433
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.1e-18 Score=172.80 Aligned_cols=146 Identities=19% Similarity=0.176 Sum_probs=113.5
Q ss_pred ceeeeeeeccCCceeEEEEe--cCCCcEEEEEEEecccccc-------------------hhHHHHHHHHHHHHHHHhCC
Q 008759 330 YWQKGDLLGRGSFGSVYEGI--SDDGFFFAVKEVSLLDQGS-------------------QAKQSISQLEQEIALLSRFE 388 (554)
Q Consensus 330 ~y~i~~~LG~GsfG~VY~a~--~~~g~~vAvK~v~~~~~~~-------------------~~~~~~~~~~~Ei~iL~~l~ 388 (554)
.|.+.+.||+|+||.||+|. ..+|+.||+|++....... ........+..|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 57889999999999999998 4789999999987532110 00112234678999999997
Q ss_pred CCc--eeeeeeeccCCCcEEEEEeecccCchHHHH-hhhcCChHHHHHHHHHHHHHHHHHHHCC-ccccCCccccEEEcC
Q 008759 389 HEN--IVQYYGTDKDESKLYIFLELVTKGSLLNLY-QRYHLRDSQVSAYTRQILLGLKYLHDQD-VVHRDIKCANILVDA 464 (554)
Q Consensus 389 Hpn--IVkl~~~~~~~~~~~LVmE~~~ggsL~~ll-~~~~l~e~~i~~i~~QIl~gL~yLHs~g-IIHrDIKPeNILld~ 464 (554)
+.+ +.+++.. ...|+||||+.+++|..++ ....+....+..++.||+.+|.+||++| |+||||||+|||++
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~- 183 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH- 183 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence 533 4455543 2358999999998887654 3445666677899999999999999999 99999999999998
Q ss_pred CCcEEEEecCcccccc
Q 008759 465 NGSVKLADFGLAKATK 480 (554)
Q Consensus 465 ~g~vKL~DFGlA~~~~ 480 (554)
++.++|+|||++....
T Consensus 184 ~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 184 DGKVVIIDVSQSVELD 199 (237)
T ss_pred CCCEEEEEChhhhccC
Confidence 8899999999876443
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.4e-19 Score=203.66 Aligned_cols=203 Identities=22% Similarity=0.272 Sum_probs=157.5
Q ss_pred ccccccceeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCC
Q 008759 324 FKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES 403 (554)
Q Consensus 324 ~~~~~~~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~ 403 (554)
|..+..+|...+.||.+.|=+|.+|++..|. |++|++...+....-....++ .+|++ ...+++||.+++.-+-..+.
T Consensus 18 fsd~~~e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qr-L~~ik-~~l~~~pn~lPfqk~~~t~k 94 (1431)
T KOG1240|consen 18 FSDLSVECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQR-LEEIK-FALMKAPNCLPFQKVLVTDK 94 (1431)
T ss_pred hhcCccceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHH-HHHHH-HHhhcCCcccchHHHHHhhH
Confidence 3334447888999999999999999998887 999999865544333333333 34455 56678999999988877888
Q ss_pred cEEEEEeecccCchHHHHhhhc-CChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccccc-
Q 008759 404 KLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL- 481 (554)
Q Consensus 404 ~~~LVmE~~~ggsL~~ll~~~~-l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~- 481 (554)
..|||-+|+.. +|++.+...+ +..-+.+.|+.||+.||..+|+.||+|||||.+||||+.-+.+.|+||-..+-...
T Consensus 95 AAylvRqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP 173 (1431)
T KOG1240|consen 95 AAYLVRQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLP 173 (1431)
T ss_pred HHHHHHHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCC
Confidence 88999999977 7888776554 56677888999999999999999999999999999999999999999987654321
Q ss_pred -CC---cc----CccCCCcccChhhhcccC--------CC-CCchhhHHHHHHHHHHHHc-CCCCCC
Q 008759 482 -ND---VK----SCRGTAFWMAPEVINNKN--------KG-YGLPADIWSLGCTVLEMLT-SQIPYA 530 (554)
Q Consensus 482 -~~---~~----s~~GT~~Y~APEvl~~~~--------~~-~s~ksDIwSLGvllyeLLT-G~~PF~ 530 (554)
.. .. +...-..|+|||.+.... .. ..++.||||+||+++||++ |++||.
T Consensus 174 eDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~ 240 (1431)
T KOG1240|consen 174 EDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT 240 (1431)
T ss_pred CCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc
Confidence 11 11 112234499999986522 11 4678999999999999998 899994
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=5.1e-18 Score=164.36 Aligned_cols=139 Identities=21% Similarity=0.260 Sum_probs=113.3
Q ss_pred eeeccCCceeEEEEecCCCcEEEEEEEeccccc---chhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEEEee
Q 008759 335 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQG---SQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLEL 411 (554)
Q Consensus 335 ~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~---~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LVmE~ 411 (554)
+.||+|++|.||+|.+ +|..+++|........ .........+.+|+.++..+.|++|.....++...+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 5677888976532211 11122235678899999999999887766666667788999999
Q ss_pred cccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccc
Q 008759 412 VTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA 478 (554)
Q Consensus 412 ~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~ 478 (554)
+.|++|.+++..... ....++.+++.+|.+||+.|++|+|++|.|||++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~~~---~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNGM---EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhccH---HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999999998865332 7788999999999999999999999999999998 88999999998865
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.5e-18 Score=198.03 Aligned_cols=198 Identities=22% Similarity=0.293 Sum_probs=152.9
Q ss_pred CCccccccccceeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCC---CCceeeee
Q 008759 320 PNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE---HENIVQYY 396 (554)
Q Consensus 320 ~~~~~~~~~~~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~---HpnIVkl~ 396 (554)
+...+......|.|-+.||+|+||.||+|...+|+.||+|+-+......- .+. .+++.+|+ -+.|..+.
T Consensus 689 ~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEf------YI~--~q~~~RLk~~~~~~~~~~~ 760 (974)
T KOG1166|consen 689 PNTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEF------YIC--LQVMERLKPQMLPSIMHIS 760 (974)
T ss_pred ccceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceee------eeh--HHHHHhhchhhhcchHHHH
Confidence 33344455678999999999999999999998899999997653221110 011 12223333 24455566
Q ss_pred eeccCCCcEEEEEeecccCchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcC-------CCcE
Q 008759 397 GTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA-------NGSV 468 (554)
Q Consensus 397 ~~~~~~~~~~LVmE~~~ggsL~~ll~~~-~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~-------~g~v 468 (554)
.+..-.+.-+||+||...|+|.++++.. .+++.-+..++.|++..|++||..+|||+||||+|+||.. .--+
T Consensus 761 ~a~~~~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l 840 (974)
T KOG1166|consen 761 SAHVFQNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGL 840 (974)
T ss_pred HHHccCCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccce
Confidence 6666677789999999999999999864 5888889999999999999999999999999999999942 2358
Q ss_pred EEEecCccccc---ccC-CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCC
Q 008759 469 KLADFGLAKAT---KLN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQI 527 (554)
Q Consensus 469 KL~DFGlA~~~---~~~-~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~ 527 (554)
+|+|||-+--. ..+ .....++|-.+-.+|+..++. +++.+|.|.|+-+++-||.|++
T Consensus 841 ~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grp--WtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 841 YLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRP--WTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCC--CchhhhhHHHHHHHHHHHHHHH
Confidence 99999987432 222 345567899999999997665 8899999999999999999864
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.75 E-value=1e-17 Score=160.95 Aligned_cols=136 Identities=24% Similarity=0.281 Sum_probs=107.5
Q ss_pred eeccCCceeEEEEecCCCcEEEEEEEeccccc---chhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEEEeec
Q 008759 336 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQG---SQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELV 412 (554)
Q Consensus 336 ~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~---~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LVmE~~ 412 (554)
.||+|+||.||+|.+ ++..+++|........ ........++.+|+.++..+.|+++......+...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 5678999986532211 112233467789999999999887654444444566779999999
Q ss_pred ccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccc
Q 008759 413 TKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT 479 (554)
Q Consensus 413 ~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~ 479 (554)
.|++|.+++..... .++.|++.+|.+||+.|++|+|++|.|||++ ++.++++|||++...
T Consensus 80 ~g~~l~~~~~~~~~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEGND------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhcHH------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 99999988755321 7899999999999999999999999999998 899999999987653
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=1e-17 Score=161.90 Aligned_cols=142 Identities=20% Similarity=0.194 Sum_probs=110.5
Q ss_pred ceeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccch-----------------hHHHHHHHHHHHHHHHhCCCC--
Q 008759 330 YWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQ-----------------AKQSISQLEQEIALLSRFEHE-- 390 (554)
Q Consensus 330 ~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~-----------------~~~~~~~~~~Ei~iL~~l~Hp-- 390 (554)
.|.+.+.||+|+||.||++...+|+.+|+|++........ ..........|+.++..+.|.
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 3778899999999999999998899999998764221100 001112366788889888777
Q ss_pred ceeeeeeeccCCCcEEEEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEE
Q 008759 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKL 470 (554)
Q Consensus 391 nIVkl~~~~~~~~~~~LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL 470 (554)
.+..+++. ...++||||+.|++|..+... .....++.+++.++.++|..||+|+||||+|||++.++.++|
T Consensus 96 ~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-----~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~l 166 (198)
T cd05144 96 PVPKPIDW----NRHAVVMEYIDGVELYRVRVL-----EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIYI 166 (198)
T ss_pred CCCceeec----CCceEEEEEeCCcchhhcccc-----ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEEE
Confidence 44555543 345899999999998765431 345678899999999999999999999999999999999999
Q ss_pred EecCcccccc
Q 008759 471 ADFGLAKATK 480 (554)
Q Consensus 471 ~DFGlA~~~~ 480 (554)
+|||++....
T Consensus 167 iDfg~~~~~~ 176 (198)
T cd05144 167 IDWPQMVSTD 176 (198)
T ss_pred EECCccccCC
Confidence 9999985543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.5e-17 Score=182.95 Aligned_cols=141 Identities=21% Similarity=0.229 Sum_probs=111.9
Q ss_pred ceeeeeeeccCCceeEEEEecCCCcEEEEEEEeccccc---chhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEE
Q 008759 330 YWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQG---SQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (554)
Q Consensus 330 ~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~---~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~ 406 (554)
.|...+.||+|+||+||++.+.... +++|+....... ........++.+|+.++..++|++|+..+.++......+
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~ 412 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKT 412 (535)
T ss_pred ccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCE
Confidence 3456788999999999999875443 344433211111 112223456889999999999999988777776777789
Q ss_pred EEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccc
Q 008759 407 IFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT 479 (554)
Q Consensus 407 LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~ 479 (554)
+||||+.+++|.+++. ....++.|++.+|.+||+.||+||||||+|||+ .++.++|+|||+++..
T Consensus 413 lv~E~~~g~~L~~~l~-------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 413 IVMEYIGGKDLKDVLE-------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred EEEEecCCCcHHHHHH-------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 9999999999998875 346789999999999999999999999999999 6889999999998764
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.72 E-value=8.9e-18 Score=190.89 Aligned_cols=174 Identities=29% Similarity=0.498 Sum_probs=127.7
Q ss_pred cccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCC
Q 008759 325 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES 403 (554)
Q Consensus 325 ~~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~ 403 (554)
.....+|+.+++|..|+||.||++++ .+.+.+|+|.-+. .. +.+ .+|.....|++|
T Consensus 79 ~p~e~df~~IklisngAygavylvrh~~trqrfa~kiNkq--------~l---ilR--nilt~a~npfvv---------- 135 (1205)
T KOG0606|consen 79 APSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQ--------NL---ILR--NILTFAGNPFVV---------- 135 (1205)
T ss_pred CCCccccceeEeeccCCCCceeeeeccccccchhhccccc--------ch---hhh--ccccccCCccee----------
Confidence 34456899999999999999999998 5678888853221 00 111 144444555555
Q ss_pred cEEEEEeecccCchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC
Q 008759 404 KLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN 482 (554)
Q Consensus 404 ~~~LVmE~~~ggsL~~ll~~~-~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~ 482 (554)
|+-..+++.. .++. +++.+++|||+.||+|||+||+|.||+.-|++|++|||+.+.....
T Consensus 136 -----------gDc~tllk~~g~lPv--------dmvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms 196 (1205)
T KOG0606|consen 136 -----------GDCATLLKNIGPLPV--------DMVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMS 196 (1205)
T ss_pred -----------chhhhhcccCCCCcc--------hhhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhh
Confidence 3344444432 2322 2378899999999999999999999999999999999998753211
Q ss_pred -----------------CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHH
Q 008759 483 -----------------DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTV 543 (554)
Q Consensus 483 -----------------~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~ 543 (554)
..+..+||+.|.|||++.. ++|+..+|||++|+|+|++|.|+.||.+-.+. .+|...+
T Consensus 197 ~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr--qgygkpvdwwamGiIlyeFLVgcvpffGdtpe-elfg~vi 271 (1205)
T KOG0606|consen 197 LATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILR--QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE-ELFGQVI 271 (1205)
T ss_pred ccchhhhcchHHHHHHhhhccccCCccccChhhhhh--hccCCCccHHHHHHHHHHHheeeeeccCCCHH-HHHhhhh
Confidence 1234579999999999954 45999999999999999999999999986553 3444433
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.7e-17 Score=170.99 Aligned_cols=204 Identities=26% Similarity=0.400 Sum_probs=150.4
Q ss_pred ccccceeeeeeeccCCceeEEEEecCC-C-----------------------------------cEEEEEEEecccccch
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGISDD-G-----------------------------------FFFAVKEVSLLDQGSQ 369 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~~~-g-----------------------------------~~vAvK~v~~~~~~~~ 369 (554)
..+++|++++.||+|.-..||.+...+ | ...|+|.+........
T Consensus 154 FtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~ 233 (598)
T KOG4158|consen 154 FTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSG 233 (598)
T ss_pred cchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCc
Confidence 456899999999999999999886421 1 1235555444444444
Q ss_pred hHHHHHHHHHHH------HHH--------Hh--------CCCCceeeeeeeccCC-------------------------
Q 008759 370 AKQSISQLEQEI------ALL--------SR--------FEHENIVQYYGTDKDE------------------------- 402 (554)
Q Consensus 370 ~~~~~~~~~~Ei------~iL--------~~--------l~HpnIVkl~~~~~~~------------------------- 402 (554)
....++.+-+|. .++ +. -+|||||++.++|.+.
T Consensus 234 ~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g 313 (598)
T KOG4158|consen 234 DAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAG 313 (598)
T ss_pred hHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccC
Confidence 444444444442 111 11 2499999998876432
Q ss_pred --CcEEEEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEc--CCC--cEEEEecCcc
Q 008759 403 --SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD--ANG--SVKLADFGLA 476 (554)
Q Consensus 403 --~~~~LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld--~~g--~vKL~DFGlA 476 (554)
..+|+||..... +|..++-....+......++.|+++|+.|||++||.|||+|.+|||+. +|+ .+.|+|||.+
T Consensus 314 ~~~tlylvMkrY~~-tLr~yl~~~~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCc 392 (598)
T KOG4158|consen 314 EPKTLYLVMKRYRQ-TLREYLWTRHRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCC 392 (598)
T ss_pred CCceEEEehhcchh-hHHHHHhcCCCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEccccee
Confidence 247899988766 899999888888888899999999999999999999999999999994 443 5899999987
Q ss_pred cccccC--------CccCccCCCcccChhhhcccCCC-----CCchhhHHHHHHHHHHHHcCCCCCCC
Q 008759 477 KATKLN--------DVKSCRGTAFWMAPEVINNKNKG-----YGLPADIWSLGCTVLEMLTSQIPYAP 531 (554)
Q Consensus 477 ~~~~~~--------~~~s~~GT~~Y~APEvl~~~~~~-----~s~ksDIwSLGvllyeLLTG~~PF~~ 531 (554)
-.-... ......|.-..||||+....... | .++|.|+.|.+.||+++...||+.
T Consensus 393 LAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny-~kAD~WA~GalaYEIfg~~NPFY~ 459 (598)
T KOG4158|consen 393 LADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNY-EKADTWAAGALAYEIFGRSNPFYK 459 (598)
T ss_pred eeccccccccccccccccCCCcceecchhhhhcCCCCceeecc-chhhhhhhhhhHHHHhccCCcccc
Confidence 543321 12233478889999998654322 2 379999999999999999999987
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.7e-16 Score=149.43 Aligned_cols=141 Identities=23% Similarity=0.249 Sum_probs=99.2
Q ss_pred eeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHH-------------------HHHHHHHHHHHHhCCCC--ce
Q 008759 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQS-------------------ISQLEQEIALLSRFEHE--NI 392 (554)
Q Consensus 334 ~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~-------------------~~~~~~Ei~iL~~l~Hp--nI 392 (554)
++.||+|+||+||+|.+.+++.||+|++............ ......|...+..+.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 5689999999999999988999999998743211111000 00113455555555433 24
Q ss_pred eeeeeeccCCCcEEEEEeecccCchHH-HHhhhcCChHHHHHHHHHHHHHHHHHHH-CCccccCCccccEEEcCCCcEEE
Q 008759 393 VQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGSVKL 470 (554)
Q Consensus 393 Vkl~~~~~~~~~~~LVmE~~~ggsL~~-ll~~~~l~e~~i~~i~~QIl~gL~yLHs-~gIIHrDIKPeNILld~~g~vKL 470 (554)
.+++++ ...++||||+.++.+.. .+...... ..+..++.+++.++.++|. .||+|+||||+|||++ ++.++|
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~~l 155 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKVYI 155 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcEEE
Confidence 445543 23589999999954321 12211111 5678899999999999999 9999999999999999 999999
Q ss_pred EecCcccccc
Q 008759 471 ADFGLAKATK 480 (554)
Q Consensus 471 ~DFGlA~~~~ 480 (554)
+|||.+....
T Consensus 156 iDfg~a~~~~ 165 (187)
T cd05119 156 IDVPQAVEID 165 (187)
T ss_pred EECccccccc
Confidence 9999886543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.1e-15 Score=153.29 Aligned_cols=141 Identities=18% Similarity=0.214 Sum_probs=105.3
Q ss_pred eeeec-cCCceeEEEEecCCCcEEEEEEEecccc--------cchhHHHHHHHHHHHHHHHhCCCCce--eeeeeeccCC
Q 008759 334 GDLLG-RGSFGSVYEGISDDGFFFAVKEVSLLDQ--------GSQAKQSISQLEQEIALLSRFEHENI--VQYYGTDKDE 402 (554)
Q Consensus 334 ~~~LG-~GsfG~VY~a~~~~g~~vAvK~v~~~~~--------~~~~~~~~~~~~~Ei~iL~~l~HpnI--Vkl~~~~~~~ 402 (554)
+..|| .|+.|+||.+... +..+++|.+..... .........++.+|+.++..+.|++| ++.++.....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 34577 7888888888765 67889998853110 00011233567889999999998875 6666654332
Q ss_pred -C---cEEEEEeeccc-CchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccc
Q 008759 403 -S---KLYIFLELVTK-GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477 (554)
Q Consensus 403 -~---~~~LVmE~~~g-gsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~ 477 (554)
. ..++|||+++| .+|.+++....+++. .+.||+.+|.+||++||+|+||||.|||++.++.++|+|||.+.
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~ 190 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEAPLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRGE 190 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcCCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCcc
Confidence 2 23599999997 689888876655544 36789999999999999999999999999999999999999875
Q ss_pred cc
Q 008759 478 AT 479 (554)
Q Consensus 478 ~~ 479 (554)
..
T Consensus 191 ~~ 192 (239)
T PRK01723 191 LR 192 (239)
T ss_pred cC
Confidence 53
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.3e-16 Score=159.15 Aligned_cols=207 Identities=18% Similarity=0.317 Sum_probs=159.3
Q ss_pred cceeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEE
Q 008759 329 TYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LV 408 (554)
....+..+|.+...|..|+|+++.+ .++.|++.+..- .......|..|.-.|+.+.||||+.+++.|....++.++
T Consensus 190 ~~lnl~tkl~e~hsgelwrgrwqgn-divakil~vr~~---t~risrdfneefp~lrifshpnilpvlgacnsppnlv~i 265 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRGRWQGN-DIVAKILNVREV---TARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVII 265 (448)
T ss_pred hhhhhhhhhccCCCcccccccccCc-chhhhhhhhhhc---chhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEe
Confidence 3455667899999999999999744 456676654221 122235678889999999999999999999999999999
Q ss_pred EeecccCchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHHCC--ccccCCccccEEEcCCCcEEEEecCcccccccCC
Q 008759 409 LELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQD--VVHRDIKCANILVDANGSVKLADFGLAKATKLND 483 (554)
Q Consensus 409 mE~~~ggsL~~ll~~~---~l~e~~i~~i~~QIl~gL~yLHs~g--IIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~ 483 (554)
..||..|+|+.++... -....++.+++..|+.|+.|||+.. |.---|+...++|+++.+.+|. .+-+++.. +
T Consensus 266 sq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltaris-mad~kfsf--q 342 (448)
T KOG0195|consen 266 SQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARIS-MADTKFSF--Q 342 (448)
T ss_pred eeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhhee-cccceeee--e
Confidence 9999999999999764 3677889999999999999999975 4455788899999998776654 11111111 1
Q ss_pred ccCccCCCcccChhhhcccCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHH
Q 008759 484 VKSCRGTAFWMAPEVINNKNKGYG-LPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKT 542 (554)
Q Consensus 484 ~~s~~GT~~Y~APEvl~~~~~~~s-~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~ 542 (554)
.......|.||+||.+..+....+ .++|+|||.+++|||.|...||....+++--++|.
T Consensus 343 e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia 402 (448)
T KOG0195|consen 343 EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA 402 (448)
T ss_pred ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh
Confidence 122335788999999977665533 47899999999999999999999877777665553
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.5e-15 Score=135.79 Aligned_cols=131 Identities=21% Similarity=0.247 Sum_probs=109.5
Q ss_pred eeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCC--CceeeeeeeccCCCcEEEEEe
Q 008759 333 KGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH--ENIVQYYGTDKDESKLYIFLE 410 (554)
Q Consensus 333 i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~H--pnIVkl~~~~~~~~~~~LVmE 410 (554)
+.+.||.|.++.||++...+ ..+++|.+..... ...+.+|+.++..++| .++++++..+...+..|++||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e 73 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-------GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLME 73 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc-------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEE
Confidence 35789999999999999855 7889998754221 3467789999998876 588999998888889999999
Q ss_pred ecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHC---CccccCCccccEEEcCCCcEEEEecCccc
Q 008759 411 LVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ---DVVHRDIKCANILVDANGSVKLADFGLAK 477 (554)
Q Consensus 411 ~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~---gIIHrDIKPeNILld~~g~vKL~DFGlA~ 477 (554)
|+.++.+..+ +......++.+++.+|.+||.. +++|+||+|.|||++..+.++++|||++.
T Consensus 74 ~~~g~~~~~~------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~ 137 (155)
T cd05120 74 WIEGETLDEV------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAG 137 (155)
T ss_pred ecCCeecccC------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccccc
Confidence 9999877654 4456677899999999999985 69999999999999998999999999764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.6e-15 Score=162.95 Aligned_cols=117 Identities=30% Similarity=0.509 Sum_probs=101.2
Q ss_pred CcEEEEEeecccCchHHHHhhhc----CChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccc
Q 008759 403 SKLYIFLELVTKGSLLNLYQRYH----LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA 478 (554)
Q Consensus 403 ~~~~LVmE~~~ggsL~~ll~~~~----l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~ 478 (554)
.++||.|++|...+|.+|+.+.. .+....+.++.|+..+++| +|.+|+|+||.||++..+.++||.|||+...
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS 405 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence 36899999999999999997533 5566788899999999999 9999999999999999999999999999876
Q ss_pred cccCC--------ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc
Q 008759 479 TKLND--------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT 524 (554)
Q Consensus 479 ~~~~~--------~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT 524 (554)
..... ...-.||.+||+||.+.+.. |+.++|||+||+||+||++
T Consensus 406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~--y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQ--YSEKVDIYALGLILAELLI 457 (516)
T ss_pred cccCCcccchhhhhhhcccccccCCHHHHhhhh--hhhhcchhhHHHHHHHHHH
Confidence 54332 33446999999999997654 9999999999999999997
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.53 E-value=5.1e-16 Score=174.36 Aligned_cols=202 Identities=31% Similarity=0.458 Sum_probs=164.7
Q ss_pred cceeeeeeeccCCceeEEEEec--CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCC-CCceeeeeeeccCCCcE
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS--DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDESKL 405 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~--~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIVkl~~~~~~~~~~ 405 (554)
..|.+.+.||+|+|+.|-+... .....+|+|.+.... .......++..|..+-..+. |.|++.+++...+....
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~---~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~ 96 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP---KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSY 96 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCC---CccchhhhcCccccccccccccccccccCCccCCCccc
Confidence 4567777899999999998877 345566666555432 22334455666777777776 99999999999999999
Q ss_pred EEEEeecccCchHHHH-hhh--cCChHHHHHHHHHHHHHHHHHH-HCCccccCCccccEEEcCCC-cEEEEecCcccccc
Q 008759 406 YIFLELVTKGSLLNLY-QRY--HLRDSQVSAYTRQILLGLKYLH-DQDVVHRDIKCANILVDANG-SVKLADFGLAKATK 480 (554)
Q Consensus 406 ~LVmE~~~ggsL~~ll-~~~--~l~e~~i~~i~~QIl~gL~yLH-s~gIIHrDIKPeNILld~~g-~vKL~DFGlA~~~~ 480 (554)
+++++|..++++...+ ... .........++.|+..+|.|+| ..++.|+||||+|.+++..+ .+++.|||+|....
T Consensus 97 ~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 97 LLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYR 176 (601)
T ss_pred ccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence 9999999999998877 432 5777888999999999999999 99999999999999999999 99999999998765
Q ss_pred c-CC----ccCccC-CCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh
Q 008759 481 L-ND----VKSCRG-TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC 534 (554)
Q Consensus 481 ~-~~----~~s~~G-T~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~ 534 (554)
. +. ....+| ++.|+|||...+.. ......|+||.|+++..|++|..||.....
T Consensus 177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~-~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~ 235 (601)
T KOG0590|consen 177 NKNGAERSLKDRCGSSPPYGAPEHLSGKA-YRGPSVDVWSLGIVLSAMLTGELPWDFPSR 235 (601)
T ss_pred ccCCcceeeecccCCCCCCCCcccccchh-hcCCCcccccccccccccccCCCCcccccc
Confidence 5 22 234457 99999999987642 356789999999999999999999976543
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.45 E-value=3.8e-13 Score=146.22 Aligned_cols=143 Identities=20% Similarity=0.162 Sum_probs=97.2
Q ss_pred eeeccCCceeEEEEecCCCcEEEEEEEecccccchh-----------------------------HHHHH------HHHH
Q 008759 335 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQA-----------------------------KQSIS------QLEQ 379 (554)
Q Consensus 335 ~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~-----------------------------~~~~~------~~~~ 379 (554)
+.||.|++|.||+|+..+|+.||||+.+........ .+... .+.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 579999999999999999999999997532110000 00001 2334
Q ss_pred HHHHHHhCC-----CCcee--eeeeeccCCCcEEEEEeecccCchHHHHhhhcCChHHHHHHHHHHHH-HHHHHHHCCcc
Q 008759 380 EIALLSRFE-----HENIV--QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILL-GLKYLHDQDVV 451 (554)
Q Consensus 380 Ei~iL~~l~-----HpnIV--kl~~~~~~~~~~~LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~-gL~yLHs~gII 451 (554)
|...+.++. +++|. ++|. ...+..+|||||+.|++|.++........ ....++.+++. .+..+|..|++
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~--~~~~~~vLvmE~i~G~~L~~~~~~~~~~~-~~~~ia~~~~~~~l~ql~~~g~~ 279 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYW--DRTSERVLTMEWIDGIPLSDIAALDEAGL-DRKALAENLARSFLNQVLRDGFF 279 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEeh--hhcCCceEEEEeECCcccccHHHHHhcCC-CHHHHHHHHHHHHHHHHHhCCce
Confidence 554444442 33332 3332 23445799999999999988764321111 23345666655 47789999999
Q ss_pred ccCCccccEEEcCCCcEEEEecCcccccc
Q 008759 452 HRDIKCANILVDANGSVKLADFGLAKATK 480 (554)
Q Consensus 452 HrDIKPeNILld~~g~vKL~DFGlA~~~~ 480 (554)
|+|++|.|||++.+|.++|+|||++....
T Consensus 280 H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 280 HADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred eCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 99999999999999999999999986654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.41 E-value=3.7e-12 Score=124.34 Aligned_cols=142 Identities=17% Similarity=0.140 Sum_probs=103.7
Q ss_pred eeeeccCCceeEEEEecCC-------CcEEEEEEEecccc---------------------cchhHHHHHHHHHHHHHHH
Q 008759 334 GDLLGRGSFGSVYEGISDD-------GFFFAVKEVSLLDQ---------------------GSQAKQSISQLEQEIALLS 385 (554)
Q Consensus 334 ~~~LG~GsfG~VY~a~~~~-------g~~vAvK~v~~~~~---------------------~~~~~~~~~~~~~Ei~iL~ 385 (554)
..+||.|.-+.||.|...+ +..+|+|+++.... ....+.......+|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4579999999999998753 57999999864110 0111222233458999999
Q ss_pred hCCC--CceeeeeeeccCCCcEEEEEeecccCchH-HHHhhhcCChHHHHHHHHHHHHHHHHH-HHCCccccCCccccEE
Q 008759 386 RFEH--ENIVQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYL-HDQDVVHRDIKCANIL 461 (554)
Q Consensus 386 ~l~H--pnIVkl~~~~~~~~~~~LVmE~~~ggsL~-~ll~~~~l~e~~i~~i~~QIl~gL~yL-Hs~gIIHrDIKPeNIL 461 (554)
++.. -++.+++++ ...+|||||+.+..+. ..++...+...++..+..|++.+|..| |+.||||+||++.|||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL 157 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML 157 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 8864 345566654 4568999999875442 234444556666778889999999998 8999999999999999
Q ss_pred EcCCCcEEEEecCcccccc
Q 008759 462 VDANGSVKLADFGLAKATK 480 (554)
Q Consensus 462 ld~~g~vKL~DFGlA~~~~ 480 (554)
++ ++.++|+|||.+....
T Consensus 158 ~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 158 WH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred EE-CCcEEEEECCCceeCC
Confidence 96 5789999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.38 E-value=5.2e-13 Score=145.29 Aligned_cols=148 Identities=28% Similarity=0.521 Sum_probs=122.1
Q ss_pred HHhCCCCceeeeeeeccCCCcEEEEEeecccCchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHHCCc-cccCCccccE
Q 008759 384 LSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDV-VHRDIKCANI 460 (554)
Q Consensus 384 L~~l~HpnIVkl~~~~~~~~~~~LVmE~~~ggsL~~ll~~~--~l~e~~i~~i~~QIl~gL~yLHs~gI-IHrDIKPeNI 460 (554)
|+.+.|.|+.+++|.+.+....+.|.+||..|+|.+.+... .+++.-...+++.|+.||.|||.-.| .|+.|+..|.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 35678999999999999999999999999999999998764 45556667789999999999998765 9999999999
Q ss_pred EEcCCCcEEEEecCccccccc----CCccCccCCCcccChhhhcccCC-C----CCchhhHHHHHHHHHHHHcCCCCCCC
Q 008759 461 LVDANGSVKLADFGLAKATKL----NDVKSCRGTAFWMAPEVINNKNK-G----YGLPADIWSLGCTVLEMLTSQIPYAP 531 (554)
Q Consensus 461 Lld~~g~vKL~DFGlA~~~~~----~~~~s~~GT~~Y~APEvl~~~~~-~----~s~ksDIwSLGvllyeLLTG~~PF~~ 531 (554)
+++....+||+|||+...... .......-...|.|||++..... . .+.+.|+||||++++|+++.+-||..
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~ 160 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL 160 (484)
T ss_pred eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence 999999999999999765432 11112223455999999976311 1 36679999999999999999999976
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.36 E-value=9.4e-13 Score=145.94 Aligned_cols=145 Identities=15% Similarity=0.120 Sum_probs=92.1
Q ss_pred ccceeeeeeeccCCceeEEEEecCC-CcEEEEEEEecccccc-----------------------------hhHHHHHHH
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGS-----------------------------QAKQSISQL 377 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~~~-g~~vAvK~v~~~~~~~-----------------------------~~~~~~~~~ 377 (554)
...|.. +.||.|++|.||+|+..+ |+.||||+........ ...+..+.+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345665 789999999999999966 9999999986321000 001122223
Q ss_pred HHHHH------HHHhCC----CCceeeeeeec-cCCCcEEEEEeecccCchHHH--HhhhcC-----ChHHHHHHHHHHH
Q 008759 378 EQEIA------LLSRFE----HENIVQYYGTD-KDESKLYIFLELVTKGSLLNL--YQRYHL-----RDSQVSAYTRQIL 439 (554)
Q Consensus 378 ~~Ei~------iL~~l~----HpnIVkl~~~~-~~~~~~~LVmE~~~ggsL~~l--l~~~~l-----~e~~i~~i~~QIl 439 (554)
.+|+. .+.++. +.+.+.+-..+ ...+..+|||||+.|+.+.++ +...+. .+..+..++.|+
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi- 276 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV- 276 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-
Confidence 33333 333221 22222221211 123456799999999999774 333332 233334444444
Q ss_pred HHHHHHHHCCccccCCccccEEEcCCC----cEEEEecCcccccc
Q 008759 440 LGLKYLHDQDVVHRDIKCANILVDANG----SVKLADFGLAKATK 480 (554)
Q Consensus 440 ~gL~yLHs~gIIHrDIKPeNILld~~g----~vKL~DFGlA~~~~ 480 (554)
+..|++|+|+||.|||++.+| .++++|||++....
T Consensus 277 ------f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 277 ------FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred ------HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 458999999999999999888 99999999986543
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.35 E-value=2e-12 Score=120.45 Aligned_cols=127 Identities=20% Similarity=0.161 Sum_probs=94.1
Q ss_pred eeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCce-eeeeeeccCCCcEEEEEeec
Q 008759 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI-VQYYGTDKDESKLYIFLELV 412 (554)
Q Consensus 334 ~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnI-Vkl~~~~~~~~~~~LVmE~~ 412 (554)
.+.|+.|.++.||++... +..|++|....... ....+..|+.++..+.+.++ .+++..+. ...++||||+
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~------~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i 73 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE------LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFI 73 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc------cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEec
Confidence 357899999999998865 67899998653211 11235678888888765444 45555443 3358999999
Q ss_pred ccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCc-----cccCCccccEEEcCCCcEEEEecCccc
Q 008759 413 TKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV-----VHRDIKCANILVDANGSVKLADFGLAK 477 (554)
Q Consensus 413 ~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gI-----IHrDIKPeNILld~~g~vKL~DFGlA~ 477 (554)
+|.++... . .....++.+++.+|..||..++ +|+|++|.|||++ ++.++|+|||.+.
T Consensus 74 ~G~~l~~~----~---~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 74 EGSELLTE----D---FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred CCCccccc----c---ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 99887643 1 1123457899999999999985 9999999999998 7789999999864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.23 E-value=1.1e-10 Score=112.32 Aligned_cols=137 Identities=20% Similarity=0.206 Sum_probs=101.0
Q ss_pred eeeccCCceeEEEEecCCCcEEEEEEEecc---cccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEEEee
Q 008759 335 DLLGRGSFGSVYEGISDDGFFFAVKEVSLL---DQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLEL 411 (554)
Q Consensus 335 ~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~---~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LVmE~ 411 (554)
.+|++|+-+.+|.+.+.+. .+++|.-..+ ......+-...+..+|.+++.+++--.|.-.+-++.+.+...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~g~-~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGL-PAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeeccCc-ceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 4688999999999966433 3555543221 11122233345677899999988766665444455566777899999
Q ss_pred cccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccc
Q 008759 412 VTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT 479 (554)
Q Consensus 412 ~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~ 479 (554)
++|..|.+++... ...+++.+-.-+.-||..||+|+||.++||++..+ .+.++||||+...
T Consensus 81 I~G~~lkd~l~~~------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~-~i~~IDfGLg~~s 141 (204)
T COG3642 81 IEGELLKDALEEA------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG-RIYFIDFGLGEFS 141 (204)
T ss_pred eCChhHHHHHHhc------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC-cEEEEECCccccc
Confidence 9999999888765 24567888888889999999999999999999654 4999999998643
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.2e-10 Score=128.83 Aligned_cols=162 Identities=25% Similarity=0.360 Sum_probs=122.7
Q ss_pred CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEEEeecccCchHHHHhhhcCChHH
Q 008759 351 DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQ 430 (554)
Q Consensus 351 ~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LVmE~~~ggsL~~ll~~~~l~e~~ 430 (554)
.++.++.+..+..... .......+-+.-|+.++||||+++++.+...+.+|||+|-+.- |..++++-+ ...
T Consensus 35 ~~~~~vsVF~~~~~~~-----~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~P--l~~~lk~l~--~~~ 105 (690)
T KOG1243|consen 35 ADGGPVSVFVYKRSNG-----EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRP--LETVLKELG--KEE 105 (690)
T ss_pred ccCCceEEEEEeCCCc-----hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecccc--HHHHHHHhH--HHH
Confidence 5677777777664222 3334566777889999999999999999999999999998864 666666533 667
Q ss_pred HHHHHHHHHHHHHHHH-HCCccccCCccccEEEcCCCcEEEEecCcccccccCC--ccCccCCCcccChhhhcccCCCCC
Q 008759 431 VSAYTRQILLGLKYLH-DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VKSCRGTAFWMAPEVINNKNKGYG 507 (554)
Q Consensus 431 i~~i~~QIl~gL~yLH-s~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~--~~s~~GT~~Y~APEvl~~~~~~~s 507 (554)
+..-+.||+.||.||| +++++|++|.-.-|+|+..|..||++|-++....... .....--..|..|+.+... .
T Consensus 106 v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s----~ 181 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPS----E 181 (690)
T ss_pred HHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCcc----c
Confidence 7788999999999997 6789999999999999999999999998875433221 1111122236677765322 1
Q ss_pred chhhHHHHHHHHHHHHcC
Q 008759 508 LPADIWSLGCTVLEMLTS 525 (554)
Q Consensus 508 ~ksDIwSLGvllyeLLTG 525 (554)
-..|.|-|||++++++.|
T Consensus 182 ~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cchhhhhHHHHHHHHhCc
Confidence 347999999999999999
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.17 E-value=1.4e-10 Score=112.14 Aligned_cols=139 Identities=19% Similarity=0.202 Sum_probs=101.1
Q ss_pred eeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCC--ceeeeeeeccCC---CcEEEEE
Q 008759 335 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE--NIVQYYGTDKDE---SKLYIFL 409 (554)
Q Consensus 335 ~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hp--nIVkl~~~~~~~---~~~~LVm 409 (554)
+.|+.|.++.||++...+|..|++|........ .....+.+|+.++..+.+. ++.+++.+.... +..++||
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~----~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~ 79 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL----PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVM 79 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC----cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEE
Confidence 568999999999998876788999987542211 1234577899999988753 456677766553 3678999
Q ss_pred eecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHH------------------------------------------
Q 008759 410 ELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD------------------------------------------ 447 (554)
Q Consensus 410 E~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs------------------------------------------ 447 (554)
||+.|.++...+....++..+...++.+++..|.+||+
T Consensus 80 e~i~G~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 80 ERVDGRVLRDRLLRPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred EEeCCEecCCCCCCCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 99999887664432345555566666666666666663
Q ss_pred --------------CCccccCCccccEEEcC--CCcEEEEecCccc
Q 008759 448 --------------QDVVHRDIKCANILVDA--NGSVKLADFGLAK 477 (554)
Q Consensus 448 --------------~gIIHrDIKPeNILld~--~g~vKL~DFGlA~ 477 (554)
..++|+|+++.|||++. ++.+.|+||+.+.
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 23689999999999988 5678999998753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.13 E-value=5.2e-10 Score=108.62 Aligned_cols=131 Identities=27% Similarity=0.284 Sum_probs=88.7
Q ss_pred eEEEEecCCCcEEEEEEEeccc---------------------ccchhHHHHHHHHHHHHHHHhCCCC--ceeeeeeecc
Q 008759 344 SVYEGISDDGFFFAVKEVSLLD---------------------QGSQAKQSISQLEQEIALLSRFEHE--NIVQYYGTDK 400 (554)
Q Consensus 344 ~VY~a~~~~g~~vAvK~v~~~~---------------------~~~~~~~~~~~~~~Ei~iL~~l~Hp--nIVkl~~~~~ 400 (554)
.||.|...+|..+|+|..+... .............+|.+.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899999899999999986410 1122233345678899999999866 456666553
Q ss_pred CCCcEEEEEeecc--cCchHHHHhhhcCChHHHHHHHHHHHHHHHH-HHHCCccccCCccccEEEcCCCcEEEEecCccc
Q 008759 401 DESKLYIFLELVT--KGSLLNLYQRYHLRDSQVSAYTRQILLGLKY-LHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477 (554)
Q Consensus 401 ~~~~~~LVmE~~~--ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~y-LHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~ 477 (554)
..+|||||++ |..+..+. ...+.......++.+++..+.. +|..||+|+||.+.|||++.+ .+.|+|||.+.
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~-~~~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~qav 154 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLK-DVDLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQAV 154 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHH-HCGGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTTEE
T ss_pred ---CCEEEEEecCCCccchhhHH-hccccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCcce
Confidence 3479999999 65565443 3333355667788888885555 589999999999999999877 99999999875
Q ss_pred ccc
Q 008759 478 ATK 480 (554)
Q Consensus 478 ~~~ 480 (554)
...
T Consensus 155 ~~~ 157 (188)
T PF01163_consen 155 DSS 157 (188)
T ss_dssp ETT
T ss_pred ecC
Confidence 543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.13 E-value=5.6e-10 Score=107.23 Aligned_cols=146 Identities=23% Similarity=0.277 Sum_probs=106.4
Q ss_pred eeeeeccCCceeEEEEecCCCcEEEEEEEecc---cccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEEE
Q 008759 333 KGDLLGRGSFGSVYEGISDDGFFFAVKEVSLL---DQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFL 409 (554)
Q Consensus 333 i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~---~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LVm 409 (554)
...+|-+|+-+.|+++.+. |+.+.+|.-... ......+-...+..+|+++|.++.--.|.-..-+|.+...-+|+|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4678999999999999875 566666653321 122223334567889999999887656644444455666678999
Q ss_pred eeccc-CchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCC---cEEEEecCccccc
Q 008759 410 ELVTK-GSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG---SVKLADFGLAKAT 479 (554)
Q Consensus 410 E~~~g-gsL~~ll~~~---~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g---~vKL~DFGlA~~~ 479 (554)
||++| .++.+++... ...+.....++++|-..|.-||.++|||+||..+||++..+| .+.++|||++...
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 99988 4677777642 233333468899999999999999999999999999997665 3589999997543
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.12 E-value=5.1e-11 Score=130.24 Aligned_cols=197 Identities=27% Similarity=0.332 Sum_probs=152.1
Q ss_pred cceeeeeeecc--CCceeEEEEec---CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCC-CCceeeeeeeccCC
Q 008759 329 TYWQKGDLLGR--GSFGSVYEGIS---DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDE 402 (554)
Q Consensus 329 ~~y~i~~~LG~--GsfG~VY~a~~---~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIVkl~~~~~~~ 402 (554)
..+.+.+.+|. |.+|.||.+.. .++..+|+|.-+....... .-..-.+|+.-..+++ |+|.++.+..+...
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~---~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~ 190 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPL---DSKRKLREFLSHHKIDSHENPVRDSPAWEGS 190 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCcc---ccccccchhhcccccCccccccccCcccccC
Confidence 35566778999 99999999876 5688899987443221111 1112235555555554 89999999999999
Q ss_pred CcEEEEEeecccCchHHHHhh-h-cCChHHHHHHHHHHHH----HHHHHHHCCccccCCccccEEEcCC-CcEEEEecCc
Q 008759 403 SKLYIFLELVTKGSLLNLYQR-Y-HLRDSQVSAYTRQILL----GLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGL 475 (554)
Q Consensus 403 ~~~~LVmE~~~ggsL~~ll~~-~-~l~e~~i~~i~~QIl~----gL~yLHs~gIIHrDIKPeNILld~~-g~vKL~DFGl 475 (554)
+.+|+-+|++. .+|..+... . .+++..++.++.+... ||.++|..+++|-|+||+||++..+ ...+++|||+
T Consensus 191 ~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~ 269 (524)
T KOG0601|consen 191 GILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGL 269 (524)
T ss_pred Ccceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcce
Confidence 99999999997 467766654 2 3788889999999999 9999999999999999999999999 8899999999
Q ss_pred ccccccCCc-------cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008759 476 AKATKLNDV-------KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM 532 (554)
Q Consensus 476 A~~~~~~~~-------~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~ 532 (554)
...+..... ....|...|++||++++. ++...|+|+||.++++-.++..++...
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l---~~~~~di~sl~ev~l~~~l~~~~~~~g 330 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL---ATFASDIFSLGEVILEAILGSHLPSVG 330 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhccc---cchHhhhcchhhhhHhhHhhcccccCC
Confidence 877655432 122477889999998654 678999999999999998876655433
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.09 E-value=8.4e-11 Score=128.59 Aligned_cols=198 Identities=24% Similarity=0.189 Sum_probs=148.1
Q ss_pred cccccceeeeeeeccCCceeEEEEec--CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhC-CCCceeeeeeeccC
Q 008759 325 KRIITYWQKGDLLGRGSFGSVYEGIS--DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKD 401 (554)
Q Consensus 325 ~~~~~~y~i~~~LG~GsfG~VY~a~~--~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIVkl~~~~~~ 401 (554)
.....+|.++..||.|.|+.||.+.. .++..|++|.+....... ...+ .-..|+.+...+ .|.+++.++..|..
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~--~~di-~sl~ev~l~~~l~~~~~~~g~~~~W~~ 337 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATF--ASDI-FSLGEVILEAILGSHLPSVGKNSSWSQ 337 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccch--Hhhh-cchhhhhHhhHhhcccccCCCCCCccc
Confidence 34567899999999999999998754 578899999876433322 1222 233566666665 49999999999998
Q ss_pred CCcEEEEEeecccCchHHHHh-hhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCC-CcEEEEecCccccc
Q 008759 402 ESKLYIFLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAKAT 479 (554)
Q Consensus 402 ~~~~~LVmE~~~ggsL~~ll~-~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~-g~vKL~DFGlA~~~ 479 (554)
..+.|+-.|||.++++..... ...+.+...+.+..|++.++.++|++.++|+|+||+||++..+ +..++.|||..+..
T Consensus 338 ~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~ 417 (524)
T KOG0601|consen 338 LRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRL 417 (524)
T ss_pred cccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccc
Confidence 889999999999998765442 2357788889999999999999999999999999999999876 78899999987642
Q ss_pred ccCCccCccCCCccc-ChhhhcccCCCCCchhhHHHHHHHHHHHHcCCC
Q 008759 480 KLNDVKSCRGTAFWM-APEVINNKNKGYGLPADIWSLGCTVLEMLTSQI 527 (554)
Q Consensus 480 ~~~~~~s~~GT~~Y~-APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~ 527 (554)
...... ....-+++ ..|++... ..+..+.|+|+||..+++.++|..
T Consensus 418 ~~~~~~-~~~~~r~~p~~~~~~e~-~~~~~~~~~~sl~~~~~e~~~~~~ 464 (524)
T KOG0601|consen 418 AFSSGV-FHHIDRLYPIAEILLED-YPHLSKADIFSLGLSVDEAITGSP 464 (524)
T ss_pred ceeccc-ccccccccccchhhccc-cccccccccccccccccccccCcc
Confidence 211111 12333444 25555433 247789999999999999888754
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.09 E-value=3.4e-11 Score=138.00 Aligned_cols=210 Identities=20% Similarity=0.250 Sum_probs=158.7
Q ss_pred ccccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCC
Q 008759 324 FKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE 402 (554)
Q Consensus 324 ~~~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~ 402 (554)
+....+.+.+.+.+-.|.++.++.+.- ..|...+.|+........ ....+.+..+-.++-...+|.++.....+...
T Consensus 799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~--~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~r 876 (1205)
T KOG0606|consen 799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIR--TNDYESIRSKSNILITPRSPAVVRSFPSFPCR 876 (1205)
T ss_pred ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhc--cccccccCCccCccccCCCCceecccCCCCCC
Confidence 445667888899999999999998876 456666666554322111 11122333344444445568888877777788
Q ss_pred CcEEEEEeecccCchHHHHhhhc-CChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccc-
Q 008759 403 SKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK- 480 (554)
Q Consensus 403 ~~~~LVmE~~~ggsL~~ll~~~~-l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~- 480 (554)
...+++++|+.++.|...++..+ ....-.+.++..+..++++||...++|+|++|.|+|+..+|+.++.|||+.....
T Consensus 877 sP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~ 956 (1205)
T KOG0606|consen 877 SPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL 956 (1205)
T ss_pred CCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCcccccccccc
Confidence 89999999999999999988755 6666677788999999999999999999999999999999999999998543210
Q ss_pred ------c--------------------------CCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCC
Q 008759 481 ------L--------------------------NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIP 528 (554)
Q Consensus 481 ------~--------------------------~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~P 528 (554)
. .......+|+.|.+||.+.+.. .+..+|+|++|+++++.++|..|
T Consensus 957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~--hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR--HGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccccc--CCCcchhhhhhhhhhhhhcCCCC
Confidence 0 0012335899999999997655 56789999999999999999999
Q ss_pred CCCCChhHH
Q 008759 529 YAPMECVSA 537 (554)
Q Consensus 529 F~~~e~~~~ 537 (554)
|....+-+.
T Consensus 1035 ~na~tpq~~ 1043 (1205)
T KOG0606|consen 1035 FNAETPQQI 1043 (1205)
T ss_pred CCCcchhhh
Confidence 987665433
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.97 E-value=9.4e-09 Score=105.14 Aligned_cols=143 Identities=12% Similarity=0.084 Sum_probs=95.0
Q ss_pred eeeccCCceeEEEEecCCCcEEEEEEEecccccchhHH------HHHHHHHHHHHHHhCCCCce--eeeeeeccC-----
Q 008759 335 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQ------SISQLEQEIALLSRFEHENI--VQYYGTDKD----- 401 (554)
Q Consensus 335 ~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~------~~~~~~~Ei~iL~~l~HpnI--Vkl~~~~~~----- 401 (554)
+.+-......|+++.. +|+.|.+|...........+. -...+.+|+..+..+...+| ..++.++..
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 3444444445666544 467888997642111000000 01136688888877753333 233333321
Q ss_pred CCcEEEEEeecccC-chHHHHhh---hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcC-------CCcEEE
Q 008759 402 ESKLYIFLELVTKG-SLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA-------NGSVKL 470 (554)
Q Consensus 402 ~~~~~LVmE~~~gg-sL~~ll~~---~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~-------~g~vKL 470 (554)
...-+||||++++. +|.+++.. ..........++.+++..+..||..||+|+||++.|||++. ++.+.|
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~L 186 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSV 186 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEE
Confidence 23578999999986 78888763 23455667789999999999999999999999999999975 468999
Q ss_pred EecCcccc
Q 008759 471 ADFGLAKA 478 (554)
Q Consensus 471 ~DFGlA~~ 478 (554)
+||+.+..
T Consensus 187 IDl~r~~~ 194 (268)
T PRK15123 187 IDLHRAQI 194 (268)
T ss_pred EECCcccc
Confidence 99998753
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.95 E-value=7.4e-09 Score=104.98 Aligned_cols=141 Identities=25% Similarity=0.262 Sum_probs=106.6
Q ss_pred ceeeeeeeccCCceeEEEEecCCCcEEEEEEEecc-----------------cccchhHHHHHHHHHHHHHHHhCCCC--
Q 008759 330 YWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLL-----------------DQGSQAKQSISQLEQEIALLSRFEHE-- 390 (554)
Q Consensus 330 ~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~-----------------~~~~~~~~~~~~~~~Ei~iL~~l~Hp-- 390 (554)
-+.++..||.|.-+.||.|.+..|..+|+|.-+.. .............++|..+|+++...
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 35678899999999999999999999999975421 11111122334567899999988654
Q ss_pred ceeeeeeeccCCCcEEEEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEE
Q 008759 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKL 470 (554)
Q Consensus 391 nIVkl~~~~~~~~~~~LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL 470 (554)
.|.+.+++ +...+||||++|-.|... .+.......++..|+.-+..+-..||||+|+++-|||++.+|.+.+
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~v 243 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRL----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVV 243 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeecc----cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEE
Confidence 56666653 566899999999776543 2235556667777888777777999999999999999999999999
Q ss_pred EecCcccc
Q 008759 471 ADFGLAKA 478 (554)
Q Consensus 471 ~DFGlA~~ 478 (554)
+||--+..
T Consensus 244 IDwPQ~v~ 251 (304)
T COG0478 244 IDWPQAVP 251 (304)
T ss_pred EeCccccc
Confidence 99975543
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.84 E-value=4.9e-09 Score=107.96 Aligned_cols=145 Identities=25% Similarity=0.400 Sum_probs=109.5
Q ss_pred HHHHHhCCCCceeeeeeeccCCC-----cEEEEEeecccCchHHHHhhh-----cCChHHHHHHHHHHHHHHHHHHHCC-
Q 008759 381 IALLSRFEHENIVQYYGTDKDES-----KLYIFLELVTKGSLLNLYQRY-----HLRDSQVSAYTRQILLGLKYLHDQD- 449 (554)
Q Consensus 381 i~iL~~l~HpnIVkl~~~~~~~~-----~~~LVmE~~~ggsL~~ll~~~-----~l~e~~i~~i~~QIl~gL~yLHs~g- 449 (554)
+.-|-++-|.|||+++.++.+.. ...+++|||..|+|..+|++. .+......+|+.||+.||.|||+..
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~P 197 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCC
Confidence 33455567999999988876543 478999999999999999753 3778888999999999999999986
Q ss_pred -ccccCCccccEEEcCCCcEEEEecCcccccc-------cCCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHH
Q 008759 450 -VVHRDIKCANILVDANGSVKLADFGLAKATK-------LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLE 521 (554)
Q Consensus 450 -IIHrDIKPeNILld~~g~vKL~DFGlA~~~~-------~~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllye 521 (554)
|+|+++.++-|++..+|-|||.--- -.... ........+-++|.+||.= .....+.++|||+||...++
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~a-p~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg--~~tn~~~a~dIy~fgmcAle 274 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVA-PDSTHPSVNSTREAEKSVNTSLPGFSAPESG--TTTNTTGASDIYKFGMCALE 274 (458)
T ss_pred ccccCCcchhheeecCCceEEecccC-ccccchhhhhhhHhhhhccccCCccccCCcC--cccccccchhhhhhhHHHHH
Confidence 9999999999999999988875211 11111 0111123467889999963 22234568999999999999
Q ss_pred HHcCCCC
Q 008759 522 MLTSQIP 528 (554)
Q Consensus 522 LLTG~~P 528 (554)
|..|..-
T Consensus 275 mailEiq 281 (458)
T KOG1266|consen 275 MAILEIQ 281 (458)
T ss_pred HHHheec
Confidence 9877664
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.82 E-value=5e-08 Score=105.73 Aligned_cols=163 Identities=17% Similarity=0.262 Sum_probs=125.3
Q ss_pred eeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccC----CCcEEEEEeeccc-Cc
Q 008759 343 GSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD----ESKLYIFLELVTK-GS 416 (554)
Q Consensus 343 G~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~----~~~~~LVmE~~~g-gs 416 (554)
.+.|+++. .+|..|++|.+.........+ ...-+++++++.|.|||++..+|.. +.-+++|++|.++ ++
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk-----~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~T 364 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNK-----DTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPT 364 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCccc-----chHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCch
Confidence 47899988 889999999984322222211 2344678999999999999988763 4468999999876 47
Q ss_pred hHHHHhh----------------hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccc
Q 008759 417 LLNLYQR----------------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK 480 (554)
Q Consensus 417 L~~ll~~----------------~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~ 480 (554)
|.+++.. .+.++..++.|+.||..||.++|+.|+..+-|.+.+||++.+.+++|..+|+.....
T Consensus 365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence 7776531 136778899999999999999999999999999999999999899999888766554
Q ss_pred cCCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCC
Q 008759 481 LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQI 527 (554)
Q Consensus 481 ~~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~ 527 (554)
.+.. +-+.. -++-|.=.||.+++.|.||..
T Consensus 445 ~d~~------------~~le~-----~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 445 EDPT------------EPLES-----QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CCCC------------cchhH-----HhhhhHHHHHHHHHHHhhccc
Confidence 4331 11211 235799999999999999955
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.74 E-value=5.9e-08 Score=95.12 Aligned_cols=104 Identities=25% Similarity=0.319 Sum_probs=79.0
Q ss_pred HHHHHHHHHHHhCCCCce--eeeeeeccCC----CcEEEEEeecccC-chHHHHhh-hcCChHHHHHHHHHHHHHHHHHH
Q 008759 375 SQLEQEIALLSRFEHENI--VQYYGTDKDE----SKLYIFLELVTKG-SLLNLYQR-YHLRDSQVSAYTRQILLGLKYLH 446 (554)
Q Consensus 375 ~~~~~Ei~iL~~l~HpnI--Vkl~~~~~~~----~~~~LVmE~~~gg-sL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLH 446 (554)
.+..+|...+..+..-+| .+.+++.... ...+||+|++++. +|.+++.. ..+.......++.++...+.-||
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH 135 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH 135 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence 356677777766653322 3333333221 3458999999884 78888876 23566677889999999999999
Q ss_pred HCCccccCCccccEEEcCCC---cEEEEecCcccc
Q 008759 447 DQDVVHRDIKCANILVDANG---SVKLADFGLAKA 478 (554)
Q Consensus 447 s~gIIHrDIKPeNILld~~g---~vKL~DFGlA~~ 478 (554)
.+||+|+|+++.|||++.++ .+.|+||+.++.
T Consensus 136 ~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 136 DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99999999999999999887 899999997654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.65 E-value=3.6e-07 Score=91.95 Aligned_cols=141 Identities=18% Similarity=0.188 Sum_probs=97.1
Q ss_pred eeeccCCceeEEEEecCCCcEEEEEEEeccccc-------------------chhHHHHHHHHHHHHHHHhCCC--Ccee
Q 008759 335 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQG-------------------SQAKQSISQLEQEIALLSRFEH--ENIV 393 (554)
Q Consensus 335 ~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~-------------------~~~~~~~~~~~~Ei~iL~~l~H--pnIV 393 (554)
.+|..|.-+.||+|...++..+|+|+++..... ............|+.-|.++.. =.+.
T Consensus 54 g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 54 GCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 378889999999999988999999998742111 1111112233455655555532 2233
Q ss_pred eeeeeccCCCcEEEEEeecccC-chHHHHhhhcCChHHHHHHHHHHHHHHHHHHH-CCccccCCccccEEEcCCCcEEEE
Q 008759 394 QYYGTDKDESKLYIFLELVTKG-SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGSVKLA 471 (554)
Q Consensus 394 kl~~~~~~~~~~~LVmE~~~gg-sL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs-~gIIHrDIKPeNILld~~g~vKL~ 471 (554)
+.+.+. ...|||||+... .-.-.|+..++...+...+..+++..+.-|-. .++||+||+.-|||+. ++.+.|+
T Consensus 134 ~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~iI 208 (268)
T COG1718 134 EPIAFR----NNVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPYII 208 (268)
T ss_pred Cceeec----CCeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEEEE
Confidence 344433 347999999764 22223333444455677888999999988877 8999999999999998 8999999
Q ss_pred ecCcccccc
Q 008759 472 DFGLAKATK 480 (554)
Q Consensus 472 DFGlA~~~~ 480 (554)
|||-|....
T Consensus 209 D~~QaV~~~ 217 (268)
T COG1718 209 DVSQAVTID 217 (268)
T ss_pred ECccccccC
Confidence 999876554
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.56 E-value=7.3e-07 Score=94.90 Aligned_cols=191 Identities=17% Similarity=0.177 Sum_probs=127.1
Q ss_pred eeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhC-CCCceeeeee------eccCCC-
Q 008759 332 QKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYG------TDKDES- 403 (554)
Q Consensus 332 ~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIVkl~~------~~~~~~- 403 (554)
..+..||+|+-+.+|-.-.- .-.+.|++.......+. +.+..|... .||-+-.-+. ++-...
T Consensus 14 ~~gr~LgqGgea~ly~l~e~--~d~VAKIYh~Pppa~~a--------qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~ 83 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV--RDQVAKIYHAPPPAAQA--------QKVAELAATPDAPLLNYRVAWPQATLHGGRRGK 83 (637)
T ss_pred CCCccccCCccceeeecchh--hchhheeecCCCchHHH--------HHHHHhccCCCCcchhhhhcccHHHhhCCCccc
Confidence 35677999999999965331 12355666543322211 223334444 3553322111 122222
Q ss_pred cEEEEEeecccC-chHHHHhh------h-cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCc
Q 008759 404 KLYIFLELVTKG-SLLNLYQR------Y-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL 475 (554)
Q Consensus 404 ~~~LVmE~~~gg-sL~~ll~~------~-~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGl 475 (554)
.+-++|..+.+. .+..++.. + ...+.-..+.++.|+.+...||..|.+-+|++++|||+.+++.|.|+|-..
T Consensus 84 ~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDs 163 (637)
T COG4248 84 VIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDS 163 (637)
T ss_pred eeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccc
Confidence 367888888764 33444421 2 256677888999999999999999999999999999999999999998765
Q ss_pred ccccccCCc-cCccCCCcccChhhhccc---CCCCCchhhHHHHHHHHHHHHcC-CCCCCCC
Q 008759 476 AKATKLNDV-KSCRGTAFWMAPEVINNK---NKGYGLPADIWSLGCTVLEMLTS-QIPYAPM 532 (554)
Q Consensus 476 A~~~~~~~~-~s~~GT~~Y~APEvl~~~---~~~~s~ksDIwSLGvllyeLLTG-~~PF~~~ 532 (554)
.....++.. .-.+|...|.+||...-. ..+.+...|.|.||++++++|.| +.||.+.
T Consensus 164 fqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI 225 (637)
T COG4248 164 FQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI 225 (637)
T ss_pred eeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence 444333332 234589999999987521 11245678999999999999985 9999864
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.53 E-value=7.1e-07 Score=88.22 Aligned_cols=140 Identities=16% Similarity=0.157 Sum_probs=96.4
Q ss_pred eccCCceeEEEEecCCCcEEEEEEEecccccchh-HHHHHHHHHHHHHHHhCCCCc--eeeeeeec--cC--CCcEEEEE
Q 008759 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQA-KQSISQLEQEIALLSRFEHEN--IVQYYGTD--KD--ESKLYIFL 409 (554)
Q Consensus 337 LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~-~~~~~~~~~Ei~iL~~l~Hpn--IVkl~~~~--~~--~~~~~LVm 409 (554)
-|+||-+.|+.....+. .|-+|.-......... ..-...|.+|+..|..+...+ +.++.... .. .-.-+||+
T Consensus 26 ~~rgG~SgV~r~~~~g~-~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERNGK-KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeCCc-EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 35688888888655433 5667765411111100 112356889999988886433 34444221 11 22468999
Q ss_pred eeccc-CchHHHHhhhc---CChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCc--EEEEecCccc
Q 008759 410 ELVTK-GSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS--VKLADFGLAK 477 (554)
Q Consensus 410 E~~~g-gsL~~ll~~~~---l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~--vKL~DFGlA~ 477 (554)
|-+.+ .+|.+++.... .+......++.++...|.-||+.|+.|+|+.+.|||++.+|. ++++||--++
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 97764 48888887644 356666789999999999999999999999999999987777 9999997554
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.49 E-value=5.5e-07 Score=99.84 Aligned_cols=144 Identities=17% Similarity=0.213 Sum_probs=92.3
Q ss_pred eeeccCCceeEEEEecCCCcEEEEEEEecccc----------------------c---chhHHHH----HH------HHH
Q 008759 335 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQ----------------------G---SQAKQSI----SQ------LEQ 379 (554)
Q Consensus 335 ~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~----------------------~---~~~~~~~----~~------~~~ 379 (554)
+.|+.++-|.||+|+..+|+.||||+.+..-. . ......+ +. +.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 57999999999999999999999999753110 0 0111111 11 223
Q ss_pred HHHHHHhCC-----CCceeeeeeeccCCCcEEEEEeecccCchHHH--HhhhcCChHHHHHHHHHHHHHHHHHHHCCccc
Q 008759 380 EIALLSRFE-----HENIVQYYGTDKDESKLYIFLELVTKGSLLNL--YQRYHLRDSQVSAYTRQILLGLKYLHDQDVVH 452 (554)
Q Consensus 380 Ei~iL~~l~-----HpnIVkl~~~~~~~~~~~LVmE~~~ggsL~~l--l~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIH 452 (554)
|..-+.+++ .++|.=..-++...+.-.|+|||+.|-.+.++ ++..+++...+.....+++ +..+=..|++|
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~dgffH 288 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLRDGFFH 288 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHhcCccc
Confidence 433333332 23332222223334566899999999988876 4555666444443332222 22233479999
Q ss_pred cCCccccEEEcCCCcEEEEecCcccccc
Q 008759 453 RDIKCANILVDANGSVKLADFGLAKATK 480 (554)
Q Consensus 453 rDIKPeNILld~~g~vKL~DFGlA~~~~ 480 (554)
.|..|.||+++.+|.+.+.|||+.....
T Consensus 289 aDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 289 ADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred cCCCccceEEecCCcEEEEcCcceecCC
Confidence 9999999999999999999999975543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.47 E-value=2.2e-06 Score=85.30 Aligned_cols=139 Identities=14% Similarity=0.146 Sum_probs=86.3
Q ss_pred ccceeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHH------HHHHHHHHHhCC---CCceeeeee-
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQ------LEQEIALLSRFE---HENIVQYYG- 397 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~------~~~Ei~iL~~l~---HpnIVkl~~- 397 (554)
.+.|.+.+.+-......|.+-. -+|..+++|........ .+..... ..+.+..+..++ ...+..++.
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIe-i~~~kyIlK~pr~~~~r--~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIE-IDGKKYILKEPREENRR--PERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred hCCceEEEeecCCCccEEEEEE-ECCcEEEEeccchhhhh--HHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 3467777777776666666543 45688899987642211 1111111 122333333332 222333222
Q ss_pred ----eccCCCcEEEEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEec
Q 008759 398 ----TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADF 473 (554)
Q Consensus 398 ----~~~~~~~~~LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DF 473 (554)
.+......+|+|||++|..|.++.. +.+ .+...|..+|..||+.|++|+|+.|.||+++. +.++++||
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~---i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~-~~i~iID~ 178 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED---IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSN-NGIRIIDT 178 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh---cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEEC-CcEEEEEC
Confidence 2333345679999999988866532 222 24466778899999999999999999999975 55999999
Q ss_pred Cccc
Q 008759 474 GLAK 477 (554)
Q Consensus 474 GlA~ 477 (554)
+..+
T Consensus 179 ~~k~ 182 (229)
T PF06176_consen 179 QGKR 182 (229)
T ss_pred cccc
Confidence 8643
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.33 E-value=7.6e-06 Score=79.06 Aligned_cols=136 Identities=21% Similarity=0.275 Sum_probs=79.6
Q ss_pred eeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCC--ceeeeeeec---cCCCcEEEE
Q 008759 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE--NIVQYYGTD---KDESKLYIF 408 (554)
Q Consensus 334 ~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hp--nIVkl~~~~---~~~~~~~LV 408 (554)
++.|+.|..+.||++...+ ..+++|..... .....+.+|..+++.+... .+.+++... ......+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~-------~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~ 73 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP-------DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLL 73 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH-------HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEE
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC-------CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEE
Confidence 4679999999999998877 58999986531 3345667788887777533 244555532 233457999
Q ss_pred EeecccCchHH----------------HHh---hh-----cCChHH------HHH---H------------HHHHHH-HH
Q 008759 409 LELVTKGSLLN----------------LYQ---RY-----HLRDSQ------VSA---Y------------TRQILL-GL 442 (554)
Q Consensus 409 mE~~~ggsL~~----------------ll~---~~-----~l~e~~------i~~---i------------~~QIl~-gL 442 (554)
|+++.|..+.. ++. +. .+.... ... . ...+.. .+
T Consensus 74 ~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (239)
T PF01636_consen 74 MEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLL 153 (239)
T ss_dssp EEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHH
T ss_pred EEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHH
Confidence 99999987766 111 11 000000 000 0 011222 23
Q ss_pred HHHHH-------CCccccCCccccEEEc-CCCcEEEEecCccc
Q 008759 443 KYLHD-------QDVVHRDIKCANILVD-ANGSVKLADFGLAK 477 (554)
Q Consensus 443 ~yLHs-------~gIIHrDIKPeNILld-~~g~vKL~DFGlA~ 477 (554)
..++. ..++|+|+.|.|||++ .++.+-|+||+.+.
T Consensus 154 ~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 154 QELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 33332 3599999999999999 66777899998753
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.21 E-value=8.4e-06 Score=81.30 Aligned_cols=132 Identities=12% Similarity=0.148 Sum_probs=80.8
Q ss_pred eeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCc--eeeeeeeccCCCcEEEEEeec
Q 008759 335 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN--IVQYYGTDKDESKLYIFLELV 412 (554)
Q Consensus 335 ~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hpn--IVkl~~~~~~~~~~~LVmE~~ 412 (554)
..||+|..+.||+. .+..+++|...... ....+.+|.+++..+..-+ +.+.+.+....+...+|||++
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~-------~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i 76 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF-------DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELI 76 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC-------CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeec
Confidence 46899999999984 24467888775311 1234578888888876433 456677777777788999999
Q ss_pred ccCc-hHHH--------------H-------hhh---cCChHH-HHHHHHH----------HHH-HHHHHHH----CCcc
Q 008759 413 TKGS-LLNL--------------Y-------QRY---HLRDSQ-VSAYTRQ----------ILL-GLKYLHD----QDVV 451 (554)
Q Consensus 413 ~ggs-L~~l--------------l-------~~~---~l~e~~-i~~i~~Q----------Il~-gL~yLHs----~gII 451 (554)
.|.. +... + +.. ...... ...+..+ +.. ...+|.. ..++
T Consensus 77 ~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~ 156 (226)
T TIGR02172 77 VGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCL 156 (226)
T ss_pred CCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceE
Confidence 9963 1111 0 110 001000 0111111 111 1122221 2478
Q ss_pred ccCCccccEEEcCCCcEEEEecCccc
Q 008759 452 HRDIKCANILVDANGSVKLADFGLAK 477 (554)
Q Consensus 452 HrDIKPeNILld~~g~vKL~DFGlA~ 477 (554)
|+|+.|.||+++.++ +.|+||+.+.
T Consensus 157 HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 157 HGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred ecCCCCCcEEEcCCC-cEEEechhcC
Confidence 999999999999888 9999999764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.18 E-value=1e-05 Score=89.88 Aligned_cols=144 Identities=16% Similarity=0.119 Sum_probs=93.2
Q ss_pred eeeccCCceeEEEEecCCCcEEEEEEEecccccc--------------------------hhHHHHHH------HHHHHH
Q 008759 335 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGS--------------------------QAKQSISQ------LEQEIA 382 (554)
Q Consensus 335 ~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~--------------------------~~~~~~~~------~~~Ei~ 382 (554)
+.||.-+.|.||+|+.++|..||+|+-+...... ...+..+. |.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 5699999999999999999999999864311000 00111111 222332
Q ss_pred H----HHhCCCCc------eeeeeeeccCCCcEEEEEeecccCchHH--HHhhhcCChHHHHHHHHHHHHHHHHHHHCCc
Q 008759 383 L----LSRFEHEN------IVQYYGTDKDESKLYIFLELVTKGSLLN--LYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450 (554)
Q Consensus 383 i----L~~l~Hpn------IVkl~~~~~~~~~~~LVmE~~~ggsL~~--ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gI 450 (554)
- .+.+.|-+ |.++|.. ....-.|+||||.|..+.+ .+.+.+++...+...+.+...-+- =..|+
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~--~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~qI--f~~Gf 322 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWD--LSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQI--FKTGF 322 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhh--cCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHHH--HhcCC
Confidence 2 22333444 3333332 2345789999999987655 556677777766554444443332 24589
Q ss_pred cccCCccccEEEcC----CCcEEEEecCcccccccC
Q 008759 451 VHRDIKCANILVDA----NGSVKLADFGLAKATKLN 482 (554)
Q Consensus 451 IHrDIKPeNILld~----~g~vKL~DFGlA~~~~~~ 482 (554)
+|+|-.|.||++.. ++.+.+.|||+.......
T Consensus 323 fHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 323 FHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred ccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 99999999999984 568999999998765543
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.14 E-value=2.1e-05 Score=78.35 Aligned_cols=74 Identities=14% Similarity=0.095 Sum_probs=49.9
Q ss_pred eccCCc-eeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCC-CCceeeeeeeccCCCcEEEEEeeccc
Q 008759 337 LGRGSF-GSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDESKLYIFLELVTK 414 (554)
Q Consensus 337 LG~Gsf-G~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIVkl~~~~~~~~~~~LVmE~~~g 414 (554)
|-.|.. ..||+.... +..+.+|...... ...+.+|+.++..+. +--+.++++++...+..++|||++.|
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~--------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G 76 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP--------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPG 76 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc--------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCC
Confidence 444555 789998764 3678888765321 234567888877774 33355777777666778999999999
Q ss_pred CchHH
Q 008759 415 GSLLN 419 (554)
Q Consensus 415 gsL~~ 419 (554)
.+|..
T Consensus 77 ~~l~~ 81 (244)
T cd05150 77 VPAAA 81 (244)
T ss_pred ccHhH
Confidence 77653
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.11 E-value=4.1e-05 Score=75.15 Aligned_cols=135 Identities=21% Similarity=0.331 Sum_probs=93.6
Q ss_pred eeeeccCCceeEEEEecCCCcEEEEEEEecccccc-----------hhHHHHHHHHHHHHHHHhCC------CCceeeee
Q 008759 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGS-----------QAKQSISQLEQEIALLSRFE------HENIVQYY 396 (554)
Q Consensus 334 ~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~-----------~~~~~~~~~~~Ei~iL~~l~------HpnIVkl~ 396 (554)
..+||+|+.-.||. +.+....+||+........ .......+..+|+.....+. +.+|.++|
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 35799999999996 4555567888876533000 00011234455555444444 78899999
Q ss_pred eeccCCCcEEEEEeeccc------CchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCC----
Q 008759 397 GTDKDESKLYIFLELVTK------GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG---- 466 (554)
Q Consensus 397 ~~~~~~~~~~LVmE~~~g------gsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g---- 466 (554)
|+..++....+|+|.+.. -+|.++++...+.. .+. ..+-.-..||-+.+|+.+||+|.||++..+.
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~~~~-~~~---~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~ 159 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEGGLTE-ELR---QALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGEF 159 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcCCccH-HHH---HHHHHHHHHHHHcCCeecCCCcccEEEEecCCCce
Confidence 999999999999998753 26888888777766 433 3344455678899999999999999996432
Q ss_pred cEEEEe-cC
Q 008759 467 SVKLAD-FG 474 (554)
Q Consensus 467 ~vKL~D-FG 474 (554)
.+.|+| ||
T Consensus 160 ~lvlIDG~G 168 (199)
T PF10707_consen 160 RLVLIDGLG 168 (199)
T ss_pred EEEEEeCCC
Confidence 577777 44
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.99 E-value=7.8e-07 Score=99.45 Aligned_cols=92 Identities=27% Similarity=0.386 Sum_probs=72.5
Q ss_pred HHHHHHHHHHH-CCccccCCccccEEEcCCCcEEEEecCcccccccCCcc-----------CccCCCcccChhhhcccCC
Q 008759 437 QILLGLKYLHD-QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK-----------SCRGTAFWMAPEVINNKNK 504 (554)
Q Consensus 437 QIl~gL~yLHs-~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~~~-----------s~~GT~~Y~APEvl~~~~~ 504 (554)
++..||.|+|. .++||++|.|++|.++.+|..||+.|+++......... ...-...|.|||++.+..
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~- 185 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT- 185 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc-
Confidence 44489999996 57999999999999999999999999998765442111 112456799999997643
Q ss_pred CCCchhhHHHHHHHHHHHH-cCCCCCC
Q 008759 505 GYGLPADIWSLGCTVLEML-TSQIPYA 530 (554)
Q Consensus 505 ~~s~ksDIwSLGvllyeLL-TG~~PF~ 530 (554)
.+.++|+|||||++|.+. .|+.-|.
T Consensus 186 -~~~~sd~fSlG~li~~i~~~gk~i~~ 211 (700)
T KOG2137|consen 186 -NTPASDVFSLGVLIYTIYNGGKSIIA 211 (700)
T ss_pred -ccccccceeeeeEEEEEecCCcchhh
Confidence 678999999999999998 4555554
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.95 E-value=4e-05 Score=73.86 Aligned_cols=129 Identities=20% Similarity=0.178 Sum_probs=91.7
Q ss_pred eeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCce-eeeeeeccCCCcEEEEEe
Q 008759 332 QKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI-VQYYGTDKDESKLYIFLE 410 (554)
Q Consensus 332 ~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnI-Vkl~~~~~~~~~~~LVmE 410 (554)
+..+.|++|++|.||+|.+..+ .+|+|+-... .....++.|.++|..+.-.++ .++|.+..+ ++.||
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~~~-~~a~Kvrr~d-------s~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me 92 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWRGG-EVALKVRRRD-------SPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRME 92 (201)
T ss_pred hhhhhhhcccccEEEEeeccCc-eEEEEEecCC-------cchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhh
Confidence 4556799999999999988644 7888876532 223568899999999886665 456665443 45699
Q ss_pred ecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCc-cccEEEcCCCcEEEEecCcccc
Q 008759 411 LVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIK-CANILVDANGSVKLADFGLAKA 478 (554)
Q Consensus 411 ~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIK-PeNILld~~g~vKL~DFGlA~~ 478 (554)
|+.|-.|..+.... . +.-+..++..-..|-..||-|+.|. |..+++..++.+.|+||..|+.
T Consensus 93 ~i~G~~L~~~~~~~--~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 93 YIDGRPLGKLEIGG--D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhcCcchhhhhhcc--c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 99998887765421 1 2234456666666788899999997 4444454666999999998864
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.93 E-value=5.4e-05 Score=75.24 Aligned_cols=72 Identities=13% Similarity=0.131 Sum_probs=44.1
Q ss_pred eeeccCCce-eEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCC---ceeeeeeeccCC---CcEEE
Q 008759 335 DLLGRGSFG-SVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE---NIVQYYGTDKDE---SKLYI 407 (554)
Q Consensus 335 ~~LG~GsfG-~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hp---nIVkl~~~~~~~---~~~~L 407 (554)
+.|+.|+.. .||+. +..+++|.... ......+.+|..++..+... -+.+++...... ...|+
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~-------~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~ 71 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSA-------AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWS 71 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCc-------cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceE
Confidence 457766666 59986 33577776442 11234677888888777532 234455544332 24588
Q ss_pred EEeecccCch
Q 008759 408 FLELVTKGSL 417 (554)
Q Consensus 408 VmE~~~ggsL 417 (554)
+|+++.|.++
T Consensus 72 l~~~i~G~~l 81 (235)
T cd05155 72 VYRWLEGETA 81 (235)
T ss_pred EEEeecCCCC
Confidence 9999998765
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.93 E-value=1.8e-06 Score=95.84 Aligned_cols=187 Identities=24% Similarity=0.222 Sum_probs=136.6
Q ss_pred cccceeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCc-eeeeeeeccCCCcE
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN-IVQYYGTDKDESKL 405 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hpn-IVkl~~~~~~~~~~ 405 (554)
..+.+...+-+++|+++++|+.+....+....+.+... ....-++++|.+++||| .+..++.+..++..
T Consensus 240 k~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~----------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~ 309 (829)
T KOG0576|consen 240 KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT----------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYL 309 (829)
T ss_pred CccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc----------hhhHHHHHHHHHccCCCCcccccccCCccccc
Confidence 34455666778999999999998744444445555421 22345788999999999 78888888888999
Q ss_pred EEEEeecccC-chHHHHh--hhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC
Q 008759 406 YIFLELVTKG-SLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN 482 (554)
Q Consensus 406 ~LVmE~~~gg-sL~~ll~--~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~ 482 (554)
+++|+++.++ +...... ...+.+.+...+++.-+.+|.+||+.-=+|+| |||. .++..+..||+........
T Consensus 310 ~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~-s~~~~~~~~~~v~~~L~~~ 384 (829)
T KOG0576|consen 310 WIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILG-SEEEVKLLDFAVPPQLTRT 384 (829)
T ss_pred chhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccc-cccccccccccCCcccCcc
Confidence 9999999887 2222111 12344455667788888999999988778998 7776 4478999999987654433
Q ss_pred -CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 008759 483 -DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYA 530 (554)
Q Consensus 483 -~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~ 530 (554)
...+..+|+.+++||+.... .+....|.|++|+-..+|--|-+|-.
T Consensus 385 ~~~~t~~~~~~~~~pev~~~~--~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 385 MKPRTAIGTPEPLAPEVIQEN--TIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred cccccCCCCCCCCCchhhccc--ccccCCCccCCCcchhhcCCCCCCCC
Confidence 34556799999999988554 37788999999987777766766543
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.91 E-value=6.7e-05 Score=88.20 Aligned_cols=79 Identities=15% Similarity=0.204 Sum_probs=54.7
Q ss_pred eeeeccCCceeEEEEecCCC---cEEEEEEEecccccchhHHHHHHHHHHHHHHHhCC-CCce--eeeeeeccCC---Cc
Q 008759 334 GDLLGRGSFGSVYEGISDDG---FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENI--VQYYGTDKDE---SK 404 (554)
Q Consensus 334 ~~~LG~GsfG~VY~a~~~~g---~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnI--Vkl~~~~~~~---~~ 404 (554)
.+.|+.|.++.+|+....++ ..+++|+....... .....+.+|+.+++.+. |.+| .+++..+.+. +.
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~----~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~ 118 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL----QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGT 118 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC----ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCC
Confidence 46789999999999876443 46777765421111 11235779999999885 6665 6777776654 46
Q ss_pred EEEEEeecccCc
Q 008759 405 LYIFLELVTKGS 416 (554)
Q Consensus 405 ~~LVmE~~~ggs 416 (554)
.|+||||+.|..
T Consensus 119 ~flVME~v~G~~ 130 (822)
T PLN02876 119 AFYIMEYLEGRI 130 (822)
T ss_pred ceEEEEecCCcc
Confidence 799999998864
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.89 E-value=9.5e-06 Score=84.56 Aligned_cols=140 Identities=17% Similarity=0.198 Sum_probs=98.6
Q ss_pred ceeeeeeeccCCceeEEEEecCCCcEEEEEEEecc-----------------cccchhHHHHHHHHHHHHHHHhCC-CCc
Q 008759 330 YWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLL-----------------DQGSQAKQSISQLEQEIALLSRFE-HEN 391 (554)
Q Consensus 330 ~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~-----------------~~~~~~~~~~~~~~~Ei~iL~~l~-Hpn 391 (554)
-+.+++.||-|.-+.||.+-+.+|+.+++|.-++. ....+..-..-...+|+..|+.+. |-+
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 35678999999999999999999999999975321 111111112223456787777774 332
Q ss_pred -eeeeeeeccCCCcEEEEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEE
Q 008759 392 -IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKL 470 (554)
Q Consensus 392 -IVkl~~~~~~~~~~~LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL 470 (554)
+.+.++ .+..++|||++.|-.|...-+ ...+..+...+..-+.-|-..|+||+|++--||+|..++.+++
T Consensus 173 pVPkpiD----~~RH~Vvmelv~g~Pl~~v~~-----v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~v 243 (465)
T KOG2268|consen 173 PVPKPID----HNRHCVVMELVDGYPLRQVRH-----VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIVV 243 (465)
T ss_pred CCCCccc----ccceeeHHHhhcccceeeeee-----cCChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEEE
Confidence 334444 345689999999877654321 1223345666667777889999999999999999999999999
Q ss_pred EecCcccc
Q 008759 471 ADFGLAKA 478 (554)
Q Consensus 471 ~DFGlA~~ 478 (554)
+||--...
T Consensus 244 IDFPQmvS 251 (465)
T KOG2268|consen 244 IDFPQMVS 251 (465)
T ss_pred eechHhhc
Confidence 99975433
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.89 E-value=0.00027 Score=69.60 Aligned_cols=132 Identities=25% Similarity=0.277 Sum_probs=90.7
Q ss_pred cccceeeeeeeccCCc-eeEEEEecCCCcEEEEEEEec---ccc-------cchh------HHHHHHHHHHHHHHHhCC-
Q 008759 327 IITYWQKGDLLGRGSF-GSVYEGISDDGFFFAVKEVSL---LDQ-------GSQA------KQSISQLEQEIALLSRFE- 388 (554)
Q Consensus 327 ~~~~y~i~~~LG~Gsf-G~VY~a~~~~g~~vAvK~v~~---~~~-------~~~~------~~~~~~~~~Ei~iL~~l~- 388 (554)
....++.++.||.|.- |.||++... |+.||+|.+.. ... .... .....-|..|.+...+++
T Consensus 35 h~~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke 113 (207)
T PF13095_consen 35 HGDDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKE 113 (207)
T ss_pred CCCcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHh
Confidence 3478999999999999 999999764 66999999432 100 0000 123345667777666554
Q ss_pred --CCce--eeeeeeccCC------------------CcEEEEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHH
Q 008759 389 --HENI--VQYYGTDKDE------------------SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLH 446 (554)
Q Consensus 389 --HpnI--Vkl~~~~~~~------------------~~~~LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLH 446 (554)
+.++ |+++|+..-. ....||.||+.... .+.. .-+.+|++-|..+|
T Consensus 114 ~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------~~~~----~~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 114 AGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------PLQI----RDIPQMLRDLKILH 181 (207)
T ss_pred ccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------ccch----hHHHHHHHHHHHHH
Confidence 5566 8998875221 12357888776643 1222 23578888899999
Q ss_pred HCCccccCCccccEEEcCCCcEEEEecCcc
Q 008759 447 DQDVVHRDIKCANILVDANGSVKLADFGLA 476 (554)
Q Consensus 447 s~gIIHrDIKPeNILld~~g~vKL~DFGlA 476 (554)
..||+-+|+++.|.. .-||+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HCCeeeccCcccccc-----CCEEEecccC
Confidence 999999999999985 3478999863
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.82 E-value=0.00021 Score=75.77 Aligned_cols=145 Identities=18% Similarity=0.187 Sum_probs=101.3
Q ss_pred eeeeeeccCCceeEEEEecCCCcEEEEEEEeccc---------------------ccchhHHHHHHHHHHHHHHHhCCCC
Q 008759 332 QKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLD---------------------QGSQAKQSISQLEQEIALLSRFEHE 390 (554)
Q Consensus 332 ~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~---------------------~~~~~~~~~~~~~~Ei~iL~~l~Hp 390 (554)
.+..+|..|.-+.||.|...+|..+|||+++... .....+-..-..+.|++-|.+++..
T Consensus 147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 4556799999999999999999999999985310 1111222333456677777777644
Q ss_pred ceeeeeeeccCCCcEEEEEeecccC-chHHHHhhhcCChHHHHHHHHHHHHHHHHH-HHCCccccCCccccEEEcCCCcE
Q 008759 391 NIVQYYGTDKDESKLYIFLELVTKG-SLLNLYQRYHLRDSQVSAYTRQILLGLKYL-HDQDVVHRDIKCANILVDANGSV 468 (554)
Q Consensus 391 nIVkl~~~~~~~~~~~LVmE~~~gg-sL~~ll~~~~l~e~~i~~i~~QIl~gL~yL-Hs~gIIHrDIKPeNILld~~g~v 468 (554)
.|.-.--. .-....|||+|+.+. --...|+...+....+..+-.|++.-+.-| |.+++||.||.--|+|+ .+|.+
T Consensus 227 GIP~PePI--lLk~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hdG~l 303 (520)
T KOG2270|consen 227 GIPCPEPI--LLKNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HDGKL 303 (520)
T ss_pred CCCCCCce--eeecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-ECCEE
Confidence 43211000 012347999999753 334456666788778888888888887777 56899999999999999 78899
Q ss_pred EEEecCccccc
Q 008759 469 KLADFGLAKAT 479 (554)
Q Consensus 469 KL~DFGlA~~~ 479 (554)
.|+|.+-+...
T Consensus 304 yiIDVSQSVE~ 314 (520)
T KOG2270|consen 304 YIIDVSQSVEH 314 (520)
T ss_pred EEEEccccccC
Confidence 99999866443
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.81 E-value=6.3e-05 Score=73.12 Aligned_cols=97 Identities=25% Similarity=0.212 Sum_probs=79.2
Q ss_pred HHHHHHHHhCCC-CceeeeeeeccCCCcEEEEEeecccCchHH----HHhhhcCChHHHHHHHHHHHHHHHHHHH---CC
Q 008759 378 EQEIALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLLN----LYQRYHLRDSQVSAYTRQILLGLKYLHD---QD 449 (554)
Q Consensus 378 ~~Ei~iL~~l~H-pnIVkl~~~~~~~~~~~LVmE~~~ggsL~~----ll~~~~l~e~~i~~i~~QIl~gL~yLHs---~g 449 (554)
..|.-+++.+++ +++.+++|+|-. ++|.||+..+++.. +.+-...++..+..|+.+++..+.+|+. ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 357888888876 699999999843 68999999776642 2222356888999999999999999997 34
Q ss_pred ccccCCccccEEEcCCCcEEEEecCcccc
Q 008759 450 VVHRDIKCANILVDANGSVKLADFGLAKA 478 (554)
Q Consensus 450 IIHrDIKPeNILld~~g~vKL~DFGlA~~ 478 (554)
+...|++++||-++.+|.+|++|...+..
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcch
Confidence 77899999999999999999999987643
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.00058 Score=67.36 Aligned_cols=74 Identities=12% Similarity=0.087 Sum_probs=47.6
Q ss_pred eeeeccCCceeEEEEecCC--CcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCc-eeeeeeeccCCCcEEEEEe
Q 008759 334 GDLLGRGSFGSVYEGISDD--GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN-IVQYYGTDKDESKLYIFLE 410 (554)
Q Consensus 334 ~~~LG~GsfG~VY~a~~~~--g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hpn-IVkl~~~~~~~~~~~LVmE 410 (554)
++.|..|-.+.+|++...+ +..|++|........ .....+|+.++..+...+ ..+++..+.. .++||
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~------~~d~~~E~~~~~~l~~~gl~P~v~~~~~~----~~l~e 72 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL------IIDRERELRIHKLLSKHGLAPKLYATFQN----GLIYE 72 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc------eecHHHHHHHHHHHHhCCCCCeEEEEeCC----cEEEE
Confidence 3567888889999998764 678889976531111 112346787887775333 3455554432 47999
Q ss_pred ecccCch
Q 008759 411 LVTKGSL 417 (554)
Q Consensus 411 ~~~ggsL 417 (554)
|++|.++
T Consensus 73 ~i~G~~l 79 (235)
T cd05157 73 FIPGRTL 79 (235)
T ss_pred eeCCCcC
Confidence 9998765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.00098 Score=69.19 Aligned_cols=77 Identities=13% Similarity=0.118 Sum_probs=53.3
Q ss_pred eeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCC---CceeeeeeeccC---CCcEE
Q 008759 333 KGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH---ENIVQYYGTDKD---ESKLY 406 (554)
Q Consensus 333 i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~H---pnIVkl~~~~~~---~~~~~ 406 (554)
-.+.||.|..+.||.....+++ +.+|..+.. .....+..|...|+.+.. -.+.++++.+.. .+..+
T Consensus 18 ~~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~~-------~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~ 89 (297)
T PRK10593 18 RVECISEQPYAALWALYDSQGN-PMPLMARSF-------STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDV 89 (297)
T ss_pred eeeecCCccceeEEEEEcCCCC-EEEEEeccc-------ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeE
Confidence 3567999999999998776564 666764320 011356788888887753 356777776543 46689
Q ss_pred EEEeecccCch
Q 008759 407 IFLELVTKGSL 417 (554)
Q Consensus 407 LVmE~~~ggsL 417 (554)
||||++.+.++
T Consensus 90 LVmE~i~G~~~ 100 (297)
T PRK10593 90 LLLERLRGVSV 100 (297)
T ss_pred EEEeccCCEec
Confidence 99999998654
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.00058 Score=69.85 Aligned_cols=136 Identities=15% Similarity=0.124 Sum_probs=80.0
Q ss_pred eeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCc--eeeeeeec------cCCCcE
Q 008759 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN--IVQYYGTD------KDESKL 405 (554)
Q Consensus 334 ~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hpn--IVkl~~~~------~~~~~~ 405 (554)
.+.|..|....+|+....+ ..+++|++.. . ....+..|+.++..+.+.+ +.+++... ...+..
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~--~------~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~ 89 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK--V------SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKP 89 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCC--C------ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCce
Confidence 4567788888999986644 4688887652 1 1134556777776664322 44444321 224567
Q ss_pred EEEEeecccCchHH----H-------H---hh--hcCCh--------HHHH------------HHHHHHHHHHHHHHH--
Q 008759 406 YIFLELVTKGSLLN----L-------Y---QR--YHLRD--------SQVS------------AYTRQILLGLKYLHD-- 447 (554)
Q Consensus 406 ~LVmE~~~ggsL~~----l-------l---~~--~~l~e--------~~i~------------~i~~QIl~gL~yLHs-- 447 (554)
++|++|++|..+.. . + +. ..+.. .... .....+...+.++..
T Consensus 90 ~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~ 169 (296)
T cd05153 90 AALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFD 169 (296)
T ss_pred EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhh
Confidence 89999999866421 1 1 10 01100 0000 011112233444443
Q ss_pred -----CCccccCCccccEEEcCCCcEEEEecCcccc
Q 008759 448 -----QDVVHRDIKCANILVDANGSVKLADFGLAKA 478 (554)
Q Consensus 448 -----~gIIHrDIKPeNILld~~g~vKL~DFGlA~~ 478 (554)
.+++|+|+.|.|||++.++.+.|+||+.+..
T Consensus 170 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 170 PSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred hhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 4699999999999999877778999997643
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.0022 Score=69.50 Aligned_cols=80 Identities=16% Similarity=0.177 Sum_probs=53.0
Q ss_pred eeeccCCceeEEEEecCCC-cEEEEEEEecccc--cchhHHHHHHHHHHHHHHHhCC---CCceeeeeeeccCCCcEEEE
Q 008759 335 DLLGRGSFGSVYEGISDDG-FFFAVKEVSLLDQ--GSQAKQSISQLEQEIALLSRFE---HENIVQYYGTDKDESKLYIF 408 (554)
Q Consensus 335 ~~LG~GsfG~VY~a~~~~g-~~vAvK~v~~~~~--~~~~~~~~~~~~~Ei~iL~~l~---HpnIVkl~~~~~~~~~~~LV 408 (554)
+.||.|.++.||++.+.+| +.++||....... .....-...+...|.+.|..+. ..++.++|.+. ....++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCEEE
Confidence 5699999999999999776 5899997531111 0100123345666777777653 24577777763 3567899
Q ss_pred EeecccCc
Q 008759 409 LELVTKGS 416 (554)
Q Consensus 409 mE~~~ggs 416 (554)
||++++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99988643
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.0006 Score=68.60 Aligned_cols=132 Identities=18% Similarity=0.222 Sum_probs=74.4
Q ss_pred eeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCce-eeeeeeccCCCcEEEEEeeccc
Q 008759 336 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI-VQYYGTDKDESKLYIFLELVTK 414 (554)
Q Consensus 336 ~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnI-Vkl~~~~~~~~~~~LVmE~~~g 414 (554)
.+..|-.+.+|+.. .++..+++|......... .....+|..+++.+....+ .+++..+. -++||||++|
T Consensus 3 ~~~~G~tn~~y~~~-~~~~~~vlR~~~~~~~~~-----~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G 72 (256)
T TIGR02721 3 TLSGGLTNRSWRIE-HPGISFVWRPQSPVCKAL-----GVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEG 72 (256)
T ss_pred cCCCcCcCCeEEEE-eCCccEEEeeCCcccccc-----cCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccC
Confidence 35567788899886 446678888654211100 0123567788877754333 34444432 2689999998
Q ss_pred CchHH--------------HHhh---hc-----CCh-HHHHHHHHHH---------HHHHHHHHH--------CCccccC
Q 008759 415 GSLLN--------------LYQR---YH-----LRD-SQVSAYTRQI---------LLGLKYLHD--------QDVVHRD 454 (554)
Q Consensus 415 gsL~~--------------ll~~---~~-----l~e-~~i~~i~~QI---------l~gL~yLHs--------~gIIHrD 454 (554)
..+.. .+.+ .. +.. ..+..+..++ ...+..+-. ..++|+|
T Consensus 73 ~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~D 152 (256)
T TIGR02721 73 EVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMD 152 (256)
T ss_pred cccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCC
Confidence 66431 1111 11 111 1122222222 111222222 2489999
Q ss_pred CccccEEEcCCCcEEEEecCcccc
Q 008759 455 IKCANILVDANGSVKLADFGLAKA 478 (554)
Q Consensus 455 IKPeNILld~~g~vKL~DFGlA~~ 478 (554)
+.|.|||++.++ +.|+||..+..
T Consensus 153 l~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 153 VHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CCcCcEEEeCCC-CEEEeccccCc
Confidence 999999998877 78999997753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.0029 Score=65.45 Aligned_cols=136 Identities=18% Similarity=0.136 Sum_probs=78.0
Q ss_pred eeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCC--ceeeeeeec------cCCCcE
Q 008759 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE--NIVQYYGTD------KDESKL 405 (554)
Q Consensus 334 ~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hp--nIVkl~~~~------~~~~~~ 405 (554)
.+.|+.|....+|+....++ .+++|.+.... . ...+..|++++..+... .+.+++... ...+..
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~----~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~ 98 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV----K---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKP 98 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCC----C---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeE
Confidence 55677888889999876555 57788765311 0 12234555666555321 234444321 224567
Q ss_pred EEEEeecccCchH----H-------HH---hh--hcCC--------hHHH-----H----------HHHHHHHHHHHHHH
Q 008759 406 YIFLELVTKGSLL----N-------LY---QR--YHLR--------DSQV-----S----------AYTRQILLGLKYLH 446 (554)
Q Consensus 406 ~LVmE~~~ggsL~----~-------ll---~~--~~l~--------e~~i-----~----------~i~~QIl~gL~yLH 446 (554)
+++|+|++|..+. . .+ +. .+++ .... . .....+...+.++.
T Consensus 99 ~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~ 178 (307)
T TIGR00938 99 ACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLD 178 (307)
T ss_pred EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHH
Confidence 8999999885431 1 11 11 0110 0000 0 00112233455553
Q ss_pred H-------CCccccCCccccEEEcCCCcEEEEecCccc
Q 008759 447 D-------QDVVHRDIKCANILVDANGSVKLADFGLAK 477 (554)
Q Consensus 447 s-------~gIIHrDIKPeNILld~~g~vKL~DFGlA~ 477 (554)
. .+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 179 ~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 179 KFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 2 579999999999999988877899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.0012 Score=67.87 Aligned_cols=73 Identities=16% Similarity=0.210 Sum_probs=46.1
Q ss_pred eeeccCCceeEEEEecCC-------CcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCce-eeeeeeccCCCcEE
Q 008759 335 DLLGRGSFGSVYEGISDD-------GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI-VQYYGTDKDESKLY 406 (554)
Q Consensus 335 ~~LG~GsfG~VY~a~~~~-------g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnI-Vkl~~~~~~~~~~~ 406 (554)
+.|..|-...||+....+ ++.|++|+...... ......+|+.++..+...++ .++++.+.. .
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~------~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~ 73 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE------LLIDRERELVVFARLSERNLGPKLYGIFPN----G 73 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc------ceechHHHHHHHHHHHhCCCCCceEEEeCC----C
Confidence 456677778999987654 57899998653211 11234577777777753333 355555542 3
Q ss_pred EEEeecccCch
Q 008759 407 IFLELVTKGSL 417 (554)
Q Consensus 407 LVmE~~~ggsL 417 (554)
+|+||++|..+
T Consensus 74 ~v~e~i~G~~l 84 (302)
T cd05156 74 RIEEFIPSRTL 84 (302)
T ss_pred chhheeCCCcC
Confidence 68999888665
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.0016 Score=77.21 Aligned_cols=190 Identities=21% Similarity=0.248 Sum_probs=125.0
Q ss_pred eccCCceeEEEEecCC-----CcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCc----EEE
Q 008759 337 LGRGSFGSVYEGISDD-----GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK----LYI 407 (554)
Q Consensus 337 LG~GsfG~VY~a~~~~-----g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~----~~L 407 (554)
|..-++|++++..+.- -..+-++. ........+..+...+.|+..+.+..|+|++.++.+...... ..+
T Consensus 186 ls~~~~~~l~l~k~~~~~qs~~~~~~~s~--~~~~~~~~k~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v 263 (1351)
T KOG1035|consen 186 LSHLTQGTLLLVKWVEQAQSLSEPIEISH--DYESTPCGKKEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDV 263 (1351)
T ss_pred eccccCceEEEEehhhhHHhhcCcccccC--cccCccchHHHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHH
Confidence 5666777777765510 01111110 011112334556667778888999999999999887654322 233
Q ss_pred EEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccc---cEEEcCCCcEEEE--ecCccccccc
Q 008759 408 FLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCA---NILVDANGSVKLA--DFGLAKATKL 481 (554)
Q Consensus 408 VmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPe---NILld~~g~vKL~--DFGlA~~~~~ 481 (554)
..+++.+-++...++. ..++...++.+..+++.||.|+|+....|.-|... +-.++..+.+.+. ||+..+....
T Consensus 264 ~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d 343 (1351)
T KOG1035|consen 264 LQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPD 343 (1351)
T ss_pred HHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhccceeEEecccccccccCccceeecchhhhcccccCCC
Confidence 4567777788877776 45788889999999999999999996666555444 4444556667766 8887765544
Q ss_pred CCc-cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCC
Q 008759 482 NDV-KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIP 528 (554)
Q Consensus 482 ~~~-~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~P 528 (554)
... .....+..|.++|.............|+|++|.++..+..|..+
T Consensus 344 ~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i 391 (1351)
T KOG1035|consen 344 NEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDI 391 (1351)
T ss_pred cccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCcc
Confidence 332 22335566888888765543344557999999999999987553
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.0073 Score=62.61 Aligned_cols=30 Identities=27% Similarity=0.411 Sum_probs=25.8
Q ss_pred CCccccCCccccEEEcCCCcEEEEecCccc
Q 008759 448 QDVVHRDIKCANILVDANGSVKLADFGLAK 477 (554)
Q Consensus 448 ~gIIHrDIKPeNILld~~g~vKL~DFGlA~ 477 (554)
.++||+|+.+.|||++.+...-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 479999999999999866556899999875
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.02 E-value=0.00033 Score=84.49 Aligned_cols=149 Identities=16% Similarity=0.085 Sum_probs=108.9
Q ss_pred HHHHHHHhCCCCceeeeeeecc--CCCcEEEEEeecccCchHHHHhhh-----cCChHHHHHHHHHHHHHHHHHHHCC--
Q 008759 379 QEIALLSRFEHENIVQYYGTDK--DESKLYIFLELVTKGSLLNLYQRY-----HLRDSQVSAYTRQILLGLKYLHDQD-- 449 (554)
Q Consensus 379 ~Ei~iL~~l~HpnIVkl~~~~~--~~~~~~LVmE~~~ggsL~~ll~~~-----~l~e~~i~~i~~QIl~gL~yLHs~g-- 449 (554)
.|...++...|+++...+.--. .....|..++|+.+|.+...+.++ .+...-+....++.+.+..-+|...
T Consensus 1278 ~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnl 1357 (2724)
T KOG1826|consen 1278 SERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNL 1357 (2724)
T ss_pred hhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccC
Confidence 4444556678999887766433 345678999999999999988653 2333344444555466666666542
Q ss_pred ---ccccCCccccEEEcCCCcEEEEecCccccccc--CCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc
Q 008759 450 ---VVHRDIKCANILVDANGSVKLADFGLAKATKL--NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT 524 (554)
Q Consensus 450 ---IIHrDIKPeNILld~~g~vKL~DFGlA~~~~~--~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT 524 (554)
.+|++||+-|.+|..+..+|+.++|+.+.... .......+++.|+.+++.+.-. ++.++|+|.+|+.+|..--
T Consensus 1358 g~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik--~t~rsdilr~s~~ly~rs~ 1435 (2724)
T KOG1826|consen 1358 GNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIK--FTKRSDILRRSLSLYLRSD 1435 (2724)
T ss_pred CccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHh--hhhHHHHHHHHHHHHHHhc
Confidence 68999999999999999999999999873221 1233455888999999886654 6677999999999999887
Q ss_pred CCCCC
Q 008759 525 SQIPY 529 (554)
Q Consensus 525 G~~PF 529 (554)
|..+|
T Consensus 1436 ~n~~f 1440 (2724)
T KOG1826|consen 1436 GNAYF 1440 (2724)
T ss_pred ccHHH
Confidence 77766
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.01 E-value=0.0041 Score=63.97 Aligned_cols=30 Identities=33% Similarity=0.495 Sum_probs=25.0
Q ss_pred CccccCCccccEEEcCCCc-EEEEecCcccc
Q 008759 449 DVVHRDIKCANILVDANGS-VKLADFGLAKA 478 (554)
Q Consensus 449 gIIHrDIKPeNILld~~g~-vKL~DFGlA~~ 478 (554)
.++|+|+++.|||++.++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 3899999999999987565 46999998754
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.67 E-value=0.018 Score=59.75 Aligned_cols=30 Identities=20% Similarity=0.249 Sum_probs=27.3
Q ss_pred CccccCCccccEEEcCCCcEEEEecCcccc
Q 008759 449 DVVHRDIKCANILVDANGSVKLADFGLAKA 478 (554)
Q Consensus 449 gIIHrDIKPeNILld~~g~vKL~DFGlA~~ 478 (554)
+++|+|+.+.|||++.++.+.|+||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 699999999999999999999999987643
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.62 E-value=0.0089 Score=63.92 Aligned_cols=78 Identities=15% Similarity=0.157 Sum_probs=48.7
Q ss_pred eeccCCceeEEEEecCCC-cEEEEEEEecccc--cchhHHHHHHHHHHHHHHHhCC--CC-ceeeeeeeccCCCcEEEEE
Q 008759 336 LLGRGSFGSVYEGISDDG-FFFAVKEVSLLDQ--GSQAKQSISQLEQEIALLSRFE--HE-NIVQYYGTDKDESKLYIFL 409 (554)
Q Consensus 336 ~LG~GsfG~VY~a~~~~g-~~vAvK~v~~~~~--~~~~~~~~~~~~~Ei~iL~~l~--Hp-nIVkl~~~~~~~~~~~LVm 409 (554)
-||.|....||++.+.+| +.++||.-..... .....-...+..-|...|+... -| .+.++|.+ +.....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 379999999999998654 6899986532111 1111223345556777776653 34 45566654 455567999
Q ss_pred eecccC
Q 008759 410 ELVTKG 415 (554)
Q Consensus 410 E~~~gg 415 (554)
|++...
T Consensus 80 EdL~~~ 85 (370)
T TIGR01767 80 EDLSHH 85 (370)
T ss_pred hhCccc
Confidence 988553
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.55 E-value=0.019 Score=60.85 Aligned_cols=135 Identities=13% Similarity=0.118 Sum_probs=77.8
Q ss_pred eeeeccCCceeEEEEecC-----CCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCce-eeeeeeccCCCcEEE
Q 008759 334 GDLLGRGSFGSVYEGISD-----DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI-VQYYGTDKDESKLYI 407 (554)
Q Consensus 334 ~~~LG~GsfG~VY~a~~~-----~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnI-Vkl~~~~~~~~~~~L 407 (554)
...|-.|-...+|++... .++.|++|+..... ...+. ..+|+.++..+..-++ .++++.+... .
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t-----~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~ 110 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV-----ELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----R 110 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC-----Ceeec-hHHHHHHHHHHHHcCCCCceEEEECCc----e
Confidence 345656888899998642 23678888765321 11112 2567888877764444 3566666432 5
Q ss_pred EEeecccCchHH--------------HHhh---hcC-------ChHHHHHHHHHHH-----------------HHHHHH-
Q 008759 408 FLELVTKGSLLN--------------LYQR---YHL-------RDSQVSAYTRQIL-----------------LGLKYL- 445 (554)
Q Consensus 408 VmE~~~ggsL~~--------------ll~~---~~l-------~e~~i~~i~~QIl-----------------~gL~yL- 445 (554)
|++|+.+.+|.. .+.+ ..+ ...++..+..++. ..+..|
T Consensus 111 v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~ 190 (344)
T PLN02236 111 VEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLE 190 (344)
T ss_pred EEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHH
Confidence 799998766531 1111 011 1122333332211 111112
Q ss_pred ---H----HCCccccCCccccEEEcC-CCcEEEEecCcccc
Q 008759 446 ---H----DQDVVHRDIKCANILVDA-NGSVKLADFGLAKA 478 (554)
Q Consensus 446 ---H----s~gIIHrDIKPeNILld~-~g~vKL~DFGlA~~ 478 (554)
. ...++|+|+++.|||++. ++.+.|+||..+..
T Consensus 191 ~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 191 KELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred HHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 1 225899999999999986 47899999988753
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.44 E-value=0.053 Score=55.65 Aligned_cols=29 Identities=28% Similarity=0.468 Sum_probs=25.5
Q ss_pred CCccccCCccccEEEcCCCcEEEEecCccc
Q 008759 448 QDVVHRDIKCANILVDANGSVKLADFGLAK 477 (554)
Q Consensus 448 ~gIIHrDIKPeNILld~~g~vKL~DFGlA~ 477 (554)
.+++|+|+.+.|||++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 47899999999999987 678999999664
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.38 E-value=0.017 Score=60.79 Aligned_cols=134 Identities=10% Similarity=0.166 Sum_probs=75.3
Q ss_pred eeeeccCCceeEEEEecCC----CcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCce-eeeeeeccCCCcEEEE
Q 008759 334 GDLLGRGSFGSVYEGISDD----GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI-VQYYGTDKDESKLYIF 408 (554)
Q Consensus 334 ~~~LG~GsfG~VY~a~~~~----g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnI-Vkl~~~~~~~~~~~LV 408 (554)
.+.|..|=...+|+....+ +..|++|+....... .-.-.+|..+++.+..-++ .++++++... +|
T Consensus 19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~------~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i 88 (330)
T PLN02421 19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY------VIDRERELQAIKYLSAAGFGAKLLGVFGNG----MI 88 (330)
T ss_pred EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe------EechHHHHHHHHHHHhcCCCCceeEEeCCc----Ee
Confidence 3445557778899886432 347888876532111 1122467777877765444 4566655322 58
Q ss_pred EeecccCchHH--------------HHhh---hcC-------ChHHHHHHHHHH----------------------HHHH
Q 008759 409 LELVTKGSLLN--------------LYQR---YHL-------RDSQVSAYTRQI----------------------LLGL 442 (554)
Q Consensus 409 mE~~~ggsL~~--------------ll~~---~~l-------~e~~i~~i~~QI----------------------l~gL 442 (554)
.+|+.+..|.. .+++ ..+ ....+..+..++ ..-+
T Consensus 89 ~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 168 (330)
T PLN02421 89 QSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEI 168 (330)
T ss_pred ehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHH
Confidence 88887765421 1111 111 112222332222 1112
Q ss_pred HHHH----HCC----ccccCCccccEEEcC-CCcEEEEecCccc
Q 008759 443 KYLH----DQD----VVHRDIKCANILVDA-NGSVKLADFGLAK 477 (554)
Q Consensus 443 ~yLH----s~g----IIHrDIKPeNILld~-~g~vKL~DFGlA~ 477 (554)
..+. ..+ ++|.|+.+.|||++. ++.++++||..|-
T Consensus 169 ~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 169 VELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred HHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 2221 112 799999999999975 5789999999874
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.06 E-value=0.022 Score=61.70 Aligned_cols=79 Identities=16% Similarity=0.162 Sum_probs=50.8
Q ss_pred eeeeccCCceeEEEEecC-CCcEEEEEEEecccc-cchhHHHHHHHHHHHHHHHhCC--CC-ceeeeeeeccCCCcEEEE
Q 008759 334 GDLLGRGSFGSVYEGISD-DGFFFAVKEVSLLDQ-GSQAKQSISQLEQEIALLSRFE--HE-NIVQYYGTDKDESKLYIF 408 (554)
Q Consensus 334 ~~~LG~GsfG~VY~a~~~-~g~~vAvK~v~~~~~-~~~~~~~~~~~~~Ei~iL~~l~--Hp-nIVkl~~~~~~~~~~~LV 408 (554)
.+.||-|.-.-||++.+. .++.++||.-..... .....-...+..-|..+|+... .| ++.++|.+ +.....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 466899999999999984 356788886532111 1122334456667777777654 34 46667665 44556788
Q ss_pred Eeeccc
Q 008759 409 LELVTK 414 (554)
Q Consensus 409 mE~~~g 414 (554)
||++..
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 888754
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.93 E-value=0.04 Score=58.94 Aligned_cols=74 Identities=23% Similarity=0.337 Sum_probs=54.9
Q ss_pred CCcEEEEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHC-CccccCCccccEEEcCCCcEEEEecCcccccc
Q 008759 402 ESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ-DVVHRDIKCANILVDANGSVKLADFGLAKATK 480 (554)
Q Consensus 402 ~~~~~LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~-gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~ 480 (554)
..+.|++|++..+ .+... ......++..++++.+..+.-+..+ .+-|||+.-.||||+ +|+|.|+||-+++...
T Consensus 298 ~~y~yl~~kdhgt-~is~i---k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl~~ 372 (488)
T COG5072 298 TLYLYLHFKDHGT-PISII---KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRLSY 372 (488)
T ss_pred ceEEEEEEecCCc-eeeee---ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeeccc
Confidence 3456777776533 33321 2235577888888888877777654 588999999999998 9999999999998543
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.90 E-value=0.11 Score=56.71 Aligned_cols=78 Identities=17% Similarity=0.175 Sum_probs=49.6
Q ss_pred eeeeccCCceeEEEEecCCCcEEEEEEEecccc--cchhHHHHHHHHHHHHHHHhCC---CCceeeeeeeccCCCcEEEE
Q 008759 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQ--GSQAKQSISQLEQEIALLSRFE---HENIVQYYGTDKDESKLYIF 408 (554)
Q Consensus 334 ~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~--~~~~~~~~~~~~~Ei~iL~~l~---HpnIVkl~~~~~~~~~~~LV 408 (554)
.+.||.|....||+..+. +..++||.-..... .........+...|...|+.+. ..++.++|.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 467899999999998874 45688887542111 0000112333445566665553 247788888876 446788
Q ss_pred Eeeccc
Q 008759 409 LELVTK 414 (554)
Q Consensus 409 mE~~~g 414 (554)
||++++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999977
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.32 E-value=0.18 Score=53.22 Aligned_cols=141 Identities=13% Similarity=0.214 Sum_probs=78.5
Q ss_pred eeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCc--eeeeeeeccCCC--cEEEEE
Q 008759 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN--IVQYYGTDKDES--KLYIFL 409 (554)
Q Consensus 334 ~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hpn--IVkl~~~~~~~~--~~~LVm 409 (554)
++.+-.|.-..+|..... ++.+++. ... ............+|+.++..+.--- +...++.|.++. ..|.||
T Consensus 30 v~~~~~G~sn~t~~~~~~-~~~~vlR-~P~---~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~ 104 (321)
T COG3173 30 VEEISGGWSNDTFRLGDT-GQKYVLR-KPP---RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVM 104 (321)
T ss_pred eeeccCCcccceEEEecC-CceEEEe-cCC---ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEE
Confidence 334433433445554444 6667777 221 1111233445667888887764322 233455555544 679999
Q ss_pred eecccCchHH------------------HHhh---------------hcCChHHHHHHHHHH--------------HHHH
Q 008759 410 ELVTKGSLLN------------------LYQR---------------YHLRDSQVSAYTRQI--------------LLGL 442 (554)
Q Consensus 410 E~~~ggsL~~------------------ll~~---------------~~l~e~~i~~i~~QI--------------l~gL 442 (554)
+|++|..+.+ +|.. ......++..+..+. ..-.
T Consensus 105 ~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~ 184 (321)
T COG3173 105 EWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLI 184 (321)
T ss_pred EEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHH
Confidence 9999843211 1110 001112222233222 2234
Q ss_pred HHHHHC--------CccccCCccccEEEcCCCcEEEEecCccccc
Q 008759 443 KYLHDQ--------DVVHRDIKCANILVDANGSVKLADFGLAKAT 479 (554)
Q Consensus 443 ~yLHs~--------gIIHrDIKPeNILld~~g~vKL~DFGlA~~~ 479 (554)
.+|+.+ .++|+|+.+.||+|+.++-+=|+||+++...
T Consensus 185 ~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 185 KWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred HHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 555543 3899999999999999988999999988653
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.31 E-value=0.14 Score=62.06 Aligned_cols=31 Identities=45% Similarity=0.622 Sum_probs=26.1
Q ss_pred CCccccCCccccEEEcCCC--cEE-EEecCcccc
Q 008759 448 QDVVHRDIKCANILVDANG--SVK-LADFGLAKA 478 (554)
Q Consensus 448 ~gIIHrDIKPeNILld~~g--~vK-L~DFGlA~~ 478 (554)
.++||+|+++.|||++.++ .+. |+|||.+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 4799999999999998775 565 999997643
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.24 E-value=0.11 Score=56.27 Aligned_cols=81 Identities=15% Similarity=0.199 Sum_probs=46.5
Q ss_pred eeeeeccCCceeEEEEecCCC--cEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCce-eeeeeeccCCCcEEEEE
Q 008759 333 KGDLLGRGSFGSVYEGISDDG--FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI-VQYYGTDKDESKLYIFL 409 (554)
Q Consensus 333 i~~~LG~GsfG~VY~a~~~~g--~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnI-Vkl~~~~~~~~~~~LVm 409 (554)
..+.|..|-.+.+|++...++ ..+.+|.+.....+ ......-.-.+|+.+++.+...++ .++++.+.. ++|.
T Consensus 54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g-~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~ 128 (383)
T PTZ00384 54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSS-TYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQ 128 (383)
T ss_pred EEEEeCCcccceEEEEEecCCCCCccccceEEEEecc-CCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEE
Confidence 345566688889999875332 23333322111101 111111223578888888875544 567777753 6999
Q ss_pred eecccCchH
Q 008759 410 ELVTKGSLL 418 (554)
Q Consensus 410 E~~~ggsL~ 418 (554)
||++|.+|.
T Consensus 129 efIeGr~l~ 137 (383)
T PTZ00384 129 EWVEGNTMG 137 (383)
T ss_pred EEeccccCC
Confidence 999987653
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.15 E-value=0.13 Score=53.51 Aligned_cols=75 Identities=17% Similarity=0.177 Sum_probs=44.5
Q ss_pred eeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCC---CCceeeeeeeccCCCcEEEE
Q 008759 332 QKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE---HENIVQYYGTDKDESKLYIF 408 (554)
Q Consensus 332 ~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~---HpnIVkl~~~~~~~~~~~LV 408 (554)
+-.+.|+.|....+|+.. .+++.|.+|+-.... ...+..|..-|+.|. --.+.+++.++...+..|||
T Consensus 20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~~~--------~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLl 90 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNSESG--------RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLL 90 (288)
T ss_dssp -EEEEE--SSSSEEEEEE-TTS-EEEEEEEEGGG--------CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEE
T ss_pred eeeEecCCCChhheEEEE-CCCccEEEEecChhh--------HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEE
Confidence 345678999999999987 567788888765211 123556766666663 44577888888777777999
Q ss_pred EeecccC
Q 008759 409 LELVTKG 415 (554)
Q Consensus 409 mE~~~gg 415 (554)
|||++.+
T Consensus 91 le~l~~~ 97 (288)
T PF03881_consen 91 LEFLEMG 97 (288)
T ss_dssp EE-----
T ss_pred EEeecCC
Confidence 9999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=95.10 E-value=0.12 Score=52.87 Aligned_cols=28 Identities=43% Similarity=0.624 Sum_probs=23.6
Q ss_pred ccccCCccccEEEcCC--C---cEEEEecCccc
Q 008759 450 VVHRDIKCANILVDAN--G---SVKLADFGLAK 477 (554)
Q Consensus 450 IIHrDIKPeNILld~~--g---~vKL~DFGlA~ 477 (554)
|+|||++..|||+..+ | .++++||-+++
T Consensus 217 l~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~ 249 (294)
T PF02958_consen 217 LCHGDFWTNNILFKYDDDGKPIDVVLIDFQLAR 249 (294)
T ss_pred EEcCccCHHhEeEccccccccccceeecccccc
Confidence 8999999999999655 3 58999998653
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.96 E-value=0.49 Score=49.71 Aligned_cols=71 Identities=15% Similarity=0.073 Sum_probs=41.2
Q ss_pred CCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCc--eeeee---e--eccCCCcEEEEEeec
Q 008759 340 GSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN--IVQYY---G--TDKDESKLYIFLELV 412 (554)
Q Consensus 340 GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hpn--IVkl~---~--~~~~~~~~~LVmE~~ 412 (554)
+.-..||+....++..|++|+..... . ....+..|+..+..+.... ++... | ....++..+.+++++
T Consensus 36 s~eN~vy~v~~~~~~~~vlKv~r~~~---~---~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~ 109 (325)
T PRK11768 36 SYENRVYQFGDEDGRRVVAKFYRPER---W---SDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRR 109 (325)
T ss_pred cccceEEEEecCCCCEEEEEEcCccc---C---CHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeee
Confidence 44568999988888889999875211 1 1234556666665553211 22211 1 112245678899999
Q ss_pred ccCc
Q 008759 413 TKGS 416 (554)
Q Consensus 413 ~ggs 416 (554)
.|..
T Consensus 110 ~G~~ 113 (325)
T PRK11768 110 GGRA 113 (325)
T ss_pred CCCC
Confidence 8764
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=93.64 E-value=0.34 Score=49.14 Aligned_cols=74 Identities=16% Similarity=0.185 Sum_probs=47.7
Q ss_pred eeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCC---CCceeeeeeeccCCCcEEEEEeec
Q 008759 336 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE---HENIVQYYGTDKDESKLYIFLELV 412 (554)
Q Consensus 336 ~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~---HpnIVkl~~~~~~~~~~~LVmE~~ 412 (554)
.+.-|.....|...+ ....|-+|+-. .....-+..|+.-|..+. .-.+.+++.+....++.|+||||+
T Consensus 23 ~v~gG~inea~~v~d-g~~~~FvK~n~--------~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L 93 (286)
T COG3001 23 EVSGGDINEAWRLRD-GTDPFFVKCNQ--------REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYL 93 (286)
T ss_pred ccCCccccceeEeec-CCcceEEEecc--------hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeec
Confidence 344444445555443 34566677432 333455666766665554 455788999999999999999999
Q ss_pred ccCchH
Q 008759 413 TKGSLL 418 (554)
Q Consensus 413 ~ggsL~ 418 (554)
+-+.+.
T Consensus 94 ~~~~~d 99 (286)
T COG3001 94 PTGPLD 99 (286)
T ss_pred cCCCCC
Confidence 876553
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=93.40 E-value=0.31 Score=49.25 Aligned_cols=85 Identities=22% Similarity=0.232 Sum_probs=58.2
Q ss_pred HHHHHHHHHHhCCCCceeeeeeeccCCCcEEEEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHH--CCcccc
Q 008759 376 QLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD--QDVVHR 453 (554)
Q Consensus 376 ~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs--~gIIHr 453 (554)
-+.++.+++.++. .|+++..- ..-.+.+++|.|-.-... . ..++.-=+..|.-.|+ .+.+|+
T Consensus 104 ~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i~-----------~-~N~i~agi~~L~~fH~~~~~~lHG 167 (308)
T PF07387_consen 104 LYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKIN-----------F-SNFITAGIKDLMDFHSENQHCLHG 167 (308)
T ss_pred hhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcccc-----------h-hHHHHHhHHHHHHhhccCCCeecC
Confidence 3456788887763 57777743 344577899988552111 0 1112222456777784 469999
Q ss_pred CCccccEEEcCCCcEEEEecCcc
Q 008759 454 DIKCANILVDANGSVKLADFGLA 476 (554)
Q Consensus 454 DIKPeNILld~~g~vKL~DFGlA 476 (554)
|-.|+|||-+..|.+||.|-+..
T Consensus 168 D~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 168 DCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred CCChhheeecCCCCEEecChhhh
Confidence 99999999999999999998754
|
The function of this family is unknown. |
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.36 E-value=0.66 Score=51.13 Aligned_cols=75 Identities=11% Similarity=-0.032 Sum_probs=44.5
Q ss_pred eeeeeccCCceeEEEEecCC---------CcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCce-eeeeeeccCC
Q 008759 333 KGDLLGRGSFGSVYEGISDD---------GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI-VQYYGTDKDE 402 (554)
Q Consensus 333 i~~~LG~GsfG~VY~a~~~~---------g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnI-Vkl~~~~~~~ 402 (554)
-++.|..|-...+|++...+ ++.|.+++.-.... . +-.-.+|..+++.+...+| .++++.+.
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te-----~-lIdR~~E~~v~~~ls~~gi~P~l~~~f~-- 180 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVD-----E-LYNPISEFEVYKTMSKYRIAPQLLNTFS-- 180 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCcc-----c-eeCHHHHHHHHHHHHHCCCCCceEEEeC--
Confidence 45667778888899886431 45778887643111 1 1123456666666654444 35566553
Q ss_pred CcEEEEEeecccCch
Q 008759 403 SKLYIFLELVTKGSL 417 (554)
Q Consensus 403 ~~~~LVmE~~~ggsL 417 (554)
-+.|.||++|.+|
T Consensus 181 --gg~I~efi~g~~l 193 (442)
T PTZ00296 181 --GGRIEEWLYGDPL 193 (442)
T ss_pred --CCEEEEeeCCccC
Confidence 2467899987644
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=92.37 E-value=0.32 Score=54.23 Aligned_cols=114 Identities=23% Similarity=0.399 Sum_probs=70.2
Q ss_pred HHHHHHHHHHHhCCCCceeeeeeeccCC-CcEEEEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCcccc
Q 008759 375 SQLEQEIALLSRFEHENIVQYYGTDKDE-SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHR 453 (554)
Q Consensus 375 ~~~~~Ei~iL~~l~HpnIVkl~~~~~~~-~~~~LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHr 453 (554)
.++.....+++.+.|+|..+++++-... ....+|||++.. +|++++....+...... ..|+.|-
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~~-Sled~~~~~~l~~~s~~--------------~~~~~~~ 91 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYTM-SLEDILKTGNLKDESLL--------------AHGVLHL 91 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhcc-chHHHHHhcccchhhhc--------------cccccee
Confidence 3456667889999999999999875443 347889999865 88888765443221111 1222221
Q ss_pred CCccccEEEcCCCcEEEEecCcccccccCCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008759 454 DIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME 533 (554)
Q Consensus 454 DIKPeNILld~~g~vKL~DFGlA~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e 533 (554)
| .++++| -++.. | |-. .++|+|||++|.++.++.-|...|....
T Consensus 92 -----~-------~~~~td-~~~t~--------------~--~~~-------~~pKsdVwsl~~i~~el~L~~~l~~~~~ 135 (725)
T KOG1093|consen 92 -----N-------IIYITD-HFLTK--------------Y--PSP-------IGPKSDVWSLGFIILELYLGISLEAELT 135 (725)
T ss_pred -----h-------hhhccc-ccccc--------------C--CCC-------CCcchhhhhHHHHHHHHHHhhHHHHHHH
Confidence 2 223333 11000 0 111 2248999999999999999988777665
Q ss_pred hhHHHH
Q 008759 534 CVSAIF 539 (554)
Q Consensus 534 ~~~~i~ 539 (554)
..+...
T Consensus 136 ~s~~l~ 141 (725)
T KOG1093|consen 136 ESEYLE 141 (725)
T ss_pred HHHHHH
Confidence 544433
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=91.40 E-value=0.52 Score=51.40 Aligned_cols=59 Identities=17% Similarity=0.166 Sum_probs=44.2
Q ss_pred EEEEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHH-HHCCccccCCccccEEEc
Q 008759 405 LYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYL-HDQDVVHRDIKCANILVD 463 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yL-Hs~gIIHrDIKPeNILld 463 (554)
..|+-+|+.|..+..++.....++.-.+.++.-...||..+ --.|++|.|+.|.||++.
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlir 379 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWKSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIR 379 (565)
T ss_pred ceeeeeccccccHHhhhhcccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEE
Confidence 45666788888898888877777766666666555555443 346899999999999994
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 554 | ||||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-34 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-34 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-34 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-34 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-34 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-33 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-33 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-32 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-31 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-27 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-27 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-27 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 6e-27 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 8e-27 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-26 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-26 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-26 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-26 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-26 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-26 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-26 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-26 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-26 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-26 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-26 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-26 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-26 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-26 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-26 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-26 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 6e-26 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 7e-26 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 7e-26 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-26 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 8e-26 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 9e-26 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-25 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-25 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-25 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-25 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-25 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-25 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-25 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-25 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 9e-25 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-24 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-24 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-24 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-24 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-23 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-23 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-23 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-23 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 5e-23 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-23 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 8e-23 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 9e-23 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-22 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-22 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-22 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-22 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-22 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-22 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-22 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-22 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-22 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-22 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-22 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-22 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-22 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-22 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-22 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-22 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-22 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-22 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 6e-22 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 7e-22 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 7e-22 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 8e-22 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 8e-22 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-22 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 9e-22 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 9e-22 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-21 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-21 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-21 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-21 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-21 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-21 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-21 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-21 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-21 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-21 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-21 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-21 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-21 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-21 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-21 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-21 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-21 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-21 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-21 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-21 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-21 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-21 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-21 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-21 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-21 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-21 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-21 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-21 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-21 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-21 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-21 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-21 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-21 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-21 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-21 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-21 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-21 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-21 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-21 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-21 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-21 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-21 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-21 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-21 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-21 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-21 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-21 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-21 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-21 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-21 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-21 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-21 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-21 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-21 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-21 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-21 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-21 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-21 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-21 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-21 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-21 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-21 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-21 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-21 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-21 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 6e-21 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-21 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-21 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-21 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 6e-21 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 6e-21 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 6e-21 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 6e-21 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-21 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 6e-21 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-21 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 6e-21 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-21 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 6e-21 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 6e-21 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 7e-21 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 7e-21 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-21 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 7e-21 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 7e-21 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 7e-21 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 7e-21 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 7e-21 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 7e-21 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 7e-21 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 7e-21 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 7e-21 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 8e-21 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 8e-21 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 8e-21 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 8e-21 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 8e-21 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 8e-21 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 8e-21 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 9e-21 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-21 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-20 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-20 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-20 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-20 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-20 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-20 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-20 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-20 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-20 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-20 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-20 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-20 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-20 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-20 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-20 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-20 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-20 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-20 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-20 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-20 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-20 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-20 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-20 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-20 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-20 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-20 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-20 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-20 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-20 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-20 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-20 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-20 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-20 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-20 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-20 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-20 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-20 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-20 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-20 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-20 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-20 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-20 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-20 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-20 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-20 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-20 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-20 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-20 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-20 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-20 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-20 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-20 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-20 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-20 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-20 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-20 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-20 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-20 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-20 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-20 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-20 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-20 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-20 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-20 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-20 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-20 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-20 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-20 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-20 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-20 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-20 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-20 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-20 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-20 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-20 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-20 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-20 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-20 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-20 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-20 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-20 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-20 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-20 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-20 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-20 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-20 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-20 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-20 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-20 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-20 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-20 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-20 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-20 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-20 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-20 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-20 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-20 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-20 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-20 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-20 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-20 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-20 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-20 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-20 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-20 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-20 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-20 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-20 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-20 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-20 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-20 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 5e-20 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 5e-20 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 6e-20 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 6e-20 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 6e-20 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 6e-20 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-20 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 6e-20 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 6e-20 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 7e-20 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 7e-20 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 7e-20 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-20 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 7e-20 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-20 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-20 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 9e-20 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 9e-20 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 9e-20 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 9e-20 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 9e-20 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 9e-20 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-19 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-19 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-19 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-19 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-19 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-19 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-19 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-19 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-19 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-19 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-19 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-19 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-19 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-19 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-19 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-19 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-19 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-19 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-19 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-19 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-19 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-19 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-19 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-19 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-19 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-19 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-19 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-19 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-19 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-19 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-19 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-19 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-19 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-19 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-19 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-19 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-19 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-19 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-19 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-19 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-19 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-19 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-19 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-19 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-19 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-19 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-19 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-19 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-19 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-19 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-19 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-19 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-19 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-19 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-19 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-19 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-19 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-19 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-19 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 5e-19 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-19 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 5e-19 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-19 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-19 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-19 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-19 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 5e-19 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 6e-19 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 6e-19 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 6e-19 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-19 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 6e-19 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 6e-19 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 6e-19 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 6e-19 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-19 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 6e-19 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 6e-19 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 6e-19 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 6e-19 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 6e-19 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 6e-19 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 6e-19 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 6e-19 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 6e-19 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 6e-19 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 6e-19 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 7e-19 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 7e-19 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 7e-19 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 7e-19 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 7e-19 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 7e-19 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 7e-19 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 7e-19 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 7e-19 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 7e-19 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 8e-19 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 8e-19 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 8e-19 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 8e-19 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 8e-19 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 8e-19 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 9e-19 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 9e-19 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 9e-19 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 9e-19 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-18 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-18 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-18 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-18 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-18 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-18 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-18 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-18 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-18 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-18 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-18 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-18 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-18 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-18 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-18 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-18 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-18 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-18 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-18 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-18 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-18 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-18 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-18 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-18 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-18 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-18 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-18 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-18 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-18 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-18 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-18 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-18 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-18 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-18 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-18 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-18 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-18 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-18 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-18 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-18 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-18 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-18 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-18 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-18 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-18 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-18 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-18 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-18 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-18 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-18 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-18 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-18 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-18 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-18 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-18 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-18 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-18 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-18 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-18 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-18 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-18 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-18 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-18 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-18 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-18 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-18 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 5e-18 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 5e-18 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 5e-18 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-18 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 6e-18 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 6e-18 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 7e-18 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 7e-18 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-18 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 7e-18 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 7e-18 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-18 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 8e-18 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-18 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 9e-18 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-17 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-17 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-17 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-17 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-17 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-17 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-17 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-17 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-17 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-17 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-17 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-17 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-17 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-17 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-17 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-17 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-17 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-17 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-17 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-17 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-17 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-17 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-17 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-17 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-17 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-17 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-17 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-17 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-17 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-17 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-17 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-17 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-17 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-17 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-17 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-17 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-17 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-17 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-17 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-17 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-17 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-17 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-17 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-17 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-17 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-17 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-17 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-17 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-17 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-17 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-17 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-17 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-17 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-17 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-17 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-17 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-17 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-17 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-17 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 5e-17 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 5e-17 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-17 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 6e-17 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 6e-17 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 6e-17 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 7e-17 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 7e-17 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 7e-17 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 7e-17 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 7e-17 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 8e-17 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-16 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-16 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-16 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-16 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-16 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-16 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-16 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-16 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-16 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-16 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-16 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-16 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-16 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-16 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-16 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-16 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-16 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-16 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-16 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-16 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-16 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-16 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-16 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-16 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-16 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-16 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-16 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-16 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-16 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-16 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-16 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-16 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-16 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-16 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-16 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-16 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-16 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-16 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-16 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-16 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-16 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-16 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-16 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-16 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-16 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-16 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-16 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-16 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-16 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-16 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-16 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-16 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 4e-16 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-16 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 5e-16 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-16 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-16 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-16 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 5e-16 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 5e-16 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 6e-16 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 6e-16 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-16 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 6e-16 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 6e-16 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-16 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 7e-16 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-16 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-16 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 8e-16 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-16 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 9e-16 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 9e-16 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-16 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 9e-16 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-16 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-15 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-15 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-15 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-15 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-15 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-15 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-15 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-15 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-15 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-15 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-15 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-15 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-15 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-15 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-15 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-15 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-15 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-15 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-15 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-15 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-15 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-15 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-15 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-15 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-15 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-15 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-15 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-15 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-15 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-15 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-15 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-15 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-15 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-15 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-15 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-15 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-15 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-15 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-15 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-15 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-15 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-15 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-15 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-15 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 4e-15 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-15 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 4e-15 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-15 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-15 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-15 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-15 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-15 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 5e-15 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 5e-15 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 5e-15 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 5e-15 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 5e-15 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 5e-15 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-15 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-15 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 5e-15 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 5e-15 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 5e-15 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 5e-15 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-15 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-15 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 5e-15 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-15 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 6e-15 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 6e-15 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 6e-15 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-15 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 7e-15 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-15 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 7e-15 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 7e-15 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 7e-15 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 7e-15 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 7e-15 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 8e-15 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-15 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 9e-15 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-15 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 9e-15 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 9e-15 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 9e-15 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 9e-15 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-14 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-14 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-14 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-14 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-14 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-14 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-14 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-14 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-14 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-14 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-14 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-14 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-14 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-14 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-14 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-14 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-14 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-14 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-14 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-14 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-14 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-14 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-14 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-14 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-14 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-14 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-14 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-14 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-14 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-14 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-14 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-14 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-14 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-14 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-14 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-14 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-14 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-14 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-14 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-14 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-14 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-14 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-14 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-14 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-14 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-14 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-14 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-14 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-14 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-14 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-14 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-14 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-14 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-14 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-14 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-14 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-14 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-14 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-14 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-14 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-14 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-14 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-14 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-14 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-14 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-14 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-14 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-14 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-14 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-14 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-14 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-14 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-14 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-14 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-14 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-14 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-14 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-14 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-14 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-14 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-14 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-14 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-14 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-14 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-14 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-14 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-14 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-14 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-14 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 4e-14 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-14 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-14 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-14 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-14 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-14 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-14 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-14 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-14 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-14 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-14 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-14 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-14 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-14 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-14 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-14 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 4e-14 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-14 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-14 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-14 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-14 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-14 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-14 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-14 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 4e-14 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-14 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 4e-14 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 5e-14 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 5e-14 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 5e-14 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 5e-14 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 5e-14 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 5e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 5e-14 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 5e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-14 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-14 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 6e-14 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 6e-14 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 6e-14 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 6e-14 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-14 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 7e-14 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 7e-14 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 7e-14 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 7e-14 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 7e-14 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 8e-14 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 8e-14 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 8e-14 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 8e-14 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 9e-14 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 9e-14 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 9e-14 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-13 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-13 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-13 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-13 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-13 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-13 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-13 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-13 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-13 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-13 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-13 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-13 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-13 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-13 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-13 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-13 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-13 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-13 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-13 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-13 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-13 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 4e-13 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-13 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-13 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 4e-13 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-13 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-13 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-13 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 4e-13 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-13 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 5e-13 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 5e-13 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 5e-13 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-13 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 5e-13 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 5e-13 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 6e-13 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 6e-13 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-13 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 7e-13 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 7e-13 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 7e-13 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-13 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 9e-13 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-12 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-12 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-12 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-12 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-12 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-12 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-12 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-12 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-12 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-12 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-12 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-12 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-12 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-12 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-12 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-12 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-12 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-12 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-12 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-12 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 3e-12 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-12 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-12 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-12 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-12 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-12 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-12 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-12 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-12 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 6e-12 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 6e-12 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-12 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 6e-12 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 7e-12 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 7e-12 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 7e-12 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 8e-12 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 9e-12 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-11 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-11 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-11 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-11 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-11 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-11 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-11 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-11 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-11 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-11 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-11 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-11 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-11 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-11 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-11 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 3e-11 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 3e-11 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-11 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 5e-11 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 5e-11 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 7e-11 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 7e-11 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 9e-11 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-10 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-10 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-10 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-10 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-10 |
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 336 bits (864), Expect = e-113
Identities = 88/241 (36%), Positives = 131/241 (54%), Gaps = 14/241 (5%)
Query: 308 SSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQ 366
S +TE S + +LG+G++G VY G + A+KE+ D
Sbjct: 1 SMRSTEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS 60
Query: 367 GSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH- 425
+ L +EIAL +H+NIVQY G+ + + IF+E V GSL L +
Sbjct: 61 -----RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWG 115
Query: 426 ---LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA-NGSVKLADFGLAK--AT 479
+ + YT+QIL GLKYLHD +VHRDIK N+L++ +G +K++DFG +K A
Sbjct: 116 PLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175
Query: 480 KLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM-ECVSAI 538
++ GT +MAPE+I+ +GYG ADIWSLGCT++EM T + P+ + E +A+
Sbjct: 176 INPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAM 235
Query: 539 F 539
F
Sbjct: 236 F 236
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 303 bits (778), Expect = e-100
Identities = 71/249 (28%), Positives = 125/249 (50%), Gaps = 21/249 (8%)
Query: 302 EHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKE 360
+ D +S +GR + + +GRGSF +VY+G+ ++ A E
Sbjct: 5 NQQQDDIEELETKAVGMSNDGR------FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCE 58
Query: 361 VSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYG----TDKDESKLYIFLELVTKGS 416
+ K + ++E +L +H NIV++Y T K + + + EL+T G+
Sbjct: 59 LQDRKL---TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGT 115
Query: 417 LLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQD--VVHRDIKCANILVDA-NGSVKLAD 472
L +R+ ++ + ++ RQIL GL++LH + ++HRD+KC NI + GSVK+ D
Sbjct: 116 LKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGD 175
Query: 473 FGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM 532
GLA + + K+ GT +MAPE+ Y D+++ G +LEM TS+ PY+
Sbjct: 176 LGLATLKRASFAKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSEC 232
Query: 533 ECVSAIFIK 541
+ + I+ +
Sbjct: 233 QNAAQIYRR 241
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 290 bits (744), Expect = 3e-94
Identities = 71/249 (28%), Positives = 106/249 (42%), Gaps = 24/249 (9%)
Query: 301 TEHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVK 359
E ED+ TE + + + ++ + + +GRGSFG V+ GF AVK
Sbjct: 32 PETEDNEGVLLTEKLKPV--DYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVK 89
Query: 360 EVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN 419
+V L +E+ + IV YG ++ + IF+EL+ GSL
Sbjct: 90 KVRLEVF----------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQ 139
Query: 420 LYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS-VKLADFGLAK 477
L ++ L + + Y Q L GL+YLH + ++H D+K N+L+ ++GS L DFG A
Sbjct: 140 LIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHAL 199
Query: 478 -------ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYA 530
L GT MAPEV+ K DIWS C +L ML P+
Sbjct: 200 CLQPDGLGKSLLTGDYIPGTETHMAPEVV--MGKPCDAKVDIWSSCCMMLHMLNGCHPWT 257
Query: 531 PMECVSAIF 539
Sbjct: 258 QYFRGPLCL 266
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 254 bits (651), Expect = 5e-81
Identities = 53/238 (22%), Positives = 102/238 (42%), Gaps = 30/238 (12%)
Query: 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 384
R T + + + +G G FGSV++ + DG +A+K GS +Q+ L + A
Sbjct: 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNA--LREVYAHA 65
Query: 385 SRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-----HLRDSQVSAYTRQIL 439
+H ++V+Y+ ++ + I E GSL + + +++++ Q+
Sbjct: 66 VLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 125
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGS-------------------VKLADFGLAKATK 480
GL+Y+H +VH DIK +NI + K+ D G T+
Sbjct: 126 RGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH--VTR 183
Query: 481 LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAI 538
++ + G + ++A EV+ N + ADI++L TV+ ++ + I
Sbjct: 184 ISSPQVEEGDSRFLANEVLQE-NYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEI 240
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 250 bits (640), Expect = 4e-79
Identities = 68/244 (27%), Positives = 107/244 (43%), Gaps = 12/244 (4%)
Query: 302 EHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKE 360
++S T P + P+ +Q+ LG GS+G V++ S +DG +AVK
Sbjct: 32 SFRGEASETLQSPGYD--PSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKR 89
Query: 361 VSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNL 420
+G + + L + + +H V+ ++ LY+ EL SL
Sbjct: 90 SMSPFRGPKDRARK--LAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELCG-PSLQQH 146
Query: 421 YQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA 478
+ + L ++QV Y R LL L +LH Q +VH D+K ANI + G KL DFGL
Sbjct: 147 CEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVE 206
Query: 479 -TKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSA 537
+ G +MAPE++ YG AD++SLG T+LE+ + E
Sbjct: 207 LGTAGAGEVQEGDPRYMAPELLQG---SYGTAADVFSLGLTILEVACNMELPHGGEGWQQ 263
Query: 538 IFIK 541
+
Sbjct: 264 LRQG 267
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 242 bits (619), Expect = 4e-75
Identities = 53/245 (21%), Positives = 104/245 (42%), Gaps = 21/245 (8%)
Query: 302 EHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEV 361
+ T + ++ S N + +G G V++ +++ +A+K V
Sbjct: 29 HMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYV 88
Query: 362 SLLDQGSQAKQSISQLEQEIALLSRFEH--ENIVQYYGTDKDESKLYIFLELVTKGSLLN 419
+L Q++ EIA L++ + + I++ Y + + +Y+ +E L +
Sbjct: 89 NL---EEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNS 144
Query: 420 -LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA 478
L ++ + + +Y + +L + +H +VH D+K AN L+ +G +KL DFG+A
Sbjct: 145 WLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQ 203
Query: 479 ----TKLNDVKSCRGTAFWMAPEVINNKN---------KGYGLPADIWSLGCTVLEMLTS 525
T S G +M PE I + + +D+WSLGC + M
Sbjct: 204 MQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG 263
Query: 526 QIPYA 530
+ P+
Sbjct: 264 KTPFQ 268
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 236 bits (605), Expect = 5e-74
Identities = 71/231 (30%), Positives = 116/231 (50%), Gaps = 13/231 (5%)
Query: 307 SSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLD 365
+P + P+ + + + + +GRG F VY DG A+K+V + D
Sbjct: 11 PPVPQFQPQKALRPDMGYNTLANF-RIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFD 69
Query: 366 QGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY- 424
++ + +EI LL + H N+++YY + ++++L I LEL G L + + +
Sbjct: 70 LMDA--KARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFK 127
Query: 425 ----HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA-- 478
+ + V Y Q+ L+++H + V+HRDIK AN+ + A G VKL D GL +
Sbjct: 128 KQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187
Query: 479 TKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY 529
+K S GT ++M+PE I GY +DIWSLGC + EM Q P+
Sbjct: 188 SKTTAAHSLVGTPYYMSPERI--HENGYNFKSDIWSLGCLLYEMAALQSPF 236
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 226 bits (579), Expect = 4e-70
Identities = 55/245 (22%), Positives = 105/245 (42%), Gaps = 22/245 (8%)
Query: 302 EHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEV 361
H SS N+ + Y +G G V++ +++ +A+K V
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMSVKGRIY-SILKQIGSGGSSKVFQVLNEKKQIYAIKYV 60
Query: 362 SLLDQGSQAKQSISQLEQEIALLSRFEH--ENIVQYYGTDKDESKLYIFLELVTKGSLLN 419
+L Q++ EIA L++ + + I++ Y + + +Y+ +E L +
Sbjct: 61 NL---EEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNS 116
Query: 420 -LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA 478
L ++ + + +Y + +L + +H +VH D+K AN L+ +G +KL DFG+A
Sbjct: 117 WLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQ 175
Query: 479 TKLNDV----KSCRGTAFWMAPEVINNKN---------KGYGLPADIWSLGCTVLEMLTS 525
+ + S GT +M PE I + + +D+WSLGC + M
Sbjct: 176 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG 235
Query: 526 QIPYA 530
+ P+
Sbjct: 236 KTPFQ 240
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 228 bits (582), Expect = 4e-70
Identities = 54/229 (23%), Positives = 103/229 (44%), Gaps = 27/229 (11%)
Query: 318 ISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQL 377
IS GR + +G G V++ +++ +A+K V+L Q++
Sbjct: 4 ISVKGR------IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNL---EEADNQTLDSY 54
Query: 378 EQEIALLSRFEH--ENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAY 434
EIA L++ + + I++ Y + + +Y+ +E L + L ++ + + +Y
Sbjct: 55 RNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSY 113
Query: 435 TRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV----KSCRGT 490
+ +L + +H +VH D+K AN L+ +G +KL DFG+A + + S GT
Sbjct: 114 WKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGT 172
Query: 491 AFWMAPEVINNKN---------KGYGLPADIWSLGCTVLEMLTSQIPYA 530
+M PE I + + +D+WSLGC + M + P+
Sbjct: 173 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 221
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 2e-66
Identities = 67/224 (29%), Positives = 124/224 (55%), Gaps = 12/224 (5%)
Query: 312 TEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQA 370
+ + + N F+ + Y + +G GSFG S +DG + +KE+++ S+
Sbjct: 8 SSGVDLGTENLYFQSMEKY-VRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKE 66
Query: 371 KQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSL---LNLYQRYHLR 427
++ +E+A+L+ +H NIVQY + ++ LYI ++ G L +N + +
Sbjct: 67 REES---RREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQ 123
Query: 428 DSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--K 485
+ Q+ + QI L LK++HD+ ++HRDIK NI + +G+V+L DFG+A+ +
Sbjct: 124 EDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELAR 183
Query: 486 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY 529
+C GT ++++PE+ +NK Y +DIW+LGC + E+ T + +
Sbjct: 184 ACIGTPYYLSPEIC--ENKPYNNKSDIWALGCVLYELCTLKHAF 225
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 3e-65
Identities = 86/243 (35%), Positives = 133/243 (54%), Gaps = 20/243 (8%)
Query: 302 EHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKE 360
H S P F ++ + +G+GSFG V++GI A+K
Sbjct: 2 AHSPVQSGLPGMQNLKADPEELFTKL-------EKIGKGSFGEVFKGIDNRTQKVVAIKI 54
Query: 361 VSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNL 420
+ L +A+ I ++QEI +LS+ + + +YYG+ ++KL+I +E + GS L+L
Sbjct: 55 IDL----EEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDL 110
Query: 421 YQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK 480
+ L ++Q++ R+IL GL YLH + +HRDIK AN+L+ +G VKLADFG+ A +
Sbjct: 111 LEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGV--AGQ 168
Query: 481 LNDVKSCR----GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVS 536
L D + R GT FWMAPEVI K Y ADIWSLG T +E+ + P++ + +
Sbjct: 169 LTDTQIKRNTFVGTPFWMAPEVI--KQSAYDSKADIWSLGITAIELARGEPPHSELHPMK 226
Query: 537 AIF 539
+F
Sbjct: 227 VLF 229
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 4e-63
Identities = 66/219 (30%), Positives = 111/219 (50%), Gaps = 17/219 (7%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
W+ LG G+FG VY+ + + G A K + ++++ + EI +L+ +H
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIET-----KSEEELEDYIVEIEILATCDH 75
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHD 447
IV+ G + KL+I +E G++ + L + Q+ RQ+L L +LH
Sbjct: 76 PYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS 135
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR----GTAFWMAPEVI---N 500
+ ++HRD+K N+L+ G ++LADFG+ + K R GT +WMAPEV+
Sbjct: 136 KRIIHRDLKAGNVLMTLEGDIRLADFGV--SAKNLKTLQKRDSFIGTPYWMAPEVVMCET 193
Query: 501 NKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIF 539
K+ Y ADIWSLG T++EM + P+ + + +
Sbjct: 194 MKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL 232
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 210 bits (535), Expect = 3e-62
Identities = 60/246 (24%), Positives = 105/246 (42%), Gaps = 36/246 (14%)
Query: 293 LSESCSFTTEHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDD 352
+ S S + D+ +S G+ + D+LG G+ G++ D
Sbjct: 1 MGSSPSLEQDDGDEETSVVIV--------GKIS-----FCPKDVLGHGAEGTIVYRGMFD 47
Query: 353 GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESKLYIFLEL 411
AVK + + S ++E+ LL EH N+++Y+ T+KD YI +EL
Sbjct: 48 NRDVAVKRIL--------PECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99
Query: 412 VTKGSLLNLYQRYHLRDSQVSAYT--RQILLGLKYLHDQDVVHRDIKCANILVDANGS-- 467
+L ++ + T +Q GL +LH ++VHRD+K NIL+ +
Sbjct: 100 CA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHG 158
Query: 468 ---VKLADFGLAK-----ATKLNDVKSCRGTAFWMAPEVIN-NKNKGYGLPADIWSLGCT 518
++DFGL K + GT W+APE+++ + + DI+S GC
Sbjct: 159 KIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCV 218
Query: 519 VLEMLT 524
+++
Sbjct: 219 FYYVIS 224
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 6e-62
Identities = 68/217 (31%), Positives = 116/217 (53%), Gaps = 14/217 (6%)
Query: 329 TYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
+ + + +G+G+ G+VY + G A+++++L Q + EI ++
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-----PKKELIINEILVMREN 74
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
++ NIV Y + +L++ +E + GSL ++ + + Q++A R+ L L++LH
Sbjct: 75 KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHS 134
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR----GTAFWMAPEVINNKN 503
V+HRDIK NIL+ +GSVKL DFG ++ +S R GT +WMAPEV+
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGF--CAQITPEQSKRSTMVGTPYWMAPEVV--TR 190
Query: 504 KGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFI 540
K YG DIWSLG +EM+ + PY + A+++
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL 227
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 2e-61
Identities = 69/237 (29%), Positives = 111/237 (46%), Gaps = 20/237 (8%)
Query: 315 MSNISPNGRFKRIIT------YWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQG 367
+++ + ++ +G GS G V G AVK + L Q
Sbjct: 25 VTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ- 83
Query: 368 SQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLR 427
Q L E+ ++ ++H N+V+ Y + +L++ +E + G+L ++ + L
Sbjct: 84 ----QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLN 139
Query: 428 DSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSC 487
+ Q++ +L L YLH Q V+HRDIK +IL+ +G VKL+DFG +++
Sbjct: 140 EEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGF--CAQISKDVPK 197
Query: 488 R----GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFI 540
R GT +WMAPEVI Y DIWSLG V+EM+ + PY V A+
Sbjct: 198 RKSLVGTPYWMAPEVI--SRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR 252
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 3e-61
Identities = 63/231 (27%), Positives = 111/231 (48%), Gaps = 39/231 (16%)
Query: 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 384
R + +++ +LG+G+FG V + + D ++A+K++ ++ +S + E+ LL
Sbjct: 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH------TEEKLSTILSEVMLL 56
Query: 385 SRFEHENIVQYYGTDKDE-------------SKLYIFLELVTKGSLLNLYQRYHLRDSQV 431
+ H+ +V+YY + S L+I +E G+L +L +L +
Sbjct: 57 ASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRD 116
Query: 432 SA--YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK------------ 477
RQIL L Y+H Q ++HRD+K NI +D + +VK+ DFGLAK
Sbjct: 117 EYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 478 ----ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT 524
+++ S GTA ++A EV++ Y D++SLG EM+
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGT-GHYNEKIDMYSLGIIFFEMIY 226
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 3e-61
Identities = 72/233 (30%), Positives = 113/233 (48%), Gaps = 16/233 (6%)
Query: 312 TEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQA 370
E P F + +G GSFG+VY + A+K++S + Q+
Sbjct: 44 AELFFKDDPEKLFSDL-------REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK--QS 94
Query: 371 KQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRD 428
+ + +E+ L + H N +QY G E ++ +E GS +L + + L++
Sbjct: 95 NEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQE 153
Query: 429 SQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR 488
+++A T L GL YLH +++HRD+K NIL+ G VKL DFG A+ + S
Sbjct: 154 VEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGS--ASIMAPANSFV 211
Query: 489 GTAFWMAPEVI-NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFI 540
GT +WMAPEVI Y D+WSLG T +E+ + P M +SA++
Sbjct: 212 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH 264
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 5e-61
Identities = 53/254 (20%), Positives = 108/254 (42%), Gaps = 24/254 (9%)
Query: 303 HEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRG--SFGSVYEGI-SDDGFFFAVK 359
H + + MS+ P G ++ ++G+G +V G + V+
Sbjct: 5 HHHHMENLYFQGMSSFLPEG------GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVR 58
Query: 360 EVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN 419
++L + + + ++ L+ E+ + F H NIV Y T +++L++ + GS +
Sbjct: 59 RINL---EACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKD 115
Query: 420 LYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA 476
L + + + ++ + +L L Y+H VHR +K ++IL+ +G V L+
Sbjct: 116 LICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSN 175
Query: 477 ---------KATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQI 527
+ + K W++PEV+ +GY +DI+S+G T E+ +
Sbjct: 176 LSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHV 235
Query: 528 PYAPMECVSAIFIK 541
P+ M + K
Sbjct: 236 PFKDMPATQMLLEK 249
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 5e-61
Identities = 57/223 (25%), Positives = 102/223 (45%), Gaps = 34/223 (15%)
Query: 332 QKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
++ +L+G G FG V++ DG + +K V ++ + E+E+ L++ +H
Sbjct: 14 KEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE---------KAEREVKALAKLDHV 64
Query: 391 NIVQYYG----------------TDKDESKLYIFLELVTKGSLLNLYQRY---HLRDSQV 431
NIV Y G + L+I +E KG+L ++ L
Sbjct: 65 NIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLA 124
Query: 432 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-KSCRGT 490
QI G+ Y+H + +++RD+K +NI + VK+ DFGL + K + +GT
Sbjct: 125 LELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGT 184
Query: 491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME 533
+M+PE I ++ YG D+++LG + E+L + E
Sbjct: 185 LRYMSPEQI--SSQDYGKEVDLYALGLILAELLH--VCDTAFE 223
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 6e-61
Identities = 78/218 (35%), Positives = 124/218 (56%), Gaps = 18/218 (8%)
Query: 329 TYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
+ + LG GS+GSVY+ I + G A+K+V + + ++ +EI+++ +
Sbjct: 29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-------LQEIIKEISIMQQC 81
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYL 445
+ ++V+YYG+ + L+I +E GS+ ++ + + L + +++ + L GL+YL
Sbjct: 82 DSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYL 141
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR----GTAFWMAPEVINN 501
H +HRDIK NIL++ G KLADFG+ A +L D + R GT FWMAPEVI
Sbjct: 142 HFMRKIHRDIKAGNILLNTEGHAKLADFGV--AGQLTDTMAKRNTVIGTPFWMAPEVI-- 197
Query: 502 KNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIF 539
+ GY ADIWSLG T +EM + PYA + + AIF
Sbjct: 198 QEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIF 235
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 1e-60
Identities = 72/238 (30%), Positives = 121/238 (50%), Gaps = 25/238 (10%)
Query: 315 MSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQS 373
MS S + ++ +++G G+ V A+K ++L + + S
Sbjct: 1 MSEDSSALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINL----EKCQTS 56
Query: 374 ISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-------- 425
+ +L +EI +S+ H NIV YY + + +L++ ++L++ GS+L++ +
Sbjct: 57 MDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSG 116
Query: 426 -LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA---KATKL 481
L +S ++ R++L GL+YLH +HRD+K NIL+ +GSV++ADFG++
Sbjct: 117 VLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGD 176
Query: 482 NDVKSCR----GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYA---PM 532
R GT WMAPEV+ + +GY ADIWS G T +E+ T PY PM
Sbjct: 177 ITRNKVRKTFVGTPCWMAPEVM-EQVRGYDFKADIWSFGITAIELATGAAPYHKYPPM 233
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 7e-60
Identities = 77/251 (30%), Positives = 123/251 (49%), Gaps = 34/251 (13%)
Query: 315 MSNISPNGRFKRII--------TYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLD 365
M++ SP I ++ +L+G G++G VY+G G A+K + +
Sbjct: 2 MASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-- 59
Query: 366 QGSQAKQSISQLEQEIALLSRF-EHENIVQYYG------TDKDESKLYIFLELVTKGSLL 418
+++QEI +L ++ H NI YYG + +L++ +E GS+
Sbjct: 60 ----TGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVT 115
Query: 419 NLYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL 475
+L + L++ ++ R+IL GL +LH V+HRDIK N+L+ N VKL DFG+
Sbjct: 116 DLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGV 175
Query: 476 AKATKLNDVKSCR----GTAFWMAPEVI---NNKNKGYGLPADIWSLGCTVLEMLTSQIP 528
+ +L+ R GT +WMAPEVI N + Y +D+WSLG T +EM P
Sbjct: 176 --SAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233
Query: 529 YAPMECVSAIF 539
M + A+F
Sbjct: 234 LCDMHPMRALF 244
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 9e-58
Identities = 66/213 (30%), Positives = 100/213 (46%), Gaps = 20/213 (9%)
Query: 332 QKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
+ +G GS+G + DG KE+ KQ L E+ LL +H
Sbjct: 9 EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQ---MLVSEVNLLRELKHP 65
Query: 391 NIVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRY-----HLRDSQVSAYTRQILLGLK 443
NIV+YY D+ + LYI +E G L ++ + +L + V Q+ L LK
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 444 YLHDQ-----DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--KSCRGTAFWMAP 496
H + V+HRD+K AN+ +D +VKL DFGLA+ + K+ GT ++M+P
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSP 185
Query: 497 EVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY 529
E + Y +DIWSLGC + E+ P+
Sbjct: 186 EQM--NRMSYNEKSDIWSLGCLLYELCALMPPF 216
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 6e-57
Identities = 57/224 (25%), Positives = 96/224 (42%), Gaps = 37/224 (16%)
Query: 332 QKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
+ LGRG FG V+E + D +A+K + L + + ++ +E+ L++ EH
Sbjct: 8 EPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRL----PNRELAREKVMREVKALAKLEHP 63
Query: 391 NIVQYYGTDKDESK------------LYIFLELVTKGSLLNLYQR----YHLRDSQVSAY 434
IV+Y+ +++ LYI ++L K +L + S
Sbjct: 64 GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123
Query: 435 TRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA--------------TK 480
QI +++LH + ++HRD+K +NI + VK+ DFGL A
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 481 LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT 524
GT +M+PE I+ Y DI+SLG + E+L
Sbjct: 184 YARHTGQVGTKLYMSPEQIH--GNSYSHKVDIFSLGLILFELLY 225
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 183 bits (468), Expect = 4e-54
Identities = 59/215 (27%), Positives = 110/215 (51%), Gaps = 15/215 (6%)
Query: 322 GRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEV--SLLDQGSQAKQSISQLE 378
I ++ G+LLG+GSF VY S G A+K + + + ++ ++
Sbjct: 4 TCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQR----VQ 59
Query: 379 QEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTR 436
E+ + + +H +I++ Y +D + +Y+ LE+ G + + +++ +
Sbjct: 60 NEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMH 119
Query: 437 QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK---SCRGTAFW 493
QI+ G+ YLH ++HRD+ +N+L+ N ++K+ADFGLA K+ K C GT +
Sbjct: 120 QIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC-GTPNY 178
Query: 494 MAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIP 528
++PE+ +GL +D+WSLGC +L + P
Sbjct: 179 ISPEIAT--RSAHGLESDVWSLGCMFYTLLIGRPP 211
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 7e-54
Identities = 58/206 (28%), Positives = 107/206 (51%), Gaps = 13/206 (6%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
++K LG G+ G V++ G A K + L +Q+ +E+ +L
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL----EIKPAIRNQIIRELQVLHECNS 90
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQ 448
IV +YG + ++ I +E + GSL + ++ + + + + ++ GL YL ++
Sbjct: 91 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 150
Query: 449 -DVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VKSCRGTAFWMAPEVINNKNKG 505
++HRD+K +NILV++ G +KL DFG+ + +L D S GT +M+PE + +
Sbjct: 151 HKIMHRDVKPSNILVNSRGEIKLCDFGV--SGQLIDSMANSFVGTRSYMSPERL--QGTH 206
Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAP 531
Y + +DIWS+G +++EM + P P
Sbjct: 207 YSVQSDIWSMGLSLVEMAVGRYPIPP 232
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 1e-53
Identities = 65/239 (27%), Positives = 115/239 (48%), Gaps = 21/239 (8%)
Query: 309 STTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQG 367
S + ISP + + +GRG++GSV + + G AVK +
Sbjct: 2 SIESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRS---- 57
Query: 368 SQAKQSISQLEQEIA-LLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH- 425
+ ++ QL ++ ++ + IVQ+YG E +I +EL++ S Y+ +
Sbjct: 58 TVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYS 116
Query: 426 -----LRDSQVSAYTRQILLGLKYLHDQD-VVHRDIKCANILVDANGSVKLADFGLAKAT 479
+ + + T + L +L + ++HRDIK +NIL+D +G++KL DFG+ +
Sbjct: 117 VLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGI--SG 174
Query: 480 KLNDVKSCR---GTAFWMAPEVIN--NKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME 533
+L D + G +MAPE I+ +GY + +D+WSLG T+ E+ T + PY
Sbjct: 175 QLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWN 233
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 2e-53
Identities = 68/211 (32%), Positives = 113/211 (53%), Gaps = 15/211 (7%)
Query: 325 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEV--SLLDQGSQAKQSISQLEQEI 381
+ Y +G LG+G F +E D FA K V SLL + Q ++ + EI
Sbjct: 12 RSRRRY-VRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK----MSMEI 66
Query: 382 ALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILL 440
++ H+++V ++G +D +++ LEL + SLL +R L + + Y RQI+L
Sbjct: 67 SIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL 126
Query: 441 GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK---SCRGTAFWMAPE 497
G +YLH V+HRD+K N+ ++ + VK+ DFGLA + + + C GT ++APE
Sbjct: 127 GCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTPNYIAPE 185
Query: 498 VINNKNKGYGLPADIWSLGCTVLEMLTSQIP 528
V++ KG+ D+WS+GC + +L + P
Sbjct: 186 VLS--KKGHSFEVDVWSIGCIMYTLLVGKPP 214
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 2e-53
Identities = 63/225 (28%), Positives = 107/225 (47%), Gaps = 24/225 (10%)
Query: 331 WQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIA-LLSRFE 388
+ LGRG++G V + G AVK + + Q +L ++ + +
Sbjct: 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRA----TVNSQEQKRLLMDLDISMRTVD 64
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD-----SQVSAYTRQILLGLK 443
V +YG E ++I +EL+ SL Y++ + + I+ L+
Sbjct: 65 CPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALE 123
Query: 444 YLHDQD-VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR---GTAFWMAPEVI 499
+LH + V+HRD+K +N+L++A G VK+ DFG++ L D + G +MAPE I
Sbjct: 124 HLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISG--YLVDDVAKDIDAGCKPYMAPERI 181
Query: 500 NN--KNKGYGLPADIWSLGCTVLEMLTSQIPYA----PMECVSAI 538
N KGY + +DIWSLG T++E+ + PY P + + +
Sbjct: 182 NPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV 226
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 3e-53
Identities = 70/229 (30%), Positives = 116/229 (50%), Gaps = 14/229 (6%)
Query: 307 SSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEV--SL 363
+ P I R + +G LG+G F +E D FA K V SL
Sbjct: 19 GAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSL 78
Query: 364 LDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQ 422
L + Q ++ + EI++ H+++V ++G +D +++ LEL + SLL +
Sbjct: 79 LLKPHQREK----MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR 134
Query: 423 RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN 482
R L + + Y RQI+LG +YLH V+HRD+K N+ ++ + VK+ DFGLA + +
Sbjct: 135 RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194
Query: 483 DVK---SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIP 528
+ C GT ++APEV++ KG+ D+WS+GC + +L + P
Sbjct: 195 GERKKVLC-GTPNYIAPEVLS--KKGHSFEVDVWSIGCIMYTLLVGKPP 240
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 8e-52
Identities = 56/247 (22%), Positives = 106/247 (42%), Gaps = 24/247 (9%)
Query: 304 EDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVS- 362
+D S+ + N + + I ++ L +G F + D F+A+K+
Sbjct: 7 KDILSNYSNLIYLNKYVKEK-DKYINDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEK 64
Query: 363 -----------LLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLEL 411
+ K + E+ +++ ++E + G + ++YI E
Sbjct: 65 SLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEY 124
Query: 412 VTKGSL---------LNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ-DVVHRDIKCANIL 461
+ S+ L+ + + + +L Y+H++ ++ HRD+K +NIL
Sbjct: 125 MENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNIL 184
Query: 462 VDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLE 521
+D NG VKL+DFG ++ +K RGT +M PE +N++ G DIWSLG +
Sbjct: 185 MDKNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYV 244
Query: 522 MLTSQIP 528
M + +P
Sbjct: 245 MFYNVVP 251
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 1e-51
Identities = 63/208 (30%), Positives = 107/208 (51%), Gaps = 18/208 (8%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIA-LLSRFEHENIVQ 394
+G G+ G V++ G AVK++ S K+ ++ ++ +L + IVQ
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRR----SGNKEENKRILMDLDVVLKSHDCPYIVQ 88
Query: 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQ-DVV 451
+GT + ++I +EL+ L +R + + + T I+ L YL ++ V+
Sbjct: 89 CFGTFITNTDVFIAMELMG-TCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVI 147
Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR---GTAFWMAPEVIN---NKNKG 505
HRD+K +NIL+D G +KL DFG+ + +L D K+ G A +MAPE I+
Sbjct: 148 HRDVKPSNILLDERGQIKLCDFGI--SGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPD 205
Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAPME 533
Y + AD+WSLG +++E+ T Q PY +
Sbjct: 206 YDIRADVWSLGISLVELATGQFPYKNCK 233
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 1e-51
Identities = 57/220 (25%), Positives = 98/220 (44%), Gaps = 22/220 (10%)
Query: 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE 388
W D+LG+G+ +V+ G G FA+K + + + +E +L +
Sbjct: 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNN----ISFLRPVDVQMREFEVLKKLN 65
Query: 389 HENIVQYYGT--DKDESKLYIFLELVTKGSLLN-LYQR---YHLRDSQVSAYTRQILLGL 442
H+NIV+ + + + +E GSL L + Y L +S+ R ++ G+
Sbjct: 66 HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 443 KYLHDQDVVHRDIKCANILV----DANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPE 497
+L + +VHR+IK NI+ D KL DFG A+ + ++ S GT ++ P+
Sbjct: 126 NHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPD 185
Query: 498 VINNK------NKGYGLPADIWSLGCTVLEMLTSQIPYAP 531
+ K YG D+WS+G T T +P+ P
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP 225
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 2e-51
Identities = 61/198 (30%), Positives = 98/198 (49%), Gaps = 8/198 (4%)
Query: 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
G LG+G FG+VY F A+K V Q +A QL +E+ + S H NI
Sbjct: 14 GRPLGKGKFGNVYLAREKQSKFILALK-VLFKAQLEKAGV-EHQLRREVEIQSHLRHPNI 71
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVV 451
++ YG D +++Y+ LE G++ Q+ + + + Y ++ L Y H + V+
Sbjct: 72 LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVI 131
Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLNDVK-SCRGTAFWMAPEVINNKNKGYGLPA 510
HRDIK N+L+ + G +K+ADFG + + C GT ++ PE+I + +
Sbjct: 132 HRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC-GTLDYLPPEMIE--GRMHDEKV 188
Query: 511 DIWSLGCTVLEMLTSQIP 528
D+WSLG E L + P
Sbjct: 189 DLWSLGVLCYEFLVGKPP 206
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 5e-51
Identities = 57/226 (25%), Positives = 103/226 (45%), Gaps = 21/226 (9%)
Query: 334 GDLLGRGSFGSVYEGI-SDDGFFFAVKEV--SLLDQGSQAKQSISQLEQEIALLSRFEHE 390
+G+G FG V++G D A+K + + ++ + + ++E+ ++S H
Sbjct: 24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTR-----QILLGLKYL 445
NIV+ YG + + +E V G L Y R + + + I LG++Y+
Sbjct: 84 NIVKLYGLMHN--PPRMVMEFVPCGDL---YHRLLDKAHPIKWSVKLRLMLDIALGIEYM 138
Query: 446 HDQD--VVHRDIKCANILVDANG-----SVKLADFGLAKATKLNDVKSCRGTAFWMAPEV 498
+Q+ +VHRD++ NI + + K+ADFGL++ ++ V G WMAPE
Sbjct: 139 QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-QSVHSVSGLLGNFQWMAPET 197
Query: 499 INNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTVA 544
I + + Y AD +S + +LT + P+ FI +
Sbjct: 198 IGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIR 243
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 6e-51
Identities = 63/217 (29%), Positives = 102/217 (47%), Gaps = 15/217 (6%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
+++G G FG VY G AVK + D Q+I + QE L + +H NI+
Sbjct: 12 EEIIGIGGFGKVYRAFWI-GDEVAVK-AARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ---DV 450
G E L + +E G L + + + + QI G+ YLHD+ +
Sbjct: 70 ALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPI 129
Query: 451 VHRDIKCANILVD--------ANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNK 502
+HRD+K +NIL+ +N +K+ DFGLA+ S G WMAPEVI
Sbjct: 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEVIRAS 189
Query: 503 NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIF 539
+ +D+WS G + E+LT ++P+ ++ ++ +
Sbjct: 190 M--FSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAY 224
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 9e-51
Identities = 64/244 (26%), Positives = 106/244 (43%), Gaps = 43/244 (17%)
Query: 316 SNISPNGRFKRIIT-YWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSI 374
S I+ F++ + +LG GS G+V S G AVK +
Sbjct: 1 SRIANIPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRML--------IDFC 52
Query: 375 SQLEQEIALLSRF-EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA 433
EI LL+ +H N+++YY ++ + LYI LEL +L +L + ++ D +
Sbjct: 53 DIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKL 111
Query: 434 YT--------RQILLGLKYLHDQDVVHRDIKCANILVD-------------ANGSVKLAD 472
RQI G+ +LH ++HRD+K NILV N + ++D
Sbjct: 112 QKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISD 171
Query: 473 FGLAK------ATKLNDVKSCRGTAFWMAPEVINNKN-----KGYGLPADIWSLGCTVLE 521
FGL K ++ ++ + GT+ W APE++ N + DI+S+GC
Sbjct: 172 FGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYY 231
Query: 522 MLTS 525
+L+
Sbjct: 232 ILSK 235
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 1e-50
Identities = 55/220 (25%), Positives = 91/220 (41%), Gaps = 27/220 (12%)
Query: 332 QKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
LG G F V DG F+A+K + + +Q + ++E + F H
Sbjct: 32 LFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE-----QQDREEAQREADMHRLFNHP 86
Query: 391 NIVQYYG----TDKDESKLYIFLELVTKGSLLNLYQRY-----HLRDSQVSAYTRQILLG 441
NI++ + + ++ L +G+L N +R L + Q+ I G
Sbjct: 87 NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146
Query: 442 LKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA-----------KATKLNDVKSCRGT 490
L+ +H + HRD+K NIL+ G L D G +A L D + R T
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 491 AFWMAPEVINNK-NKGYGLPADIWSLGCTVLEMLTSQIPY 529
+ APE+ + + + D+WSLGC + M+ + PY
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPY 246
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 176 bits (447), Expect = 5e-50
Identities = 57/220 (25%), Positives = 99/220 (45%), Gaps = 22/220 (10%)
Query: 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE 388
W D+LG+G+ +V+ G G FA+K + + + +E +L +
Sbjct: 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNN----ISFLRPVDVQMREFEVLKKLN 65
Query: 389 HENIVQYYGT--DKDESKLYIFLELVTKGSLLN-LYQR---YHLRDSQVSAYTRQILLGL 442
H+NIV+ + + + +E GSL L + Y L +S+ R ++ G+
Sbjct: 66 HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 443 KYLHDQDVVHRDIKCANILV----DANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPE 497
+L + +VHR+IK NI+ D KL DFG A+ + ++ S GT ++ P+
Sbjct: 126 NHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPD 185
Query: 498 VI------NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP 531
+ + K YG D+WS+G T T +P+ P
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP 225
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 7e-50
Identities = 66/215 (30%), Positives = 111/215 (51%), Gaps = 16/215 (7%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
+ +G GSFG+V+ G AVK +L + + +++ +E+A++ R H NIV
Sbjct: 42 KEKIGAGSFGTVHRAEWH-GSDVAVK---ILMEQDFHAERVNEFLREVAIMKRLRHPNIV 97
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNL----YQRYHLRDSQVSAYTRQILLGLKYLHDQD 449
+ G L I E +++GSL L R L + + + + G+ YLH+++
Sbjct: 98 LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN 157
Query: 450 --VVHRDIKCANILVDANGSVKLADFGLA--KATKLNDVKSCRGTAFWMAPEVINNKNKG 505
+VHR++K N+LVD +VK+ DFGL+ KA+ KS GT WMAPEV+ ++
Sbjct: 158 PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEP-- 215
Query: 506 YGLPADIWSLGCTVL-EMLTSQIPYAPMECVSAIF 539
+D++S G +L E+ T Q P+ + +
Sbjct: 216 SNEKSDVYSFG-VILWELATLQQPWGNLNPAQVVA 249
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 1e-49
Identities = 63/215 (29%), Positives = 104/215 (48%), Gaps = 17/215 (7%)
Query: 334 GDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
G +G GSFG+VY+G D AVK +L+ + Q + + E+ +L + H NI
Sbjct: 29 GQRIGSGSFGTVYKGKWHGD---VAVK---MLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 82
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNL--YQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
+ + G +L I + SL + ++ RQ G+ YLH + +
Sbjct: 83 LLFMGYSTAP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSI 141
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKL----NDVKSCRGTAFWMAPEVINNKNKG- 505
+HRD+K NI + + +VK+ DFGLA + + G+ WMAPEVI ++
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 506 YGLPADIWSLGCTVL-EMLTSQIPYAPMECVSAIF 539
Y +D+++ G VL E++T Q+PY+ + I
Sbjct: 202 YSFQSDVYAFG-IVLYELMTGQLPYSNINNRDQII 235
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 2e-49
Identities = 68/238 (28%), Positives = 119/238 (50%), Gaps = 29/238 (12%)
Query: 319 SPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVS--------------- 362
S + + + D +G+GS+G V + +D ++A+K +S
Sbjct: 3 SGSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPP 62
Query: 363 ------LLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYG--TDKDESKLYIFLELVTK 414
Q + I Q+ QEIA+L + +H N+V+ D +E LY+ ELV +
Sbjct: 63 PRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQ 122
Query: 415 GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFG 474
G ++ + L + Q Y + ++ G++YLH Q ++HRDIK +N+LV +G +K+ADFG
Sbjct: 123 GPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFG 182
Query: 475 LAKATKLNDV---KSCRGTAFWMAPEVINNKNKGY-GLPADIWSLGCTVLEMLTSQIP 528
++ K +D + GT +MAPE ++ K + G D+W++G T+ + Q P
Sbjct: 183 VSNEFKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 9e-49
Identities = 59/200 (29%), Positives = 96/200 (48%), Gaps = 12/200 (6%)
Query: 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEV--SLLDQGSQAKQSISQLEQEIALLSRFEHE 390
G LG+G FG+VY + F A+K + S L++ Q L +EI + S H
Sbjct: 19 GRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ----LRREIEIQSHLRHP 74
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQD 449
NI++ Y D ++Y+ LE +G L Q++ + + + + ++ L Y H++
Sbjct: 75 NILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK 134
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK-SCRGTAFWMAPEVINNKNKGYGL 508
V+HRDIK N+L+ G +K+ADFG + + C GT ++ PE+I K +
Sbjct: 135 VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC-GTLDYLPPEMIE--GKTHDE 191
Query: 509 PADIWSLGCTVLEMLTSQIP 528
D+W G E L P
Sbjct: 192 KVDLWCAGVLCYEFLVGMPP 211
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 5e-48
Identities = 56/229 (24%), Positives = 101/229 (44%), Gaps = 26/229 (11%)
Query: 334 GDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
G++LG+G FG + + G +KE L+ + ++ +E+ ++ EH N+
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKE--LIRFDEETQR---TFLKEVKVMRCLEHPNV 69
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDV 450
+++ G + +L E + G+L + + SQ ++ + I G+ YLH ++
Sbjct: 70 LKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNI 129
Query: 451 VHRDIKCANILVDANGSVKLADFGLA----------------KATKLNDVKSCRGTAFWM 494
+HRD+ N LV N +V +ADFGLA K + G +WM
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 495 APEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTV 543
APE+IN ++ Y D++S G + E++ + F V
Sbjct: 190 APEMINGRS--YDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV 236
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 6e-47
Identities = 51/223 (22%), Positives = 99/223 (44%), Gaps = 24/223 (10%)
Query: 334 GDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
G+L+G+G FG VY G + A++ L+D + + ++E+ + HEN+
Sbjct: 38 GELIGKGRFGQVYHGRWHGE---VAIR---LIDIERDNEDQLKAFKREVMAYRQTRHENV 91
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNL--YQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
V + G L I L +L ++ + L ++ ++I+ G+ YLH + +
Sbjct: 92 VLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGI 151
Query: 451 VHRDIKCANILVDANGSVKLADFGLAK-------ATKLNDVKSCRGTAFWMAPEVINNKN 503
+H+D+K N+ D NG V + DFGL + + ++ G +APE+I +
Sbjct: 152 LHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210
Query: 504 KGYGLP-------ADIWSLGCTVLEMLTSQIPYAPMECVSAIF 539
+D+++LG E+ + P+ + I+
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIW 253
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 2e-46
Identities = 64/272 (23%), Positives = 104/272 (38%), Gaps = 52/272 (19%)
Query: 303 HEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEV 361
H S+ E + G + + +G+GS+G V I A+K +
Sbjct: 2 HHHHHHSSGRENL--YFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIM 59
Query: 362 SLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLL--- 418
+ + + +++ E+ L+ + H NI + Y +DE + + +EL G LL
Sbjct: 60 NKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKL 119
Query: 419 --------------------------------------NLYQRYHLRDSQVSAYTRQILL 440
+ R+ +S RQI
Sbjct: 120 NVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179
Query: 441 GLKYLHDQDVVHRDIKCANILV--DANGSVKLADFGLAKATKLNDVKSCR------GTAF 492
L YLH+Q + HRDIK N L + + +KL DFGL+K + GT +
Sbjct: 180 ALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPY 239
Query: 493 WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT 524
++APEV+N N+ YG D WS G + +L
Sbjct: 240 FVAPEVLNTTNESYGPKCDAWSAGVLLHLLLM 271
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 165 bits (418), Expect = 4e-46
Identities = 42/313 (13%), Positives = 91/313 (29%), Gaps = 48/313 (15%)
Query: 261 RALSSSSDDEDNEKEGEEADRAIVKEEEDDMVLSESCSFTTEHEDDSSSTTTEPMSNISP 320
SS ++ + G+ + V + S + + S++
Sbjct: 5 HHHSSGRENLYFQGPGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRV 64
Query: 321 NGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQ 379
+G +LG+ + E + G F V ++ +I Q+++
Sbjct: 65 ESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTER--PPSNAIKQMKE 122
Query: 380 EIALLSRF-------------------------EHENIVQYYGTDKDESKLYIFLEL-VT 413
E+ L + + +++ ++D L F
Sbjct: 123 EVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM 182
Query: 414 KGSLLNLY--------QRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN 465
+ +L L T Q++ L LH +VH ++ +I++D
Sbjct: 183 QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQR 242
Query: 466 GSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNK---------NKGYGLPADIWSLG 516
G V L F + + + PE+ + D W+LG
Sbjct: 243 GGVFLTGFEHLV--RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALG 300
Query: 517 CTVLEMLTSQIPY 529
+ + + +P
Sbjct: 301 LVIYWIWCADLPI 313
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 1e-45
Identities = 54/195 (27%), Positives = 90/195 (46%), Gaps = 13/195 (6%)
Query: 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVS---LLDQGSQAKQSISQLEQEIALLSRFEH 389
LG G+ G V A++ +S ++ +E EI +L + H
Sbjct: 140 SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNH 199
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
I++ D YI LEL+ G L + + L+++ Y Q+LL ++YLH+
Sbjct: 200 PCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN 258
Query: 449 DVVHRDIKCANILV---DANGSVKLADFGLAKATKLNDV--KSCRGTAFWMAPEVINNKN 503
++HRD+K N+L+ + + +K+ DFG +K + C GT ++APEV+ +
Sbjct: 259 GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC-GTPTYLAPEVLVSVG 317
Query: 504 -KGYGLPADIWSLGC 517
GY D WSLG
Sbjct: 318 TAGYNRAVDCWSLGV 332
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 1e-45
Identities = 58/218 (26%), Positives = 104/218 (47%), Gaps = 21/218 (9%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
+++GRG+FG V + A+K++ +++ E+ LSR H NIV
Sbjct: 13 EEVVGRGAFGVVCKAK-WRAKDVAIKQI-------ESESERKAFIVELRQLSRVNHPNIV 64
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNL----YQRYHLRDSQVSAYTRQILLGLKYLHDQD 449
+ YG + + + +E GSL N+ + + ++ Q G+ YLH
Sbjct: 65 KLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 450 ---VVHRDIKCANILVDANGSV-KLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKG 505
++HRD+K N+L+ A G+V K+ DFG A + + + +G+A WMAPEV +
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ-THMTNNKGSAAWMAPEVF--EGSN 179
Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTV 543
Y D++S G + E++T + P+ + + + V
Sbjct: 180 YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAV 217
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 3e-45
Identities = 39/217 (17%), Positives = 81/217 (37%), Gaps = 20/217 (9%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
L G +++G G VK +L + + +E L F H N++
Sbjct: 15 LTKLNENHSGELWKGR-WQGNDIVVK---VLKVRDWSTRKSRDFNEECPRLRIFSHPNVL 70
Query: 394 QYYG--TDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQ 448
G + + GSL N+ + + SQ + + G+ +LH
Sbjct: 71 PVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL 130
Query: 449 D--VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNK-NKG 505
+ + + ++++D + + +++ + + W+APE + K
Sbjct: 131 EPLIPRHALNSRSVMIDEDMTARISMADVKFSF---QSPGRMYAPAWVAPEALQKKPEDT 187
Query: 506 YGLPADIWSLGCTVL-EMLTSQIPYA---PMECVSAI 538
AD+WS +L E++T ++P+A ME +
Sbjct: 188 NRRSADMWSFA-VLLWELVTREVPFADLSNMEIGMKV 223
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 5e-45
Identities = 55/195 (28%), Positives = 90/195 (46%), Gaps = 13/195 (6%)
Query: 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVS---LLDQGSQAKQSISQLEQEIALLSRFEH 389
LG G+ G V A+K +S ++ +E EI +L + H
Sbjct: 15 SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 74
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
I++ D YI LEL+ G L + + L+++ Y Q+LL ++YLH+
Sbjct: 75 PCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN 133
Query: 449 DVVHRDIKCANILV---DANGSVKLADFGLAKATKLNDV--KSCRGTAFWMAPEVINNKN 503
++HRD+K N+L+ + + +K+ DFG +K + C GT ++APEV+ +
Sbjct: 134 GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC-GTPTYLAPEVLVSVG 192
Query: 504 K-GYGLPADIWSLGC 517
GY D WSLG
Sbjct: 193 TAGYNRAVDCWSLGV 207
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 9e-45
Identities = 60/242 (24%), Positives = 112/242 (46%), Gaps = 26/242 (10%)
Query: 301 TEHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVK 359
T E + + + + + ++ G +LG GSF +V +A+K
Sbjct: 4 TAAEPRPGAGSLQHAQPPPQPRKKR--PEDFKFGKILGEGSFSTVVLARELATSREYAIK 61
Query: 360 EVSLLDQGSQAKQSISQLEQ------EIALLSRFEHENIVQYYGTDKDESKLYIFLELVT 413
+ K+ I + + E ++SR +H V+ Y T +D+ KLY L
Sbjct: 62 ILE--------KRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAK 113
Query: 414 KGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLAD 472
G LL ++ D + YT +I+ L+YLH + ++HRD+K NIL++ + +++ D
Sbjct: 114 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 173
Query: 473 FGLAKATKLNDVKS-----CRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQI 527
FG AK ++ GTA +++PE++ K +D+W+LGC + +++
Sbjct: 174 FGTAKVLSPESKQARANSFV-GTAQYVSPELLT--EKSACKSSDLWALGCIIYQLVAGLP 230
Query: 528 PY 529
P+
Sbjct: 231 PF 232
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 1e-44
Identities = 59/189 (31%), Positives = 96/189 (50%), Gaps = 12/189 (6%)
Query: 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
++LG G+F V+ G FA+K + S LE EIA+L + +HENI
Sbjct: 14 MEVLGSGAFSEVFLVKQRLTGKLFALKCIK-----KSPAFRDSSLENEIAVLKKIKHENI 68
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
V + + Y+ ++LV+ G L + + +R + S +Q+L +KYLH+ +V
Sbjct: 69 VTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIV 128
Query: 452 HRDIKCANILV---DANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGL 508
HRD+K N+L + N + + DFGL+K + + + GT ++APEV+ K Y
Sbjct: 129 HRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPEVL--AQKPYSK 186
Query: 509 PADIWSLGC 517
D WS+G
Sbjct: 187 AVDCWSIGV 195
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 1e-44
Identities = 63/293 (21%), Positives = 117/293 (39%), Gaps = 35/293 (11%)
Query: 258 MNDRALSSSSDDEDNEKEGEEADRAIVKEEEDDMVLSESCSFTTEHEDDSSSTTTEPMSN 317
M+ SS D KE A R I + + + + S+
Sbjct: 1 MHHHHHHSSGVDNKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKK 60
Query: 318 ISP----------------------NGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGF 354
++ K + D++GRG V + G
Sbjct: 61 LNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGH 120
Query: 355 FFAVKEVS---LLDQGSQAKQSISQLEQEIALLSR-FEHENIVQYYGTDKDESKLYIFLE 410
FAVK + Q ++ +E +L + H +I+ + + S +++ +
Sbjct: 121 EFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFD 180
Query: 411 LVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVK 469
L+ KG L + L ++ L + + + R +L + +LH ++VHRD+K NIL+D N ++
Sbjct: 181 LMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIR 240
Query: 470 LADFGLAKATKLNDV--KSCRGTAFWMAPEVINNK----NKGYGLPADIWSLG 516
L+DFG + + + + C GT ++APE++ + GYG D+W+ G
Sbjct: 241 LSDFGFSCHLEPGEKLRELC-GTPGYLAPEILKCSMDETHPGYGKEVDLWACG 292
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 1e-44
Identities = 29/265 (10%), Positives = 72/265 (27%), Gaps = 39/265 (14%)
Query: 300 TTEHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAV 358
+ ++T + + + + + + L G V+ + FA+
Sbjct: 33 PAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFAL 92
Query: 359 KEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGT-------------------- 398
K ++ + +L + +R E+ +
Sbjct: 93 K--VFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQ 150
Query: 399 ------DKDESKLYIFLELVTKGSLLNLY--------QRYHLRDSQVSAYTRQILLGLKY 444
D + + + L L+ R + T Q++
Sbjct: 151 LSPGQDDYAVANYLLLMPAA-SVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAAN 209
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNK 504
L + +VH N+ + +G + L D + + E +N
Sbjct: 210 LQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG-TRGPASSVPVTYAPREFLNASTA 268
Query: 505 GYGLPADIWSLGCTVLEMLTSQIPY 529
+ + W LG ++ + +P+
Sbjct: 269 TFTHALNAWQLGLSIYRVWCLFLPF 293
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 2e-44
Identities = 58/189 (30%), Positives = 97/189 (51%), Gaps = 11/189 (5%)
Query: 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
+ LG+G+F V + G FA K +++ + + +LE+E + + +H NI
Sbjct: 11 KEELGKGAFSVVRRCVHKTTGLEFAAK---IINTKKLSARDFQKLEREARICRKLQHPNI 67
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
V+ + + ++ES Y+ +LVT G L + R ++ S +QIL + Y H +V
Sbjct: 68 VRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIV 127
Query: 452 HRDIKCANILV---DANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPEVINNKNKGYG 507
HR++K N+L+ +VKLADFGLA ++ GT +++PEV+ K Y
Sbjct: 128 HRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVL--KKDPYS 185
Query: 508 LPADIWSLG 516
P DIW+ G
Sbjct: 186 KPVDIWACG 194
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 2e-44
Identities = 54/195 (27%), Positives = 95/195 (48%), Gaps = 12/195 (6%)
Query: 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVS----LLDQGSQAKQSISQLEQEIALLSR-F 387
++LGRG V I +AVK + + ++ +E+ +L +
Sbjct: 22 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS 81
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLH 446
H NI+Q T + + ++ +L+ KG L + L ++ L + + R +L + LH
Sbjct: 82 GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALH 141
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPEVI----NN 501
++VHRD+K NIL+D + ++KL DFG + + + GT ++APE+I N+
Sbjct: 142 KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMND 201
Query: 502 KNKGYGLPADIWSLG 516
+ GYG D+WS G
Sbjct: 202 NHPGYGKEVDMWSTG 216
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 3e-44
Identities = 60/216 (27%), Positives = 98/216 (45%), Gaps = 20/216 (9%)
Query: 311 TTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQ 369
+ N+ G + LG G+FG V+ G +K ++ +
Sbjct: 7 HSSGRENLYFQGTIDD---LFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINK----DR 59
Query: 370 AKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLL-----NLYQRY 424
++ + Q+E EI +L +H NI++ + +D +YI +E G LL +
Sbjct: 60 SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGK 119
Query: 425 HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKATKL 481
L + V+ +Q++ L Y H Q VVH+D+K NIL + +K+ DFGLA+ K
Sbjct: 120 ALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS 179
Query: 482 NDV-KSCRGTAFWMAPEVINNKNKGYGLPADIWSLG 516
++ + GTA +MAPEV + DIWS G
Sbjct: 180 DEHSTNAAGTALYMAPEVF---KRDVTFKCDIWSAG 212
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 1e-43
Identities = 56/205 (27%), Positives = 96/205 (46%), Gaps = 20/205 (9%)
Query: 321 NGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQ 379
+ F + K LG GSF + + FAVK +S K+ + ++
Sbjct: 3 DSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIIS--------KRMEANTQK 54
Query: 380 EIALLSRF-EHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQ 437
EI L H NIV+ + D+ ++ +EL+ G L + ++ H +++ S R+
Sbjct: 55 EITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRK 114
Query: 438 ILLGLKYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKATKLNDVK---SCRGTA 491
++ + ++HD VVHRD+K N+L + N +K+ DFG A+ ++ C T
Sbjct: 115 LVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTL 173
Query: 492 FWMAPEVINNKNKGYGLPADIWSLG 516
+ APE++ GY D+WSLG
Sbjct: 174 HYAAPELL--NQNGYDESCDLWSLG 196
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 2e-43
Identities = 59/198 (29%), Positives = 102/198 (51%), Gaps = 12/198 (6%)
Query: 325 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
+ +LG+GSFG V + +AVK ++++ S + S + +E+ L
Sbjct: 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVK---VINKASAKNKDTSTILREVEL 74
Query: 384 LSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGL 442
L + +H NI++ + +D S YI EL T G L + + +R + + +Q+ G+
Sbjct: 75 LKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGI 134
Query: 443 KYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPEV 498
Y+H ++VHRD+K NIL+ + + +K+ DFGL+ + N K GTA+++APEV
Sbjct: 135 TYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEV 194
Query: 499 INNKNKGYGLPADIWSLG 516
+ Y D+WS G
Sbjct: 195 L---RGTYDEKCDVWSAG 209
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 2e-43
Identities = 59/197 (29%), Positives = 92/197 (46%), Gaps = 19/197 (9%)
Query: 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
+++G+G F V I+ + G FAVK V + S S L++E ++ +H +I
Sbjct: 29 CEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHI 88
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDS----QVSAYTRQILLGLKYLHD 447
V+ T + LY+ E + L + +R S Y RQIL L+Y HD
Sbjct: 89 VELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD 148
Query: 448 QDVVHRDIKCANILV---DANGSVKLADFGLAK-----ATKLNDVKSCRGTAFWMAPEVI 499
+++HRD+K +L+ + + VKL FG+A GT +MAPEV+
Sbjct: 149 NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR--V-GTPHFMAPEVV 205
Query: 500 NNKNKGYGLPADIWSLG 516
K + YG P D+W G
Sbjct: 206 --KREPYGKPVDVWGCG 220
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 2e-43
Identities = 48/245 (19%), Positives = 86/245 (35%), Gaps = 34/245 (13%)
Query: 312 TEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDD------GFFFAVKEVSLLD 365
+ I P F+ LLG G+F VYE D F +K
Sbjct: 48 QCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQK--- 104
Query: 366 QGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH 425
Q + L +++Y ++ + EL + G+LLN Y
Sbjct: 105 --PANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYK 162
Query: 426 LRDSQ------VSAYTRQILLGLKYLHDQDVVHRDIKCANILV-----------DANGSV 468
+ V ++ ++L ++ +HD +++H DIK N ++ D + +
Sbjct: 163 NTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGL 222
Query: 469 KLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT 524
L D G + KL + T+ + E+++ NK + D + + TV ML
Sbjct: 223 ALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLS--NKPWNYQIDYFGVAATVYCMLF 280
Query: 525 SQIPY 529
Sbjct: 281 GTYMK 285
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 4e-43
Identities = 58/191 (30%), Positives = 103/191 (53%), Gaps = 10/191 (5%)
Query: 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL-LDQGSQAKQSISQLEQEIALLSRFEHEN 391
G+ LG G F V + G +A K + S+ S ++E+E+ +L H N
Sbjct: 10 GEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPN 69
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
I+ + ++++ + + LELV+ G L + L ++ L + + + + +QIL G+ YLH + +
Sbjct: 70 IITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRI 129
Query: 451 VHRDIKCANILV----DANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPEVINNKNKG 505
H D+K NI++ N +KL DFG+A + + K+ GT ++APE++N +
Sbjct: 130 AHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVN--YEP 187
Query: 506 YGLPADIWSLG 516
GL AD+WS+G
Sbjct: 188 LGLEADMWSIG 198
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 6e-43
Identities = 58/190 (30%), Positives = 97/190 (51%), Gaps = 13/190 (6%)
Query: 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
+ LG+G+F V + G FA K +++ + + +LE+E + + +H NI
Sbjct: 34 KEELGKGAFSVVRRCVHKTTGLEFAAK---IINTKKLSARDFQKLEREARICRKLQHPNI 90
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
V+ + + ++ES Y+ +LVT G L + R ++ S +QIL + Y H +V
Sbjct: 91 VRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIV 150
Query: 452 HRDIKCANILV---DANGSVKLADFGLAKATKLNDV--KSCRGTAFWMAPEVINNKNKGY 506
HR++K N+L+ +VKLADFGLA ++ GT +++PEV+ K Y
Sbjct: 151 HRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA-GTPGYLSPEVL--KKDPY 207
Query: 507 GLPADIWSLG 516
P DIW+ G
Sbjct: 208 SKPVDIWACG 217
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 8e-43
Identities = 54/192 (28%), Positives = 93/192 (48%), Gaps = 20/192 (10%)
Query: 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLE---QEIALLSRFEH 389
+ +GRGS+G V + A K++ K + ++ QEI ++ +H
Sbjct: 14 ENTIGRGSWGEVKIAVQKGTRIRRAAKKIP--------KYFVEDVDRFKQEIEIMKSLDH 65
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
NI++ Y T +D + +Y+ +EL T G L + + R+S + + +L + Y H
Sbjct: 66 PNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL 125
Query: 449 DVVHRDIKCANILV---DANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPEVINNKNK 504
+V HRD+K N L + +KL DFGLA K + ++ GT ++++P+V+
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL---EG 182
Query: 505 GYGLPADIWSLG 516
YG D WS G
Sbjct: 183 LYGPECDEWSAG 194
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 8e-43
Identities = 54/189 (28%), Positives = 93/189 (49%), Gaps = 15/189 (7%)
Query: 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
LGRG+ VY +A+K + + EI +L R H NI
Sbjct: 58 ESELGRGATSIVYRCKQKGTQKPYALKVLK-------KTVDKKIVRTEIGVLLRLSHPNI 110
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
++ + +++ + LELVT G L + + ++ + + + +QIL + YLH+ +V
Sbjct: 111 IKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIV 170
Query: 452 HRDIKCANILV---DANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPEVINNKNKGYG 507
HRD+K N+L + +K+ADFGL+K + + K+ GT + APE++ + YG
Sbjct: 171 HRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEIL--RGCAYG 228
Query: 508 LPADIWSLG 516
D+WS+G
Sbjct: 229 PEVDMWSVG 237
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 161 bits (408), Expect = 1e-42
Identities = 58/222 (26%), Positives = 94/222 (42%), Gaps = 21/222 (9%)
Query: 325 KRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
+ W+ + LG G FG V I D G A+K+ Q K + + EI +
Sbjct: 10 TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQ---CRQELSPK-NRERWCLEIQI 65
Query: 384 LSRFEHENIVQYYGTDKDESKL------YIFLELVTKGSL---LNLYQRYH-LRDSQVSA 433
+ + H N+V KL + +E G L LN ++ L++ +
Sbjct: 66 MKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRT 125
Query: 434 YTRQILLGLKYLHDQDVVHRDIKCANILVDANGS---VKLADFGLAKATKLNDV-KSCRG 489
I L+YLH+ ++HRD+K NI++ K+ D G AK ++ G
Sbjct: 126 LLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVG 185
Query: 490 TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP 531
T ++APE++ + K Y + D WS G E +T P+ P
Sbjct: 186 TLQYLAPELL--EQKKYTVTVDYWSFGTLAFECITGFRPFLP 225
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-42
Identities = 60/225 (26%), Positives = 89/225 (39%), Gaps = 31/225 (13%)
Query: 332 QKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
+ +G+G +G V+ G G AVK S S+ ++S + E E+ HEN
Sbjct: 11 TLLECVGKGRYGEVWRGSWQ-GENVAVKIFS-----SRDEKSWFR-ETELYNTVMLRHEN 63
Query: 392 IVQYYGTDKDES----KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
I+ + +D +L++ GSL + Q L I GL +LH
Sbjct: 64 ILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHI 123
Query: 448 QD--------VVHRDIKCANILVDANGSVKLADFGLAK------ATKLNDVKSCRGTAFW 493
+ + HRD+K NILV NG +AD GLA GT +
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 494 MAPEVINNK----NKGYGLPADIWSLGCTVL-EMLTSQIPYAPME 533
MAPEV++ DIW+ G VL E+ + +E
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFG-LVLWEVARRMVSNGIVE 227
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 2e-42
Identities = 58/191 (30%), Positives = 104/191 (54%), Gaps = 10/191 (5%)
Query: 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL-LDQGSQAKQSISQLEQEIALLSRFEHEN 391
G+ LG G F V + G +A K + + S+ S ++E+E+++L + H N
Sbjct: 17 GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
++ + ++ + + + LELV+ G L + L Q+ L + + +++ +QIL G+ YLH + +
Sbjct: 77 VITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKI 136
Query: 451 VHRDIKCANILV----DANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPEVINNKNKG 505
H D+K NI++ +KL DFGLA + K+ GT ++APE++N +
Sbjct: 137 AHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN--YEP 194
Query: 506 YGLPADIWSLG 516
GL AD+WS+G
Sbjct: 195 LGLEADMWSIG 205
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 2e-42
Identities = 58/202 (28%), Positives = 101/202 (50%), Gaps = 12/202 (5%)
Query: 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
LG G++G V A+K + S + S S+L +E+A+L +H NI
Sbjct: 42 VKKLGSGAYGEVLLCRDKVTHVERAIKIIRKT---SVSTSSNSKLLEEVAVLKLLDHPNI 98
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
++ Y +D+ Y+ +E G L + + R + + +Q+L G+ YLH ++V
Sbjct: 99 MKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIV 158
Query: 452 HRDIKCANILV---DANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPEVINNKNKGYG 507
HRD+K N+L+ + + +K+ DFGL+ + K GTA+++APEV+ K Y
Sbjct: 159 HRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVL---RKKYD 215
Query: 508 LPADIWSLGCTVLEMLTSQIPY 529
D+WS+G + +L P+
Sbjct: 216 EKCDVWSIGVILFILLAGYPPF 237
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 3e-42
Identities = 60/211 (28%), Positives = 106/211 (50%), Gaps = 11/211 (5%)
Query: 325 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
++ +LG+GSFG V G AVK +S + + K L +E+ L
Sbjct: 22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISK--RQVKQKTDKESLLREVQL 79
Query: 384 LSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGL 442
L + +H NI++ Y +D+ Y+ E+ T G L + + R + + RQ+L G+
Sbjct: 80 LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGI 139
Query: 443 KYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPEV 498
Y+H +VHRD+K N+L+ + ++++ DFGL+ + + K GTA+++APEV
Sbjct: 140 TYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEV 199
Query: 499 INNKNKGYGLPADIWSLGCTVLEMLTSQIPY 529
+ + Y D+WS G + +L+ P+
Sbjct: 200 L---HGTYDEKCDVWSTGVILYILLSGCPPF 227
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 3e-42
Identities = 44/198 (22%), Positives = 88/198 (44%), Gaps = 14/198 (7%)
Query: 325 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
K + + + LGRG FG V+ + + K V + +++EI++
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV------KGTDQVLVKKEISI 54
Query: 384 LSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN--LYQRYHLRDSQVSAYTRQILLG 441
L+ H NI+ + + + +L + E ++ + + L + ++ +Y Q+
Sbjct: 55 LNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEA 114
Query: 442 LKYLHDQDVVHRDIKCANILV--DANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPEV 498
L++LH ++ H DI+ NI+ + ++K+ +FG A+ K D + + APEV
Sbjct: 115 LQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV 174
Query: 499 INNKNKGYGLPADIWSLG 516
+ D+WSLG
Sbjct: 175 HQ--HDVVSTATDMWSLG 190
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 3e-42
Identities = 58/216 (26%), Positives = 102/216 (47%), Gaps = 17/216 (7%)
Query: 323 RFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVS--------LLDQGSQAKQS 373
+ +I + K LG G++G V + A+K + D ++
Sbjct: 30 KEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKF 89
Query: 374 ISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVS 432
++ EI+LL +H NI++ + +D+ Y+ E G L + R+ + +
Sbjct: 90 HEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAA 149
Query: 433 AYTRQILLGLKYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKATKLNDV-KSCR 488
+QIL G+ YLH ++VHRDIK NIL+ ++ ++K+ DFGL+ + +
Sbjct: 150 NIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRL 209
Query: 489 GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT 524
GTA+++APEV+ K Y D+WS G + +L
Sbjct: 210 GTAYYIAPEVL---KKKYNEKCDVWSCGVIMYILLC 242
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 3e-42
Identities = 65/258 (25%), Positives = 104/258 (40%), Gaps = 45/258 (17%)
Query: 304 EDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSL 363
E SS + + + K+I Q +G+G +G V+ G G AVK
Sbjct: 16 EQSQSSGSGSGLPLLVQRTIAKQI----QMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFT 70
Query: 364 LDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVT----KGSLLN 419
++ S + E EI HENI+ + D + + L L+T GSL
Sbjct: 71 TEEASWFR------ETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSL-- 122
Query: 420 LYQRYHLRDSQVSAYTR-----QILLGLKYLHDQD--------VVHRDIKCANILVDANG 466
+L+ + + A + + GL +LH + + HRD+K NILV NG
Sbjct: 123 ---YDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG 179
Query: 467 SVKLADFGLA------KATKLNDVKSCRGTAFWMAPEVI----NNKNKGYGLPADIWSLG 516
+ +AD GLA + GT +M PEV+ N + + AD++S G
Sbjct: 180 TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFG 239
Query: 517 CTVL-EMLTSQIPYAPME 533
+L E+ + +E
Sbjct: 240 L-ILWEVARRCVSGGIVE 256
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 4e-42
Identities = 64/220 (29%), Positives = 109/220 (49%), Gaps = 15/220 (6%)
Query: 311 TTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQ 369
+ N+ G F Y +LG+GSFG V + +AVK ++ S
Sbjct: 7 HSSGRENLYFQGTFAER--Y-NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKA---SA 60
Query: 370 AKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRD 428
+ S + +E+ LL + +H NI++ + +D S YI EL T G L + + +R +
Sbjct: 61 KNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSE 120
Query: 429 SQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKATKLNDV- 484
+ +Q+ G+ Y+H ++VHRD+K NIL+ + + +K+ DFGL+ + N
Sbjct: 121 HDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM 180
Query: 485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT 524
K GTA+++APEV+ Y D+WS G + +L+
Sbjct: 181 KDRIGTAYYIAPEVL---RGTYDEKCDVWSAGVILYILLS 217
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 1e-41
Identities = 56/191 (29%), Positives = 101/191 (52%), Gaps = 10/191 (5%)
Query: 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEHEN 391
G+ LG G F V + G +A K + + S+ S +E+E+++L +H N
Sbjct: 16 GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
++ + ++++ + + LELV G L + L ++ L + + + + +QIL G+ YLH +
Sbjct: 76 VITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQI 135
Query: 451 VHRDIKCANILV----DANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPEVINNKNKG 505
H D+K NI++ +K+ DFGLA + K+ GT ++APE++N +
Sbjct: 136 AHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN--YEP 193
Query: 506 YGLPADIWSLG 516
GL AD+WS+G
Sbjct: 194 LGLEADMWSIG 204
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-41
Identities = 60/211 (28%), Positives = 105/211 (49%), Gaps = 15/211 (7%)
Query: 326 RIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 384
+ W LG G++G V + AVK V + +A +++EI +
Sbjct: 4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEICIN 59
Query: 385 SRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLK 443
HEN+V++YG ++ + Y+FLE + G L + + + + + Q++ G+
Sbjct: 60 KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 119
Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-----KSCRGTAFWMAPEV 498
YLH + HRDIK N+L+D ++K++DFGLA + N+ K C GT ++APE+
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPEL 178
Query: 499 INNKNKGY-GLPADIWSLGCTVLEMLTSQIP 528
+ + + P D+WS G + ML ++P
Sbjct: 179 LK--RREFHAEPVDVWSCGIVLTAMLAGELP 207
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 1e-41
Identities = 58/191 (30%), Positives = 103/191 (53%), Gaps = 10/191 (5%)
Query: 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEHEN 391
G+ LG G F V + G +A K + + S+ ++E+E+++L + H N
Sbjct: 17 GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPN 76
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
I+ + ++ + + + LELV+ G L + L Q+ L + + +++ +QIL G+ YLH + +
Sbjct: 77 IITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKI 136
Query: 451 VHRDIKCANILV----DANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPEVINNKNKG 505
H D+K NI++ +KL DFGLA + K+ GT ++APE++N +
Sbjct: 137 AHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN--YEP 194
Query: 506 YGLPADIWSLG 516
GL AD+WS+G
Sbjct: 195 LGLEADMWSIG 205
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 2e-41
Identities = 54/191 (28%), Positives = 93/191 (48%), Gaps = 14/191 (7%)
Query: 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
+ LG+G+F V + G +A + + + + +LE+E + +H NI
Sbjct: 16 FEELGKGAFSVVRRCVKVLAGQEYAAMII---NTKKLSARDHQKLEREARICRLLKHPNI 72
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
V+ + + +E Y+ +LVT G L + R + ++ S +QIL + + H VV
Sbjct: 73 VRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVV 132
Query: 452 HRDIKCANILV---DANGSVKLADFGLAKATKLNDV---KSCRGTAFWMAPEVINNKNKG 505
HR++K N+L+ +VKLADFGLA + GT +++PEV+ +
Sbjct: 133 HRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPGYLSPEVL--RKDP 189
Query: 506 YGLPADIWSLG 516
YG P D+W+ G
Sbjct: 190 YGKPVDLWACG 200
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-41
Identities = 52/228 (22%), Positives = 93/228 (40%), Gaps = 35/228 (15%)
Query: 332 QKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR-FEH 389
+ +L G F VYE G +A+K + + ++ + QE+ + + H
Sbjct: 31 RVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE-----EEKNRAIIQEVCFMKKLSGH 85
Query: 390 ENIVQYYG-------TDKDESKLYIFLELVTKGSLLNLYQRYHLRD----SQVSAYTRQI 438
NIVQ+ ++ L + KG L+ ++ R V Q
Sbjct: 86 PNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQT 145
Query: 439 LLGLKYLHDQD--VVHRDIKCANILVDANGSVKLADFGLA--------------KATKLN 482
++++H Q ++HRD+K N+L+ G++KL DFG A + +
Sbjct: 146 CRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205
Query: 483 DVKSCRGTAFWMAPEVIN-NKNKGYGLPADIWSLGCTVLEMLTSQIPY 529
+ + T + PE+I+ N G DIW+LGC + + Q P+
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF 253
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-41
Identities = 70/267 (26%), Positives = 108/267 (40%), Gaps = 33/267 (12%)
Query: 289 DDMVLSESCSFTTEHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEG 348
D +SE + D ++S + + + + I + +G+G FG V+ G
Sbjct: 6 DRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTI----VLQESIGKGRFGEVWRG 61
Query: 349 ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408
G AVK S S+ ++S + E EI HENI+ + D ++ +
Sbjct: 62 KWR-GEEVAVKIFS-----SREERSWFR-EAEIYQTVMLRHENILGFIAADNKDNGTWTQ 114
Query: 409 LELVT----KGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ--------DVVHRDIK 456
L LV+ GSL + RY + + GL +LH + + HRD+K
Sbjct: 115 LWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLK 174
Query: 457 CANILVDANGSVKLADFGLAK------ATKLNDVKSCRGTAFWMAPEVI----NNKNKGY 506
NILV NG+ +AD GLA T GT +MAPEV+ N K+
Sbjct: 175 SKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFES 234
Query: 507 GLPADIWSLGCTVLEMLTSQIPYAPME 533
ADI+++G E+ E
Sbjct: 235 FKRADIYAMGLVFWEIARRCSIGGIHE 261
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 2e-41
Identities = 60/210 (28%), Positives = 104/210 (49%), Gaps = 30/210 (14%)
Query: 336 LLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQ------EIALLSRFE 388
+G+GSFG V D +A+K ++ KQ + + E+ ++ E
Sbjct: 22 AIGKGSFGKVCIVQKNDTKKMYAMKYMN--------KQKCVERNEVRNVFKELQIMQGLE 73
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLR------DSQVSAYTRQILLGL 442
H +V + + +DE +++ ++L+ G L RYHL+ + V + ++++ L
Sbjct: 74 HPFLVNLWYSFQDEEDMFMVVDLLLGGDL-----RYHLQQNVHFKEETVKLFICELVMAL 128
Query: 443 KYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS--CRGTAFWMAPEVIN 500
YL +Q ++HRD+K NIL+D +G V + DF +A + GT +MAPE+ +
Sbjct: 129 DYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA-GTKPYMAPEMFS 187
Query: 501 NKN-KGYGLPADIWSLGCTVLEMLTSQIPY 529
++ GY D WSLG T E+L + PY
Sbjct: 188 SRKGAGYSFAVDWWSLGVTAYELLRGRRPY 217
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 5e-41
Identities = 61/216 (28%), Positives = 106/216 (49%), Gaps = 25/216 (11%)
Query: 319 SPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQL 377
S +GRF+ + Y + D+LG G+ V I+ +AVK + Q S++
Sbjct: 5 SFSGRFEDV--YQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEK-----QPGHIRSRV 57
Query: 378 EQEIALLSRFE-HENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYT 435
+E+ +L + + H N+++ ++E + Y+ E + GS+L+ +++R H + + S
Sbjct: 58 FREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVV 117
Query: 436 RQILLGLKYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKATKLNDVKSCR---- 488
+ + L +LH++ + HRD+K NIL + VK+ DF L KLN S
Sbjct: 118 QDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPE 177
Query: 489 -----GTAFWMAPEVIN---NKNKGYGLPADIWSLG 516
G+A +MAPEV+ + Y D+WSLG
Sbjct: 178 LLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLG 213
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 7e-41
Identities = 69/254 (27%), Positives = 101/254 (39%), Gaps = 46/254 (18%)
Query: 302 EHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEV 361
H S Q ++ RG FG V++ + AVK
Sbjct: 5 HHHHSSGVDLGTENLYFQSMPL--------QLLEVKARGRFGCVWKAQLL-NEYVAVKIF 55
Query: 362 SLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVT----KGSL 417
Q KQS Q E E+ L +HENI+Q+ G +K + + + L L+T KGSL
Sbjct: 56 P-----IQDKQSW-QNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSL 109
Query: 418 LNLYQRYHLRDSQVSAYTR-QILL----GLKYLHDQD----------VVHRDIKCANILV 462
L+ + VS I GL YLH+ + HRDIK N+L+
Sbjct: 110 -----SDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL 164
Query: 463 DANGSVKLADFGLAK----ATKLNDVKSCRGTAFWMAPEVIN---NKNKGYGLPADIWSL 515
N + +ADFGLA D GT +MAPEV+ N + L D++++
Sbjct: 165 KNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAM 224
Query: 516 GCTVLEMLTSQIPY 529
G + E+ +
Sbjct: 225 GLVLWELASRCTAA 238
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 1e-40
Identities = 58/271 (21%), Positives = 97/271 (35%), Gaps = 74/271 (27%)
Query: 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVK----------------EVSLLDQ-- 366
R +T ++ +GRG FG V+E + D +A+K EV L +
Sbjct: 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 62
Query: 367 -----------------------------------GSQAKQSISQLEQEIALLSRFEHEN 391
+ + +I + F +N
Sbjct: 63 HPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKN 122
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRD----SQVSAYTRQILLGLKYLHD 447
V + LYI ++L K +L + R + QI +++LH
Sbjct: 123 TVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS 182
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR--------------GTAFW 493
+ ++HRD+K +NI + VK+ DFGL A ++ + GT +
Sbjct: 183 KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242
Query: 494 MAPEVINNKNKGYGLPADIWSLGCTVLEMLT 524
M+PE I+ N Y DI+SLG + E+L
Sbjct: 243 MSPEQIHGNN--YSHKVDIFSLGLILFELLY 271
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 1e-40
Identities = 57/257 (22%), Positives = 105/257 (40%), Gaps = 13/257 (5%)
Query: 266 SSDDEDNEKEGEEADRAIVKEEEDDMVLSESCSFTTEHEDDSSSTTTEPMSNISPNGRFK 325
G+E R + ++ + + + D+ + +
Sbjct: 94 CEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHD 153
Query: 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 384
++ ++ + LG G+FG V+ G FA K V + + + +EI +
Sbjct: 154 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVM-----TPHESDKETVRKEIQTM 208
Query: 385 SRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN--LYQRYHLRDSQVSAYTRQILLGL 442
S H +V + +D++++ + E ++ G L + + + + Y RQ+ GL
Sbjct: 209 SVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGL 268
Query: 443 KYLHDQDVVHRDIKCANILV--DANGSVKLADFGLAKATKLND-VKSCRGTAFWMAPEVI 499
++H+ + VH D+K NI+ + +KL DFGL VK GTA + APEV
Sbjct: 269 CHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA 328
Query: 500 NNKNKGYGLPADIWSLG 516
K G D+WS+G
Sbjct: 329 EGKP--VGYYTDMWSVG 343
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-40
Identities = 54/238 (22%), Positives = 106/238 (44%), Gaps = 13/238 (5%)
Query: 285 KEEEDDMVLSESCSFTTEHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGS 344
V + D + + + Y+ + LG G+FG
Sbjct: 7 HHHHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGV 66
Query: 345 VYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES 403
V+ + G F K ++ + ++ EI+++++ H ++ + +D+
Sbjct: 67 VHRCVEKATGRVFVAKFIN-----TPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY 121
Query: 404 KLYIFLELVTKGSLLN--LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANIL 461
++ + LE ++ G L + + Y + +++V Y RQ GLK++H+ +VH DIK NI+
Sbjct: 122 EMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIM 181
Query: 462 V--DANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPEVINNKNKGYGLPADIWSLG 516
SVK+ DFGLA +++ K TA + APE+++ + G D+W++G
Sbjct: 182 CETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVD--REPVGFYTDMWAIG 237
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-40
Identities = 60/211 (28%), Positives = 105/211 (49%), Gaps = 15/211 (7%)
Query: 326 RIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 384
+ W LG G++G V + AVK V + +A +++EI +
Sbjct: 4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEICIN 59
Query: 385 SRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLK 443
HEN+V++YG ++ + Y+FLE + G L + + + + + Q++ G+
Sbjct: 60 KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 119
Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-----KSCRGTAFWMAPEV 498
YLH + HRDIK N+L+D ++K++DFGLA + N+ K C GT ++APE+
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPEL 178
Query: 499 INNKNKGY-GLPADIWSLGCTVLEMLTSQIP 528
+ + + P D+WS G + ML ++P
Sbjct: 179 LK--RREFHAEPVDVWSCGIVLTAMLAGELP 207
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 2e-40
Identities = 58/270 (21%), Positives = 118/270 (43%), Gaps = 24/270 (8%)
Query: 264 SSSSDDEDNEKEGEEADRAIVKEEEDDMVLSESCSFTTEHEDDSSSTTTEPMSNISPNGR 323
+++ + D+ + + + T S T+ + +P
Sbjct: 13 DLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAP 72
Query: 324 FKRIITYWQKGDL-----------LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAK 371
F I ++G + LG G FG V++ G A K + ++
Sbjct: 73 FDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIK-----TRGM 127
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN--LYQRYHLRDS 429
+ +++ EI+++++ +H N++Q Y + ++ + + +E V G L + + + Y+L +
Sbjct: 128 KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTEL 187
Query: 430 QVSAYTRQILLGLKYLHDQDVVHRDIKCANILV--DANGSVKLADFGLAKATKLNDVKSC 487
+ +QI G++++H ++H D+K NIL +K+ DFGLA+ K +
Sbjct: 188 DTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV 247
Query: 488 R-GTAFWMAPEVINNKNKGYGLPADIWSLG 516
GT ++APEV+N P D+WS+G
Sbjct: 248 NFGTPEFLAPEVVN--YDFVSFPTDMWSVG 275
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 4e-40
Identities = 60/193 (31%), Positives = 93/193 (48%), Gaps = 22/193 (11%)
Query: 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHEN 391
+ +G GS+ I FAVK + +S +EI +L R+ +H N
Sbjct: 27 KEDIGVGSYSVCKRCIHKATNMEFAVKIID---------KSKRDPTEEIEILLRYGQHPN 77
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
I+ D +Y+ EL+ G LL+ + ++ + + SA I ++YLH Q V
Sbjct: 78 IITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGV 137
Query: 451 VHRDIKCANILV----DANGSVKLADFGLAKATKLNDVK---SCRGTAFWMAPEVINNKN 503
VHRD+K +NIL S+++ DFG AK + + C TA ++APEV+ +
Sbjct: 138 VHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-YTANFVAPEVL--ER 194
Query: 504 KGYGLPADIWSLG 516
+GY DIWSLG
Sbjct: 195 QGYDAACDIWSLG 207
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 4e-40
Identities = 68/205 (33%), Positives = 100/205 (48%), Gaps = 18/205 (8%)
Query: 332 QKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR 386
+K LG G FG V G AVK L + + S +QEI +L
Sbjct: 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKA---LKADAGPQH-RSGWKQEIDILRT 89
Query: 387 FEHENIVQYYG--TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
HE+I++Y G D + L + +E V GSL + R+ + +Q+ + +QI G+ Y
Sbjct: 90 LYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAY 149
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND---VKSCRGTA--FWMAPEVI 499
LH Q +HRD+ N+L+D + VK+ DFGLAKA G + FW APE +
Sbjct: 150 LHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 209
Query: 500 NNKNKGYGLPADIWSLGCTVLEMLT 524
K + +D+WS G T+ E+LT
Sbjct: 210 KE-YK-FYYASDVWSFGVTLYELLT 232
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 4e-40
Identities = 55/225 (24%), Positives = 95/225 (42%), Gaps = 20/225 (8%)
Query: 303 HEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEV 361
H S F Y LGRG F V + IS G +A K
Sbjct: 5 HHHSSGVDLGTENLYFQSMENFNNF--YILTSKELGRGKFAVVRQCISKSTGQEYAAK-- 60
Query: 362 SLLDQGSQAKQSISQLEQEIALLSRFEH-ENIVQYYGTDKDESKLYIFLELVTKGSLLN- 419
L + + + +++ EIA+L + ++ + ++ S++ + LE G + +
Sbjct: 61 -FLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSL 119
Query: 420 ----LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV---DANGSVKLAD 472
L + D V +QIL G+ YLH ++VH D+K NIL+ G +K+ D
Sbjct: 120 CLPELAEMVSEND--VIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVD 177
Query: 473 FGLAKATKLNDV-KSCRGTAFWMAPEVINNKNKGYGLPADIWSLG 516
FG+++ + GT ++APE++N D+W++G
Sbjct: 178 FGMSRKIGHACELREIMGTPEYLAPEILN--YDPITTATDMWNIG 220
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 5e-40
Identities = 64/217 (29%), Positives = 109/217 (50%), Gaps = 18/217 (8%)
Query: 326 RIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQG--SQAKQSISQLEQEIA 382
++I + GDLLG GS+G V E + S+ AVK +L + + + +++EI
Sbjct: 2 KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVK---ILKKKKLRRIPNGEANVKKEIQ 58
Query: 383 LLSRFEHENIVQYYG--TDKDESKLYIFLELVTKGS--LLNLYQRYHLRDSQVSAYTRQI 438
LL R H+N++Q ++++ K+Y+ +E G +L+ Q Y Q+
Sbjct: 59 LLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQL 118
Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK-----SCRGTAFW 493
+ GL+YLH Q +VH+DIK N+L+ G++K++ G+A+A S G+ +
Sbjct: 119 IDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ-GSPAF 177
Query: 494 MAPEVINNKNKGY-GLPADIWSLGCTVLEMLTSQIPY 529
PE+ N + G DIWS G T+ + T P+
Sbjct: 178 QPPEIANGL-DTFSGFKVDIWSAGVTLYNITTGLYPF 213
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 3e-39
Identities = 63/217 (29%), Positives = 99/217 (45%), Gaps = 24/217 (11%)
Query: 332 QKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR 386
+ LG+G+FGSV + G AVK L G ++ ++EI +L
Sbjct: 26 KYISQLGKGNFGSVELCRYDPLGDNTGALVAVK--QLQHSGPDQQRD---FQREIQILKA 80
Query: 387 FEHENIVQYYG--TDKDESKLYIFLELVTKGSLLNLY---QRYHLRDSQVSAYTRQILLG 441
+ IV+Y G L + +E + G L + + R L S++ Y+ QI G
Sbjct: 81 LHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRD-FLQRHRARLDASRLLLYSSQICKG 139
Query: 442 LKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--KSCRGTAF---WMAP 496
++YL + VHRD+ NILV++ VK+ADFGLAK L+ W AP
Sbjct: 140 MEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAP 199
Query: 497 EVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPM 532
E +++ N + +D+WS G + E+ T +P
Sbjct: 200 ESLSD-NI-FSRQSDVWSFGVVLYELFTYCDKSCSPS 234
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 4e-39
Identities = 61/251 (24%), Positives = 110/251 (43%), Gaps = 21/251 (8%)
Query: 292 VLSESCSFTTEHEDDSSSTTTEPMSNISPNGRFKRI-ITYWQKGDLLGRGSFGSVYE-GI 349
L F ++ + + R R+ ++ ++GRG+FG V
Sbjct: 31 ALVYDLDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRH 90
Query: 350 SDDGFFFAVKEVSLLDQGSQAKQSISQLEQ------EIALLSRFEHENIVQYYGTDKDES 403
+A+K +S K + + E +++ +VQ + +D+
Sbjct: 91 KSTRKVYAMKLLS--------KFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 142
Query: 404 KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD 463
LY+ +E + G L+NL Y + + YT +++L L +H +HRD+K N+L+D
Sbjct: 143 YLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD 202
Query: 464 ANGSVKLADFGLAKATKLNDVKSCR---GTAFWMAPEVINNK--NKGYGLPADIWSLGCT 518
+G +KLADFG + C GT +++PEV+ ++ + YG D WS+G
Sbjct: 203 KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVF 262
Query: 519 VLEMLTSQIPY 529
+ EML P+
Sbjct: 263 LYEMLVGDTPF 273
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 4e-39
Identities = 63/261 (24%), Positives = 105/261 (40%), Gaps = 41/261 (15%)
Query: 307 SSSTTTEPMSNISPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVK 359
+ + + + R + + LG+G+FGSV + G AVK
Sbjct: 17 TENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVK 76
Query: 360 EVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYG--TDKDESKLYIFLELVTKGSL 417
+ L ++ E+EI +L +H+NIV+Y G L + +E + GSL
Sbjct: 77 K---LQHSTEEHLR--DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL 131
Query: 418 LNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL 475
+ Q++ + ++ YT QI G++YL + +HRD+ NILV+ VK+ DFGL
Sbjct: 132 RDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGL 191
Query: 476 AKATKLNDV--KSCRGTAF---WMAPEVIN-NKNKGYGLPADIWSLGCTVLEMLT----- 524
K + K W APE + +K + + +D+WS G + E+ T
Sbjct: 192 TKVLPQDKEYYKVKEPGESPIFWYAPESLTESK---FSVASDVWSFGVVLYELFTYIEKS 248
Query: 525 -----------SQIPYAPMEC 534
M
Sbjct: 249 KSPPAEFMRMIGNDKQGQMIV 269
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 6e-39
Identities = 62/234 (26%), Positives = 99/234 (42%), Gaps = 39/234 (16%)
Query: 332 QKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR 386
+ LG+G+FGSV + G AVK+ L ++ E+EI +L
Sbjct: 13 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKK---LQHSTEEHLR--DFEREIEILKS 67
Query: 387 FEHENIVQYYG--TDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGL 442
+H+NIV+Y G L + +E + GSL + Q++ + ++ YT QI G+
Sbjct: 68 LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 127
Query: 443 KYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--KSCRGTAF---WMAPE 497
+YL + +HRD+ NILV+ VK+ DFGL K + K W APE
Sbjct: 128 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPE 187
Query: 498 VIN-NKNKGYGLPADIWSLGCTVLEMLT----------------SQIPYAPMEC 534
+ +K + + +D+WS G + E+ T M
Sbjct: 188 SLTESK---FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 238
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 6e-39
Identities = 67/204 (32%), Positives = 112/204 (54%), Gaps = 23/204 (11%)
Query: 336 LLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQ------EIALLSRFE 388
LG GSFG V+ S +G ++A+K + K+ + +L+Q E +LS
Sbjct: 13 TLGTGSFGRVHLIRSRHNGRYYAMKVLK--------KEIVVRLKQVEHTNDERLMLSIVT 64
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHD 447
H I++ +GT +D ++++ ++ + G L +L ++ + V+ Y ++ L L+YLH
Sbjct: 65 HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 124
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS--CRGTAFWMAPEVINNKNKG 505
+D+++RD+K NIL+D NG +K+ DFG AK + DV C GT ++APEV++ K
Sbjct: 125 KDIIYRDLKPENILLDKNGHIKITDFGFAK--YVPDVTYTLC-GTPDYIAPEVVS--TKP 179
Query: 506 YGLPADIWSLGCTVLEMLTSQIPY 529
Y D WS G + EML P+
Sbjct: 180 YNKSIDWWSFGILIYEMLAGYTPF 203
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 6e-39
Identities = 67/207 (32%), Positives = 98/207 (47%), Gaps = 29/207 (14%)
Query: 336 LLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQ------EIALLSRFE 388
LG GSFG V + G +A+K + KQ + +L+Q E +L
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKILD--------KQKVVKLKQIEHTLNEKRILQAVN 99
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV----SA--YTRQILLGL 442
+V+ + KD S LY+ +E V G + HLR A Y QI+L
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMF-----SHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 443 KYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNK 502
+YLH D+++RD+K N+L+D G +++ DFG AK K C GT +APE+I
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC-GTPEALAPEII--L 211
Query: 503 NKGYGLPADIWSLGCTVLEMLTSQIPY 529
+KGY D W+LG + EM P+
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPF 238
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-38
Identities = 59/206 (28%), Positives = 98/206 (47%), Gaps = 16/206 (7%)
Query: 337 LGRGSFGSVYEGI---SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
LG G+FG+V +G AVK L + +L E ++ + ++ IV
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKI---LKNEANDPALKDELLAEANVMQQLDNPYIV 81
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVH 452
+ G + ES + +E+ G L L Q H++D + Q+ +G+KYL + + VH
Sbjct: 82 RMIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 140
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLND--VKSCRGTAF---WMAPEVINNKNKGYG 507
RD+ N+L+ K++DFGL+KA + ++ K+ + W APE IN +
Sbjct: 141 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK--FS 198
Query: 508 LPADIWSLGCTVLEMLTS-QIPYAPM 532
+D+WS G + E + Q PY M
Sbjct: 199 SKSDVWSFGVLMWEAFSYGQKPYRGM 224
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-38
Identities = 48/193 (24%), Positives = 83/193 (43%), Gaps = 22/193 (11%)
Query: 335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
+LG G G V E G A+K + ++ E + +IV
Sbjct: 35 QVLGLGVNGKVLECFHRRTGQKCALKLLY--------DSPKARQEVDH-HWQASGGPHIV 85
Query: 394 QYYGT----DKDESKLYIFLELVTKGSLLN-LYQRYHLRDS--QVSAYTRQILLGLKYLH 446
+ L I +E + G L + + +R + + + R I +++LH
Sbjct: 86 CILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH 145
Query: 447 DQDVVHRDIKCANILV---DANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKN 503
++ HRD+K N+L + + +KL DFG AK T N +++ T +++APEV+
Sbjct: 146 SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVL--GP 203
Query: 504 KGYGLPADIWSLG 516
+ Y D+WSLG
Sbjct: 204 EKYDKSCDMWSLG 216
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-38
Identities = 64/227 (28%), Positives = 109/227 (48%), Gaps = 21/227 (9%)
Query: 320 PNGRFKRIITYWQ--KGDLLGRGSFGSVYEGI-SDDGFFF----AVKEVSLLDQGSQAKQ 372
PN RI+ + K +LG G+FG+VY+G+ +G A+KE L + + K
Sbjct: 4 PNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE---LREATSPKA 60
Query: 373 SISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN--LYQRYHLRDSQ 430
+ L E +++ ++ ++ + G + + + +L+ G LL+ + ++
Sbjct: 61 NKEIL-DEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQY 118
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VKSCRG 489
+ + QI G+ YL D+ +VHRD+ N+LV VK+ DFGLAK + G
Sbjct: 119 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 178
Query: 490 TAF---WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPM 532
WMA E I ++ Y +D+WS G TV E++T PY +
Sbjct: 179 GKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGI 223
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-38
Identities = 59/205 (28%), Positives = 96/205 (46%), Gaps = 14/205 (6%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
LG G FG V G + AVK ++ +GS ++ + QE + + H +V
Sbjct: 13 LKELGSGQFGVVKLGKWKGQYDVAVK---MIKEGSMSED---EFFQEAQTMMKLSHPKLV 66
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
++YG E +YI E ++ G LLN + L SQ+ + G+ +L +
Sbjct: 67 KFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFI 126
Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGL 508
HRD+ N LVD + VK++DFG+ + + S GT F W APEV + Y
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFK--YSS 184
Query: 509 PADIWSLGCTVLEMLTS-QIPYAPM 532
+D+W+ G + E+ + ++PY
Sbjct: 185 KSDVWAFGILMWEVFSLGKMPYDLY 209
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 3e-38
Identities = 60/231 (25%), Positives = 95/231 (41%), Gaps = 19/231 (8%)
Query: 316 SNISPNGRFKRII--TYWQKGDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQ 369
+ P +I + + LG GSFG V G S AVK L
Sbjct: 3 AGEGPLQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVK--CLKPDVLS 60
Query: 370 AKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN--LYQRYHLR 427
+++ +E+ + +H N+++ YG + + EL GSLL+ + H
Sbjct: 61 QPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFL 119
Query: 428 DSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VK 485
+S Y Q+ G+ YL + +HRD+ N+L+ VK+ DFGL +A ND
Sbjct: 120 LGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYV 179
Query: 486 SCRGTAF---WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPM 532
W APE + + + +D W G T+ EM T Q P+ +
Sbjct: 180 MQEHRKVPFAWCAPESLKTRT--FSHASDTWMFGVTLWEMFTYGQEPWIGL 228
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 3e-38
Identities = 64/232 (27%), Positives = 104/232 (44%), Gaps = 14/232 (6%)
Query: 307 SSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVS--- 362
+ + ++P + + + +Q G LLG G FGSVY GI D A+K V
Sbjct: 21 MAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDR 80
Query: 363 LLDQGSQAKQSISQLEQEIALLSRFEHE--NIVQYYGTDKDESKLYIFLELVT-KGSLLN 419
+ D G + ++ E+ LL + +++ + + LE L +
Sbjct: 81 ISDWGELPNGT--RVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFD 138
Query: 420 -LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAK 477
+ +R L++ ++ Q+L +++ H+ V+HRDIK NIL+D N G +KL DFG
Sbjct: 139 FITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 198
Query: 478 ATKLNDVKSCRGTAFWMAPEVINNKNKGY-GLPADIWSLGCTVLEMLTSQIP 528
K GT + PE I Y G A +WSLG + +M+ IP
Sbjct: 199 LLKDTVYTDFDGTRVYSPPEWIR--YHRYHGRSAAVWSLGILLYDMVCGDIP 248
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 6e-38
Identities = 55/232 (23%), Positives = 91/232 (39%), Gaps = 39/232 (16%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
+L+GRG +G+VY+G D AVK S +Q+ E+ I + EH+NI
Sbjct: 18 LELIGRGRYGAVYKGSLD-ERPVAVKVFS-----FANRQNFIN-EKNIYRVPLMEHDNIA 70
Query: 394 QYYGTDK-----DESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
++ D+ + + +E GSL + + GL YLH +
Sbjct: 71 RFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTE 130
Query: 449 D---------VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR----------G 489
+ HRD+ N+LV +G+ ++DFGL+ N + G
Sbjct: 131 LPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVG 190
Query: 490 TAFWMAPEVINN-----KNKGYGLPADIWSLGCTVLEML---TSQIPYAPME 533
T +MAPEV+ + D+++LG E+ T P +
Sbjct: 191 TIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP 242
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 8e-38
Identities = 56/218 (25%), Positives = 110/218 (50%), Gaps = 11/218 (5%)
Query: 316 SNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSI 374
++I+ + I ++ +G+G+F V G A+K ++D+ S+
Sbjct: 2 NSIASCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIK---IIDKTQLNPTSL 58
Query: 375 SQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSA 433
+L +E+ ++ H NIV+ + + E LY+ +E + G + + L +++ + +
Sbjct: 59 QKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARS 118
Query: 434 YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--KSCRGTA 491
RQI+ ++Y H + +VHRD+K N+L+DA+ ++K+ADFG + + C G
Sbjct: 119 KFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC-GAP 177
Query: 492 FWMAPEVINNKNKGY-GLPADIWSLGCTVLEMLTSQIP 528
+ APE+ K Y G D+WSLG + +++ +P
Sbjct: 178 PYAAPELFQ--GKKYDGPEVDVWSLGVILYTLVSGSLP 213
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 8e-38
Identities = 67/230 (29%), Positives = 107/230 (46%), Gaps = 23/230 (10%)
Query: 309 STTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSL 363
+ +P + + P F++ + ++ LG G FG V + G AVK
Sbjct: 4 VSEKKPATEVDPT-HFEK--RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKS--- 57
Query: 364 LDQGSQAKQSISQLEQEIALLSRFEHENIVQYYG--TDKDESKLYIFLELVTKGSLLNLY 421
L S I+ L++EI +L HENIV+Y G T+ + + + +E + GSL
Sbjct: 58 LKPESGGNH-IADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL 116
Query: 422 Q--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT 479
+ + Q Y QI G+ YL + VHRD+ N+LV++ VK+ DFGL KA
Sbjct: 117 PKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 176
Query: 480 KLNDV--KSCRGTAF---WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT 524
+ + W APE + +K + + +D+WS G T+ E+LT
Sbjct: 177 ETDKEYYTVKDDRDSPVFWYAPECLMQ-SK-FYIASDVWSFGVTLHELLT 224
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 1e-37
Identities = 51/205 (24%), Positives = 94/205 (45%), Gaps = 14/205 (6%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
+G G FG V+ G + A+K + +G+ +++ +E ++ + H +V
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDKVAIK---TIREGAMSEE---DFIEEAEVMMKLSHPKLV 66
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
Q YG +++ + + E + G L + + R + + G+ YL + V+
Sbjct: 67 QLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVI 126
Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGL 508
HRD+ N LV N +K++DFG+ + + S GT F W +PEV + Y
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR--YSS 184
Query: 509 PADIWSLGCTVLEMLTS-QIPYAPM 532
+D+WS G + E+ + +IPY
Sbjct: 185 KSDVWSFGVLMWEVFSEGKIPYENR 209
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 1e-37
Identities = 57/214 (26%), Positives = 101/214 (47%), Gaps = 12/214 (5%)
Query: 325 KRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVS---LLDQGSQAKQSISQLEQE 380
+ LG G+FG V+ + + VK + +L+ + ++ E
Sbjct: 20 GEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLE 79
Query: 381 IALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQI 438
IA+LSR EH NI++ +++ + +E G L + + L + S RQ+
Sbjct: 80 IAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQL 139
Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--KSCRGTAFWMAP 496
+ + YL +D++HRDIK NI++ + ++KL DFG A + + C GT + AP
Sbjct: 140 VSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC-GTIEYCAP 198
Query: 497 EVINNKNKGY-GLPADIWSLGCTVLEMLTSQIPY 529
EV+ Y G ++WSLG T+ ++ + P+
Sbjct: 199 EVLM--GNPYRGPELEMWSLGVTLYTLVFEENPF 230
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 1e-37
Identities = 64/216 (29%), Positives = 108/216 (50%), Gaps = 12/216 (5%)
Query: 320 PNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQS-ISQL 377
+ I ++ GD LG G+FG V G G AVK +L++ + ++
Sbjct: 2 SKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVK---ILNRQKIRSLDVVGKI 58
Query: 378 EQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTR 436
++EI L F H +I++ Y + ++ +E V+ G L + + + + + + +
Sbjct: 59 KREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQ 118
Query: 437 QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--KSCRGTAFWM 494
QIL + Y H VVHRD+K N+L+DA+ + K+ADFGL+ + SC G+ +
Sbjct: 119 QILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC-GSPNYA 177
Query: 495 APEVINNKNKGY-GLPADIWSLGCTVLEMLTSQIPY 529
APEVI+ + Y G DIWS G + +L +P+
Sbjct: 178 APEVIS--GRLYAGPEVDIWSCGVILYALLCGTLPF 211
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 4e-37
Identities = 62/275 (22%), Positives = 117/275 (42%), Gaps = 26/275 (9%)
Query: 273 EKEGEEADRAIVKEEEDD--MVLSESCSFTTEHEDDSSSTTTEPMSNISPNGRFKRI-IT 329
+ + + E D + L + C+ + + + E + + R+
Sbjct: 15 DGPAQTNGQCFSVETLLDILICLYDECNNSPLRREKNILEYLEWAKPFTSKVKQMRLHRE 74
Query: 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQ------EIA 382
++ ++GRG+FG V + FA+K ++ K + + + E
Sbjct: 75 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILN--------KWEMLKRAETACFREERD 126
Query: 383 LLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA--YTRQILL 440
+L + + I + +D++ LY+ ++ G LL L ++ R + A Y ++++
Sbjct: 127 VLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVI 186
Query: 441 GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR---GTAFWMAPE 497
+ +H VHRDIK NIL+D NG ++LADFG + GT +++PE
Sbjct: 187 AIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPE 246
Query: 498 VINNK---NKGYGLPADIWSLGCTVLEMLTSQIPY 529
++ YG D WSLG + EML + P+
Sbjct: 247 ILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPF 281
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 4e-37
Identities = 51/317 (16%), Positives = 99/317 (31%), Gaps = 60/317 (18%)
Query: 276 GEEADRAIVK---EEEDDMVLSESCSFTTEHEDDSSSTT----TEPMSNISPNGRFKRII 328
G + +++ + + + D ST+ +P S G R +
Sbjct: 21 GTDPGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTL 80
Query: 329 TYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
+G +LG+ + E + G F V ++ +I Q+++E+ L
Sbjct: 81 V---RGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPP--SNAIKQMKEEVLRLRLL 135
Query: 388 -------------------------EHENIVQYYGTDKDESKLYIFL-------ELVTKG 415
+ + +++ ++D L F L T G
Sbjct: 136 RGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFG 195
Query: 416 SLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADF 473
+L + H L T Q++ L LH +VH ++ +I++D G V L F
Sbjct: 196 EVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGF 255
Query: 474 GLAKATKLNDVKSCRGTAFWMAPEVI--------NNKNKGYGLPADIWSLGCTVLEMLTS 525
+ + PE + D W+LG + + +
Sbjct: 256 EHLV--RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA 313
Query: 526 QIPY---APMECVSAIF 539
+P A + IF
Sbjct: 314 DLPNTDDAALGGSEWIF 330
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 5e-37
Identities = 55/205 (26%), Positives = 99/205 (48%), Gaps = 14/205 (6%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
LG G FG V G + A+K ++ +GS ++ + +E ++ HE +V
Sbjct: 29 LKELGTGQFGVVKYGKWRGQYDVAIK---MIKEGSMSED---EFIEEAKVMMNLSHEKLV 82
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
Q YG + ++I E + G LLN + R+ + Q+ + + ++YL + +
Sbjct: 83 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL 142
Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYGL 508
HRD+ N LV+ G VK++DFGL++ ++ S G+ F W PEV+ +
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK--FSS 200
Query: 509 PADIWSLGCTVLEMLTS-QIPYAPM 532
+DIW+ G + E+ + ++PY
Sbjct: 201 KSDIWAFGVLMWEIYSLGKMPYERF 225
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 8e-37
Identities = 61/207 (29%), Positives = 105/207 (50%), Gaps = 18/207 (8%)
Query: 337 LGRGSFGSVYEGI---SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
LG G+FGSV +G+ A+K L QG++ + ++ +E ++ + ++ IV
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKV---LKQGTEKADT-EEMMREAQIMHQLDNPYIV 73
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
+ G + E+ L + +E+ G L R + S V+ Q+ +G+KYL +++ V
Sbjct: 74 RLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 132
Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLNDV--KSCRGTAF---WMAPEVINNKNKGY 506
HRD+ N+L+ K++DFGL+KA +D + + W APE IN + +
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK--F 190
Query: 507 GLPADIWSLGCTVLEMLT-SQIPYAPM 532
+D+WS G T+ E L+ Q PY M
Sbjct: 191 SSRSDVWSYGVTMWEALSYGQKPYKKM 217
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 9e-37
Identities = 54/239 (22%), Positives = 95/239 (39%), Gaps = 28/239 (11%)
Query: 294 SESCSFTTEHEDDSSSTTTEPMSNISPNGRFKR---IITYWQKGDLLGRGSFGSVYEGIS 350
+ P ++ + K+ I Y +LG G G V + +
Sbjct: 24 PTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFN 83
Query: 351 -DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKD----ESK 404
FA+K + + +E+ L R + +IV+ ++
Sbjct: 84 KRTQEKFALKMLQ----------DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 133
Query: 405 LYIFLELVTKGSLLN-LYQRYHLRDS--QVSAYTRQILLGLKYLHDQDVVHRDIKCANIL 461
L I +E + G L + + R + + S + I ++YLH ++ HRD+K N+L
Sbjct: 134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 193
Query: 462 V---DANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPEVINNKNKGYGLPADIWSLG 516
N +KL DFG AK T ++ + T +++APEV+ + Y D+WSLG
Sbjct: 194 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL--GPEKYDKSCDMWSLG 250
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 9e-37
Identities = 57/208 (27%), Positives = 90/208 (43%), Gaps = 16/208 (7%)
Query: 334 GDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
G+ +GRG+FG V+ G D AVK + L QE +L ++ H NI
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVK---SCRETLPPDLKAKFL-QEARILKQYSHPNI 174
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLY---QRYHLRDSQVSAYTRQILLGLKYLHDQD 449
V+ G + +YI +ELV G L + + LR + G++YL +
Sbjct: 175 VRLIGVCTQKQPIYIVMELVQGGDFLT-FLRTEGARLRVKTLLQMVGDAAAGMEYLESKC 233
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----WMAPEVINNKNKG 505
+HRD+ N LV +K++DFG+++ + G W APE +N
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGR-- 291
Query: 506 YGLPADIWSLGCTVLEMLTS-QIPYAPM 532
Y +D+WS G + E + PY +
Sbjct: 292 YSSESDVWSFGILLWETFSLGASPYPNL 319
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-36
Identities = 59/210 (28%), Positives = 95/210 (45%), Gaps = 19/210 (9%)
Query: 334 GDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
+LG G FG VYEG+ + AVK + + E ++ +H
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKT---CKKDCTLDNKEKFM-SEAVIMKNLDH 72
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLY---QRYHLRDSQVSAYTRQILLGLKYLH 446
+IV+ G ++E +I +EL G L + Y + L+ + Y+ QI + YL
Sbjct: 73 PHIVKLIGIIEEEP-TWIIMELYPYGELGH-YLERNKNSLKVLTLVLYSLQICKAMAYLE 130
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKN 503
+ VHRDI NILV + VKL DFGL++ + D T WM+PE IN +
Sbjct: 131 SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRR 190
Query: 504 KGYGLPADIWSLGCTVLEMLT-SQIPYAPM 532
+ +D+W + E+L+ + P+ +
Sbjct: 191 --FTTASDVWMFAVCMWEILSFGKQPFFWL 218
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-36
Identities = 73/295 (24%), Positives = 129/295 (43%), Gaps = 35/295 (11%)
Query: 261 RALSSSSDDEDNEKEGEEADRAIVKEEEDDMVLSESCS--FTTEHEDDSSSTTTEPMSNI 318
R + + ++ ++ ++ + +V + F E+ + +
Sbjct: 106 REIFDTYIMKELLACSHPFSKSAIEHVQGHLVKKQVPPDLFQPYIEEICQNLRGDVFQKF 165
Query: 319 SPNGRFKRIITY-WQKGD------------LLGRGSFGSVYEGIS-DDGFFFAVKEVSLL 364
+ +F R + + + ++GRG FG VY D G +A+K L
Sbjct: 166 IESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMK---CL 222
Query: 365 DQGSQAKQSISQLEQE---------IALLSRFEHENIVQYYGTDKDESKLYIFLELVTKG 415
D K+ I + E ++L+S + IV KL L+L+ G
Sbjct: 223 D-----KKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGG 277
Query: 416 SLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFG 474
L L Q ++ + Y +I+LGL+++H++ VV+RD+K ANIL+D +G V+++D G
Sbjct: 278 DLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLG 337
Query: 475 LAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY 529
LA + GT +MAPEV+ K Y AD +SLGC + ++L P+
Sbjct: 338 LACDFSKKKPHASVGTHGYMAPEVL-QKGVAYDSSADWFSLGCMLFKLLRGHSPF 391
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-36
Identities = 63/211 (29%), Positives = 99/211 (46%), Gaps = 21/211 (9%)
Query: 334 GDLLGRGSFGSVYEGI--SDDGFFF--AVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
G +G G FG V++GI S + A+K + L QE + +F+H
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKT---CKNCTSDSVREKFL-QEALTMRQFDH 75
Query: 390 ENIVQYYG--TDKDESKLYIFLELVTKGSLLN--LYQRYHLRDSQVSAYTRQILLGLKYL 445
+IV+ G T E+ ++I +EL T G L + ++Y L + + Y Q+ L YL
Sbjct: 76 PHIVKLIGVIT---ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 132
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNK 502
+ VHRDI N+LV +N VKL DFGL++ + + WMAPE IN +
Sbjct: 133 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 192
Query: 503 NKGYGLPADIWSLGCTVLEMLT-SQIPYAPM 532
+ +D+W G + E+L P+ +
Sbjct: 193 R--FTSASDVWMFGVCMWEILMHGVKPFQGV 221
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 4e-36
Identities = 67/272 (24%), Positives = 116/272 (42%), Gaps = 32/272 (11%)
Query: 274 KEGEEADRAIVKEEEDDMVLSESCSFTTEHEDDSSSTTTEPMSNISPNGRFKRIITYWQK 333
EE + T + ++ T + F+ +
Sbjct: 7 HHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIE-NFELL------ 59
Query: 334 GDLLGRGSFGSVY----EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIA------- 382
+LG G++G V+ D G +A+K + K +I Q +
Sbjct: 60 -KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLK--------KATIVQKAKTTEHTRTERQ 110
Query: 383 LLSRFEHEN-IVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILL 440
+L +V + + E+KL++ L+ + G L L QR + +V Y +I+L
Sbjct: 111 VLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVL 170
Query: 441 GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR---GTAFWMAPE 497
L++LH +++RDIK NIL+D+NG V L DFGL+K ++ + GT +MAP+
Sbjct: 171 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 230
Query: 498 VINNKNKGYGLPADIWSLGCTVLEMLTSQIPY 529
++ + G+ D WSLG + E+LT P+
Sbjct: 231 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPF 262
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 4e-36
Identities = 59/213 (27%), Positives = 92/213 (43%), Gaps = 22/213 (10%)
Query: 334 GDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
++G G G V G A+K L G +Q L E +++ +F+H
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIK---ALKAGYTERQRRDFL-SEASIMGQFDH 109
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLH 446
NI++ G I E + GSL + R H Q+ R + G++YL
Sbjct: 110 PNIIRLEGVVTRGRLAMIVTEYMENGSLDT-FLRTHDGQFTIMQLVGMLRGVGAGMRYLS 168
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VKSCRGTAF---WMAPEVIN- 500
D VHRD+ N+LVD+N K++DFGL++ + + + G W APE I
Sbjct: 169 DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAF 228
Query: 501 NKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPM 532
+ +D+WS G + E+L + PY M
Sbjct: 229 RT---FSSASDVWSFGVVMWEVLAYGERPYWNM 258
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 4e-36
Identities = 62/246 (25%), Positives = 101/246 (41%), Gaps = 23/246 (9%)
Query: 298 SFTTEHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFF 356
S T+ + P R + ++ G LLG+G FG+V+ G D
Sbjct: 1 SMLTKPLQGPPAPPGTPTPPPGGKDR-EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQV 59
Query: 357 AVKEVS---LLDQGSQAKQSISQLEQEIALLSR----FEHENIVQYYGTDKDESKLYIFL 409
A+K + +L + E+ALL + H +++ + + + L
Sbjct: 60 AIKVIPRNRVLGWSPLSDSV--TCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVL 117
Query: 410 ELVTKGS-LLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA-NG 466
E L + + ++ L + + Q++ +++ H + VVHRDIK NIL+D G
Sbjct: 118 ERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRG 177
Query: 467 SVKLADFGLA---KATKLNDVKSCRGTAFWMAPEVINNKNKGY-GLPADIWSLGCTVLEM 522
KL DFG D GT + PE I+ Y LPA +WSLG + +M
Sbjct: 178 CAKLIDFGSGALLHDEPYTD--FD-GTRVYSPPEWIS--RHQYHALPATVWSLGILLYDM 232
Query: 523 LTSQIP 528
+ IP
Sbjct: 233 VCGDIP 238
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 7e-36
Identities = 66/241 (27%), Positives = 107/241 (44%), Gaps = 38/241 (15%)
Query: 304 EDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSL 363
+D + + +R I Y ++G GSFG V++ + A+K+V L
Sbjct: 19 DDPNKVIKVLASDGKTG---EQREIAY-TNCKVIGNGSFGVVFQAKLVESDEVAIKKV-L 73
Query: 364 LDQGSQAKQSISQLEQEIALLSRFEHENIVQYY------GTDKDESKLYIFLELVTKGSL 417
D+ + + E+ ++ +H N+V G KDE L + LE V +
Sbjct: 74 QDKRFKNR--------ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE--- 122
Query: 418 LNLYQ--RYHLRDSQ------VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSV 468
+Y+ R++ + Q + Y Q+L L Y+H + HRDIK N+L+D G +
Sbjct: 123 -TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVL 181
Query: 469 KLADFGLAKATKLNDVKS---CRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTS 525
KL DFG AK + C + ++ APE+I Y DIWS GC + E++
Sbjct: 182 KLIDFGSAKILIAGEPNVSYIC--SRYYRAPELIFG-ATNYTTNIDIWSTGCVMAELMQG 238
Query: 526 Q 526
Q
Sbjct: 239 Q 239
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 8e-36
Identities = 67/206 (32%), Positives = 104/206 (50%), Gaps = 16/206 (7%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
LG+G FG V+ G + A+K L G+ + + QE ++ + HE +V
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIK---TLKPGTMSPE---AFLQEAQVMKKLRHEKLV 242
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNL---YQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
Q Y +E +YI E ++KGSLL+ +LR Q+ QI G+ Y+ +
Sbjct: 243 QLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 301
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGYG 507
VHRD++ ANILV N K+ADFGLA+ + N+ + +G F W APE +
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--FT 359
Query: 508 LPADIWSLGCTVLEMLT-SQIPYAPM 532
+ +D+WS G + E+ T ++PY M
Sbjct: 360 IKSDVWSFGILLTELTTKGRVPYPGM 385
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-35
Identities = 69/242 (28%), Positives = 110/242 (45%), Gaps = 36/242 (14%)
Query: 304 EDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVS 362
D S T ++ + ++Y ++G GSFG VY+ D G A+K+V
Sbjct: 30 RDKDGSKVTTVVATPGQGPDRPQEVSY-TDTKVIGNGSFGVVYQAKLCDSGELVAIKKV- 87
Query: 363 LLDQGSQAKQSISQLEQEIALLSRFEHENIVQYY------GTDKDESKLYIFLELVTKGS 416
L D+ + + E+ ++ + +H NIV+ G KDE L + L+ V +
Sbjct: 88 LQDKRFKNR--------ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-- 137
Query: 417 LLNLYQ--RYHLRDSQ------VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GS 467
+Y+ R++ R Q V Y Q+ L Y+H + HRDIK N+L+D +
Sbjct: 138 --TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAV 195
Query: 468 VKLADFGLAKATKLNDVKS---CRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT 524
+KL DFG AK + C + ++ APE+I Y D+WS GC + E+L
Sbjct: 196 LKLCDFGSAKQLVRGEPNVSYIC--SRYYRAPELIFG-ATDYTSSIDVWSAGCVLAELLL 252
Query: 525 SQ 526
Q
Sbjct: 253 GQ 254
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 1e-35
Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 16/207 (7%)
Query: 334 GDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
LG G +G VYEG+ AVK L + + + + +E A++ +H N+
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVK---TLKEDTMEVE---EFLKEAAVMKEIKHPNL 71
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNL---YQRYHLRDSQVSAYTRQILLGLKYLHDQD 449
VQ G E YI E +T G+LL+ R + + QI ++YL ++
Sbjct: 72 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 131
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGY 506
+HRD+ N LV N VK+ADFGL++ + + G F W APE + +
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK--F 189
Query: 507 GLPADIWSLGCTVLEMLTS-QIPYAPM 532
+ +D+W+ G + E+ T PY +
Sbjct: 190 SIKSDVWAFGVLLWEIATYGMSPYPGI 216
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 62/227 (27%), Positives = 102/227 (44%), Gaps = 21/227 (9%)
Query: 320 PNGRFKRII--TYWQKGDLLGRGSFGSVYEGI-SDDGFFF----AVKEVSLLDQGSQAKQ 372
RI T +K +LG G FG+V++G+ +G +K ++ S Q
Sbjct: 2 AMKVLARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKV---IEDKSGR-Q 57
Query: 373 SISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN--LYQRYHLRDSQ 430
S + + + +H +IV+ G S L + + + GSLL+ R L
Sbjct: 58 SFQAVTDHMLAIGSLDHAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGALGPQL 116
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-KSCRG 489
+ + QI G+ YL + +VHR++ N+L+ + V++ADFG+A +D
Sbjct: 117 LLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE 176
Query: 490 TAF---WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPM 532
WMA E I+ Y +D+WS G TV E++T PYA +
Sbjct: 177 AKTPIKWMALESIHFGK--YTHQSDVWSYGVTVWELMTFGAEPYAGL 221
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-35
Identities = 63/229 (27%), Positives = 110/229 (48%), Gaps = 21/229 (9%)
Query: 319 SPNGRFKRIITYWQ--KGDLLGRGSFGSVYEGI-SDDGFFF----AVKEVSLLDQGSQAK 371
+PN RI+ + K +LG G+FG+VY+G+ +G A+KE L + + K
Sbjct: 3 APNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE---LREATSPK 59
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN--LYQRYHLRDS 429
++ E +++ ++ ++ + G + + + +L+ G LL+ + ++
Sbjct: 60 A-NKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQ 117
Query: 430 QVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VKSCR 488
+ + QI G+ YL D+ +VHRD+ N+LV VK+ DFGLAK +
Sbjct: 118 YLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 177
Query: 489 GTAF---WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPME 533
G WMA E I ++ Y +D+WS G TV E++T PY +
Sbjct: 178 GGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMTFGSKPYDGIP 224
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-35
Identities = 69/221 (31%), Positives = 111/221 (50%), Gaps = 13/221 (5%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQ 372
PM+ + I ++ GD LG G+FG V G G AVK +L++
Sbjct: 2 PMAE-KQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVK---ILNRQKIRSL 57
Query: 373 S-ISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQ 430
+ ++ +EI L F H +I++ Y S +++ +E V+ G L + + + L + +
Sbjct: 58 DVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKE 117
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--KSCR 488
+QIL G+ Y H VVHRD+K N+L+DA+ + K+ADFGL+ + SC
Sbjct: 118 SRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC- 176
Query: 489 GTAFWMAPEVINNKNKGY-GLPADIWSLGCTVLEMLTSQIP 528
G+ + APEVI+ + Y G DIWS G + +L +P
Sbjct: 177 GSPNYAAPEVIS--GRLYAGPEVDIWSSGVILYALLCGTLP 215
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-35
Identities = 60/229 (26%), Positives = 99/229 (43%), Gaps = 19/229 (8%)
Query: 306 DSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLL 364
D + TT P+ + +G G+FG AVK +
Sbjct: 2 DRAPVTTGPLDM-----PIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVK---YI 53
Query: 365 DQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQR 423
++G +++EI H NIV++ + L I +E + G L +
Sbjct: 54 ERG---AAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNA 110
Query: 424 YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN--GSVKLADFGLAKATKL 481
+ + + +Q+L G+ Y H + HRD+K N L+D + +K+ DFG +K++ L
Sbjct: 111 GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170
Query: 482 NDV-KSCRGTAFWMAPEVINNKNKGY-GLPADIWSLGCTVLEMLTSQIP 528
+ KS GT ++APEV+ + Y G AD+WS G T+ ML P
Sbjct: 171 HSQPKSTVGTPAYIAPEVLL--RQEYDGKIADVWSCGVTLYVMLVGAYP 217
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-35
Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 21/213 (9%)
Query: 334 GDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE 388
++G G FG VY+G+ A+K L G KQ + L E ++ +F
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKT---LKAGYTEKQRVDFL-GEAGIMGQFS 104
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYL 445
H NI++ G + I E + G+L + R Q+ R I G+KYL
Sbjct: 105 HHNIIRLEGVISKYKPMMIITEYMENGALDK-FLREKDGEFSVLQLVGMLRGIAAGMKYL 163
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VKSCRGTAF---WMAPEVIN 500
+ + VHRD+ NILV++N K++DFGL++ + + + G W APE I+
Sbjct: 164 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 223
Query: 501 NKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPM 532
+ + +D+WS G + E++T + PY +
Sbjct: 224 YRK--FTSASDVWSFGIVMWEVMTYGERPYWEL 254
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-35
Identities = 65/209 (31%), Positives = 106/209 (50%), Gaps = 22/209 (10%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
+ LG G FG V+ G + AVK L QGS + E L+ + +H+ +V
Sbjct: 18 VERLGAGQFGEVWMGYYNGHTKVAVK---SLKQGSMSPD---AFLAEANLMKQLQHQRLV 71
Query: 394 QYYG--TDKDESKLYIFLELVTKGSLLNLY----QRYHLRDSQVSAYTRQILLGLKYLHD 447
+ Y T + +YI E + GSL++ + L +++ QI G+ ++ +
Sbjct: 72 RLYAVVT---QEPIYIITEYMENGSLVD-FLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNK 504
++ +HRD++ ANILV S K+ADFGLA+ + N+ + G F W APE IN
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT- 186
Query: 505 GYGLPADIWSLGCTVLEMLT-SQIPYAPM 532
+ + +D+WS G + E++T +IPY M
Sbjct: 187 -FTIKSDVWSFGILLTEIVTHGRIPYPGM 214
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 4e-35
Identities = 67/207 (32%), Positives = 107/207 (51%), Gaps = 24/207 (11%)
Query: 336 LLGRGSFGSVY----EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ-----EIALLSR 386
+LG+GSFG V+ SD +A+K + K ++ ++ E +L
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLK--------KATLKVRDRVRTKMERDILVE 82
Query: 387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYL 445
H IV+ + + E KLY+ L+ + G L L + + V Y ++ L L +L
Sbjct: 83 VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHL 142
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEVINNK 502
H +++RD+K NIL+D G +KL DFGL+K + ++ K+ C GT +MAPEV+N
Sbjct: 143 HSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC-GTVEYMAPEVVN-- 199
Query: 503 NKGYGLPADIWSLGCTVLEMLTSQIPY 529
+G+ AD WS G + EMLT +P+
Sbjct: 200 RRGHTQSADWWSFGVLMFEMLTGTLPF 226
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 4e-35
Identities = 62/210 (29%), Positives = 104/210 (49%), Gaps = 13/210 (6%)
Query: 325 KRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQS-ISQLEQEIA 382
KR I + + LG GSFG V A+K + + K ++E+EI+
Sbjct: 5 KRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALK---FISRQLLKKSDMHMRVEREIS 61
Query: 383 LLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLG 441
L H +I++ Y + + + +E G L + + ++ + + + + +QI+
Sbjct: 62 YLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICA 120
Query: 442 LKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--KSCRGTAFWMAPEVI 499
++Y H +VHRD+K N+L+D N +VK+ADFGL+ + SC G+ + APEVI
Sbjct: 121 IEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC-GSPNYAAPEVI 179
Query: 500 NNKNKGY-GLPADIWSLGCTVLEMLTSQIP 528
N K Y G D+WS G + ML ++P
Sbjct: 180 N--GKLYAGPEVDVWSCGIVLYVMLVGRLP 207
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 4e-35
Identities = 63/260 (24%), Positives = 108/260 (41%), Gaps = 34/260 (13%)
Query: 292 VLSESCSFTTEHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGD-----LLGRGSFGSVY 346
+ + + +D + + I + R+ Q+ D ++GRG+F V
Sbjct: 23 GVHQELGASELAQDKYVADFLQWAEPIVVRLKEVRL----QRDDFEILKVIGRGAFSEVA 78
Query: 347 EGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQ------EIALLSRFEHENIVQYYGTD 399
G +A+K ++ K + + + E +L + I Q +
Sbjct: 79 VVKMKQTGQVYAMKIMN--------KWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130
Query: 400 KDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA--YTRQILLGLKYLHDQDVVHRDIKC 457
+DE+ LY+ +E G LL L ++ R A Y +I++ + +H VHRDIK
Sbjct: 131 QDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKP 190
Query: 458 ANILVDANGSVKLADFGLAKATKLNDVKSCR---GTAFWMAPEVINNKNKG-----YGLP 509
NIL+D G ++LADFG + + GT +++PE++ G YG
Sbjct: 191 DNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPE 250
Query: 510 ADIWSLGCTVLEMLTSQIPY 529
D W+LG EM Q P+
Sbjct: 251 CDWWALGVFAYEMFYGQTPF 270
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 5e-35
Identities = 67/208 (32%), Positives = 104/208 (50%), Gaps = 20/208 (9%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
LG+G FG V+ G + A+K L G+ + + QE ++ + HE +V
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIK---TLKPGTMSPE---AFLQEAQVMKKLRHEKLV 325
Query: 394 QYYG--TDKDESKLYIFLELVTKGSLLNL---YQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
Q Y + E +YI E ++KGSLL+ +LR Q+ QI G+ Y+
Sbjct: 326 QLYAVVS---EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 382
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKG 505
+ VHRD++ ANILV N K+ADFGLA+ + N+ + +G F W APE
Sbjct: 383 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR-- 440
Query: 506 YGLPADIWSLGCTVLEMLT-SQIPYAPM 532
+ + +D+WS G + E+ T ++PY M
Sbjct: 441 FTIKSDVWSFGILLTELTTKGRVPYPGM 468
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 5e-35
Identities = 60/207 (28%), Positives = 106/207 (51%), Gaps = 18/207 (8%)
Query: 337 LGRGSFGSVYEGI---SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
LG G+FGSV +G+ A+K L QG++ + + +E ++ + ++ IV
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKV---LKQGTEKADTEEMM-REAQIMHQLDNPYIV 399
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLN--LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
+ G + E+ L + +E+ G L + +R + S V+ Q+ +G+KYL +++ V
Sbjct: 400 RLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 458
Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLNDV--KSCRGTAF---WMAPEVINNKNKGY 506
HR++ N+L+ K++DFGL+KA +D + + W APE IN + +
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK--F 516
Query: 507 GLPADIWSLGCTVLEMLT-SQIPYAPM 532
+D+WS G T+ E L+ Q PY M
Sbjct: 517 SSRSDVWSYGVTMWEALSYGQKPYKKM 543
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 6e-35
Identities = 63/213 (29%), Positives = 98/213 (46%), Gaps = 22/213 (10%)
Query: 334 GDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
++G G FG V G S A+K L G KQ L E +++ +F+H
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIK---TLKVGYTEKQRRDFL-GEASIMGQFDH 105
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLH 446
NI++ G + I E + GSL + + R H Q+ R I G+KYL
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDS-FLRKHDAQFTVIQLVGMLRGIASGMKYLS 164
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--VKSCRGTAF---WMAPEVIN- 500
D VHRD+ NIL+++N K++DFGL + + + + RG W +PE I
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 501 NKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPM 532
K + +D+WS G + E+++ + PY M
Sbjct: 225 RK---FTSASDVWSYGIVLWEVMSYGERPYWEM 254
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 6e-35
Identities = 63/241 (26%), Positives = 107/241 (44%), Gaps = 36/241 (14%)
Query: 308 SSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQ 366
S + + + K + + Q + G+G+FG+V G G A+K+V +
Sbjct: 3 GSMMSLNAAAAADERSRKEMDRF-QVERMAGQGTFGTVQLGKEKSTGMSVAIKKV--IQD 59
Query: 367 GSQAKQSISQLEQEIALLSRFEHENIVQYY-------GTDKDESKLYIFLELVTKGSLLN 419
+ + Q + L+ H NIVQ D+ + L + +E V
Sbjct: 60 PRFRNREL----QIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD----T 111
Query: 420 LYQ--RYHLRDSQ------VSAYTRQILLGLKYLHDQ--DVVHRDIKCANILVD-ANGSV 468
L++ R + R + + Q++ + LH +V HRDIK N+LV+ A+G++
Sbjct: 112 LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTL 171
Query: 469 KLADFGLAKATKLNDVKS---CRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTS 525
KL DFG AK ++ C + ++ APE+I N+ Y DIWS+GC EM+
Sbjct: 172 KLCDFGSAKKLSPSEPNVAYIC--SRYYRAPELIFG-NQHYTTAVDIWSVGCIFAEMMLG 228
Query: 526 Q 526
+
Sbjct: 229 E 229
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 6e-35
Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 26/209 (12%)
Query: 336 LLGRGSFGSVY----EGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIA-------LL 384
+LG+G +G V+ ++ G FA+K + K I + ++ A +L
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLK--------KAMIVRNAKDTAHTKAERNIL 75
Query: 385 SRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLK 443
+H IV + KLY+ LE ++ G L L + + Y +I + L
Sbjct: 76 EEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALG 135
Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEVIN 500
+LH + +++RD+K NI+++ G VKL DFGL K + + + C GT +MAPE++
Sbjct: 136 HLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC-GTIEYMAPEILM 194
Query: 501 NKNKGYGLPADIWSLGCTVLEMLTSQIPY 529
G+ D WSLG + +MLT P+
Sbjct: 195 --RSGHNRAVDWWSLGALMYDMLTGAPPF 221
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 6e-35
Identities = 76/277 (27%), Positives = 121/277 (43%), Gaps = 30/277 (10%)
Query: 273 EKEGEEADRAIVKEEEDDMVLSESCSFTTEHEDDSSSTTTEPMSNISPNGRFKRI----I 328
+KEGE A +I K ++ S + + DD + E + P+ R I I
Sbjct: 333 QKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRERI 392
Query: 329 TYWQKGDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 384
G +G G FG V++GI + A+K + L QE +
Sbjct: 393 E---LGRCIGEGQFGDVHQGIYMSPENPAMAVAIK---TCKNCTSDSVREKFL-QEALTM 445
Query: 385 SRFEHENIVQYYG--TDKDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQIL 439
+F+H +IV+ G T E+ ++I +EL T G L + + + L + + Y Q+
Sbjct: 446 RQFDHPHIVKLIGVIT---ENPVWIIMELCTLGELRS-FLQVRKFSLDLASLILYAYQLS 501
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAP 496
L YL + VHRDI N+LV +N VKL DFGL++ + + WMAP
Sbjct: 502 TALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 561
Query: 497 EVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPM 532
E IN + + +D+W G + E+L P+ +
Sbjct: 562 ESINFRR--FTSASDVWMFGVCMWEILMHGVKPFQGV 596
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-34
Identities = 46/220 (20%), Positives = 89/220 (40%), Gaps = 31/220 (14%)
Query: 334 GDLLGRGSFGSVYEGI---SDDGFFFAVKEVSL--LDQGSQAKQSISQLEQEIALLSRFE 388
+ LG+G+F +++G+ D EV L LD+ + + +++S+
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSE--SFFEAASMMSKLS 70
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLH 446
H+++V YG + + E V GSL + + + +Q+ + +L
Sbjct: 71 HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE 130
Query: 447 DQDVVHRDIKCANILVDA--------NGSVKLADFGLAKATKLND-----VKSCRGTAFW 493
+ ++H ++ NIL+ +KL+D G++ D + W
Sbjct: 131 ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIP-------W 183
Query: 494 MAPEVINNKNKGYGLPADIWSLGCTVLEMLTS-QIPYAPM 532
+ PE I N K L D WS G T+ E+ + P + +
Sbjct: 184 VPPECIEN-PKNLNLATDKWSFGTTLWEICSGGDKPLSAL 222
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-34
Identities = 62/207 (29%), Positives = 105/207 (50%), Gaps = 18/207 (8%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
LG G FG V+ + AVK + GS + + E ++ +H+ +V
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVK---TMKPGSMSVE---AFLAEANVMKTLQHDKLV 246
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA----YTRQILLGLKYLHDQD 449
+ + E +YI E + KGSLL+ + + Q ++ QI G+ ++ ++
Sbjct: 247 KLHAVVTKEP-IYIITEFMAKGSLLD-FLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN 304
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGY 506
+HRD++ ANILV A+ K+ADFGLA+ + N+ + G F W APE IN + +
Sbjct: 305 YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS--F 362
Query: 507 GLPADIWSLGCTVLEMLTS-QIPYAPM 532
+ +D+WS G ++E++T +IPY M
Sbjct: 363 TIKSDVWSFGILLMEIVTYGRIPYPGM 389
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-34
Identities = 64/232 (27%), Positives = 105/232 (45%), Gaps = 22/232 (9%)
Query: 306 DSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLL 364
++ + + + ++ L+G GS+G V + + D G A+K+
Sbjct: 2 GHHHHHHSSGVDLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLES 61
Query: 365 DQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY 424
D K + +EI LL + HEN+V K + + Y+ E V ++L+ + +
Sbjct: 62 DDDKMVK--KIAM-REIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELF 117
Query: 425 --HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN 482
L V Y QI+ G+ + H +++HRDIK NILV +G VKL DFG A+
Sbjct: 118 PNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFART---- 173
Query: 483 DVKSCRGTAF-------WM-APEVINNKNKGYGLPADIWSLGCTVLEMLTSQ 526
+ G + W APE++ K YG D+W++GC V EM +
Sbjct: 174 --LAAPGEVYDDEVATRWYRAPELLVGDVK-YGKAVDVWAIGCLVTEMFMGE 222
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 3e-34
Identities = 59/208 (28%), Positives = 95/208 (45%), Gaps = 18/208 (8%)
Query: 334 GDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
LG G +G VYEG+ AVK L + + + +E A++ +H N+
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVK---TLKEDTMEVEE---FLKEAAVMKEIKHPNL 278
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLY----QRYHLRDSQVSAYTRQILLGLKYLHDQ 448
VQ G E YI E +T G+LL+ Y R + + QI ++YL +
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLD-YLRECNRQEVSAVVLLYMATQISSAMEYLEKK 337
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKG 505
+ +HR++ N LV N VK+ADFGL++ + + G F W APE +
Sbjct: 338 NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK-- 395
Query: 506 YGLPADIWSLGCTVLEMLT-SQIPYAPM 532
+ + +D+W+ G + E+ T PY +
Sbjct: 396 FSIKSDVWAFGVLLWEIATYGMSPYPGI 423
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 129 bits (328), Expect = 5e-34
Identities = 71/222 (31%), Positives = 117/222 (52%), Gaps = 23/222 (10%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSL--LDQGSQAK 371
S+ N F+ ++ +QK + +G G++G VY+ G A+K + L D+G
Sbjct: 6 HHSSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGI--- 62
Query: 372 QSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI---FLELVTKGSLLNLYQRYHLRD 428
+ + +EI+LL H NIV E L + F+E K L + L+D
Sbjct: 63 -PSTAI-REISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDE--NKTGLQD 118
Query: 429 SQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL------N 482
SQ+ Y Q+L G+ + H ++HRD+K N+L++++G++KLADFGLA+A + +
Sbjct: 119 SQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH 178
Query: 483 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT 524
+V T ++ AP+V+ +K Y DIWS+GC EM+T
Sbjct: 179 EVV----TLWYRAPDVLMG-SKKYSTSVDIWSIGCIFAEMIT 215
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 5e-34
Identities = 55/219 (25%), Positives = 94/219 (42%), Gaps = 29/219 (13%)
Query: 334 GDLLGRGSFGSVYEGI--SDDGFFF--AVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
G +LG+G FGSV E +DG F AVK +L A I + +E A + F+H
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVK---MLKADIIASSDIEEFLREAACMKEFDH 84
Query: 390 ENIVQYYG--TDKD----ESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILL--- 440
++ + G + L + G L + Q L+
Sbjct: 85 PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHA-FLLASRIGENPFNLPLQTLVRFM 143
Query: 441 -----GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF--- 492
G++YL ++ +HRD+ N ++ + +V +ADFGL++ D +
Sbjct: 144 VDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPV 203
Query: 493 -WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY 529
W+A E + + Y + +D+W+ G T+ E++T Q PY
Sbjct: 204 KWLALESLADNL--YTVHSDVWAFGVTMWEIMTRGQTPY 240
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 8e-34
Identities = 56/214 (26%), Positives = 108/214 (50%), Gaps = 36/214 (16%)
Query: 336 LLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ------EIALLSRFE 388
+LGRG FG V+ + G +A K+++ K+ + + + E +L++
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLN--------KKRLKKRKGYQGAMVEKKILAKVH 243
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA----------YTRQI 438
IV + ++ L + + ++ G + RYH+ + YT QI
Sbjct: 244 SRFIVSLAYAFETKTDLCLVMTIMNGGDI-----RYHIYNVDEDNPGFQEPRAIFYTAQI 298
Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMA 495
+ GL++LH +++++RD+K N+L+D +G+V+++D GLA K K+ GT +MA
Sbjct: 299 VSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMA 357
Query: 496 PEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY 529
PE++ + Y D ++LG T+ EM+ ++ P+
Sbjct: 358 PELL--LGEEYDFSVDYFALGVTLYEMIAARGPF 389
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-33
Identities = 58/205 (28%), Positives = 99/205 (48%), Gaps = 21/205 (10%)
Query: 336 LLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ------EIALLSRFE 388
+LG+G FG V + G +A K++ K+ I + + E +L +
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLE--------KKRIKKRKGEAMALNEKQILEKVN 242
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSL---LNLYQRYHLRDSQVSAYTRQILLGLKYL 445
+V + + L + L L+ G L + + +++ Y +I GL+ L
Sbjct: 243 SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDL 302
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VKSCRGTAFWMAPEVINNKNK 504
H + +V+RD+K NIL+D +G ++++D GLA +K GT +MAPEV+ KN+
Sbjct: 303 HRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV--KNE 360
Query: 505 GYGLPADIWSLGCTVLEMLTSQIPY 529
Y D W+LGC + EM+ Q P+
Sbjct: 361 RYTFSPDWWALGCLLYEMIAGQSPF 385
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-33
Identities = 54/207 (26%), Positives = 95/207 (45%), Gaps = 22/207 (10%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
+G+G FG V G G AVK + + A+ E +++++ H N+V
Sbjct: 26 LQTIGKGEFGDVMLGDYR-GNKVAVK---CIKNDATAQA----FLAEASVMTQLRHSNLV 77
Query: 394 QYYGT-DKDESKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHDQD 449
Q G +++ LYI E + KGSL++ + R L + ++ + ++YL +
Sbjct: 78 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN 137
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNKNKGY 506
VHRD+ N+LV + K++DFGL K + W APE + K +
Sbjct: 138 FVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKK--F 191
Query: 507 GLPADIWSLGCTVLEMLTS-QIPYAPM 532
+D+WS G + E+ + ++PY +
Sbjct: 192 STKSDVWSFGILLWEIYSFGRVPYPRI 218
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-33
Identities = 65/271 (23%), Positives = 118/271 (43%), Gaps = 24/271 (8%)
Query: 271 DNEKEGEEADRAIVKEEEDDMVLSESCSFTTEHEDDSSSTTTEPMSNISPNGRFKRIITY 330
+ +E EE AI + D + + S ++ E M + + +
Sbjct: 91 ETPEEREEWTTAI-QTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNE 149
Query: 331 WQKGDLLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQ------EIAL 383
++ LLG+G+FG V G ++A+K + K+ I ++ E +
Sbjct: 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILK--------KEVIVAKDEVAHTLTENRV 201
Query: 384 LSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGL 442
L H + + + +L +E G L L + + + Y +I+ L
Sbjct: 202 LQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSAL 261
Query: 443 KYLH-DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEV 498
YLH +++VV+RD+K N+++D +G +K+ DFGL K + C GT ++APEV
Sbjct: 262 DYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC-GTPEYLAPEV 320
Query: 499 INNKNKGYGLPADIWSLGCTVLEMLTSQIPY 529
+ + YG D W LG + EM+ ++P+
Sbjct: 321 LE--DNDYGRAVDWWGLGVVMYEMMCGRLPF 349
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-33
Identities = 54/201 (26%), Positives = 99/201 (49%), Gaps = 10/201 (4%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
++K +G GS+G V++ + D G A+K+ + K L +EI +L + +H
Sbjct: 5 YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIK--KIAL-REIRMLKQLKH 61
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHD 447
N+V + + +L++ E ++L+ RY + + V + T Q L + + H
Sbjct: 62 PNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHK 120
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKL-NDVKSCRGTAFWM-APEVINNKNKG 505
+ +HRD+K NIL+ + +KL DFG A+ +D W +PE++ +
Sbjct: 121 HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQ- 179
Query: 506 YGLPADIWSLGCTVLEMLTSQ 526
YG P D+W++GC E+L+
Sbjct: 180 YGPPVDVWAIGCVFAELLSGV 200
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-33
Identities = 68/213 (31%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 325 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL-LDQGSQAKQSISQLEQEIA 382
+ ++ +G G++G+VY+ G F A+K V + G IS + +E+A
Sbjct: 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTV-REVA 63
Query: 383 LL---SRFEHENIVQ-----YYGTDKDESKLYIFLELVTK--GSLLNLYQRYHLRDSQVS 432
LL FEH N+V+ E K+ + E V + + L+ L +
Sbjct: 64 LLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIK 123
Query: 433 AYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF 492
RQ L GL +LH +VHRD+K NILV + G+VKLADFGLA+ +
Sbjct: 124 DLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTL 183
Query: 493 WM-APEVINNKNKGYGLPADIWSLGCTVLEMLT 524
W APEV+ Y P D+WS+GC EM
Sbjct: 184 WYRAPEVLLQST--YATPVDMWSVGCIFAEMFR 214
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 4e-33
Identities = 63/213 (29%), Positives = 108/213 (50%), Gaps = 24/213 (11%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL--LDQGSQAKQSISQLEQEIALLSRF 387
++K + +G G++G+V++ + + A+K V L D+G S L +EI LL
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGV----PSSAL-REICLLKEL 58
Query: 388 EHENIVQYYGTDKDESKLYI---FLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
+H+NIV+ + + KL + F + K + L V ++ Q+L GL +
Sbjct: 59 KHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGF 116
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL------NDVKSCRGTAFWMAPEV 498
H ++V+HRD+K N+L++ NG +KLA+FGLA+A + +V T ++ P+V
Sbjct: 117 CHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV----TLWYRPPDV 172
Query: 499 INNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP 531
+ K Y D+WS GC E+ + P P
Sbjct: 173 LFG-AKLYSTSIDMWSAGCIFAELANAGRPLFP 204
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 4e-33
Identities = 61/205 (29%), Positives = 108/205 (52%), Gaps = 23/205 (11%)
Query: 331 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSL--LDQGSQAKQSISQLEQEIALLSRFE 388
+ + +G G++G VY+ ++ G FA+K++ L D+G + + +EI++L +
Sbjct: 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGI----PSTTI-REISILKELK 58
Query: 389 HENIVQYYGTDKDESKLYI---FLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYL 445
H NIV+ Y + +L + L+ K L L ++ Q+L G+ Y
Sbjct: 59 HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYC 116
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL------NDVKSCRGTAFWMAPEVI 499
HD+ V+HRD+K N+L++ G +K+ADFGLA+A + +++ T ++ AP+V+
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV----TLWYRAPDVL 172
Query: 500 NNKNKGYGLPADIWSLGCTVLEMLT 524
+K Y DIWS+GC EM+
Sbjct: 173 MG-SKKYSTTIDIWSVGCIFAEMVN 196
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 6e-33
Identities = 60/291 (20%), Positives = 116/291 (39%), Gaps = 45/291 (15%)
Query: 279 ADRAIVKEEEDDMVLSESCSFTTEHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLG 338
+ A ++ + E + +++P +++ +I ++ L+G
Sbjct: 3 SHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIG 62
Query: 339 RGSFGSVYEGI-SDDGFFFAVKEVSL-LDQGSQAKQSISQLEQEIALLSRFEHENIVQYY 396
GS+G V E + A+K++ + K+ + +EIA+L+R H+++V+
Sbjct: 63 TGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRIL----REIAILNRLNHDHVVKVL 118
Query: 397 GTDKDES-----KLYIFLELVTKGSLLN--LYQRYHLRDSQVSAYTRQILLGLKYLHDQD 449
+ +LY+ LE+ S +L + + +L+G+KY+H
Sbjct: 119 DIVIPKDVEKFDELYVVLEIA--DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG 176
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWM--------------- 494
++HRD+K AN LV+ + SVK+ DFGLA+ + + +
Sbjct: 177 ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNL 236
Query: 495 --------------APEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP 531
APE+I + Y D+WS+GC E+L
Sbjct: 237 KRQLTGHVVTRWYRAPELILL-QENYTEAIDVWSIGCIFAELLNMIKENVA 286
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 8e-33
Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 22/205 (10%)
Query: 336 LLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQ------EIALLSRFE 388
LLG+G+FG V G ++A+K + K+ I ++ E +L
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILR--------KEVIIAKDEVAHTVTESRVLQNTR 63
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHD 447
H + + +L +E G L L + + + Y +I+ L+YLH
Sbjct: 64 HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEVINNKNK 504
+DVV+RDIK N+++D +G +K+ DFGL K + C GT ++APEV+ ++
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVL--EDN 180
Query: 505 GYGLPADIWSLGCTVLEMLTSQIPY 529
YG D W LG + EM+ ++P+
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPF 205
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-32
Identities = 58/214 (27%), Positives = 98/214 (45%), Gaps = 20/214 (9%)
Query: 334 GDLLGRGSFGSVYEGI--SDDGFFF--AVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
+++GRG FG VY G +DG AVK L++ + + +SQ E ++ F H
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVK---SLNRITDIGE-VSQFLTEGIIMKDFSH 85
Query: 390 ENIVQYYGT-DKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLH 446
N++ G + E + L + G L N + ++ + + Q+ G+KYL
Sbjct: 86 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA 145
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF------WMAPEVIN 500
+ VHRD+ N ++D +VK+ADFGLA+ + S WMA E +
Sbjct: 146 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 205
Query: 501 NKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPME 533
+ + +D+WS G + E++T PY +
Sbjct: 206 TQK--FTTKSDVWSFGVLLWELMTRGAPPYPDVN 237
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-32
Identities = 58/218 (26%), Positives = 96/218 (44%), Gaps = 28/218 (12%)
Query: 334 GDLLGRGSFGSVYEGI--SDDGFFF--AVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
G +LG G FGSV EG +DG AVK + + +++ I + E A + F H
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVK---TMKLDNSSQREIEEFLSEAACMKDFSH 95
Query: 390 ENIVQYYG--TDKD---ESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYT--------R 436
N+++ G + K + L + G L Y Y ++
Sbjct: 96 PNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHT-YLLYSRLETGPKHIPLQTLLKFMV 154
Query: 437 QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---- 492
I LG++YL +++ +HRD+ N ++ + +V +ADFGL+K D A
Sbjct: 155 DIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 214
Query: 493 WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY 529
W+A E + + Y +D+W+ G T+ E+ T PY
Sbjct: 215 WIAIESLAD-RV-YTSKSDVWAFGVTMWEIATRGMTPY 250
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-32
Identities = 54/219 (24%), Positives = 94/219 (42%), Gaps = 26/219 (11%)
Query: 332 QKGDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
++G+G FG VY G + + A+K +S Q + +E L+
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLS----RITEMQQVEAFLREGLLMRGL 79
Query: 388 EHENIVQYYGT-DKDESKLYIFLELVTKGSLLN--LYQRYHLRDSQVSAYTRQILLGLKY 444
H N++ G E ++ L + G LL + + + ++ Q+ G++Y
Sbjct: 80 NHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEY 139
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND---VKSCRGTAF---WMAPEV 498
L +Q VHRD+ N ++D + +VK+ADFGLA+ + V+ R W A E
Sbjct: 140 LAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALES 199
Query: 499 INNKNKGYGL---PADIWSLGCTVLEMLT-SQIPYAPME 533
+ +D+WS G + E+LT PY ++
Sbjct: 200 LQ-----TYRFTTKSDVWSFGVLLWELLTRGAPPYRHID 233
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 2e-32
Identities = 68/213 (31%), Positives = 107/213 (50%), Gaps = 23/213 (10%)
Query: 325 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSI-SQLEQEIA 382
K ++K D LG G F +VY+ + A+K++ L S+AK I +EI
Sbjct: 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKI-KLGHRSEAKDGINRTALREIK 64
Query: 383 LLSRFEHENIVQYYGTDKDESKLYI---FLELVTKGSLLNLYQRYHLRDSQVSAYTRQIL 439
LL H NI+ +S + + F+E + + + L S + AY L
Sbjct: 65 LLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKD--NSLVLTPSHIKAYMLMTL 122
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA--------TKLNDVKSCRGTA 491
GL+YLH ++HRD+K N+L+D NG +KLADFGLAK+ T + V T
Sbjct: 123 QGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYT--HQVV----TR 176
Query: 492 FWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT 524
++ APE++ + YG+ D+W++GC + E+L
Sbjct: 177 WYRAPELLFGA-RMYGVGVDMWAVGCILAELLL 208
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 54/212 (25%), Positives = 103/212 (48%), Gaps = 25/212 (11%)
Query: 336 LLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQ--------LEQEIALLSR 386
++GRGS+ V + +A+K V K+ ++ E+ +
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKVVK--------KELVNDDEDIDWVQTEKHV-FEQA 66
Query: 387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYL 445
H +V + + ES+L+ +E V G L+ + ++ L + Y+ +I L L YL
Sbjct: 67 SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYL 126
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEVINNK 502
H++ +++RD+K N+L+D+ G +KL D+G+ K + C GT ++APE++ +
Sbjct: 127 HERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-GTPNYIAPEIL--R 183
Query: 503 NKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC 534
+ YG D W+LG + EM+ + P+ +
Sbjct: 184 GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGS 215
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 52/243 (21%), Positives = 105/243 (43%), Gaps = 28/243 (11%)
Query: 298 SFTTEHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFF 356
H + T P S I +++ LG G++G VY+ I
Sbjct: 3 HHHHHHMGTLEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETV 62
Query: 357 AVKEVSL--LDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTK 414
A+K + L ++G + + +E++LL +H NI++ +L++ E
Sbjct: 63 AIKRIRLEHEEEGV----PGTAI-REVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN 117
Query: 415 --GSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-----GS 467
++ + + + ++ Q++ G+ + H + +HRD+K N+L+ +
Sbjct: 118 DLKKYMD--KNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPV 175
Query: 468 VKLADFGLAKATKL------NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLE 521
+K+ DFGLA+A + +++ T ++ PE++ ++ Y DIWS+ C E
Sbjct: 176 LKIGDFGLARAFGIPIRQFTHEII----TLWYRPPEILLG-SRHYSTSVDIWSIACIWAE 230
Query: 522 MLT 524
ML
Sbjct: 231 MLM 233
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-32
Identities = 55/211 (26%), Positives = 94/211 (44%), Gaps = 30/211 (14%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLE--QEIALLSRFEHEN 391
+G+G FG V G G AVK + K + E +++++ H N
Sbjct: 198 LQTIGKGEFGDVMLGDYR-GNKVAVKCI---------KNDATAQAFLAEASVMTQLRHSN 247
Query: 392 IVQYYG--TDKDESKLYIFLELVTKGSLLNLY----QRYHLRDSQVSAYTRQILLGLKYL 445
+VQ G +++ LYI E + KGSL++ Y R L + ++ + ++YL
Sbjct: 248 LVQLLGVIV-EEKGGLYIVTEYMAKGSLVD-YLRSRGRSVLGGDCLLKFSLDVCEAMEYL 305
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF---WMAPEVINNK 502
+ VHRD+ N+LV + K++DFGL K + W APE + K
Sbjct: 306 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREK 361
Query: 503 NKGYGLPADIWSLGCTVLEMLTS-QIPYAPM 532
+ +D+WS G + E+ + ++PY +
Sbjct: 362 K--FSTKSDVWSFGILLWEIYSFGRVPYPRI 390
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-32
Identities = 63/214 (29%), Positives = 99/214 (46%), Gaps = 20/214 (9%)
Query: 325 KRIITYWQKGDLLGRGSFGSVYEGIS--DDGFFFAVKEVSL--LDQG--SQAKQSISQLE 378
R ++ +G G++G V++ + G F A+K V + ++G + ++ L
Sbjct: 7 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLR 66
Query: 379 QEIALLSRFEHENIVQ-----YYGTDKDESKLYIFLELVTK--GSLLNLYQRYHLRDSQV 431
L FEH N+V+ E+KL + E V + + L+ + +
Sbjct: 67 H----LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETI 122
Query: 432 SAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA 491
Q+L GL +LH VVHRD+K NILV ++G +KLADFGLA+ +
Sbjct: 123 KDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVT 182
Query: 492 FWM-APEVINNKNKGYGLPADIWSLGCTVLEMLT 524
W APEV+ + Y P D+WS+GC EM
Sbjct: 183 LWYRAPEVLLQSS--YATPVDLWSVGCIFAEMFR 214
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-32
Identities = 70/265 (26%), Positives = 115/265 (43%), Gaps = 56/265 (21%)
Query: 307 SSSTTTEPMSNISPNGRFKRIITYWQ---------KGDLLGRGSFGSVYEGISDDGFFFA 357
++++ + +S+ + L+G G FG VY+G+ DG A
Sbjct: 8 ATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVA 67
Query: 358 VKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYG--TDKDESKL-YIFLELVTK 414
+K S Q I + E EI LS H ++V G +++E L Y + +
Sbjct: 68 LK---RRTPESS--QGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIY---KYMEN 119
Query: 415 GSLLNLYQRYHLRDSQVSAY-----TR-QILL----GLKYLHDQDVVHRDIKCANILVDA 464
G+L + HL S + R +I + GL YLH + ++HRD+K NIL+D
Sbjct: 120 GNL-----KRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDE 174
Query: 465 NGSVKLADFGLAKATKLND-------VKSCRGTAFWMAPE-VINNK--NKGYGLPADIWS 514
N K+ DFG++K D VK GT ++ PE I + K +D++S
Sbjct: 175 NFVPKITDFGISKKGTELDQTHLSTVVK---GTLGYIDPEYFIKGRLTEK-----SDVYS 226
Query: 515 LGCTVLEMLTSQ---IPYAPMECVS 536
G + E+L ++ + P E V+
Sbjct: 227 FGVVLFEVLCARSAIVQSLPREMVN 251
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 4e-32
Identities = 63/214 (29%), Positives = 94/214 (43%), Gaps = 35/214 (16%)
Query: 334 GDLLGRGSFGSVYEGISDD---GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
L+GRG G VYE +D A+K L+ L + +R + E
Sbjct: 39 RRLVGRGGMGDVYEA--EDTVRERIVALK---LMS---------ETLSSDPVFRTRMQRE 84
Query: 391 ----------NIVQYYGTDKDESKLYIFLELVTKGSLLN--LYQRYHLRDSQVSAYTRQI 438
++V + + + +LY+ + L+ G L L ++ L + A RQI
Sbjct: 85 ARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLI-NGVDLAAMLRRQGPLAPPRAVAIVRQI 143
Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA---TKLNDVKSCRGTAFWMA 495
L H HRD+K NILV A+ L DFG+A A KL + + GT ++MA
Sbjct: 144 GSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMA 203
Query: 496 PEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY 529
PE + + Y ADI++L C + E LT PY
Sbjct: 204 PERFSESHATY--RADIYALTCVLYECLTGSPPY 235
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 5e-32
Identities = 82/386 (21%), Positives = 144/386 (37%), Gaps = 44/386 (11%)
Query: 167 TQVAELSCRASGAGNNDALAVMETTELPPSGLAESSACCVSSNYVKGIKGVRPPLLKPPP 226
+ A+ G +D ++ P S + + SS + + R L +
Sbjct: 178 VRDAKNLVPMDPNGLSDPYVKLKLIPDPKSESKQKTKTIKSSLNPEWNETFRFQLKESDK 237
Query: 227 GMRQPVIDNACSTWDILR--DFAPKDGITPSSVMNDRALSSSSDDEDNEKE----GEEAD 280
R V WD+ DF S + E E +
Sbjct: 238 DRRLSV---EIWDWDLTSRNDFMGSLSFGISELQKAGVDGWFKLLSQEEGEYFNVPVPPE 294
Query: 281 RAIVKEEEDDMVLSESCSFTTEHEDDSSSTTTEPMSNISPNGRFK----RIITYWQKGDL 336
+ EE T+ ++ ++ T N R K + +
Sbjct: 295 GSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLM------V 348
Query: 337 LGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQ--------LEQEIALLSRF 387
LG+GSFG V +AVK + K + Q +E+ + L
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILK--------KDVVIQDDDVECTMVEKRV-LALPG 399
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSL-LNLYQRYHLRDSQVSAYTRQILLGLKYLH 446
+ + Q + + +LY +E V G L ++ Q ++ Y +I +GL +L
Sbjct: 400 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ 459
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEVINNKN 503
+ +++RD+K N+++D+ G +K+ADFG+ K + V + C GT ++APE+I
Sbjct: 460 SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC-GTPDYIAPEIIA--Y 516
Query: 504 KGYGLPADIWSLGCTVLEMLTSQIPY 529
+ YG D W+ G + EML Q P+
Sbjct: 517 QPYGKSVDWWAFGVLLYEMLAGQAPF 542
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 6e-32
Identities = 62/231 (26%), Positives = 106/231 (45%), Gaps = 28/231 (12%)
Query: 315 MSNISPNGRFK--RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAK 371
M+ + ++ ++K +G+G+FG V++ G A+K+V + K
Sbjct: 1 MAKQYDSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLM----ENEK 56
Query: 372 QSI-SQLEQEIALLSRFEHENIVQ--------YYGTDKDESKLYI---FLELVTKGSLLN 419
+ +EI +L +HEN+V ++ + +Y+ F E G L N
Sbjct: 57 EGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN 116
Query: 420 LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT 479
S++ + +L GL Y+H ++HRD+K AN+L+ +G +KLADFGLA+A
Sbjct: 117 --VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 174
Query: 480 KLNDVKSCRG------TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT 524
L T ++ PE++ + YG P D+W GC + EM T
Sbjct: 175 SLAKNSQPNRYTNRVVTLWYRPPELLLG-ERDYGPPIDLWGAGCIMAEMWT 224
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 7e-32
Identities = 65/208 (31%), Positives = 115/208 (55%), Gaps = 24/208 (11%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL-LDQGSQAKQSISQLEQEIALLSRFE 388
+++ + LG G++ +VY+G++ G + A+KEV L ++G+ + + +EI+L+ +
Sbjct: 7 FKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGT----PSTAI-REISLMKELK 61
Query: 389 HENIVQYYGTDKDESKLYI---FLELVTKG---SLLNLYQRYHLRDSQVSAYTRQILLGL 442
HENIV+ Y E+KL + F++ K S L + V + Q+L GL
Sbjct: 62 HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGL 121
Query: 443 KYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL------NDVKSCRGTAFWMAP 496
+ H+ ++HRD+K N+L++ G +KL DFGLA+A + ++V T ++ AP
Sbjct: 122 AFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV----TLWYRAP 177
Query: 497 EVINNKNKGYGLPADIWSLGCTVLEMLT 524
+V+ ++ Y DIWS GC + EM+T
Sbjct: 178 DVLMG-SRTYSTSIDIWSCGCILAEMIT 204
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 8e-32
Identities = 63/205 (30%), Positives = 103/205 (50%), Gaps = 23/205 (11%)
Query: 331 WQKGDLLGRGSFGSVYEGISDD-GFFFAVKEVSL-LDQGSQAKQSISQLEQEIALLSRFE 388
+ K D LG G++ +VY+G S A+KE+ L ++G+ + + +E++LL +
Sbjct: 4 YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGA----PCTAI-REVSLLKDLK 58
Query: 389 HENIVQYYGTDKDESKLYI---FLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYL 445
H NIV + E L + +L+ K L + + V + Q+L GL Y
Sbjct: 59 HANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDD--CGNIINMHNVKLFLFQLLRGLAYC 116
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL------NDVKSCRGTAFWMAPEVI 499
H Q V+HRD+K N+L++ G +KLADFGLA+A + N+V T ++ P+++
Sbjct: 117 HRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV----TLWYRPPDIL 172
Query: 500 NNKNKGYGLPADIWSLGCTVLEMLT 524
Y D+W +GC EM T
Sbjct: 173 LGS-TDYSTQIDMWGVGCIFYEMAT 196
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 8e-32
Identities = 45/199 (22%), Positives = 72/199 (36%), Gaps = 44/199 (22%)
Query: 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF- 387
Y +LG G G V + + FA+K + + +E+ L R
Sbjct: 19 YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ----------DCPKARREVELHWRAS 68
Query: 388 EHENIVQYYG----TDKDESKLYIFLELVTKGSLLN-LYQRYHLRDS--QVSAYTRQILL 440
+ +IV+ L I +E + G L + + R + + S + I
Sbjct: 69 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 128
Query: 441 GLKYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPE 497
++YLH ++ HRD+K N+L N +KL DFG A E
Sbjct: 129 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF-------------------AKE 169
Query: 498 VINNKNKGYGLPADIWSLG 516
+ Y D+WSLG
Sbjct: 170 TT---GEKYDKSCDMWSLG 185
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 9e-32
Identities = 57/217 (26%), Positives = 96/217 (44%), Gaps = 26/217 (11%)
Query: 334 GDLLGRGSFGSVYEGI--SDDGFFF--AVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
+++GRG FG VY G +DG AVK L++ + + +SQ E ++ F H
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVK---SLNRITDIGE-VSQFLTEGIIMKDFSH 149
Query: 390 ENIVQYYGT-DKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLH 446
N++ G + E + L + G L N + ++ + + Q+ G+K+L
Sbjct: 150 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA 209
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF------WMAPEVIN 500
+ VHRD+ N ++D +VK+ADFGLA+ + S WMA E +
Sbjct: 210 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 269
Query: 501 NKNKGYGL---PADIWSLGCTVLEMLT-SQIPYAPME 533
+D+WS G + E++T PY +
Sbjct: 270 -----TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN 301
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 9e-32
Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 25/207 (12%)
Query: 336 LLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQ--------LEQEIALLSR 386
+LG+GSFG V + G +AVK + K I Q E+ I L
Sbjct: 30 VLGKGSFGKVMLARVKETGDLYAVKVLK--------KDVILQDDDVECTMTEKRI-LSLA 80
Query: 387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYL 445
H + Q + + +L+ +E V G L+ + + +++ Y +I+ L +L
Sbjct: 81 RNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFL 140
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEVINNK 502
HD+ +++RD+K N+L+D G KLADFG+ K N V + C GT ++APE++ +
Sbjct: 141 HDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFC-GTPDYIAPEIL--Q 197
Query: 503 NKGYGLPADIWSLGCTVLEMLTSQIPY 529
YG D W++G + EML P+
Sbjct: 198 EMLYGPAVDWWAMGVLLYEMLCGHAPF 224
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 53/212 (25%), Positives = 103/212 (48%), Gaps = 25/212 (11%)
Query: 336 LLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQ--------LEQEIALLSR 386
++GRGS+ V + +A++ V K+ ++ E+ +
Sbjct: 59 VIGRGSYAKVLLVRLKKTDRIYAMRVVK--------KELVNDDEDIDWVQTEKHV-FEQA 109
Query: 387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYL 445
H +V + + ES+L+ +E V G L+ + ++ L + Y+ +I L L YL
Sbjct: 110 SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYL 169
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEVINNK 502
H++ +++RD+K N+L+D+ G +KL D+G+ K + C GT ++APE++ +
Sbjct: 170 HERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-GTPNYIAPEIL--R 226
Query: 503 NKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC 534
+ YG D W+LG + EM+ + P+ +
Sbjct: 227 GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGS 258
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-31
Identities = 67/224 (29%), Positives = 111/224 (49%), Gaps = 22/224 (9%)
Query: 314 PMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDD---GFFFAVKEVSLLDQGSQA 370
M N R+ +I+ D LG G +VY D A+K ++ +
Sbjct: 3 HMIGKIINERY-KIV------DKLGGGGMSTVYLAE--DTILNIKVAIK--AIFIPPREK 51
Query: 371 KQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLN--LYQRYHLRD 428
++++ + E+E+ S+ H+NIV D+++ Y+ +E + +G L+ + L
Sbjct: 52 EETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYI-EGPTLSEYIESHGPLSV 110
Query: 429 SQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA---TKLNDVK 485
+T QIL G+K+ HD +VHRDIK NIL+D+N ++K+ DFG+AKA T L
Sbjct: 111 DTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTN 170
Query: 486 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY 529
GT + +PE K + DI+S+G + EML + P+
Sbjct: 171 HVLGTVQYFSPEQA--KGEATDECTDIYSIGIVLYEMLVGEPPF 212
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 63/213 (29%), Positives = 101/213 (47%), Gaps = 37/213 (17%)
Query: 336 LLGRGSFGSVY--EGISDDGFFFAVKEVSLLDQGSQAKQSISQ--------LEQEIALLS 385
++G+GSFG V + F+AVK + K++I + E+ + LL
Sbjct: 45 VIGKGSFGKVLLARHK-AEEVFYAVKVLQ--------KKAILKKKEEKHIMSERNV-LLK 94
Query: 386 RFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA------YTRQIL 439
+H +V + + + KLY L+ + G L YHL+ + Y +I
Sbjct: 95 NVKHPFLVGLHFSFQTADKLYFVLDYINGGELF-----YHLQRERCFLEPRARFYAAEIA 149
Query: 440 LGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAP 496
L YLH ++V+RD+K NIL+D+ G + L DFGL K ++ + C GT ++AP
Sbjct: 150 SALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFC-GTPEYLAP 208
Query: 497 EVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY 529
EV++ + Y D W LG + EML P+
Sbjct: 209 EVLH--KQPYDRTVDWWCLGAVLYEMLYGLPPF 239
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 63/207 (30%), Positives = 106/207 (51%), Gaps = 25/207 (12%)
Query: 336 LLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQ--------LEQEIALLSR 386
+LG+GSFG V+ FFA+K + K + +E+ + L
Sbjct: 24 MLGKGSFGKVFLAEFKKTNQFFAIKALK--------KDVVLMDDDVECTMVEKRV-LSLA 74
Query: 387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYL 445
+EH + + T + + L+ +E + G L+ + + S+ + Y +I+LGL++L
Sbjct: 75 WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFL 134
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEVINNK 502
H + +V+RD+K NIL+D +G +K+ADFG+ K L D K+ C GT ++APE++
Sbjct: 135 HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEIL--L 191
Query: 503 NKGYGLPADIWSLGCTVLEMLTSQIPY 529
+ Y D WS G + EML Q P+
Sbjct: 192 GQKYNHSVDWWSFGVLLYEMLIGQSPF 218
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 58/209 (27%), Positives = 90/209 (43%), Gaps = 30/209 (14%)
Query: 337 LGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLE------QEIALLSRFEHE 390
+ GS+G+V G+ +G A+K V + +S +EI LL+ F H
Sbjct: 30 ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 391 NIVQYYGTDKDESK-----LYIFLELVTKGSLLNLYQ-----RYHLRDSQVSAYTRQILL 440
NI+ + LY+ EL+ +L Q R + + + ILL
Sbjct: 90 NILGLRDIFVHFEEPAMHKLYLVTELMRT----DLAQVIHDQRIVISPQHIQYFMYHILL 145
Query: 441 GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMA 495
GL LH+ VVHRD+ NIL+ N + + DF LA+ + V ++ A
Sbjct: 146 GLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYV----THRWYRA 201
Query: 496 PEVINNKNKGYGLPADIWSLGCTVLEMLT 524
PE++ KG+ D+WS GC + EM
Sbjct: 202 PELVMQ-FKGFTKLVDMWSAGCVMAEMFN 229
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 7e-31
Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 24/208 (11%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
LG G++G V G A+K++ D+ A +++ +EI +L F+HENI+
Sbjct: 19 LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL----REIKILKHFKHENIITI 74
Query: 396 YGTDKDESK-----LYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
+ + +S +YI EL+ L + L D + + Q L +K LH +V
Sbjct: 75 FNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNV 133
Query: 451 VHRDIKCANILVDANGSVKLADFGLA--KATKLNDVKSCRGTAFWM----------APEV 498
+HRD+K +N+L+++N +K+ DFGLA D G M APEV
Sbjct: 134 IHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEV 193
Query: 499 INNKNKGYGLPADIWSLGCTVLEMLTSQ 526
+ + Y D+WS GC + E+ +
Sbjct: 194 MLT-SAKYSRAMDVWSCGCILAELFLRR 220
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 9e-31
Identities = 67/215 (31%), Positives = 115/215 (53%), Gaps = 35/215 (16%)
Query: 329 TYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRF 387
G+ +G G FG VY+G ++ AVK+++ ++D + ++ Q +QEI ++++
Sbjct: 31 PISVGGNKMGEGGFGVVYKGYVNNTTV-AVKKLAAMVDITT--EELKQQFDQEIKVMAKC 87
Query: 388 EHENIVQYYG--TDKDESKL-YIFLELVTKGSLLNLYQRYHLRDSQVSA----YTR-QIL 439
+HEN+V+ G +D D+ L Y + GSLL+ L + + R +I
Sbjct: 88 QHENLVELLGFSSDGDDLCLVY---VYMPNGSLLD-----RLSCLDGTPPLSWHMRCKIA 139
Query: 440 L----GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK--SCR--GTA 491
G+ +LH+ +HRDIK ANIL+D + K++DFGLA+A++ + R GT
Sbjct: 140 QGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTT 199
Query: 492 FWMAPEVINNK--NKGYGLPADIWSLGCTVLEMLT 524
+MAPE + + K +DI+S G +LE++T
Sbjct: 200 AYMAPEALRGEITPK-----SDIYSFGVVLLEIIT 229
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 9e-31
Identities = 65/226 (28%), Positives = 97/226 (42%), Gaps = 39/226 (17%)
Query: 337 LGRGSFGSVYEGI------SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
LG G+FG V+ + D AVK +L D A++ ++E LL+ +HE
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVK--ALKDPTLAARK---DFQREAELLTNLQHE 77
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYT--------------- 435
+IV++YG D L + E + G L + R H D+ +
Sbjct: 78 HIVKFYGVCGDGDPLIMVFEYMKHGDLNK-FLRAHGPDAMILVDGQPRQAKGELGLSQML 136
Query: 436 ---RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF 492
QI G+ YL Q VHRD+ N LV AN VK+ DFG+++ D G
Sbjct: 137 HIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 196
Query: 493 ----WMAPEVIN-NKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPM 532
WM PE I K + +D+WS G + E+ T + P+ +
Sbjct: 197 LPIRWMPPESIMYRK---FTTESDVWSFGVILWEIFTYGKQPWFQL 239
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 54/222 (24%), Positives = 97/222 (43%), Gaps = 36/222 (16%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFF------AVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
LG+GSFG VYEG++ A+K +++ + ++ + E +++ F
Sbjct: 30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIK---TVNEAASMRE-RIEFLNEASVMKEF 85
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH------------LRDSQVSAYT 435
++V+ G + +EL+T+G L + Y R S++
Sbjct: 86 NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKS-YLRSLRPAMANNPVLAPPSLSKMIQMA 144
Query: 436 RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF--- 492
+I G+ YL+ VHRD+ N +V + +VK+ DFG+ + D G
Sbjct: 145 GEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 204
Query: 493 -WMAPEVINNKNKGYGL---PADIWSLGCTVLEMLT-SQIPY 529
WM+PE + G+ +D+WS G + E+ T ++ PY
Sbjct: 205 RWMSPESLK-----DGVFTTYSDVWSFGVVLWEIATLAEQPY 241
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 60/225 (26%), Positives = 88/225 (39%), Gaps = 36/225 (16%)
Query: 334 GDLLGRGSFGSVYEG----ISDDGFFF--AVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
LG G+FG VYEG + +D AVK L + + E ++S+F
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVK---TLPEVCSEQD-ELDFLMEALIISKF 90
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH---------LRDSQVSAYTRQI 438
H+NIV+ G +I +EL+ G L + + R L + R I
Sbjct: 91 NHQNIVRCIGVSLQSLPRFILMELMAGGDLKS-FLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGS---VKLADFGLAKATKLNDVKSCRGTAF--- 492
G +YL + +HRDI N L+ G K+ DFG+A+ G A
Sbjct: 150 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 209
Query: 493 -WMAPEVINNKNKGYGL---PADIWSLGCTVLEMLT-SQIPYAPM 532
WM PE G+ D WS G + E+ + +PY
Sbjct: 210 KWMPPEAFM-----EGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 249
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 57/207 (27%), Positives = 99/207 (47%), Gaps = 25/207 (12%)
Query: 336 LLGRGSFGSVYEG-ISDDGFFFAVKEVSLLDQGSQAKQSISQ--------LEQEIALLSR 386
+LG+GSFG V +AVK + K + Q +E+ + L
Sbjct: 27 VLGKGSFGKVMLSERKGTDELYAVKILK--------KDVVIQDDDVECTMVEKRV-LALP 77
Query: 387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYL 445
+ + Q + + +LY +E V G L+ + Q ++ Y +I +GL +L
Sbjct: 78 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFL 137
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEVINNK 502
+ +++RD+K N+++D+ G +K+ADFG+ K + V + C GT ++APE+I
Sbjct: 138 QSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC-GTPDYIAPEIIA-- 194
Query: 503 NKGYGLPADIWSLGCTVLEMLTSQIPY 529
+ YG D W+ G + EML Q P+
Sbjct: 195 YQPYGKSVDWWAFGVLLYEMLAGQAPF 221
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 7e-30
Identities = 61/220 (27%), Positives = 96/220 (43%), Gaps = 31/220 (14%)
Query: 330 YWQKGDLLGRGSFGSVYEGISDD---GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR 386
+ +G +GRG++G VY+ D +A+K++ A + EIALL
Sbjct: 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR-------EIALLRE 74
Query: 387 FEHENIVQYYG--TDKDESKLYI---FLE------LVTKGSLLNLYQRYHLRDSQVSAYT 435
+H N++ + K+++ + E + + + L V +
Sbjct: 75 LKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLL 134
Query: 436 RQILLGLKYLHDQDVVHRDIKCANILVDA----NGSVKLADFGLAKATKLNDVKSCRGTA 491
QIL G+ YLH V+HRD+K ANILV G VK+AD G A+
Sbjct: 135 YQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 194
Query: 492 ----FWM-APEVINNKNKGYGLPADIWSLGCTVLEMLTSQ 526
FW APE++ + Y DIW++GC E+LTS+
Sbjct: 195 VVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSE 233
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 9e-30
Identities = 62/201 (30%), Positives = 110/201 (54%), Gaps = 17/201 (8%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
+G G++G V + + A+K++S + + ++++ +EI +L RF HENI+
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL----REIKILLRFRHENIIGI 90
Query: 396 YGTDKDESK-----LYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
+ + +YI +L+ L L + HL + + + QIL GLKY+H +V
Sbjct: 91 NDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 149
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF----WM-APEVINNKNKG 505
+HRD+K +N+L++ +K+ DFGLA+ + + T + W APE++ N +KG
Sbjct: 150 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN-SKG 208
Query: 506 YGLPADIWSLGCTVLEMLTSQ 526
Y DIWS+GC + EML+++
Sbjct: 209 YTKSIDIWSVGCILAEMLSNR 229
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 57/225 (25%), Positives = 94/225 (41%), Gaps = 38/225 (16%)
Query: 337 LGRGSFGSVYEGISDDGFFF------AVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
LG G+FG V+ + AVK L + S + + ++E LL+ +H+
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVK---ALKEAS--ESARQDFQREAELLTMLQHQ 103
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYT--------------- 435
+IV+++G + L + E + G L + R H D+++ A
Sbjct: 104 HIVRFFGVCTEGRPLLMVFEYMRHGDLNR-FLRSHGPDAKLLAGGEDVAPGPLGLGQLLA 162
Query: 436 --RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF- 492
Q+ G+ YL VHRD+ N LV VK+ DFG+++ D G
Sbjct: 163 VASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 222
Query: 493 ---WMAPEVIN-NKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPM 532
WM PE I K + +D+WS G + E+ T + P+ +
Sbjct: 223 PIRWMPPESILYRK---FTTESDVWSFGVVLWEIFTYGKQPWYQL 264
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-29
Identities = 66/259 (25%), Positives = 119/259 (45%), Gaps = 26/259 (10%)
Query: 287 EEDDMVLSESCSFTTEHEDDSSSTTTEPMSNISPNGRFKR---------IITYWQKGDLL 337
E V C + D S MS + +F ++ +Q +
Sbjct: 11 EPTLDVKIAFCQGFDKQVDVSYIAKHYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPI 70
Query: 338 GRGSFGSVYEGI-SDDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
G G+ G V + A+K++S + AK++ +E+ L+ H+NI+
Sbjct: 71 GSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY----RELVLMKCVNHKNIISL 126
Query: 396 Y------GTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQD 449
T ++ +Y+ +EL+ + L + L ++S Q+L G+K+LH
Sbjct: 127 LNVFTPQKTLEEFQDVYLVMELM--DANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG 184
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSC-RGTAFWMAPEVINNKNKGYGL 508
++HRD+K +NI+V ++ ++K+ DFGLA+ + + + T ++ APEVI GY
Sbjct: 185 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI--LGMGYKE 242
Query: 509 PADIWSLGCTVLEMLTSQI 527
DIWS+GC + EM+ +I
Sbjct: 243 NVDIWSVGCIMGEMVRHKI 261
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 60/222 (27%), Positives = 85/222 (38%), Gaps = 36/222 (16%)
Query: 337 LGRGSFGSVYEGI------SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
LG G+FG VYEG AVK L + + E ++S+F H+
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVK---TLPEVCSEQD-ELDFLMEALIISKFNHQ 134
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH---------LRDSQVSAYTRQILLG 441
NIV+ G +I LEL+ G L + + R L + R I G
Sbjct: 135 NIVRCIGVSLQSLPRFILLELMAGGDLKS-FLRETRPRPSQPSSLAMLDLLHVARDIACG 193
Query: 442 LKYLHDQDVVHRDIKCANILVDANGS---VKLADFGLAKATKLNDVKSCRGTAF----WM 494
+YL + +HRDI N L+ G K+ DFG+A+ G A WM
Sbjct: 194 CQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWM 253
Query: 495 APEVINNKNKGYGL---PADIWSLGCTVLEMLT-SQIPYAPM 532
PE G+ D WS G + E+ + +PY
Sbjct: 254 PPEAFM-----EGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 290
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 53/198 (26%), Positives = 88/198 (44%), Gaps = 17/198 (8%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQ 394
LGRG + V+E I + VK + + K+ +EI +L NI+
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPVK----KKKIK----REIKILENLRGGPNIIT 95
Query: 395 YYGTDKDES--KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVH 452
KD + E V LYQ L D + Y +IL L Y H ++H
Sbjct: 96 LADIVKDPVSRTPALVFEHVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCHSMGIMH 153
Query: 453 RDIKCANILVD-ANGSVKLADFGLAKATKLNDVKSCR-GTAFWMAPEVINNKNKGYGLPA 510
RD+K N+++D + ++L D+GLA+ + R + ++ PE++ + + Y
Sbjct: 154 RDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD-YQMYDYSL 212
Query: 511 DIWSLGCTVLEMLTSQIP 528
D+WSLGC + M+ + P
Sbjct: 213 DMWSLGCMLASMIFRKEP 230
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-29
Identities = 56/229 (24%), Positives = 86/229 (37%), Gaps = 38/229 (16%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFF------AVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
+ LG FG VY+G A+K L ++ + E L +R
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIK---TLKDKAEGPL-REEFRHEAMLRARL 69
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYT------------ 435
+H N+V G + L + + G L + S V +
Sbjct: 70 QHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHE-FLVMRSPHSDVGSTDDDRTVKSALEPP 128
Query: 436 ------RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRG 489
QI G++YL VVH+D+ N+LV +VK++D GL + D G
Sbjct: 129 DFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLG 188
Query: 490 TAF----WMAPEVIN-NKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPM 532
+ WMAPE I K + + +DIWS G + E+ + PY
Sbjct: 189 NSLLPIRWMAPEAIMYGK---FSIDSDIWSYGVVLWEVFSYGLQPYCGY 234
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 4e-29
Identities = 61/262 (23%), Positives = 103/262 (39%), Gaps = 42/262 (16%)
Query: 303 HEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEV 361
H S+ E + + + L+GRGS+G VY + A+K+V
Sbjct: 2 HHHHHHSSGRENLYFQGIK-NVH-VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKV 59
Query: 362 S-LLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK-----LYIFLELVTKG 415
+ + + K+ + +EI +L+R + + I++ Y + LYI LE+
Sbjct: 60 NRMFEDLIDCKRIL----REITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA--D 113
Query: 416 SLLN--LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADF 473
S L L + + +LLG ++H+ ++HRD+K AN L++ + SVK+ DF
Sbjct: 114 SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDF 173
Query: 474 GLA--------------KATKLNDVKSCRGTAFWM----------APEVINNKNKGYGLP 509
GLA + + APE+I + Y
Sbjct: 174 GLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILL-QENYTKS 232
Query: 510 ADIWSLGCTVLEMLTSQIPYAP 531
DIWS GC E+L +
Sbjct: 233 IDIWSTGCIFAELLNMLQSHIN 254
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 4e-29
Identities = 58/200 (29%), Positives = 99/200 (49%), Gaps = 20/200 (10%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
+G G++GSV I G A+K++S AK++ +E+ LL +HEN++
Sbjct: 32 VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY----RELLLLKHMQHENVIG 87
Query: 395 YY------GTDKDESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLH 446
+ ++ Y+ + + +L + + ++ Q+L GLKY+H
Sbjct: 88 LLDVFTPASSLRNFYDFYLVMPFMQT----DLQKIMGLKFSEEKIQYLVYQMLKGLKYIH 143
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGY 506
VVHRD+K N+ V+ + +K+ DFGLA+ ++ T ++ APEVI + Y
Sbjct: 144 SAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD-AEMTGYVVTRWYRAPEVILS-WMHY 201
Query: 507 GLPADIWSLGCTVLEMLTSQ 526
DIWS+GC + EMLT +
Sbjct: 202 NQTVDIWSVGCIMAEMLTGK 221
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-29
Identities = 56/254 (22%), Positives = 99/254 (38%), Gaps = 67/254 (26%)
Query: 324 FKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIA 382
+ + G LG GSFG V E + G FA+K+V + +E+
Sbjct: 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ-----DPRYKN----RELD 52
Query: 383 LLSRFEHENIVQ----YYGTD----------------------------------KDESK 404
++ +H NI++ +Y T
Sbjct: 53 IMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKY 112
Query: 405 LYIFLELVTKGSLLNLYQ--RYHLRDSQ------VSAYTRQILLGLKYLHDQDVVHRDIK 456
L + +E V L++ + +R + +S Y Q+ + ++H + HRDIK
Sbjct: 113 LNVIMEYVP----DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIK 168
Query: 457 CANILVDAN-GSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEVINNKNKGYGLPADI 512
N+LV++ ++KL DFG AK ++ C + F+ APE++ Y D+
Sbjct: 169 PQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYIC--SRFYRAPELMLG-ATEYTPSIDL 225
Query: 513 WSLGCTVLEMLTSQ 526
WS+GC E++ +
Sbjct: 226 WSIGCVFGELILGK 239
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 7e-29
Identities = 58/201 (28%), Positives = 101/201 (50%), Gaps = 21/201 (10%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
+G G+ G V + A+K++S + AK++ +E+ L+ H+NI+
Sbjct: 33 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY----RELVLMKCVNHKNIIG 88
Query: 395 YYGTDKDESK------LYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLH 446
+ +YI +EL+ NL Q + L ++S Q+L G+K+LH
Sbjct: 89 LLNVFTPQKSLEEFQDVYIVMELMDA----NLCQVIQMELDHERMSYLLYQMLCGIKHLH 144
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSC-RGTAFWMAPEVINNKNKG 505
++HRD+K +NI+V ++ ++K+ DFGLA+ + + + T ++ APEVI G
Sbjct: 145 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI--LGMG 202
Query: 506 YGLPADIWSLGCTVLEMLTSQ 526
Y DIWS+GC + EM+
Sbjct: 203 YKENVDIWSVGCIMGEMIKGG 223
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-28
Identities = 50/205 (24%), Positives = 86/205 (41%), Gaps = 22/205 (10%)
Query: 334 GDLLGRGSFGSVYEGISD---DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
+ G G +Y + D +G +K L+ G Q+++ E++ + H
Sbjct: 85 KGCIAHGGLGWIYLAL-DRNVNGRPVVLKG--LVHSGDAEAQAMAMAERQFL--AEVVHP 139
Query: 391 NIVQYY--GTDKD---ESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYL 445
+IVQ + D + YI +E V G L + L ++ AY +IL L YL
Sbjct: 140 SIVQIFNFVEHTDRHGDPVGYIVMEYVG-GQSLKRSKGQKLPVAEAIAYLLEILPALSYL 198
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKG 505
H +V+ D+K NI++ +KL D G +N GT + APE++ +
Sbjct: 199 HSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVSR--INSFGYLYGTPGFQAPEIV----RT 251
Query: 506 YGLPA-DIWSLGCTVLEMLTSQIPY 529
A DI+++G T+ +
Sbjct: 252 GPTVATDIYTVGRTLAALTLDLPTR 276
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 64/208 (30%), Positives = 102/208 (49%), Gaps = 35/208 (16%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSL-LDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
+G G++GSV + G AVK++S AK++ +E+ LL +HEN++
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY----RELRLLKHMKHENVIG 92
Query: 395 YY------GTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
+ ++ + +Y+ L+ L N+ + L D V QIL GLKY+H
Sbjct: 93 LLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA 151
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWM----------APEV 498
D++HRD+K +N+ V+ + +K+ DFGLA R TA M APE+
Sbjct: 152 DIIHRDLKPSNLAVNEDCELKILDFGLA-----------RHTADEMTGYVATRWYRAPEI 200
Query: 499 INNKNKGYGLPADIWSLGCTVLEMLTSQ 526
+ N Y DIWS+GC + E+LT +
Sbjct: 201 MLN-WMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 70/221 (31%), Positives = 100/221 (45%), Gaps = 49/221 (22%)
Query: 336 LLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQY 395
+LGRG FG VY+G DG AVK L ++ +Q + Q + E+ ++S H N+++
Sbjct: 37 ILGRGGFGKVYKGRLADGTLVAVK--RLKEERTQGGEL--QFQTEVEMISMAVHRNLLRL 92
Query: 396 YG--TDKDESKL-YIFLELVTKGSLLNLYQRYHLRDSQVSAY-----TR-QILLG----L 442
G E L Y + GS+ LR+ S R +I LG L
Sbjct: 93 RGFCMTPTERLLVY---PYMANGSV-----ASCLRERPESQPPLDWPKRQRIALGSARGL 144
Query: 443 KYLHDQ---DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSC------RGTAFW 493
YLHD ++HRD+K ANIL+D + DFGLA KL D K RGT
Sbjct: 145 AYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA---KLMDYKDTHVTTAVRGTIGH 201
Query: 494 MAPE-----VINNKNKGYGLPADIWSLGCTVLEMLTSQIPY 529
+APE + K D++ G +LE++T Q +
Sbjct: 202 IAPEYLSTGKSSEK-------TDVFGYGVMLLELITGQRAF 235
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-28
Identities = 59/231 (25%), Positives = 91/231 (39%), Gaps = 40/231 (17%)
Query: 334 GDLLGRGSFGSVYEGI------SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
G LGRG+FG V E + AVK L + + L E+ +L
Sbjct: 32 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVK--MLKEGATH--SEHRALMSELKILIHI 87
Query: 388 -EHENIVQYYG--TDKDESKLYIFLELVTKGSLLNLYQRYH------------------L 426
H N+V G T L + +E G+L Y R L
Sbjct: 88 GHHLNVVNLLGACTKPGGP-LMVIVEFCKFGNLST-YLRSKRNEFVPYKVAPEDLYKDFL 145
Query: 427 RDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-K 485
+ Y+ Q+ G+++L + +HRD+ NIL+ VK+ DFGLA+ +
Sbjct: 146 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 205
Query: 486 SCRGTAF---WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPM 532
WMAPE I ++ Y + +D+WS G + E+ + PY +
Sbjct: 206 RKGDARLPLKWMAPETIFDRV--YTIQSDVWSFGVLLWEIFSLGASPYPGV 254
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 5e-28
Identities = 62/231 (26%), Positives = 87/231 (37%), Gaps = 39/231 (16%)
Query: 334 GDLLGRGSFGSVYEGI------SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
G LG G+FG V E SD AVK +L + + L E+ +LS
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVK---MLKPSAHLTE-REALMSELKVLSYL 83
Query: 388 -EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYT----------- 435
H NIV G + E G LLN + R S +
Sbjct: 84 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLN-FLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 436 ---------RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-K 485
Q+ G+ +L ++ +HRD+ NIL+ K+ DFGLA+ K +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202
Query: 486 SCRGTAF---WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPM 532
WMAPE I N Y +D+WS G + E+ + PY M
Sbjct: 203 VKGNARLPVKWMAPESIFNCV--YTFESDVWSYGIFLWELFSLGSSPYPGM 251
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 7e-28
Identities = 63/231 (27%), Positives = 98/231 (42%), Gaps = 39/231 (16%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFF--------AVKEVSLLDQGSQAKQSISQLEQEIALLS 385
G LG G+FG V + AVK L D ++ + +S L E+ ++
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVK--MLKDDATE--KDLSDLVSEMEMMK 95
Query: 386 RF-EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYT--------- 435
+H+NI+ G + LY+ +E +KG+L Y R +Y
Sbjct: 96 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE-YLRARRPPGMEYSYDINRVPEEQM 154
Query: 436 ---------RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-K 485
Q+ G++YL Q +HRD+ N+LV N +K+ADFGLA+ D K
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214
Query: 486 SCRGTAF---WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPM 532
WMAPE + ++ Y +D+WS G + E+ T PY +
Sbjct: 215 KTTNGRLPVKWMAPEALFDRV--YTHQSDVWSFGVLMWEIFTLGGSPYPGI 263
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 7e-28
Identities = 56/198 (28%), Positives = 99/198 (50%), Gaps = 15/198 (7%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRFEHENIVQ 394
+G G++G+V + G A+K++ AK++ +E+ LL HEN++
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAY----RELRLLKHMRHENVIG 88
Query: 395 YY------GTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
T D + Y+ + + L L + L + ++ Q+L GL+Y+H
Sbjct: 89 LLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAA 147
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGL 508
++HRD+K N+ V+ + +K+ DFGLA+ +++ T ++ APEVI N Y
Sbjct: 148 GIIHRDLKPGNLAVNEDCELKILDFGLARQAD-SEMTGYVVTRWYRAPEVILN-WMRYTQ 205
Query: 509 PADIWSLGCTVLEMLTSQ 526
DIWS+GC + EM+T +
Sbjct: 206 TVDIWSVGCIMAEMITGK 223
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 8e-28
Identities = 55/220 (25%), Positives = 93/220 (42%), Gaps = 41/220 (18%)
Query: 334 GDLLGRGSFGSVYEGISDD---GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-- 388
G++LG G V+ D AVK +L + L ++ + RF
Sbjct: 17 GEILGFGGMSEVHLAR--DLRDHRDVAVK---VLR---------ADLARDPSFYLRFRRE 62
Query: 389 --------HENIVQYY--GTDKDESKL--YIFLELVTKGSLLN--LYQRYHLRDSQVSAY 434
H IV Y G + + YI +E V G L ++ + +
Sbjct: 63 AQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYV-DGVTLRDIVHTEGPMTPKRAIEV 121
Query: 435 TRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR-----G 489
L + H ++HRD+K ANI++ A +VK+ DFG+A+A + + G
Sbjct: 122 IADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIG 181
Query: 490 TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY 529
TA +++PE + +D++SLGC + E+LT + P+
Sbjct: 182 TAQYLSPEQA--RGDSVDARSDVYSLGCVLYEVLTGEPPF 219
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 56/233 (24%), Positives = 93/233 (39%), Gaps = 44/233 (18%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFF------AVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
G LG G FG V + + AVK +L + + + + L E +L +
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVK---MLKENASPSE-LRDLLSEFNVLKQV 83
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH---------------------- 425
H ++++ YG + L + +E GSL + R
Sbjct: 84 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRG-FLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 426 ----LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL 481
L + ++ QI G++YL + +VHRD+ NILV +K++DFGL++
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYE 202
Query: 482 NDV-KSCRGTAF---WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY 529
D WMA E + + Y +D+WS G + E++T PY
Sbjct: 203 EDSYVKRSQGRIPVKWMAIESLFDHI--YTTQSDVWSFGVLLWEIVTLGGNPY 253
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 59/228 (25%), Positives = 96/228 (42%), Gaps = 39/228 (17%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFF--------AVKEVSLLDQGSQAKQSISQLEQEIALLS 385
G LG G+FG V + AVK L ++ + +S L E+ ++
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVK--MLKSDATE--KDLSDLISEMEMMK 129
Query: 386 RF-EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYT--------- 435
+H+NI+ G + LY+ +E +KG+L Y + +Y
Sbjct: 130 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE-YLQARRPPGLEYSYNPSHNPEEQL 188
Query: 436 ---------RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-K 485
Q+ G++YL + +HRD+ N+LV + +K+ADFGLA+ D K
Sbjct: 189 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 248
Query: 486 SCRGTAF---WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY 529
WMAPE + ++ Y +D+WS G + E+ T PY
Sbjct: 249 KTTNGRLPVKWMAPEALFDRI--YTHQSDVWSFGVLLWEIFTLGGSPY 294
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 56/211 (26%), Positives = 101/211 (47%), Gaps = 28/211 (13%)
Query: 337 LGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV-- 393
LG G G V+ + +D A+K++ L D K ++ +EI ++ R +H+NIV
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDP-QSVKHAL----REIKIIRRLDHDNIVKV 73
Query: 394 ------------QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLG 441
G+ + + +YI E + + L N+ ++ L + + Q+L G
Sbjct: 74 FEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLLEEHARLFMYQLLRG 132
Query: 442 LKYLHDQDVVHRDIKCANILVDA-NGSVKLADFGLAKATKLNDVKSCRGTAF----WM-A 495
LKY+H +V+HRD+K AN+ ++ + +K+ DFGLA+ + + W +
Sbjct: 133 LKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRS 192
Query: 496 PEVINNKNKGYGLPADIWSLGCTVLEMLTSQ 526
P ++ + Y D+W+ GC EMLT +
Sbjct: 193 PRLLLS-PNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 58/234 (24%), Positives = 95/234 (40%), Gaps = 46/234 (19%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFF------AVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
+G G+FG V++ + + AVK +L + + A + ++E AL++ F
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVK---MLKEEASADM-QADFQREAALMAEF 107
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYT------------ 435
++ NIV+ G + + E + G L + R + S
Sbjct: 108 DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNE-FLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 436 --------------RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL 481
RQ+ G+ YL ++ VHRD+ N LV N VK+ADFGL++
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 226
Query: 482 NDVKSCRGTAF----WMAPEVIN-NKNKGYGLPADIWSLGCTVLEMLT-SQIPY 529
D G WM PE I N+ Y +D+W+ G + E+ + PY
Sbjct: 227 ADYYKADGNDAIPIRWMPPESIFYNR---YTTESDVWAYGVVLWEIFSYGLQPY 277
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 63/228 (27%), Positives = 96/228 (42%), Gaps = 39/228 (17%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFF--------AVKEVSLLDQGSQAKQSISQLEQEIALLS 385
G LG G FG V + AVK L D ++ + +S L E+ ++
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVK--MLKDDATE--KDLSDLVSEMEMMK 141
Query: 386 RF-EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYT--------- 435
+H+NI+ G + LY+ +E +KG+L Y R +Y
Sbjct: 142 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE-YLRARRPPGMEYSYDINRVPEEQM 200
Query: 436 ---------RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-K 485
Q+ G++YL Q +HRD+ N+LV N +K+ADFGLA+ D K
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 260
Query: 486 SCRGTAF---WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY 529
WMAPE + ++ Y +D+WS G + E+ T PY
Sbjct: 261 KTTNGRLPVKWMAPEALFDRV--YTHQSDVWSFGVLMWEIFTLGGSPY 306
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 57/227 (25%), Positives = 91/227 (40%), Gaps = 35/227 (15%)
Query: 334 GDLLGRGSFGSVYEG-ISDDGFFF--AVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EH 389
D++G G+FG V + I DG A+K + + + E+ +L + H
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIK---RMKEYASKDD-HRDFAGELEVLCKLGHH 85
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYT-------------- 435
NI+ G + LY+ +E G+LL+ + R A+
Sbjct: 86 PNIINLLGACEHRGYLYLAIEYAPHGNLLD-FLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 436 ----RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTA 491
+ G+ YL + +HRD+ NILV N K+ADFGL++
Sbjct: 145 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGR 202
Query: 492 F---WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMEC 534
WMA E +N Y +D+WS G + E+++ PY M C
Sbjct: 203 LPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIVSLGGTPYCGMTC 247
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 8e-27
Identities = 60/226 (26%), Positives = 93/226 (41%), Gaps = 39/226 (17%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFF------AVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
G LG G+FG V E + AVK +L + A + L E+ ++S
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVK---MLKSTAHADE-KEALMSELKIMSHL 106
Query: 388 -EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYT----------- 435
+HENIV G + + E G LLN + R R +
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLN-FLRRKSRVLETDPAFAIANSTASTRD 165
Query: 436 -----RQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGT 490
Q+ G+ +L ++ +HRD+ N+L+ K+ DFGLA+ + +G
Sbjct: 166 LLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 225
Query: 491 AF----WMAPEVINNKNKGYGLPADIWSLGCTVL--EMLT-SQIPY 529
A WMAPE I + Y + +D+WS G +L E+ + PY
Sbjct: 226 ARLPVKWMAPESIFDCV--YTVQSDVWSYG--ILLWEIFSLGLNPY 267
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 54/227 (23%), Positives = 100/227 (44%), Gaps = 48/227 (21%)
Query: 335 DLLGRGSFGSVYEGI-SDDGFFFAVKEVS-LLDQGSQAKQSISQLEQEIALLSRF-EHEN 391
LG+G++G V++ I G AVK++ + A+++ +EI +L+ HEN
Sbjct: 15 KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF----REIMILTELSGHEN 70
Query: 392 IVQYYGTDKDESK--LYIFLEL-------VTKGSLLNLYQRYHLRDSQVSAYTRQILLGL 442
IV + ++ +Y+ + V + ++L Q++ +
Sbjct: 71 IVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILE--------PVHKQYVVYQLIKVI 122
Query: 443 KYLHDQDVVHRDIKCANILVDANGSVKLADFGLA-------------KATKLNDVKSCRG 489
KYLH ++HRD+K +NIL++A VK+ADFGL+ + + ++
Sbjct: 123 KYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDD 182
Query: 490 TAFWM----------APEVINNKNKGYGLPADIWSLGCTVLEMLTSQ 526
+ APE++ + Y D+WSLGC + E+L +
Sbjct: 183 DQPILTDYVATRWYRAPEILLG-STKYTKGIDMWSLGCILGEILCGK 228
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 6e-26
Identities = 61/236 (25%), Positives = 95/236 (40%), Gaps = 44/236 (18%)
Query: 334 GDLLGRGSFGSVYEG----ISDDGFFF--AVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
G +LG G+FG V IS G AVK L ++ +++ L E+ ++++
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVK--MLKEKADSSERE--ALMSELKMMTQL 105
Query: 388 -EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH--------------------- 425
HENIV G +Y+ E G LLN Y R
Sbjct: 106 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLN-YLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 426 ----LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL 481
L + + Q+ G+++L + VHRD+ N+LV VK+ DFGLA+
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMS 224
Query: 482 NDV-KSCRGTAF---WMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPM 532
+ WMAPE + Y + +D+WS G + E+ + PY +
Sbjct: 225 DSNYVVRGNARLPVKWMAPESLFEGI--YTIKSDVWSYGILLWEIFSLGVNPYPGI 278
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 9e-22
Identities = 26/207 (12%), Positives = 52/207 (25%), Gaps = 33/207 (15%)
Query: 334 GDLLGRGSFGSVYEGISDD--GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
G ++ + D A+ + QG + + LSR +
Sbjct: 36 LIFHGGVPPLQFWQAL-DTALDRQVALTF--VDPQGVLPDDVLQETLSRTLRLSRIDKPG 92
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
+ + + + E + GSL + + + H V
Sbjct: 93 VARVLDVVHTRAGGLVVAEWIRGGSLQEVADT-SPSPVGAIRAMQSLAAAADAAHRAGVA 151
Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPAD 511
+ + V +G V LA M D
Sbjct: 152 LSIDHPSRVRVSIDGDVVLAYPAT------------------MPDA---------NPQDD 184
Query: 512 IWSLGCTVLEMLTSQIPYAPMECVSAI 538
I +G ++ +L ++ P S +
Sbjct: 185 IRGIGASLYALLVNRWPLPEAGVRSGL 211
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 2e-21
Identities = 55/210 (26%), Positives = 89/210 (42%), Gaps = 38/210 (18%)
Query: 335 DLLGRGSFGSVYEGI-SDDGFFFAVKEV----SLLDQGSQAKQSISQLEQEIALLSRF-- 387
++G+GSFG V + A+K V Q +EI +L
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA----------AEEIRILEHLRK 152
Query: 388 ----EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQ-----RYH-LRDSQVSAYTRQ 437
N++ + + + EL++ +NLY+ ++ V +
Sbjct: 153 QDKDNTMNVIHMLENFTFRNHICMTFELLS----MNLYELIKKNKFQGFSLPLVRKFAHS 208
Query: 438 ILLGLKYLHDQDVVHRDIKCANILVDANGS--VKLADFGLAKATKLND-VKSCRGTAFWM 494
IL L LH ++H D+K NIL+ G +K+ DFG + + V + + F+
Sbjct: 209 ILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGS--SCYEHQRVYTYIQSRFYR 266
Query: 495 APEVINNKNKGYGLPADIWSLGCTVLEMLT 524
APEVI YG+P D+WSLGC + E+LT
Sbjct: 267 APEVI--LGARYGMPIDMWSLGCILAELLT 294
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 8e-21
Identities = 51/239 (21%), Positives = 93/239 (38%), Gaps = 61/239 (25%)
Query: 321 NGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVK--------------EVSLLD 365
+ R+ ++ LG G F +V+ + A+K E+ LL
Sbjct: 18 DARYI-LV------RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQ 70
Query: 366 QGSQAKQSISQLEQE---IALLSRFEHEN-------IVQYYGTDKDESKLYIFLELVTKG 415
+ + A + + LL F H+ +V + L ++
Sbjct: 71 RVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMV----FEVLGENLLALIKK---- 122
Query: 416 SLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ-DVVHRDIKCANILVD------ANGSV 468
++ L V ++Q+LLGL Y+H + ++H DIK N+L++ +
Sbjct: 123 ---YEHRGIPL--IYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQI 177
Query: 469 KLADFGLA---KATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT 524
K+AD G A N +++ + +PEV+ +G ADIWS C + E++T
Sbjct: 178 KIADLGNACWYDEHYTNSIQTR----EYRSPEVL--LGAPWGCGADIWSTACLIFELIT 230
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 56/237 (23%), Positives = 86/237 (36%), Gaps = 74/237 (31%)
Query: 335 DLLGRGSFGSVYEGI--SDDGFFFAVK--------------EVSLLDQGSQAKQSISQLE 378
D LG G+FG V E I G AVK E+ +L + ++ +
Sbjct: 20 DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVL-------EHLNTTD 72
Query: 379 QE-----IALLSRFEHEN---IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQ 430
+ +L FEH IV + Y F++ N + + L
Sbjct: 73 PNSTFRCVQMLEWFEHHGHICIV----FELLGLSTYDFIKE-------NGFLPFRL--DH 119
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG-------------------SVKLA 471
+ QI + +LH + H D+K NIL + +K+
Sbjct: 120 IRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVV 179
Query: 472 DFGLAKATKLNDVKSC----RGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT 524
DFG AT ++ S R + APEVI G+ P D+WS+GC ++E
Sbjct: 180 DFG--SATYDDEHHSTLVSTR---HYRAPEVI--LALGWSQPCDVWSIGCILIEYYL 229
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 4e-19
Identities = 53/237 (22%), Positives = 87/237 (36%), Gaps = 70/237 (29%)
Query: 335 DLLGRGSFGSVYEGI-SDDGFFFAVK--------------EVSLLDQGSQAKQSISQLEQ 379
+G G+FG V D+ ++AVK E +L + + + +
Sbjct: 41 RKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNI-- 98
Query: 380 EIALLSRFEHEN---IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTR 436
+ +F + + ++ + LY + N Y +H+ + Y
Sbjct: 99 -VKYHGKFMYYDHMCLI----FEPLGPSLYEIITR-------NNYNGFHI--EDIKLYCI 144
Query: 437 QILLGLKYLHDQDVVHRDIKCANILVDANG-------------------------SVKLA 471
+IL L YL + H D+K NIL+D +KL
Sbjct: 145 EILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLI 204
Query: 472 DFGLAKATKLNDVKSC----RGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT 524
DFG AT +D R + APEVI N G+ + +D+WS GC + E+ T
Sbjct: 205 DFG--CATFKSDYHGSIINTR---QYRAPEVI--LNLGWDVSSDMWSFGCVLAELYT 254
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 8e-19
Identities = 52/221 (23%), Positives = 89/221 (40%), Gaps = 58/221 (26%)
Query: 335 DLLGRGSFGSVYEGI-SDDGFFFAVK--------------EVSLLDQGSQAKQSISQLEQ 379
L+G+GSFG V + + + A+K EV LL+ +++ +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLEL-------MNKHDT 112
Query: 380 E-----IALLSRFEHEN---IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQV 431
E + L F N +V + LY L ++ L +
Sbjct: 113 EMKYYIVHLKRHFMFRNHLCLV----FEMLSYNLYDLLRN-------TNFRGVSL--NLT 159
Query: 432 SAYTRQILLGLKYLHDQD--VVHRDIKCANILV--DANGSVKLADFGLAKATKLNDVKSC 487
+ +Q+ L +L + ++H D+K NIL+ ++K+ DFG + +L
Sbjct: 160 RKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG--SSCQLGQRIYQ 217
Query: 488 ----RGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT 524
R F+ +PEV+ Y L D+WSLGC ++EM T
Sbjct: 218 YIQSR---FYRSPEVL--LGMPYDLAIDMWSLGCILVEMHT 253
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 52/237 (21%), Positives = 87/237 (36%), Gaps = 74/237 (31%)
Query: 335 DLLGRGSFGSVYEGI--SDDGFFFAVK--------------EVSLLDQGSQAKQSISQLE 378
LG G+FG V E + + A+K E+++L + I + +
Sbjct: 25 GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVL-------KKIKEKD 77
Query: 379 QE-----IALLSRFEHEN---IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQ 430
+E + + F I + + FL+ N +Q Y L
Sbjct: 78 KENKFLCVLMSDWFNFHGHMCIA----FELLGKNTFEFLKE-------NNFQPYPL--PH 124
Query: 431 VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG-------------------SVKLA 471
V Q+ L++LH+ + H D+K NIL + S+++A
Sbjct: 125 VRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVA 184
Query: 472 DFGLAKATKLNDVKSC----RGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT 524
DFG AT ++ + R + PEVI G+ P D+WS+GC + E
Sbjct: 185 DFG--SATFDHEHHTTIVATR---HYRPPEVI--LELGWAQPCDVWSIGCILFEYYR 234
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 2e-16
Identities = 54/235 (22%), Positives = 98/235 (41%), Gaps = 39/235 (16%)
Query: 315 MSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQS 373
MS + + +++ G +G GSFG ++EG + + A+K +
Sbjct: 1 MSGQN-----NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP-------RRSD 48
Query: 374 ISQLEQEIALLSRFEH-ENI--VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQ 430
QL E I V Y+G + + + ++L+ SL +L + S
Sbjct: 49 APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN--VLVIDLLGP-SLEDLLDLCGRKFSV 105
Query: 431 --VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS-----VKLADFGLAK-----A 478
V+ +Q+L ++ +H++ +V+RDIK N L+ S + + DFG+ K
Sbjct: 106 KTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 165
Query: 479 TKL----NDVKSCRGTAFWMAPEVINN-KNKGYGLPADIWSLGCTVLEMLTSQIP 528
TK + K+ GTA +M+ IN + D+ +LG + L +P
Sbjct: 166 TKQHIPYREKKNLSGTARYMS---INTHLGREQSRRDDLEALGHVFMYFLRGSLP 217
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 2e-16
Identities = 52/226 (23%), Positives = 93/226 (41%), Gaps = 40/226 (17%)
Query: 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 384
R+ ++ G +G GSFG +Y G G A+K K QL E +
Sbjct: 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLEC-------VKTKHPQLHIESKIY 58
Query: 385 SRFEH-ENI--VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYT-----R 436
+ I +++ G + D + + +EL+ +L ++ + S T
Sbjct: 59 KMMQGGVGIPTIRWCGAEGDYN--VMVMELLGP----SLEDLFNFCSRKFSLKTVLLLAD 112
Query: 437 QILLGLKYLHDQDVVHRDIKCANILVDANG---SVKLADFGLAKATKLN---------DV 484
Q++ ++Y+H ++ +HRD+K N L+ V + DFGLAK + +
Sbjct: 113 QMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYREN 172
Query: 485 KSCRGTAFWMAPEVINNKNKGYGLP--ADIWSLGCTVLEMLTSQIP 528
K+ GTA + + IN + G D+ SLG ++ +P
Sbjct: 173 KNLTGTARYAS---INT-HLGIEQSRRDDLESLGYVLMYFNLGSLP 214
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 49/232 (21%), Positives = 85/232 (36%), Gaps = 42/232 (18%)
Query: 331 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
W+ G +G+G FG +Y + ++ L E+ R
Sbjct: 37 WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVE---PSDNGPLFTELKFYQRAAKP 93
Query: 391 NIVQ-----------------YYGTDKDESKLYIFL--ELVTKGSLLNLYQRYHLRDSQ- 430
+Q G K Y F+ + L +Y+ R S+
Sbjct: 94 EQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQKIYEANAKRFSRK 152
Query: 431 -VSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS--VKLADFGLAK---------A 478
V + +IL L+Y+H+ + VH DIK +N+L++ V L D+GLA A
Sbjct: 153 TVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKA 212
Query: 479 TKLNDVKSCRGTAFWMAPEVINNKNKGYGLP--ADIWSLGCTVLEMLTSQIP 528
+ + GT + + I+ + G D+ LG +++ LT +P
Sbjct: 213 YAADPKRCHDGTIEFTS---IDA-HNGVAPSRRGDLEILGYCMIQWLTGHLP 260
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 78.8 bits (194), Expect = 5e-16
Identities = 34/116 (29%), Positives = 59/116 (50%), Gaps = 7/116 (6%)
Query: 423 RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN 482
+ L + Y+ Q+ G+++L + +HRD+ NIL+ VK+ DFGLA+ +
Sbjct: 187 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 246
Query: 483 DVKSCRGTAF----WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTS-QIPYAPME 533
+G A WMAPE I ++ Y + +D+WS G + E+ + PY ++
Sbjct: 247 PDYVRKGDARLPLKWMAPETIFDRV--YTIQSDVWSFGVLLWEIFSLGASPYPGVK 300
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 6e-06
Identities = 32/160 (20%), Positives = 53/160 (33%), Gaps = 11/160 (6%)
Query: 334 GDLLGRGSFGSVYE----GISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
G LGRG+FG V E GI V L + + L E+ +L
Sbjct: 27 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGH 84
Query: 389 HENIVQYYGT-DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
H N+V G K L + +E G+L + + G Y+
Sbjct: 85 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGA 144
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSC 487
+ D+K + ++ S + F K+ + +
Sbjct: 145 ---IPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 181
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 2e-15
Identities = 49/233 (21%), Positives = 86/233 (36%), Gaps = 47/233 (20%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
W G +G G FG +Y + A V + Q L E+ R
Sbjct: 39 WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKV------EYQENGPLFSELKFYQRVAK 92
Query: 390 ENIVQ-----------------YYGTDKDESKLYIFL--ELVTK--GSLLNLYQRYHLRD 428
++ ++ G + + + Y F+ E + + +
Sbjct: 93 KDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKST 152
Query: 429 SQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS--VKLADFGLAK--------- 477
V ++L L+Y+H+ + VH DIK AN+L+ V LAD+GL+
Sbjct: 153 --VLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHK 210
Query: 478 ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLP--ADIWSLGCTVLEMLTSQIP 528
+ N K GT + + ++ +KG L +D+ LG +L L ++P
Sbjct: 211 QYQENPRKGHNGTIEFTS---LDA-HKGVALSRRSDVEILGYCMLRWLCGKLP 259
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 76.1 bits (186), Expect = 3e-15
Identities = 34/217 (15%), Positives = 66/217 (30%), Gaps = 51/217 (23%)
Query: 308 SSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQ- 366
S P S+ P + +R +K +G G FG V++ I+D A+K +++
Sbjct: 6 SQKGPVPFSHCLPTEKLQRC----EK---IGEGVFGEVFQTIADHTPV-AIKIIAIEGPD 57
Query: 367 --GSQAKQSISQLEQEIALLSRFE---------HENIVQYYG------------------ 397
+++ ++ EI + E +
Sbjct: 58 LVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDH 117
Query: 398 ------------TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYL 445
+ +L+I LE G L + + + Q+ L
Sbjct: 118 YNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVA 177
Query: 446 HDQ-DVVHRDIKCANILVDANGSVKLADFGLAKATKL 481
HRD+ N+L+ KL K++ +
Sbjct: 178 EASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTI 214
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 75.4 bits (185), Expect = 1e-14
Identities = 52/223 (23%), Positives = 94/223 (42%), Gaps = 32/223 (14%)
Query: 325 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
R+ ++ G +G GSFG +Y G + A+K + K QL E +
Sbjct: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLEN-------VKTKHPQLLYESKI 55
Query: 384 LSRFE-HENI--VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQ--VSAYTRQI 438
+ I V+++G + D + + ++L+ SL +L+ + S V Q+
Sbjct: 56 YRILQGGTGIPNVRWFGVEGDYN--VLVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQM 112
Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGS---VKLADFGLAKATKLN---------DVKS 486
+ ++++H + +HRDIK N L+ V + DFGLAK + + K+
Sbjct: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKN 172
Query: 487 CRGTAFWMAPEVINN-KNKGYGLPADIWSLGCTVLEMLTSQIP 528
GTA + + +N D+ SLG ++ L +P
Sbjct: 173 LTGTARYAS---VNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 45/227 (19%), Positives = 81/227 (35%), Gaps = 32/227 (14%)
Query: 331 WQKGDLLGRGSFGSVYEGISDDGFF---------FAVK---EVSLLDQGSQAKQSISQLE 378
W+ R + G +YE F++K + L Q ++
Sbjct: 44 WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPL 103
Query: 379 Q--EIALLSRFEHENIVQYYGTDKDESKLYIF-LELVTK--GSLLNLYQRYHLRDSQVSA 433
Q + L I G + K L + + S L++ ++ L + V
Sbjct: 104 QVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQ 163
Query: 434 YTRQILLGLKYLHDQDVVHRDIKCANILVDANGS--VKLADFGLAK---------ATKLN 482
++L L++LH+ + VH ++ NI VD V LA +G A A
Sbjct: 164 VACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEG 223
Query: 483 DVKSCRGTAFWMAPEVINN-KNKGYGLPADIWSLGCTVLEMLTSQIP 528
G +++ ++ K G +D+ SLG +L+ L +P
Sbjct: 224 SRSPHEGDLEFIS---MDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 3e-14
Identities = 55/225 (24%), Positives = 94/225 (41%), Gaps = 36/225 (16%)
Query: 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVK-EVSLLDQGSQAKQSISQLEQEIAL 383
+ ++ G +G G+FG + G + + A+K E K QL E
Sbjct: 6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLE--------PMKSRAPQLHLEYRF 57
Query: 384 LSRFEH-ENI--VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQ--VSAYTRQI 438
+ + I V Y+G + + LEL+ SL +L+ S V Q+
Sbjct: 58 YKQLGSGDGIPQVYYFGPCGKYN--AMVLELLGP-SLEDLFDLCDRTFSLKTVLMIAIQL 114
Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGS-----VKLADFGLAK-----ATKL----NDV 484
+ ++Y+H +++++RD+K N L+ G+ + + DF LAK TK +
Sbjct: 115 ISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREH 174
Query: 485 KSCRGTAFWMAPEVINN-KNKGYGLPADIWSLGCTVLEMLTSQIP 528
KS GTA +M+ IN K D+ +LG + L +P
Sbjct: 175 KSLTGTARYMS---INTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 36/168 (21%), Positives = 52/168 (30%), Gaps = 54/168 (32%)
Query: 416 SLLNLYQRYHLR---DSQVSAYTRQILLGLKYLHDQ-DVVHRDIKCANILVDANGSVKLA 471
LL + + + V +Q+L GL YLH + ++H DIK NIL+ N
Sbjct: 130 HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRR 189
Query: 472 DFGLAKATKLNDVKSCR----------------------------------GTAFWM--- 494
A + + G A W+
Sbjct: 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH 249
Query: 495 -----------APEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP 531
+ EV+ GY PADIWS C E+ T + P
Sbjct: 250 FTEDIQTRQYRSLEVL--IGSGYNTPADIWSTACMAFELATGDYLFEP 295
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 48.7 bits (115), Expect = 4e-06
Identities = 54/462 (11%), Positives = 126/462 (27%), Gaps = 118/462 (25%)
Query: 95 EDF---AIPAAAWEARKNRSASDLL-PRSRLKQLDTLKETVER-QSDAAGAVVGELCDRV 149
++F + ++ + + L T+ Q + V E+
Sbjct: 31 DNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRIN 90
Query: 150 SDIVRIRNETELTRTKLTQVAELSCRASGAGNNDALAVMETTELPPSGLAESSACCVSSN 209
+ +TE + + + R +N A + L P
Sbjct: 91 YKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQP-------------- 136
Query: 210 YVKGIKGVRPPL--LKPPP-----GM----RQPVIDNACSTWDILRDFAPKDGI------ 252
+R L L+P G+ + V + C ++ + I
Sbjct: 137 ----YLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMD--FKIFWLNLK 190
Query: 253 ---TPSSVMN---------DRALSSSSDDEDNEK----EGEEADRAIVKEEE-------- 288
+P +V+ D +S SD N K + R ++K +
Sbjct: 191 NCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVL 250
Query: 289 DDMVLSESC--SFTTEHEDDSSST--TTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGS 344
+ V + +F + S TT RFK++ D L +
Sbjct: 251 LN-VQNAKAWNAF-----NLSCKILLTT----------RFKQVT------DFLSAATTTH 288
Query: 345 VYEGISDDGF-------FFA-VKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV--- 393
+ + D + + +++++ + +
Sbjct: 289 ISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLT-TNPRR--LSIIAESIRDGLATWD 345
Query: 394 --QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHL--RDSQVSAYTRQIL-LGLKYLHDQ 448
++ DK + + L ++ ++ R + + + ++ +
Sbjct: 346 NWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVM 405
Query: 449 DVVHRDIKCANI-LVD---ANGSVKLADFGLAKATKLNDVKS 486
VV+ K LV+ ++ + L KL + +
Sbjct: 406 VVVN---KLHKYSLVEKQPKESTISIPSIYLELKVKLENEYA 444
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 554 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.82 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.73 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.32 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.27 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.13 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.1 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.87 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.56 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.48 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.31 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.26 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.11 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.11 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.02 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.75 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.61 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.6 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.59 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.43 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.32 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.27 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.09 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.05 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.02 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.92 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.74 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.54 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.8 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.99 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 94.33 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-49 Score=405.98 Aligned_cols=212 Identities=26% Similarity=0.452 Sum_probs=186.8
Q ss_pred ccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEE
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~ 406 (554)
.++|++++.||+|+||+||+|++ .+|+.||+|++..... ......+.+.+|+.+|+.++|||||+++++|.+.+++|
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~--~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~y 108 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY 108 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHC--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 46899999999999999999998 7899999999974221 11223467899999999999999999999999999999
Q ss_pred EEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC---
Q 008759 407 IFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--- 482 (554)
Q Consensus 407 LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~--- 482 (554)
||||||.||+|.+++++ ..+++..++.|+.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+.....
T Consensus 109 ivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~ 188 (311)
T 4aw0_A 109 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 188 (311)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence 99999999999999976 46999999999999999999999999999999999999999999999999999875422
Q ss_pred -CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHH
Q 008759 483 -DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTV 543 (554)
Q Consensus 483 -~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~ 543 (554)
...+.+||+.|||||++.+. .|+.++|||||||++|+|+||++||...+..+.+.+|..
T Consensus 189 ~~~~~~~GTp~YmAPEvl~~~--~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~ 248 (311)
T 4aw0_A 189 ARANSFVGTAQYVSPELLTEK--SACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIK 248 (311)
T ss_dssp CCBCCCCSCGGGCCHHHHHHS--CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred ccccCcccCcccCCHHHHcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence 24567899999999999765 489999999999999999999999998776666555544
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-49 Score=412.04 Aligned_cols=208 Identities=33% Similarity=0.553 Sum_probs=186.7
Q ss_pred cceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEE
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~L 407 (554)
+.|++++.||+|+||+||+|++ .+|+.||||++....... .+.+.+|+.+|+.++|||||+++++|.+.+.+||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~-----~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~i 148 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR-----RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWV 148 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS-----GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH-----HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 5799999999999999999998 689999999997543322 2457899999999999999999999999999999
Q ss_pred EEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC--Ccc
Q 008759 408 FLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--DVK 485 (554)
Q Consensus 408 VmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~--~~~ 485 (554)
|||||.||+|.+++.+..+++.+++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+..... ...
T Consensus 149 vmEy~~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~ 228 (346)
T 4fih_A 149 VMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK 228 (346)
T ss_dssp EECCCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBC
T ss_pred EEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCccc
Confidence 999999999999999889999999999999999999999999999999999999999999999999999875433 345
Q ss_pred CccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHH
Q 008759 486 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTV 543 (554)
Q Consensus 486 s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~ 543 (554)
+.+||+.|||||++.+. .|+.++|||||||++|||++|++||.+....+.+..+..
T Consensus 229 ~~~GTp~YmAPEvl~~~--~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~ 284 (346)
T 4fih_A 229 SLVGTPYWMAPELISRL--PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD 284 (346)
T ss_dssp CCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH
T ss_pred ccccCcCcCCHHHHCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHc
Confidence 67899999999999654 489999999999999999999999998887776665543
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-49 Score=410.88 Aligned_cols=213 Identities=29% Similarity=0.558 Sum_probs=182.4
Q ss_pred cccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcE
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL 405 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~ 405 (554)
.+++|++++.||+|+||+||+|++ .+|+.||||++...... ....+.+.+|+.+|+.++|||||+++++|.+.+.+
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~---~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~ 98 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMS---SKEREESRREVAVLANMKHPNIVQYRESFEENGSL 98 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSC---HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCC---HHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEE
Confidence 357899999999999999999998 78999999999754322 23457889999999999999999999999999999
Q ss_pred EEEEeecccCchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC
Q 008759 406 YIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN 482 (554)
Q Consensus 406 ~LVmE~~~ggsL~~ll~~~---~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~ 482 (554)
|||||||.||+|.+++... .+++.+++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.....
T Consensus 99 yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 99 YIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp EEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 9999999999999999643 3688999999999999999999999999999999999999999999999999875432
Q ss_pred --CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHHH
Q 008759 483 --DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTVA 544 (554)
Q Consensus 483 --~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~~ 544 (554)
.....+||+.|||||++.+. .|+.++|||||||++|||+||+.||......+.+.++...
T Consensus 179 ~~~~~~~~GT~~YmAPE~l~~~--~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~ 240 (350)
T 4b9d_A 179 VELARACIGTPYYLSPEICENK--PYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISG 240 (350)
T ss_dssp HHHHHHHHSCCTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT
T ss_pred cccccccCCCccccCHHHHCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC
Confidence 23456799999999999764 4899999999999999999999999998887777776653
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-48 Score=413.02 Aligned_cols=209 Identities=33% Similarity=0.547 Sum_probs=187.8
Q ss_pred ccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEE
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~ 406 (554)
.++|++++.||+|+||+||+|++ .+|+.||||++....... .+.+.+|+.+|+.++|||||+++++|.+.+.+|
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~-----~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ 224 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR-----RELLFNEVVIMRDYQHENVVEMYNSYLVGDELW 224 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS-----GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH-----HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEE
Confidence 35799999999999999999998 789999999997543322 245789999999999999999999999999999
Q ss_pred EEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC--Cc
Q 008759 407 IFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--DV 484 (554)
Q Consensus 407 LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~--~~ 484 (554)
||||||.||+|.++++...+++.+++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+..... ..
T Consensus 225 iVmEy~~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~ 304 (423)
T 4fie_A 225 VVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR 304 (423)
T ss_dssp EEEECCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCB
T ss_pred EEEeCCCCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCccc
Confidence 9999999999999999889999999999999999999999999999999999999999999999999999875433 34
Q ss_pred cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHH
Q 008759 485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTV 543 (554)
Q Consensus 485 ~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~ 543 (554)
.+.+||+.|||||++.+. .|+.++|||||||++|||++|+.||.+....+.+..+..
T Consensus 305 ~~~~GTp~YmAPEvl~~~--~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~ 361 (423)
T 4fie_A 305 KSLVGTPYWMAPELISRL--PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD 361 (423)
T ss_dssp CCCEECTTTCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH
T ss_pred cccccCcCcCCHHHHCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHc
Confidence 567899999999999654 489999999999999999999999999888777666543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=389.88 Aligned_cols=208 Identities=31% Similarity=0.580 Sum_probs=182.0
Q ss_pred ceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccC----CCc
Q 008759 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD----ESK 404 (554)
Q Consensus 330 ~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~----~~~ 404 (554)
+|++.+.||+|+||+||+|.+ .++..||+|++..... .....+.+.+|+.+|+.++|||||+++++|.+ ...
T Consensus 27 ~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~---~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~ 103 (290)
T 3fpq_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL---TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEE
T ss_pred eEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcE
Confidence 457788999999999999998 6799999999875332 23345778999999999999999999998854 456
Q ss_pred EEEEEeecccCchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHHCC--ccccCCccccEEEcC-CCcEEEEecCcccccc
Q 008759 405 LYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQD--VVHRDIKCANILVDA-NGSVKLADFGLAKATK 480 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~~-~l~e~~i~~i~~QIl~gL~yLHs~g--IIHrDIKPeNILld~-~g~vKL~DFGlA~~~~ 480 (554)
+|||||||.+|+|.+++++. .+++..++.|+.||+.||.|||++| ||||||||+||||+. +|.+||+|||+|+...
T Consensus 104 ~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 89999999999999999764 6899999999999999999999999 999999999999974 7999999999998766
Q ss_pred cCCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHH
Q 008759 481 LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTV 543 (554)
Q Consensus 481 ~~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~ 543 (554)
.....+.+||+.|||||++.+ .|+.++|||||||++|||+||+.||........++..+.
T Consensus 184 ~~~~~~~~GTp~YmAPE~~~~---~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~ 243 (290)
T 3fpq_A 184 ASFAKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT 243 (290)
T ss_dssp TTSBEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHT
T ss_pred CCccCCcccCccccCHHHcCC---CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHH
Confidence 666667789999999999853 489999999999999999999999998877777666543
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-47 Score=385.07 Aligned_cols=207 Identities=28% Similarity=0.449 Sum_probs=165.2
Q ss_pred ccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEE
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~ 406 (554)
+++|++++.||+|+||+||+|.+ .+|+.||+|++...... .......+.+|+.+|+.++|||||++++++.+.+.+|
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ 89 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLA--KSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEII 89 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcC--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 46899999999999999999998 78999999998753221 1223467889999999999999999999999999999
Q ss_pred EEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC-Cc
Q 008759 407 IFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-DV 484 (554)
Q Consensus 407 LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~-~~ 484 (554)
|||||+ +|+|.+++.+ ..+++.+++.|++||+.||.|||++||+||||||+|||++.++++||+|||+|+..... ..
T Consensus 90 ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~ 168 (275)
T 3hyh_A 90 MVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFL 168 (275)
T ss_dssp EEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred EEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCcc
Confidence 999999 5688887765 57999999999999999999999999999999999999999999999999999875433 34
Q ss_pred cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHH
Q 008759 485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAI 538 (554)
Q Consensus 485 ~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i 538 (554)
.+.+||+.|||||++.+.. .++.++|||||||++|+|+||+.||......+.+
T Consensus 169 ~~~~GT~~Y~APE~~~~~~-y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~ 221 (275)
T 3hyh_A 169 KTSCGSPNYAAPEVISGKL-YAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLF 221 (275)
T ss_dssp ------CTTSCHHHHSSSS-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred CCeeECcccCChhhhcCCC-CCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 5678999999999997543 2468999999999999999999999876554433
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=395.16 Aligned_cols=210 Identities=30% Similarity=0.480 Sum_probs=177.6
Q ss_pred cceeeeeeeccCCceeEEEEec----CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCc
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~----~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~ 404 (554)
++|++++.||+|+||+||+|++ .+++.||+|++......... ..++.+|+.+|+.++|||||+++++|.+.+.
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~---~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 100 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD---RVRTKMERDILVEVNHPFIVKLHYAFQTEGK 100 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE---CC------CCCCCCCCTTEECEEEEEEETTE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH---HHHHHHHHHHHHHCCCCCCCeEEEEEEECCE
Confidence 6899999999999999999986 35789999998753322111 1357789999999999999999999999999
Q ss_pred EEEEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccccc--
Q 008759 405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL-- 481 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~-- 481 (554)
+|||||||.||+|.+++.+ ..+++.+++.|+.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+....
T Consensus 101 ~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 180 (304)
T 3ubd_A 101 LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 180 (304)
T ss_dssp EEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred EEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCC
Confidence 9999999999999999976 4699999999999999999999999999999999999999999999999999986432
Q ss_pred CCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHH
Q 008759 482 NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTV 543 (554)
Q Consensus 482 ~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~ 543 (554)
....+.+||+.|||||++.+. .|+.++|||||||++|||+||+.||.+.+..+.+.++..
T Consensus 181 ~~~~~~~GT~~YmAPE~~~~~--~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~ 240 (304)
T 3ubd_A 181 KKAYSFCGTVEYMAPEVVNRR--GHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK 240 (304)
T ss_dssp CCCCSCCCCGGGCCHHHHHTS--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred ccccccccCcccCCHHHhccC--CCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHc
Confidence 334567899999999999654 489999999999999999999999998887776666543
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=397.40 Aligned_cols=206 Identities=31% Similarity=0.460 Sum_probs=179.2
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCc
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~ 404 (554)
...++|++.++||+|+||+||+|++ .+|+.||||++..... ..+|+.+++.++|||||+++++|.+.+.
T Consensus 55 ~~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----------~~~E~~il~~l~HpnIV~l~~~~~~~~~ 124 (336)
T 4g3f_A 55 EEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----------RVEELVACAGLSSPRIVPLYGAVREGPW 124 (336)
T ss_dssp BTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----------CTHHHHTTTTCCCTTBCCEEEEEEETTE
T ss_pred cchhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----------HHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 3456899999999999999999998 7799999999975221 2379999999999999999999999999
Q ss_pred EEEEEeecccCchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCC-cEEEEecCcccccccC
Q 008759 405 LYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG-SVKLADFGLAKATKLN 482 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~~-~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g-~vKL~DFGlA~~~~~~ 482 (554)
+|||||||.||+|.+++++. .+++..++.|+.||+.||.|||++|||||||||+||||+.+| ++||+|||+|+.....
T Consensus 125 ~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 125 VNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred EEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence 99999999999999999764 699999999999999999999999999999999999999988 6999999999875432
Q ss_pred C-------ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHH
Q 008759 483 D-------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTV 543 (554)
Q Consensus 483 ~-------~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~ 543 (554)
. ....+||+.|||||++.+. .|+.++|||||||++|||+||+.||......+.+.++..
T Consensus 205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~--~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~ 270 (336)
T 4g3f_A 205 GLGKSLLTGDYIPGTETHMAPEVVMGK--PCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS 270 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHH
T ss_pred CcccceecCCccccCccccCHHHHCCC--CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHc
Confidence 1 2235799999999999764 489999999999999999999999988766665555544
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=385.52 Aligned_cols=208 Identities=29% Similarity=0.463 Sum_probs=179.7
Q ss_pred cceeeeeeeccCCceeEEEEecC------CCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCC
Q 008759 329 TYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE 402 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~~------~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~ 402 (554)
++|.+.+.||+|+||+||+|.+. ++..||+|++... .....+.|.+|+.+|++++|||||+++++|.+.
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-----~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~ 87 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-----SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG 87 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC-----CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC-----ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence 57999999999999999999753 5789999998642 233457799999999999999999999999999
Q ss_pred CcEEEEEeecccCchHHHHhhh--------------cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcE
Q 008759 403 SKLYIFLELVTKGSLLNLYQRY--------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSV 468 (554)
Q Consensus 403 ~~~~LVmE~~~ggsL~~ll~~~--------------~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~v 468 (554)
+.+|||||||.+|+|.++++.. .+++.++..|+.||+.||.|||+++||||||||+|||++.++.+
T Consensus 88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~ 167 (299)
T 4asz_A 88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV 167 (299)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcE
Confidence 9999999999999999999753 48999999999999999999999999999999999999999999
Q ss_pred EEEecCcccccccCC----ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHH
Q 008759 469 KLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIFIKTV 543 (554)
Q Consensus 469 KL~DFGlA~~~~~~~----~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i~~i~~ 543 (554)
||+|||+++...... .....||+.|||||++.+. .|+.++|||||||++|||+| |+.||......+.+..+..
T Consensus 168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~--~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~ 245 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ 245 (299)
T ss_dssp EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHH
T ss_pred EECCcccceecCCCCceeecCceecChhhcCHHHHcCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 999999998643322 1234589999999999765 48999999999999999999 9999999888776655543
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-46 Score=385.13 Aligned_cols=209 Identities=27% Similarity=0.425 Sum_probs=175.9
Q ss_pred ccceeeeeeeccCCceeEEEEecC------CCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccC
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD 401 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~~------~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~ 401 (554)
.++|.+.+.||+|+||+||+|.+. ++..||||++... .....+.|.+|+.+|++++|||||+++++|.+
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-----~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~ 114 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-----SESARQDFQREAELLTMLQHQHIVRFFGVCTE 114 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC-----SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC-----CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 357899999999999999999753 5789999998632 23445779999999999999999999999999
Q ss_pred CCcEEEEEeecccCchHHHHhhh----------------cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCC
Q 008759 402 ESKLYIFLELVTKGSLLNLYQRY----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN 465 (554)
Q Consensus 402 ~~~~~LVmE~~~ggsL~~ll~~~----------------~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~ 465 (554)
.+.+|||||||.+|+|.++++.. .+++.++..|+.||+.||.|||+++||||||||+||||+.+
T Consensus 115 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~ 194 (329)
T 4aoj_A 115 GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQG 194 (329)
T ss_dssp SSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETT
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCC
Confidence 99999999999999999998652 48899999999999999999999999999999999999999
Q ss_pred CcEEEEecCcccccccCC----ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHHHH
Q 008759 466 GSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIFI 540 (554)
Q Consensus 466 g~vKL~DFGlA~~~~~~~----~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i~~ 540 (554)
+.+||+|||+++...... .....||+.|||||++.+. .|+.++|||||||++|||+| |+.||......+.+..
T Consensus 195 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~--~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~ 272 (329)
T 4aoj_A 195 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR--KFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDC 272 (329)
T ss_dssp TEEEECCCC----------------CCCCGGGCCHHHHTTC--CCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHH
T ss_pred CcEEEcccccceeccCCCcceecCcccccccccChhhhcCC--CCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 999999999998653322 2345699999999999654 48999999999999999999 9999999888776655
Q ss_pred HHH
Q 008759 541 KTV 543 (554)
Q Consensus 541 i~~ 543 (554)
+..
T Consensus 273 i~~ 275 (329)
T 4aoj_A 273 ITQ 275 (329)
T ss_dssp HHH
T ss_pred HHc
Confidence 543
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-46 Score=383.08 Aligned_cols=211 Identities=28% Similarity=0.505 Sum_probs=177.5
Q ss_pred ccccceeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcE
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL 405 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~ 405 (554)
...+++++++.||+|+||+||+|.+.+ .||||+++.... ..+..+.|.+|+.+|++++|||||++++++.. +.+
T Consensus 33 i~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~---~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~ 106 (307)
T 3omv_A 33 IEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDP---TPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNL 106 (307)
T ss_dssp CCTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSC
T ss_pred EcHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeE
Confidence 334678899999999999999998754 589998865332 23456789999999999999999999998754 578
Q ss_pred EEEEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccccc--
Q 008759 406 YIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL-- 481 (554)
Q Consensus 406 ~LVmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~-- 481 (554)
|||||||.+|+|.+++.. ..+++.++..|+.||+.||.|||+++||||||||+||||+.++.+||+|||+|+....
T Consensus 107 ~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~ 186 (307)
T 3omv_A 107 AIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS 186 (307)
T ss_dssp EEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence 999999999999999965 4699999999999999999999999999999999999999999999999999986432
Q ss_pred --CCccCccCCCcccChhhhcccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHH
Q 008759 482 --NDVKSCRGTAFWMAPEVINNKN-KGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKT 542 (554)
Q Consensus 482 --~~~~s~~GT~~Y~APEvl~~~~-~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~ 542 (554)
......+||+.|||||++.+.. ..|+.++|||||||++|||+||+.||........+..+.
T Consensus 187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~ 250 (307)
T 3omv_A 187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMV 250 (307)
T ss_dssp -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHH
T ss_pred cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHH
Confidence 2234567999999999997542 348999999999999999999999999887766655543
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=378.24 Aligned_cols=209 Identities=24% Similarity=0.396 Sum_probs=179.3
Q ss_pred ccceeeeeeeccCCceeEEEEec------CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccC
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD 401 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~------~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~ 401 (554)
...+++.+.||+|+||+||+|.+ .+++.||||++..... ....+.|.+|+.++.+++|||||++++++.+
T Consensus 25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~----~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~ 100 (308)
T 4gt4_A 25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE----GPLREEFRHEAMLRARLQHPNVVCLLGVVTK 100 (308)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CC----C-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccC----hHHHHHHHHHHHHHHhCCCCCCCCcceEEEE
Confidence 45788999999999999999985 3578999999864322 2234678999999999999999999999999
Q ss_pred CCcEEEEEeecccCchHHHHhh-----------------hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcC
Q 008759 402 ESKLYIFLELVTKGSLLNLYQR-----------------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA 464 (554)
Q Consensus 402 ~~~~~LVmE~~~ggsL~~ll~~-----------------~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~ 464 (554)
.+.+|||||||.+|+|.+++.. ..+++.++..|+.||+.||.|||+++||||||||+||||+.
T Consensus 101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~ 180 (308)
T 4gt4_A 101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYD 180 (308)
T ss_dssp SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECC
Confidence 9999999999999999999953 24888999999999999999999999999999999999999
Q ss_pred CCcEEEEecCcccccccC----CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHHH
Q 008759 465 NGSVKLADFGLAKATKLN----DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIF 539 (554)
Q Consensus 465 ~g~vKL~DFGlA~~~~~~----~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i~ 539 (554)
++.+||+|||+++..... ......||+.|||||++.+. .|+.++|||||||++|||+| |..||.+....+.+.
T Consensus 181 ~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~--~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~ 258 (308)
T 4gt4_A 181 KLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYG--KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE 258 (308)
T ss_dssp GGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHH
T ss_pred CCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCC--CCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 999999999999865332 23345799999999999765 48999999999999999998 899999988776655
Q ss_pred HHH
Q 008759 540 IKT 542 (554)
Q Consensus 540 ~i~ 542 (554)
.+.
T Consensus 259 ~i~ 261 (308)
T 4gt4_A 259 MIR 261 (308)
T ss_dssp HHH
T ss_pred HHH
Confidence 544
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-45 Score=387.76 Aligned_cols=213 Identities=25% Similarity=0.439 Sum_probs=183.0
Q ss_pred cccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccC----
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD---- 401 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~---- 401 (554)
+.++|++++.||+|+||+||+|++ .+|+.||||++..... .....+.+.+|+.+|+.++|||||++++++..
T Consensus 52 i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 128 (398)
T 4b99_A 52 VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD---VVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPY 128 (398)
T ss_dssp CCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS---SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCT
T ss_pred CCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc---chHHHHHHHHHHHHHHhcCCCCcceEeeeeeccccc
Confidence 346899999999999999999998 7899999999864322 23345678899999999999999999998653
Q ss_pred --CCcEEEEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccc
Q 008759 402 --ESKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA 478 (554)
Q Consensus 402 --~~~~~LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~ 478 (554)
.+.+|||||||. |+|.+++.+ ..+++..++.|++||+.||.|||++|||||||||+|||++.+|.+||+|||+++.
T Consensus 129 ~~~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 129 GEFKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARG 207 (398)
T ss_dssp TTCCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred ccCCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeee
Confidence 467999999997 468888865 5699999999999999999999999999999999999999999999999999986
Q ss_pred ccc------CCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHHH
Q 008759 479 TKL------NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTVA 544 (554)
Q Consensus 479 ~~~------~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~~ 544 (554)
... ....+.+||++|||||++.+.. .|+.++|||||||++|||++|++||.+.+..+.+.+|...
T Consensus 208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~-~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~ 278 (398)
T 4b99_A 208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLH-EYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMV 278 (398)
T ss_dssp C-------CCCCCSSCCCCTTCCHHHHTTCS-CCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHH
T ss_pred cccCccccccccccceeChHhcCHHHhcCCC-CCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHh
Confidence 432 2345678999999999986543 4799999999999999999999999998888887777543
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=376.02 Aligned_cols=197 Identities=30% Similarity=0.515 Sum_probs=161.1
Q ss_pred cccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCC--
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES-- 403 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~-- 403 (554)
++++|++++.||+|+||+||+|++ .+|+.||+|++.... .....+.+.+|+.+|+.++|||||+++++|.+.+
T Consensus 3 ~l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~----~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~ 78 (299)
T 4g31_A 3 YLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN----RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTT 78 (299)
T ss_dssp HHHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS----SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--
T ss_pred cchhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcc
Confidence 457899999999999999999998 689999999987532 2334467889999999999999999999886543
Q ss_pred ----------cEEEEEeecccCchHHHHhhhc----CChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEE
Q 008759 404 ----------KLYIFLELVTKGSLLNLYQRYH----LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVK 469 (554)
Q Consensus 404 ----------~~~LVmE~~~ggsL~~ll~~~~----l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vK 469 (554)
++|||||||.+|+|.+++.... .....++.|+.||+.||.|||++|||||||||+|||++.+|.+|
T Consensus 79 ~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vK 158 (299)
T 4g31_A 79 EKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVK 158 (299)
T ss_dssp --------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEE
T ss_pred ccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEE
Confidence 4799999999999999997642 34456889999999999999999999999999999999999999
Q ss_pred EEecCcccccccCC--------------ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008759 470 LADFGLAKATKLND--------------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM 532 (554)
Q Consensus 470 L~DFGlA~~~~~~~--------------~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~ 532 (554)
|+|||+|+...... ..+.+||+.|||||++.+. .|+.++|||||||++|||++ ||...
T Consensus 159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~--~y~~~~DiwSlGvilyell~---Pf~~~ 230 (299)
T 4g31_A 159 VGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN--SYSHKVDIFSLGLILFELLY---PFSTQ 230 (299)
T ss_dssp ECCCCCC--------------------------CCCTTSCHHHHTTC--CCCTHHHHHHHHHHHHHHHS---CCSSH
T ss_pred EccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCC--CCCCHHHHHHHHHHHHHHcc---CCCCc
Confidence 99999998654321 2235699999999999764 48999999999999999996 88653
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=377.25 Aligned_cols=209 Identities=24% Similarity=0.371 Sum_probs=176.3
Q ss_pred cccccceeeeeeeccCCceeEEEEec----CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhC-CCCceeeeeeec
Q 008759 325 KRIITYWQKGDLLGRGSFGSVYEGIS----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTD 399 (554)
Q Consensus 325 ~~~~~~y~i~~~LG~GsfG~VY~a~~----~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIVkl~~~~ 399 (554)
..+.+.|++++.||+|+||+||+|++ .+++.||+|.+.... ...++.+|+.+|..+ +|||||+++++|
T Consensus 17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-------~~~~~~~E~~~l~~~~~h~nIv~l~~~~ 89 (361)
T 4f9c_A 17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-------HPIRIAAELQCLTVAGGQDNVMGVKYCF 89 (361)
T ss_dssp GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-------CHHHHHHHHHHHHHTCSBTTBCCCSEEE
T ss_pred CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-------CHHHHHHHHHHHHHhcCCCCCceEEEEE
Confidence 35667899999999999999999986 357899999886421 124577899999988 699999999999
Q ss_pred cCCCcEEEEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCC-CcEEEEecCcccc
Q 008759 400 KDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAKA 478 (554)
Q Consensus 400 ~~~~~~~LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~-g~vKL~DFGlA~~ 478 (554)
.+.+++||||||+.+|+|.++++ .+++.+++.|++||+.||.|||++|||||||||+|||++.+ +.+||+|||+|+.
T Consensus 90 ~~~~~~~lvmE~~~g~~L~~~~~--~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 90 RKNDHVVIAMPYLEHESFLDILN--SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp EETTEEEEEEECCCCCCHHHHHT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EECCEEEEEEeCCCcccHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 99999999999999999999985 58999999999999999999999999999999999999877 8999999999975
Q ss_pred cccC------------------------------CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCC
Q 008759 479 TKLN------------------------------DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIP 528 (554)
Q Consensus 479 ~~~~------------------------------~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~P 528 (554)
.... ...+.+||++|||||++.+.. .|+.++|||||||++|+|+||+.|
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~y~~~~DiWSlG~il~ell~G~~P 246 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCP-NQTTAIDMWSAGVIFLSLLSGRYP 246 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCS-CCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCC-CCCCccchhhhHHHHHHHHHCCCC
Confidence 4321 123457999999999996543 589999999999999999999999
Q ss_pred CCCC-ChhHHHHHHHH
Q 008759 529 YAPM-ECVSAIFIKTV 543 (554)
Q Consensus 529 F~~~-e~~~~i~~i~~ 543 (554)
|... +..+++.+|..
T Consensus 247 f~~~~~~~~~l~~I~~ 262 (361)
T 4f9c_A 247 FYKASDDLTALAQIMT 262 (361)
T ss_dssp SSCCSSHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHH
Confidence 9765 45555555543
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=402.68 Aligned_cols=206 Identities=29% Similarity=0.441 Sum_probs=178.7
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccc-hhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCC
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGS-QAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES 403 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~-~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~ 403 (554)
..+++|+++++||+|+||+||+|++ .+|+.||||++....... ...........++.++..++|||||+++++|.+.+
T Consensus 186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~ 265 (689)
T 3v5w_A 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD 265 (689)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred CchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC
Confidence 3467899999999999999999998 789999999997432111 11122223334567777889999999999999999
Q ss_pred cEEEEEeecccCchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC
Q 008759 404 KLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN 482 (554)
Q Consensus 404 ~~~LVmE~~~ggsL~~ll~~~-~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~ 482 (554)
++|||||||.||+|..++.+. .+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.....
T Consensus 266 ~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~ 345 (689)
T 3v5w_A 266 KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 345 (689)
T ss_dssp EEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCCC
Confidence 999999999999999999764 6999999999999999999999999999999999999999999999999999887777
Q ss_pred CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008759 483 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM 532 (554)
Q Consensus 483 ~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~ 532 (554)
...+.+||+.|||||++... ..|+.++|||||||++|||++|++||...
T Consensus 346 ~~~t~~GTp~YmAPEvl~~~-~~y~~~vDiWSLGvilYEmLtG~~PF~~~ 394 (689)
T 3v5w_A 346 KPHASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQH 394 (689)
T ss_dssp CCCSCCSCGGGCCHHHHSTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCGG
T ss_pred CCCCccCCcCccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 77778999999999999643 35899999999999999999999999753
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=371.42 Aligned_cols=211 Identities=27% Similarity=0.425 Sum_probs=178.3
Q ss_pred ccccceeeeeeeccCCceeEEEEecC------CCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCC-Cceeeeeee
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH-ENIVQYYGT 398 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~~------~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~H-pnIVkl~~~ 398 (554)
...++|++++.||+|+||+||+|.+. .++.||+|.+.... .....+.+.+|+.+|.++.| ||||+++++
T Consensus 61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~----~~~~~~~~~~E~~il~~l~hhpnIV~l~g~ 136 (353)
T 4ase_A 61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA----THSEHRALMSELKILIHIGHHLNVVNLLGA 136 (353)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc----ChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence 33578999999999999999999862 24689999886422 22345678999999999975 899999999
Q ss_pred ccC-CCcEEEEEeecccCchHHHHhhh-----------------cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccE
Q 008759 399 DKD-ESKLYIFLELVTKGSLLNLYQRY-----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANI 460 (554)
Q Consensus 399 ~~~-~~~~~LVmE~~~ggsL~~ll~~~-----------------~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNI 460 (554)
|.. .+.+|||||||.+|+|.++++.. .+++.++..|+.||+.||.|||+++||||||||+||
T Consensus 137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NI 216 (353)
T 4ase_A 137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 216 (353)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccce
Confidence 865 45789999999999999999642 278899999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCcccccccCC----ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChh
Q 008759 461 LVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECV 535 (554)
Q Consensus 461 Lld~~g~vKL~DFGlA~~~~~~~----~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~ 535 (554)
|++.++.+||+|||+|+...... ....+||+.|||||++.+. .|+.++|||||||++|||+| |+.||.+....
T Consensus 217 Ll~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~--~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~ 294 (353)
T 4ase_A 217 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 294 (353)
T ss_dssp EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred eeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcC--CCCCcccEeehHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999998654332 2245689999999999765 48999999999999999998 99999988776
Q ss_pred HHHHHHH
Q 008759 536 SAIFIKT 542 (554)
Q Consensus 536 ~~i~~i~ 542 (554)
+.+.+.+
T Consensus 295 ~~~~~~i 301 (353)
T 4ase_A 295 EEFCRRL 301 (353)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 6665544
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-44 Score=365.85 Aligned_cols=196 Identities=29% Similarity=0.385 Sum_probs=163.5
Q ss_pred ccceeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCC----
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES---- 403 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~---- 403 (554)
.++|.+.+.||+|+||+||+|.+ +|+.||||++.... ......+.|+..+..++|||||++++++...+
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~------~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~ 74 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 74 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc------hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCce
Confidence 35789999999999999999987 58899999986321 11123345677778899999999999987643
Q ss_pred cEEEEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHC--------CccccCCccccEEEcCCCcEEEEecCc
Q 008759 404 KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ--------DVVHRDIKCANILVDANGSVKLADFGL 475 (554)
Q Consensus 404 ~~~LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~--------gIIHrDIKPeNILld~~g~vKL~DFGl 475 (554)
.+|||||||++|+|.+++++..+++..+..++.|++.||.|||++ +||||||||+||||+.++++||+|||+
T Consensus 75 ~~~lV~Ey~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl 154 (303)
T 3hmm_A 75 QLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEEecCCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence 589999999999999999999999999999999999999999987 999999999999999999999999999
Q ss_pred ccccccCC------ccCccCCCcccChhhhcccCC----CCCchhhHHHHHHHHHHHHcCCCCCC
Q 008759 476 AKATKLND------VKSCRGTAFWMAPEVINNKNK----GYGLPADIWSLGCTVLEMLTSQIPYA 530 (554)
Q Consensus 476 A~~~~~~~------~~s~~GT~~Y~APEvl~~~~~----~~s~ksDIwSLGvllyeLLTG~~PF~ 530 (554)
++...... ....+||+.|||||++.+... .|+.++|||||||++|||+||..||.
T Consensus 155 a~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~ 219 (303)
T 3hmm_A 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 219 (303)
T ss_dssp CEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTT
T ss_pred CccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCC
Confidence 98654322 223569999999999965421 25679999999999999999977654
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=390.23 Aligned_cols=211 Identities=26% Similarity=0.414 Sum_probs=186.7
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCc
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~ 404 (554)
.++++|++++.||+|+||+||+|.+ .+|+.||+|++.... ....+.+.+|+.+|+.++|||||+++++|.+.+.
T Consensus 154 ~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~-----~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 228 (573)
T 3uto_A 154 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-----ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNE 228 (573)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-----HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSE
T ss_pred cCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc-----hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence 3567899999999999999999998 789999999987422 2234678899999999999999999999999999
Q ss_pred EEEEEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCC--CcEEEEecCcccccc
Q 008759 405 LYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN--GSVKLADFGLAKATK 480 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~--g~vKL~DFGlA~~~~ 480 (554)
+|||||||.||+|.+++.. ..+++.+++.|++||+.||.|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 229 ~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~ 308 (573)
T 3uto_A 229 MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 308 (573)
T ss_dssp EEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECC
T ss_pred EEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEcc
Confidence 9999999999999998853 469999999999999999999999999999999999999854 899999999998765
Q ss_pred cCC-ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHH
Q 008759 481 LND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTV 543 (554)
Q Consensus 481 ~~~-~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~ 543 (554)
... ....+||+.|||||++.+. .|+.++|||||||++|+|++|+.||.+....+.+..+..
T Consensus 309 ~~~~~~~~~GT~~y~APEv~~~~--~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~ 370 (573)
T 3uto_A 309 PKQSVKVTTGTAEFAAPEVAEGK--PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKS 370 (573)
T ss_dssp TTSEEEEECSSGGGCCHHHHTTC--CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHT
T ss_pred CCCceeeeEECccccCHHHhCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHh
Confidence 443 4556799999999999764 489999999999999999999999999888777766654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=332.32 Aligned_cols=209 Identities=32% Similarity=0.583 Sum_probs=185.6
Q ss_pred cccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcE
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL 405 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~ 405 (554)
..++|++.+.||+|+||+||+|.+ .+++.||+|++....... .+.+.+|+.+++.++||||+++++++...+.+
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 92 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-----KELIINEILVMRENKNPNIVNYLDSYLVGDEL 92 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC-----HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH-----HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEE
Confidence 456899999999999999999998 789999999987533222 34578999999999999999999999999999
Q ss_pred EEEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC--C
Q 008759 406 YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--D 483 (554)
Q Consensus 406 ~LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~--~ 483 (554)
|+||||+.+++|.+++....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus 93 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 172 (297)
T 3fxz_A 93 WVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (297)
T ss_dssp EEEEECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred EEEEECCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccc
Confidence 99999999999999999888999999999999999999999999999999999999999999999999998765433 2
Q ss_pred ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHH
Q 008759 484 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKT 542 (554)
Q Consensus 484 ~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~ 542 (554)
.....||+.|+|||++.+. .++.++|||||||++|+|++|+.||........++.+.
T Consensus 173 ~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~ 229 (297)
T 3fxz_A 173 RSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA 229 (297)
T ss_dssp BCCCCSCGGGCCHHHHHCS--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred cCCccCCcCccChhhhcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 3455799999999999654 48899999999999999999999999888777666554
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=342.76 Aligned_cols=214 Identities=27% Similarity=0.427 Sum_probs=179.7
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhC-CCCceeeeeeeccCCC
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDES 403 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIVkl~~~~~~~~ 403 (554)
...++|+++++||+|+||+||+|++ .+++.||+|++..... ........+.+|+.++..+ +||||+++++++.+.+
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~--~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~ 97 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVI--LQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPD 97 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH--HHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHh--cchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Confidence 3457899999999999999999998 6799999999874211 1223345678899999988 6999999999999999
Q ss_pred cEEEEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccccc-
Q 008759 404 KLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL- 481 (554)
Q Consensus 404 ~~~LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~- 481 (554)
.+|+||||+.+|+|..++++ ..+++..++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 98 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~ 177 (353)
T 3txo_A 98 RLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN 177 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccC
Confidence 99999999999999998876 4699999999999999999999999999999999999999999999999999975332
Q ss_pred -CCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHH
Q 008759 482 -NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTV 543 (554)
Q Consensus 482 -~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~ 543 (554)
......+||+.|+|||++.+.. |+.++|||||||++|+|++|+.||......+.+.++..
T Consensus 178 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~ 238 (353)
T 3txo_A 178 GVTTATFCGTPDYIAPEILQEML--YGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN 238 (353)
T ss_dssp --------CCGGGCCHHHHHHHH--CTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CccccccCCCcCeEChhhcCCCC--cCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence 2344567999999999997654 88999999999999999999999998877665555543
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=338.45 Aligned_cols=210 Identities=28% Similarity=0.464 Sum_probs=181.9
Q ss_pred ccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEE
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~ 406 (554)
.++|++++.||+|+||+||+|.+ .+|+.||+|++..... ........+.+|+.+|..++||||+++++++.+.+.+|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 81 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVI--IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHh--hhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence 57899999999999999999998 6799999999874211 11223456789999999999999999999999999999
Q ss_pred EEEeecccCchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccc--cCC
Q 008759 407 IFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK--LND 483 (554)
Q Consensus 407 LVmE~~~ggsL~~ll~~~-~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~--~~~ 483 (554)
+||||+.+|+|..++.+. .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++... ...
T Consensus 82 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~ 161 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT 161 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCc
Confidence 999999999999988764 58999999999999999999999999999999999999999999999999997532 233
Q ss_pred ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHH
Q 008759 484 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIK 541 (554)
Q Consensus 484 ~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i 541 (554)
....+||+.|+|||++.+. .|+.++|||||||++|+|++|+.||......+....+
T Consensus 162 ~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i 217 (337)
T 1o6l_A 162 MKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217 (337)
T ss_dssp BCCCEECGGGCCGGGGSSS--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred ccccccChhhCChhhhcCC--CCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 4566799999999999654 4889999999999999999999999887665544433
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=351.92 Aligned_cols=216 Identities=26% Similarity=0.433 Sum_probs=186.0
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCc
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~ 404 (554)
...++|+++++||+|+||+||+|.+ .+++.||+|++...... .......+.+|+.++..++||||++++++|.+...
T Consensus 66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~--~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 143 (410)
T 3v8s_A 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI--KRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 143 (410)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH--HTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhh--hhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence 3457899999999999999999998 67899999998742110 01112347789999999999999999999999999
Q ss_pred EEEEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC-
Q 008759 405 LYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND- 483 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~- 483 (554)
+||||||+.+|+|.+++++..+++..++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus 144 ~~lV~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~ 223 (410)
T 3v8s_A 144 LYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 223 (410)
T ss_dssp EEEEECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSE
T ss_pred EEEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCc
Confidence 9999999999999999998889999999999999999999999999999999999999999999999999997654432
Q ss_pred --ccCccCCCcccChhhhcccCCC--CCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHH
Q 008759 484 --VKSCRGTAFWMAPEVINNKNKG--YGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTV 543 (554)
Q Consensus 484 --~~s~~GT~~Y~APEvl~~~~~~--~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~ 543 (554)
....+||+.|+|||++.+.... |+.++|||||||++|+|++|+.||......+...++..
T Consensus 224 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~ 287 (410)
T 3v8s_A 224 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMN 287 (410)
T ss_dssp EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT
T ss_pred ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHh
Confidence 3356799999999999754322 77899999999999999999999998877666666554
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=334.81 Aligned_cols=213 Identities=24% Similarity=0.437 Sum_probs=185.9
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCc
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~ 404 (554)
...++|++++.||+|+||.||+|.+ .+|+.||+|++..... .....+.+.+|+.+++.++||||+++++++...+.
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 88 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL---NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKT 88 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCE
Confidence 3467899999999999999999998 7899999999875332 23445678899999999999999999999999999
Q ss_pred EEEEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC-
Q 008759 405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN- 482 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~- 482 (554)
+|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 168 (328)
T 3fe3_A 89 LYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG 168 (328)
T ss_dssp EEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred EEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence 9999999999999998865 56999999999999999999999999999999999999999999999999999765433
Q ss_pred CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHH
Q 008759 483 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKT 542 (554)
Q Consensus 483 ~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~ 542 (554)
.....+||+.|+|||++.+.. ..+.++|||||||++|+|++|+.||......+...++.
T Consensus 169 ~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~ 227 (328)
T 3fe3_A 169 KLDAFCGAPPYAAPELFQGKK-YDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVL 227 (328)
T ss_dssp GGGTTSSSGGGCCHHHHHTCC-CCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred ccccccCCcceeCcccccCCC-cCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 345667999999999997653 23589999999999999999999999887666555443
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=324.93 Aligned_cols=212 Identities=29% Similarity=0.438 Sum_probs=181.2
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCc
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~ 404 (554)
.+.++|++++.||+|+||.||+|.+ .++..||+|++..... ......+.+.+|+.++..++||||+++++++...+.
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~ 85 (294)
T 4eqm_A 8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPR--EKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDC 85 (294)
T ss_dssp CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSS--CCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSE
T ss_pred HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCcc--ccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCe
Confidence 4567899999999999999999998 6799999999865332 224456788999999999999999999999999999
Q ss_pred EEEEEeecccCchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC
Q 008759 405 LYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND 483 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~~-~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~ 483 (554)
+|+||||+.+++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 86 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 165 (294)
T 4eqm_A 86 YYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS 165 (294)
T ss_dssp EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence 99999999999999998764 58999999999999999999999999999999999999999999999999997654322
Q ss_pred ---ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHH
Q 008759 484 ---VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIK 541 (554)
Q Consensus 484 ---~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i 541 (554)
.....||+.|+|||++.+. .++.++|||||||++|+|++|+.||......+...+.
T Consensus 166 ~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~ 224 (294)
T 4eqm_A 166 LTQTNHVLGTVQYFSPEQAKGE--ATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKH 224 (294)
T ss_dssp ---------CCSSCCHHHHHTC--CCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHH
T ss_pred ccccCccccCccccCHhHhcCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 2345699999999999664 4788999999999999999999999988776655444
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=332.93 Aligned_cols=211 Identities=29% Similarity=0.480 Sum_probs=183.6
Q ss_pred ccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEE
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~ 406 (554)
.++|++++.||+|+||.||+|++ .+|+.||+|++..... ........+.+|+.++..++||||+++++++.+...+|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 82 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIV--VRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF 82 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence 57899999999999999999998 6799999999874211 11122456778999999999999999999999999999
Q ss_pred EEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCCcc
Q 008759 407 IFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK 485 (554)
Q Consensus 407 LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~~~ 485 (554)
+||||+.+|+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.... ...
T Consensus 83 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~-~~~ 161 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-VTY 161 (318)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS-CBC
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC-ccc
Confidence 99999999999999976 4689999999999999999999999999999999999999999999999999976543 334
Q ss_pred CccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHH
Q 008759 486 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTV 543 (554)
Q Consensus 486 s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~ 543 (554)
..+||+.|+|||++.+. .++.++|||||||++|+|++|+.||......+...++..
T Consensus 162 ~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~ 217 (318)
T 1fot_A 162 TLCGTPDYIAPEVVSTK--PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN 217 (318)
T ss_dssp CCCSCTTTCCHHHHTTC--CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH
T ss_pred cccCCccccCHhHhcCC--CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 56799999999999654 488999999999999999999999998877666555543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=344.23 Aligned_cols=201 Identities=27% Similarity=0.498 Sum_probs=175.3
Q ss_pred cccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhC-CCCceeeeeeeccCCCc
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESK 404 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIVkl~~~~~~~~~ 404 (554)
..++|+++++||+|+||+||+|++ .+++.||+|++...... .......+.+|..++..+ +||||++++++|.+.+.
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~--~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 127 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVN--DDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 127 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC------CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhcc--CHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCE
Confidence 357899999999999999999998 67899999999753321 223345677899998876 89999999999999999
Q ss_pred EEEEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccc--cc
Q 008759 405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT--KL 481 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~--~~ 481 (554)
+||||||+.+|+|..++++ ..+++..++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.. ..
T Consensus 128 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~ 207 (396)
T 4dc2_A 128 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 207 (396)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccCC
Confidence 9999999999999998876 46999999999999999999999999999999999999999999999999999753 22
Q ss_pred CCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008759 482 NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP 531 (554)
Q Consensus 482 ~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~ 531 (554)
......+||+.|+|||++.+. .|+.++|||||||++|+|++|+.||..
T Consensus 208 ~~~~~~~gt~~Y~aPE~l~~~--~~~~~~DiwslGvllyell~G~~Pf~~ 255 (396)
T 4dc2_A 208 DTTSTFCGTPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFDI 255 (396)
T ss_dssp CCBCCCCBCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSTT
T ss_pred CccccccCCcccCCchhhcCC--CCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence 344567799999999999654 489999999999999999999999964
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=336.19 Aligned_cols=212 Identities=29% Similarity=0.462 Sum_probs=181.5
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhC-CCCceeeeeeeccCCC
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDES 403 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIVkl~~~~~~~~ 403 (554)
...++|++.+.||+|+||.||+|.+ .+++.||+|++...... .......+..|..++..+ +||||+++++++.+.+
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~ 91 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVL--MDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE 91 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHH--HTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhh--hhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence 4467899999999999999999998 67999999999742111 112235577888888876 8999999999999999
Q ss_pred cEEEEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccc--
Q 008759 404 KLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK-- 480 (554)
Q Consensus 404 ~~~LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~-- 480 (554)
.+|+||||+.+|+|..++.+ ..+++..+..|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 92 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 171 (345)
T 1xjd_A 92 NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 171 (345)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccC
Confidence 99999999999999999876 569999999999999999999999999999999999999999999999999997643
Q ss_pred cCCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHH
Q 008759 481 LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIK 541 (554)
Q Consensus 481 ~~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i 541 (554)
.......+||+.|+|||++.+. .|+.++|||||||++|+|++|+.||...+..+.+..+
T Consensus 172 ~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i 230 (345)
T 1xjd_A 172 DAKTNTFCGTPDYIAPEILLGQ--KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI 230 (345)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CCcccCCCCCcccCChhhhcCC--CCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 2334566799999999999654 4889999999999999999999999987765554444
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=333.12 Aligned_cols=200 Identities=28% Similarity=0.506 Sum_probs=177.4
Q ss_pred ccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhC-CCCceeeeeeeccCCCcE
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESKL 405 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIVkl~~~~~~~~~~ 405 (554)
.++|++++.||+|+||.||+|++ .+++.||+|++...... .......+.+|+.++..+ +||||+++++++.+.+.+
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 85 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVN--DDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 85 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSC--SHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhc--chHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEE
Confidence 57899999999999999999998 67899999999753322 234456788999999887 899999999999999999
Q ss_pred EEEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccc--cC
Q 008759 406 YIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK--LN 482 (554)
Q Consensus 406 ~LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~--~~ 482 (554)
|+||||+.+|+|..++.+ ..+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++... ..
T Consensus 86 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~ 165 (345)
T 3a8x_A 86 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 165 (345)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTC
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCCC
Confidence 999999999999998876 469999999999999999999999999999999999999999999999999997532 23
Q ss_pred CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008759 483 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP 531 (554)
Q Consensus 483 ~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~ 531 (554)
.....+||+.|+|||++.+. .|+.++|||||||++|+|++|+.||..
T Consensus 166 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~ 212 (345)
T 3a8x_A 166 TTSTFCGTPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFDI 212 (345)
T ss_dssp CBCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cccccCCCccccCccccCCC--CCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence 34556799999999999654 488999999999999999999999975
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=339.35 Aligned_cols=213 Identities=28% Similarity=0.420 Sum_probs=175.2
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHH-HHhCCCCceeeeeeeccCCC
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL-LSRFEHENIVQYYGTDKDES 403 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~i-L~~l~HpnIVkl~~~~~~~~ 403 (554)
...++|++++.||+|+||.||+|++ .+++.||+|++....... ......+..|..+ ++.++||||+++++++.+.+
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~--~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~ 112 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILK--KKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD 112 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC---------------CCBCCCCCTTBCCEEEEEECSS
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhh--hHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCC
Confidence 4567999999999999999999998 678999999997533221 2234456677766 56789999999999999999
Q ss_pred cEEEEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccc--
Q 008759 404 KLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK-- 480 (554)
Q Consensus 404 ~~~LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~-- 480 (554)
.+|+||||+.+|+|..++++ ..+.+..++.|+.||+.||.|||++||+||||||+|||++.+|++||+|||+++...
T Consensus 113 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 113 KLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence 99999999999999999876 458999999999999999999999999999999999999999999999999997632
Q ss_pred cCCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHH
Q 008759 481 LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKT 542 (554)
Q Consensus 481 ~~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~ 542 (554)
.......+||+.|+|||++.+. .|+.++|||||||++|+|++|..||......+....+.
T Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~ 252 (373)
T 2r5t_A 193 NSTTSTFCGTPEYLAPEVLHKQ--PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL 252 (373)
T ss_dssp CCCCCSBSCCCCCCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHH
T ss_pred CCccccccCCccccCHHHhCCC--CCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence 2234566799999999999654 48999999999999999999999999877665554443
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=348.93 Aligned_cols=216 Identities=25% Similarity=0.388 Sum_probs=184.3
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCc
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~ 404 (554)
...++|+++++||+|+||+||+|++ .+++.||+|++...... .......+.+|+.++..++||||++++++|.+.+.
T Consensus 71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~ 148 (437)
T 4aw2_A 71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEML--KRAETACFREERDVLVNGDSKWITTLHYAFQDDNN 148 (437)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHH--HTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhh--hHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCE
Confidence 3457899999999999999999998 56899999998742111 11112347789999999999999999999999999
Q ss_pred EEEEEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC
Q 008759 405 LYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN 482 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~ 482 (554)
+||||||+.+|+|.+++.+ ..+++..++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 149 ~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 228 (437)
T 4aw2_A 149 LYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 228 (437)
T ss_dssp EEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccC
Confidence 9999999999999999976 56999999999999999999999999999999999999999999999999999765433
Q ss_pred C---ccCccCCCcccChhhhccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHH
Q 008759 483 D---VKSCRGTAFWMAPEVINNK---NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTV 543 (554)
Q Consensus 483 ~---~~s~~GT~~Y~APEvl~~~---~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~ 543 (554)
. ....+||+.|+|||++... ...|+.++|||||||++|||++|+.||......+...++..
T Consensus 229 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~ 295 (437)
T 4aw2_A 229 GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 295 (437)
T ss_dssp SCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT
T ss_pred CCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhh
Confidence 2 2335799999999999631 23488999999999999999999999998887776666654
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=325.50 Aligned_cols=214 Identities=30% Similarity=0.506 Sum_probs=180.9
Q ss_pred ccccccceeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCC
Q 008759 324 FKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES 403 (554)
Q Consensus 324 ~~~~~~~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~ 403 (554)
.+.+.++|++++.||+|+||+||+|.+.+++.||+|++..... .......+.+|+.+++.++||||+++++++.+..
T Consensus 16 ~q~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 92 (311)
T 3niz_A 16 FQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAE---DEGIPSTAIREISLLKELHHPNIVSLIDVIHSER 92 (311)
T ss_dssp EECSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC---------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSS
T ss_pred ecchHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccc---cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCC
Confidence 4567789999999999999999999998899999999864322 1223456789999999999999999999999999
Q ss_pred cEEEEEeecccCchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccccc
Q 008759 404 KLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL 481 (554)
Q Consensus 404 ~~~LVmE~~~ggsL~~ll~~~--~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~ 481 (554)
.+|+||||+.+ +|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 93 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 171 (311)
T 3niz_A 93 CLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGI 171 (311)
T ss_dssp CEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred EEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence 99999999986 677766543 489999999999999999999999999999999999999999999999999976542
Q ss_pred C--CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHH
Q 008759 482 N--DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKT 542 (554)
Q Consensus 482 ~--~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~ 542 (554)
. ......||+.|+|||++.+.. .++.++|||||||++|+|++|+.||......+.+..+.
T Consensus 172 ~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 233 (311)
T 3niz_A 172 PVRSYTHEVVTLWYRAPDVLMGSK-KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIF 233 (311)
T ss_dssp CCC---CCCCCCTTCCHHHHTTCC-SCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHH
T ss_pred CcccccCCcccCCcCCHHHhcCCC-CCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 2 234456899999999986532 47899999999999999999999999877666655544
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=335.17 Aligned_cols=211 Identities=28% Similarity=0.440 Sum_probs=183.9
Q ss_pred cccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcE
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL 405 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~ 405 (554)
..++|++++.||+|+||.||+|.+ .+|+.||+|++..... ........+.+|+.+|+.++||||+++++++.+...+
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 116 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV--VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL 116 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHh--ccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 357899999999999999999998 6799999999864221 1112345788999999999999999999999999999
Q ss_pred EEEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCCc
Q 008759 406 YIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV 484 (554)
Q Consensus 406 ~LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~~ 484 (554)
|+||||+.+|+|.+++.+ ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++..... .
T Consensus 117 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-~ 195 (350)
T 1rdq_E 117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-T 195 (350)
T ss_dssp EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-B
T ss_pred EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC-c
Confidence 999999999999999876 46899999999999999999999999999999999999999999999999999866443 3
Q ss_pred cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHH
Q 008759 485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKT 542 (554)
Q Consensus 485 ~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~ 542 (554)
...+||+.|+|||++.+. .++.++|||||||++|+|++|+.||......+...++.
T Consensus 196 ~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~ 251 (350)
T 1rdq_E 196 WTLCGTPEALAPEIILSK--GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV 251 (350)
T ss_dssp CCCEECGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred ccccCCccccCHHHhcCC--CCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHH
Confidence 456799999999999654 48899999999999999999999999877665554443
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=335.61 Aligned_cols=211 Identities=26% Similarity=0.402 Sum_probs=181.5
Q ss_pred cccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhC-CCCceeeeeeeccCCCc
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESK 404 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIVkl~~~~~~~~~ 404 (554)
..++|++++.||+|+||+||+|.+ .+++.||+|++...... .......+..|..++..+ +||||+++++++.+.+.
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~--~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 95 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVI--QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 95 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHH--HTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh--cchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence 457899999999999999999998 56899999998742211 112345677899999887 79999999999999999
Q ss_pred EEEEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccc--c
Q 008759 405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK--L 481 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~--~ 481 (554)
+|+||||+.+|+|..++.+ ..+++..++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+++... .
T Consensus 96 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 175 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 175 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC
Confidence 9999999999999999876 569999999999999999999999999999999999999999999999999997632 2
Q ss_pred CCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHH
Q 008759 482 NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIK 541 (554)
Q Consensus 482 ~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i 541 (554)
......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||......+.+..+
T Consensus 176 ~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i 233 (353)
T 2i0e_A 176 VTTKTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI 233 (353)
T ss_dssp CCBCCCCSCGGGCCHHHHTTC--CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred cccccccCCccccChhhhcCC--CcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 234566799999999999654 4889999999999999999999999987665554444
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=344.45 Aligned_cols=216 Identities=26% Similarity=0.394 Sum_probs=184.8
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCc
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~ 404 (554)
...++|+++++||+|+||+||+|++ .+++.||+|++..... ........+.+|+.++..++||||++++++|.+.+.
T Consensus 58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~--~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~ 135 (412)
T 2vd5_A 58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDM--LKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENY 135 (412)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH--HHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHh--hhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence 3457899999999999999999998 6899999999874211 111223457789999999999999999999999999
Q ss_pred EEEEEeecccCchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC
Q 008759 405 LYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN 482 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~~--~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~ 482 (554)
+||||||+.+|+|.+++.+. .+++..++.|+.||+.||.|||++||+||||||+|||++.+|++||+|||+++.....
T Consensus 136 ~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~ 215 (412)
T 2vd5_A 136 LYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD 215 (412)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCC
Confidence 99999999999999999863 5999999999999999999999999999999999999999999999999999765433
Q ss_pred C---ccCccCCCcccChhhhccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHH
Q 008759 483 D---VKSCRGTAFWMAPEVINNK-----NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTV 543 (554)
Q Consensus 483 ~---~~s~~GT~~Y~APEvl~~~-----~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~ 543 (554)
. ....+||+.|+|||++... ...|+.++|||||||++|||++|+.||......+...++..
T Consensus 216 ~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~ 284 (412)
T 2vd5_A 216 GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVH 284 (412)
T ss_dssp SCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT
T ss_pred CccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 2 2345799999999999642 23478999999999999999999999998877666555543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=335.91 Aligned_cols=212 Identities=26% Similarity=0.435 Sum_probs=174.4
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCC-CCceeeeeeeccCCC
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDES 403 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIVkl~~~~~~~~ 403 (554)
.+.++|++++.||+|+||.||+|.+ .+++.||+|++.... ........+.+|+.++..+. ||||+++++++...+
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 82 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF---QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADN 82 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC-----CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTT
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc---cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCC
Confidence 4567999999999999999999998 789999999986422 22344567789999999997 999999999986544
Q ss_pred --cEEEEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccccc
Q 008759 404 --KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL 481 (554)
Q Consensus 404 --~~~LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~ 481 (554)
.+|+||||+.+ +|..++....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 83 ~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 161 (388)
T 3oz6_A 83 DRDVYLVFDYMET-DLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVN 161 (388)
T ss_dssp SSCEEEEEECCSE-EHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSS
T ss_pred CCEEEEEecccCc-CHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccc
Confidence 79999999985 899999888899999999999999999999999999999999999999999999999999975422
Q ss_pred -----------------------CCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHH
Q 008759 482 -----------------------NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAI 538 (554)
Q Consensus 482 -----------------------~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i 538 (554)
......+||++|+|||++.+. ..|+.++|||||||++|+|++|+.||.+.+..+.+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~ 240 (388)
T 3oz6_A 162 IRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGS-TKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQL 240 (388)
T ss_dssp CCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred cccccccccccccccccccccccccccCCcccCCcCCHHHhcCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 112345799999999999653 35899999999999999999999999999888877
Q ss_pred HHHH
Q 008759 539 FIKT 542 (554)
Q Consensus 539 ~~i~ 542 (554)
.++.
T Consensus 241 ~~i~ 244 (388)
T 3oz6_A 241 ERII 244 (388)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7665
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=334.73 Aligned_cols=214 Identities=27% Similarity=0.488 Sum_probs=184.2
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccch-hHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCC
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQ-AKQSISQLEQEIALLSRFEHENIVQYYGTDKDES 403 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~-~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~ 403 (554)
.+.++|++++.||+|+||.||+|.+ .+|+.||+|++........ .......+.+|+.+|..++||||+++++++.+..
T Consensus 9 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 88 (361)
T 2yab_A 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRT 88 (361)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCC
Confidence 4567899999999999999999998 6799999999975432211 0112356889999999999999999999999999
Q ss_pred cEEEEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCC----cEEEEecCcccc
Q 008759 404 KLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG----SVKLADFGLAKA 478 (554)
Q Consensus 404 ~~~LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g----~vKL~DFGlA~~ 478 (554)
.+|+||||+.+|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~ 168 (361)
T 2yab_A 89 DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (361)
T ss_dssp EEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceE
Confidence 99999999999999999976 4689999999999999999999999999999999999998877 799999999987
Q ss_pred cccC-CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHH
Q 008759 479 TKLN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIK 541 (554)
Q Consensus 479 ~~~~-~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i 541 (554)
.... ......||+.|+|||++.+. .|+.++|||||||++|+|++|..||......+.+..+
T Consensus 169 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i 230 (361)
T 2yab_A 169 IEDGVEFKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI 230 (361)
T ss_dssp CCTTCCCCCCCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH
T ss_pred cCCCCccccCCCCccEECchHHcCC--CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 5543 34556799999999999654 4889999999999999999999999887666555444
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-39 Score=328.53 Aligned_cols=209 Identities=22% Similarity=0.366 Sum_probs=182.2
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCc
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~ 404 (554)
.+.++|++++.||+|+||.||+|.+ .+++.||+|.+... ......+.+|+.+++.++||||+++++++.+.+.
T Consensus 2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~------~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 75 (321)
T 1tki_A 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK------GTDQVLVKKEISILNIARHRNILHLHESFESMEE 75 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC------THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTE
T ss_pred chhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC------cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCE
Confidence 4567999999999999999999998 67899999998642 1223567899999999999999999999999999
Q ss_pred EEEEEeecccCchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcC--CCcEEEEecCcccccc
Q 008759 405 LYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA--NGSVKLADFGLAKATK 480 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~~--~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~--~g~vKL~DFGlA~~~~ 480 (554)
+|+||||+.+++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++...
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~ 155 (321)
T 1tki_A 76 LVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp EEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred EEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECC
Confidence 99999999999999999764 5899999999999999999999999999999999999987 7899999999998764
Q ss_pred cCC-ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHH
Q 008759 481 LND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKT 542 (554)
Q Consensus 481 ~~~-~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~ 542 (554)
... .....||+.|+|||++.+. .++.++|||||||++|+|++|..||......+.+..+.
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 216 (321)
T 1tki_A 156 PGDNFRLLFTAPEYYAPEVHQHD--VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIM 216 (321)
T ss_dssp TTCEEEEEESCGGGSCHHHHTTC--EECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred CCCccccccCChhhcCcHHhcCC--CCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHH
Confidence 433 3445699999999999654 37899999999999999999999998877665544443
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=329.31 Aligned_cols=223 Identities=29% Similarity=0.497 Sum_probs=184.5
Q ss_pred CCccccccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeee
Q 008759 320 PNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGT 398 (554)
Q Consensus 320 ~~~~~~~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~ 398 (554)
..+....+.++|++++.||+|+||.||+|.+ .++..||+|++...............+.+|+.+++.++||||++++++
T Consensus 17 q~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 96 (345)
T 3hko_A 17 QGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEV 96 (345)
T ss_dssp CCBCHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cCchhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehh
Confidence 3345667788999999999999999999998 778999999987532222223445678999999999999999999999
Q ss_pred ccCCCcEEEEEeecccCchHHHHhh-----------------------------------------hcCChHHHHHHHHH
Q 008759 399 DKDESKLYIFLELVTKGSLLNLYQR-----------------------------------------YHLRDSQVSAYTRQ 437 (554)
Q Consensus 399 ~~~~~~~~LVmE~~~ggsL~~ll~~-----------------------------------------~~l~e~~i~~i~~Q 437 (554)
+.+.+.+|+||||+.+|+|.+++.. ..+++..++.++.|
T Consensus 97 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~q 176 (345)
T 3hko_A 97 YEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQ 176 (345)
T ss_dssp EECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHH
T ss_pred hccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHH
Confidence 9999999999999999999998852 12356778889999
Q ss_pred HHHHHHHHHHCCccccCCccccEEEcCCC--cEEEEecCcccccccC------CccCccCCCcccChhhhcccCCCCCch
Q 008759 438 ILLGLKYLHDQDVVHRDIKCANILVDANG--SVKLADFGLAKATKLN------DVKSCRGTAFWMAPEVINNKNKGYGLP 509 (554)
Q Consensus 438 Il~gL~yLHs~gIIHrDIKPeNILld~~g--~vKL~DFGlA~~~~~~------~~~s~~GT~~Y~APEvl~~~~~~~s~k 509 (554)
|+.||.|||++||+||||||+|||++.++ .+||+|||+++..... ......||+.|+|||++.+....++.+
T Consensus 177 i~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 177 IFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 99999999999999999999999998777 8999999999764321 123456999999999997655568999
Q ss_pred hhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHH
Q 008759 510 ADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKT 542 (554)
Q Consensus 510 sDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~ 542 (554)
+|||||||++|+|++|+.||......+.+..+.
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~ 289 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVNDADTISQVL 289 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHH
Confidence 999999999999999999999887776665543
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=327.03 Aligned_cols=213 Identities=27% Similarity=0.421 Sum_probs=173.4
Q ss_pred cccceeeeeeeccCCceeEEEEec----CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCC
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGIS----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE 402 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~----~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~ 402 (554)
..++|++.+.||+|+||.||+|.+ .+++.||+|++...... ........+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 93 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIV-RNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG 93 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC---------------HHHHHHHCCCTTBCCEEEEEECS
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC
Confidence 357899999999999999999987 57899999998753221 1123345678899999999999999999999999
Q ss_pred CcEEEEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccccc
Q 008759 403 SKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL 481 (554)
Q Consensus 403 ~~~~LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~ 481 (554)
+.+|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 173 (327)
T 3a62_A 94 GKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH 173 (327)
T ss_dssp SCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC-----
T ss_pred CEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccccccc
Confidence 999999999999999999876 4589999999999999999999999999999999999999999999999999875432
Q ss_pred --CCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHH
Q 008759 482 --NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKT 542 (554)
Q Consensus 482 --~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~ 542 (554)
.......||+.|+|||++.+. .++.++|||||||++|+|++|+.||......+.+..+.
T Consensus 174 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~ 234 (327)
T 3a62_A 174 DGTVTHTFCGTIEYMAPEILMRS--GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKIL 234 (327)
T ss_dssp -----CTTSSCCTTSCHHHHTTS--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred CCccccccCCCcCccCHhhCcCC--CCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 223456799999999999654 47899999999999999999999999877665554443
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=337.77 Aligned_cols=204 Identities=27% Similarity=0.531 Sum_probs=179.3
Q ss_pred cccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcE
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL 405 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~ 405 (554)
..++|++++.||+|+||.||+|.+ .+++.||+|++..... ........+.+|+.+|+.++|||||+++++|.+.+.+
T Consensus 13 ~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~--~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 90 (384)
T 4fr4_A 13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKC--VERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDM 90 (384)
T ss_dssp CGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhc--ccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 457899999999999999999998 6789999999874221 1122346788999999999999999999999999999
Q ss_pred EEEEeecccCchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccccc-CC
Q 008759 406 YIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL-ND 483 (554)
Q Consensus 406 ~LVmE~~~ggsL~~ll~~~-~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~-~~ 483 (554)
|+||||+.+|+|..++... .+++..++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.... ..
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~ 170 (384)
T 4fr4_A 91 FMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ 170 (384)
T ss_dssp EEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCCCc
Confidence 9999999999999999864 699999999999999999999999999999999999999999999999999987543 33
Q ss_pred ccCccCCCcccChhhhccc-CCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008759 484 VKSCRGTAFWMAPEVINNK-NKGYGLPADIWSLGCTVLEMLTSQIPYAPM 532 (554)
Q Consensus 484 ~~s~~GT~~Y~APEvl~~~-~~~~s~ksDIwSLGvllyeLLTG~~PF~~~ 532 (554)
....+||+.|+|||++... ...|+.++|||||||++|+|++|+.||...
T Consensus 171 ~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~ 220 (384)
T 4fr4_A 171 ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIR 220 (384)
T ss_dssp BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCC
T ss_pred eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCC
Confidence 4567799999999999653 335889999999999999999999999753
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=333.80 Aligned_cols=204 Identities=29% Similarity=0.502 Sum_probs=174.7
Q ss_pred cccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcE
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL 405 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~ 405 (554)
+.+.|++.+.||+|+||+||+|.+ .+++.||+|++.............+.+.+|+.+++.++||||+++++++.+.+.+
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 457899999999999999999998 6799999999874221111111245688999999999999999999999999999
Q ss_pred EEEEeecccCchHHHHhhh-----cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCc---EEEEecCccc
Q 008759 406 YIFLELVTKGSLLNLYQRY-----HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS---VKLADFGLAK 477 (554)
Q Consensus 406 ~LVmE~~~ggsL~~ll~~~-----~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~---vKL~DFGlA~ 477 (554)
|+||||+.+++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||++.
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~ 181 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI 181 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCE
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCccee
Confidence 9999999999998877542 3899999999999999999999999999999999999987655 9999999997
Q ss_pred ccccCC--ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008759 478 ATKLND--VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM 532 (554)
Q Consensus 478 ~~~~~~--~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~ 532 (554)
...... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||...
T Consensus 182 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~ 236 (351)
T 3c0i_A 182 QLGESGLVAGGRVGTPHFMAPEVVKRE--PYGKPVDVWGCGVILFILLSGCLPFYGT 236 (351)
T ss_dssp ECCTTSCBCCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred EecCCCeeecCCcCCcCccCHHHHcCC--CCCchHhhHHHHHHHHHHHHCCCCCCCc
Confidence 654432 2345799999999999654 4889999999999999999999999874
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=319.03 Aligned_cols=210 Identities=28% Similarity=0.494 Sum_probs=178.1
Q ss_pred cceeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEE
Q 008759 329 TYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LV 408 (554)
++|++++.||+|+||+||+|.+.+++.||+|++...... ......+.+|+.+++.++||||+++++++...+.+|+|
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKED---EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGG---GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccc---cccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEE
Confidence 579999999999999999999988999999998753321 11224577999999999999999999999999999999
Q ss_pred EeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC--Cc
Q 008759 409 LELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--DV 484 (554)
Q Consensus 409 mE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~--~~ 484 (554)
|||+.+ +|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... ..
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (288)
T 1ob3_A 79 FEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY 157 (288)
T ss_dssp EECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred EEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccccc
Confidence 999987 88888865 46899999999999999999999999999999999999999999999999998765422 23
Q ss_pred cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHH
Q 008759 485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTV 543 (554)
Q Consensus 485 ~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~ 543 (554)
....||+.|+|||++.+.. .++.++|||||||++|+|++|+.||......+.+..+..
T Consensus 158 ~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~ 215 (288)
T 1ob3_A 158 THEIVTLWYRAPDVLMGSK-KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFR 215 (288)
T ss_dssp ----CCCTTCCHHHHTTCC-SCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred ccccccccccCchheeCCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 3456899999999986432 478999999999999999999999998877766665543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=330.46 Aligned_cols=211 Identities=27% Similarity=0.454 Sum_probs=182.5
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCc
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~ 404 (554)
.+.++|++++.||+|+||.||+|.+ .+++.||+|++...... ......+.+|+.+++.++||||+++++++.+.+.
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~ 102 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS---ARDFQKLEREARICRKLQHPNIVRLHDSIQEESF 102 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC---HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE
Confidence 4567899999999999999999998 67999999999753322 2345678899999999999999999999999999
Q ss_pred EEEEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCC---cEEEEecCcccccc
Q 008759 405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG---SVKLADFGLAKATK 480 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g---~vKL~DFGlA~~~~ 480 (554)
+|+||||+.+|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~ 182 (362)
T 2bdw_A 103 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182 (362)
T ss_dssp EEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence 9999999999999988865 4589999999999999999999999999999999999998654 59999999997655
Q ss_pred cC-CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHH
Q 008759 481 LN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIK 541 (554)
Q Consensus 481 ~~-~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i 541 (554)
.. ......||+.|+|||++.+. .|+.++|||||||++|+|++|+.||...+..+.+..+
T Consensus 183 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i 242 (362)
T 2bdw_A 183 DSEAWHGFAGTPGYLSPEVLKKD--PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 242 (362)
T ss_dssp TCCSCCCSCSCTTTCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CCcccccCCCCccccCHHHHccC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 33 23456799999999999654 4889999999999999999999999887765554444
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=321.99 Aligned_cols=211 Identities=32% Similarity=0.561 Sum_probs=175.0
Q ss_pred cccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccch---------------------hHHHHHHHHHHHHHH
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQ---------------------AKQSISQLEQEIALL 384 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~---------------------~~~~~~~~~~Ei~iL 384 (554)
..++|++.+.||+|+||.||+|.+ .+++.||+|++........ .....+.+.+|+.++
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 457899999999999999999998 6789999999875322110 112245688999999
Q ss_pred HhCCCCceeeeeeeccC--CCcEEEEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEE
Q 008759 385 SRFEHENIVQYYGTDKD--ESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV 462 (554)
Q Consensus 385 ~~l~HpnIVkl~~~~~~--~~~~~LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILl 462 (554)
+.++||||+++++++.+ ...+|+||||+.+++|.+++....+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~ 170 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV 170 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE
Confidence 99999999999999876 5689999999999999988777789999999999999999999999999999999999999
Q ss_pred cCCCcEEEEecCcccccccCC--ccCccCCCcccChhhhcccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCChhHH
Q 008759 463 DANGSVKLADFGLAKATKLND--VKSCRGTAFWMAPEVINNKNKG-YGLPADIWSLGCTVLEMLTSQIPYAPMECVSA 537 (554)
Q Consensus 463 d~~g~vKL~DFGlA~~~~~~~--~~s~~GT~~Y~APEvl~~~~~~-~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~ 537 (554)
+.++.+||+|||+++...... .....||+.|+|||++.+.... ++.++|||||||++|+|++|+.||........
T Consensus 171 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 248 (298)
T 2zv2_A 171 GEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCL 248 (298)
T ss_dssp CTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred CCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHH
Confidence 999999999999997654332 3445799999999998654322 36789999999999999999999987765443
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=322.24 Aligned_cols=212 Identities=29% Similarity=0.486 Sum_probs=175.2
Q ss_pred ccccccceeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCC
Q 008759 324 FKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES 403 (554)
Q Consensus 324 ~~~~~~~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~ 403 (554)
+....++|++.+.||+|+||+||+|.+ ++..||+|++..... .......+.+|+.++++++||||+++++++....
T Consensus 32 ~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 107 (309)
T 3p86_A 32 MDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDF---HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP 107 (309)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCC---SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred ccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence 334467899999999999999999987 578899999864332 2344567889999999999999999999999999
Q ss_pred cEEEEEeecccCchHHHHhhhc----CChHHHHHHHHHHHHHHHHHHHCC--ccccCCccccEEEcCCCcEEEEecCccc
Q 008759 404 KLYIFLELVTKGSLLNLYQRYH----LRDSQVSAYTRQILLGLKYLHDQD--VVHRDIKCANILVDANGSVKLADFGLAK 477 (554)
Q Consensus 404 ~~~LVmE~~~ggsL~~ll~~~~----l~e~~i~~i~~QIl~gL~yLHs~g--IIHrDIKPeNILld~~g~vKL~DFGlA~ 477 (554)
.+|+||||+.+++|.+++.... +++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 187 (309)
T 3p86_A 108 NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR 187 (309)
T ss_dssp CCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC---
T ss_pred ceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCc
Confidence 9999999999999999997643 899999999999999999999999 9999999999999999999999999987
Q ss_pred ccccC--CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHH
Q 008759 478 ATKLN--DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIK 541 (554)
Q Consensus 478 ~~~~~--~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i 541 (554)
..... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||......+.+..+
T Consensus 188 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~ 251 (309)
T 3p86_A 188 LKASTFLSSKSAAGTPEWMAPEVLRDE--PSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAV 251 (309)
T ss_dssp --------------CCTTSCHHHHTTC--CCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHH
T ss_pred cccccccccccCCCCccccChhhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 54332 23445699999999999654 3788999999999999999999999988776655443
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=316.59 Aligned_cols=208 Identities=28% Similarity=0.458 Sum_probs=174.9
Q ss_pred cceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEE
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~L 407 (554)
++|++++.||+|+||+||+|.+ .+++.||+|++...... ......+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 78 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD---EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTL 78 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSS---TTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCc---CCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEE
Confidence 5799999999999999999998 67999999999754332 2234567899999999999999999999999999999
Q ss_pred EEeecccCchHHHHh-hhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC--Cc
Q 008759 408 FLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--DV 484 (554)
Q Consensus 408 VmE~~~ggsL~~ll~-~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~--~~ 484 (554)
||||+.++.+..+.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... ..
T Consensus 79 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (292)
T 3o0g_A 79 VFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY 158 (292)
T ss_dssp EEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCC
T ss_pred EEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccccc
Confidence 999998754444444 356999999999999999999999999999999999999999999999999999765432 33
Q ss_pred cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHH
Q 008759 485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFI 540 (554)
Q Consensus 485 ~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~ 540 (554)
....||+.|+|||++.+.. .++.++|||||||++|+|++|..||.........+.
T Consensus 159 ~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~ 213 (292)
T 3o0g_A 159 SAEVVTLWYRPPDVLFGAK-LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLK 213 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCS-CCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHH
T ss_pred cCCccccCCcChHHHcCCC-CcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHH
Confidence 4557899999999986543 478999999999999999998888655544444333
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=342.31 Aligned_cols=212 Identities=26% Similarity=0.455 Sum_probs=174.0
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCc
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~ 404 (554)
...++|+++++||+|+||.||+|.+ .+++.||+|++..... ........+.+|+.+++.++||||+++++++...+.
T Consensus 145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~ 222 (446)
T 4ejn_A 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVI--VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDR 222 (446)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH--C-------------CCCCCSCTTSCCEEEEEEETTE
T ss_pred CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhh--hhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCE
Confidence 3467899999999999999999998 7899999999874211 122334567789999999999999999999999999
Q ss_pred EEEEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHH-CCccccCCccccEEEcCCCcEEEEecCccccccc-
Q 008759 405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGSVKLADFGLAKATKL- 481 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs-~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~- 481 (554)
+|+||||+.+++|..++.. ..+++..+..++.||+.||.|||+ +||+||||||+||||+.++.+||+|||+++....
T Consensus 223 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 302 (446)
T 4ejn_A 223 LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 302 (446)
T ss_dssp EEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred EEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence 9999999999999998876 468999999999999999999998 9999999999999999999999999999975322
Q ss_pred -CCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHH
Q 008759 482 -NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIK 541 (554)
Q Consensus 482 -~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i 541 (554)
......+||+.|+|||++.+. .|+.++|||||||++|+|++|+.||......+....+
T Consensus 303 ~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i 361 (446)
T 4ejn_A 303 GATMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 361 (446)
T ss_dssp ----CCSSSCGGGCCHHHHHTS--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CcccccccCCccccCHhhcCCC--CCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHH
Confidence 234556799999999999654 4899999999999999999999999987766554444
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=320.65 Aligned_cols=198 Identities=26% Similarity=0.495 Sum_probs=175.2
Q ss_pred ccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEE
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~ 406 (554)
.++|.++++||+|+||+||+|.+ .++..||+|++.. ........+.+|+.++..++||||+++++++.+.+.+|
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~-----~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 83 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR-----FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLN 83 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC-----CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc-----CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeE
Confidence 46899999999999999999998 6799999998853 22345577899999999999999999999999999999
Q ss_pred EEEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCCc
Q 008759 407 IFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV 484 (554)
Q Consensus 407 LVmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~~ 484 (554)
+||||+.+++|.++++. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 84 FITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp EEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred EEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 99999999999999986 5689999999999999999999999999999999999999999999999999976433221
Q ss_pred ----------------cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008759 485 ----------------KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM 532 (554)
Q Consensus 485 ----------------~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~ 532 (554)
....||+.|+|||++.+. .++.++|||||||++|+|++|..||...
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~g~~~~~~~ 225 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGR--SYDEKVDVFSFGIVLCEIIGRVNADPDY 225 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHTCCSSTTT
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCC--CCCcHHHHHHHHHHHHHHhcCCCCCcch
Confidence 145699999999999654 4889999999999999999999999753
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=330.25 Aligned_cols=209 Identities=28% Similarity=0.487 Sum_probs=178.8
Q ss_pred ccccceeeeeeeccCCceeEEEEec--------CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhC-CCCceeeee
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS--------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYY 396 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~--------~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIVkl~ 396 (554)
...++|++++.||+|+||.||+|.+ .++..||+|++.... .......+.+|+.+++.+ +||||++++
T Consensus 78 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~hpnIv~~~ 153 (370)
T 2psq_A 78 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA----TEKDLSDLVSEMEMMKMIGKHKNIINLL 153 (370)
T ss_dssp CCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC----BHHHHHHHHHHHHHHHHSCCCTTBCCEE
T ss_pred ccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc----CHHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence 3457899999999999999999975 345679999886421 234467789999999999 899999999
Q ss_pred eeccCCCcEEEEEeecccCchHHHHhhh-----------------cCChHHHHHHHHHHHHHHHHHHHCCccccCCcccc
Q 008759 397 GTDKDESKLYIFLELVTKGSLLNLYQRY-----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCAN 459 (554)
Q Consensus 397 ~~~~~~~~~~LVmE~~~ggsL~~ll~~~-----------------~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeN 459 (554)
+++...+.+|+||||+.+|+|.+++... .+++..+..++.||+.||.|||++||+||||||+|
T Consensus 154 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N 233 (370)
T 2psq_A 154 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN 233 (370)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred EEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhh
Confidence 9999999999999999999999999764 36888999999999999999999999999999999
Q ss_pred EEEcCCCcEEEEecCcccccccCC----ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCh
Q 008759 460 ILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMEC 534 (554)
Q Consensus 460 ILld~~g~vKL~DFGlA~~~~~~~----~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~ 534 (554)
||++.++.+||+|||+++...... .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.....
T Consensus 234 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DvwslG~il~ellt~g~~p~~~~~~ 311 (370)
T 2psq_A 234 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 311 (370)
T ss_dssp EEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred EEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCC--CCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 999999999999999998654322 2234578899999999654 48999999999999999999 9999998766
Q ss_pred hHHHHH
Q 008759 535 VSAIFI 540 (554)
Q Consensus 535 ~~~i~~ 540 (554)
.+.+..
T Consensus 312 ~~~~~~ 317 (370)
T 2psq_A 312 EELFKL 317 (370)
T ss_dssp GGHHHH
T ss_pred HHHHHH
Confidence 554443
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=324.27 Aligned_cols=213 Identities=25% Similarity=0.393 Sum_probs=177.0
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCc
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~ 404 (554)
.+.++|++++.||+|+||.||+|.+ .+++.||+|++..... ........+.+|+.++..++||||+++++++.....
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 86 (311)
T 3ork_A 9 HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLA--RDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP 86 (311)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTT--TSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEET
T ss_pred eecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCcccc--CCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCC
Confidence 4567899999999999999999998 7899999999875322 224455678899999999999999999998866543
Q ss_pred ----EEEEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccc
Q 008759 405 ----LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT 479 (554)
Q Consensus 405 ----~~LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~ 479 (554)
+|+||||+.+++|.++++. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 87 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~ 166 (311)
T 3ork_A 87 AGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAI 166 (311)
T ss_dssp TEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred CCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence 4999999999999999875 46899999999999999999999999999999999999999999999999999765
Q ss_pred ccC-----CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHH
Q 008759 480 KLN-----DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKT 542 (554)
Q Consensus 480 ~~~-----~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~ 542 (554)
... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||......+..+.+.
T Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~ 232 (311)
T 3ork_A 167 ADSGNSVTQTAAVIGTAQYLSPEQARGD--SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV 232 (311)
T ss_dssp ---------------CCTTCCHHHHHTC--CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred cccccccccccccCcCcccCCHHHhcCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHh
Confidence 432 12234689999999999654 48899999999999999999999999887766655544
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=327.64 Aligned_cols=207 Identities=28% Similarity=0.523 Sum_probs=177.3
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCc
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~ 404 (554)
.+.++|++++.||+|+||+||+|.+ .+++.||+|++..... ....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 4 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 79 (323)
T 3tki_A 4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA----VDCPENIKKEICINKMLNHENVVKFYGHRREGNI 79 (323)
T ss_dssp TTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----------CHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc----cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCe
Confidence 3567999999999999999999998 5899999999864322 2223567899999999999999999999999999
Q ss_pred EEEEEeecccCchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC-
Q 008759 405 LYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN- 482 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~~-~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~- 482 (554)
.|+||||+.+++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 80 QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp EEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred EEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 99999999999999988764 6999999999999999999999999999999999999999999999999999764322
Q ss_pred ---CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHH
Q 008759 483 ---DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSA 537 (554)
Q Consensus 483 ---~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~ 537 (554)
......||+.|+|||++.+.. .++.++|||||||++|+|++|+.||........
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 216 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRRE-FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ 216 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSS-BCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH
T ss_pred cccccCCCccCcCccCcHHhccCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH
Confidence 234567999999999996543 247789999999999999999999987655433
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=324.17 Aligned_cols=214 Identities=28% Similarity=0.500 Sum_probs=183.2
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccch-hHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCC
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQ-AKQSISQLEQEIALLSRFEHENIVQYYGTDKDES 403 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~-~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~ 403 (554)
.+.++|++++.||+|+||.||+|.+ .+++.||+|++........ .......+.+|+.+|..++||||+++++++....
T Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 87 (326)
T 2y0a_A 8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT 87 (326)
T ss_dssp CHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 4557899999999999999999998 6799999999975432211 0112456889999999999999999999999999
Q ss_pred cEEEEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCC----cEEEEecCcccc
Q 008759 404 KLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG----SVKLADFGLAKA 478 (554)
Q Consensus 404 ~~~LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g----~vKL~DFGlA~~ 478 (554)
.+|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~ 167 (326)
T 2y0a_A 88 DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167 (326)
T ss_dssp EEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeE
Confidence 99999999999999999875 4689999999999999999999999999999999999999887 899999999987
Q ss_pred ccc-CCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHH
Q 008759 479 TKL-NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIK 541 (554)
Q Consensus 479 ~~~-~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i 541 (554)
... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||......+.+..+
T Consensus 168 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~ 229 (326)
T 2y0a_A 168 IDFGNEFKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV 229 (326)
T ss_dssp CCTTSCCCCCCSCTTTCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH
T ss_pred CCCCCccccccCCcCcCCceeecCC--CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH
Confidence 543 334456799999999999654 4889999999999999999999999887665554433
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=323.60 Aligned_cols=209 Identities=31% Similarity=0.552 Sum_probs=166.4
Q ss_pred ccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEE
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~ 406 (554)
.++|++++.||+|+||.||+|.+ .+++.||+|++....... ....+.+|+.+++.++||||+++++++...+.+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 79 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEG----TPSTAIREISLMKELKHENIVRLYDVIHTENKLT 79 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTC----SCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccc----cHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEE
Confidence 35799999999999999999998 679999999997543221 1245778999999999999999999999999999
Q ss_pred EEEeecccCchHHHHhhh-------cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccc
Q 008759 407 IFLELVTKGSLLNLYQRY-------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT 479 (554)
Q Consensus 407 LVmE~~~ggsL~~ll~~~-------~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~ 479 (554)
+||||+.+ +|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 80 lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 80 LVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAF 158 (317)
T ss_dssp EEEECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred EEEEecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence 99999985 898888653 4888999999999999999999999999999999999999999999999999765
Q ss_pred cc--CCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHH
Q 008759 480 KL--NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKT 542 (554)
Q Consensus 480 ~~--~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~ 542 (554)
.. .......||+.|+|||++.+. ..++.++|||||||++|+|++|+.||......+.+..+.
T Consensus 159 ~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~ 222 (317)
T 2pmi_A 159 GIPVNTFSSEVVTLWYRAPDVLMGS-RTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIF 222 (317)
T ss_dssp TSCCCCCCCCCSCCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred CCCcccCCCCcccccccCchHhhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 43 233455799999999998653 247899999999999999999999999887766655543
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=330.49 Aligned_cols=202 Identities=21% Similarity=0.297 Sum_probs=171.8
Q ss_pred CCccccccccceeeeeeeccCCceeEEEEe-----c-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCC---CC
Q 008759 320 PNGRFKRIITYWQKGDLLGRGSFGSVYEGI-----S-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE---HE 390 (554)
Q Consensus 320 ~~~~~~~~~~~y~i~~~LG~GsfG~VY~a~-----~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~---Hp 390 (554)
+...+....++|.+.++||+|+||+||+|. + .+++.||+|++.... ...+..|+.++..++ |+
T Consensus 56 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~e~~~~~~l~~~~~~ 127 (365)
T 3e7e_A 56 PKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN--------PWEFYIGTQLMERLKPSMQH 127 (365)
T ss_dssp SSCEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC--------HHHHHHHHHHHHHSCGGGGG
T ss_pred cceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC--------hhHHHHHHHHHHHhhhhhhh
Confidence 334455556789999999999999999994 3 678999999986421 234567777777776 89
Q ss_pred ceeeeeeeccCCCcEEEEEeecccCchHHHHhh------hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcC
Q 008759 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQR------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA 464 (554)
Q Consensus 391 nIVkl~~~~~~~~~~~LVmE~~~ggsL~~ll~~------~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~ 464 (554)
||+++++++...+..||||||+.+|+|.+++.. ..+++..+..|+.||+.||.|||++||+||||||+|||++.
T Consensus 128 ~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~ 207 (365)
T 3e7e_A 128 MFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGN 207 (365)
T ss_dssp GBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECG
T ss_pred hhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecc
Confidence 999999999999999999999999999999963 35899999999999999999999999999999999999998
Q ss_pred -----------CCcEEEEecCcccccc----cCCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 008759 465 -----------NGSVKLADFGLAKATK----LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY 529 (554)
Q Consensus 465 -----------~g~vKL~DFGlA~~~~----~~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF 529 (554)
++.+||+|||+++... .......+||+.|+|||++.+.. |+.++|||||||++|+|+||+.||
T Consensus 208 ~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~elltg~~pf 285 (365)
T 3e7e_A 208 GFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKP--WNYQIDYFGVAATVYCMLFGTYMK 285 (365)
T ss_dssp GGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCC--BSTHHHHHHHHHHHHHHHHSSCCC
T ss_pred cccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCC--CCccccHHHHHHHHHHHHhCCCcc
Confidence 8999999999996543 12234567999999999996644 899999999999999999999998
Q ss_pred CC
Q 008759 530 AP 531 (554)
Q Consensus 530 ~~ 531 (554)
..
T Consensus 286 ~~ 287 (365)
T 3e7e_A 286 VK 287 (365)
T ss_dssp EE
T ss_pred cc
Confidence 53
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=328.75 Aligned_cols=218 Identities=22% Similarity=0.385 Sum_probs=187.0
Q ss_pred ccccccceeeeeeeccC--CceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeecc
Q 008759 324 FKRIITYWQKGDLLGRG--SFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK 400 (554)
Q Consensus 324 ~~~~~~~y~i~~~LG~G--sfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~ 400 (554)
+....++|+++++||+| +||+||+|.+ .+++.||+|++..... .......+.+|+.+++.++|||||++++++.
T Consensus 20 ~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 96 (389)
T 3gni_B 20 FLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC---SNEMVTFLQGELHVSKLFNHPNIVPYRATFI 96 (389)
T ss_dssp CCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred ccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc---ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEE
Confidence 44556789999999999 9999999999 5899999999975332 2345677889999999999999999999999
Q ss_pred CCCcEEEEEeecccCchHHHHhh---hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccc
Q 008759 401 DESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477 (554)
Q Consensus 401 ~~~~~~LVmE~~~ggsL~~ll~~---~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~ 477 (554)
+.+.+|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~ 176 (389)
T 3gni_B 97 ADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNL 176 (389)
T ss_dssp ETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCE
T ss_pred ECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccce
Confidence 99999999999999999999875 468999999999999999999999999999999999999999999999999875
Q ss_pred cccc---------CCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHHH
Q 008759 478 ATKL---------NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTVA 544 (554)
Q Consensus 478 ~~~~---------~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~~ 544 (554)
.... .......||+.|+|||++.+....++.++|||||||++|+|++|+.||......+.+..+...
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~ 252 (389)
T 3gni_B 177 SMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNG 252 (389)
T ss_dssp ECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---
T ss_pred eeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC
Confidence 4321 112334689999999999765456899999999999999999999999988777776655543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=323.08 Aligned_cols=206 Identities=28% Similarity=0.437 Sum_probs=179.3
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCC-----CCceeeeeeec
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-----HENIVQYYGTD 399 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~-----HpnIVkl~~~~ 399 (554)
.+.++|+++++||+|+||+||+|.+ .+++.||+|++.. .......+..|+.++..+. ||||+++++++
T Consensus 32 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~------~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~ 105 (360)
T 3llt_A 32 LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN------IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKF 105 (360)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS------CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEE
T ss_pred EecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc------chhhhhhhHHHHHHHHHhcccCCCCCCeeccccee
Confidence 4567999999999999999999998 6789999999863 1233456678999999886 99999999999
Q ss_pred cCCCcEEEEEeecccCchHHHHhhhc---CChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcC------------
Q 008759 400 KDESKLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA------------ 464 (554)
Q Consensus 400 ~~~~~~~LVmE~~~ggsL~~ll~~~~---l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~------------ 464 (554)
...+.+|+||||+ +++|.+++.... +++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 106 ~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~ 184 (360)
T 3llt_A 106 MYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRR 184 (360)
T ss_dssp EETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEEC
T ss_pred eECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhc
Confidence 9999999999999 889999987643 899999999999999999999999999999999999975
Q ss_pred -------------CCcEEEEecCcccccccCCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008759 465 -------------NGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP 531 (554)
Q Consensus 465 -------------~g~vKL~DFGlA~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~ 531 (554)
++.+||+|||+++.... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||..
T Consensus 185 ~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~-~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~ 261 (360)
T 3llt_A 185 VTDGKKIQIYRTKSTGIKLIDFGCATFKSD-YHGSIINTRQYRAPEVILNL--GWDVSSDMWSFGCVLAELYTGSLLFRT 261 (360)
T ss_dssp TTTCCEEEEEEESCCCEEECCCTTCEETTS-CCCSCCSCGGGCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccccccccccCCCCEEEEeccCceecCC-CCcCccCcccccCcHHHcCC--CCCCccchHHHHHHHHHHHHCCCCCCC
Confidence 78999999999976443 33456799999999999754 488999999999999999999999998
Q ss_pred CChhHHHHHH
Q 008759 532 MECVSAIFIK 541 (554)
Q Consensus 532 ~e~~~~i~~i 541 (554)
....+.+..+
T Consensus 262 ~~~~~~~~~~ 271 (360)
T 3llt_A 262 HEHMEHLAMM 271 (360)
T ss_dssp SSHHHHHHHH
T ss_pred CcHHHHHHHH
Confidence 8776655444
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=340.80 Aligned_cols=212 Identities=27% Similarity=0.425 Sum_probs=177.0
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCC--
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE-- 402 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~-- 402 (554)
.+.++|++++.||+|+||+||+|.+ .+++.||+|++.... ......+++.+|+.+|+.++||||+++++++...
T Consensus 59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~---~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 135 (464)
T 3ttj_A 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF---QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKT 135 (464)
T ss_dssp EEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG---GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCS
T ss_pred eecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc---cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCc
Confidence 4567899999999999999999998 679999999987432 2234456788999999999999999999998654
Q ss_pred ----CcEEEEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccc
Q 008759 403 ----SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA 478 (554)
Q Consensus 403 ----~~~~LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~ 478 (554)
..+||||||+.++ |...+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 136 ~~~~~~~~lv~E~~~~~-l~~~~~-~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~ 213 (464)
T 3ttj_A 136 LEEFQDVYLVMELMDAN-LCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 213 (464)
T ss_dssp TTTCCEEEEEEECCSEE-HHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred cccCCeEEEEEeCCCCC-HHHHHh-hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence 4579999999875 555554 3589999999999999999999999999999999999999999999999999987
Q ss_pred cccC-CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHHH
Q 008759 479 TKLN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTVA 544 (554)
Q Consensus 479 ~~~~-~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~~ 544 (554)
.... ......||++|+|||++.+. .|+.++|||||||++|+|++|+.||.+.+..+.+.++...
T Consensus 214 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~ 278 (464)
T 3ttj_A 214 AGTSFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 278 (464)
T ss_dssp ---CCCC----CCCTTCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred cCCCcccCCCcccccccCHHHHcCC--CCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 6543 34456799999999999764 4899999999999999999999999999888877776543
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=320.99 Aligned_cols=204 Identities=27% Similarity=0.530 Sum_probs=174.6
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCC-
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES- 403 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~- 403 (554)
...++|+++++||+|+||+||+|.+ .+++.||+|++...... .....+.+|+.+++.++||||+++++++....
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 81 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL----RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTT 81 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG----SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTT
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc----chHHHHHHHHHHHHhcCCCCcceEEEEeecCCC
Confidence 3457899999999999999999998 56999999998743221 12356679999999999999999999887654
Q ss_pred -cEEEEEeecccCchHHHHhhhc----CChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEE----cCCCcEEEEecC
Q 008759 404 -KLYIFLELVTKGSLLNLYQRYH----LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV----DANGSVKLADFG 474 (554)
Q Consensus 404 -~~~LVmE~~~ggsL~~ll~~~~----l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILl----d~~g~vKL~DFG 474 (554)
.+|+||||+.+++|.+++.... +++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg 161 (319)
T 4euu_A 82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (319)
T ss_dssp CCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCT
T ss_pred ceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCC
Confidence 7899999999999999997642 8999999999999999999999999999999999999 778889999999
Q ss_pred cccccccC-CccCccCCCcccChhhhccc------CCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008759 475 LAKATKLN-DVKSCRGTAFWMAPEVINNK------NKGYGLPADIWSLGCTVLEMLTSQIPYAPME 533 (554)
Q Consensus 475 lA~~~~~~-~~~s~~GT~~Y~APEvl~~~------~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e 533 (554)
+++..... ......||+.|+|||++... ...++.++|||||||++|+|++|+.||....
T Consensus 162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 227 (319)
T 4euu_A 162 AARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE 227 (319)
T ss_dssp TCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTT
T ss_pred CceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99875433 33456799999999998631 2357889999999999999999999997543
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=337.95 Aligned_cols=212 Identities=27% Similarity=0.392 Sum_probs=181.8
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCc
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~ 404 (554)
.+.++|++++.||+|+||+||+|.+ .+|+.||+|++..... .......+.+|+.+++.++||||+++++++.+.+.
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~---~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 84 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL---SARDHQKLEREARICRLLKHPNIVRLHDSISEEGH 84 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC---HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCE
Confidence 5668999999999999999999998 7899999999875332 23345678899999999999999999999999999
Q ss_pred EEEEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEc---CCCcEEEEecCcccccc
Q 008759 405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD---ANGSVKLADFGLAKATK 480 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld---~~g~vKL~DFGlA~~~~ 480 (554)
+|+||||+.+|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 85 ~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~ 164 (444)
T 3soa_A 85 HYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164 (444)
T ss_dssp EEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred EEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence 9999999999999888765 5689999999999999999999999999999999999998 46789999999997654
Q ss_pred cCC--ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHH
Q 008759 481 LND--VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKT 542 (554)
Q Consensus 481 ~~~--~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~ 542 (554)
... .....||+.|+|||++.+. .|+.++|||||||++|+|++|..||......+.+..+.
T Consensus 165 ~~~~~~~~~~gt~~Y~APE~l~~~--~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~ 226 (444)
T 3soa_A 165 GEQQAWFGFAGTPGYLSPEVLRKD--PYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIK 226 (444)
T ss_dssp TTCCBCCCSCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred CCCceeecccCCcccCCHHHhcCC--CCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHH
Confidence 432 3456799999999999654 48899999999999999999999998876655544443
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=328.10 Aligned_cols=212 Identities=25% Similarity=0.454 Sum_probs=179.0
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCC--
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE-- 402 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~-- 402 (554)
.+.+.|++.+.||+|+||.||+|.+ .+|+.||+|++.... ......+.+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 98 (367)
T 1cm8_A 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF---QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDET 98 (367)
T ss_dssp CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT---SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSS
T ss_pred eecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc---cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCc
Confidence 4567899999999999999999998 789999999986422 2234456788999999999999999999998765
Q ss_pred ----CcEEEEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccc
Q 008759 403 ----SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA 478 (554)
Q Consensus 403 ----~~~~LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~ 478 (554)
..+|+||||+ +++|.++++...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 99 ~~~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (367)
T 1cm8_A 99 LDDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 177 (367)
T ss_dssp TTTCCCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred cccCceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence 3469999999 77999999888899999999999999999999999999999999999999999999999999987
Q ss_pred cccCCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHH
Q 008759 479 TKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTV 543 (554)
Q Consensus 479 ~~~~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~ 543 (554)
... ......+|++|+|||++.+.. .++.++|||||||++|+|++|+.||.+.+..+.+..+..
T Consensus 178 ~~~-~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~ 240 (367)
T 1cm8_A 178 ADS-EMTGYVVTRWYRAPEVILNWM-RYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMK 240 (367)
T ss_dssp CCS-SCCSSCSCGGGCCTHHHHTTT-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred ccc-ccCcCcCCCCcCCHHHHhCCC-CCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 543 344567999999999987532 488999999999999999999999999888777766654
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=309.14 Aligned_cols=211 Identities=21% Similarity=0.365 Sum_probs=181.8
Q ss_pred ccccccceeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCC
Q 008759 324 FKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES 403 (554)
Q Consensus 324 ~~~~~~~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~ 403 (554)
+....++|++.+.||+|+||.||+|.+.+++.||+|++...... .+.+.+|+.++++++||||+++++++.+..
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 78 (269)
T 4hcu_A 5 WVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS------EEDFIEEAEVMMKLSHPKLVQLYGVCLEQA 78 (269)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC------HHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred EEeChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccC------HHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 33445789999999999999999999988899999998743221 245789999999999999999999999999
Q ss_pred cEEEEEeecccCchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccccc
Q 008759 404 KLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL 481 (554)
Q Consensus 404 ~~~LVmE~~~ggsL~~ll~~~--~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~ 481 (554)
.+|+||||+.+++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 158 (269)
T 4hcu_A 79 PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 158 (269)
T ss_dssp SEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred ceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccc
Confidence 999999999999999999753 489999999999999999999999999999999999999999999999999976533
Q ss_pred C---CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHH
Q 008759 482 N---DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIFIKT 542 (554)
Q Consensus 482 ~---~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i~~i~ 542 (554)
. ......+|+.|+|||++.+.. ++.++|||||||++|+|++ |+.||......+....+.
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~ 221 (269)
T 4hcu_A 159 DQYTSSTGTKFPVKWASPEVFSFSR--YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS 221 (269)
T ss_dssp HHHHSTTSTTCCGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH
T ss_pred cccccccCcccccccCCHHHhcCCC--CCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Confidence 2 223345778899999996543 8899999999999999999 999999877765554443
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=318.98 Aligned_cols=215 Identities=30% Similarity=0.489 Sum_probs=175.2
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhC---CCCceeeeeeeccC
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF---EHENIVQYYGTDKD 401 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l---~HpnIVkl~~~~~~ 401 (554)
.+.++|++++.||+|+||+||+|.+ .+++.||+|++...............+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 3457899999999999999999998 7899999999875332211111122345666666555 59999999999876
Q ss_pred CC-----cEEEEEeecccCchHHHHhhhc---CChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEec
Q 008759 402 ES-----KLYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADF 473 (554)
Q Consensus 402 ~~-----~~~LVmE~~~ggsL~~ll~~~~---l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DF 473 (554)
.. .+++||||+.+ +|.+++.... +++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Df 164 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADF 164 (308)
T ss_dssp CCSSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSC
T ss_pred cCCCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeC
Confidence 54 58999999985 9999887643 899999999999999999999999999999999999999999999999
Q ss_pred CcccccccC-CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHH
Q 008759 474 GLAKATKLN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTV 543 (554)
Q Consensus 474 GlA~~~~~~-~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~ 543 (554)
|+++..... ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||......+.+.++..
T Consensus 165 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~ 233 (308)
T 3g33_A 165 GLARIYSYQMALTPVVVTLWYRAPEVLLQST--YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFD 233 (308)
T ss_dssp SCTTTSTTCCCSGGGGCCCSSCCHHHHHTSC--CCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHH
T ss_pred ccccccCCCcccCCccccccccCchHHcCCC--CCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 999765433 334567999999999996544 88999999999999999999999999887777666543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=311.93 Aligned_cols=212 Identities=23% Similarity=0.415 Sum_probs=180.4
Q ss_pred cccccccceeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCC
Q 008759 323 RFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE 402 (554)
Q Consensus 323 ~~~~~~~~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~ 402 (554)
.+....++|++++.||+|+||.||+|.+.++..||+|++...... ...+.+|+.++..++|+||+++++++.+.
T Consensus 18 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 91 (283)
T 3gen_A 18 SWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS------EDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 91 (283)
T ss_dssp TTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC------HHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred CccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC------HHHHHHHHHHHhcCCCCCEeeEEEEEecC
Confidence 344556799999999999999999999988899999998743221 24578999999999999999999999999
Q ss_pred CcEEEEEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccc
Q 008759 403 SKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK 480 (554)
Q Consensus 403 ~~~~LVmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~ 480 (554)
+.+|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 171 (283)
T 3gen_A 92 RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 171 (283)
T ss_dssp SSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBC
T ss_pred CCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccc
Confidence 999999999999999999976 569999999999999999999999999999999999999999999999999997653
Q ss_pred cCC---ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHH
Q 008759 481 LND---VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIFIKT 542 (554)
Q Consensus 481 ~~~---~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i~~i~ 542 (554)
... .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |+.||......+....+.
T Consensus 172 ~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~ 235 (283)
T 3gen_A 172 DDEYTSSVGSKFPVRWSPPEVLMYSK--FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA 235 (283)
T ss_dssp CHHHHSTTSTTSCGGGCCHHHHHHCC--CSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred ccccccccCCccCcccCCHHHhccCC--CCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHh
Confidence 321 23344778899999997553 8899999999999999998 999999887665554443
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=318.76 Aligned_cols=199 Identities=30% Similarity=0.492 Sum_probs=168.3
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCC-
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES- 403 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~- 403 (554)
++.++|++++.||+|+||.||+|.+ .+++.||+|++..... ....+.+.+|+.+++.++||||+++++++.+..
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 78 (332)
T 3qd2_B 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR----ELAREKVMREVKALAKLEHPGIVRYFNAWLETPP 78 (332)
T ss_dssp HHHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCST----TTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCS
T ss_pred hhhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCc----hhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEecc
Confidence 4568899999999999999999998 5899999999975332 223467889999999999999999999875432
Q ss_pred --------------------------------------------------------cEEEEEeecccCchHHHHhhh---
Q 008759 404 --------------------------------------------------------KLYIFLELVTKGSLLNLYQRY--- 424 (554)
Q Consensus 404 --------------------------------------------------------~~~LVmE~~~ggsL~~ll~~~--- 424 (554)
.+|+||||+.+++|.+++...
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~ 158 (332)
T 3qd2_B 79 EKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL 158 (332)
T ss_dssp CHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG
T ss_pred chhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc
Confidence 389999999999999999864
Q ss_pred -cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC--------------CccCccC
Q 008759 425 -HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--------------DVKSCRG 489 (554)
Q Consensus 425 -~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~--------------~~~s~~G 489 (554)
...+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... ......|
T Consensus 159 ~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~g 238 (332)
T 3qd2_B 159 EDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG 238 (332)
T ss_dssp GGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-
T ss_pred cchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCC
Confidence 2455568899999999999999999999999999999999999999999999865433 1233469
Q ss_pred CCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 008759 490 TAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYA 530 (554)
Q Consensus 490 T~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~ 530 (554)
|+.|+|||++.+. .++.++|||||||++|+|++|..|+.
T Consensus 239 t~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~~~~~~ 277 (332)
T 3qd2_B 239 TKLYMSPEQIHGN--NYSHKVDIFSLGLILFELLYSFSTQM 277 (332)
T ss_dssp CGGGSCHHHHHCC--CCCTHHHHHHHHHHHHHHHSCCCCHH
T ss_pred CcCccChHHhcCC--CCcchhhHHHHHHHHHHHHHcCCChh
Confidence 9999999999654 48899999999999999999887763
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=321.52 Aligned_cols=197 Identities=24% Similarity=0.346 Sum_probs=173.4
Q ss_pred cccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhC-CCCceeeeeeeccCCCc
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESK 404 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIVkl~~~~~~~~~ 404 (554)
+.++|++++.||+|+||.||+|.+ .+++.||+|++...... ..+.+|+.+++.+ +|+||+++++++...+.
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 79 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-------PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKY 79 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS-------CCHHHHHHHHHHHCSCTTSCCEEEEEEETTE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch-------HHHHHHHHHHHHhhCCCCCCEEEEEEecCCc
Confidence 457899999999999999999998 78999999998753221 2467899999999 89999999999999999
Q ss_pred EEEEEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCc-----EEEEecCccc
Q 008759 405 LYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS-----VKLADFGLAK 477 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~-----vKL~DFGlA~ 477 (554)
.|+||||+ +++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||+++
T Consensus 80 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~ 158 (330)
T 2izr_A 80 NAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158 (330)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred cEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence 99999999 8899999984 57999999999999999999999999999999999999998887 9999999998
Q ss_pred ccccCC---------ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008759 478 ATKLND---------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME 533 (554)
Q Consensus 478 ~~~~~~---------~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e 533 (554)
...... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~g~~Pf~~~~ 221 (330)
T 2izr_A 159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGK--EQSRRDDLEALGHMFMYFLRGSLPWQGLK 221 (330)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred eeecCCCCccccccccCCcCCCccccChHHHcCC--CCCchhHHHHHHHHHHHHhcCCCCccccc
Confidence 653322 2356799999999999764 48999999999999999999999998753
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=310.28 Aligned_cols=210 Identities=30% Similarity=0.507 Sum_probs=170.2
Q ss_pred ccceeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEE
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~L 407 (554)
.++|++.+.||+|+||.||+|.+. +..||+|++...... ......+.+.+|+.+++.++||||+++++++...+.+|+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDE-DISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL 83 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC-----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcc-cHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence 468999999999999999999975 789999988643221 112334678899999999999999999999999999999
Q ss_pred EEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCC---ccccCCccccEEEcC--------CCcEEEEecCcc
Q 008759 408 FLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQD---VVHRDIKCANILVDA--------NGSVKLADFGLA 476 (554)
Q Consensus 408 VmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~g---IIHrDIKPeNILld~--------~g~vKL~DFGlA 476 (554)
||||+.+++|.+++....+++..+..++.||+.||.|||++| |+||||||+|||++. ++.+||+|||++
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~ 163 (271)
T 3dtc_A 84 VMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA 163 (271)
T ss_dssp EEECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-
T ss_pred EEEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcc
Confidence 999999999999998888999999999999999999999999 899999999999986 778999999999
Q ss_pred cccccCCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHH
Q 008759 477 KATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIK 541 (554)
Q Consensus 477 ~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i 541 (554)
............||+.|+|||++.+. .++.++|||||||++|+|++|+.||............
T Consensus 164 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 226 (271)
T 3dtc_A 164 REWHRTTKMSAAGAYAWMAPEVIRAS--MFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGV 226 (271)
T ss_dssp ------------CCGGGSCHHHHHHC--CCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHH
T ss_pred cccccccccCCCCccceeCHHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh
Confidence 87655555566799999999999654 3889999999999999999999999988766655443
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=310.72 Aligned_cols=211 Identities=27% Similarity=0.484 Sum_probs=178.5
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCc
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~ 404 (554)
...++|++++.||+|+||.||+|.+ .++..||+|++..... ........+.+|+.+++.++||||+++++++.+.+.
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 83 (279)
T 3fdn_A 6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATR 83 (279)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH--HHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEecccc--chhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCE
Confidence 3467899999999999999999988 6788999999864221 112224568899999999999999999999999999
Q ss_pred EEEEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC
Q 008759 405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND 483 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~ 483 (554)
+|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~ 163 (279)
T 3fdn_A 84 VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 163 (279)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCccc
Confidence 9999999999999998876 568999999999999999999999999999999999999999999999999987665555
Q ss_pred ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHH
Q 008759 484 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFI 540 (554)
Q Consensus 484 ~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~ 540 (554)
.....||+.|+|||++.+. .++.++|||||||++|+|++|..||......+....
T Consensus 164 ~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~ 218 (279)
T 3fdn_A 164 RTDLCGTLDYLPPEMIEGR--MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR 218 (279)
T ss_dssp ----CCCCTTCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH
T ss_pred ccccCCCCCccCHhHhccC--CCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHH
Confidence 5566799999999999654 478899999999999999999999998766554433
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-38 Score=320.10 Aligned_cols=205 Identities=34% Similarity=0.539 Sum_probs=180.6
Q ss_pred ceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEE
Q 008759 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (554)
Q Consensus 330 ~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LV 408 (554)
.|...+.||+|+||.||+|.+ .+|+.||+|++...... ..+.+.+|+.++..++||||+++++++...+.+|+|
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 120 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ-----RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVL 120 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-----SHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh-----HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEE
Confidence 578888999999999999998 58999999998753322 235678999999999999999999999999999999
Q ss_pred EeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC--CccC
Q 008759 409 LELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--DVKS 486 (554)
Q Consensus 409 mE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~--~~~s 486 (554)
|||+.+++|.+++.+..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ....
T Consensus 121 ~e~~~~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 200 (321)
T 2c30_A 121 MEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS 200 (321)
T ss_dssp ECCCCSCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCC
T ss_pred EecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcccccc
Confidence 99999999999999888999999999999999999999999999999999999999999999999998765432 2345
Q ss_pred ccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHH
Q 008759 487 CRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIK 541 (554)
Q Consensus 487 ~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i 541 (554)
..||+.|+|||++.+. .++.++|||||||++|+|++|+.||......+.+..+
T Consensus 201 ~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~ 253 (321)
T 2c30_A 201 LVGTPYWMAPEVISRS--LYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL 253 (321)
T ss_dssp CCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred ccCCccccCHhhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 6799999999999654 4788999999999999999999999887766554443
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=313.44 Aligned_cols=212 Identities=24% Similarity=0.434 Sum_probs=178.7
Q ss_pred ccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEE
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~ 406 (554)
.++|++++.||+|+||+||+|.+ .+++.||+|++.... ......+.+.+|+.+++.++||||+++++++...+.+|
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE---DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLH 78 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC---C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc---cchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEE
Confidence 56899999999999999999998 679999999886432 22334567889999999999999999999999999999
Q ss_pred EEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC--C
Q 008759 407 IFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--D 483 (554)
Q Consensus 407 LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~--~ 483 (554)
+||||+.+++|..++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus 79 lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 158 (311)
T 4agu_A 79 LVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY 158 (311)
T ss_dssp EEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc
Confidence 99999999999998875 46899999999999999999999999999999999999999999999999999765422 2
Q ss_pred ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHH
Q 008759 484 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTV 543 (554)
Q Consensus 484 ~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~ 543 (554)
.....||+.|+|||++.+.. .++.++|||||||++|+|++|+.||......+.+..+..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 217 (311)
T 4agu_A 159 YDDEVATRWYRSPELLVGDT-QYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRK 217 (311)
T ss_dssp -------GGGCCHHHHHTCS-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cCCCcCCccccChHHHhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 34456999999999986533 478999999999999999999999999887777665543
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-38 Score=320.54 Aligned_cols=210 Identities=25% Similarity=0.396 Sum_probs=177.9
Q ss_pred cccceeeeeeeccCCceeEEEEecC----CCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCC
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGISD----DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE 402 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~~----~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~ 402 (554)
..++|++.+.||+|+||.||+|.+. .+..||+|++.... .....+.+.+|+.++..++||||+++++++.+.
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 122 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY----TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG 122 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC----CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC----CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 3568999999999999999999983 34569999987421 233456788999999999999999999999999
Q ss_pred CcEEEEEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccc
Q 008759 403 SKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK 480 (554)
Q Consensus 403 ~~~~LVmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~ 480 (554)
+.+|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 123 RLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp GCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred CccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 999999999999999999965 368999999999999999999999999999999999999999999999999998654
Q ss_pred cCC-----ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHH
Q 008759 481 LND-----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIFIKT 542 (554)
Q Consensus 481 ~~~-----~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i~~i~ 542 (554)
... .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||......+.+..+.
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~ 268 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRT--FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE 268 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCE--ECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH
T ss_pred cCccceeeccCCCCcccccCHhHhcCCC--CCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH
Confidence 332 12234678899999996544 8899999999999999999 999999887766555443
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-38 Score=321.67 Aligned_cols=212 Identities=26% Similarity=0.441 Sum_probs=178.0
Q ss_pred ccccccceeeeeeeccCCceeEEEEe-----c-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhC-CCCceeeee
Q 008759 324 FKRIITYWQKGDLLGRGSFGSVYEGI-----S-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYY 396 (554)
Q Consensus 324 ~~~~~~~y~i~~~LG~GsfG~VY~a~-----~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIVkl~ 396 (554)
+....++|++++.||+|+||.||+|. . .+++.||+|++.... .....+.+.+|+.++..+ +||||++++
T Consensus 17 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~hpniv~~~ 92 (359)
T 3vhe_A 17 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA----THSEHRALMSELKILIHIGHHLNVVNLL 92 (359)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC----CHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence 44456799999999999999999997 3 567899999986422 233456789999999999 789999999
Q ss_pred eeccCCC-cEEEEEeecccCchHHHHhhhc--------------------------------------------------
Q 008759 397 GTDKDES-KLYIFLELVTKGSLLNLYQRYH-------------------------------------------------- 425 (554)
Q Consensus 397 ~~~~~~~-~~~LVmE~~~ggsL~~ll~~~~-------------------------------------------------- 425 (554)
+++...+ .+|+||||+.+|+|.+++....
T Consensus 93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (359)
T 3vhe_A 93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS 172 (359)
T ss_dssp EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence 9987755 4999999999999999987532
Q ss_pred -----------------CChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC----c
Q 008759 426 -----------------LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----V 484 (554)
Q Consensus 426 -----------------l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~----~ 484 (554)
+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... .
T Consensus 173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 252 (359)
T 3vhe_A 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 252 (359)
T ss_dssp -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC
T ss_pred cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhc
Confidence 8889999999999999999999999999999999999999999999999997653322 2
Q ss_pred cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHHHHH
Q 008759 485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIFIK 541 (554)
Q Consensus 485 ~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i~~i 541 (554)
....||+.|+|||++.+. .++.++|||||||++|+|+| |..||......+.+...
T Consensus 253 ~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~ 308 (359)
T 3vhe_A 253 GDARLPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 308 (359)
T ss_dssp --CEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHH
T ss_pred cccCCCceeEChhhhcCC--CCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHH
Confidence 334588999999999754 48899999999999999998 99999887655544443
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=307.47 Aligned_cols=209 Identities=25% Similarity=0.418 Sum_probs=181.2
Q ss_pred ccccceeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcE
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL 405 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~ 405 (554)
...++|++.+.||+|+||.||+|.+.++..||+|++...... ...+.+|+.++..++||||+++++++.....+
T Consensus 5 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~------~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (268)
T 3sxs_A 5 LKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS------EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPI 78 (268)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC------HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred echhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc------HHHHHHHHHHHHhCCCCCEeeEEEEEccCCce
Confidence 345789999999999999999999988889999998743221 24578999999999999999999999999999
Q ss_pred EEEEeecccCchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC
Q 008759 406 YIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND 483 (554)
Q Consensus 406 ~LVmE~~~ggsL~~ll~~~--~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~ 483 (554)
|+||||+.+++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 79 YIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred EEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 9999999999999998763 48999999999999999999999999999999999999999999999999997654443
Q ss_pred c---cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHH
Q 008759 484 V---KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIFIKT 542 (554)
Q Consensus 484 ~---~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i~~i~ 542 (554)
. ....+|+.|+|||++.+.. ++.++|||||||++|+|++ |+.||......+....+.
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~ 219 (268)
T 3sxs_A 159 YVSSVGTKFPVKWSAPEVFHYFK--YSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS 219 (268)
T ss_dssp EEECCSCCCCGGGCCHHHHHHSE--EETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred hhcccCCCcCcccCCHHHHhccC--CchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHH
Confidence 2 2334677899999996544 7889999999999999999 999998877766555443
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=323.01 Aligned_cols=208 Identities=27% Similarity=0.445 Sum_probs=166.6
Q ss_pred cccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCC
Q 008759 325 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES 403 (554)
Q Consensus 325 ~~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~ 403 (554)
..+.++|++.+.||+|+||.||+|.+ .+++.||+|++.... ..+.+.+|+.++..++||||+++++++...+
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 121 (349)
T 2w4o_A 49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-------DKKIVRTEIGVLLRLSHPNIIKLKEIFETPT 121 (349)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------------CHHHHHCCCTTBCCEEEEEECSS
T ss_pred ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-------hHHHHHHHHHHHHhCCCCCCcceeeeEecCC
Confidence 34567899999999999999999998 568899999987421 2345778999999999999999999999999
Q ss_pred cEEEEEeecccCchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcC---CCcEEEEecCccccc
Q 008759 404 KLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA---NGSVKLADFGLAKAT 479 (554)
Q Consensus 404 ~~~LVmE~~~ggsL~~ll~~~-~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~---~g~vKL~DFGlA~~~ 479 (554)
.+|+||||+.+++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++..
T Consensus 122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 122 EISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp EEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred eEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 999999999999999988764 5899999999999999999999999999999999999975 889999999999765
Q ss_pred ccCC-ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHH
Q 008759 480 KLND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIK 541 (554)
Q Consensus 480 ~~~~-~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i 541 (554)
.... .....||+.|+|||++.+. .++.++|||||||++|+|++|..||......+.++..
T Consensus 202 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~ 262 (349)
T 2w4o_A 202 EHQVLMKTVCGTPGYCAPEILRGC--AYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRR 262 (349)
T ss_dssp -----------CGGGSCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHH
T ss_pred CcccccccccCCCCccCHHHhcCC--CCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHH
Confidence 4332 3455699999999999654 4889999999999999999999999887665544443
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=306.25 Aligned_cols=211 Identities=27% Similarity=0.458 Sum_probs=181.8
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCc
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~ 404 (554)
.+.++|++.+.||+|+||.||+|.+ .+++.||+|++..... .......+.+|+.+++.++||||+++++++...+.
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 79 (284)
T 3kk8_A 3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL---SARDFQKLEREARICRKLQHPNIVRLHDSIQEESF 79 (284)
T ss_dssp TTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC---CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCE
Confidence 4567899999999999999999998 6799999999875332 23345678899999999999999999999999999
Q ss_pred EEEEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCc---EEEEecCcccccc
Q 008759 405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS---VKLADFGLAKATK 480 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~---vKL~DFGlA~~~~ 480 (554)
.|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||++....
T Consensus 80 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 80 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 9999999999999887765 45899999999999999999999999999999999999987665 9999999997654
Q ss_pred cCC-ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHH
Q 008759 481 LND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIK 541 (554)
Q Consensus 481 ~~~-~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i 541 (554)
... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||......+....+
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 219 (284)
T 3kk8_A 160 DSEAWHGFAGTPGYLSPEVLKKD--PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 219 (284)
T ss_dssp SSCBCCCSCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred cCccccCCCCCcCCcCchhhcCC--CCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHH
Confidence 433 3446799999999999654 4789999999999999999999999887665544443
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=318.14 Aligned_cols=210 Identities=26% Similarity=0.403 Sum_probs=179.7
Q ss_pred ccccceeeeeeeccCCceeEEEEecC------CCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeec
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTD 399 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~~------~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~ 399 (554)
...++|++++.||+|+||.||+|.+. +++.||+|++.... .......+.+|+.+++.++||||+++++++
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA----SADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc----CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 34578999999999999999999874 34899999986422 233456789999999999999999999999
Q ss_pred cCCCcEEEEEeecccCchHHHHhh-------------------------hcCChHHHHHHHHHHHHHHHHHHHCCccccC
Q 008759 400 KDESKLYIFLELVTKGSLLNLYQR-------------------------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRD 454 (554)
Q Consensus 400 ~~~~~~~LVmE~~~ggsL~~ll~~-------------------------~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrD 454 (554)
...+.+|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+|||
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~D 199 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 199 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 999999999999999999999976 4588899999999999999999999999999
Q ss_pred CccccEEEcCCCcEEEEecCcccccccC----CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCC
Q 008759 455 IKCANILVDANGSVKLADFGLAKATKLN----DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPY 529 (554)
Q Consensus 455 IKPeNILld~~g~vKL~DFGlA~~~~~~----~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF 529 (554)
|||+|||++.++.+||+|||+++..... ......+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||
T Consensus 200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~Di~slG~il~el~t~g~~p~ 277 (343)
T 1luf_A 200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR--YTTESDVWAYGVVLWEIFSYGLQPY 277 (343)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCC--cCcccccHHHHHHHHHHHhcCCCcC
Confidence 9999999999999999999998754322 223445889999999997544 8899999999999999999 99999
Q ss_pred CCCChhHHHHHH
Q 008759 530 APMECVSAIFIK 541 (554)
Q Consensus 530 ~~~e~~~~i~~i 541 (554)
......+.+..+
T Consensus 278 ~~~~~~~~~~~~ 289 (343)
T 1luf_A 278 YGMAHEEVIYYV 289 (343)
T ss_dssp TTSCHHHHHHHH
T ss_pred CCCChHHHHHHH
Confidence 988766655444
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=328.51 Aligned_cols=209 Identities=26% Similarity=0.474 Sum_probs=181.3
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCc
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~ 404 (554)
.+.++|++++.||+|+||.||+|.+ .+++.||+|++.... ......+.+|+.++..++||||+++++++.+...
T Consensus 48 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-----~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~ 122 (387)
T 1kob_A 48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-----PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYE 122 (387)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-----HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSE
T ss_pred ccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc-----hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCE
Confidence 3457899999999999999999998 678999999987422 2233568899999999999999999999999999
Q ss_pred EEEEEeecccCchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcC--CCcEEEEecCcccccc
Q 008759 405 LYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA--NGSVKLADFGLAKATK 480 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~~--~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~--~g~vKL~DFGlA~~~~ 480 (554)
+|+||||+.+++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++...
T Consensus 123 ~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~ 202 (387)
T 1kob_A 123 MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 202 (387)
T ss_dssp EEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred EEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecC
Confidence 99999999999999988753 5899999999999999999999999999999999999974 4789999999998764
Q ss_pred cCC-ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHH
Q 008759 481 LND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIK 541 (554)
Q Consensus 481 ~~~-~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i 541 (554)
... .....||+.|+|||++.+. .++.++|||||||++|+|++|..||......+.+..+
T Consensus 203 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i 262 (387)
T 1kob_A 203 PDEIVKVTTATAEFAAPEIVDRE--PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV 262 (387)
T ss_dssp TTSCEEEECSSGGGCCHHHHTTC--CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH
T ss_pred CCcceeeeccCCCccCchhccCC--CCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 432 3345699999999999654 4889999999999999999999999987766555444
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=307.31 Aligned_cols=209 Identities=27% Similarity=0.502 Sum_probs=181.6
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCc
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~ 404 (554)
.+.++|++.+.||+|+||.||+|.+ .++..+|+|++...... ....+.+|+.+++.++||||+++++++.+...
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (277)
T 3f3z_A 6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE-----DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTD 80 (277)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS-----CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc-----hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCe
Confidence 4567899999999999999999998 66889999998753322 23568899999999999999999999999999
Q ss_pred EEEEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEE---cCCCcEEEEecCcccccc
Q 008759 405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKATK 480 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILl---d~~g~vKL~DFGlA~~~~ 480 (554)
+|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 81 IYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 9999999999999988865 458999999999999999999999999999999999999 788999999999997654
Q ss_pred cC-CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHH
Q 008759 481 LN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKT 542 (554)
Q Consensus 481 ~~-~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~ 542 (554)
.. ......||+.|+|||++.+. ++.++|||||||++|+|++|+.||......+.+..+.
T Consensus 161 ~~~~~~~~~~t~~y~aPE~~~~~---~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 220 (277)
T 3f3z_A 161 PGKMMRTKVGTPYYVSPQVLEGL---YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIR 220 (277)
T ss_dssp TTSCBCCCCSCTTTCCHHHHTTC---BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CccchhccCCCCCccChHHhccc---CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 33 33456799999999998542 7889999999999999999999999887766555443
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=320.91 Aligned_cols=203 Identities=26% Similarity=0.405 Sum_probs=177.3
Q ss_pred cccccccceeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCC
Q 008759 323 RFKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE 402 (554)
Q Consensus 323 ~~~~~~~~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~ 402 (554)
.+....++|++.+.||+|+||.||+|.+.+++.||+|++..... ...+.+.+|+.+++.++||||+++++++...
T Consensus 33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 107 (321)
T 2qkw_B 33 DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESS-----QGIEEFETEIETLSFCRHPHLVSLIGFCDER 107 (321)
T ss_dssp CCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCS-----SHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred HHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccCh-----HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 34556789999999999999999999998899999998764321 2346788999999999999999999999999
Q ss_pred CcEEEEEeecccCchHHHHhhh-----cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccc
Q 008759 403 SKLYIFLELVTKGSLLNLYQRY-----HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477 (554)
Q Consensus 403 ~~~~LVmE~~~ggsL~~ll~~~-----~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~ 477 (554)
+.+|+||||+.+++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 187 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISK 187 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCE
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccc
Confidence 9999999999999999988653 38889999999999999999999999999999999999999999999999987
Q ss_pred ccccC----CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008759 478 ATKLN----DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM 532 (554)
Q Consensus 478 ~~~~~----~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~ 532 (554)
..... ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...
T Consensus 188 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Di~slG~il~ell~g~~p~~~~ 244 (321)
T 2qkw_B 188 KGTELDQTHLSTVVKGTLGYIDPEYFIKGR--LTEKSDVYSFGVVLFEVLCARSAIVQS 244 (321)
T ss_dssp ECSSSSCCCCBCCCEEETTTCCHHHHHHCB--CCTHHHHHHHHHHHHHHHHCCTTCSCS
T ss_pred ccccccccccccccCCCccccCHHHhcCCC--CCcccchHhHHHHHHHHHhCCCccccc
Confidence 54321 123345899999999996654 889999999999999999999999754
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=321.04 Aligned_cols=215 Identities=28% Similarity=0.435 Sum_probs=176.1
Q ss_pred cccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcE
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL 405 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~ 405 (554)
..++|++++.||+|+||.||+|.+ .+|+.||+|++...............+.+|+.+++.++||||+++++++.+.+.+
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 457899999999999999999999 6799999999875332222222234678999999999999999999999999999
Q ss_pred EEEEeecccCchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC-
Q 008759 406 YIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN- 482 (554)
Q Consensus 406 ~LVmE~~~ggsL~~ll~~~--~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~- 482 (554)
|+||||+.+ +|..++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 88 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 166 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 166 (346)
T ss_dssp EEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred EEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCc
Confidence 999999997 788887654 4889999999999999999999999999999999999999999999999999765432
Q ss_pred -CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHH
Q 008759 483 -DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTV 543 (554)
Q Consensus 483 -~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~ 543 (554)
......||+.|+|||++.+.. .++.++|||||||++|+|++|..||......+.+..+..
T Consensus 167 ~~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~ 227 (346)
T 1ua2_A 167 RAYTHQVVTRWYRAPELLFGAR-MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFE 227 (346)
T ss_dssp CCCCCSCCCCTTCCHHHHTTCS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred ccCCcccccccccCchHhhCCC-CCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence 234567999999999986432 478999999999999999999999999887777666554
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-38 Score=327.76 Aligned_cols=213 Identities=29% Similarity=0.481 Sum_probs=166.1
Q ss_pred cccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCC-
Q 008759 325 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE- 402 (554)
Q Consensus 325 ~~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~- 402 (554)
-.+.++|++++.||+|+||.||+|.+ .+|+.||+|++.... ......+.+.+|+.+++.++||||+++++++...
T Consensus 25 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 101 (367)
T 2fst_X 25 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF---QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 101 (367)
T ss_dssp EEEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT---SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred cCCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc---cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC
Confidence 34568999999999999999999997 789999999986422 1233456788999999999999999999988654
Q ss_pred -----CcEEEEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccc
Q 008759 403 -----SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477 (554)
Q Consensus 403 -----~~~~LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~ 477 (554)
..+|+|||++ +++|.+++....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 102 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~ 180 (367)
T 2fst_X 102 SLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 180 (367)
T ss_dssp SGGGCCCCEEEEECC-CEECC-----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-----
T ss_pred ccccCCeEEEEeccc-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccc
Confidence 5689999999 6799999988889999999999999999999999999999999999999999999999999997
Q ss_pred ccccCCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHH
Q 008759 478 ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTV 543 (554)
Q Consensus 478 ~~~~~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~ 543 (554)
..... .....||++|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+..
T Consensus 181 ~~~~~-~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~ 244 (367)
T 2fst_X 181 HTADE-MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 244 (367)
T ss_dssp -----------CCCTTCCHHHHTTC-CSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred ccccc-CCCcCcCcCccChHHHcCC-cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 65432 3456799999999998653 2488999999999999999999999999888777666544
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=323.19 Aligned_cols=200 Identities=28% Similarity=0.400 Sum_probs=163.9
Q ss_pred cccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcE
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL 405 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~ 405 (554)
..++|++++.||+|+||+||++.+ .+++.||+|++...... ...+.+|+.+++.++||||+++++++.+.+.+
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 91 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI------DENVQREIINHRSLRHPNIVRFKEVILTPTHL 91 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS------CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc------cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEE
Confidence 457899999999999999999999 58999999998743221 14577999999999999999999999999999
Q ss_pred EEEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCc--EEEEecCccccccc-
Q 008759 406 YIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS--VKLADFGLAKATKL- 481 (554)
Q Consensus 406 ~LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~--vKL~DFGlA~~~~~- 481 (554)
|+||||+.+|+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++....
T Consensus 92 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 92 AIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred EEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 999999999999998865 56999999999999999999999999999999999999987765 99999999875332
Q ss_pred CCccCccCCCcccChhhhcccCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCh
Q 008759 482 NDVKSCRGTAFWMAPEVINNKNKGYG-LPADIWSLGCTVLEMLTSQIPYAPMEC 534 (554)
Q Consensus 482 ~~~~s~~GT~~Y~APEvl~~~~~~~s-~ksDIwSLGvllyeLLTG~~PF~~~e~ 534 (554)
.......||+.|+|||++.+.. +. .++|||||||++|+|++|+.||.....
T Consensus 172 ~~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 223 (361)
T 3uc3_A 172 SQPKSTVGTPAYIAPEVLLRQE--YDGKIADVWSCGVTLYVMLVGAYPFEDPEE 223 (361)
T ss_dssp ---------CTTSCHHHHHCSS--CCHHHHHHHHHHHHHHHHHHSSCSCC----
T ss_pred CCCCCCcCCCCcCChhhhcCCC--CCCCeeeeehhHHHHHHHHhCCCCCCCCcc
Confidence 2334567999999999996543 44 458999999999999999999987543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=331.99 Aligned_cols=203 Identities=28% Similarity=0.503 Sum_probs=159.0
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccC---
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD--- 401 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~--- 401 (554)
.+.++|+++++||+|+||+||+|.+ .+++.||+|++.... ......+++.+|+.+|+.++||||+++++++..
T Consensus 50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 126 (458)
T 3rp9_A 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF---EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDV 126 (458)
T ss_dssp CSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTT---SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCT
T ss_pred ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh---cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCc
Confidence 3457899999999999999999998 689999999986422 223445678899999999999999999999843
Q ss_pred --CCcEEEEEeecccCchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccc
Q 008759 402 --ESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA 478 (554)
Q Consensus 402 --~~~~~LVmE~~~ggsL~~ll~~~-~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~ 478 (554)
...+|+||||+. ++|..++... .+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.
T Consensus 127 ~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 127 EKFDELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLART 205 (458)
T ss_dssp TTCCCEEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred ccCceEEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchh
Confidence 357999999986 5888888764 599999999999999999999999999999999999999999999999999976
Q ss_pred cccC-----------------------------CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-----
Q 008759 479 TKLN-----------------------------DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT----- 524 (554)
Q Consensus 479 ~~~~-----------------------------~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT----- 524 (554)
.... .....+||++|+|||++... ..|+.++|||||||++|||++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~~DiwSlG~il~elltg~~~~ 284 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQ-ENYTEAIDVWSIGCIFAELLNMIKEN 284 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHTTSTTT
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCC-CCCCcHhHHHHHHHHHHHHHHhcccc
Confidence 5321 12345689999999987433 248999999999999999999
Q ss_pred ------CCCCCCCCC
Q 008759 525 ------SQIPYAPME 533 (554)
Q Consensus 525 ------G~~PF~~~e 533 (554)
|+++|.+..
T Consensus 285 ~~~~~~~~p~f~g~~ 299 (458)
T 3rp9_A 285 VAYHADRGPLFPGSS 299 (458)
T ss_dssp CSSGGGCCCSCC---
T ss_pred ccccccccccCCCCc
Confidence 777776654
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=325.59 Aligned_cols=203 Identities=29% Similarity=0.461 Sum_probs=174.5
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCc
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~ 404 (554)
...+.|.+++.||+|+||.||+|.+ .+++.||+|++..... ........+.+|+.+++.++||||+++++++...+.
T Consensus 6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 83 (336)
T 3h4j_B 6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLL--KKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTD 83 (336)
T ss_dssp SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH--HHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHc--cchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE
Confidence 4567899999999999999999998 7899999999874211 111123468899999999999999999999999999
Q ss_pred EEEEEeecccCchHHHHh-hhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC-
Q 008759 405 LYIFLELVTKGSLLNLYQ-RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN- 482 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~-~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~- 482 (554)
+|+||||+ +|+|.+++. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~ 162 (336)
T 3h4j_B 84 IVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162 (336)
T ss_dssp EEEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred EEEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence 99999999 567777665 457999999999999999999999999999999999999999999999999999765433
Q ss_pred CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008759 483 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM 532 (554)
Q Consensus 483 ~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~ 532 (554)
.....+||+.|+|||++.+.. ..+.++|||||||++|+|++|+.||...
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~~ll~g~~Pf~~~ 211 (336)
T 3h4j_B 163 FLKTSCGSPNYAAPEVINGKL-YAGPEVDVWSCGIVLYVMLVGRLPFDDE 211 (336)
T ss_dssp TTCCCTTSTTTSCGGGSCCSG-GGCHHHHHHHHHHHHHHHHHSSCSSBCS
T ss_pred ccccccCCcCcCCHHHHcCCC-CCCCccchhHHHHHHHHHHhCCCCCCCc
Confidence 345567999999999996543 2378999999999999999999999754
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=310.21 Aligned_cols=214 Identities=29% Similarity=0.450 Sum_probs=182.3
Q ss_pred ccccccccceeeeeeeccCCceeEEEEec------CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhC-CCCceee
Q 008759 322 GRFKRIITYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQ 394 (554)
Q Consensus 322 ~~~~~~~~~y~i~~~LG~GsfG~VY~a~~------~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIVk 394 (554)
..+....++|++++.||+|+||.||+|.+ .+++.||+|++.... .....+.+.+|+.++..+ +||||++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~h~~i~~ 91 (313)
T 1t46_A 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA----HLTEREALMSELKVLSYLGNHMNIVN 91 (313)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC----CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch----hHHHHHHHHHHHHHHhhcccCCCeee
Confidence 34555567999999999999999999974 467899999987422 123346788999999999 8999999
Q ss_pred eeeeccCCCcEEEEEeecccCchHHHHhhh-------------------cCChHHHHHHHHHHHHHHHHHHHCCccccCC
Q 008759 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRY-------------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDI 455 (554)
Q Consensus 395 l~~~~~~~~~~~LVmE~~~ggsL~~ll~~~-------------------~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDI 455 (554)
+++++...+..|+||||+.+|+|.+++... .+++..+..++.||+.||.|||++||+||||
T Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl 171 (313)
T 1t46_A 92 LLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDL 171 (313)
T ss_dssp EEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCC
Confidence 999999999999999999999999998764 2889999999999999999999999999999
Q ss_pred ccccEEEcCCCcEEEEecCcccccccCCc----cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCC
Q 008759 456 KCANILVDANGSVKLADFGLAKATKLNDV----KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYA 530 (554)
Q Consensus 456 KPeNILld~~g~vKL~DFGlA~~~~~~~~----~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~ 530 (554)
||+|||++.++.+||+|||++........ ....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.
T Consensus 172 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~ 249 (313)
T 1t46_A 172 AARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC--VYTFESDVWSYGIFLWELFSLGSSPYP 249 (313)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred ccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCC--CCChHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999976544322 234477889999998654 48899999999999999999 999998
Q ss_pred CCChhHHHHHH
Q 008759 531 PMECVSAIFIK 541 (554)
Q Consensus 531 ~~e~~~~i~~i 541 (554)
.......+...
T Consensus 250 ~~~~~~~~~~~ 260 (313)
T 1t46_A 250 GMPVDSKFYKM 260 (313)
T ss_dssp TCCSSHHHHHH
T ss_pred cccchhHHHHH
Confidence 87665554443
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=319.69 Aligned_cols=211 Identities=28% Similarity=0.527 Sum_probs=182.4
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCC--
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE-- 402 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~-- 402 (554)
.+.++|++++.||+|+||.||+|.+ .++..||+|++... ........+.+|+.++..++||||+++++++...
T Consensus 24 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 99 (364)
T 3qyz_A 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF----EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI 99 (364)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT----TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred cccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc----cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCc
Confidence 4457899999999999999999998 67899999998642 2233456788999999999999999999988654
Q ss_pred ---CcEEEEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccc
Q 008759 403 ---SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT 479 (554)
Q Consensus 403 ---~~~~LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~ 479 (554)
..+|+||||+.+ +|.+++....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 100 ~~~~~~~iv~e~~~~-~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 178 (364)
T 3qyz_A 100 EQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA 178 (364)
T ss_dssp TTCCCEEEEEECCSE-EHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred cccceEEEEEcccCc-CHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEec
Confidence 468999999986 8999998888999999999999999999999999999999999999999999999999999765
Q ss_pred ccCC-----ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHH
Q 008759 480 KLND-----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKT 542 (554)
Q Consensus 480 ~~~~-----~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~ 542 (554)
.... .....||+.|+|||++.+.. .++.++|||||||++|+|++|+.||......+.+..+.
T Consensus 179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~ 245 (364)
T 3qyz_A 179 DPDHDHTGFLTEYVATRWYRAPEIMLNSK-GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 245 (364)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCHHHHHTBC-SCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHH
T ss_pred CCCCCccccccccccccCCCCCHHhcCCC-CCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHH
Confidence 4221 24457999999999875433 47899999999999999999999999888777766654
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=321.91 Aligned_cols=210 Identities=27% Similarity=0.472 Sum_probs=180.0
Q ss_pred ccccccceeeeeeeccCCceeEEEEec--------CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhC-CCCceee
Q 008759 324 FKRIITYWQKGDLLGRGSFGSVYEGIS--------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQ 394 (554)
Q Consensus 324 ~~~~~~~y~i~~~LG~GsfG~VY~a~~--------~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIVk 394 (554)
+....++|.+++.||+|+||.||+|.+ ..+..||+|++... ........+.+|+.+++.+ +||||++
T Consensus 64 ~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~~hpnIv~ 139 (382)
T 3tt0_A 64 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD----ATEKDLSDLISEMEMMKMIGKHKNIIN 139 (382)
T ss_dssp TBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT----CCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc----cCHHHHHHHHHHHHHHHHhcCCchhhh
Confidence 444567999999999999999999985 23468999998642 2234457788999999999 8999999
Q ss_pred eeeeccCCCcEEEEEeecccCchHHHHhhhc-----------------CChHHHHHHHHHHHHHHHHHHHCCccccCCcc
Q 008759 395 YYGTDKDESKLYIFLELVTKGSLLNLYQRYH-----------------LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKC 457 (554)
Q Consensus 395 l~~~~~~~~~~~LVmE~~~ggsL~~ll~~~~-----------------l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKP 457 (554)
+++++...+.+|+||||+.+|+|.+++.... +++..++.++.||+.||.|||++||+||||||
T Consensus 140 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp 219 (382)
T 3tt0_A 140 LLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAA 219 (382)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred heeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCc
Confidence 9999999999999999999999999997643 89999999999999999999999999999999
Q ss_pred ccEEEcCCCcEEEEecCcccccccC----CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008759 458 ANILVDANGSVKLADFGLAKATKLN----DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPM 532 (554)
Q Consensus 458 eNILld~~g~vKL~DFGlA~~~~~~----~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~ 532 (554)
+|||++.++.+||+|||+++..... ......+|+.|+|||++.+. .++.++|||||||++|+|++ |..||...
T Consensus 220 ~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwslG~il~ellt~g~~p~~~~ 297 (382)
T 3tt0_A 220 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR--IYTHQSDVWSFGVLLWEIFTLGGSPYPGV 297 (382)
T ss_dssp GGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCC--CCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999765432 22334578899999999654 48999999999999999999 99999987
Q ss_pred ChhHHHH
Q 008759 533 ECVSAIF 539 (554)
Q Consensus 533 e~~~~i~ 539 (554)
...+...
T Consensus 298 ~~~~~~~ 304 (382)
T 3tt0_A 298 PVEELFK 304 (382)
T ss_dssp CHHHHHH
T ss_pred CHHHHHH
Confidence 7655443
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-37 Score=321.91 Aligned_cols=209 Identities=25% Similarity=0.476 Sum_probs=174.3
Q ss_pred cccceee--eeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCC
Q 008759 327 IITYWQK--GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES 403 (554)
Q Consensus 327 ~~~~y~i--~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~ 403 (554)
+...|.+ .++||+|+||.||+|.+ .+|+.||+|++.... ....+.+.+|+.++..++||||+++++++...+
T Consensus 85 ~~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 159 (373)
T 2x4f_A 85 VNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG-----MKDKEEVKNEISVMNQLDHANLIQLYDAFESKN 159 (373)
T ss_dssp GGGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCS-----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred cccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc-----cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 3345555 67899999999999998 679999999987522 233467889999999999999999999999999
Q ss_pred cEEEEEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEE--cCCCcEEEEecCccccc
Q 008759 404 KLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV--DANGSVKLADFGLAKAT 479 (554)
Q Consensus 404 ~~~LVmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILl--d~~g~vKL~DFGlA~~~ 479 (554)
.+||||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 160 ~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~ 239 (373)
T 2x4f_A 160 DIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRY 239 (373)
T ss_dssp EEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEEC
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceec
Confidence 99999999999999988864 358999999999999999999999999999999999999 56789999999999875
Q ss_pred ccCC-ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHH
Q 008759 480 KLND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKT 542 (554)
Q Consensus 480 ~~~~-~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~ 542 (554)
.... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||......+.+..+.
T Consensus 240 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~ 301 (373)
T 2x4f_A 240 KPREKLKVNFGTPEFLAPEVVNYD--FVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNIL 301 (373)
T ss_dssp CTTCBCCCCCSSCTTCCHHHHTTC--BCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred CCccccccccCCCcEeChhhccCC--CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 4432 3445699999999999654 48899999999999999999999999887766655544
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=311.27 Aligned_cols=209 Identities=26% Similarity=0.442 Sum_probs=178.9
Q ss_pred ccccccceeeeeeeccCCceeEEEEec------CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeee
Q 008759 324 FKRIITYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYG 397 (554)
Q Consensus 324 ~~~~~~~y~i~~~LG~GsfG~VY~a~~------~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~ 397 (554)
+....++|.+++.||+|+||.||+|.+ .++..||+|++.... .....+.+.+|+.+++.++||||+++++
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~hp~iv~~~~ 93 (314)
T 2ivs_A 18 WEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA----SPSELRDLLSEFNVLKQVNHPHVIKLYG 93 (314)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC----CHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred cccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC----CHHHHHHHHHHHHHHhhCCCCceeeEEE
Confidence 334467899999999999999999986 345889999886422 2344577889999999999999999999
Q ss_pred eccCCCcEEEEEeecccCchHHHHhhh-------------------------cCChHHHHHHHHHHHHHHHHHHHCCccc
Q 008759 398 TDKDESKLYIFLELVTKGSLLNLYQRY-------------------------HLRDSQVSAYTRQILLGLKYLHDQDVVH 452 (554)
Q Consensus 398 ~~~~~~~~~LVmE~~~ggsL~~ll~~~-------------------------~l~e~~i~~i~~QIl~gL~yLHs~gIIH 452 (554)
++...+.+|+||||+.+++|.+++... .+++..+..++.||+.||.|||++||+|
T Consensus 94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH 173 (314)
T 2ivs_A 94 ACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVH 173 (314)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred EEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcc
Confidence 999999999999999999999999753 2788899999999999999999999999
Q ss_pred cCCccccEEEcCCCcEEEEecCcccccccCC----ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCC
Q 008759 453 RDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQI 527 (554)
Q Consensus 453 rDIKPeNILld~~g~vKL~DFGlA~~~~~~~----~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~ 527 (554)
|||||+|||++.++.+||+|||++....... .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..
T Consensus 174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~el~t~g~~ 251 (314)
T 2ivs_A 174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHI--YTTQSDVWSFGVLLWEIVTLGGN 251 (314)
T ss_dssp CCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCE--ECHHHHHHHHHHHHHHHHTTSCC
T ss_pred cccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCC--cCchhhHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999997654322 22345788899999997643 7899999999999999999 999
Q ss_pred CCCCCChhHHH
Q 008759 528 PYAPMECVSAI 538 (554)
Q Consensus 528 PF~~~e~~~~i 538 (554)
||......+..
T Consensus 252 p~~~~~~~~~~ 262 (314)
T 2ivs_A 252 PYPGIPPERLF 262 (314)
T ss_dssp SSTTCCGGGHH
T ss_pred CCCCCCHHHHH
Confidence 99887665443
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=324.13 Aligned_cols=210 Identities=27% Similarity=0.429 Sum_probs=177.3
Q ss_pred cccceeeeeeeccCCceeEEEEec------CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeecc
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK 400 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~------~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~ 400 (554)
..++|++++.||+|+||+||+|.+ .++..||+|++... ........+.+|+.++..++||||+++++++.
T Consensus 69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 144 (367)
T 3l9p_A 69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV----CSEQDELDFLMEALIISKFNHQNIVRCIGVSL 144 (367)
T ss_dssp CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS----CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc----cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 356899999999999999999983 45778999988632 12334457889999999999999999999999
Q ss_pred CCCcEEEEEeecccCchHHHHhhh--------cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCC---cEE
Q 008759 401 DESKLYIFLELVTKGSLLNLYQRY--------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG---SVK 469 (554)
Q Consensus 401 ~~~~~~LVmE~~~ggsL~~ll~~~--------~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g---~vK 469 (554)
.....|+||||+.+|+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.+| .+|
T Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 145 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEE
Confidence 999999999999999999999764 388899999999999999999999999999999999999655 599
Q ss_pred EEecCccccccc----CCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHH
Q 008759 470 LADFGLAKATKL----NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIFIKT 542 (554)
Q Consensus 470 L~DFGlA~~~~~----~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i~~i~ 542 (554)
|+|||+++.... .......||+.|+|||++.+. .++.++|||||||++|+|++ |..||......+.+..+.
T Consensus 225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~ 300 (367)
T 3l9p_A 225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 300 (367)
T ss_dssp ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred ECCCccccccccccccccCCCcCCcccEECHHHhcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 999999975322 122334589999999999654 48999999999999999998 999999887765554443
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=331.13 Aligned_cols=195 Identities=27% Similarity=0.428 Sum_probs=161.0
Q ss_pred cccceeee-eeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHH-HhCCCCceeeeeeeccC--
Q 008759 327 IITYWQKG-DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL-SRFEHENIVQYYGTDKD-- 401 (554)
Q Consensus 327 ~~~~y~i~-~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL-~~l~HpnIVkl~~~~~~-- 401 (554)
+.+.|.+. ++||+|+||+||+|.+ .+++.||+|++... ..+.+|+.++ +..+||||+++++++..
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~----------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~ 128 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----------PKARREVELHWRASQCPHIVRIVDVYENLY 128 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc----------hhHHHHHHHHHHhcCCCCcceEeEEEeecc
Confidence 44566665 7999999999999998 67999999998621 2355778776 45589999999998764
Q ss_pred --CCcEEEEEeecccCchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcC---CCcEEEEec
Q 008759 402 --ESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA---NGSVKLADF 473 (554)
Q Consensus 402 --~~~~~LVmE~~~ggsL~~ll~~~---~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~---~g~vKL~DF 473 (554)
..++||||||+.+|+|.+++... .+++..++.|+.||+.||.|||++||+||||||+|||++. ++.+||+||
T Consensus 129 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DF 208 (400)
T 1nxk_A 129 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF 208 (400)
T ss_dssp TTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCC
T ss_pred cCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEec
Confidence 56799999999999999999763 4899999999999999999999999999999999999987 789999999
Q ss_pred CcccccccC-CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008759 474 GLAKATKLN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME 533 (554)
Q Consensus 474 GlA~~~~~~-~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e 533 (554)
|+++..... .....+||+.|+|||++.+. .|+.++|||||||++|+|++|+.||....
T Consensus 209 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~ 267 (400)
T 1nxk_A 209 GFAKETTSHNSLTTPCYTPYYVAPEVLGPE--KYDKSCDMWSLGVIMYILLCGYPPFYSNH 267 (400)
T ss_dssp TTCEECC-----------CTTCCGGGSCCC--CSSSHHHHHHHHHHHHHHHHSSCSCCCCT
T ss_pred ccccccCCCCccccCCCCCCccCHhhcCCC--CCCCcccHHHHHHHHHHHHhCCCCCCCCc
Confidence 999865432 34456799999999998554 48899999999999999999999997654
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=307.80 Aligned_cols=210 Identities=27% Similarity=0.479 Sum_probs=182.1
Q ss_pred cccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcE
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL 405 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~ 405 (554)
..++|++++.||+|+||.||+|.+ .++..||+|++..... ........+.+|+.++..++||||+++++++.+.+.+
T Consensus 12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 89 (284)
T 2vgo_A 12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQL--EKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRI 89 (284)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEccccc--chHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEE
Confidence 457899999999999999999998 5788999999864211 1111235688999999999999999999999999999
Q ss_pred EEEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCCc
Q 008759 406 YIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV 484 (554)
Q Consensus 406 ~LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~~ 484 (554)
|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 169 (284)
T 2vgo_A 90 YLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR 169 (284)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSCB
T ss_pred EEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccccc
Confidence 999999999999998876 4689999999999999999999999999999999999999999999999999876655555
Q ss_pred cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHH
Q 008759 485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFI 540 (554)
Q Consensus 485 ~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~ 540 (554)
....||+.|+|||++.+. .++.++|||||||++|+|++|..||......+....
T Consensus 170 ~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 223 (284)
T 2vgo_A 170 RTMCGTLDYLPPEMIEGK--THDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRR 223 (284)
T ss_dssp CCCCSCGGGCCHHHHTTC--CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH
T ss_pred ccccCCCCcCCHHHhccC--CCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHH
Confidence 566799999999999654 478899999999999999999999988766554433
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=350.28 Aligned_cols=213 Identities=26% Similarity=0.398 Sum_probs=183.4
Q ss_pred cccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhC-CCCceeeeeeeccCCCc
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESK 404 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIVkl~~~~~~~~~ 404 (554)
..++|++++.||+|+||.||+|.+ .+++.||+|++..... ........+..|..+|..+ +|+||+++++++.+.+.
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~--~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~ 416 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVV--IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 416 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHH--HHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEecccc--ccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence 467899999999999999999998 6789999999874211 1122345677899999887 69999999999999999
Q ss_pred EEEEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccc--c
Q 008759 405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK--L 481 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~--~ 481 (554)
+||||||+.+|+|..++++ ..+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+++... .
T Consensus 417 ~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~ 496 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 496 (674)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTT
T ss_pred EEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCC
Confidence 9999999999999999986 569999999999999999999999999999999999999999999999999998532 2
Q ss_pred CCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHH
Q 008759 482 NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTV 543 (554)
Q Consensus 482 ~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~ 543 (554)
......+||+.|+|||++.+. .|+.++|||||||++|||++|+.||...+..+.+.+|..
T Consensus 497 ~~~~~~~GT~~Y~APE~l~~~--~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~ 556 (674)
T 3pfq_A 497 VTTKTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME 556 (674)
T ss_dssp CCBCCCCSCSSSCCHHHHTCC--CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHS
T ss_pred cccccccCCCcccCHhhhcCC--CCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Confidence 334566799999999999654 489999999999999999999999998877666555543
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=341.22 Aligned_cols=201 Identities=26% Similarity=0.463 Sum_probs=176.9
Q ss_pred ccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEE
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~ 406 (554)
.++|.+.++||+|+||.||+|++ .+|+.||+|++..... ........+.+|+.++..++||||+++++++.+.+.+|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~--~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 261 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRL--KKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLC 261 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHh--hhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEE
Confidence 46899999999999999999998 6799999999874221 11122456789999999999999999999999999999
Q ss_pred EEEeecccCchHHHHhhh-----cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccccc
Q 008759 407 IFLELVTKGSLLNLYQRY-----HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL 481 (554)
Q Consensus 407 LVmE~~~ggsL~~ll~~~-----~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~ 481 (554)
+||||+.||+|..++... .+++..++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 999999999999988753 489999999999999999999999999999999999999999999999999987544
Q ss_pred CC--ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008759 482 ND--VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM 532 (554)
Q Consensus 482 ~~--~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~ 532 (554)
.. ....+||+.|+|||++.+. .|+.++|||||||++|+|++|+.||...
T Consensus 342 ~~~~~~~~~GT~~Y~APE~l~~~--~~~~~~DiwSlGvilyelltG~~PF~~~ 392 (543)
T 3c4z_A 342 GQTKTKGYAGTPGFMAPELLLGE--EYDFSVDYFALGVTLYEMIAARGPFRAR 392 (543)
T ss_dssp TCCCBCCCCSCTTTSCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCT
T ss_pred CCcccccccCCccccChhhhcCC--CCChHHhcCcchHHHHHHHhCCCCCCCC
Confidence 32 2345799999999999654 4899999999999999999999999875
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-37 Score=313.78 Aligned_cols=211 Identities=30% Similarity=0.524 Sum_probs=182.9
Q ss_pred cccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcE
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL 405 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~ 405 (554)
..++|.+++.||+|+||.||++.+ .+++.||+|++...... .......+.+|+.+++.++|+||+++++++.+.+.+
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 116 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLL--KPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV 116 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeE
Confidence 356899999999999999999998 67889999998753222 233456788999999999999999999999999999
Q ss_pred EEEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccccc--C
Q 008759 406 YIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL--N 482 (554)
Q Consensus 406 ~LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~--~ 482 (554)
|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .
T Consensus 117 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 196 (335)
T 2owb_A 117 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 196 (335)
T ss_dssp EEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred EEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcc
Confidence 999999999999998876 4689999999999999999999999999999999999999999999999999976542 2
Q ss_pred CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHH
Q 008759 483 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIK 541 (554)
Q Consensus 483 ~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i 541 (554)
......||+.|+|||++.+. .++.++|||||||++|+|++|+.||......+.+..+
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 253 (335)
T 2owb_A 197 RKKVLCGTPNYIAPEVLSKK--GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI 253 (335)
T ss_dssp CBCCCCSCCSSCCHHHHHTS--CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred cccccCCCccccCHHHhccC--CCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH
Confidence 23445699999999999654 4788999999999999999999999887665554443
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=316.93 Aligned_cols=204 Identities=24% Similarity=0.457 Sum_probs=171.5
Q ss_pred ccccceeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCC--CceeeeeeeccCCC
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH--ENIVQYYGTDKDES 403 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~H--pnIVkl~~~~~~~~ 403 (554)
...+.|++++.||+|+||.||++.+.+++.||+|++..... .......+.+|+.+|..++| +||+++++++....
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~ 82 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA---DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 82 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred eecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeecccc---chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCC
Confidence 34568999999999999999999998899999999875332 23445778899999999986 99999999999999
Q ss_pred cEEEEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC
Q 008759 404 KLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN 482 (554)
Q Consensus 404 ~~~LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~ 482 (554)
.+|+||| +.+++|.+++.. ..+++..+..|+.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.....
T Consensus 83 ~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 83 YIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 160 (343)
T ss_dssp EEEEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred EEEEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence 9999999 567799998876 4689999999999999999999999999999999999996 688999999999765433
Q ss_pred C----ccCccCCCcccChhhhccc---------CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh
Q 008759 483 D----VKSCRGTAFWMAPEVINNK---------NKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC 534 (554)
Q Consensus 483 ~----~~s~~GT~~Y~APEvl~~~---------~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~ 534 (554)
. .....||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.....
T Consensus 161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 225 (343)
T 3dbq_A 161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN 225 (343)
T ss_dssp ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS
T ss_pred cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh
Confidence 2 2345699999999998641 13478899999999999999999999987543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-37 Score=305.64 Aligned_cols=210 Identities=31% Similarity=0.550 Sum_probs=181.6
Q ss_pred cccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccC----
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD---- 401 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~---- 401 (554)
...+|++.+.||+|+||.||+|.+ .++..||+|++..... .......+.+|+.+++.++||||+++++++..
T Consensus 24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (290)
T 1t4h_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL---TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKG 100 (290)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSS
T ss_pred CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh---CHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCC
Confidence 345789999999999999999998 6788999999875332 23345778899999999999999999998654
Q ss_pred CCcEEEEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCC--ccccCCccccEEEc-CCCcEEEEecCccc
Q 008759 402 ESKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQD--VVHRDIKCANILVD-ANGSVKLADFGLAK 477 (554)
Q Consensus 402 ~~~~~LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~g--IIHrDIKPeNILld-~~g~vKL~DFGlA~ 477 (554)
...+|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++.
T Consensus 101 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 101 KKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp CEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred CceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 4568999999999999999987 56899999999999999999999999 99999999999997 78999999999997
Q ss_pred ccccCCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHH
Q 008759 478 ATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKT 542 (554)
Q Consensus 478 ~~~~~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~ 542 (554)
...........||+.|+|||++.+ .++.++|||||||++|+|++|+.||........++...
T Consensus 181 ~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 242 (290)
T 1t4h_A 181 LKRASFAKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV 242 (290)
T ss_dssp GCCTTSBEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHH
T ss_pred cccccccccccCCcCcCCHHHHhc---cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHH
Confidence 766555566779999999998853 37899999999999999999999999876666655443
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-37 Score=313.77 Aligned_cols=216 Identities=29% Similarity=0.475 Sum_probs=182.6
Q ss_pred ccccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCC
Q 008759 324 FKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE 402 (554)
Q Consensus 324 ~~~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~ 402 (554)
+-...++|++++.||+|+||.||+|.+ .+++.||+|++..... .....+.+.+|+.+++.++||||+++++++...
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 96 (331)
T 4aaa_A 20 YFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD---DKMVKKIAMREIKLLKQLRHENLVNLLEVCKKK 96 (331)
T ss_dssp CCBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSS---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred hhhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCC---chHHHHHHHHHHHHHhhCCCCCEeeEEEEeecC
Confidence 335568999999999999999999998 6699999999864332 233446678999999999999999999999999
Q ss_pred CcEEEEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccccc
Q 008759 403 SKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL 481 (554)
Q Consensus 403 ~~~~LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~ 481 (554)
+.+|+||||+.+++|..++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 97 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 97 KRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp TEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred CEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 999999999999999988654 5699999999999999999999999999999999999999999999999999976433
Q ss_pred C--CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHH
Q 008759 482 N--DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTV 543 (554)
Q Consensus 482 ~--~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~ 543 (554)
. ......||+.|+|||++.+.. .++.++|||||||++|+|++|+.||......+.+..+..
T Consensus 177 ~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 239 (331)
T 4aaa_A 177 PGEVYDDEVATRWYRAPELLVGDV-KYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMM 239 (331)
T ss_dssp -------CCCCCTTCCHHHHTTCT-TCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred CccccCCCcCCccccCcccccCCC-CcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Confidence 2 234456999999999986542 478999999999999999999999999888777766653
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=304.77 Aligned_cols=211 Identities=31% Similarity=0.535 Sum_probs=182.5
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCc
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~ 404 (554)
...++|.+++.||+|+||.||+|.+ .+++.||+|++...... .......+.+|+.+++.++|+||+++++++.+.+.
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 89 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLL--KPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDF 89 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhcc--CHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCE
Confidence 3457899999999999999999998 57899999998753322 23345678899999999999999999999999999
Q ss_pred EEEEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccccc--
Q 008759 405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL-- 481 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~-- 481 (554)
+|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 90 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 169 (294)
T 2rku_A 90 VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 169 (294)
T ss_dssp EEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence 9999999999999998876 4689999999999999999999999999999999999999999999999999976542
Q ss_pred CCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHH
Q 008759 482 NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFI 540 (554)
Q Consensus 482 ~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~ 540 (554)
.......||+.|+|||++.+. .++.++|||||||++|+|++|+.||......+....
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~ 226 (294)
T 2rku_A 170 ERKKVLCGTPNYIAPEVLSKK--GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLR 226 (294)
T ss_dssp CCBCCCCSCCSSCCHHHHTTS--CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH
T ss_pred cccccccCCCCcCCcchhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 223445699999999999654 478899999999999999999999988766554443
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=314.37 Aligned_cols=214 Identities=27% Similarity=0.491 Sum_probs=183.3
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccch-hHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCC
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQ-AKQSISQLEQEIALLSRFEHENIVQYYGTDKDES 403 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~-~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~ 403 (554)
.+.++|++++.||+|+||.||+|.+ .+++.||+|++........ .......+.+|+.++..++||||+++++++.+.+
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 88 (321)
T 2a2a_A 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRT 88 (321)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 4567899999999999999999998 6799999999975432211 1112356889999999999999999999999999
Q ss_pred cEEEEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCC----cEEEEecCcccc
Q 008759 404 KLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG----SVKLADFGLAKA 478 (554)
Q Consensus 404 ~~~LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g----~vKL~DFGlA~~ 478 (554)
.+|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~ 168 (321)
T 2a2a_A 89 DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (321)
T ss_dssp EEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCcccee
Confidence 99999999999999999876 4588999999999999999999999999999999999999888 799999999976
Q ss_pred cccC-CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHH
Q 008759 479 TKLN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIK 541 (554)
Q Consensus 479 ~~~~-~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i 541 (554)
.... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||......+.+..+
T Consensus 169 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i 230 (321)
T 2a2a_A 169 IEDGVEFKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI 230 (321)
T ss_dssp CCTTCCCCCCCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH
T ss_pred cCccccccccCCCCCccCcccccCC--CCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 5443 23455699999999999654 4789999999999999999999999887665554443
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=317.64 Aligned_cols=213 Identities=23% Similarity=0.420 Sum_probs=174.3
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCc
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~ 404 (554)
...++|++++.||+|+||+||+|.+ .+++.||+|++..... .......+.+|+.+++.++||||+++++++.+.+.
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE---EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHR 107 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC-----------CHHHHHHGGGCCCTTBCCEEEEEEETTE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc---ccccchhHHHHHHHHHHcCCCCcceEEEEEecCCE
Confidence 4567899999999999999999997 6899999999864322 22334567799999999999999999999999999
Q ss_pred EEEEEeecccCchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEc-----CCCcEEEEecCcccc
Q 008759 405 LYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD-----ANGSVKLADFGLAKA 478 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~~-~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld-----~~g~vKL~DFGlA~~ 478 (554)
+|+||||+.+ +|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.
T Consensus 108 ~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~ 186 (329)
T 3gbz_A 108 LHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186 (329)
T ss_dssp EEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred EEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence 9999999986 888888764 699999999999999999999999999999999999994 445699999999976
Q ss_pred cccC--CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHH
Q 008759 479 TKLN--DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTV 543 (554)
Q Consensus 479 ~~~~--~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~ 543 (554)
.... ......||+.|+|||++.+.. .++.++|||||||++|+|++|+.||......+.+..+..
T Consensus 187 ~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~ 252 (329)
T 3gbz_A 187 FGIPIRQFTHEIITLWYRPPEILLGSR-HYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFE 252 (329)
T ss_dssp HC-----------CCTTCCHHHHTTCC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred cCCcccccCCCcCCccccCHHHhcCCC-CCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHH
Confidence 5422 234456899999999996533 478999999999999999999999999888877776654
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-37 Score=318.83 Aligned_cols=210 Identities=32% Similarity=0.543 Sum_probs=181.2
Q ss_pred ccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEE
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~ 406 (554)
.+.|.+.+.||+|+||+||+|.+ .+++.||+|++..... ........+.+|+.+++.++||||+++++++...+..|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 130 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK--QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW 130 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSS--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccc--cchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEE
Confidence 45799999999999999999998 7899999999875332 22344567889999999999999999999999999999
Q ss_pred EEEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCCc
Q 008759 407 IFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV 484 (554)
Q Consensus 407 LVmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~~ 484 (554)
+||||+.| +|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .
T Consensus 131 lv~e~~~g-~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~--~ 207 (348)
T 1u5q_A 131 LVMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--A 207 (348)
T ss_dssp EEEECCSE-EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--B
T ss_pred EEEecCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC--C
Confidence 99999985 77777643 4689999999999999999999999999999999999999999999999999876543 3
Q ss_pred cCccCCCcccChhhhccc-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHH
Q 008759 485 KSCRGTAFWMAPEVINNK-NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKT 542 (554)
Q Consensus 485 ~s~~GT~~Y~APEvl~~~-~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~ 542 (554)
....||+.|+|||++... ...++.++|||||||++|+|++|+.||......+.++.+.
T Consensus 208 ~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~ 266 (348)
T 1u5q_A 208 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA 266 (348)
T ss_dssp CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 345799999999998642 2347889999999999999999999999888777666554
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=307.08 Aligned_cols=211 Identities=29% Similarity=0.456 Sum_probs=168.8
Q ss_pred ccccccceeeeeeeccCCceeEEEEecC----CCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeec
Q 008759 324 FKRIITYWQKGDLLGRGSFGSVYEGISD----DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTD 399 (554)
Q Consensus 324 ~~~~~~~y~i~~~LG~GsfG~VY~a~~~----~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~ 399 (554)
+....++|++++.||+|+||.||+|.+. .+..||+|.+... ......+.+.+|+.+++.++||||+++++++
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 85 (281)
T 1mp8_A 10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC----TSDSVREKFLQEALTMRQFDHPHIVKLIGVI 85 (281)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT----TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred eEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc----CCHHHHHHHHHHHHHHHhCCCCccceEEEEE
Confidence 4455679999999999999999999873 3457899987642 2234456788999999999999999999998
Q ss_pred cCCCcEEEEEeecccCchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccc
Q 008759 400 KDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477 (554)
Q Consensus 400 ~~~~~~~LVmE~~~ggsL~~ll~~~--~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~ 477 (554)
. .+.+|+||||+.+++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 86 ~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (281)
T 1mp8_A 86 T-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 164 (281)
T ss_dssp C-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred c-cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECcccccc
Confidence 4 56789999999999999999754 58999999999999999999999999999999999999999999999999997
Q ss_pred ccccCC---ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHHHHH
Q 008759 478 ATKLND---VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIFIK 541 (554)
Q Consensus 478 ~~~~~~---~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i~~i 541 (554)
...... .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||......+.+..+
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i 230 (281)
T 1mp8_A 165 YMEDSTYYKASKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 230 (281)
T ss_dssp --------------CCGGGCCHHHHHHC--CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH
T ss_pred ccCcccccccccCCCcccccChhhcccC--CCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHH
Confidence 654332 2233477899999999654 48899999999999999997 99999987766655444
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=318.91 Aligned_cols=209 Identities=29% Similarity=0.474 Sum_probs=172.0
Q ss_pred cceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEE
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~L 407 (554)
++|++++.||+|+||+||+|.+ .+++.||+|++..... ......+.+|+.+++.++||||+++++++...+.+|+
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 77 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE----EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL 77 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC----------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc----cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEE
Confidence 5799999999999999999998 5899999999864221 1111234579999999999999999999999999999
Q ss_pred EEeecccCchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC--C
Q 008759 408 FLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--D 483 (554)
Q Consensus 408 VmE~~~ggsL~~ll~~~--~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~--~ 483 (554)
||||+.+ +|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus 78 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 156 (324)
T 3mtl_A 78 VFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT 156 (324)
T ss_dssp EEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred Eeccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCccc
Confidence 9999986 888877653 4889999999999999999999999999999999999999999999999998764422 2
Q ss_pred ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHH
Q 008759 484 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTV 543 (554)
Q Consensus 484 ~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~ 543 (554)
.....||+.|+|||++.+.. .++.++|||||||++|+|++|+.||......+.+..+..
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~ 215 (324)
T 3mtl_A 157 YDNEVVTLWYRPPDILLGST-DYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFR 215 (324)
T ss_dssp ------CGGGCCHHHHTTCC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cccccCcccccChhhhcCCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 33456899999999986533 478999999999999999999999999877766555443
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=324.96 Aligned_cols=210 Identities=26% Similarity=0.451 Sum_probs=179.6
Q ss_pred ccccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCC
Q 008759 324 FKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE 402 (554)
Q Consensus 324 ~~~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~ 402 (554)
+....++|++++.||+|+||.||+|.+ .+++.||+|++.... .......+.+|+.+++.++||||+++++++...
T Consensus 109 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 184 (377)
T 3cbl_A 109 WVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL----PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK 184 (377)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS----CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred cEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC----CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecC
Confidence 334457899999999999999999998 589999999886321 233445688999999999999999999999999
Q ss_pred CcEEEEEeecccCchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccc
Q 008759 403 SKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK 480 (554)
Q Consensus 403 ~~~~LVmE~~~ggsL~~ll~~~--~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~ 480 (554)
+.+|+||||+.+|+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 185 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~ 264 (377)
T 3cbl_A 185 QPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEA 264 (377)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred CCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence 9999999999999999999764 48999999999999999999999999999999999999999999999999987644
Q ss_pred cCCcc----CccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHHH
Q 008759 481 LNDVK----SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIF 539 (554)
Q Consensus 481 ~~~~~----s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i~ 539 (554)
..... ...+++.|+|||++.+.. ++.++|||||||++|||++ |..||......+...
T Consensus 265 ~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~ 326 (377)
T 3cbl_A 265 DGVYAASGGLRQVPVKWTAPEALNYGR--YSSESDVWSFGILLWETFSLGASPYPNLSNQQTRE 326 (377)
T ss_dssp TSEEECCSSCCEEEGGGSCHHHHHHCE--EEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHH
T ss_pred CCceeecCCCCCCCcCcCCHhHhccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 32221 123567899999997543 7899999999999999998 999999887655443
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=326.91 Aligned_cols=197 Identities=30% Similarity=0.533 Sum_probs=167.3
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCC--
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE-- 402 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~-- 402 (554)
.+.++|++++.||+|+||.||+|.+ .+++.||+|++.... ......+++.+|+.+|+.++|+||+++++++...
T Consensus 23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 99 (432)
T 3n9x_A 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF---EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDL 99 (432)
T ss_dssp CCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT---TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCT
T ss_pred eecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh---cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCC
Confidence 4567999999999999999999998 678999999986432 2234457789999999999999999999998766
Q ss_pred ---CcEEEEEeecccCchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccc
Q 008759 403 ---SKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA 478 (554)
Q Consensus 403 ---~~~~LVmE~~~ggsL~~ll~~~-~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~ 478 (554)
..+|+||||+.+ +|.+++... .+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.
T Consensus 100 ~~~~~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 100 LKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLART 178 (432)
T ss_dssp TTCCCEEEEEECCSE-EHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred CcCCeEEEEEecCCc-CHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence 579999999975 899988764 599999999999999999999999999999999999999999999999999986
Q ss_pred cccC------------------------CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCC
Q 008759 479 TKLN------------------------DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQI 527 (554)
Q Consensus 479 ~~~~------------------------~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~ 527 (554)
.... .....+||++|+|||++... ..|+.++|||||||++|||++|..
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~~~~~DiwSlG~il~ell~g~~ 250 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQ-ENYTKSIDIWSTGCIFAELLNMLQ 250 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHTTCT
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcC-CCCCcccccchHHHHHHHHHhccc
Confidence 5432 12456799999999987543 358999999999999999998433
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=319.57 Aligned_cols=205 Identities=27% Similarity=0.467 Sum_probs=179.6
Q ss_pred cccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcE
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL 405 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~ 405 (554)
..++|++.+.||+|+||.||+|.+ .++..||+|++.... .......+.+|+.++..++||||+++++++...+.+
T Consensus 31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 106 (360)
T 3eqc_A 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI----KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI 106 (360)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC----CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEE
T ss_pred ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc----CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEE
Confidence 356899999999999999999998 589999999987532 234456788999999999999999999999999999
Q ss_pred EEEEeecccCchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHHC-CccccCCccccEEEcCCCcEEEEecCcccccccCC
Q 008759 406 YIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQ-DVVHRDIKCANILVDANGSVKLADFGLAKATKLND 483 (554)
Q Consensus 406 ~LVmE~~~ggsL~~ll~~~-~l~e~~i~~i~~QIl~gL~yLHs~-gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~ 483 (554)
|+||||+.+++|.+++... .+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++.......
T Consensus 107 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 186 (360)
T 3eqc_A 107 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 186 (360)
T ss_dssp EEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC
T ss_pred EEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCccccccc
Confidence 9999999999999999764 689999999999999999999996 99999999999999999999999999987655444
Q ss_pred ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHH
Q 008759 484 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSA 537 (554)
Q Consensus 484 ~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~ 537 (554)
.....||+.|+|||++.+. .++.++|||||||++|+|++|+.||......+.
T Consensus 187 ~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 238 (360)
T 3eqc_A 187 ANSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEL 238 (360)
T ss_dssp ----CCCCTTCCHHHHTTC--CCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHH
T ss_pred ccCCCCCCCeECHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 5566799999999999654 488999999999999999999999998765543
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-37 Score=313.52 Aligned_cols=210 Identities=28% Similarity=0.510 Sum_probs=179.2
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCC--
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE-- 402 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~-- 402 (554)
.+.++|++++.||+|+||.||+|.+ .+|+.||+|++.... .......+.+|+.+++.++||||+++++++...
T Consensus 8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 83 (353)
T 2b9h_A 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD----KPLFALRTLREIKILKHFKHENIITIFNIQRPDSF 83 (353)
T ss_dssp CSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS----SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCS
T ss_pred ccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc----cchHHHHHHHHHHHHHhCcCCCcCCeeeeeccccc
Confidence 4567999999999999999999998 679999999986322 233456778999999999999999999987653
Q ss_pred ---CcEEEEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccc
Q 008759 403 ---SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT 479 (554)
Q Consensus 403 ---~~~~LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~ 479 (554)
..+|+||||+.+ +|.+++....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 84 ~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 84 ENFNEVYIIQELMQT-DLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp TTCCCEEEEECCCSE-EHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred CccceEEEEEeccCc-cHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 679999999985 8999998888999999999999999999999999999999999999999999999999999765
Q ss_pred ccCC------------ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHH
Q 008759 480 KLND------------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIK 541 (554)
Q Consensus 480 ~~~~------------~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i 541 (554)
.... .....||+.|+|||++... ..++.++|||||||++|+|++|+.||......+.+..+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 235 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTS-AKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLI 235 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSC-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred ccccccccCccccccchhhccccccccCCeeeccC-CCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH
Confidence 3221 2234689999999998543 34889999999999999999999999988776655544
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=342.65 Aligned_cols=203 Identities=27% Similarity=0.463 Sum_probs=178.0
Q ss_pred cccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcE
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL 405 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~ 405 (554)
..++|++.++||+|+||.||+|.+ .+|+.||+|++...... .......+.+|+.+|..++||||+++++++.+.+.+
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~--~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 259 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK--KRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDAL 259 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH--HTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhh--hhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEE
Confidence 356899999999999999999998 68999999998742211 112235678999999999999999999999999999
Q ss_pred EEEEeecccCchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC
Q 008759 406 YIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN 482 (554)
Q Consensus 406 ~LVmE~~~ggsL~~ll~~~---~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~ 482 (554)
|+||||+.||+|..++... .+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+++.....
T Consensus 260 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~ 339 (576)
T 2acx_A 260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339 (576)
T ss_dssp EEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence 9999999999999988763 3899999999999999999999999999999999999999999999999999876443
Q ss_pred -CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008759 483 -DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME 533 (554)
Q Consensus 483 -~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e 533 (554)
.....+||+.|+|||++.+. .|+.++|||||||++|+|++|+.||....
T Consensus 340 ~~~~~~~GT~~Y~APEvl~~~--~~~~~~DiwSLGvilyeLltG~~PF~~~~ 389 (576)
T 2acx_A 340 QTIKGRVGTVGYMAPEVVKNE--RYTFSPDWWALGCLLYEMIAGQSPFQQRK 389 (576)
T ss_dssp CCEECCCSCGGGCCHHHHTTC--EESSHHHHHHHHHHHHHHHHSSCSSSCSS
T ss_pred ccccccCCCccccCHHHHcCC--CCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence 33456799999999999654 48899999999999999999999998753
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=318.20 Aligned_cols=202 Identities=27% Similarity=0.388 Sum_probs=172.2
Q ss_pred ccccccceeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCC
Q 008759 324 FKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES 403 (554)
Q Consensus 324 ~~~~~~~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~ 403 (554)
+....++|+++++||+|+||+||+|.+. ++.||+|++... .........|+.++..++||||+++++++....
T Consensus 19 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 91 (322)
T 3soc_A 19 LYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ------DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGT 91 (322)
T ss_dssp EEETTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGG------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred cccchhhchhhheecccCceEEEEEEEC-CCEEEEEEeecC------chHHHHHHHHHHHHhcCCCCCchhhcceeccCC
Confidence 3344578999999999999999999876 789999998642 122344567899999999999999999987643
Q ss_pred ----cEEEEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHC----------CccccCCccccEEEcCCCcEE
Q 008759 404 ----KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ----------DVVHRDIKCANILVDANGSVK 469 (554)
Q Consensus 404 ----~~~LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~----------gIIHrDIKPeNILld~~g~vK 469 (554)
.+|+||||+.+|+|.++++...+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+|
T Consensus 92 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~k 171 (322)
T 3soc_A 92 SVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTAC 171 (322)
T ss_dssp SSSEEEEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEE
T ss_pred CCCceEEEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEE
Confidence 479999999999999999988899999999999999999999999 999999999999999999999
Q ss_pred EEecCcccccccCC----ccCccCCCcccChhhhcccC---CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008759 470 LADFGLAKATKLND----VKSCRGTAFWMAPEVINNKN---KGYGLPADIWSLGCTVLEMLTSQIPYAPM 532 (554)
Q Consensus 470 L~DFGlA~~~~~~~----~~s~~GT~~Y~APEvl~~~~---~~~s~ksDIwSLGvllyeLLTG~~PF~~~ 532 (554)
|+|||+++...... .....||+.|+|||++.+.. ..++.++|||||||++|+|+||+.||...
T Consensus 172 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~ 241 (322)
T 3soc_A 172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGP 241 (322)
T ss_dssp ECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSC
T ss_pred EccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCC
Confidence 99999997644322 23356999999999997532 12566889999999999999999999753
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-37 Score=308.14 Aligned_cols=209 Identities=37% Similarity=0.666 Sum_probs=183.8
Q ss_pred cccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcE
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL 405 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~ 405 (554)
..+.|++++.||+|+||.||+|.+ .+++.||+|++...... .....+.+|+.++..++||||+++++++.....+
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 95 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE----DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKL 95 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS----TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH----HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeE
Confidence 456799999999999999999997 67999999998753322 2346788999999999999999999999999999
Q ss_pred EEEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC--C
Q 008759 406 YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--D 483 (554)
Q Consensus 406 ~LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~--~ 483 (554)
|+||||+.+++|.+++....+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++...... .
T Consensus 96 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 175 (303)
T 3a7i_A 96 WIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 175 (303)
T ss_dssp EEEEECCTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCC
T ss_pred EEEEEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccccc
Confidence 99999999999999999888999999999999999999999999999999999999999999999999999765433 2
Q ss_pred ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHH
Q 008759 484 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIK 541 (554)
Q Consensus 484 ~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i 541 (554)
.....||+.|+|||++.+. .++.++|||||||++|+|++|+.||......+.+..+
T Consensus 176 ~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~ 231 (303)
T 3a7i_A 176 RNTFVGTPFWMAPEVIKQS--AYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLI 231 (303)
T ss_dssp BCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred cCccCCCcCccCHHHHhcC--CCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHh
Confidence 3345699999999999654 4788999999999999999999999988776655443
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=310.69 Aligned_cols=208 Identities=29% Similarity=0.450 Sum_probs=178.9
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCc
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~ 404 (554)
.+.++|.+.+.||+|+||.||+|.+ .+|+.||+|++..... .....+.+|+.++..++||||+++++++.+.+.
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (304)
T 2jam_A 6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA-----FRDSSLENEIAVLKKIKHENIVTLEDIYESTTH 80 (304)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-----------HHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc-----cchHHHHHHHHHHHhCCCCCeeehhhhcccCCE
Confidence 3557899999999999999999998 6899999999874321 123467899999999999999999999999999
Q ss_pred EEEEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEE---cCCCcEEEEecCcccccc
Q 008759 405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKATK 480 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILl---d~~g~vKL~DFGlA~~~~ 480 (554)
+|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 81 YYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred EEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 9999999999999998865 468999999999999999999999999999999999999 778999999999987655
Q ss_pred cCCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHH
Q 008759 481 LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFI 540 (554)
Q Consensus 481 ~~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~ 540 (554)
........||+.|+|||++.+. .++.++|||||||++|+|++|+.||......+.+..
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 218 (304)
T 2jam_A 161 NGIMSTACGTPGYVAPEVLAQK--PYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEK 218 (304)
T ss_dssp CBTTHHHHSCCCBCCTTTBSSC--SCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH
T ss_pred CCccccccCCCCccChHHhccC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 4444455699999999998654 488999999999999999999999988765544333
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=307.84 Aligned_cols=207 Identities=30% Similarity=0.479 Sum_probs=174.6
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCc
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~ 404 (554)
.+.+.|.+.+.||+|+||.||+|.+ .++..+|+|++...... .....+.+|+.+++.++||||+++++++.+...
T Consensus 19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 94 (285)
T 3is5_A 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ----VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHN 94 (285)
T ss_dssp CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC----SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc----hhHHHHHHHHHHHHhCCCchHHhHHHheecCCe
Confidence 3557899999999999999999998 67899999998753321 124568899999999999999999999999999
Q ss_pred EEEEEeecccCchHHHHhh-----hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEE---cCCCcEEEEecCcc
Q 008759 405 LYIFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV---DANGSVKLADFGLA 476 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~-----~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILl---d~~g~vKL~DFGlA 476 (554)
+|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a 174 (285)
T 3is5_A 95 MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLA 174 (285)
T ss_dssp EEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCC
T ss_pred EEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecc
Confidence 9999999999999988754 358999999999999999999999999999999999999 45678999999999
Q ss_pred cccccC-CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHH
Q 008759 477 KATKLN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIF 539 (554)
Q Consensus 477 ~~~~~~-~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~ 539 (554)
...... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||......+...
T Consensus 175 ~~~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~ 235 (285)
T 3is5_A 175 ELFKSDEHSTNAAGTALYMAPEVFKR---DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQ 235 (285)
T ss_dssp CC----------CTTGGGCCHHHHTT---CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred eecCCcccCcCcccccCcCChHHhcc---CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHh
Confidence 765433 2345669999999999843 47899999999999999999999998876555443
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-37 Score=300.43 Aligned_cols=207 Identities=22% Similarity=0.363 Sum_probs=179.4
Q ss_pred cccceeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEE
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~ 406 (554)
-.++|++.+.||+|+||.||+|.+.++..||+|++...... .+.+.+|+.++..++||||+++++++.+.+.+|
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (267)
T 3t9t_A 6 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS------EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC 79 (267)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC------HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred chhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC------HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeE
Confidence 34689999999999999999999988899999998753221 246789999999999999999999999999999
Q ss_pred EEEeecccCchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC--
Q 008759 407 IFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-- 482 (554)
Q Consensus 407 LVmE~~~ggsL~~ll~~~--~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~-- 482 (554)
+||||+.+++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 159 (267)
T 3t9t_A 80 LVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 159 (267)
T ss_dssp EEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred EEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccccc
Confidence 999999999999999764 4899999999999999999999999999999999999999999999999998765322
Q ss_pred -CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHHHHH
Q 008759 483 -DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIFIK 541 (554)
Q Consensus 483 -~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i~~i 541 (554)
......+|+.|+|||++.+. .++.++|||||||++|+|++ |+.||......+....+
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i 218 (267)
T 3t9t_A 160 TSSTGTKFPVKWASPEVFSFS--RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 218 (267)
T ss_dssp HSTTSTTCCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH
T ss_pred cccccccccccccChhhhcCC--CccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHH
Confidence 12334578889999999654 47899999999999999999 99999987665544433
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-37 Score=318.74 Aligned_cols=211 Identities=27% Similarity=0.424 Sum_probs=172.4
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCC-
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES- 403 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~- 403 (554)
.+.++|++++.||+|+||.||+|.+ .+++.||+|++..... .......+.+|+.+++.++||||+++++++....
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 98 (371)
T 2xrw_A 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ---NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKS 98 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTS---SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCS
T ss_pred chhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccC---ChHHHHHHHHHHHHHHhcCCCCccceEEeeccccc
Confidence 3567899999999999999999998 6799999999874322 2344567889999999999999999999987654
Q ss_pred -----cEEEEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccc
Q 008759 404 -----KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA 478 (554)
Q Consensus 404 -----~~~LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~ 478 (554)
.+|+||||+.+ +|.+++. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 99 ~~~~~~~~lv~e~~~~-~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 99 LEEFQDVYIVMELMDA-NLCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 176 (371)
T ss_dssp TTTCCEEEEEEECCSE-EHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred cccccceEEEEEcCCC-CHHHHHh-hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence 78999999986 6777775 4689999999999999999999999999999999999999999999999999976
Q ss_pred cccC-CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHH
Q 008759 479 TKLN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTV 543 (554)
Q Consensus 479 ~~~~-~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~ 543 (554)
.... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+.+..+..
T Consensus 177 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~ 240 (371)
T 2xrw_A 177 AGTSFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIE 240 (371)
T ss_dssp -------------CTTCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC
T ss_pred cccccccCCceecCCccCHHHhcCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 5433 23456799999999999754 488999999999999999999999999887776665543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=315.09 Aligned_cols=212 Identities=26% Similarity=0.455 Sum_probs=178.0
Q ss_pred ccccccceeeeeeeccCCceeEEEEec------CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhC-CCCceeeee
Q 008759 324 FKRIITYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYY 396 (554)
Q Consensus 324 ~~~~~~~y~i~~~LG~GsfG~VY~a~~------~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIVkl~ 396 (554)
+....++|++++.||+|+||.||+|.+ .++..||+|++.... .......+.+|+.++..+ +||||++++
T Consensus 40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 115 (344)
T 1rjb_A 40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA----DSSEREALMSELKMMTQLGSHENIVNLL 115 (344)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC----------CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc----CHHHHHHHHHHHHHHHhhcCCCCeeeEE
Confidence 334457899999999999999999985 356789999987422 223346788999999999 899999999
Q ss_pred eeccCCCcEEEEEeecccCchHHHHhhhc------------------------CChHHHHHHHHHHHHHHHHHHHCCccc
Q 008759 397 GTDKDESKLYIFLELVTKGSLLNLYQRYH------------------------LRDSQVSAYTRQILLGLKYLHDQDVVH 452 (554)
Q Consensus 397 ~~~~~~~~~~LVmE~~~ggsL~~ll~~~~------------------------l~e~~i~~i~~QIl~gL~yLHs~gIIH 452 (554)
+++...+.+|+||||+.+|+|.+++.... +++..+..++.||+.||.|||++||+|
T Consensus 116 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH 195 (344)
T 1rjb_A 116 GACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVH 195 (344)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred EEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 99999999999999999999999997532 688899999999999999999999999
Q ss_pred cCCccccEEEcCCCcEEEEecCcccccccCCc----cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCC
Q 008759 453 RDIKCANILVDANGSVKLADFGLAKATKLNDV----KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQI 527 (554)
Q Consensus 453 rDIKPeNILld~~g~vKL~DFGlA~~~~~~~~----~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~ 527 (554)
|||||+|||++.++.+||+|||++........ ....+|+.|+|||++.+. .++.++|||||||++|+|+| |..
T Consensus 196 ~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~ 273 (344)
T 1rjb_A 196 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG--IYTIKSDVWSYGILLWEIFSLGVN 273 (344)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred CCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccC--CCChhHhHHHHHHHHHHHHcCCCC
Confidence 99999999999999999999999976543321 234478899999999654 48899999999999999998 999
Q ss_pred CCCCCChhHHHHHH
Q 008759 528 PYAPMECVSAIFIK 541 (554)
Q Consensus 528 PF~~~e~~~~i~~i 541 (554)
||........+...
T Consensus 274 p~~~~~~~~~~~~~ 287 (344)
T 1rjb_A 274 PYPGIPVDANFYKL 287 (344)
T ss_dssp SSTTCCCSHHHHHH
T ss_pred CcccCCcHHHHHHH
Confidence 99887655554443
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=321.48 Aligned_cols=203 Identities=24% Similarity=0.457 Sum_probs=171.8
Q ss_pred ccccceeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCC--CCceeeeeeeccCCC
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE--HENIVQYYGTDKDES 403 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~--HpnIVkl~~~~~~~~ 403 (554)
.....|++++.||+|+||.||+|.+.+++.||+|++..... .......+.+|+.+|..++ |+||+++++++...+
T Consensus 53 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~ 129 (390)
T 2zmd_A 53 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA---DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 129 (390)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred ccCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccc---cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCC
Confidence 34467999999999999999999998899999999875332 2345577899999999996 599999999999999
Q ss_pred cEEEEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC
Q 008759 404 KLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN 482 (554)
Q Consensus 404 ~~~LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~ 482 (554)
.+||||| +.+++|.+++.. ..+++..+..|+.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.....
T Consensus 130 ~~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 130 YIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp EEEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred EEEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 9999999 567799998876 4588889999999999999999999999999999999995 689999999999865433
Q ss_pred C----ccCccCCCcccChhhhccc---------CCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008759 483 D----VKSCRGTAFWMAPEVINNK---------NKGYGLPADIWSLGCTVLEMLTSQIPYAPME 533 (554)
Q Consensus 483 ~----~~s~~GT~~Y~APEvl~~~---------~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e 533 (554)
. .....||+.|+|||++.+. ...++.++|||||||++|+|++|+.||....
T Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~ 271 (390)
T 2zmd_A 208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 271 (390)
T ss_dssp ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh
Confidence 2 2345799999999998652 1248899999999999999999999998754
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-37 Score=314.78 Aligned_cols=212 Identities=27% Similarity=0.487 Sum_probs=177.0
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccC---
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD--- 401 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~--- 401 (554)
...++|++++.||+|+||.||+|.+ .+++.||+|++........ ....+.+|+.+++.++||||+++++++..
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 90 (351)
T 3mi9_A 14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEG---FPITALREIKILQLLKHENVVNLIEICRTKAS 90 (351)
T ss_dssp CBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSS---SCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--
T ss_pred ccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEeccccccc---chHHHHHHHHHHHhccCCCcccHhheeecccc
Confidence 3457899999999999999999998 7899999998865432221 12456789999999999999999998866
Q ss_pred -----CCcEEEEEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecC
Q 008759 402 -----ESKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFG 474 (554)
Q Consensus 402 -----~~~~~LVmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFG 474 (554)
.+.+|+||||+.+ +|...+.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 91 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 91 PYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp ------CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred ccccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccch
Confidence 4568999999987 66666654 468999999999999999999999999999999999999999999999999
Q ss_pred ccccccc------CCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHH
Q 008759 475 LAKATKL------NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKT 542 (554)
Q Consensus 475 lA~~~~~------~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~ 542 (554)
+++.... .......||+.|+|||++.+.. .++.++|||||||++|+|++|+.||......+.+..+.
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~ 242 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGER-DYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 242 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCC-SCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCC-CCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 9976432 2234456899999999986532 47899999999999999999999999887766555443
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=310.64 Aligned_cols=198 Identities=28% Similarity=0.415 Sum_probs=166.5
Q ss_pred ccccceeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHh--CCCCceeeeeeeccC--
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR--FEHENIVQYYGTDKD-- 401 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~--l~HpnIVkl~~~~~~-- 401 (554)
.+.++|++++.||+|+||+||+|.+ +++.||+|++... ....+..|.+++.. ++||||+++++++..
T Consensus 5 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--------~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~ 75 (301)
T 3q4u_A 5 TVARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR--------DEKSWFRETELYNTVMLRHENILGFIASDMTSR 75 (301)
T ss_dssp CCGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG--------GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE
T ss_pred cccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc--------cchhhHHHHHHHHHhhccCcCeeeEEEeecccc
Confidence 4567999999999999999999988 6889999998631 12334456666655 789999999998543
Q ss_pred --CCcEEEEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHH--------HCCccccCCccccEEEcCCCcEEEE
Q 008759 402 --ESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLH--------DQDVVHRDIKCANILVDANGSVKLA 471 (554)
Q Consensus 402 --~~~~~LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLH--------s~gIIHrDIKPeNILld~~g~vKL~ 471 (554)
...+|+||||+.+|+|.++++...+++..+..++.||+.||.||| ++||+||||||+|||++.++.+||+
T Consensus 76 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 76 HSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp TTEEEEEEEECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEEC
T ss_pred CCCceeEEehhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEe
Confidence 456899999999999999998888999999999999999999999 9999999999999999999999999
Q ss_pred ecCcccccccCC------ccCccCCCcccChhhhcccCC----CCCchhhHHHHHHHHHHHHcC----------CCCCCC
Q 008759 472 DFGLAKATKLND------VKSCRGTAFWMAPEVINNKNK----GYGLPADIWSLGCTVLEMLTS----------QIPYAP 531 (554)
Q Consensus 472 DFGlA~~~~~~~------~~s~~GT~~Y~APEvl~~~~~----~~s~ksDIwSLGvllyeLLTG----------~~PF~~ 531 (554)
|||+++...... .....||+.|+|||++.+... .++.++|||||||++|+|++| ..||..
T Consensus 156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 999997543322 223479999999999976432 244689999999999999999 899975
Q ss_pred C
Q 008759 532 M 532 (554)
Q Consensus 532 ~ 532 (554)
.
T Consensus 236 ~ 236 (301)
T 3q4u_A 236 V 236 (301)
T ss_dssp T
T ss_pred c
Confidence 4
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=310.07 Aligned_cols=203 Identities=32% Similarity=0.424 Sum_probs=166.0
Q ss_pred cccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHh-CCCCceeeeeeeccCC
Q 008759 325 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR-FEHENIVQYYGTDKDE 402 (554)
Q Consensus 325 ~~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~-l~HpnIVkl~~~~~~~ 402 (554)
..+.++|++.++||+|+||+||+|.+ .+++.||+|++...... ... ......|+..+.. .+|+||+++++++.+.
T Consensus 53 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~-~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~ 129 (311)
T 3p1a_A 53 SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRG--PKD-RARKLAEVGSHEKVGQHPCCVRLEQAWEEG 129 (311)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCS--HHH-HHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred chhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccC--hHH-HHHHHHHHHHHHHhcCCCcEEEEEEEEEeC
Confidence 34557899999999999999999998 58999999987643222 122 2334455555544 4899999999999999
Q ss_pred CcEEEEEeecccCchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccc
Q 008759 403 SKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK 480 (554)
Q Consensus 403 ~~~~LVmE~~~ggsL~~ll~~~--~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~ 480 (554)
+.+|+||||+ +++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 130 ~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~ 208 (311)
T 3p1a_A 130 GILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG 208 (311)
T ss_dssp TEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred CEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence 9999999999 55888877653 48999999999999999999999999999999999999999999999999987654
Q ss_pred cCC-ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh
Q 008759 481 LND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC 534 (554)
Q Consensus 481 ~~~-~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~ 534 (554)
... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||...+.
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~el~~g~~~~~~~~~ 260 (311)
T 3p1a_A 209 TAGAGEVQEGDPRYMAPELLQG---SYGTAADVFSLGLTILEVACNMELPHGGEG 260 (311)
T ss_dssp ------CCCCCGGGCCGGGGGT---CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH
T ss_pred cCCCCcccCCCccccCHhHhcC---CCCchhhHHHHHHHHHHHHhCCCCCCCccH
Confidence 332 334569999999999864 478999999999999999999777655433
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=308.65 Aligned_cols=199 Identities=30% Similarity=0.518 Sum_probs=169.1
Q ss_pred cccceeeeeeeccCCceeEEEEe----c-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccC
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGI----S-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD 401 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~----~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~ 401 (554)
..++|++++.||+|+||+||+|. + .+++.||+|++... .....+.+.+|+.++..++||||+++++++..
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 82 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-----TEEHLRDFEREIEILKSLQHDNIVKYKGVCYS 82 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC-----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECH
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC-----CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 35789999999999999999997 3 57899999998632 23445678899999999999999999998754
Q ss_pred --CCcEEEEEeecccCchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccc
Q 008759 402 --ESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477 (554)
Q Consensus 402 --~~~~~LVmE~~~ggsL~~ll~~~--~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~ 477 (554)
...+|+||||+.+++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 83 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp HHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred CCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 35689999999999999999764 48999999999999999999999999999999999999999999999999997
Q ss_pred ccccCC-----ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008759 478 ATKLND-----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM 532 (554)
Q Consensus 478 ~~~~~~-----~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~ 532 (554)
...... .....+|..|+|||++.+.. ++.++|||||||++|+|+||..||...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~~l~~g~~~~~~~ 220 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTESK--FSVASDVWSFGVVLYELFTYIEKSKSP 220 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHHHTTCTTCSH
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcCCC--CChHHHHHHHHHHHHHHHhcccccCCC
Confidence 654322 22344778899999997654 899999999999999999999998653
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=306.15 Aligned_cols=210 Identities=27% Similarity=0.480 Sum_probs=173.4
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeec-----
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTD----- 399 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~----- 399 (554)
.+.++|++++.||+|+||.||+|.+ .+++.||+|++... .....+.+.+|+.+++.++||||+++++++
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 82 (320)
T 2i6l_A 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT-----DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGS 82 (320)
T ss_dssp EETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC-----SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSC
T ss_pred ccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC-----ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccc
Confidence 4567899999999999999999998 56999999998742 234456788999999999999999999876
Q ss_pred ---------cCCCcEEEEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEc-CCCcEE
Q 008759 400 ---------KDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD-ANGSVK 469 (554)
Q Consensus 400 ---------~~~~~~~LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld-~~g~vK 469 (554)
.....+|+||||+. |+|.+++.+..+++..+..++.||+.||.|||++||+||||||+|||++ .++.+|
T Consensus 83 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 83 QLTDDVGSLTELNSVYIVQEYME-TDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp BCCC----CCSCSEEEEEEECCS-EEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEE
T ss_pred ccccccccccccCceeEEeeccC-CCHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEE
Confidence 34467899999998 4999999888899999999999999999999999999999999999997 567999
Q ss_pred EEecCcccccccC-----CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHH
Q 008759 470 LADFGLAKATKLN-----DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKT 542 (554)
Q Consensus 470 L~DFGlA~~~~~~-----~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~ 542 (554)
|+|||+++..... ......+|..|+|||++.... .++.++|||||||++|+|++|+.||......+.+..+.
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 238 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPN-NYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLIL 238 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTT-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCcc-cCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9999999765321 223445799999999986532 48899999999999999999999999887766655443
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=318.80 Aligned_cols=199 Identities=28% Similarity=0.387 Sum_probs=168.8
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCC--------CCceeeee
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE--------HENIVQYY 396 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~--------HpnIVkl~ 396 (554)
.+.++|++.++||+|+||+||+|++ .+++.||+|++... ......+.+|+.+++.++ |+||++++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~ 107 (397)
T 1wak_A 34 LFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA------EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLL 107 (397)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC------HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEE
T ss_pred hcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC------CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeee
Confidence 4567899999999999999999998 77899999998631 233466788999998885 78899999
Q ss_pred eecc----CCCcEEEEEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHC-CccccCCccccEEEcCCC---
Q 008759 397 GTDK----DESKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQ-DVVHRDIKCANILVDANG--- 466 (554)
Q Consensus 397 ~~~~----~~~~~~LVmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~-gIIHrDIKPeNILld~~g--- 466 (554)
+++. ....+|+||||+.++.+..++.. ..+++..++.|+.||+.||.|||++ ||+||||||+||||+.++
T Consensus 108 ~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~ 187 (397)
T 1wak_A 108 DDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYI 187 (397)
T ss_dssp EEEEEEETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHH
T ss_pred cceeecCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhh
Confidence 9987 56789999999965444444443 3589999999999999999999998 999999999999998776
Q ss_pred ----------------------------------------------cEEEEecCcccccccCCccCccCCCcccChhhhc
Q 008759 467 ----------------------------------------------SVKLADFGLAKATKLNDVKSCRGTAFWMAPEVIN 500 (554)
Q Consensus 467 ----------------------------------------------~vKL~DFGlA~~~~~~~~~s~~GT~~Y~APEvl~ 500 (554)
.+||+|||++...... .....||+.|+|||++.
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-~~~~~gt~~y~aPE~~~ 266 (397)
T 1wak_A 188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-FTEDIQTRQYRSLEVLI 266 (397)
T ss_dssp HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-SCSCCSCGGGCCHHHHH
T ss_pred hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-CccCCCCCcccCChhhc
Confidence 7999999999766533 34557999999999997
Q ss_pred ccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008759 501 NKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME 533 (554)
Q Consensus 501 ~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e 533 (554)
+.. ++.++|||||||++|+|++|+.||....
T Consensus 267 ~~~--~~~~~DiwslG~il~elltg~~pf~~~~ 297 (397)
T 1wak_A 267 GSG--YNTPADIWSTACMAFELATGDYLFEPHS 297 (397)
T ss_dssp TSC--CCTHHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred CCC--CCcHHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 644 8899999999999999999999998654
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=334.24 Aligned_cols=213 Identities=30% Similarity=0.461 Sum_probs=183.6
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCc
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~ 404 (554)
...++|.+++.||+|+||.||+|.+ .+|+.||+|++..... ........+.+|+.+++.++||||+++++++...+.
T Consensus 13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~--~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~ 90 (476)
T 2y94_A 13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKI--RSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSD 90 (476)
T ss_dssp CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHH--HHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhc--cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 3467899999999999999999998 6899999999874211 111234578899999999999999999999999999
Q ss_pred EEEEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC-
Q 008759 405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN- 482 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~- 482 (554)
+|+||||+.+++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 91 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~ 170 (476)
T 2y94_A 91 IFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 170 (476)
T ss_dssp EEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence 9999999999999999875 46899999999999999999999999999999999999999999999999999875443
Q ss_pred CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHH
Q 008759 483 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIK 541 (554)
Q Consensus 483 ~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i 541 (554)
.....+||+.|+|||++.+.. .++.++|||||||++|+|++|+.||......+...++
T Consensus 171 ~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i 228 (476)
T 2y94_A 171 FLRTSCGSPNYAAPEVISGRL-YAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKI 228 (476)
T ss_dssp CBCCCCSCSTTCCHHHHTTCC-BCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHH
T ss_pred cccccCCCcCeEChhhccCCC-CCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHH
Confidence 344567999999999997543 2478999999999999999999999887665544444
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=315.25 Aligned_cols=203 Identities=28% Similarity=0.496 Sum_probs=165.6
Q ss_pred ccceeeeeeeccCCceeEEEEec-CCCcEE----EEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCC
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFF----AVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE 402 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~-~~g~~v----AvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~ 402 (554)
.++|++.++||+|+||+||+|.+ .+++.+ |+|.+.. .......+.+.+|+.++..++||||+++++++...
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 89 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE----ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-----------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccc----ccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence 46899999999999999999997 455554 6665542 12223346788999999999999999999999875
Q ss_pred CcEEEEEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccc
Q 008759 403 SKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK 480 (554)
Q Consensus 403 ~~~~LVmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~ 480 (554)
. .++||||+.+|+|.+++.. ..+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 90 ~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp S-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred C-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 4 7899999999999999876 458999999999999999999999999999999999999999999999999997654
Q ss_pred cCC----ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHH
Q 008759 481 LND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSA 537 (554)
Q Consensus 481 ~~~----~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~ 537 (554)
... .....+|+.|+|||++.+. .++.++|||||||++|+|++ |+.||......+.
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~ 228 (327)
T 3poz_A 169 AEEKEYHAEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 228 (327)
T ss_dssp TTCC-------CCCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH
T ss_pred CCcccccccCCCccccccChHHhccC--CCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHH
Confidence 322 2233468899999999764 48999999999999999999 9999988765443
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-37 Score=331.03 Aligned_cols=212 Identities=28% Similarity=0.498 Sum_probs=181.3
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCc
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~ 404 (554)
.+.++|+++++||+|+||+||+|.+ .+++.||+|++....... .....+.+|+.+++.++||||+++++++.+...
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 95 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN---KDTSTILREVELLKKLDHPNIMKLFEILEDSSS 95 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC---SCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc---hHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCE
Confidence 4567899999999999999999998 689999999986432211 123568899999999999999999999999999
Q ss_pred EEEEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEc---CCCcEEEEecCcccccc
Q 008759 405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD---ANGSVKLADFGLAKATK 480 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld---~~g~vKL~DFGlA~~~~ 480 (554)
+|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++...
T Consensus 96 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 175 (486)
T 3mwu_A 96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (486)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence 9999999999999887765 5799999999999999999999999999999999999995 45679999999997654
Q ss_pred cC-CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHH
Q 008759 481 LN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTV 543 (554)
Q Consensus 481 ~~-~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~ 543 (554)
.. ......||+.|+|||++.+ .|+.++|||||||++|+|++|+.||......+.+..+..
T Consensus 176 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 236 (486)
T 3mwu_A 176 QNTKMKDRIGTAYYIAPEVLRG---TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET 236 (486)
T ss_dssp CC----CCTTGGGGCCGGGGGS---CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CCCccCCCcCCCCCCCHHHhCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 33 3345679999999999864 389999999999999999999999998877666555443
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=318.27 Aligned_cols=205 Identities=28% Similarity=0.455 Sum_probs=169.1
Q ss_pred ccceeeeeeeccCCceeEEEEec-CCCcE----EEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCC
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFF----FAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE 402 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~-~~g~~----vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~ 402 (554)
.++|++++.||+|+||+||+|.+ .++.. +|+|.+..... ......+.+|+.++..++||||+++++++. .
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~ 86 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG----RQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-G 86 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS----CSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-B
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc----HHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-C
Confidence 46899999999999999999997 55655 66666542211 112234668999999999999999999886 5
Q ss_pred CcEEEEEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccc
Q 008759 403 SKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK 480 (554)
Q Consensus 403 ~~~~LVmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~ 480 (554)
...++||||+.+|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 87 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 87 SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccC
Confidence 678999999999999999875 368999999999999999999999999999999999999999999999999998754
Q ss_pred cCC----ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHHH
Q 008759 481 LND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIF 539 (554)
Q Consensus 481 ~~~----~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i~ 539 (554)
... .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |+.||......+...
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~ 228 (325)
T 3kex_A 167 PDDKQLLYSEAKTPIKWMALESIHFGK--YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPD 228 (325)
T ss_dssp CCTTCCC-----CCTTTSCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHH
T ss_pred cccccccccCCCCcccccChHHhccCC--CChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHH
Confidence 332 23445788999999996544 8899999999999999999 999999876554433
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=304.01 Aligned_cols=205 Identities=28% Similarity=0.534 Sum_probs=178.0
Q ss_pred cccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcE
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL 405 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~ 405 (554)
+.++|++++.||+|+||.||+|.+ .+++.||+|++..... ......+.+|+.+++.++||||+++++++.+.+..
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA----VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQ 80 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC----TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc----hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEE
Confidence 457899999999999999999998 5799999999875332 12346788999999999999999999999999999
Q ss_pred EEEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC--
Q 008759 406 YIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-- 482 (554)
Q Consensus 406 ~LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~-- 482 (554)
|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (276)
T 2yex_A 81 YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (276)
T ss_dssp EEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred EEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence 999999999999998875 46899999999999999999999999999999999999999999999999998764322
Q ss_pred --CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhH
Q 008759 483 --DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVS 536 (554)
Q Consensus 483 --~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~ 536 (554)
......||+.|+|||++.+.. .++.++|||||||++|+|++|+.||.......
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 215 (276)
T 2yex_A 161 ERLLNKMCGTLPYVAPELLKRRE-FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC 215 (276)
T ss_dssp ECCBCCCCSCGGGCCGGGGTCSS-BCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS
T ss_pred hhcccCCccccCccChHHHhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCchHH
Confidence 234556999999999986543 24678999999999999999999998765443
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=317.61 Aligned_cols=218 Identities=24% Similarity=0.470 Sum_probs=185.9
Q ss_pred ccccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEeccccc---chhHHHHHHHHHHHHHHHhC-CCCceeeeeee
Q 008759 324 FKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQG---SQAKQSISQLEQEIALLSRF-EHENIVQYYGT 398 (554)
Q Consensus 324 ~~~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~---~~~~~~~~~~~~Ei~iL~~l-~HpnIVkl~~~ 398 (554)
+..+.++|++.+.||+|+||.||+|.+ .+|+.||||++...... .........+.+|+.++..+ +||||++++++
T Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 345567899999999999999999998 57999999998754321 12233456788999999999 79999999999
Q ss_pred ccCCCcEEEEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccc
Q 008759 399 DKDESKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477 (554)
Q Consensus 399 ~~~~~~~~LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~ 477 (554)
+...+..|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+|+||||+|||++.+|.+||+|||++.
T Consensus 169 ~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~ 248 (365)
T 2y7j_A 169 YESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSC 248 (365)
T ss_dssp EEBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EeeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCccc
Confidence 9999999999999999999999876 469999999999999999999999999999999999999999999999999987
Q ss_pred ccccC-CccCccCCCcccChhhhccc----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHH
Q 008759 478 ATKLN-DVKSCRGTAFWMAPEVINNK----NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIK 541 (554)
Q Consensus 478 ~~~~~-~~~s~~GT~~Y~APEvl~~~----~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i 541 (554)
..... ......||+.|+|||++.+. ...++.++|||||||++|+|++|+.||........+..+
T Consensus 249 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i 317 (365)
T 2y7j_A 249 HLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMI 317 (365)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred ccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 65433 34456799999999998643 224788999999999999999999999887665544433
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=317.37 Aligned_cols=195 Identities=30% Similarity=0.505 Sum_probs=153.0
Q ss_pred ccceeee---eeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCC-CCceeeeeeeccCC
Q 008759 328 ITYWQKG---DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDE 402 (554)
Q Consensus 328 ~~~y~i~---~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIVkl~~~~~~~ 402 (554)
.++|++. +.||+|+||.||+|.+ .+++.||+|++... ....+.+|+.++..+. ||||+++++++.+.
T Consensus 7 ~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~ 78 (325)
T 3kn6_A 7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR--------MEANTQKEITALKLCEGHPNIVKLHEVFHDQ 78 (325)
T ss_dssp HHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG--------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred hhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh--------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcC
Confidence 4566664 7899999999999998 67999999998631 2245678999999997 99999999999999
Q ss_pred CcEEEEEeecccCchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCC---cEEEEecCcccc
Q 008759 403 SKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG---SVKLADFGLAKA 478 (554)
Q Consensus 403 ~~~~LVmE~~~ggsL~~ll~~~-~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g---~vKL~DFGlA~~ 478 (554)
..+|+||||+.+++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~ 158 (325)
T 3kn6_A 79 LHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARL 158 (325)
T ss_dssp SEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEE
T ss_pred CEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEecccccee
Confidence 9999999999999999988764 589999999999999999999999999999999999998766 899999999976
Q ss_pred cccC--CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008759 479 TKLN--DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM 532 (554)
Q Consensus 479 ~~~~--~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~ 532 (554)
.... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...
T Consensus 159 ~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~ 212 (325)
T 3kn6_A 159 KPPDNQPLKTPCFTLHYAAPELLNQN--GYDESCDLWSLGVILYTMLSGQVPFQSH 212 (325)
T ss_dssp CCC----------------------C--CCCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred cCCCCCcccccCCCcCccCHHHhcCC--CCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 4332 23455689999999999654 4899999999999999999999999864
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=302.73 Aligned_cols=216 Identities=25% Similarity=0.456 Sum_probs=183.2
Q ss_pred cccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEeccccc----chhHHHHHHHHHHHHHHHhCC-CCceeeeeee
Q 008759 325 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQG----SQAKQSISQLEQEIALLSRFE-HENIVQYYGT 398 (554)
Q Consensus 325 ~~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~----~~~~~~~~~~~~Ei~iL~~l~-HpnIVkl~~~ 398 (554)
..+.++|++.+.||+|+||.||+|.+ .+++.||+|++...... .........+.+|+.++.++. ||||++++++
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 92 (298)
T 1phk_A 13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT 92 (298)
T ss_dssp --CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred cchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeee
Confidence 35678999999999999999999998 67899999999754321 112334567889999999996 9999999999
Q ss_pred ccCCCcEEEEEeecccCchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccc
Q 008759 399 DKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477 (554)
Q Consensus 399 ~~~~~~~~LVmE~~~ggsL~~ll~~~-~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~ 477 (554)
+.....+|+||||+.+++|.+++... .+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.
T Consensus 93 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 172 (298)
T 1phk_A 93 YETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC 172 (298)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred eccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchh
Confidence 99999999999999999999998764 68999999999999999999999999999999999999999999999999987
Q ss_pred ccccC-CccCccCCCcccChhhhccc----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHH
Q 008759 478 ATKLN-DVKSCRGTAFWMAPEVINNK----NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFI 540 (554)
Q Consensus 478 ~~~~~-~~~s~~GT~~Y~APEvl~~~----~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~ 540 (554)
..... ......||+.|+|||++.+. ...++.++|||||||++|+|++|..||......+....
T Consensus 173 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~ 240 (298)
T 1phk_A 173 QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM 240 (298)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred hcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHH
Confidence 65433 33455699999999998532 23478899999999999999999999988766554433
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=303.42 Aligned_cols=208 Identities=27% Similarity=0.464 Sum_probs=175.0
Q ss_pred cccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhH--HHHHHHHHHHHHHHhCCCCceeeeeeeccCCC
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAK--QSISQLEQEIALLSRFEHENIVQYYGTDKDES 403 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~ 403 (554)
..++|++.+.||+|+||+||+|.+ .+++.||+|++.......... ...+.+.+|+.+++.++||||+++++++.+..
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP 96 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence 346899999999999999999998 689999999986533222111 11267889999999999999999999987655
Q ss_pred cEEEEEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCC--ccccCCccccEEEcCCCc-----EEEEecC
Q 008759 404 KLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQD--VVHRDIKCANILVDANGS-----VKLADFG 474 (554)
Q Consensus 404 ~~~LVmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~g--IIHrDIKPeNILld~~g~-----vKL~DFG 474 (554)
++||||+.+++|.+++.. ..+++..+..++.||+.||.|||++| |+||||||+|||++.++. +||+|||
T Consensus 97 --~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg 174 (287)
T 4f0f_A 97 --RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG 174 (287)
T ss_dssp --EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCT
T ss_pred --eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCC
Confidence 799999999999888754 35899999999999999999999999 999999999999988876 9999999
Q ss_pred cccccccCCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHH
Q 008759 475 LAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSA 537 (554)
Q Consensus 475 lA~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~ 537 (554)
+++.... ......||+.|+|||++......++.++|||||||++|+|++|+.||......+.
T Consensus 175 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 236 (287)
T 4f0f_A 175 LSQQSVH-SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI 236 (287)
T ss_dssp TCBCCSS-CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH
T ss_pred ccccccc-cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH
Confidence 9875433 3445679999999999855444578899999999999999999999987654433
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-37 Score=310.36 Aligned_cols=211 Identities=25% Similarity=0.412 Sum_probs=164.1
Q ss_pred ccccceeeeeeeccCCceeEEEEecCC-Cc---EEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccC
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGISDD-GF---FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD 401 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~~~-g~---~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~ 401 (554)
...++|++++.||+|+||.||+|.+.. +. .||+|++..... .....+.+.+|+.+++.++||||+++++++..
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 96 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII---ASSDIEEFLREAACMKEFDHPHVAKLVGVSLR 96 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC---------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccccc---CHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence 345689999999999999999999843 33 799998864221 22345678899999999999999999999877
Q ss_pred CCcE------EEEEeecccCchHHHHhhh-------cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcE
Q 008759 402 ESKL------YIFLELVTKGSLLNLYQRY-------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSV 468 (554)
Q Consensus 402 ~~~~------~LVmE~~~ggsL~~ll~~~-------~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~v 468 (554)
.... |+||||+.+++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~ 176 (323)
T 3qup_A 97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTV 176 (323)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCE
T ss_pred cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCE
Confidence 6654 9999999999999998653 48899999999999999999999999999999999999999999
Q ss_pred EEEecCcccccccCC----ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHHHHH
Q 008759 469 KLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIFIK 541 (554)
Q Consensus 469 KL~DFGlA~~~~~~~----~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i~~i 541 (554)
||+|||+++...... .....+|+.|+|||++.+. .++.++|||||||++|+|++ |+.||......+....+
T Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~ 252 (323)
T 3qup_A 177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADN--LYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL 252 (323)
T ss_dssp EECCCCC-----------------CCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH
T ss_pred EEeeccccccccccccccccccccCcccccCchhhcCC--CCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHH
Confidence 999999997654322 2233467889999999665 38899999999999999999 99999987766554443
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=302.71 Aligned_cols=212 Identities=27% Similarity=0.475 Sum_probs=178.1
Q ss_pred cccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccch-hHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCc
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQ-AKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~-~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~ 404 (554)
+.++|++++.||+|+||.||+|.+ .+++.||+|++........ .....+.+.+|+.+++.++||||+++++++.....
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 82 (283)
T 3bhy_A 3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTD 82 (283)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCe
Confidence 346899999999999999999998 5799999999875432211 11124568899999999999999999999999999
Q ss_pred EEEEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCC----cEEEEecCccccc
Q 008759 405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG----SVKLADFGLAKAT 479 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g----~vKL~DFGlA~~~ 479 (554)
+|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~ 162 (283)
T 3bhy_A 83 VVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI 162 (283)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceec
Confidence 9999999999999999875 4689999999999999999999999999999999999998877 8999999998765
Q ss_pred ccC-CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHH
Q 008759 480 KLN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFI 540 (554)
Q Consensus 480 ~~~-~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~ 540 (554)
... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||......+.+..
T Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~ 222 (283)
T 3bhy_A 163 EAGNEFKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGETKQETLTN 222 (283)
T ss_dssp C--------CCCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH
T ss_pred cCCCcccccCCCcCccCcceecCC--CCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHH
Confidence 432 23445699999999999654 478999999999999999999999988766554433
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=318.85 Aligned_cols=203 Identities=21% Similarity=0.330 Sum_probs=165.3
Q ss_pred cccceeeeeeeccCCceeEEEEecCC------CcEEEEEEEecccccchhH-HH-----HHHHHHHHHHHHhCCCCceee
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGISDD------GFFFAVKEVSLLDQGSQAK-QS-----ISQLEQEIALLSRFEHENIVQ 394 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~~~------g~~vAvK~v~~~~~~~~~~-~~-----~~~~~~Ei~iL~~l~HpnIVk 394 (554)
..+.|++++.||+|+||.||+|.+.. ++.||+|++.......... .. ...+..|+..+..++|+||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 44589999999999999999998843 4789999987532111000 00 112345666778889999999
Q ss_pred eeeeccCC----CcEEEEEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEc--CCC
Q 008759 395 YYGTDKDE----SKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD--ANG 466 (554)
Q Consensus 395 l~~~~~~~----~~~~LVmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld--~~g 466 (554)
+++++... ..+||||||+ +++|.+++.. ..+++..+..|+.||+.||.|||++||+||||||+|||++ .++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~ 191 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD 191 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTT
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCC
Confidence 99988664 4589999999 8999999976 4599999999999999999999999999999999999999 889
Q ss_pred cEEEEecCcccccccCC---------ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008759 467 SVKLADFGLAKATKLND---------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM 532 (554)
Q Consensus 467 ~vKL~DFGlA~~~~~~~---------~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~ 532 (554)
.+||+|||+++...... .....||+.|+|||++.+.. ++.++|||||||++|+|+||+.||...
T Consensus 192 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Di~slG~~l~el~~g~~Pf~~~ 264 (364)
T 3op5_A 192 QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVA--PSRRGDLEILGYCMIQWLTGHLPWEDN 264 (364)
T ss_dssp CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCC--CCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCC--CCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 99999999997543221 13345999999999996543 899999999999999999999999864
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=318.48 Aligned_cols=206 Identities=25% Similarity=0.420 Sum_probs=173.3
Q ss_pred cccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeecc-----
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK----- 400 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~----- 400 (554)
..++|++++.||+|+||+||+|.+ .+|+.||+|++...... ..+|+.+++.++||||+++++++.
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~---------~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 75 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY---------KNRELDIMKVLDHVNIIKLVDYFYTTGDE 75 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS---------CCHHHHHHTTCCCTTBCCEEEEEEEC---
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch---------HHHHHHHHHHcCCCCccchhheeeecCcc
Confidence 456899999999999999999998 78999999998643221 237999999999999999999873
Q ss_pred ---------------------------------CCCcEEEEEeecccCchHHHHhh-----hcCChHHHHHHHHHHHHHH
Q 008759 401 ---------------------------------DESKLYIFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGL 442 (554)
Q Consensus 401 ---------------------------------~~~~~~LVmE~~~ggsL~~ll~~-----~~l~e~~i~~i~~QIl~gL 442 (554)
....+++||||+.+ +|.+++.. ..+++..++.++.||+.||
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL 154 (383)
T 3eb0_A 76 EPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAV 154 (383)
T ss_dssp ----------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Confidence 33458999999996 77766643 4589999999999999999
Q ss_pred HHHHHCCccccCCccccEEEc-CCCcEEEEecCccccccc-CCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHH
Q 008759 443 KYLHDQDVVHRDIKCANILVD-ANGSVKLADFGLAKATKL-NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVL 520 (554)
Q Consensus 443 ~yLHs~gIIHrDIKPeNILld-~~g~vKL~DFGlA~~~~~-~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvlly 520 (554)
.|||++||+||||||+|||++ .++.+||+|||+++.... .......||+.|+|||++.+.. .++.++|||||||++|
T Consensus 155 ~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~ 233 (383)
T 3eb0_A 155 GFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGAT-EYTPSIDLWSIGCVFG 233 (383)
T ss_dssp HHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCS-SCCTHHHHHHHHHHHH
T ss_pred HHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCC-CCCcchhhhhHHHHHH
Confidence 999999999999999999997 688999999999986533 3344567899999999986533 4789999999999999
Q ss_pred HHHcCCCCCCCCChhHHHHHHHH
Q 008759 521 EMLTSQIPYAPMECVSAIFIKTV 543 (554)
Q Consensus 521 eLLTG~~PF~~~e~~~~i~~i~~ 543 (554)
+|++|+.||......+.+..+..
T Consensus 234 ell~g~~pf~~~~~~~~~~~i~~ 256 (383)
T 3eb0_A 234 ELILGKPLFSGETSIDQLVRIIQ 256 (383)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHH
T ss_pred HHHhCCCCCCCCChHHHHHHHHH
Confidence 99999999999888887777654
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=310.42 Aligned_cols=213 Identities=27% Similarity=0.459 Sum_probs=179.6
Q ss_pred cccccccceeeeeeeccCCceeEEEEecC-CC-----cEEEEEEEecccccchhHHHHHHHHHHHHHHHhC-CCCceeee
Q 008759 323 RFKRIITYWQKGDLLGRGSFGSVYEGISD-DG-----FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQY 395 (554)
Q Consensus 323 ~~~~~~~~y~i~~~LG~GsfG~VY~a~~~-~g-----~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIVkl 395 (554)
.+....++|++++.||+|+||.||+|.+. ++ ..||+|.+.... .......+.+|+.++..+ +||||+++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~h~~iv~~ 115 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA----HADEKEALMSELKIMSHLGQHENIVNL 115 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC----CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc----ChHHHHHHHHHHHHHHhhcCCCCeeeE
Confidence 45555679999999999999999999873 33 479999886422 223456788999999999 89999999
Q ss_pred eeeccCCCcEEEEEeecccCchHHHHhhh---------------cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccE
Q 008759 396 YGTDKDESKLYIFLELVTKGSLLNLYQRY---------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANI 460 (554)
Q Consensus 396 ~~~~~~~~~~~LVmE~~~ggsL~~ll~~~---------------~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNI 460 (554)
++++...+.+|+||||+.+|+|.+++... .+++..+..++.||+.||.|||++||+||||||+||
T Consensus 116 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NI 195 (333)
T 2i1m_A 116 LGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNV 195 (333)
T ss_dssp EEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGC
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceE
Confidence 99999999999999999999999998643 368899999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCcccccccCC----ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChh
Q 008759 461 LVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECV 535 (554)
Q Consensus 461 Lld~~g~vKL~DFGlA~~~~~~~----~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~ 535 (554)
|++.++.+||+|||++....... .....+|+.|+|||++.+. .++.++|||||||++|+|+| |..||......
T Consensus 196 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 273 (333)
T 2i1m_A 196 LLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDC--VYTVQSDVWSYGILLWEIFSLGLNPYPGILVN 273 (333)
T ss_dssp EEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS
T ss_pred EECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccC--CCChHHHHHHHHHHHHHHHcCCCCCCcccchh
Confidence 99999999999999997654332 1234467889999998754 48899999999999999999 99999887655
Q ss_pred HHHHHH
Q 008759 536 SAIFIK 541 (554)
Q Consensus 536 ~~i~~i 541 (554)
..+...
T Consensus 274 ~~~~~~ 279 (333)
T 2i1m_A 274 SKFYKL 279 (333)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 544443
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=305.21 Aligned_cols=205 Identities=28% Similarity=0.566 Sum_probs=159.3
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCc
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~ 404 (554)
...++|++++.||+|+||.||+|.+ .+++.||+|++..... ........+.+|+.++..++||||+++++++.+.+.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 85 (278)
T 3cok_A 8 EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAM--YKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNY 85 (278)
T ss_dssp SSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSE
T ss_pred cccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhh--hhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCe
Confidence 3457899999999999999999998 6899999999864211 111224678899999999999999999999999999
Q ss_pred EEEEEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC
Q 008759 405 LYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN 482 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~ 482 (554)
+|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 86 VYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP 165 (278)
T ss_dssp EEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred EEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence 9999999999999999876 45899999999999999999999999999999999999999999999999998765422
Q ss_pred --CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh
Q 008759 483 --DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC 534 (554)
Q Consensus 483 --~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~ 534 (554)
......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.....
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 217 (278)
T 3cok_A 166 HEKHYTLCGTPNYISPEIATRS--AHGLESDVWSLGCMFYTLLIGRPPFDTDTV 217 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSC
T ss_pred CCcceeccCCCCcCCcchhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCChhH
Confidence 22345689999999998654 378899999999999999999999986543
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=316.71 Aligned_cols=201 Identities=28% Similarity=0.456 Sum_probs=174.4
Q ss_pred ccccccceeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCC
Q 008759 324 FKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES 403 (554)
Q Consensus 324 ~~~~~~~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~ 403 (554)
+....++|++.+.||+|+||.||+|.+.+++.||+|++...... .....+.+|+.++..++||||+++++++...+
T Consensus 25 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 100 (326)
T 3uim_A 25 LQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQ----GGELQFQTEVEMISMAVHRNLLRLRGFCMTPT 100 (326)
T ss_dssp HHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC---------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSS
T ss_pred HHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCc----hHHHHHHHHHHHHHhccCCCccceEEEEecCC
Confidence 44566789999999999999999999888999999998743211 11225789999999999999999999999999
Q ss_pred cEEEEEeecccCchHHHHhhh-----cCChHHHHHHHHHHHHHHHHHHHC---CccccCCccccEEEcCCCcEEEEecCc
Q 008759 404 KLYIFLELVTKGSLLNLYQRY-----HLRDSQVSAYTRQILLGLKYLHDQ---DVVHRDIKCANILVDANGSVKLADFGL 475 (554)
Q Consensus 404 ~~~LVmE~~~ggsL~~ll~~~-----~l~e~~i~~i~~QIl~gL~yLHs~---gIIHrDIKPeNILld~~g~vKL~DFGl 475 (554)
..|+||||+.+++|.+++... .+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 180 (326)
T 3uim_A 101 ERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 180 (326)
T ss_dssp CCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSS
T ss_pred ceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcc
Confidence 999999999999999999753 288999999999999999999999 999999999999999999999999999
Q ss_pred ccccccCC---ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 008759 476 AKATKLND---VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYA 530 (554)
Q Consensus 476 A~~~~~~~---~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~ 530 (554)
++...... .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~g~~pf~ 236 (326)
T 3uim_A 181 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK--SSEKTDVFGYGVMLLELITGQRAFD 236 (326)
T ss_dssp CEECCSSSSCEECCCCSCGGGCCHHHHHHSE--ECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred ccccCcccccccccccCCcCccCHHHhccCC--CCccccchhHHHHHHHHHhCCCccc
Confidence 97654322 23345999999999996554 7899999999999999999999995
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=330.56 Aligned_cols=211 Identities=27% Similarity=0.480 Sum_probs=177.0
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCc
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~ 404 (554)
.+.++|++++.||+|+||+||+|.+ .++..||+|++........ ....+.+|+.+++.++||||+++++++.+...
T Consensus 34 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 110 (494)
T 3lij_A 34 HLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTS---SNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRN 110 (494)
T ss_dssp CHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----C---TTHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred chhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCch---HHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE
Confidence 3556899999999999999999998 6889999999875332111 23567899999999999999999999999999
Q ss_pred EEEEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCC---CcEEEEecCcccccc
Q 008759 405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN---GSVKLADFGLAKATK 480 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~---g~vKL~DFGlA~~~~ 480 (554)
+|+||||+.+|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.. +.+||+|||++....
T Consensus 111 ~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~ 190 (494)
T 3lij_A 111 YYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190 (494)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence 9999999999999887765 579999999999999999999999999999999999999764 459999999997654
Q ss_pred cC-CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHH
Q 008759 481 LN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKT 542 (554)
Q Consensus 481 ~~-~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~ 542 (554)
.. ......||+.|+|||++.+ .|+.++|||||||++|+|++|+.||......+.+..+.
T Consensus 191 ~~~~~~~~~gt~~y~aPE~l~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 250 (494)
T 3lij_A 191 NQKKMKERLGTAYYIAPEVLRK---KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVE 250 (494)
T ss_dssp TTBCBCCCCSCTTTCCHHHHTT---CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CCccccccCCCcCeeCHHHHcc---cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 33 3445679999999999853 48899999999999999999999999887766555443
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=322.78 Aligned_cols=205 Identities=28% Similarity=0.462 Sum_probs=172.5
Q ss_pred cccceeeeeeeccCCceeEEEEec----CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhC-CCCceeeeeeeccC
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGIS----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKD 401 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~----~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIVkl~~~~~~ 401 (554)
..++|++++.||+|+||.||+|.+ .+++.||+|++....... .......+.+|+.++..+ +|+||+++++++..
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 130 (355)
T 1vzo_A 52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQ-KAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 130 (355)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEE-EESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhh-hhhHHHHHHHHHHHHHHccCCCceeEEEEEEee
Confidence 357899999999999999999987 478999999986422110 011123456789999998 69999999999999
Q ss_pred CCcEEEEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccc
Q 008759 402 ESKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK 480 (554)
Q Consensus 402 ~~~~~LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~ 480 (554)
.+.+|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 131 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 210 (355)
T 1vzo_A 131 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 210 (355)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred CceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence 9999999999999999999876 468999999999999999999999999999999999999999999999999997543
Q ss_pred cC---CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008759 481 LN---DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM 532 (554)
Q Consensus 481 ~~---~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~ 532 (554)
.. ......||+.|+|||++.+....++.++|||||||++|+|++|+.||...
T Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~ 265 (355)
T 1vzo_A 211 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD 265 (355)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCT
T ss_pred cCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccC
Confidence 22 22345699999999999765445788999999999999999999999753
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-37 Score=320.99 Aligned_cols=207 Identities=26% Similarity=0.453 Sum_probs=167.6
Q ss_pred ccceeeeeeeccCCceeEEEEecC----CCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCC
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGISD----DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES 403 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~~----~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~ 403 (554)
.++|.+.+.||+|+||.||+|.+. ++..||+|++.... .....+.+.+|+.++.+++||||+++++++...+
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 119 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY----TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK 119 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC----CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc----CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence 458999999999999999999874 57789999986422 2334567899999999999999999999999999
Q ss_pred cEEEEEeecccCchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccccc
Q 008759 404 KLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL 481 (554)
Q Consensus 404 ~~~LVmE~~~ggsL~~ll~~~--~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~ 481 (554)
.+|+||||+.+++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 120 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 199 (373)
T 2qol_A 120 PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLED 199 (373)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred ceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence 999999999999999999764 589999999999999999999999999999999999999999999999999976543
Q ss_pred CC-----ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHHHH
Q 008759 482 ND-----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIFI 540 (554)
Q Consensus 482 ~~-----~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i~~ 540 (554)
.. .....+|+.|+|||++.+. .++.++|||||||++|+|++ |+.||......+.+..
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~ 262 (373)
T 2qol_A 200 DPEAAYTTRGGKIPIRWTSPEAIAYR--KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKA 262 (373)
T ss_dssp --------------CTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHH
T ss_pred CCccceeccCCCcCCCccChhhhccC--CcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 22 1122357789999999654 48899999999999999998 9999988776554433
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=308.04 Aligned_cols=203 Identities=26% Similarity=0.453 Sum_probs=174.2
Q ss_pred ccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCC-CCceeeeeeeccC--CC
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKD--ES 403 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIVkl~~~~~~--~~ 403 (554)
.++|++++.||+|+||.||+|.+ .+++.||+|++.... .+.+.+|+.+++.++ ||||+++++++.. ..
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~ 106 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--------KKKIKREIKILENLRGGPNIITLADIVKDPVSR 106 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC--------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTC
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc--------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCC
Confidence 46899999999999999999988 789999999986311 246789999999997 9999999999887 66
Q ss_pred cEEEEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCC-cEEEEecCcccccccC
Q 008759 404 KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG-SVKLADFGLAKATKLN 482 (554)
Q Consensus 404 ~~~LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g-~vKL~DFGlA~~~~~~ 482 (554)
..++||||+.+++|..+++ .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 107 ~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~ 184 (330)
T 3nsz_A 107 TPALVFEHVNNTDFKQLYQ--TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 184 (330)
T ss_dssp CEEEEEECCCCCCHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred ceEEEEeccCchhHHHHHH--hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence 8999999999999999875 488999999999999999999999999999999999999777 8999999999765433
Q ss_pred -CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC-ChhHHHHHH
Q 008759 483 -DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM-ECVSAIFIK 541 (554)
Q Consensus 483 -~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~-e~~~~i~~i 541 (554)
......||+.|+|||++.+. ..++.++|||||||++|+|++|+.||... ...+.+..+
T Consensus 185 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~ 244 (330)
T 3nsz_A 185 QEYNVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI 244 (330)
T ss_dssp CCCCSCCSCGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHH
T ss_pred CccccccccccccChhhhcCC-CcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHH
Confidence 34456799999999998653 34889999999999999999999999654 444444433
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=304.63 Aligned_cols=198 Identities=23% Similarity=0.324 Sum_probs=172.8
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhC-CCCceeeeeeeccCCC
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDES 403 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIVkl~~~~~~~~ 403 (554)
.+.++|++++.||+|+||.||+|.+ .+++.||+|++..... ...+.+|+.++..+ +|+||+++++++....
T Consensus 7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~ 79 (298)
T 1csn_A 7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-------APQLRDEYRTYKLLAGCTGIPNVYYFGQEGL 79 (298)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-------SCCHHHHHHHHHHTTTCTTCCCEEEEEEETT
T ss_pred ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-------cHHHHHHHHHHHHHhcCCCCCeEEeecCCCc
Confidence 4567899999999999999999997 7899999998864222 13467899999999 7999999999999999
Q ss_pred cEEEEEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCc-----EEEEecCcc
Q 008759 404 KLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS-----VKLADFGLA 476 (554)
Q Consensus 404 ~~~LVmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~-----vKL~DFGlA 476 (554)
..|+||||+ +++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||++
T Consensus 80 ~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~ 158 (298)
T 1csn_A 80 HNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158 (298)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred eeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence 999999999 8899999985 35899999999999999999999999999999999999987776 999999999
Q ss_pred cccccCC---------ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008759 477 KATKLND---------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME 533 (554)
Q Consensus 477 ~~~~~~~---------~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e 533 (554)
+...... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~~~ 222 (298)
T 1csn_A 159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGR--EQSRRDDLEALGHVFMYFLRGSLPWQGLK 222 (298)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred cccccccccccccccCccCCCCCcccCCchhhcCC--CCChHHHHHHHHHHHHHHHcCCCCcchhh
Confidence 7654321 2345699999999998654 48999999999999999999999998753
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=330.93 Aligned_cols=213 Identities=28% Similarity=0.469 Sum_probs=183.6
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCc
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~ 404 (554)
.+.++|++.+.||+|+||.||+|.+ .+++.||+|++....... ......+.+|+.+++.++||||+++++++.+.+.
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 100 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQ--KTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGY 100 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCB--SSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhccc--chHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 4567899999999999999999998 689999999987533221 1224578899999999999999999999999999
Q ss_pred EEEEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEE---cCCCcEEEEecCcccccc
Q 008759 405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKATK 480 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILl---d~~g~vKL~DFGlA~~~~ 480 (554)
+|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 101 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 180 (484)
T 3nyv_A 101 FYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180 (484)
T ss_dssp EEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence 9999999999999988765 568999999999999999999999999999999999999 567899999999997654
Q ss_pred cC-CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHH
Q 008759 481 LN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTV 543 (554)
Q Consensus 481 ~~-~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~ 543 (554)
.. ......||+.|+|||++.+ .|+.++|||||||++|+|++|+.||......+.+..+..
T Consensus 181 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 241 (484)
T 3nyv_A 181 ASKKMKDKIGTAYYIAPEVLHG---TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK 241 (484)
T ss_dssp CCCSHHHHTTGGGTCCHHHHHT---CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred cccccccCCCCccccCceeecC---CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc
Confidence 33 2345569999999999864 388999999999999999999999998877666555443
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=310.44 Aligned_cols=208 Identities=28% Similarity=0.494 Sum_probs=176.8
Q ss_pred cccccceeeeeeeccCCceeEEEEec--------CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhC-CCCceeee
Q 008759 325 KRIITYWQKGDLLGRGSFGSVYEGIS--------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQY 395 (554)
Q Consensus 325 ~~~~~~y~i~~~LG~GsfG~VY~a~~--------~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIVkl 395 (554)
....++|++++.||+|+||.||+|.+ .++..||+|++.... .......+.+|+.++..+ +||||+++
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~hp~iv~~ 106 (334)
T 2pvf_A 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA----TEKDLSDLVSEMEMMKMIGKHKNIINL 106 (334)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC----CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC----cHHHHHHHHHHHHHHHHhhcCCCEeeE
Confidence 34457999999999999999999986 356789999986422 234456788999999999 89999999
Q ss_pred eeeccCCCcEEEEEeecccCchHHHHhhhc-----------------CChHHHHHHHHHHHHHHHHHHHCCccccCCccc
Q 008759 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYH-----------------LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCA 458 (554)
Q Consensus 396 ~~~~~~~~~~~LVmE~~~ggsL~~ll~~~~-----------------l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPe 458 (554)
++++...+.+|+||||+.+++|.+++.... +++..+..++.||+.||.|||++||+||||||+
T Consensus 107 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~ 186 (334)
T 2pvf_A 107 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAAR 186 (334)
T ss_dssp EEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred EEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccc
Confidence 999999999999999999999999997542 788899999999999999999999999999999
Q ss_pred cEEEcCCCcEEEEecCcccccccCC----ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 008759 459 NILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPME 533 (554)
Q Consensus 459 NILld~~g~vKL~DFGlA~~~~~~~----~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e 533 (554)
|||++.++.+||+|||+++...... .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||....
T Consensus 187 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~ellt~g~~p~~~~~ 264 (334)
T 2pvf_A 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV--YTHQSDVWSFGVLMWEIFTLGGSPYPGIP 264 (334)
T ss_dssp GEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCE--ECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred eEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCC--cChHHHHHHHHHHHHHHHhCCCCCcCcCC
Confidence 9999999999999999997654322 22345788999999996543 7899999999999999999 999998876
Q ss_pred hhHHH
Q 008759 534 CVSAI 538 (554)
Q Consensus 534 ~~~~i 538 (554)
..+..
T Consensus 265 ~~~~~ 269 (334)
T 2pvf_A 265 VEELF 269 (334)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 55443
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=329.72 Aligned_cols=214 Identities=27% Similarity=0.449 Sum_probs=180.2
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccch--------hHHHHHHHHHHHHHHHhCCCCceeeee
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQ--------AKQSISQLEQEIALLSRFEHENIVQYY 396 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~--------~~~~~~~~~~Ei~iL~~l~HpnIVkl~ 396 (554)
.+.++|.++++||+|+||+||+|.+ .++..||+|++........ .......+.+|+.+++.++||||++++
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 4567899999999999999999998 6789999999875322110 012245788999999999999999999
Q ss_pred eeccCCCcEEEEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCC---cEEEEe
Q 008759 397 GTDKDESKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG---SVKLAD 472 (554)
Q Consensus 397 ~~~~~~~~~~LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g---~vKL~D 472 (554)
+++.+...+|+||||+.+|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|
T Consensus 113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~D 192 (504)
T 3q5i_A 113 DVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVD 192 (504)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECC
T ss_pred EEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEE
Confidence 999999999999999999999888765 5699999999999999999999999999999999999998776 699999
Q ss_pred cCcccccccC-CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHH
Q 008759 473 FGLAKATKLN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKT 542 (554)
Q Consensus 473 FGlA~~~~~~-~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~ 542 (554)
||++...... ......||+.|+|||++.+ .|+.++|||||||++|+|++|..||......+.+..+.
T Consensus 193 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 260 (504)
T 3q5i_A 193 FGLSSFFSKDYKLRDRLGTAYYIAPEVLKK---KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVE 260 (504)
T ss_dssp CTTCEECCTTSCBCCCCSCTTTCCHHHHTT---CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CCCCEEcCCCCccccccCCcCCCCHHHhcc---CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9999865443 3455679999999999853 47899999999999999999999999887766555544
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=298.92 Aligned_cols=208 Identities=17% Similarity=0.304 Sum_probs=177.9
Q ss_pred cccceeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCC--Cc
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE--SK 404 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~--~~ 404 (554)
..++|++.+.||+|+||.||+|.+. +..||+|++..... .....+.+.+|+.+++.++||||+++++++.+. ..
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 83 (271)
T 3kmu_A 8 DFKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDW---STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPH 83 (271)
T ss_dssp CGGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTC---CHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSS
T ss_pred CHHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEeccccc---CHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCC
Confidence 4578999999999999999999985 88899999875322 233446789999999999999999999998876 78
Q ss_pred EEEEEeecccCchHHHHhhhc---CChHHHHHHHHHHHHHHHHHHHCC--ccccCCccccEEEcCCCcEEEEecCccccc
Q 008759 405 LYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQD--VVHRDIKCANILVDANGSVKLADFGLAKAT 479 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~~~---l~e~~i~~i~~QIl~gL~yLHs~g--IIHrDIKPeNILld~~g~vKL~DFGlA~~~ 479 (554)
+++||||+.+++|.+++.... +++..+..++.||+.||.|||++| |+||||||+|||++.++.++|+|||+....
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 84 PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp CEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred eEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeee
Confidence 999999999999999998653 899999999999999999999999 999999999999999999999999986543
Q ss_pred ccCCccCccCCCcccChhhhcccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHH
Q 008759 480 KLNDVKSCRGTAFWMAPEVINNKNK-GYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIK 541 (554)
Q Consensus 480 ~~~~~~s~~GT~~Y~APEvl~~~~~-~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i 541 (554)
.. ....||+.|+|||++.+... .++.++|||||||++|+|++|+.||......+.....
T Consensus 164 ~~---~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~ 223 (271)
T 3kmu_A 164 QS---PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKV 223 (271)
T ss_dssp SC---TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHH
T ss_pred cc---cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHH
Confidence 32 33468999999999976431 2345899999999999999999999988776655444
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=300.44 Aligned_cols=203 Identities=23% Similarity=0.345 Sum_probs=173.2
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhC-CCCceeeeeeeccCCC
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDES 403 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIVkl~~~~~~~~ 403 (554)
++.++|++.+.||+|+||+||+|.+ .+++.||+|++...... ......+.+|+.++..+ +||||+++++++.+.+
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~ 84 (289)
T 1x8b_A 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAG---SVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDD 84 (289)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTT---SHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETT
T ss_pred cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccc---cHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCC
Confidence 4567899999999999999999998 58999999998753322 22345678899999998 8999999999999999
Q ss_pred cEEEEEeecccCchHHHHhh-----hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCC-------------
Q 008759 404 KLYIFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN------------- 465 (554)
Q Consensus 404 ~~~LVmE~~~ggsL~~ll~~-----~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~------------- 465 (554)
.+|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~ 164 (289)
T 1x8b_A 85 HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDED 164 (289)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---------------
T ss_pred eEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccc
Confidence 99999999999999999875 348999999999999999999999999999999999999844
Q ss_pred ------CcEEEEecCcccccccCCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh
Q 008759 466 ------GSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC 534 (554)
Q Consensus 466 ------g~vKL~DFGlA~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~ 534 (554)
..+||+|||++...... ....||+.|+|||++.+.. .++.++|||||||++|+|++|..||.....
T Consensus 165 ~~~~~~~~~kl~Dfg~~~~~~~~--~~~~gt~~y~aPE~~~~~~-~~~~~~Di~slG~il~~l~~~~~~~~~~~~ 236 (289)
T 1x8b_A 165 DWASNKVMFKIGDLGHVTRISSP--QVEEGDSRFLANEVLQENY-THLPKADIFALALTVVCAAGAEPLPRNGDQ 236 (289)
T ss_dssp -----CCCEEECCCTTCEETTCS--CCCCCCGGGCCHHHHTTCC-TTHHHHHHHHHHHHHHHHTTCCCCCSSSHH
T ss_pred cccCCceEEEEcccccccccCCc--cccCCCccccChhHhcCCC-CCCchhhHHHHHHHHHHHhcCCCCCcchhH
Confidence 47999999998765443 2345999999999996542 466899999999999999999988765543
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=302.56 Aligned_cols=209 Identities=31% Similarity=0.491 Sum_probs=176.6
Q ss_pred cccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeec--cCCC
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTD--KDES 403 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~--~~~~ 403 (554)
..++|++++.||+|+||.||+|.+ .+++.||+|++..... .....+.+.+|+.+++.++||||+++++++ ....
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM---TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNT 80 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGT
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC---CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCc
Confidence 457899999999999999999998 6799999999875332 233456788999999999999999999977 4467
Q ss_pred cEEEEEeecccCchHHHHhhh-----cCChHHHHHHHHHHHHHHHHHHHCC-----ccccCCccccEEEcCCCcEEEEec
Q 008759 404 KLYIFLELVTKGSLLNLYQRY-----HLRDSQVSAYTRQILLGLKYLHDQD-----VVHRDIKCANILVDANGSVKLADF 473 (554)
Q Consensus 404 ~~~LVmE~~~ggsL~~ll~~~-----~l~e~~i~~i~~QIl~gL~yLHs~g-----IIHrDIKPeNILld~~g~vKL~DF 473 (554)
.+|+||||+.+++|.+++... .+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+||
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~df 160 (279)
T 2w5a_A 81 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 160 (279)
T ss_dssp EEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCC
T ss_pred eEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence 899999999999999998753 2899999999999999999999999 999999999999999999999999
Q ss_pred CcccccccCC--ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHH
Q 008759 474 GLAKATKLND--VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFI 540 (554)
Q Consensus 474 GlA~~~~~~~--~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~ 540 (554)
|++....... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||......+....
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~ 227 (279)
T 2w5a_A 161 GLARILNHDTSFAKTFVGTPYYMSPEQMNRM--SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGK 227 (279)
T ss_dssp CHHHHC---CHHHHHHHSCCTTCCHHHHHCC---CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred chheeeccccccccccCCCccccChHHhccC--CCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHH
Confidence 9987654332 1234689999999999654 488999999999999999999999998776544433
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-37 Score=304.43 Aligned_cols=200 Identities=21% Similarity=0.369 Sum_probs=170.1
Q ss_pred ccceeeeeeeccCCceeEEEEec-CCC-------cEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeec
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS-DDG-------FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTD 399 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~-~~g-------~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~ 399 (554)
.++|++.+.||+|+||+||+|.+ .++ ..||+|++.... ....+.+.+|+.+++.++||||+++++++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 81 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH-----RNYSESFFEAASMMSKLSHKHLVLNYGVC 81 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG-----GGGHHHHHHHHHHHHTSCCTTBCCEEEEE
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc-----HHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence 56899999999999999999988 334 469999886422 22346788999999999999999999999
Q ss_pred cCCCcEEEEEeecccCchHHHHhhhc--CChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCc--------EE
Q 008759 400 KDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS--------VK 469 (554)
Q Consensus 400 ~~~~~~~LVmE~~~ggsL~~ll~~~~--l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~--------vK 469 (554)
...+..|+||||+.+++|.+++.... +++..+..++.||+.||.|||++||+||||||+|||++.++. +|
T Consensus 82 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 82 VCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred EeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceee
Confidence 99999999999999999999997643 899999999999999999999999999999999999998887 99
Q ss_pred EEecCcccccccCCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcC-CCCCCCCChh
Q 008759 470 LADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTS-QIPYAPMECV 535 (554)
Q Consensus 470 L~DFGlA~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG-~~PF~~~e~~ 535 (554)
|+|||++..... .....+|+.|+|||++.+. ..++.++|||||||++|+|++| .+||......
T Consensus 162 l~Dfg~~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~ 225 (289)
T 4fvq_A 162 LSDPGISITVLP--KDILQERIPWVPPECIENP-KNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ 225 (289)
T ss_dssp ECCCCSCTTTSC--HHHHHHTTTTSCHHHHHCG-GGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred eccCcccccccC--ccccCCcCcccCHHHhCCC-CCCCchhHHHHHHHHHHHHHcCCCCCccccchH
Confidence 999999865432 2234588999999999752 2488999999999999999995 5555555543
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=307.43 Aligned_cols=208 Identities=37% Similarity=0.656 Sum_probs=175.1
Q ss_pred cccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCC
Q 008759 325 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES 403 (554)
Q Consensus 325 ~~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~ 403 (554)
....+.|++.+.||+|+||.||+|.+ .+|+.||+|.+.... ....+.+|+.++..++||||+++++++...+
T Consensus 25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 97 (314)
T 3com_A 25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-------DLQEIIKEISIMQQCDSPHVVKYYGSYFKNT 97 (314)
T ss_dssp -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-------CCHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-------HHHHHHHHHHHHHhCCCCCCccEEEEEEeCC
Confidence 44567899999999999999999998 579999999987532 1245788999999999999999999999999
Q ss_pred cEEEEEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccccc
Q 008759 404 KLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL 481 (554)
Q Consensus 404 ~~~LVmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~ 481 (554)
.+|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.....
T Consensus 98 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (314)
T 3com_A 98 DLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD 177 (314)
T ss_dssp EEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred EEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence 99999999999999999863 4689999999999999999999999999999999999999999999999999976543
Q ss_pred C--CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHH
Q 008759 482 N--DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIK 541 (554)
Q Consensus 482 ~--~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i 541 (554)
. ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||........++.+
T Consensus 178 ~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~ 237 (314)
T 3com_A 178 TMAKRNTVIGTPFWMAPEVIQEI--GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMI 237 (314)
T ss_dssp TBSCBCCCCSCGGGCCHHHHSSS--CBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred hccccCccCCCCCccChhhcCCC--CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 2 23345699999999999654 4788999999999999999999999988776665543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-37 Score=309.48 Aligned_cols=203 Identities=28% Similarity=0.469 Sum_probs=169.0
Q ss_pred ccccceeee-eeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhC-CCCceeeeeeeccCC
Q 008759 326 RIITYWQKG-DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDE 402 (554)
Q Consensus 326 ~~~~~y~i~-~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIVkl~~~~~~~ 402 (554)
++.+.|++. ++||+|+||+||+|.+ .+++.||+|++..... .....+.+|+.++.++ +||||+++++++.+.
T Consensus 9 ~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~ 83 (316)
T 2ac3_A 9 RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG-----HIRSRVFREVEMLYQCQGHRNVLELIEFFEEE 83 (316)
T ss_dssp CTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS-----CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred ccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc-----hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence 445678885 7899999999999998 6899999999875322 1235678999999885 799999999999999
Q ss_pred CcEEEEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCc---EEEEecCcccc
Q 008759 403 SKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS---VKLADFGLAKA 478 (554)
Q Consensus 403 ~~~~LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~---vKL~DFGlA~~ 478 (554)
+.+|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||++..
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~ 163 (316)
T 2ac3_A 84 DRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163 (316)
T ss_dssp TEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred CEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence 999999999999999999876 46899999999999999999999999999999999999988776 99999999875
Q ss_pred cccC---------CccCccCCCcccChhhhcccC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008759 479 TKLN---------DVKSCRGTAFWMAPEVINNKN---KGYGLPADIWSLGCTVLEMLTSQIPYAPME 533 (554)
Q Consensus 479 ~~~~---------~~~s~~GT~~Y~APEvl~~~~---~~~s~ksDIwSLGvllyeLLTG~~PF~~~e 533 (554)
.... ......||+.|+|||++.... ..++.++|||||||++|+|++|+.||....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 230 (316)
T 2ac3_A 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRC 230 (316)
T ss_dssp ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccc
Confidence 4321 122345999999999986421 236789999999999999999999998753
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=324.66 Aligned_cols=209 Identities=28% Similarity=0.479 Sum_probs=180.1
Q ss_pred ccccccceeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCC
Q 008759 324 FKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES 403 (554)
Q Consensus 324 ~~~~~~~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~ 403 (554)
+....++|++.+.||+|+||.||+|.+.++..||+|++..... ..+.+.+|+.+++.++||||+++++++. ..
T Consensus 183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~ 255 (454)
T 1qcf_A 183 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM------SVEAFLAEANVMKTLQHDKLVKLHAVVT-KE 255 (454)
T ss_dssp SBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSB------CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred eeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCc------cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CC
Confidence 3445678999999999999999999998889999999874321 2457889999999999999999999986 56
Q ss_pred cEEEEEeecccCchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccc
Q 008759 404 KLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK 480 (554)
Q Consensus 404 ~~~LVmE~~~ggsL~~ll~~~---~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~ 480 (554)
.+|+||||+.+|+|.++++.. .++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 256 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 335 (454)
T 1qcf_A 256 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIE 335 (454)
T ss_dssp SCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred ccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence 789999999999999999753 58889999999999999999999999999999999999999999999999998654
Q ss_pred cCC---ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHHHHH
Q 008759 481 LND---VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIFIK 541 (554)
Q Consensus 481 ~~~---~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i~~i 541 (554)
... .....+|+.|+|||++... .++.++|||||||++|||+| |+.||......+.+..+
T Consensus 336 ~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i 398 (454)
T 1qcf_A 336 DNEYTAREGAKFPIKWTAPEAINFG--SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL 398 (454)
T ss_dssp CHHHHTTCSSSSCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred CCceeccCCCcccccccCHHHhccC--CCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 321 2334467889999999654 38999999999999999999 99999988776655444
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=303.92 Aligned_cols=207 Identities=27% Similarity=0.469 Sum_probs=179.4
Q ss_pred ccccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCC
Q 008759 324 FKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE 402 (554)
Q Consensus 324 ~~~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~ 402 (554)
+....++|++.+.||+|+||.||+|.+ .++..||+|.+.... ...+.+.+|+.+++.++||||+++++++.+.
T Consensus 8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 81 (288)
T 3kfa_A 8 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT------MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 81 (288)
T ss_dssp TBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS------THHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred ccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH------HHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 344567899999999999999999998 568999999986421 2346788999999999999999999999999
Q ss_pred CcEEEEEeecccCchHHHHhh---hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccc
Q 008759 403 SKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT 479 (554)
Q Consensus 403 ~~~~LVmE~~~ggsL~~ll~~---~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~ 479 (554)
..+|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 82 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~ 161 (288)
T 3kfa_A 82 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM 161 (288)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred CCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceec
Confidence 999999999999999999975 34899999999999999999999999999999999999999999999999999765
Q ss_pred ccCCc---cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHH
Q 008759 480 KLNDV---KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAI 538 (554)
Q Consensus 480 ~~~~~---~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i 538 (554)
..... ....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||...+..+..
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~ 222 (288)
T 3kfa_A 162 TGDTYTAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 222 (288)
T ss_dssp CSSSSEEETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred cCCccccccCCccccCcCChhhhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 44332 233467889999999654 38899999999999999999 99999887655443
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-37 Score=316.70 Aligned_cols=196 Identities=32% Similarity=0.489 Sum_probs=169.6
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhC-CCCceeeeeeeccCCC
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDES 403 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIVkl~~~~~~~~ 403 (554)
.+.+.|++++.||+|+||.||+|.+ .+++.||+|++..... ...+|+.++.++ +||||+++++++.+..
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~ 89 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---------DPTEEIEILLRYGQHPNIITLKDVYDDGK 89 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC---------CCHHHHHHHHHHTTSTTBCCEEEEEECSS
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC---------ChHHHHHHHHHhcCCCCcCeEEEEEEcCC
Confidence 4567899999999999999999998 6799999999875322 124677778777 7999999999999999
Q ss_pred cEEEEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCC----CcEEEEecCcccc
Q 008759 404 KLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN----GSVKLADFGLAKA 478 (554)
Q Consensus 404 ~~~LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~----g~vKL~DFGlA~~ 478 (554)
.+|+||||+.+|+|.+++.+ ..+++..+..++.||+.||.|||++||+||||||+|||+..+ +.+||+|||+++.
T Consensus 90 ~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 90 YVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp EEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 99999999999999998865 458999999999999999999999999999999999998543 3599999999986
Q ss_pred cccC--CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008759 479 TKLN--DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM 532 (554)
Q Consensus 479 ~~~~--~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~ 532 (554)
.... .....+||+.|+|||++.+.. |+.++|||||||++|+|++|..||...
T Consensus 170 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~ell~g~~Pf~~~ 223 (342)
T 2qr7_A 170 LRAENGLLMTPCYTANFVAPEVLERQG--YDAACDIWSLGVLLYTMLTGYTPFANG 223 (342)
T ss_dssp CBCTTCCBCCSSCCSSCCCHHHHHHHH--HHHHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred CcCCCCceeccCCCccccCHHHhcCCC--CCCccCeeeHhHHHHHHhcCCCCCCCC
Confidence 5432 334567999999999997643 788999999999999999999999863
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=308.21 Aligned_cols=211 Identities=24% Similarity=0.416 Sum_probs=179.0
Q ss_pred ccccccceeeeeeeccCCceeEEEEecC------CCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeee
Q 008759 324 FKRIITYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYG 397 (554)
Q Consensus 324 ~~~~~~~y~i~~~LG~GsfG~VY~a~~~------~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~ 397 (554)
+....++|++.+.||+|+||.||+|.+. ++..||+|.+.... .......+.+|+.+++.++||||+++++
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 95 (322)
T 1p4o_A 20 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA----SMRERIEFLNEASVMKEFNCHHVVRLLG 95 (322)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS----CHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred hcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc----CHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence 4455678999999999999999999764 47889999886422 2233457889999999999999999999
Q ss_pred eccCCCcEEEEEeecccCchHHHHhh-----------hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCC
Q 008759 398 TDKDESKLYIFLELVTKGSLLNLYQR-----------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG 466 (554)
Q Consensus 398 ~~~~~~~~~LVmE~~~ggsL~~ll~~-----------~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g 466 (554)
++.+.+.+|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF 175 (322)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC
T ss_pred EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCC
Confidence 99999999999999999999999875 2358889999999999999999999999999999999999999
Q ss_pred cEEEEecCcccccccCC----ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHHHH
Q 008759 467 SVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIFI 540 (554)
Q Consensus 467 ~vKL~DFGlA~~~~~~~----~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i~~ 540 (554)
.+||+|||+++...... .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||......+....
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 252 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV--FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 252 (322)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHH
T ss_pred eEEECcCccccccccccccccccCCCCCCCccChhhhccCC--CCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHH
Confidence 99999999987543322 22334688999999996543 8899999999999999999 8999988776554443
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=319.91 Aligned_cols=207 Identities=26% Similarity=0.366 Sum_probs=173.5
Q ss_pred cccceeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCC----
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE---- 402 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~---- 402 (554)
...+|+++++||+|+||+||+|.+..+..+|+|++...... ..+|+.+++.++||||+++++++...
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~---------~~~E~~il~~l~h~niv~l~~~~~~~~~~~ 108 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF---------KNRELQIMRIVKHPNVVDLKAFFYSNGDKK 108 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS---------CCHHHHHHHTCCCTTBCCEEEEEEEESSSS
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch---------HHHHHHHHHhCCCCCcceEEEEEEecCCCC
Confidence 45689999999999999999999976677999988643221 23689999999999999999988433
Q ss_pred --CcEEEEEeecccCchHHHHh----hhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEc-CCCcEEEEecCc
Q 008759 403 --SKLYIFLELVTKGSLLNLYQ----RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD-ANGSVKLADFGL 475 (554)
Q Consensus 403 --~~~~LVmE~~~ggsL~~ll~----~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld-~~g~vKL~DFGl 475 (554)
..+|+||||+.++.+..+.. ...+++..++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 109 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~ 188 (394)
T 4e7w_A 109 DEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGS 188 (394)
T ss_dssp SCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred CceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCC
Confidence 34889999999865544332 34689999999999999999999999999999999999999 799999999999
Q ss_pred cccccc-CCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHH
Q 008759 476 AKATKL-NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTV 543 (554)
Q Consensus 476 A~~~~~-~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~ 543 (554)
++.... .......||+.|+|||++.+.. .|+.++|||||||++|+|++|+.||.+....+.+..+..
T Consensus 189 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~ 256 (394)
T 4e7w_A 189 AKILIAGEPNVSYICSRYYRAPELIFGAT-NYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIK 256 (394)
T ss_dssp CEECCTTCCCCSSCSCGGGCCHHHHTTCS-SCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred cccccCCCCCcccccCcCccCHHHHcCCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 986533 3344567999999999986543 489999999999999999999999999888877776654
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=308.14 Aligned_cols=210 Identities=32% Similarity=0.572 Sum_probs=162.1
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCc
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~ 404 (554)
...++|++++.||+|+||.||+|.+ .+++.||+|++.... .......+.+|+.++..++||||+++++++...+.
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 87 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK----CQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE 87 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC--------------------CCCCCCCTTBCCEEEEEESSSC
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhh----cchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCC
Confidence 4457899999999999999999998 678999999886422 12334567899999999999999999999999999
Q ss_pred EEEEEeecccCchHHHHhh---------hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCc
Q 008759 405 LYIFLELVTKGSLLNLYQR---------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL 475 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~---------~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGl 475 (554)
+|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccc
Confidence 9999999999999998863 3489999999999999999999999999999999999999999999999999
Q ss_pred ccccccC-------CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHH
Q 008759 476 AKATKLN-------DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFI 540 (554)
Q Consensus 476 A~~~~~~-------~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~ 540 (554)
+...... ......||+.|+|||++.+.. .++.++|||||||++|+|++|+.||......+.+..
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 238 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVR-GYDFKADIWSFGITAIELATGAAPYHKYPPMKVLML 238 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHHH-CCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHH
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhcccc-CCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHH
Confidence 8754322 123446999999999986532 378899999999999999999999988766555443
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=301.35 Aligned_cols=208 Identities=29% Similarity=0.492 Sum_probs=178.1
Q ss_pred ccccccceeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCC
Q 008759 324 FKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES 403 (554)
Q Consensus 324 ~~~~~~~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~ 403 (554)
+....+.|++++.||+|+||.||+|.+.++..||+|.+..... ....+.+|+.+++.++||||+++++++. .+
T Consensus 8 ~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~ 80 (279)
T 1qpc_A 8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM------SPDAFLAEANLMKQLQHQRLVRLYAVVT-QE 80 (279)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS------CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred cccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc------cHHHHHHHHHHHHhCCCcCcceEEEEEc-CC
Confidence 4445678999999999999999999998888999999864321 1356889999999999999999999876 45
Q ss_pred cEEEEEeecccCchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccc
Q 008759 404 KLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK 480 (554)
Q Consensus 404 ~~~LVmE~~~ggsL~~ll~~~---~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~ 480 (554)
..|+||||+.+++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 81 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 160 (279)
T 1qpc_A 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (279)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence 689999999999999998753 58999999999999999999999999999999999999999999999999997654
Q ss_pred cCCc---cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHHHH
Q 008759 481 LNDV---KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIFI 540 (554)
Q Consensus 481 ~~~~---~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i~~ 540 (554)
.... ....+|+.|+|||++.+.. ++.++|||||||++|+|++ |+.||......+.+..
T Consensus 161 ~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 222 (279)
T 1qpc_A 161 DNEYTAREGAKFPIKWTAPEAINYGT--FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN 222 (279)
T ss_dssp SSCEECCTTCCCCTTTSCHHHHHHCE--ECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH
T ss_pred CcccccccCCCCccCccChhhhccCC--CCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHH
Confidence 4322 2344678899999996543 7889999999999999999 9999998776554433
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=311.55 Aligned_cols=216 Identities=25% Similarity=0.434 Sum_probs=173.7
Q ss_pred cccccceeeeeeeccCCceeEEEEecCCCcEEEEEEEeccccc------chhHHHHHHHHHHHHHHHhCCCCceeeeeee
Q 008759 325 KRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQG------SQAKQSISQLEQEIALLSRFEHENIVQYYGT 398 (554)
Q Consensus 325 ~~~~~~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~------~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~ 398 (554)
..+.+.|++++.||+|+||.||+|.+.++..||+|++...... .......+.+.+|+.++..++||||++++++
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 97 (362)
T 3pg1_A 18 HAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI 97 (362)
T ss_dssp HHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred HHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence 3456789999999999999999999988999999998643221 1223445778999999999999999999998
Q ss_pred c-----cCCCcEEEEEeecccCchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEE
Q 008759 399 D-----KDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLA 471 (554)
Q Consensus 399 ~-----~~~~~~~LVmE~~~ggsL~~ll~~~--~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~ 471 (554)
+ .....+|+||||+.+ +|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~ 176 (362)
T 3pg1_A 98 FVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITIC 176 (362)
T ss_dssp EEECCTTTCCEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred EEeccCCCcceEEEEEccCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEE
Confidence 8 344578999999985 777776553 58999999999999999999999999999999999999999999999
Q ss_pred ecCcccccccC-CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHH
Q 008759 472 DFGLAKATKLN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKT 542 (554)
Q Consensus 472 DFGlA~~~~~~-~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~ 542 (554)
|||++...... ......||+.|+|||++.+.. .++.++|||||||++|+|++|+.||......+.+..+.
T Consensus 177 Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~ 247 (362)
T 3pg1_A 177 DFNLAREDTADANKTHYVTHRWYRAPELVMQFK-GFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIV 247 (362)
T ss_dssp CTTC---------------CGGGCCHHHHTTCT-TCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred ecCcccccccccccceecccceecCcHHhcCCC-CCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99999754332 234456999999999986532 48899999999999999999999999887766655544
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=322.67 Aligned_cols=205 Identities=28% Similarity=0.430 Sum_probs=171.3
Q ss_pred ccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccC-----
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD----- 401 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~----- 401 (554)
...|++++.||+|+||.||+|.+ .+++.||+|++..... ...+|+.+|+.++|+|||+++++|..
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~---------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~ 123 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKK 123 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT---------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTT
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch---------hHHHHHHHHHHcCCCCccceeeEEeccCCCC
Confidence 45799999999999999999998 6799999999864221 12379999999999999999988742
Q ss_pred -CCcEEEEEeecccCchHHHHhh-----hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCC-CcEEEEecC
Q 008759 402 -ESKLYIFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFG 474 (554)
Q Consensus 402 -~~~~~LVmE~~~ggsL~~ll~~-----~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~-g~vKL~DFG 474 (554)
..++++||||+.+ +|..++.. ..+++..++.|+.||+.||.|||++||+||||||+||||+.+ +.+||+|||
T Consensus 124 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG 202 (420)
T 1j1b_A 124 DEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFG 202 (420)
T ss_dssp TEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred cceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccch
Confidence 2347799999987 55555432 458999999999999999999999999999999999999965 578999999
Q ss_pred ccccccc-CCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHH
Q 008759 475 LAKATKL-NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTV 543 (554)
Q Consensus 475 lA~~~~~-~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~ 543 (554)
+++.... .......||+.|+|||++.+.. .|+.++|||||||++|||++|+.||......+.+..+..
T Consensus 203 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~ 271 (420)
T 1j1b_A 203 SAKQLVRGEPNVSYICSRYYRAPELIFGAT-DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 271 (420)
T ss_dssp TCEECCTTCCCCSCCSCTTSCCHHHHTTCS-SCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred hhhhcccCCCceeeeeCCCcCCHHHHcCCC-CCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9986543 2344567999999999986542 488999999999999999999999999888777776654
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=300.58 Aligned_cols=204 Identities=29% Similarity=0.445 Sum_probs=161.2
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCc
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~ 404 (554)
...++|++++.||+|+||+||+|.+ .+++.||+|++..... .......+.++...++.++||||+++++++...+.
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~ 80 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN---SQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGD 80 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C---HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSS
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC---cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCC
Confidence 3457899999999999999999998 7899999999864321 22233445555666888899999999999999999
Q ss_pred EEEEEeecccCchHHHHhh-----hcCChHHHHHHHHHHHHHHHHHHHC-CccccCCccccEEEcCCCcEEEEecCcccc
Q 008759 405 LYIFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQ-DVVHRDIKCANILVDANGSVKLADFGLAKA 478 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~-----~~l~e~~i~~i~~QIl~gL~yLHs~-gIIHrDIKPeNILld~~g~vKL~DFGlA~~ 478 (554)
+|+||||+.+ +|.+++.. ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++..
T Consensus 81 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T 3fme_A 81 VWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGY 159 (290)
T ss_dssp EEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-----
T ss_pred EEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccc
Confidence 9999999986 77776653 3689999999999999999999998 999999999999999999999999999976
Q ss_pred cccCC-ccCccCCCcccChhhhcc--cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008759 479 TKLND-VKSCRGTAFWMAPEVINN--KNKGYGLPADIWSLGCTVLEMLTSQIPYAPME 533 (554)
Q Consensus 479 ~~~~~-~~s~~GT~~Y~APEvl~~--~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e 533 (554)
..... .....||+.|+|||++.. ....++.++|||||||++|+|++|+.||....
T Consensus 160 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 217 (290)
T 3fme_A 160 LVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWG 217 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCS
T ss_pred ccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccC
Confidence 54332 233469999999999742 22347899999999999999999999998743
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=318.93 Aligned_cols=206 Identities=27% Similarity=0.420 Sum_probs=176.2
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccch---hHHHHHHHHHHHHHHHhCCCCceeeeeeeccC
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQ---AKQSISQLEQEIALLSRFEHENIVQYYGTDKD 401 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~---~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~ 401 (554)
.+.++|++.+.||+|+||.||+|.+ .+++.||+|++........ .......+.+|+.+++.++||||+++++++.+
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 4567899999999999999999997 7899999999975332111 01122346689999999999999999999999
Q ss_pred CCcEEEEEeecccC-chHHHHhhh-cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccc
Q 008759 402 ESKLYIFLELVTKG-SLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT 479 (554)
Q Consensus 402 ~~~~~LVmE~~~gg-sL~~ll~~~-~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~ 479 (554)
.+.+|+||||+.+| +|..++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 180 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL 180 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceEC
Confidence 99999999999776 999998765 6999999999999999999999999999999999999999999999999999865
Q ss_pred ccCC-ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008759 480 KLND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM 532 (554)
Q Consensus 480 ~~~~-~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~ 532 (554)
.... .....||+.|+|||++.+.. .++.++|||||||++|+|++|+.||...
T Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~ 233 (335)
T 3dls_A 181 ERGKLFYTFCGTIEYCAPEVLMGNP-YRGPELEMWSLGVTLYTLVFEENPFCEL 233 (335)
T ss_dssp CTTCCBCEECSCGGGCCHHHHTTCC-BCSHHHHHHHHHHHHHHHHHSSCSCSSG
T ss_pred CCCCceeccCCCccccChhhhcCCC-CCCCcccchhHHHHHHHHHhCCCchhhH
Confidence 4433 34566999999999996543 2378999999999999999999999753
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=323.73 Aligned_cols=203 Identities=27% Similarity=0.522 Sum_probs=172.9
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCC-
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES- 403 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~- 403 (554)
...++|++.++||+|+||+||+|.+ .+++.||+|++...... .....+.+|+.+++.++||||+++++++...+
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 81 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL----RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTT 81 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG----SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTT
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc----chHHHHHHHHHHHHhcCCCCCCeEEEeeccCCC
Confidence 3457899999999999999999998 66999999998743221 22356678999999999999999999987654
Q ss_pred -cEEEEEeecccCchHHHHhhhc----CChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEE----cCCCcEEEEecC
Q 008759 404 -KLYIFLELVTKGSLLNLYQRYH----LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV----DANGSVKLADFG 474 (554)
Q Consensus 404 -~~~LVmE~~~ggsL~~ll~~~~----l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILl----d~~g~vKL~DFG 474 (554)
.+|+||||+.+++|.+++.... +++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG 161 (396)
T 4eut_A 82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (396)
T ss_dssp CCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGG
T ss_pred CeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCC
Confidence 7899999999999999997532 8999999999999999999999999999999999999 777889999999
Q ss_pred cccccccC-CccCccCCCcccChhhhcccC------CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008759 475 LAKATKLN-DVKSCRGTAFWMAPEVINNKN------KGYGLPADIWSLGCTVLEMLTSQIPYAPM 532 (554)
Q Consensus 475 lA~~~~~~-~~~s~~GT~~Y~APEvl~~~~------~~~s~ksDIwSLGvllyeLLTG~~PF~~~ 532 (554)
+++..... ......||+.|+|||++.... ..++.++|||||||++|+|++|+.||...
T Consensus 162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~ 226 (396)
T 4eut_A 162 AARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF 226 (396)
T ss_dssp GCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECT
T ss_pred CceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 99765433 234567999999999986421 23678999999999999999999999753
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=306.05 Aligned_cols=211 Identities=27% Similarity=0.441 Sum_probs=177.2
Q ss_pred ccccccceeeeeeeccCCceeEEEEec------CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhC-CCCceeeee
Q 008759 324 FKRIITYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYY 396 (554)
Q Consensus 324 ~~~~~~~y~i~~~LG~GsfG~VY~a~~------~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIVkl~ 396 (554)
+....++|++++.||+|+||.||+|.+ .+++.||+|++.... .......+.+|+.++..+ +||||++++
T Consensus 22 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 22 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA----THSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred eecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC----CcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 334467899999999999999999973 467899999986422 233446788999999999 699999999
Q ss_pred eeccCCC-cEEEEEeecccCchHHHHhhhc-----------------CChHHHHHHHHHHHHHHHHHHHCCccccCCccc
Q 008759 397 GTDKDES-KLYIFLELVTKGSLLNLYQRYH-----------------LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCA 458 (554)
Q Consensus 397 ~~~~~~~-~~~LVmE~~~ggsL~~ll~~~~-----------------l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPe 458 (554)
+++...+ .+|+||||+.+++|.+++.... +++..+..++.||+.||.|||++||+||||||+
T Consensus 98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~ 177 (316)
T 2xir_A 98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 177 (316)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccc
Confidence 9987654 5999999999999999997643 788899999999999999999999999999999
Q ss_pred cEEEcCCCcEEEEecCcccccccCC----ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 008759 459 NILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPME 533 (554)
Q Consensus 459 NILld~~g~vKL~DFGlA~~~~~~~----~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e 533 (554)
|||++.++.+||+|||+++...... .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||....
T Consensus 178 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 255 (316)
T 2xir_A 178 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVK 255 (316)
T ss_dssp GEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred eEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccc--cccchhHHHHHHHHHHHHHhCCCCCCcccc
Confidence 9999999999999999997654322 1234578899999999654 48899999999999999998 999998876
Q ss_pred hhHHHHH
Q 008759 534 CVSAIFI 540 (554)
Q Consensus 534 ~~~~i~~ 540 (554)
..+.+..
T Consensus 256 ~~~~~~~ 262 (316)
T 2xir_A 256 IDEEFCR 262 (316)
T ss_dssp CSHHHHH
T ss_pred hhHHHHH
Confidence 5554443
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=304.68 Aligned_cols=212 Identities=31% Similarity=0.563 Sum_probs=176.8
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCc
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~ 404 (554)
...+.|++++.||+|+||.||+|.+ .++..||+|++.... ......+.+|+.++..++||||+++++++...+.
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 90 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS-----EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGK 90 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC---------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-C
T ss_pred CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC-----HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCe
Confidence 4567899999999999999999999 578999999986432 2224568899999999999999999999999999
Q ss_pred EEEEEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccccc-
Q 008759 405 LYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL- 481 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~- 481 (554)
+|+||||+.+++|..++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 91 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (302)
T 2j7t_A 91 LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT 170 (302)
T ss_dssp EEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH
T ss_pred EEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc
Confidence 9999999999999998865 4689999999999999999999999999999999999999999999999998754221
Q ss_pred -CCccCccCCCcccChhhhcc---cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHH
Q 008759 482 -NDVKSCRGTAFWMAPEVINN---KNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKT 542 (554)
Q Consensus 482 -~~~~s~~GT~~Y~APEvl~~---~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~ 542 (554)
.......||+.|+|||++.. ....++.++|||||||++|+|++|..||........+..+.
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 235 (302)
T 2j7t_A 171 LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA 235 (302)
T ss_dssp HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHh
Confidence 12234569999999999842 23347889999999999999999999999887766555443
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=303.23 Aligned_cols=211 Identities=28% Similarity=0.517 Sum_probs=168.4
Q ss_pred ccccceeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcE
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL 405 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~ 405 (554)
...++|++++.||+|+||.||+|.+.. .+|+|++..... .....+.+.+|+.+++.++|+||+++++++ ....+
T Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~ 94 (289)
T 3og7_A 21 IPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAP---TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQL 94 (289)
T ss_dssp CCTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSC
T ss_pred cCccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCC---CHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCcc
Confidence 345689999999999999999998754 599999875432 234457788999999999999999999965 55678
Q ss_pred EEEEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccccc--
Q 008759 406 YIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL-- 481 (554)
Q Consensus 406 ~LVmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~-- 481 (554)
++||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 174 (289)
T 3og7_A 95 AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS 174 (289)
T ss_dssp EEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred EEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccccccc
Confidence 999999999999999864 4589999999999999999999999999999999999999999999999999875432
Q ss_pred --CCccCccCCCcccChhhhccc-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHH
Q 008759 482 --NDVKSCRGTAFWMAPEVINNK-NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKT 542 (554)
Q Consensus 482 --~~~~s~~GT~~Y~APEvl~~~-~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~ 542 (554)
.......||+.|+|||++... ...++.++|||||||++|+|++|+.||......+.+....
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~ 238 (289)
T 3og7_A 175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 238 (289)
T ss_dssp ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHH
T ss_pred ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHh
Confidence 223345699999999998632 2347889999999999999999999999877666555443
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=321.83 Aligned_cols=208 Identities=26% Similarity=0.410 Sum_probs=177.9
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhC------CCCceeeeeee
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF------EHENIVQYYGT 398 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l------~HpnIVkl~~~ 398 (554)
.+..+|+++++||+|+||.||+|.+ .+++.||+|++... ......+.+|+.++..+ +|+||+++++.
T Consensus 94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~------~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~ 167 (429)
T 3kvw_A 94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE------KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLEN 167 (429)
T ss_dssp EETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC------HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEE
T ss_pred cccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc------cchHHHHHHHHHHHHHHhhccccCCcCEEEEEee
Confidence 3556899999999999999999988 67899999998642 22335566777777766 57799999999
Q ss_pred ccCCCcEEEEEeecccCchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCc--EEEEec
Q 008759 399 DKDESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS--VKLADF 473 (554)
Q Consensus 399 ~~~~~~~~LVmE~~~ggsL~~ll~~~---~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~--vKL~DF 473 (554)
+...+.+|+||||+.+ +|.+++... .+++..++.|+.||+.||.|||++||+||||||+||||+.++. +||+||
T Consensus 168 ~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DF 246 (429)
T 3kvw_A 168 FTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDF 246 (429)
T ss_dssp EEETTEEEEEECCCCC-BHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCC
T ss_pred cccCCeEEEEEeccCC-CHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeec
Confidence 9999999999999974 888888764 3899999999999999999999999999999999999999987 999999
Q ss_pred CcccccccCCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHH
Q 008759 474 GLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTV 543 (554)
Q Consensus 474 GlA~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~ 543 (554)
|+++.... ......||+.|+|||++.+.. |+.++|||||||++|+|++|+.||...+..+.+..+..
T Consensus 247 G~a~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~ 313 (429)
T 3kvw_A 247 GSSCYEHQ-RVYTYIQSRFYRAPEVILGAR--YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIE 313 (429)
T ss_dssp TTCEETTC-CCCSSCSCGGGCCHHHHHTBC--CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred ccceecCC-cccccCCCCCccChHHHhCCC--CCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 99876543 344567999999999997654 89999999999999999999999999887776665543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-36 Score=305.09 Aligned_cols=213 Identities=33% Similarity=0.630 Sum_probs=174.9
Q ss_pred ccccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhC-CCCceeeeeeeccC
Q 008759 324 FKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKD 401 (554)
Q Consensus 324 ~~~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIVkl~~~~~~ 401 (554)
+....+.|++++.||+|+||.||+|.+ .+++.||+|++...... ...+.+|+.++..+ +||||+++++++..
T Consensus 19 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~------~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 92 (326)
T 2x7f_A 19 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE------EEEIKQEINMLKKYSHHRNIATYYGAFIK 92 (326)
T ss_dssp CCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST------THHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred ccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc------HHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence 334567899999999999999999998 68999999998743221 24677899999998 79999999999865
Q ss_pred ------CCcEEEEEeecccCchHHHHhh---hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEe
Q 008759 402 ------ESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLAD 472 (554)
Q Consensus 402 ------~~~~~LVmE~~~ggsL~~ll~~---~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~D 472 (554)
.+.+|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~D 172 (326)
T 2x7f_A 93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVD 172 (326)
T ss_dssp CC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECC
T ss_pred ccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEee
Confidence 5689999999999999999975 4589999999999999999999999999999999999999999999999
Q ss_pred cCcccccccC--CccCccCCCcccChhhhccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHH
Q 008759 473 FGLAKATKLN--DVKSCRGTAFWMAPEVINNK---NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKT 542 (554)
Q Consensus 473 FGlA~~~~~~--~~~s~~GT~~Y~APEvl~~~---~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~ 542 (554)
||++...... ......||+.|+|||++... ...++.++|||||||++|+|++|..||........++.+.
T Consensus 173 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 247 (326)
T 2x7f_A 173 FGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP 247 (326)
T ss_dssp CTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred CcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhh
Confidence 9998765432 23345699999999998632 2347889999999999999999999999888766655443
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=304.49 Aligned_cols=212 Identities=28% Similarity=0.490 Sum_probs=172.9
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeec--cCC
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTD--KDE 402 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~--~~~ 402 (554)
++.++|++++.||+|+||.||+|.+ .++..||+|++...... ........+.+|+.+++.++|+||+++++++ ...
T Consensus 2 ~l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (305)
T 2wtk_C 2 KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLR-RIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEK 80 (305)
T ss_dssp ---CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHH-HSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC--
T ss_pred ccccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEecccccc-ccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Confidence 3567899999999999999999998 67899999998742211 1112346788999999999999999999988 455
Q ss_pred CcEEEEEeecccCchHHHHhh---hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccc
Q 008759 403 SKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT 479 (554)
Q Consensus 403 ~~~~LVmE~~~ggsL~~ll~~---~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~ 479 (554)
..+|+||||+.++ |.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 81 ~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 81 QKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp -CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred CeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeecccccccc
Confidence 6899999999987 6666553 45899999999999999999999999999999999999999999999999999765
Q ss_pred ccC----CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHH
Q 008759 480 KLN----DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIF 539 (554)
Q Consensus 480 ~~~----~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~ 539 (554)
... ......||+.|+|||++.+....++.++|||||||++|+|++|+.||......+...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~ 223 (305)
T 2wtk_C 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFE 223 (305)
T ss_dssp CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH
Confidence 321 223456999999999997544335789999999999999999999999876554433
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=313.50 Aligned_cols=210 Identities=28% Similarity=0.467 Sum_probs=176.6
Q ss_pred cccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcE
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL 405 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~ 405 (554)
+.++|.+++.||+|+||.||+|.+ .+|+.||+|++..... .......+.+|+.+++.++||||+++++++...+..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 116 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ---SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSL 116 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTS---SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSS
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEeccccc---chhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCc
Confidence 457899999999999999999998 6799999999874322 234456788999999999999999999999877654
Q ss_pred ------EEEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccc
Q 008759 406 ------YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT 479 (554)
Q Consensus 406 ------~LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~ 479 (554)
|+||||+.+ +|..++. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 117 ~~~~~~~lv~e~~~~-~l~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 194 (371)
T 4exu_A 117 RNFYDFYLVMPFMQT-DLQKIMG-MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHA 194 (371)
T ss_dssp TTCCCCEEEEECCCE-EHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC---
T ss_pred ccceeEEEEEccccc-cHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccc
Confidence 999999985 7877764 45999999999999999999999999999999999999999999999999999765
Q ss_pred ccCCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHH
Q 008759 480 KLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTV 543 (554)
Q Consensus 480 ~~~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~ 543 (554)
... .....||+.|+|||++.+. ..++.++|||||||++|+|++|+.||...+..+.+..+..
T Consensus 195 ~~~-~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~ 256 (371)
T 4exu_A 195 DAE-MTGYVVTRWYRAPEVILSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILK 256 (371)
T ss_dssp ------CTTCCCTTSCHHHHSCC-SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred ccC-cCCcccCccccCHHHhcCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 432 3445689999999998653 2488999999999999999999999999887777666543
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=306.01 Aligned_cols=205 Identities=28% Similarity=0.391 Sum_probs=169.1
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCc
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~ 404 (554)
...++|++.+.||+|+||.||+|.+ .+++.||+|++..... ........+.+|+.++..++||||+++++++...+.
T Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~ 108 (309)
T 2h34_A 31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLS--SDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQ 108 (309)
T ss_dssp ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGG--GSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccc--cCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCe
Confidence 4567899999999999999999998 5789999999864322 223445778899999999999999999999999999
Q ss_pred EEEEEeecccCchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC
Q 008759 405 LYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND 483 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~~-~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~ 483 (554)
+|+||||+.+++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 188 (309)
T 2h34_A 109 LYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEK 188 (309)
T ss_dssp EEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence 99999999999999998764 58999999999999999999999999999999999999999999999999987654332
Q ss_pred ---ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh
Q 008759 484 ---VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC 534 (554)
Q Consensus 484 ---~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~ 534 (554)
.....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.....
T Consensus 189 ~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 240 (309)
T 2h34_A 189 LTQLGNTVGTLYYMAPERFSES--HATYRADIYALTCVLYECLTGSPPYQGDQL 240 (309)
T ss_dssp --------CCGGGCCGGGTCC------CCCHHHHHHHHHHHHHHSSCSSCSCHH
T ss_pred cccccccCCCcCccCHHHHcCC--CCCchHhHHHHHHHHHHHHHCCCCCCCchH
Confidence 2345699999999998654 478899999999999999999999987654
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=323.08 Aligned_cols=205 Identities=26% Similarity=0.462 Sum_probs=174.6
Q ss_pred ccccceeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCC-c
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES-K 404 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~-~ 404 (554)
...++|++.+.||+|+||.||+|.+. ++.||+|++.... ..+.+.+|+.++++++||||+++++++.... .
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 261 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 261 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT-------TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSC
T ss_pred cChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch-------HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCc
Confidence 34578999999999999999999885 6799999987422 2356889999999999999999999876654 7
Q ss_pred EEEEEeecccCchHHHHhhhc---CChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccccc
Q 008759 405 LYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL 481 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~~~---l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~ 481 (554)
+|+||||+.+|+|.++++..+ +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 262 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 341 (450)
T 1k9a_A 262 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 341 (450)
T ss_dssp EEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence 999999999999999998643 68899999999999999999999999999999999999999999999999975433
Q ss_pred CCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHHHHH
Q 008759 482 NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIFIK 541 (554)
Q Consensus 482 ~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i~~i 541 (554)
.. ....+++.|+|||++.+. .++.++|||||||++|||++ |+.||......+.+..+
T Consensus 342 ~~-~~~~~~~~y~aPE~~~~~--~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i 399 (450)
T 1k9a_A 342 TQ-DTGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV 399 (450)
T ss_dssp ------CCCTTTSCHHHHHSS--CCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHH
T ss_pred cc-cCCCCCcceeCHHHhcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 22 233578899999999654 48999999999999999998 99999987765554443
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=298.16 Aligned_cols=210 Identities=29% Similarity=0.478 Sum_probs=172.1
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCc
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~ 404 (554)
...++|++++.||+|+||.||+|.+ .+++.||+|++..... ........+.+|+.+++.++||||+++++++...+.
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 85 (276)
T 2h6d_A 8 VKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKI--RSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTD 85 (276)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred ceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccc--cchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCe
Confidence 3457899999999999999999998 5899999999874211 112234578899999999999999999999999999
Q ss_pred EEEEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC
Q 008759 405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND 483 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~ 483 (554)
+|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.......
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 165 (276)
T 2h6d_A 86 FFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165 (276)
T ss_dssp EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred EEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence 9999999999999999875 468999999999999999999999999999999999999999999999999987654332
Q ss_pred -ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHH
Q 008759 484 -VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAI 538 (554)
Q Consensus 484 -~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i 538 (554)
.....+|+.|+|||++.+.. ..+.++||||||+++|+|++|+.||......+..
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~ 220 (276)
T 2h6d_A 166 FLRTSCGSPNYAAPEVISGRL-YAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLF 220 (276)
T ss_dssp -----------CCTGGGTTSC-CCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred ceecccCCccccCHHHHcCCC-CCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHH
Confidence 33456899999999986543 2367999999999999999999999876654433
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=321.02 Aligned_cols=203 Identities=18% Similarity=0.245 Sum_probs=162.7
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHH---HHHHhCCCCceeeee-----
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEI---ALLSRFEHENIVQYY----- 396 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei---~iL~~l~HpnIVkl~----- 396 (554)
...++|++++.||+|+||.||+|.+ .+|+.||+|++....... ....+.+.+|+ .+++.++|||||+++
T Consensus 70 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~ 147 (377)
T 3byv_A 70 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPP--SNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIF 147 (377)
T ss_dssp CCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CC--TTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCC
T ss_pred CCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccc--hHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhh
Confidence 3457899999999999999999998 679999999997432222 22346788999 455566799999998
Q ss_pred --eeccCCC-----------------cEEEEEeecccCchHHHHhhh-cCCh-------HHHHHHHHHHHHHHHHHHHCC
Q 008759 397 --GTDKDES-----------------KLYIFLELVTKGSLLNLYQRY-HLRD-------SQVSAYTRQILLGLKYLHDQD 449 (554)
Q Consensus 397 --~~~~~~~-----------------~~~LVmE~~~ggsL~~ll~~~-~l~e-------~~i~~i~~QIl~gL~yLHs~g 449 (554)
+++...+ ..||||||+ +|+|.+++... .+++ ..+..|+.||+.||.|||++|
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ 226 (377)
T 3byv_A 148 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG 226 (377)
T ss_dssp CSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred hhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC
Confidence 4444332 389999999 57999998753 3555 777789999999999999999
Q ss_pred ccccCCccccEEEcCCCcEEEEecCcccccccCCccCccCCCcccChhhhccc---------CCCCCchhhHHHHHHHHH
Q 008759 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNK---------NKGYGLPADIWSLGCTVL 520 (554)
Q Consensus 450 IIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~~~s~~GT~~Y~APEvl~~~---------~~~~s~ksDIwSLGvlly 520 (554)
|+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. ...++.++|||||||++|
T Consensus 227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ 304 (377)
T 3byv_A 227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY 304 (377)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTC-EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHH
T ss_pred eecCCCCHHHEEEcCCCCEEEEechhheecCC-cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHH
Confidence 99999999999999999999999999976432 3344567 999999999765 013889999999999999
Q ss_pred HHHcCCCCCCCCC
Q 008759 521 EMLTSQIPYAPME 533 (554)
Q Consensus 521 eLLTG~~PF~~~e 533 (554)
+|++|+.||....
T Consensus 305 elltg~~Pf~~~~ 317 (377)
T 3byv_A 305 WIWCADLPITKDA 317 (377)
T ss_dssp HHHHSSCCC----
T ss_pred HHHHCCCCCcccc
Confidence 9999999997644
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-36 Score=303.84 Aligned_cols=205 Identities=26% Similarity=0.409 Sum_probs=175.3
Q ss_pred ccccceeeeeeeccCCceeEEEEec--CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCC------ceeeeee
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS--DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE------NIVQYYG 397 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~--~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hp------nIVkl~~ 397 (554)
.+.++|++.+.||+|+||.||+|.+ .+++.||+|++... ......+.+|+.++..++|+ +|+++++
T Consensus 11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~------~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~ 84 (339)
T 1z57_A 11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV------DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLE 84 (339)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS------HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEE
T ss_pred CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC------CchhHHHHHHHHHHHHhhhcCCCCceeeEeeec
Confidence 4567999999999999999999987 46899999998631 23345677889888888765 4999999
Q ss_pred eccCCCcEEEEEeecccCchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcC----------
Q 008759 398 TDKDESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA---------- 464 (554)
Q Consensus 398 ~~~~~~~~~LVmE~~~ggsL~~ll~~~---~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~---------- 464 (554)
++...+.+|+||||+ +++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 85 ~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~ 163 (339)
T 1z57_A 85 WFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPK 163 (339)
T ss_dssp EEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC--
T ss_pred ccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCc
Confidence 999999999999999 77999988764 4789999999999999999999999999999999999987
Q ss_pred ---------CCcEEEEecCcccccccCCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChh
Q 008759 465 ---------NGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECV 535 (554)
Q Consensus 465 ---------~g~vKL~DFGlA~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~ 535 (554)
++.+||+|||+++.... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||......
T Consensus 164 ~~~~~~~~~~~~~kl~Dfg~~~~~~~-~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 240 (339)
T 1z57_A 164 IKRDERTLINPDIKVVDFGSATYDDE-HHSTLVSTRHYRAPEVILAL--GWSQPCDVWSIGCILIEYYLGFTVFPTHDSK 240 (339)
T ss_dssp --CEEEEESCCCEEECCCSSCEETTS-CCCSSCSCGGGCCHHHHTTS--CCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred cccccccccCCCceEeeCcccccCcc-ccccccCCccccChHHhhCC--CCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence 67899999999876543 23456799999999999654 4889999999999999999999999987766
Q ss_pred HHHHH
Q 008759 536 SAIFI 540 (554)
Q Consensus 536 ~~i~~ 540 (554)
+.+..
T Consensus 241 ~~~~~ 245 (339)
T 1z57_A 241 EHLAM 245 (339)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 55443
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=312.29 Aligned_cols=204 Identities=28% Similarity=0.487 Sum_probs=165.5
Q ss_pred ccceeeeeeeccCCceeEEEEec-CCCcEE----EEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCC
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFF----AVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE 402 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~-~~g~~v----AvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~ 402 (554)
.++|+++++||+|+||.||+|.+ .+++.+ ++|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 89 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT----SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS----SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc----CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC
Confidence 46899999999999999999997 556655 555543211 122345688999999999999999999998875
Q ss_pred CcEEEEEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccc
Q 008759 403 SKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK 480 (554)
Q Consensus 403 ~~~~LVmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~ 480 (554)
. .++||+|+.+|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 90 ~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp S-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred C-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 4 8899999999999999875 358999999999999999999999999999999999999999999999999997653
Q ss_pred cCC----ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHH
Q 008759 481 LND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAI 538 (554)
Q Consensus 481 ~~~----~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i 538 (554)
... .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||......+..
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~ 229 (327)
T 3lzb_A 169 AEEKEYHAEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229 (327)
T ss_dssp -----------CCCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH
T ss_pred CccccccccCCCccccccCHHHHcCC--CCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH
Confidence 322 2233468889999999754 48999999999999999999 99999887665443
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-37 Score=325.66 Aligned_cols=208 Identities=26% Similarity=0.452 Sum_probs=166.0
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccc---hhHHHHHHHHHHHHHHHhCCCCceeeeeeeccC
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGS---QAKQSISQLEQEIALLSRFEHENIVQYYGTDKD 401 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~---~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~ 401 (554)
.+.++|.+.+.||+|+||+||+|.+ .+++.||+|++....... ........+.+|+.+|++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 4567899999999999999999998 778999999987533211 112223357899999999999999999999754
Q ss_pred CCcEEEEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCC---cEEEEecCccc
Q 008759 402 ESKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG---SVKLADFGLAK 477 (554)
Q Consensus 402 ~~~~~LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g---~vKL~DFGlA~ 477 (554)
..+|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~ 290 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred -CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccce
Confidence 558999999999999988765 4689999999999999999999999999999999999997654 59999999998
Q ss_pred ccccCC-ccCccCCCcccChhhhccc-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh
Q 008759 478 ATKLND-VKSCRGTAFWMAPEVINNK-NKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC 534 (554)
Q Consensus 478 ~~~~~~-~~s~~GT~~Y~APEvl~~~-~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~ 534 (554)
...... .....||+.|+|||++.+. ...|+.++|||||||++|+|++|+.||.....
T Consensus 291 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~ 349 (419)
T 3i6u_A 291 ILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 349 (419)
T ss_dssp SCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSS
T ss_pred ecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcc
Confidence 754432 3456799999999998642 23578899999999999999999999986543
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=309.68 Aligned_cols=208 Identities=27% Similarity=0.468 Sum_probs=170.6
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEeccccc---chhHHHHHHHHHHHHHHHhCCCCceeeeeeeccC
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQG---SQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD 401 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~---~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~ 401 (554)
.+.++|++.+.||+|+||.||+|.+ .+++.||+|++...... .........+.+|+.++..++||||+++++++..
T Consensus 7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 86 (322)
T 2ycf_A 7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 86 (322)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC
Confidence 4557899999999999999999998 67899999998643211 1112223457899999999999999999999876
Q ss_pred CCcEEEEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCc---EEEEecCccc
Q 008759 402 ESKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS---VKLADFGLAK 477 (554)
Q Consensus 402 ~~~~~LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~---vKL~DFGlA~ 477 (554)
.. +|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||++.
T Consensus 87 ~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 165 (322)
T 2ycf_A 87 ED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 165 (322)
T ss_dssp SS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCE
T ss_pred Cc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccce
Confidence 54 8999999999999998865 46899999999999999999999999999999999999987664 9999999987
Q ss_pred ccccCC-ccCccCCCcccChhhhcc-cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh
Q 008759 478 ATKLND-VKSCRGTAFWMAPEVINN-KNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC 534 (554)
Q Consensus 478 ~~~~~~-~~s~~GT~~Y~APEvl~~-~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~ 534 (554)
...... .....||+.|+|||++.. ....++.++|||||||++|+|++|..||.....
T Consensus 166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 224 (322)
T 2ycf_A 166 ILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 224 (322)
T ss_dssp ECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTC
T ss_pred ecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch
Confidence 654332 233469999999999853 233578999999999999999999999976543
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-36 Score=299.15 Aligned_cols=206 Identities=28% Similarity=0.475 Sum_probs=173.9
Q ss_pred ccceeeee-eeccCCceeEEEEec---CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCC
Q 008759 328 ITYWQKGD-LLGRGSFGSVYEGIS---DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES 403 (554)
Q Consensus 328 ~~~y~i~~-~LG~GsfG~VY~a~~---~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~ 403 (554)
.++|.+.+ .||+|+||.||+|.+ .++..||+|++... ......+.+.+|+.++..++||||+++++++ ..+
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~ 82 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG----TEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAE 82 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS----CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESS
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc----cchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCC
Confidence 35566665 999999999999985 36788999998743 2234567789999999999999999999998 456
Q ss_pred cEEEEEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccccc
Q 008759 404 KLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL 481 (554)
Q Consensus 404 ~~~LVmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~ 481 (554)
.+|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 83 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 79999999999999999864 4589999999999999999999999999999999999999999999999999976543
Q ss_pred CC-----ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHHHH
Q 008759 482 ND-----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIFI 540 (554)
Q Consensus 482 ~~-----~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i~~ 540 (554)
.. .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |+.||......+....
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~ 225 (287)
T 1u59_A 163 DDSYYTARSAGKWPLKWYAPECINFRK--FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF 225 (287)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCE--ECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHH
T ss_pred CcceeeccccccccccccCHHHhccCC--CCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHH
Confidence 22 22334688999999996543 7899999999999999998 9999988776554433
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=309.09 Aligned_cols=212 Identities=25% Similarity=0.448 Sum_probs=178.0
Q ss_pred ccccceeee-eeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCC-CCceeeeeeeccCC
Q 008759 326 RIITYWQKG-DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDE 402 (554)
Q Consensus 326 ~~~~~y~i~-~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIVkl~~~~~~~ 402 (554)
.+.++|.+. +.||+|+||.||+|.+ .+++.||+|++........ ....+.+|+.++..+. ||||+++++++...
T Consensus 25 ~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~ 101 (327)
T 3lm5_A 25 NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQD---CRAEILHEIAVLELAKSCPRVINLHEVYENT 101 (327)
T ss_dssp HHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEE---CHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred hhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchH---HHHHHHHHHHHHHhccCCCCEEEEEEEEEeC
Confidence 456778887 8999999999999998 6799999999875433221 2356789999999985 69999999999999
Q ss_pred CcEEEEEeecccCchHHHHhh---hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcC---CCcEEEEecCcc
Q 008759 403 SKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA---NGSVKLADFGLA 476 (554)
Q Consensus 403 ~~~~LVmE~~~ggsL~~ll~~---~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~---~g~vKL~DFGlA 476 (554)
..+|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++
T Consensus 102 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a 181 (327)
T 3lm5_A 102 SEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMS 181 (327)
T ss_dssp SEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGC
T ss_pred CeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccc
Confidence 999999999999999998754 45899999999999999999999999999999999999987 789999999999
Q ss_pred cccccC-CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHH
Q 008759 477 KATKLN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKT 542 (554)
Q Consensus 477 ~~~~~~-~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~ 542 (554)
+..... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||......+....+.
T Consensus 182 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 246 (327)
T 3lm5_A 182 RKIGHACELREIMGTPEYLAPEILNYD--PITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNIS 246 (327)
T ss_dssp EEC---------CCCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred cccCCccccccccCCcCccCCeeecCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHH
Confidence 865433 23455799999999999654 48899999999999999999999998887766555443
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=303.89 Aligned_cols=197 Identities=31% Similarity=0.521 Sum_probs=168.8
Q ss_pred ccceeeeeeeccCCceeEEEEe----c-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCC
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGI----S-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE 402 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~----~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~ 402 (554)
.++|++++.||+|+||.||+|. + .+++.||+|++..... ......+.+|+.++..++||||+++++++...
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG----GNHIADLKKEIEILRNLYHENIVKYKGICTED 95 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC---------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc----chhHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence 4579999999999999999998 3 6789999999874321 22345688999999999999999999998876
Q ss_pred --CcEEEEEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccc
Q 008759 403 --SKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA 478 (554)
Q Consensus 403 --~~~~LVmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~ 478 (554)
..+|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 96 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 96 GGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp --CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred CCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccccc
Confidence 678999999999999999854 3589999999999999999999999999999999999999999999999999976
Q ss_pred cccCC-----ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 008759 479 TKLND-----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYA 530 (554)
Q Consensus 479 ~~~~~-----~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~ 530 (554)
..... .....+|..|+|||++.+.. ++.++|||||||++|+|++|..||.
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~g~~p~~ 230 (302)
T 4e5w_A 176 IETDKEYYTVKDDRDSPVFWYAPECLMQSK--FYIASDVWSFGVTLHELLTYCDSDS 230 (302)
T ss_dssp CCTTCCEEECCCCTTCCGGGCCHHHHHHCE--EEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred ccCCCcceeccCCCCCCccccCCeeecCCC--CCcchhHHHHHHHHHHHHHccCCCc
Confidence 54332 23445888899999996654 7889999999999999999999864
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=307.22 Aligned_cols=198 Identities=28% Similarity=0.435 Sum_probs=164.0
Q ss_pred ccccceeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHh--CCCCceeeeeeeccCC-
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR--FEHENIVQYYGTDKDE- 402 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~--l~HpnIVkl~~~~~~~- 402 (554)
.+.++|++++.||+|+||.||+|.+. ++.||+|++.... ......|.+++.. ++||||+++++++...
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 104 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE--------EASWFRETEIYQTVLMRHENILGFIAADIKGT 104 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG--------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred ccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc--------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence 45679999999999999999999886 8899999986321 1223344555544 4899999999998776
Q ss_pred ---CcEEEEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHC--------CccccCCccccEEEcCCCcEEEE
Q 008759 403 ---SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ--------DVVHRDIKCANILVDANGSVKLA 471 (554)
Q Consensus 403 ---~~~~LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~--------gIIHrDIKPeNILld~~g~vKL~ 471 (554)
..+|+||||+.+|+|.++++...+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+
T Consensus 105 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~ 184 (337)
T 3mdy_A 105 GSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA 184 (337)
T ss_dssp GGGCEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred CCCCceEEEEeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence 7899999999999999999988999999999999999999999999 99999999999999999999999
Q ss_pred ecCcccccccCCc------cCccCCCcccChhhhcccCCCCC----chhhHHHHHHHHHHHHcC----------CCCCCC
Q 008759 472 DFGLAKATKLNDV------KSCRGTAFWMAPEVINNKNKGYG----LPADIWSLGCTVLEMLTS----------QIPYAP 531 (554)
Q Consensus 472 DFGlA~~~~~~~~------~s~~GT~~Y~APEvl~~~~~~~s----~ksDIwSLGvllyeLLTG----------~~PF~~ 531 (554)
|||+++....... ....||+.|+|||++.+...... .++|||||||++|+|+|| +.||..
T Consensus 185 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~ 264 (337)
T 3mdy_A 185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD 264 (337)
T ss_dssp CCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhh
Confidence 9999976433221 24579999999999965432211 249999999999999999 778865
Q ss_pred C
Q 008759 532 M 532 (554)
Q Consensus 532 ~ 532 (554)
.
T Consensus 265 ~ 265 (337)
T 3mdy_A 265 L 265 (337)
T ss_dssp T
T ss_pred h
Confidence 4
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=308.10 Aligned_cols=205 Identities=28% Similarity=0.542 Sum_probs=171.8
Q ss_pred ccceeeeeeeccCCceeEEEEec-CCCcEE--EEEEEecccccchhHHHHHHHHHHHHHHHhC-CCCceeeeeeeccCCC
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFF--AVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDES 403 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~-~~g~~v--AvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIVkl~~~~~~~~ 403 (554)
.++|++.+.||+|+||.||+|.+ .++..+ |+|.+.... .......+.+|+.++..+ +||||+++++++.+.+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 99 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA----SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 99 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC----------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc----chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC
Confidence 46899999999999999999998 566654 888876421 233345688999999999 8999999999999999
Q ss_pred cEEEEEeecccCchHHHHhhh-----------------cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCC
Q 008759 404 KLYIFLELVTKGSLLNLYQRY-----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG 466 (554)
Q Consensus 404 ~~~LVmE~~~ggsL~~ll~~~-----------------~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g 466 (554)
.+|+||||+.+++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 179 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC
Confidence 999999999999999998754 489999999999999999999999999999999999999999
Q ss_pred cEEEEecCcccccccC-CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHH
Q 008759 467 SVKLADFGLAKATKLN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAI 538 (554)
Q Consensus 467 ~vKL~DFGlA~~~~~~-~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i 538 (554)
.+||+|||+++..... ......+++.|+|||++.+.. ++.++|||||||++|+|++ |..||......+..
T Consensus 180 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~ 251 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY 251 (327)
T ss_dssp CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCE--ECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH
T ss_pred eEEEcccCcCccccccccccCCCCCccccChhhhcccc--CCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHH
Confidence 9999999998753322 223345788999999996543 7899999999999999998 99999887765443
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=307.30 Aligned_cols=198 Identities=34% Similarity=0.517 Sum_probs=171.2
Q ss_pred cceeeeeeeccCCceeEEEEec-----CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccC--
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS-----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD-- 401 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~-----~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~-- 401 (554)
++|++++.||+|+||+||++.. .+++.||+|++.... .......+.+|+.+++.++||||+++++++.+
T Consensus 31 r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (318)
T 3lxp_A 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA----GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG 106 (318)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC----CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred HHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc----ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCC
Confidence 3569999999999999988753 478999999987431 23445678899999999999999999999876
Q ss_pred CCcEEEEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccccc
Q 008759 402 ESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL 481 (554)
Q Consensus 402 ~~~~~LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~ 481 (554)
...+|+||||+.+++|.+++....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 186 (318)
T 3lxp_A 107 AASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186 (318)
T ss_dssp TTEEEEEECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred CceEEEEEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccccc
Confidence 46789999999999999999988899999999999999999999999999999999999999999999999999987544
Q ss_pred CC-----ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008759 482 ND-----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM 532 (554)
Q Consensus 482 ~~-----~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~ 532 (554)
.. .....+|+.|+|||++.+.. ++.++|||||||++|+|++|..||...
T Consensus 187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~ll~g~~p~~~~ 240 (318)
T 3lxp_A 187 GHEYYRVREDGDSPVFWYAPECLKEYK--FYYASDVWSFGVTLYELLTHCDSSQSP 240 (318)
T ss_dssp TCSEEEC---CCCCGGGCCHHHHHHCE--EEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred cccccccccCCCCCceeeChHHhcCCC--CCcHHHHHHHHHHHHHHHhCCCccccc
Confidence 32 23345888899999997644 788999999999999999999999754
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=317.20 Aligned_cols=199 Identities=31% Similarity=0.503 Sum_probs=156.6
Q ss_pred ccccceee-eeeeccCCceeEEEEecC---CCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeec--
Q 008759 326 RIITYWQK-GDLLGRGSFGSVYEGISD---DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTD-- 399 (554)
Q Consensus 326 ~~~~~y~i-~~~LG~GsfG~VY~a~~~---~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~-- 399 (554)
++.+.|.+ +++||+|+||+||+|.+. +++.||+|++..... ...+.+|+.+|+.++||||+++++++
T Consensus 17 ~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~E~~~l~~l~hpniv~~~~~~~~ 89 (405)
T 3rgf_A 17 RVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-------SMSACREIALLRELKHPNVISLQKVFLS 89 (405)
T ss_dssp CHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-------CHHHHHHHHHHHHCCCTTBCCCCEEEEE
T ss_pred hhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-------CHHHHHHHHHHHhcCCCCeeeEeeEEec
Confidence 45567777 668999999999999953 688999999864221 13467899999999999999999998
Q ss_pred cCCCcEEEEEeecccCchHHHHhhh----------cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEE----cCC
Q 008759 400 KDESKLYIFLELVTKGSLLNLYQRY----------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV----DAN 465 (554)
Q Consensus 400 ~~~~~~~LVmE~~~ggsL~~ll~~~----------~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILl----d~~ 465 (554)
.....+|+||||+.+ +|.+++... .+++..++.|+.||+.||.|||++||+||||||+|||| +.+
T Consensus 90 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~ 168 (405)
T 3rgf_A 90 HADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPER 168 (405)
T ss_dssp TTTTEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTT
T ss_pred CCCCeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCC
Confidence 457789999999986 677666432 38999999999999999999999999999999999999 677
Q ss_pred CcEEEEecCcccccccC-----CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008759 466 GSVKLADFGLAKATKLN-----DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME 533 (554)
Q Consensus 466 g~vKL~DFGlA~~~~~~-----~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e 533 (554)
+.+||+|||+++..... ......||+.|+|||++.+.. .++.++|||||||++|+|++|+.||....
T Consensus 169 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 169 GRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGAR-HYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp TCEEECCTTCCC----------------CCCTTCCHHHHTTCC-SCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred CcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCC-cccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence 89999999999765432 234567999999999996533 48899999999999999999999997653
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=297.71 Aligned_cols=204 Identities=26% Similarity=0.460 Sum_probs=169.5
Q ss_pred cceeeeeeeccCCceeEEEEec-C---CCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCc
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS-D---DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~-~---~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~ 404 (554)
-.|.++++||+|+||+||+|.+ . ++..+|+|.+... ......+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 96 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI----TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEG 96 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC----CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc----ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCC
Confidence 3678889999999999999986 2 2337999988642 223445778899999999999999999999977665
Q ss_pred E-EEEEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccccc
Q 008759 405 L-YIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL 481 (554)
Q Consensus 405 ~-~LVmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~ 481 (554)
. ++||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 97 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 97 LPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp CCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred CcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 5 999999999999999976 4588899999999999999999999999999999999999999999999999975432
Q ss_pred ------CCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcC-CCCCCCCChhHHH
Q 008759 482 ------NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTS-QIPYAPMECVSAI 538 (554)
Q Consensus 482 ------~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG-~~PF~~~e~~~~i 538 (554)
.......+|+.|+|||++.+. .++.++|||||||++|+|++| .+||...+..+..
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~ 238 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQTY--RFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLT 238 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTTC--CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHH
T ss_pred CcccccccCcCCCCCccccChhhhccC--CCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHH
Confidence 223345688999999999654 488999999999999999995 5555555554443
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=296.48 Aligned_cols=206 Identities=29% Similarity=0.461 Sum_probs=172.1
Q ss_pred ccccceeeeeeeccCCceeEEEEecC----CCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccC
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGISD----DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD 401 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~~----~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~ 401 (554)
...++|++.+.||+|+||.||+|.+. ++..||+|.+.... .....+.+.+|+.+++.++||||+++++++.+
T Consensus 9 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 84 (281)
T 3cc6_A 9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC----TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE 84 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS----CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS
T ss_pred ecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc----CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC
Confidence 44578999999999999999999862 23469999886422 23345678899999999999999999999865
Q ss_pred CCcEEEEEeecccCchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccc
Q 008759 402 ESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT 479 (554)
Q Consensus 402 ~~~~~LVmE~~~ggsL~~ll~~~--~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~ 479 (554)
+..|+||||+.+++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 85 -~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 85 -EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred -CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccc
Confidence 4568999999999999999764 4899999999999999999999999999999999999999999999999998765
Q ss_pred ccCC---ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHH
Q 008759 480 KLND---VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAI 538 (554)
Q Consensus 480 ~~~~---~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i 538 (554)
.... .....+|+.|+|||++.+. .++.++|||||||++|+|++ |+.||......+..
T Consensus 164 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~ 224 (281)
T 3cc6_A 164 EDEDYYKASVTRLPIKWMSPESINFR--RFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI 224 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHH
T ss_pred ccccccccccCCCCcceeCchhhccC--CCCchhccHHHHHHHHHHHhCCCCCcccCChHHHH
Confidence 4332 2334578899999999654 48899999999999999998 99999876655443
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-36 Score=299.19 Aligned_cols=207 Identities=27% Similarity=0.470 Sum_probs=170.4
Q ss_pred ccceeeeeeeccCCceeEEEEecCC----CcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeec-cCC
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGISDD----GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTD-KDE 402 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~~~----g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~-~~~ 402 (554)
...|++.+.||+|+||.||+|.+.+ ...+|+|.+... ......+.+.+|+.++++++||||+++++++ ...
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 99 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI----TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE 99 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC----CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC----CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCC
Confidence 4579999999999999999998632 336888887642 2234456788999999999999999999984 556
Q ss_pred CcEEEEEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccc
Q 008759 403 SKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK 480 (554)
Q Consensus 403 ~~~~LVmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~ 480 (554)
+..|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 100 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~ 179 (298)
T 3f66_A 100 GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 179 (298)
T ss_dssp SCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred CceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccccccc
Confidence 788999999999999999975 348889999999999999999999999999999999999999999999999997543
Q ss_pred cC------CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHHHH
Q 008759 481 LN------DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIFI 540 (554)
Q Consensus 481 ~~------~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i~~ 540 (554)
.. ......+|+.|+|||++.+. .++.++|||||||++|+|++ |.+||......+....
T Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~ 244 (298)
T 3f66_A 180 DKEYYSVHNKTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY 244 (298)
T ss_dssp CGGGCBC-----CCBCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHH
T ss_pred ccchhccccccCCCCCccccChHHhcCC--CCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHH
Confidence 22 22334578899999999654 38899999999999999999 6777776655544433
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=299.89 Aligned_cols=201 Identities=40% Similarity=0.665 Sum_probs=171.0
Q ss_pred cceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEE
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~L 407 (554)
..|....+||+|+||.||+|.+ .++..||+|.+.... ....+.+.+|+.+++.++||||+++++++...+.+++
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 96 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD-----SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKI 96 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC-----C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc-----hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEE
Confidence 3445556899999999999998 678999999987432 2234668899999999999999999999999999999
Q ss_pred EEeecccCchHHHHhhh----cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcC-CCcEEEEecCcccccccC
Q 008759 408 FLELVTKGSLLNLYQRY----HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA-NGSVKLADFGLAKATKLN 482 (554)
Q Consensus 408 VmE~~~ggsL~~ll~~~----~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~-~g~vKL~DFGlA~~~~~~ 482 (554)
||||+.+++|.+++... .+++..+..++.||+.||.|||++||+|+||||+|||++. ++.+||+|||++......
T Consensus 97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~ 176 (295)
T 2clq_A 97 FMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI 176 (295)
T ss_dssp EEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-
T ss_pred EEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCC
Confidence 99999999999998764 3568888999999999999999999999999999999987 899999999998765432
Q ss_pred --CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh
Q 008759 483 --DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC 534 (554)
Q Consensus 483 --~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~ 534 (554)
......||+.|+|||++.+....++.++|||||||++|+|++|+.||.....
T Consensus 177 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 230 (295)
T 2clq_A 177 NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE 230 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSS
T ss_pred CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCc
Confidence 2334569999999999976544578999999999999999999999986543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-36 Score=302.33 Aligned_cols=211 Identities=30% Similarity=0.499 Sum_probs=175.0
Q ss_pred ccccceeeeeeeccCCceeEEEEec--CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhC---CCCceeeeeeecc
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS--DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF---EHENIVQYYGTDK 400 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~--~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l---~HpnIVkl~~~~~ 400 (554)
...++|++.+.||+|+||.||+|.+ .+++.||+|++......... ...+.+|+.+++.+ +||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~---~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~ 84 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM---PLSTIREVAVLRHLETFEHPNVVRLFDVCT 84 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSC---BCTHHHHHHHHHHHHHTCCTTBCCEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccC---CchhhHHHHHHHhhhccCCCCeEeeeeeee
Confidence 4567899999999999999999998 46889999998753321111 12344566666555 8999999999886
Q ss_pred -----CCCcEEEEEeecccCchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEe
Q 008759 401 -----DESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLAD 472 (554)
Q Consensus 401 -----~~~~~~LVmE~~~ggsL~~ll~~~---~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~D 472 (554)
....+|+||||+. ++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 85 VSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp EEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECS
T ss_pred ecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEec
Confidence 5678999999998 5999988763 389999999999999999999999999999999999999999999999
Q ss_pred cCcccccccC-CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHH
Q 008759 473 FGLAKATKLN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKT 542 (554)
Q Consensus 473 FGlA~~~~~~-~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~ 542 (554)
||++...... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||......+.+..+.
T Consensus 164 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~ 232 (326)
T 1blx_A 164 FGLARIYSFQMALTSVVVTLWYRAPEVLLQS--SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL 232 (326)
T ss_dssp CCSCCCCCGGGGGCCCCCCCTTCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred CcccccccCCCCccccccccceeCHHHHhcC--CCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence 9998765432 23445689999999999654 48899999999999999999999999888776665554
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=299.97 Aligned_cols=202 Identities=34% Similarity=0.590 Sum_probs=164.8
Q ss_pred cccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcE
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL 405 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~ 405 (554)
..++|++.+.||+|+||.||+|.+ .+++.||+|++...... .......+.+|+.+++.++||||+++++++...+.+
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 107 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLM--DAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNEL 107 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhcc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcE
Confidence 456899999999999999999998 68999999998753222 234456788999999999999999999999999999
Q ss_pred EEEEeecccCchHHHHhh-----hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccc
Q 008759 406 YIFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK 480 (554)
Q Consensus 406 ~LVmE~~~ggsL~~ll~~-----~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~ 480 (554)
|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 999999999999998864 348899999999999999999999999999999999999999999999999987654
Q ss_pred cCC--ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008759 481 LND--VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM 532 (554)
Q Consensus 481 ~~~--~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~ 532 (554)
... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||...
T Consensus 188 ~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~ 239 (310)
T 2wqm_A 188 SKTTAAHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGD 239 (310)
T ss_dssp -----------CCSSCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred CCCccccccCCCeeEeChHHhCCC--CCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 322 2345689999999998654 4889999999999999999999999764
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=300.10 Aligned_cols=197 Identities=23% Similarity=0.327 Sum_probs=164.6
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeee-ccCCC
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGT-DKDES 403 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~-~~~~~ 403 (554)
.+.++|++++.||+|+||.||+|.+ .+++.||+|++..... ...+.+|+.++..++|++++..+.. +...+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~ 78 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-------HPQLHIESKIYKMMQGGVGIPTIRWCGAEGD 78 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETT
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-------chHHHHHHHHHHHhcCCCCCCeeeeecCCCC
Confidence 4567899999999999999999998 7899999998764222 1346789999999998876666554 46677
Q ss_pred cEEEEEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEE---cCCCcEEEEecCcccc
Q 008759 404 KLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKA 478 (554)
Q Consensus 404 ~~~LVmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILl---d~~g~vKL~DFGlA~~ 478 (554)
..|+||||+ +++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 79 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~ 157 (296)
T 4hgt_A 79 YNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred ceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence 899999999 8899999873 569999999999999999999999999999999999999 7889999999999976
Q ss_pred cccCC---------ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008759 479 TKLND---------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM 532 (554)
Q Consensus 479 ~~~~~---------~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~ 532 (554)
..... .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~g~~pf~~~ 218 (296)
T 4hgt_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIE--QSRRDDLESLGYVLMYFNLGSLPWQGL 218 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCC--CCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred ccCcccCccCCCCcccccCCCccccchHHhcCCC--CCchhHHHHHHHHHHHHhcCCCCCccc
Confidence 54322 23456999999999996543 889999999999999999999999864
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-36 Score=321.65 Aligned_cols=209 Identities=30% Similarity=0.464 Sum_probs=175.0
Q ss_pred ccccccceeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCC
Q 008759 324 FKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES 403 (554)
Q Consensus 324 ~~~~~~~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~ 403 (554)
+....++|++.+.||+|+||.||+|.+..+..||+|++..... ..+.+.+|+.+++.++||||+++++++.. .
T Consensus 179 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~ 251 (452)
T 1fmk_A 179 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM------SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E 251 (452)
T ss_dssp SBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS------CHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred cccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC------CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-C
Confidence 3345578999999999999999999998888899999874321 12468899999999999999999999876 6
Q ss_pred cEEEEEeecccCchHHHHhh---hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccc
Q 008759 404 KLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK 480 (554)
Q Consensus 404 ~~~LVmE~~~ggsL~~ll~~---~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~ 480 (554)
.+|+||||+.+|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 252 ~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 331 (452)
T 1fmk_A 252 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 331 (452)
T ss_dssp SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred ceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecC
Confidence 78999999999999999974 248999999999999999999999999999999999999999999999999998654
Q ss_pred cCCc---cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHHHHH
Q 008759 481 LNDV---KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIFIK 541 (554)
Q Consensus 481 ~~~~---~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i~~i 541 (554)
.... ....+|+.|+|||++... .++.++|||||||++|+|++ |+.||......+.+..+
T Consensus 332 ~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i 394 (452)
T 1fmk_A 332 DNEYTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 394 (452)
T ss_dssp -----------CCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH
T ss_pred CCceecccCCcccccccCHhHHhcC--CCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 3322 233467889999999754 48999999999999999999 99999988776655443
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-36 Score=326.04 Aligned_cols=207 Identities=27% Similarity=0.468 Sum_probs=178.9
Q ss_pred ccccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCC
Q 008759 324 FKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE 402 (554)
Q Consensus 324 ~~~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~ 402 (554)
+.....+|++.+.||+|+||.||+|.+ .++..||+|++..... ..+.+.+|+.+++.++||||+++++++...
T Consensus 215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 288 (495)
T 1opk_A 215 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM------EVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 288 (495)
T ss_dssp CBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc------chHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 334456899999999999999999998 4589999999864221 135688999999999999999999999999
Q ss_pred CcEEEEEeecccCchHHHHhh---hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccc
Q 008759 403 SKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT 479 (554)
Q Consensus 403 ~~~~LVmE~~~ggsL~~ll~~---~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~ 479 (554)
..+||||||+.+|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 289 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 368 (495)
T 1opk_A 289 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLM 368 (495)
T ss_dssp SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECC
T ss_pred CcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceec
Confidence 999999999999999999975 34889999999999999999999999999999999999999999999999999875
Q ss_pred ccCCc---cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHH
Q 008759 480 KLNDV---KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAI 538 (554)
Q Consensus 480 ~~~~~---~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i 538 (554)
..... ....+|+.|+|||++.... ++.++|||||||++|||++ |..||...+..+..
T Consensus 369 ~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~ 429 (495)
T 1opk_A 369 TGDTYTAHAGAKFPIKWTAPESLAYNK--FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 429 (495)
T ss_dssp TTCCEECCTTCCCCGGGCCHHHHHHCE--ECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred cCCceeecCCCcCCcceeCHhHHhcCC--CCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 44332 2334678899999997543 8899999999999999999 99999987765443
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=305.73 Aligned_cols=207 Identities=26% Similarity=0.453 Sum_probs=170.7
Q ss_pred ccceeeeeeeccCCceeEEEEecC-C----CcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCC
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGISD-D----GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE 402 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~~-~----g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~ 402 (554)
..+|.+.+.||+|+||.||+|.+. + +..||+|++.... .......+.+|+.++..++||||+++++++...
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 118 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY----TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 118 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC----CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC
Confidence 468999999999999999999873 2 2459999886422 223345788999999999999999999999999
Q ss_pred CcEEEEEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccc
Q 008759 403 SKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK 480 (554)
Q Consensus 403 ~~~~LVmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~ 480 (554)
+.+|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 119 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 119 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 198 (333)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred CCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence 999999999999999999875 458999999999999999999999999999999999999999999999999997654
Q ss_pred cCC-----ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHHHH
Q 008759 481 LND-----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIFI 540 (554)
Q Consensus 481 ~~~-----~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i~~ 540 (554)
... .....+|+.|+|||++.+. .++.++|||||||++|+|++ |+.||......+.+..
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~ 262 (333)
T 1mqb_A 199 DDPEATYTTSGGKIPIRWTAPEAISYR--KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKA 262 (333)
T ss_dssp ------------CCCGGGSCHHHHHSC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH
T ss_pred cccccccccCCCCccccccCchhcccC--CCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHH
Confidence 322 1123467889999999654 48899999999999999999 9999988776554433
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-36 Score=309.45 Aligned_cols=202 Identities=22% Similarity=0.313 Sum_probs=163.9
Q ss_pred cccceeeeeeeccCCceeEEEEecC----CCcEEEEEEEecccccchhH-H-----HHHHHHHHHHHHHhCCCCceeeee
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGISD----DGFFFAVKEVSLLDQGSQAK-Q-----SISQLEQEIALLSRFEHENIVQYY 396 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~~----~g~~vAvK~v~~~~~~~~~~-~-----~~~~~~~Ei~iL~~l~HpnIVkl~ 396 (554)
..++|++++.||+|+||.||+|.+. ++..+|+|++.......... . ....+.+|+.++..++||||++++
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~ 114 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY 114 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence 3468999999999999999999984 68899999987532211111 0 112356788999999999999999
Q ss_pred eeccC----CCcEEEEEeecccCchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCC--cEE
Q 008759 397 GTDKD----ESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG--SVK 469 (554)
Q Consensus 397 ~~~~~----~~~~~LVmE~~~ggsL~~ll~~~-~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g--~vK 469 (554)
+++.. ...+|+||||+ +++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+|
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~k 193 (345)
T 2v62_A 115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVY 193 (345)
T ss_dssp EEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEE
T ss_pred cccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEE
Confidence 99877 77899999999 88999998764 689999999999999999999999999999999999999887 999
Q ss_pred EEecCcccccccC---------CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008759 470 LADFGLAKATKLN---------DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP 531 (554)
Q Consensus 470 L~DFGlA~~~~~~---------~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~ 531 (554)
|+|||+++..... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||..
T Consensus 194 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~g~~pf~~ 262 (345)
T 2v62_A 194 LADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV--ALSRRSDVEILGYCMLRWLCGKLPWEQ 262 (345)
T ss_dssp ECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTC--CCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred EEeCCCceecccccccccchhccccccCCCccccCHHHhcCC--CCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 9999999764321 11345699999999999754 489999999999999999999999965
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=307.91 Aligned_cols=198 Identities=28% Similarity=0.403 Sum_probs=161.1
Q ss_pred cccceeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeec-----cC
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTD-----KD 401 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~-----~~ 401 (554)
..++|++++.||+|+||.||+|.+ +++.||+|++.... .. ......|+..+..++|+||+++++.+ ..
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~-----~~-~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 83 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN-----RQ-NFINEKNIYRVPLMEHDNIARFIVGDERVTADG 83 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG-----HH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTS
T ss_pred ChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc-----hh-hHHHHHHHHHHHhccCcchhhheecccccccCC
Confidence 357899999999999999999976 68899999986421 11 11122344445568999999999743 33
Q ss_pred CCcEEEEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHC---------CccccCCccccEEEcCCCcEEEEe
Q 008759 402 ESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ---------DVVHRDIKCANILVDANGSVKLAD 472 (554)
Q Consensus 402 ~~~~~LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~---------gIIHrDIKPeNILld~~g~vKL~D 472 (554)
...+|+||||+.+|+|.+++....+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|
T Consensus 84 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D 163 (336)
T 3g2f_A 84 RMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD 163 (336)
T ss_dssp CEEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred CceEEEEEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEee
Confidence 44689999999999999999988889999999999999999999999 999999999999999999999999
Q ss_pred cCcccccccC----------CccCccCCCcccChhhhcccC-----CCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008759 473 FGLAKATKLN----------DVKSCRGTAFWMAPEVINNKN-----KGYGLPADIWSLGCTVLEMLTSQIPYAP 531 (554)
Q Consensus 473 FGlA~~~~~~----------~~~s~~GT~~Y~APEvl~~~~-----~~~s~ksDIwSLGvllyeLLTG~~PF~~ 531 (554)
||+++..... ......||+.|+|||++.+.. ..++.++|||||||++|+|++|..||..
T Consensus 164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~ 237 (336)
T 3g2f_A 164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP 237 (336)
T ss_dssp CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGST
T ss_pred ccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCC
Confidence 9999765322 122446999999999996521 1256789999999999999999877754
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-36 Score=297.97 Aligned_cols=197 Identities=32% Similarity=0.590 Sum_probs=164.1
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccC---
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD--- 401 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~--- 401 (554)
++.++|++++.||+|+||.||+|.+ .+++.||+|++.. .......+.+|+.+++.++||||+++++++.+
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 76 (303)
T 1zy4_A 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH------TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRN 76 (303)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE------EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCC
T ss_pred cccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec------cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcc
Confidence 3567899999999999999999998 6899999999863 12345678899999999999999999997643
Q ss_pred ----------CCcEEEEEeecccCchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEE
Q 008759 402 ----------ESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVK 469 (554)
Q Consensus 402 ----------~~~~~LVmE~~~ggsL~~ll~~~--~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vK 469 (554)
...+|+||||+.+++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus 77 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~k 156 (303)
T 1zy4_A 77 FVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVK 156 (303)
T ss_dssp CCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEE
T ss_pred hhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEE
Confidence 45789999999999999999753 477889999999999999999999999999999999999999999
Q ss_pred EEecCccccccc----------------CCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008759 470 LADFGLAKATKL----------------NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM 532 (554)
Q Consensus 470 L~DFGlA~~~~~----------------~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~ 532 (554)
|+|||++..... .......||+.|+|||++.+.. .++.++|||||||++|+|++ ||...
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Di~slG~il~~l~~---p~~~~ 231 (303)
T 1zy4_A 157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTG-HYNEKIDMYSLGIIFFEMIY---PFSTG 231 (303)
T ss_dssp ECCCCCCSCTTC-------------------------CTTSCHHHHTSCS-CCCTHHHHHHHHHHHHHHHS---CCSSH
T ss_pred EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCC-CCcchhhHHHHHHHHHHHHh---ccCCc
Confidence 999999876432 1223456899999999996542 47899999999999999998 66543
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-36 Score=305.05 Aligned_cols=208 Identities=26% Similarity=0.416 Sum_probs=172.4
Q ss_pred cccceeeeeeeccCCceeEEEEec------CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeecc
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK 400 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~------~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~ 400 (554)
..++|++++.||+|+||.||+|.+ .++..||+|++.... .......+.+|+.+++.++||||+++++++.
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 103 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC----SEQDELDFLMEALIISKFNHQNIVRCIGVSL 103 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC----CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc----chhhHHHHHHHHHHHhhCCCCCCCeEEEEEc
Confidence 457899999999999999999984 467899999986321 2334467889999999999999999999999
Q ss_pred CCCcEEEEEeecccCchHHHHhhh--------cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCC---CcEE
Q 008759 401 DESKLYIFLELVTKGSLLNLYQRY--------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN---GSVK 469 (554)
Q Consensus 401 ~~~~~~LVmE~~~ggsL~~ll~~~--------~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~---g~vK 469 (554)
....+|+||||+.+++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.+ ..+|
T Consensus 104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEE
Confidence 999999999999999999999764 38888999999999999999999999999999999999844 4699
Q ss_pred EEecCcccccccCC----ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHHHH
Q 008759 470 LADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIFI 540 (554)
Q Consensus 470 L~DFGlA~~~~~~~----~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i~~ 540 (554)
|+|||++....... .....+|+.|+|||++.+. .++.++|||||||++|+|+| |+.||......+.+..
T Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~ 257 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF 257 (327)
T ss_dssp ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH
T ss_pred ECccccccccccccccccCCCcCCCcceeCHhHhcCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHH
Confidence 99999987543221 2234578999999999654 38899999999999999998 9999988766554433
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=295.82 Aligned_cols=197 Identities=23% Similarity=0.328 Sum_probs=168.7
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeee-ccCCC
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGT-DKDES 403 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~-~~~~~ 403 (554)
.+.++|++++.||+|+||.||+|.+ .+++.||+|++...... ..+.+|+.++..++|++++..+.. +....
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~ 78 (296)
T 3uzp_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-------PQLHIESKIYKMMQGGVGIPTIRWCGAEGD 78 (296)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC-------CHHHHHHHHHHHHTTSTTCCCEEEEEEETT
T ss_pred eeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch-------hHHHHHHHHHHHhhcCCCCCccccccCCCC
Confidence 4567899999999999999999998 78999999998753321 247789999999998876655554 46677
Q ss_pred cEEEEEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEE---cCCCcEEEEecCcccc
Q 008759 404 KLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKA 478 (554)
Q Consensus 404 ~~~LVmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILl---d~~g~vKL~DFGlA~~ 478 (554)
..|+||||+ +++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 79 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 157 (296)
T 3uzp_A 79 YNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred ceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence 889999999 8899999873 469999999999999999999999999999999999999 4889999999999976
Q ss_pred cccCC---------ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008759 479 TKLND---------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM 532 (554)
Q Consensus 479 ~~~~~---------~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~ 532 (554)
..... .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~g~~pf~~~ 218 (296)
T 3uzp_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIE--QSRRDDLESLGYVLMYFNLGSLPWQGL 218 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCC--CCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred ccccccccccccccccccccccccCChhhhcCCC--CCcchhhHHHHHHHHHHHhCCCCCCCc
Confidence 54332 24456999999999996544 889999999999999999999999864
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=301.18 Aligned_cols=210 Identities=27% Similarity=0.447 Sum_probs=167.5
Q ss_pred ccccceeeeeeeccCCceeEEEEecC----CCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccC
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGISD----DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD 401 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~~----~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~ 401 (554)
...++|.+++.||+|+||.||+|.+. ++..||+|++..... .......+.+|+.++..++||||+++++++..
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 107 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS---SQREIEEFLSEAACMKDFSHPNVIRLLGVCIE 107 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC---CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc---chhHHHHHHHHHHHHhcCCCCCeeeeeEEEee
Confidence 34578999999999999999999762 456899999864322 23345678899999999999999999999876
Q ss_pred CC-----cEEEEEeecccCchHHHHhh-------hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEE
Q 008759 402 ES-----KLYIFLELVTKGSLLNLYQR-------YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVK 469 (554)
Q Consensus 402 ~~-----~~~LVmE~~~ggsL~~ll~~-------~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vK 469 (554)
.. ..|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus 108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~k 187 (313)
T 3brb_A 108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVC 187 (313)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEE
T ss_pred ccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEE
Confidence 54 45999999999999998842 3488999999999999999999999999999999999999999999
Q ss_pred EEecCcccccccCC----ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHHHH
Q 008759 470 LADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIFI 540 (554)
Q Consensus 470 L~DFGlA~~~~~~~----~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i~~ 540 (554)
|+|||+++...... .....+++.|+|||++.+. .++.++|||||||++|+|++ |..||......+....
T Consensus 188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 261 (313)
T 3brb_A 188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADR--VYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDY 261 (313)
T ss_dssp ECSCSCC----------------CCGGGSCHHHHHSS--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH
T ss_pred EeecCcceecccccccCcccccCCCccccCchhhcCC--CccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHH
Confidence 99999987654322 2234578899999999654 48899999999999999999 9999988766554433
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-36 Score=302.62 Aligned_cols=202 Identities=26% Similarity=0.424 Sum_probs=154.3
Q ss_pred cccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCC-CCceeeeeeec-----
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTD----- 399 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIVkl~~~~----- 399 (554)
...+|++.++||+|+||.||+|.+ .+++.||+|++... .......+.+|+.++..+. ||||+++++++
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 100 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN-----EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKE 100 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES-----SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTT
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC-----chHHHHHHHHHHHHHHHhccCCChhhcccccccccc
Confidence 345899999999999999999998 68999999988532 2334567889999999996 99999999987
Q ss_pred ---cCCCcEEEEEeecccCchHHHHhh----hcCChHHHHHHHHHHHHHHHHHHHCC--ccccCCccccEEEcCCCcEEE
Q 008759 400 ---KDESKLYIFLELVTKGSLLNLYQR----YHLRDSQVSAYTRQILLGLKYLHDQD--VVHRDIKCANILVDANGSVKL 470 (554)
Q Consensus 400 ---~~~~~~~LVmE~~~ggsL~~ll~~----~~l~e~~i~~i~~QIl~gL~yLHs~g--IIHrDIKPeNILld~~g~vKL 470 (554)
.....+|+||||+. |+|.+++.. ..+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||
T Consensus 101 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl 179 (337)
T 3ll6_A 101 ESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKL 179 (337)
T ss_dssp TSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEB
T ss_pred ccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEE
Confidence 34456899999997 588887754 35899999999999999999999999 999999999999999999999
Q ss_pred EecCcccccccCCc--------------cCccCCCcccChhhhcc-cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh
Q 008759 471 ADFGLAKATKLNDV--------------KSCRGTAFWMAPEVINN-KNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC 534 (554)
Q Consensus 471 ~DFGlA~~~~~~~~--------------~s~~GT~~Y~APEvl~~-~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~ 534 (554)
+|||+++....... ....||+.|+|||++.. ....++.++|||||||++|+|++|+.||.....
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~ 258 (337)
T 3ll6_A 180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK 258 (337)
T ss_dssp CCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred ecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH
Confidence 99999976543211 13458999999999842 233478899999999999999999999976543
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=298.27 Aligned_cols=195 Identities=29% Similarity=0.505 Sum_probs=170.2
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccC---
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD--- 401 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~--- 401 (554)
.+..+|++++.||+|+||.||+|.+ .+++.||+|++.... ..+.+|+.++..++||||+++++++..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 78 (284)
T 2a19_B 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---------EKAEREVKALAKLDHVNIVHYNGCWDGFDY 78 (284)
T ss_dssp HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEE
T ss_pred hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---------HHHHHHHHHHHhCCCCCEEEEeeeEecccc
Confidence 4567899999999999999999998 589999999987532 235689999999999999999998743
Q ss_pred -------------CCcEEEEEeecccCchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCC
Q 008759 402 -------------ESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN 465 (554)
Q Consensus 402 -------------~~~~~LVmE~~~ggsL~~ll~~~---~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~ 465 (554)
...+|+||||+.+++|.+++... .+++..+..++.||+.||.|||++||+|+||||+|||++.+
T Consensus 79 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~ 158 (284)
T 2a19_B 79 DPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDT 158 (284)
T ss_dssp C---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET
T ss_pred CcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCC
Confidence 44589999999999999999653 58999999999999999999999999999999999999999
Q ss_pred CcEEEEecCcccccccC-CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008759 466 GSVKLADFGLAKATKLN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP 531 (554)
Q Consensus 466 g~vKL~DFGlA~~~~~~-~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~ 531 (554)
+.+||+|||++...... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||..
T Consensus 159 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~~~~~~~ 223 (284)
T 2a19_B 159 KQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQ--DYGKEVDLYALGLILAELLHVCDTAFE 223 (284)
T ss_dssp TEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCS--CCCTHHHHHHHHHHHHHHHSCCSSHHH
T ss_pred CCEEECcchhheeccccccccccCCcccccChhhhccC--CCcchhhhHHHHHHHHHHHhcCCcchh
Confidence 99999999998765433 23445699999999999654 478999999999999999999998853
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-36 Score=296.79 Aligned_cols=202 Identities=26% Similarity=0.474 Sum_probs=166.6
Q ss_pred ccccceeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccC-CCc
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD-ESK 404 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~-~~~ 404 (554)
...++|++.+.||+|+||+||++.+. ++.||+|++.... ..+.+.+|+.++..++||||+++++++.. .+.
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~-------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (278)
T 1byg_A 18 LNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 89 (278)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC---------HHHHHTHHHHTTCCCTTBCCEEEEECCC--C
T ss_pred CChhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh-------HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCc
Confidence 44678999999999999999999875 7899999886321 23568899999999999999999998654 457
Q ss_pred EEEEEeecccCchHHHHhhhc---CChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccccc
Q 008759 405 LYIFLELVTKGSLLNLYQRYH---LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL 481 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~~~---l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~ 481 (554)
+|+||||+.+++|.+++.... +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 90 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred eEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 999999999999999987643 88999999999999999999999999999999999999999999999999875543
Q ss_pred CCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHH
Q 008759 482 NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAI 538 (554)
Q Consensus 482 ~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i 538 (554)
. .....+++.|+|||++.+. .++.++|||||||++|+|++ |+.||......+..
T Consensus 170 ~-~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~ 224 (278)
T 1byg_A 170 T-QDTGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV 224 (278)
T ss_dssp -------CCTTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHH
T ss_pred c-ccCCCccccccCHHHhCCC--CCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 2 2234578999999999654 48899999999999999998 99999887655443
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-36 Score=307.78 Aligned_cols=209 Identities=28% Similarity=0.466 Sum_probs=175.3
Q ss_pred cccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCc-
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK- 404 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~- 404 (554)
+.++|.+.+.||+|+||.||+|.+ .+|+.||+|++.... ........+.+|+.+++.++||||+++++++.....
T Consensus 22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 98 (353)
T 3coi_A 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF---QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSL 98 (353)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT---SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSG
T ss_pred cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc---cchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccc
Confidence 457899999999999999999998 679999999986432 223345678899999999999999999999877654
Q ss_pred -----EEEEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccc
Q 008759 405 -----LYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT 479 (554)
Q Consensus 405 -----~~LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~ 479 (554)
+|+||||+.+ +|..++.. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 99 ~~~~~~~lv~e~~~~-~l~~~~~~-~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 176 (353)
T 3coi_A 99 RNFYDFYLVMPFMQT-DLQKIMGL-KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHA 176 (353)
T ss_dssp GGCCCCEEEEECCSE-EGGGTTTS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC-
T ss_pred ccceeEEEEeccccC-CHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCC
Confidence 5999999985 88777643 5899999999999999999999999999999999999999999999999998765
Q ss_pred ccCCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHH
Q 008759 480 KLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKT 542 (554)
Q Consensus 480 ~~~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~ 542 (554)
... .....+|+.|+|||++.+. ..++.++|||||||++|+|++|+.||......+.+..+.
T Consensus 177 ~~~-~~~~~~t~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~ 237 (353)
T 3coi_A 177 DAE-MTGYVVTRWYRAPEVILSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQIL 237 (353)
T ss_dssp --------CCSBCCSCHHHHSCC-SCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHH
T ss_pred CCC-ccccccCcCcCCHHHHhCc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 432 3445689999999998653 247889999999999999999999999988766655544
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-36 Score=301.33 Aligned_cols=198 Identities=30% Similarity=0.481 Sum_probs=170.2
Q ss_pred eeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEEEe
Q 008759 331 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLE 410 (554)
Q Consensus 331 y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LVmE 410 (554)
|..++.||+|+||.||+|.+ ++..||+|++...... ......+.+.+|+.+++.++||||+++++++...+.+|+|||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 110 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDI-TTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV 110 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTS-CTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cccCCccccCCCeEEEEEEE-CCceEEEEEEecccCc-chHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence 45568999999999999987 5789999998643221 122345678899999999999999999999999999999999
Q ss_pred ecccCchHHHHhh----hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC---
Q 008759 411 LVTKGSLLNLYQR----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--- 483 (554)
Q Consensus 411 ~~~ggsL~~ll~~----~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~--- 483 (554)
|+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 190 (307)
T 2nru_A 111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190 (307)
T ss_dssp CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCE
T ss_pred ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccc
Confidence 9999999999864 248899999999999999999999999999999999999999999999999987654321
Q ss_pred -ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008759 484 -VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME 533 (554)
Q Consensus 484 -~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e 533 (554)
.....||+.|+|||++.+. ++.++|||||||++|+|++|..||....
T Consensus 191 ~~~~~~g~~~y~aPE~~~~~---~~~~~Dv~slG~il~~l~~g~~p~~~~~ 238 (307)
T 2nru_A 191 MTSRIVGTTAYMAPEALRGE---ITPKSDIYSFGVVLLEIITGLPAVDEHR 238 (307)
T ss_dssp ECSSCCSCGGGCCHHHHTTE---ECTHHHHHHHHHHHHHHHHCCCSBCTTB
T ss_pred cccccCCCcCcCChHHhcCC---CCccchhHHHHHHHHHHHHCCCCcccCc
Confidence 2334689999999998643 6889999999999999999999998654
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=313.11 Aligned_cols=201 Identities=13% Similarity=0.154 Sum_probs=153.4
Q ss_pred ccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhC--CCCceeeeeeecc----
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF--EHENIVQYYGTDK---- 400 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l--~HpnIVkl~~~~~---- 400 (554)
...|++++.||+|+||.||+|.+ .+++.||+|++...... .......+.+|+.++..+ +||||++++..+.
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d 138 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAEN--SRSELERLHEATFAAARLLGESPEEARDRRRLLLPSD 138 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTT--HHHHHHHHHHHHHHHHHHHC----------CBCCCCE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccc--cccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeeh
Confidence 34699999999999999999998 68999999999864321 234455677785444444 6999888664332
Q ss_pred ---CC-----------------CcEEEEEeecccCchHHHHhhh--cCChHHH------HHHHHHHHHHHHHHHHCCccc
Q 008759 401 ---DE-----------------SKLYIFLELVTKGSLLNLYQRY--HLRDSQV------SAYTRQILLGLKYLHDQDVVH 452 (554)
Q Consensus 401 ---~~-----------------~~~~LVmE~~~ggsL~~ll~~~--~l~e~~i------~~i~~QIl~gL~yLHs~gIIH 452 (554)
.. ..+||||||+. ++|.+++... .+....+ ..++.||+.||.|||++||+|
T Consensus 139 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivH 217 (371)
T 3q60_A 139 AVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVH 217 (371)
T ss_dssp EEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred heecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCcc
Confidence 11 34899999999 7999999753 3555555 577799999999999999999
Q ss_pred cCCccccEEEcCCCcEEEEecCcccccccCCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008759 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM 532 (554)
Q Consensus 453 rDIKPeNILld~~g~vKL~DFGlA~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~ 532 (554)
|||||+|||++.+|.+||+|||+++...... ....+|+.|+|||++.+....++.++|||||||++|+|++|+.||...
T Consensus 218 rDikp~NIll~~~~~~kL~DFG~a~~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~ 296 (371)
T 3q60_A 218 GHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV 296 (371)
T ss_dssp TTCSGGGEEECTTSCEEECCGGGEEETTCEE-EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBC
T ss_pred CcCCHHHEEECCCCCEEEEecceeeecCCCc-cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 9999999999999999999999998654322 144577999999999653345899999999999999999999999866
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=302.32 Aligned_cols=206 Identities=24% Similarity=0.380 Sum_probs=172.4
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCC-cEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCc------eeeeee
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDG-FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN------IVQYYG 397 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g-~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hpn------IVkl~~ 397 (554)
.+.++|++.+.||+|+||+||+|.+ .++ ..||+|++... ......+.+|+.+++.++|++ ++.+++
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~------~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~ 89 (355)
T 2eu9_A 16 WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV------GKYREAARLEINVLKKIKEKDKENKFLCVLMSD 89 (355)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC------HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEE
T ss_pred eecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc------ccchhHHHHHHHHHHHHhhcCCCCceeEEEeee
Confidence 4567999999999999999999998 444 78999998631 233456778999998887655 899999
Q ss_pred eccCCCcEEEEEeecccCchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEE------------
Q 008759 398 TDKDESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV------------ 462 (554)
Q Consensus 398 ~~~~~~~~~LVmE~~~ggsL~~ll~~~---~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILl------------ 462 (554)
++...+.+|+||||+.+ +|.+++... .+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 90 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~ 168 (355)
T 2eu9_A 90 WFNFHGHMCIAFELLGK-NTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEH 168 (355)
T ss_dssp EEEETTEEEEEEECCCC-BHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC
T ss_pred eeeeCCeEEEEEeccCC-ChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccc
Confidence 99999999999999955 555555443 58999999999999999999999999999999999999
Q ss_pred -------cCCCcEEEEecCcccccccCCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChh
Q 008759 463 -------DANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECV 535 (554)
Q Consensus 463 -------d~~g~vKL~DFGlA~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~ 535 (554)
+.++.+||+|||+++.... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||......
T Consensus 169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~-~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 245 (355)
T 2eu9_A 169 KSCEEKSVKNTSIRVADFGSATFDHE-HHTTIVATRHYRPPEVILEL--GWAQPCDVWSIGCILFEYYRGFTLFQTHENR 245 (355)
T ss_dssp -CCCEEEESCCCEEECCCTTCEETTS-CCCSSCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ccccccccCCCcEEEeecCccccccc-cccCCcCCCcccCCeeeecC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence 5678999999999976443 33456799999999999654 4889999999999999999999999988776
Q ss_pred HHHHHH
Q 008759 536 SAIFIK 541 (554)
Q Consensus 536 ~~i~~i 541 (554)
+.+..+
T Consensus 246 ~~~~~~ 251 (355)
T 2eu9_A 246 EHLVMM 251 (355)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 654443
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-36 Score=304.07 Aligned_cols=198 Identities=31% Similarity=0.519 Sum_probs=172.0
Q ss_pred ccceeeeeeeccCCceeEEEEe----c-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeecc--
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGI----S-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK-- 400 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~----~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~-- 400 (554)
.++|++++.||+|+||.||+|. + .++..||+|++... .....+.+.+|+.+++.++|+||+++++++.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 96 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS-----GPDQQRDFQREIQILKALHSDFIVKYRGVSYGP 96 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC-----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC-----CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecC
Confidence 3589999999999999999998 3 67899999998742 2334567889999999999999999999875
Q ss_pred CCCcEEEEEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccc
Q 008759 401 DESKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA 478 (554)
Q Consensus 401 ~~~~~~LVmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~ 478 (554)
....+|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 97 GRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp SSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred CCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEccccccee
Confidence 55679999999999999999976 3589999999999999999999999999999999999999999999999999976
Q ss_pred cccCC-----ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008759 479 TKLND-----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM 532 (554)
Q Consensus 479 ~~~~~-----~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~ 532 (554)
..... .....+|+.|+|||++.+.. ++.++|||||||++|+|++|+.||...
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~ll~g~~p~~~~ 233 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESLSDNI--FSRQSDVWSFGVVLYELFTYCDKSCSP 233 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHHHHCE--EEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred cccCCccceeeccCCccccccCHHHhccCC--CChHHhHHHHHHHHHHHHhCCCCCccc
Confidence 54332 23345888899999996643 788999999999999999999999654
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-36 Score=302.96 Aligned_cols=200 Identities=26% Similarity=0.385 Sum_probs=168.9
Q ss_pred cccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeecc----C
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK----D 401 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~----~ 401 (554)
..++|++++.||+|+||.||+|.+ .+++.||+|++... .......+.+|+.+++.++||||+++++++. .
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 101 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH-----EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGA 101 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES-----SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETT
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC-----CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCC
Confidence 346899999999999999999998 78999999988642 2344567889999999999999999999886 3
Q ss_pred CCcEEEEEeecccCchHHHHhh-----hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcc
Q 008759 402 ESKLYIFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA 476 (554)
Q Consensus 402 ~~~~~LVmE~~~ggsL~~ll~~-----~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA 476 (554)
...+|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 102 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 102 KHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred CceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence 4578999999999999998875 45899999999999999999999999999999999999999999999999988
Q ss_pred cccccCC-----------ccCccCCCcccChhhhcccC-CCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008759 477 KATKLND-----------VKSCRGTAFWMAPEVINNKN-KGYGLPADIWSLGCTVLEMLTSQIPYAP 531 (554)
Q Consensus 477 ~~~~~~~-----------~~s~~GT~~Y~APEvl~~~~-~~~s~ksDIwSLGvllyeLLTG~~PF~~ 531 (554)
....... .....||+.|+|||++.... ..++.++|||||||++|+|++|+.||..
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 248 (317)
T 2buj_A 182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248 (317)
T ss_dssp EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhh
Confidence 6543211 11234799999999986432 1267899999999999999999999953
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=297.51 Aligned_cols=207 Identities=27% Similarity=0.453 Sum_probs=172.9
Q ss_pred ccceeeee-eeccCCceeEEEEec---CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCC
Q 008759 328 ITYWQKGD-LLGRGSFGSVYEGIS---DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES 403 (554)
Q Consensus 328 ~~~y~i~~-~LG~GsfG~VY~a~~---~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~ 403 (554)
.++|++.+ .||+|+||.||+|.+ .+++.||+|++..... .....+.+.+|+.++..++||||+++++++ ..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~ 90 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN---DPALKDELLAEANVMQQLDNPYIVRMIGIC-EAE 90 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC--------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESS
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc---CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCC
Confidence 46788888 999999999999954 4578999999874321 223356788999999999999999999998 567
Q ss_pred cEEEEEeecccCchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC
Q 008759 404 KLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN 482 (554)
Q Consensus 404 ~~~LVmE~~~ggsL~~ll~~~-~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~ 482 (554)
.+|+||||+.+++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 91 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (291)
T 1xbb_A 91 SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 170 (291)
T ss_dssp SEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred CcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccC
Confidence 789999999999999999764 5899999999999999999999999999999999999999999999999999765433
Q ss_pred C-----ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHHHH
Q 008759 483 D-----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIFI 540 (554)
Q Consensus 483 ~-----~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i~~ 540 (554)
. .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |+.||......+....
T Consensus 171 ~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~ 232 (291)
T 1xbb_A 171 ENYYKAQTHGKWPVKWYAPECINYYK--FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM 232 (291)
T ss_dssp CSEEEC----CCCGGGCCHHHHHHCE--EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH
T ss_pred CCcccccccCCCCceeeChHHhccCC--CChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 2 12234678899999996543 7889999999999999999 9999998776554433
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-36 Score=306.63 Aligned_cols=207 Identities=26% Similarity=0.467 Sum_probs=178.5
Q ss_pred ccccceeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchh------------HHHHHHHHHHHHHHHhCCCCcee
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQA------------KQSISQLEQEIALLSRFEHENIV 393 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~------------~~~~~~~~~Ei~iL~~l~HpnIV 393 (554)
...++|++++.||+|+||.||+|.+ +++.||+|++......... ......+.+|+.++..++||||+
T Consensus 28 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 106 (348)
T 2pml_X 28 KYINDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCL 106 (348)
T ss_dssp EEETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBC
T ss_pred cccCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcc
Confidence 3467999999999999999999999 8999999998742211100 01125788999999999999999
Q ss_pred eeeeeccCCCcEEEEEeecccCchHHH------Hhh---hcCChHHHHHHHHHHHHHHHHHHH-CCccccCCccccEEEc
Q 008759 394 QYYGTDKDESKLYIFLELVTKGSLLNL------YQR---YHLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVD 463 (554)
Q Consensus 394 kl~~~~~~~~~~~LVmE~~~ggsL~~l------l~~---~~l~e~~i~~i~~QIl~gL~yLHs-~gIIHrDIKPeNILld 463 (554)
++++++.+.+.+|+||||+.+++|.++ +.. ..+++..+..++.||+.||.|||+ +||+||||||+|||++
T Consensus 107 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~ 186 (348)
T 2pml_X 107 TCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMD 186 (348)
T ss_dssp CCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEEC
T ss_pred eEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEc
Confidence 999999999999999999999999988 543 468999999999999999999999 9999999999999999
Q ss_pred CCCcEEEEecCcccccccCCccCccCCCcccChhhhcccCCCCCc-hhhHHHHHHHHHHHHcCCCCCCCCCh
Q 008759 464 ANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGL-PADIWSLGCTVLEMLTSQIPYAPMEC 534 (554)
Q Consensus 464 ~~g~vKL~DFGlA~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~s~-ksDIwSLGvllyeLLTG~~PF~~~e~ 534 (554)
.++.+||+|||++............||+.|+|||++.+.. .++. ++|||||||++|+|++|+.||.....
T Consensus 187 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 257 (348)
T 2pml_X 187 KNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNES-SYNGAKVDIWSLGICLYVMFYNVVPFSLKIS 257 (348)
T ss_dssp TTSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCC-CEEHHHHHHHHHHHHHHHHHHSSCSSCCSSC
T ss_pred CCCcEEEeccccccccccccccCCCCCcCccCchhhcCCC-CCCcchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 9999999999999876555555667999999999996542 3555 89999999999999999999987765
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-36 Score=309.96 Aligned_cols=193 Identities=21% Similarity=0.290 Sum_probs=165.3
Q ss_pred ccceeeeeeeccCCceeEEEEecC---------CCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceee----
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGISD---------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQ---- 394 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~~---------~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVk---- 394 (554)
.++|++++.||+|+||.||+|.+. +++.||+|++... ..+.+|+.++..++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----------~~~~~E~~~l~~l~h~niv~~~~~ 110 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----------GRLFNEQNFFQRAAKPLQVNKWKK 110 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----------STHHHHHHHHHHHCCHHHHHHHHH
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----------chHHHHHHHHHHhcccchhhhhhh
Confidence 478999999999999999999984 3899999998742 24678999999999999988
Q ss_pred -----------eeeeccC-CCcEEEEEeecccCchHHHHhh---hcCChHHHHHHHHHHHHHHHHHHHCCccccCCcccc
Q 008759 395 -----------YYGTDKD-ESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCAN 459 (554)
Q Consensus 395 -----------l~~~~~~-~~~~~LVmE~~~ggsL~~ll~~---~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeN 459 (554)
+++++.. ...+|+||||+ +++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|
T Consensus 111 ~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~N 189 (352)
T 2jii_A 111 LYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAEN 189 (352)
T ss_dssp HTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGG
T ss_pred hccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHH
Confidence 4555544 67899999999 8999999986 469999999999999999999999999999999999
Q ss_pred EEEcCCC--cEEEEecCcccccccC---------CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCC
Q 008759 460 ILVDANG--SVKLADFGLAKATKLN---------DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIP 528 (554)
Q Consensus 460 ILld~~g--~vKL~DFGlA~~~~~~---------~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~P 528 (554)
||++.++ .+||+|||+++..... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.|
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~p 267 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGC--GPSRRSDLQSLGYCMLKWLYGFLP 267 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSCCT
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCC
Confidence 9999998 9999999999764322 11334699999999999654 488999999999999999999999
Q ss_pred CCCCC
Q 008759 529 YAPME 533 (554)
Q Consensus 529 F~~~e 533 (554)
|....
T Consensus 268 f~~~~ 272 (352)
T 2jii_A 268 WTNCL 272 (352)
T ss_dssp TGGGT
T ss_pred cccCC
Confidence 98764
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=299.98 Aligned_cols=193 Identities=29% Similarity=0.513 Sum_probs=161.2
Q ss_pred ccceeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEE
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~L 407 (554)
.++|++.+.||+|+||.||+|.+. ++.||+|.+.. ....+.+.+|+.+++.++||||+++++++.+ ..|+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~-------~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~l 76 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIES-------ESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCL 76 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSS-------TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEE
T ss_pred HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecC-------hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEE
Confidence 468999999999999999999875 67899998753 1224578899999999999999999998874 4899
Q ss_pred EEeecccCchHHHHhhh----cCChHHHHHHHHHHHHHHHHHHH---CCccccCCccccEEEcCCCc-EEEEecCccccc
Q 008759 408 FLELVTKGSLLNLYQRY----HLRDSQVSAYTRQILLGLKYLHD---QDVVHRDIKCANILVDANGS-VKLADFGLAKAT 479 (554)
Q Consensus 408 VmE~~~ggsL~~ll~~~----~l~e~~i~~i~~QIl~gL~yLHs---~gIIHrDIKPeNILld~~g~-vKL~DFGlA~~~ 479 (554)
||||+.+++|.+++... .+....+..++.||+.||.|||+ +||+||||||+|||++.++. +||+|||++...
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~ 156 (307)
T 2eva_A 77 VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI 156 (307)
T ss_dssp EEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----
T ss_pred EEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccc
Confidence 99999999999999764 26788899999999999999999 89999999999999998886 799999998755
Q ss_pred ccCCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008759 480 KLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME 533 (554)
Q Consensus 480 ~~~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e 533 (554)
... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||....
T Consensus 157 ~~~-~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~p~~~~~ 207 (307)
T 2eva_A 157 QTH-MTNNKGSAAWMAPEVFEGS--NYSEKCDVFSWGIILWEVITRRKPFDEIG 207 (307)
T ss_dssp ---------CCTTSSCHHHHTCC--CCCTHHHHHHHHHHHHHHHHTCCTTTTTC
T ss_pred ccc-cccCCCCCceEChhhhCCC--CCCcHHHHHHHHHHHHHHHHCCCCchhhC
Confidence 432 2344699999999999654 48899999999999999999999998653
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=325.84 Aligned_cols=209 Identities=30% Similarity=0.463 Sum_probs=179.3
Q ss_pred ccccccceeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCC
Q 008759 324 FKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES 403 (554)
Q Consensus 324 ~~~~~~~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~ 403 (554)
+....++|++.+.||+|+||.||+|.+..+..||+|++..... ..+.+.+|+.+|+.++|+||+++++++.. .
T Consensus 262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~ 334 (535)
T 2h8h_A 262 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM------SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E 334 (535)
T ss_dssp SBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS------CHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred eecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC------CHHHHHHHHHHHHhCCCCCEeeEEEEEee-c
Confidence 3445678999999999999999999998888899999874321 12468899999999999999999999876 6
Q ss_pred cEEEEEeecccCchHHHHhh---hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccc
Q 008759 404 KLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK 480 (554)
Q Consensus 404 ~~~LVmE~~~ggsL~~ll~~---~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~ 480 (554)
.+||||||+.+|+|.++++. ..+++..+..|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++...
T Consensus 335 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 414 (535)
T 2h8h_A 335 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 414 (535)
T ss_dssp SCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred cceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence 78999999999999999975 248999999999999999999999999999999999999999999999999997654
Q ss_pred cCC---ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHHHHH
Q 008759 481 LND---VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIFIK 541 (554)
Q Consensus 481 ~~~---~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i~~i 541 (554)
... .....++..|+|||++... .++.++|||||||++|||++ |+.||......+.+..+
T Consensus 415 ~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i 477 (535)
T 2h8h_A 415 DNEYTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 477 (535)
T ss_dssp CHHHHTTCSTTSCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHH
T ss_pred CCceecccCCcCcccccCHHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 321 2234477889999999754 48999999999999999999 99999988776655443
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=308.62 Aligned_cols=209 Identities=24% Similarity=0.406 Sum_probs=177.7
Q ss_pred cccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCC-CC-----ceeeeee
Q 008759 325 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HE-----NIVQYYG 397 (554)
Q Consensus 325 ~~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~-Hp-----nIVkl~~ 397 (554)
..+.++|++.+.||+|+||+||+|.+ .+++.||+|++... ......+..|+.++..++ |+ +|+++++
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~ 123 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK------KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKR 123 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS------HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEE
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc------HHHHHHHHHHHHHHHHHHhcccccceeEEEeee
Confidence 34578999999999999999999998 67899999998631 233456677888888775 44 4999999
Q ss_pred eccCCCcEEEEEeecccCchHHHHhhh---cCChHHHHHHHHHHHHHHHHHH--HCCccccCCccccEEEc--CCCcEEE
Q 008759 398 TDKDESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLH--DQDVVHRDIKCANILVD--ANGSVKL 470 (554)
Q Consensus 398 ~~~~~~~~~LVmE~~~ggsL~~ll~~~---~l~e~~i~~i~~QIl~gL~yLH--s~gIIHrDIKPeNILld--~~g~vKL 470 (554)
++...+.+|+||||+.+ +|.+++... .+++..+..++.||+.||.||| ++||+||||||+|||++ .++.+||
T Consensus 124 ~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL 202 (382)
T 2vx3_A 124 HFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKI 202 (382)
T ss_dssp EEEETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEE
T ss_pred eeccCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEE
Confidence 99999999999999975 899988764 4899999999999999999999 57999999999999995 4778999
Q ss_pred EecCcccccccCCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHH
Q 008759 471 ADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTV 543 (554)
Q Consensus 471 ~DFGlA~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~ 543 (554)
+|||+++.... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||......+.+..+..
T Consensus 203 ~DFG~a~~~~~-~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~ 272 (382)
T 2vx3_A 203 VDFGSSCQLGQ-RIYQYIQSRFYRSPEVLLGM--PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVE 272 (382)
T ss_dssp CCCTTCEETTC-CCCSSCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred EeccCceeccc-ccccccCCccccChHHHcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 99999977643 33456799999999999764 488999999999999999999999999888777666554
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=304.29 Aligned_cols=213 Identities=25% Similarity=0.346 Sum_probs=163.9
Q ss_pred ccccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCC
Q 008759 324 FKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE 402 (554)
Q Consensus 324 ~~~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~ 402 (554)
.....++|++.+.||+|+||.||+|.+ .+++.||+|++....... ....+++..+..++||||+++++++...
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~~l~~l~h~niv~~~~~~~~~ 91 (360)
T 3e3p_A 18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR------NRELQIMQDLAVLHHPNIVQLQSYFYTL 91 (360)
T ss_dssp HHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC------CHHHHHHHHHHHHCCTTBCCEEEEEEEE
T ss_pred chhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc------HHHHHHHHHHHhcCCCCcccHHHhhhcc
Confidence 345578999999999999999999998 679999999886432221 2345677888889999999999988543
Q ss_pred C-------cEEEEEeecccCchHHHH---h-hhcCChHHHHHHHHHHHHHHHHHH--HCCccccCCccccEEEcC-CCcE
Q 008759 403 S-------KLYIFLELVTKGSLLNLY---Q-RYHLRDSQVSAYTRQILLGLKYLH--DQDVVHRDIKCANILVDA-NGSV 468 (554)
Q Consensus 403 ~-------~~~LVmE~~~ggsL~~ll---~-~~~l~e~~i~~i~~QIl~gL~yLH--s~gIIHrDIKPeNILld~-~g~v 468 (554)
. .+|+||||+.++.+..+. . ...+++..+..++.||+.||.||| ++||+||||||+|||++. ++.+
T Consensus 92 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 92 GERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp CSSCTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEE
T ss_pred ccccccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcE
Confidence 2 388999999985433322 2 235888999999999999999999 999999999999999996 8999
Q ss_pred EEEecCcccccccC-CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHH
Q 008759 469 KLADFGLAKATKLN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTV 543 (554)
Q Consensus 469 KL~DFGlA~~~~~~-~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~ 543 (554)
||+|||+++..... ......||+.|+|||++.+.. .++.++|||||||++|+|++|+.||......+.+..+..
T Consensus 172 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~ 246 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQ-HYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVR 246 (360)
T ss_dssp EECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCS-SCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred EEeeCCCceecCCCCCcccccCCcceeCHHHHcCCC-CCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHH
Confidence 99999999865433 334557899999999985433 478999999999999999999999999887776665543
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=294.53 Aligned_cols=209 Identities=28% Similarity=0.507 Sum_probs=178.5
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCc
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~ 404 (554)
.+.++|++++.||+|+||.||+|.+ .+++.||+|++....... .....+.+|+.+++.++||||+++++++...+.
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 95 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN---KDTSTILREVELLKKLDHPNIMKLFEILEDSSS 95 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSS---SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccch---HHHHHHHHHHHHHHhccCCCccEEEEEEeCCCe
Confidence 3467899999999999999999998 579999999987533221 223568899999999999999999999999999
Q ss_pred EEEEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCC---CcEEEEecCcccccc
Q 008759 405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN---GSVKLADFGLAKATK 480 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~---g~vKL~DFGlA~~~~ 480 (554)
+|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+|+||||+|||++.+ +.+||+|||++....
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~ 175 (287)
T 2wei_A 96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (287)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence 9999999999999887764 568999999999999999999999999999999999999764 479999999987654
Q ss_pred cCC-ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHH
Q 008759 481 LND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFI 540 (554)
Q Consensus 481 ~~~-~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~ 540 (554)
... .....+|+.|+|||++.+ .++.++|||||||++|+|++|..||......+.+..
T Consensus 176 ~~~~~~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~ 233 (287)
T 2wei_A 176 QNTKMKDRIGTAYYIAPEVLRG---TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKR 233 (287)
T ss_dssp CCSSCSCHHHHHTTCCHHHHTT---CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred CCCccccccCcccccChHHhcC---CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 332 334458999999999854 378899999999999999999999998776554443
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=294.59 Aligned_cols=210 Identities=27% Similarity=0.441 Sum_probs=167.2
Q ss_pred cccceeeeeeeccCCceeEEEEec--CCCc--EEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCC
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGIS--DDGF--FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDE 402 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~--~~g~--~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~ 402 (554)
..++|++++.||+|+||+||+|.+ .++. .||+|++..... ......+.+.+|+.++..++||||+++++++...
T Consensus 16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 93 (291)
T 1u46_A 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVL--SQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP 93 (291)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC----------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCcc--CCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC
Confidence 356899999999999999999985 2333 689998764221 1234457788999999999999999999998876
Q ss_pred CcEEEEEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccc
Q 008759 403 SKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK 480 (554)
Q Consensus 403 ~~~~LVmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~ 480 (554)
. .++||||+.+++|.+++.. ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++....
T Consensus 94 ~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 172 (291)
T 1u46_A 94 P-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 172 (291)
T ss_dssp S-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred C-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccccc
Confidence 5 8999999999999998876 358999999999999999999999999999999999999999999999999987654
Q ss_pred cCC-----ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHHHHH
Q 008759 481 LND-----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIFIK 541 (554)
Q Consensus 481 ~~~-----~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i~~i 541 (554)
... .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |+.||......+.+..+
T Consensus 173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~ 237 (291)
T 1u46_A 173 QNDDHYVMQEHRKVPFAWCAPESLKTRT--FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 237 (291)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCE--EEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH
T ss_pred ccccchhhhccCCCCceeeCchhhcCCC--CCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHH
Confidence 332 22345788899999996543 7889999999999999999 99999987766554443
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-36 Score=302.38 Aligned_cols=205 Identities=27% Similarity=0.440 Sum_probs=166.6
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchh-HHHHHHHHHHHHHHHhC----CCCceeeeeeec
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQA-KQSISQLEQEIALLSRF----EHENIVQYYGTD 399 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~-~~~~~~~~~Ei~iL~~l----~HpnIVkl~~~~ 399 (554)
.+.++|++++.||+|+||.||+|.+ .+++.||+|++......... ......+.+|+.++..+ +|+||+++++++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 4567899999999999999999998 67899999998643221111 11223456788888888 899999999999
Q ss_pred cCCCcEEEEEee-cccCchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEc-CCCcEEEEecCcc
Q 008759 400 KDESKLYIFLEL-VTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD-ANGSVKLADFGLA 476 (554)
Q Consensus 400 ~~~~~~~LVmE~-~~ggsL~~ll~~~-~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld-~~g~vKL~DFGlA 476 (554)
...+..++|||+ +.+++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 108 ~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~ 187 (312)
T 2iwi_A 108 ETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSG 187 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSC
T ss_pred ecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchh
Confidence 999999999999 7899999998764 589999999999999999999999999999999999999 8899999999999
Q ss_pred cccccCCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008759 477 KATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP 531 (554)
Q Consensus 477 ~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~ 531 (554)
............||+.|+|||++.+.. .++.++|||||||++|+|++|+.||..
T Consensus 188 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~ 241 (312)
T 2iwi_A 188 ALLHDEPYTDFDGTRVYSPPEWISRHQ-YHALPATVWSLGILLYDMVCGDIPFER 241 (312)
T ss_dssp EECCSSCBCCCCSCTTTSCHHHHHHSC-BCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred hhcccCcccccCCcccccCceeeecCC-CCCccchHHHHHHHHHHHHHCCCCCCC
Confidence 877666666777999999999986543 235689999999999999999999975
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=302.83 Aligned_cols=198 Identities=29% Similarity=0.446 Sum_probs=170.6
Q ss_pred ccccceeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHh--CCCCceeeeeeeccCCC
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR--FEHENIVQYYGTDKDES 403 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~--l~HpnIVkl~~~~~~~~ 403 (554)
.+.++|++.+.||+|+||.||+|.+ +++.||+|++... ....+.+|++++.. ++||||+++++++....
T Consensus 39 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~--------~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~ 109 (342)
T 1b6c_B 39 TIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR--------EERSWFREAEIYQTVMLRHENILGFIAADNKDN 109 (342)
T ss_dssp HHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG--------GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC
T ss_pred cccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch--------hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC
Confidence 4567899999999999999999988 4889999998631 12456678888877 78999999999988765
Q ss_pred ----cEEEEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHH--------HCCccccCCccccEEEcCCCcEEEE
Q 008759 404 ----KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLH--------DQDVVHRDIKCANILVDANGSVKLA 471 (554)
Q Consensus 404 ----~~~LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLH--------s~gIIHrDIKPeNILld~~g~vKL~ 471 (554)
.+|+||||+.+|+|.+++++..+++..+..++.||+.||.||| ++||+||||||+|||++.++.+||+
T Consensus 110 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 189 (342)
T 1b6c_B 110 GTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 189 (342)
T ss_dssp SSCCCEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEEC
T ss_pred CccceeEEEEeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEE
Confidence 8999999999999999999888999999999999999999999 8999999999999999999999999
Q ss_pred ecCcccccccCC------ccCccCCCcccChhhhcccCC----CCCchhhHHHHHHHHHHHHcC----------CCCCCC
Q 008759 472 DFGLAKATKLND------VKSCRGTAFWMAPEVINNKNK----GYGLPADIWSLGCTVLEMLTS----------QIPYAP 531 (554)
Q Consensus 472 DFGlA~~~~~~~------~~s~~GT~~Y~APEvl~~~~~----~~s~ksDIwSLGvllyeLLTG----------~~PF~~ 531 (554)
|||++....... .....||+.|+|||++.+... .++.++|||||||++|+|++| ..||..
T Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~ 269 (342)
T 1b6c_B 190 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 269 (342)
T ss_dssp CCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred ECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccc
Confidence 999997654332 234569999999999965421 123689999999999999999 889976
Q ss_pred C
Q 008759 532 M 532 (554)
Q Consensus 532 ~ 532 (554)
.
T Consensus 270 ~ 270 (342)
T 1b6c_B 270 L 270 (342)
T ss_dssp T
T ss_pred c
Confidence 5
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-35 Score=294.72 Aligned_cols=209 Identities=29% Similarity=0.467 Sum_probs=158.9
Q ss_pred cccccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccC
Q 008759 323 RFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD 401 (554)
Q Consensus 323 ~~~~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~ 401 (554)
.+....++|++++.||+|+||.||+|.+ .+++.||+|++..... .......+.++..++..++||||+++++++..
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~ 95 (318)
T 2dyl_A 19 RYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN---KEENKRILMDLDVVLKSHDCPYIVQCFGTFIT 95 (318)
T ss_dssp EEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC---HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred hhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc---chHHHHHHHHHHHHHHhcCCCceeeEEEEEec
Confidence 4556678999999999999999999998 5799999999875322 12223344455567888899999999999999
Q ss_pred CCcEEEEEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHC-CccccCCccccEEEcCCCcEEEEecCcccc
Q 008759 402 ESKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQ-DVVHRDIKCANILVDANGSVKLADFGLAKA 478 (554)
Q Consensus 402 ~~~~~LVmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~-gIIHrDIKPeNILld~~g~vKL~DFGlA~~ 478 (554)
.+.+|+||||+ ++.+..++.. ..+++..+..++.||+.||.|||++ ||+|+||||+|||++.++.+||+|||++..
T Consensus 96 ~~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 174 (318)
T 2dyl_A 96 NTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGR 174 (318)
T ss_dssp SSEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred CCcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchh
Confidence 99999999999 4566666553 4689999999999999999999996 999999999999999999999999999876
Q ss_pred cccC-CccCccCCCcccChhhhcc---cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChh
Q 008759 479 TKLN-DVKSCRGTAFWMAPEVINN---KNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECV 535 (554)
Q Consensus 479 ~~~~-~~~s~~GT~~Y~APEvl~~---~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~ 535 (554)
.... ......||+.|+|||++.. ....++.++|||||||++|+|++|+.||......
T Consensus 175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 235 (318)
T 2dyl_A 175 LVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD 235 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH
T ss_pred ccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc
Confidence 5432 2334569999999999853 1234788999999999999999999999875443
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=301.47 Aligned_cols=209 Identities=29% Similarity=0.491 Sum_probs=155.3
Q ss_pred CCccccccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHH-HHHhCCCCceeeeee
Q 008759 320 PNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIA-LLSRFEHENIVQYYG 397 (554)
Q Consensus 320 ~~~~~~~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~-iL~~l~HpnIVkl~~ 397 (554)
+...+....++|++++.||+|+||.||+|.+ .+++.||+|++..... ......+..|+. +++.++||||+++++
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~e~~~~~~~~~h~niv~~~~ 88 (327)
T 3aln_A 13 PEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD----EKEQKQLLMDLDVVMRSSDCPYIVQFYG 88 (327)
T ss_dssp CCEEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC----HHHHHHHHHHHHHHHSSCCCTTBCCEEE
T ss_pred hHHhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC----chHHHHHHHHHHHHHHcCCCCcEeeeee
Confidence 3344555568999999999999999999998 6899999999875321 222344555555 777889999999999
Q ss_pred eccCCCcEEEEEeecccCchHHHHh------hhcCChHHHHHHHHHHHHHHHHHHHC-CccccCCccccEEEcCCCcEEE
Q 008759 398 TDKDESKLYIFLELVTKGSLLNLYQ------RYHLRDSQVSAYTRQILLGLKYLHDQ-DVVHRDIKCANILVDANGSVKL 470 (554)
Q Consensus 398 ~~~~~~~~~LVmE~~~ggsL~~ll~------~~~l~e~~i~~i~~QIl~gL~yLHs~-gIIHrDIKPeNILld~~g~vKL 470 (554)
++...+..|+||||+.+ +|.+++. ...+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||
T Consensus 89 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl 167 (327)
T 3aln_A 89 ALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKL 167 (327)
T ss_dssp EEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEE
T ss_pred EEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEE
Confidence 99999999999999987 7777765 34689999999999999999999999 9999999999999999999999
Q ss_pred EecCcccccccCC-ccCccCCCcccChhhhccc--CCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008759 471 ADFGLAKATKLND-VKSCRGTAFWMAPEVINNK--NKGYGLPADIWSLGCTVLEMLTSQIPYAPME 533 (554)
Q Consensus 471 ~DFGlA~~~~~~~-~~s~~GT~~Y~APEvl~~~--~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e 533 (554)
+|||+++...... .....||+.|+|||++... ...++.++|||||||++|+|++|+.||....
T Consensus 168 ~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 233 (327)
T 3aln_A 168 CDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWN 233 (327)
T ss_dssp CCCSSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-
T ss_pred ccCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence 9999997654332 2334699999999998431 2347899999999999999999999997643
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=311.16 Aligned_cols=205 Identities=26% Similarity=0.466 Sum_probs=162.9
Q ss_pred cceeeeeeeccCCceeEEEEecC--C--CcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeecc-CCC
Q 008759 329 TYWQKGDLLGRGSFGSVYEGISD--D--GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK-DES 403 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~~--~--g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~-~~~ 403 (554)
..|++.+.||+|+||+||+|.+. + +..+|+|.+.... .....+.+.+|+.+++.++||||+++++++. ..+
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~ 164 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT----DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 164 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS----CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSS
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC----CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCC
Confidence 46889999999999999999862 2 2467888875322 2334577889999999999999999999864 456
Q ss_pred cEEEEEeecccCchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccccc
Q 008759 404 KLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL 481 (554)
Q Consensus 404 ~~~LVmE~~~ggsL~~ll~~~--~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~ 481 (554)
..|+||||+.+|+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 165 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244 (373)
T ss_dssp CCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred CeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccc
Confidence 889999999999999999753 478889999999999999999999999999999999999999999999999975432
Q ss_pred CC------ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHHH
Q 008759 482 ND------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIF 539 (554)
Q Consensus 482 ~~------~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i~ 539 (554)
.. .....+|+.|+|||++.+. .++.++|||||||++|+|+| |.+||......+...
T Consensus 245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~ 307 (373)
T 3c1x_A 245 KEFDSVHNKTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 307 (373)
T ss_dssp -------------CCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHH
T ss_pred cccccccccCCCCCcccccChHHhcCC--CCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHH
Confidence 21 2234578889999999754 48899999999999999999 788888765544433
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-36 Score=304.56 Aligned_cols=211 Identities=27% Similarity=0.428 Sum_probs=175.7
Q ss_pred CccccccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchh-HHHHHHHHHHHHHHHhCC--CCceeeee
Q 008759 321 NGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQA-KQSISQLEQEIALLSRFE--HENIVQYY 396 (554)
Q Consensus 321 ~~~~~~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~-~~~~~~~~~Ei~iL~~l~--HpnIVkl~ 396 (554)
......+.++|++++.||+|+||.||+|.+ .+++.||+|++......... ......+.+|+.++..++ |+||++++
T Consensus 35 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~ 114 (320)
T 3a99_A 35 GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL 114 (320)
T ss_dssp -----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEE
T ss_pred ccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEE
Confidence 333445678899999999999999999997 78899999999753221100 011134567899999986 59999999
Q ss_pred eeccCCCcEEEEEeeccc-CchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEc-CCCcEEEEec
Q 008759 397 GTDKDESKLYIFLELVTK-GSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD-ANGSVKLADF 473 (554)
Q Consensus 397 ~~~~~~~~~~LVmE~~~g-gsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld-~~g~vKL~DF 473 (554)
+++...+.+++|||++.+ ++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+||
T Consensus 115 ~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Df 194 (320)
T 3a99_A 115 DWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 194 (320)
T ss_dssp EEEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred EEEecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeC
Confidence 999999999999999986 899998875 4689999999999999999999999999999999999999 7899999999
Q ss_pred CcccccccCCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008759 474 GLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM 532 (554)
Q Consensus 474 GlA~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~ 532 (554)
|+++...........||+.|+|||++.+.. .++.++|||||||++|+|++|+.||...
T Consensus 195 g~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~ 252 (320)
T 3a99_A 195 GSGALLKDTVYTDFDGTRVYSPPEWIRYHR-YHGRSAAVWSLGILLYDMVCGDIPFEHD 252 (320)
T ss_dssp TTCEECCSSCBCCCCSCGGGSCHHHHHHSC-BCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred ccccccccccccCCCCCccCCChHHhccCC-CCCccchHHhHHHHHHHHHHCCCCCCCh
Confidence 999877666666677999999999986543 2467899999999999999999999753
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-36 Score=302.51 Aligned_cols=212 Identities=23% Similarity=0.455 Sum_probs=173.4
Q ss_pred ccccccceeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCC
Q 008759 324 FKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES 403 (554)
Q Consensus 324 ~~~~~~~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~ 403 (554)
+....++|++++.||+|+||.||+|.+.. .+|+|++....... ...+.+.+|+.+++.++|+||+++++++....
T Consensus 28 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 28 WDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNE---DQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102 (319)
T ss_dssp SSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCC---CCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred ccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCH---HHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 33456789999999999999999998854 49999887532211 11234668999999999999999999999999
Q ss_pred cEEEEEeecccCchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccccc
Q 008759 404 KLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL 481 (554)
Q Consensus 404 ~~~LVmE~~~ggsL~~ll~~~--~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~ 481 (554)
.+|+||||+.+++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.....
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~ 181 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGV 181 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC----
T ss_pred ceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccccc
Confidence 999999999999999999864 489999999999999999999999999999999999997 78999999999765421
Q ss_pred -------CCccCccCCCcccChhhhccc-------CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHH
Q 008759 482 -------NDVKSCRGTAFWMAPEVINNK-------NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIK 541 (554)
Q Consensus 482 -------~~~~s~~GT~~Y~APEvl~~~-------~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i 541 (554)
.......||+.|+|||++... ...++.++|||||||++|+|++|+.||...........+
T Consensus 182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~ 255 (319)
T 2y4i_B 182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM 255 (319)
T ss_dssp ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHH
T ss_pred ccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Confidence 122334589999999998652 234788999999999999999999999987765554443
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=316.23 Aligned_cols=199 Identities=24% Similarity=0.330 Sum_probs=170.9
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCC-CceeeeeeeccCCC
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH-ENIVQYYGTDKDES 403 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~H-pnIVkl~~~~~~~~ 403 (554)
.+.++|+++++||+|+||.||+|.+ .+++.||||++...... ..+.+|+.++..++| ++|..+..++...+
T Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-------~~~~~E~~il~~L~~~~~i~~i~~~~~~~~ 76 (483)
T 3sv0_A 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-------PQLLYESKIYRILQGGTGIPNVRWFGVEGD 76 (483)
T ss_dssp EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-------CCHHHHHHHHHHTTTSTTCCCEEEEEEETT
T ss_pred CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeeCC
Confidence 4567899999999999999999998 78999999987753322 236789999999987 55666666777788
Q ss_pred cEEEEEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEE---cCCCcEEEEecCcccc
Q 008759 404 KLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKA 478 (554)
Q Consensus 404 ~~~LVmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILl---d~~g~vKL~DFGlA~~ 478 (554)
..||||||+ +++|.+++.. ..+++..++.|+.||+.||.|||++|||||||||+|||| +.++.+||+|||+++.
T Consensus 77 ~~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (483)
T 3sv0_A 77 YNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (483)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred EEEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCccee
Confidence 899999999 8899999974 569999999999999999999999999999999999999 6889999999999986
Q ss_pred cccCC---------ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh
Q 008759 479 TKLND---------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC 534 (554)
Q Consensus 479 ~~~~~---------~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~ 534 (554)
..... .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~s~~sDvwSlGvil~elltG~~Pf~~~~~ 218 (483)
T 3sv0_A 156 YRDTSTHQHIPYRENKNLTGTARYASVNTHLGIE--QSRRDDLESLGYVLMYFLRGSLPWQGLKA 218 (483)
T ss_dssp CBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC--CCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred ccCCccccccccccccccCCCccccCHHHhcCCC--CChHHHHHHHHHHHHHHHhCCCCCccccc
Confidence 54332 12567999999999996544 88999999999999999999999987543
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=305.16 Aligned_cols=197 Identities=25% Similarity=0.391 Sum_probs=146.0
Q ss_pred ccccceeeee-eeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccC--
Q 008759 326 RIITYWQKGD-LLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD-- 401 (554)
Q Consensus 326 ~~~~~y~i~~-~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~-- 401 (554)
.+.++|.+.+ +||+|+||+||+|.+ .+++.||+|++... .. ...+....+..+.|+||+++++++..
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~ 95 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS------PK---ARQEVDHHWQASGGPHIVCILDVYENMH 95 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS------HH---HHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc------HH---HHHHHHHHHHhcCCCChHHHHHHHhhcc
Confidence 5667889854 699999999999998 57999999998631 11 11222334667799999999998865
Q ss_pred --CCcEEEEEeecccCchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcC---CCcEEEEec
Q 008759 402 --ESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA---NGSVKLADF 473 (554)
Q Consensus 402 --~~~~~LVmE~~~ggsL~~ll~~~---~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~---~g~vKL~DF 473 (554)
...+|+||||+.+|+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+||
T Consensus 96 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Df 175 (336)
T 3fhr_A 96 HGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDF 175 (336)
T ss_dssp TTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred CCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEecc
Confidence 45689999999999999999764 4899999999999999999999999999999999999976 455999999
Q ss_pred CcccccccCCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008759 474 GLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME 533 (554)
Q Consensus 474 GlA~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e 533 (554)
|+++...........||+.|+|||++.+. .++.++|||||||++|+|++|+.||....
T Consensus 176 g~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~ 233 (336)
T 3fhr_A 176 GFAKETTQNALQTPCYTPYYVAPEVLGPE--KYDKSCDMWSLGVIMYILLCGFPPFYSNT 233 (336)
T ss_dssp TTCEEC----------------------C--HHHHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred ccceeccccccccCCCCcCccChhhhCCC--CCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence 99987666555667799999999998544 37889999999999999999999997654
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-35 Score=299.33 Aligned_cols=198 Identities=30% Similarity=0.525 Sum_probs=170.7
Q ss_pred cccceeeeeeeccCCceeEEEEe----c-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccC
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGI----S-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD 401 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~----~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~ 401 (554)
..++|++++.||+|+||.||+|. + .+++.||+|++... .....+.+.+|+.+++.++||||+++++++..
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 113 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-----TEEHLRDFEREIEILKSLQHDNIVKYKGVCYS 113 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC-----CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC-----CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Confidence 35689999999999999999998 2 57899999998742 23345678899999999999999999998766
Q ss_pred CC--cEEEEEeecccCchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccc
Q 008759 402 ES--KLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477 (554)
Q Consensus 402 ~~--~~~LVmE~~~ggsL~~ll~~~--~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~ 477 (554)
.+ .+++||||+.+++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 114 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 114 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp ----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred cCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchh
Confidence 44 789999999999999999764 48999999999999999999999999999999999999999999999999997
Q ss_pred ccccCC-----ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008759 478 ATKLND-----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP 531 (554)
Q Consensus 478 ~~~~~~-----~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~ 531 (554)
...... .....++..|+|||++.+.. ++.++|||||||++|+|+||..||..
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~il~el~tg~~~~~~ 250 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTESK--FSVASDVWSFGVVLYELFTYIEKSKS 250 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHHCE--EEHHHHHHHHHHHHHHHHHTTCGGGS
T ss_pred hccccccccccccCCCCceeEECchhhcCCC--CCchhhHHHHHHHHHHHHhcCCCCCC
Confidence 654332 22345778899999997643 78899999999999999999999864
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=293.47 Aligned_cols=204 Identities=24% Similarity=0.455 Sum_probs=170.0
Q ss_pred ccccceeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCC--CCceeeeeeeccCCC
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE--HENIVQYYGTDKDES 403 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~--HpnIVkl~~~~~~~~ 403 (554)
...++|++++.||+|+||.||+|.+.+++.||+|++..... .......+.+|+.++..++ |+||+++++++....
T Consensus 25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~ 101 (313)
T 3cek_A 25 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA---DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 101 (313)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSC---CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSS
T ss_pred eccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccc---cccchHHHHHHHHHHHhccccCCceEEEEEEeecCC
Confidence 44568999999999999999999998899999999875332 2344577889999999997 599999999999999
Q ss_pred cEEEEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC
Q 008759 404 KLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN 482 (554)
Q Consensus 404 ~~~LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~ 482 (554)
.+|+||| +.+++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.....
T Consensus 102 ~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~ 179 (313)
T 3cek_A 102 YIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 179 (313)
T ss_dssp EEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC----
T ss_pred EEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccCc
Confidence 9999999 567799998876 4689999999999999999999999999999999999995 589999999999765432
Q ss_pred C----ccCccCCCcccChhhhccc---------CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh
Q 008759 483 D----VKSCRGTAFWMAPEVINNK---------NKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC 534 (554)
Q Consensus 483 ~----~~s~~GT~~Y~APEvl~~~---------~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~ 534 (554)
. .....||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.....
T Consensus 180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 244 (313)
T 3cek_A 180 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN 244 (313)
T ss_dssp ----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS
T ss_pred cccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH
Confidence 2 2344689999999998652 12478899999999999999999999987643
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-35 Score=302.50 Aligned_cols=196 Identities=28% Similarity=0.411 Sum_probs=165.3
Q ss_pred ccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCC-----------CCceeee
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-----------HENIVQY 395 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~-----------HpnIVkl 395 (554)
.++|++++.||+|+||+||+|.+ .+++.||+|++... ......+.+|+.++..++ |+||+++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~ 91 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD------KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL 91 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC------HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC------ccchhhhhHHHHHHHHhhcccccchhccccchHHHH
Confidence 46899999999999999999998 78999999998631 223456778888888876 8899999
Q ss_pred eeeccCCC----cEEEEEeecccCchHHHHhh---hcCChHHHHHHHHHHHHHHHHHHHC-CccccCCccccEEEc----
Q 008759 396 YGTDKDES----KLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQ-DVVHRDIKCANILVD---- 463 (554)
Q Consensus 396 ~~~~~~~~----~~~LVmE~~~ggsL~~ll~~---~~l~e~~i~~i~~QIl~gL~yLHs~-gIIHrDIKPeNILld---- 463 (554)
++++...+ .+++||||+ +++|.+++.. ..+++..+..++.||+.||.|||++ ||+||||||+|||++
T Consensus 92 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 92 LDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp CEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEET
T ss_pred HHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCC
Confidence 99987544 789999999 7899998875 3489999999999999999999998 999999999999995
Q ss_pred --CCCcEEEEecCcccccccCCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008759 464 --ANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME 533 (554)
Q Consensus 464 --~~g~vKL~DFGlA~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e 533 (554)
..+.+||+|||++...... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||....
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~~-~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~~~ 239 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDEH-YTNSIQTREYRSPEVLLGA--PWGCGADIWSTACLIFELITGDFLFEPDE 239 (373)
T ss_dssp TTTEEEEEECCCTTCEETTBC-CCSCCSCGGGCCHHHHHTC--CCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred CcCcceEEEcccccccccCCC-CCCCCCCccccCcHHHhCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence 3448999999999765433 3445799999999999764 38899999999999999999999998654
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-35 Score=324.75 Aligned_cols=207 Identities=28% Similarity=0.469 Sum_probs=170.8
Q ss_pred cceeeee-eeccCCceeEEEEec---CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCc
Q 008759 329 TYWQKGD-LLGRGSFGSVYEGIS---DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (554)
Q Consensus 329 ~~y~i~~-~LG~GsfG~VY~a~~---~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~ 404 (554)
+.+.+.+ .||+|+||.||+|.+ .++..||+|++..... ....+.+.+|+.+|..++|||||++++++.. +.
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~----~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~ 409 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE----KADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA 409 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCS----STTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SS
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCC----hHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CC
Confidence 3455555 899999999999976 3567899999874321 2234678899999999999999999999876 56
Q ss_pred EEEEEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC
Q 008759 405 LYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN 482 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~ 482 (554)
+||||||+.+|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 410 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~ 489 (613)
T 2ozo_A 410 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGAD 489 (613)
T ss_dssp EEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred eEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence 9999999999999999864 45899999999999999999999999999999999999999999999999999865432
Q ss_pred C-----ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHH
Q 008759 483 D-----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIFIKT 542 (554)
Q Consensus 483 ~-----~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i~~i~ 542 (554)
. .....+|+.|+|||++.+. .++.++|||||||++|||++ |+.||......+.+..+.
T Consensus 490 ~~~~~~~~~~~~~~~y~APE~~~~~--~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~ 553 (613)
T 2ozo_A 490 DSYYTARSAGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 553 (613)
T ss_dssp ------------CCTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHH
T ss_pred CceeeeccCCCCccceeCHhhhcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH
Confidence 2 1122356889999999654 48999999999999999998 999999987766554443
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=312.09 Aligned_cols=197 Identities=17% Similarity=0.257 Sum_probs=161.1
Q ss_pred ccceeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccc---hhHHHHHHHHHHHHHHHhCC---------C------
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGS---QAKQSISQLEQEIALLSRFE---------H------ 389 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~---~~~~~~~~~~~Ei~iL~~l~---------H------ 389 (554)
.++|++++.||+|+||+||+|++ +|+.||+|++....... ......+.+.+|+.+++.++ |
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46899999999999999999998 68999999998643210 11122356778888888776 4
Q ss_pred -----------CceeeeeeeccC-------------CCcEEEEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHH
Q 008759 390 -----------ENIVQYYGTDKD-------------ESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYL 445 (554)
Q Consensus 390 -----------pnIVkl~~~~~~-------------~~~~~LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yL 445 (554)
|||++++++|.+ ...+||||||+.+|++.+.+.+..+++..++.|+.||+.||.||
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL~~l 177 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVA 177 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHHHHHH
Confidence 555555555543 78899999999999776666667789999999999999999999
Q ss_pred H-HCCccccCCccccEEEcCCC--------------------cEEEEecCcccccccCCccCccCCCcccChhhhcccCC
Q 008759 446 H-DQDVVHRDIKCANILVDANG--------------------SVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNK 504 (554)
Q Consensus 446 H-s~gIIHrDIKPeNILld~~g--------------------~vKL~DFGlA~~~~~~~~~s~~GT~~Y~APEvl~~~~~ 504 (554)
| ++||+||||||+|||++.++ .+||+|||+++..... ...||+.|+|||++.+..
T Consensus 178 H~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~---~~~gt~~y~aPE~~~g~~- 253 (336)
T 2vuw_A 178 EASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG---IVVFCDVSMDEDLFTGDG- 253 (336)
T ss_dssp HHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT---EEECCCCTTCSGGGCCCS-
T ss_pred HHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC---cEEEeecccChhhhcCCC-
Confidence 9 99999999999999999887 8999999999876533 347999999999996543
Q ss_pred CCCchhhHHHHHHH-HHHHHcCCCCCCC
Q 008759 505 GYGLPADIWSLGCT-VLEMLTSQIPYAP 531 (554)
Q Consensus 505 ~~s~ksDIwSLGvl-lyeLLTG~~PF~~ 531 (554)
+.++|||||+++ .+++++|..||..
T Consensus 254 --~~~~Diwsl~~~~~~~~~~g~~p~~~ 279 (336)
T 2vuw_A 254 --DYQFDIYRLMKKENNNRWGEYHPYSN 279 (336)
T ss_dssp --SHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred --ccceehhhhhCCCCcccccccCCCcc
Confidence 789999998777 7788899999965
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-34 Score=321.13 Aligned_cols=203 Identities=27% Similarity=0.456 Sum_probs=168.6
Q ss_pred eeeeccCCceeEEEEec---CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEEEe
Q 008759 334 GDLLGRGSFGSVYEGIS---DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLE 410 (554)
Q Consensus 334 ~~~LG~GsfG~VY~a~~---~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LVmE 410 (554)
.+.||+|+||.||+|.+ .+++.||+|++...... ....+.+.+|+.++..++|||||++++++.. ..+|||||
T Consensus 374 ~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E 449 (635)
T 4fl3_A 374 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND---PALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVME 449 (635)
T ss_dssp EEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGC---GGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEE
T ss_pred CCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEE
Confidence 45899999999999965 45689999998753221 2234678899999999999999999999864 56899999
Q ss_pred ecccCchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC-----c
Q 008759 411 LVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-----V 484 (554)
Q Consensus 411 ~~~ggsL~~ll~~~-~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~-----~ 484 (554)
|+.+|+|.++++.. .+++..+..|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++...... .
T Consensus 450 ~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 529 (635)
T 4fl3_A 450 MAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 529 (635)
T ss_dssp CCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred ccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence 99999999999764 58999999999999999999999999999999999999999999999999998654322 2
Q ss_pred cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHH
Q 008759 485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIFIKT 542 (554)
Q Consensus 485 ~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i~~i~ 542 (554)
....+|+.|+|||++.+. .++.++|||||||++|||++ |+.||......+....+.
T Consensus 530 ~~~~~t~~y~APE~~~~~--~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~ 586 (635)
T 4fl3_A 530 THGKWPVKWYAPECINYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 586 (635)
T ss_dssp -----CGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH
T ss_pred cCCCCceeeeChhhhcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 233467889999999654 48999999999999999998 999999988766554443
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-34 Score=320.03 Aligned_cols=213 Identities=29% Similarity=0.448 Sum_probs=176.8
Q ss_pred ccccccceeeeeeeccCCceeEEEEecC----CCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeec
Q 008759 324 FKRIITYWQKGDLLGRGSFGSVYEGISD----DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTD 399 (554)
Q Consensus 324 ~~~~~~~y~i~~~LG~GsfG~VY~a~~~----~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~ 399 (554)
+....++|++++.||+|+||.||+|.+. .+..||+|.+... ......+.+.+|+.++..++||||+++++++
T Consensus 385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 460 (656)
T 2j0j_A 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC----TSDSVREKFLQEALTMRQFDHPHIVKLIGVI 460 (656)
T ss_dssp TBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST----TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc----CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 3444578999999999999999999873 3567899987642 2234456788999999999999999999998
Q ss_pred cCCCcEEEEEeecccCchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccc
Q 008759 400 KDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477 (554)
Q Consensus 400 ~~~~~~~LVmE~~~ggsL~~ll~~~--~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~ 477 (554)
. .+.+|+||||+.+|+|.++++.. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 461 ~-~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~ 539 (656)
T 2j0j_A 461 T-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 539 (656)
T ss_dssp C-SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred e-cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCe
Confidence 5 46789999999999999999754 58899999999999999999999999999999999999999999999999997
Q ss_pred ccccCC---ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHH
Q 008759 478 ATKLND---VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIFIKTV 543 (554)
Q Consensus 478 ~~~~~~---~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i~~i~~ 543 (554)
...... .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||......+.+..+..
T Consensus 540 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~ 607 (656)
T 2j0j_A 540 YMEDSTYYKASKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN 607 (656)
T ss_dssp SCCC----------CCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHH
T ss_pred ecCCCcceeccCCCCCcceeCHHHhcCC--CCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc
Confidence 654332 1234477899999999654 48999999999999999997 9999998877766555443
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=307.08 Aligned_cols=198 Identities=30% Similarity=0.454 Sum_probs=159.3
Q ss_pred cccceeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhC-CCCceeeeeeeccCCCcE
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESKL 405 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIVkl~~~~~~~~~~ 405 (554)
+.+.|.+.+.||+|+||+||.+...+|+.||+|++... ....+.+|+.++..+ +||||+++++++.+...+
T Consensus 13 l~~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~--------~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~ 84 (434)
T 2rio_A 13 LKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID--------FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFL 84 (434)
T ss_dssp CSSCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG--------GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEE
T ss_pred hhheeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH--------HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeE
Confidence 44567888999999999998776678999999988641 123467899999876 899999999999999999
Q ss_pred EEEEeecccCchHHHHhhhcC--------ChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCC------------
Q 008759 406 YIFLELVTKGSLLNLYQRYHL--------RDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN------------ 465 (554)
Q Consensus 406 ~LVmE~~~ggsL~~ll~~~~l--------~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~------------ 465 (554)
|+||||+. |+|.+++..... .+..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 85 ~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~ 163 (434)
T 2rio_A 85 YIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAE 163 (434)
T ss_dssp EEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCC
T ss_pred EEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCC
Confidence 99999996 599999976432 222356799999999999999999999999999999754
Q ss_pred -CcEEEEecCcccccccCC------ccCccCCCcccChhhhccc-----CCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008759 466 -GSVKLADFGLAKATKLND------VKSCRGTAFWMAPEVINNK-----NKGYGLPADIWSLGCTVLEMLT-SQIPYAPM 532 (554)
Q Consensus 466 -g~vKL~DFGlA~~~~~~~------~~s~~GT~~Y~APEvl~~~-----~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~ 532 (554)
+.+||+|||+++...... .....||+.|+|||++.+. ...++.++|||||||++|+|++ |..||...
T Consensus 164 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~ 243 (434)
T 2rio_A 164 NLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 243 (434)
T ss_dssp SCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCST
T ss_pred ceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCc
Confidence 489999999998654332 2245699999999999652 2358899999999999999999 99999765
Q ss_pred C
Q 008759 533 E 533 (554)
Q Consensus 533 e 533 (554)
.
T Consensus 244 ~ 244 (434)
T 2rio_A 244 Y 244 (434)
T ss_dssp T
T ss_pred h
Confidence 3
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=324.93 Aligned_cols=195 Identities=23% Similarity=0.308 Sum_probs=167.2
Q ss_pred ccccceeeeeeeccCCceeEEEEecC--CCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCC
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGISD--DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES 403 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~~--~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~ 403 (554)
.+.++|++.++||+|+||.||+|.+. +++.||+|++... ........+.+|+.++..++||||+++++++...+
T Consensus 77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 152 (681)
T 2pzi_A 77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS----GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTD 152 (681)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS----CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEEC
T ss_pred EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc----CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecC
Confidence 34579999999999999999999984 6899999987642 12334567889999999999999999999987765
Q ss_pred c-----EEEEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccc
Q 008759 404 K-----LYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA 478 (554)
Q Consensus 404 ~-----~~LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~ 478 (554)
. .||||||+.+++|.+++.. .+++.++..|+.||+.||.|||++|||||||||+|||++.+ .+||+|||+++.
T Consensus 153 ~~~~~~~~lv~E~~~g~~L~~~~~~-~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 153 RHGDPVGYIVMEYVGGQSLKRSKGQ-KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSR 230 (681)
T ss_dssp TTSCEEEEEEEECCCCEECC----C-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred CCCCceeEEEEEeCCCCcHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchh
Confidence 5 7999999999999988766 79999999999999999999999999999999999999875 999999999976
Q ss_pred cccCCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008759 479 TKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAP 531 (554)
Q Consensus 479 ~~~~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~ 531 (554)
.... ....||+.|+|||++.+. ++.++|||||||++|+|++|..||..
T Consensus 231 ~~~~--~~~~gt~~y~aPE~~~~~---~~~~sDi~slG~~l~~l~~g~~~~~~ 278 (681)
T 2pzi_A 231 INSF--GYLYGTPGFQAPEIVRTG---PTVATDIYTVGRTLAALTLDLPTRNG 278 (681)
T ss_dssp TTCC--SCCCCCTTTSCTTHHHHC---SCHHHHHHHHHHHHHHHHSCCCEETT
T ss_pred cccC--CccCCCccccCHHHHcCC---CCCceehhhhHHHHHHHHhCCCCCcc
Confidence 5433 456799999999998653 47899999999999999999999864
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=284.95 Aligned_cols=178 Identities=13% Similarity=0.073 Sum_probs=155.6
Q ss_pred cccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcE
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL 405 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~ 405 (554)
+.++|++.+.||+|+||.||+|.+ .+++.||+|++...... .......+.+|+.++..++||||+++++++...+.+
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 106 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVL--PDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGG 106 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCS--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECccccc--CHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcE
Confidence 456899999999999999999999 56999999998753322 234557788999999999999999999999999999
Q ss_pred EEEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCCcc
Q 008759 406 YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK 485 (554)
Q Consensus 406 ~LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~~~ 485 (554)
|+||||+.+++|.+++++. ....++..|+.||+.||.|||++||+||||||+|||++.+|.+||+++|
T Consensus 107 ~lv~e~~~g~~L~~~l~~~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~----------- 174 (286)
T 3uqc_A 107 LVVAEWIRGGSLQEVADTS-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA----------- 174 (286)
T ss_dssp EEEEECCCEEEHHHHHTTC-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC-----------
T ss_pred EEEEEecCCCCHHHHHhcC-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc-----------
Confidence 9999999999999999654 4666788999999999999999999999999999999999999998543
Q ss_pred CccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh
Q 008759 486 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC 534 (554)
Q Consensus 486 s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~ 534 (554)
|++ .++.++|||||||++|+|+||+.||.....
T Consensus 175 -------~~~---------~~~~~~Di~slG~il~elltg~~Pf~~~~~ 207 (286)
T 3uqc_A 175 -------TMP---------DANPQDDIRGIGASLYALLVNRWPLPEAGV 207 (286)
T ss_dssp -------CCT---------TCCHHHHHHHHHHHHHHHHHSEECSCCCSB
T ss_pred -------ccC---------CCCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence 333 267899999999999999999999987543
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=307.30 Aligned_cols=198 Identities=28% Similarity=0.405 Sum_probs=159.9
Q ss_pred ccceeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhC-CCCceeeeeeeccCCCcEE
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESKLY 406 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIVkl~~~~~~~~~~~ 406 (554)
...|.+.++||+|+||+||.....+++.||||++..... ..+.+|+.+|+.+ +|||||++++++.+...+|
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~--------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~ 94 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF--------SFADREVQLLRESDEHPNVIRYFCTEKDRQFQY 94 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE--------EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEE
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH--------HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEE
Confidence 347999999999999997655557789999999864221 1245799999998 7999999999999999999
Q ss_pred EEEeecccCchHHHHhhhc--CChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcC---C--CcEEEEecCccccc
Q 008759 407 IFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA---N--GSVKLADFGLAKAT 479 (554)
Q Consensus 407 LVmE~~~ggsL~~ll~~~~--l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~---~--g~vKL~DFGlA~~~ 479 (554)
|||||+.+ +|.+++.... +.+..+..++.||+.||.|||++||+||||||+|||++. + ..+||+|||+++..
T Consensus 95 lv~E~~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~ 173 (432)
T 3p23_A 95 IAIELCAA-TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173 (432)
T ss_dssp EEEECCSE-EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred EEEECCCC-CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence 99999975 9999887643 555567889999999999999999999999999999953 2 35889999999765
Q ss_pred ccC-----CccCccCCCcccChhhhccc-CCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCh
Q 008759 480 KLN-----DVKSCRGTAFWMAPEVINNK-NKGYGLPADIWSLGCTVLEMLT-SQIPYAPMEC 534 (554)
Q Consensus 480 ~~~-----~~~s~~GT~~Y~APEvl~~~-~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~ 534 (554)
... ......||+.|+|||++.+. ...++.++|||||||++|+|++ |..||.....
T Consensus 174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~ 235 (432)
T 3p23_A 174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ 235 (432)
T ss_dssp ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT
T ss_pred cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH
Confidence 432 23345699999999999643 2346789999999999999999 9999975533
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-33 Score=315.47 Aligned_cols=200 Identities=26% Similarity=0.474 Sum_probs=170.7
Q ss_pred cccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccC----
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD---- 401 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~---- 401 (554)
..++|++.+.||+|+||.||+|.+ .+|+.||+|++... ........+.+|+.++..++||||+++++++..
T Consensus 12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~----~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~ 87 (676)
T 3qa8_A 12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE----LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKL 87 (676)
T ss_dssp -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC----CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCC
T ss_pred CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc----CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccc
Confidence 347899999999999999999998 67999999988642 123445678899999999999999999998765
Q ss_pred --CCcEEEEEeecccCchHHHHhhh----cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCc---EEEEe
Q 008759 402 --ESKLYIFLELVTKGSLLNLYQRY----HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS---VKLAD 472 (554)
Q Consensus 402 --~~~~~LVmE~~~ggsL~~ll~~~----~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~---vKL~D 472 (554)
.+..|+||||+.+++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|
T Consensus 88 ~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~D 167 (676)
T 3qa8_A 88 APNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIID 167 (676)
T ss_dssp CTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred cCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcc
Confidence 67789999999999999999763 4899999999999999999999999999999999999997765 99999
Q ss_pred cCcccccccCC-ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008759 473 FGLAKATKLND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM 532 (554)
Q Consensus 473 FGlA~~~~~~~-~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~ 532 (554)
||++....... .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.
T Consensus 168 FG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~--~~s~ksDIwSLGviLyeLltG~~Pf~~~ 226 (676)
T 3qa8_A 168 LGYAKELDQGELCTEFVGTLQYLAPELLEQK--KYTVTVDYWSFGTLAFECITGFRPFLPN 226 (676)
T ss_dssp CCCCCBTTSCCCCCCCCSCCTTCSSCSSCCS--CCSTTHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccccccccccccccccCCcccCChHHhccC--CCCchhHHHHHHHHHHHHHHCCCCCCcc
Confidence 99998755433 3456799999999998654 4889999999999999999999999754
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-32 Score=276.52 Aligned_cols=175 Identities=27% Similarity=0.416 Sum_probs=150.4
Q ss_pred ccccceeee-eeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHH-HhCCCCceeeeeeeccC-
Q 008759 326 RIITYWQKG-DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL-SRFEHENIVQYYGTDKD- 401 (554)
Q Consensus 326 ~~~~~y~i~-~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL-~~l~HpnIVkl~~~~~~- 401 (554)
.+.++|.+. ++||+|+||.||+|.+ .+++.||+|++... ..+.+|+.++ +.++||||+++++++..
T Consensus 14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~ 83 (299)
T 3m2w_A 14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----------PKARREVELHWRASQCPHIVRIVDVYENL 83 (299)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred ccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc----------HHHHHHHHHHHHhccCCCchhHHhhhhhh
Confidence 345667776 8899999999999998 78999999998631 2355788777 66689999999998876
Q ss_pred ---CCcEEEEEeecccCchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcC---CCcEEEEe
Q 008759 402 ---ESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA---NGSVKLAD 472 (554)
Q Consensus 402 ---~~~~~LVmE~~~ggsL~~ll~~~---~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~---~g~vKL~D 472 (554)
...+|+||||+.+++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~D 163 (299)
T 3m2w_A 84 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD 163 (299)
T ss_dssp ETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred cCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEec
Confidence 67899999999999999999764 4899999999999999999999999999999999999998 78999999
Q ss_pred cCcccccccCCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008759 473 FGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM 532 (554)
Q Consensus 473 FGlA~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~ 532 (554)
||++..... ..++.++|||||||++|+|++|+.||...
T Consensus 164 fg~a~~~~~----------------------~~~~~~~DiwslG~il~el~tg~~pf~~~ 201 (299)
T 3m2w_A 164 FGFAKETTG----------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSN 201 (299)
T ss_dssp CTTCEECTT----------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-
T ss_pred ccccccccc----------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 998754321 13678999999999999999999999654
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-33 Score=294.18 Aligned_cols=202 Identities=18% Similarity=0.234 Sum_probs=154.2
Q ss_pred ccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCC-Ccee------------
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH-ENIV------------ 393 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~H-pnIV------------ 393 (554)
...|.++++||+|+||+||+|.+ .+|+.||||++...... .....+.+.+|+.++..++| .|+.
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~--~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~ 154 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERP--PSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 154 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC------CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCC
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCc--cHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccch
Confidence 34688999999999999999997 78999999988743221 22335678899999999977 2211
Q ss_pred ---ee------eeeccC-----CCcEEEEEeecccCchHHHHh--------hhcCChHHHHHHHHHHHHHHHHHHHCCcc
Q 008759 394 ---QY------YGTDKD-----ESKLYIFLELVTKGSLLNLYQ--------RYHLRDSQVSAYTRQILLGLKYLHDQDVV 451 (554)
Q Consensus 394 ---kl------~~~~~~-----~~~~~LVmE~~~ggsL~~ll~--------~~~l~e~~i~~i~~QIl~gL~yLHs~gII 451 (554)
.+ +..+.. ...++++|+++ +++|.++++ ...+++..+..++.||+.||.|||++||+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ii 233 (413)
T 3dzo_A 155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLV 233 (413)
T ss_dssp EEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred hhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 11 111111 22467777766 468988885 23467778889999999999999999999
Q ss_pred ccCCccccEEEcCCCcEEEEecCcccccccCCccCccCCCcccChhhhccc--------CCCCCchhhHHHHHHHHHHHH
Q 008759 452 HRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNK--------NKGYGLPADIWSLGCTVLEML 523 (554)
Q Consensus 452 HrDIKPeNILld~~g~vKL~DFGlA~~~~~~~~~s~~GT~~Y~APEvl~~~--------~~~~s~ksDIwSLGvllyeLL 523 (554)
||||||+||||+.++.+||+|||+++..... ....+| +.|+|||++... ...++.++|||||||++|+|+
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ell 311 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW 311 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE-ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc-cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHH
Confidence 9999999999999999999999998765433 344567 999999999421 223778999999999999999
Q ss_pred cCCCCCCCCCh
Q 008759 524 TSQIPYAPMEC 534 (554)
Q Consensus 524 TG~~PF~~~e~ 534 (554)
+|+.||.....
T Consensus 312 tg~~Pf~~~~~ 322 (413)
T 3dzo_A 312 CADLPNTDDAA 322 (413)
T ss_dssp HSSCCCCTTGG
T ss_pred HCCCCCCCcch
Confidence 99999987543
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.8e-31 Score=294.60 Aligned_cols=187 Identities=14% Similarity=0.083 Sum_probs=132.6
Q ss_pred eeccCCceeEEEEec-CCCcEEEEEEEeccc-----ccchhHHHHHHHHHHHHHHHhC-CCCceeeeeeeccCCCcEEEE
Q 008759 336 LLGRGSFGSVYEGIS-DDGFFFAVKEVSLLD-----QGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDESKLYIF 408 (554)
Q Consensus 336 ~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~-----~~~~~~~~~~~~~~Ei~iL~~l-~HpnIVkl~~~~~~~~~~~LV 408 (554)
.++.|++|.+..++. ..|+.|++|++.... .........+.+.+|+.+|+++ .|+||+++++++.++..+|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 456677777766554 568899999987532 1223344556799999999999 699999999999999999999
Q ss_pred EeecccCchHHHHhhhc-CChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC--Ccc
Q 008759 409 LELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--DVK 485 (554)
Q Consensus 409 mE~~~ggsL~~ll~~~~-l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~--~~~ 485 (554)
|||++|++|.+++.+.+ ++. ..|+.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+..... ...
T Consensus 321 MEyv~G~~L~d~i~~~~~l~~---~~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~~ 397 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGEEIDR---EKILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWPT 397 (569)
T ss_dssp EECCCSEEHHHHHHTTCCCCH---HHHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCSH
T ss_pred EecCCCCcHHHHHHhCCCCCH---HHHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCcccc
Confidence 99999999999998754 544 358999999999999999999999999999999999999999999865433 344
Q ss_pred CccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCC
Q 008759 486 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIP 528 (554)
Q Consensus 486 s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~P 528 (554)
+.+||+.|||||++.+. +..++|+|++|+++++|+++..+
T Consensus 398 t~vGTp~YmAPE~l~g~---~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 398 NLVQSFFVFVNELFAEN---KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp HHHHHHHHHHHHHC--------------------CCCCTTHHH
T ss_pred CceechhhccHHHhCCC---CCCcccccccccchhhhccccch
Confidence 56799999999999653 46689999999998877665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=7.1e-28 Score=265.61 Aligned_cols=189 Identities=20% Similarity=0.233 Sum_probs=147.0
Q ss_pred eeeeeeccCCceeEEEEecCCCcEEEEEEEecccccc---hhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEE
Q 008759 332 QKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGS---QAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (554)
Q Consensus 332 ~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~---~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LV 408 (554)
...++||+|+||.||+|.. .+..+++|+........ ......+++.+|+.++++++||||+++..++...+..|||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4467899999999999954 46788888875432221 2223356789999999999999999555555566778999
Q ss_pred EeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC-----
Q 008759 409 LELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----- 483 (554)
Q Consensus 409 mE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~----- 483 (554)
|||+.+++|.+++.. +..++.||+.||.|||++||+||||||+|||++. .+||+|||+++......
T Consensus 418 mE~~~ggsL~~~l~~-------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~ 488 (540)
T 3en9_A 418 MSYINGKLAKDVIED-------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVD 488 (540)
T ss_dssp EECCCSEEHHHHSTT-------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHH
T ss_pred EECCCCCCHHHHHHH-------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccccc
Confidence 999999999999876 5689999999999999999999999999999988 99999999998764421
Q ss_pred ----ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 008759 484 ----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYA 530 (554)
Q Consensus 484 ----~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~ 530 (554)
.....||+.|||||++......|+...|+|+..+-.++.+.++-+|.
T Consensus 489 ~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 489 LIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred hhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 13557999999999997644457888999999999988888877774
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=4.1e-24 Score=216.58 Aligned_cols=150 Identities=17% Similarity=0.138 Sum_probs=119.0
Q ss_pred cceeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccc-------------hhHHHHHHHHHHHHHHHhCCCCceeee
Q 008759 329 TYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGS-------------QAKQSISQLEQEIALLSRFEHENIVQY 395 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~-------------~~~~~~~~~~~Ei~iL~~l~HpnIVkl 395 (554)
..|.+++.||+|+||.||+|.+.+|+.||+|++....... ........+.+|+.+++.++ | +++
T Consensus 90 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v 166 (282)
T 1zar_A 90 KVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAV 166 (282)
T ss_dssp SCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSS
T ss_pred eEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCc
Confidence 3566779999999999999999889999999986421110 00124567889999999998 4 555
Q ss_pred eeeccCCCcEEEEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCc
Q 008759 396 YGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL 475 (554)
Q Consensus 396 ~~~~~~~~~~~LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGl 475 (554)
++++. .+..|+||||+.|++|.+ +. ......++.||+.||.|||++||+||||||+|||++ ++.+||+|||+
T Consensus 167 ~~~~~-~~~~~lvmE~~~g~~L~~-l~-----~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~ 238 (282)
T 1zar_A 167 PKVYA-WEGNAVLMELIDAKELYR-VR-----VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQ 238 (282)
T ss_dssp CCEEE-EETTEEEEECCCCEEGGG-CC-----CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTT
T ss_pred CeEEe-ccceEEEEEecCCCcHHH-cc-----hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCC
Confidence 55443 356799999999999987 32 234557999999999999999999999999999999 99999999999
Q ss_pred ccccccCCccCccCCCcccChhhhc
Q 008759 476 AKATKLNDVKSCRGTAFWMAPEVIN 500 (554)
Q Consensus 476 A~~~~~~~~~s~~GT~~Y~APEvl~ 500 (554)
++. +..|+|||++.
T Consensus 239 a~~-----------~~~~~a~e~l~ 252 (282)
T 1zar_A 239 SVE-----------VGEEGWREILE 252 (282)
T ss_dssp CEE-----------TTSTTHHHHHH
T ss_pred CeE-----------CCCCCHHHHHH
Confidence 853 34578999874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=3.1e-20 Score=185.11 Aligned_cols=142 Identities=22% Similarity=0.266 Sum_probs=109.3
Q ss_pred ceeeeeeeccCCceeEEEEec-CCCcE--EEEEEEecccccch-------------------hHHHHHHHHHHHHHHHhC
Q 008759 330 YWQKGDLLGRGSFGSVYEGIS-DDGFF--FAVKEVSLLDQGSQ-------------------AKQSISQLEQEIALLSRF 387 (554)
Q Consensus 330 ~y~i~~~LG~GsfG~VY~a~~-~~g~~--vAvK~v~~~~~~~~-------------------~~~~~~~~~~Ei~iL~~l 387 (554)
.|.+++.||+|+||.||+|.+ .+|+. ||+|++........ .......+.+|+.+|..+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 478899999999999999998 78989 99998754211100 112234678999999999
Q ss_pred CCCce--eeeeeeccCCCcEEEEEeeccc-C----chHHHHhhhcCChHHHHHHHHHHHHHHHHHH-HCCccccCCcccc
Q 008759 388 EHENI--VQYYGTDKDESKLYIFLELVTK-G----SLLNLYQRYHLRDSQVSAYTRQILLGLKYLH-DQDVVHRDIKCAN 459 (554)
Q Consensus 388 ~HpnI--Vkl~~~~~~~~~~~LVmE~~~g-g----sL~~ll~~~~l~e~~i~~i~~QIl~gL~yLH-s~gIIHrDIKPeN 459 (554)
.|++| ..+++. +..+|||||+.+ | .|.++... .++..+..++.||+.+|.||| ++||+||||||+|
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~N 201 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE--LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYN 201 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG--GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTS
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc--cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHH
Confidence 87754 344443 356899999953 3 66665432 235567889999999999999 9999999999999
Q ss_pred EEEcCCCcEEEEecCccccc
Q 008759 460 ILVDANGSVKLADFGLAKAT 479 (554)
Q Consensus 460 ILld~~g~vKL~DFGlA~~~ 479 (554)
||++. .++|+|||++...
T Consensus 202 ILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 202 IMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp EEESS--SEEECCCTTCEET
T ss_pred EEEcC--cEEEEECcccccC
Confidence 99988 9999999998654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.73 E-value=2e-18 Score=183.19 Aligned_cols=141 Identities=15% Similarity=0.140 Sum_probs=100.0
Q ss_pred ceeeeeeeccCCceeEEEEecCCCcEEEEEEEeccccc-------------chh----HHHHHHHHHHHHHHHhCCCCce
Q 008759 330 YWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQG-------------SQA----KQSISQLEQEIALLSRFEHENI 392 (554)
Q Consensus 330 ~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~-------------~~~----~~~~~~~~~Ei~iL~~l~HpnI 392 (554)
-|.++++||+|+||.||+|.+.+|+.||||+++..... ... ........+|...|.++.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 38999999999999999999999999999987532100 000 0111112345555555543332
Q ss_pred --eeeeeeccCCCcEEEEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCC----
Q 008759 393 --VQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG---- 466 (554)
Q Consensus 393 --Vkl~~~~~~~~~~~LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g---- 466 (554)
...++. ...+|||||+.|++|..+.. ......++.||+.+|.+||++|||||||||.|||++.+|
T Consensus 176 ~vp~p~~~----~~~~LVME~i~G~~L~~l~~-----~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d 246 (397)
T 4gyi_A 176 PVPEPIAQ----SRHTIVMSLVDALPMRQVSS-----VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAED 246 (397)
T ss_dssp SCCCEEEE----ETTEEEEECCSCEEGGGCCC-----CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSC
T ss_pred CCCeeeec----cCceEEEEecCCccHhhhcc-----cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCccc
Confidence 122221 12379999999988865422 234567889999999999999999999999999998877
Q ss_pred ------cEEEEecCccccc
Q 008759 467 ------SVKLADFGLAKAT 479 (554)
Q Consensus 467 ------~vKL~DFGlA~~~ 479 (554)
.+.|+||+-+...
T Consensus 247 ~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 247 PSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp TTSEEEEEEECCCTTCEET
T ss_pred ccccccceEEEEeCCcccC
Confidence 3899999977543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.32 E-value=3.3e-12 Score=125.71 Aligned_cols=142 Identities=13% Similarity=0.129 Sum_probs=110.8
Q ss_pred ccccceeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCC-CCceeeeeeeccCCCc
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDESK 404 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIVkl~~~~~~~~~ 404 (554)
..+..|.+...++.|+++.||++... +..+++|......... ...+.+|+.+++.+. +..+.++++++...+.
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~ 84 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGT-----TYDVEREKDMMLWLEGKLPVPKVLHFERHDGW 84 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTS-----TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred HHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCC-----HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCc
Confidence 34567888899999999999999765 6789999886421111 124778899998885 6677889988888889
Q ss_pred EEEEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHH-------------------------------------
Q 008759 405 LYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD------------------------------------- 447 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs------------------------------------- 447 (554)
.|+||||++|.+|...+. .......++.++..+|..||+
T Consensus 85 ~~lv~e~i~G~~l~~~~~----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 85 SNLLMSEADGVLCSEEYE----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEEEEECCSSEEHHHHCC----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred eEEEEEecCCeehhhccC----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 999999999999876521 222345688999999999998
Q ss_pred ----------------------CCccccCCccccEEEcCCCcEEEEecCccc
Q 008759 448 ----------------------QDVVHRDIKCANILVDANGSVKLADFGLAK 477 (554)
Q Consensus 448 ----------------------~gIIHrDIKPeNILld~~g~vKL~DFGlA~ 477 (554)
..++|+|++|.|||++.++.+.|+||+.+.
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 448999999999999876556799999764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.27 E-value=5.1e-12 Score=122.76 Aligned_cols=136 Identities=19% Similarity=0.157 Sum_probs=99.2
Q ss_pred cccceeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCc--eeeeeeeccCCCc
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN--IVQYYGTDKDESK 404 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hpn--IVkl~~~~~~~~~ 404 (554)
....|.+..+.+.|..+.||++...+|..+++|..... ....+.+|+.+++.+.+.+ +.+++.++...+.
T Consensus 18 ~~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~--------~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~ 89 (264)
T 1nd4_A 18 RLFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG--------ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGR 89 (264)
T ss_dssp TTTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC--------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSC
T ss_pred hcCCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc--------cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCC
Confidence 34456665544567779999998777888999987532 1134668888888886444 4568888887788
Q ss_pred EEEEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCC-----------------------------------
Q 008759 405 LYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQD----------------------------------- 449 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~g----------------------------------- 449 (554)
.|+||||++|.+|. .. ... ...++.++...|..||+..
T Consensus 90 ~~~v~e~i~G~~l~--~~--~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (264)
T 1nd4_A 90 DWLLLGEVPGQDLL--SS--HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH 162 (264)
T ss_dssp EEEEEECCSSEETT--TS--CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred CEEEEEecCCcccC--cC--cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhc
Confidence 99999999998884 11 111 2346677777777777643
Q ss_pred -----------------------ccccCCccccEEEcCCCcEEEEecCccc
Q 008759 450 -----------------------VVHRDIKCANILVDANGSVKLADFGLAK 477 (554)
Q Consensus 450 -----------------------IIHrDIKPeNILld~~g~vKL~DFGlA~ 477 (554)
++|+|++|.|||++.++.+.|+||+.+.
T Consensus 163 ~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 163 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred cCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 9999999999999876667799999864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.13 E-value=1.5e-10 Score=117.11 Aligned_cols=182 Identities=18% Similarity=0.168 Sum_probs=120.2
Q ss_pred eeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCC-CCc--eeeeeeeccCCC---cEEE
Q 008759 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HEN--IVQYYGTDKDES---KLYI 407 (554)
Q Consensus 334 ~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~-Hpn--IVkl~~~~~~~~---~~~L 407 (554)
.+.|+.|..+.||++. ..+++|.... ......+.+|+.+|+.+. +.. +.+++..+.... ..|+
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~-------~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~ 93 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKH-------SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFA 93 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESS-------HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCE
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCC-------cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceE
Confidence 3458999999999973 4688887542 133467889999998873 332 345555543333 4589
Q ss_pred EEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 008759 408 FLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD---------------------------------------- 447 (554)
Q Consensus 408 VmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs---------------------------------------- 447 (554)
||++++|.+|..... ..++..+...++.|+...|..||+
T Consensus 94 vm~~i~G~~l~~~~~-~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 94 GFTKIKGVPLTPLLL-NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp EEECCCCEECCHHHH-HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred EEcccCCeECCcccc-ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 999999988865322 356777777888888888888885
Q ss_pred ------------------CCccccCCccccEEEcC--CCcEEEEecCcccccccCCccCccCCCcc---cChhhhcccCC
Q 008759 448 ------------------QDVVHRDIKCANILVDA--NGSVKLADFGLAKATKLNDVKSCRGTAFW---MAPEVINNKNK 504 (554)
Q Consensus 448 ------------------~gIIHrDIKPeNILld~--~g~vKL~DFGlA~~~~~~~~~s~~GT~~Y---~APEvl~~~~~ 504 (554)
..++|+|++|.|||++. ++.+.|+||+.+....... -......+ ..|+.......
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~--Dl~~~~~~~~~~~~~~~~~~l~ 250 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN--DFISLMEDDEEYGMEFVSKILN 250 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH--HHHTTCCTTTSCCHHHHHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH--HHHHHHhhccccCHHHHHHHHH
Confidence 13799999999999988 4567899999875432110 00000011 22332211000
Q ss_pred CC------------CchhhHHHHHHHHHHHHcCCCCC
Q 008759 505 GY------------GLPADIWSLGCTVLEMLTSQIPY 529 (554)
Q Consensus 505 ~~------------s~ksDIwSLGvllyeLLTG~~PF 529 (554)
.| ....++|+++.++|.+.+|..+|
T Consensus 251 ~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 251 HYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 01 12268999999999999998876
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.10 E-value=2.4e-10 Score=118.12 Aligned_cols=140 Identities=13% Similarity=0.234 Sum_probs=103.0
Q ss_pred eeeeeccCCceeEEEEecCCCcEEEEEEEe--cccccchhHHHHHHHHHHHHHHHhCCC--CceeeeeeeccCC---CcE
Q 008759 333 KGDLLGRGSFGSVYEGISDDGFFFAVKEVS--LLDQGSQAKQSISQLEQEIALLSRFEH--ENIVQYYGTDKDE---SKL 405 (554)
Q Consensus 333 i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~--~~~~~~~~~~~~~~~~~Ei~iL~~l~H--pnIVkl~~~~~~~---~~~ 405 (554)
..+.|+.|.++.||++...+ ..+++|+.. .... ......+.+|+.+++.+.. ..+.+++.++.+. +..
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~----~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~ 116 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKL----LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRA 116 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS-CEEEEECCCC--------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSC
T ss_pred eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCC----CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCe
Confidence 35678999999999988764 577888654 2110 1122467789999998874 4577888877665 458
Q ss_pred EEEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHH--------------------------------------
Q 008759 406 YIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD-------------------------------------- 447 (554)
Q Consensus 406 ~LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs-------------------------------------- 447 (554)
|+||||+.|..+.+.. ...++..+...++.+++..|..||+
T Consensus 117 ~~vme~v~G~~l~~~~-~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 117 FYIMEFVSGRVLWDQS-LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp EEEEECCCCBCCCCTT-CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EEEEEecCCeecCCCc-cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 9999999998774311 1246677788899999999999997
Q ss_pred --------------------CCccccCCccccEEEcCCCc--EEEEecCcccc
Q 008759 448 --------------------QDVVHRDIKCANILVDANGS--VKLADFGLAKA 478 (554)
Q Consensus 448 --------------------~gIIHrDIKPeNILld~~g~--vKL~DFGlA~~ 478 (554)
..++|+|+++.|||++.++. +.|+||+++..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 35899999999999987753 68999998864
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.56 E-value=8.6e-07 Score=89.99 Aligned_cols=133 Identities=20% Similarity=0.154 Sum_probs=89.2
Q ss_pred eeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCC---ceeeeeeecc-CCCcEEEEE
Q 008759 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE---NIVQYYGTDK-DESKLYIFL 409 (554)
Q Consensus 334 ~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hp---nIVkl~~~~~-~~~~~~LVm 409 (554)
.+.++.|....||+. +..+++|.... ......+.+|..+|..+.+. .+.+++.++. ..+..|+||
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~-------~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~ 92 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS-------QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGY 92 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS-------HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEE
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC-------chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEE
Confidence 356888999999998 56788887431 22346788999999998742 2455565553 456688999
Q ss_pred eecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHH------------------------------------------
Q 008759 410 ELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD------------------------------------------ 447 (554)
Q Consensus 410 E~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs------------------------------------------ 447 (554)
|+++|..|....- ..++..+...++.++...|..||+
T Consensus 93 e~i~G~~l~~~~~-~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 93 RKVQGQILGEDGM-AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp ECCCSEECHHHHH-TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred eccCCeECchhhh-hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 9999988765211 122333333444444444444442
Q ss_pred ------------------CCccccCCccccEEEcC---CCcE-EEEecCcccc
Q 008759 448 ------------------QDVVHRDIKCANILVDA---NGSV-KLADFGLAKA 478 (554)
Q Consensus 448 ------------------~gIIHrDIKPeNILld~---~g~v-KL~DFGlA~~ 478 (554)
..++|+|+++.|||++. ++.+ .|+||+.+..
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 13699999999999987 4554 8999998754
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.48 E-value=1.5e-06 Score=85.29 Aligned_cols=131 Identities=13% Similarity=0.164 Sum_probs=89.2
Q ss_pred eccCCce-eEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCC-CCceeeeeeeccCCCcEEEEEeecc
Q 008759 337 LGRGSFG-SVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDESKLYIFLELVT 413 (554)
Q Consensus 337 LG~GsfG-~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIVkl~~~~~~~~~~~LVmE~~~ 413 (554)
+..|..| .||+... .++..+++|.... .....+.+|..+|+.+. +--+.+++.++.+.+..|+|||++.
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~--------~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~ 103 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKG--------SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIP 103 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEET--------HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCC
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCC--------CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeC
Confidence 4445444 6998877 4567889997652 12345778888888774 2235677888888889999999999
Q ss_pred cCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHC---------------------------------------------
Q 008759 414 KGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ--------------------------------------------- 448 (554)
Q Consensus 414 ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~--------------------------------------------- 448 (554)
|.++.+..... ......++.++...|..||..
T Consensus 104 G~~~~~~~~~~---~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 104 GKTAFQVLEEY---PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp SEEHHHHHHHC---GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred CccccccccCC---HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 98876654321 112223444444444444421
Q ss_pred -------------CccccCCccccEEEcCCCcEEEEecCcccc
Q 008759 449 -------------DVVHRDIKCANILVDANGSVKLADFGLAKA 478 (554)
Q Consensus 449 -------------gIIHrDIKPeNILld~~g~vKL~DFGlA~~ 478 (554)
.++|+|+.+.|||++.++.+-|+||+.+..
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 168999999999998877777999998643
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.11 E-value=5.5e-06 Score=86.53 Aligned_cols=80 Identities=13% Similarity=0.142 Sum_probs=48.1
Q ss_pred eeeeccCCceeEEEEec-CCCcEEEEEEEecccc-cchh-HHHHHHHHHHHHHHHhCCC--C-ceeeeeeeccCCCcEEE
Q 008759 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQ-GSQA-KQSISQLEQEIALLSRFEH--E-NIVQYYGTDKDESKLYI 407 (554)
Q Consensus 334 ~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~-~~~~-~~~~~~~~~Ei~iL~~l~H--p-nIVkl~~~~~~~~~~~L 407 (554)
.+.||.|.++.||++.. .+++.+++|....... .... .....++..|..+|..+.. + .+.+++.+. ....++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccEE
Confidence 46799999999999986 3568899997653111 0000 0012345678888877632 3 344566543 345689
Q ss_pred EEeecccC
Q 008759 408 FLELVTKG 415 (554)
Q Consensus 408 VmE~~~gg 415 (554)
|||++.+.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999774
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.11 E-value=1.3e-05 Score=80.62 Aligned_cols=30 Identities=20% Similarity=0.366 Sum_probs=27.4
Q ss_pred CCccccCCccccEEEcCCCcEEEEecCccc
Q 008759 448 QDVVHRDIKCANILVDANGSVKLADFGLAK 477 (554)
Q Consensus 448 ~gIIHrDIKPeNILld~~g~vKL~DFGlA~ 477 (554)
..++|+|+++.|||++.++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 579999999999999888899999999874
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.02 E-value=2.2e-05 Score=80.46 Aligned_cols=84 Identities=4% Similarity=-0.029 Sum_probs=51.8
Q ss_pred eeeeee-ccCCceeEEEEecC-------CCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCC---Cceeeeeeecc
Q 008759 332 QKGDLL-GRGSFGSVYEGISD-------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH---ENIVQYYGTDK 400 (554)
Q Consensus 332 ~i~~~L-G~GsfG~VY~a~~~-------~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~H---pnIVkl~~~~~ 400 (554)
...+.| +.|..+.+|+.... ++..+++|........... ....+.+|+.+++.+.. -.+.+++.++.
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~--~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~ 100 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVF--PTYRLDHQFEVIRLVGELTDVPVPRVRWIET 100 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSS--SCCCHHHHHHHHHHHHHHCCSCCCCEEEEEC
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccC--chhHHHHHHHHHHHHhhcCCCCCCcEEEEcc
Confidence 345678 88999999988654 2667888876432100000 01235567777766642 24566776665
Q ss_pred CC---CcEEEEEeecccCch
Q 008759 401 DE---SKLYIFLELVTKGSL 417 (554)
Q Consensus 401 ~~---~~~~LVmE~~~ggsL 417 (554)
+. +..|+||||++|..+
T Consensus 101 ~~~~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 101 TGDVLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp SSTTTSSCEEEEECCCCBCC
T ss_pred CCCccCCceEEEEecCCCCh
Confidence 54 357899999988654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.75 E-value=0.00013 Score=76.87 Aligned_cols=31 Identities=16% Similarity=0.355 Sum_probs=27.2
Q ss_pred HCCccccCCccccEEEcCCCcEEEEecCcccc
Q 008759 447 DQDVVHRDIKCANILVDANGSVKLADFGLAKA 478 (554)
Q Consensus 447 s~gIIHrDIKPeNILld~~g~vKL~DFGlA~~ 478 (554)
...++|+|+++.|||++.++ ++|+||+.+..
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 46799999999999998776 99999998754
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.61 E-value=0.00027 Score=72.42 Aligned_cols=75 Identities=17% Similarity=0.159 Sum_probs=56.9
Q ss_pred eeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCC---CCceeeeeeeccCCCcEEEEEe
Q 008759 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE---HENIVQYYGTDKDESKLYIFLE 410 (554)
Q Consensus 334 ~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~---HpnIVkl~~~~~~~~~~~LVmE 410 (554)
.+.|+.|.+..+|+.... +..+++|..... ....+..|...|+.+. ...+.+++.++...+..|+|||
T Consensus 41 ~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~--------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme 111 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDE-VQTVFVKINERS--------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLE 111 (312)
T ss_dssp EEEECCSSSSEEEEEESS-SCEEEEEEEEGG--------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEE
T ss_pred eEEeCCccceeeeEEEEC-CCeEEEEeCCcc--------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEE
Confidence 467899999999998764 667888876531 1345678888887774 2557788888777788999999
Q ss_pred ecccCch
Q 008759 411 LVTKGSL 417 (554)
Q Consensus 411 ~~~ggsL 417 (554)
|+++..+
T Consensus 112 ~l~G~~~ 118 (312)
T 3jr1_A 112 ALNKSKN 118 (312)
T ss_dssp CCCCCCC
T ss_pred eccCCCC
Confidence 9998754
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.60 E-value=0.00014 Score=73.80 Aligned_cols=31 Identities=35% Similarity=0.397 Sum_probs=26.9
Q ss_pred CCccccCCccccEEEcCC----CcEEEEecCcccc
Q 008759 448 QDVVHRDIKCANILVDAN----GSVKLADFGLAKA 478 (554)
Q Consensus 448 ~gIIHrDIKPeNILld~~----g~vKL~DFGlA~~ 478 (554)
..++|+|+.+.|||++.+ +.+.|+||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 469999999999999875 6899999998754
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.59 E-value=0.0002 Score=71.78 Aligned_cols=131 Identities=9% Similarity=0.070 Sum_probs=72.4
Q ss_pred eeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCce-eeeeeeccCCCcEEEEEeec
Q 008759 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI-VQYYGTDKDESKLYIFLELV 412 (554)
Q Consensus 334 ~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnI-Vkl~~~~~~~~~~~LVmE~~ 412 (554)
.+.|+.|..+.+|++ ..+++|+....... .....+|+.+++.+...++ .+++..+. +.-++++||+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~------~~~r~~E~~~l~~l~~~g~~P~~~~~~~--~~~~~v~e~i 89 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE------YINRANEAVAAREAAKAGVSPEVLHVDP--ATGVMVTRYI 89 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----------CCCHHHHHHHHHHHHHTTSSCCEEEECT--TTCCEEEECC
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc------eeCHHHHHHHHHHHHHcCCCCceEEEEC--CCCEEEEeec
Confidence 678999999999998 45888877532111 1112356666665542222 45555543 3347899999
Q ss_pred -ccCchHH---------------HHhh---hc--CC-----hHHHHHHHHH--------------HHHHHHHHH----H-
Q 008759 413 -TKGSLLN---------------LYQR---YH--LR-----DSQVSAYTRQ--------------ILLGLKYLH----D- 447 (554)
Q Consensus 413 -~ggsL~~---------------ll~~---~~--l~-----e~~i~~i~~Q--------------Il~gL~yLH----s- 447 (554)
.|.++.. .+.+ .. +. ...+..+..+ +...+..|. .
T Consensus 90 ~~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~ 169 (301)
T 3dxq_A 90 AGAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAH 169 (301)
T ss_dssp TTCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSS
T ss_pred CCCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhc
Confidence 6654421 0111 00 10 0111111111 111111111 1
Q ss_pred ---CCccccCCccccEEEcCCCcEEEEecCcccc
Q 008759 448 ---QDVVHRDIKCANILVDANGSVKLADFGLAKA 478 (554)
Q Consensus 448 ---~gIIHrDIKPeNILld~~g~vKL~DFGlA~~ 478 (554)
..++|+|+.+.||| ..++.+.|+||..+..
T Consensus 170 ~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 170 PLPLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred CCCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 23899999999999 5677899999997753
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.43 E-value=0.00061 Score=67.77 Aligned_cols=78 Identities=17% Similarity=0.021 Sum_probs=53.8
Q ss_pred ceeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCC---ceeeeeeeccCCCcEE
Q 008759 330 YWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE---NIVQYYGTDKDESKLY 406 (554)
Q Consensus 330 ~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hp---nIVkl~~~~~~~~~~~ 406 (554)
...-.+.+|.|..+.||+....+|+.|++|+........ ...+..|+..|+.+... -+.+++.... -+
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~-----~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~~----~~ 86 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPAL-----DGLFRAEALGLDWLGRSFGSPVPQVAGWDD----RT 86 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCC-----TTHHHHHHHHHHHHTCSTTCCSCCEEEEET----TE
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcch-----hhHHHHHHHHHHHHHhhCCCCcceEEeccC----ce
Confidence 455677899999999999999999999999765322111 12356788888877421 2445555432 37
Q ss_pred EEEeecccCc
Q 008759 407 IFLELVTKGS 416 (554)
Q Consensus 407 LVmE~~~ggs 416 (554)
+||||+.++.
T Consensus 87 lv~e~l~~~~ 96 (288)
T 3f7w_A 87 LAMEWVDERP 96 (288)
T ss_dssp EEEECCCCCC
T ss_pred EEEEeecccC
Confidence 8999988764
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.32 E-value=0.00082 Score=67.46 Aligned_cols=138 Identities=12% Similarity=0.075 Sum_probs=75.9
Q ss_pred eeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCc--eeeeeeec------cCCCc
Q 008759 333 KGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN--IVQYYGTD------KDESK 404 (554)
Q Consensus 333 i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hpn--IVkl~~~~------~~~~~ 404 (554)
-.+.|+.|....+|+....+| .+++|...... ....+..|+.++..+...+ +.+++... ...+.
T Consensus 26 ~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~-------~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~ 97 (322)
T 2ppq_A 26 SYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV-------EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGR 97 (322)
T ss_dssp EEEEECC---EEEEEEEESSC-CEEEEEECC----------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTE
T ss_pred EeeccCCCcccceEEEEeCCc-cEEEEEeCCCC-------CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCE
Confidence 345688898899999877655 67888876310 1123445666665553212 23333221 12356
Q ss_pred EEEEEeecccCchH-----------HH---Hhh----hcCC------hHHHHH---------------HHHHHHHHHHHH
Q 008759 405 LYIFLELVTKGSLL-----------NL---YQR----YHLR------DSQVSA---------------YTRQILLGLKYL 445 (554)
Q Consensus 405 ~~LVmE~~~ggsL~-----------~l---l~~----~~l~------e~~i~~---------------i~~QIl~gL~yL 445 (554)
.+++|+|++|..+. .. ++. ...+ ...... +...+...+.+|
T Consensus 98 ~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l 177 (322)
T 2ppq_A 98 PAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYL 177 (322)
T ss_dssp EEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHH
T ss_pred EEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHH
Confidence 78999999886431 01 111 1111 000000 001133445555
Q ss_pred HH-------CCccccCCccccEEEcCCCcEEEEecCcccc
Q 008759 446 HD-------QDVVHRDIKCANILVDANGSVKLADFGLAKA 478 (554)
Q Consensus 446 Hs-------~gIIHrDIKPeNILld~~g~vKL~DFGlA~~ 478 (554)
+. .+++|+|+.+.|||++.++.+.|+||+.+..
T Consensus 178 ~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 178 AAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp HHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 52 3699999999999998776668999998753
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.27 E-value=0.00064 Score=68.45 Aligned_cols=75 Identities=13% Similarity=0.055 Sum_probs=46.1
Q ss_pred eeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCc--eeeeeee-----ccCCCcEEE
Q 008759 335 DLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN--IVQYYGT-----DKDESKLYI 407 (554)
Q Consensus 335 ~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hpn--IVkl~~~-----~~~~~~~~L 407 (554)
..|+ |....||++...+|+.+++|....... . ...+..|..++..+.... +.+++.. ....+..++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~---~---~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~ 104 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERW---T---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFA 104 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTS---C---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEE
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCC---C---HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEE
Confidence 3466 788899998877777899998752111 1 124456666666654212 3444443 112456688
Q ss_pred EEeecccCc
Q 008759 408 FLELVTKGS 416 (554)
Q Consensus 408 VmE~~~ggs 416 (554)
+|++++|..
T Consensus 105 l~~~i~G~~ 113 (328)
T 1zyl_A 105 VFPSVGGRQ 113 (328)
T ss_dssp EEECCCCEE
T ss_pred EEEecCCCC
Confidence 999998854
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.09 E-value=0.00081 Score=71.61 Aligned_cols=74 Identities=11% Similarity=0.051 Sum_probs=48.3
Q ss_pred eeeeeccCCceeEEEEecCC--------CcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCce-eeeeeeccCCC
Q 008759 333 KGDLLGRGSFGSVYEGISDD--------GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI-VQYYGTDKDES 403 (554)
Q Consensus 333 i~~~LG~GsfG~VY~a~~~~--------g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnI-Vkl~~~~~~~~ 403 (554)
-.+.|+.|....||++...+ +..+++|+.... . . ...+..|+.++..+...++ .++++.+..
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~-~----~~~li~E~~~l~~L~~~g~~P~l~~~~~~-- 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--E-T----ESHLVAESVIFTLLSERHLGPKLYGIFSG-- 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--C-C----HHHHHHHHHHHHHHHHTTSSSCEEEEETT--
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--C-c----HHHHHHHHHHHHHHHhCCCCCcEEEEeCC--
Confidence 35678889999999997642 578899987421 1 1 1234468877777753333 567776643
Q ss_pred cEEEEEeecccCch
Q 008759 404 KLYIFLELVTKGSL 417 (554)
Q Consensus 404 ~~~LVmE~~~ggsL 417 (554)
.+||||++|.+|
T Consensus 148 --g~v~e~l~G~~l 159 (429)
T 1nw1_A 148 --GRLEEYIPSRPL 159 (429)
T ss_dssp --EEEECCCCEEEC
T ss_pred --CEEEEEeCCccc
Confidence 389999987443
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.05 E-value=0.0011 Score=69.78 Aligned_cols=134 Identities=16% Similarity=0.129 Sum_probs=79.5
Q ss_pred eeeccCCceeEEEEecC--------CCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCC-CCceeeeeeeccCCCcE
Q 008759 335 DLLGRGSFGSVYEGISD--------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDESKL 405 (554)
Q Consensus 335 ~~LG~GsfG~VY~a~~~--------~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIVkl~~~~~~~~~~ 405 (554)
+.|..|-...+|++... ++..|++|+..... .....+.+|..+++.+. +.-..++++.+..
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~------~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~---- 125 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL------QGVDSLVLESVMFAILAERSLGPQLYGVFPE---- 125 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc------chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----
Confidence 46777888889998764 35788898753211 11234457888887774 2223567776654
Q ss_pred EEEEeecccCchHH--------------HHh---hhc------C--ChHHHHHHHHHHHH-------------------H
Q 008759 406 YIFLELVTKGSLLN--------------LYQ---RYH------L--RDSQVSAYTRQILL-------------------G 441 (554)
Q Consensus 406 ~LVmE~~~ggsL~~--------------ll~---~~~------l--~e~~i~~i~~QIl~-------------------g 441 (554)
.+||||++|.+|.. .+. ... . -..++..+..++-. .
T Consensus 126 g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~ 205 (379)
T 3feg_A 126 GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDE 205 (379)
T ss_dssp EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHH
T ss_pred ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHH
Confidence 29999999865421 111 111 1 12455555554422 2
Q ss_pred HHHHH----H----CCccccCCccccEEEcCC----CcEEEEecCcccc
Q 008759 442 LKYLH----D----QDVVHRDIKCANILVDAN----GSVKLADFGLAKA 478 (554)
Q Consensus 442 L~yLH----s----~gIIHrDIKPeNILld~~----g~vKL~DFGlA~~ 478 (554)
+..|. . ..++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 206 ~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 206 MGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 33332 2 248999999999999876 7899999998753
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.02 E-value=0.00049 Score=71.01 Aligned_cols=73 Identities=8% Similarity=-0.093 Sum_probs=41.8
Q ss_pred eeeeccCCceeEEEEecCC---------CcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCc-eeeeeeeccCCC
Q 008759 334 GDLLGRGSFGSVYEGISDD---------GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN-IVQYYGTDKDES 403 (554)
Q Consensus 334 ~~~LG~GsfG~VY~a~~~~---------g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hpn-IVkl~~~~~~~~ 403 (554)
.+.|+.|....+|++...+ +..+++|+....... ......|..+++.+...+ +.++++.+.
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~------~~~~~~E~~~l~~L~~~g~~P~~~~~~~--- 108 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE------LYNTISEFEVYKTMSKYKIAPQLLNTFN--- 108 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG------TSCHHHHHHHHHHHHHTTSSCCEEEEET---
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc------eecHHHHHHHHHHHHhcCCCCceEEecC---
Confidence 4568888889999987643 267888876531111 011246677776664323 346665542
Q ss_pred cEEEEEeecccCc
Q 008759 404 KLYIFLELVTKGS 416 (554)
Q Consensus 404 ~~~LVmE~~~ggs 416 (554)
-++||||++|..
T Consensus 109 -~~~v~e~i~G~~ 120 (369)
T 3c5i_A 109 -GGRIEEWLYGDP 120 (369)
T ss_dssp -TEEEEECCCSEE
T ss_pred -CcEEEEEecCCc
Confidence 278999998754
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.92 E-value=0.0062 Score=62.39 Aligned_cols=31 Identities=26% Similarity=0.388 Sum_probs=27.3
Q ss_pred CCccccCCccccEEEcCCCcEEEEecCcccc
Q 008759 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA 478 (554)
Q Consensus 448 ~gIIHrDIKPeNILld~~g~vKL~DFGlA~~ 478 (554)
..++|+|+.+.|||++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3599999999999999888999999987654
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.74 E-value=0.015 Score=62.54 Aligned_cols=74 Identities=11% Similarity=-0.001 Sum_probs=47.1
Q ss_pred eeeeccCCceeEEEEecCC-CcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCce-eeeeeeccCCCcEEEEEee
Q 008759 334 GDLLGRGSFGSVYEGISDD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI-VQYYGTDKDESKLYIFLEL 411 (554)
Q Consensus 334 ~~~LG~GsfG~VY~a~~~~-g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnI-Vkl~~~~~~~~~~~LVmE~ 411 (554)
.+.|+.|-...+|++...+ +..|++|+......... ...+|+.++..+...++ .++++++.. .+||||
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i------dR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~ 182 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII------NREREKKISCILYNKNIAKKIYVFFTN----GRIEEF 182 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS------CHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEEC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc------CHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEe
Confidence 4678889999999998754 57888987743111110 11478888888865444 567777632 359999
Q ss_pred cccCch
Q 008759 412 VTKGSL 417 (554)
Q Consensus 412 ~~ggsL 417 (554)
++|.+|
T Consensus 183 I~G~~l 188 (458)
T 2qg7_A 183 MDGYAL 188 (458)
T ss_dssp CCSEEC
T ss_pred eCCccC
Confidence 987544
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.80 E-value=0.024 Score=60.33 Aligned_cols=74 Identities=5% Similarity=-0.129 Sum_probs=46.0
Q ss_pred eeeeccCCceeEEEEecCC--------CcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCC-CceeeeeeeccCCCc
Q 008759 334 GDLLGRGSFGSVYEGISDD--------GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH-ENIVQYYGTDKDESK 404 (554)
Q Consensus 334 ~~~LG~GsfG~VY~a~~~~--------g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~H-pnIVkl~~~~~~~~~ 404 (554)
++.|..|-...+|++...+ +..|++++........ -...+|..+++.+.. .-..++++.+.
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~------idR~~E~~~l~~L~~~gi~P~l~~~~~---- 144 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKF------YDSKVELDVFRYLSNINIAPNIIADFP---- 144 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CC------CCHHHHHHHHHHHHHTTSSCCEEEEET----
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchh------cCHHHHHHHHHHHHhcCCCCCEEEEcC----
Confidence 4567778888999987642 5788888764321111 112467777766642 22345565443
Q ss_pred EEEEEeecccCch
Q 008759 405 LYIFLELVTKGSL 417 (554)
Q Consensus 405 ~~LVmE~~~ggsL 417 (554)
-++||||++|..|
T Consensus 145 ~~~I~efI~G~~l 157 (424)
T 3mes_A 145 EGRIEEFIDGEPL 157 (424)
T ss_dssp TEEEEECCCSEEC
T ss_pred CCEEEEEeCCccC
Confidence 2789999998653
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.99 E-value=0.11 Score=54.23 Aligned_cols=29 Identities=28% Similarity=0.421 Sum_probs=24.8
Q ss_pred ccccCCccccEEE------cCCCcEEEEecCcccc
Q 008759 450 VVHRDIKCANILV------DANGSVKLADFGLAKA 478 (554)
Q Consensus 450 IIHrDIKPeNILl------d~~g~vKL~DFGlA~~ 478 (554)
++|+|+.+.|||+ +.++.++++||-.|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6799999999999 4567899999998753
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=94.33 E-value=0.21 Score=48.70 Aligned_cols=99 Identities=22% Similarity=0.124 Sum_probs=65.5
Q ss_pred chHHHHhh--hcCChHHHHHHHHHHHHHHHHHH-HCCccccCCccccEEEcCCCcEEEEecCcccccccCCccCccCCCc
Q 008759 416 SLLNLYQR--YHLRDSQVSAYTRQILLGLKYLH-DQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF 492 (554)
Q Consensus 416 sL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLH-s~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~~~s~~GT~~ 492 (554)
+|.++|+. .++++++++.++.|.+.+|.-+- .+.-..+=+.|..|++..+|.|.+.+ +.+. .....
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~----------~~~~~ 102 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD----------AGEPP 102 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc----------ccccC
Confidence 78998875 46999999999999999987762 22222334457999999999997663 1110 12234
Q ss_pred ccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCC
Q 008759 493 WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIP 528 (554)
Q Consensus 493 Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~P 528 (554)
+.+||... ...+.+.-|||||+++|.-|--.+|
T Consensus 103 ~~~pe~~~---~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 103 PVAGKLGY---SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ----CCSS---SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred CCChhhcc---ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 66888752 2346789999999999998874443
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 554 | ||||
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-58 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 8e-58 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-57 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-57 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-57 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-56 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-56 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-54 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 8e-53 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-52 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-51 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-51 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-51 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-49 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-48 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-48 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-48 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-48 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-47 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-47 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-46 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-46 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-46 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-46 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-46 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 7e-46 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 8e-46 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-45 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-44 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-44 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-44 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-44 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-43 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-43 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-43 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 7e-43 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 8e-43 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 8e-43 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-42 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-42 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-42 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-42 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-42 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-41 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-41 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-41 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-41 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 8e-41 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-40 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-40 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-40 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-40 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-40 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 9e-40 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-39 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-37 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-37 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-36 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-36 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 8e-35 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-34 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 7e-28 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-27 |
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 194 bits (493), Expect = 4e-58
Identities = 72/232 (31%), Positives = 112/232 (48%), Gaps = 14/232 (6%)
Query: 311 TTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQ 369
E P F + +G GSFG+VY + A+K++S G Q
Sbjct: 4 VAELFFKDDPEKLFSDL-------REIGHGSFGAVYFARDVRNSEVVAIKKMSY--SGKQ 54
Query: 370 AKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSL-LNLYQRYHLRD 428
+ + + +E+ L + H N +QY G E ++ +E + L + L++
Sbjct: 55 SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQE 114
Query: 429 SQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR 488
+++A T L GL YLH +++HRD+K NIL+ G VKL DFG A + S
Sbjct: 115 VEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSAS--IMAPANSFV 172
Query: 489 GTAFWMAPEVINNKNKG-YGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIF 539
GT +WMAPEVI ++G Y D+WSLG T +E+ + P M +SA++
Sbjct: 173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY 224
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 8e-58
Identities = 67/218 (30%), Positives = 114/218 (52%), Gaps = 13/218 (5%)
Query: 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE 388
+W+ LG G+FG VY+ + + A K + +++++ + EI +L+ +
Sbjct: 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVID-----TKSEEELEDYMVEIDILASCD 67
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLH 446
H NIV+ E+ L+I +E G++ + L +SQ+ +Q L L YLH
Sbjct: 68 HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH 127
Query: 447 DQDVVHRDIKCANILVDANGSVKLADFGLAK--ATKLNDVKSCRGTAFWMAPEVI---NN 501
D ++HRD+K NIL +G +KLADFG++ + S GT +WMAPEV+ +
Sbjct: 128 DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETS 187
Query: 502 KNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIF 539
K++ Y AD+WSLG T++EM + P+ + + +
Sbjct: 188 KDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLL 225
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 1e-57
Identities = 56/206 (27%), Positives = 105/206 (50%), Gaps = 9/206 (4%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
++K LG G+ G V++ G A K + L +Q+ +E+ +L
Sbjct: 8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL----EIKPAIRNQIIRELQVLHECNS 63
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQ 448
IV +YG + ++ I +E + GSL + ++ + + + + ++ GL YL ++
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 449 -DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYG 507
++HRD+K +NILV++ G +KL DFG++ + S GT +M+PE + Y
Sbjct: 124 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQ--GTHYS 181
Query: 508 LPADIWSLGCTVLEMLTSQIPYAPME 533
+ +DIWS+G +++EM + P P +
Sbjct: 182 VQSDIWSMGLSLVEMAVGRYPIPPPD 207
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (485), Expect = 2e-57
Identities = 57/201 (28%), Positives = 100/201 (49%), Gaps = 6/201 (2%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
++ G LG+G FG+VY F A+K + + QL +E+ + S H
Sbjct: 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLF--KAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQ 448
NI++ YG D +++Y+ LE G++ Q+ + + + Y ++ L Y H +
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 125
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGL 508
V+HRDIK N+L+ + G +K+ADFG + + + GT ++ PE+I + + +
Sbjct: 126 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMI--EGRMHDE 183
Query: 509 PADIWSLGCTVLEMLTSQIPY 529
D+WSLG E L + P+
Sbjct: 184 KVDLWSLGVLCYEFLVGKPPF 204
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (485), Expect = 2e-57
Identities = 73/233 (31%), Positives = 124/233 (53%), Gaps = 21/233 (9%)
Query: 318 ISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQ 376
+S +GRF + +GRGSF +VY+G+ ++ A E L K +
Sbjct: 4 MSNDGRFLKF------DIEIGRGSFKTVYKGLDTETTVEVAWCE---LQDRKLTKSERQR 54
Query: 377 LEQEIALLSRFEHENIVQYYG----TDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQV 431
++E +L +H NIV++Y T K + + + EL+T G+L +R+ ++ +
Sbjct: 55 FKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVL 114
Query: 432 SAYTRQILLGLKYLHDQD--VVHRDIKCANILVDA-NGSVKLADFGLAKATKLNDVKSCR 488
++ RQIL GL++LH + ++HRD+KC NI + GSVK+ D GLA + + K+
Sbjct: 115 RSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI 174
Query: 489 GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIK 541
GT +MAPE+ K Y D+++ G +LEM TS+ PY+ + + I+ +
Sbjct: 175 GTPEFMAPEMYEEK---YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR 224
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 3e-56
Identities = 61/216 (28%), Positives = 102/216 (47%), Gaps = 13/216 (6%)
Query: 331 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
G +G GSFG+VY+G AVK +L+ + Q + + E+ +L + H
Sbjct: 10 ITVGQRIGSGSFGTVYKGKWHGDV--AVK---MLNVTAPTPQQLQAFKNEVGVLRKTRHV 64
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQ 448
NI+ + G +L I + SL + ++ RQ G+ YLH +
Sbjct: 65 NILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 123
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNK 504
++HRD+K NI + + +VK+ DFGLA + G+ WMAPEVI ++K
Sbjct: 124 SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 183
Query: 505 G-YGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIF 539
Y +D+++ G + E++T Q+PY+ + I
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII 219
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 4e-56
Identities = 58/205 (28%), Positives = 106/205 (51%), Gaps = 11/205 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
W LG G++G V ++ AVK V + +A +++EI + H
Sbjct: 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEICINKMLNH 62
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
EN+V++YG ++ + Y+FLE + G L + + + + + Q++ G+ YLH
Sbjct: 63 ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 122
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNK 504
+ HRDIK N+L+D ++K++DFGLA + N+ + GT ++APE++ + +
Sbjct: 123 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR-E 181
Query: 505 GYGLPADIWSLGCTVLEMLTSQIPY 529
+ P D+WS G + ML ++P+
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPW 206
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 1e-54
Identities = 69/225 (30%), Positives = 115/225 (51%), Gaps = 17/225 (7%)
Query: 320 PNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLE 378
P ++ R + +G+G+ G+VY + G A+++++L Q +
Sbjct: 18 PKKKYTRF-------EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-----PKKELII 65
Query: 379 QEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQI 438
EI ++ ++ NIV Y + +L++ +E + GSL ++ + + Q++A R+
Sbjct: 66 NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCREC 125
Query: 439 LLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK--SCRGTAFWMAP 496
L L++LH V+HRDIK NIL+ +GSVKL DFG K + GT +WMAP
Sbjct: 126 LQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 185
Query: 497 EVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIK 541
EV+ K YG DIWSLG +EM+ + PY + A+++
Sbjct: 186 EVV--TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI 228
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 8e-53
Identities = 57/205 (27%), Positives = 106/205 (51%), Gaps = 10/205 (4%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
++ G +LG GSF +V +A+K + + + + + +E ++SR +H
Sbjct: 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEK--RHIIKENKVPYVTRERDVMSRLDH 67
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQ 448
V+ Y T +D+ KLY L G LL ++ ++ YT +I+ L+YLH +
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKA----TKLNDVKSCRGTAFWMAPEVINNKNK 504
++HRD+K NIL++ + +++ DFG AK +K S GTA +++PE++ K
Sbjct: 128 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL--TEK 185
Query: 505 GYGLPADIWSLGCTVLEMLTSQIPY 529
+D+W+LGC + +++ P+
Sbjct: 186 SACKSSDLWALGCIIYQLVAGLPPF 210
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 4e-52
Identities = 69/218 (31%), Positives = 104/218 (47%), Gaps = 20/218 (9%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
++ +G GS+G + DG KE LD GS + L E+ LL +H
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKE---LDYGSMTEAEKQMLVSEVNLLRELKH 62
Query: 390 ENIVQYY--GTDKDESKLYIFLELVTKGSLLNLYQRY-----HLRDSQVSAYTRQILLGL 442
NIV+YY D+ + LYI +E G L ++ + +L + V Q+ L L
Sbjct: 63 PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122
Query: 443 KYLHDQD-----VVHRDIKCANILVDANGSVKLADFGLAKATKLND--VKSCRGTAFWMA 495
K H + V+HRD+K AN+ +D +VKL DFGLA+ + K+ GT ++M+
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMS 182
Query: 496 PEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME 533
PE +N Y +DIWSLGC + E+ P+
Sbjct: 183 PEQMN--RMSYNEKSDIWSLGCLLYELCALMPPFTAFS 218
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 178 bits (452), Expect = 1e-51
Identities = 54/221 (24%), Positives = 109/221 (49%), Gaps = 13/221 (5%)
Query: 325 KRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
+ Y+ + LG G+FG V+ + G F K ++ + ++ EI++
Sbjct: 25 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFIN-----TPYPLDKYTVKNEISI 79
Query: 384 LSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLG 441
+++ H ++ + +D+ ++ + LE ++ G L + Y + +++V Y RQ G
Sbjct: 80 MNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEG 139
Query: 442 LKYLHDQDVVHRDIKCANILVDA--NGSVKLADFGLAKATKLNDVKSCR-GTAFWMAPEV 498
LK++H+ +VH DIK NI+ + SVK+ DFGLA +++ TA + APE+
Sbjct: 140 LKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEI 199
Query: 499 INNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIF 539
++ + G D+W++G +L+ P+A + + +
Sbjct: 200 VD--REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQ 238
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 176 bits (446), Expect = 1e-51
Identities = 59/211 (27%), Positives = 108/211 (51%), Gaps = 12/211 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQ----EIALLS 385
++ ++LGRG V I +AVK + + GS + + + +L + E+ +L
Sbjct: 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64
Query: 386 RF-EHENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLK 443
+ H NI+Q T + + ++ +L+ KG L + L ++ L + + R +L +
Sbjct: 65 KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVIC 124
Query: 444 YLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-VKSCRGTAFWMAPEVI--- 499
LH ++VHRD+K NIL+D + ++KL DFG + + ++ GT ++APE+I
Sbjct: 125 ALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECS 184
Query: 500 -NNKNKGYGLPADIWSLGCTVLEMLTSQIPY 529
N+ + GYG D+WS G + +L P+
Sbjct: 185 MNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 215
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 177 bits (450), Expect = 2e-51
Identities = 55/223 (24%), Positives = 98/223 (43%), Gaps = 13/223 (5%)
Query: 323 RFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEI 381
+ ++ ++ + LG G+FG V+ G FA K V + + +EI
Sbjct: 20 KHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE-----SDKETVRKEI 74
Query: 382 ALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQIL 439
+S H +V + +D++++ + E ++ G L + + + + Y RQ+
Sbjct: 75 QTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVC 134
Query: 440 LGLKYLHDQDVVHRDIKCANILV--DANGSVKLADFGLAK-ATKLNDVKSCRGTAFWMAP 496
GL ++H+ + VH D+K NI+ + +KL DFGL VK GTA + AP
Sbjct: 135 KGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAP 194
Query: 497 EVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIF 539
EV + K G D+WS+G +L+ P+ +
Sbjct: 195 EVA--EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLR 235
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 3e-49
Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 8/210 (3%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL-LDQGSQAKQSISQLEQEIALLSRF- 387
+Q G LLG G FGSVY GI D A+K V + +++ E+ LL +
Sbjct: 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 388 -EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQILLGLKY 444
+++ + + LE L + +R L++ ++ Q+L +++
Sbjct: 66 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125
Query: 445 LHDQDVVHRDIKCANILVDAN-GSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKN 503
H+ V+HRDIK NIL+D N G +KL DFG K GT + PE I
Sbjct: 126 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYH- 184
Query: 504 KGYGLPADIWSLGCTVLEMLTSQIPYAPME 533
+ +G A +WSLG + +M+ IP+ E
Sbjct: 185 RYHGRSAAVWSLGILLYDMVCGDIPFEHDE 214
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 169 bits (428), Expect = 1e-48
Identities = 59/205 (28%), Positives = 97/205 (47%), Gaps = 12/205 (5%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
+ D+LG G+F V A+K ++ + +E EIA+L + +H
Sbjct: 11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAK----KALEGKEGSMENEIAVLHKIKH 66
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
NIV + LY+ ++LV+ G L + + ++ + S Q+L +KYLHD
Sbjct: 67 PNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL 126
Query: 449 DVVHRDIKCANILV---DANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPEVINNKNK 504
+VHRD+K N+L D + + ++DFGL+K V + GT ++APEV+ K
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVL--AQK 184
Query: 505 GYGLPADIWSLGCTVLEMLTSQIPY 529
Y D WS+G +L P+
Sbjct: 185 PYSKAVDCWSIGVIAYILLCGYPPF 209
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 1e-48
Identities = 61/203 (30%), Positives = 104/203 (51%), Gaps = 7/203 (3%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
+ +LG+GSFG V+ FFA+K + D + ++ L +EH
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKK-DVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
+ + T + + L+ +E + G L+ + + S+ + Y +I+LGL++LH +
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK 122
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK--SCRGTAFWMAPEVINNKNKGY 506
+V+RD+K NIL+D +G +K+ADFG+ K L D K + GT ++APE++ + Y
Sbjct: 123 GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEIL--LGQKY 180
Query: 507 GLPADIWSLGCTVLEMLTSQIPY 529
D WS G + EML Q P+
Sbjct: 181 NHSVDWWSFGVLLYEMLIGQSPF 203
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 169 bits (430), Expect = 2e-48
Identities = 62/202 (30%), Positives = 105/202 (51%), Gaps = 4/202 (1%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLE-QEIALLSRFE 388
+ ++GRG FG VY D G +A+K + + ++++ E ++L+S +
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 389 HENIVQYYGTDKDESKLYIFLELVTKGSLL-NLYQRYHLRDSQVSAYTRQILLGLKYLHD 447
IV KL L+L+ G L +L Q ++ + Y +I+LGL+++H+
Sbjct: 66 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 125
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYG 507
+ VV+RD+K ANIL+D +G V+++D GLA + GT +MAPEV+ Y
Sbjct: 126 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQK-GVAYD 184
Query: 508 LPADIWSLGCTVLEMLTSQIPY 529
AD +SLGC + ++L P+
Sbjct: 185 SSADWFSLGCMLFKLLRGHSPF 206
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 3e-48
Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 8/212 (3%)
Query: 335 DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
D LG G F +VY+ + A+K++ L + +EI LL H NI+
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVH 452
+S + + + + + + L S + AY L GL+YLH ++H
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILH 123
Query: 453 RDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR--GTAFWMAPEVINNKNKGYGLPA 510
RD+K N+L+D NG +KLADFGLAK+ + T ++ APE++ + YG+
Sbjct: 124 RDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFG-ARMYGVGV 182
Query: 511 DIWSLGCTVLEMLTSQIPYA---PMECVSAIF 539
D+W++GC + E+L ++ ++ IF
Sbjct: 183 DMWAVGCILAELLLRVPFLPGDSDLDQLTRIF 214
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 1e-47
Identities = 52/205 (25%), Positives = 92/205 (44%), Gaps = 14/205 (6%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
LG G FG V G + A+K + + S + +E ++ HE +V
Sbjct: 9 LKELGTGQFGVVKYGKWRGQYDVAIKMIK------EGSMSEDEFIEEAKVMMNLSHEKLV 62
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNL--YQRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
Q YG + ++I E + G LLN R+ + Q+ + + ++YL + +
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL 122
Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEVINNKNKGYGL 508
HRD+ N LV+ G VK++DFGL++ ++ S + W PEV+ +
Sbjct: 123 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLM--YSKFSS 180
Query: 509 PADIWSLGCTVLEMLTS-QIPYAPM 532
+DIW+ G + E+ + ++PY
Sbjct: 181 KSDIWAFGVLMWEIYSLGKMPYERF 205
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 1e-47
Identities = 44/211 (20%), Positives = 85/211 (40%), Gaps = 13/211 (6%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
+G G FG V+ G + A+K + + S +E ++ + H +V
Sbjct: 10 VQEIGSGQFGLVHLGYWLNKDKVAIKTIR------EGAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS--QVSAYTRQILLGLKYLHDQDVV 451
Q YG +++ + + E + G L + + + + + G+ YL + V+
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVI 123
Query: 452 HRDIKCANILVDANGSVKLADFGLAKA---TKLNDVKSCRGTAFWMAPEVINNKNKGYGL 508
HRD+ N LV N +K++DFG+ + + + W +PEV + Y
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS--FSRYSS 181
Query: 509 PADIWSLGCTVLEMLTSQIPYAPMECVSAIF 539
+D+WS G + E+ + S +
Sbjct: 182 KSDVWSFGVLMWEVFSEGKIPYENRSNSEVV 212
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 1e-46
Identities = 59/214 (27%), Positives = 96/214 (44%), Gaps = 15/214 (7%)
Query: 332 QKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
+ + LG G FG V+ G + AVK + Q S E L+ + +H+
Sbjct: 16 KLVERLGAGQFGEVWMGYYNGHTKVAVKSLK------QGSMSPDAFLAEANLMKQLQHQR 69
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSL---LNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
+V+ Y E +YI E + GSL L L +++ QI G+ ++ ++
Sbjct: 70 LVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV---KSCRGTAFWMAPEVINNKNKG 505
+ +HRD++ ANILV S K+ADFGLA+ + N+ + + W APE IN
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 188
Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIF 539
+D+WS G + E++T P +
Sbjct: 189 I--KSDVWSFGILLTEIVTHGRIPYPGMTNPEVI 220
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 2e-46
Identities = 47/211 (22%), Positives = 96/211 (45%), Gaps = 14/211 (6%)
Query: 325 KRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIAL 383
K + + + LGRG FG V+ + + + K V + +++EI++
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV------KGTDQVLVKKEISI 54
Query: 384 LSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLG 441
L+ H NI+ + + + +L + E ++ + + L + ++ +Y Q+
Sbjct: 55 LNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEA 114
Query: 442 LKYLHDQDVVHRDIKCANILVDA--NGSVKLADFGLAKATKLND-VKSCRGTAFWMAPEV 498
L++LH ++ H DI+ NI+ + ++K+ +FG A+ K D + + APEV
Sbjct: 115 LQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV 174
Query: 499 INNKNKGYGLPADIWSLGCTVLEMLTSQIPY 529
++ D+WSLG V +L+ P+
Sbjct: 175 H--QHDVVSTATDMWSLGTLVYVLLSGINPF 203
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 2e-46
Identities = 57/208 (27%), Positives = 103/208 (49%), Gaps = 10/208 (4%)
Query: 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSL-LDQGSQAKQSISQLEQEIALLSRF 387
Y+ G+ LG G F V + G +A K + + S+ S +E+E+++L
Sbjct: 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLH 446
+H N++ + ++++ + + LELV G L + L + + + + +QIL G+ YLH
Sbjct: 71 QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 130
Query: 447 DQDVVHRDIKCANILVDANGS----VKLADFGLAKATKLNDVKSCR-GTAFWMAPEVINN 501
+ H D+K NI++ +K+ DFGLA + GT ++APE++N
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN- 189
Query: 502 KNKGYGLPADIWSLGCTVLEMLTSQIPY 529
+ GL AD+WS+G +L+ P+
Sbjct: 190 -YEPLGLEADMWSIGVITYILLSGASPF 216
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (407), Expect = 3e-46
Identities = 52/212 (24%), Positives = 95/212 (44%), Gaps = 15/212 (7%)
Query: 332 QKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
+ +G+G FG V G G AVK + + E +++++ H N
Sbjct: 10 KLLQTIGKGEFGDVMLGD-YRGNKVAVKCIKN-------DATAQAFLAEASVMTQLRHSN 61
Query: 392 IVQYYGTD-KDESKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHD 447
+VQ G +++ LYI E + KGSL++ + R L + ++ + ++YL
Sbjct: 62 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 121
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYG 507
+ VHRD+ N+LV + K++DFGL K + + + W APE + + K +
Sbjct: 122 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS-STQDTGKLPVKWTAPEAL--REKKFS 178
Query: 508 LPADIWSLGCTVLEMLTSQIPYAPMECVSAIF 539
+D+WS G + E+ + P + +
Sbjct: 179 TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV 210
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 5e-46
Identities = 62/212 (29%), Positives = 97/212 (45%), Gaps = 15/212 (7%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
LG+G FG V+ G + A+K + S QE ++ + HE +V
Sbjct: 22 EVKLGQGCFGEVWMGTWNGTTRVAIKTLK------PGTMSPEAFLQEAQVMKKLRHEKLV 75
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDV 450
Q Y +E +YI E ++KGSLL+ + +LR Q+ QI G+ Y+ +
Sbjct: 76 QLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 134
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDV---KSCRGTAFWMAPEVINNKNKGYG 507
VHRD++ ANILV N K+ADFGLA+ + N+ + + W APE +
Sbjct: 135 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL--YGRFT 192
Query: 508 LPADIWSLGCTVLEMLTSQIPYAPMECVSAIF 539
+ +D+WS G + E+ T P +
Sbjct: 193 IKSDVWSFGILLTELTTKGRVPYPGMVNREVL 224
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 7e-46
Identities = 58/206 (28%), Positives = 94/206 (45%), Gaps = 16/206 (7%)
Query: 337 LGRGSFGSVYEGI---SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
LG G+FG+V +G AVK +L + +L E ++ + ++ IV
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVK---ILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVH 452
+ G + ES + +E+ G L L Q H++D + Q+ +G+KYL + + VH
Sbjct: 72 RMIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 130
Query: 453 RDIKCANILVDANGSVKLADFGLAKA-----TKLNDVKSCRGTAFWMAPEVINNKNKGYG 507
RD+ N+L+ K++DFGL+KA + W APE IN +
Sbjct: 131 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN--YYKFS 188
Query: 508 LPADIWSLGCTVLEMLTS-QIPYAPM 532
+D+WS G + E + Q PY M
Sbjct: 189 SKSDVWSFGVLMWEAFSYGQKPYRGM 214
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 161 bits (408), Expect = 8e-46
Identities = 64/213 (30%), Positives = 110/213 (51%), Gaps = 10/213 (4%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
+Q LG GSFG V+ S +G ++A+K + + + + E +LS H
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKK--EIVVRLKQVEHTNDERLMLSIVTH 63
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSA-YTRQILLGLKYLHDQ 448
I++ +GT +D ++++ ++ + G L +L ++ + V+ Y ++ L L+YLH +
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK 123
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGL 508
D+++RD+K NIL+D NG +K+ DFG AK + + GT ++APEV+ K Y
Sbjct: 124 DIIYRDLKPENILLDKNGHIKITDFGFAKYVP-DVTYTLCGTPDYIAPEVV--STKPYNK 180
Query: 509 PADIWSLGCTVLEMLTSQIPYA---PMECVSAI 538
D WS G + EML P+ M+ I
Sbjct: 181 SIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI 213
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 2e-45
Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 18/208 (8%)
Query: 337 LGRGSFGSVYEGI---SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
LG G+FGSV +G+ A+K + K ++ +E ++ + ++ IV
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQ----GTEKADTEEMMREAQIMHQLDNPYIV 72
Query: 394 QYYGTDKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQILLGLKYLHDQDVV 451
+ G + E L + +E+ G L +R + S V+ Q+ +G+KYL +++ V
Sbjct: 73 RLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 131
Query: 452 HRDIKCANILVDANGSVKLADFGLAKATKLNDV-----KSCRGTAFWMAPEVINNKNKGY 506
HRD+ N+L+ K++DFGL+KA +D + + W APE IN + +
Sbjct: 132 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN--FRKF 189
Query: 507 GLPADIWSLGCTVLEMLTS-QIPYAPME 533
+D+WS G T+ E L+ Q PY M+
Sbjct: 190 SSRSDVWSYGVTMWEALSYGQKPYKKMK 217
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 157 bits (397), Expect = 2e-44
Identities = 55/219 (25%), Positives = 96/219 (43%), Gaps = 20/219 (9%)
Query: 334 GDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
++G G FG V G F A+K + ++ E +++ +F+H
Sbjct: 31 EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKS----GYTEKQRRDFLSEASIMGQFDH 86
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS--QVSAYTRQILLGLKYLHD 447
N++ G + + I E + GSL + ++ + + Q+ R I G+KYL D
Sbjct: 87 PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLAD 146
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA-------TKLNDVKSCRGTAFWMAPEVIN 500
+ VHRD+ NILV++N K++DFGL++ + W APE I
Sbjct: 147 MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQ 206
Query: 501 NKNKGYGLPADIWSLGCTVLEMLTS-QIPYAPMECVSAI 538
+ + +D+WS G + E+++ + PY M I
Sbjct: 207 --YRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVI 243
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 156 bits (395), Expect = 2e-44
Identities = 61/214 (28%), Positives = 106/214 (49%), Gaps = 10/214 (4%)
Query: 332 QKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN 391
+ +G G++G VY+ ++ G FA+K++ L + +EI++L +H N
Sbjct: 5 HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPS---TTIREISILKELKHSN 61
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNL-YQRYHLRDSQVSAYTRQILLGLKYLHDQDV 450
IV+ Y + +L + E + + L L ++ Q+L G+ Y HD+ V
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRV 121
Query: 451 VHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR--GTAFWMAPEVINNKNKGYGL 508
+HRD+K N+L++ G +K+ADFGLA+A + K T ++ AP+V+ +K Y
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG-SKKYST 180
Query: 509 PADIWSLGCTVLEMLTSQIPYA---PMECVSAIF 539
DIWS+GC EM+ + + + IF
Sbjct: 181 TIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIF 214
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 3e-44
Identities = 65/214 (30%), Positives = 109/214 (50%), Gaps = 9/214 (4%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
+QK + +G G++G VY+ + G A+K++ L ++ + S +EI+LL H
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 60
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHD 447
NIV+ E+KLY+ E + + + + + +Y Q+L GL + H
Sbjct: 61 PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKA--TKLNDVKSCRGTAFWMAPEVINNKNKG 505
V+HRD+K N+L++ G++KLADFGLA+A + T ++ APE++ K
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG-CKY 179
Query: 506 YGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIF 539
Y DIWSLGC EM+T + + + +F
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF 213
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 4e-44
Identities = 57/221 (25%), Positives = 96/221 (43%), Gaps = 17/221 (7%)
Query: 331 WQKGDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR 386
+ + LG GSFG V G S AVK + +++ +E+ +
Sbjct: 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLK--PDVLSQPEAMDDFIREVNAMHS 67
Query: 387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKY 444
+H N+++ YG + + EL GSLL+ +++ H +S Y Q+ G+ Y
Sbjct: 68 LDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-----VKSCRGTAFWMAPEVI 499
L + +HRD+ N+L+ VK+ DFGL +A ND + + W APE +
Sbjct: 127 LESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186
Query: 500 NNKNKGYGLPADIWSLGCTVLEMLTS-QIPYAPMECVSAIF 539
+ + +D W G T+ EM T Q P+ + +
Sbjct: 187 K--TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH 225
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 1e-43
Identities = 64/230 (27%), Positives = 111/230 (48%), Gaps = 11/230 (4%)
Query: 310 TTTEPMSNISPNGRFKRI-ITYWQKGDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLL 364
T + + G +++ I ++ +LG G++G V+ D G +A+K +
Sbjct: 4 TVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKK- 62
Query: 365 DQGSQAKQSISQLEQEIALLSRFEHE-NIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQ 422
Q ++ E +L +V + + E+KL++ L+ + G L L Q
Sbjct: 63 ATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ 122
Query: 423 RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA---KAT 479
R + +V Y +I+L L++LH +++RDIK NIL+D+NG V L DFGL+ A
Sbjct: 123 RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD 182
Query: 480 KLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY 529
+ GT +MAP+++ + G+ D WSLG + E+LT P+
Sbjct: 183 ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPF 232
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 3e-43
Identities = 57/222 (25%), Positives = 105/222 (47%), Gaps = 20/222 (9%)
Query: 324 FKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIA 382
F ++ ++K +G+G+FG V++ G A+K+V + ++ +EI
Sbjct: 5 FCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPI---TALREIK 61
Query: 383 LLSRFEHENIVQYYGT--------DKDESKLYIFLELVTKGSL-LNLYQRYHLRDSQVSA 433
+L +HEN+V ++ + +Y+ + L S++
Sbjct: 62 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKR 121
Query: 434 YTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKA------TKLNDVKSC 487
+ +L GL Y+H ++HRD+K AN+L+ +G +KLADFGLA+A ++ N +
Sbjct: 122 VMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR 181
Query: 488 RGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY 529
T ++ PE++ + + YG P D+W GC + EM T
Sbjct: 182 VVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIM 222
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 4e-43
Identities = 57/203 (28%), Positives = 97/203 (47%), Gaps = 8/203 (3%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
+ LLG+G+FG V G ++A+K + + AK ++ E +L H
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRK--EVIIAKDEVAHTVTESRVLQNTRH 64
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
+ + +L +E G L L + + + Y +I+ L+YLH +
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR--GTAFWMAPEVINNKNKGY 506
DVV+RDIK N+++D +G +K+ DFGL K + GT ++APEV+ ++ Y
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL--EDNDY 182
Query: 507 GLPADIWSLGCTVLEMLTSQIPY 529
G D W LG + EM+ ++P+
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPF 205
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 7e-43
Identities = 62/209 (29%), Positives = 98/209 (46%), Gaps = 12/209 (5%)
Query: 331 WQKGDLLGRGSFGSVYEG--ISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE 388
++ +G G++G V++ + + G F A+K V + S + + L FE
Sbjct: 9 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 68
Query: 389 HENIVQYYG-----TDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLG 441
H N+V+ + E+KL + E V + L + + + Q+L G
Sbjct: 69 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRG 128
Query: 442 LKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV-KSCRGTAFWMAPEVIN 500
L +LH VVHRD+K NILV ++G +KLADFGLA+ S T ++ APEV+
Sbjct: 129 LDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVL- 187
Query: 501 NKNKGYGLPADIWSLGCTVLEMLTSQIPY 529
Y P D+WS+GC EM + +
Sbjct: 188 -LQSSYATPVDLWSVGCIFAEMFRRKPLF 215
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 8e-43
Identities = 60/217 (27%), Positives = 98/217 (45%), Gaps = 16/217 (7%)
Query: 334 GDLLGRGSFGSVYEGI----SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
G +G G FG V++GI + A+K S ++ QE + +F+H
Sbjct: 12 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK----FLQEALTMRQFDH 67
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH--LRDSQVSAYTRQILLGLKYLHD 447
+IV+ G E+ ++I +EL T G L + Q L + + Y Q+ L YL
Sbjct: 68 PHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 126
Query: 448 QDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK---SCRGTAFWMAPEVINNKNK 504
+ VHRDI N+LV +N VKL DFGL++ + + + WMAPE IN +
Sbjct: 127 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN--FR 184
Query: 505 GYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIK 541
+ +D+W G + E+L + + + +
Sbjct: 185 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR 221
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 8e-43
Identities = 64/243 (26%), Positives = 97/243 (39%), Gaps = 29/243 (11%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIV 393
+ +G+G FG V+ G G AVK S ++ S + E EI HENI+
Sbjct: 8 QESIGKGRFGEVWRGK-WRGEEVAVKIFSSREERSWFR------EAEIYQTVMLRHENIL 60
Query: 394 QYYGTDKDE----SKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLH--- 446
+ D + ++L++ + GSL + RY + + GL +LH
Sbjct: 61 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEI 120
Query: 447 -----DQDVVHRDIKCANILVDANGSVKLADFGL------AKATKLNDVKSCRGTAFWMA 495
+ HRD+K NILV NG+ +AD GL A T GT +MA
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180
Query: 496 PEV----INNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTVAVTVIIIL 551
PEV IN K+ ADI+++G E+ E + V +
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240
Query: 552 IKK 554
++K
Sbjct: 241 MRK 243
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 151 bits (381), Expect = 3e-42
Identities = 56/213 (26%), Positives = 97/213 (45%), Gaps = 15/213 (7%)
Query: 334 GDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI 392
LG G +G VYEG+ AVK + + + + +E A++ +H N+
Sbjct: 22 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVEEFLKEAAVMKEIKHPNL 75
Query: 393 VQYYGTDKDESKLYIFLELVTKGSLLNLYQ---RYHLRDSQVSAYTRQILLGLKYLHDQD 449
VQ G E YI E +T G+LL+ + R + + QI ++YL ++
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 135
Query: 450 VVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS---CRGTAFWMAPEVINNKNKGY 506
+HRD+ N LV N VK+ADFGL++ + + + W APE + +
Sbjct: 136 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL--AYNKF 193
Query: 507 GLPADIWSLGCTVLEMLTSQIPYAPMECVSAIF 539
+ +D+W+ G + E+ T + P +S ++
Sbjct: 194 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 226
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 150 bits (379), Expect = 4e-42
Identities = 52/220 (23%), Positives = 95/220 (43%), Gaps = 15/220 (6%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
++ G++LG G V+ AVK + ++ + +E + H
Sbjct: 9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRA--DLARDPSFYLRFRREAQNAAALNH 66
Query: 390 ENIVQYYGTDKDESK----LYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKY 444
IV Y T + E+ YI +E V +L ++ + + L +
Sbjct: 67 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 126
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAK-----ATKLNDVKSCRGTAFWMAPEVI 499
H ++HRD+K ANI++ A +VK+ DFG+A+ + + GTA +++PE
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186
Query: 500 NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIF 539
+ +D++SLGC + E+LT + P+ VS +
Sbjct: 187 --RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY 224
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 4e-42
Identities = 55/213 (25%), Positives = 91/213 (42%), Gaps = 25/213 (11%)
Query: 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR-F 387
Y +LG G G V + + FA+K + Q + +E+ L R
Sbjct: 13 YKVTSQVLGLGINGKVLQIFNKRTQEKFALKML----------QDCPKARREVELHWRAS 62
Query: 388 EHENIVQYYGT----DKDESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILL 440
+ +IV+ L I +E + G L + Q + + S + I
Sbjct: 63 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 122
Query: 441 GLKYLHDQDVVHRDIKCANILVDA---NGSVKLADFGLAK-ATKLNDVKSCRGTAFWMAP 496
++YLH ++ HRD+K N+L + N +KL DFG AK T N + + T +++AP
Sbjct: 123 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 182
Query: 497 EVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY 529
EV+ + Y D+WSLG + +L P+
Sbjct: 183 EVLG--PEKYDKSCDMWSLGVIMYILLCGYPPF 213
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 5e-42
Identities = 58/209 (27%), Positives = 104/209 (49%), Gaps = 15/209 (7%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
+ +G G++G V + A+K++S + + ++ +EI +L RF H
Sbjct: 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQR----TLREIKILLRFRH 65
Query: 390 ENIVQYYGTDKDES----KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYL 445
ENI+ + + K + + L L + HL + + + QIL GLKY+
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYI 125
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAF-----WMAPEVIN 500
H +V+HRD+K +N+L++ +K+ DFGLA+ + + T + + APE++
Sbjct: 126 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 185
Query: 501 NKNKGYGLPADIWSLGCTVLEMLTSQIPY 529
N GY DIWS+GC + EML+++ +
Sbjct: 186 NSK-GYTKSIDIWSVGCILAEMLSNRPIF 213
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 5e-42
Identities = 60/245 (24%), Positives = 96/245 (39%), Gaps = 41/245 (16%)
Query: 334 GDLLGRGSFGSVYEGI------SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
G +LG G+FG V + AVK + S+ + L E+ ++++
Sbjct: 42 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREA----LMSELKMMTQL 97
Query: 388 E-HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH--------------------- 425
HENIV G +Y+ E G LLN +
Sbjct: 98 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157
Query: 426 ---LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN 482
L + + Q+ G+++L + VHRD+ N+LV VK+ DFGLA+ +
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 217
Query: 483 D----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAI 538
+ R WMAPE + Y + +D+WS G + E+ + + P V A
Sbjct: 218 SNYVVRGNARLPVKWMAPESL--FEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN 275
Query: 539 FIKTV 543
F K +
Sbjct: 276 FYKLI 280
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 1e-41
Identities = 51/220 (23%), Positives = 89/220 (40%), Gaps = 18/220 (8%)
Query: 332 QKGDLLGRGSFGSVYEGISDDG-----FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR 386
+ ++G G FG VY+G+ A+K + ++ E ++ +
Sbjct: 10 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKA----GYTEKQRVDFLGEAGIMGQ 65
Query: 387 FEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLY--QRYHLRDSQVSAYTRQILLGLKY 444
F H NI++ G + I E + G+L + Q+ R I G+KY
Sbjct: 66 FSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKY 125
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAK-----ATKLNDVKSCRGTAFWMAPEVI 499
L + + VHRD+ NILV++N K++DFGL++ + W APE I
Sbjct: 126 LANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 185
Query: 500 NNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIF 539
+ + +D+WS G + E++T +
Sbjct: 186 SYRKFTS--ASDVWSFGIVMWEVMTYGERPYWELSNHEVM 223
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 2e-41
Identities = 59/214 (27%), Positives = 99/214 (46%), Gaps = 6/214 (2%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
++K + +G G++G+V++ + + A+K V L D +EI LL +H
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPS---SALREICLLKELKH 60
Query: 390 ENIVQYYGTDKDESKLYIFLELVTKGSL-LNLYQRYHLRDSQVSAYTRQILLGLKYLHDQ 448
+NIV+ + + KL + E + L V ++ Q+L GL + H +
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 449 DVVHRDIKCANILVDANGSVKLADFGLAKATKL-NDVKSCRGTAFWMAPEVINNKNKGYG 507
+V+HRD+K N+L++ NG +KLA+FGLA+A + S W P + K Y
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYS 180
Query: 508 LPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIK 541
D+WS GC E+ + P P V +
Sbjct: 181 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKR 214
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 2e-41
Identities = 61/251 (24%), Positives = 105/251 (41%), Gaps = 24/251 (9%)
Query: 306 DSSSTTTEPMSNISPN--GRFKRIITYWQKGDLLGRGSFGSVYEGISDD----GFFFAVK 359
D S+ E + + G I+ + +++GRG FG VY G D AVK
Sbjct: 5 DLSALNPELVQAVQHVVIGPSSLIVHF---NEVIGRGHFGCVYHGTLLDNDGKKIHCAVK 61
Query: 360 EVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTD-KDESKLYIFLELVTKGSLL 418
++ + +SQ E ++ F H N++ G + E + L + G L
Sbjct: 62 SLNRITD----IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 117
Query: 419 NLY--QRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLA 476
N + ++ + + Q+ G+K+L + VHRD+ N ++D +VK+ADFGLA
Sbjct: 118 NFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLA 177
Query: 477 KATKLNDVKS------CRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYA 530
+ + S + WMA E + + +D+WS G + E++T P
Sbjct: 178 RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTT--KSDVWSFGVLLWELMTRGAPPY 235
Query: 531 PMECVSAIFIK 541
P I +
Sbjct: 236 PDVNTFDITVY 246
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 2e-41
Identities = 66/235 (28%), Positives = 103/235 (43%), Gaps = 25/235 (10%)
Query: 308 SSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQ 366
S TT + R + + +Y ++G GSFG VY+ D G A+K+V
Sbjct: 1 SKVTTVVATPGQGPDRPQEV-SY-TDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----- 53
Query: 367 GSQAKQSISQLEQEIALLSRFEHENIVQYY------GTDKDESKLYIFLELVTKGSLLNL 420
Q +E+ ++ + +H NIV+ G KDE L + L+ V +
Sbjct: 54 ----LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVA 109
Query: 421 YQ----RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGS-VKLADFGL 475
+ L V Y Q+ L Y+H + HRDIK N+L+D + + +KL DFG
Sbjct: 110 RHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGS 169
Query: 476 AKATKLND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY 529
AK + S + ++ APE+I Y D+WS GC + E+L Q +
Sbjct: 170 AKQLVRGEPNVSYICSRYYRAPELIFGAT-DYTSSIDVWSAGCVLAELLLGQPIF 223
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 148 bits (374), Expect = 8e-41
Identities = 53/221 (23%), Positives = 94/221 (42%), Gaps = 17/221 (7%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-E 388
+Q LGRG + V+E I+ + VK + ++++EI +L
Sbjct: 37 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILK--------PVKKKKIKREIKILENLRG 88
Query: 389 HENIVQYYGT--DKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLH 446
NI+ D + E V LYQ L D + Y +IL L Y H
Sbjct: 89 GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT--LTDYDIRFYMYEILKALDYCH 146
Query: 447 DQDVVHRDIKCANILVDA-NGSVKLADFGLAKATKLNDVKSCR-GTAFWMAPEVINNKNK 504
++HRD+K N+++D + ++L D+GLA+ + R + ++ PE++ + +
Sbjct: 147 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD-YQ 205
Query: 505 GYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTVAV 545
Y D+WSLGC + M+ + P+ ++ V
Sbjct: 206 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV 246
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 148 bits (375), Expect = 1e-40
Identities = 68/234 (29%), Positives = 106/234 (45%), Gaps = 14/234 (5%)
Query: 298 SFTTEHEDDSSSTTTEPMSNISPNGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFF 356
F + ++D P N + +F RI LG GSFG V + G +
Sbjct: 17 EFLAKAKEDFLKKWETPSQNTAQLDQFDRI-------KTLGTGSFGRVMLVKHKESGNHY 69
Query: 357 AVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGS 416
A+K + Q + I E +L +V+ + KD S LY+ +E V G
Sbjct: 70 AMKILDK--QKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGE 127
Query: 417 LLN-LYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGL 475
+ + L + + Y QI+L +YLH D+++RD+K N+L+D G +++ DFG
Sbjct: 128 MFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF 187
Query: 476 AKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPY 529
AK K + GT +APE+I +KGY D W+LG + EM P+
Sbjct: 188 AKRVK-GRTWTLCGTPEALAPEII--LSKGYNKAVDWWALGVLIYEMAAGYPPF 238
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 2e-40
Identities = 57/229 (24%), Positives = 103/229 (44%), Gaps = 20/229 (8%)
Query: 324 FKRIITY--WQKGDLLGRGSFGSVYEGI-----SDDGFFFAVKEVSLLDQGSQAKQSISQ 376
RI+ ++K +LG G+FG+VY+G+ A+KE+ ++ +
Sbjct: 2 LLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS----PKANKE 57
Query: 377 LEQEIALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDS--QVSAY 434
+ E +++ ++ ++ + G + + +L+ G LL+ + + + +
Sbjct: 58 ILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW 116
Query: 435 TRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND----VKSCRGT 490
QI G+ YL D+ +VHRD+ N+LV VK+ DFGLAK + + +
Sbjct: 117 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 176
Query: 491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIF 539
WMA E I ++ Y +D+WS G TV E++T S I
Sbjct: 177 IKWMALESI--LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 223
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 3e-40
Identities = 63/240 (26%), Positives = 92/240 (38%), Gaps = 36/240 (15%)
Query: 334 GDLLGRGSFGSVYEGI------SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
G LG G+FG V E SD AVK + S L E+ +LS
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKP----SAHLTEREALMSELKVLSYL 83
Query: 388 E-HENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-------------------LR 427
H NIV G + E G LLN +R L
Sbjct: 84 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143
Query: 428 DSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS- 486
+ +++ Q+ G+ +L ++ +HRD+ NIL+ K+ DFGLA+ K +
Sbjct: 144 LEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203
Query: 487 ---CRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTV 543
R WMAPE I N + +D+WS G + E+ + P V + F K +
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTF--ESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI 261
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 4e-40
Identities = 54/228 (23%), Positives = 93/228 (40%), Gaps = 24/228 (10%)
Query: 334 GDLLGRGSFGSVYEGI-SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HEN 391
D++G G+FG V + DG + + S K E+ +L + H N
Sbjct: 15 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS--KDDHRDFAGELEVLCKLGHHPN 72
Query: 392 IVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-----------------LRDSQVSAY 434
I+ G + LY+ +E G+LL+ ++ L Q+ +
Sbjct: 73 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 132
Query: 435 TRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK-SCRGTAFW 493
+ G+ YL + +HRD+ NILV N K+ADFGL++ ++ K R W
Sbjct: 133 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRW 192
Query: 494 MAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIK 541
MA E +N +D+WS G + E+++ + ++ K
Sbjct: 193 MAIESLNYSVYTT--NSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 238
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 145 bits (367), Expect = 4e-40
Identities = 51/232 (21%), Positives = 90/232 (38%), Gaps = 41/232 (17%)
Query: 332 QKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLS 385
+ +G G+FG V++ + + AVK + + + ++E AL++
Sbjct: 16 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKE----EASADMQADFQREAALMA 71
Query: 386 RFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-------------------- 425
F++ NIV+ G + + E + G L +
Sbjct: 72 EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 131
Query: 426 -----LRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK 480
L ++ RQ+ G+ YL ++ VHRD+ N LV N VK+ADFGL++
Sbjct: 132 PGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 191
Query: 481 LNDVK----SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIP 528
D + WM PE I Y +D+W+ G + E+ + +
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFYNR--YTTESDVWAYGVVLWEIFSYGLQ 241
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 144 bits (364), Expect = 9e-40
Identities = 42/227 (18%), Positives = 85/227 (37%), Gaps = 26/227 (11%)
Query: 331 WQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH 389
++ G +G GSFG ++EG + + A+K + QL E
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR-------RSDAPQLRDEYRTYKLLAG 59
Query: 390 -ENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-LRDSQVSAYTRQILLGLKYLHD 447
I Y ++ + ++L+ L V+ +Q+L ++ +H+
Sbjct: 60 CTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE 119
Query: 448 QDVVHRDIKCANILVDA-----NGSVKLADFGLAKATK---------LNDVKSCRGTAFW 493
+ +V+RDIK N L+ + + DFG+ K + + K+ GTA +
Sbjct: 120 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 179
Query: 494 MAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFI 540
M+ + D+ +LG + L +P+ ++ +
Sbjct: 180 MSINTHL--GREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK 224
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 144 bits (363), Expect = 1e-39
Identities = 45/230 (19%), Positives = 81/230 (35%), Gaps = 24/230 (10%)
Query: 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 384
R+ ++ G +G GSFG +Y G G A+K + K QL E +
Sbjct: 4 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV-------KTKHPQLHIESKIY 56
Query: 385 SRFEHEN-IVQYYGTDKDESKLYIFLELVTKGSL-LNLYQRYHLRDSQVSAYTRQILLGL 442
+ I + + +EL+ L + V Q++ +
Sbjct: 57 KMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRI 116
Query: 443 KYLHDQDVVHRDIKCANILV---DANGSVKLADFGLAKATKLNDVKSC---------RGT 490
+Y+H ++ +HRD+K N L+ V + DFGLAK + GT
Sbjct: 117 EYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 176
Query: 491 AFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFI 540
A + + D+ SLG ++ +P+ ++ +
Sbjct: 177 ARYASINTH--LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK 224
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 1e-37
Identities = 54/204 (26%), Positives = 99/204 (48%), Gaps = 11/204 (5%)
Query: 332 QKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
+ +G G++G+V + G A+K+ L + Q++ + +E+ LL HE
Sbjct: 21 RDLQPVGSGAYGAVCSAVDGRTGAKVAIKK---LYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 391 NIVQYYGTDKDESKLYIFLELVTKGSLL-----NLYQRYHLRDSQVSAYTRQILLGLKYL 445
N++ + L F + + L + L + ++ Q+L GL+Y+
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 137
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKG 505
H ++HRD+K N+ V+ + +K+ DFGLA+ +++ T ++ APEVI N
Sbjct: 138 HAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD-SEMTGYVVTRWYRAPEVILN-WMR 195
Query: 506 YGLPADIWSLGCTVLEMLTSQIPY 529
Y DIWS+GC + EM+T + +
Sbjct: 196 YTQTVDIWSVGCIMAEMITGKTLF 219
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 2e-37
Identities = 61/204 (29%), Positives = 101/204 (49%), Gaps = 11/204 (5%)
Query: 332 QKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
Q +G G++GSV G AVK+ L + Q+ + +E+ LL +HE
Sbjct: 21 QNLSPVGSGAYGSVCAAFDTKTGLRVAVKK---LSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 391 NIVQYYG-----TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYL 445
N++ +E + + L N+ + L D V QIL GLKY+
Sbjct: 78 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 137
Query: 446 HDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKG 505
H D++HRD+K +N+ V+ + +K+ DFGLA+ T +++ T ++ APE++ N
Sbjct: 138 HSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-DEMTGYVATRWYRAPEIMLN-WMH 195
Query: 506 YGLPADIWSLGCTVLEMLTSQIPY 529
Y DIWS+GC + E+LT + +
Sbjct: 196 YNQTVDIWSVGCIMAELLTGRTLF 219
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 1e-36
Identities = 50/216 (23%), Positives = 91/216 (42%), Gaps = 27/216 (12%)
Query: 334 GDLLGRGSFGSVYEGI------SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF 387
LG+GSFG VYEG+ + A+K V+ + + + + E +++ F
Sbjct: 25 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE----AASMRERIEFLNEASVMKEF 80
Query: 388 EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYH-----------LRDSQVSAYTR 436
++V+ G + +EL+T+G L + + S++
Sbjct: 81 NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 140
Query: 437 QILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSC----RGTAF 492
+I G+ YL+ VHRD+ N +V + +VK+ DFG+ + D
Sbjct: 141 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 200
Query: 493 WMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIP 528
WM+PE + K+ + +D+WS G + E+ T
Sbjct: 201 WMSPESL--KDGVFTTYSDVWSFGVVLWEIATLAEQ 234
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 3e-36
Identities = 59/236 (25%), Positives = 98/236 (41%), Gaps = 36/236 (15%)
Query: 334 GDLLGRGSFGSVYEGI--------SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLS 385
G LG G+FG V + AVK + ++ +S L E+ ++
Sbjct: 18 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS----DATEKDLSDLISEMEMMK 73
Query: 386 RF-EHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRY-----------------HLR 427
+H+NI+ G + LY+ +E +KG+L Q L
Sbjct: 74 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133
Query: 428 DSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV--- 484
+ + Q+ G++YL + +HRD+ N+LV + +K+ADFGLA+ D
Sbjct: 134 SKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193
Query: 485 -KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIF 539
+ R WMAPE + ++ Y +D+WS G + E+ T P V +F
Sbjct: 194 TTNGRLPVKWMAPEAL--FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 247
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 8e-35
Identities = 53/206 (25%), Positives = 98/206 (47%), Gaps = 15/206 (7%)
Query: 332 QKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE 390
Q +G G+ G V A+K+ L + Q + + +E+ L+ H+
Sbjct: 20 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKK---LSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 391 NIVQYYG------TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKY 444
NI+ T ++ +Y+ +EL+ + ++S Q+L G+K+
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE--RMSYLLYQMLCGIKH 134
Query: 445 LHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCR-GTAFWMAPEVINNKN 503
LH ++HRD+K +NI+V ++ ++K+ DFGLA+ + + + T ++ APEVI
Sbjct: 135 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 194
Query: 504 KGYGLPADIWSLGCTVLEMLTSQIPY 529
DIWS+GC + EM+ +I +
Sbjct: 195 YKE--NVDIWSVGCIMGEMVRHKILF 218
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 5e-34
Identities = 57/241 (23%), Positives = 97/241 (40%), Gaps = 33/241 (13%)
Query: 331 WQKGDLLGRGSFGSVYEGI------SDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALL 384
+ G LGRG+FG V E + AVK +L +G+ + + + + L+
Sbjct: 15 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVK---MLKEGATHSEHRALMSELKILI 71
Query: 385 SRFEHENIVQYYG-TDKDESKLYIFLELVTKGSLLNLYQRY-----------------HL 426
H N+V G K L + +E G+L + L
Sbjct: 72 HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 131
Query: 427 RDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--- 483
+ Y+ Q+ G+++L + +HRD+ NIL+ VK+ DFGLA+ +
Sbjct: 132 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 191
Query: 484 -VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKT 542
R WMAPE I ++ Y + +D+WS G + E+ + P + F +
Sbjct: 192 RKGDARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 249
Query: 543 V 543
+
Sbjct: 250 L 250
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 112 bits (281), Expect = 7e-28
Identities = 55/238 (23%), Positives = 94/238 (39%), Gaps = 41/238 (17%)
Query: 321 NGRFKRIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQ 379
+ R+ LG G F +V+ + A+K V K E
Sbjct: 12 DARY-------ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVR------GDKVYTEAAED 58
Query: 380 EIALLSRFEHENIVQ-------------YYGTDKDESKLYIFLELVTKG----SLLNLYQ 422
EI LL R + + + K + +++ + G +L+ Y+
Sbjct: 59 EIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYE 118
Query: 423 RYHLRDSQVSAYTRQILLGLKYLHDQD-VVHRDIKCANILVDANG------SVKLADFGL 475
+ V ++Q+LLGL Y+H + ++H DIK N+L++ +K+AD G
Sbjct: 119 HRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGN 178
Query: 476 AKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME 533
A + S T + +PEV+ +G ADIWS C + E++T + P E
Sbjct: 179 ACWYDEHYTNSI-QTREYRSPEVL--LGAPWGCGADIWSTACLIFELITGDFLFEPDE 233
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 106 bits (264), Expect = 5e-27
Identities = 32/202 (15%), Positives = 63/202 (31%), Gaps = 29/202 (14%)
Query: 334 GDLLGRGSFGSVYEGISDDGFFFAVKEVSL-------------LDQGSQAKQSISQLEQE 380
G L+G G +V+ S+ VK + + +I E
Sbjct: 5 GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 381 IALLSRFEHENIVQYYGTDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILL 440
L + + + + Y + + + +EL+ L + IL
Sbjct: 65 FRALQKLQGLAVPKVYAWEGN----AVLMELIDAKELYRVRVENPDE------VLDMILE 114
Query: 441 GLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKSCRGTAFWMAPEVIN 500
+ + + +VH D+ N+LV G + + DF + + I
Sbjct: 115 EVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWR----EILERDVRNII 169
Query: 501 N-KNKGYGLPADIWSLGCTVLE 521
++ Y DI S +L+
Sbjct: 170 TYFSRTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 554 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.91 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.34 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.99 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.79 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.04 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.72 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.59 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-47 Score=381.20 Aligned_cols=210 Identities=27% Similarity=0.489 Sum_probs=186.5
Q ss_pred ccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEE
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~ 406 (554)
+++|++++.||+|+||+||+|++ .+++.||+|++..... ........+.+|+.+++.++|||||++++++.+.+.+|
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 82 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY 82 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHc--cChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEE
Confidence 57899999999999999999999 6799999999874221 11223456889999999999999999999999999999
Q ss_pred EEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCCcc
Q 008759 407 IFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK 485 (554)
Q Consensus 407 LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~~~ 485 (554)
|||||+.+|+|.+++.+ ..+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++........
T Consensus 83 ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 162 (263)
T d2j4za1 83 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT 162 (263)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCCCE
T ss_pred EEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCCccc
Confidence 99999999999999876 46999999999999999999999999999999999999999999999999999887766666
Q ss_pred CccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHH
Q 008759 486 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIK 541 (554)
Q Consensus 486 s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i 541 (554)
...||+.|||||++.+. .|+.++|||||||++|+|++|+.||......+.+.++
T Consensus 163 ~~~Gt~~Y~APE~~~~~--~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i 216 (263)
T d2j4za1 163 TLCGTLDYLPPEMIEGR--MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 216 (263)
T ss_dssp ETTEEGGGCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred ccCCCCcccCHHHHcCC--CCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 77899999999999764 4899999999999999999999999887766655444
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-47 Score=386.47 Aligned_cols=209 Identities=32% Similarity=0.590 Sum_probs=187.1
Q ss_pred cceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEE
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~L 407 (554)
++|++.+.||+|+||+||+|.+ .+|+.||+|++...... ..+.+.+|+.+++.++|||||+++++|.+.+.+||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 94 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-----KKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 94 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS-----CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh-----HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEE
Confidence 4789999999999999999998 78999999998753322 13568899999999999999999999999999999
Q ss_pred EEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC--Ccc
Q 008759 408 FLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--DVK 485 (554)
Q Consensus 408 VmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~--~~~ 485 (554)
||||+.+|+|.+++.+..+++.+++.|+.||+.||.|||++||+||||||+|||++.+|++||+|||+++..... ...
T Consensus 95 vmEy~~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~ 174 (293)
T d1yhwa1 95 VMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 174 (293)
T ss_dssp EEECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBC
T ss_pred EEEecCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccccccc
Confidence 999999999999998889999999999999999999999999999999999999999999999999999875432 345
Q ss_pred CccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHHH
Q 008759 486 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTVA 544 (554)
Q Consensus 486 s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~~ 544 (554)
..+||+.|||||++.+. .|+.++|||||||++|+|+||+.||.+....+.++.+...
T Consensus 175 ~~~gt~~Y~aPE~~~~~--~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~ 231 (293)
T d1yhwa1 175 TMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN 231 (293)
T ss_dssp CCCSCGGGCCHHHHSSS--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHH
T ss_pred ccccCCCccChhhhcCC--CCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhC
Confidence 56799999999999764 4899999999999999999999999998887777766543
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-47 Score=383.08 Aligned_cols=209 Identities=27% Similarity=0.524 Sum_probs=179.4
Q ss_pred cccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcE
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL 405 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~ 405 (554)
+.++|++++.||+|+||+||+|++ .+|+.||+|++..... ....+.+.+|+.+|++++|||||++++++.+.+.+
T Consensus 3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~----~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~ 78 (271)
T d1nvra_ 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA----VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQ 78 (271)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----------CHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc----chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCcee
Confidence 467899999999999999999998 6799999999875321 22345688999999999999999999999999999
Q ss_pred EEEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC--
Q 008759 406 YIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-- 482 (554)
Q Consensus 406 ~LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~-- 482 (554)
||||||+.+|+|.++++. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 79 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 79 YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp EEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred EEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence 999999999999998875 46999999999999999999999999999999999999999999999999999875432
Q ss_pred --CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHH
Q 008759 483 --DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFI 540 (554)
Q Consensus 483 --~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~ 540 (554)
.....+||+.|||||++.+.. .++.++|||||||++|+|+||+.||.........+.
T Consensus 159 ~~~~~~~~GT~~Y~APE~~~~~~-~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~ 217 (271)
T d1nvra_ 159 ERLLNKMCGTLPYVAPELLKRRE-FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 217 (271)
T ss_dssp ECCBCCCCSCGGGSCTHHHHCSS-BCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHH
T ss_pred cccccceeeCcCccCHhHhcCCC-CCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 244567999999999996543 246789999999999999999999987655444443
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-47 Score=387.91 Aligned_cols=203 Identities=28% Similarity=0.477 Sum_probs=179.8
Q ss_pred ccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEE
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~ 406 (554)
.++|++++.||+|+||+||+|++ .+|+.||+|++..... ......+.+|+.+|+.++|||||+++++|.+.+++|
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 80 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK----PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 80 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCC----TTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhC----HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 56899999999999999999998 6899999999875322 223457889999999999999999999999999999
Q ss_pred EEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHC-CccccCCccccEEEcCCCcEEEEecCcccccccCCc
Q 008759 407 IFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQ-DVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV 484 (554)
Q Consensus 407 LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~-gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~~ 484 (554)
|||||+.+|+|.+++.+ ..+++..++.++.||+.||.|||++ ||+||||||+||||+.+|.+||+|||+|+.......
T Consensus 81 iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~ 160 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA 160 (322)
T ss_dssp EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHTC
T ss_pred EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCcc
Confidence 99999999999999876 4699999999999999999999974 999999999999999999999999999987665556
Q ss_pred cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhH
Q 008759 485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVS 536 (554)
Q Consensus 485 ~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~ 536 (554)
.+.+||+.|||||++.+. .|+.++|||||||++|||++|+.||.+.+..+
T Consensus 161 ~~~~GT~~Y~APEvl~~~--~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~ 210 (322)
T d1s9ja_ 161 NSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 210 (322)
T ss_dssp ---CCSSCCCCHHHHHCS--CCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTH
T ss_pred ccccCCccccCchHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 677899999999999765 48999999999999999999999998765443
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-46 Score=377.81 Aligned_cols=210 Identities=27% Similarity=0.466 Sum_probs=181.6
Q ss_pred cceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEE
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~L 407 (554)
++|++++.||+|+||+||+|.+ .+|+.||+|++..... ......+.+.+|+.++++++|||||++++++.+.+.+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 85 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 85 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHc--cCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEE
Confidence 5799999999999999999998 6899999999874221 112234678899999999999999999999999999999
Q ss_pred EEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC----
Q 008759 408 FLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN---- 482 (554)
Q Consensus 408 VmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~---- 482 (554)
||||+.+|+|.+++.. ..+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+.....
T Consensus 86 vmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~ 165 (288)
T d1uu3a_ 86 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 165 (288)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred EEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCccc
Confidence 9999999999998875 56999999999999999999999999999999999999999999999999999875422
Q ss_pred CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHH
Q 008759 483 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKT 542 (554)
Q Consensus 483 ~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~ 542 (554)
.....+||+.|||||++.+. .|+.++|||||||++|+|+||+.||...+..+...++.
T Consensus 166 ~~~~~~GT~~Y~APE~~~~~--~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~ 223 (288)
T d1uu3a_ 166 RANSFVGTAQYVSPELLTEK--SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII 223 (288)
T ss_dssp ----CCCCGGGCCHHHHHTC--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred ccccccCCccccCceeeccC--CCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHH
Confidence 23456799999999999765 48999999999999999999999999877666555544
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-46 Score=377.69 Aligned_cols=211 Identities=31% Similarity=0.574 Sum_probs=184.6
Q ss_pred cceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEE
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~L 407 (554)
+.|++++.||+|+||+||+|++ .+++.||+|++..... ...+.+.+|+.+|+.++|||||++++++.+.+.+||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-----~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 86 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE-----EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWI 86 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS-----GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH-----HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEE
Confidence 5799999999999999999998 6899999999875322 223567899999999999999999999999999999
Q ss_pred EEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC--C
Q 008759 408 FLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--D 483 (554)
Q Consensus 408 VmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~--~ 483 (554)
||||+.+|+|.+++.+ ..+++.+++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+++..... .
T Consensus 87 vmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~ 166 (288)
T d2jfla1 87 LIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR 166 (288)
T ss_dssp EEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHH
T ss_pred EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCccc
Confidence 9999999999998765 35999999999999999999999999999999999999999999999999998754322 2
Q ss_pred ccCccCCCcccChhhhccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHHH
Q 008759 484 VKSCRGTAFWMAPEVINNK---NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTVA 544 (554)
Q Consensus 484 ~~s~~GT~~Y~APEvl~~~---~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~~ 544 (554)
.....||+.|||||++... ...|+.++|||||||++|+|+||+.||......+.+.++...
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~ 230 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS 230 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHS
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC
Confidence 3456799999999998532 334889999999999999999999999998888877766543
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-45 Score=368.19 Aligned_cols=208 Identities=31% Similarity=0.580 Sum_probs=181.0
Q ss_pred ceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccC----CCc
Q 008759 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD----ESK 404 (554)
Q Consensus 330 ~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~----~~~ 404 (554)
+|++.+.||+|+||+||+|++ .+++.||+|++..... .....+.+.+|+++|++++|||||+++++|.+ ...
T Consensus 10 y~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~---~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 86 (270)
T d1t4ha_ 10 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL---TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 86 (270)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred EEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCE
Confidence 467788999999999999998 6789999999875332 23345678999999999999999999998754 456
Q ss_pred EEEEEeecccCchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHHCC--ccccCCccccEEEc-CCCcEEEEecCcccccc
Q 008759 405 LYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQD--VVHRDIKCANILVD-ANGSVKLADFGLAKATK 480 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~~-~l~e~~i~~i~~QIl~gL~yLHs~g--IIHrDIKPeNILld-~~g~vKL~DFGlA~~~~ 480 (554)
+||||||+.+|+|.+++++. .+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++...
T Consensus 87 ~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 87 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 89999999999999998764 6899999999999999999999999 99999999999996 57899999999998766
Q ss_pred cCCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHH
Q 008759 481 LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTV 543 (554)
Q Consensus 481 ~~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~ 543 (554)
.......+||+.|||||++.+ .|+.++|||||||++|+|++|+.||........+++.+.
T Consensus 167 ~~~~~~~~GT~~Y~aPE~~~~---~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~ 226 (270)
T d1t4ha_ 167 ASFAKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT 226 (270)
T ss_dssp TTSBEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHT
T ss_pred CCccCCcccCccccCHHHhCC---CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHH
Confidence 666667789999999999854 389999999999999999999999998777776665543
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-45 Score=380.62 Aligned_cols=211 Identities=27% Similarity=0.466 Sum_probs=184.9
Q ss_pred cccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcE
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL 405 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~ 405 (554)
.+++|++++.||+|+||+||+|++ .+|+.||+|++..... .......++.+|+.+|+.++||||++++++|.+.+.+
T Consensus 3 ~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~--~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 80 (337)
T d1o6la_ 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVI--IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRL 80 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEE
T ss_pred chHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhc--cCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccc
Confidence 457899999999999999999998 7899999999974221 1122356788999999999999999999999999999
Q ss_pred EEEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccccc--C
Q 008759 406 YIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL--N 482 (554)
Q Consensus 406 ~LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~--~ 482 (554)
|+||||+.+|+|..++.+ ..+++..++.|+.||+.||.|||++|||||||||+|||++.+|.+||+|||+++.... .
T Consensus 81 ~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~ 160 (337)
T d1o6la_ 81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred ccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCc
Confidence 999999999999998876 4689999999999999999999999999999999999999999999999999986433 3
Q ss_pred CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHH
Q 008759 483 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIK 541 (554)
Q Consensus 483 ~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i 541 (554)
.....+||+.|||||++.+. .|+.++|||||||++|||++|++||...+..+.+.++
T Consensus 161 ~~~~~~GT~~Y~aPE~~~~~--~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i 217 (337)
T d1o6la_ 161 TMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSS--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred ccccceeCHHHhhhhhccCC--CCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHH
Confidence 34567899999999999654 4899999999999999999999999988765544443
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.4e-45 Score=375.79 Aligned_cols=211 Identities=32% Similarity=0.526 Sum_probs=185.8
Q ss_pred cceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEE
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~L 407 (554)
+.|++++.||+|+||+||+|++ .+++.||||++..... ......+.+.+|+.+|++++|||||++++++.+.+.+||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i 92 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK--QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 92 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSS--CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhc--cCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEE
Confidence 4699999999999999999998 7899999999875332 234456778999999999999999999999999999999
Q ss_pred EEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCCccC
Q 008759 408 FLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVKS 486 (554)
Q Consensus 408 VmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~~~s 486 (554)
|||||.+|+|..++.. ..+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ...
T Consensus 93 v~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~--~~~ 170 (309)
T d1u5ra_ 93 VMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--ANS 170 (309)
T ss_dssp EEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--BCC
T ss_pred EEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC--CCc
Confidence 9999999999876654 5699999999999999999999999999999999999999999999999999976543 345
Q ss_pred ccCCCcccChhhhcccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHH
Q 008759 487 CRGTAFWMAPEVINNKN-KGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTV 543 (554)
Q Consensus 487 ~~GT~~Y~APEvl~~~~-~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~ 543 (554)
..||+.|||||++.+.. ..|+.++|||||||++|+|++|+.||.+....+.++++..
T Consensus 171 ~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~ 228 (309)
T d1u5ra_ 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 228 (309)
T ss_dssp CCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH
T ss_pred cccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh
Confidence 67999999999996532 3488999999999999999999999999888887776654
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=370.22 Aligned_cols=209 Identities=31% Similarity=0.485 Sum_probs=170.9
Q ss_pred cceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccC--CCcE
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD--ESKL 405 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~--~~~~ 405 (554)
++|++.+.||+|+||+||+|++ .+|+.||+|++...... ....+.+.+|+.++++++|||||++++++.+ .+.+
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~ 80 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT---EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 80 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSC---HHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCC---HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEE
Confidence 6899999999999999999998 67999999998754322 3345678899999999999999999998854 5678
Q ss_pred EEEEeecccCchHHHHhh-----hcCChHHHHHHHHHHHHHHHHHHHCC-----ccccCCccccEEEcCCCcEEEEecCc
Q 008759 406 YIFLELVTKGSLLNLYQR-----YHLRDSQVSAYTRQILLGLKYLHDQD-----VVHRDIKCANILVDANGSVKLADFGL 475 (554)
Q Consensus 406 ~LVmE~~~ggsL~~ll~~-----~~l~e~~i~~i~~QIl~gL~yLHs~g-----IIHrDIKPeNILld~~g~vKL~DFGl 475 (554)
||||||+.+|+|.+++.+ ..+++..++.++.||+.||.|||++| ||||||||+|||++.++.+||+|||+
T Consensus 81 ~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~ 160 (269)
T d2java1 81 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 160 (269)
T ss_dssp EEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHH
T ss_pred EEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccc
Confidence 999999999999998864 35899999999999999999999976 99999999999999999999999999
Q ss_pred ccccccC--CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHH
Q 008759 476 AKATKLN--DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKT 542 (554)
Q Consensus 476 A~~~~~~--~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~ 542 (554)
++..... ......||+.|||||++.+. .|+.++|||||||++|+|+||+.||......+.+.++.
T Consensus 161 a~~~~~~~~~~~~~~gt~~Y~APE~l~~~--~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~ 227 (269)
T d2java1 161 ARILNHDTSFAKAFVGTPYYMSPEQMNRM--SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR 227 (269)
T ss_dssp HHHC-----------CCCSCCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred eeecccCCCccccCCCCcccCCHHHHcCC--CCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHH
Confidence 9875433 23456799999999999654 48999999999999999999999999887766554443
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.4e-45 Score=376.79 Aligned_cols=211 Identities=29% Similarity=0.480 Sum_probs=185.2
Q ss_pred ccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEE
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~ 406 (554)
+++|++++.||+|+||+||+|++ .+|+.||+|++..... ......+.+.+|+.+|+.++|||||++++++.+.+.+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~--~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 80 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIV--VRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF 80 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHc--cCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeee
Confidence 56899999999999999999998 7799999999874211 11223467889999999999999999999999999999
Q ss_pred EEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCCcc
Q 008759 407 IFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK 485 (554)
Q Consensus 407 LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~~~ 485 (554)
+||||+.||+|..++.. ..+.+..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+++.... ...
T Consensus 81 ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~-~~~ 159 (316)
T d1fota_ 81 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-VTY 159 (316)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS-CBC
T ss_pred eEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecc-ccc
Confidence 99999999999998876 4578888999999999999999999999999999999999999999999999987653 344
Q ss_pred CccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHH
Q 008759 486 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTV 543 (554)
Q Consensus 486 s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~ 543 (554)
+.+||+.|||||++.+. .|+.++|||||||++|+|+||+.||......+.+.++..
T Consensus 160 ~~~Gt~~Y~APE~l~~~--~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~ 215 (316)
T d1fota_ 160 TLCGTPDYIAPEVVSTK--PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN 215 (316)
T ss_dssp CCCSCTTTCCHHHHTTC--CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH
T ss_pred cccCcccccCHHHHcCC--CCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHc
Confidence 57799999999999654 488999999999999999999999998877776666544
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.1e-45 Score=375.71 Aligned_cols=212 Identities=27% Similarity=0.413 Sum_probs=169.5
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCc
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~ 404 (554)
.+.+.|++++.||+|+||+||+|++ .+++.||+|++...... .....+.+|+.+|+.++|||||++++++.+.+.
T Consensus 6 di~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 81 (307)
T d1a06a_ 6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE----GKEGSMENEIAVLHKIKHPNIVALDDIYESGGH 81 (307)
T ss_dssp CGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC--------------CHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred CCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh----hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 3556799999999999999999998 67999999998753221 223567899999999999999999999999999
Q ss_pred EEEEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEc---CCCcEEEEecCcccccc
Q 008759 405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD---ANGSVKLADFGLAKATK 480 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld---~~g~vKL~DFGlA~~~~ 480 (554)
+||||||+.||+|.+++.. ..+++..+..|+.||+.||.|||++||+||||||+|||+. .++.+||+|||+++...
T Consensus 82 ~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 82 LYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp EEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred EEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 9999999999999999876 4699999999999999999999999999999999999995 57899999999998765
Q ss_pred cC-CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHH
Q 008759 481 LN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTV 543 (554)
Q Consensus 481 ~~-~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~ 543 (554)
.. .....+||+.|||||++.+. .|+.++|||||||++|+|++|+.||......+....+..
T Consensus 162 ~~~~~~~~~GT~~y~APE~~~~~--~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~ 223 (307)
T d1a06a_ 162 PGSVLSTACGTPGYVAPEVLAQK--PYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILK 223 (307)
T ss_dssp -----------CTTSCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHT
T ss_pred CCCeeeeeeeCccccCcHHHcCC--CCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhc
Confidence 43 34456799999999999654 489999999999999999999999998877666555543
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=7.7e-45 Score=378.22 Aligned_cols=210 Identities=26% Similarity=0.417 Sum_probs=184.2
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCc
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~ 404 (554)
.++++|++++.||+|+||+||+|++ .+|+.||+|++.... ....+.+.+|+.+|+.++|||||++++++.+.+.
T Consensus 23 ~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~-----~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 97 (350)
T d1koaa2 23 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-----ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNE 97 (350)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS-----HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTE
T ss_pred CCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc-----hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 4568999999999999999999998 689999999986422 2234678899999999999999999999999999
Q ss_pred EEEEEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcC--CCcEEEEecCcccccc
Q 008759 405 LYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA--NGSVKLADFGLAKATK 480 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~--~g~vKL~DFGlA~~~~ 480 (554)
+||||||+.+|+|.+++.. ..+++..++.|+.||+.||.|||++|||||||||+|||++. ++.+||+|||+++...
T Consensus 98 ~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~ 177 (350)
T d1koaa2 98 MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 177 (350)
T ss_dssp EEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECC
T ss_pred EEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecc
Confidence 9999999999999999853 46999999999999999999999999999999999999964 5789999999998765
Q ss_pred cC-CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHH
Q 008759 481 LN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKT 542 (554)
Q Consensus 481 ~~-~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~ 542 (554)
.. ......||+.|||||++.+. .|+.++|||||||++|+|++|+.||.+....+.+..+.
T Consensus 178 ~~~~~~~~~gT~~Y~aPEv~~~~--~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~ 238 (350)
T d1koaa2 178 PKQSVKVTTGTAEFAAPEVAEGK--PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVK 238 (350)
T ss_dssp TTSCEEEECSCTTTCCHHHHHTC--CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred cccccceecCcccccCHHHHcCC--CCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 43 34456799999999999764 48899999999999999999999999877766655554
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-44 Score=365.70 Aligned_cols=215 Identities=27% Similarity=0.496 Sum_probs=186.2
Q ss_pred cccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccc-hhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCc
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGS-QAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~-~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~ 404 (554)
+.++|++++.||+|+||+||+|++ .+|+.||+|++....... ......+.+.+|+.+|++++|||||+++++|.+.+.
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 457899999999999999999998 689999999997533221 111234678899999999999999999999999999
Q ss_pred EEEEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCC----cEEEEecCccccc
Q 008759 405 LYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG----SVKLADFGLAKAT 479 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g----~vKL~DFGlA~~~ 479 (554)
+||||||+.+|+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 88 ~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~ 167 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 167 (293)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhc
Confidence 9999999999999999876 4699999999999999999999999999999999999998776 5999999999876
Q ss_pred ccC-CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHH
Q 008759 480 KLN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTV 543 (554)
Q Consensus 480 ~~~-~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~ 543 (554)
... ......||+.|+|||++.+. .|+.++|||||||++|+|++|+.||.+....+.+..+..
T Consensus 168 ~~~~~~~~~~~t~~y~APE~~~~~--~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~ 230 (293)
T d1jksa_ 168 DFGNEFKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA 230 (293)
T ss_dssp TTSCBCSCCCCCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHT
T ss_pred CCCccccccCCCCcccCHHHHcCC--CCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHh
Confidence 543 34556799999999999654 489999999999999999999999998877766655443
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.4e-44 Score=376.50 Aligned_cols=210 Identities=26% Similarity=0.467 Sum_probs=185.0
Q ss_pred cccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcE
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL 405 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~ 405 (554)
+.++|++++.||+|+||+||+|++ .+|+.||+|++.... ......+.+|+.+|+.++|||||+++++|.+++.+
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~ 101 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-----PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEM 101 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-----HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEE
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc-----hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 457899999999999999999998 689999999987422 22245688999999999999999999999999999
Q ss_pred EEEEeecccCchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEc--CCCcEEEEecCccccccc
Q 008759 406 YIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVD--ANGSVKLADFGLAKATKL 481 (554)
Q Consensus 406 ~LVmE~~~ggsL~~ll~~~--~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld--~~g~vKL~DFGlA~~~~~ 481 (554)
|||||||.+|+|.+++... .+++.+++.|+.||+.||.|||++|||||||||+||||+ .++.+||+|||+++....
T Consensus 102 ~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~ 181 (352)
T d1koba_ 102 VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 181 (352)
T ss_dssp EEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred EEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCC
Confidence 9999999999999877643 589999999999999999999999999999999999997 578999999999987654
Q ss_pred CC-ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHH
Q 008759 482 ND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTV 543 (554)
Q Consensus 482 ~~-~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~ 543 (554)
.. .....||+.|||||++.+. .|+.++|||||||++|+|+||+.||.+....+.+..+..
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~ 242 (352)
T d1koba_ 182 DEIVKVTTATAEFAAPEIVDRE--PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKR 242 (352)
T ss_dssp TSCEEEECSSGGGCCHHHHTTC--CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHH
T ss_pred CCceeeccCcccccCHHHHcCC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 43 4456799999999999654 489999999999999999999999998888777666544
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-44 Score=376.67 Aligned_cols=211 Identities=28% Similarity=0.441 Sum_probs=185.5
Q ss_pred ccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEE
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~ 406 (554)
+++|++++.||+|+||+||+|.+ .+|+.||+|++..... ......+.+.+|+.+|+.++|||||++++++.+...+|
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 117 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV--VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHc--cCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccc
Confidence 46899999999999999999998 6899999999864211 11223457889999999999999999999999999999
Q ss_pred EEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCCcc
Q 008759 407 IFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDVK 485 (554)
Q Consensus 407 LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~~~ 485 (554)
+||||+.+|+|..++.+ ..+++..++.|+.||+.||.|||++|||||||||+|||++.+|.+||+|||+++..... ..
T Consensus 118 ~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-~~ 196 (350)
T d1rdqe_ 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-TW 196 (350)
T ss_dssp EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-BC
T ss_pred cccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc-cc
Confidence 99999999999998876 47999999999999999999999999999999999999999999999999999876543 34
Q ss_pred CccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHH
Q 008759 486 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTV 543 (554)
Q Consensus 486 s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~ 543 (554)
...||+.|||||++.+. .|+.++|||||||++|+|+||+.||.+.+..+.+.++..
T Consensus 197 ~~~Gt~~Y~APE~~~~~--~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~ 252 (350)
T d1rdqe_ 197 TLCGTPEALAPEIILSK--GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS 252 (350)
T ss_dssp CCEECGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred cccCccccCCHHHHcCC--CCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhc
Confidence 56799999999999764 488999999999999999999999998877666665544
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-44 Score=361.66 Aligned_cols=209 Identities=28% Similarity=0.516 Sum_probs=175.4
Q ss_pred ccceeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEE
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~L 407 (554)
.++|++++.||+|+||+||+|+++. .||||++...... ....+.+.+|+.+|++++|||||++++++. ...+||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~l 80 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPT---PQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAI 80 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCC---TTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEE
Confidence 4678999999999999999998753 5999998653322 234567899999999999999999999875 456899
Q ss_pred EEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC---
Q 008759 408 FLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--- 482 (554)
Q Consensus 408 VmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~--- 482 (554)
||||+.+|+|.+++.. ..+++..+..|+.||+.||.|||++|||||||||+|||++.++.+||+|||+++.....
T Consensus 81 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~ 160 (276)
T d1uwha_ 81 VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 160 (276)
T ss_dssp EEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence 9999999999999864 35899999999999999999999999999999999999999999999999999765322
Q ss_pred -CccCccCCCcccChhhhcccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHH
Q 008759 483 -DVKSCRGTAFWMAPEVINNKN-KGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKT 542 (554)
Q Consensus 483 -~~~s~~GT~~Y~APEvl~~~~-~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~ 542 (554)
......||+.|||||++.+.. ..|+.++|||||||++|||+||+.||......+.+....
T Consensus 161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~ 222 (276)
T d1uwha_ 161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 222 (276)
T ss_dssp -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHH
T ss_pred ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHH
Confidence 234567999999999996543 348999999999999999999999999887766655444
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-44 Score=364.54 Aligned_cols=210 Identities=28% Similarity=0.436 Sum_probs=177.0
Q ss_pred eeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEEEee
Q 008759 333 KGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLEL 411 (554)
Q Consensus 333 i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LVmE~ 411 (554)
.+++||+|+||+||+|++ .+|+.||||++.............+.+.+|+.+|+.++|||||++++++.+.+++||||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 468899999999999998 6799999999875433322223345688999999999999999999999999999999999
Q ss_pred cccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC--CccCcc
Q 008759 412 VTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--DVKSCR 488 (554)
Q Consensus 412 ~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~--~~~s~~ 488 (554)
+.++++..++.. ..+++..+..+++||+.||.|||++||+||||||+|||++.++.+||+|||+++..... .....+
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~~ 161 (299)
T d1ua2a_ 82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV 161 (299)
T ss_dssp CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSC
T ss_pred hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCccccccee
Confidence 999888777664 46899999999999999999999999999999999999999999999999999765433 334567
Q ss_pred CCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHH
Q 008759 489 GTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTV 543 (554)
Q Consensus 489 GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~ 543 (554)
||+.|+|||++.... .|+.++|||||||++|+|+||+.||......+.+.++..
T Consensus 162 gt~~y~aPE~~~~~~-~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~ 215 (299)
T d1ua2a_ 162 VTRWYRAPELLFGAR-MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFE 215 (299)
T ss_dssp CCCTTCCHHHHTTCS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred cChhhccHHHHccCC-CCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHH
Confidence 999999999986443 589999999999999999999999999888887776654
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.8e-44 Score=374.67 Aligned_cols=205 Identities=29% Similarity=0.446 Sum_probs=176.8
Q ss_pred ccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccc-hhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcE
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGS-QAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL 405 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~-~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~ 405 (554)
+++|+++++||+|+||.||+|++ .+|+.||+|++....... ..........+++.+++.++|||||+++++|.+.+.+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 56899999999999999999998 679999999986422111 1112222334457778888999999999999999999
Q ss_pred EEEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCCc
Q 008759 406 YIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLNDV 484 (554)
Q Consensus 406 ~LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~~ 484 (554)
||||||+.+|+|..++.+ ..+++..++.|+.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+.......
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~~ 162 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 162 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSSCC
T ss_pred EEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCCcc
Confidence 999999999999999875 4688999999999999999999999999999999999999999999999999987776666
Q ss_pred cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008759 485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME 533 (554)
Q Consensus 485 ~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e 533 (554)
....||+.|||||++... ..|+.++|||||||++|+|+||+.||....
T Consensus 163 ~~~~GT~~y~APE~~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~ 210 (364)
T d1omwa3 163 HASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHK 210 (364)
T ss_dssp CSCCSCGGGCCHHHHSTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCSSC
T ss_pred cccccccccchhHHhhcC-CCCCcccchhHHHHHHHHHHhCCCCCCCCC
Confidence 677899999999999643 358999999999999999999999998654
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.5e-43 Score=357.01 Aligned_cols=216 Identities=26% Similarity=0.454 Sum_probs=187.6
Q ss_pred ccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccc----hhHHHHHHHHHHHHHHHhCC-CCceeeeeeeccC
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGS----QAKQSISQLEQEIALLSRFE-HENIVQYYGTDKD 401 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~----~~~~~~~~~~~Ei~iL~~l~-HpnIVkl~~~~~~ 401 (554)
.++|++++.||+|+||+||+|++ .+|+.||+|++....... ..+...+.+.+|+.++++++ |||||++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 57899999999999999999998 789999999997643322 22334457889999999997 9999999999999
Q ss_pred CCcEEEEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccc
Q 008759 402 ESKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK 480 (554)
Q Consensus 402 ~~~~~LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~ 480 (554)
++.+||||||+.+|+|.++++. ..+++.+++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 161 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 161 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence 9999999999999999999965 579999999999999999999999999999999999999999999999999998765
Q ss_pred cC-CccCccCCCcccChhhhccc----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHH
Q 008759 481 LN-DVKSCRGTAFWMAPEVINNK----NKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTV 543 (554)
Q Consensus 481 ~~-~~~s~~GT~~Y~APEvl~~~----~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~ 543 (554)
.. ......||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.+....+....+..
T Consensus 162 ~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~ 229 (277)
T d1phka_ 162 PGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS 229 (277)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHh
Confidence 33 34556799999999998642 23478899999999999999999999998887666555543
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.4e-44 Score=362.21 Aligned_cols=208 Identities=27% Similarity=0.438 Sum_probs=179.2
Q ss_pred cccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcE
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKL 405 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~ 405 (554)
..++|++++.||+|+||+||+|.+ .+++.||+|++..... ..+.+.+|+.+|+.++|||||+++++|.+.+.+
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~------~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM------EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 88 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc------hHHHHHHHHHHHHhCCCCCEecCCccEeeCCee
Confidence 456899999999999999999998 5789999998864221 235688999999999999999999999999999
Q ss_pred EEEEeecccCchHHHHhh---hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC
Q 008759 406 YIFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN 482 (554)
Q Consensus 406 ~LVmE~~~ggsL~~ll~~---~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~ 482 (554)
||||||+.+|+|..++.. ..+++..+..|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 89 ~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (287)
T d1opja_ 89 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 168 (287)
T ss_dssp EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred EEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCC
Confidence 999999999999999865 35899999999999999999999999999999999999999999999999999876543
Q ss_pred Cc---cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHH
Q 008759 483 DV---KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKT 542 (554)
Q Consensus 483 ~~---~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~ 542 (554)
.. ....||+.|+|||++.+. .|+.++|||||||++|||++|..||........++.++
T Consensus 169 ~~~~~~~~~g~~~y~aPE~~~~~--~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i 229 (287)
T d1opja_ 169 TYTAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 229 (287)
T ss_dssp SSEEETTEEECGGGCCHHHHHHC--CCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred CceeeccccccccccChHHHcCC--CCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHH
Confidence 32 233478999999999765 48999999999999999999877776655555555443
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.1e-43 Score=355.99 Aligned_cols=214 Identities=25% Similarity=0.374 Sum_probs=178.6
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCC-
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES- 403 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~- 403 (554)
.+.++|++.+.||+|+||+||+|.+ .+|+.||+|++..... ........+.+|+.+++.++|||||++++++...+
T Consensus 4 ~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~ 81 (277)
T d1o6ya_ 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLA--RDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP 81 (277)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTT--TCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECS
T ss_pred CccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhc--cCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccC
Confidence 3457899999999999999999998 7899999999875332 22345578999999999999999999999886543
Q ss_pred ---cEEEEEeecccCchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccc
Q 008759 404 ---KLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT 479 (554)
Q Consensus 404 ---~~~LVmE~~~ggsL~~ll~~~-~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~ 479 (554)
.+||||||+.|++|..++... .+++.+++.|+.||+.||.|||++||+||||||+|||++.++.++|+|||++...
T Consensus 82 ~~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 82 AGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAI 161 (277)
T ss_dssp SSEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred CCceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhh
Confidence 489999999999999888664 6999999999999999999999999999999999999999999999999998654
Q ss_pred ccC-----CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHH
Q 008759 480 KLN-----DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTV 543 (554)
Q Consensus 480 ~~~-----~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~ 543 (554)
... .....+||+.|||||++.+. .|+.++|||||||++|+|+||++||......+.++++..
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~--~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~ 228 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSPEQARGD--SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR 228 (277)
T ss_dssp C----------------TTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred ccccccccccccccCcccccCHHHHcCC--CCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHh
Confidence 322 23455799999999999654 489999999999999999999999998888777766654
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-43 Score=364.94 Aligned_cols=210 Identities=22% Similarity=0.363 Sum_probs=183.9
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCc
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~ 404 (554)
.+.++|++++.||+|+||+||+|.+ .+++.||+|++.... .....+.+|+.+|+.++|||||+++++|.+.++
T Consensus 2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~------~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~ 75 (321)
T d1tkia_ 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG------TDQVLVKKEISILNIARHRNILHLHESFESMEE 75 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT------HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTE
T ss_pred CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc------ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence 4668899999999999999999998 689999999997422 122457899999999999999999999999999
Q ss_pred EEEEEeecccCchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCC--CcEEEEecCcccccc
Q 008759 405 LYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN--GSVKLADFGLAKATK 480 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~~--~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~--g~vKL~DFGlA~~~~ 480 (554)
+|||||||.||+|.++++.. .+++.+++.|+.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 76 ~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~ 155 (321)
T d1tkia_ 76 LVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp EEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccc
Confidence 99999999999999999754 58999999999999999999999999999999999999854 489999999998765
Q ss_pred cCC-ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHH
Q 008759 481 LND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTV 543 (554)
Q Consensus 481 ~~~-~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~ 543 (554)
... .....+|+.|+|||++.+.. |+.++|||||||++|+|++|+.||......+.+..+..
T Consensus 156 ~~~~~~~~~~t~~y~ape~~~~~~--~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~ 217 (321)
T d1tkia_ 156 PGDNFRLLFTAPEYYAPEVHQHDV--VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMN 217 (321)
T ss_dssp TTCEEEEEESCGGGSCHHHHTTCE--ECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH
T ss_pred cCCcccccccccccccchhccCCC--CCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 433 34566999999999986544 88999999999999999999999998887766666544
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-43 Score=363.67 Aligned_cols=211 Identities=29% Similarity=0.499 Sum_probs=180.5
Q ss_pred ccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHH-hCCCCceeeeeeeccCCCcE
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLS-RFEHENIVQYYGTDKDESKL 405 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~-~l~HpnIVkl~~~~~~~~~~ 405 (554)
+++|++++.||+|+||+||+|++ .+++.||+|++..... ........+..|..++. .++|||||++++++.+.+.+
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~--~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~ 78 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVV--LMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 78 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhc--cChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCce
Confidence 36899999999999999999999 6899999999974211 11122345566666654 68999999999999999999
Q ss_pred EEEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccccc--C
Q 008759 406 YIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL--N 482 (554)
Q Consensus 406 ~LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~--~ 482 (554)
||||||+.+|+|..++.. ..+++.+++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++.... .
T Consensus 79 yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~ 158 (320)
T d1xjda_ 79 FFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 158 (320)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred eEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccccc
Confidence 999999999999999976 4699999999999999999999999999999999999999999999999999986543 2
Q ss_pred CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHH
Q 008759 483 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKT 542 (554)
Q Consensus 483 ~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~ 542 (554)
......||+.|+|||++.+. .|+.++|||||||++|+|+||+.||.+....+.+.++.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~ 216 (320)
T d1xjda_ 159 KTNTFCGTPDYIAPEILLGQ--KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR 216 (320)
T ss_dssp CBCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred cccccCCCCCcCCHHHHcCC--CCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 34456799999999999764 48999999999999999999999999877766555543
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-44 Score=354.78 Aligned_cols=205 Identities=22% Similarity=0.380 Sum_probs=167.9
Q ss_pred cceeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEE
Q 008759 329 TYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LV 408 (554)
++|++++.||+|+||+||+|.+.+++.||+|++...... .+.+.+|+.++++++|||||++++++...+.+|+|
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~------~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv 78 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS------EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 78 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSC------HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCc------HHHHHHHHHHHHhcCCCCcccccceeccCCceEEE
Confidence 479999999999999999999988899999998642221 24688999999999999999999999999999999
Q ss_pred EeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC---
Q 008759 409 LELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--- 483 (554)
Q Consensus 409 mE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~--- 483 (554)
|||+.+|+|.+++.. ..+++..+..|+.||+.||.|||+++|+||||||+|||++.++.+||+|||+++......
T Consensus 79 ~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 79 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred EEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence 999999999998865 458889999999999999999999999999999999999999999999999997654332
Q ss_pred ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHHHHH
Q 008759 484 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIFIK 541 (554)
Q Consensus 484 ~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i~~i 541 (554)
.....||+.|+|||++.+. .|+.++|||||||++|||+| |.+||......+.+..+
T Consensus 159 ~~~~~gt~~y~aPE~l~~~--~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i 215 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFS--RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 215 (263)
T ss_dssp ------CTTSCCHHHHTTC--CCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHH
T ss_pred ecceecCcccCChHHhcCC--CCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHH
Confidence 2335689999999999654 48999999999999999999 56666665554444433
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.6e-43 Score=360.04 Aligned_cols=209 Identities=27% Similarity=0.472 Sum_probs=168.5
Q ss_pred ccceeeeeeeccCCceeEEEEecC-CCc---EEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCC
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGISD-DGF---FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES 403 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~~-~g~---~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~ 403 (554)
.++|++.++||+|+||+||+|.+. +++ .||+|.+... ......+.+.+|+.+|++++|||||++++++...+
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~ 100 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG----YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST 100 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS----CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc----cCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 367999999999999999999873 333 5777776532 12344567899999999999999999999999999
Q ss_pred cEEEEEeecccCchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccccc
Q 008759 404 KLYIFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL 481 (554)
Q Consensus 404 ~~~LVmE~~~ggsL~~ll~~~--~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~ 481 (554)
.+|+||||+.+|+|.+++... .+++.++..|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++....
T Consensus 101 ~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 101 PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccC
Confidence 999999999999999988763 589999999999999999999999999999999999999999999999999986543
Q ss_pred CCc-------cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHH
Q 008759 482 NDV-------KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIFIKT 542 (554)
Q Consensus 482 ~~~-------~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i~~i~ 542 (554)
... ....||+.|||||++.+. .|+.++|||||||++|||+| |+.||......+.+..+.
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~ 247 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYR--KFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE 247 (299)
T ss_dssp ---------------CGGGSCHHHHHSC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH
T ss_pred CCCcceeeecccccCCccccCHHHHhcC--CCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 221 123478999999999654 48999999999999999998 899999988766555443
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-43 Score=353.33 Aligned_cols=203 Identities=29% Similarity=0.494 Sum_probs=172.6
Q ss_pred cccceeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEE
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~ 406 (554)
..++|++++.||+|+||+||+|.+++++.||||++..... ..+.+.+|+.++++++|||||++++++.+ +.+|
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~------~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~ 83 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM------SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIY 83 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS------CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred CHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcC------CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeE
Confidence 3468999999999999999999998889999999864222 12468899999999999999999998754 5679
Q ss_pred EEEeecccCchHHHHhh---hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC
Q 008759 407 IFLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND 483 (554)
Q Consensus 407 LVmE~~~ggsL~~ll~~---~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~ 483 (554)
|||||+.+|+|.+++.. ..+++..+..|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++......
T Consensus 84 iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~ 163 (272)
T d1qpca_ 84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (272)
T ss_dssp EEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred EEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCc
Confidence 99999999999987754 258999999999999999999999999999999999999999999999999998765432
Q ss_pred ---ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCC-CCCCCChhHHH
Q 008759 484 ---VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQI-PYAPMECVSAI 538 (554)
Q Consensus 484 ---~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~-PF~~~e~~~~i 538 (554)
.....||+.|||||++.+.. |+.++|||||||++|||+||.. ||......+.+
T Consensus 164 ~~~~~~~~gt~~y~APE~~~~~~--~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~ 220 (272)
T d1qpca_ 164 YTAREGAKFPIKWTAPEAINYGT--FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI 220 (272)
T ss_dssp EECCTTCCCCTTTSCHHHHHHCE--ECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH
T ss_pred cccccccCCcccccChHHHhCCC--CCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 23456899999999997544 8899999999999999999554 55555544433
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-43 Score=361.27 Aligned_cols=210 Identities=27% Similarity=0.447 Sum_probs=176.6
Q ss_pred ccceeeeeeeccCCceeEEEEecC-CC-----cEEEEEEEecccccchhHHHHHHHHHHHHHHHhC-CCCceeeeeeecc
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGISD-DG-----FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDK 400 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~~-~g-----~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIVkl~~~~~ 400 (554)
.++|+++++||+|+||+||+|++. .+ ..||+|.+.... .......+.+|+.++.++ +|||||++++++.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~ 111 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA----DSSEREALMSELKMMTQLGSHENIVNLLGACT 111 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC----------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc----CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe
Confidence 468999999999999999999873 22 368888875322 223345688999999988 8999999999999
Q ss_pred CCCcEEEEEeecccCchHHHHhhh------------------------cCChHHHHHHHHHHHHHHHHHHHCCccccCCc
Q 008759 401 DESKLYIFLELVTKGSLLNLYQRY------------------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIK 456 (554)
Q Consensus 401 ~~~~~~LVmE~~~ggsL~~ll~~~------------------------~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIK 456 (554)
+.+.+||||||+.+|+|.++++.. .+++..++.|+.||+.||.|||++||||||||
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlK 191 (325)
T d1rjba_ 112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLA 191 (325)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCc
Confidence 999999999999999999998643 37888999999999999999999999999999
Q ss_pred cccEEEcCCCcEEEEecCcccccccCCc----cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCC
Q 008759 457 CANILVDANGSVKLADFGLAKATKLNDV----KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAP 531 (554)
Q Consensus 457 PeNILld~~g~vKL~DFGlA~~~~~~~~----~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~ 531 (554)
|+|||++.++.+||+|||+|+....... ....||+.|||||++.+. .|+.++|||||||++|||+| |+.||.+
T Consensus 192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~~DiwS~Gvil~emlt~g~~Pf~~ 269 (325)
T d1rjba_ 192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG--IYTIKSDVWSYGILLWEIFSLGVNPYPG 269 (325)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred hhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCC--CCCcceeccchhHHHHHHHhCCCCCCCC
Confidence 9999999999999999999986544322 244579999999999755 48999999999999999998 8999998
Q ss_pred CChhHHHHHHHH
Q 008759 532 MECVSAIFIKTV 543 (554)
Q Consensus 532 ~e~~~~i~~i~~ 543 (554)
....+.+.++..
T Consensus 270 ~~~~~~~~~~~~ 281 (325)
T d1rjba_ 270 IPVDANFYKLIQ 281 (325)
T ss_dssp CCCSHHHHHHHH
T ss_pred CCHHHHHHHHHh
Confidence 877766666543
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-43 Score=354.41 Aligned_cols=212 Identities=30% Similarity=0.486 Sum_probs=180.8
Q ss_pred ccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEE
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~ 406 (554)
+++|++++.||+|+||+||+|.+ .+|+.||+|++..... .......+.+|+.+|++++|||||++++++.+.+++|
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~ 77 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE---TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLY 77 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC----------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc---ChHHHHHHHHHHHHHHhCCCCcEEEecccccccccee
Confidence 36899999999999999999998 7899999999964321 1223467889999999999999999999999999999
Q ss_pred EEEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC--
Q 008759 407 IFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN-- 482 (554)
Q Consensus 407 LVmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~-- 482 (554)
+||||+.++.+..+... .++++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+++.....
T Consensus 78 iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~ 157 (298)
T d1gz8a_ 78 LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 157 (298)
T ss_dssp EEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB
T ss_pred EEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCcc
Confidence 99999987655544433 46999999999999999999999999999999999999999999999999999875433
Q ss_pred CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHH
Q 008759 483 DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTV 543 (554)
Q Consensus 483 ~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~ 543 (554)
......||+.|+|||++.... .++.++|||||||++|+|++|+.||......+.++++..
T Consensus 158 ~~~~~~gt~~y~apE~~~~~~-~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~ 217 (298)
T d1gz8a_ 158 TYTHEVVTLWYRAPEILLGCK-YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR 217 (298)
T ss_dssp CTTCCBCCCTTCCHHHHTTCS-SCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cceeecccceeeehhhhcccc-CCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHH
Confidence 344557999999999986544 468899999999999999999999999888888777654
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-43 Score=352.34 Aligned_cols=207 Identities=28% Similarity=0.482 Sum_probs=175.8
Q ss_pred cceeeeee-eccCCceeEEEEec---CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCc
Q 008759 329 TYWQKGDL-LGRGSFGSVYEGIS---DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (554)
Q Consensus 329 ~~y~i~~~-LG~GsfG~VY~a~~---~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~ 404 (554)
++|.+.+. ||+|+||+||+|.+ .++..||||++... ......+.+.+|+.+|++++|||||++++++.. +.
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~----~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~ 82 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG----TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA 82 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS----CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SS
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh----cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-Ce
Confidence 56888885 99999999999976 34567999998642 223456788999999999999999999999865 56
Q ss_pred EEEEEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC
Q 008759 405 LYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN 482 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~ 482 (554)
+||||||+++|+|.+++.. ..+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 83 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccccc
Confidence 8999999999999998864 46999999999999999999999999999999999999999999999999999865432
Q ss_pred C-----ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHH
Q 008759 483 D-----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIFIKT 542 (554)
Q Consensus 483 ~-----~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i~~i~ 542 (554)
. .....||+.|||||++.+.. ++.++|||||||++|||+| |+.||......+.+..+.
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~ 226 (285)
T d1u59a_ 163 DSYYTARSAGKWPLKWYAPECINFRK--FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 226 (285)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCE--ECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH
T ss_pred ccccccccccccCccccChHHHhCCC--CCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 2 23446899999999997654 8999999999999999998 999999887766554443
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-43 Score=347.97 Aligned_cols=207 Identities=24% Similarity=0.429 Sum_probs=181.4
Q ss_pred cceeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEE
Q 008759 329 TYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIF 408 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LV 408 (554)
++|+++++||+|+||+||+|++++++.||+|++...... .+.+.+|+.++.+++|||||++++++.+.+.+|+|
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~------~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv 77 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS------EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 77 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC------HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCC------HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Confidence 478899999999999999999988999999998753221 24688999999999999999999999999999999
Q ss_pred EeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC---
Q 008759 409 LELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--- 483 (554)
Q Consensus 409 mE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~--- 483 (554)
|||+.+|+|..++.. ..+.+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 78 ~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 157 (258)
T d1k2pa_ 78 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 157 (258)
T ss_dssp EECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred EEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence 999999999988654 468899999999999999999999999999999999999999999999999997654332
Q ss_pred ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHH
Q 008759 484 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIFIKTV 543 (554)
Q Consensus 484 ~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i~~i~~ 543 (554)
.....||+.|+|||++.+.. |+.++|||||||++|||+| |+.||......+...++..
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~--~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~ 216 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMYSK--FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ 216 (258)
T ss_dssp CCCSCCCGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHT
T ss_pred ecccCCCCCcCCcHHhcCCC--CCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHh
Confidence 23456899999999997654 8999999999999999998 8999999887776655544
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-43 Score=352.50 Aligned_cols=205 Identities=29% Similarity=0.450 Sum_probs=174.4
Q ss_pred cccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchh-HHHHHHHHHHHHHHHhCC--CCceeeeeeeccCC
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQA-KQSISQLEQEIALLSRFE--HENIVQYYGTDKDE 402 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~-~~~~~~~~~Ei~iL~~l~--HpnIVkl~~~~~~~ 402 (554)
+.++|+++++||+|+||+||+|++ .+|+.||+|++......... .....++.+|+.+|++++ |||||++++++.+.
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence 356899999999999999999998 68999999998753221110 011233568999999986 89999999999999
Q ss_pred CcEEEEEeeccc-CchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCC-CcEEEEecCccccc
Q 008759 403 SKLYIFLELVTK-GSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDAN-GSVKLADFGLAKAT 479 (554)
Q Consensus 403 ~~~~LVmE~~~g-gsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~-g~vKL~DFGlA~~~ 479 (554)
+.+|+||||+.+ +++.+++.. ..+++..++.|+.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++..
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~ 161 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 161 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceec
Confidence 999999999976 577777764 579999999999999999999999999999999999999854 79999999999877
Q ss_pred ccCCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008759 480 KLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM 532 (554)
Q Consensus 480 ~~~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~ 532 (554)
.........||+.|+|||++.+.. .++.++|||||||++|+|+||+.||...
T Consensus 162 ~~~~~~~~~GT~~y~aPE~~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~ 213 (273)
T d1xwsa_ 162 KDTVYTDFDGTRVYSPPEWIRYHR-YHGRSAAVWSLGILLYDMVCGDIPFEHD 213 (273)
T ss_dssp CSSCBCCCCSCGGGSCHHHHHHSC-BCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred ccccccccccCCCcCCHHHHcCCC-CCCcccccccceeeehhHhhCCCCCCCc
Confidence 766667788999999999997543 3567899999999999999999999753
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-42 Score=348.68 Aligned_cols=202 Identities=27% Similarity=0.460 Sum_probs=168.9
Q ss_pred eeeccCCceeEEEEec---CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEEEEee
Q 008759 335 DLLGRGSFGSVYEGIS---DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYIFLEL 411 (554)
Q Consensus 335 ~~LG~GsfG~VY~a~~---~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~LVmE~ 411 (554)
+.||+|+||+||+|.+ .+++.||+|++..... .....+.+.+|+.+|++++|||||++++++.. +..||||||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~ 88 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN---DPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEM 88 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC--------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEEC
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC---CHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEc
Confidence 4799999999999976 3457899999864221 23345678999999999999999999999865 467899999
Q ss_pred cccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC-----cc
Q 008759 412 VTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND-----VK 485 (554)
Q Consensus 412 ~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~-----~~ 485 (554)
+++|+|.+++++ ..+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ..
T Consensus 89 ~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~ 168 (277)
T d1xbba_ 89 AELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 168 (277)
T ss_dssp CTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC--
T ss_pred CCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccccc
Confidence 999999999876 469999999999999999999999999999999999999999999999999998654332 22
Q ss_pred CccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHH
Q 008759 486 SCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIFIKT 542 (554)
Q Consensus 486 s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i~~i~ 542 (554)
...||+.|||||++.+.. ++.++|||||||++|||+| |+.||......+....+.
T Consensus 169 ~~~gt~~y~APE~l~~~~--~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~ 224 (277)
T d1xbba_ 169 HGKWPVKWYAPECINYYK--FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 224 (277)
T ss_dssp --CCCGGGCCHHHHHHCE--EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH
T ss_pred ccCCCceecCchhhcCCC--CCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHH
Confidence 346899999999997654 8899999999999999998 999999887765544443
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.5e-42 Score=345.72 Aligned_cols=212 Identities=27% Similarity=0.460 Sum_probs=182.2
Q ss_pred ccceeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEE
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~L 407 (554)
+++|++++.||+|+||+||+|.+.+|+.||+|++...... ....+.+.+|+.+|+.++|||||++++++...+..|+
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i 77 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKED---EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVL 77 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGG---GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEE
T ss_pred CCCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcC---hHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeE
Confidence 3689999999999999999999999999999999653321 2224678899999999999999999999999999999
Q ss_pred EEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC--c
Q 008759 408 FLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND--V 484 (554)
Q Consensus 408 VmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~--~ 484 (554)
+||++.++.+..+.+. ..+++..+..|+.||+.||.|||++|||||||||+|||++.++.+||+|||++....... .
T Consensus 78 ~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 157 (286)
T d1ob3a_ 78 VFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY 157 (286)
T ss_dssp EEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred EEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCcccc
Confidence 9999999888877764 569999999999999999999999999999999999999999999999999997654332 3
Q ss_pred cCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHH
Q 008759 485 KSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTV 543 (554)
Q Consensus 485 ~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~ 543 (554)
....+++.|+|||++.... .++.++|||||||++|||++|+.||......+.+.++..
T Consensus 158 ~~~~~~~~y~~pE~~~~~~-~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~ 215 (286)
T d1ob3a_ 158 THEIVTLWYRAPDVLMGSK-KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFR 215 (286)
T ss_dssp ----CCCTTCCHHHHTTCC-SCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred ceecccchhhhHHHHhCCC-CCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence 3446899999999986543 478999999999999999999999999888777766543
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-42 Score=345.07 Aligned_cols=207 Identities=25% Similarity=0.409 Sum_probs=167.2
Q ss_pred cceeeeeeeccCCceeEEEEecCC-C----cEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCC
Q 008759 329 TYWQKGDLLGRGSFGSVYEGISDD-G----FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES 403 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~~~-g----~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~ 403 (554)
+.|++.++||+|+||.||+|.+.+ + ..||||++.... .......+.+|+.++++++|||||++++++.+.+
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~ 82 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY----TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK 82 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc----ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCC
Confidence 468899999999999999998743 2 479999886422 2233457889999999999999999999999999
Q ss_pred cEEEEEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccccc
Q 008759 404 KLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL 481 (554)
Q Consensus 404 ~~~LVmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~ 481 (554)
.+++||||+.++++.+++.. ..+++.++..++.||+.||.|||+++|+||||||+||||+.++.+||+|||+++....
T Consensus 83 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 83 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred ceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccC
Confidence 99999999999999988765 4589999999999999999999999999999999999999999999999999986543
Q ss_pred CC-----ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHH
Q 008759 482 ND-----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIK 541 (554)
Q Consensus 482 ~~-----~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i 541 (554)
.. .....||+.|||||++.+. .++.++|||||||++|||++|..||........++..
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~~--~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~ 225 (283)
T d1mqba_ 163 DPEATYTTSGGKIPIRWTAPEAISYR--KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKA 225 (283)
T ss_dssp -----------CCCGGGSCHHHHHSC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH
T ss_pred CCccceEeccCCCCccccCHHHHccC--CCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHH
Confidence 22 2234589999999999654 4899999999999999999966655544444444433
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-42 Score=345.47 Aligned_cols=213 Identities=31% Similarity=0.479 Sum_probs=174.5
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CC-CcEEEEEEEecccccchhHHHHHHHHHHHHHHHh---CCCCceeeeeeecc
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DD-GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR---FEHENIVQYYGTDK 400 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~-g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~---l~HpnIVkl~~~~~ 400 (554)
+..++|++++.||+|+||+||+|++ .+ ++.||+|++......... ...+.+|+.+|+. ++||||++++++|.
T Consensus 4 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~---~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~ 80 (305)
T d1blxa_ 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM---PLSTIREVAVLRHLETFEHPNVVRLFDVCT 80 (305)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSC---BCTHHHHHHHHHHHHHTCCTTBCCEEEEEE
T ss_pred CCcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchH---HHHHHHHHHHHHHHhhcCCCCcceeeeeec
Confidence 4467899999999999999999998 44 678999998753222111 1234466666555 48999999999874
Q ss_pred -----CCCcEEEEEeecccCchHHHHh--hhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEec
Q 008759 401 -----DESKLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADF 473 (554)
Q Consensus 401 -----~~~~~~LVmE~~~ggsL~~ll~--~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DF 473 (554)
....+|++|||+.++.+..... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 81 VSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp EEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred ccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecch
Confidence 3457899999999987765443 346899999999999999999999999999999999999999999999999
Q ss_pred Cccccccc-CCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHH
Q 008759 474 GLAKATKL-NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTV 543 (554)
Q Consensus 474 GlA~~~~~-~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~ 543 (554)
|+++.... .......||+.|||||++.+. .|+.++|||||||++|||++|+.||......+.+.++..
T Consensus 161 g~~~~~~~~~~~~~~~gT~~Y~APE~~~~~--~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~ 229 (305)
T d1blxa_ 161 GLARIYSFQMALTSVVVTLWYRAPEVLLQS--SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILD 229 (305)
T ss_dssp CSCCCCCGGGGGCCCCCCCTTCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred hhhhhhcccccCCCcccChhhcCcchhcCC--CCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence 99876533 234566799999999999664 489999999999999999999999999888777766643
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-42 Score=341.93 Aligned_cols=209 Identities=30% Similarity=0.469 Sum_probs=167.6
Q ss_pred ccceeeeeeeccCCceeEEEEecC-C---CcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCC
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGISD-D---GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES 403 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~~-~---g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~ 403 (554)
.++|++++.||+|+||+||+|.+. + +..||+|.+... ......+.+.+|+.++++++|||||++++++. ++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~----~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~ 80 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC----TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 80 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT----TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SS
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc----cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC
Confidence 468999999999999999999873 2 346777776432 22344567899999999999999999999985 56
Q ss_pred cEEEEEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccccc
Q 008759 404 KLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL 481 (554)
Q Consensus 404 ~~~LVmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~ 481 (554)
.+|+||||+.+|+|..++.. ..+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 81 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 160 (273)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred eEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccC
Confidence 78999999999999998764 3589999999999999999999999999999999999999999999999999986543
Q ss_pred CC---ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHHH
Q 008759 482 ND---VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIFIKTV 543 (554)
Q Consensus 482 ~~---~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i~~i~~ 543 (554)
.. .....||+.|+|||++.+. .|+.++|||||||++|||+| |.+||......+.+.++..
T Consensus 161 ~~~~~~~~~~gt~~y~apE~l~~~--~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~ 224 (273)
T d1mp8a_ 161 STYYKASKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN 224 (273)
T ss_dssp ----------CCGGGCCHHHHHHC--CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT
T ss_pred CcceeccceecCcccchhhHhccC--CCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence 22 2345689999999999765 48999999999999999998 8999998887776655543
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-42 Score=357.94 Aligned_cols=196 Identities=28% Similarity=0.436 Sum_probs=168.3
Q ss_pred ccccceeee-eeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHh-CCCCceeeeeeeccC-
Q 008759 326 RIITYWQKG-DLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSR-FEHENIVQYYGTDKD- 401 (554)
Q Consensus 326 ~~~~~y~i~-~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~-l~HpnIVkl~~~~~~- 401 (554)
.+.++|++. ++||+|+||+||+|++ .+++.||||++... ..+.+|+.++.+ .+|||||+++++|.+
T Consensus 8 ~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~----------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~ 77 (335)
T d2ozaa1 8 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----------PKARREVELHWRASQCPHIVRIVDVYENL 77 (335)
T ss_dssp CGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS----------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred CcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc----------HHHHHHHHHHHHhcCCCCCCeEEEEEeec
Confidence 356788876 5699999999999998 78999999998631 245688888654 589999999998864
Q ss_pred ---CCcEEEEEeecccCchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcC---CCcEEEEe
Q 008759 402 ---ESKLYIFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA---NGSVKLAD 472 (554)
Q Consensus 402 ---~~~~~LVmE~~~ggsL~~ll~~~---~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~---~g~vKL~D 472 (554)
...+|||||||.||+|.+++.+. .+++.+++.|+.||+.||.|||++||+||||||+|||++. ++.+||+|
T Consensus 78 ~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~D 157 (335)
T d2ozaa1 78 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD 157 (335)
T ss_dssp ETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECC
T ss_pred ccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccc
Confidence 46799999999999999999763 5899999999999999999999999999999999999975 46799999
Q ss_pred cCccccccc-CCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008759 473 FGLAKATKL-NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME 533 (554)
Q Consensus 473 FGlA~~~~~-~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e 533 (554)
||+++.... .......||+.|||||++.+.. |+.++|||||||++|+|+||+.||.+..
T Consensus 158 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~--y~~~~DiwSlGvily~lltg~~Pf~~~~ 217 (335)
T d2ozaa1 158 FGFAKETTSHNSLTTPCYTPYYVAPEVLGPEK--YDKSCDMWSLGVIMYILLCGYPPFYSNH 217 (335)
T ss_dssp CTTCEECCCCCCCCCCSCCCSSCCCCCCCGGG--GSHHHHHHHHHHHHHHHTTSSCSCEETT
T ss_pred cceeeeccCCCccccccCCcccCCcHHHcCCC--CCHHHHHHhhchhHHHHhhCCCCCCCCC
Confidence 999986543 3445667999999999996544 8999999999999999999999997543
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-41 Score=349.04 Aligned_cols=211 Identities=25% Similarity=0.453 Sum_probs=177.9
Q ss_pred cccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCC--
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES-- 403 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~-- 403 (554)
+.++|++++.||+|+||+||+|.+ .+|+.||+|++.... ......+.+.+|+.+|+.++|||||+++++|...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~---~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~ 92 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF---QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETL 92 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT---SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSST
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh---cChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccc
Confidence 467899999999999999999998 679999999986422 22345577889999999999999999999987654
Q ss_pred ----cEEEEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccc
Q 008759 404 ----KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT 479 (554)
Q Consensus 404 ----~~~LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~ 479 (554)
.+|+||||+ +.+|..+++...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~~~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~ 171 (346)
T d1cm8a_ 93 DDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA 171 (346)
T ss_dssp TTCCCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred cccceEEEEEecc-cccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceecc
Confidence 579999999 558888888889999999999999999999999999999999999999999999999999999876
Q ss_pred ccCCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHH
Q 008759 480 KLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTV 543 (554)
Q Consensus 480 ~~~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~ 543 (554)
.. ......||+.|+|||++.+.. .++.++|||||||++|+|++|+.||.+.+..+.+..+..
T Consensus 172 ~~-~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~ 233 (346)
T d1cm8a_ 172 DS-EMTGYVVTRWYRAPEVILNWM-RYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMK 233 (346)
T ss_dssp CS-SCCSSCSCGGGCCTHHHHTTT-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CC-ccccccccccccCHHHHcCCC-CCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHh
Confidence 53 345567999999999986543 478899999999999999999999999887776655443
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-41 Score=341.30 Aligned_cols=202 Identities=30% Similarity=0.445 Sum_probs=167.2
Q ss_pred ccceeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEEE
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLYI 407 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~L 407 (554)
.++|++++.||+|+||+||+|++.+++.||+|++...... .+.+.+|+.++++++|+|||++++++.+ +.+|+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~------~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~l 88 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS------PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 88 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC------HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCC------HHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEE
Confidence 4789999999999999999999988888999998643221 2468899999999999999999999854 56899
Q ss_pred EEeecccCchHHHHhh---hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC-
Q 008759 408 FLELVTKGSLLNLYQR---YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND- 483 (554)
Q Consensus 408 VmE~~~ggsL~~ll~~---~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~- 483 (554)
||||+.+|+|..++.. ..+++.++..|+.||+.||.|||++||+||||||+||||+.++++||+|||+++......
T Consensus 89 v~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~ 168 (285)
T d1fmka3 89 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 168 (285)
T ss_dssp EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred EEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCc
Confidence 9999999999988764 358999999999999999999999999999999999999999999999999997654332
Q ss_pred --ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHH
Q 008759 484 --VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAI 538 (554)
Q Consensus 484 --~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i 538 (554)
.....||+.|+|||++.... ++.++|||||||++|||+||..||........+
T Consensus 169 ~~~~~~~gt~~y~aPE~~~~~~--~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~ 223 (285)
T d1fmka3 169 TARQGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREV 223 (285)
T ss_dssp -------CCGGGSCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH
T ss_pred eeeccccccccccChHHHhCCC--CCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHH
Confidence 23356899999999996544 899999999999999999965555544443333
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-41 Score=347.05 Aligned_cols=203 Identities=28% Similarity=0.491 Sum_probs=166.6
Q ss_pred cceeeeeeeccCCceeEEEEec-CCCc----EEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCC
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS-DDGF----FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES 403 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~-~~g~----~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~ 403 (554)
++|+++++||+|+||+||+|.+ .+|+ .||+|.+... ......+.+.+|+.++++++|||||++++++.+.
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~- 83 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA----TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS- 83 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC--------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc----cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-
Confidence 4699999999999999999987 4555 4677766532 1222346789999999999999999999998764
Q ss_pred cEEEEEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccccc
Q 008759 404 KLYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL 481 (554)
Q Consensus 404 ~~~LVmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~ 481 (554)
..+++||++.+++|.+++.. ..+++..+..|+.||+.||.|||++|||||||||+|||++.++.+||+|||+++....
T Consensus 84 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 84 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 56788999999999887765 3689999999999999999999999999999999999999999999999999987543
Q ss_pred CC----ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHH
Q 008759 482 ND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAI 538 (554)
Q Consensus 482 ~~----~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i 538 (554)
.. .....||+.|||||++.+. .|+.++|||||||++|||+| |.+||......+..
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~~--~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~ 223 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 223 (317)
T ss_dssp TCC--------CCTTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHH
T ss_pred ccccccccccccCccccChHHHhcC--CCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHH
Confidence 22 2234589999999999765 48999999999999999999 89999887665543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-41 Score=347.43 Aligned_cols=212 Identities=27% Similarity=0.489 Sum_probs=177.0
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCC-
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES- 403 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~- 403 (554)
.+..+|++++.||+|+||+||+|.+ .+|+.||||++.... .....+.+.+|+.+|+.++||||+++++++....
T Consensus 5 ~i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~----~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~ 80 (345)
T d1pmea_ 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE----HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI 80 (345)
T ss_dssp CCCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT----CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred CcCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc----ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccc
Confidence 3456899999999999999999998 789999999986422 2344567889999999999999999999986543
Q ss_pred ---cEEEEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccc
Q 008759 404 ---KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK 480 (554)
Q Consensus 404 ---~~~LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~ 480 (554)
..+++++++.+|+|.++++..++++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~~~~~~l~~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 81 EQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp TTCCCEEEEEECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred cccceEEEEEeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence 23455566778899999998899999999999999999999999999999999999999999999999999997643
Q ss_pred cC-----CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHH
Q 008759 481 LN-----DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKT 542 (554)
Q Consensus 481 ~~-----~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~ 542 (554)
.. ......||+.|+|||++.... .++.++|||||||++|+|++|+.||......+....+.
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~ 226 (345)
T d1pmea_ 161 PDHDHTGFLTEYVATRWYRAPEIMLNSK-GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 226 (345)
T ss_dssp GGGCBCCTTCCCCSCGGGCCGGGTTTBC-SCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred CCCccceeeccccccceechHHHhhcCC-CCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHh
Confidence 22 234456999999999985543 47899999999999999999999999887766655543
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-41 Score=338.26 Aligned_cols=209 Identities=27% Similarity=0.437 Sum_probs=165.4
Q ss_pred ccceeeeeeeccCCceeEEEEecC------CCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhC-CCCceeeeeeecc
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDK 400 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~~------~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIVkl~~~~~ 400 (554)
.++|++++.||+|+||.||+|.+. +++.||+|++.... .....+.+.+|..++.++ +|+||+.+++++.
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~----~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~ 87 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA----THSEHRALMSELKILIHIGHHLNVVNLLGACT 87 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC--------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc----CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeec
Confidence 468999999999999999999852 35789999876321 223345677787777766 6899999999876
Q ss_pred C-CCcEEEEEeecccCchHHHHhhh-----------------cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEE
Q 008759 401 D-ESKLYIFLELVTKGSLLNLYQRY-----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILV 462 (554)
Q Consensus 401 ~-~~~~~LVmE~~~ggsL~~ll~~~-----------------~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILl 462 (554)
. ...+|+||||+.+|+|.++++.. .+++.++..|+.||+.||.|||++|||||||||+||||
T Consensus 88 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl 167 (299)
T d1ywna1 88 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL 167 (299)
T ss_dssp STTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred cCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeE
Confidence 5 45789999999999999998642 37889999999999999999999999999999999999
Q ss_pred cCCCcEEEEecCcccccccC----CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcC-CCCCCCCChhHH
Q 008759 463 DANGSVKLADFGLAKATKLN----DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTS-QIPYAPMECVSA 537 (554)
Q Consensus 463 d~~g~vKL~DFGlA~~~~~~----~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG-~~PF~~~e~~~~ 537 (554)
+.++.+||+|||+++..... ......||+.|||||++.+. .++.++|||||||++|||+|| ..||......+.
T Consensus 168 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~--~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~ 245 (299)
T d1ywna1 168 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 245 (299)
T ss_dssp CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcC--CCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence 99999999999999764332 22345699999999999764 489999999999999999996 568887766665
Q ss_pred HHHHH
Q 008759 538 IFIKT 542 (554)
Q Consensus 538 i~~i~ 542 (554)
+..++
T Consensus 246 ~~~~~ 250 (299)
T d1ywna1 246 FCRRL 250 (299)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 55443
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-40 Score=339.29 Aligned_cols=211 Identities=27% Similarity=0.467 Sum_probs=174.8
Q ss_pred ccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccC-----
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD----- 401 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~----- 401 (554)
.++|++++.||+|+||+||+|++ .+|+.||||++...... ......+.+|+.+|+.++|+||+++++.+..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~ 85 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK---EGFPITALREIKILQLLKHENVVNLIEICRTKASPY 85 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CT---TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc---hHHHHHHHHHHHHHHHhcCCCccceEeeeecccccc
Confidence 57899999999999999999998 78999999998653322 1223567899999999999999999998744
Q ss_pred ---CCcEEEEEeecccCchHHHHhh-hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccc
Q 008759 402 ---ESKLYIFLELVTKGSLLNLYQR-YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477 (554)
Q Consensus 402 ---~~~~~LVmE~~~ggsL~~ll~~-~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~ 477 (554)
.+++|+||||+.++.+..+... ..+++..++.+++||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 86 ~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 86 NRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp -----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceee
Confidence 4568999999998877655443 468999999999999999999999999999999999999999999999999997
Q ss_pred cccc------CCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHH
Q 008759 478 ATKL------NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKT 542 (554)
Q Consensus 478 ~~~~------~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~ 542 (554)
.... ......+||+.|+|||++.+.. .|+.++|||||||++|+|++|+.||.+....+.+..+.
T Consensus 166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~-~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~ 235 (318)
T d3blha1 166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGER-DYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 235 (318)
T ss_dssp ECCC-----CCCCCSCCSCGGGCCHHHHTTCS-SCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred ecccccccccccccceecCHHHhhHHHHcCCC-CCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHH
Confidence 5432 2234457999999999986543 58999999999999999999999999877766655443
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-40 Score=344.19 Aligned_cols=204 Identities=29% Similarity=0.423 Sum_probs=172.9
Q ss_pred ceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeecc------CC
Q 008759 330 YWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDK------DE 402 (554)
Q Consensus 330 ~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~------~~ 402 (554)
.|+.+++||+|+||+||+|++ .+|+.||||++..... .+.+|+.+|++++|+||++++++|. +.
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~---------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~ 91 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 91 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSC
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch---------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCc
Confidence 699999999999999999999 6899999999875322 1237999999999999999999874 33
Q ss_pred CcEEEEEeecccCchHHHHh----hhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCC-cEEEEecCccc
Q 008759 403 SKLYIFLELVTKGSLLNLYQ----RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG-SVKLADFGLAK 477 (554)
Q Consensus 403 ~~~~LVmE~~~ggsL~~ll~----~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g-~vKL~DFGlA~ 477 (554)
.++||||||+.++.+..+.. ...+++..++.|+.||+.||.|||++||+||||||+|||++.++ .+||+|||+++
T Consensus 92 ~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~ 171 (350)
T d1q5ka_ 92 VYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171 (350)
T ss_dssp CEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred eEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchh
Confidence 46899999999875544432 23599999999999999999999999999999999999999875 89999999998
Q ss_pred cccc-CCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHH
Q 008759 478 ATKL-NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTV 543 (554)
Q Consensus 478 ~~~~-~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~ 543 (554)
.... ....+..||+.|+|||++.+.. .|+.++|||||||++|||++|+.||......+.+..+..
T Consensus 172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~ 237 (350)
T d1q5ka_ 172 QLVRGEPNVSYICSRYYRAPELIFGAT-DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 237 (350)
T ss_dssp ECCTTSCCCSCCSCTTSCCHHHHTTCS-SCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHH
T ss_pred hccCCcccccccccccccChHHhhccc-CCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHH
Confidence 6543 3455667999999999986543 589999999999999999999999998888777766543
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-40 Score=337.74 Aligned_cols=208 Identities=26% Similarity=0.421 Sum_probs=176.5
Q ss_pred ccceeeeeeeccCCceeEEEEec------CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccC
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD 401 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~------~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~ 401 (554)
.++|++++.||+|+||+||+|++ .++..||||++.... .....+.+.+|+.+|+.++||||+++++++..
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~----~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 87 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA----SADMQADFQREAALMAEFDNPNIVKLLGVCAV 87 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc----ChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence 46899999999999999999985 346789999886422 23345678999999999999999999999999
Q ss_pred CCcEEEEEeecccCchHHHHhhh-------------------------cCChHHHHHHHHHHHHHHHHHHHCCccccCCc
Q 008759 402 ESKLYIFLELVTKGSLLNLYQRY-------------------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIK 456 (554)
Q Consensus 402 ~~~~~LVmE~~~ggsL~~ll~~~-------------------------~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIK 456 (554)
.+..+++|||+.+|+|.+++... .+++..+..|+.||+.||.|||+++|||||||
T Consensus 88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlK 167 (301)
T d1lufa_ 88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA 167 (301)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEc
Confidence 99999999999999999988642 27888999999999999999999999999999
Q ss_pred cccEEEcCCCcEEEEecCcccccccC----CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCC-CCCCC
Q 008759 457 CANILVDANGSVKLADFGLAKATKLN----DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQ-IPYAP 531 (554)
Q Consensus 457 PeNILld~~g~vKL~DFGlA~~~~~~----~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~-~PF~~ 531 (554)
|+|||++.++.+||+|||+++..... ...+..||+.|+|||++.+.. |+.++|||||||++|||++|. +||..
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~t~ksDVwS~Gvvl~ell~~~~~p~~~ 245 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR--YTTESDVWAYGVVLWEIFSYGLQPYYG 245 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCC--CChhhhhccchhhHHHHHccCCCCCCC
Confidence 99999999999999999999754322 223456889999999997654 899999999999999999985 67887
Q ss_pred CChhHHHHHH
Q 008759 532 MECVSAIFIK 541 (554)
Q Consensus 532 ~e~~~~i~~i 541 (554)
....+.+..+
T Consensus 246 ~~~~e~~~~v 255 (301)
T d1lufa_ 246 MAHEEVIYYV 255 (301)
T ss_dssp SCHHHHHHHH
T ss_pred CCHHHHHHHH
Confidence 7776655443
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-41 Score=335.11 Aligned_cols=204 Identities=25% Similarity=0.464 Sum_probs=168.8
Q ss_pred ccceeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccC-CCcEE
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD-ESKLY 406 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~-~~~~~ 406 (554)
.++|++++.||+|+||.||+|.+. |..||+|+++... ..+.+.+|+.++++++|||||++++++.+ .+.+|
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~-------~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~ 77 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 77 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC---------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCE
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH-------HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEE
Confidence 468999999999999999999985 7789999986321 23568899999999999999999998854 46789
Q ss_pred EEEeecccCchHHHHhhh---cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC
Q 008759 407 IFLELVTKGSLLNLYQRY---HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND 483 (554)
Q Consensus 407 LVmE~~~ggsL~~ll~~~---~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~ 483 (554)
|||||+.+|+|.+++... .+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.....
T Consensus 78 lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~- 156 (262)
T d1byga_ 78 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 156 (262)
T ss_dssp EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC-
Confidence 999999999999998653 4899999999999999999999999999999999999999999999999999765433
Q ss_pred ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHH
Q 008759 484 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIFIKT 542 (554)
Q Consensus 484 ~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i~~i~ 542 (554)
.....+|+.|+|||++.+. .++.++|||||||++|||+| |++||......+.+..+.
T Consensus 157 ~~~~~~~~~y~aPE~l~~~--~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~ 214 (262)
T d1byga_ 157 QDTGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 214 (262)
T ss_dssp -----CCTTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT
T ss_pred CccccccccCCChHHHhCC--CCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH
Confidence 3345689999999999765 48999999999999999998 799998887776655543
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-40 Score=328.91 Aligned_cols=209 Identities=28% Similarity=0.459 Sum_probs=181.1
Q ss_pred ccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCcEE
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESKLY 406 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~~~ 406 (554)
+++|++++.||+|+||+||+|++ .+++.||+|+++.... ......++.+|+.+|+.++||||+++++++.+...++
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 77 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD---DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLT 77 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS---STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC---ChHHHHHHHHHHHHHHhcCcCCEEeecccccccccee
Confidence 36899999999999999999998 7899999999975432 2234577899999999999999999999999999999
Q ss_pred EEEeecccCchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC--C
Q 008759 407 IFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN--D 483 (554)
Q Consensus 407 LVmE~~~ggsL~~ll~~~-~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~--~ 483 (554)
+||+++.+++|..+++.. .+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++..... .
T Consensus 78 iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~ 157 (292)
T d1unla_ 78 LVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp EEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC
T ss_pred EEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCcc
Confidence 999999999998887654 6899999999999999999999999999999999999999999999999999875433 2
Q ss_pred ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHH
Q 008759 484 VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFI 540 (554)
Q Consensus 484 ~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~ 540 (554)
.....+++.|+|||++.... .++.++|||||||++|+|++|+.||.........+.
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~-~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~ 213 (292)
T d1unla_ 158 YSAEVVTLWYRPPDVLFGAK-LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLK 213 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCS-CCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHH
T ss_pred ceeeccccchhhhhHhccCC-CCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHH
Confidence 33455888999999986543 478999999999999999999999877665555444
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-40 Score=334.64 Aligned_cols=213 Identities=29% Similarity=0.450 Sum_probs=179.9
Q ss_pred ccccccceeeeeeeccCCceeEEEEec------CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhC-CCCceeeee
Q 008759 324 FKRIITYWQKGDLLGRGSFGSVYEGIS------DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYY 396 (554)
Q Consensus 324 ~~~~~~~y~i~~~LG~GsfG~VY~a~~------~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIVkl~ 396 (554)
+....++|+++++||+|+||.||+|.+ .+++.||+|++.... .......+.+|+.++..+ +|||||+++
T Consensus 18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~----~~~~~~~~~~E~~~~~~l~~HpnIv~~~ 93 (311)
T d1t46a_ 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA----HLTEREALMSELKVLSYLGNHMNIVNLL 93 (311)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc----CHHHHHHHHHHHHHHHhccCCCCEEEEE
Confidence 433457999999999999999999974 456799999987432 233445788999999998 699999999
Q ss_pred eeccCCCcEEEEEeecccCchHHHHhhh-------------------cCChHHHHHHHHHHHHHHHHHHHCCccccCCcc
Q 008759 397 GTDKDESKLYIFLELVTKGSLLNLYQRY-------------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKC 457 (554)
Q Consensus 397 ~~~~~~~~~~LVmE~~~ggsL~~ll~~~-------------------~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKP 457 (554)
+++.+...+||||||+.+|+|.++++.. .+++..+..|+.||+.||.|||++||+||||||
T Consensus 94 g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp 173 (311)
T d1t46a_ 94 GACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAA 173 (311)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred EEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccc
Confidence 9999999999999999999999998653 378899999999999999999999999999999
Q ss_pred ccEEEcCCCcEEEEecCcccccccCC----ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 008759 458 ANILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPM 532 (554)
Q Consensus 458 eNILld~~g~vKL~DFGlA~~~~~~~----~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~ 532 (554)
+|||++.++.+||+|||+++...... .....||+.|+|||++.+. .++.++|||||||++|||+| |.+||...
T Consensus 174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DIwS~G~~l~ellt~g~p~~~~~ 251 (311)
T d1t46a_ 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC--VYTFESDVWSYGIFLWELFSLGSSPYPGM 251 (311)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred ccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCC--CCCCcccccchHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999998754332 2345689999999999754 48999999999999999999 66667666
Q ss_pred ChhHHHHHHH
Q 008759 533 ECVSAIFIKT 542 (554)
Q Consensus 533 e~~~~i~~i~ 542 (554)
...+.+.++.
T Consensus 252 ~~~~~~~~~i 261 (311)
T d1t46a_ 252 PVDSKFYKMI 261 (311)
T ss_dssp CSSHHHHHHH
T ss_pred CHHHHHHHHH
Confidence 6655555543
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-40 Score=333.61 Aligned_cols=206 Identities=28% Similarity=0.475 Sum_probs=170.2
Q ss_pred ccccceeeeeeeccCCceeEEEEecC--------CCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhC-CCCceeeee
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGISD--------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYY 396 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~~--------~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIVkl~ 396 (554)
...++|++++.||+|+||.||+|++. ++..||+|++.... .......+.+|...+.++ +|||||+++
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~----~~~~~~~~~~e~~~l~~~~~HpnIv~~~ 85 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA----TEKDLSDLISEMEMMKMIGKHKNIINLL 85 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc----ChHHHHHHHHHHHHHHHhcCCCeEEecc
Confidence 34579999999999999999999862 23479999886422 223346678888888887 799999999
Q ss_pred eeccCCCcEEEEEeecccCchHHHHhhh-----------------cCChHHHHHHHHHHHHHHHHHHHCCccccCCcccc
Q 008759 397 GTDKDESKLYIFLELVTKGSLLNLYQRY-----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCAN 459 (554)
Q Consensus 397 ~~~~~~~~~~LVmE~~~ggsL~~ll~~~-----------------~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeN 459 (554)
+++.+++.+|+||||+.+|+|.+++... .+++.++..++.||+.||.|||+++||||||||+|
T Consensus 86 ~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~N 165 (299)
T d1fgka_ 86 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 165 (299)
T ss_dssp EEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred cccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccc
Confidence 9999999999999999999999999643 37899999999999999999999999999999999
Q ss_pred EEEcCCCcEEEEecCcccccccCC----ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCh
Q 008759 460 ILVDANGSVKLADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMEC 534 (554)
Q Consensus 460 ILld~~g~vKL~DFGlA~~~~~~~----~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~ 534 (554)
||++.++.+||+|||+++...... .....+|+.|+|||++.+. .|+.++|||||||++|||++ |.+||.....
T Consensus 166 iLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~--~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~ 243 (299)
T d1fgka_ 166 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR--IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243 (299)
T ss_dssp EEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred eeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCC--CCCchhhhHHhHHHHHHhccCCCCCCCCCCH
Confidence 999999999999999998654332 2345689999999999764 48999999999999999998 7999987776
Q ss_pred hHH
Q 008759 535 VSA 537 (554)
Q Consensus 535 ~~~ 537 (554)
.+.
T Consensus 244 ~~~ 246 (299)
T d1fgka_ 244 EEL 246 (299)
T ss_dssp HHH
T ss_pred HHH
Confidence 543
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-40 Score=339.76 Aligned_cols=212 Identities=29% Similarity=0.461 Sum_probs=177.9
Q ss_pred cccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccC----
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD---- 401 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~---- 401 (554)
+.++|++++.||+|+||+||+|++ .+|+.||||++..... .....+++.+|+.+|+.++|||||++++++..
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~---~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~ 92 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ---SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL 92 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTS---SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSST
T ss_pred CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhc---ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecccc
Confidence 457899999999999999999998 7899999999874322 23345678899999999999999999998753
Q ss_pred -CCcEEEEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccc
Q 008759 402 -ESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATK 480 (554)
Q Consensus 402 -~~~~~LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~ 480 (554)
....+++|+++.+|+|.++++..++++..++.|+.||+.||.|||++||+||||||+|||++.+|.+|++|||++....
T Consensus 93 ~~~~~~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~ 172 (348)
T d2gfsa1 93 EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 172 (348)
T ss_dssp TTCCCCEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCT
T ss_pred ccCceEEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccC
Confidence 3345667778889999999988899999999999999999999999999999999999999999999999999986654
Q ss_pred cCCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHHH
Q 008759 481 LNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKTV 543 (554)
Q Consensus 481 ~~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~~ 543 (554)
. ......||+.|+|||++.+.. .++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 173 ~-~~~~~~g~~~y~apE~~~~~~-~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~ 233 (348)
T d2gfsa1 173 D-EMTGYVATRWYRAPEIMLNWM-HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 233 (348)
T ss_dssp G-GGSSSCHHHHTSCHHHHTTCS-CCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred c-ccccccccccccCchhhcCCc-cCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 3 334566999999999976543 468899999999999999999999998877766655543
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-40 Score=330.79 Aligned_cols=209 Identities=27% Similarity=0.460 Sum_probs=167.7
Q ss_pred cceeeeeeeccCCceeEEEEec--CCC--cEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCCc
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS--DDG--FFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDESK 404 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~--~~g--~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~~ 404 (554)
++|++.+.||+|+||.||+|.+ .++ ..||+|++..... ...+..+.+.+|+.+|++++|||||++++++.+ ..
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~--~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~ 84 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVL--SQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PP 84 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC----------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhc--CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cc
Confidence 5799999999999999999986 233 3689998764322 223445778999999999999999999999965 57
Q ss_pred EEEEEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccC
Q 008759 405 LYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLN 482 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~ 482 (554)
+++||||+.+|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~ 164 (273)
T d1u46a_ 85 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 164 (273)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred hheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccC
Confidence 7899999999999987754 45999999999999999999999999999999999999999999999999999875433
Q ss_pred C-----ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChhHHHHHHH
Q 008759 483 D-----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLT-SQIPYAPMECVSAIFIKT 542 (554)
Q Consensus 483 ~-----~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLT-G~~PF~~~e~~~~i~~i~ 542 (554)
. .....||..|+|||++.+.. ++.++|||||||++|||+| |+.||......+.+..+.
T Consensus 165 ~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~ 228 (273)
T d1u46a_ 165 DDHYVMQEHRKVPFAWCAPESLKTRT--FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID 228 (273)
T ss_dssp CCEEEC-----CCGGGCCHHHHHHCE--EEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH
T ss_pred CCcceecCccccCcccCCHHHHhCCC--CCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHH
Confidence 2 22345788999999997654 8899999999999999998 899999888777665543
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=6e-40 Score=335.59 Aligned_cols=197 Identities=26% Similarity=0.453 Sum_probs=170.9
Q ss_pred ccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCC-CCceeeeeeeccC--CC
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKD--ES 403 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIVkl~~~~~~--~~ 403 (554)
.++|+++++||+|+||+||+|++ .+|+.||+|++.... .+++.+|+.+|..++ ||||++++++|.. ..
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~ 105 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--------KKKIKREIKILENLRGGPNIITLADIVKDPVSR 105 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC--------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTC
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH--------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCC
Confidence 36899999999999999999998 789999999986321 245789999999995 9999999999864 45
Q ss_pred cEEEEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCC-cEEEEecCccccccc-
Q 008759 404 KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG-SVKLADFGLAKATKL- 481 (554)
Q Consensus 404 ~~~LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g-~vKL~DFGlA~~~~~- 481 (554)
.+|+||||+.+++|..+. ..+++..++.+++||+.||.|||++||+||||||+||||+.++ .+||+|||+++....
T Consensus 106 ~~~~v~e~~~~~~L~~~~--~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 106 TPALVFEHVNNTDFKQLY--QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp SEEEEEECCCSCBGGGTT--TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred ceeEEEeecCCCcHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCC
Confidence 799999999999998764 3689999999999999999999999999999999999998655 699999999987544
Q ss_pred CCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChh
Q 008759 482 NDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECV 535 (554)
Q Consensus 482 ~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~ 535 (554)
.......+|+.|+|||++.+.. .++.++|||||||++|+|++|+.||......
T Consensus 184 ~~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~ 236 (328)
T d3bqca1 184 QEYNVRVASRYFKGPELLVDYQ-MYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 236 (328)
T ss_dssp CCCCSCCSCGGGCCHHHHTTCC-CCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH
T ss_pred CcccccccCccccCcccccCCC-CCCcccchhhhhhhhHHhccCCCCCCCCchh
Confidence 3455667999999999986543 4789999999999999999999999876543
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-40 Score=341.82 Aligned_cols=210 Identities=28% Similarity=0.454 Sum_probs=176.4
Q ss_pred ccceeeeeeeccCCceeEEEEec----CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCC-CceeeeeeeccCC
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS----DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH-ENIVQYYGTDKDE 402 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~----~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~H-pnIVkl~~~~~~~ 402 (554)
+++|++++.||+|+||+||+|.+ .+|+.||+|++........ ....+.+.+|+.++++++| |||+++++++.+.
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~-~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~ 101 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQK-AKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 101 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEE-ESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccc-hHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC
Confidence 57899999999999999999975 3588999999864322111 1123457789999999976 8999999999999
Q ss_pred CcEEEEEeecccCchHHHHhhh-cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccccc
Q 008759 403 SKLYIFLELVTKGSLLNLYQRY-HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKL 481 (554)
Q Consensus 403 ~~~~LVmE~~~ggsL~~ll~~~-~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~ 481 (554)
..+|++|||+.+|+|..++... .+.+..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 102 ~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~ 181 (322)
T d1vzoa_ 102 TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA 181 (322)
T ss_dssp TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred CceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhcc
Confidence 9999999999999999998764 688999999999999999999999999999999999999999999999999976432
Q ss_pred C---CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHH
Q 008759 482 N---DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAI 538 (554)
Q Consensus 482 ~---~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i 538 (554)
. ......|++.|++||++.+....++.++|||||||++|+|++|+.||......+..
T Consensus 182 ~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~ 241 (322)
T d1vzoa_ 182 DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ 241 (322)
T ss_dssp GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH
T ss_pred cccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 2 23455699999999999766556788999999999999999999999876544433
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=6.7e-40 Score=331.59 Aligned_cols=198 Identities=22% Similarity=0.336 Sum_probs=169.5
Q ss_pred cccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCC-CceeeeeeeccCCCc
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEH-ENIVQYYGTDKDESK 404 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~H-pnIVkl~~~~~~~~~ 404 (554)
+.++|++++.||+|+||+||+|++ .+|+.||+|++...... ..+.+|++++..+.| +||+.+++++.....
T Consensus 3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-------~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~ 75 (293)
T d1csna_ 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-------PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLH 75 (293)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-------CCHHHHHHHHHHTTTCTTCCCEEEEEEETTE
T ss_pred CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc-------HHHHHHHHHHHHhcCCCCCCEEEEEeecCCc
Confidence 356899999999999999999998 67999999987643221 235678888988875 899999999999999
Q ss_pred EEEEEeecccCchHHHHhh--hcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcC-----CCcEEEEecCccc
Q 008759 405 LYIFLELVTKGSLLNLYQR--YHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA-----NGSVKLADFGLAK 477 (554)
Q Consensus 405 ~~LVmE~~~ggsL~~ll~~--~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~-----~g~vKL~DFGlA~ 477 (554)
.|+||||+ +++|.++++. ..++...+..++.|++.||.|||++||+||||||+|||++. ++.+||+|||+++
T Consensus 76 ~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 76 NVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred cEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeE
Confidence 99999999 5688888865 35899999999999999999999999999999999999964 5789999999998
Q ss_pred ccccC---------CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh
Q 008759 478 ATKLN---------DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMEC 534 (554)
Q Consensus 478 ~~~~~---------~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~ 534 (554)
..... ......||+.|||||++.+. .++.++|||||||++|||+||+.||.+...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~--~~~~~~DiwSlG~~l~elltg~~Pf~~~~~ 218 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGR--EQSRRDDLEALGHVFMYFLRGSLPWQGLKA 218 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCS
T ss_pred EcccCccccceeecccCceEEchhhcCHHHhcCC--CCChHHHHHHhhHHHHHHHhCCCcCCCccc
Confidence 64322 23345799999999999764 489999999999999999999999986543
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-40 Score=334.37 Aligned_cols=207 Identities=28% Similarity=0.509 Sum_probs=170.3
Q ss_pred ccceeeeeeeccCCceeEEEEec-CCCc--EEEEEEEecccccchhHHHHHHHHHHHHHHHhC-CCCceeeeeeeccCCC
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGIS-DDGF--FFAVKEVSLLDQGSQAKQSISQLEQEIALLSRF-EHENIVQYYGTDKDES 403 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~-~~g~--~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIVkl~~~~~~~~ 403 (554)
.++|+++++||+|+||+||+|.+ .++. .||+|.+... ......+.+.+|+.+|+++ +|||||++++++.+.+
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~ 84 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY----ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 84 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC----------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcc----cChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC
Confidence 36899999999999999999998 4555 4566766432 1223456789999999998 7999999999999999
Q ss_pred cEEEEEeecccCchHHHHhhh-----------------cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCC
Q 008759 404 KLYIFLELVTKGSLLNLYQRY-----------------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANG 466 (554)
Q Consensus 404 ~~~LVmE~~~ggsL~~ll~~~-----------------~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g 466 (554)
.+|+||||+.+|+|.++++.. .+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 164 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC
Confidence 999999999999999998642 488999999999999999999999999999999999999999
Q ss_pred cEEEEecCcccccccCC-ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCC-CCCCCCChhHHHHH
Q 008759 467 SVKLADFGLAKATKLND-VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQ-IPYAPMECVSAIFI 540 (554)
Q Consensus 467 ~vKL~DFGlA~~~~~~~-~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~-~PF~~~e~~~~i~~ 540 (554)
.+||+|||+++...... .....||..|+|||.+.+.. |+.++|||||||++|||++|. +||......+....
T Consensus 165 ~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~ 238 (309)
T d1fvra_ 165 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 238 (309)
T ss_dssp CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCE--ECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH
T ss_pred ceEEccccccccccccccccceecCCcccchHHhccCC--CCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 99999999997654332 23456899999999997654 899999999999999999965 57777665554433
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-39 Score=336.52 Aligned_cols=209 Identities=27% Similarity=0.412 Sum_probs=169.2
Q ss_pred cccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccC----
Q 008759 327 IITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD---- 401 (554)
Q Consensus 327 ~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~---- 401 (554)
+.++|+++++||+|+||+||+|++ .+|+.||||++..... ......++.+|+.+|+.++|||||+++++|..
T Consensus 15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~---~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~ 91 (355)
T d2b1pa1 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ---NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL 91 (355)
T ss_dssp EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS---SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCST
T ss_pred ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc---CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccccc
Confidence 457899999999999999999998 6799999999975332 23445678899999999999999999999853
Q ss_pred --CCcEEEEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccccc
Q 008759 402 --ESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKAT 479 (554)
Q Consensus 402 --~~~~~LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~ 479 (554)
..++|+||||+.++.+..+ . ..+++..++.+++||+.||.|||++||+||||||+|||++.++.+|++|||+++..
T Consensus 92 ~~~~~~~iv~Ey~~~~l~~~~-~-~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~ 169 (355)
T d2b1pa1 92 EEFQDVYLVMELMDANLCQVI-Q-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_dssp TTCCEEEEEEECCSEEHHHHH-T-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred ccCceeEEEEeccchHHHHhh-h-cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcc
Confidence 4689999999988655544 3 46899999999999999999999999999999999999999999999999998765
Q ss_pred ccC-CccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHHHHHHH
Q 008759 480 KLN-DVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSAIFIKT 542 (554)
Q Consensus 480 ~~~-~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~i~~i~ 542 (554)
... ......+|+.|+|||++.+. .++.++|||||||++|+|++|++||...+......++.
T Consensus 170 ~~~~~~~~~~~t~~y~aPE~l~~~--~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~ 231 (355)
T d2b1pa1 170 GTSFMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 231 (355)
T ss_dssp -----------CCTTCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred ccccccccccccccccChhhhcCC--CCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHH
Confidence 443 33455699999999999764 48899999999999999999999999887766665554
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-40 Score=333.56 Aligned_cols=197 Identities=28% Similarity=0.375 Sum_probs=163.6
Q ss_pred ccceeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccCCC----
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKDES---- 403 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~~~---- 403 (554)
...|.+.+.||+|+||.||+|++ +|+.||+|++.... ......+.|+..+..++|||||++++++.+.+
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~------~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~ 74 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 74 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc------hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcce
Confidence 46789999999999999999986 58899999886321 11122334566667789999999999987543
Q ss_pred cEEEEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHH--------CCccccCCccccEEEcCCCcEEEEecCc
Q 008759 404 KLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHD--------QDVVHRDIKCANILVDANGSVKLADFGL 475 (554)
Q Consensus 404 ~~~LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs--------~gIIHrDIKPeNILld~~g~vKL~DFGl 475 (554)
.+||||||+.+|+|.+++++..+++..+..++.|++.||.|||+ +||+||||||+||||+.++.+||+|||+
T Consensus 75 ~~~lv~Ey~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 75 QLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEEEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 68999999999999999999899999999999999999999996 5999999999999999999999999999
Q ss_pred ccccccCC------ccCccCCCcccChhhhcccCC----CCCchhhHHHHHHHHHHHHcCCCCCCC
Q 008759 476 AKATKLND------VKSCRGTAFWMAPEVINNKNK----GYGLPADIWSLGCTVLEMLTSQIPYAP 531 (554)
Q Consensus 476 A~~~~~~~------~~s~~GT~~Y~APEvl~~~~~----~~s~ksDIwSLGvllyeLLTG~~PF~~ 531 (554)
++...... .....||+.|||||++.+... .++.++|||||||++|||+||..||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~ 220 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 220 (303)
T ss_dssp CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCc
Confidence 98654322 234569999999999865422 156789999999999999999988743
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-39 Score=330.07 Aligned_cols=208 Identities=25% Similarity=0.414 Sum_probs=176.8
Q ss_pred ccceeeeeeeccCCceeEEEEecC------CCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccC
Q 008759 328 ITYWQKGDLLGRGSFGSVYEGISD------DGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD 401 (554)
Q Consensus 328 ~~~y~i~~~LG~GsfG~VY~a~~~------~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~ 401 (554)
.++|++++.||+|+||+||+|.+. ++..||||++.... .......+.+|+.++++++|||||++++++..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~----~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~ 94 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA----SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 94 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS----CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc----ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence 478999999999999999999863 35789999886321 23344678899999999999999999999999
Q ss_pred CCcEEEEEeecccCchHHHHhhh-----------cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEE
Q 008759 402 ESKLYIFLELVTKGSLLNLYQRY-----------HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKL 470 (554)
Q Consensus 402 ~~~~~LVmE~~~ggsL~~ll~~~-----------~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL 470 (554)
.+..++||||+.+|+|.+++... .+++..+..++.|++.||.|||+++|+||||||+|||++.++++||
T Consensus 95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl 174 (308)
T d1p4oa_ 95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 174 (308)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEE
T ss_pred CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEE
Confidence 99999999999999999988642 2577889999999999999999999999999999999999999999
Q ss_pred EecCcccccccCC----ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcC-CCCCCCCChhHHHHHH
Q 008759 471 ADFGLAKATKLND----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTS-QIPYAPMECVSAIFIK 541 (554)
Q Consensus 471 ~DFGlA~~~~~~~----~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG-~~PF~~~e~~~~i~~i 541 (554)
+|||+++...... .....||+.|+|||.+.+.. ++.++|||||||++|||+|| .+||......+.+..+
T Consensus 175 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~--~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i 248 (308)
T d1p4oa_ 175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV--FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 248 (308)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC--CCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH
T ss_pred eecccceeccCCcceeeccceecccccCCHHHHccCC--CCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 9999997653322 23345899999999997654 88999999999999999998 5788877766655444
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7e-39 Score=323.52 Aligned_cols=202 Identities=23% Similarity=0.336 Sum_probs=164.4
Q ss_pred ccccceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCc-eeeeeeeccCCC
Q 008759 326 RIITYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHEN-IVQYYGTDKDES 403 (554)
Q Consensus 326 ~~~~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hpn-IVkl~~~~~~~~ 403 (554)
++.++|++++.||+|+||+||+|++ .+|+.||||++...... ..+..|+++++.++|+| |+.+++++.+.+
T Consensus 4 ~vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-------~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~ 76 (299)
T d1ckia_ 4 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-------PQLHIESKIYKMMQGGVGIPTIRWCGAEGD 76 (299)
T ss_dssp EETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-------CCHHHHHHHHHHSTTSTTCCCEEEEEEETT
T ss_pred eECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-------HHHHHHHHHHHHccCCCcccEEEEEEecCC
Confidence 3456899999999999999999998 77999999988753221 24678999999998766 555566677888
Q ss_pred cEEEEEeecccCchHHHHh--hhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcC---CCcEEEEecCcccc
Q 008759 404 KLYIFLELVTKGSLLNLYQ--RYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDA---NGSVKLADFGLAKA 478 (554)
Q Consensus 404 ~~~LVmE~~~ggsL~~ll~--~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~---~g~vKL~DFGlA~~ 478 (554)
..++||||+.+ +|...+. ...+++..+..++.|++.||+|||++|||||||||+|||++. +..+||+|||+++.
T Consensus 77 ~~~ivme~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~ 155 (299)
T d1ckia_ 77 YNVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 155 (299)
T ss_dssp EEEEEEECCCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEE
T ss_pred EEEEEEEEcCC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCccee
Confidence 99999999966 4555443 246999999999999999999999999999999999999864 45799999999986
Q ss_pred cccCC---------ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChhHH
Q 008759 479 TKLND---------VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPMECVSA 537 (554)
Q Consensus 479 ~~~~~---------~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e~~~~ 537 (554)
..... .....||+.|||||++.+.. ++.++|||||||++|||+||+.||......+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~ 221 (299)
T d1ckia_ 156 YRDARTHQHIPYRENKNLTGTARYASINTHLGIE--QSRRDDLESLGYVLMYFNLGSLPWQGLKAATK 221 (299)
T ss_dssp CBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBC--CCHHHHHHHHHHHHHHHHHSSCTTCCCC----
T ss_pred ccccccccceeccccCCcCCCccccCHHHHhCCC--CCChhhEEecCHHHHHHHhCCCcccccchHHH
Confidence 54321 23457999999999997654 89999999999999999999999987655443
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-39 Score=326.40 Aligned_cols=195 Identities=28% Similarity=0.484 Sum_probs=164.3
Q ss_pred eeeeeeccCCceeEEEEecCC----CcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCceeeeeeeccC-CCcEE
Q 008759 332 QKGDLLGRGSFGSVYEGISDD----GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENIVQYYGTDKD-ESKLY 406 (554)
Q Consensus 332 ~i~~~LG~GsfG~VY~a~~~~----g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~~~~~-~~~~~ 406 (554)
+..++||+|+||+||+|.+.. ...||||++... ......+++.+|+.+|++++|||||++++++.. +..++
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~----~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~ 105 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI----TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 105 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC----CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc----cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceE
Confidence 336789999999999998732 236899988632 234456789999999999999999999998764 56899
Q ss_pred EEEeecccCchHHHHhhh--cCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCcccccccCC-
Q 008759 407 IFLELVTKGSLLNLYQRY--HLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAKATKLND- 483 (554)
Q Consensus 407 LVmE~~~ggsL~~ll~~~--~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~~~~~~~- 483 (554)
+||||+.+|+|.+++... .+.+..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++......
T Consensus 106 lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 106 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred EEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 999999999999988754 46678889999999999999999999999999999999999999999999998654332
Q ss_pred -----ccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 008759 484 -----VKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPM 532 (554)
Q Consensus 484 -----~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~ 532 (554)
.....||+.|+|||++.... ++.++|||||||++|||+||..||...
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDI~SfGivl~El~t~~~p~~~~ 237 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQK--FTTKSDVWSFGVLLWELMTRGAPPYPD 237 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCC--CCHHHHHHHHHHHHHHHHTTSCCSCC-
T ss_pred ccceecccccccccccChHHHhcCC--CCChhHhhhhHHHHHHHHHCCCCCCCC
Confidence 22345899999999987644 899999999999999999987777654
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=8.2e-34 Score=292.01 Aligned_cols=196 Identities=27% Similarity=0.379 Sum_probs=156.0
Q ss_pred cceeeeeeeccCCceeEEEEec-CCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCC-----------CCceeeee
Q 008759 329 TYWQKGDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-----------HENIVQYY 396 (554)
Q Consensus 329 ~~y~i~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~-----------HpnIVkl~ 396 (554)
++|+++++||+|+||+||+|++ .+|+.||||++... ....+.+.+|+.+++.++ |+||++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~------~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~ 86 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD------KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL 86 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC------HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc------ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEE
Confidence 4699999999999999999998 78999999998742 122345677888887765 57899999
Q ss_pred eeccC--CCcEEEEEeecccCchHHHHh----hhcCChHHHHHHHHHHHHHHHHHHH-CCccccCCccccEEEcCCCc--
Q 008759 397 GTDKD--ESKLYIFLELVTKGSLLNLYQ----RYHLRDSQVSAYTRQILLGLKYLHD-QDVVHRDIKCANILVDANGS-- 467 (554)
Q Consensus 397 ~~~~~--~~~~~LVmE~~~ggsL~~ll~----~~~l~e~~i~~i~~QIl~gL~yLHs-~gIIHrDIKPeNILld~~g~-- 467 (554)
+++.. ....+++|+++..+....... ...+.+..++.++.||+.||.|||+ .||+||||||+||||+.++.
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 87 DHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp EEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred EEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccc
Confidence 88754 356677777765554333221 2468889999999999999999998 89999999999999987653
Q ss_pred ----EEEEecCcccccccCCccCccCCCcccChhhhcccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 008759 468 ----VKLADFGLAKATKLNDVKSCRGTAFWMAPEVINNKNKGYGLPADIWSLGCTVLEMLTSQIPYAPME 533 (554)
Q Consensus 468 ----vKL~DFGlA~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~s~ksDIwSLGvllyeLLTG~~PF~~~e 533 (554)
++|+|||.+...... .....||+.|+|||++... .|+.++|||||||++++|++|+.||.+.+
T Consensus 167 ~~~~~kl~dfg~s~~~~~~-~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~el~~g~~pF~~~~ 233 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDEH-YTNSIQTREYRSPEVLLGA--PWGCGADIWSTACLIFELITGDFLFEPDE 233 (362)
T ss_dssp TEEEEEECCCTTCEETTBC-CCSCCSCGGGCCHHHHHTC--CCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred ccceeeEeecccccccccc-cccccccccccChhhcccc--CCCccccccchHHHHHHHHHCCCCCCCCc
Confidence 999999998765433 3456799999999999754 48899999999999999999999998654
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.91 E-value=2.7e-25 Score=209.57 Aligned_cols=169 Identities=18% Similarity=0.178 Sum_probs=125.1
Q ss_pred eeeeeeeccCCceeEEEEecCCCcEEEEEEEecccc-------------cchhHHHHHHHHHHHHHHHhCCCCceeeeee
Q 008759 331 WQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQ-------------GSQAKQSISQLEQEIALLSRFEHENIVQYYG 397 (554)
Q Consensus 331 y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~-------------~~~~~~~~~~~~~Ei~iL~~l~HpnIVkl~~ 397 (554)
+.++++||+|+||+||+|.+.+|+.||+|+++.... .............|+..+.++.|.+++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 467899999999999999998899999998753110 0111222344567889999999999999887
Q ss_pred eccCCCcEEEEEeecccCchHHHHhhhcCChHHHHHHHHHHHHHHHHHHHCCccccCCccccEEEcCCCcEEEEecCccc
Q 008759 398 TDKDESKLYIFLELVTKGSLLNLYQRYHLRDSQVSAYTRQILLGLKYLHDQDVVHRDIKCANILVDANGSVKLADFGLAK 477 (554)
Q Consensus 398 ~~~~~~~~~LVmE~~~ggsL~~ll~~~~l~e~~i~~i~~QIl~gL~yLHs~gIIHrDIKPeNILld~~g~vKL~DFGlA~ 477 (554)
+.. .+++|||+.+..+. .+....+..++.||+.+|.|||++||+||||||+|||++.+ .++|+|||+|+
T Consensus 82 ~~~----~~lvme~~~~~~~~------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~a~ 150 (191)
T d1zara2 82 WEG----NAVLMELIDAKELY------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQSV 150 (191)
T ss_dssp EET----TEEEEECCCCEEGG------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTTCE
T ss_pred ecC----CEEEEEeecccccc------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCCcc
Confidence 643 37999999987653 35566677899999999999999999999999999999865 58999999987
Q ss_pred ccccCCccCccCCCcccCh------hhhcccCCCCCchhhHHHHHHHH
Q 008759 478 ATKLNDVKSCRGTAFWMAP------EVINNKNKGYGLPADIWSLGCTV 519 (554)
Q Consensus 478 ~~~~~~~~s~~GT~~Y~AP------Evl~~~~~~~s~ksDIwSLGvll 519 (554)
........ .|+.. +.+ .+.|+.++|+||+.--+
T Consensus 151 ~~~~~~~~------~~l~rd~~~~~~~f---~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 151 EVGEEGWR------EILERDVRNIITYF---SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp ETTSTTHH------HHHHHHHHHHHHHH---HHHHCCCCCHHHHHHHH
T ss_pred cCCCCCcH------HHHHHHHHHHHHHH---cCCCCCcccHHHHHHHH
Confidence 65433221 12211 122 12377889999985443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.34 E-value=5.2e-07 Score=85.85 Aligned_cols=90 Identities=11% Similarity=0.080 Sum_probs=58.8
Q ss_pred ccccccceeeeeeeccCCceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCC-CCceeeeeeeccCC
Q 008759 324 FKRIITYWQKGDLLGRGSFGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDE 402 (554)
Q Consensus 324 ~~~~~~~y~i~~~LG~GsfG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIVkl~~~~~~~ 402 (554)
.+..+..|+..+..+.++.+.||+.... ++.+++|........ ....+.+|..++..+. +--+.+++.++...
T Consensus 9 l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~-----~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~ 82 (263)
T d1j7la_ 9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKG-----TTYDVEREKDMMLWLEGKLPVPKVLHFERHD 82 (263)
T ss_dssp HHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGTT-----STTCHHHHHHHHHHHTTTSCCCCEEEEEEET
T ss_pred HHHhhhceEEEEcCCCCCCCcEEEEEeC-CCeEEEEEcCCCccc-----chhhHHHHHHHHHHHhccCCCCcEEEEEecC
Confidence 3445567777776665666789998654 556677876532211 1223567777776664 32255677777777
Q ss_pred CcEEEEEeecccCchHH
Q 008759 403 SKLYIFLELVTKGSLLN 419 (554)
Q Consensus 403 ~~~~LVmE~~~ggsL~~ 419 (554)
+..|+||+++.|.++..
T Consensus 83 ~~~~lv~~~l~G~~~~~ 99 (263)
T d1j7la_ 83 GWSNLLMSEADGVLCSE 99 (263)
T ss_dssp TEEEEEEECCSSEEHHH
T ss_pred CceEEEEEecccccccc
Confidence 88999999999987754
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.99 E-value=1.6e-05 Score=74.86 Aligned_cols=134 Identities=18% Similarity=0.119 Sum_probs=81.6
Q ss_pred eeccCC-ceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCC--ceeeeeeeccCCCcEEEEEeec
Q 008759 336 LLGRGS-FGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHE--NIVQYYGTDKDESKLYIFLELV 412 (554)
Q Consensus 336 ~LG~Gs-fG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hp--nIVkl~~~~~~~~~~~LVmE~~ 412 (554)
.+..|. -+.||+....++..+++|....... ..+..|...++.+... .+.+++.+..+.+..|+||+++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~--------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i 88 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL--------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV 88 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT--------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH--------hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEee
Confidence 344554 3679999888888899997653221 1245666666665432 2566777777888899999999
Q ss_pred ccCchHH--------------HHhhhc--------CCh--HHHH-HH---H----------------HHHHHHHHHHHHC
Q 008759 413 TKGSLLN--------------LYQRYH--------LRD--SQVS-AY---T----------------RQILLGLKYLHDQ 448 (554)
Q Consensus 413 ~ggsL~~--------------ll~~~~--------l~e--~~i~-~i---~----------------~QIl~gL~yLHs~ 448 (554)
+|.++.. ++.+-+ +.. .... .. . ......+..+...
T Consensus 89 ~G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 168 (255)
T d1nd4a_ 89 PGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKAR 168 (255)
T ss_dssp SSEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHT
T ss_pred eccccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHh
Confidence 8865421 111100 000 0000 00 0 0012233444432
Q ss_pred -------CccccCCccccEEEcCCCcEEEEecCccc
Q 008759 449 -------DVVHRDIKCANILVDANGSVKLADFGLAK 477 (554)
Q Consensus 449 -------gIIHrDIKPeNILld~~g~vKL~DFGlA~ 477 (554)
.++|+|+.|.|||++.++.+-|+||+.+.
T Consensus 169 ~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 169 MPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp CCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred CCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 27999999999999877667899999764
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.79 E-value=1.9e-05 Score=80.66 Aligned_cols=81 Identities=15% Similarity=0.182 Sum_probs=47.7
Q ss_pred eeeeccCCceeEEEEec-CCCcEEEEEEEecccc--cchhHHHHHHHHHHHHHHHhCC-C--CceeeeeeeccCCCcEEE
Q 008759 334 GDLLGRGSFGSVYEGIS-DDGFFFAVKEVSLLDQ--GSQAKQSISQLEQEIALLSRFE-H--ENIVQYYGTDKDESKLYI 407 (554)
Q Consensus 334 ~~~LG~GsfG~VY~a~~-~~g~~vAvK~v~~~~~--~~~~~~~~~~~~~Ei~iL~~l~-H--pnIVkl~~~~~~~~~~~L 407 (554)
.+.||.|....||++.+ .+++.+++|....... .........+...|...|..+. + ..+.+++.+. ....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEE
Confidence 34689999999999988 4467899986542111 0000111223446777776553 2 3456666653 345678
Q ss_pred EEeecccCc
Q 008759 408 FLELVTKGS 416 (554)
Q Consensus 408 VmE~~~ggs 416 (554)
|||++.+..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997754
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.04 E-value=0.00071 Score=66.53 Aligned_cols=69 Identities=13% Similarity=0.066 Sum_probs=43.3
Q ss_pred ceeEEEEecCCCcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCCCCce--eeeee-----eccCCCcEEEEEeeccc
Q 008759 342 FGSVYEGISDDGFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFEHENI--VQYYG-----TDKDESKLYIFLELVTK 414 (554)
Q Consensus 342 fG~VY~a~~~~g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnI--Vkl~~-----~~~~~~~~~LVmE~~~g 414 (554)
-..||++...+|..|++|+...... ...++..|+..+..|...+| +..+. .+......+.+++++.|
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~~------s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPERW------TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTTS------CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred cceeEEEEcCCCCEEEEEEeCCCCC------CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 4689999999999999998763211 12446677777766642222 11111 12335568889999887
Q ss_pred Cc
Q 008759 415 GS 416 (554)
Q Consensus 415 gs 416 (554)
..
T Consensus 109 ~~ 110 (325)
T d1zyla1 109 RQ 110 (325)
T ss_dssp EE
T ss_pred cC
Confidence 43
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.72 E-value=0.0024 Score=64.25 Aligned_cols=73 Identities=11% Similarity=0.002 Sum_probs=47.3
Q ss_pred eeeeccCCceeEEEEecCC--------CcEEEEEEEecccccchhHHHHHHHHHHHHHHHhCC-CCceeeeeeeccCCCc
Q 008759 334 GDLLGRGSFGSVYEGISDD--------GFFFAVKEVSLLDQGSQAKQSISQLEQEIALLSRFE-HENIVQYYGTDKDESK 404 (554)
Q Consensus 334 ~~~LG~GsfG~VY~a~~~~--------g~~vAvK~v~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIVkl~~~~~~~~~ 404 (554)
++.|+.|-...+|++...+ ...|++++.-. ... .....+|..+++.+. +.-..++++++..
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~------~idr~~E~~i~~~ls~~gl~Pkll~~~~~--- 116 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PET------ESHLVAESVIFTLLSERHLGPKLYGIFSG--- 116 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCC------HHHHHHHHHHHHHHHHTTSSSCEEEEETT---
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cch------hhHHHHHHHHHHHHHhCCCCCeEEEEcCC---
Confidence 4678889999999987533 34566666542 111 122446777777775 3334578887754
Q ss_pred EEEEEeecccCch
Q 008759 405 LYIFLELVTKGSL 417 (554)
Q Consensus 405 ~~LVmE~~~ggsL 417 (554)
++||||+.|..|
T Consensus 117 -g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 -GRLEEYIPSRPL 128 (395)
T ss_dssp -EEEECCCCEEEC
T ss_pred -ceEEEEeccccC
Confidence 689999987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.59 E-value=0.003 Score=60.99 Aligned_cols=30 Identities=27% Similarity=0.318 Sum_probs=26.9
Q ss_pred CCccccCCccccEEEcCCCcEEEEecCccc
Q 008759 448 QDVVHRDIKCANILVDANGSVKLADFGLAK 477 (554)
Q Consensus 448 ~gIIHrDIKPeNILld~~g~vKL~DFGlA~ 477 (554)
.|+||+|+.++|||++.+...-|+||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 469999999999999988777899999875
|